PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Musteata, M; Nicolescu, A; Solcan, G; Deleanu, C				Musteata, Mihai; Nicolescu, Alina; Solcan, Gheorghe; Deleanu, Calin			The H-1 NMR Profile of Healthy Dog Cerebrospinal Fluid	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HIGH-RESOLUTION H-1-NMR; TRAUMATIC BRAIN-INJURY; MASS-SPECTROMETRY; METABOLITE CONCENTRATIONS; SUBARACHNOID HEMORRHAGE; PYRUVATE CONCENTRATIONS; PORTOSYSTEMIC SHUNTS; HUMAN PLASMA; AMINO-ACIDS	The availability of data for reference values in cerebrospinal fluid for healthy humans is limited due to obvious practical and ethical issues. The variability of reported values for metabolites in human cerebrospinal fluid is quite large. Dogs present great similarities with humans, including in cases of central nervous system pathologies. The paper presents the first study on healthy dog cerebrospinal fluid metabolomic profile using H-1 NMR spectroscopy. A number of 13 metabolites have been identified and quantified from cerebrospinal fluid collected from a group of 10 mix breed healthy dogs. The biological variability as resulting from the relative standard deviation of the physiological concentrations of the identified metabolites had a mean of 18.20% (range between 9.3% and 44.8%). The reported concentrations for metabolites may be used as normal reference values. The homogeneity of the obtained results and the low biologic variability show that the 1H NMR analysis of the dog's cerebrospinal fluid is reliable in designing and interpreting clinical and therapeutic trials in dogs with central nervous system pathologies.	[Musteata, Mihai; Solcan, Gheorghe] Univ Agr Sci & Vet Med Iasi, Fac Vet Med, Clin Dept, Iasi, Romania; [Nicolescu, Alina; Deleanu, Calin] Roumanian Acad, Inst Macromol Chem, Grp Biospect, Iasi, Romania; [Nicolescu, Alina; Deleanu, Calin] Roumanian Acad, Ctr Organ Chem, Grp Biospect, Bucharest, Romania	Ion Ionescu de la Brad Iasi University of Life Sciences; Romanian Academy of Sciences; Petru Poni Institute of Macromolecular Chemistry; Romanian Academy of Sciences	Deleanu, C (corresponding author), Roumanian Acad, Inst Macromol Chem, Grp Biospect, Iasi, Romania.	calin.deleanu@yahoo.com	Deleanu, Calin/G-7446-2011; Musteata, Mihai/B-7144-2011; Nicolescu, Alina/M-8562-2017	Deleanu, Calin/0000-0001-8206-5227; Nicolescu, Alina/0000-0001-7022-8893; Musteata, Mihai/0000-0002-8371-9170; Solcan, Gheorghe/0000-0002-3067-9574	Romanian National Authority for Scientific Research, (CNCS-UEFISCDI) [PD 628/2010, PN-II-ID-PCCE-2011-2-0045]	Romanian National Authority for Scientific Research, (CNCS-UEFISCDI)(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	The research was supported by the Romanian National Authority for Scientific Research, (CNCS-UEFISCDI), through grants PD 628/2010 and PN-II-ID-PCCE-2011-2-0045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasly J, 1997, ACTA NEUROL SCAND, V95, P9, DOI 10.1111/j.1600-0404.1997.tb00060.x; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bechter K, 2011, NEUROL PSYCHIAT BR, V17, P51, DOI 10.1016/j.npbr.2011.06.003; Benoist JF, 2003, CLIN CHEM, V49, P487, DOI 10.1373/49.3.487; Blasco H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013223; Butterworth J, 1997, METAB BRAIN DIS, V12, P299, DOI 10.1023/A:1022378209979; Ciurtin C, 2007, REV CHIM-BUCHAREST, V58, P51; COMMODARI F, 1991, NMR BIOMED, V4, P192, DOI 10.1002/nbm.1940040407; Crews B, 2009, ANAL CHEM, V81, P8538, DOI 10.1021/ac9014947; Dawidowicz AL, 2003, BIOMED CHROMATOGR, V17, P447, DOI 10.1002/bmc.269; Dekker LJ, 2005, MOL CELL PROTEOMICS, V4, P1341, DOI 10.1074/mcp.M500081-MCP200; Di Terlizzi R, 2006, VET J, V172, P422, DOI 10.1016/j.tvjl.2005.07.021; Dunne VG, 2005, NMR BIOMED, V18, P24, DOI 10.1002/nbm.918; Ellenberger C, 2004, AM J VET RES, V65, P1108, DOI 10.2460/ajvr.2004.65.1108; Gomez-Mancilla B, 2005, NeuroRx, V2, P683, DOI 10.1602/neurorx.2.4.683; Holmes Elaine, 2006, NeuroRx, V3, P358, DOI 10.1016/j.nurx.2006.05.004; Holt DE, 2002, AM J VET RES, V63, P1167, DOI 10.2460/ajvr.2002.63.1167; Hong L, 2011, J PHARMACEUT BIOMED, V54, P1101, DOI 10.1016/j.jpba.2010.11.031; Hutchesson A, 1997, CLIN CHEM, V43, P158; Iwabuchi T, 1973, STROKE, V4, P207, DOI 10.1161/01.STR.4.2.207; Jukarainen NM, 2008, METABOLOMICS, V4, P150, DOI 10.1007/s11306-008-0106-6; KOSCHOREK F, 1993, NEUROSURG REV, V16, P307, DOI 10.1007/BF00383842; Kosicek M, 2010, ANAL BIOANAL CHEM, V398, P2929, DOI 10.1007/s00216-010-4273-8; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Levine J, 2000, BIOL PSYCHIAT, V47, P586, DOI 10.1016/S0006-3223(99)00284-X; Levine J, 2000, J NEURAL TRANSM, V107, P843, DOI 10.1007/s007020070064; Li FY, 2006, NEUROBIOL DIS, V21, P35, DOI 10.1016/j.nbd.2005.06.009; Lindon JC, 2003, ANAL CHEM, V75, p384A, DOI 10.1021/ac031386+; Lutz NW, 1998, FEBS LETT, V425, P345, DOI 10.1016/S0014-5793(98)00262-2; Maillet S, 1998, BRAIN RES PROTOC, V3, P123, DOI 10.1016/S1385-299X(98)00033-6; Mandal R, 2012, GENOME MED, V4, DOI 10.1186/gm337; MELLERUP ET, 1981, ACTA PSYCHIAT SCAND, V63, P57, DOI 10.1111/j.1600-0447.1981.tb00650.x; Mishur RJ, 2012, MASS SPECTROM REV, V31, P70, DOI 10.1002/mas.20338; Nagashima H, 2010, EUR SPINE J, V19, P1363, DOI 10.1007/s00586-010-1453-3; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicolescu A, 2012, REV ROUM CHIM, V57, P653; Nicolescu A, 2011, REV CHIM-BUCHAREST, V62, P1150; Oliver SG, 1997, MICROBIOL-UK, V143, P1483, DOI 10.1099/00221287-143-5-1483; Oreskovic D, 2010, BRAIN RES REV, V64, P241, DOI 10.1016/j.brainresrev.2010.04.006; Pugliese M, 2005, PROG NEURO-PSYCHOPH, V29, P603, DOI 10.1016/j.pnpbp.2005.01.017; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; Salomon RM, 2003, BIOL PSYCHIAT, V54, P96, DOI 10.1016/S0006-3223(02)01740-7; Satoh H, 2007, BRAIN RES, V1133, P200, DOI 10.1016/j.brainres.2006.11.039; Silverstone PH, 2005, BIPOLAR DISORD, V7, P1, DOI 10.1111/j.1399-5618.2004.00174.x; Sinclair AJ, 2010, NMR BIOMED, V23, P123, DOI 10.1002/nbm.1428; SMITH AR, 1978, ANN SURG, V187, P343, DOI 10.1097/00000658-197803000-00024; Stefan LI, 2010, REV ROUM CHIM, V55, P1033; Stoop MP, 2010, MOL CELL PROTEOMICS, V9, P2063, DOI 10.1074/mcp.M900877-MCP200; Subramanian A, 2005, NMR BIOMED, V18, P213, DOI 10.1002/nbm.944; SUGI T, 1975, STROKE, V6, P715, DOI 10.1161/01.STR.6.6.715; TALLAKSEN CME, 1992, AM J CLIN NUTR, V56, P559, DOI 10.1093/ajcn/56.3.559; Tarnaris Andrew, 2006, Cerebrospinal Fluid Res, V3, P11, DOI 10.1186/1743-8454-3-11; Toczylowska B, 2006, BRAIN RES, V1104, P183, DOI 10.1016/j.brainres.2006.05.057; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; WEVERS RA, 1995, CLIN CHEM, V41, P744; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Witsberger TH, 2012, JAVMA-J AM VET MED A, V240, P555, DOI 10.2460/javma.240.5.555; Wolowicka L, 1975, Resuscitation, V4, P33, DOI 10.1016/0300-9572(75)90062-3; Wuolikainen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017947; Zwingmann C, 2005, NEUROCHEM INT, V47, P19, DOI 10.1016/j.neuint.2005.04.003	62	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e81192	10.1371/journal.pone.0081192	http://dx.doi.org/10.1371/journal.pone.0081192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376499	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000003
J	Nahirnyj, A; Livne-Bar, I; Guo, XX; Sivak, JM				Nahirnyj, Adrian; Livne-Bar, Izhar; Guo, Xiaoxin; Sivak, Jeremy M.			ROS Detoxification and Proinflammatory Cytokines Are Linked by p38 MAPK Signaling in a Model of Mature Astrocyte Activation	PLOS ONE			English	Article							GANGLION-CELL DEATH; OXIDATIVE STRESS; GLUTAMINE-SYNTHETASE; OPTIC-NERVE; FUNCTIONAL EXPRESSION; BINDING-PROTEIN; GLIAL-CELLS; BRAIN; RETINA; INTERLEUKIN-6	Astrocytes are the most abundant glial cell in the retinal nerve fiber layer (NFL) and optic nerve head (ONH), and perform essential roles in maintaining retinal ganglion cell (RGC) detoxification and homeostasis. Mature astrocytes are relatively quiescent, but rapidly undergo a phenotypic switch in response to insult, characterized by upregulation of intermediate filament proteins, loss of glutamate buffering, secretion of pro-inflammatory cytokines, and increased antioxidant production. These changes result in both positive and negative influences on RGCs. However, the mechanism regulating these responses is still unclear, and pharmacologic strategies to modulate select aspects of this switch have not been thoroughly explored. Here we describe a system for rapid culture of mature astrocytes from the adult rat retina that remain relatively quiescent, but respond robustly when challenged with oxidative damage, a key pathogenic stress associated with inner retinal injury. When primary astrocytes were exposed to reactive oxygen species (ROS) we consistently observed characteristic changes in activation markers, along with increased expression of detoxifying genes, and secretion of proinflammatory cytokines. This in vitro model was then used for a pilot chemical screen to target specific aspects of this switch. Increased activity of p38 alpha and beta Mitogen Activated Protein Kinases (MAPKs) were identified as a necessary signal regulating expression of MnSOD, and heme oxygenase 1 (HO-1), with consequent changes in ROS-mediated injury. Additionally, multiplex cytokine profiling detected p38 MAPK-dependent secretion of IL-6, MCP-1, and MIP-2 alpha, which are proinflammatory signals recently implicated in damage to the inner retina. These data provide a mechanism to link increased oxidative stress to proinflammatory signaling by astrocytes, and establish this assay as a useful model to further dissect factors regulating the reactive switch.	[Nahirnyj, Adrian; Livne-Bar, Izhar; Guo, Xiaoxin; Sivak, Jeremy M.] Univ Hlth Network, Toronto Western Res Inst, Dept Vis Sci, Toronto, ON, Canada; [Sivak, Jeremy M.] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Sivak, Jeremy M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Sivak, JM (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Dept Vis Sci, Toronto, ON, Canada.	jsivak@uhnres.utoronto.ca	Sivak, Jeremy/AAA-3467-2022	Sivak, Jeremy/0000-0002-8776-223X	Canadian National Institute for the Blind (CNIB); Canadian Institutes for Health Research; Glaucoma Research Society of Canada; David and Sandra Smith Postdoctoral Fellowship	Canadian National Institute for the Blind (CNIB); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Glaucoma Research Society of Canada; David and Sandra Smith Postdoctoral Fellowship	This work was supported by the Canadian National Institute for the Blind (CNIB), Canadian Institutes for Health Research, and the Glaucoma Research Society of Canada. J. M. Sivak is the Toronto General and Western Hospital Foundation Glaucoma Research Chair. I. Livne-Bar is supported by the David and Sandra Smith Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Arden GB, 2011, CURR DIABETES REV, V7, P291, DOI 10.2174/157339911797415620; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bachstetter AD, 2010, AGING DIS, V1, P199; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chan D, 2012, TIMECOURSE HYPOXIA R; Chan-Ling T, 2009, GLIA, V57, P39, DOI 10.1002/glia.20733; Chang ML, 2007, J ANAT, V210, P54, DOI 10.1111/j.1469-7580.2006.00671.x; Chidlow G, 2012, NEUROBIOL DIS, V48, P568, DOI 10.1016/j.nbd.2012.07.026; Cole R, 2001, PROTOCOLS NEURAL CEL, P117, DOI [10.1385/1-59259-207-4:117, DOI 10.1385/1-59259-207-4:117]; de Melo J, 2012, P NATL ACAD SCI USA, V109, P4657, DOI 10.1073/pnas.1107488109; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Gallagher TF, 1997, BIOORGAN MED CHEM, V5, P49, DOI 10.1016/S0968-0896(96)00212-X; Gorovits R, 1997, P NATL ACAD SCI USA, V94, P7024, DOI 10.1073/pnas.94.13.7024; Guo X, 2013, ARVO M SEATTL WA; Gutsaeva DR, 2008, J NEUROSCI, V28, P2015, DOI 10.1523/JNEUROSCI.5654-07.2008; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Hinojosa AE, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-77; Inman DM, 2011, GLAUCOMA CURRENT CLI, P26; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Jiang XS, 2012, MOL VIS, V18, P2982; Jo N, 2003, INVEST OPHTH VIS SCI, V44, P4054, DOI 10.1167/iovs.02-1308; Johnson EC, 2009, J GLAUCOMA, V18, P341, DOI 10.1097/IJG.0b013e31818c6ef6; Johnson PT, 1997, EXP EYE RES, V64, P759, DOI 10.1006/exer.1996.0270; Kikuchi M, 2000, J NEUROSCI, V20, P5037; Kikumura A, 2012, BRIT J OPHTHALMOL, V96, P1259, DOI 10.1136/bjophthalmol-2012-301490; Krajnc D, 1996, BRAIN RES, V707, P134, DOI 10.1016/0006-8993(95)01372-5; Kuchtey J, 2010, INVEST OPHTH VIS SCI, V51, P6441, DOI 10.1167/iovs.10-5216; Lorber B, 2012, NEUROBIOL DIS, V45, P243, DOI 10.1016/j.nbd.2011.08.008; Mansour H, 2008, AGING CELL, V7, P526, DOI 10.1111/j.1474-9726.2008.00402.x; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Moreno MC, 2005, FASEB J, V19, P1161, DOI 10.1096/fj.04-3313fje; Osborne NN, 2010, EXP EYE RES, V90, P750, DOI 10.1016/j.exer.2010.03.008; Paintlia MK, 2012, J BIOL CHEM; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pfister M, 2013, CLIN OPHTHALMOL, V7, P1061, DOI 10.2147/OPTH.S42786; REICHENBACH A, 1995, GLIA, V13, P195, DOI 10.1002/glia.440130306; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; REINHARDT CA, 1995, TOXICOL IN VITRO, V9, P369, DOI 10.1016/0887-2333(95)00029-8; Rogers RS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012302; Ronaldson PT, 2008, J NEUROCHEM, V106, P1298, DOI 10.1111/j.1471-4159.2008.05479.x; Ronaldson PT, 2004, J NEUROCHEM, V89, P788, DOI 10.1111/j.1471-4159.2004.02417.x; Saint-Geniez M, 2013, AM J PATHOL, V182, P255, DOI 10.1016/j.ajpath.2012.09.003; Sappington RM, 2006, INVEST OPHTH VIS SCI, V47, P2932, DOI 10.1167/iovs.05-1407; Schmuck G, 2002, NEUROTOX RES, V4, P1, DOI 10.1080/10298420290007574; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shin JH, 2011, NEUROSCI LETT, V501, P132, DOI 10.1016/j.neulet.2011.06.061; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Sivak JM, 2013, INVEST OPHTH VIS SCI, V54, P871, DOI 10.1167/iovs.12-10827; Soliman ML, 2012, J NEUROIMMUNE PHARM; Stanke J, 2010, J COMP NEUROL, V518, P2316, DOI 10.1002/cne.22335; Sugino T, 2000, J NEUROSCI, V20, P4506, DOI 10.1523/JNEUROSCI.20-12-04506.2000; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Syapin PJ, 2008, BRIT J PHARMACOL, V155, P623, DOI 10.1038/bjp.2008.342; Tezel G, 2011, EXP EYE RES, V93, P178, DOI 10.1016/j.exer.2010.07.009; Tezel G, 2009, INVEST OPHTH VIS SCI, V50, P1001, DOI 10.1167/iovs.08-2717; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yu AL, 2008, INVEST OPHTH VIS SCI, V49, P5403, DOI 10.1167/iovs.07-1478	65	42	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83049	10.1371/journal.pone.0083049	http://dx.doi.org/10.1371/journal.pone.0083049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376630	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000053
J	Ortega-Martorell, S; Ruiz, H; Vellido, A; Olier, I; Romero, E; Julia-Sape, M; Martin, JD; Jarman, IH; Arus, C; Lisboa, PJG				Ortega-Martorell, Sandra; Ruiz, Hector; Vellido, Alfredo; Olier, Ivan; Romero, Enrique; Julia-Sape, Margarida; Martin, Jose D.; Jarman, Ian H.; Arus, Carles; Lisboa, Paulo J. G.			A Novel Semi-Supervised Methodology for Extracting Tumor Type-Specific MRS Sources in Human Brain Data	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; NONNEGATIVE MATRIX FACTORIZATION; DECISION-SUPPORT-SYSTEM; HIGH-GRADE GLIOMAS; H-1 MRS; CLASSIFICATION; VIVO; DIFFERENTIATION; MULTICENTER; ALGORITHMS	Background: The clinical investigation of human brain tumors often starts with a non-invasive imaging study, providing information about the tumor extent and location, but little insight into the biochemistry of the analyzed tissue. Magnetic Resonance Spectroscopy can complement imaging by supplying a metabolic fingerprint of the tissue. This study analyzes single-voxel magnetic resonance spectra, which represent signal information in the frequency domain. Given that a single voxel may contain a heterogeneous mix of tissues, signal source identification is a relevant challenge for the problem of tumor type classification from the spectroscopic signal. Methodology/Principal Findings: Non-negative matrix factorization techniques have recently shown their potential for the identification of meaningful sources from brain tissue spectroscopy data. In this study, we use a convex variant of these methods that is capable of handling negatively-valued data and generating sources that can be interpreted as tumor class prototypes. A novel approach to convex non-negative matrix factorization is proposed, in which prior knowledge about class information is utilized in model optimization. Class-specific information is integrated into this semi-supervised process by setting the metric of a latent variable space where the matrix factorization is carried out. The reported experimental study comprises 196 cases from different tumor types drawn from two international, multi-center databases. The results indicate that the proposed approach outperforms a purely unsupervised process by achieving near perfect correlation of the extracted sources with the mean spectra of the tumor types. It also improves tissue type classification. Conclusions/Significance: We show that source extraction by unsupervised matrix factorization benefits from the integration of the available class information, so operating in a semi-supervised learning manner, for discriminative source identification and brain tumor labeling from single-voxel spectroscopy data. We are confident that the proposed methodology has wider applicability for biomedical signal processing.	[Ortega-Martorell, Sandra; Ruiz, Hector; Jarman, Ian H.; Lisboa, Paulo J. G.] Liverpool John Moores Univ, Dept Math & Stat, Liverpool L3 5UX, Merseyside, England; [Vellido, Alfredo; Romero, Enrique] Univ Politecn Cataluna, BarcelonaTech, Dept Comp Languages & Syst, Barcelona, Spain; [Olier, Ivan] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Julia-Sape, Margarida; Arus, Carles] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Cerdanyola Del Valles, Spain; [Julia-Sape, Margarida] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Cerdanyola Del Valles, Spain; [Julia-Sape, Margarida; Arus, Carles] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Cerdanyola Del Valles, Spain; [Martin, Jose D.] Univ Valencia, Dept Ingn Elect, E-46100 Burjassot, Spain	Liverpool John Moores University; Universitat Politecnica de Catalunya; University of Manchester; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Autonomous University of Barcelona; Autonomous University of Barcelona; University of Valencia	Lisboa, PJG (corresponding author), Liverpool John Moores Univ, Dept Math & Stat, Liverpool L3 5UX, Merseyside, England.	P.J.Lisboa@ljmu.ac.uk	Martín-Guerrero, José D./L-8146-2014; Julià-Sapé, Margarida/AIC-9348-2022; Arus, Carles/C-2361-2009; Julià-Sapé, Margarida/A-4003-2009; Ortega-Martorell, Sandra/F-5345-2012; Ortega-Martorell, Sandra/O-7805-2019; Vellido, Alfredo/AAH-2654-2019	Martín-Guerrero, José D./0000-0001-9378-0285; Julià-Sapé, Margarida/0000-0002-3316-9027; Arus, Carles/0000-0003-2510-2671; Julià-Sapé, Margarida/0000-0002-3316-9027; Ortega-Martorell, Sandra/0000-0001-9927-3209; Vellido, Alfredo/0000-0002-9843-1911; Olier, Ivan/0000-0002-5679-7501	Spanish I+D+i National Plan [TIN2009-13895-C02-01, TIN2012-31377]; CIBER-BBN, initiative of the VI National RDI Plan; CIBER; Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion [PHENOIMA: SAF2008-03323]; Ministerio de Economia y Competitividad in Spain [MARESCAN: SAF2011-23870]; European Union	Spanish I+D+i National Plan; CIBER-BBN, initiative of the VI National RDI Plan; CIBER; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad in Spain(Spanish Government); European Union(European Commission)	This research was partially supported by the Spanish I+D+i National Plan under grants TIN2009-13895-C02-01 and TIN2012-31377; it was also partially supported by CIBER-BBN, which is an initiative of the VI National R&D&I Plan 2008-2011, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund; and by projects PHENOIMA: SAF2008-03323, from Ministerio de Ciencia e Innovacion and MARESCAN: SAF2011-23870 from Ministerio de Economia y Competitividad, in Spain. SOM is funded by the European Union under the 7th framework programme, "Marie Curie" Intra-European Fellowships, 2013-2015 EU Marie Curie Fellowship (FP7-PEOPLE-2012-IEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari S, 2001, IEEE T INFORM THEORY, V47, P1701, DOI 10.1109/18.930911; Barba I, 2001, J NEUROSURG, V94, P55, DOI 10.3171/jns.2001.94.1.0055; Borg I., 1997, MODERN MULTIDIMENSIO; Candiota AP, 2011, JBR-BTR, V94, P319, DOI 10.5334/jbr-btr.698; CARDOSO JF, 1993, IEE PROC-F, V140, P362, DOI 10.1049/ip-f-2.1993.0054; Castells X, 2012, BRIT J CANCER, V106, P1816, DOI 10.1038/bjc.2012.174; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; DeAngelis LM, 2011, J CLIN ONCOL, V29, P4473, DOI 10.1200/JCO.2011.37.5873; Devos A, 2004, J MAGN RESON, V170, P164, DOI 10.1016/j.jmr.2004.06.010; Ding C, 2010, IEEE T PATTERN ANAL, V32, P45, DOI 10.1109/TPAMI.2008.277; Ellison DW, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-7; Esposito M, 2011, ENG APPL ARTIF INTEL, V24, P1340, DOI 10.1016/j.engappai.2011.02.002; Fan G, 2004, CLIN RADIOL, V59, P77, DOI 10.1016/j.crad.2003.08.006; Garcia-Gomez JM, 2009, BIOL MED, V22, P5; Gibb A, 2011, KNOWL ENG REV, V26, P353, DOI 10.1017/S0269888911000154; Heiser WJ, 1995, RECENT ADV DESCRIPTI, P157; Herminghaus S, 2002, NMR BIOMED, V15, P385, DOI 10.1002/nbm.793; Howe FA, 2003, NMR BIOMED, V16, P123, DOI 10.1002/nbm.822; Huang Y, 2003, STAT MED, V22, P147, DOI 10.1002/sim.1321; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Ishimaru H, 2001, EUR RADIOL, V11, P1784, DOI 10.1007/s003300000814; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Julia-Sape M, 2006, MAGN RESON MATER PHY, V19, P22, DOI 10.1007/s10334-005-0023-x; Julia-Sape M, 2006, J NEUROSURG, V105, P6, DOI 10.3171/jns.2006.105.1.6; Julia-Sape M, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas035; Julia-Sape M, 2012, NMR BIOMED, V25, P661, DOI 10.1002/nbm.1782; JUTTEN C, 1991, SIGNAL PROCESS, V24, P1, DOI 10.1016/0165-1684(91)90079-X; Kaski S, 2000, IEEE IJCNN, P547, DOI 10.1109/IJCNN.2000.861526; Kiers HAL, 2002, COMPUT STAT DATA AN, V41, P157, DOI 10.1016/S0167-9473(02)00142-1; Kleihues P, 2000, PATHOLOGY GENETICS T; Kounelakis MG, 2011, IEEE T INF TECHNOL B, V15, P647, DOI 10.1109/TITB.2011.2131146; Kros JM, 2011, J NEUROPATH EXP NEUR, V70, P101, DOI 10.1097/NEN.0b013e31820681aa; Law M, 2003, AM J NEURORADIOL, V24, P1989; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee JA, 2007, INFORM SCI STAT, P1; Lisboa PJG, 2010, IEEE COMPUT INTELL M, V5, P14, DOI 10.1109/MCI.2009.935311; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lukas L, 2004, ARTIF INTELL MED, V31, P73, DOI 10.1016/j.artmed.2004.01.001; Martinez-Bisbal MC, 2004, NMR BIOMED, V17, P191, DOI 10.1002/nbm.888; Murphy M, 2002, BRIT J NEUROSURG, V16, P329, DOI 10.1080/0268869021000007687; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Opstad KS, 2004, J MAGN RESON IMAGING, V20, P187, DOI 10.1002/jmri.20093; Ortega-Martorell S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-38; Ortega-Martorell S, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P3279, DOI 10.1109/IJCNN.2011.6033656; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Perez-Ruiz A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-581; Ruiz H, 2012, P IEEE WORLD C COMP, P3008; Ruiz H., 2011, EUR S ART NEUR NETW, P381; Saez C, 2008, 25 ANN SCI M EUR SOC; Sajda P, 2004, IEEE T MED IMAGING, V23, P1453, DOI 10.1109/TMI.2004.834626; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; SAVA AC, 2010, 32 ANN INT C IEEE EN, P3658; Tate AR, 2006, NMR BIOMED, V19, P411, DOI 10.1002/nbm.1016; Tate AR, 1998, NMR BIOMED, V11, P177, DOI 10.1002/(SICI)1099-1492(199806/08)11:4/5<177::AID-NBM534>3.0.CO;2-U; Vellido A, 2012, NMR BIOMED, V25, P819, DOI 10.1002/nbm.1797; Vellido A., 2012, INESANN, P163; Vellido A, 2009, NEUROCOMPUTING, V72, P3085, DOI 10.1016/j.neucom.2009.03.010; Vilamala A, 2013, PATTERN RECOGN LETT, V34, P1734, DOI 10.1016/j.patrec.2013.05.023; Wilson M, 2009, P 17 SCI M INT SOC M, V526, P4337; Zafeiriou S, 2006, IEEE T NEURAL NETWOR, V17, P683, DOI 10.1109/TNN.2006.873291; Zhang Zhihua, 2003, ICML, V2, P872	63	17	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83773	10.1371/journal.pone.0083773	http://dx.doi.org/10.1371/journal.pone.0083773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376744	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000112
J	Sineva, EV; Rumfeldt, JAO; Halpert, JR; Davydov, DR				Sineva, Elena V.; Rumfeldt, Jessica A. O.; Halpert, James R.; Davydov, Dmitri R.			A Large-Scale Allosteric Transition in Cytochrome P450 3A4 Revealed by Luminescence Resonance Energy Transfer (LRET)	PLOS ONE			English	Article							SUBSTRATE-BINDING SITES; HUMAN LIVER-MICROSOMES; ALPHA-NAPHTHOFLAVONE; P450-P450 INTERACTIONS; FLUORESCENT-PROBE; DRUG-METABOLISM; LIGAND-BINDING; QUANTUM YIELDS; PIVOTAL ROLE; P450	Effector-induced allosteric transitions in cytochrome P450 3A4 (CYP3A4) were investigated by luminescence resonance energy transfer (LRET) between two SH-reactive probes attached to various pairs of distantly located cysteine residues, namely the double-cysteine mutants CYP3A4(C64/C468), CYP3A4(C377/C468) and CYP3A4(C64/C121). Successive equimolar labeling of these proteins with the phosphorescent probe erythrosine iodoacetamide (donor) and the near-infrared fluorophore DY-731 maleimide (acceptor) allowed us to establish donor/acceptor pairs sensitive to conformational motions. The interactions of all three double-labeled mutants with the allosteric activators alpha-naphthoflavone and testosterone resulted in an increase in the distance between the probes. A similar effect was elicited by cholesterol. These changes in distance vary from 1.3 to 8.5 angstrom, depending on the position of the donor/acceptor pair and the nature of the effector. In contrast, the changes in the interprobe distance caused by such substrates as bromocriptine or 1-pyrenebutanol were only marginal. Our results provide a decisive support to the paradigm of allosteric modulation of CYP3A4 and indicate that the conformational transition caused by allosteric effectors increases the spatial separation between the beta-domain of the enzyme (bearing residues Cys(64) and Cys(377)) and the alpha-domain, where Cys(121) and Cys(468) are located.	[Sineva, Elena V.; Rumfeldt, Jessica A. O.; Halpert, James R.; Davydov, Dmitri R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Sineva, Elena V.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Rumfeldt, Jessica A. O.] Univ Waterloo, Dept Biol & Chem, Waterloo, ON N2L 3G1, Canada	University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Waterloo	Davydov, DR (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	ddavydov@ucsd.edu	Sineva, Elena/A-5267-2008; Davydov, Dmitri R/H-2736-2013	Sineva, Elena/0000-0003-2307-0581; Davydov, Dmitri R/0000-0001-8520-0033	National Institutes of Health [GM054995]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054995, R01GM054995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health grant GM054995. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMLER E, 1992, BIOPHYS J, V61, P553, DOI 10.1016/S0006-3495(92)81859-3; Atkins WM, 2011, BIOCHEMISTRY-US, V50, P3866, DOI 10.1021/bi200275r; Atkins WM, 2001, CHEM RES TOXICOL, V14, P338, DOI 10.1021/tx0002132; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; BOWERS PG, 1967, PROC R SOC LON SER-A, V299, P348, DOI 10.1098/rspa.1967.0141; Davydov DR, 2007, BIOCHEMISTRY-US, V46, P7852, DOI 10.1021/bi602400y; Davydov DR, 2006, BIOPHYS CHEM, V123, P95, DOI 10.1016/j.bpc.2006.04.007; Davydov DR, 2013, BIOCHEM J, V453, P219, DOI 10.1042/BJ20130398; Davydov DR, 2012, J BIOL CHEM, V287, P6797, DOI 10.1074/jbc.M111.325654; Davydov DR, 2011, EXPERT OPIN DRUG MET, V7, P543, DOI 10.1517/17425255.2011.562194; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Davydov DR, 2005, BIOPHYS J, V89, P418, DOI 10.1529/biophysj.104.058479; DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dixon JM, 2005, PHOTOCHEM PHOTOBIOL, V81, P212, DOI 10.1562/2004-11-06-TSN-361.1; dos Remedios C.G., 1999, RESONANCE ENERGY TRA, P1; Duchowicz R, 1998, PHOTOCHEM PHOTOBIOL, V68, P494, DOI 10.1562/0031-8655(1998)068<0494:KSOEPA>2.3.CO;2; Faulkner S, 2005, APPL SPECTROSC REV, V40, P1, DOI 10.1081/ASR-200038308; Fernando H, 2006, BIOCHEMISTRY-US, V45, P4199, DOI 10.1021/bi052491b; Fernando H, 2007, ARCH BIOCHEM BIOPHYS, V460, P129, DOI 10.1016/j.abb.2006.12.025; Fernando H, 2011, XENOBIOTICA, V41, P281, DOI 10.3109/00498254.2010.538748; Gay SC, 2010, FUTURE MED CHEM, V2, P1451, DOI 10.4155/FMC.10.229; GrahamLorence S, 1996, FASEB J, V10, P206, DOI 10.1096/fasebj.10.2.8641554; HAAS E, 1978, BIOCHEMISTRY-US, V17, P5064, DOI 10.1021/bi00616a032; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; HUNZIKER PE, 1980, BIOCHEM J, V187, P515, DOI 10.1042/bj1870515; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Kenworthy KE, 2001, DRUG METAB DISPOS, V29, P1644; Koley AP, 1997, J BIOL CHEM, V272, P3149, DOI 10.1074/jbc.272.6.3149; Lettinga MP, 2000, PHYS CHEM CHEM PHYS, V2, P3697, DOI 10.1039/a909707d; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Ma Q, 2008, CURR DRUG METAB, V9, P374, DOI 10.2174/138920008784746337; Nakajima M, 1999, XENOBIOTICA, V29, P885, DOI 10.1080/004982599238137; Nakamura H, 2002, DRUG METAB DISPOS, V30, P534, DOI 10.1124/dmd.30.5.534; Otyepka M, 2012, CURR DRUG METAB, V13, P130, DOI 10.2174/138920012798918372; Pochapsky TC, 2010, ANTIOXID REDOX SIGN, V13, P1273, DOI 10.1089/ars.2010.3109; Roberts AG, 2007, ARCH BIOCHEM BIOPHYS, V463, P89, DOI 10.1016/j.abb.2007.03.006; Segel IH, 1975, ENZYME KINETICS BEHA; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Sevrioukova IF, 2013, DALTON T, V42, P3116, DOI 10.1039/c2dt31833d; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; Shinkyo R, 2011, J BIOL CHEM, V286, P18426, DOI 10.1074/jbc.M111.240457; Tsalkova TN, 2007, BIOCHEMISTRY-US, V46, P106, DOI 10.1021/bi061944p; Turro N. J., 2010, MODERN MOL PHOTOCHEM; VESTLING MM, 1994, RAPID COMMUN MASS SP, V8, P786, DOI 10.1002/rcm.1290080925; Wilderman PR, 2012, CURR DRUG METAB, V13, P167; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Xiao M, 2001, J AM CHEM SOC, V123, P7067, DOI 10.1021/ja0031669; Yu XF, 2013, BIOTECHNOL APPL BIOC, V60, P134, DOI 10.1002/bab.1074	50	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83898	10.1371/journal.pone.0083898	http://dx.doi.org/10.1371/journal.pone.0083898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376769	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000129
J	Unachukwu, UJ; Sauane, M; Vazquez, M; Redenti, S				Unachukwu, Uchenna J.; Sauane, Moira; Vazquez, Maribel; Redenti, Stephen			Microfluidic Generated EGF-Gradients Induce Chemokinesis of Transplantable Retinal Progenitor Cells via the JAK/STAT and PI3Kinase Signaling Pathways	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HUMAN NEURAL PROGENITORS; FACTOR RECEPTOR; CHONDROITIN SULFATE; FOCAL ADHESIONS; FACTOR-ALPHA; STEM-CELLS; MIGRATION; INTEGRATION; EXPRESSION	A growing number of studies are evaluating retinal progenitor cell (RPC) transplantation as an approach to repair retinal degeneration and restore visual function. To advance cell-replacement strategies for a practical retinal therapy, it is important to define the molecular and biochemical mechanisms guiding RPC motility. We have analyzed RPC expression of the epidermal growth factor receptor (EGFR) and evaluated whether exposure to epidermal growth factor (EGF) can coordinate motogenic activity in vitro. Using Boyden chamber analysis as an initial high-throughput screen, we determined that RPC motility was optimally stimulated by EGF concentrations in the range of 20-400ng/ml, with decreased stimulation at higher concentrations, suggesting concentration-dependence of EGF-induced motility. Using bioinformatics analysis of the EGF ligand in a retina-specific gene network pathway, we predicted a chemotactic function for EGF involving the MAPK and JAK-STAT intracellular signaling pathways. Based on targeted inhibition studies, we show that ligand binding, phosphorylation of EGFR and activation of the intracellular STAT3 and PI3kinase signaling pathways are necessary to drive RPC motility. Using engineered microfluidic devices to generate quantifiable steady-state gradients of EGF coupled with live-cell tracking, we analyzed the dynamics of individual RPC motility. Microfluidic analysis, including center of mass and maximum accumulated distance, revealed that EGF induced motility is chemokinetic with optimal activity observed in response to low concentration gradients. Our combined results show that EGFR expressing RPCs exhibit enhanced chemokinetic motility in the presence of low nanomole levels of EGF. These findings may serve to inform further studies evaluating the extent to which EGFR activity, in response to endogenous ligand, drives motility and migration of RPCs in retinal transplantation paradigms.	[Unachukwu, Uchenna J.] CUNY, Biochem Doctoral Program, Grad Sch & Univ Ctr, New York, NY 10021 USA; [Sauane, Moira] CUNY, Dept Biol Sci, Herbert Lehman Coll, Bronx, NY USA; [Vazquez, Maribel] CUNY, Dept Biomed Engn, New York, NY 10021 USA; [Redenti, Stephen] CUNY, Biochem Doctoral Program, Grad Sch & Univ Ctr, Dept Biol Sci Herbert Lehman Coll, Bronx, NY 10468 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Redenti, S (corresponding author), CUNY, Biochem Doctoral Program, Grad Sch & Univ Ctr, Dept Biol Sci Herbert Lehman Coll, Bronx, NY 10468 USA.	stephen.redenti@lehman.cuny.edu	Vazquez, Maribel/AAN-2958-2020	Vazquez, Maribel/0000-0002-6184-3103; unachukwu, uchenna/0000-0001-8248-5723	National Institute of General Medical Sciences (NIGMS) [GM096935]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM096935] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institute of General Medical Sciences (NIGMS) GM096935 grant (SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aizawa Y, 2012, BIOMATERIALS, V33, P5198, DOI 10.1016/j.biomaterials.2012.03.062; Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; *AM NEIAPB, 2002, VIS PROBL US REP REP; Andreazzoli M, 2009, BIRTH DEFECTS RES C, V87, P284, DOI 10.1002/bdrc.20161; Baker PS, 2009, CURR OPIN OPHTHALMOL, V20, P175, DOI 10.1097/ICU.0b013e328329b5f2; Belletti B, 2010, MOL CELL BIOL, V30, P2229, DOI 10.1128/MCB.00723-09; BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; BERKERS JAM, 1991, J BIOL CHEM, V266, P922; Blong CC, 2010, J NEUROSCI RES, V88, P1445, DOI 10.1002/jnr.22324; Booth EO, 2005, BIOINFORMATICS, V21, P4371, DOI 10.1093/bioinformatics/bti726; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Cao L, 2006, GLIA, V54, P536, DOI 10.1002/glia.20403; Caric D, 2001, DEVELOPMENT, V128, P4203; Chen Hong-Chen, 2004, V294, P15; Chen HY, 2007, J COMP NEUROL, V500, P299, DOI 10.1002/cne.21161; Chen M, 1997, J Biopharm Stat, V7, P355, DOI 10.1080/10543409708835193; Chen Z, 2010, PATHOBIOLOGY, V77, P88, DOI 10.1159/000278290; Chiaramello S, 2007, EUR J NEUROSCI, V26, P1780, DOI 10.1111/j.1460-9568.2007.05818.x; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Close JL, 2006, GLIA, V54, P94, DOI 10.1002/glia.20361; Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010; Dudu V, 2012, CELL MOL BIOENG, V5, P402, DOI 10.1007/s12195-012-0253-8; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; FASSIO JB, 1989, INVEST OPHTH VIS SCI, V30, P1916; Gentilini D, 2007, MOL HUM REPROD, V13, P317, DOI 10.1093/molehr/gam001; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Ho WC, 2001, EXP CELL RES, V263, P254, DOI 10.1006/excr.2000.5112; Hollyfield JG, 1999, INVEST OPHTH VIS SCI, V40, P2767; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jiang CH, 2010, MOL VIS, V16, P983; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P960, DOI 10.1167/iovs.09-3884; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; Khodosevich K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00028; Khodosevich K, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.007.2009; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h; Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179; KONG Q, 2010, DIFFERENCES J BIOMED, V132; Kong QJ, 2011, EXP CELL RES, V317, P1491, DOI 10.1016/j.yexcr.2011.04.003; Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Li SW, 2009, MOL ENDOCRINOL, V23, P901, DOI 10.1210/me.2008-0368; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Mieziewska K, 1996, MICROSC RES TECHNIQ, V35, P463; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Nikukar H, 2013, ACS NANO, V7, P2758, DOI 10.1021/nn400202j; Paguirigan AL, 2008, BIOESSAYS, V30, P811, DOI 10.1002/bies.20804; Park JY, 2009, STEM CELLS, V27, P2646, DOI 10.1002/stem.202; PATEL B, 1994, BRIT J OPHTHALMOL, V78, P714, DOI 10.1136/bjo.78.9.714; Petit A, 2007, P NATL ACAD SCI USA, V104, P17837, DOI 10.1073/pnas.0703240104; Phillips MJ, 2011, INVEST OPHTH VIS SCI, V52, P1439, DOI 10.1167/iovs.10-6400; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Redenti S, 2009, BIOMATERIALS, V30, P3405, DOI 10.1016/j.biomaterials.2009.02.046; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROQUE RS, 1992, INVEST OPHTH VIS SCI, V33, P2587; Schmitt S, 2009, INVEST OPHTH VIS SCI, V50, P5901, DOI 10.1167/iovs.08-3067; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Singhal S, 2008, STEM CELLS, V26, P1074, DOI 10.1634/stemcells.2007-0898; Sodha S, 2011, J BIOMAT SCI-POLYM E, V22, P443, DOI 10.1163/092050610X487738; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; Tucker BA, 2010, BIOMATERIALS, V31, P9, DOI 10.1016/j.biomaterials.2009.09.015; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P3201, DOI 10.1167/iovs.08-1831; Wells A, 2002, ACTA ONCOL, V41, P124, DOI 10.1080/028418602753669481; West EL, 2008, EXP EYE RES, V86, P601, DOI 10.1016/j.exer.2008.01.004; West EL, 2009, PROG BRAIN RES, V175, P3, DOI 10.1016/S0079-6123(09)17501-5; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Xie H, 1998, J CELL SCI, V111, P615; ZAMAN, 2006, P NATL ACAD SCI USA, V103, P13897, DOI DOI 10.1073/PNAS.0606646103.PUBMED:16832052; Zhang Q, 2011, MOLECULES, V16, P10146, DOI 10.3390/molecules161210146; Zhao H, 2009, INVEST OPHTH VIS SCI, V50, P5384, DOI 10.1167/iovs.08-3163	78	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83906	10.1371/journal.pone.0083906	http://dx.doi.org/10.1371/journal.pone.0083906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376770	gold, Green Published			2022-12-27	WOS:000328882000130
J	Calmettes, G; Weiss, JN				Calmettes, Guillaume; Weiss, James N.			A Quantitative Method to Track Protein Translocation between Intracellular Compartments in Real-Time in Live Cells Using Weighted Local Variance Image Analysis	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; CARDIAC MYOCYTES; MITOCHONDRIAL; CARDIOMYOCYTES; FLUORESCENCE; METABOLISM; ACTIVATION; ADULT	The genetic expression of cloned fluorescent proteins coupled to time-lapse fluorescence microscopy has opened the door to he direct visualization of a wide range of molecular interactions in living cells. In particular, he dynamic translocation of proteins can now be explored in real time at he single-cell level. Here we propose a reliable, easy-to-implement quantitative image processing method to assess protein translocation in living cells based on the computation of spatial variance maps of time-lapse images. The method is first illustrated and validated on simulated images of a fluorescently-labeled protein translocating from mitochondria to cytoplasm, and then applied to experimental data obtained with fluorescently-labeled hexokinase 2 in different cell types imaged by regular or confocal microscopy. The method was found to be robust with respect to cell morphology changes and mitochondrial dynamics (fusion, fission, movement) during the time-lapse imaging. Its ease of implementation should facilitate its application to a broad spectrum of e-lapse imaging studies.	[Calmettes, Guillaume] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, UCLA Cardiovasc Res Lab, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, UCLA Cardiovasc Res Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Calmettes, G (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, UCLA Cardiovasc Res Lab, Los Angeles, CA 90095 USA.	gcalmettes@mednet.ucla.edu			National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) [P50 HL080111, R01 HL071870, R01 HL095663]; NIH/NHLBI [HHSN268201000035C]; Laubisch and Kawata Endowments; American Heart Association (Western States) [11POST6110007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095663, R01HL071870, P01HL080111] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Laubisch and Kawata Endowments; American Heart Association (Western States)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) grants P50 HL080111, R01 HL071870, R01 HL095663, NIH/NHLBI Contract #: HHSN268201000035C (Mitochondria! Proteomics Center), and by the Laubisch and Kawata Endowments. GC was supported by a Postdoctoral J. William Fulbright Fellowship and a Postdoctoral Fellowship award (No. 11POST6110007) from the American Heart Association (Western States). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BURT PJ, 1983, COMPUT VISION GRAPH, V21, P368, DOI 10.1016/S0734-189X(83)80049-8; Calmettes G, 2013, J GEN PHYSIOL, V142, P425, DOI 10.1085/jgp.201310968; Calmettes G, 2012, J PHYSIOL-LONDON, V590, P3403, DOI 10.1113/jphysiol.2012.239376; Canny J, 1986, COMPUTATIONAL APPROA, P698; CARRINGTON WA, 1995, SCIENCE, V268, P1483, DOI 10.1126/science.7770772; Drake F., 2001, PYTHON REFERENCE MAN; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Fabijanska A, 2011, VARIANCE FILTER EDGE, P151; GOLDHABER JI, 1989, J CLIN INVEST, V83, P1800, DOI 10.1172/JCI114085; Gurel E, 2009, J APPL PHYSIOL, V106, P1909, DOI 10.1152/japplphysiol.90537.2008; Hausenloy DJ, 2004, AM J PHYSIOL-HEART C, V287, pH841, DOI 10.1152/ajpheart.00678.2003; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; Jones E., 2001, SCIPY OPEN SOURCE SC; Law MWK, 2007, IEEE T MED IMAGING, V26, P1224, DOI 10.1109/TMI.2007.903231; Ludbrook J, 2002, CLIN EXP PHARMACOL P, V29, P527, DOI 10.1046/j.1440-1681.2002.03686.x; LYNCH RM, 1991, J CELL BIOL, V112, P385, DOI 10.1083/jcb.112.3.385; Maddaford TG, 1999, AM J PHYSIOL-HEART C, V277, pH788, DOI 10.1152/ajpheart.1999.277.2.H788; Mockridge JW, 2000, BIOCHEM BIOPH RES CO, V270, P947, DOI 10.1006/bbrc.2000.2522; Oliphant T. E., 2001, NUMPY FAST SOPHISTIC; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Punn A, 2000, BIOCHEM J, V350, P891, DOI 10.1042/0264-6021:3500891; ROHR S, 1991, CIRC RES, V68, P114, DOI 10.1161/01.RES.68.1.114; Russ JC., 2011, IMAGE PROCESSING HDB; Sobel I. E., 1970, THESIS STANFORD U PA; Venable PW, 2013, J PHYSIOL-LONDON, V591, P2781, DOI 10.1113/jphysiol.2012.248153; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Yongquan X, 2009, MOVING OBJECT DETECT, P347	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e81988	10.1371/journal.pone.0081988	http://dx.doi.org/10.1371/journal.pone.0081988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376509	Green Published, gold			2022-12-27	WOS:000328745100013
J	da Costa, ECB; Amorim, R; da Silva, FC; Rocha, DR; Papa, MP; de Arruda, LB; Mohana-Borges, R; Ferreira, VF; Tanuri, A; da Costa, LJ; Ferreira, SB				da Costa, Emmerson C. B.; Amorim, Raquel; da Silva, Fernando C.; Rocha, David R.; Papa, Michelle P.; de Arruda, Luciana B.; Mohana-Borges, Ronaldo; Ferreira, Vitor F.; Tanuri, Amilcar; da Costa, Luciana J.; Ferreira, Sabrina B.			Synthetic 1,4-Pyran Naphthoquinones Are Potent Inhibitors of Dengue Virus Replication	PLOS ONE			English	Article							BETA-LAPACHONE; TRYPANOSOMA-CRUZI; NS3 PROTEASE; HELICASE ACTIVITY; NS2B COFACTOR; RNA HELICASE; DERIVATIVES; TRIPHOSPHATASE; RECOMBINANT; 1,4-NAPHTHOQUINONE	Dengue virus infection is a serious public health problem in endemic areas of he world where 2,5 billion people live. Clinical manifestations of the Dengue infection range from a mild fever to fatal cases of hemorrhagic fever. Although being the most rapidly spreading mosquito-borne viral infection in the world, until now no strategies are available for effective prevention or control of Dengue infection. In this scenario, the development of compounds that specifically inhibit viral replication with minimal effects to the human hosts will have a substantial effect in minimizing the symptoms of the disease and help to prevent viral transmission in the affected population. The aim of this study was to screen compounds with potential activity against dengue virus from a library of synthetic naphthoquinones Several 1,2- and 1,4-pyran naphthoquinones were synthesized by a three-component reaction of lawsone, aldehyde (formaldehyde or arylaldehydes) and different dienophiles adequately substituted. These compounds were tested for he ability to inhibit the ATPase activity of the viral NS3 enzyme in in vitro assays and the replication of dengue virus in cultured cells. We have identified two 1,4-pyran naphthoquinones, which inhibited dengue virus replication in mammal cells by 99.0% and three others that reduced the dengue virus ATPase activity of NS3 by two-fold in in vitro assays	[da Costa, Emmerson C. B.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil; [Amorim, Raquel; Papa, Michelle P.; de Arruda, Luciana B.; da Costa, Luciana J.] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil; [da Silva, Fernando C.; Rocha, David R.; Ferreira, Vitor F.] Univ Fed Fluminense, Dept Quim Organ, Inst Quim, BR-24000 Niteroi, RJ, Brazil; [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil; [Ferreira, Sabrina B.] Univ Fed Rio de Janeiro, Dept Quim Organ, Inst Quim, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	da Costa, LJ (corresponding author), Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.	ljcosta@micro.ufrj.br; sabrinab@iq.ufrj.br	Costa, Luciana J/B-7878-2013; Amorim, Raquel/M-8161-2013; Ferreira, Sabrina Baptista/AAC-9368-2019; da Rocha, David R/J-9912-2012; Arruda, Luciana B/N-9086-2013; ferreira, Vitor francisco/Y-4031-2019; Arruda, Luciana/B-5806-2014; Borges, Ronaldo S Mohana/C-5575-2013; Tanuri, Amilcar/AAM-8601-2021; da Silva, Fernando de Carvalho/E-3408-2014; Ferreira, Sabrina/GSI-4468-2022	Amorim, Raquel/0000-0002-1605-0702; Ferreira, Sabrina Baptista/0000-0002-5363-0888; da Rocha, David R/0000-0002-7928-8646; ferreira, Vitor francisco/0000-0002-2166-766X; da Silva, Fernando de Carvalho/0000-0002-2042-3778; Premazzi Papa, Michelle/0000-0003-1957-666X	CNPq (Brazil); CAPES-FAPERJ; CAPES; CNPq [471588/2009-1]; FAPERJ-PRONEX [110.574/2010]; CNPq INCT-Dengue	CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-FAPERJ(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ-PRONEX(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq INCT-Dengue(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	Fellowships granted to VFF by CNPq (Brazil), DRR by CAPES-FAPERJ and SBF and RA by CAPES are gratefully acknowledged. This work was partially supported by CAPES; CNPq grant 471588/2009-1; FAPERJ-PRONEX grant number 110.574/2010 and CNPq INCT-Dengue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RD, 1994, MUTAT RES-FUND MOL M, V309, P109, DOI 10.1016/0027-5107(94)90048-5; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Boguszewska-Chachulska AM, 2004, FEBS LETT, V567, P253, DOI 10.1016/j.febslet.2004.04.072; BOOTHMAN DA, 1989, CANCER RES, V49, P605; Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213; da Rocha DR, 2011, ORG BIOMOL CHEM, V9, P4315, DOI 10.1039/c1ob05209h; da Silva AJM, 2009, J BRAZIL CHEM SOC, V20, P176, DOI 10.1590/S0103-50532009000100026; da Silva EN, 2010, J MED CHEM, V53, P504, DOI 10.1021/jm900865m; da Silva FD, 2009, J BRAZIL CHEM SOC, V20, P1478, DOI 10.1590/S0103-50532009000800014; De Burghgraeve T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037244; DRISCOLL JS, 1974, CANCER CHEMOTH REP 3, V4, P3; Ertl P, 1999, BIOORG MED CHEM LETT, V9, P2863, DOI 10.1016/S0960-894X(99)00489-8; Eyong KO, 2008, BIOORG MED CHEM LETT, V18, P5387, DOI 10.1016/j.bmcl.2008.09.053; FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995; Ferreira S, 2013, MEDCHEMCOMM UNPUB; Ferreira SB, 2011, EUR J MED CHEM, V46, P3071, DOI 10.1016/j.ejmech.2011.03.012; Ferreira VF, 2006, BIOORGAN MED CHEM, V14, P5459, DOI 10.1016/j.bmc.2006.04.046; Ferreira VF, 2010, ORG BIOMOL CHEM, V8, P4793, DOI 10.1039/c0ob00277a; Fiske CH, 1927, SCIENCE, V65, P401, DOI 10.1126/science.65.1686.401; Francisco AI, 2010, J BRAZIL CHEM SOC, V21, P1293, DOI 10.1590/S0103-50532010000700017; Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244; GUIRAUD P, 1994, PLANTA MED, V60, P373, DOI 10.1055/s-2006-959504; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Halstead Scott B, 2005, Vaccine, V23, P849, DOI 10.1016/j.vaccine.2004.03.069; Hussain H, 2007, ARKIVOC, P145, DOI 10.3998/ark.5550190.0008.204; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Jorqueira A, 2006, PARASITOL RES, V99, P429, DOI 10.1007/s00436-006-0153-8; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Lima NMF, 2004, MEM I OSWALDO CRUZ, V99, P757, DOI 10.1590/S0074-02762004000700017; Lima NMF, 2002, J BRAZIL CHEM SOC, V13, P822, DOI 10.1590/S0103-50532002000600015; Liu KKC, 2004, MINI-REV MED CHEM, V4, P1105; LOPES JN, 1978, ANN TROP MED PARASIT, V72, P523, DOI 10.1080/00034983.1978.11719356; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147; Monks Terrence J, 2002, Curr Drug Metab, V3, P425, DOI 10.2174/1389200023337388; Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004; Perez-Sacau E, 2005, CHEM BIODIVERS, V2, P264, DOI 10.1002/cbdv.200590009; Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Silva TMS, 2005, BIOORGAN MED CHEM, V13, P193, DOI 10.1016/j.bmc.2004.09.043; Teixeira MJ, 2005, INFECT IMMUN, V73, P1191, DOI 10.1128/IAI.73.2.1191-1195.2005; WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587; WHO, 2009, DENG GUID DIAGN TREA; Who, 2006, SCI WORK GROUP REP D; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005	50	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82504	10.1371/journal.pone.0082504	http://dx.doi.org/10.1371/journal.pone.0082504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376541	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100035
J	Foks, AC; Ran, IA; Frodermann, V; Bot, I; van Santbrink, PJ; Kuiper, J; van Puijvelde, GHM				Foks, Amanda C.; Ran, Ingrid A.; Frodermann, Vanessa; Bot, Ilze; van Santbrink, Peter J.; Kuiper, Johan; van Puijvelde, Gijs H. M.			Agonistic Anti-TIGIT Treatment Inhibits T Cell Responses in LDLr Deficient Mice without Affecting Atherosclerotic Lesion Development	PLOS ONE			English	Article							INFLAMMATORY MECHANISMS; DENDRITIC CELLS; CD226; ATHEROGENESIS; IMMUNE; NECTIN	Objective: Co-stimulatory and co-inhibitory molecules are mainly expressed on T cells and antigen presenting cells and strongly orchestrate adaptive immune responses. Whereas co-stimulatory molecules enhance immune responses, signaling via co-inhibitory molecules dampens the immune system, thereby showing great therapeutic potential to prevent cardiovascular diseases. Signaling via co-inhibitory T cell immunoglobulin and ITIM domain (TIGIT directly inhibits T cell activation and proliferation, and therefore represents a novel therapeutic candidate to specifically dampen pro-atherogenic T cell reactivity. In the present study, we used an agonistic anti-TIGIT antibody to determine the effect of excessive TIGIT-signaling on atherosclerosis. Methods and Results:TIGIT was upregulated on CD4(+) T cells isolated from mice fed a Western-type diet in comparison with mice fed a chow diet. Agonistic anti-TIGIT suppressed T cell activation and proliferation both in vitro and in vivo. However, agonistic anti-TIGIT treatment of LDLr-/- mice fed a Western-type diet for 4 or 8 weeks did not affect atherosclerotic lesion development in comparison with PBS and Armenian Hamster IgG treatment. Furthermore, elevated percentages of dendritic cells were observed in the blood and spleen of agonistic anti-TIGIT-treated mice. Additionally, these cells showed an increased activation status but decreased IL-10 production. Conclusions: Despite the inhibition of splenic T cell responses, agonistic anti-TIGIT treatment does not affect initial atherosclerosis development, possibly due to increased activity of dendritic cells.	[Foks, Amanda C.; Ran, Ingrid A.; Frodermann, Vanessa; Bot, Ilze; van Santbrink, Peter J.; Kuiper, Johan; van Puijvelde, Gijs H. M.] Leiden Univ, Div Biopharmaceut, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	van Puijvelde, GHM (corresponding author), Leiden Univ, Div Biopharmaceut, Leiden, Netherlands.	puijvelde@lacdr.leidenuniv.nl	van Puijvelde, Gijs/AAM-9889-2020	Frodermann, Vanessa/0000-0001-5566-6692; Foks, Amanda/0000-0002-9747-3458; Bot, Ilze/0000-0002-1242-1959	Netherlands Heart Foundation [20088048, 2007T039]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by two grants from the Netherlands Heart Foundation: 20088048 and 2007T039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Elhage R, 2004, AM J PATHOL, V165, P2013, DOI 10.1016/S0002-9440(10)63252-X; Fuchs A, 2006, SEMIN CANCER BIOL, V16, P359, DOI 10.1016/j.semcancer.2006.07.002; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Hansson GK, 2009, J THROMB HAEMOST, V7, P328, DOI 10.1111/j.1538-7836.2009.03416.x; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Levin SD, 2011, EUR J IMMUNOL, V41, P902, DOI 10.1002/eji.201041136; Lozano E, 2012, J IMMUNOL, V188, P3869, DOI 10.4049/jimmunol.1103627; Manthey HD, 2011, THROMB HAEMOSTASIS, V106, P772, DOI 10.1160/TH11-05-0296; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Sakisaka T, 2004, CURR OPIN CELL BIOL, V16, P513, DOI 10.1016/j.ceb.2004.07.007; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; van Wanrooij EJA, 2007, ARTERIOSCL THROM VAS, V27, P204, DOI 10.1161/01.ATV.0000251007.07648.81; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674	17	10	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83134	10.1371/journal.pone.0083134	http://dx.doi.org/10.1371/journal.pone.0083134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376654	Green Published, gold			2022-12-27	WOS:000328745100096
J	Ning, YY; Shang, Y; Huang, HD; Zhang, JX; Dong, YC; Xu, WJ; Li, Q				Ning, Yunye; Shang, Yan; Huang, Haidong; Zhang, Jingxi; Dong, Yuchao; Xu, Wujian; Li, Qiang			Attenuation of Cigarette Smoke-Induced Airway Mucus Production by Hydrogen-Rich Saline in Rats	PLOS ONE			English	Article							THERAPEUTIC ANTIOXIDANT; OXIDATIVE STRESS; CELL METAPLASIA; LUNGS; WATER; COPD	Background: Over-production of mucus is an important pathophysiological feature in chronic airway disease such as chronic obstructive pulmonary disease (COPD) and asthma. Cigarette smoking (CS) is the leading cause of COPD. Oxidative stress plays a key role in CS-induced airway abnormal mucus production. Hydrogen protected cells and tissues against oxidative damage by scavenging hydroxyl radicals. In the present study we investigated the effect of hydrogen on CS-induced mucus production in rats. Methods: Male Sprague-Dawley rats were divided into four groups: sham control, CS group, hydrogen-rich saline pretreatment group and hydrogen-rich saline control group. Lung morphology and tissue biochemical changes were determined by immunohistochemistry, Alcian Blue/periodic acid-Schiff staining, TUNEL, western blot and realtime RT-PCR. Results: Hydrogen-rich saline pretreatment attenuated CS-induced mucus accumulation in the bronchiolar lumen, goblet cell hyperplasia, muc5ac over-expression and abnormal cell apoptosis in the airway epithelium as well as malondialdehyde increase in the BALF. The phosphorylation of EGFR at Tyr1068 and Nrf2 up-regulation expression in the rat lungs challenged by CS exposure were also abrogated by hydrogen-rich saline. Conclusion: Hydrogen-rich saline pretreatment ameliorated CS-induced airway mucus production and airway epithelium damage in rats. The protective role of hydrogen on CS-exposed rat lungs was achieved at least partly by its free radical scavenging ability. This is the first report to demonstrate that intraperitoneal administration of hydrogen-rich saline protected rat airways against CS damage and it could be promising in treating abnormal airway mucus production in COPD.	[Ning, Yunye; Shang, Yan; Huang, Haidong; Zhang, Jingxi; Dong, Yuchao; Xu, Wujian; Li, Qiang] Second Mil Med Univ, Changhai Hosp, Dept Resp Med, Shanghai, Peoples R China	Naval Medical University	Li, Q (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Resp Med, Shanghai, Peoples R China.	liqressh@hotmail.com			National Natural Science Foundation of China [81100012, 81000006, 81370136, 81170060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [Grant No. 81100012, 81000006, 81370136, 81170060]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2007, PLOS MED, V4, P779, DOI 10.1371/journal.pmed.0040112; Burgel PR, 2010, EUR RESPIR REV, V19, P94, DOI 10.1183/09059180.00004410; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Chen L, 2010, EUR RESPIR J, V36, P638, DOI 10.1183/09031936.00029409; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; D'Agostini F, 2001, CARCINOGENESIS, V22, P375, DOI 10.1093/carcin/22.3.375; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Hardeland R, 2012, CRIT CARE MED, V40, P1382, DOI 10.1097/CCM.0b013e318241112a; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Huang CS, 2010, FREE RADICAL RES, V44, P971, DOI 10.3109/10715762.2010.500328; Kajiyama S, 2008, NUTR RES, V28, P137, DOI 10.1016/j.nutres.2008.01.008; Lin JL, 2010, COPD, V7, P291, DOI 10.3109/15412555.2010.496818; Liu SL, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00019; MacNee W, 1999, AM J RESP CRIT CARE, V160, pS58, DOI 10.1164/ajrccm.160.supplement_1.15; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Nakao A, 2010, J CLIN BIOCHEM NUTR, V46, P140, DOI 10.3164/jcbn.09-100; Nakao A, 2009, J CLIN BIOCHEM NUTR, V44, P1, DOI 10.3164/jcbn.08-193R; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Perez-Vilar J, 2006, J BIOL CHEM, V281, P4844, DOI 10.1074/jbc.M510520200; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Repine JE, 1997, AM J RESP CRIT CARE, V156, P341, DOI 10.1164/ajrccm.156.2.9611013; Sadowska AM, 2012, THER ADV RESPIR DIS, V6, P127, DOI 10.1177/1753465812437563; Shimizu T, 2001, AM J RESP CRIT CARE, V164, P1077, DOI 10.1164/ajrccm.164.6.2012058; Sivaprasad U, 2010, J IMMUNOL, V184; Stevenson CS, 2005, AM J PHYSIOL-LUNG C, V288, pL514, DOI 10.1152/ajplung.00317.2004; Sun QA, 2011, J SURG RES, V165, pE43, DOI 10.1016/j.jss.2010.09.024; Voynow JA, 2006, AM J RESP CELL MOL, V34, P661, DOI 10.1165/rcmb.2006-0035SF; Yageta Y, 2011, J VIROL, V85, P4679, DOI 10.1128/JVI.02456-10	30	33	36	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83429	10.1371/journal.pone.0083429	http://dx.doi.org/10.1371/journal.pone.0083429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376700	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100118
J	Reamon-Buettner, SM; Sattlegger, E; Ciribilli, Y; Inga, A; Wessel, A; Borlak, J				Reamon-Buettner, Stella Marie; Sattlegger, Evelyn; Ciribilli, Yari; Inga, Alberto; Wessel, Armin; Borlak, Juergen			Transcriptional Defect of an Inherited NKX2-5 Haplotype Comprising a SNP, a Nonsynonymous and a Synonymous Mutation, Associated with Human Congenital Heart Disease	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; SEPTATION DEFECTS; CURRENT KNOWLEDGE; BINDING DOMAIN; HAND1; PATHOGENESIS; GENETICS; COUNCIL; YOUNG	Germline mutations in cardiac-specific transcription factor genes have been associated with congenital heart disease (CHD) and the homeodomain transcription factor NKX2-5 is an important member of this group. Indeed, more than 40 heterozygous NKX2-5 germline mutations have been observed in individuals with CHD, and these are spread along the coding region, with many shown to impact protein function. In pursuit of understanding causes of CHD, we analyzed n = 49 cardiac biopsies from 28 patients and identified by direct sequencing two nonsynonymous NKX2-5 alterations affecting alanine 119, namely c.356C>A (p.A119E) and c.355G>T, (p.A119S), in patients with AVSD and HLHS, respectively. In functional assays, a significant reduction in transcriptional activities could be determined for the NKX2-5 variants. Importantly, in one family the mother, besides p.A119E, carried a synonymous mutant allele in the homeodomain (c.543G>A, p.Q181), and a synonymous dbSNP (c.63A>G, p.E21) in the transactivation domain of the protein, that were transmitted to the CHD daughter. The presence of these variants in-cis with the p.A119E mutation led to a further reduction in transcriptional activities. Such difference in activity may be in part related to reduced protein expression for the double variant c.356C>A and c.543G>A. We propose changes in mRNA stability and folding, due to a silent mutation and a dbSNP in the NKX2-5 coding region to contribute to the functional defect. Although the clinical significance of the NKX2-5 haplotype identified in the CHD patients remains to be ascertained, we provide evidence of an interaction of a dbSNP, with synonymous and nonsynonymous mutations to negatively impact NKX2-5 transcriptional activity.	[Reamon-Buettner, Stella Marie] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany; [Sattlegger, Evelyn] Massey Univ, Inst Nat Sci, Auckland, New Zealand; [Ciribilli, Yari; Inga, Alberto] Univ Trento, Ctr Integrat Biol, Lab Transcript Networks, Mattarello, Italy; [Wessel, Armin] Hannover Med Sch, Dept Pediat Cardiol & Intens Care Med, Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany	Fraunhofer Gesellschaft; Massey University; University of Trento; Hannover Medical School; Hannover Medical School	Borlak, J (corresponding author), Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany.	Borlak.Juergen@mh-hannover.de	Inga, Alberto/AAC-3815-2022; Ciribilli, Yari/K-2751-2018	Inga, Alberto/0000-0002-8767-1637; Ciribilli, Yari/0000-0001-9231-379X	Ministry of Science and Culture, Lower Saxony, Germany [25A.5-76251-99-3/00]; ISAT Linkages Fund; Massey University Research Fund, New Zealand [ISATA06-54, 06/5053]; German Research Foundation (DFG)	Ministry of Science and Culture, Lower Saxony, Germany; ISAT Linkages Fund; Massey University Research Fund, New Zealand; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Ministry of Science and Culture, Lower Saxony, Germany [grant number 25A.5-76251-99-3/00 to Juergen Borlak]; ISAT Linkages Fund and Massey University Research Fund, New Zealand [grant numbers ISATA06-54, 06/5053 to Evelyn Sattlegger]. The charge for this publication was covered by the German Research Foundation (DFG) sponsorship "open access publication''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Dentice M, 2006, J CLIN ENDOCR METAB, V91, P1428, DOI 10.1210/jc.2005-1350; Draus JM, 2009, J MED GENET, V46, P115, DOI 10.1136/jmg.2008.060277; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Funke-Kaiser H, 2003, FASEB J, V17, P1487, DOI 10.1096/fj.02-0700fje; Gottlieb B, 2009, HUM MUTAT, V30, P1043, DOI 10.1002/humu.21046; Hobbs CA, 2005, AM J MED GENET A, V134A, P223, DOI 10.1002/ajmg.a.30509; Inga A, 2005, HUM MOL GENET, V14, P1965, DOI 10.1093/hmg/ddi202; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Kaiser K, 2005, PEDIATR RES, V58, P818, DOI 10.1203/00006450-200510000-00041; Kelly M, 2009, CIRC-CARDIOVASC GENE, V2, P182, DOI 10.1161/CIRCGENETICS.108.836478; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Posch MG, 2008, AM J MED GENET A, V146A, P251, DOI 10.1002/ajmg.a.32042; Rajagopal SK, 2007, J MOL CELL CARDIOL, V43, P677, DOI 10.1016/j.yjmcc.2007.06.004; Reamon-Buettner SM, 2008, HUM MOL GENET, V17, P1397, DOI 10.1093/hmg/ddn027; Reamon-Buettner SM, 2006, ANN ANAT, V188, P213, DOI 10.1016/j.aanat.2005.10.007; Reamon-Buettner SM, 2010, HUM MUTAT, V31, P1185, DOI 10.1002/humu.21345; Reamon-Buettner SM, 2009, HUM MOL GENET, V18, P3567, DOI 10.1093/hmg/ddp305; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; van Engelen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052685; Weismann CG, 2007, CURR OPIN CARDIOL, V22, P200, DOI 10.1097/HCO.0b013e3280f629c7; Winston JB, 2010, CIRCULATION, V121, P1313, DOI 10.1161/CIRCULATIONAHA.109.887687	25	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83295	10.1371/journal.pone.0083295	http://dx.doi.org/10.1371/journal.pone.0083295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376681	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100108
J	Turkcan, S; Masson, JB				Tuerkcan, Silvan; Masson, Jean-Baptiste			Bayesian Decision Tree for the Classification of the Mode of Motion in Single-Molecule Trajectories	PLOS ONE			English	Article							PARTICLE TRACKING; PLASMA-MEMBRANE; SIGNALING MOLECULES; ANCHORED PROTEIN; CELL-SURFACE; DIFFUSION; CONFINEMENT; INFERENCE; COMPLEX; NANOPARTICLES	Membrane proteins move in heterogeneous environments with spatially (sometimes temporally) varying friction and with biochemical interactions with various partners. It is important to reliably distinguish different modes of motion to improve our knowledge of the membrane architecture and to understand the nature of interactions between membrane proteins and their environments. Here, we present an analysis technique for single molecule tracking (SMT) trajectories that can determine the preferred model of motion that best matches observed trajectories. The method is based on Bayesian inference to calculate the posteriori probability of an observed trajectory according to a certain model. Information theory criteria, such as the Bayesian information criterion (BIC), the Akaike information criterion (AIC), and modified AIC (AICc), are used to select the preferred model. The considered group of models includes free Brownian motion, and confined motion in 2nd or 4th order potentials. We determine the best information criteria for classifying trajectories. We tested its limits through simulations matching large sets of experimental conditions and we built a decision tree. This decision tree first uses the BIC to distinguish between free Brownian motion and confined motion. In a second step, it classifies the confining potential further using the AK. We apply the method to experimental Clostridium Perfingens e-toxin (CPeT) receptor trajectories to show that these receptors are confined by a spring-like potential. An adaptation of this technique was applied on a sliding window in the temporal dimension along the trajectory. We applied this adaptation to experimental CPeT trajectories that lose confinement due to disaggregation of confining domains. This new technique adds another dimension to the discussion of SMT data. The mode of motion of a receptor might hold more biologically relevant information than the diffusion coefficient or domain size and may be a better tool to classify and compare different SMT experiments.	[Tuerkcan, Silvan; Masson, Jean-Baptiste] Inst Pasteur, Paris, France; [Tuerkcan, Silvan; Masson, Jean-Baptiste] CNRS, UMR 3525, Paris, France; [Tuerkcan, Silvan] INSERM, CNRS, Lab Opt & Biosci, U696, Palaiseau, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Turkcan, S (corresponding author), Inst Pasteur, Paris, France.	silvan@stanford.edu		masson, jean-baptiste/0000-0002-5484-9056	PIRIbio; French ANR, PNANO program	PIRIbio; French ANR, PNANO program(French National Research Agency (ANR))	The authors are grateful for funding from PIRIbio (http://www.agence-nationale-recherche.fr/programmes-de-recherche/appel-detail/?tx_saap_ pi1%5Buid%5D = 258) and French ANR, PNANO program (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAK LS, 1982, J CELL BIOL, V95, P846, DOI 10.1083/jcb.95.3.846; Burckhardt CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000621; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Casanova D, 2007, J AM CHEM SOC, V129, P12592, DOI 10.1021/ja0731975; Condamin S, 2008, P NATL ACAD SCI USA, V105, P5675, DOI 10.1073/pnas.0712158105; Coscoy S, 2007, B MATH BIOL, V69, P2467, DOI 10.1007/s11538-007-9227-8; Deverall MA, 2005, BIOPHYS J, V88, P1875, DOI 10.1529/biophysj.104.050559; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Frank T, 1996, FOKKER PLANCK EQUATI; Granick S, 2013, ARXIV13060505; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Helmuth JA, 2007, J STRUCT BIOL, V159, P347, DOI 10.1016/j.jsb.2007.04.003; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Jin S, 2007, BIOPHYS J, V93, P1079, DOI 10.1529/biophysj.106.102244; Kusumi A, 2005, SEMIN IMMUNOL, V17, P3, DOI 10.1016/j.smim.2004.09.004; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lord SJ, 2010, ANAL CHEM, V82, P2192, DOI 10.1021/ac9024889; MacKay D. J. C., 2003, INFORM THEORY INFERE; Masson JB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.048103; Monnier N, 2012, BIOPHYS J, V103, P616, DOI 10.1016/j.bpj.2012.06.029; Oddershede L, 2002, BIOPHYS J, V83, P3152, DOI 10.1016/S0006-3495(02)75318-6; Peters IM, 1999, CYTOMETRY, V36, P189, DOI 10.1002/(SICI)1097-0320(19990701)36:3<189::AID-CYTO7>3.0.CO;2-3; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Press W., 2001, NUMERICAL RECIPES C; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; RYAN TA, 1988, SCIENCE, V239, P61, DOI 10.1126/science.2962287; SAXTON MJ, 1993, BIOPHYS J, V64, P1766, DOI 10.1016/S0006-3495(93)81548-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sheets ED, 1997, BIOCHEMISTRY-US, V36, P12449, DOI 10.1021/bi9710939; SHEETZ MP, 1993, ANNU REV BIOPH BIOM, V22, P417, DOI 10.1146/annurev.bb.22.060193.002221; SHEETZ MP, 1989, NATURE, V340, P284, DOI 10.1038/340284a0; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Turkcan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082799; Tuerkcan S, 2013, BIOPHYS J, V105, P116, DOI [10.1016/j.bpj.2013.04.045, 10.1016/j.bpj.2013.05.045]; Turkcan S, 2012, BIOPHYS J, V102, P2299, DOI 10.1016/j.bpj.2012.03.072; Turkcan S, 2012, BIOPHYS J, V102, P2288, DOI 10.1016/j.bpj.2012.01.063; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Voisinne G, 2010, BIOPHYS J, V98, P596, DOI 10.1016/j.bpj.2009.10.051; von Toussaint U, 2011, REV MOD PHYS, V83, P943, DOI 10.1103/RevModPhys.83.943	45	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82799	10.1371/journal.pone.0082799	http://dx.doi.org/10.1371/journal.pone.0082799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376584	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100059
J	Wang, W; Ma, T; Lian, KH; Zhang, Y; Tian, HM; Ji, KH; Li, GQ				Wang, Wei; Ma, Ting; Lian, Kehui; Zhang, Yue; Tian, Huimei; Ji, Kaihua; Li, Guoqiang			Genetic Analysis of Benzothiophene Biodesulfurization Pathway of Gordonia terrae Strain C-6	PLOS ONE			English	Article							MYCOBACTERIUM-GOODII X7B; RHODOCOCCUS-ERYTHROPOLIS; DESULFURIZING BACTERIUM; FOSSIL-FUELS; DIBENZOTHIOPHENE; IDENTIFICATION; IGTS8; OVEREXPRESSION; MONOOXYGENASE; ALKANIVORANS	Sulfur can be removed from benzothiophene (BT) by some bacteria without breaking carbon-carbon bonds. However, a clear mechanism for BT desulfurization and its genetic components have not been reported in literatures so far. In this study, we used comparative transcriptomics to study differential expression of genes in Gordonia terrae C-6 cultured with BT or sodium sulfate as the sole source of sulfur. We found that 135 genes were up-regulated with BT relative to sodium sulfate as the sole sulfur source. Many of these genes encode flavin-dependent monooxygenases, alkane sulfonate monooxygenases and desulfinase, which perform similar functions to those involved in the 4S pathway of dibenzothiophene (DBT) biodesulfurization. Three of the genes were found to be located in the same operon, designated bdsABC. Cell extracts of pET28a-bdsABC transfected E. coli Rosetta (DE3) converted BT to a phenolic compound, identified as o-hydroxystyrene. These results advance our understanding of enzymes involved in the BT biodesulfurization pathway.	[Wang, Wei; Ma, Ting; Lian, Kehui; Zhang, Yue; Tian, Huimei; Ji, Kaihua; Li, Guoqiang] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China; [Wang, Wei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Wang, Wei] Tianjin Key Lab Microbial Funct Genom, Tianjin, Peoples R China	Nankai University; Nankai University	Li, GQ (corresponding author), Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China.	gqli@nankai.edu.cn		Wang, Wei/0000-0002-6660-8540	National Natural Science Foundation of China [31000056, 31170075, 31070078, 31370121]; Natural Science Foundation of Tianjin, China [09JCZDJC18000, 11JCZDJC16100, 11JCZDJC16600]; National High Technology Research and Development Program of China [2013AA064402]; Funds for National basic science personnel training [J1103503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Funds for National basic science personnel training	This work was supported by the National Natural Science Foundation of China (Grant No. 31000056, 31170075, 31070078, and 31370121), the Natural Science Foundation of Tianjin, China (Grant No. 09JCZDJC18000, 11JCZDJC16100, and 11JCZDJC16600), National High Technology Research and Development Program of China (2013AA064402) and Funds for National basic science personnel training(Grant No. J1103503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2013, MOL BIOSYST, V9, P2530, DOI 10.1039/c3mb70132h; Aggarwal S, 2012, MOL BIOSYST, V8, P2724, DOI 10.1039/c2mb25127b; Aggarwal S, 2011, FEMS MICROBIOL LETT, V315, P115, DOI 10.1111/j.1574-6968.2010.02179.x; Dinamarca MA, 2010, BIORESOURCE TECHNOL, V101, P2375, DOI 10.1016/j.biortech.2009.11.086; Chen H, 2009, BIORESOURCE TECHNOL, V100, P2085, DOI 10.1016/j.biortech.2008.10.010; Chi YS, 2011, GREEN CHEM, V13, P1224, DOI 10.1039/c0gc00745e; Coco WM, 2001, NAT BIOTECHNOL, V19, P354, DOI 10.1038/86744; Davoodi-Dehaghani F, 2010, BIORESOURCE TECHNOL, V101, P1102, DOI 10.1016/j.biortech.2009.08.058; DENOME SA, 1994, J BACTERIOL, V176, P6707, DOI 10.1128/JB.176.21.6707-6716.1994; DENOME SA, 1993, APPL ENVIRON MICROB, V59, P2837, DOI 10.1128/AEM.59.9.2837-2843.1993; Gilbert SC, 1998, MICROBIOL-UK, V144, P2545, DOI 10.1099/00221287-144-9-2545; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; Hasan Z, 2012, J HAZARD MATER, V205, P216, DOI 10.1016/j.jhazmat.2011.12.059; Ishii Y, 2000, BIOCHEM BIOPH RES CO, V270, P81, DOI 10.1006/bbrc.2000.2370; KODAMA K, 1973, AGR BIOL CHEM TOKYO, V37, P45, DOI 10.1080/00021369.1973.10860640; Konishi J, 2000, FEMS MICROBIOL LETT, V187, P151, DOI 10.1016/S0378-1097(00)00186-5; Kulkarni PS, 2010, GREEN CHEM, V12, P1139, DOI 10.1039/c002113j; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee WC, 2006, J BIOL CHEM, V281, P32534, DOI 10.1074/jbc.M602974200; Lei BF, 1996, J BACTERIOL, V178, P5699, DOI 10.1128/jb.178.19.5699-5705.1996; Li FL, 2005, APPL ENVIRON MICROB, V71, P276, DOI 10.1128/AEM.71.1.276-281.2005; Li GQ, 2008, APPL ENVIRON MICROB, V74, P971, DOI 10.1128/AEM.02319-07; Li JC, 2009, BIORESOURCE TECHNOL, V100, P2594, DOI 10.1016/j.biortech.2008.12.009; Li YG, 2009, BIORESOURCE TECHNOL, V100, P5092, DOI 10.1016/j.biortech.2009.05.064; Matsubara T, 2001, APPL ENVIRON MICROB, V67, P1179, DOI 10.1128/AEM.67.3.1179-1184; Mohebali G, 2008, MICROBIOL-SGM, V154, P2169, DOI 10.1099/mic.0.2008/017608-0; Monticello DJ, 2000, CURR OPIN BIOTECH, V11, P540, DOI 10.1016/S0958-1669(00)00154-3; Pawelec B, 2011, CATAL SCI TECHNOL, V1, P23, DOI 10.1039/c0cy00049c; Ren Q, 2009, FISH SHELLFISH IMMUN, V26, P787, DOI 10.1016/j.fsi.2009.03.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shavandi M, 2009, BIORESOURCE TECHNOL, V100, P475, DOI 10.1016/j.biortech.2008.06.011; Tanaka Y, 2002, APPL MICROBIOL BIOT, V59, P325, DOI 10.1007/s00253-002-0985-9; Tanaka Y, 2001, CURR MICROBIOL, V43, P187, DOI 10.1007/s002840010285; Wang W, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00381-13, DOI 10.1128/GEN0MEA.00381-13.PUBMED:23788548]; Xu P, 2009, ADV BIOCHEM ENG BIOT, V113, P255, DOI 10.1007/10_2008_16	36	26	28	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84386	10.1371/journal.pone.0084386	http://dx.doi.org/10.1371/journal.pone.0084386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367657	gold, Green Submitted, Green Published			2022-12-27	WOS:000328741900045
J	Hanafusa, S; Kawaguchi, T; Umezaki, Y; Tomioka, K; Yoshii, T				Hanafusa, Shiho; Kawaguchi, Tomoaki; Umezaki, Yujiro; Tomioka, Kenji; Yoshii, Taishi			Sexual Interactions Influence the Molecular Oscillations in DN1 Pacemaker Neurons in Drosophila melanogaster	PLOS ONE			English	Article							MALE COURTSHIP BEHAVIOR; CLOCK NEURONS; CIRCADIAN CLOCK; PERIOD; RHYTHMS; LIGHT; TEMPERATURE; GENE; CRYPTOCHROME; DRIVE	Circadian rhythms can synchronize to environmental time cues, such as light, temperature, humidity, and food availability. Previous studies have suggested that these rhythms can also be entrained by social interactions. Here, we used Drosophila melanogaster as a model to study the influence of socio-sexual interactions on the circadian clock in behavior and pacemaker neurons. If two flies of opposite sex were paired and kept in a small space, the daily activity patterns of the two flies were clearly different from the sum of the activity of single male and female flies. Compared with single flies, paired flies were more active in the night and morning, were more active during females' active phase, and were less active during males' active phase. These behavioral phenotypes are related to courtship behavior, but not to the circadian clock. Nevertheless, in male-female pairs of flies with clocks at different speeds ( wild-type and per(S) flies), clock protein cycling in the DN1 pacemaker neurons in the male brain were slightly influenced by their partners. These results suggest that sexual interactions between male-female couples can serve as a weak zeitgeber for the DN1 pacemaker neurons, but the effect is not sufficient to alter rhythms of behavioral activity.	[Hanafusa, Shiho; Kawaguchi, Tomoaki; Umezaki, Yujiro; Tomioka, Kenji; Yoshii, Taishi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Okayama University	Yoshii, T (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	yoshii@okayama-u.ac.jp	Yoshii, Taishi/C-2766-2015; Tomioka, Kenji/B-2632-2011	Yoshii, Taishi/0000-0002-7057-7986; Tomioka, Kenji/0000-0001-7951-8950	Sumitomo Foundation; Inamori Foundation; Ryobi Teien Memory Foundation;  [KAKENHI 23870021];  [25840121];  [KAKENHI 19657027];  [23657056]; Grants-in-Aid for Scientific Research [23657056] Funding Source: KAKEN	Sumitomo Foundation; Inamori Foundation; Ryobi Teien Memory Foundation(Ryobi Teien Memory Foundation); ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant for Basic Science Research Projects from the Sumitomo Foundation, Inamori Foundation, Ryobi Teien Memory Foundation and research grants from Grants-in-Aid for Scientific Research (KAKENHI 23870021 and 25840121 to TY, and KAKENHI 19657027 and 23657056 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsalam S, 2008, J INSECT PHYSIOL, V54, P1205, DOI 10.1016/j.jinsphys.2008.05.001; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Bloch G, 2001, NATURE, V410, P1048, DOI 10.1038/35074183; Bloch G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0035; Bywalez W, 2012, CHRONOBIOL INT, V29, P395, DOI 10.3109/07420528.2012.668505; Castillo-Ruiz A, 2012, PROG BRAIN RES, V199, P267, DOI 10.1016/B978-0-444-59427-3.00016-2; Choi C, 2010, CURR BIOL, V20, pR322, DOI 10.1016/j.cub.2010.02.036; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; Fujii S, 2010, P NATL ACAD SCI USA, V107, P10590, DOI 10.1073/pnas.0912457107; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hamasaka Y, 2010, GENES CELLS, V15, P1240, DOI 10.1111/j.1365-2443.2010.01456.x; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Hirsh J, 2010, CURR BIOL, V20, P209, DOI 10.1016/j.cub.2009.11.037; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kistenpfennig C, 2012, J BIOL RHYTHM, V27, P117, DOI 10.1177/0748730411434390; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Lone SR, 2012, J BIOL RHYTHM, V27, P107, DOI 10.1177/0748730411434384; Lone SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028336; Lone SR, 2011, J EXP BIOL, V214, P3742, DOI 10.1242/jeb.057554; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rieger D, 2009, J BIOL RHYTHM, V24, P271, DOI 10.1177/0748730409338508; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; Schmid B, 2011, J BIOL RHYTHM, V26, P464, DOI 10.1177/0748730411414264; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Tauber E, 2003, CURR BIOL, V13, P140, DOI 10.1016/S0960-9822(03)00004-6; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Yoshii T, 2012, PROG BRAIN RES, V199, P59, DOI 10.1016/B978-0-444-59427-3.00027-7; Yoshii T, 2010, J BIOL RHYTHM, V25, P387, DOI 10.1177/0748730410381962; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044; Zheng XZ, 2012, TRENDS NEUROSCI, V35, P574, DOI 10.1016/j.tins.2012.05.007	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84495	10.1371/journal.pone.0084495	http://dx.doi.org/10.1371/journal.pone.0084495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367668	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300145
J	Saridaki, Z; Tzardi, M; Sfakianaki, M; Papadaki, C; Voutsina, A; Kalykaki, A; Messaritakis, I; Mpananis, K; Mavroudis, D; Stathopoulos, E; Georgoulias, V; Souglakos, J				Saridaki, Zacharenia; Tzardi, Maria; Sfakianaki, Maria; Papadaki, Chara; Voutsina, Alexandra; Kalykaki, Aristea; Messaritakis, Ippokratis; Mpananis, Kyriakos; Mavroudis, Dimitris; Stathopoulos, Efstathios; Georgoulias, Vassilis; Souglakos, John			BRAFV600E Mutation Analysis in Patients with Metastatic Colorectal Cancer (mCRC) in Daily Clinical Practice: Correlations with Clinical Characteristics, and Its Impact on Patients' Outcome	PLOS ONE			English	Article							CETUXIMAB PLUS IRINOTECAN; BRAF V600E MUTATION; COLON-CANCER; MISMATCH-REPAIR; MICROSATELLITE INSTABILITY; SURVIVAL; KRAS; EXPRESSION	Background: To prospectively evaluate the usefulness of the BRAFV600E mutation detection in daily clinical practice in patients with metastatic Colorectal Cancer (mCRC). Patients and Methods: 504 mCRC patients treated with systemic chemotherapy +/- biologics were analyzed. Results: A statistically significant higher incidence of the BRAF mutation was observed in patients with ECOG-PS 2 (p=0.001), multiple metastatic sites (p=0.002),> 65 years old (p=0.004), primary tumors located in the colon (p<0.001), high-grade tumors (p=0.001) and in those with mucinous features (p=0.037). Patients with BRAFV600E mutated tumors had a statistically significantly reduced progression-free survival (PFS) compared to wild-type (wt) ones (4.1 and 11.6 months, respectively; p<0.001) and overall survival (OS) (14.0 vs. 34.6 months, respectively; p<0.001). In the multivariate analysis the BRAFV600E mutation emerged as an independent factor associated with reduced PFS (HR: 4.1, 95% CI 2.7-6.2; p<0.001) and OS (HR: 5.9, 95% CI 3.7-9.5; p<0.001). Among the 273 patients treated with salvage cetuximab or panitumumab, the BRAFV600E mutation was correlated with reduced PFS (2.2 vs. 6.0 months; p<0.0001) and OS (4.3 vs. 17.4 months; p<0.0001). Conclusions: The presence of BRAFV600E-mutation in mCRC characterizes a subgroup of patients with distinct biologic, clinical and pathological features and is associated with very poor patients' prognosis.	[Saridaki, Zacharenia; Sfakianaki, Maria; Papadaki, Chara; Voutsina, Alexandra; Kalykaki, Aristea; Messaritakis, Ippokratis; Mpananis, Kyriakos; Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John] Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Crete, Greece; [Saridaki, Zacharenia; Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John] Univ Gen Hosp, Dept Med Oncol, Iraklion, Crete, Greece; [Tzardi, Maria; Stathopoulos, Efstathios] Univ Gen Hosp, Pathol Lab, Iraklion, Crete, Greece	University of Crete; University Hospital of Heraklion; University Hospital of Heraklion	Souglakos, J (corresponding author), Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Crete, Greece.	georgsec@med.uoc.gr	Messaritakis, Ippokratis/H-6668-2019	Messaritakis, Ippokratis/0000-0003-1877-500X; PAPADAKI, CHARA/0000-0002-4591-3757	Cretan Association for Biomedical Research (CABR); Hellenic Society for Medical Oncology (HeSMO); CABR	Cretan Association for Biomedical Research (CABR); Hellenic Society for Medical Oncology (HeSMO); CABR	This work was partly supported by a grant from the Cretan Association for Biomedical Research (CABR) and the Hellenic Society for Medical Oncology (HeSMO). Z.S., I.M. and A.V. are recipients of a CABR post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Domingo E, 2004, J MED GENET, V41, P664, DOI 10.1136/jmg.2004.020651; French AJ, 2008, CLIN CANCER RES, V14, P3408, DOI 10.1158/1078-0432.CCR-07-1489; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Oliner KS, 2013, J CLIN ONCOL, V31; Oliveira C, 2003, ONCOGENE, V22, P9192, DOI 10.1038/sj.onc.1207061; Pentheroudakis G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-49; Popovici V, 2012, J CLIN ONCOL, V30, P1288, DOI 10.1200/JCO.2011.39.5814; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Saridaki Z, 2010, BRIT J CANCER, V102, P1762, DOI 10.1038/sj.bjc.6605694; Saridaki Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015980; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Souglakos J, 2009, BRIT J CANCER, V101, P465, DOI 10.1038/sj.bjc.6605164; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Wang L, 2003, CANCER RES, V63, P5209	23	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84604	10.1371/journal.pone.0084604	http://dx.doi.org/10.1371/journal.pone.0084604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367680	gold, Green Submitted, Green Published			2022-12-27	WOS:000328740300151
J	Alqumber, MAA; Mandal, RK; Haque, S; Panda, AK; Akhter, N; Ali, A				Alqumber, Mohammed A. A.; Mandal, Raju K.; Haque, Shafiul; Panda, Aditya K.; Akhter, Naseem; Ali, Arif			A Genetic Association Study of CCL5-28 C > G (rs2280788) Polymorphism with Risk of Tuberculosis: A Meta-Analysis	PLOS ONE			English	Article							BETA-CHEMOKINES; SUSCEPTIBILITY	Aim: The CC chemokine ligand 5 (CCL5), plays a key role in the inflammatory response by recruiting mononuclear cells during tuberculosis (TB) infection. Association studies of CCL5 -28 C>G (rs2280788) polymorphism and TB risk have shown inconsistent and contradictory results among different ethnic populations. The aim of this meta-analysis is to investigate the association between CCL5 -28 C>G polymorphism and TB susceptibility. Methodology: We performed quantitative synthesis for published studies based upon association between CCL5 -28 C>G polymorphism and TB risk from PubMed (Medline), EMBASE web databases. The meta-analysis was performed and pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated for all genetic models. Results: A total of six studies including 1324 TB cases and 1407 controls were involved in this meta-analysis. Variant allele (G vs. C: p = 0.257; OR = 1.809, 95% CI = 0.649 to 5.043), heterozygous (CG vs. CC: p = 0.443; OR = 1.440, 95% CI = 0.567 to 3.658) and homozygous (GG vs. CC: p = 0.160; OR = 5.140, 95% CI = 0.524 to 50.404) carriers did not show increased risk compare with those individual with the CC genotype. Similarly, no associations were found in the dominant (GG+CG vs. CC: p = 0.295; OR = 1.802, 95% CI = 0.599 to 5.412) and recessive (GG vs. CC+CG: p = 0.188; OR = 3.533, 95% CI = 0.541 to 23.085) models. Conclusions: Overall findings of this meta-analysis suggest that genetic polymorphism -28 C>G in CCL5 is not associated with increased TB risk. However, future larger studies with group of populations will be needed to analyze the relationship between the CCL5 -28 C>G polymorphism and risk of TB.	[Alqumber, Mohammed A. A.; Akhter, Naseem] Albaha Univ, Fac Appl Med Sci, Dept Lab Med, Albaha, Saudi Arabia; [Mandal, Raju K.] Sanjay Gandhi Post Grad Inst Med Sci, Dept Urol, Lucknow, Uttar Pradesh, India; [Haque, Shafiul; Ali, Arif] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India; [Panda, Aditya K.] Inst Life Sci, Dept Infect Dis Biol, Bhubaneswar, Orissa, India	Al Baha University; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Jamia Millia Islamia; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Ali, A (corresponding author), Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India.	ali.ariifali@gmail.com	AKHTER, NASEEM/ABF-4588-2021; Panda, Aditya K/E-1267-2012; HAQUE, SHAFIUL/AAN-2946-2020	AKHTER, NASEEM/0000-0003-2011-0955; Panda, Aditya K/0000-0002-1192-1978; HAQUE, SHAFIUL/0000-0002-2989-121X; Mandal, Raju/0000-0001-6206-1413				Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; [Anonymous], 2011, GLOB TUB CONTR; Areeshi MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064747; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Bellamy R, 2006, MICROBES INFECT, V8, P1119, DOI 10.1016/j.micinf.2005.10.025; Ben-Selma W, 2011, DNA CELL BIOL, V30, P789, DOI 10.1089/dna.2010.1200; Britton W J, 2007, Novartis Found Symp, V281, P79; Chu SF, 2007, GENES IMMUN, V8, P475, DOI 10.1038/sj.gene.6364412; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Copas J, 2000, Biostatistics, V1, P247, DOI 10.1093/biostatistics/1.3.247; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jang Y, 2007, CLIN SCI, V113, P349, DOI 10.1042/CS20070014; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; Lima MF, 1997, CELL MOL BIOL, V43, P1067; Liu HL, 1999, P NATL ACAD SCI USA, V96, P4581, DOI 10.1073/pnas.96.8.4581; Lykouras D, 2008, Monaldi Arch Chest Dis, V69, P24; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mendez-Samperio P, 2008, J INFECTION, V57, P374, DOI 10.1016/j.jinf.2008.08.010; Mhmoud N, 2013, TROP MED INT HEALTH, V18, P1119, DOI 10.1111/tmi.12141; Mishra G, 2012, INFECT GENET EVOL, V12, P1120, DOI 10.1016/j.meegid.2012.03.018; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Rosman M.D., 1998, FISHMANS PULMONARY D, P2483; Sanchez-Castanon M, 2009, INT J TUBERC LUNG D, V13, P480; Selvaraj P, 2011, INT J IMMUNOGENET, V38, P397, DOI 10.1111/j.1744-313X.2011.01021.x; Siveke JT, 1998, J IMMUNOL, V160, P550; Taub DD, 1996, J IMMUNOL, V156, P2095; Wu RL, 1999, BIOMETRICS, V55, P355	31	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83422	10.1371/journal.pone.0083422	http://dx.doi.org/10.1371/journal.pone.0083422			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376699	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000086
J	de Biase, D; Visani, M; Malapelle, U; Simonato, F; Cesari, V; Bellevicine, C; Pession, A; Troncone, G; Fassina, A; Tallini, G				de Biase, Dario; Visani, Michela; Malapelle, Umberto; Simonato, Francesca; Cesari, Valentina; Bellevicine, Claudio; Pession, Annalisa; Troncone, Giancarlo; Fassina, Ambrogio; Tallini, Giovanni			Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy)	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR MUTATIONS; TYROSINE KINASE INHIBITORS; PROCESS VERSION 2; REAL-TIME PCR; ACQUIRED-RESISTANCE; KRAS MUTATIONS; OPEN-LABEL; COLORECTAL-CARCINOMA; 1ST-LINE TREATMENT	Selection of lung cancer patients for therapy with tyrosine kinase inhibitors directed at EGFR requires the identification of specific EGFR mutations. In most patients with advanced, inoperable lung carcinoma limited tumor samples often represent the only material available for both histologic typing and molecular analysis. We defined a next generation sequencing protocol targeted to EGFR exons 18-21 suitable for the routine diagnosis of such clinical samples. The protocol was validated in an unselected series of 80 small biopsies (n=14) and cytology (n=66) specimens representative of the material ordinarily submitted for diagnostic evaluation to three referral medical centers in Italy. Specimens were systematically evaluated for tumor cell number and proportion relative to nonneoplastic cells. They were analyzed in batches of 100-150 amplicons per run, reaching an analytical sensitivity of 1% and obtaining an adequate number of reads, to cover all exons on all samples analyzed. Next generation sequencing was compared with Sanger sequencing. The latter identified 15 EGFR mutations in 14/80 cases (17.5%) but did not detected mutations when the proportion of neoplastic cells was below 40%. Next generation sequencing identified 31 EGFR mutations in 24/80 cases (30.0%). Mutations were detected with a proportion of neoplastic cells as low as 5%. All mutations identified by the Sanger method were confirmed. In 6 cases next generation sequencing identified exon 19 deletions or the L858R mutation not seen after Sanger sequencing, allowing the patient to be treated with tyrosine kinase inhibitors. In one additional case the R831H mutation associated with treatment resistance was identified in an EGFR wild type tumor after Sanger sequencing. Next generation sequencing is robust, cost-effective and greatly improves the detection of EGFR mutations. Its use should be promoted for the clinical diagnosis of mutations in specimens with unfavorable tumor cell content.	[de Biase, Dario; Cesari, Valentina; Tallini, Giovanni] Univ Bologna, Bellaria Hosp, Dept Med DIMES, Anat Pathol Unit, Bologna, Italy; [Visani, Michela; Cesari, Valentina; Pession, Annalisa] Univ Bologna, Dept Pharmacol & Biotechnol FaBiT, Bologna, Italy; [Malapelle, Umberto; Bellevicine, Claudio; Troncone, Giancarlo] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Simonato, Francesca; Fassina, Ambrogio] Univ Padua, Dept Med DIMED, Surg Pathol & Cytopathol Unit, Padua, Italy	AUSL di Bologna; University of Bologna; University of Bologna; University of Naples Federico II; University of Padua	Tallini, G (corresponding author), Univ Bologna, Bellaria Hosp, Dept Med DIMES, Anat Pathol Unit, Bologna, Italy.	giovanni.tallini@unibo.it	Tallini, Giovanni/F-7850-2013; Visani, Michela/K-5597-2016; de Biase, Dario/B-9274-2012	Tallini, Giovanni/0000-0003-0113-6682; Visani, Michela/0000-0002-9051-2231; de Biase, Dario/0000-0002-0609-8817; Malapelle, Umberto/0000-0003-3211-9957; Pession, Annalisa/0000-0001-9035-9698; Bellevicine, Claudio/0000-0002-7479-6457	Italian Government MURST [20093XZC57_003]	Italian Government MURST	The authors confirm that this study was supported by an Italian Government MURST grant (Grant no. 20093XZC57_003) to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aisner DL, 2012, AM J CLIN PATHOL, V138, P332, DOI 10.1309/AJCPFR12WJKCEEZZ; Akbari M, 2005, J MOL DIAGN, V7, P36, DOI 10.1016/S1525-1578(10)60006-2; Altimari A, 2013, ONCOTARGETS THER, V6, P1057, DOI 10.2147/OTT.S42369; Angulo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043842; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Araki T, 2011, ONCOL REP, V26, P1213, DOI 10.3892/or.2011.1391; Arcila M, 2011, J MOL DIAGN, V13, P64, DOI 10.1016/j.jmoldx.2010.11.005; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Beau-Faller M, 2011, J THORAC ONCOL, V6, P1006, DOI 10.1097/JTO.0b013e318211dcee; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Chang YL, 2011, CANCER SCI, V102, P282, DOI 10.1111/j.1349-7006.2010.01768.x; Chin ELH, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-6; Dufort S, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-57; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Eberhard DA, 2008, J CLIN ONCOL, V26, P983, DOI 10.1200/JCO.2007.12.9858; Ellison G, 2013, J CLIN PATHOL, V66, P79, DOI 10.1136/jclinpath-2012-201194; Fassina A, 2009, J CLIN PATHOL, V62, P1096, DOI 10.1136/jcp.2009.067587; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Il Na I, 2007, LUNG CANCER, V57, P96, DOI 10.1016/j.lungcan.2007.01.027; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Johnson BE, 2005, CANCER RES, V65, P7525, DOI 10.1158/0008-5472.CAN-05-1257; Kato Y, 2010, J THORAC ONCOL, V5, P1551, DOI 10.1097/JTO.0b013e3181e9da60; Kawada I, 2008, J THORAC ONCOL, V3, P1096, DOI 10.1097/JTO.0b013e318186fadd; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kotoula V, 2009, ENDOCR-RELAT CANCER, V16, P565, DOI 10.1677/ERC-08-0101; Lindeman NI, 2013, ARCH PATHOL LAB MED, V137, P828, DOI [10.5858/arpa.2012-0720-OA, 10.1097/JTO.0b013e318290868f]; Lozano MD, 2011, ONCOLOGIST, V16, P877, DOI 10.1634/theoncologist.2010-0155; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Malapelle U, 2013, CANCER CYTOPATHOL, V121, P552, DOI 10.1002/cncy.21322; Marchetti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042164; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; Metzger B, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-144; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Miyamae Y, 2010, J MOL DIAGN, V12, P257, DOI 10.2353/jmoldx.2010.090105; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Morandi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036084; Moskalev EA, 2013, VIRCHOWS ARCH, V462, P409, DOI 10.1007/s00428-013-1376-6; Na II, 2007, EUR J CANCER, V43, P520, DOI 10.1016/j.ejca.2006.09.025; Nomoto K, 2006, AM J CLIN PATHOL, V126, P608, DOI 10.1309/N5PQNGW2QKMX09X7; Oshita F, 2006, BRIT J CANCER, V95, P1070, DOI 10.1038/sj.bjc.6603396; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pirker Robert, 2010, J Thorac Oncol, V5, P1706, DOI 10.1097/JTO.0b013e3181f1c8de; Querings S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019601; Rekhtman N, 2011, J THORAC ONCOL, V6, P451, DOI 10.1097/JTO.0b013e31820517a3; Rosell R, 2005, LUNG CANCER-J IASLC, V50, P25, DOI 10.1016/j.lungcan.2005.05.017; Rosell R, 2012, LANCET ONCOL, V13, P971, DOI 10.1016/S1470-2045(12)70369-8; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Santos GD, 2011, CANCER CYTOPATHOL, V119, P80, DOI 10.1002/cncy.20150; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Travis WD, 2004, WHO PATHOLOGY GENETI; Tuononen K, 2013, GENE CHROMOSOME CANC, V52, P503, DOI 10.1002/gcc.22047; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; Whitehall V, 2009, J MOL DIAGN, V11, P543, DOI 10.2353/jmoldx.2009.090057; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Yang CH, 2008, J CLIN ONCOL, V26, P2745, DOI 10.1200/JCO.2007.15.6695; Yang JC, 2012, J CLIN ONCOL S, V30S; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	68	57	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83607	10.1371/journal.pone.0083607	http://dx.doi.org/10.1371/journal.pone.0083607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376723	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000101
J	Dong, ZJ; Song, TC; Yuan, C				Dong, Zijian; Song, Tiecheng; Yuan, Chuang			Inference of Gene Regulatory Networks from Genetic Perturbations with Linear Regression Model	PLOS ONE			English	Article							IDENTIFICATION; EVOLUTION	It is an effective strategy to use both genetic perturbation data and gene expression data to infer regulatory networks that aims to improve the detection accuracy of the regulatory relationships among genes. Based on both types of data, the genetic regulatory networks can be accurately modeled by Structural Equation Modeling (SEM). In this paper, a linear regression (LR) model is formulated based on the SEM, and a novel iterative scheme using Bayesian inference is proposed to estimate the parameters of the LR model (LRBI). Comparative evaluations of LRBI with other two algorithms, the Adaptive Lasso (AL-Based) and the Sparsity-aware Maximum Likelihood (SML), are also presented. Simulations show that LRBI has significantly better performance than AL-Based, and overperforms SML in terms of power of detection. Applying the LRBI algorithm to experimental data, we inferred the interactions in a network of 35 yeast genes. An open-source program of the LRBI algorithm is freely available upon request.	[Dong, Zijian] Huaihai Inst Technol, Sch Elect Engn, Lianyungang, Jiangsu, Peoples R China; [Dong, Zijian; Song, Tiecheng] Southeast Univ, Sch Informat Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Yuan, Chuang] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hang Kong, Peoples R China	Jiangsu Ocean University; Southeast University - China; Hong Kong Polytechnic University	Dong, ZJ (corresponding author), Huaihai Inst Technol, Sch Elect Engn, Lianyungang, Jiangsu, Peoples R China.	dzjian@126.com		YUAN, Chuang/0000-0003-1727-9047	National Natural Science Foundation of China [61271207, 61174013]; Natural Science Foundation of Jiangsu Province, China [BK2011398]; Jiangsu Overseas Research \& Training Program for University Prominent Young \& Middle-aged Teachers and Presidents; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Jiangsu Overseas Research \& Training Program for University Prominent Young \& Middle-aged Teachers and Presidents; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was jointly supported by the National Natural Science Foundation of China (No. 61271207, No. 61174013), the Natural Science Foundation of Jiangsu Province, China (No. BK2011398), the Jiangsu Overseas Research \& Training Program for University Prominent Young \& Middle-aged Teachers and Presidents, and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiou D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100124; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Broemeling L. D., 1985, BAYESIAN ANAL LINEAR; Cai X, 2011, GEN SIGN PROC STAT G, P66; Cai XD, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003068; Davidson E, 2005, P NATL ACAD SCI USA, V102, P4935, DOI 10.1073/pnas.0502024102; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; DeGroot M. H., 1970, OPTIMAL STAT DECISIO; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; Kramer N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-384; Lee S.-Y., 2007, STRUCTURAL EQUATION; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li JN, 2009, J MACH LEARN RES, V10, P475; Li RH, 2006, PLOS GENET, V2, P1046, DOI 10.1371/journal.pgen.0020114; Liu B, 2008, GENETICS, V178, P1763, DOI 10.1534/genetics.107.080069; Logsdon BA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001014; Neto EC, 2008, GENETICS, V179, P1089, DOI 10.1534/genetics.107.085167; Neto EC, 2010, ANN APPL STAT, V4, P320, DOI 10.1214/09-AOAS288; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Toh H, 2002, BIOINFORMATICS, V18, P287, DOI 10.1093/bioinformatics/18.2.287; Watkinson J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-10; Werhli AV, 2006, BIOINFORMATICS, V22, P2523, DOI 10.1093/bioinformatics/btl391; Xiong MM, 2004, GENETICS, V166, P1037, DOI 10.1534/genetics.166.2.1037; Zheng XY, 2003, 2003 IEEE INTELLIGENT TRANSPORTATION SYSTEMS PROCEEDINGS, VOLS. 1 & 2, P856	27	50	52	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83263	10.1371/journal.pone.0083263	http://dx.doi.org/10.1371/journal.pone.0083263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376676	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000076
J	Edwards, AL; Sangurdekar, DP; Jeong, KS; Khodursky, AB; Rybenkov, VV				Edwards, Andrea L.; Sangurdekar, Dipen P.; Jeong, Kyeong S.; Khodursky, Arkady B.; Rybenkov, Valentin V.			Transient Growth Arrest in Escherichia coli Induced by Chromosome Condensation	PLOS ONE			English	Article							RECOMBINANT PROTEINS; H-NS; DNA; MUKB; COMPLEX; OVEREXPRESSION; OVERPRODUCTION; LOCALIZATION; ARCHITECTURE; REPLICATION	MukB is a bacterial SMC (structural maintenance of chromosome) protein that regulates the global folding of the Escherichia coli chromosome by bringing distant DNA segments together. We report that moderate overproduction of MukB may lead, depending on strain and growth conditions, to transient growth arrest. In DH5 alpha cells, overproduction of MukB or MukBEF using pBAD expression system triggered growth arrest 2.5 h after induction. The exit from growth arrest was accompanied by the loss of the overproducing plasmid and a decline in the abundance of MukBEF. The arrested cells showed a compound gene expression profile which can be characterized by the following features: (i) a broad and deep downregulation of ribosomal proteins (up to 80-fold); (ii) downregulation of groups of genes encoding enzymes involved in nucleotide metabolism, respiration, and central metabolism; (iii) upregulation of some of the genes responsive to general stress; and (iv) degradation of the patterns of spatial correlations in the transcriptional activity of the chromosome. The transcriptional state of the MukB induced arrest is most similar to stationary cells and cells recovered from stationary phase into a nutrient deprived medium, to amino acid starved cells and to the cells shifting from glucose to acetate. The mukB++ state is dissimilar from all examined transcriptional states generated by protein overexpression with the possible exception of RpoE and RpoH overexpression. Thus, the transcription profile of MukB-arrested cells can be described as a combination of responses typical for other growth-arrested cells and those for overproducers of DNA binding proteins with a particularly deep down-regulation of ribosomal genes.	[Edwards, Andrea L.; Rybenkov, Valentin V.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Sangurdekar, Dipen P.; Jeong, Kyeong S.; Khodursky, Arkady B.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Minnesota System; University of Minnesota Twin Cities	Khodursky, AB (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA.	khodu001@umn.edu; valya@ou.edu			National Science Foundation [1049755]; NIH [GM066098]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066098] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1049755] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation under Grant 1049755 to VVR and award GM066098 from NIH to ABK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; Bonomo J, 2005, BIOTECHNOL BIOENG, V90, P116, DOI 10.1002/bit.20436; Chen N, 2008, J BACTERIOL, V190, P3731, DOI 10.1128/JB.01863-07; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Cui YB, 2008, NAT STRUCT MOL BIOL, V15, P411, DOI 10.1038/nsmb.1410; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; DIXON NE, 1984, P NATL ACAD SCI-BIOL, V81, P424, DOI 10.1073/pnas.81.2.424; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Efron B, 2005, LOCAL FALSE DISCOVER; Gill RT, 2000, METAB ENG, V2, P178, DOI 10.1006/mben.2000.0148; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Jeong KS, 2006, PLOS GENET, V2, P1464, DOI 10.1371/journal.pgen.0020152; JONES PG, 1987, J BACTERIOL, V169, P2092, DOI 10.1128/jb.169.5.2092-2095.1987; KAWASHIMA H, 1984, MOL GEN GENET, V193, P288, DOI 10.1007/BF00330682; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; Khodursky Arkady B, 2003, Methods Mol Biol, V224, P61; MCGOVERN V, 1994, BIOCHIMIE, V76, P1019, DOI 10.1016/0300-9084(94)90026-4; METZGER S, 1989, J BIOL CHEM, V264, P21146; Monod J., 1942, ACTUALITES SCI IND; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Oh MK, 2000, METAB ENG, V2, P201, DOI 10.1006/mben.2000.0149; Ohsumi K, 2001, MOL MICROBIOL, V40, P835, DOI 10.1046/j.1365-2958.2001.02447.x; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; Petrushenko ZM, 2010, EMBO J, V29, P1126, DOI 10.1038/emboj.2009.414; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Rybenkov VV, 2009, NAT STRUCT MOL BIOL, V16, P104, DOI 10.1038/nsmb0209-104; Sangurdekar DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-583; Sangurdekar DP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r32; She WF, 2007, J BACTERIOL, V189, P7062, DOI 10.1128/JB.00770-07; She W, 2013, MOL MICROBIOL, V87, P539, DOI 10.1111/mmi.12112; SPURIO R, 1992, MOL GEN GENET, V231, P201, DOI 10.1007/BF00279792; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tsang CK, 2007, EMBO J, V26, P448, DOI 10.1038/sj.emboj.7601488; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Wang Q, 2006, J BACTERIOL, V188, P4431, DOI 10.1128/JB.00313-06; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Xiao GH, 2011, J AM STAT ASSOC, V106, P61, DOI 10.1198/jasa.2010.ap09504; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873	46	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84027	10.1371/journal.pone.0084027	http://dx.doi.org/10.1371/journal.pone.0084027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376785	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000137
J	Ko, HK; Yu, WK; Lien, TC; Wang, JH; Slutsky, AS; Zhang, HB; Kou, YR				Ko, Hsin-Kuo; Yu, Wen-Kuang; Lien, Te-Cheng; Wang, Jia-Horng; Slutsky, Arthur S.; Zhang, Haibo; Kou, Yu Ru			Intensive Care Unit-Acquired Bacteremia in Mechanically Ventilated Patients: Clinical Features and Outcomes	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CRITICALLY-ILL PATIENTS; RISK-FACTORS; ATTRIBUTABLE MORTALITY; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL THERAPY; EXCESS MORTALITY; EPIDEMIOLOGY; IMPACT; COSTS	Intensive care unit (ICU)-acquired bacteremia (IAB) is associated with high medical expenditure and mortality. Mechanically ventilated patients represent one third of all patients admitted to ICU, but the clinical features and outcomes in mechanically ventilated patients who develop IAB remain unknown. We conducted a 3-year retrospective observational cohort study, and 1,453 patients who received mechanical ventilation on ICU admission were enrolled. Among patients enrolled, 126 patients who had developed IAB >= 48 hours after ICU admission were identified. The study patients were divided into IAB and no IAB groups, and clinical characteristics of IAB based on specific bacterial species were further analyzed. The multivariate Cox regression analysis showed that ventilator support for chronic obstructive pulmonary disease and congestive heart failure, and patients admitted from nursing home were the independent risk factors for developing IAB. Patients with IAB were significantly associated with longer length of ICU stay, prolonged ventilator use, lower rate of successful weaning, and higher rate of ventilator dependence and ICU mortality as compared to those without IAB. IAB was the independent risk factor for ICU mortality (HR, 1.510, 95% CI 1.054-1.123; p = 0.010). The clinical characteristics of IAB related to specific bacterial species included IAB due to Pseudomonas aeruginosa being likely polymicrobial, lung source and prior antibiotic use; Escherichia coli developing earlier and from urinary tract source; methicillin-resistant Staphylococcus aureus related to central venous catheter and multiple sets of positive hemoculture; and Elizabethkingia meningoseptica significantly associated with delayed/inappropriate antibiotic treatment. In summary, IAB was significantly associated with poor patient outcomes in mechanically ventilated ICU patients. The clinical features related to IAB and clinical characteristics of IAB based on specific bacterial species identified in our study may be utilized to refine the management of IAB.	[Ko, Hsin-Kuo; Yu, Wen-Kuang; Kou, Yu Ru] Natl Yang Ming Univ, Sch Med, Inst Physiol, Taipei 112, Taiwan; [Ko, Hsin-Kuo; Yu, Wen-Kuang; Lien, Te-Cheng; Wang, Jia-Horng] Taipei Vet Gen Hosp, Dept Resp Therapy, Taipei, Taiwan; [Ko, Hsin-Kuo; Slutsky, Arthur S.; Zhang, Haibo] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Slutsky, Arthur S.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Zhang, Haibo] Univ Toronto, Dept Physiol, Interdept Div Crit Care Med, Dept Anesthesia, Toronto, ON, Canada; [Kou, Yu Ru] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; National Yang Ming Chiao Tung University	Zhang, HB (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	zhangh@smh.ca; yrkou@ym.edu.tw	Slutsky, Arthur/M-3325-2019	Kou, Yu Ru/0000-0002-4681-9009	Taipei Veterans General Hospital, Taipei, Taiwan [VGH-97-A-024, VGH-98-A-065]; National Science Council, Taiwan [NSC 98-2320-B-010-016-MY3]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported through Grants VGH-97-A-024 and VGH-98-A-065 from the Taipei Veterans General Hospital, Taipei, Taiwan and Grant NSC 98-2320-B-010-016-MY3 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Blot S, 2003, J HOSP INFECT, V53, P18, DOI 10.1053/jhin.2002.1329; Blot S, 2003, INFECT CONT HOSP EP, V24, P912, DOI 10.1086/502159; Blot S, 2003, INTENS CARE MED, V29, P471, DOI 10.1007/s00134-003-1648-8; Blot SI, 2003, CHEST, V123, P1208, DOI 10.1378/chest.123.4.1208; Blot SI, 2002, EUR J CLIN MICROBIOL, V21, P471, DOI 10.1007/s10096-002-0746-9; Damas P, 2008, INTENS CARE MED, V34, P856, DOI 10.1007/s00134-008-1018-7; DiGiovine B, 1999, AM J RESP CRIT CARE, V160, P976, DOI 10.1164/ajrccm.160.3.9808145; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Garrouste-Orgeas M, 2006, CLIN INFECT DIS, V42, P1118, DOI 10.1086/500318; Hsu MS, 2011, EUR J CLIN MICROBIOL, V30, P1271, DOI 10.1007/s10096-011-1223-0; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kullar R, 2013, INFECT CONT HOSP EP, V34, P400, DOI 10.1086/669868; Kwon KT, 2007, J ANTIMICROB CHEMOTH, V59, P525, DOI 10.1093/jac/dkl499; Laupland KB, 2004, J HOSP INFECT, V58, P137, DOI 10.1016/j.jhin.2004.06.007; Laupland KB, 2002, CRIT CARE MED, V30, P2462, DOI 10.1097/00003246-200211000-00010; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lu PL, 2012, INT J ANTIMICROB AG, V40, pS37, DOI 10.1016/S0924-8579(12)70008-0; Michalopoulos A, 2011, AM J INFECT CONTROL, V39, P396, DOI 10.1016/j.ajic.2010.06.017; Osmon S, 2004, CHEST, V125, P607, DOI 10.1378/chest.125.2.607; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Renaud B, 2001, AM J RESP CRIT CARE, V163, P1584, DOI 10.1164/ajrccm.163.7.9912080; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; ROBERTS FJ, 1989, REV INFECT DIS, V11, P1029; Suljagic V, 2005, AM J INFECT CONTROL, V33, P333, DOI 10.1016/j.ajic.2005.03.010; Thompson DS, 2008, J HOSP INFECT, V69, P56, DOI 10.1016/j.jhin.2008.01.012; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754	30	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83298	10.1371/journal.pone.0083298	http://dx.doi.org/10.1371/journal.pone.0083298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376683	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000078
J	Hrabovszky, E; Molnar, CS; Borsay, BA; Gergely, P; Herczeg, L; Liposits, Z				Hrabovszky, Erik; Molnar, Csilla S.; Borsay, Beata A.; Gergely, Peter; Herczeg, Laszlo; Liposits, Zsolt			Orexinergic Input to Dopaminergic Neurons of the Human Ventral Tegmental Area	PLOS ONE			English	Article							OREXIN/HYPOCRETIN; HYPOCRETIN; REWARD; RAT; INVOLVEMENT; EXCITATION; NUCLEUS; AROUSAL; SYSTEM; REINSTATEMENT	The mesolimbic reward pathway arising from dopaminergic (DA) neurons of the ventral tegmental area (VTA) has been strongly implicated in reward processing and drug abuse. In rodents, behaviors associated with this projection are profoundly influenced by an orexinergic input from the lateral hypothalamus to the VTA. Because the existence and significance of an analogous orexigenic regulatory mechanism acting in the human VTA have been elusive, here we addressed the possibility that orexinergic neurons provide direct input to DA neurons of the human VTA. Dual-label immunohistochemistry was used and orexinergic projections to the VTA and to DA neurons of the neighboring substantia nigra (SN) were analyzed comparatively in adult male humans and rats. Orexin B-immunoreactive (IR) axons apposed to tyrosine hydroxylase (TH)-IR DA and to non-DA neurons were scarce in the VTA and SN of both species. In the VTA, 15.0 +/- 2.8% of TH-IR perikarya in humans and 3.2 +/- 0.3% in rats received orexin B-IR afferent contacts. On average, 0.24 +/- 0.05 and 0.05 +/- 0.005 orexinergic appositions per TH-IR perikaryon were detected in humans and rats, respectively. The majority (86-88%) of randomly encountered orexinergic contacts targeted the dendritic compartment of DA neurons. Finally, DA neurons of the SN also received orexinergic innervation in both species. Based on the observation of five times heavier orexinergic input to TH-IR neurons of the human, compared with the rat, VTA, we propose that orexinergic mechanism acting in the VTA may play just as important roles in reward processing and drug abuse in humans, as already established well in rodents.	[Hrabovszky, Erik; Molnar, Csilla S.; Liposits, Zsolt] Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary; [Borsay, Beata A.; Gergely, Peter; Herczeg, Laszlo] Univ Debrecen, Dept Forens Med, Fac Med, H-4012 Debrecen, Hungary; [Liposits, Zsolt] Pazmany Peter Catholic Univ, Fac Informat Technol, Dept Neurosci, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Debrecen	Hrabovszky, E (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary.	hrabovszky.erik@koki.hu	Gergely, Peter/E-1482-2013; Gergely, Peter/O-4829-2019; Liposits, Zsolt/K-8145-2019	Gergely, Peter/0000-0002-0437-4072; Gergely, Peter/0000-0002-0437-4072; Hrabovszky, Erik/0000-0001-6927-0015; Liposits, Zsolt/0000-0002-3508-2750	Hungarian Scientific Research Fund [OTKA K83710, K100722]; European Community [245009]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Community(European Commission)	This work was supported by grants from the Hungarian Scientific Research Fund (OTKA K83710, K100722) and the European Community's Seventh Framework Programme (FP7/2007-2013; grant agreement number 245009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston-Jones G, 2009, NEUROPHARMACOLOGY, V56, P112, DOI 10.1016/j.neuropharm.2008.06.060; Baimel C, 2012, PROG BRAIN RES, V198, P123, DOI 10.1016/B978-0-444-59489-1.00008-2; Balcita-Pedicino JJ, 2007, J COMP NEUROL, V503, P668, DOI 10.1002/cne.21420; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Barrot M, 2012, J NEUROSCI, V32, P14094, DOI 10.1523/JNEUROSCI.3370-12.2012; Bisetti A, 2006, NEUROSCIENCE, V142, P999, DOI 10.1016/j.neuroscience.2006.07.018; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Boutrel B, 2005, P NATL ACAD SCI USA, V102, P19168, DOI 10.1073/pnas.0507480102; Boutrel B, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00059; Bullmann T, 2010, J COMP NEUROL, V518, P2538, DOI 10.1002/cne.22351; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; Dayas CV, 2008, BIOL PSYCHIAT, V63, P152, DOI 10.1016/j.biopsych.2007.02.002; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Deurveilher S, 2006, J COMP NEUROL, V498, P667, DOI 10.1002/cne.21084; Di Sebastiano AR, 2012, PROG BRAIN RES, V198, P65, DOI 10.1016/B978-0-444-59489-1.00006-9; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Fronczek R, 2005, J CLIN ENDOCR METAB, V90, P5466, DOI 10.1210/jc.2005-0296; Georgescu D, 2003, J NEUROSCI, V23, P3106; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Harris GC, 2006, TRENDS NEUROSCI, V29, P571, DOI 10.1016/j.tins.2006.08.002; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hollander JA, 2008, P NATL ACAD SCI USA, V105, P19480, DOI 10.1073/pnas.0808023105; Hrabovszky E, 2010, EUR J NEUROSCI, V31, P1984, DOI 10.1111/j.1460-9568.2010.07239.x; Hrabovszky Erik, 2011, Front Endocrinol (Lausanne), V2, P80, DOI 10.3389/fendo.2011.00080; Korotkova TM, 2003, J NEUROSCI, V23, P7; Korotkova TM, 2002, REGUL PEPTIDES, V104, P83, DOI 10.1016/S0167-0115(01)00323-8; Kotz CM, 2006, NEUROSCIENCE, V142, P29, DOI 10.1016/j.neuroscience.2006.05.028; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; LIPOSITS Z, 1984, NEUROSCIENCE, V13, P513, DOI 10.1016/0306-4522(84)90245-8; Lu XY, 2000, HORM BEHAV, V37, P335, DOI 10.1006/hbeh.2000.1584; Mahler SV, 2012, PROG BRAIN RES, V198, P79, DOI 10.1016/B978-0-444-59489-1.00007-0; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Martin G, 2002, REGUL PEPTIDES, V104, P111, DOI 10.1016/S0167-0115(01)00354-8; Molnar CS, 2012, ENDOCRINOLOGY, V153, P5428, DOI 10.1210/en.2012-1739; Mukai K, 2009, PEPTIDES, V30, P1487, DOI 10.1016/j.peptides.2009.04.018; Nakamura T, 2000, BRAIN RES, V873, P181, DOI 10.1016/S0006-8993(00)02555-5; Narita M, 2006, J NEUROSCI, V26, P398, DOI 10.1523/JNEUROSCI.2761-05.2006; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peyron C, 1998, J NEUROSCI, V18, P9996; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sharf R, 2008, BIOL PSYCHIAT, V64, P175, DOI 10.1016/j.biopsych.2008.03.006; Sharf R, 2010, BRAIN RES, V1314, P130, DOI 10.1016/j.brainres.2009.08.028; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044726; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Vittoz NM, 2008, EUR J NEUROSCI, V28, P1629, DOI 10.1111/j.1460-9568.2008.06453.x; Vittoz NM, 2006, NEUROPSYCHOPHARMACOL, V31, P384, DOI 10.1038/sj.npp.1300807; Wang B, 2009, BIOL PSYCHIAT, V65, P857, DOI 10.1016/j.biopsych.2009.01.018; Xia JX, 2005, J NEUROSCI RES, V82, P729, DOI 10.1002/jnr.20667	49	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83029	10.1371/journal.pone.0083029	http://dx.doi.org/10.1371/journal.pone.0083029			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376626	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100079
J	Ni, XD; Huang, J; Hui, YP; Xu, R; Yang, WY; Zhou, LM				Ni, Xian-Da; Huang, Jun; Hui, Yuan-Ping; Xu, Rui; Yang, Wei-Yu; Zhou, Li-Ming			Assessment of the Rotation Motion at the Papillary Muscle Short-Axis Plane with Normal Subjects by Two-Dimensional Speckle Tracking Imaging: A Basic Clinical Study	PLOS ONE			English	Article							LEFT-VENTRICULAR ROTATION; TWIST MECHANICS; ECHOCARDIOGRAPHY	Background: The aim of this study was to observe the rotation patterns at the papillary muscle plane in the Left Ventricle(LV) with normal subjects using two-dimensional speckle tracking imaging (2D-STI). Methods: We acquired standard of the basal, the papillary muscle and the apical short-axis images of the LV in 64 subjects to estimate the LV rotation motion by 2D-STI. The rotational degrees at the papillary muscle short-axis plane were measured at 15 different time points in the analysis of two heart cycles. Results: There were counterclockwise rotation, clockwise rotation, and counterclockwise to clockwise rotation at the papillary muscle plane in the LV with normal subjects, respectively. The ROC analysis of the rotational degrees was performed at the papillary muscle short-axis plane at the peak LV torsion for predicting whether the turnaround point of twist to untwist motion pattern was located at the papillary muscle level. Sensitivity and specificity were 97% and 67%, respectively, with a cut-off value of 0.34 degrees, and an area under the ROC curve of 0.8. At the peak LV torsion, there was no correlation between the rotational degrees at the papillary muscle short-axis plane and the LVEF in the normal subjects(r = 0.000, p = 0.998). Conclusions: In the study, we conclude that there were three rotation patterns at the papillary muscle short-axis levels, and the transition from basal clockwise rotation to apical counterclockwise rotation is located at the papillary muscle level.	[Ni, Xian-Da; Hui, Yuan-Ping; Yang, Wei-Yu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Ultrasound, Wenzhou, Peoples R China; [Huang, Jun] Nanjing Med Univ, Dept Echocardiog, Changzhou Peoples Hosp 2, Changzhou, Peoples R China; [Xu, Rui] Henan Univ TCM, Affiliated Hosp 1, Dept Ultrasound, Zhengzhou, Peoples R China; [Zhou, Li-Ming] Zhejiang Univerc, Affiliated Hosp 2, Dept Ultrasound, Hangzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Nanjing Medical University; Henan University of Traditional Chinese Medicine	Ni, XD (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Ultrasound, Wenzhou, Peoples R China.	xianda.ni@gmail.com						Bertini M, 2009, JACC-CARDIOVASC IMAG, V2, P1425, DOI 10.1016/j.jcmg.2009.09.013; Buckberg G D, 2001, Semin Thorac Cardiovasc Surg, V13, P342; Chen X, 2005, ULTRASONIC IMAGING, V27, P21, DOI 10.1177/016173460502700102; Gustafsson U, 2009, EUR J ECHOCARDIOGR, V10, P56, DOI 10.1093/ejechocard/jen141; Helle-Valle T, 2005, CIRCULATION, V112, P3149, DOI 10.1161/CIRCULATIONAHA.104.531558; Lee D, 2007, CONTEMP CARDIOL, P19, DOI 10.1007/978-1-59259-977-6_2; [陆景 LU Jing], 2009, [中华超声影像学杂志, Chinese Journal of Ultrasonography], V18, P1085; [陆景 LU Jing], 2009, [中华超声影像学杂志, Chinese Journal of Ultrasonography], V18, P1013; Notomi Y, 2005, J AM COLL CARDIOL, V45, P2034, DOI 10.1016/j.jacc.2005.02.082; Popovic ZB, 2008, HEART, V94, DOI 10.1136/hrt.2007.122192; Saito M, 2009, HEART, V95, P290, DOI 10.1136/hrt.2008.145979; Sengupta PP, 2008, JACC-CARDIOVASC IMAG, V1, P366, DOI 10.1016/j.jcmg.2008.02.006; Sengupta Partho P, 2008, Heart Fail Clin, V4, P315, DOI 10.1016/j.hfc.2008.03.001; Torrent-Guasp F, 2001, J THORAC CARDIOV SUR, V122, P389, DOI 10.1067/mtc.2001.113745; Torrent-Guasp F F, 1997, Technol Health Care, V5, P13; van Dalen BM, 2009, HEART, V95, P657, DOI 10.1136/hrt.2008.152777; van Dalen BM, 2008, AM J PHYSIOL-HEART C, V295, pH1705, DOI 10.1152/ajpheart.00513.2008; van Dalen BM, 2008, J AM SOC ECHOCARDIOG, V21, P895, DOI 10.1016/j.echo.2008.02.001; van Dalen BM, 2009, EUR J ECHOCARDIOGR, V10, P669, DOI 10.1093/ejechocard/jep036; van Dalen BM, 2009, ECHOCARDIOGR-J CARD, V26, P371, DOI 10.1111/j.1540-8175.2008.00834.x	20	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83071	10.1371/journal.pone.0083071	http://dx.doi.org/10.1371/journal.pone.0083071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376634	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100084
J	Rezaei, V; Pezeshk, H; Perez-Sa'nchez, H				Rezaei, Vahid; Pezeshk, Hamid; Perez-Sa'nchez, Horacio			Generalized Baum-Welch Algorithm Based on the Similarity between Sequences	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; PROTEINS	The profile hidden Markov model (PHMM) is widely used to assign the protein sequences to their respective families. A major limitation of a PHMM is the assumption that given states the observations (amino acids) are independent. To overcome this limitation, the dependency between amino acids in a multiple sequence alignment (MSA) which is the representative of a PHMM can be appended to the PHMM. Due to the fact that with a MSA, the sequences of amino acids are biologically related, the one-by-one dependency between two amino acids can be considered. In other words, based on the MSA, the dependency between an amino acid and its corresponding amino acid located above can be combined with the PHMM. For this purpose, the new emission probability matrix which considers the one-by-one dependencies between amino acids is constructed. The parameters of a PHMM are of two types; transition and emission probabilities which are usually estimated using an EM algorithm called the Baum-Welch algorithm. We have generalized the Baum-Welch algorithm using similarity emission matrix constructed by integrating the new emission probability matrix with the common emission probability matrix. Then, the performance of similarity emission is discussed by applying it to the top twenty protein families in the Pfam database. We show that using the similarity emission in the Baum-Welch algorithm significantly outperforms the common Baum-Welch algorithm in the task of assigning protein sequences to protein families.	[Rezaei, Vahid] Univ Econ Sci, Fac Financial Sci, Dept Math & Stat, Tehran, Iran; [Rezaei, Vahid; Pezeshk, Hamid] Inst Res Fundamental Sci IPM, Sch Comp Sci, Tehran, Iran; [Pezeshk, Hamid] Univ Tehran, Sch Math Stat & Comp Sci, Tehran 14174, Iran; [Perez-Sa'nchez, Horacio] Catholic Univ Murcia UCAM, Dept Comp Sci, Murcia, Spain	University of Tehran; Universidad Catolica de Murcia	Rezaei, V (corresponding author), Univ Econ Sci, Fac Financial Sci, Dept Math & Stat, Tehran, Iran.	vhrezaei@ipm.ir	Pérez-Sánchez, Horacio/O-5017-2016	Pérez-Sánchez, Horacio/0000-0003-4468-7898; Rezaei Tabar, Vahid/0000-0001-7482-0093				BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Bilmes J. A., 1998, INT COMPUTER SCI I, V4, P126, DOI DOI 10.1080/0042098032000136147; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Holmes I, 2001, BIOINFORMATICS, V17, P803, DOI 10.1093/bioinformatics/17.9.803; Karp R. M., 2002, NOT AM MATH SOC, V49, P544; Qian B, 2004, BIOINFORMATICS, V20, P2175, DOI 10.1093/bioinformatics/bth181; Sangar V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-294; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472	10	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e80565	10.1371/journal.pone.0080565	http://dx.doi.org/10.1371/journal.pone.0080565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376498	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100003
J	Watson, AT; Daigaku, Y; Mohebi, S; Etheridge, TJ; Chahwan, C; Murray, JM; Carr, AM				Watson, Adam T.; Daigaku, Yasukazu; Mohebi, Saed; Etheridge, Thomas J.; Chahwan, Charly; Murray, Johanne M.; Carr, Antony M.			Optimisation of the Schizosaccharomyces pombe urg1 Expression System	PLOS ONE			English	Article							FISSION YEAST; POSTREPLICATION REPAIR; SELECTIVE ELIMINATION; TEMPLATE EXCHANGE; REPLICATION FORKS; INVERTED REPEATS; POMBE; GENE; RECOMBINATION; CELLS	The ability to study protein function in vivo often relies on systems that regulate the presence and absence of the protein of interest. Two limitations for previously described transcriptional control systems that are used to regulate protein expression in fission yeast are: the time taken for inducing conditions to initiate transcription and the ability to achieve very low basal transcription in the "OFF-state". In previous work, we described a Cre recombination-mediated system that allows the rapid and efficient regulation of any gene of interest by the urg1 promoter, which has a dynamic range of approximately 75-fold and which 15 induced within 30-60 minutes of uracil addition. In this report we describe easy-to-use and versatile modules that can be exploited to significantly tune down P-urg1 "OFF-levels" while maintaining an equivalent dynamic range. We also provide plasmicls and tools for combining P-urg1 transcriptional control with the auxin degron tag to help maintain a null-like phenotype. We demonstrate the utility of this system by improved regulation a HO-dependent site-specific DSB formation, by the regulation Rtf1-dependent replication fork arrest and by controlling RhP18(Rad18)-dependent post replication repair.	[Watson, Adam T.; Daigaku, Yasukazu; Mohebi, Saed; Etheridge, Thomas J.; Chahwan, Charly; Murray, Johanne M.; Carr, Antony M.] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton, E Sussex, England	University of Sussex	Carr, AM (corresponding author), Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	a.m.carr@sussex.ac.uk		Daigaku, Yasukazu/0000-0002-8404-7492; Carr, Antony Michael/0000-0002-2028-2389; Etheridge, Thomas/0000-0001-8144-6917; Watson, Adam/0000-0002-8140-8205	Medical Research Council (UK) [G1100074]; European Research Council [268788-SMI-DDR]; MRC [G1100074] Funding Source: UKRI; Medical Research Council [G1100074] Funding Source: researchfish; Worldwide Cancer Research [10-0273] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research	This work was supported by Medical Research Council (UK) grant G1100074 (www.mrc.ac.uk/) and European Research Council grant 268788-SMI-DDR (www.erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen G, 2008, J MOL BIOL, V380, P656, DOI 10.1016/j.jmb.2008.05.029; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Chen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026804; Frampton J, 2006, MOL BIOL CELL, V17, P2976, DOI 10.1091/mbc.e05-11-1008; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Kanke M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-8; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Mizuno K, 2013, NATURE, V493, P246, DOI 10.1038/nature11676; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; SAVAGEAU MA, 1975, J MOL EVOL, V5, P199, DOI 10.1007/BF01741242; VANHUFFEL C, 1994, YEAST, V10, P923, DOI 10.1002/yea.320100707; Verkade HM, 2001, MOL GENET GENOMICS, V265, P993, DOI 10.1007/s004380100494; Watson A, 2011, J PHASE EQUILIB DIFF, V32, P1, DOI 10.1007/s11669-010-9844-z; Watt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001428; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Yamashita A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120014; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	27	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83800	10.1371/journal.pone.0083800	http://dx.doi.org/10.1371/journal.pone.0083800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376751	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000328745100142
J	Seegelke, C; Hughes, CML; Schack, T				Seegelke, Christian; Hughes, Charmayne Mary Lee; Schack, Thomas			Simulating My Own or Others Action Plans? - Motor Representations, Not Visual Representations Are Recalled in Motor Memory	PLOS ONE			English	Article							MANUAL OBSTACLE AVOIDANCE; END-STATE COMFORT; INDIVIDUAL-DIFFERENCES; MIRROR NEURONS; OBJECT; PERCEPTION; COGNITION; KINEMATICS; IMITATION; REVEALS	Action plans are not generated from scratch for each movement, but features of recently generated plans are recalled for subsequent movements. This study investigated whether the observation of an action is sufficient to trigger plan recall processes. Participant dyads performed an object manipulation task in which one participant transported a plunger from an outer platform to a center platform of different heights (first move). Subsequently, either the same (intra-individual task condition) or the other participant (inter-individual task condition) returned the plunger to the outer platform (return moves). Grasp heights were inversely related to center target height and similar irrespective of direction (first vs. return move) and task condition (intra-vs. inter-individual). Moreover, participants' return move grasp heights were highly correlated with their own, but not with their partners' first move grasp heights. Our findings provide evidence that a simulated action plan resembles a plan of how the observer would execute that action (based on a motor representation) rather than a plan of the actually observed action (based on a visual representation).	[Seegelke, Christian; Schack, Thomas] Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp, D-33615 Bielefeld, Germany; [Seegelke, Christian; Schack, Thomas] Res Inst Cognit & Robot CoR Lab, Bielefeld, Germany; [Seegelke, Christian; Schack, Thomas] Ctr Excellence Cognit Interact Technol CITEC, Bielefeld, Germany; [Hughes, Charmayne Mary Lee] Tech Univ Munich, Dept Sport & Hlth Sci, Inst Movement Sci, D-80290 Munich, Germany	University of Bielefeld; Technical University of Munich	Seegelke, C (corresponding author), Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp, D-33615 Bielefeld, Germany.	Christian.seegelke@uni-bielefeld.de	Seegelke, Christian/AAH-9410-2019	Seegelke, Christian/0000-0001-9624-6395	German Research Foundation (DFG) [EC 277]; Honda Research Institute Europe	German Research Foundation (DFG)(German Research Foundation (DFG)); Honda Research Institute Europe	This research was funded by the German Research Foundation (DFG; EC 277). Christian Seegelke gratefully acknowledges the financial support from Honda Research Institute Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Balliet D, 2011, PSYCHOL BULL, V137, P881, DOI 10.1037/a0025354; Becchio C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00117; Belot M, 2013, P NATL ACAD SCI USA, V110, P2763, DOI 10.1073/pnas.1209981110; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Blakemore SJ, 2005, NEUROPSYCHOLOGIA, V43, P260, DOI 10.1016/j.neuropsychologia.2004.11.012; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Castiello U, 2002, ATTENTION PERFORM, V19, P315; Castiello U, 2003, J EXP PSYCHOL HUMAN, V29, P416, DOI 10.1037/0096-1523.29.2.416; Cohen RG, 2004, EXP BRAIN RES, V157, P486, DOI 10.1007/s00221-004-1862-9; Cook R, 2012, P ROY SOC B-BIOL SCI, V279, P780, DOI 10.1098/rspb.2011.1024; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Dragovic M, 2004, ACTA NEUROPSYCHIATR, V16, P212, DOI 10.1111/j.0924-2708.2004.00087.x; Edwards MG, 2003, BRAIN COGNITION, V53, P495, DOI 10.1016/S0278-2626(03)00210-0; Etzel JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003690; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Griffiths D, 2009, Q J EXP PSYCHOL, V62, P2450, DOI 10.1080/17470210903103059; Hughes CML, 2012, EXP BRAIN RES, V219, P391, DOI 10.1007/s00221-012-3100-1; Hughes CML, 2012, J MOTOR BEHAV, V44, P195, DOI 10.1080/00222895.2012.672483; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jax SA, 2007, J EXP PSYCHOL HUMAN, V33, P425, DOI 10.1037/0096-1523.33.2.425; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Knoblich G, 2001, PSYCHOL SCI, V12, P467, DOI 10.1111/1467-9280.00387; Mason AH, 2005, EXP BRAIN RES, V163, P173, DOI 10.1007/s00221-004-2157-x; Meulenbroek RGJ, 2007, EXP BRAIN RES, V180, P333, DOI 10.1007/s00221-007-0861-z; Ocampo B, 2010, EXP BRAIN RES, V201, P743, DOI 10.1007/s00221-009-2089-6; Oosterhof NN, 2010, J NEUROPHYSIOL, V104, P1077, DOI 10.1152/jn.00326.2010; Poljac E, 2009, PSYCHOL RES-PSYCH FO, V73, P407, DOI 10.1007/s00426-008-0151-9; Rosenbaum DA, 1996, ACTA PSYCHOL, V94, P59, DOI 10.1016/0001-6918(95)00062-3; ROSENBAUM DA, 1992, HUM MOVEMENT SCI, V11, P61, DOI 10.1016/0167-9457(92)90050-L; Rosenbaum DA, 2006, PSYCHON B REV, V13, P918, DOI 10.3758/BF03194019; Rosenbaum DA, 2012, PSYCHOL BULL, V138, P924, DOI 10.1037/a0027839; Sacheli LM, 2013, EXP BRAIN RES, V226, P473, DOI 10.1007/s00221-013-3459-7; Schutz C, 2011, MOTOR CONTROL, V15, P321, DOI 10.1123/mcj.15.3.321; Seegelke C, 2012, EXP BRAIN RES, V222, P125, DOI 10.1007/s00221-012-3203-8; Seegelke C, 2011, EXP BRAIN RES, V215, P65, DOI 10.1007/s00221-011-2872-z; van der Wel RPRD, 2007, J EXP PSYCHOL HUMAN, V33, P1117, DOI 10.1037/0096-1523.33.5.1117; van Schie HT, 2008, J EXP PSYCHOL HUMAN, V34, P1493, DOI 10.1037/a0011750; Weigelt M, 2007, EXP BRAIN RES, V179, P191, DOI 10.1007/s00221-006-0780-4; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7	46	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84662	10.1371/journal.pone.0084662	http://dx.doi.org/10.1371/journal.pone.0084662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367689	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300155
J	Cihalova, D; Hofman, J; Ceckova, M; Staud, F				Cihalova, Daniela; Hofman, Jakub; Ceckova, Martina; Staud, Frantisek			Purvalanol A, Olomoucine II and Roscovitine Inhibit ABCB1 Transporter and Synergistically Potentiate Cytotoxic Effects of Daunorubicin In Vitro	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; DEPENDENT KINASE INHIBITOR; SELICICLIB R-ROSCOVITINE; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; ABCG2 TRANSPORTER; PHASE-I; FLAVOPIRIDOL; CHEMOTHERAPY; PENETRATION	Cyclin-dependent kinase inhibitors (CDKi) have high potential applicability in anticancer therapy, but various aspects of their pharmacokinetics, especially their interactions with drug efflux transporters, have not yet been evaluated in detail. Thus, we investigated interactions of five CDKi (purvalanol A, olomoucine II, roscovitine, flavopiridol and SNS-032) with the ABCB1 transporter. Four of the compounds inhibited efflux of two ABCB1 substrates, Hoechst 33342 and daunorubicin, in MDCKII-ABCB1 cells: Olomoucine II most strongly, followed by roscovitine, purvalanol A, and flavopiridol. SNS-032 inhibited ABCB1-mediated efflux of Hoechst 33342 but not daunorubicin. In addition, purvalanol A, SNS-032 and flavopiridol lowered the stimulated ATPase activity in ABCB1 membrane preparations, while olomoucine II and roscovitine not only inhibited the stimulated ATPase but also significantly activated the basal ABCB1 ATPase, suggesting that these two CDKi are ABCB1 substrates. We further revealed that the strongest ABCB1 inhibitors (purvalanol A, olomoucine II and roscovitine) synergistically potentiate the antiproliferative effect of daunorubicin, a commonly used anticancer drug and ABCB1 substrate, in MDCKII-ABCB1 cells as well as in human carcinoma HCT-8 and HepG2 cells. We suggest that this pronounced synergism is at least partly caused by (i) CDKi-mediated inhibition of ABCB1 transporter leading to increased intracellular retention of daunorubicin and (ii) native cytotoxic activity of the CDKi. Our results indicate that co-administration of the tested CDKi with anticancer drugs that are ABCB1 substrates may allow significant dose reduction in the treatment of ABCB1-expressing tumors.	[Cihalova, Daniela; Hofman, Jakub; Ceckova, Martina; Staud, Frantisek] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Pharmacol & Toxicol, Hradec Kralove, Czech Republic	Charles University Prague	Staud, F (corresponding author), Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Pharmacol & Toxicol, Hradec Kralove, Czech Republic.	frantisek.staud@faf.cuni.cz	Staud, Frantisek/F-4596-2010; Ceckova, Martina/M-1849-2018; Hofman, Jakub/T-6461-2017	Staud, Frantisek/0000-0001-6712-097X; Ceckova, Martina/0000-0003-2936-7212; Hofman, Jakub/0000-0002-4285-7681	Grant Agency of Charles University in Prague [700912/C/2012, SVV/2013/267-003]; LAOreal-UNESCO	Grant Agency of Charles University in Prague; LAOreal-UNESCO	Supported by grants 700912/C/2012 and SVV/2013/267-003 (Grant Agency of Charles University in Prague) and by the LAOreal-UNESCO Scholarship for Women in Science 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza MSI, 2008, WORLD J GASTROENTERO, V14, P5162, DOI 10.3748/wjg.14.5162; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Appleyard MVCL, 2009, INT J CANCER, V124, P465, DOI 10.1002/ijc.23938; Bodo A, 2003, TOXICOL LETT, V140, P133, DOI 10.1016/S0378-4274(02)00497-6; Caceres G, 2012, CANCER RES, V72, P4204, DOI 10.1158/0008-5472.CAN-12-0743; Ceckova M, 2006, CLIN EXP PHARMACOL P, V33, P58, DOI 10.1111/j.1440-1681.2006.04324.x; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chu XY, 2013, EXPERT OPIN DRUG MET, V9, P237, DOI 10.1517/17425255.2013.741589; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; COLE SPC, 1994, CANCER RES, V54, P5902; Coley HM, 2007, ANTICANCER RES, V27, P273; Dai Y, 2003, CURR OPIN PHARMACOL, V3, P362, DOI 10.1016/S1471-4892(03)00079-1; Dantzig AH, 1996, CANCER RES, V56, P4171; Fromm MF, 2000, INT J CLIN PHARM TH, V38, P69; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Guendel I, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-7; Hofman J, 2013, PLOS ONE IN PRESS; Hofman J, 2012, PHARMACOL RES, V65, P312, DOI 10.1016/j.phrs.2011.11.017; Holcakova Jitka, 2010, Antiviral Chemistry & Chemotherapy, V20, P133, DOI 10.3851/IMP1460; Kamath AV, 2005, CANCER CHEMOTH PHARM, V55, P110, DOI 10.1007/s00280-004-0873-3; Kodaira H, 2010, J PHARMACOL EXP THER, V333, P788, DOI 10.1124/jpet.109.162321; Krystof V, 2010, CURR DRUG TARGETS, V11, P291, DOI 10.2174/138945010790711950; LALANDE ME, 1981, P NATL ACAD SCI-BIOL, V78, P363, DOI 10.1073/pnas.78.1.363; Le Tourneau C, 2010, EUR J CANCER, V46, P3243, DOI 10.1016/j.ejca.2010.08.001; Li Y, 2010, CURR MED CHEM, V17, P786, DOI 10.2174/092986710790514507; Lin TS, 2009, J CLIN ONCOL, V27, P6012, DOI 10.1200/JCO.2009.22.6944; O'Connor R, 2009, CURR CANCER DRUG TAR, V9, P273, DOI 10.2174/156800909788166583; Rajnai Z, 2010, DRUG METAB DISPOS, V38, P2000, DOI 10.1124/dmd.110.032805; Riddick DS, 2005, DRUG METAB DISPOS, V33, P1083, DOI 10.1124/dmd.105.004374; Schang Luis M., 2006, Antiviral Chemistry & Chemotherapy, V17, P293; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; SPOELSTRA EC, 1992, EUR J BIOCHEM, V207, P567, DOI 10.1111/j.1432-1033.1992.tb17083.x; Staud F, 2005, INT J BIOCHEM CELL B, V37, P720, DOI 10.1016/j.biocel.2004.11.004; Staud F, 2010, METHODS MOL BIOL, V596, P199, DOI 10.1007/978-1-60761-416-6_10; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Tang FX, 2004, J PHARM SCI-US, V93, P1185, DOI 10.1002/jps.20046; Tong WG, 2010, J CLIN ONCOL, V28, P3015, DOI 10.1200/JCO.2009.26.1347; Wang EJ, 2000, DRUG METAB DISPOS, V28, P522; Wang EJ, 2001, BIOCHEM BIOPH RES CO, V289, P580, DOI 10.1006/bbrc.2001.6000; Wang LM, 2010, MINI-REV MED CHEM, V10, P1058, DOI 10.2174/1389557511009011058; Weiss J, 2007, J ANTIMICROB CHEMOTH, V59, P238, DOI 10.1093/jac/dkl474; Zamek-Gliszczynski MJ, 2012, CLIN PHARMACOL THER, V92, P553, DOI 10.1038/clpt.2012.126; Zhou L, 2009, DRUG METAB DISPOS, V37, P946, DOI 10.1124/dmd.108.024489	46	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83467	10.1371/journal.pone.0083467	http://dx.doi.org/10.1371/journal.pone.0083467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376706	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000089
J	de Macedo-Silva, ST; Urbina, JA; de Souza, W; Rodrigues, JCF				de Macedo-Silva, Sara Teixeira; Urbina, Julio A.; de Souza, Wanderley; Fernandes Rodrigues, Juliany Cola			In Vitro Activity of the Antifungal Azoles Itraconazole and Posaconazole against Leishmania amazonensis	PLOS ONE			English	Article							TRYPANOSOMA SCHIZOTRYPANUM CRUZI; CUTANEOUS LEISHMANIASIS; TRANSFERASE INHIBITORS; STEROL COMPOSITION; SCH 56592; AMIODARONE; GROWTH; ULTRASTRUCTURE; BIOSYNTHESIS; COINFECTION	Leishmaniasis, caused by protozoan parasites of the Leishmania genus, is one of the most prevalent neglected tropical diseases. It is endemic in 98 countries, causing considerable morbidity and mortality. Pentavalent antimonials are the first line of treatment for leishmaniasis except in India. In resistant cases, miltefosine, amphotericin B and pentamidine are used. These treatments are unsatisfactory due to toxicity, limited efficacy, high cost and difficult administration. Thus, there is an urgent need to develop drugs that are efficacious, safe, and more accessible to patients. Trypanosomatids, including Leishmania spp. and Trypanosoma cruzi, have an essential requirement for ergosterol and other 24-alkyl sterols, which are absent in mammalian cells. Inhibition of ergosterol biosynthesis is increasingly recognized as a promising target for the development of new chemotherapeutic agents. The aim of this work was to investigate the antiproliferative, physiological and ultrastructural effects against Leishmania amazonensis of itraconazole (ITZ) and posaconazole (POSA), two azole antifungal agents that inhibit sterol C14 alpha-demethylase (CYP51). Antiproliferative studies demonstrated potent activity of POSA and ITZ: for promastigotes, the IC50 values were 2.74 mu M and 0.44 mu M for POSA and ITZ, respectively, and for intracellular amastigotes, the corresponding values were 1.63 mu M and 0.08 mu M, for both stages after 72 h of treatment. Physiological studies revealed that both inhibitors induced a collapse of the mitochondrial membrane potential (Delta Psi m), which was consistent with ultrastructural alterations in the mitochondrion. Intense mitochondrial swelling, disorganization and rupture of mitochondrial membranes were observed by transmission electron microscopy. In addition, accumulation of lipid bodies, appearance of autophagosome-like structures and alterations in the kinetoplast were also observed. In conclusion, our results indicate that ITZ and POSA are potent inhibitors of L. amazonensis and suggest that these drugs could represent novel therapies for the treatment of leishmaniasis, either alone or in combination with other agents.	[de Macedo-Silva, Sara Teixeira; de Souza, Wanderley; Fernandes Rodrigues, Juliany Cola] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil; [de Macedo-Silva, Sara Teixeira; de Souza, Wanderley; Fernandes Rodrigues, Juliany Cola] Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Urbina, Julio A.] Inst Venezolano Invest Cient, Ctr Bioquim & Biofis, Caracas, Venezuela; [de Souza, Wanderley; Fernandes Rodrigues, Juliany Cola] Inmetro, Inst Nacl Metrol Qualidade & Tecnol, Rio De Janeiro, Brazil; [Fernandes Rodrigues, Juliany Cola] Univ Fed Rio de Janeiro, Nucleo Multidisciplinar Pesquisa Biol NUMPEX BIO, Duque De Caxias, Brazil	Universidade Federal do Rio de Janeiro; Venezuelan Institute Science Research; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro	Rodrigues, JCF (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil.	juliany.rodrigues@xerem.ufrj.br	Rodrigues, Juliany Cola Fernandes/X-4977-2019; Rodrigues, Juliany Cola Fernandes/H-2836-2012	Rodrigues, Juliany Cola Fernandes/0000-0001-6807-8101; 	Conselho Nacional de Desenvolvimento Cientifico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Financiadora de Estudos e Projetos (FINEP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Financiadora de Estudos e Projetos (FINEP), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abdely HM, 1999, ANTIMICROB AGENTS CH, V43, P2910, DOI 10.1128/AAC.43.12.2910; Alsip S.A., 1986, FUNGAL DISEASES LUNG, P335; Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Baroni A, 2009, DERMATOL THER, V22, pS27, DOI 10.1111/j.1529-8019.2009.01264.x; BARRAL A, 1991, AM J TROP MED HYG, V44, P536, DOI 10.4269/ajtmh.1991.44.536; Benaim G, 2006, J MED CHEM, V49, P892, DOI 10.1021/jm050691f; Consigli J, 2006, INT J DERMATOL, V45, P46, DOI 10.1111/j.1365-4632.2004.02429.x; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; de Macedo-Silva ST, 2011, MOL BIOL INT, V2011; de Souza Wanderley, 2009, Interdiscip Perspect Infect Dis, V2009, P642502, DOI 10.1155/2009/642502; ESPINELINGROFF A, 1984, ANTIMICROB AGENTS CH, V26, P5, DOI 10.1128/AAC.26.1.5; FAERGEMANN J, 1984, ANTIMICROB AGENTS CH, V26, P773, DOI 10.1128/AAC.26.5.773; Rodrigues JCF, 2008, ANTIMICROB AGENTS CH, V52, P4098, DOI 10.1128/AAC.01616-07; Rodrigues JCF, 2008, CURR PHARM DESIGN, V14, P925, DOI 10.2174/138161208784041033; Galgiani JN, 1997, ANTIMICROB AGENTS CH, V41, P180, DOI 10.1128/AAC.41.1.180; Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]; Grimaldi G Jr, 1991, Prog Clin Parasitol, V2, P73; Henriques C, 2011, ANAL METHODS-UK, V3, P2148, DOI 10.1039/c1ay05219e; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; LAINSON R, 1994, MEM I OSWALDO CRUZ, V89, P435, DOI 10.1590/S0074-02761994000300027; LIEW FY, 1993, ADV PARASIT, V32, P161, DOI 10.1016/S0065-308X(08)60208-0; Menna-Barreto RFS, 2009, PARASITOLOGY, V136, P499, DOI 10.1017/S0031182009005745; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nassiri-Kashani M, 2005, J EUR ACAD DERMATOL, V19, P80, DOI 10.1111/j.1468-3083.2004.01133.x; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Palmie-Peixoto IV, 2006, FEMS MICROBIOL LETT, V255, P33, DOI 10.1111/j.1574-6968.2005.00056.x; Perfect JR, 1996, ANTIMICROB AGENTS CH, V40, P1910, DOI 10.1128/AAC.40.8.1910; Godinho JLP, 2012, INT J ANTIMICROB AG, V39, P326, DOI 10.1016/j.ijantimicag.2011.11.008; Rodrigues CO, 2001, J EUKARYOT MICROBIOL, V48, P588, DOI 10.1111/j.1550-7408.2001.tb00195.x; Rodrigues JCF, 2002, ANTIMICROB AGENTS CH, V46, P487, DOI 10.1128/AAC.46.2.487-499.2002; Rodrigues JCF, 2007, PROTIST, V158, P447, DOI 10.1016/j.protis.2007.05.004; ROSENTHAL E, 1995, T ROY SOC TROP MED H, V89, P159, DOI 10.1016/0035-9203(95)90476-X; SAAG MS, 1988, ANTIMICROB AGENTS CH, V32, P1, DOI 10.1128/AAC.32.1.1; Sengupta S, 2011, MOL BIOL INT, V2011; Serrano-Martin X, 2009, ANTIMICROB AGENTS CH, V53, P1403, DOI 10.1128/AAC.01215-08; Singh P, 2011, ANTIMICROB AGENTS CH, V55, P2971, DOI 10.1128/AAC.00201-11; Singh Sarman, 2004, Journal of Infection and Chemotherapy, V10, P307, DOI 10.1007/s10156-004-0348-9; Uchida K, 2001, INT J ANTIMICROB AG, V18, P167, DOI 10.1016/S0924-8579(01)00363-6; URBINA JA, 1995, MOL BIOCHEM PARASIT, V73, P199, DOI 10.1016/0166-6851(95)00117-J; Urbina JA, 1998, ANTIMICROB AGENTS CH, V42, P1771, DOI 10.1128/AAC.42.7.1771; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; van Griensven J, 2010, LANCET INFECT DIS, V10, P184, DOI 10.1016/S1473-3099(10)70011-6; VANCUTSEM J, 1984, ANTIMICROB AGENTS CH, V26, P527, DOI 10.1128/AAC.26.4.527; Veiga-Santos P, 2012, INT J ANTIMICROB AG, V40, P61, DOI 10.1016/j.ijantimicag.2012.03.009; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; WARREN LG, 1960, J PARASITOL, V46, P529, DOI 10.2307/3274932	48	65	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83247	10.1371/journal.pone.0083247	http://dx.doi.org/10.1371/journal.pone.0083247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376670	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000074
J	Dunn, AG; Mandl, KD; Coiera, E; Bourgeois, FT				Dunn, Adam G.; Mandl, Kenneth D.; Coiera, Enrico; Bourgeois, Florence T.			The Effects of Industry Sponsorship on Comparator Selection in Trial Registrations for Neuropsychiatric Conditions in Children	PLOS ONE			English	Article							RANDOMIZED-CONTROLLED-TRIALS; COMPARATIVE EFFICACY; CLINICAL-TRIALS; YOUNG-ADULTS; TRENDS; MEDICATIONS; ADOLESCENTS; PATTERNS; JOURNALS; PLACEBO	Pediatric populations continue to be understudied in clinical drug trials despite the increasing use of pharmacotherapy in children, particularly with psychotropic drugs. Most pertinent to the clinical selection of drug interventions are trials directly comparing drugs against other drugs. The aim was to measure the prevalence of active drug comparators in neuropsychiatric drug trials in children and identify the effects of funding source on comparator selection. We analyzed the selection of drugs and drug comparisons in clinical trials registered between January 2006 and May 2012. Completed and ongoing interventional trials examining treatments for six neuropsychiatric conditions in children were included. Networks of drug comparisons for each condition were constructed using information about the trial study arms. Of 421 eligible trial registrations, 228 (63,699 participants) were drug trials addressing ADHD (106 trials), autism spectrum disorders (47), unipolar depression (16), seizure disorders (38), migraines and other headaches (15), or schizophrenia (11). Active drug comparators were used in only 11.0% of drug trials while 44.7% used a placebo control and 44.3% no drug or placebo comparator. Even among conditions with well-established pharmacotherapeutic options, almost all drug interventions were compared to a placebo. Active comparisons were more common among trials without industry funding (17% vs. 8%, p=0.04). Trials with industry funding differed from non-industry trials in terms of the drugs studied and the comparators selected. For 73% (61/84) of drugs and 90% (19/21) of unique comparisons, trials were funded exclusively by either industry or non-industry. We found that industry and non-industry differed when choosing comparators and active drug comparators were rare for both groups. This gap in pediatric research activity limits the evidence available to clinicians treating children and suggests a need to reassess the design and funding of pediatric trials in order to optimize the information derived from pediatric participation in clinical trials.	[Dunn, Adam G.; Coiera, Enrico] Univ New S Wales, Ctr Hlth Informat, Australian Inst Hlth Innovat, Sydney, NSW, Australia; [Mandl, Kenneth D.] Boston Childrens Hosp, Childrens Hosp Informat Program, Harvard MIT Hlth Sci & Technol, Boston, MA USA; [Mandl, Kenneth D.; Bourgeois, Florence T.] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Mandl, Kenneth D.; Bourgeois, Florence T.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	University of New South Wales Sydney; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bourgeois, FT (corresponding author), Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA.	florence.bourgeois@childrens.harvard.edu	Bourgeois, Florence/H-6710-2016; Dunn, Adam/H-4425-2019	Bourgeois, Florence/0000-0001-7798-4560; Dunn, Adam/0000-0002-1720-8209; Coiera, Enrico/0000-0002-6444-6584	National Institute of Child Health and Human Development [1R21HD072382]; National Health and Medical Research Council [568612, 1045065]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD072382] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by National Institute of Child Health and Human Development (1R21HD072382) and the National Health and Medical Research Council (Program Grant 568612 and Project Grant 1045065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BS, 1999, SOC NETWORKS, V21, P239, DOI 10.1016/S0378-8733(99)00011-8; Arruda MA, 2013, JAMA PEDIATR, V167, P300, DOI 10.1001/jamapediatrics.2013.1105; Bourgeois FT, 2012, PEDIATRICS, V130, P285, DOI 10.1542/peds.2012-0139; Bourgeois FT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028820, 10.1371/journal.pone.0050906]; Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; Cohen E, 2007, J CLIN EPIDEMIOL, V60, P118, DOI 10.1016/j.jclinepi.2006.03.015; Cohen E, 2010, ARCH PEDIAT ADOL MED, V164, P283, DOI 10.1001/archpediatrics.2009.291; Cooper WO, 2006, AMBUL PEDIATR, V6, P79, DOI 10.1016/j.ambp.2005.11.002; Cox ER, 2008, PEDIATRICS, V122, pE1053, DOI 10.1542/peds.2008-0214; Czaja AS, 2012, PHARMACOEPIDEM DR S, V21, P997, DOI 10.1002/pds.3312; DeMauro SB, 2011, PEDIATRICS, V128, pE639, DOI 10.1542/peds.2011-0377; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Dunn AG, 2012, CLIN PHARMACOL THER, V91, P685, DOI 10.1038/clpt.2011.279; Dunn AG, 2011, SOC SCI MED, V72, P1064, DOI 10.1016/j.socscimed.2011.01.029; Estellat C, 2012, ARCH INTERN MED, V172, P237, DOI 10.1001/archinternmed.2011.1209; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Hochman M, 2010, JAMA-J AM MED ASSOC, V303, P951, DOI 10.1001/jama.2010.240; Hunkeler EM, 2005, J CHILD ADOL PSYCHOP, V15, P26, DOI 10.1089/cap.2005.15.26; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Kappagoda S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6512; Lathyris DN, 2010, EUR J CLIN INVEST, V40, P172, DOI 10.1111/j.1365-2362.2009.02240.x; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Malozowski S, 2008, ANN INTERN MED, V148, P702, DOI 10.7326/0003-4819-148-9-200805060-00010; Olfson M, 2002, J AM ACAD CHILD PSY, V41, P514, DOI 10.1097/00004583-200205000-00008; PASQUALI SK, 2012, STATUS PEDIAT CLIN T; Rani F, 2008, PEDIATRICS, V121, P1002, DOI 10.1542/peds.2007-2008; Rheims S, 2008, PLOS MED, V5, P1223, DOI 10.1371/journal.pmed.0050166; Rizos EC, 2011, J CLIN EPIDEMIOL, V64, P830, DOI 10.1016/j.jclinepi.2010.11.017; Roberts LW, 2001, BIOL PSYCHIAT, V49, P887, DOI 10.1016/S0006-3223(01)01111-8; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Sammons HM, 2005, EUR J CLIN PHARMACOL, V61, P165, DOI 10.1007/s00228-005-0894-9; Seida JC, 2012, PEDIATRICS, V129, pE771, DOI 10.1542/peds.2011-2158; Smyth RL, 1999, LANCET, V354, pS21; Sorenson C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4849; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; STANG A, 2005, PLOS MED, V72, DOI DOI 10.1371/J0URNAL.PMED.0020072.PUBMED:15783259; Steinbrook R, 2002, NEW ENGL J MED, V347, P1462, DOI 10.1056/NEJMhpr021646; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Thomson D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013106; Vitiello B, 2004, BIOL PSYCHIAT, V56, P3, DOI 10.1016/j.biopsych.2004.03.011; Watts G, 2007, BRIT MED J, V335, P1227, DOI 10.1136/bmj.39423.581042.DB; *WHO COLL CTR DRUG, METH INT LANG DRUG U; Zito JM, 2003, ARCH PEDIAT ADOL MED, V157, P17, DOI 10.1001/archpedi.157.1.17	44	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84951	10.1371/journal.pone.0084951	http://dx.doi.org/10.1371/journal.pone.0084951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	278IG	24376857	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000171
J	Horeman, T; Meijer, EJ; Harlaar, JJ; Lange, JF; van den Dobbelsteen, JJ; Dankelman, J				Horeman, Tim; Meijer, Evert-jan; Harlaar, Joris J.; Lange, Johan F.; van den Dobbelsteen, John J.; Dankelman, Jenny			Force Sensing in Surgical Sutures	PLOS ONE			English	Article							LAPAROTOMY; SURGERY; TENSION; CLOSURE	The tension in a suture is an important factor in the process of wound healing. If there is too much tension in the suture, the blood flow is restricted and necrosis can occur. If the tension is too low, the incision opens up and cannot heal properly. The purpose of this paper is to describe the design and evaluation of the Stitch Force (SF) sensor and the Hook-In Force (HIF) sensor. These sensors were developed to measure the force on a tensioned suture inside a closed incision and to measure the pulling force used to close the incision. The accuracy of both sensors is high enough to determine the relation between the force in the thread of a stitch and the pulling force applied on the suture by the physician. In a pilot study, a continuous suture of 7 stitches was applied on the fascia of the abdominal wall of multiple pigs to study this relationship. The results show that the max force in the thread of the second stitch drops from 3 (SD 1.2) to 1 (SD 0.3) newton after the 4th stitch was placed. During placement of the 5th, 6th and 7th stitch, the force in the 2nd stitch was not influenced anymore. This study indicates that in a continuous suture the force in the thread remains constant up to more than 3 stiches away from the pulled loose end of the suture. When a force feedback tool is developed specially for suturing in surgery on patients, the proposed sensors can be used to determine safety threshold for different types of tissue and sutures.	[Horeman, Tim; van den Dobbelsteen, John J.; Dankelman, Jenny] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [Meijer, Evert-jan; Harlaar, Joris J.; Lange, Johan F.] Erasmus MC, Dept Dept Surg, Rotterdam, Netherlands	Delft University of Technology; Erasmus University Rotterdam; Erasmus MC	Horeman, T (corresponding author), Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands.	T.Horeman@tudelft.nl	Dankelman, Jenny/H-9100-2017; van den dobbelsteen, John/ABE-5312-2021	Dankelman, Jenny/0000-0003-3951-2129; 				BASSINI R, 1988, MED BIOL ENG COMPUT, V26, P451, DOI 10.1007/BF02442310; Bevis PM, 2010, BRIT J SURG, V97, P1497, DOI 10.1002/bjs.7137; Cummings JF, 2000, J INVEST SURG, V13, P253, DOI 10.1080/08941930050206265; Hoer J, 2001, LANGENBECK ARCH SURG, V386, P218, DOI 10.1007/s004230000196; HOGSTROM H, 1990, SURGERY, V107, P215; Horeman T, 2013, J SURG ED; Horeman T, 2012, SURG ENDOSC, V26, P242, DOI 10.1007/s00464-011-1861-4; Klink CD, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-36; MUDGE M, 1985, BRIT J SURG, V72, P70, DOI 10.1002/bjs.1800720127; Oshima N, 2007, IEEE INT CONF ROBOT, P2285, DOI 10.1109/ROBOT.2007.363660; Rath A, 2008, HERNIA, V2, P145; STONE IK, 1986, SURG GYNECOL OBSTET, V163, P448; Webster C, 2003, J SURG RES, V109, P130, DOI 10.1016/S0022-4804(02)00097-5	13	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84466	10.1371/journal.pone.0084466	http://dx.doi.org/10.1371/journal.pone.0084466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376812	Green Published, gold			2022-12-27	WOS:000328882000150
J	Moret, I; Sanchez-Izquierdo, D; Iborra, M; Tortosa, L; Navarro-Puche, A; Nos, P; Cervera, J; Beltran, B				Moret, Ines; Sanchez-Izquierdo, Dolors; Iborra, Marisa; Tortosa, Luis; Navarro-Puche, Ana; Nos, Pilar; Cervera, Jose; Beltran, Belen			Assessing an Improved Protocol for Plasma microRNA Extraction	PLOS ONE			English	Article							CIRCULATING MICRORNAS; GENE-EXPRESSION; RNA; QUANTIFICATION; IDENTIFICATION; BIOMARKERS; MARKERS; CANCER; MIRNAS; SERUM	The first step in biomarkers discovery is to identify the best protocols for their purification and analysis. This issue is critical when considering peripheral blood samples (plasma and serum) that are clinically interesting but meet several methodological problems, mainly complexity and low biomarker concentration. Analysis of small molecules, such as circulating microRNAs, should overcome these disadvantages. The present study describes an optimal RNA extraction method of microRNAs from human plasma samples. Different reagents and commercially available kits have been analyzed, identifying also the best pre-analytical conditions for plasma isolation. Between all of them, the column-based approaches were shown to be the most effective. In this context, miRNeasy Serum/Plasma Kit (from Qiagen) rendered more concentrated RNA, that was better suited for microarrays studies and did not require extra purification steps for sample concentration and purification than phenol based extraction methods. We also present evidences that the addition of low doses of an RNA carrier before starting the extraction process improves microRNA purification while an already published carrier dose can result in significant bias over microRNA profiles. Quality controls for best protocol selection were developed by spectrophotometry measurement of contaminants and microfluidics electrophoresis (Agilent 2100 Bioanalyzer) for RNA integrity. Selected donor and patient plasma samples and matched biopsies were tested by Affymetrix microarray technology to compare differentially expressed microRNAs. In summary, this study defines an optimized protocol for microRNA purification from human blood samples, increasing the performance of assays and shedding light over the best way to discover and use these biomarkers in clinical practice.	[Moret, Ines; Sanchez-Izquierdo, Dolors; Iborra, Marisa; Tortosa, Luis; Navarro-Puche, Ana; Nos, Pilar; Beltran, Belen] Hosp La Fe, Inst Invest Sanitaria, E-46009 Valencia, Spain; [Moret, Ines; Iborra, Marisa; Tortosa, Luis; Nos, Pilar; Beltran, Belen] CIBEREHD, Barcelona, Spain; [Sanchez-Izquierdo, Dolors] Hosp Univ & Politecn La Fe, Genom Unit, Valencia, Spain; [Iborra, Marisa; Nos, Pilar; Beltran, Belen] Hosp Univ & Politecn La Fe, Gastroenterol Unit, Valencia, Spain; [Cervera, Jose] Hosp Univ & Politecn La Fe, Dept Genet, Valencia, Spain	Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Beltran, B (corresponding author), Hosp La Fe, Inst Invest Sanitaria, E-46009 Valencia, Spain.	belenbeltranniclos@gmail.com	Cervera, Jose/ABF-2143-2020; Beltrán, Belén/ABH-6802-2020; Moret, Inés/ABI-1001-2020	Cervera, Jose/0000-0001-8252-1106; Beltran, Belen/0000-0002-7063-6376	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III [CA10/01027, FIS PS09/01827]; GETECCU/Otsuka	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III(Instituto de Salud Carlos III); GETECCU/Otsuka	Supported by public fundings from the "Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III: CA10/01027 and FIS PS09/01827", and a grant from GETECCU/Otsuka 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, AM J TRANSL RES, V3, P28; Andreasen D, 2010, METHODS, V50, pS6, DOI 10.1016/j.ymeth.2010.01.006; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Duttagupta R, 2013, WIRES RNA, V4, P129, DOI 10.1002/wrna.1149; Duttagupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031241; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Eldh M, 2012, MOL IMMUNOL, V50, P278, DOI 10.1016/j.molimm.2012.02.001; FAIRBANKS VF, 1992, CLIN CHEM, V38, P132; Fleissner F, 2012, AM J TRANSPLANT, V12, P289, DOI 10.1111/j.1600-6143.2011.03790.x; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; McAlexander Melissa A., 2013, Frontiers in Genetics, V4, P83, DOI 10.3389/fgene.2013.00083; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nair N, 2013, MOL CELL BIOCHEM, V376, P33, DOI 10.1007/s11010-012-1546-x; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang Z, 2010, MICRORNA EXPRESSION DETECTION METHODS, P1, DOI 10.1007/978-3-642-04928-6; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138	33	70	72	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82753	10.1371/journal.pone.0082753	http://dx.doi.org/10.1371/journal.pone.0082753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376572	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000026
J	Contreras-Huerta, LS; Baker, KS; Reynolds, KJ; Batalha, L; Cunnington, R				Sebastian Contreras-Huerta, Luis; Baker, Katharine S.; Reynolds, Katherine J.; Batalha, Luisa; Cunnington, Ross			Racial Bias in Neural Empathic Responses to Pain	PLOS ONE			English	Article							OLD-WORLD MONKEY; IN-GROUP BIAS; OTHERS PAIN; AMYGDALA ACTIVITY; GROUP MEMBERSHIP; RACE; PERCEPTION; OUTGROUP; FMRI; ATTENTION	Recent studies have shown that perceiving the pain of others activates brain regions in the observer associated with both somatosensory and affective-motivational aspects of pain, principally involving regions of the anterior cingulate and anterior insula cortex. The degree of these empathic neural responses is modulated by racial bias, such that stronger neural activation is elicited by observing pain in people of the same racial group compared with people of another racial group. The aim of the present study was to examine whether a more general social group category, other than race, could similarly modulate neural empathic responses and perhaps account for the apparent racial bias reported in previous studies. Using a minimal group paradigm, we assigned participants to one of two mixed-race teams. We use the term race to refer to the Chinese or Caucasian appearance of faces and whether the ethnic group represented was the same or different from the appearance of the participant' own face. Using fMRI, we measured neural empathic responses as participants observed members of their own group or other group, and members of their own race or other race, receiving either painful or non-painful touch. Participants showed clear group biases, with no significant effect of race, on behavioral measures of implicit (affective priming) and explicit group identification. Neural responses to observed pain in the anterior cingulate cortex, insula cortex, and somatosensory areas showed significantly greater activation when observing pain in own-race compared with other-race individuals, with no significant effect of minimal groups. These results suggest that racial bias in neural empathic responses is not influenced by minimal forms of group categorization, despite the clear association participants showed with in-group more than out-group members. We suggest that race may be an automatic and unconscious mechanism that drives the initial neural responses to observed pain in others.	[Sebastian Contreras-Huerta, Luis; Baker, Katharine S.; Cunnington, Ross] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Sebastian Contreras-Huerta, Luis] Univ Diego Portales, Lab Cognit & Social Neurosci LaNCyS, UDP INECO Fdn Core Neurosci UIFCoN, Santiago, Chile; [Sebastian Contreras-Huerta, Luis] Univ Diego Portales, Ctr Study Argumentat & Reasoning, Santiago, Chile; [Baker, Katharine S.; Cunnington, Ross] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Baker, Katharine S.] Stanford Univ, Sch Med, Dept Anesthesiol, Stanford, CA 94305 USA; [Reynolds, Katherine J.; Batalha, Luisa] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia	University of Queensland; University Diego Portales; University Diego Portales; University of Queensland; Stanford University; Australian National University	Cunnington, R (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	r.cunnington@uq.edu.au	Reynolds, Katherine/GRR-4312-2022; Batalha, luisa/I-3022-2015	Contreras-Huerta, Luis Sebastian/0000-0001-7747-590X; Cunnington, Ross/0000-0002-7423-4809; Batalha, luisa/0000-0001-8052-4039; Reynolds, Katherine/0000-0002-2282-7290	Australian Research Council; Australian National University, Canberra [FT0991468]	Australian Research Council(Australian Research Council); Australian National University, Canberra(Australian National University)	This study was supported by funding of the Australian Research Council and the Australian National University, Canberra (FT0991468). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitsuki Y, 2009, NEUROIMAGE, V47, P722, DOI 10.1016/j.neuroimage.2009.04.091; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Amodio DM, 2004, PSYCHOL SCI, V15, P88, DOI 10.1111/j.0963-7214.2004.01502003.x; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Avenanti A, 2006, NEUROIMAGE, V32, P316, DOI 10.1016/j.neuroimage.2006.03.010; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Azevedo RT, 2012, HUMAN BRAIN MAPPING; Balas B, 2010, NEUROPSYCHOLOGIA, V48, P498, DOI 10.1016/j.neuropsychologia.2009.10.007; Batson CD, 2007, J PERS SOC PSYCHOL, V93, P65, DOI 10.1037/0022-3514.93.1.65; Beer JS, 2008, NEUROIMAGE, V43, P775, DOI 10.1016/j.neuroimage.2008.08.033; Benuzzi F, 2008, J NEUROSCI, V28, P923, DOI 10.1523/JNEUROSCI.4012-07.2008; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Brown LM, 2006, BIOL PSYCHOL, V71, P303, DOI 10.1016/j.biopsycho.2005.06.003; Bruneau EG, 2012, PHILOS T R SOC B, V367, P717, DOI 10.1098/rstb.2011.0293; Budell L, 2010, NEUROIMAGE, V53, P355, DOI 10.1016/j.neuroimage.2010.05.037; Bufalari I, 2007, CEREB CORTEX, V17, P2553, DOI 10.1093/cercor/bhl161; Cheng Y, 2008, NEUROIMAGE, V40, P1833, DOI 10.1016/j.neuroimage.2008.01.064; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; Cheng YW, 2010, NEUROIMAGE, V51, P923, DOI 10.1016/j.neuroimage.2010.02.047; Cheon BK, 2011, NEUROIMAGE, V57, P642, DOI 10.1016/j.neuroimage.2011.04.031; Cikara M, 2011, J COGNITIVE NEUROSCI, V23, P3791, DOI 10.1162/jocn_a_00069; Cosmides L, 2003, TRENDS COGN SCI, V7, P173, DOI 10.1016/S1364-6613(03)00057-3; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Cunningham WA, 2001, PSYCHOL SCI, V12, P163, DOI 10.1111/1467-9280.00328; Danziger N, 2009, NEURON, V61, P203, DOI 10.1016/j.neuron.2008.11.023; de Greck M, 2012, SOC COGN AFFECT NEUR, V7, P135, DOI 10.1093/scan/nsq093; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Decety J, 2008, NEUROPSYCHOLOGIA, V46, P2607, DOI 10.1016/j.neuropsychologia.2008.05.026; Decety J, 2012, PROG NEUROBIOL, V98, P38, DOI 10.1016/j.pneurobio.2012.05.001; Decety J, 2011, EMOT REV, V3, P92, DOI 10.1177/1754073910374662; Decety J, 2010, J COGNITIVE NEUROSCI, V22, P985, DOI 10.1162/jocn.2009.21266; Eberhardt JL, 2005, AM PSYCHOL, V60, P181, DOI 10.1037/0003-066X.60.2.181; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Forgiarini M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00108; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Guo XY, 2012, SOC COGN AFFECT NEUR, V7, P535, DOI 10.1093/scan/nsr034; Gutsell JN, 2012, SOC COGN AFFECT NEUR, V7, P596, DOI 10.1093/scan/nsr035; Han SH, 2009, HUM BRAIN MAPP, V30, P3227, DOI 10.1002/hbm.20742; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Ito TA, 2005, COGN AFFECT BEHAV NE, V5, P21, DOI 10.3758/CABN.5.1.21; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Ito TA, 2009, TRENDS COGN SCI, V13, P524, DOI 10.1016/j.tics.2009.10.002; Jackson PL, 2006, PAIN, V125, P5, DOI 10.1016/j.pain.2006.09.013; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Knutson KM, 2007, HUM BRAIN MAPP, V28, P915, DOI 10.1002/hbm.20320; Kubota JT, 2007, J EXP SOC PSYCHOL, V43, P738, DOI 10.1016/j.jesp.2006.10.023; Lamm C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001292; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lamm C, 2010, J COGNITIVE NEUROSCI, V22, P362, DOI 10.1162/jocn.2009.21186; Levine M, 2005, PERS SOC PSYCHOL B, V31, P443, DOI 10.1177/0146167204271651; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; Mathur VA, 2010, NEUROIMAGE, V51, P1468, DOI 10.1016/j.neuroimage.2010.03.025; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Montalan B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00389; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Morrison I, 2007, NEUROIMAGE, V37, P642, DOI 10.1016/j.neuroimage.2007.03.079; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; MUFSON EJ, 1982, J COMP NEUROL, V212, P23, DOI 10.1002/cne.902120103; Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551; Otten S, 1999, EUR J SOC PSYCHOL, V29, P1049, DOI 10.1002/(SICI)1099-0992(199912)29:8<1049::AID-EJSP985>3.0.CO;2-Q; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Rand DG, 2009, P NATL ACAD SCI USA, V106, P6187, DOI 10.1073/pnas.0811552106; Reynolds KJ, 2007, BRIT J SOC PSYCHOL, V46, P517, DOI 10.1348/014466606X153080; Ronquillo J, 2007, SOC COGN AFFECT NEUR, V2, P39, DOI 10.1093/scan/nsl043; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Sheng F, 2012, NEUROIMAGE, V61, P786, DOI 10.1016/j.neuroimage.2012.04.028; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Vachon-Presseau E, 2012, NEUROIMAGE, V63, P54, DOI 10.1016/j.neuroimage.2012.06.030; Valeriani M, 2008, NEUROIMAGE, V40, P1419, DOI 10.1016/j.neuroimage.2007.12.056; Van Bavel JJ, 2011, J COGNITIVE NEUROSCI, V23, P3343, DOI 10.1162/jocn_a_00016; Van Bavel JJ, 2009, PERS SOC PSYCHOL B, V35, P321, DOI 10.1177/0146167208327743; Van Bavel JJ, 2008, PSYCHOL SCI, V19, P1131, DOI 10.1111/j.1467-9280.2008.02214.x; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wheeler ME, 2005, PSYCHOL SCI, V16, P56, DOI 10.1111/j.0956-7976.2005.00780.x; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009	86	56	57	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84001	10.1371/journal.pone.0084001	http://dx.doi.org/10.1371/journal.pone.0084001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	278IG	24376780	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000135
J	Shang, RF; Wang, SY; Xu, XM; Yi, YP; Guo, WZ; YuLiu; Liang, JP				Shang, Ruofeng; Wang, Shengyu; Xu, Ximing; Yi, Yunpeng; Guo, Wenzhu; YuLiu; Liang, Jianping			Chemical Synthesis and Biological Activities of Novel Pleuromutilin Derivatives with Substituted Amino Moiety	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIBIOTICS; BINDING; CHEMISTRY; COMPLEX; FIT	Novel pleuromutilin derivatives designed based on the structure of valnemulin were synthesized and evaluated for their in vitro antibacterial activities. These pleuromutilin derivatives with substituted amino moiety exhibited excellent activities against methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis, Escherichia coli, and Streptococcus agalactiae. Compound 5b showed the highest antibacterial activities and even exceeded tiamulin. Moreover, the docking experiments provided information about the binding model between the synthesized compounds and peptidyl transferase center (PTC) of 23S rRNA.	[Shang, Ruofeng; Yi, Yunpeng; Guo, Wenzhu; YuLiu; Liang, Jianping] Chinese Acad Agr Sci, Lanzhou Inst Anim Sci & Vet Pharmaceut Sci, Key Lab New Anim Drug Project Gansu Prov, Key Lab Vet Pharmacceut Dev,Minist Agr, Lanzhou, Gansu, Peoples R China; [Wang, Shengyu] Univ Hosp Gansu Tradit Chinese Med, Lanzhou, Gansu, Peoples R China; [Xu, Ximing] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Unite Biol Fonct & Adaptat, Paris, France	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Liang, JP (corresponding author), Chinese Acad Agr Sci, Lanzhou Inst Anim Sci & Vet Pharmaceut Sci, Key Lab New Anim Drug Project Gansu Prov, Key Lab Vet Pharmacceut Dev,Minist Agr, Lanzhou, Gansu, Peoples R China.	liangjp100@sina.com			Basic Scientific Research Funds in Central Agricultral Scientific Research Institutions [1610322013004]; "Five-Year'' plan of national science and technology projects in rural areas [2011AA10A214]	Basic Scientific Research Funds in Central Agricultral Scientific Research Institutions; "Five-Year'' plan of national science and technology projects in rural areas	This work was supported by Basic Scientific Research Funds in Central Agricultral Scientific Research Institutions (number 1610322013004) and "Five-Year'' plan of national science and technology projects in rural areas (number 2011AA10A214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1962, GAZZ CHIM ITAL, V92, P884; Birch A.J., 1963, CHEM IND, V14, P374; Bosling J, 2003, ANTIMICROB AGENTS CH, V47, P2892, DOI 10.1128/AAC.47.9.2892-2896.2003; Davidovich C, 2007, P NATL ACAD SCI USA, V104, P4291, DOI 10.1073/pnas.0700041104; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Dreier I, 2012, J MED CHEM, V55, P2067, DOI 10.1021/jm201266b; EGGER H, 1976, J ANTIBIOT, V29, P923, DOI 10.7164/antibiotics.29.923; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hildebrandt JF, 1982, CURR CHEMOTHER IMMUN, P346; Hunt E, 2000, DRUG FUTURE, V25, P1163, DOI 10.1358/dof.2000.025.11.858699; KAVANAGH F, 1951, P NATL ACAD SCI USA, V37, P570, DOI 10.1073/pnas.37.9.570; Ling Y, 2012, ARCH PHARM, V345, P638, DOI 10.1002/ardp.201100430; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P1458, DOI 10.1128/AAC.50.4.1458-1462.2006; Marialke J, 2008, J CHEM INF MODEL, V48, P186, DOI 10.1021/ci700124r; Marshall MS, 2009, J PHYS CHEM A, V113, P13438, DOI 10.1021/jp906086x; Moody M N, 2010, Skin Therapy Lett, V15, P1; Novak R, 2011, ANN NY ACAD SCI, V1241, P71, DOI 10.1111/j.1749-6632.2011.06219.x; Novak R, 2010, CURR OPIN INVEST DR, V11, P182; Omaima MA, 2012, J MED CHEM, V18, P76; Sader HS, 2012, J ANTIMICROB CHEMOTH, V67, P1170, DOI 10.1093/jac/dks001; Schlunzen F, 2004, MOL MICROBIOL, V54, P1287, DOI 10.1111/j.1365-2958.2004.04346.x; Goncalves RSB, 2010, CURR RESPIR MED REV, V6, P91, DOI 10.2174/157339810791171287; Shang RF, 2013, Z KRIST-NEW CRYST ST, V228, P135, DOI 10.1524/ncrs.2013.0068; Shang RF, 2013, EUR J MED CHEM, V63, P231, DOI 10.1016/j.ejmech.2013.01.048; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stierand K, 2006, BIOINFORMATICS, V22, P1710, DOI 10.1093/bioinformatics/btl150; Tang YZ, 2012, MINI-REV MED CHEM, V12, P53; VANDERSLUIS P, 1990, ACTA CRYSTALLOGR A, V46, P194, DOI 10.1107/S0108767389011189; Wang R, 2011, J VET PHARMACOL THER, V34, P247, DOI 10.1111/j.1365-2885.2010.01215.x; Wencewicz TA, 2011, J MED CHEM, V54, P6843, DOI 10.1021/jm200794r; Xu P, 2009, CHEM BIOL DRUG DES, V73, P655, DOI 10.1111/j.1747-0285.2009.00821.x; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133	32	9	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82595	10.1371/journal.pone.0082595	http://dx.doi.org/10.1371/journal.pone.0082595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376551	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000017
J	Sun, L; Rajamannan, NM; Sucosky, P				Sun, Ling; Rajamannan, Nalini M.; Sucosky, Philippe			Defining the Role of Fluid Shear Stress in the Expression of Early Signaling Markers for Calcific Aortic Valve Disease	PLOS ONE			English	Article							INTERSTITIAL-CELLS; MATRIX METALLOPROTEINASES; BIOLOGICAL-PROPERTIES; ENDOTHELIAL-CELLS; CYCLIC PRESSURE; STENOSIS; LEAFLETS; STRETCH; MECHANOBIOLOGY; HEMODYNAMICS	Calcific aortic valve disease (CAVD) is an active process presumably triggered by interplays between cardiovascular risk factors, molecular signaling networks and hemodynamic cues. While earlier studies demonstrated that alterations in fluid shear stress (FSS) on the fibrosa could trigger inflammation, the mechanisms of CAVD pathogenesis secondary to side-specific FSS abnormalities are poorly understood. This knowledge could be critical to the elucidation of key CAVD risk factors such as congenital valve defects, aging and hypertension, which are known to generate FSS disturbances. The objective of this study was to characterize ex vivo the contribution of isolated and combined abnormalities in FSS magnitude and frequency to early valvular pathogenesis. The ventricularis and fibrosa of porcine aortic valve leaflets were exposed simultaneously to different combinations of sub-physiologic/physiologic/supra-physiologic levels of FSS magnitude and frequency for 24, 48 and 72 hours in a double cone-and-plate device. Endothelial activation and paracrine signaling were investigated by measuring cell-adhesion molecule (ICAM-1, VCAM-1) and cytokine (BMP-4, TGF-beta 1) expressions, respectively. Extracellular matrix (ECM) degradation was characterized by measuring the expression and activity of the proteases MMP-2, MMP-9, cathepsin L and cathepsin S. The effect of the FSS treatment yielding the most significant pathological response was examined over a 72-hour period to characterize the time-dependence of FSS mechano-transduction. While cytokine expression was stimulated under elevated FSS magnitude at normal frequency, ECM degradation was stimulated under both elevated FSS magnitude at normal frequency and physiologic FSS magnitude at abnormal frequency. In contrast, combined FSS magnitude and frequency abnormalities essentially maintained valvular homeostasis. The pathological response under supra-physiologic FSS magnitude peaked at 48 hours but was then maintained until the 72-hour time point. This study confirms the sensitivity of valve leaflets to both FSS magnitude and frequency and suggests the ability of supra-physiologic FSS levels or abnormal FSS frequencies to initiate CAVD mechanisms.	[Sun, Ling; Sucosky, Philippe] Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA; [Sun, Ling; Sucosky, Philippe] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Rajamannan, Nalini M.] Mayo Clin, Mol Biol & Biochem, Sch Med, Rochester, MN USA	University of Notre Dame; University of Notre Dame; Mayo Clinic	Sucosky, P (corresponding author), Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA.	Philippe.Sucosky@nd.edu	Sucosky, Philippe/A-7052-2013	Sucosky, Philippe/0000-0003-0113-5858	NSF (National Science Foundation) CAREER grant; AHA (American Heart Association) Scientist Development Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL073927, R01HL085591] Funding Source: NIH RePORTER	NSF (National Science Foundation) CAREER grant; AHA (American Heart Association) Scientist Development Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research funded partially under a NSF (National Science Foundation) CAREER grant and an AHA (American Heart Association) Scientist Development Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913; Ankeny RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020969; Balachandran K, 2006, ANN BIOMED ENG, V34, P1655, DOI 10.1007/s10439-006-9167-8; Balachandran K, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/263870; Balachandran K, 2010, AM J PATHOL, V177, P49, DOI 10.2353/ajpath.2010.090631; Balachandran K, 2009, AM J PHYSIOL-HEART C, V296, pH756, DOI 10.1152/ajpheart.00900.2008; BEPPU S, 1993, AM J CARDIOL, V71, P322, DOI 10.1016/0002-9149(93)90799-I; Butcher JT, 2008, J HEART VALVE DIS, V17, P62; Butcher JT, 2006, ARTERIOSCL THROM VAS, V26, P69, DOI 10.1161/01.ATV.0000196624.70507.0d; Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a; Carabello BA, 2009, LANCET, V373, P956, DOI 10.1016/S0140-6736(09)60211-7; Chandra S, 2012, BIOMECH MODEL MECHAN, V11, P1085, DOI 10.1007/s10237-012-0375-x; CHRISTIE GW, 1995, ANN THORAC SURG, V60, pS156, DOI 10.1016/0003-4975(95)00219-B; Clark-Greuel JN, 2007, ANN THORAC SURG, V83, P946, DOI 10.1016/j.athoracsur.2006.10.026; DECK JD, 1986, CARDIOVASC RES, V20, P760, DOI 10.1093/cvr/20.10.760; Dreger SA, 2002, J HEART VALVE DIS, V11, P875; Edep ME, 2000, CARDIOVASC PATHOL, V9, P281, DOI 10.1016/S1054-8807(00)00043-0; Fisher CI, 2013, BIOMECH MODEL MECHAN, V12, P5, DOI 10.1007/s10237-012-0377-8; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goldbarg SH, 2007, J AM COLL CARDIOL, V50, P1205, DOI 10.1016/j.jacc.2007.06.024; Gu XX, 2011, AM J PHYSIOL-HEART C, V300, pH448, DOI 10.1152/ajpheart.01178.2009; Helske S, 2006, ARTERIOSCL THROM VAS, V26, P1791, DOI 10.1161/01.ATV.0000228824.01604.63; Hoehn D., 2010, CARDIOVASC ENG TECHN, V1, P165, DOI [10.1007/s13239-010-0015-5, DOI 10.1007/S13239-010-0015-5]; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Kaden JJ, 2005, INT J MOL MED, V16, P869; Kaden JJ, 2004, J HEART VALVE DIS, V13, P560; Kajbaf S, 2005, AM J KIDNEY DIS, V46, P86, DOI 10.1053/j.ajkd.2005.03.020; Little SH, 2007, HEART, V93, P848, DOI 10.1136/hrt.2006.098392; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Metzler SA, 2008, J HEART VALVE DIS, V17, P571; Miller JD, 2010, ARTERIOSCL THROM VAS, V30, P2482, DOI 10.1161/ATVBAHA.110.211029; Mohler ER, 1997, ARTERIOSCL THROM VAS, V17, P547, DOI 10.1161/01.ATV.17.3.547; Monzack EL, 2011, J HEART VALVE DIS, V20, P449; Muller AM, 2000, J PATHOL, V191, P54, DOI 10.1002/(SICI)1096-9896(200005)191:1<54::AID-PATH568>3.0.CO;2-Y; OBRIEN KD, 1995, CIRCULATION, V92, P2163, DOI 10.1161/01.CIR.92.8.2163; OLSSON M, 1994, J AM COLL CARDIOL, V23, P1162, DOI 10.1016/0735-1097(94)90606-8; Osman N, 2013, CARDIOVASC PATHOL, V22, P146, DOI 10.1016/j.carpath.2012.07.002; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Platt MO, 2006, J HEART VALVE DIS, V15, P622; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Rabkin SW, 2005, BLOOD PRESSURE, V14, P264, DOI 10.1080/08037050500233320; Rajamannan NM, 2012, J CELL BIOCHEM, V113, P1623, DOI 10.1002/jcb.24031; Rajamannan NM, 2011, J CELL BIOCHEM, V112, P2222, DOI 10.1002/jcb.23182; Rajamannan NM, 2010, AM J PHYSIOL-HEART C, V298, pH5, DOI 10.1152/ajpheart.00824.2009; Rajamannan NM, 2005, CIRCULATION, V112, pI229, DOI 10.1161/01.CIRCULATIONAHA.104.524306; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Rajamannan NM, 2002, CIRCULATION, V105, P2660, DOI 10.1161/01.CIR.0000017435.87463.72; Richards J, 2013, AM J PATHOL, V182, P1922, DOI 10.1016/j.ajpath.2013.01.037; Sabet HY, 1999, MAYO CLIN PROC, V74, P14, DOI 10.4065/74.1.14; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; Stephens EH, 2011, CARDIOVASC PATHOL, V20, P334, DOI [10.1016/j.carpath.2010.10.002, 10.1016/j.carpath.2010.07.004]; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Sucosky P, 2009, ARTERIOSCL THROM VAS, V29, P254, DOI 10.1161/ATVBAHA.108.176347; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048843; Sun L, 2011, ANN BIOMED ENG, V39, P2174, DOI 10.1007/s10439-011-0305-6; Thayer P, 2011, ANN BIOMED ENG, V39, P1654, DOI 10.1007/s10439-011-0273-x; Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa; Warnock JN, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/176412; Warnock JN, 2006, J HEART VALVE DIS, V15, P34; Weinberg EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005960; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139; Weston MW, 2001, ANN BIOMED ENG, V29, P752, DOI 10.1114/1.1397794; Wirrig EE, 2011, J MOL CELL CARDIOL, V50, P561, DOI 10.1016/j.yjmcc.2010.12.005; Xing Y, 2004, ANN BIOMED ENG, V32, P1461, DOI 10.1114/B:ABME.0000049031.07512.11; Yap CH, 2012, AM J PHYSIOL-HEART C, V303, pH721, DOI 10.1152/ajpheart.00829.2011; Yap CH, 2012, BIOMECH MODEL MECHAN, V11, P171, DOI 10.1007/s10237-011-0301-7; Yap CH, 2012, BIOMECH MODEL MECHAN, V11, P231, DOI 10.1007/s10237-011-0306-2; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394	69	55	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84433	10.1371/journal.pone.0084433	http://dx.doi.org/10.1371/journal.pone.0084433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376809	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000147
J	Wu, HB; Qin, JX; Han, J; Zhao, XJ; Ouyang, SH; Liang, Y; Zhang, D; Wang, ZZ; Wu, QH; Xie, JZ; Cui, Y; Peng, HR; Sun, QX; Liu, ZY				Wu, Haibin; Qin, Jinxia; Han, Jun; Zhao, Xiaojie; Ouyang, Shuhong; Liang, Yong; Zhang, Dong; Wang, Zhenzhong; Wu, Qiuhong; Xie, Jingzhong; Cui, Yu; Peng, Huiru; Sun, Qixin; Liu, Zhiyong			Comparative High-Resolution Mapping of the Wax Inhibitors Iw1 and Iw2 in Hexaploid Wheat	PLOS ONE			English	Article							MILDEW RESISTANCE GENE; TRITICUM-AESTIVUM L.; D-GENOME PROGENITOR; COMMON WHEAT; AEGILOPS-TAUSCHII; BREAD WHEAT; NON-GLAUCOUSNESS; CUTICULAR WAXES; POLYPLOID WHEAT; GAS-EXCHANGE	The wax (glaucousness) on wheat leaves and stems is mainly controlled by two sets of genes: glaucousness loci (W1 and W2) and non-glaucousness loci (Iw1 and Iw2). The non-glaucousness (Iw) loci act as inhibitors of the glaucousness loci (W). High-resolution comparative genetic linkage maps of the wax inhibitors Iw1 originating from Triticum dicoccoides, and Iw2 from Aegilops tauschii were developed by comparative genomics analyses of Brachypodium, sorghum and rice genomic sequences corresponding to the syntenic regions of the Iw loci in wheat. Eleven Iw1 and eight Iw2 linked EST markers were developed and mapped to linkage maps on the distal regions of chromosomes 2BS and 2DS, respectively. The Iw1 locus mapped within a 0.96 cM interval flanked by the BE498358 and CA499581 EST markers that are collinear with 122 kb, 202 kb, and 466 kb genomic regions in the Brachypodium 5S chromosome, the sorghum 6S chromosome and the rice 4S chromosome, respectively. The Iw2 locus was located in a 4.1 to 5.4-cM interval in chromosome 2DS that is flanked by the CJ886319 and CJ519831 EST markers, and this region is collinear with a 2.3 cM region spanning the Iw1 locus on chromosome 2BS. Both Iw1 and Iw2 co-segregated with the BF474014 and CJ876545 EST markers, indicating they are most likely orthologs on 2BS and 2DS. These high-resolution maps can serve as a framework for chromosome landing, physical mapping and map-based cloning of the wax inhibitors in wheat.	[Wu, Haibin; Qin, Jinxia; Han, Jun; Zhao, Xiaojie; Ouyang, Shuhong; Liang, Yong; Zhang, Dong; Wang, Zhenzhong; Wu, Qiuhong; Xie, Jingzhong; Cui, Yu; Peng, Huiru; Sun, Qixin; Liu, Zhiyong] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Key Lab Crop Heterosis Res & Utilizat, State Key Lab Agrobiotechnol,Dept Plant Genet & B, Beijing 100094, Peoples R China; [Han, Jun] China Agr Univ, Plant Sci & Technol Coll, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Sun, QX (corresponding author), China Agr Univ, Beijing Key Lab Crop Genet Improvement, Key Lab Crop Heterosis Res & Utilizat, State Key Lab Agrobiotechnol,Dept Plant Genet & B, Beijing 100094, Peoples R China.	qxsun@cau.edu.cn; zhiyongliu@cau.edu.cn	Xie, Jingzhong/AAF-5899-2020	Liu liu, Zhiyong zhi yong/0000-0002-6958-5233	NSFC [31030056]; MOST [2011AA100104]; MOE [111-2-03]; China Agricultural University	NSFC(National Natural Science Foundation of China (NSFC)); MOST; MOE(Ministry of Higher Education & Scientific Research (MHESR)); China Agricultural University	This work was financially supported by the NSFC (31030056), MOST (2011AA100104), MOE (111-2-03), and Innovation Fund for Graduate Student of China Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski NM, 2013, PLANT J, V74, P989, DOI 10.1111/tpj.12185; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; BIANCHI G, 1986, J AGR FOOD CHEM, V34, P429, DOI 10.1021/jf00069a012; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chu CG, 2008, MOL BREEDING, V22, P251, DOI 10.1007/s11032-008-9171-9; Devos KM, 2005, CURR OPIN PLANT BIOL, V8, P155, DOI 10.1016/j.pbi.2005.01.005; DRISCOLL CJ, 1964, CAN J GENET CYTOL, V6, P324, DOI 10.1139/g64-041; Dubcovsky J, 1997, THEOR APPL GENET, V95, P1169, DOI 10.1007/s001220050678; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; EIGENBRODE SD, 1995, ANNU REV ENTOMOL, V40, P171, DOI 10.1146/annurev.en.40.010195.001131; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; Faricelli ME, 2010, FUNCT INTEGR GENOMIC, V10, P293, DOI 10.1007/s10142-009-0146-7; Faris JD, 2008, FUNCT INTEGR GENOMIC, V8, P149, DOI 10.1007/s10142-008-0073-z; Gadaleta A, 2009, THEOR APPL GENET, V118, P1015, DOI 10.1007/s00122-008-0958-1; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Guyot Romain, 2004, Functional & Integrative Genomics, V4, P47, DOI 10.1007/s10142-004-0103-4; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Jenks M. A., 1999, Horticultural Reviews, V23, P1, DOI 10.1002/9780470650752.ch1; JENSEN N. F., 1962, CROP SCI, V2, P504, DOI 10.2135/cropsci1962.0011183X000200060019x; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; JOHNSON DA, 1983, CROP SCI, V23, P318, DOI 10.2135/cropsci1983.0011183X002300020033x; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lincoln S, 1992, CONSTRUCING GENETIC, V3rd; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu Q, 2007, EUPHYTICA, V155, P71, DOI 10.1007/s10681-006-9302-5; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu ZJ, 2012, THEOR APPL GENET, V124, P1041, DOI 10.1007/s00122-011-1767-5; LOWE HJB, 1985, ANN APPL BIOL, V106, P555, DOI 10.1111/j.1744-7348.1985.tb03146.x; Lu Huangjun, 2006, Functional & Integrative Genomics, V6, P90, DOI 10.1007/s10142-005-0020-1; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; RICHARDS RA, 1986, AUST J PLANT PHYSIOL, V13, P465, DOI 10.1071/PP9860465; Riederer M, 2001, J EXP BOT, V52, P2023, DOI 10.1093/jexbot/52.363.2023; Roder MS, 1998, GENETICS, V149, P2007; Rong JK, 2000, EUPHYTICA, V115, P121, DOI 10.1023/A:1003950431049; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Schnurbusch T, 2007, THEOR APPL GENET, V115, P451, DOI 10.1007/s00122-007-0579-0; SCHONHERR J, 1976, PLANTA, V131, P159, DOI 10.1007/BF00389989; Sears E. R., 1978, Proceedings of the fifth international wheat genetics symposium. Volume 1. Session IV. Cytogenetics., P389; Sears E. R., 1966, Chromosome manipulations and plant genetics., P29; Simmonds JR, 2008, EUPHYTICA, V159, P333, DOI 10.1007/s10681-007-9514-3; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Sorrells ME, 2011, GENOME, V54, P875, DOI [10.1139/G11-054, 10.1139/g11-054]; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; TSUNEWAKI K, 1966, JPN J BOT, V19, P175; Tsunewaki K, 1999, GENES GENET SYST, V74, P33, DOI 10.1266/ggs.74.33; TSUNEWAKI K, 1962, JPN J GENET, V37, P155, DOI 10.1266/jjg.37.155; Valarik M, 2006, THEOR APPL GENET, V112, P945, DOI 10.1007/s00122-005-0198-6; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Watanabe N, 2005, EUPHYTICA, V144, P119, DOI 10.1007/s10681-005-5193-0; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yoshiya K, 2011, EUPHYTICA, V177, P293, DOI 10.1007/s10681-010-0283-z; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]	54	23	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84691	10.1371/journal.pone.0084691	http://dx.doi.org/10.1371/journal.pone.0084691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376835	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000159
J	Feng, L; Liu, XY; Zhu, WL; Guo, FJ; Wu, YC; Wang, R; Chen, KX; Huang, C; Li, YM				Feng, Li; Liu, Xiaoyu; Zhu, Weiliang; Guo, Fujiang; Wu, Yingchun; Wang, Rui; Chen, Kaixian; Huang, Cheng; Li, Yiming			Inhibition of Human Neutrophil Elastase by Pentacyclic Triterpenes	PLOS ONE			English	Article							CIGARETTE-SMOKE; CDDO-ME; PROTEASE INHIBITOR; MOLECULAR DOCKING; ASTRAGALOSIDE-IV; OXIDATIVE STRESS; DOWN-REGULATION; HUMAN-LEUKOCYTE; URSOLIC ACID; RELAXATION	Scope: Inhibiting human neutrophil elastase (HNE) is a promising strategy for treating inflammatory lung diseases, such as H1N1 and SARS virus infections. The use of sivelestat, the only clinically registered synthesized HNE inhibitor, is largely limited by its risk of organ toxicity because it irreversibly inhibits HNE. Therefore, potent reversible HNE inhibitors are promising alternatives to sivelestat. Methods and Results: An in vitro HNE inhibition assay was employed to screen a series of triterpenes. Six pentacyclic triterpenes, but not tetracyclic triterpenes, significantly inhibited HNE. Of these pentacyclic triterpenes, ursolic acid exhibited the highest inhibitory potency (IC50 = 5.51 mu M). The HNE inhibitory activity of ursolic acid was further verified using a mouse model of acute smoke-induced lung inflammation. The results of nuclear magnetic resonance and HNE inhibition kinetic analysis showed that the pentacyclic triterpenes competitively and reversibly inhibited HNE. Molecular docking experiments indicated that the molecular scaffold, 28-COOH, and a double bond at an appropriate location in the pentacyclic triterpenes are important for their inhibitory activity. Conclusion: Our results provide insights into the effects of pentacyclic triterpenes on lung inflammatory actions through reversible inhibition of HNE activity.	[Feng, Li; Guo, Fujiang; Wu, Yingchun; Wang, Rui; Chen, Kaixian; Huang, Cheng; Li, Yiming] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China; [Liu, Xiaoyu] Second Mil Med Univ, Dept Biol Chem, Shanghai, Peoples R China; [Zhu, Weiliang; Chen, Kaixian] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Shanghai University of Traditional Chinese Medicine; Naval Medical University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Huang, C (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China.	chuang.shutcm@gmail.com; ymlius@163.com			National Science and Technology Major Project of China [2009ZX09311-003]; Program for Professors of Special Appointment (Eastern Scholar) in Shanghai Institutions of Higher Learning [2012-90]; "Xinlin'' scholars and outstanding team training plan of SHUTCM; National Natural Science Foundation of China [81173518]	National Science and Technology Major Project of China; Program for Professors of Special Appointment (Eastern Scholar) in Shanghai Institutions of Higher Learning; "Xinlin'' scholars and outstanding team training plan of SHUTCM; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research program was supported by the National Science and Technology Major Project of China (2009ZX09311-003), the Program for Professors of Special Appointment (Eastern Scholar) in Shanghai Institutions of Higher Learning (2012-90), the "Xinlin'' scholars and outstanding team training plan of SHUTCM and the National Natural Science Foundation of China (No. 81173518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDARD M, 1993, AM J RESP CELL MOL, V9, P455, DOI 10.1165/ajrcmb/9.4.455; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Betsuyaku T, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34 Suppl, P69; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; CAMPBELL EJ, 1988, J CELL BIOL, V106, P667, DOI 10.1083/jcb.106.3.667; Cantin Andre M, 2010, Proc Am Thorac Soc, V7, P368, DOI 10.1513/pats.201001-014AW; Churg A, 2002, AM J RESP CELL MOL, V27, P368, DOI 10.1165/rcmb.4791; CLARK RA, 1981, J BIOL CHEM, V256, P3348; Downey GP, 2013, AM J RESP CELL MOL B; Feng L, 2012, INT J BIOL MACROMOL, V51, P196, DOI 10.1016/j.ijbiomac.2012.04.023; Fitch PM, 2006, BIOCHEM SOC T, V34, P279, DOI 10.1042/BST0340279; FREEMAN R, 1974, J CHEM PHYS, V61, P4466, DOI 10.1063/1.1681764; Frighetto RTS, 2008, FOOD CHEM, V106, P767, DOI 10.1016/j.foodchem.2007.06.003; Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139; Heberle G, 2011, CURR MED CHEM, V18, P1339, DOI 10.2174/092986711795029573; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang WJ, 2008, J MED CHEM, V51, P2003, DOI 10.1021/jm700966p; Ikeda Y, 2008, MOL NUTR FOOD RES, V52, P26, DOI 10.1002/mnfr.200700389; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Li YM, 2007, BIOPHYS CHEM, V129, P212, DOI 10.1016/j.bpc.2007.05.020; Li YM, 2004, BIOORG MED CHEM LETT, V14, P1585, DOI 10.1016/j.bmcl.2003.12.055; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Liu GX, 2004, BIOORGAN MED CHEM, V12, P4147, DOI 10.1016/j.bmc.2004.05.023; Macdonald SJF, 2002, J MED CHEM, V45, P3878, DOI 10.1021/jm020881f; MACNEE W, 1989, NEW ENGL J MED, V321, P924, DOI 10.1056/NEJM198910053211402; Martini S, 2006, BIOCHEM PHARMACOL, V71, P858, DOI 10.1016/j.bcp.2005.12.010; Melzig MF, 2001, PHARMAZIE, V56, P967; Montuschi P, 2000, AM J RESP CRIT CARE, V162, P1175, DOI 10.1164/ajrccm.162.3.2001063; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Navon Gil, 1992, MAGN RESON CHEM, V30, P461; Niu Y, 2013, J ASIAN NAT PROD RES, V15, P550, DOI 10.1080/10286020.2013.781589; Ohbayashi H, 2002, EXPERT OPIN INV DRUG, V11, P965, DOI 10.1517/13543784.11.7.965; Perez-Rial S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072975; Pessina Gian Paolo, 1993, Archivum Immunologiae et Therapiae Experimentalis, V41, P343; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Rajic A, 2001, PLANTA MED, V67, P599, DOI 10.1055/s-2001-17350; Rubin H, 1996, NAT MED, V2, P632, DOI 10.1038/nm0696-632; SCUDERI P, 1989, J IMMUNOL, V143, P168; Shibata S, 2010, J ANESTH, V24, P901, DOI 10.1007/s00540-010-1030-2; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; Siedle B, 2007, PLANTA MED, V73, P401, DOI 10.1055/s-2007-967183; SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19; Stevens T, 2011, J PHARMACOL EXP THER, V339, P313, DOI 10.1124/jpet.111.182139; Thatcher TH, 2005, AM J PHYSIOL-LUNG C, V289, pL322, DOI 10.1152/ajplung.00039.2005; Thimmulappa RK, 2007, ANTIOXID REDOX SIGN, V9, P1963, DOI 10.1089/ars.2007.1745; van der Toorn M, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-45; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Veglia G, 1998, J MAGN RESON, V130, P281, DOI 10.1006/jmre.1997.1301; Wang YL, 2011, INORG CHEM, V50, P4340, DOI 10.1021/ic102331x; WENDEL A, 1990, METHOD ENZYMOL, V186, P675; Wiedow O, 2005, J INTERN MED, V257, P319, DOI 10.1111/j.1365-2796.2005.01476.x; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Wright JL, 2002, AM J RESP CRIT CARE, V166, P954, DOI 10.1164/rccm.200202-098OC; Wu Y, 2013, J CLIN PHARM THER; Xiong M, 2011, ACTA OTO-LARYNGOL, V131, P809, DOI 10.3109/00016489.2011.568524; Yao Chu-Fang, 2003, Zhong Xi Yi Jie He Xue Bao, V1, P234; Yokoyama T, 2010, INTERNAL MED, V49, P427, DOI 10.2169/internalmedicine.49.3022; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136; Zhou SF, 2005, DRUG METAB REV, V37, P41, DOI 10.1081/DMR-200028812; Zou W, 2007, CANCER BIOL THER, V6, P1614, DOI 10.4161/cbt.6.10.4763	62	18	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82794	10.1371/journal.pone.0082794	http://dx.doi.org/10.1371/journal.pone.0082794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376583	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100058
J	Ko, S; Kawasaki, I; Shim, YH				Ko, Sunhee; Kawasaki, Ichiro; Shim, Yhong-Hee			PAB-1, a Caenorhabditis elegans Poly(A)-Binding Protein, Regulates mRNA Metabolism in germline by Interacting with CGH-1 and CAR-1	PLOS ONE			English	Article							TRANSLATION INITIATION; PROCESSING BODIES; C-ELEGANS; BINDING PROTEINS; P-BODIES; COMPONENT; GRANULES; GENE; COMPLEX; CYTOKINESIS	Poly(A)-binding proteins are highly conserved among eukaryotes and regulate stability of mRNA and translation. Among C. elegans homologues, pab-1 mutants showed defects in germline mitotic proliferation. Unlike pab-1 mutants, pab-1 RNAi at every larval stage caused arrest of germline development at the following stage, indicating that pab-1 is required for the entire postembryonic germline development. This idea is supported by the observations that the mRNA level of pab-1 increased throughout postembryonic development and its protein expression was germline-enriched. PAB-1 localized to P granules and the cytoplasm in the germline. PAB-1 colocalized with CGH-1 and CAR-1 and affected their localization, suggesting that PAB-1 is a component of processing (P)-bodies that interacts with them. The mRNA and protein levels of representative germline genes, rec-8, GLP-1, rme-2, and msp-152, were decreased after pab-1 RNAi. Although the mRNA level of msp-152 was increased in cgh-1 mutant, it was also significantly reduced by pab-1 RNAi. Our results suggest that PAB-1 positively regulates the mRNA levels of germline genes, which is likely facilitated by the interaction of PAB-1 with other P-body components, CGH-1 and CAR-1.	[Ko, Sunhee; Kawasaki, Ichiro; Shim, Yhong-Hee] Konkuk Univ, Inst KU Biotechnol, Dept Biosci & Biotechnol, Seoul, South Korea	Konkuk University	Shim, YH (corresponding author), Konkuk Univ, Inst KU Biotechnol, Dept Biosci & Biotechnol, Seoul, South Korea.	yshim@konkuk.ac.kr	Shim, Yhong-hee/D-6691-2011; Kawasaki, Ichiro/D-6864-2011	Shim, Yhong-hee/0000-0002-8660-4176; Kawasaki, Ichiro/0000-0003-1722-0993	National Research Foundation of Korea (NRF) [2010-0011182, NRF-2013R1A1A2009090, 2010-0009509, NRF-2013R1A1A2009820]; Konkuk University, Korea; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Konkuk University, Korea; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) to Y. H. Shim (2010-0011182 and NRF-2013R1A1A2009090) and I. Kawasaki (2010-0009509 and NRF-2013R1A1A2009820), and by the 2012 KU Brain Pool Program of Konkuk University, Korea to I. Kawasaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BLOBEL G, 1973, P NATL ACAD SCI USA, V102, P367; Boag PR, 2008, J CELL BIOL, V182, P543, DOI 10.1083/jcb.200801183; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; BRENNER S, 1974, GENETICS, V77, P71; Ciosk R, 2004, DEVELOPMENT, V131, P4831, DOI 10.1242/dev.01352; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; CONTRERAS V, 2011, PLOS ONE, P1012, DOI DOI 10.1371/J0URNAL.P0NE; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; Evans Thomas C, 2005, WormBook, P1, DOI 10.1895/wormbook.1.34.1; Gallo CM, 2008, DEV BIOL, V323, P76, DOI 10.1016/j.ydbio.2008.07.008; GRANGE T, 1987, NUCLEIC ACIDS RES, V15, P1012; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Ko S, 2010, MOL CELLS, V30, P167, DOI 10.1007/s10059-010-0103-2; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; KUMSTA C, 2012, PLOS ONE, P1012, DOI DOI 10.1371/J0URNAL.P0NE.0035428; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Lee Min-Ho, 2006, WormBook, P1; LEFRERE V, 1990, GENE, V96, P219, DOI 10.1016/0378-1119(90)90256-Q; Maciejowski J, 2005, GENETICS, V169, P1997, DOI 10.1534/genetics.104.040121; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Navarro RE, 2005, GENESIS, V42, P172, DOI 10.1002/gene.20136; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Noble SL, 2008, J CELL BIOL, V182, P559, DOI 10.1083/jcb.200802128; Nousch M, 2013, ADV EXP MED BIOL, V757, P205, DOI 10.1007/978-1-4614-4015-4_8; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; Scheckel C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002742; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; STROME S, 1986, J EMBRYOL EXP MORPH, V97, P15; Strome Susan, 2005, WormBook, P1, DOI 10.1895/wormbook.1.9.1; Sun YY, 2011, PROTEIN CELL, V2, P918, DOI 10.1007/s13238-011-1119-x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; WARD S, 1986, J CELL BIOL, V102, P1778, DOI 10.1083/jcb.102.5.1778; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706; Yoon S, 2012, CELL CYCLE, V11, P1354, DOI 10.4161/cc.19755; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258	55	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84798	10.1371/journal.pone.0084798	http://dx.doi.org/10.1371/journal.pone.0084798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367695	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900066
J	Husemoen, LLN; Skaaby, T; Jorgensen, T; Thyssen, JP; Meldgaard, M; Szecsi, PB; Stender, S; Johansen, JD; Linneberg, A				Husemoen, Lise Lotte N.; Skaaby, Tea; Jorgensen, Torben; Thyssen, Jacob P.; Meldgaard, Michael; Szecsi, Pal B.; Stender, Steen; Johansen, Jeanne Duus; Linneberg, Allan			No Association between Loss-of-Function Mutations in filaggrin and Diabetes, Cardiovascular Disease, and All-Cause Mortality	PLOS ONE			English	Article							ATOPIC-DERMATITIS; FUNCTION VARIANTS; RISK; GENE; REGISTER	Background: Common loss-of-function mutations in the filaggrin gene (FLG) are a major predisposing risk factor for atopic disease due to reduced epidermal filaggrin protein levels. We previously observed an association between these mutations and type 2 diabetes and hypothesized that an inherited impairment of skin barrier functions could facilitate low-grade inflammation and hence increase the risk of diabetes and cardiovascular disease. We examined the association between loss-of-function mutations in FLG and diabetes, stroke, ischemic heart disease (IHD), and all-cause mortality in the general population. Methods: The R501X and 2282del4 loss-of function mutations in FLG were genotyped in four Danish study populations including a total of 13373 adults aged 15-77 years. Two of the studies also genotyped the R2447X mutation. By linkage to Danish national central registers we obtained information for all participants on dates of diagnoses of diabetes, stroke, and IHD, as well as all-cause mortality. Data were analyzed by Cox proportional hazard models and combined by fixed effect meta-analyses. Results: In meta-analyses combining the results from the four individual studies, carriage of loss-of-function mutations in FLG was not associated with incident diabetes (hazard ratio (HR) (95% confidence intervals (CI)) = 0.95 (0.73, 1.23), stroke (HR (95% CI) = 1.27 (0.97, 1.65), ischemic heart disease (HR (95% CI) = 0.92 (0.71, 1.19), and all-cause mortality (HR (95% CI) = 1.02 (0.83, 1.25)). Similar results were obtained when including prevalent cases in logistic regression models. Conclusion: Our results suggest that loss-of-function mutations in FLG are not associated with type 2 diabetes, cardiovascular disease, and all-cause mortality. However, larger studies with longer follow-up are needed to exclude any associations.	[Husemoen, Lise Lotte N.; Skaaby, Tea; Jorgensen, Torben; Linneberg, Allan] Copenhagen Univ Hosp Glostrup, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Thyssen, Jacob P.; Johansen, Jeanne Duus] Copenhagen Univ Hosp Gentofte, Dept Dermato Allergol, Natl Allergy Res Ctr, Hellerup, Denmark; [Meldgaard, Michael; Szecsi, Pal B.; Stender, Steen] Copenhagen Univ Hosp Gentofte, Dept Clin Biochem, Hellerup, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Husemoen, LLN (corresponding author), Copenhagen Univ Hosp Glostrup, Res Ctr Prevent & Hlth, Glostrup, Denmark.	lloh@regionh.dk	Johansen, Jeanne/AAM-6382-2021; Thyssen, Jacob/ABD-8517-2020; Jørgensen, Torben/Z-1335-2018	Johansen, Jeanne/0000-0002-3537-8463; stender, steen/0000-0003-1037-1158; Linneberg, Allan/0000-0002-0994-0184; Thyssen, Jacob Pontoppidan/0000-0003-3770-1743; Szecsi, Pal/0000-0003-3446-0411; Skaaby, Tea/0000-0003-0031-5726; Jorgensen, Torben/0000-0001-9453-2830	Health Insurance Foundation [2010B131]	Health Insurance Foundation	The study was supported by the Health Insurance Foundation grant No. 2010B131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; Brown SJ, 2011, J ALLERGY CLIN IMMUN, V127, P661, DOI 10.1016/j.jaci.2011.01.031; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Husemoen LLN, 2012, EUR J CLIN NUTR, V66, P1309, DOI 10.1038/ejcn.2012.134; Husemoen LLN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011735; Husemoen LLN, 2008, ALCOHOL CLIN EXP RES, V32, P1984, DOI 10.1111/j.1530-0277.2008.00780.x; Husemoen LLN, 2013, APPROACH EUR J CLIN; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Juel K, 1999, DAN MED BULL, V46, P354; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Meldgaard M, 2012, CLIN CHIM ACTA, V413, P1488, DOI 10.1016/j.cca.2012.06.014; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Olesen AB, 2001, LANCET, V357, P1749, DOI 10.1016/S0140-6736(00)04896-0; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Rasmussen SL, 1998, J HYPERTENS, V16, P1415, DOI 10.1097/00004872-199816100-00004; Rosenbauer J, 2003, DIABETOLOGIA, V46, P784, DOI 10.1007/s00125-003-1108-6; Skaaby T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057647; Thuesen BH, 2013, INT J EPIDEMIOL; Thyssen JP, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000062; Thyssen JP, 2012, J ALLERGY CLIN IMMUN; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84293	10.1371/journal.pone.0084293	http://dx.doi.org/10.1371/journal.pone.0084293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367652	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300136
J	Yan, J; Lou, XT; Xie, LM; Yu, DD; Shen, GF; Wang, YL				Yan, Jin; Lou, Xintian; Xie, Liming; Yu, Dedong; Shen, Guofang; Wang, Yilin			Assessment of Dental Age of Children Aged 3.5 to 16.9 Years Using Demirjian's Method: A Meta-Analysis Based on 26 Studies	PLOS ONE			English	Article							TURKISH CHILDREN; MATURITY; TEETH; APPLICABILITY; HETEROGENEITY; POPULATION; ACCURACY; ERUPTION	Background A method for assessing dental maturity in different populations was first developed in 1973 by Demirjian and has been widely used and accepted since then. While the accuracy for evaluating dental age using Demirjian's method compared to children's chronological age has been extensively studied in recent years, the results currently available remain controversial and ambiguous. Methods A literature search of PubMed, Embase, Web of Science, CNKI and CBM databases was conducted to identify all eligible studies published before July 12th, 2013. Weighted mean difference (WMD) with corresponding 95% confidence interval (95% CI) was used to evaluate the applicability of Demirjian's method for estimating chronological age in children. Results: A meta-analysis was conducted on 26 studies with a total of 11,499 children (5,301 boys and 6,198 girls) aged 3.5 to 16.9 years. Overall, we found that Demirjian's method overestimated dental age by 0.35 (4.2 months) and 0.39 (4.68 months) years in males and females, respectively. A subgroup analysis by age revealed that boys and girls between the ages of 5 to 14 were given a dental age estimate that was significantly more advanced than their chronological age. Differences between underestimated dental ages and actual chronological ages were lower for male and female 15-and 16-year-old subgroups, though a significant difference was found in the 16-year-old subgroup. Conclusions Demirjian's method's overestimation of actual chronological tooth age reveals the need for population-specific standards to better estimate the rate of human dental maturation.	[Yan, Jin; Lou, Xintian; Xie, Liming; Wang, Yilin] Punan Hosp Pudong New Dist, Dept Stomatol, Shanghai, Peoples R China; [Yu, Dedong; Shen, Guofang] Shanghai Jiao Tong Univ Sch Med, Shanghai Key Lab Stomatol, Dept Oral & Craniomaxillofacial Sci, Peoples Hosp 9,Coll Stomatol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Wang, YL (corresponding author), Punan Hosp Pudong New Dist, Dept Stomatol, Shanghai, Peoples R China.	ylwangshpn@163.com	Xie, Liming/AAL-9554-2020					Al-Emran Sulaiman, 2008, J Contemp Dent Pract, V9, P64; Bagherian Ali, 2011, J Oral Sci, V53, P37; Bagherpour A, 2010, FORENSIC SCI INT, V197, DOI 10.1016/j.forsciint.2009.12.051; Black SM, 1996, AM J PHYS ANTHROPOL, V101, P305, DOI 10.1002/ajpa.1331010203; Cameriere R, 2006, INT J LEGAL MED, V120, P49, DOI 10.1007/s00414-005-0047-9; Celikoglu M, 2011, J FORENSIC SCI, V56, pS220, DOI 10.1111/j.1556-4029.2010.01598.x; Chudasama PN, 2012, J FORENSIC LEG MED, V19, P22, DOI 10.1016/j.jflm.2011.09.008; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; DEMIRJIAN A, 1973, HUM BIOL, V45, P211; DEMIRJIAN A, 1976, ANN HUM BIOL, V3, P411, DOI 10.1080/03014467600001671; DEMIRJIAN A, 1985, AM J ORTHOD DENTOFAC, V88, P433, DOI 10.1016/0002-9416(85)90070-3; Eid R M R, 2002, Int J Paediatr Dent, V12, P423, DOI 10.1046/j.1365-263X.2002.00403.x; FILIPSSON R, 1975, ANN HUM BIOL, V2, P13, DOI 10.1080/03014467500000521; Flood SJ, 2011, J FORENSIC SCI, V56, P1610, DOI 10.1111/j.1556-4029.2011.01883.x; Gleiser I, 1955, AM J PHYS ANTHROP-NE, V13, P253, DOI 10.1002/ajpa.1330130206; Grover S, 2012, MED SCI LAW, V52, P32, DOI 10.1258/msl.2011.011021; Haavikko K, 1974, Proc Finn Dent Soc, V70, P15; Haavikko K, 1970, Suom Hammaslaak Toim, V66, P103; Hegde R J, 2002, J Indian Soc Pedod Prev Dent, V20, P132; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jayaraman J, 2011, J Forensic Odontostomatol, V29, P22; Kirzioglu Z, 2012, FORENSIC SCI INT, V216, P61, DOI 10.1016/j.forsciint.2011.08.018; Koshy S, 1998, FORENSIC SCI INT, V94, P73, DOI 10.1016/S0379-0738(98)00034-6; Leurs IH, 2005, EUR J ORTHODONT, V27, P309, DOI 10.1093/ejo/cji010; Liversidge H M, 1999, Int J Paediatr Dent, V9, P263; LOEVY HT, 1989, J AM DENT ASSOC, V118, P715, DOI 10.14219/jada.archive.1989.0162; Maber M, 2006, FORENSIC SCI INT, V159, pS68, DOI 10.1016/j.forsciint.2006.02.019; MAIA MC, 2010, FORENSIC SCI INT, V200, pE171; Malik P, 2012, EUR J PAEDIATR DENT, V13, P133; Mani SA, 2008, INT J PAEDIATR DENT, V18, P380, DOI 10.1111/j.1365-263X.2007.00890.x; Mitchell JC, 2009, FORENSIC SCI INT, V189, P19, DOI 10.1016/j.forsciint.2009.04.002; Nik-Hussein NN, 2011, FORENSIC SCI INT, V204, DOI 10.1016/j.forsciint.2010.08.020; Nur B, 2012, MED ORAL PATOL ORAL, V17, pE871, DOI 10.4317/medoral.18034; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Rozylo-Kalinowska I, 2011, EUR J ORTHODONT, V33, P75, DOI 10.1093/ejo/cjq031; SAPOKA A A M, 1971, Journal of the Canadian Dental Association, V37, P100; Shi Ge-Fei, 2009, Fa Yi Xue Za Zhi, V25, P168; Sukhia RH, 2012, EUR J ORTHODONT, V34, P77, DOI 10.1093/ejo/cjq161; Tao Jiang, 2007, Fa Yi Xue Za Zhi, V23, P258; Uysal Tancan, 2009, World J Orthod, V10, P383; Weddell LS, 2011, PEDIATR DENT, V33, P221; Yadava M, 2011, INT J LEGAL MED, V125, P651, DOI 10.1007/s00414-010-0491-z; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	43	35	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84672	10.1371/journal.pone.0084672	http://dx.doi.org/10.1371/journal.pone.0084672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367690	Green Submitted, gold, Green Published			2022-12-27	WOS:000328740300156
J	Besseling, RMH; Jansen, JFA; Overvliet, GM; van der Kruijs, SJM; Ebus, SCM; de Louw, A; Hofman, PAM; Vles, JSH; Aldenkamp, AP; Backes, WH				Besseling, Rene M. H.; Jansen, Jacobus F. A.; Overvliet, Geke M.; van der Kruijs, Sylvie J. M.; Ebus, Saskia C. M.; de Louw, Anton; Hofman, Paul A. M.; Vles, Johannes S. H.; Aldenkamp, Albert P.; Backes, Walter H.			Reduced Structural Connectivity between Sensorimotor and Language Areas in Rolandic Epilepsy	PLOS ONE			English	Article							BENIGN CHILDHOOD EPILEPSY; FUNCTIONAL MRI; DIFFUSION; CHILDREN; SPEECH; CORTEX; IMPAIRMENT; DENSITY; NETWORK; REPRODUCIBILITY	Introduction: Rolandic epilepsy (RE) is a childhood epilepsy with centrotemporal (rolandic) spikes, that is increasingly associated with language impairment. In this study, we tested for a white matter (connectivity) correlate, employing diffusion weighted MRI and language testing. Methods: Twenty-three children with RE and 23 matched controls (age: 8-14 years) underwent structural (T1-weighted) and diffusion-weighted MRI (b = 1200 s/mm(2), 66 gradient directions) at 3T, as well as neuropsychological language testing. Combining tractography and a cortical segmentation derived from the T1-scan, the rolandic tract were reconstructed (pre-and postcentral gyri), and tract fractional anisotropy (FA) values were compared between patients and controls. Aberrant tracts were tested for correlations with language performance. Results: Several reductions of tract FA were found in patients compared to controls, mostly in the left hemisphere; the most significant effects involved the left inferior frontal (p = 0.005) and supramarginal (p = 0.004) gyrus. In the patient group, lower tract FA values were correlated with lower language performance, among others for the connection between the left postcentral and inferior frontal gyrus (p = 0.043, R = 0.43). Conclusion: In RE, structural connectivity is reduced for several connections involving the rolandic regions, from which the epileptiform activity originates. Most of these aberrant tracts involve the left (typically language mediating) hemisphere, notably the pars opercularis of the inferior frontal gyrus (Broca's area) and the supramarginal gyrus (Wernicke's area). For the former, reduced language performance for lower tract FA was found in the patients. These findings provide a first microstructural white matter correlate for language impairment in RE.	[Besseling, Rene M. H.; Overvliet, Geke M.; van der Kruijs, Sylvie J. M.; Ebus, Saskia C. M.; de Louw, Anton; Hofman, Paul A. M.; Aldenkamp, Albert P.] Epilepsy Ctr Kempenhaeghe, Heeze, Netherlands; [Besseling, Rene M. H.; Jansen, Jacobus F. A.; van der Kruijs, Sylvie J. M.; Backes, Walter H.] Maastricht Univ, Res Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Besseling, Rene M. H.; Jansen, Jacobus F. A.; Backes, Walter H.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Overvliet, Geke M.; de Louw, Anton; Hofman, Paul A. M.; Vles, Johannes S. H.; Aldenkamp, Albert P.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Backes, WH (corresponding author), Maastricht Univ, Res Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	w.backes@mumc.nl	Jansen, Jacobus F.A./C-4098-2009	Jansen, Jacobus F.A./0000-0002-5271-8060	Dutch Epilepsy Foundation (NEF); Netherlands Organization for Scientific Research (NWO) [916.11.059]; Netherlands Organization for Health Research and Development (ZonMw)	Dutch Epilepsy Foundation (NEF); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This project was funded by the Dutch Epilepsy Foundation (NEF). The author JJ was funded by VENI research grant 916.11.059 from the Netherlands Organization for Scientific Research (NWO) and the Netherlands Organization for Health Research and Development (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes WH, 2005, EPILEPSY RES, V66, P1, DOI 10.1016/j.eplepsyres.2005.06.007; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bernal B, 2009, BRAIN, V132, P2309, DOI 10.1093/brain/awp206; Berroya AM, 2005, J CHILD NEUROL, V20, P188, DOI 10.1177/08830738050200030401; Besseling R, 2013, EPILEPSY RE IN PRESS; Besseling RMH, 2013, NEUROIMAGE-CLIN, V2, P239, DOI 10.1016/j.nicl.2013.01.004; Besseling RMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034125; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Braakman HM, 2012, EPILEPSIA; Burns MS, 2010, TOP STROKE REHABIL, V17, P401, DOI 10.1310/tsr1706-401; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Cappa SF, 2012, CORTEX; Cappa SF, 2012, CORTEX, V48, P785, DOI 10.1016/j.cortex.2012.04.010; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Clarke T, 2007, EPILEPSIA, V48, P2258; D'Ausilio A, 2012, CORTEX, V48, P882, DOI 10.1016/j.cortex.2011.05.017; Datta AN, 2013, EPILEPSIA, V54, P487, DOI 10.1111/epi.12067; Deblaere K, 2002, NEURORADIOLOGY, V44, P667, DOI 10.1007/s00234-002-0800-4; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Fonseca Viviane de Carvalho, 2012, Front Neurol, V3, P121, DOI 10.3389/fneur.2012.00121; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; Hughes JR, 2010, EPILEPSY BEHAV, V19, P197, DOI 10.1016/j.yebeh.2010.07.018; Jocic-Jakubi B, 2006, EPILEPSY BEHAV, V9, P432, DOI 10.1016/j.yebeh.2006.07.010; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Jones DK, 2012, NEUROIMAGE; Kanemura H, 2009, BRAIN DEV-JPN, V31, P771, DOI 10.1016/j.braindev.2008.12.007; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Liasis A, 2006, J NEURAL TRANSM, V113, P939, DOI 10.1007/s00702-005-0357-6; Lillywhite LM, 2009, EPILEPSIA, V50, P2276, DOI 10.1111/j.1528-1167.2009.02065.x; LOISEAU P, 1989, CLEV CLIN J MED, V56, pS17; Lundberg S, 2005, DEV MED CHILD NEUROL, V47, P603, DOI 10.1017/S0012162205001192; Lundberg S, 1999, EPILEPSIA, V40, P1808, DOI 10.1111/j.1528-1157.1999.tb01603.x; Massa R, 2001, NEUROLOGY, V57, P1071, DOI 10.1212/WNL.57.6.1071; Meister IG, 2003, NEUROPSYCHOLOGIA, V41, P401, DOI 10.1016/S0028-3932(02)00179-3; Miao W, 2012, AJNR AM J NEURORADIO; Nguyen D, 2011, EPILEPSY RES; Overvliet GM, 2010, EPILEPSY BEHAV, V19, P550, DOI 10.1016/j.yebeh.2010.09.015; Overvliet GM, 2013, NEUROIMAGE-CLIN, V2, P434, DOI 10.1016/j.nicl.2013.03.008; Panayiotopoulos CP, 2008, BRAIN, V131, P2264, DOI 10.1093/brain/awn162; Paslawski T, 2005, CAN J SCH PSYCHOL, V20, P129, DOI 10.1177/0829573506295465; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Reijmer YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044074; Rogalsky C, 2011, J COGNITIVE NEUROSCI, V23, P1664, DOI 10.1162/jocn.2010.21530; Rogalsky C, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.014.2008; Rose S, 2012, NEUROIMAGE, V59, P2661, DOI 10.1016/j.neuroimage.2011.08.054; Schoene-Bake JC, 2009, NEUROIMAGE, V46, P569, DOI 10.1016/j.neuroimage.2009.03.013; Semel E., 2010, CLIN EVALUATION LANG; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Taki Y, 2012, HUM BRAIN MAPP; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Vannest J, 2009, AM J ROENTGENOL, V192, P1190, DOI 10.2214/AJR.08.2246; Vlooswijk MCG, 2010, NEUROLOGY, V75, P395, DOI 10.1212/WNL.0b013e3181ebdd3e	63	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83568	10.1371/journal.pone.0083568	http://dx.doi.org/10.1371/journal.pone.0083568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376719	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000097
J	Dvorzhak, A; Gertler, C; Harnack, D; Grantyn, R				Dvorzhak, Anton; Gertler, Christoph; Harnack, Daniel; Grantyn, Rosemarie			High Frequency Stimulation of the Subthalamic Nucleus Leads to Presynaptic GABA(B)-Dependent Depression of Subthalamo-Nigral Afferents	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; EXCITATORY SYNAPTIC-TRANSMISSION; SUBSTANTIA-NIGRA; BASAL GANGLIA; PARKINSONS-DISEASE; NEURONAL-ACTIVITY; FUNCTIONAL-ANATOMY; GLOBUS-PALLIDUS; PARS RETICULATA; RAT MODEL	Patients with akinesia benefit from chronic high frequency stimulation (HFS) of the subthalamic nucleus (STN). Among the mechanisms contributing to the therapeutic success of HFS-STN might be a suppression of activity in the output region of the basal ganglia. Indeed, recordings in the substantia nigra pars reticulata (SNr) of fully adult mice revealed that HFS-STN consistently produced a reduction of compound glutamatergic excitatory postsynaptic currents at a time when the tetrodotoxin-sensitive components of the local field potentials had already recovered after the high frequency activation. These observations suggest that HFS-STN not only alters action potential conduction on the way towards the SNr but also modifies synaptic transmission within the SNr. A classical conditioning-test paradigm was then designed to better separate the causes from the indicators of synaptic depression. A bipolar platinum-iridium macroelectrode delivered conditioning HFS trains to a larger group of fibers in the STN, while a separate high-ohmic glass micropipette in the rostral SNr provided test stimuli at minimal intensity to single fibers. The conditioning-test interval was set to 100 ms, i. e. the time required to recover the excitability of subthalamo-nigral axons after HFS-STN. The continuity of STN axons passing from the conditioning to the test sites was examined by an action potential occlusion test. About two thirds of the subthalamo-nigral afferents were occlusion-negative, i. e. they were not among the fibers directly activated by the conditioning STN stimulation. Nonetheless, occlusion-negative afferents exhibited signs of presynaptic depression that could be eliminated by blocking GABA(B) receptors with CGP55845 (1 mu M). Further analysis of single fiber-activated responses supported the proposal that the heterosynaptic depression of synaptic glutamate release during and after HFS-STN is mainly caused by the tonic release of GABA from co-activated striato-nigral afferents to the SNr. This mechanism would be consistent with a gain-of- function hypothesis of DBS.	[Dvorzhak, Anton; Grantyn, Rosemarie] Charite, Dept Expt Neurol, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Gertler, Christoph; Harnack, Daniel] Charite, Dept Expt Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Grantyn, R (corresponding author), Charite, Dept Expt Neurol, Cluster Excellence NeuroCure, D-13353 Berlin, Germany.	rosemarie.grantyn@charite.de		Dvorzhak, Anton/0000-0002-1787-4850	German Research Council DFG [Gr986/10-1, Exc 257/1]; CHDI foundation [A-4480]; Charite Research Funds	German Research Council DFG(German Research Foundation (DFG)); CHDI foundation; Charite Research Funds	This work was supported by the German Research Council DFG (Gr986/10-1, Exc 257/1), CHDI foundation (A-4480), and Charite Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi AA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013680; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; BARKER JL, 1988, J PHYSIOL-LONDON, V403, P41, DOI 10.1113/jphysiol.1988.sp017237; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Benazzouz A, 2000, NEUROSCIENCE, V99, P289, DOI 10.1016/S0306-4522(00)00199-8; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Beurrier C, 2006, NEUROSCIENCE, V140, P77, DOI 10.1016/j.neuroscience.2006.02.029; Beurrier C, 2009, NEUROSCIENCE, V158, P1608, DOI 10.1016/j.neuroscience.2008.11.018; Bosch C, 2011, J PHYSIOL-LONDON, V589, P4189, DOI 10.1113/jphysiol.2011.211367; Boyes J, 2003, EUR J NEUROSCI, V18, P3279, DOI 10.1111/j.1460-9568.2003.03076.x; Bruet N, 2003, J NEUROPATH EXP NEUR, V62, P1228, DOI 10.1093/jnen/62.12.1228; Chang JY, 2008, NEUROSCI BIOBEHAV R, V32, P352, DOI 10.1016/j.neubiorev.2007.09.002; Connelly WM, 2010, J NEUROSCI, V30, P14854, DOI 10.1523/JNEUROSCI.3895-10.2010; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P326, DOI 10.1113/jphysiol.1955.sp005412; Aceves JD, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00006; Dejean C, 2009, CEREB CORTEX, V19, P1055, DOI 10.1093/cercor/bhn149; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Deniau JM, 2010, EUR J NEUROSCI, V32, P1080, DOI 10.1111/j.1460-9568.2010.07413.x; Dvorzhak A, 2013, J PHYSIOL-LONDON, V591, P1145, DOI 10.1113/jphysiol.2012.241018; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; FUKAMI Y, 1980, J PHYSIOL-LONDON, V298, P483, DOI 10.1113/jphysiol.1980.sp013096; Grantyn R, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00013; Gubellini P, 2009, PROG NEUROBIOL, V89, P79, DOI 10.1016/j.pneurobio.2009.06.003; Harnack D, 2008, EXP NEUROL, V210, P257, DOI 10.1016/j.expneurol.2007.10.002; Henneberger C, 2007, CEREB CORTEX, V17, P2039, DOI 10.1093/cercor/bhl112; Hernandez A, 2006, J NEUROPHYSIOL, V96, P2877, DOI 10.1152/jn.00664.2006; Kirischuk S, 2002, J PHYSIOL-LONDON, V543, P99, DOI 10.1113/jphysiol.2002.021576; Kirmse K, 2006, J NEUROSCI, V26, P4216, DOI 10.1523/JNEUROSCI.0589-06.2006; Kirmse K, 2008, J PHYSIOL-LONDON, V586, P5665, DOI 10.1113/jphysiol.2008.161943; KITA H, 1983, J COMP NEUROL, V215, P245, DOI 10.1002/cne.902150302; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Laviv T, 2010, NEURON, V67, P253, DOI 10.1016/j.neuron.2010.06.022; Ledonne A, 2012, EXP NEUROL, V233, P292, DOI 10.1016/j.expneurol.2011.10.018; Lee KH, 2006, EUR J NEUROSCI, V23, P1005, DOI 10.1111/j.1460-9568.2006.04638.x; Levy R, 2001, BRAIN, V124, P2105, DOI 10.1093/brain/124.10.2105; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; LINDBLOM U, 1966, EXP NEUROL, V15, P63, DOI 10.1016/0014-4886(66)90034-3; Lozano AM, 2004, PARKINSONISM RELAT D, V10, pS49, DOI 10.1016/j.parkreldis.2003.12.006; Lozano AM, 2013, NEURON, V77, P406, DOI 10.1016/j.neuron.2013.01.020; Maesawa S, 2004, J NEUROSURG, V100, P679, DOI 10.3171/jns.2004.100.4.0679; Maurice N, 2003, J NEUROSCI, V23, P9929; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; Meissner W, 2003, J NEUROCHEM, V85, P601, DOI 10.1046/j.1471-4159.2003.01665.x; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Miyazaki T, 1998, J PHYSIOL-LONDON, V513, P805, DOI 10.1111/j.1469-7793.1998.805ba.x; Mrachacz-Kersting N, 2012, J PHYSIOL-LONDON, V590, P1669, DOI 10.1113/jphysiol.2011.222851; Nambu A, 2004, PROG BRAIN RES, V143, P461, DOI 10.1016/S0079-6123(03)43043-4; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Parent M, 2007, PARKINSONISM RELAT D, V13, pS292, DOI 10.1016/S1353-8020(08)70018-X; Paul G, 2004, EXP NEUROL, V185, P272, DOI 10.1016/S0014-4886(03)00363-7; Regehr WG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005702; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Sgambato-Faure V, 2012, PROG NEUROBIOL, V96, P69, DOI 10.1016/j.pneurobio.2011.10.005; Shen KZ, 1997, J PHYSIOL-LONDON, V505, P153, DOI 10.1111/j.1469-7793.1997.153bc.x; Shimo Y, 2009, EUR J NEUROSCI, V29, P104, DOI 10.1111/j.1460-9568.2008.06565.x; SMITH Y, 1988, BRAIN RES, V453, P353, DOI 10.1016/0006-8993(88)90177-1; Steigerwald F, 2008, J NEUROPHYSIOL, V100, P2515, DOI 10.1152/jn.90574.2008; Tai CH, 2003, FASEB J, V17, P1820, DOI 10.1096/fj.03-0163com; TAKAHASHI T, 1992, J PHYSIOL-LONDON, V450, P593, DOI 10.1113/jphysiol.1992.sp019145; Takahashi T, 1998, J NEUROSCI, V18, P3138; Temel Y, 2006, BRAIN RES, V1120, P100, DOI 10.1016/j.brainres.2006.08.082; Tepper JM, 2007, PROG BRAIN RES, V160, P3, DOI 10.1016/S0079-6123(06)60001-0; Thanawala MS, 2013, J NEUROSCI, V33, P4625, DOI 10.1523/JNEUROSCI.4031-12.2013; Thomson AM, 2003, J COMPUT NEUROSCI, V15, P159, DOI 10.1023/A:1025812808362; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; WALDMEIER PC, 1994, BRIT J PHARMACOL, V113, P1515, DOI 10.1111/j.1476-5381.1994.tb17168.x; Wallmichrath I, 2002, NEUROSCIENCE, V113, P671, DOI 10.1016/S0306-4522(02)00109-4; Wenzelburger R, 2003, MOVEMENT DISORD, V18, P1162, DOI 10.1002/mds.10501; Whitmer D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00155; Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200; Windels F, 2000, EUR J NEUROSCI, V12, P4141, DOI 10.1046/j.1460-9568.2000.00296.x; Wittmann M, 2001, NEUROSCIENCE, V105, P881, DOI 10.1016/S0306-4522(01)00254-8; Wojtowicz AM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00188; WU LG, 1995, J PHYSIOL-LONDON, V485, P649, DOI 10.1113/jphysiol.1995.sp020759; Zheng F, 2011, J PHYSIOL-LONDON, V589, P2781, DOI 10.1113/jphysiol.2011.205807	77	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82191	10.1371/journal.pone.0082191	http://dx.doi.org/10.1371/journal.pone.0082191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376521	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000009
J	Laurent, C; Leduc, A; Pottier, I; Prevost, V; Sichel, F; Lefaix, JL				Laurent, Carine; Leduc, Alexandre; Pottier, Ivannah; Prevost, Virginie; Sichel, Francois; Lefaix, Jean-Louis			Dramatic Increase in Oxidative Stress in Carbon-Irradiated Normal Human Skin Fibroblasts	PLOS ONE			English	Article							HUMAN EPITHELIAL-CELLS; SPACE RADIATION; DIETARY-SUPPLEMENTS; ALPHA-TOCOPHEROL; ION IRRADIATION; DNA-DAMAGE; GAMMA-RAYS; PENTOXIFYLLINE; FIBROSIS; THERAPY	Skin complications were recently reported after carbon-ion (C-ion) radiation therapy. Oxidative stress is considered an important pathway in the appearance of late skin reactions. We evaluated oxidative stress in normal human skin fibroblasts after carbon-ion vs. X-ray irradiation. Survival curves and radiobiological parameters were calculated. DNA damage was quantified, as were lipid peroxidation (LPO), protein carbonylation and antioxidant enzyme activities. Reduced and oxidized glutathione ratios (GSH/GSSG) were determined. Proinflammatory cytokine secretion in culture supernatants was evaluated. The relative biological effectiveness (RBE) of C-ions vs. X-rays was 4.8 at D-0 (irradiation dose corresponding to a surviving fraction of 37%). Surviving fraction at 2 Gy (SF2) was 71.8% and 7.6% for X-rays and C-ions, respectively. Compared with X-rays, immediate DNA damage was increased less after C-ions, but a late increase was observed at D-10% (irradiation dose corresponding to a surviving fraction of 10%). LPO products and protein carbonyls were only increased 24 hours after C-ions. After X-rays, superoxide dismutase (SOD) activity was strongly increased immediately and on day 14 at D-0% (irradiation dose corresponding to a surviving fraction of around 0%), catalase activity was unchanged and glutathione peroxidase (GPx) activity was increased only on day 14. These activities were decreased after C-ions compared with X-rays. GSH/GSSG was unchanged after X-rays but was decreased immediately after C-ion irradiation before an increase from day 7. Secretion of IL-6 was increased at late times after X-ray irradiation. After C-ion irradiation, IL-6 concentration was increased on day 7 but was lower compared with X-rays at later times. C-ion effects on normal human skin fibroblasts seemed to be harmful in comparison with X-rays as they produce late DNA damage, LPO products and protein carbonyls, and as they decrease antioxidant defences. Mechanisms leading to this discrepancy between the two types of radiation should be investigated.	[Laurent, Carine; Leduc, Alexandre] ARCHADE Adv Resource Ctr Hadrontherapy Europe Pro, SAPHYN Sante Phys Nucl, Caen, France; [Pottier, Ivannah; Sichel, Francois] Univ Caen Basse Normandie, EA4651, Caen, France; [Pottier, Ivannah; Sichel, Francois] CLCC Ctr Lutte Canc Francois Baclesse, Caen, France; [Prevost, Virginie] Univ Caen Basse Normandie, INSERM, Canc & Prevent U1086, Caen, France; [Lefaix, Jean-Louis] IRCM, DSV, CEA, LARIA, Caen, France	Universite de Caen Normandie; UNICANCER; Centre Francois Baclesse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Laurent, C (corresponding author), ARCHADE Adv Resource Ctr Hadrontherapy Europe Pro, SAPHYN Sante Phys Nucl, Caen, France.	c.laurent@mail.baclesse.fr	PREVOST, Virginie/ABE-4043-2020; leduc, alexandre/ABE-7968-2020; MOUTEL, Grégoire/N-8777-2015	PREVOST, Virginie/0000-0003-2873-6063; Leduc, Alexandre/0000-0002-4084-7041; Pottier, Ivannah/0000-0002-4186-0547	Conseil Regional de Basse-Normandie; FEDER; Electricite de France-Service de Radioprotection; Commissariat a l'Energie Atomique; Ligue contre le Cancer (Calvados, Orne, Manche, Eure, Seine-Maritime)	Conseil Regional de Basse-Normandie(Region Normandie); FEDER(European Commission); Electricite de France-Service de Radioprotection; Commissariat a l'Energie Atomique(French Atomic Energy Commission); Ligue contre le Cancer (Calvados, Orne, Manche, Eure, Seine-Maritime)	This work was supported by grants from the Conseil Regional de Basse-Normandie, FEDER, Electricite de France-Service de Radioprotection, the Commissariat a l'Energie Atomique and the Ligue contre le Cancer (Calvados, Orne, Manche, Eure, Seine-Maritime). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beuve M, 2008, INT J RADIAT ONCOL, V71, P635, DOI 10.1016/j.ijrobp.2007.10.050; Delanian S, 2005, J CLIN ONCOL, V23, P8570, DOI 10.1200/JCO.2005.02.4729; Fushimi K, 2008, RADIOTHER ONCOL, V89, P237, DOI 10.1016/j.radonc.2008.04.015; Guan J, 2006, RADIAT RES, V165, P373, DOI 10.1667/RR3523.1; Guan J, 2004, RADIAT RES, V162, P572, DOI 10.1667/RR3249; Haase O, 2004, RADIOTHER ONCOL, V73, pS144, DOI 10.1016/S0167-8140(04)80037-9; Imadome K, 2008, CANCER BIOL THER, V7, P208, DOI 10.4161/cbt.7.2.5255; Kennedy AR, 2007, RADIAT ENVIRON BIOPH, V46, P201, DOI 10.1007/s00411-007-0105-4; Kennedy AR, 2004, FREE RADICAL BIO MED, V36, P259, DOI 10.1016/j.freeradbiomed.2003.10.010; Laurent C, 2005, RADIAT RES, V164, P63, DOI 10.1667/RR3383; Laurent C, 2006, INT J RADIAT BIOL, V82, P309, DOI 10.1080/09553000600733150; MASUDA K, 1980, INT J RADIAT ONCOL, V6, P1539, DOI 10.1016/0360-3016(80)90012-7; Monzen S, 2009, J RADIAT RES, V50, P477, DOI 10.1269/jrr.09058; Paganetti H, 2002, INT J RADIAT ONCOL, V53, P407, DOI 10.1016/S0360-3016(02)02754-2; Pautard C, 2008, NUCL INSTRUM METH A, V588, P448, DOI 10.1016/j.nima.2008.01.098; PUCK TT, 1956, J EXP MED, V103, P273, DOI 10.1084/jem.103.2.273; Suit H, 2010, RADIOTHER ONCOL, V95, P3, DOI 10.1016/j.radonc.2010.01.015; Wan XS, 2006, INT J RADIAT ONCOL, V64, P1475, DOI 10.1016/j.ijrobp.2005.11.024; Wan XS, 2005, RADIAT RES, V163, P364, DOI 10.1667/0033-7587(2005)163[0364:DOOSIB]2.0.CO;2; Yanagi T, 2010, RADIOTHER ONCOL, V95, P60, DOI 10.1016/j.radonc.2009.08.041	20	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85158	10.1371/journal.pone.0085158	http://dx.doi.org/10.1371/journal.pone.0085158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376870	Green Submitted, gold, Green Published			2022-12-27	WOS:000328882000178
J	Li, ZQ; Zhang, S; Luo, JY; Wang, CY; Lv, LM; Dong, SL; Cui, JJ				Li, Zhao-Qun; Zhang, Shuai; Luo, Jun-Yu; Wang, Chun-Yi; Lv, Li-Min; Dong, Shuang-Lin; Cui, Jin-Jie			Ecological Adaption Analysis of the Cotton Aphid (Aphis gossypii) in Different Phenotypes by Transcriptome Comparison	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; STRESS; GENES; EXPRESSION; LIFE; DEGRADATION; POPULATIONS; SILKWORM; TOOL	Background: The cotton aphid, Aphis gossypii Glover, is a destructive insect pest worldwide; it directly or indirectly damages (virus transmission) 300 species of host plants. Knowledge of their ecologically adaptive mechanisms at the molecular level may provide an essential and urgent method to effectively control this pest. However, no transcriptome information is available for the cotton aphid and sequence data are scarce. Therefore, we obtained transcriptome data. Results: To facilitate such a study, two cotton aphid transcriptomes at different growth stages of cotton, seedling and summer, were sequenced. A total of 161,396 and 66,668 contigs were obtained and assembled into 83,671 and 42,438 transcripts, respectively. After combining the raw date for both transcriptomes, the sequences were reassembled into 66,695 transcripts, and 52,160 were annotated based on BLASTX analyses. Comparison of the transcriptomes revealed that summer presented less challenges for the cotton aphids than the seedling stage of cotton. In total, 58 putative heat shock protein genes and 66 candidate cytochrome p450 genes were identified with BLASTX. Conclusions: Our results form a basis for exploring the molecular mechanisms of ecological adaption in the cotton aphid. Our study also provides a baseline for the exploration of abiotic stress responses. In addition, it provides large-scale sequence information for further studies on this species.	[Li, Zhao-Qun; Zhang, Shuai; Luo, Jun-Yu; Wang, Chun-Yi; Lv, Li-Min; Cui, Jin-Jie] Inst Cotton Res CAAS, State Key Lab Cotton Biol, Anyang, Peoples R China; [Li, Zhao-Qun; Dong, Shuang-Lin] Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Educ Minist, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University	Dong, SL (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Educ Minist, Nanjing, Jiangsu, Peoples R China.	sldong@njau.edu.cn; cuijinjie@126.com		Zhang, Shuai/0000-0003-3646-1522	Ministry of Agricultural [2011ZX08011-002]; Ministry of Science and Technology [2012BAD19B05]; National Natural Science Foundation of China [31071978]	Ministry of Agricultural; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Agricultural (2011ZX08011-002), the Ministry of Science and Technology (2012BAD19B05), and the National Natural Science Foundation of China (31071978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JW, 2011, GENE, V480, P42, DOI 10.1016/j.gene.2011.03.002; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benoit JB, 2010, J INSECT PHYSIOL, V56, P151, DOI 10.1016/j.jinsphys.2009.09.012; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Dingle H., 1986, P11; Doroszuk A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-167; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Frydenberg J, 2003, MOL ECOL, V12, P2025, DOI 10.1046/j.1365-294X.2002.01882.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graham AM, 2012, J HERED, V103, P400, DOI 10.1093/jhered/esr150; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073524; GUPTA RS, 1994, CURR BIOL, V4, P1104, DOI 10.1016/S0960-9822(00)00249-9; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Huang QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050383; Jia Haibo, 2011, Int J Biochem Mol Biol, V2, P47; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Ferreiro MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-483; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Maibeche-Coisne M, 2004, CHEM SENSES, V29, P381, DOI 10.1093/chemse/bjh039; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Nauen R, 2003, B ENTOMOL RES, V93, P47, DOI 10.1079/BER2002215; Nguyen TTA, 2009, INSECT BIOCHEM MOLEC, V39, P20, DOI 10.1016/j.ibmb.2008.09.014; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Sadacharan SK, 2001, HISTOCHEM CELL BIOL, V116, P507, DOI 10.1007/s00418-001-0344-4; Sang W, 2012, J INSECT PHYSIOL, V58, P830, DOI 10.1016/j.jinsphys.2012.03.007; Shamaei-Tousi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001198; Slosser JE, 2002, J ECON ENTOMOL, V95, P299, DOI 10.1603/0022-0493-95.2.299; SZYPERSKI T, 1994, P NATL ACAD SCI USA, V91, P11343, DOI 10.1073/pnas.91.24.11343; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAUBER MJ, 1982, SCIENCE, V218, P690, DOI 10.1126/science.218.4573.690; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Walsh A, 2008, BIOL REPROD, V78, P983, DOI 10.1095/biolreprod.107.066860; Wang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047954; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yebenes H, 2011, TRENDS BIOCHEM SCI, V36, P424, DOI 10.1016/j.tibs.2011.05.003; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	56	29	32	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83180	10.1371/journal.pone.0083180	http://dx.doi.org/10.1371/journal.pone.0083180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376660	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000067
J	Liu, YQ; Jin, C; Xing, AJ; Liu, XR; Chen, SH; Li, DQ; Feng, P; Liu, JQ; Li, ZG; Wu, SL				Liu, Yeqiang; Jin, Cheng; Xing, Aijun; Liu, Xiurong; Chen, Shuohua; Li, Dongqing; Feng, Ping; Liu, Jinquan; Li, Zhiguo; Wu, Shouling			Serum Uric Acid Levels and the Risk of Impaired Fasting Glucose: A Prospective Study in Adults of North China	PLOS ONE			English	Article							IDEAL CARDIOVASCULAR HEALTH; ASSOCIATION; MORTALITY; INSULIN; HYPERURICEMIA; HYPERTENSION; PREVALENCE; RESISTANCE; STROKE; WOMEN	Objective: To prospectively investigate the association between serum uric acid (SUA) level and incidence of impaired fasting glucose (IFG) in adult Chinese. Methods: We evaluated 13,328 women and 41,350 men without diabetes and IFG. The participants were classified into quintile according to baseline level of SUA. Data were analyzed to examine the association between SUA levels and the incidence of IFG. We used Cox regression models to estimate the relative risk of IFG after adjusting for known risk factors. Results: For men, the second quintile of SUA has the lowest cumulative incidence of IFG (29.9%); the fifth quintile of SUA has the highest cumulative incidence of IFG (35.6%). After corrected with Cox regression, the first quartile and the fourth quartile have higher cumulative incidence of IFG than the second quintile, with the HR of 1.11(1.05-1.17) and 1.07(1.01-1.13), respectively. For women, the first quartile of SUA has the lowest cumulative incidence of IFG (20.7%), while the fifth quintile of SUA has the highest cumulative incidence of IFG (30.0%). However, there is no significant difference in IFG between different quintile after adjusted with Cox regression. Conclusions: The results of this prospective study suggest that there is a higher risk of developing IFG in association with low or high SUA concentrations for men. These relationships were independent of other known risk factors. There is no significant correlation in the risk of developing IFG in association with SUA concentrations for women. Analyses excluding participants with hypertension or with hyperlipidemia and analyses with participants stratified by age reached similar conclusion.	[Liu, Yeqiang; Feng, Ping; Liu, Jinquan] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China; [Liu, Yeqiang; Jin, Cheng; Xing, Aijun; Liu, Xiurong; Chen, Shuohua; Li, Dongqing; Wu, Shouling] Hebei United Univ, Kailuan Hosp, Tangshan, Peoples R China; [Li, Zhiguo] Hebei United Univ, Tangshan, Peoples R China	Tianjin Medical University; North China University of Science & Technology; North China University of Science & Technology	Wu, SL (corresponding author), Hebei United Univ, Kailuan Hosp, Tangshan, Peoples R China.	Wushouling@gmail.com			Kailuan (Group) LLC.; National Natural Science Foundation of China [81100518]	Kailuan (Group) LLC.; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Kailuan (Group) LLC. Yeqiang Liu and Zhiguo Li were partially supported by National Natural Science Foundation of China (No. 81100518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; CANNON PJ, 1966, NEW ENGL J MED, V275, P457, DOI 10.1056/NEJM196609012750902; Chou P, 2001, J RHEUMATOL, V28, P571; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; DIAB HN, 2010, VASC DIS RES, V7, P40, DOI DOI 10.1177/1479164109347408.PUBMED:20368231; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Gerber Y, 2006, EUR J CARDIOV PREV R, V13, P193, DOI 10.1097/01.hjr.0000192745.26973.00; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Jia ZX, 2011, DIABETES RES CLIN PR, V92, P265, DOI 10.1016/j.diabres.2011.01.021; Johnson RJ, 2013, HYPERTENSION, V61, P948, DOI 10.1161/HYPERTENSIONAHA.111.00650; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kramer CK, 2009, DIABETES CARE, V32, P1272, DOI 10.2337/dc09-0275; Krishnan E, 2012, AM J EPIDEMIOL, V176, P108, DOI 10.1093/aje/kws002; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Maxwell AJ, 2001, J AM COLL CARDIOL, V38, P1850, DOI 10.1016/S0735-1097(01)01643-6; Mazza A, 2001, EUR J EPIDEMIOL, V17, P1097, DOI 10.1023/A:1021216713504; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Perticone F, 2012, DIABETES CARE, V35, P153, DOI 10.2337/dc11-1727; Pfister R, 2011, DIABETOLOGIA, V54, P2561, DOI 10.1007/s00125-011-2235-0; Schulze MB, 2005, ANNU REV PUBL HEALTH, V26, P445, DOI 10.1146/annurev.publhealth.26.021304.144532; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; Wang AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061665; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Yamada T, 2011, DIABETES METAB, V37, P252, DOI 10.1016/j.diabet.2010.10.009; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Yuan HJ, 2011, CHINESE MED J-PEKING, V124, P1443, DOI 10.3760/cma.j.issn.0366-6999.2011.10.001; Zhang Q, 2013, STROKE, V44, P2451, DOI 10.1161/STROKEAHA.113.678839; Zhang YN, 2013, MOL CELL ENDOCRINOL, V375, P89, DOI 10.1016/j.mce.2013.04.027	32	13	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84712	10.1371/journal.pone.0084712	http://dx.doi.org/10.1371/journal.pone.0084712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376838	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000161
J	Muthusamy, S; Cheng, M; Jeong, JJ; Kumar, A; Dudeja, PK; Malakooti, J				Muthusamy, Saminathan; Cheng, Ming; Jeong, Jong-Jin; Kumar, Anoop; Dudeja, Pradeep K.; Malakooti, Jaleh			Extracellular Acidosis Stimulates NHE2 Expression through Activation of Transcription Factor Egr-1 in the Intestinal Epithelial Cells	PLOS ONE			English	Article							CHRONIC METABOLIC-ACIDOSIS; PLASMA-MEMBRANE; TISSUE DISTRIBUTION; NA+/H+ EXCHANGERS; NA/H ANTIPORTER; COLONIC CRYPTS; UP-REGULATION; GENE FAMILY; PH; RAT	Na+/H+ exchangers (NHEs) play important roles in regulating internal pH (pH(i)), cell volume and neutral Na+ absorption in the human intestine. Earlier studies have shown that low extracellular pH (pH(e)) and metabolic acidosis increases the expression and function of NHE1-3 genes. However, transcriptional mechanisms involved remained unknown. Therefore, we investigated the molecular mechanisms underlying acid-induced NHE2 expression in C2BBe1 and SK-CO15 intestinal epithelial cells. Assessing total RNA and protein by RT-PCR and Western blot analysis, respectively, displayed significant increases in the NHE2 mRNA and protein levels in cells exposed to acidic media (pH 6.5 and 6.7) compared to normal medium. Acid treatment was also associated with a significant enhancement in NHE2 transport activity. Quantification of the heterogeneous nuclear RNA indicated that the rate of NHE2 transcription was increased in response to acid. Furthermore, acid caused a significant increase in NHE2 promoter activity confirming transcriptional upregulation. Through functional and mutational studies the acid-response element was mapped to a 15-nucleotide GC-rich sequence at bp 2337 to 2323 upstream from the transcription start site. We previously identified this element as an overlapping Egr-1/Sp1/Egr-1 motif that was essential for the NHE2 upregulation by mitogen-induced transcription factor Egr-1. Cells exposed to acid exhibited a temporal increase in Egr-1 mRNA and protein expression. These events were followed by Egr-1 nuclear accumulation, as detected by immunofluorescence microscopy, and potentiated its in vitro and in vivo interaction with the NHE2 promoter. Disruption of ESE motif and knockdown of Egr-1 expression by targeted small interfering RNA abrogated the acid-induced NHE2 transcriptional activity. These data indicate that the acid-dependent NHE2 stimulation is implemented by transcriptional upregulation of NHE2 via acid-induced Egr-1 in the intestinal epithelial cells.	[Muthusamy, Saminathan; Cheng, Ming; Jeong, Jong-Jin; Kumar, Anoop; Dudeja, Pradeep K.; Malakooti, Jaleh] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Dudeja, PK (corresponding author), Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60607 USA.	pkdudeja@uic.edu			National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK-33349, R01 DK-81858, DK54016, DK-92441, P01DK-67887]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054016, R01DK033349, R01DK081858, R01DK092441, P01DK067887] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants R01DK-33349 (J. Malakooti), R01 DK-81858, DK54016 and DK-92441 (PK Dudeja), and P01DK-67887 (J. Malakooti and PK Dudeja) and Department of Veterans Affairs (PKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MMM, 2009, J CELL BIOCHEM, V108, P249, DOI 10.1002/jcb.22247; Al-Sarraj A, 2005, J CELL BIOCHEM, V94, P153, DOI 10.1002/jcb.20305; Ambuhl PM, 1996, AM J PHYSIOL-RENAL, V271, pF917, DOI 10.1152/ajprenal.1996.271.4.F917; AMEMIYA M, 1995, AM J PHYSIOL-CELL PH, V269, pC126, DOI 10.1152/ajpcell.1995.269.1.C126; Amin MR, 2011, INFLAMM BOWEL DIS, V17, P720, DOI 10.1002/ibd.21419; Arena EA, 2012, AM J PHYSIOL-CELL PH, V302, pC412, DOI 10.1152/ajpcell.00163.2011; Bachmann O, 2004, AM J PHYSIOL-GASTR L, V287, pG125, DOI 10.1152/ajpgi.00332.2003; Bhattacharyya S, 2013, J PATHOL, V229, P286, DOI 10.1002/path.4131; Bookstein C, 1997, AM J PHYSIOL-CELL PH, V273, pC1496, DOI 10.1152/ajpcell.1997.273.5.C1496; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chu J, 2002, AM J PHYSIOL-CELL PH, V283, pC358; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Gens JS, 2007, BBA-BIOMEMBRANES, V1768, P1023, DOI 10.1016/j.bbamem.2007.01.003; HORIE S, 1992, P NATL ACAD SCI USA, V89, P5236, DOI 10.1073/pnas.89.12.5236; Huang RP, 1997, J CELL BIOCHEM, V66, P489, DOI 10.1002/(SICI)1097-4644(19970915)66:4<489::AID-JCB8>3.0.CO;2-H; IGARASHI P, 1992, AM J PHYSIOL, V263, pF83, DOI 10.1152/ajprenal.1992.263.1.F83; Kawamata K, 2006, BIOMED RES-TOKYO, V27, P15, DOI 10.2220/biomedres.27.15; KHACHIGIAN LM, 1995, J BIOL CHEM, V270, P27679, DOI 10.1074/jbc.270.46.27679; Lee SH, 2008, BIOCHEM BIOPH RES CO, V369, P320, DOI 10.1016/j.bbrc.2008.01.168; Lucioni A, 2002, AM J PHYSIOL-GASTR L, V283, pG51, DOI 10.1152/ajpgi.00529.2001; MAHNENSMITH RL, 1985, CIRC RES, V56, P773, DOI 10.1161/01.RES.56.6.773; Malakooti J, 2005, AM J PHYSIOL-GASTR L, V289, pG653, DOI 10.1152/ajpgi.00010.2005; Malakooti J, 1999, AM J PHYSIOL-GASTR L, V277, pG383, DOI 10.1152/ajpgi.1999.277.2.G383; MOE OW, 1991, J CLIN INVEST, V88, P1703, DOI 10.1172/JCI115487; Moeser AJ, 2008, AM J PHYSIOL-GASTR L, V295, pG791, DOI 10.1152/ajpgi.00538.2007; Muthusamy S, 2012, AM J PHYSIOL-GASTR L, V302, pG317, DOI 10.1152/ajpgi.00363.2011; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; PYE G, 1990, GUT, V31, P1355, DOI 10.1136/gut.31.12.1355; Shi Q, 2000, J INTERF CYTOK RES, V20, P1023, DOI 10.1089/10799900050198471; Xu L, 2002, J BIOL CHEM, V277, P11368, DOI 10.1074/jbc.M108347200; Xue L, 2011, J BIOL CHEM, V286, P38375, DOI 10.1074/jbc.M111.268219; YAMAJI Y, 1994, J CLIN INVEST, V94, P1297, DOI 10.1172/JCI117448; Yoo BK, 2012, AM J PHYSIOL-GASTR L, V303, pG180, DOI 10.1152/ajpgi.00069.2012; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Zarate N, 2010, AM J PHYSIOL-GASTR L, V299, pG1276, DOI 10.1152/ajpgi.00127.2010	38	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82023	10.1371/journal.pone.0082023	http://dx.doi.org/10.1371/journal.pone.0082023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376510	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000004
J	Abell, J; Kirzinger, MWB; Gordon, Y; Kirk, J; Kokes, R; Lynas, K; Mandinyenya, B; Youldon, D				Abell, Jackie; Kirzinger, Morgan W. B.; Gordon, Yvonne; Kirk, Jacqui; Kokes, Rae; Lynas, Kirsty; Mandinyenya, Bob; Youldon, David			A Social Network Analysis of Social Cohesion in a Constructed Pride: Implications for Ex Situ Reintroduction of the African Lion (Panthera leo)	PLOS ONE			English	Article							BEHAVIOR; PLAY	Animal conservation practices include the grouping of captive related and unrelated individuals to form a social structure which is characteristic of that species in the wild. In response to the rapid decline of wild African lion (Panthera leo) populations, an array of conservational strategies have been adopted. Ex situ reintroduction of the African lion requires the construction of socially cohesive pride structures prior to wild release. This pilot study adopted a social network theory approach to quantitatively assess a captive pride's social structure and the relationships between individuals within them. Group composition (who is present in a group) and social interaction data (social licking, greeting, play) was observed and recorded to assess social cohesion within a released semi-wild pride. UCINET and SOCPROG software was utilised to represent and analyse these social networks. Results indicate that the pride is socially cohesive, does not exhibit random associations, and the role of socially influential keystone individuals is important for maintaining social bondedness within a lion pride. These results are potentially informative for h structure of lion prides, in captivity an in the wild, an could have implications for captive and wild-founder reintroductions.	[Abell, Jackie] Coventry Univ, Coventry, W Midlands, England; [Abell, Jackie] African Lion & Environm Res Trust, Livingstone, Zambia; [Kirzinger, Morgan W. B.] Univ Regina, Regina, SK S4S 0A2, Canada; [Gordon, Yvonne; Lynas, Kirsty; Mandinyenya, Bob] African Lion & Environm Res Trust, Gweru, Zimbabwe; [Kirk, Jacqui; Kokes, Rae; Youldon, David] African Lion & Environm Res Trust, Livingstone, Zambia	Coventry University; University of Regina	Abell, J (corresponding author), Coventry Univ, Coventry, W Midlands, England.	Jackie@lionalert.org		Abell, Jackie/0000-0001-8891-7881				Abell J, 2013, OPEN SCI REPOSITORY, DOI [10.7392/open access.70081975, DOI 10.7392/0PEN]; Abell J, 2013, OPEN SCI REPOSITORY, DOI [10.7392/openaccess.70081986, DOI 10.7392/0PENACCESS.70081986]; Adamson J, 2000, BORN FREE FULL STORY, P432; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Bauer H., 2008, IUCN RED LIST THREAT; Beck B. B., 1994, P265; Bertram B, 1978, PRIDE LIONS, P253; Blaustein A.R., 1987, P287; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Carlstead Kathy, 1996, P317; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Jule KR, 2008, BIOL CONSERV, V141, P355, DOI 10.1016/j.biocon.2007.11.007; Kilian PJ, 2003, S AFR J WILDL RES, V33, P119; KLEIMAN DG, 1989, BIOSCIENCE, V39, P152, DOI 10.2307/1311025; Krause J, 2007, BEHAV ECOL SOCIOBIOL, V62, P15, DOI 10.1007/s00265-007-0445-8; Krause J, 2009, BEHAV ECOL SOCIOBIOL, V63, P967, DOI 10.1007/s00265-009-0747-0; LANCY DF, 1980, ANNU REV ANTHROPOL, V9, P471, DOI 10.1146/annurev.an.09.100180.002351; Law G., 1997, International Zoo Yearbook, V35, P197, DOI 10.1111/j.1748-1090.1997.tb01210.x; Le Hellaye Y, 2010, BEHAV ECOL SOCIOBIOL, V64, P349, DOI 10.1007/s00265-009-0851-1; MANTEL N, 1967, CANCER RES, V27, P209; McDougall PT, 2006, ANIM CONSERV, V9, P39, DOI 10.1111/j.1469-1795.2005.00004.x; Mosser A, 2009, ANIM BEHAV, V78, P359, DOI 10.1016/j.anbehav.2009.04.024; Packer C, 1997, SCI AM, V276, P52, DOI 10.1038/scientificamerican0597-52; Packer C, 2001, SCIENCE, V293, P690, DOI 10.1126/science.1062320; Packer C., 1986, P429; Patterson G, 1994, LAST FREE, P157; Pellis SM, 1996, AGGRESS VIOLENT BEH, V1, P249, DOI 10.1016/1359-1789(95)00016-X; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; SCHALLER G B, 1972, P480; SCHENKEL RUDOLPH, 1966, SYMP ZOOL SOC LONDON, V18, P11; Schulte BA, 2000, ZOO BIOL, V19, P447, DOI 10.1002/1098-2361(2000)19:5&lt;447::AID-ZOO12&gt;3.0.CO;2-#; Smith JE, 2011, ANIM BEHAV, V81, P401, DOI 10.1016/j.anbehav.2010.11.007; SMITH PK, 1982, BEHAV BRAIN SCI, V5, P139, DOI 10.1017/S0140525X0001092X; Spong G, 2004, BEHAV ECOL SOCIOBIOL, V55, P325, DOI 10.1007/s00265-003-0723-z; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Whitehead H., 2008, ANAL ANIMAL SOC QUAN, P336; Wilson E.O., 1975, P1	39	16	16	8	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82541	10.1371/journal.pone.0082541	http://dx.doi.org/10.1371/journal.pone.0082541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376544	Green Published, gold			2022-12-27	WOS:000328745100036
J	Emori, M; Tsukahara, T; Murase, M; Kano, M; Murata, K; Takahashi, A; Kubo, T; Asanuma, H; Yasuda, K; Kochin, V; Kaya, M; Nagoya, S; Nishio, J; Iwasaki, H; Sonoda, T; Hasegawa, T; Torigoe, T; Wada, T; Yamashita, T; Sato, N				Emori, Makoto; Tsukahara, Tomohide; Murase, Masaki; Kano, Masanobu; Murata, Kenji; Takahashi, Akari; Kubo, Terufumi; Asanuma, Hiroko; Yasuda, Kazuyo; Kochin, Vitaly; Kaya, Mitsunori; Nagoya, Satoshi; Nishio, Jun; Iwasaki, Hiroshi; Sonoda, Tomoko; Hasegawa, Tadashi; Torigoe, Toshihiko; Wada, Takuro; Yamashita, Toshihiko; Sato, Noriyuki			High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma	PLOS ONE			English	Article							MALIGNANT FIBROUS HISTIOCYTOMA; ALDEHYDE DEHYDROGENASE; CYTOGENETIC CHARACTERIZATION; IDENTIFICATION; ESTABLISHMENT; HYBRIDIZATION; OSTEOSARCOMA; PLURIPOTENCY; MARKER; IMPACT	Epithelioid sarcoma (ES) is a relatively rare, highly malignant soft tissue sarcoma. The mainstay of treatment is resection or amputation. Currently other therapeutic options available for this disease are limited. Therefore, a novel therapeutic option needs to be developed. In the present study, we established a new human ES cell line (ESX) and analyzed the characteristics of its cancer stem-like cells/cancer-initiating cells (CSCs/CICs) based on ALDH1 activity. We demonstrated that a subpopulation of ESX cells with high in ALDH1 activity (ALDH(high) cells) correlated with enhanced clonogenic ability, sphere-formation ability, and invasiveness in vitro and showed higher tumorigenicity in vivo. Next, using gene expression profiling, we identified CD109, a GPI-anchored protein upregulated in the ALDH(high) cells. CD109 mRNA was highly expressed in various sarcoma cell lines, but weakly expressed in normal adult tissues. CD109-positive cells in ESX predominantly formed spheres in culture, whereas siCD109 reduced ALDH1 expression and inhibited the cell proliferation in vitro. Subsequently, we evaluated the expression of CD109 protein in 80 clinical specimens of soft tissue sarcoma. We found a strong correlation between CD109 protein expression and the prognosis (P = 0.009). In conclusion, CD 109 might be a CSC/CIC marker in epithelioid sarcoma. Moreover, CD109 is a promising prognostic biomarker and a molecular target of cancer therapy for sarcomas including ES.	[Emori, Makoto; Murase, Masaki; Kano, Masanobu; Murata, Kenji; Kaya, Mitsunori; Nagoya, Satoshi; Wada, Takuro; Yamashita, Toshihiko] Sapporo Med Univ, Sch Med, Dept Orthoped Surg, Chuo Ku, Sapporo, Hokkaido, Japan; [Emori, Makoto; Tsukahara, Tomohide; Murase, Masaki; Kano, Masanobu; Murata, Kenji; Takahashi, Akari; Kubo, Terufumi; Yasuda, Kazuyo; Kochin, Vitaly; Torigoe, Toshihiko; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido, Japan; [Asanuma, Hiroko; Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Chuo Ku, Sapporo, Hokkaido, Japan; [Nishio, Jun] Fukuoka Univ, Sch Med, Dept Orthoped Surg, Jonan Ward, Fukuoka 81401, Japan; [Iwasaki, Hiroshi] Fukuoka Univ, Sch Med, Dept Pathol, Jonan Ward, Fukuoka 81401, Japan; [Sonoda, Tomoko] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Chuo Ku, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Fukuoka University; Fukuoka University; Sapporo Medical University	Tsukahara, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido, Japan.	tukahara@sapmed.ac.jp			JSPS KAKENHI [21249025, 20390403, 22689041]; Government to the National Cancer Center [23-A-10, 23-A-44]; NOASTEC [H24-S-5]; Suhara Memorial Foundation [H24-12]; Grants-in-Aid for Scientific Research [24659165] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Government to the National Cancer Center; NOASTEC; Suhara Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by grants from JSPS KAKENHI (21249025, 20390403, 22689041), Management Expenses Grants from the Government to the National Cancer Center (23-A-10, 23-A-44), NOASTEC (H24-S-5) and Suhara Memorial Foundation (H24-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013943; Bizet AA, 2011, BBA-MOL CELL RES, V1813, P742, DOI 10.1016/j.bbamcr.2011.01.028; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cheung AMS, 2007, LEUKEMIA, V21, P1423, DOI 10.1038/sj.leu.2404721; Cheung H, 2010, CANCER RES, V70, P5163, DOI [10.1158/0008-5472.CAN-09-3806, DOI 10.1158/0008-5472.CAN-09-3806]; CORDOBA JC, 1994, CANCER GENET CYTOGEN, V72, P151, DOI 10.1016/0165-4608(94)90132-5; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; GERHARZ CD, 1990, INT J CANCER, V45, P143, DOI 10.1002/ijc.2910450126; Hagikura M, 2010, PATHOL INT, V60, P735, DOI 10.1111/j.1440-1827.2010.02592.x; Hagiwara S, 2010, ONCOGENE, V29, P2181, DOI 10.1038/onc.2009.506; Hagiwara S, 2008, CANCER SCI, V99, P1916, DOI 10.1111/j.1349-7006.2008.00949.x; Helson C, 1995, INT J ONCOL, V7, P51; Hollmann TJ, 2011, AM J SURG PATHOL, V35, pE47, DOI 10.1097/PAS.0b013e31822b325b; Hwang SM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/946403; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Ishibe T, 2005, CLIN CANCER RES, V11, P2702, DOI 10.1158/1078-0432.CCR-04-2057; Iwasaki H, 1996, CANCER GENET CYTOGEN, V91, P46, DOI 10.1016/S0165-4608(95)00315-0; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; KELLAND LR, 1988, BRIT J CANCER, V58, P322, DOI 10.1038/bjc.1988.211; Kimura S, 2008, J ORTHOP RES, V26, P271, DOI 10.1002/jor.20497; Kusakabe H, 1997, ARCH DERMATOL RES, V289, P224, DOI 10.1007/s004030050184; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Man XY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3877; Miura Y, 2012, PATHOL INT, V62, P16, DOI 10.1111/j.1440-1827.2011.02739.x; Murase M, 2009, BRIT J CANCER, V101, P1425, DOI 10.1038/sj.bjc.6605330; Murray LJ, 1999, EXP HEMATOL, V27, P1282, DOI 10.1016/S0301-472X(99)00071-5; Nabeta Yuki, 2003, J Orthop Sci, V8, P554, DOI 10.1007/s00776-003-0663-5; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishio J, 2005, INT J ONCOL, V27, P361; REEVES BR, 1987, J NATL CANCER I, V78, P7, DOI 10.1093/jnci/78.1.7; ROCHE H, 1993, INT J CANCER, V54, P663, DOI 10.1002/ijc.2910540423; RUSSO JE, 1988, CANCER RES, V48, P2963; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; SONOBE H, 1993, VIRCHOWS ARCH B, V63, P219, DOI 10.1007/BF02899265; STENMAN G, 1990, CANCER, V65, P2006, DOI 10.1002/1097-0142(19900501)65:9<2006::AID-CNCR2820650921>3.0.CO;2-Q; SUTHERLAND DR, 1991, BLOOD, V77, P84; Tsukahara T, 2006, J ORTHOP RES, V24, P94, DOI 10.1002/jor.20019; Tsukahara T, 2008, CANCER SCI, V99, P368, DOI 10.1111/j.1349-7006.2008.00695.x; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Velcheti V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061427; Visus C, 2007, CANCER RES, V67, P10538, DOI 10.1158/0008-5472.CAN-07-1346; WADA T, 1988, CANCER RES, V48, P2273; Weiss SW, 2008, ENZINGER WEISSS SOFT, P303; Yasuda K, 2013, PLOS ONE IN PRESS	48	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84187	10.1371/journal.pone.0084187	http://dx.doi.org/10.1371/journal.pone.0084187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376795	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100159
J	Guan, LX; Gao, L; Wang, LL; Li, M; Yin, Y; Yu, L; Gao, CJ				Guan, Lixun; Gao, Li; Wang, Lili; Li, Meng; Yin, Yue; Yu, Li; Gao, Chunji			The Frequency and Clinical Significance of IDH1 Mutations in Chinese Acute Myeloid Leukemia Patients	PLOS ONE			English	Article							ISOCITRATE-DEHYDROGENASE 1; MOLECULAR ALTERATIONS; PROGNOSTIC IMPACT; GENES; AML	Objective: Mutations in the gene encoding isocitrate dehydrogenease 1 (IDH1) occur in various hematopoietic tumors including acute myeloid leukemia (AML), myeloproliferative neoplasms and myelodysplastic syndromes. IDH1 mutations are significant in both diagnosis and prognosis of these conditions. In the present study we determined the prevalence and clinical significance of IDH1 mutations in 349 samples from newly diagnosed AML patients. Results: Of the 349 AML patient specimens analyzed, 35 (10.03%) were found to have IDH1 mutations including 4 IDH1 R132 mutations and 31 non-R132 mutations. IDH1 non-R132 mutations were largely concentrated within AML-M1 (35.72%, p<0.01). We identified five IDH1 mutations that were novel to AML: (1) c.299 G>A, p.R100Q; (2) c.311G>T, p.G104V; (3) c.322T>C, p.F108L; (4) c.356G>A, p.R119Q; and (5) c.388A>G, p.I130V. In addition, we identified three IDH1 mutations that were previously described in AML. The frequency of IDH1 mutations in AML patients with normal karyotype was 9.9%. IDH1 non-R132 mutations were concurrent with mutations in FLT3-ITD (p<0.01), CEBPA (p<0.01), and NRAS (p<0.01), as well as the overexpression of MN1 (p<0.01) and WT1(p<0.01). The overall survival (OS) in the patients with IDH1 non-R132 mutations compared to patients without IDH1 mutations don't reach statistically significance (median 521 days vs median: not reached; n.s.). Conclusion: IDH1 non-R132 mutations occurred frequently in newly diagnosed adult Chinese AML patients, and these mutations were associated with genetic alterations. The OS was not influenced by IDH1 non-R132 mutations in the present study.	[Guan, Lixun; Wang, Lili; Li, Meng; Yin, Yue; Yu, Li; Gao, Chunji] PLA, Gen Hosp, Dept Hematol, Beijing, Peoples R China; [Guan, Lixun; Wang, Lili; Li, Meng; Yin, Yue; Yu, Li; Gao, Chunji] PLA, Gen Hosp, Hainan Branch, Beijing, Peoples R China; [Gao, Li] China Japan Friendship Hosp, Dept Hematol, Beijing, Peoples R China	China-Japan Friendship Hospital	Gao, CJ (corresponding author), PLA, Gen Hosp, Dept Hematol, Beijing, Peoples R China.	gaochunji@medmail.com.cn	wang, lili/HDL-7210-2022		China NSFC [81070451]; Hainan social development special funding [SF201306]	China NSFC(National Natural Science Foundation of China (NSFC)); Hainan social development special funding	This work was funded by China NSFC (NO. 81070451) and Hainan social development special funding(SF201306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, BLOOD, V116, P2122, DOI 10.1182/blood-2009-11-250878; Andersson AK, 2011, LEUKEMIA, V25, P1570, DOI 10.1038/leu.2011.133; Arber DA, 2008, WHO CLASSIFICATION T, P110; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Boissel N, 2010, J CLIN ONCOL, V28, P3717, DOI 10.1200/JCO.2010.28.2285; Chotirat S, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-5; Chou WC, 2010, BLOOD, V115, P2749, DOI 10.1182/blood-2009-11-253070; Green CL, 2011, BLOOD, V118, P409, DOI 10.1182/blood-2010-12-322479; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Gupta R, 2013, MODERN PATHOL, V26, P619, DOI 10.1038/modpathol.2012.210; Ho PA, 2010, LEUKEMIA, V24, P909, DOI 10.1038/leu.2010.56; Lin J, 2012, ANN HEMATOL, V91, P519, DOI 10.1007/s00277-011-1352-7; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Patel KP, 2011, AM J CLIN PATHOL, V135, P35, DOI 10.1309/AJCPD7NR2RMNQDVF; Schnittger S, 2010, BLOOD, V116, P5486, DOI 10.1182/blood-2010-02-267955; Thol F, 2010, BLOOD, V116, P614, DOI 10.1182/blood-2010-03-272146; Wagner K, 2010, J CLIN ONCOL, V28, P2356, DOI 10.1200/JCO.2009.27.6899; Ward PS, 2012, ONCOGENE, V31, P2491, DOI 10.1038/onc.2011.416; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110; Zhang YQ, 2011, LEUKEMIA RES, V35, P1301, DOI 10.1016/j.leukres.2011.01.019; Zou Y, 2010, BIOCHEM BIOPH RES CO, V402, P378, DOI 10.1016/j.bbrc.2010.10.038	23	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83334	10.1371/journal.pone.0083334	http://dx.doi.org/10.1371/journal.pone.0083334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376688	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100113
J	Nijiati, M; Saidaming, A; Qiao, J; Cheng, ZH; Qiu, CC; Sun, YJ				Nijiati, Muyesai; Saidaming, Abulajiang; Qiao, Jun; Cheng, Zuheng; Qiu, Changchun; Sun, Yujing			GNB3, eNOS, and Mitochondria! DNA Polymorphisms Correlate to Natural Longevity in a Xinjiang Uygur Population	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ESSENTIAL-HYPERTENSION; G-PROTEINS; DISEASES; RISK; AGE; CENTENARIANS; ASSOCIATION; DYSFUNCTION; MUTATIONS	Background: In centenarian populations, application of the positive biology approach (examination of positive phenotypes in aging) has revealed that mitochondria! DNA (mtDNA) mutation accumulation may be linked to human longevity; however, the role of guanine nucleotide-binding protein (G protein) abnormalities modulated by G-protein beta-3 (GNB3) and nitrate (NO2) production associated with endothelial nitric oxide synthase (eNOS), commonly appearing in age-related diseases, remains undetermined. Objective: The association between the mtDNA 5178A/C, mtDNA 10398A/G, GNB3 C825T, and eNOS polymorphisms and longevity in a Uygur population (Xinjiang region, China) were investigated. Methods: A total of 275 experimental subjects aged >= 100 or with 4 generations currently living were screened for inclusion in the centenarian (>100 years) and nonagenarian groups (90-100 years), and 112 65-70 year old control subjects were selected. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to examine mtDNA 5178A/C, mtDNA 10398A/G, GNB3 C825T, and eNOS. Associations between polymorphic loci, genotypes, and longevity were analyzed. Results: 165 included subjects (M:F = 107:58; mean age = 97 3 years; mean age 100-113 years) were assigned to the centenarian (M:F = 46/19; n = 65) and nonagenarian groups (M:F = 61/39; n = 100). Associations between mtDNA C5178A and A10398G polymorphisms with longevity in the centenarian group with mtDNA genotype frequencies 5178A and 103986 were 66.79% and 36.8%. Conclusions: Applying the overwhelming longevity observed in Uygur populations, these findings demonstrate that mtDNA 5178A/C and 10398A/G, GNB3 C825T, and eNOS polymorphisms are useful as a genetic basis for longevity.	[Nijiati, Muyesai; Cheng, Zuheng] Xinjiang Uiygur Autonomous Reg Peoples Hosp, Cardiol Dept Internal Med, Urumqi, Peoples R China; [Saidaming, Abulajiang; Qiao, Jun] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiac Surg, Urumqi, Peoples R China; [Qiu, Changchun; Sun, Yujing] CAMS, Inst Basic Med Sci, Beijing, Peoples R China; [Qiu, Changchun; Sun, Yujing] PUMC, Beijing, Peoples R China	Xinjiang Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Nijiati, M (corresponding author), Xinjiang Uiygur Autonomous Reg Peoples Hosp, Cardiol Dept Internal Med, Urumqi, Peoples R China.	muyassar11medsci@126.com; ablajans@yahoo.com.cn			NSFC (Natural Science Foundation of China), USA [30160089]; China Medical Foundation [CMB96-657]	NSFC (Natural Science Foundation of China), USA; China Medical Foundation(China Medical University)	The study was supported by NSFC (Natural Science Foundation of China) (No. 30160089) and USA and China Medical Foundation (No. CMB96-657). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affairs DoEaS, 2011, WORLD POP PROSP 2010; Alakus H, 2009, WORLD J GASTROENTERO, V15, P6061, DOI 10.3748/wjg.15.6061; Angeline T, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/462607; Bae Y, 2007, J HUM HYPERTENS, V21, P159, DOI 10.1038/sj.jhh.1002110; Benn M, 2008, CIRCULATION, V117, P2492, DOI 10.1161/CIRCULATIONAHA.107.756809; BIRNBAUMER L, 1990, CRIT REV BIOCHEM MOL, V25, P225, DOI 10.3109/10409239009090610; Canter JA, 2005, CANCER RES, V65, P8028, DOI 10.1158/0008-5472.CAN-05-1428; Caruso C, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-5; Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9; Chun Y, 2011, CHINA BOASTS NEARLY; Hingorani AD, 2003, CURR HYPERTENS REP, V5, P19, DOI 10.1007/s11906-003-0006-0; Hurowitz EH, 2000, DNA RES, V7, P111, DOI 10.1093/dnares/7.2.111; Jernigan MB, 1992, AGING CHINESE SOC HO; Kannisto V, 1994, ODENSE MONOGRAPHS PO; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Lal S, 2005, ANN HUM GENET, V69, P639, DOI 10.1111/j.1529-8817.2005.00192.x; Li W, 2004, J MOL CELL CARDIOL, V37, P671, DOI 10.1016/j.yjmcc.2004.05.005; Li XH, 1996, NEUROBIOL AGING, V17, P115, DOI 10.1016/0197-4580(95)02023-3; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Paradies G, 2013, MECH AGEING DEV, V134, P1, DOI 10.1016/j.mad.2012.12.006; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Perls T, 2001, J GERONTOL A-BIOL, V56, pM67, DOI 10.1093/gerona/56.2.M67; PERLS TT, 1995, SCI AM, V272, P70, DOI 10.1038/scientificamerican0195-70; Poon LW, 2008, ANNU REV GERONTOL GE, V27, P231; Puca AA, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-26; Ruiz JR, 2012, AGE, V34, P1269, DOI 10.1007/s11357-011-9296-3; Siegerink B, 2009, J THROMB HAEMOST, V7, P385, DOI 10.1111/j.1538-7836.2008.03266.x; Sofowora G, 2001, PHARMACOGENETICS, V11, P809, DOI 10.1097/00008571-200112000-00009; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Thatcher AR, 1996, FORCE MORTALITY AGE; Wang Z, 2003, AGE VALIDATION HAN C; Xin Y, 2009, CLIN SCI, V117, P67, DOI 10.1042/CS20080476; Yang XR, 2012, MOL BIOL REP, V39, P9123, DOI 10.1007/s11033-012-1784-8	34	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e81806	10.1371/journal.pone.0081806	http://dx.doi.org/10.1371/journal.pone.0081806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376503	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100007
J	Chaturvedi, R; Singha, PK; Dey, S				Chaturvedi, Ratna; Singha, Prajjal Kanti; Dey, Satyahari			Water Soluble Bioactives of Nacre Mediate Antioxidant Activity and Osteoblast Differentiation	PLOS ONE			English	Article							PINCTADA-MAXIMA; MATRIX PROTEIN; PEARL OYSTER; ORGANIC MATRIX; OXIDATIVE STRESS; BONE-FORMATION; IMPLANTS; STIMULATION; EVOLUTION; FRACTION	The water soluble matrix of nacre is a proven osteoinductive material. In spite of the differences in the biomolecular compositions of nacre obtained from multiple species of oysters, the common biochemical properties of those principles substantiate their biological activity. However, the mechanism by which nacre stimulates bone differentiation remains largely unknown. Since the positive impact of antioxidants on bone metabolism is well acknowledged, in this study we investigated the antioxidant potential of a water soluble matrix (WSM) obtained from the nacre of the marine oyster Pinctada fucata, which could regulate its osteoblast differentiation activity. Enhanced levels of ALP activity observed in pre-osteoblast cells upon treatment with WSM, suggested the induction of bone differentiation events. Furthermore, bone nodule formation and up-regulation of bone differentiation marker transcripts, i.e. collagen type-1 and osteocalcin by WSM confirmed its ability to induce differentiation of the preosteoblasts into mature osteoblasts. Remarkably, same WSM fraction upon pre-treatment lowered the H2O2 and UV-B induced oxidative damages in keratinocytes, thus indicating the antioxidant potential of WSM. This was further confirmed from the in vitro scavenging of ABTS and DPPH free radicals and inhibition of lipid peroxidation by WSM. Together, these results indicate that WSM poses both antioxidant potential and osteoblast differentiation property. Thus, bioactivities associated with nacre holds potential in the development of therapeutics for bone regeneration and against oxidative stress induced damages in cells.	[Chaturvedi, Ratna; Dey, Satyahari] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India; [Singha, Prajjal Kanti] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of Texas System; University of Texas Health San Antonio	Chaturvedi, R (corresponding author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.	ratna.ch@gmail.com	Chaturvedi, Ratna/B-1570-2015	Chaturvedi, Ratna/0000-0002-4979-9525	Ministry of Human Resource Development (MHRD); IIT Kharagpur, India	Ministry of Human Resource Development (MHRD)(Ministry of Human Resource Development (MHRD), Government of India); IIT Kharagpur, India	Ministry of Human Resource Development (MHRD) and IIT Kharagpur, India, provided fellowship to carry out the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MJ, 2000, J EXP ZOOL, V288, P327, DOI 10.1002/1097-010X(20001215)288:4<327::AID-JEZ5>3.0.CO;2-#; Arai M, 2007, IUBMB LIFE, V59, P27, DOI 10.1080/15216540601156188; Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5; Bai ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053617; BAX BE, 1992, BIOCHEM BIOPH RES CO, V183, P1153, DOI 10.1016/S0006-291X(05)80311-0; Bedouet L, 2001, COMP BIOCHEM PHYS B, V128, P389, DOI 10.1016/S1096-4959(00)00337-7; Bedouet L, 2007, MAR BIOTECHNOL, V9, P437, DOI 10.1007/s10126-007-7120-y; Bedouet L, 2007, MAR BIOTECHNOL, V9, P638, DOI 10.1007/s10126-007-9017-1; Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019; BHARGAVA U, 1988, BONE, V9, P155, DOI 10.1016/8756-3282(88)90005-1; Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cao G, 1996, Zhongguo Zhong Yao Za Zhi, V21, P635; Dash R, 2008, BMB REP, V41, P236, DOI 10.5483/BMBRep.2008.41.3.236; Dash R, 2008, MOL CELL BIOCHEM, V311, P111, DOI 10.1007/s11010-008-9702-z; Flausse A, 2013, J BIOMED MATER RES A, V101, P3211, DOI 10.1002/jbm.a.34629; Furuhashi T, 2010, COMP BIOCHEM PHYS B, V155, P195, DOI 10.1016/j.cbpb.2009.11.007; GU WZ, 1988, J TRADIT CHIN MED, V8, P247; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Kim H, 2012, BIOMATERIALS, V33, P7489, DOI 10.1016/j.biomaterials.2012.06.098; Kroger N, 2009, SCIENCE, V325, P1351, DOI 10.1126/science.1177055; Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6; Lecoeur L, 1997, BIOMATERIALS, V18, P989, DOI 10.1016/S0142-9612(97)00025-2; Lee K, 2012, MOL BIOL REP, V39, P3211, DOI 10.1007/s11033-011-1088-4; Liao HH, 2002, BIOMATERIALS, V23, P2693, DOI 10.1016/S0142-9612(01)00421-5; Liu YC, 2006, FISHERIES SCI, V72, P388, DOI 10.1111/j.1444-2906.2006.01161.x; Lopez E, 2000, TISSUE CELL, V32, P95, DOI 10.1054/tice.1999.0091; LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8; Luegmayr E, 2004, CELL DEATH DIFFER, V11, pS108, DOI 10.1038/sj.cdd.4401399; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; Marie B, 2010, CHEMBIOCHEM, V11, P2138, DOI 10.1002/cbic.201000276; Marie B, 2009, MATER RES SOC SYMP P, V1187, P3; Marie B, 2009, CHEMBIOCHEM, V10, P1495, DOI 10.1002/cbic.200900009; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Miyamoto H, 2013, ZOOL SCI, V30, P801, DOI 10.2108/zsj.30.801; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217; Noguchi T, 2007, FISHERIES SCI, V73, P1177, DOI 10.1111/j.1444-2906.2007.01450.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Parhami F, 2003, PROSTAG LEUKOTR ESS, V68, P373, DOI 10.1016/S0952-3278(03)00061-9; Parhami F, 2000, ARTERIOSCL THROM VAS, V20, P2346, DOI 10.1161/01.ATV.20.11.2346; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0; Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553; RUNGBY J, 1993, HISTOCHEM J, V25, P446, DOI 10.1007/BF00157809; SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881; SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0; Sud D, 2001, TISSUE CELL, V33, P154, DOI 10.1054/tice.2000.0166; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; TAN W, 1988, SENOIR MED J, V8, P109; Torita A, 2007, FISHERIES SCI, V73, P1388, DOI 10.1111/j.1444-2906.2007.01482.x; WANG D, 1994, CHINESE HERBAL MED, V25, P203; Wang Jian-jun, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P220; Wang Jian-jun, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1838; Wang XY, 2011, COMP BIOCHEM PHYS B, V158, P173, DOI 10.1016/j.cbpb.2010.11.004; Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798; Wu YY, 2013, J FUNCT FOODS, V5, P527, DOI 10.1016/j.jff.2013.01.016; Yan ZG, 2007, BIOMACROMOLECULES, V8, P3597, DOI 10.1021/bm0701494; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6; ZHOU Y, 2007, COMP BIOCH PHYSL B, V148, P158	65	33	36	10	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84584	10.1371/journal.pone.0084584	http://dx.doi.org/10.1371/journal.pone.0084584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367677	Green Submitted, gold, Green Published			2022-12-27	WOS:000328741900056
J	Carlini, F; Traore, K; Cherouat, N; Roubertoux, P; Buhler, S; Cortey, M; Simon, S; Doumbo, O; Chiaroni, J; Picard, C; Di Cristofaro, J				Carlini, Federico; Traore, Karim; Cherouat, Nissem; Roubertoux, Pierre; Buhler, Stephane; Cortey, Marti; Simon, Sophie; Doumbo, Ogobara; Chiaroni, Jacques; Picard, Christophe; Di Cristofaro, Julie			HLA-G UTR Haplotype Conservation in the Malian Population: Association with Soluble HLA-G	PLOS ONE			English	Article							3' UNTRANSLATED REGION; G GENE; LINKAGE DISEQUILIBRIUM; G POLYMORPHISMS; TRANSPLANT RECIPIENTS; ALLOGRAFT ACCEPTANCE; AFRICAN POPULATIONS; ALLELE FREQUENCIES; G EXPRESSION; A SUBREGION	The HLA-G molecule plays an important role in immunomodulation. In a previous study carried out on a southern French population our team showed that HLA-G haplotypes, defined by SNPs in the coding region and specific SNPs located in 5'URR and 3'UTR regulatory regions, are associated with differential soluble HLA-G expression (sHLA-G). Furthermore, the structure of these HLA-G haplotypes appears to be conserved in geographically distant populations. The aim of our study is to confirm these expectations in a sub-Saharan African population and to explore additional factors, such as HLA-A alleles, that might influence sHLA-G expression. DNA and plasma samples were collected from 229 Malians; HLA-G and HLA-A genotyping were respectively performed by the Snap Shot (R) method and by Luminex (TM) technology. sHLA-G dosage was performed using an ELISA kit. HLA-G and HLA-A allelic and haplotypic frequencies were estimated using an EM algorithm from the Gene[Rate] program. Associations between genetic and non genetic parameters with sHLA-G were performed using a non-parametric test with GRAPH PAD Prism 5. Our results reveal a good conservation of the HLA-G UTR haplotype structure in populations with different origins and demographic histories. These UTR haplotypes appear to be involved in different sHLA-G expression patterns. Specifically, the UTR-2 haplotype was associated with low sHLA-G levels, displaying a dominant negative effect. Furthermore, an allelic effect of both HLA-G and HLA-A, as well as non genetic parameters, such as age and gender possibly linked to osteogenesis and sexual hormones, also seem to be involved in the modulation of sHLA-G. These data suggest that further investigation in larger cohorts and in populations from various ethnical backgrounds is necessary not only to detect new functional polymorphism in HLA-G regulatory regions, but also to reveal the extent of biological phenomena that influence sHLA-G secretion and this might therefore have an impact on transplantation practice.	[Carlini, Federico; Cortey, Marti; Chiaroni, Jacques; Picard, Christophe; Di Cristofaro, Julie] Aix Marseille Univ, CNRS, ADES UMR 7268, EFS, Marseille, France; [Traore, Karim; Doumbo, Ogobara] Fac Med Pharm & Dent, Dept Epidemiol Parasit Dis, Malaria Res & Training Ctr, Bamako, Mali; [Cherouat, Nissem; Simon, Sophie; Picard, Christophe] Etab Francais Sang Alpes Mediterranee, Immunogenet Lab, Marseille, France; [Roubertoux, Pierre] Aix Marseille Univ, Fac Med, INSERM, Genet Med & Dev U491, Marseille, France; [Buhler, Stephane] Univ Geneva, Dept Genet & Evolut, Anthropol Unit, Lab Anthropol Genet & Peopling Hist AGP, Geneva, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Geneva	Di Cristofaro, J (corresponding author), Aix Marseille Univ, CNRS, ADES UMR 7268, EFS, Marseille, France.	julie.dicristofaro@efs.sante.fr	Carlini, Federico/AAA-9050-2019; Chiaroni, Jacques/ABA-2944-2021	Carlini, Federico/0000-0003-3503-5169; Chiaroni, Jacques/0000-0002-3133-8990; Buhler, Stephane/0000-0001-6675-5287; Di Cristofaro, Julie/0000-0001-7867-6455; Traore, Karim/0000-0002-9553-6611	Etablissement Francais du Sang (EFS) Alpes Mediterranee, Marseilles, France; Malaria Research and Training Center, Bamako, Mali	Etablissement Francais du Sang (EFS) Alpes Mediterranee, Marseilles, France; Malaria Research and Training Center, Bamako, Mali	This study was funded by the Etablissement Francais du Sang (EFS) Alpes Mediterranee, Marseilles, France and by the Malaria Research and Training Center, Bamako, Mali. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamashvili IM, 1996, TRANSPLANTATION, V61, P984, DOI 10.1097/00007890-199603270-00028; Adams EJ, 2000, IMMUNOGENETICS, V51, P410, DOI 10.1007/s002510050639; Aldrich CL, 2001, MOL HUM REPROD, V7, P1167, DOI 10.1093/molehr/7.12.1167; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Buhler S, 2010, TISSUE ANTIGENS, V75, P500, DOI 10.1111/j.1399-0039.2010.01469.x; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74; Castelli EC, 2011, MOL BIOL EVOL, V28, P3069, DOI 10.1093/molbev/msr138; Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028; Alves DCC, 2012, HUM IMMUNOL, V73, P52, DOI 10.1016/j.humimm.2011.10.007; Creput C, 2003, NEPHROLOGIE, V24, P451; Deschaseaux F, 2013, FASEB J; Di Cristofaro J, 2013, HUM IMMUNOL, V74, P203, DOI 10.1016/j.humimm.2012.10.027; DOBBE LME, 1988, IMMUNOGENETICS, V27, P203, DOI 10.1007/BF00346587; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; DOXIADIS I, 1989, BLUT, V59, P449, DOI 10.1007/BF00349066; Dunker K, 2008, TISSUE ANTIGENS, V72, P137, DOI 10.1111/j.1399-0039.2008.01090.x; ELKAHLOUN A, 1992, IMMUNOGENETICS, V35, P183; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flajollet S, 2009, J IMMUNOL, V183, P6948, DOI 10.4049/jimmunol.0902053; Garcia A, 2013, INFECT GENET EVOL, V16, P263, DOI 10.1016/j.meegid.2013.02.021; GERAGHTY DE, 1992, J IMMUNOL, V149, P1934; GERAGHTY DE, 1992, P NATL ACAD SCI USA, V89, P2669, DOI 10.1073/pnas.89.7.2669; Gonzalez A, 2012, CRIT REV CL LAB SCI, V49, P63, DOI 10.3109/10408363.2012.677947; Gu X, 1999, MOL BIOL EVOL, V16, P147, DOI 10.1093/oxfordjournals.molbev.a026097; Hviid TV, 2002, TISSUE ANTIGENS, V60, P122, DOI 10.1034/j.1399-0039.2002.600202.x; Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z; Hviid TVF, 2006, HUM REPROD UPDATE, V12, P209, DOI 10.1093/humupd/dmi048; Ishitani A, 1999, IMMUNOGENETICS, V49, P808, DOI 10.1007/s002510050555; Jassem RM, 2012, HUM IMMUNOL, V73, P811, DOI 10.1016/j.humimm.2012.05.009; Julie DC, 2011, TISSUE ANTIGENS, V77, P193, DOI 10.1111/j.1399-0039.2010.01599.x; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Kulski JK, 2010, IMMUNOGENETICS, V62, P211, DOI 10.1007/s00251-010-0427-2; Kuroki K, 2007, EUR J IMMUNOL, V37, P1727, DOI 10.1002/eji.200737515; Lajoie J, 2010, HUM IMMUNOL, V71, P182, DOI 10.1016/j.humimm.2009.11.007; Larsen MH, 2010, TISSUE ANTIGENS, V75, P253, DOI 10.1111/j.1399-0039.2009.01435.x; Larsen MH, 2009, HUM IMMUNOL, V70, P1026, DOI 10.1016/j.humimm.2009.07.015; Le Gal FA, 1999, INT IMMUNOL, V11, P1351, DOI 10.1093/intimm/11.8.1351; Lila N, 2001, P NATL ACAD SCI USA, V98, P12150, DOI 10.1073/pnas.201407398; Liu H, 2013, ACTA HAEMATOL-BASEL, V130, P160, DOI 10.1159/000350488; Matte C, 2000, HUM IMMUNOL, V61, P1150, DOI 10.1016/S0198-8859(00)00200-7; Menier C, 2009, HUM IMMUNOL, V70, P1006, DOI 10.1016/j.humimm.2009.07.021; MORALES P, 1993, IMMUNOGENETICS, V38, P323; Moreau P, 2008, BIOL REPROD, V79, P459, DOI 10.1095/biolreprod.108.068874; Naji A, 2007, BLOOD, V110, P3936, DOI 10.1182/blood-2007-04-083139; Ober C, 2003, AM J HUM GENET, V72, P1425, DOI 10.1086/375501; Ober C, 1996, J REPROD IMMUNOL, V32, P111, DOI 10.1016/S0165-0378(96)01000-5; PELLEGRINO MA, 1974, EUR J IMMUNOL, V4, P250, DOI 10.1002/eji.1830040405; Pfeiffer KA, 2001, MOL HUM REPROD, V7, P373, DOI 10.1093/molehr/7.4.373; Picard C, 2012, HUM IMMUNOL; Pirri A, 2009, TRANSPL IMMUNOL, V20, P143, DOI 10.1016/j.trim.2008.09.012; Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Sabbagh A, 2013, TISSUE ANTIGENS, V82, P53, DOI 10.1111/tan.12140; Sheshgiri R, 2008, CIRCULATION, V118, pS58, DOI 10.1161/CIRCULATIONAHA.107.757781; Sheshgiri R, 2008, J HEART LUNG TRANSPL, V27, P522, DOI 10.1016/j.healun.2008.02.004; Shi WW, 2011, HUM IMMUNOL, V72, P1068, DOI 10.1016/j.humimm.2011.06.012; SHUKLA H, 1991, GENOMICS, V10, P905, DOI 10.1016/0888-7543(91)90178-H; Svendsen SG, 2013, HUM IMMUNOL, V74, P818, DOI 10.1016/j.humimm.2013.03.003; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; van der Ven K, 1998, HUM IMMUNOL, V59, P302, DOI 10.1016/S0198-8859(98)00021-4; Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187; VENDITTI CP, 1992, GENOMICS, V14, P1003, DOI 10.1016/S0888-7543(05)80123-5; Yie SM, 2006, HUM REPROD, V21, P46, DOI 10.1093/humrep/dei305; Zarkhin V, 2010, TRANSPLANTATION, V90, P1000, DOI 10.1097/TP.0b013e3181f546af; Zheng XQ, 2013, CLIN EXP MED; Zilberman S, 2012, EUR J IMMUNOL, V42, P1599, DOI 10.1002/eji.201141761	71	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82517	10.1371/journal.pone.0082517	http://dx.doi.org/10.1371/journal.pone.0082517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376542	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000014
J	Cordon-Obras, C; Cano, J; Gonzalez-Pacanowska, D; Benito, A; Navarro, M; Bart, JM				Cordon-Obras, Carlos; Cano, Jorge; Gonzalez-Pacanowska, Dolores; Benito, Agustin; Navarro, Miguel; Bart, Jean-Mathieu			Trypanosoma brucei gambiense Adaptation to Different Mammalian Sera Is Associated with VSG Expression Site Plasticity	PLOS ONE			English	Article							VARIANT SURFACE GLYCOPROTEIN; HUMAN AFRICAN TRYPANOSOMIASIS; TRANSFERRIN-BINDING PROTEIN; SLEEPING SICKNESS FOCUS; BLOOD-STREAM FORMS; ANTIGENIC VARIATION; HOST-RANGE; RECEPTOR; GENE; RESISTANCE		[Cordon-Obras, Carlos; Gonzalez-Pacanowska, Dolores; Navarro, Miguel; Bart, Jean-Mathieu] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Cano, Jorge; Benito, Agustin; Bart, Jean-Mathieu] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT)	Navarro, M (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	miguel.navarro@ipb.csic.es	Bart, Jean-Mathieu/N-2598-2014; Cano, Jorge/E-2962-2016; Navarro, Miguel/C-3685-2009; Cano, Jorge/AAV-6392-2020	Bart, Jean-Mathieu/0000-0001-5707-3778; Cano, Jorge/0000-0001-9864-5058; Navarro, Miguel/0000-0003-2301-2699; Cano, Jorge/0000-0001-9864-5058; Benito, Agustin/0000-0001-8229-5540; , Carlos/0000-0002-6455-5094; Gonzalez-Pacanowska, Dolores/0000-0002-4303-5209	Spanish Ministerio de Ciencia e Innovacion, Plan Nacional [SAF2012-40029]; Junta de Andalucia [CTS-5841]; Fondo de Investigacion Sanitaria (FIS) [PI10/01128]; VI PN de I+D+I; ISCIII -Subdireccion General de Redes y Centros de Investigacion Cooperativa (RICET) [RD12/0018/0001, RD12/0018/0015]; Miguel Servet Fellowship [CP09/00300]	Spanish Ministerio de Ciencia e Innovacion, Plan Nacional(Ministry of Science and Innovation, Spain (MICINN)); Junta de Andalucia(Junta de Andalucia); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); VI PN de I+D+I; ISCIII -Subdireccion General de Redes y Centros de Investigacion Cooperativa (RICET); Miguel Servet Fellowship	This work was supported by grants from the Spanish Ministerio de Ciencia e Innovacion, Plan Nacional (SAF2012-40029), Junta de Andalucia (CTS-5841), Fondo de Investigacion Sanitaria (FIS) PI10/01128 and VI PN de I+D+I 2008-2011, ISCIII -Subdireccion General de Redes y Centros de Investigacion Cooperativa (RICET) RD12/0018/0001 and RD12/0018/0015. JMB is supported by a Miguel Servet Fellowship CP09/00300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALINE RF, 1989, EXP PARASITOL, V68, P57, DOI 10.1016/0014-4894(89)90008-8; Ansorge I, 1999, MOL BIOCHEM PARASIT, V101, P81, DOI 10.1016/S0166-6851(99)00060-2; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Berberof M, 2001, MOL BIOCHEM PARASIT, V113, P127, DOI 10.1016/S0166-6851(01)00208-0; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Berriman M, 2002, MOL BIOCHEM PARASIT, V122, P131, DOI 10.1016/S0166-6851(02)00092-0; Biebinger S, 2003, MOL BIOCHEM PARASIT, V132, P93, DOI 10.1016/j.molbiopara.2003.07.005; Bitter W, 1998, NATURE, V391, P499, DOI 10.1038/35166; Blum JA, 2012, EUR J CLIN MICROBIOL, V31, P905, DOI 10.1007/s10096-011-1403-y; Borst P, 1996, ARCH MED RES, V27, P379; Capewell P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001287; Castillo-Acosta VM, 2013, MOL MICROBIOL, V90, P665, DOI 10.1111/mmi.12359; Checchi F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000303; Cordon-Obras C, 2009, TROP MED INT HEALTH, V14, P535, DOI 10.1111/j.1365-3156.2009.02271.x; CROSS GAM, 1984, J CELL BIOCHEM, V24, P79, DOI 10.1002/jcb.240240107; DEGREEF C, 1989, MOL BIOCHEM PARASIT, V36, P169, DOI 10.1016/0166-6851(89)90189-8; DEGREEF C, 1992, ANN SOC BELG MED TR, V72, P13; DIFFLEY P, 1987, AM J TROP MED HYG, V36, P533, DOI 10.4269/ajtmh.1987.36.533; DUKES P, 1992, ACTA TROP, V51, P123, DOI 10.1016/0001-706X(92)90054-2; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; ENYARU JCK, 1993, ACTA TROP, V54, P31, DOI 10.1016/0001-706X(93)90066-K; Faulkner SD, 2006, EUKARYOT CELL, V5, P1276, DOI 10.1128/EC.00116-06; Felu C, 2007, AM J TROP MED HYG, V76, P922, DOI 10.4269/ajtmh.2007.76.922; Gerrits H, 2002, MOL BIOCHEM PARASIT, V119, P237, DOI 10.1016/S0166-6851(01)00417-0; GIBSON W C, 1986, Parasitology Today, V2, P255, DOI 10.1016/0169-4758(86)90011-6; Herder S, 2002, PARASITE, V9, P345, DOI 10.1051/parasite/2002094345; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Hoare C, 1972, TRYPANOSOMES MAMMALS; HOBBS MR, 1990, MOL BIOCHEM PARASIT, V43, P1, DOI 10.1016/0166-6851(90)90125-6; Horn D, 2004, CURR MOL MED, V4, P563, DOI 10.2174/1566524043360078; Horn D, 2010, CURR OPIN MICROBIOL, V13, P700, DOI 10.1016/j.mib.2010.08.009; Isobe T, 2003, J MOL EVOL, V56, P377, DOI 10.1007/s00239-002-2408-z; Jackson AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000658; Jamonneau V, 2004, PARASITOLOGY, V129, P693, DOI 10.1017/S0031182004005876; Kieft R, 2010, P NATL ACAD SCI USA, V107, P16137, DOI 10.1073/pnas.1007074107; KOOTER JM, 1988, GENE, V69, P1, DOI 10.1016/0378-1119(88)90372-1; KUZOE FAS, 2004, TDRIDETRY051 SPEC PR; Landeira D, 2009, J CELL BIOL, V186, P243, DOI 10.1083/jcb.200902119; LIGTENBERG MJL, 1994, EMBO J, V13, P2565, DOI 10.1002/j.1460-2075.1994.tb06546.x; Louis FJ, 2002, B SOC PATHOL EXOT, V95, P331; Lutumba P, 2005, EMERG INFECT DIS, V11, P1382; Mussmann R, 2004, J BIOL CHEM, V279, P40690, DOI 10.1074/jbc.M404697200; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; Navarro M, 1998, MOL BIOCHEM PARASIT, V94, P53, DOI 10.1016/S0166-6851(98)00049-8; Njiokou F, 2006, INFECT GENET EVOL, V6, P147, DOI 10.1016/j.meegid.2005.04.003; NJIOKOU F, 2005, 28 M ISCTRC ADD AB E; PAYS E, 1990, EMBO J, V9, P3145, DOI 10.1002/j.1460-2075.1990.tb07512.x; Pays E, 2001, MOL BIOCHEM PARASIT, V114, P1, DOI 10.1016/S0166-6851(01)00242-0; Penchenier L, 2005, VET PARASITOL, V133, P7, DOI 10.1016/j.vetpar.2005.04.034; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Salmon D, 1997, EMBO J, V16, P7272, DOI 10.1093/emboj/16.24.7272; Salmon D, 2012, SCIENCE, V337, P463, DOI 10.1126/science.1222753; SCHELL D, 1991, EMBO J, V10, P1061, DOI 10.1002/j.1460-2075.1991.tb08045.x; SCHELL D, 1991, PARASITOL RES, V77, P558, DOI 10.1007/BF00931012; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Simarro PP, 2006, TROP MED INT HEALTH, V11, P636, DOI 10.1111/j.1365-3156.2006.01624.x; Simo G, 2008, EXP PARASITOL, V118, P172, DOI 10.1016/j.exppara.2007.07.010; Simo G, 2006, VET PARASITOL, V139, P57, DOI 10.1016/j.vetpar.2006.02.026; Steverding D, 1998, PARASITOL RES, V84, P59, DOI 10.1007/s004360050357; STEVERDING D, 1994, EUR J CELL BIOL, V64, P78; Steverding Dietmar, 2000, Parasitology International, V48, P191, DOI 10.1016/S1383-5769(99)00018-5; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; THATCHER LF, 2011, MOL PLANT MICROBE IN; Turner CMR, 2004, PARASITOLOGY, V129, P445, DOI 10.1017/S0031182004005906; Uzureau P, 2013, NATURE, V501, P430, DOI 10.1038/nature12516; van Luenen HGAM, 2005, MOL MICROBIOL, V58, P151, DOI 10.1111/j.1365-2958.2005.04831.x; Vanhamme Luc, 2010, Infectious Disorders - Drug Targets, V10, P266; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Wiley M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018335; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7; Young R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-385	76	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85072	10.1371/journal.pone.0085072	http://dx.doi.org/10.1371/journal.pone.0085072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376866	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000177
J	Guo, JC; Li, J; Yang, YC; Zhou, L; Zhang, TP; Zhao, YP				Guo, Jun-Chao; Li, Jian; Yang, Ying-Chi; Zhou, Li; Zhang, Tai-Ping; Zhao, Yu-Pei			Oligonucleotide Microarray Identifies Genes Differentially Expressed during Tumorigenesis of DMBA-Induced Pancreatic Cancer in Rats	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR7; DUCTAL ADENOCARCINOMA; CELL-LINE; INTRAEPITHELIAL NEOPLASIA; CARCINOMA; SURVIVAL; ESTABLISHMENT; AZASERINE; MODELS; TUMORS	The extremely dismal prognosis of pancreatic cancer (PC) is attributed, at least in part, to lack of early diagnosis. Therefore, identifying differentially expressed genes in multiple steps of tumorigenesis of PC is of great interest. In the present study, a 7,12-dimethylbenzanthraene (DMBA)-induced PC model was established in male Sprague-Dawley rats. The gene expression profile was screened using an oligonucleotide microarray, followed by real-time quantitative polymerase chain reaction (qRT-PCR) and immunohistochemical staining validation. A total of 661 differentially expressed genes were identified in stages of pancreatic carcinogenesis. According to GO classification, these genes were involved in multiple molecular pathways. Using two-way hierarchical clustering analysis, normal pancreas, acute and chronic pancreatitis, PanIN, early and advanced pancreatic cancer were completely discriminated. Furthermore, 11 upregulated and 142 downregulated genes (probes) were found by Mann-Kendall trend Monotone test, indicating homologous genes of rat and human. The qRT-PCR and immunohistochemistry analysis of CXCR7 and UBe2c, two of the identified genes, confirmed the microarray results. In human PC cell lines, knockdown of CXCR7 resulted in decreased migration and invasion. Collectively, our data identified several promising markers and therapeutic targets of PC based on a comprehensive screening and systemic validation.	[Guo, Jun-Chao; Li, Jian; Yang, Ying-Chi; Zhou, Li; Zhang, Tai-Ping; Zhao, Yu-Pei] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Zhang, TP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China.	tpingzhang@yahoo.com; zhao8028@263.net	Zhou, Li/GSE-4531-2022		research special fund for public welfare industry of health, the translational research of early diagnosis and comprehensive treatment in pancreatic cancer [201202007]	research special fund for public welfare industry of health, the translational research of early diagnosis and comprehensive treatment in pancreatic cancer	The study was supported by the research special fund for public welfare industry of health, the translational research of early diagnosis and comprehensive treatment in pancreatic cancer (number 201202007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bockman DE, 2003, LAB INVEST, V83, P853, DOI 10.1097/01.LAB.0000074918.31303.5A; Boros LG, 2005, PANCREAS, V31, P337, DOI 10.1097/01.mpa.0000186524.53253.fb; Chatterjee D, 2012, AM J SURG PATHOL, V36, P409, DOI 10.1097/PAS.0b013e31824104c5; DRUCKER BJ, 1988, IN VITRO CELL DEV B, V24, P1179, DOI 10.1007/BF02624187; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Gebauer F, 2011, J SURG ONCOL, V104, P140, DOI 10.1002/jso.21957; GINGELL R, 1976, J NATL CANCER I, V57, P1175, DOI 10.1093/jnci/57.5.1175; Hallemeier Christopher L, 2011, Am J Clin Oncol, V34, P567, DOI 10.1097/COC.0b013e3181f946fc; Hao MG, 2012, BIOCHEM PHARMACOL, V84, P204, DOI 10.1016/j.bcp.2012.04.007; Hao ZL, 2012, TUMOR BIOL, V33, P723, DOI 10.1007/s13277-011-0291-1; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Heinrich EL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-68; Herreros-Villanueva M, 2012, WORLD J GASTROENTERO, V18, P1286, DOI 10.3748/wjg.v18.i12.1286; Ito Y, 2002, PANCREATOLOGY, V2, P138, DOI 10.1159/000055904; Jimenez RE, 1999, AM J PATHOL, V154, P1223, DOI 10.1016/S0002-9440(10)65374-6; Kalinina T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-295; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; LONGNECKER DS, 1975, CANCER RES, V35, P2249; Marechal R, 2009, BRIT J CANCER, V100, P1444, DOI 10.1038/sj.bjc.6605020; Monnier J, 2012, EUR J CANCER, V48, P138, DOI 10.1016/j.ejca.2011.06.044; Osvaldt AB, 2006, SURGERY, V140, P803, DOI 10.1016/j.surg.2006.02.012; POUR P, 1975, CANCER, V36, P379, DOI 10.1002/1097-0142(197508)36:2<379::AID-CNCR2820360213>3.0.CO;2-R; Rivera JA, 1997, SURGERY, V122, P82, DOI 10.1016/S0039-6060(97)90268-3; Robinson SM, 2012, EJSO-EUR J SURG ONC, V38, P333, DOI 10.1016/j.ejso.2011.12.020; ROEBUCK BD, 1984, LAB INVEST, V50, P141; Rogers A, 2012, PANCREATOLOGY, V12, P130, DOI 10.1016/j.pan.2011.12.011; Schrevel M, 2012, BRIT J CANCER, V106, P1520, DOI 10.1038/bjc.2012.110; Tan XG, 2010, HEPATOB PANCREAT DIS, V9, P639; Wang L, 2011, WORLD J GASTROENTERO, V17, P1434, DOI 10.3748/wjg.v17.i11.1434; Weber A, 2010, PANCREAS, V39, P1247, DOI 10.1097/MPA.0b013e3181e21b1b; YASUDA D, 1993, INT J ONCOL, V3, P641; Z'graggen K, 2001, ANN SURG, V233, P688, DOI 10.1097/00000658-200105000-00013; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010; Yu-Pei Z, 2007, CHINESE MED J-PEKING, V120, P1743, DOI 10.1097/00029330-200710020-00003	35	11	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82910	10.1371/journal.pone.0082910	http://dx.doi.org/10.1371/journal.pone.0082910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376604	Green Submitted, gold, Green Published			2022-12-27	WOS:000328882000037
J	Kirita, K; Ishii, G; Matsuwaki, R; Matsumura, Y; Umemura, S; Matsumoto, S; Yoh, K; Niho, S; Goto, K; Ohmatsu, H; Ohe, Y; Nagai, K; Ochiai, A				Kirita, Keisuke; Ishii, Genichiro; Matsuwaki, Rie; Matsumura, Yuki; Umemura, Shigeki; Matsumoto, Shingo; Yoh, Kiyotaka; Niho, Seiji; Goto, Koichi; Ohmatsu, Hironobu; Ohe, Yuichiro; Nagai, Kanji; Ochiai, Atsushi			Identification of Biological Properties of Intralymphatic Tumor Related to the Development of Lymph Node Metastasis in Lung Adenocarcinoma	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 1; STEM-CELLS; MESENCHYMAL TRANSITION; CANCER; SOX2; EXPRESSION; STAGE; MARKER; RATIO; OCT4	Background: Intralymphatic tumors in the extratumoral area are considered to represent the preceding phase of lymph node metastasis. The aim of this study was to clarify the biological properties of intralymphatic tumors susceptible to the development of lymph node metastasis, with special reference to the expression of cancer initiating/stem cell (CIC/CSC) related markers in cancer cells and the number of infiltrating stromal cells. Material and Methods: Primary lung adenocarcinomas with lymphatic permeation in the extratumoral area were retrospectively examined (n = 107). We examined the expression levels of CIC/CSC related markers including ALDH1, OCT4, NANOG, SOX2 and Caveolin-1 in the intralymphatic cancer cells to evaluate their relationship to lymph node metastasis. Moreover, the number of infiltrating stromal cells expressing CD34, a-smooth muscle actin, and CD204 were also evaluated. Results: Among the intralymphatic tissues, low ALDH1 expression in cancer cells, high SOX2 expression in cancer cells, and a high number of CD204(+) macrophages were independent predictive factors for lymph node metastasis (P = 0.004, P = 0.008, and P = 0.028, respectively). Among these factors, only low ALDH1 expression in cancer cells was significantly correlated with the farther spreading of lymph node metastasis (mediastinal lymph node, pathological N2) (P = 0.046) and the metastatic lymph node ratio (metastatic/resected) (P = 0.028). On the other hand, in the primary tumors, ALDH1 expression in the cancer cells was not associated with lymph node metastasis. Intralymphatic cancer cells expressing low ALDH1 levels exhibited lower E-cadherin expression levels than cancer cells with high levels of ALDH1 expression (P = 0.015). Conclusions: Intralymphatic cancer cells expressing low levels of ALDH1 and infiltrating macrophages expressing CD204 have a critical impact on lymph node metastasis. Our study also highlighted the significance of evaluating the biological properties of intralymphatic tumors for tumor metastasis.	[Kirita, Keisuke; Ishii, Genichiro; Matsuwaki, Rie; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, Chiba, Japan; [Kirita, Keisuke; Umemura, Shigeki; Matsumoto, Shingo; Yoh, Kiyotaka; Niho, Seiji; Goto, Koichi; Ohmatsu, Hironobu; Ohe, Yuichiro] Natl Canc Ctr Hosp East, Div Thorac Oncol, Chiba, Japan; [Matsuwaki, Rie; Matsumura, Yuki; Nagai, Kanji] Natl Canc Ctr Hosp East, Div Thorac Surg, Chiba, Japan; [Kirita, Keisuke; Ohe, Yuichiro] Juntendo Univ, Grad Sch Med, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Juntendo University	Ishii, G (corresponding author), Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, Chiba, Japan.	gishii@east.ncc.go.jp	Ishii, Genichiro/E-2913-2012		National Cancer Center Research and Development Fund [23-A-12, 23-K-18]; Foundation for the Promotion of Cancer Research, 3rd-Term Comprehensive 10-Year Strategy for Cancer Control; National Institute of Biomedical Innovation (NIBIO); JSPS KAKENHI [24659185]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Foundation for the Promotion of Cancer Research, 3rd-Term Comprehensive 10-Year Strategy for Cancer Control; National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Cancer Center Research and Development Fund (23-A-12 and 23-K-18), the Foundation for the Promotion of Cancer Research, 3rd-Term Comprehensive 10-Year Strategy for Cancer Control, the Advanced research for medical products Mining Programme of the National Institute of Biomedical Innovation (NIBIO), and JSPS KAKENHI (24659185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger AC, 2005, J CLIN ONCOL, V23, P8706, DOI 10.1200/JCO.2005.02.8852; Brechot JM, 1996, CANCER-AM CANCER SOC, V78, P2111, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2111::AID-CNCR11>3.3.CO;2-N; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Chunhacha Preedakorn, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P149; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Dimou A, 2012, AM J PATHOL, V181, P1436, DOI 10.1016/j.ajpath.2012.06.037; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Fujisawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034437; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Greenstein AJ, 2008, J AM COLL SURGEONS, V206, P239, DOI 10.1016/j.jamcollsurg.2007.09.003; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; John D, 2012, J THORAC ONCOL, V7; Jonnalagadda S, 2011, CANCER-AM CANCER SOC, V117, P4724, DOI 10.1002/cncr.26093; Kawata M, 2012, J BIOCHEM, V151, P205, DOI 10.1093/jb/mvr136; Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625; Li XX, 2012, INT J MOL SCI, V13, P7663, DOI 10.3390/ijms13067663; Liebscher CA, 2013, HUM PATHOL; Luo WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056324; Luzzi L, 2000, LUNG CANC, V30; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matsumura Y, 2012, CANCER SCI, V103, P1342, DOI 10.1111/j.1349-7006.2012.02275.x; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Okudela K, 2013, INT J CLIN EXP PATHO, V6; Prasmickaite L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010731; Saijo T, 2007, LUNG CANCER, V55, P61, DOI 10.1016/j.lungcan.2006.09.027; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Vinh-Hung V, 2004, BREAST CANCER RES, V6, pR680, DOI 10.1186/bcr934; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94	33	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83537	10.1371/journal.pone.0083537	http://dx.doi.org/10.1371/journal.pone.0083537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376714	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000095
J	Liu, LF; Cao, XX; Zou, L; Li, ZY; Cao, XC; Cai, JF				Liu, Lifeng; Cao, Xuexin; Zou, Lin; Li, Zongyu; Cao, Xuecheng; Cai, Jinfang			Extended Anterolateral Thigh Flaps for Reconstruction of Extensive Defects of the Foot and Ankle	PLOS ONE			English	Article							SOFT-TISSUE DEFECTS; VASCULAR ANATOMY; EXPERIENCE; SALVAGE	The anterolateral thigh flap has been used for coverage of defects in the foot and ankle for years. Conventional extended anterolateral thigh flaps do not undergo thinning procedures, which limit their application. Here, a clinical series of 24 patients is reported in which extended anterolateral thigh flaps were used for posttraumatic foot and ankle reconstruction. Of the 24 flaps, 14 were simple extended anterolateral thigh fasciocutaneous flaps and 10 were thinned extended anterolateral thigh flaps. One artery and two veins, including a superficial vein and an accompanying vein, were anastomosed to vascularize each flap. Follow-up of the 24 patients ranged from 10 months to 4 years postoperatively. All 24 flaps survived successfully, except one case that had partial flap necrosis distally due to excessive thinning. The cutaneous flap territory ranged from 250 cm(2) to 400 cm(2) (mean, 297 cm(2)). Only one patient received a debulking procedure. No ulceration occurred in any of the flaps due to contact with the shoe. The extended anterolateral thigh flap is a good alternative for extensive soft tissue defects of the foot and ankle. This study also supports the high reliability and excellent vascular supply of moderate thinned extended ALT flaps.	[Liu, Lifeng; Cao, Xuexin; Zou, Lin; Li, Zongyu; Cao, Xuecheng; Cai, Jinfang] Jinan Mil Command, Gen Hosp, Orthopead Dept, Jinan, Peoples R China		Liu, LF (corresponding author), Jinan Mil Command, Gen Hosp, Orthopead Dept, Jinan, Peoples R China.	doctorliu90@hotmail.com	Cao, Xuecheng/L-5141-2019					Baumeister SP, 2003, PLAST RECONSTR SURG, V112, P129, DOI 10.1097/01.PRS.0000066167.68966.66; Baumeister S, 2008, PLAST RECONSTR SURG, V122, P962, DOI 10.1097/PRS.0b013e3181811ca0; Baumeister S, 2009, TECH ORTHOP, V24, P96, DOI 10.1097/BTO.0b013e3181b30553; Benito-Ruiz J, 2004, ANN PLAS SURG, V52, P380, DOI 10.1097/01.sap.0000105520.24063.bb; Chang SM, 2004, MICROSURG, V24, P430, DOI 10.1002/micr.20069; Demirtas Y, 2010, FOOT ANKLE INT, V31, P47, DOI 10.3113/FAI.2010.0047; Fraccalvieri M, 2008, FOOT ANKLE INT, V29, P191, DOI 10.3113/FAI.2008.0191; Kawai K, 2004, PLAST RECONSTR SURG, V114, P1108, DOI 10.1097/01.prs.0000135332.97062.7f; Kimata Y, 1998, PLAST RECONSTR SURG, V102, P1517, DOI 10.1097/00006534-199810000-00026; Kimata Y, 2000, PLAST RECONSTR SURG, V106, P584, DOI 10.1097/00006534-200009030-00009; KOSHIMA I, 1993, PLAST RECONSTR SURG, V92, P421, DOI 10.1097/00006534-199309000-00005; Kuo YR, 2002, ANN PLAS SURG, V48, P161, DOI 10.1097/00000637-200202000-00008; MASQUELET AC, 1992, PLAST RECONSTR SURG, V89, P1115, DOI 10.1097/00006534-199206000-00018; Mosahebi A, 2008, PLAST RECONSTR SURG, V122, P492, DOI 10.1097/PRS.0b013e31817dc4c0; Ribuffo D, 2005, PLAST RECONSTR SURG, V115, P464, DOI 10.1097/01.PRS.0000149481.73952.F3; Rodriguez ED, 2009, J TRAUMA, V66, P1311, DOI 10.1097/TA.0b013e318187cc87; Rubino C, 2009, J PLAST RECONSTR AES, V62, P1666, DOI 10.1016/j.bjps.2008.05.045; Saint-Cyr M, 2009, PLAST RECONSTR SURG, V123, P1245, DOI 10.1097/PRS.0b013e31819e2718; Santanelli F, 2002, PLAST RECONSTR SURG, V109, P2314, DOI 10.1097/00006534-200206000-00023; Santanelli F, 2007, FOOT RECONSTRUCTION; SONG YG, 1984, BRIT J PLAST SURG, V37, P149, DOI 10.1016/0007-1226(84)90002-X; Wei FC, 2004, PLAST RECONSTR SURG, V114, P910, DOI 10.1097/01.PRS.0000133171.65075.81; Wei FC, 2002, PLAST RECONSTR SURG, V109, P2219, DOI 10.1097/00006534-200206000-00007; Yidirim S, 2003, ANN PLAS SURG, V51, P37, DOI 10.1097/01.SAP.0000054179.04469.8C; Zhang QX, 2010, J RECONSTR MICROSURG, V26, P87, DOI 10.1055/s-0029-1243292; Zhang QX, 2010, J PLAST RECONSTR AES, V63, P365, DOI 10.1016/j.bjps.2008.09.028	26	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83696	10.1371/journal.pone.0083696	http://dx.doi.org/10.1371/journal.pone.0083696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376731	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000107
J	Liu, L; Wei, JR; Huang, JP				Liu, Lu; Wei, Jianrong; Huang, Jiping			Scaling and Volatility of Breakouts and Breakdowns in Stock Price Dynamics	PLOS ONE			English	Article							TECHNICAL ANALYSIS; MARKET PRICES; BEHAVIOR; DISTRIBUTIONS; RETURNS	Background: Because the movement of stock prices is not only ubiquitous in financial markets but also crucial for investors, extensive studies have been done to understand the law behind it. In particular, since the financial crisis in 2008, researchers have a more interest in investigating large market volatilities in order to grasp changing market trends. Methodology/Principal Findings: In this work, we analyze the breakouts and breakdowns of both the Standard & Poor's 500 Index in the US stock market and the Shanghai Composite Index in the Chinese stock market. The breakout usually represents an ongoing upward trend in technical analysis while the breakdown represents an ongoing downward trend. Based on the renormalization method, we introduce two parameters to quantize breakouts and breakdowns, respectively. We discover scaling behavior, characterized by power-law distributions for both the breakouts and breakdowns in the two financial markets with different power-law exponents, which reflect different market volatilities. In detail, the market volatility for breakdowns is usually larger than that for breakouts. Moreover, as an emerging market, the Chinese stock market has larger market volatilities for both the breakouts and breakdowns than the US stock market (a mature market). Further, the short-term volatilities show similar features for both the US stock market and the Chinese stock market. However, the medium-term volatilities in the US stock market are almost symmetrical for the breakouts and breakdowns, whereas those in the Chinese stock market appear to be asymmetrical for the breakouts and breakdowns. Conclusions/Signicance: The methodology presented here provides a way to understand scaling and hence volatilities of breakouts and breakdowns in stock price dynamics. Our findings not only reveal the features of market volatilities but also make a comparison between mature and emerging financial markets.	[Huang, Jiping] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Surface Phys, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Huang, JP (corresponding author), Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China.	jphuang@fudan.edu.cn			National Natural Science Foundation of China [11075035, 11222544]; Fok Ying Tung Education Foundation [131008]; Program for New Century Excellent Talents in University [NCET-12-0121]; Shanghai Rising-Star Program [12QA1400200]; Chinese National Key Basic Research Special Fund [2011CB922004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Rising-Star Program; Chinese National Key Basic Research Special Fund(National Basic Research Program of China)	This work is supported by the National Natural Science Foundation of China under Grant Nos. 11075035 and 11222544 (http://www.nsfc.gov.cn/), by the Fok Ying Tung Education Foundation under Grant No. 131008 (http://www.moe.edu.cn/), by the Program for New Century Excellent Talents in University (NCET-12-0121) (http://www.moe.edu.cn/), by the Shanghai Rising-Star Program (No. 12QA1400200) (http://www.stcsm.gov.cn/), and by the Chinese National Key Basic Research Special Fund under Grant No. 2011CB922004 (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achelis SB, 2001, TECHNICAL ANAL A Z; Black F., 1976, P BUS EC STAT SECT A, P177; Brown DP, 1989, REV FINANC STUD, V2, P527, DOI 10.1093/rfs/2.4.527; Brunnermeier MK., 2003, ASSET PRICING ASYMME; CAMPBELL JY, 1993, Q J ECON, V108, P905, DOI 10.2307/2118454; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cont R., 2007, LONG MEMORY EC, P289, DOI [10.1007/978-3-540-34625-8_10, DOI 10.1007/978-3-540-34625-8_10]; Cont R, 2001, QUANT FINANC, V1, P223, DOI [10.1080/713665670, 10.1088/1469-7688/1/2/304]; Cookson R, 2011, FINANCIAL TIMES; FAMA EF, 1965, J BUS, V38, P34, DOI 10.1086/294743; Fuentes MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008243; Johnson NF, 2011, FINANCIAL MARKET COM; Lo AW, 2000, J FINANC, V55, P1705, DOI 10.1111/0022-1082.00265; LO AW, 1991, ECONOMETRICA, V59, P1279, DOI 10.2307/2938368; Lux T, 1998, J ECON BEHAV ORGAN, V33, P143, DOI 10.1016/S0167-2681(97)00088-7; Lux T., 2000, INT J THEORETICAL AP, V3, P675, DOI DOI 10.1142/S0219024900000826; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Mantegna RN, 1999, PHYSICA A, V274, P216, DOI 10.1016/S0378-4371(99)00395-7; Mantegna RN, 1999, INTRO ECONOPHYSICS C; Mitchell ML, 2000, J BUS, V73, P287, DOI 10.1086/209645; Osler CL, 2000, FEDERAL RESERVE BANK, V6, P53; Park CH, 2007, J ECON SURV, V21, P786, DOI 10.1111/j.1467-6419.2007.00519.x; Preis T, 2011, P NATL ACAD SCI USA, V108, P7674, DOI 10.1073/pnas.1019484108; Preis T, 2010, J STAT PHYS, V138, P431, DOI 10.1007/s10955-009-9914-y; Sornette D., 2010, BRUSSELS EC REV CAHI, V53, P201; STEIN EM, 1991, REV FINANC STUD, V4, P727, DOI 10.1093/rfs/4.4.727; TAYLOR MP, 1992, J INT MONEY FINANC, V11, P304, DOI 10.1016/0261-5606(92)90048-3; Wei JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051666; Zhao L, 2011, P NATL ACAD SCI USA, V108, P15058, DOI 10.1073/pnas.1105239108; Zhou WC, 2009, PHYSICA A, V388, P891, DOI 10.1016/j.physa.2008.11.028; Zwillinger D., 2010, CRC STANDARD PROBABI	31	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82771	10.1371/journal.pone.0082771	http://dx.doi.org/10.1371/journal.pone.0082771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	278IG	24376577	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000030
J	Nogueira, LM; Sampson, JN; Chu, LW; Yu, K; Andriole, G; Church, T; Stanczyk, FZ; Koshiol, J; Hsing, AW				Nogueira, Leticia M.; Sampson, Joshua N.; Chu, Lisa W.; Yu, Kai; Andriole, Gerald; Church, Timothy; Stanczyk, Frank Z.; Koshiol, Jill; Hsing, Ann W.			Individual Variations in Serum Melatonin Levels through Time: Implications for Epidemiologic Studies	PLOS ONE			English	Article							BREAST-CANCER RISK; NIGHT-SHIFT WORK; URINARY 6-SULFATOXYMELATONIN LEVELS; LIFE-STYLE FACTORS; LIGHT-AT-NIGHT; SLEEP DURATION; CIRCADIAN DISRUPTION; PLASMA MELATONIN; PROSTATE-CANCER; MAGNETIC-FIELDS	Melatonin, a marker for the circadian rhythm with serum levels peaking between 2AM and 5AM, is hypothesized to possess anti-cancer properties, making it a mechanistic candidate for the probable carcinogenic effect of circadian rhythm disruption. In order to weigh epidemiologic evidence on the association of melatonin with cancer, we must first understand the laboratory and biological sources of variability in melatonin levels measured in samples. Participants for this methodological study were men enrolled in the Prostate Lung Colorectal and Ovarian Cancer Screening Trial (PLCO). We measured serum melatonin levels over a five year period in 97 individuals to test if melatonin levels are steady over time. The Pearson correlation coefficient between two measures separated by 1 year was 0.87, while the correlation between two measures separated by 5 years was to 0.70. In an additional cross-sectional study of 292 individuals, we used Analysis of Variance to identify differences in melatonin levels between different lifestyle and environmental characteristics. Serum melatonin levels were slightly higher in samples collected from 130 individuals during the winter, (6.36 +/- 0.59 pg/ml) than in samples collected from 119 individuals during the summer (4.83 +/- 0.62 pg/ml). Serum melatonin levels were lowest in current smokers (3.02 +/- 1.25 pg/ml, p = 0.007) compared to never (6.66 +/- 0.66 pg/ml) and former (5.59 +/- 0.50 pg/ml) smokers whereas BMI did not significantly affect serum melatonin levels in this study. In conclusion, the high 5 year correlation of melatonin levels implies that single measurements may be used to detect population level associations between melatonin and risk of cancer. Furthermore, our results reiterate the need to record season of sample collection, and individual characteristics in order to maximize study power and prevent confounding.	[Nogueira, Leticia M.; Sampson, Joshua N.; Yu, Kai; Koshiol, Jill] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Chu, Lisa W.; Hsing, Ann W.] Canc Prevent Inst Calif, Fremont, CA USA; [Andriole, Gerald] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA; [Church, Timothy] Univ Minnesota, Sch Publ Hlth, Dept Environm Hlth Sci, Minneapolis, MN USA; [Stanczyk, Frank Z.] Univ So Calif, Keck Sch Med, Dept Obstet Gynecol & Prevent Med, Los Angeles, CA 90033 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cancer Prevention Institute of California; Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities; University of Southern California	Nogueira, LM (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	leticia.nogueira@nih.gov	Church, Timothy/AAH-7017-2020; koshiol, Jill/L-8686-2014; Nogueira, Leticia/J-2547-2019	Church, Timothy/0000-0003-3292-5035; koshiol, Jill/0000-0002-3832-6204; Stanczyk, Frank/0000-0002-3607-121X	Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services	Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and contracts from the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2009, ANAL BIOCHEM, V394, P237, DOI 10.1016/j.ab.2009.07.029; Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002; ARENDT J, 1985, J CLIN ENDOCR METAB, V60, P1166, DOI 10.1210/jcem-60-6-1166; Band PR, 1996, AM J EPIDEMIOL, V143, P137; BECKFRIIS J, 1984, PSYCHONEUROENDOCRINO, V9, P261, DOI 10.1016/0306-4530(84)90005-2; Benloucif S, 2005, J BIOL RHYTHM, V20, P178, DOI 10.1177/0748730404273983; Bhatti P, 2013, OCCUP ENVIRON MED, V70, P231, DOI 10.1136/oemed-2012-101146; Bhatti P, 2012, AM J EPIDEMIOL, V176, P760, DOI 10.1093/aje/kws311; Black A, 2009, PROSTATE CANC SCREEN, P361; Bracci M, 2013, J BIOL REG HOMEOS AG, V27, P267; Brainard GC, 2001, J NEUROSCI, V21, P6405; Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31; Davis S, 2001, JNCI-J NATL CANCER I, V93, P1557, DOI 10.1093/jnci/93.20.1557; Davis S, 2001, AM J EPIDEMIOL, V154, P591, DOI 10.1093/aje/154.7.591; Erren TC, 2008, NATURWISSENSCHAFTEN, V95, P367, DOI 10.1007/s00114-007-0335-y; Erren TC, 2013, INT J CANCER, V133, P2010, DOI 10.1002/ijc.28212; Erren TC, 2013, AM J EPIDEMIOL, V177, P1020, DOI 10.1093/aje/kwt056; Erren Thomas C, 2010, Epidemiol Perspect Innov, V7, P11, DOI 10.1186/1742-5573-7-11; Erren TC, 2010, NEUROENDOCRINOL LETT, V31, P1; FERNANDEZ B, 1990, J STEROID BIOCHEM, V35, P257, DOI 10.1016/0022-4731(90)90282-W; FERRIER IN, 1982, CLIN ENDOCRINOL, V17, P181, DOI 10.1111/j.1365-2265.1982.tb01577.x; Fideleff HL, 2006, J PINEAL RES, V40, P214, DOI 10.1111/j.1600-079X.2005.00301.x; Forman JP, 2010, J HYPERTENS, V28, P446, DOI 10.1097/HJH.0b013e3283340c16; Fritschi L, 2013, BRIT J CANCER, V109, P2472, DOI 10.1038/bjc.2013.544; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Graham C, 1998, J PINEAL RES, V24, P230, DOI 10.1111/j.1600-079X.1998.tb00538.x; Grundy A, 2013, OCCUP ENV MED; Grundy A, 2013, CANCER EPIDEMIOL, V37, P606, DOI 10.1016/j.canep.2013.04.006; Hansen J, 2006, CANCER CAUSE CONTROL, V17, P531, DOI 10.1007/s10552-005-9006-5; Hansen J, 2001, JNCI-J NATL CANCER I, V93, P1513, DOI 10.1093/jnci/93.20.1513; Hansen J, 2001, EPIDEMIOLOGY, V12, P74, DOI 10.1097/00001648-200101000-00013; Hansen J, 2012, OCCUP ENVIRON MED, V69, P551, DOI 10.1136/oemed-2011-100240; Hansen J, 2012, EUR J CANCER, V48, P1722, DOI 10.1016/j.ejca.2011.07.005; Hattori A, 2013, OBESITY, V21, P856, DOI 10.1002/oby.20313; Haus EL, 2013, SLEEP MED REV, V17, P273, DOI 10.1016/j.smrv.2012.08.003; Higuchi S, 2011, J PHYSIOL ANTHROPOL, V30, P251, DOI 10.2114/jpa2.30.251; Hill SM, 2011, J MAMMARY GLAND BIOL, V16, P235, DOI 10.1007/s10911-011-9222-4; HONMA KI, 1992, AM J PHYSIOL, V262, pR885, DOI 10.1152/ajpregu.1992.262.5.R885; Hsing AW, 2010, CANCER EPIDEM BIOMAR, V19, P932, DOI 10.1158/1055-9965.EPI-10-0004; ILLNEROVA H, 1985, BRAIN RES, V328, P186, DOI 10.1016/0006-8993(85)91342-3; Jia YJ, 2013, CANCER EPIDEMIOL, V37, P197, DOI 10.1016/j.canep.2013.01.005; Kakizaki M, 2008, BRIT J CANCER, V99, P1502, DOI 10.1038/sj.bjc.6604684; Kedrosky P, 2011, WORLD POPULATION DIS; KENNAWAY DJ, 1986, ACTA ENDOCRINOL-COP, V113, P450, DOI 10.1530/acta.0.1130450; KIVELA A, 1988, ACTA PHYSIOL SCAND, V132, P321, DOI 10.1111/j.1748-1716.1988.tb08335.x; Kloog I, 2009, CHRONOBIOL INT, V26, P108, DOI 10.1080/07420520802694020; Knutsson A, 2013, SCAND J WORK ENV HEA, V39, P170, DOI 10.5271/sjweh.3323; Kubo T, 2011, INT J UROL, V18, P206, DOI 10.1111/j.1442-2042.2010.02714.x; Kubo T, 2006, AM J EPIDEMIOL, V164, P549, DOI 10.1093/aje/kwj232; Lahti TA, 2008, INT J CANCER, V123, P2148, DOI 10.1002/ijc.23566; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Leppaluoto Juhani, 2004, Int J Circumpolar Health, V63 Suppl 2, P161; Levallois P, 2001, AM J EPIDEMIOL, V154, P601, DOI 10.1093/aje/154.7.601; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; Lie JAS, 2006, CANCER CAUSE CONTROL, V17, P39, DOI 10.1007/s10552-005-3639-2; Lie JAS, 2011, AM J EPIDEMIOL, V173, P1272, DOI 10.1093/aje/kwr014; Mantele S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037123; Mahlberg R, 2006, PSYCHONEUROENDOCRINO, V31, P634, DOI 10.1016/j.psyneuen.2006.01.009; Mediavilla MD, 2010, CURR MED CHEM, V17, P4462, DOI 10.2174/092986710794183015; Megdal SP, 2005, EUR J CANCER, V41, P2023, DOI 10.1016/j.ejca.2005.05.010; Menegaux F, 2012, ARCH MAL PROF ENVIRO, V73, P547, DOI 10.1016/j.admp.2012.03.009; Mirick DK, 2008, CANCER EPIDEM BIOMAR, V17, P3306, DOI 10.1158/1055-9965.EPI-08-0605; Morera AL, 2006, J PINEAL RES, V41, P279, DOI 10.1111/j.1600-079X.2006.00365.x; O'Leary ES, 2006, AM J EPIDEMIOL, V164, P358, DOI 10.1093/aje/kwj211; Ostrowska, 1996, Endocr Regul, V30, P19; Ozguner F, 2005, TOXICOL IND HEALTH, V21, P21, DOI 10.1191/0748233705th211oa; Parent M-E, 2012, AM J EPIDEMIOLOGY; Parent ME, 2012, AM J EPIDEMIOL, V176, P751, DOI 10.1093/aje/kws318; Patel D, 2006, OCCUP MED-OXFORD, V56, P433, DOI 10.1093/occmed/kql078; Pesch B, 2010, SCAND J WORK ENV HEA, V36, P134, DOI 10.5271/sjweh.2890; Pronk A, 2010, AM J EPIDEMIOL, V171, P953, DOI 10.1093/aje/kwq029; Reiter Russel J., 2007, Critical Reviews in Oncogenesis, V13, P303; SAVITZ DA, 1994, EPIDEMIOLOGY, V5, P550; Schernhammer ES, 2006, J PINEAL RES, V40, P116, DOI 10.1111/j.1600-079X.2005.00285.x; Schernhammer ES, 2006, EPIDEMIOLOGY, V17, P108, DOI 10.1097/01.ede.0000190539.03500.c1; Schernhammer ES, 2005, J NATL CANCER I, V97, P1084, DOI 10.1093/jnci/dji190; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Schernhammer ES, 2008, JNCI-J NATL CANCER I, V100, P898, DOI 10.1093/jnci/djn171; Schernhammer ES, 2010, CANCER EPIDEM BIOMAR, V19, P729, DOI 10.1158/1055-9965.EPI-09-1229; Schernhammer ES, 2009, CANCER EPIDEM BIOMAR, V18, P74, DOI 10.1158/1055-9965.EPI-08-0637; Stevens RG, 2000, EPIDEMIOLOGY, V11, P660, DOI 10.1097/00001648-200011000-00008; Stevens RG, 2006, CANCER CAUSE CONTROL, V17, P501, DOI 10.1007/s10552-005-9001-x; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; STOKKAN KA, 1994, J PINEAL RES, V16, P33, DOI 10.1111/j.1600-079X.1994.tb00079.x; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Travis RC, 2004, JNCI-J NATL CANCER I, V96, P475, DOI 10.1093/jnci/djh077; Travis RC, 2003, CANCER EPIDEM BIOMAR, V12, P806; Tynes T, 1996, CANCER CAUSE CONTROL, V7, P197, DOI 10.1007/BF00051295; Ursing C, 2005, EUR J CLIN PHARMACOL, V61, P197, DOI 10.1007/s00228-005-0908-7; Villeneuve S, 2011, AM J IND MED, V54, P499, DOI 10.1002/ajim.20952; Viswanathan AN, 2009, CANCER LETT, V281, P1, DOI 10.1016/j.canlet.2008.11.002; Wada K, 2013, ANN EPIDEMIOL, V23, P60, DOI 10.1016/j.annepidem.2012.11.003; Wang F, 2013, ANN ONCOLOGY; WIRZJUSTICE A, 1979, PSYCHIAT RES, V1, P53, DOI 10.1016/0165-1781(79)90028-3; Wu AH, 2008, CARCINOGENESIS, V29, P1244, DOI 10.1093/carcin/bgn100; Youngstedt SD, 2002, ENVIRON RES, V89, P201, DOI 10.1006/enrs.2002.4370	98	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83208	10.1371/journal.pone.0083208	http://dx.doi.org/10.1371/journal.pone.0083208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376664	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000069
J	Pombo, M; Turra, A				Pombo, Maira; Turra, Alexander			Issues to Be Considered in Counting Burrows as a Measure of Atlantic Ghost Crab Populations, an Important Bioindicator of Sandy Beaches	PLOS ONE			English	Article							OCYPODE-QUADRATA FABRICIUS; OFF-ROAD VEHICLES; INDICATOR; CRUSTACEA; IMPACTS; BRAZIL; ECOSYSTEMS; HABITATS; THREATS; TOOL	The use of indirect estimates of ghost-crab populations to assess beach disturbance has several advantages, including non-destructiveness, ease and low cost, although this strategy may add some degree of noise to estimates of population parameters. Resolution of these shortcomings may allow wider use of these populations as an indicator of differences in quality among beaches. This study analyzed to what extent the number of crab burrows may diverge from the number of animals, considering beach morphology, burrow depth and signs of occupation as contributing factors or indicators of a higher or lower occupation rate. We estimated the occupation rate of crabs in burrows on nine low-use beaches, which were previously categorized as dissipative, intermediate or reflexive. Three random 2-m-wide transects were laid perpendicular to the shoreline, where burrows were counted and excavated to search for crabs. The depth and signs of recent activity around the burrows were also recorded. The occupation rate differed on the different beaches, but morphodynamics was not identified as a grouping factor. A considerable number of burrows that lacked signs of recent activity proved to be occupied, and the proportions of these burrows also differed among beaches. Virtually all burrows less than 10 cm deep were unoccupied; the occupation rate tended to increase gradually to a burrow depth of 20-35 cm. Other methods (water, smoke, and traps) were applied to measure the effectiveness of excavating as a method for burrow counts. Traps and excavation proved to be the best methods. These observations illustrate the possible degree of unreliability of comparisons of beaches based on indirect measures. Combining burrow depth assessment with surrounding signs of occupation proved to be a useful tool to minimize biases.	[Pombo, Maira; Turra, Alexander] Univ Sao Paulo, Dept Biol Oceanog, Oceanog Inst, Sao Paulo, Brazil	Universidade de Sao Paulo	Pombo, M (corresponding author), Univ Sao Paulo, Dept Biol Oceanog, Oceanog Inst, Sao Paulo, Brazil.	mairapombo@gmail.com	Turra, Alexander/G-1352-2012; Pombo, Maíra/J-7791-2015	Turra, Alexander/0000-0003-2225-8371; 	State of SALo Paulo Research Foundation (FAPESP); ReBentos - Network for Monitoring Benthic Coastal Habitats	State of SALo Paulo Research Foundation (FAPESP); ReBentos - Network for Monitoring Benthic Coastal Habitats	This study was supported by the State of SALo Paulo Research Foundation (FAPESP) and is part of the ReBentos - Network for Monitoring Benthic Coastal Habitats. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto R. M. F., 1999, Revista Brasileira de Biologia, V59, P95; Barros F, 2001, BIOL CONSERV, V97, P399, DOI 10.1016/S0006-3207(00)00116-6; Blankensteyn A, 2006, REV BRAS ZOOL, V23, P870, DOI 10.1590/S0101-81752006000300034; Branco JO, 2010, J SHELLFISH RES, V29, P503, DOI 10.2983/035.029.0229; Brown AC, 2002, ENVIRON CONSERV, V29, P62, DOI 10.1017/S037689290200005X; De Chirananda, 2005, Ichnos, V12, P11, DOI 10.1080/10420940590914471; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Defeo O, 2011, MAR ECOL PROG SER, V433, P29, DOI 10.3354/meps09206; Fanini L, 2005, OCEANOLOGIA; Fanini L, 2007, MAR BIOL, V152, P1169, DOI 10.1007/s00227-007-0764-3; Fisher JB, 1979, CRUSTACEANA S, V5, P31; Lucrezi S, 2010, MAR FRESHWATER RES, V61, P951, DOI 10.1071/MF09259; Lucrezi S, 2009, ENVIRON MONIT ASSESS, V152, P413, DOI 10.1007/s10661-008-0326-2; Magalhaes WF, 2009, BRAZ J OCEANOGR, V57, P149, DOI 10.1590/S1679-87592009000200008; MILNE LJ, 1946, AM NAT, V80, P362, DOI 10.1086/281450; Neves FM, 2006, BIOL CONSERV, V133, P431, DOI 10.1016/j.biocon.2006.04.041; Noriega R, 2012, J COASTAL RES, V28, P123, DOI 10.2112/JCOASTRES-D-09-00173.1; Schlacher TA, 2007, MAR ECOL-EVOL PERSP, V28, P354, DOI 10.1111/j.1439-0485.2007.00156.x; Schlacher TA, 2011, ECOL INDIC, V11, P284, DOI 10.1016/j.ecolind.2010.05.006; STEINER AJ, 1981, BIOL CONSERV, V20, P111, DOI 10.1016/0006-3207(81)90022-7; Turra A, 2005, J NAT HIST, V39, P2163, DOI 10.1080/00222930500060165; Turra A, 2013, GLOBAL CHANGE BIOL, V19, P1965, DOI 10.1111/gcb.12186; Valero-Pacheco E, 2007, CRUSTACEANA, V80, P313, DOI 10.1163/156854007780162479; Veloso VG, 2011, ECOL INDIC, V11, P782, DOI 10.1016/j.ecolind.2010.10.004; Veloso VG, 2010, BRAZ J OCEANOGR, V58, P13, DOI 10.1590/S1679-87592010000100002; WOLCOTT TG, 1978, J EXP MAR BIOL ECOL, V31, P67, DOI 10.1016/0022-0981(78)90137-5; WOLCOTT TG, 1984, BIOL CONSERV, V29, P217, DOI 10.1016/0006-3207(84)90100-9	27	26	26	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83792	10.1371/journal.pone.0083792	http://dx.doi.org/10.1371/journal.pone.0083792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376748	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000113
J	van de Weert-van Leeuwen, PB; de Vrankrijker, AMM; Fentz, J; Ciofu, O; Wojtaszewski, JFP; Arets, HGM; Hulzebos, HJ; van der Ent, CK; Beekman, JM; Johansen, HK				van de Weert-van Leeuwen, Pauline B.; de Vrankrijker, Angelica M. M.; Fentz, Joachim; Ciofu, Oana; Wojtaszewski, Jorgen F. P.; Arets, Hubertus G. M.; Hulzebos, Hendrikus J.; van der Ent, Cornelis K.; Beekman, Jeffrey M.; Johansen, Helle K.			Effect of Long-Term Voluntary Exercise Wheel Running on Susceptibility to Bacterial Pulmonary Infections in a Mouse Model	PLOS ONE			English	Article							SKELETAL-MUSCLE ADAPTATION; PSEUDOMONAS-AERUGINOSA; EXPRESSION; PROTEIN; INFLAMMATION; PGC-1-ALPHA; MECHANISMS; AGE	Regular moderate exercise has been suggested to exert anti-inflammatory effects and improve immune effector functions, resulting in reduced disease incidence and viral infection susceptibility. Whether regular exercise also affects bacterial infection susceptibility is unknown. The aim of this study was to investigate whether regular voluntary exercise wheel running prior to a pulmonary infection with bacteria (P. aeruginosa) affects lung bacteriology, sickness severity and phagocyte immune function in mice. Balb/c mice were randomly placed in a cage with or without a running wheel. After 28 days, mice were intranasally infected with P. aeruginosa. Our study showed that regular exercise resulted in a higher sickness severity score and bacterial (P. aeruginosa) loads in the lungs. The phagocytic capacity of monocytes and neutrophils from spleen and lungs was not affected. Although regular moderate exercise has many health benefits, healthy mice showed increased bacterial (P. aeruginosa) load and symptoms, after regular voluntary exercise, with perseverance of the phagocytic capacity of monocytes and neutrophils. Whether patients, suffering from bacterial infectious diseases, should be encouraged to engage in exercise and physical activities with caution requires further research.	[van de Weert-van Leeuwen, Pauline B.; de Vrankrijker, Angelica M. M.; Arets, Hubertus G. M.; van der Ent, Cornelis K.; Beekman, Jeffrey M.] Univ Med Ctr Utrecht, Dept Pediat Pulmonol, Utrecht, Netherlands; [van de Weert-van Leeuwen, Pauline B.; Beekman, Jeffrey M.] Univ Med Ctr Utrecht, Dept Translat Immunol, Utrecht, Netherlands; [van de Weert-van Leeuwen, Pauline B.; Beekman, Jeffrey M.] Univ Med Ctr Utrecht, Ctr Mol & Cellular Intervent, Utrecht, Netherlands; [Ciofu, Oana] Univ Copenhagen, Panum Inst, Dept Int Hlth Immunol & Microbiol, DK-2200 Copenhagen, Denmark; [Johansen, Helle K.] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Fentz, Joachim; Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Sect Mol Physiol, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Hulzebos, Hendrikus J.] Univ Med Ctr Utrecht, Child Dev & Exercise Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Utrecht University; Utrecht University Medical Center	van de Weert-van Leeuwen, PB (corresponding author), Univ Med Ctr Utrecht, Dept Pediat Pulmonol, Utrecht, Netherlands.	p.b.vanleeuwen-3@umcutrecht.nl	Beekman, Jeffrey M/I-7781-2014; Wojtaszewski, Jørgen FP/P-6583-2014; Ciofu, Oana/AAE-2413-2020; Fentz, Joachim/B-1973-2015	Beekman, Jeffrey M/0000-0003-4886-3756; Wojtaszewski, Jørgen FP/0000-0001-9785-6830; Fentz, Joachim/0000-0002-9334-1298; wojtaszewski, jorgen/0000-0001-8185-3408; Ciofu, Oana/0000-0001-5648-4858; Van der Ent, Cornelis/0000-0002-2501-4121	Dutch Cystic Fibrosis Foundation (NCFS)	Dutch Cystic Fibrosis Foundation (NCFS)	This work was supported by the Dutch Cystic Fibrosis Foundation (NCFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Allewelt M, 2000, INFECT IMMUN, V68, P3998, DOI 10.1128/IAI.68.7.3998-4004.2000; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; Davis JM, 1997, J APPL PHYSIOL, V83, P1461, DOI 10.1152/jappl.1997.83.5.1461; de Vrankrijker AMM, 2009, J MED VIROL, V81, P2096, DOI 10.1002/jmv.21623; Flynn MG, 2003, J APPL PHYSIOL, V95, P1833, DOI 10.1152/japplphysiol.00359.2003; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; HACK V, 1994, J APPL PHYSIOL, V77, P1731, DOI 10.1152/jappl.1994.77.4.1731; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005; Ikeda S, 2006, ACTA PHYSIOL, V188, P217, DOI 10.1111/j.1748-1716.2006.01623.x; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Kohut ML, 2009, J INFECT DIS, V200, P1434, DOI 10.1086/606014; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Lowder T, 2010, BRAIN BEHAV IMMUN, V24, P153, DOI 10.1016/j.bbi.2009.09.011; Mathur N, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/109502; McFarlin BK, 2004, MED SCI SPORT EXER, V36, P1876, DOI 10.1249/01.MSS.0000145465.71269.10; McFarlin BK, 2006, J GERONTOL A-BIOL, V61, P388, DOI 10.1093/gerona/61.4.388; Mehl KA, 2005, J APPL PHYSIOL, V98, P2219, DOI 10.1152/japplphysiol.00975.2004; MORRISON AJ, 1984, REV INFECT DIS, V6, pS627; Murphy EA, 2004, AM J PHYSIOL-REG I, V287, pR1354, DOI 10.1152/ajpregu.00274.2004; Nibbering P. H., 1996, Frontiers in Bioscience (online), V1, pA25; Nieman DC, 2011, BRIT J SPORT MED, V45, P987, DOI 10.1136/bjsm.2010.077875; Noble EG, 1999, J APPL PHYSIOL, V86, P1696, DOI 10.1152/jappl.1999.86.5.1696; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Pedersen BK, 2003, SCAND J MED SCI SPOR, V13, P56, DOI 10.1034/j.1600-0838.2003.20218.x; Perkhofer S, 2007, MYCOPATHOLOGIA, V163, P303, DOI 10.1007/s11046-007-9013-z; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Stewart LK, 2005, BRAIN BEHAV IMMUN, V19, P389, DOI 10.1016/j.bbi.2005.04.003; Syu GD, 2012, MED SCI SPORT EXER, V44, P1021, DOI 10.1249/MSS.0b013e3182408639; Thomas LA, 2005, BRAIN BEHAV IMMUN, V19, P377, DOI 10.1016/j.bbi.2005.04.002; Timmerman KL, 2008, J LEUKOCYTE BIOL, V84, P1271, DOI 10.1189/jlb.0408244; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64	37	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82869	10.1371/journal.pone.0082869	http://dx.doi.org/10.1371/journal.pone.0082869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376599	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000035
J	Abdulsalam, AM; Ithoi, I; Al-Mekhlafi, HM; Al-Mekhlafi, AM; Ahmed, A; Surin, J				Abdulsalam, Awatif M.; Ithoi, Init; Al-Mekhlafi, Hesham M.; Al-Mekhlafi, Abdulsalam M.; Ahmed, Abdulhamid; Surin, Johari			Subtype Distribution of Blastocystis Isolates in Sebha, Libya	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; MOLECULAR CHARACTERIZATION; CLINICAL-SIGNIFICANCE; GENETIC DIVERSITY; PHYLOGENETIC ANALYSIS; DRINKING-WATER; ZOO ANIMALS; HOMINIS; IDENTIFICATION; INFECTION	Background: Blastocystis is a genetically diverse and a common intestinal parasite of humans with a controversial pathogenic potential. This study was carried out to identify the Biastocystis subtypes and their association with demographic and socioeconomic factors among outpatients living in Sebha city, Libya. Methods/Findings: Blastocystis in stool samples were cultured followed by isolation, PCR amplification of a partial SSU rDNA gene, cloning, and sequencing. The DNA sequences of isolated clones showed 98.3% to 100% identity with the reference Blastocystis isolates from the Genbank. Multiple sequence alignment showed polymorphism from one to seven base substitution and/or insertion/deletion in several groups of non-identical nucleotides clones. Phylogenetic analysis revealed three assemblage subtypes (ST) with ST1 as the most prevalent (51.1%) followed by ST2 (24.4%), ST3 (17.8%) and mixed infections of two concurrent subtypes (6.7%). Blastocystis: ST1 infection was significantly associated with female (P = 0.009) and low educational level (P = 0.034). ST2 was also significantly associated with low educational level (P= 0.008) and ST3 with diarrhoea (P = 0.008). Conclusion: Phylogenetic analysis of Libyan Blastocystis isolates identified three different subtypes; with ST1 being the predominant subtype and its infection was significantly associated with female gender and low educational level. More extensive studies are needed in order to relate each Blastocystis subtype with clinical symptoms and potential transmission sources in this community.	[Abdulsalam, Awatif M.; Ithoi, Init; Al-Mekhlafi, Hesham M.; Surin, Johari] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Abdulsalam, Awatif M.] Univ Sebha, Fac Engn & Technol, Dept Med Lab Sci, Sebha, Libya; [Al-Mekhlafi, Hesham M.; Al-Mekhlafi, Abdulsalam M.] Sanaa Univ, Fac Med & Hlth Sci, Dept Parasitol, Sanaa, Yemen; [Ahmed, Abdulhamid] Umaru Musa Yaradua Univ, Fac Nat & Appl Sci, Dept Biol, Katsina, Nigeria	Universiti Malaya; Sebha University	Abdulsalam, AM (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	fafo_1979@yahoo.com; init@um.edu.my	Abdulsalam, Awatif/ABH-9843-2020; Al-Mekhlafi, Hesham Mahyoub Sarhan/R-3568-2016; Ithoi, Init/B-8660-2010; Ahmed, Abdulhamid/I-2144-2018	Al-Mekhlafi, Hesham Mahyoub Sarhan/0000-0003-2582-7410; Ithoi, Init/0000-0001-8698-4546; Ahmed, Abdulhamid/0000-0002-0153-8334	University of Malaya [PV074/2011B]; UM High Impact Research Grant from the Ministry of Higher Education, Malaysia [UM-MOHE UM.C/625/1/HIR/MOHE/MED/18]	University of Malaya(Universiti Malaya); UM High Impact Research Grant from the Ministry of Higher Education, Malaysia	This study was supported by the University of Malaya Postgraduate Research Grant (No PV074/2011B) and UM High Impact Research Grant UM-MOHE UM.C/625/1/HIR/MOHE/MED/18 from the Ministry of Higher Education, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulsalam AM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-86; Abdulsalam AM, 2012, PARASITOLOGY, V139, P1014, DOI 10.1017/S0031182012000340; Abe N, 2004, VET PARASITOL, V120, P235, DOI 10.1016/j.vetpar.2004.01.003; Abe N, 2003, VET PARASITOL, V113, P321, DOI 10.1016/S0304-4017(03)00081-5; Aksoy U, 2007, TURKISH J PEDIATR, V49, P278; Al-Fellani Mohammed A, 2007, Sultan Qaboos Univ Med J, V7, P35; Alfellani MA, 2013, PROTIST, V164, P497, DOI 10.1016/j.protis.2013.05.003; Alfellani MA, 2013, PARASITOLOGY, V140, P966, DOI 10.1017/S0031182013000255; Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; Alsirieti SRA, 2006, JAMAHIRIYA MED J, V6, P59; Arisue N, 2003, PARASITOLOGY, V126, P1, DOI 10.1017/S0031182002002640; BohmGloning B, 1997, TROP MED INT HEALTH, V2, P771, DOI 10.1046/j.1365-3156.1997.d01-383.x; Boorom KF, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-40; Dogruman-Al F, 2008, PARASITOL RES, V103, P685, DOI 10.1007/s00436-008-1031-3; Dogruman-Al F, 2009, PARASITOL RES, V106, P263, DOI 10.1007/s00436-009-1658-8; El Safadi D, 2013, AM J TROP MED HYG, V88, P1203, DOI 10.4269/ajtmh.12-0777; Jimenez-Gonzalez DE, 2012, PARASITOL RES, V110, P1269, DOI 10.1007/s00436-011-2626-7; Eroglu F, 2009, PARASITOL RES, V105, P1589, DOI 10.1007/s00436-009-1595-6; Fayer R, 2012, PARASITOL RES, V111, P1349, DOI 10.1007/s00436-012-2971-1; Forsell J, 2012, EUR J CLIN MICROBIOL, V31, P1689, DOI 10.1007/s10096-011-1416-6; Fouad Shawky A, 2011, Arab J Gastroenterol, V12, P194, DOI 10.1016/j.ajg.2011.11.005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hussein EM, 2008, PARASITOL RES, V102, P853, DOI 10.1007/s00436-007-0833-z; Jantermtor S, 2013, PARASITOL RES, V112, P1781, DOI 10.1007/s00436-012-3218-x; Jones MS, 2009, PARASITOL RES, V104, P341, DOI 10.1007/s00436-008-1198-7; Kasssem Hamed H., 2007, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V37, P371; Kaya Selcuk, 2007, Turkiye Parazitoloji Dergisi, V31, P184; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lee LI, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-130; Leelayoova S, 2002, ANN TROP MED PARASIT, V96, P803, DOI 10.1179/000349802125002275; Leelayoova S, 2008, AM J TROP MED HYG, V79, P401, DOI 10.4269/ajtmh.2008.79.401; Li LH, 2007, PARASITOL RES, V102, P83, DOI 10.1007/s00436-007-0727-0; Li LH, 2007, PARASITOL INT, V56, P281, DOI 10.1016/j.parint.2007.06.001; Malheiros AF, 2011, AM J TROP MED HYG, V85, P1050, DOI 10.4269/ajtmh.2011.11-0481; Meloni D, 2011, PARASITOL RES, V109, P613, DOI 10.1007/s00436-011-2294-7; Motazedian H, 2008, ANN TROP MED PARASIT, V102, P85, DOI 10.1179/136485908X252197; Noel C, 2005, J CLIN MICROBIOL, V43, P348, DOI 10.1128/JCM.43.1.348-355.2005; Noel C, 2003, MOL BIOCHEM PARASIT, V126, P119, DOI 10.1016/S0166-6851(02)00246-3; Ozyurt M, 2008, PARASITOL INT, V57, P300, DOI 10.1016/j.parint.2008.01.004; Parkar U, 2007, PARASITOLOGY, V134, P359, DOI 10.1017/S0031182006001582; Parkar U, 2010, VET PARASITOL, V169, P8, DOI 10.1016/j.vetpar.2009.12.032; Petrasova J, 2011, INT J PARASITOL, V41, P1113, DOI 10.1016/j.ijpara.2011.06.010; Poirier P, 2011, J CLIN MICROBIOL, V49, P975, DOI 10.1128/JCM.01392-10; QADRI SMH, 1989, J CLIN MICROBIOL, V27, P2407, DOI 10.1128/JCM.27.11.2407-2409.1989; Rene BA, 2009, AM J TROP MED HYG, V80, P588, DOI 10.4269/ajtmh.2009.80.588; Rivera WL, 2008, VET PARASITOL, V156, P178, DOI 10.1016/j.vetpar.2008.06.001; Roberts T, 2013, EUR J CLIN MICROBIOL, V32, P335, DOI 10.1007/s10096-012-1746-z; Roberts T, 2013, VET PARASITOL, V196, P85, DOI 10.1016/j.vetpar.2013.01.011; Sadaga Gazala A., 2007, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V37, P205; Santin M, 2011, PARASITOL RES, V109, P205, DOI 10.1007/s00436-010-2244-9; Scanlan PD, 2012, TRENDS PARASITOL, V28, P327, DOI 10.1016/j.pt.2012.05.001; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Scicluna SM, 2006, PROTIST, V157, P77, DOI 10.1016/j.protis.2005.12.001; Silberman JD, 1996, NATURE, V380, P398, DOI 10.1038/380398a0; Sohail Muhammad R, 2005, Travel Med Infect Dis, V3, P33, DOI 10.1016/j.tmaid.2004.06.001; Souppart L, 2010, PARASITOL RES, V106, P505, DOI 10.1007/s00436-009-1693-5; Souppart L, 2009, PARASITOL RES, V105, P413, DOI 10.1007/s00436-009-1398-9; Stensvold CR, 2009, EPIDEMIOL INFECT, V137, P1655, DOI 10.1017/S0950268809002672; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; Stensvold CR, 2012, INFECT GENET EVOL, V12, P263, DOI 10.1016/j.meegid.2011.11.002; Stensvold CR, 2009, INT J PARASITOL, V39, P473, DOI 10.1016/j.ijpara.2008.07.006; Stensvold CR, 2009, TRENDS PARASITOL, V25, P23, DOI 10.1016/j.pt.2008.09.010; Stensvold R, 2006, J PARASITOL, V92, P1081, DOI 10.1645/GE-840R.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tan Kevin S W, 2010, Curr Infect Dis Rep, V12, P28, DOI 10.1007/s11908-009-0073-8; Tan TC, 2008, PARASITOL RES, V104, P85, DOI 10.1007/s00436-008-1163-5; Tan TC, 2006, PARASITOL RES, V99, P737, DOI 10.1007/s00436-006-0214-z; Tan TC, 2009, PARASITOL RES, V105, P1283, DOI 10.1007/s00436-009-1551-5; Thathaisong U, 2003, J CLIN MICROBIOL, V41, P967, DOI 10.1128/JCM.41.3.967-975.2003; Vassalos CM, 2010, AM J CLIN PATHOL, V133, P251, DOI 10.1309/AJCPDOWQSL6E8DMN; Dominguez-Marquez MV, 2009, PARASITOL RES, V105, P949, DOI 10.1007/s00436-009-1485-y; Vogelberg C, 2010, PARASITOL INT, V59, P469, DOI 10.1016/j.parint.2010.03.009; Whipps CM, 2010, PARASITOL RES, V106, P827, DOI 10.1007/s00436-010-1739-8; Wong KHS, 2008, PARASITOL RES, V102, P663, DOI 10.1007/s00436-007-0808-0; Yakoob J, 2004, AM J TROP MED HYG, V70, P383, DOI 10.4269/ajtmh.2004.70.383; Yakoob J, 2010, PARASITOL RES, V106, P1033, DOI 10.1007/s00436-010-1761-x; Yan Y, 2007, PARASITOL RES, V101, P1527, DOI 10.1007/s00436-007-0672-y; Yan YM, 2006, PARASITOL RES, V99, P597, DOI 10.1007/s00436-006-0186-z; Yoshikawa H, 2004, PARASITOL RES, V94, P391, DOI 10.1007/s00436-004-1230-5; Yoshikawa H, 2004, MICROBIOL-SGM, V150, P1147, DOI 10.1099/mic.0.26899-0; Yoshikawa H, 2004, PARASITOL RES, V92, P22, DOI 10.1007/s00436-003-0995-2; Yoshikawa H, 2000, J CLIN MICROBIOL, V38, P1324, DOI 10.1128/JCM.38.4.1324-1330.2000; Yoshikawa H, 2009, VET PARASITOL, V160, P295, DOI 10.1016/j.vetpar.2008.11.029; Zaman V., 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P792; Zhang X, 2012, INT J INFECT DIS, V16, pE23, DOI 10.1016/j.ijid.2011.09.012	86	35	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84372	10.1371/journal.pone.0084372	http://dx.doi.org/10.1371/journal.pone.0084372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376805	Green Published, gold			2022-12-27	WOS:000328745100166
J	Bogsted, M; Bilgrau, AE; Wardell, CP; Bertsch, U; Schmitz, A; Bodker, JS; Kjeldsen, MK; Goldschmidt, H; Morgan, GJ; Dybkaer, K; Johnsen, HE				Bogsted, Martin; Bilgrau, Anders E.; Wardell, Christopher P.; Bertsch, Uta; Schmitz, Alexander; Bodker, Julie S.; Kjeldsen, Malene K.; Goldschmidt, Hartmut; Morgan, Gareth J.; Dybkaer, Karen; Johnsen, Hans E.			Proof of the Concept to Use a Malignant B Cell Line Drug Screen Strategy for Identification and Weight of Melphalan Resistance Genes in Multiple Myeloma	PLOS ONE			English	Article							INTERNATIONAL STAGING SYSTEM; MOLECULAR CLASSIFICATION; CHONDROITIN SULFATE; HEPARAN-SULFATE; EXPRESSION; SURVIVAL; THERAPY; CHEMOSENSITIVITY; DEXAMETHASONE; ABNORMALITIES	In a conceptual study of drug resistance we have used a preclinical model of malignant B-cell lines by combining drug induced growth inhibition and gene expression profiling. In the current report a melphalan resistance profile of 19 genes were weighted by microarray data from the MRC Myeloma IX trial and time to progression following high dose melphalan, to generate an individual melphalan resistance index. The resistance index was subsequently validated in the HOVON65/GMMG-HD4 trial data set to prove the concept. Biologically, the assigned resistance indices were differentially distributed among translocations and cyclin D expression classes. Clinically, the 25% most melphalan resistant, the intermediate 50% and the 25% most sensitive patients had a median progression free survival of 18, 32 and 28 months, respectively (log-rank P-value = 0.05). Furthermore, the median overall survival was 45 months for the resistant group and not reached for the intermediate and sensitive groups (log-rank P-value = 0.003) following 38 months median observation. In a multivariate analysis, correcting for age, sex and ISS-staging, we found a high resistance index to be an independent variable associated with inferior progression free survival and overall survival. This study provides clinical proof of concept to use in vitro drug screen for identification of melphalan resistance gene signatures for future functional analysis.	[Bogsted, Martin; Bilgrau, Anders E.; Schmitz, Alexander; Bodker, Julie S.; Kjeldsen, Malene K.; Dybkaer, Karen; Johnsen, Hans E.] Aalborg Univ Hosp, Aalborg Hosp Sci & Innovat Ctr AHSIC, Dept Haematol, Aalborg, Denmark; [Wardell, Christopher P.; Morgan, Gareth J.] Inst Canc Res, Div Mol Pathol, Haematooncol Res Unit, London SW3 6JB, England; [Bertsch, Uta; Goldschmidt, Hartmut] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany; [Bertsch, Uta; Goldschmidt, Hartmut] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany; [Bogsted, Martin; Bilgrau, Anders E.] Aalborg Univ, Dept Math Sci, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Aalborg University	Johnsen, HE (corresponding author), Aalborg Univ Hosp, Aalborg Hosp Sci & Innovat Ctr AHSIC, Dept Haematol, Aalborg, Denmark.	haej@rn.dk	Wardell, Christopher/B-5053-2018; Goldschmidt, Hartmut/AAL-8069-2021	Wardell, Christopher/0000-0002-9416-7818; Bogsted, Martin/0000-0001-9192-1814; morgan, gareth/0000-0002-4271-6360; Dybkaer, Karen/0000-0003-2488-435X; Johnsen, Hans Erik/0000-0001-8253-2913	European Myeloma Network; EU 6th FP through MSCNET [LSHC-CT-2006-037602]; Danish Cancer Society [DP04017, DP07125]; Danish Research Agency [2101-07-0007, 2106-07-0021]; KE Jensen Foundation	European Myeloma Network; EU 6th FP through MSCNET; Danish Cancer Society(Danish Cancer Society); Danish Research Agency; KE Jensen Foundation	This collaborative programme on Drug Resistance in B-Cell Malignancies has been supported by research fundings of salaries and consumabels from: 1) the European Myeloma Network; http://www.myeloma-europe.org/- an independent research organization supporting research in Europe; 2) the EU 6th FP through MSCNET (HEJ coordinator, grant number #LSHC-CT-2006-037602; http://cordis.europa.eu/); 3) the Danish Cancer Society (HEJ grant numbers #DP04017, #DP07125; http://cancer.dk/), 4) the Danish Research Agency (HEJ coordinator grant numbers #2101-07-0007, #2106-07-0021; http://fivu.dk/) and the KE Jensen Foundation (HEJ 2006-2008; http://www.avjf.dk/). The funders had no role in study design, managment, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli L, 2011, CLIN CANCER RES, V17, P7402, DOI 10.1158/1078-0432.CCR-11-0596; Barlogie B, 2011, BLOOD, V118, P483, DOI 10.1182/blood-2011-05-350322; Beckman RA, 2012, P NATL ACAD SCI USA, V109, P14586, DOI 10.1073/pnas.1203559109; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; Blair BG, 2009, CLIN CANCER RES, V15, P4312, DOI 10.1158/1078-0432.CCR-09-0311; Boegsted M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019322; Boyd KD, 2012, LEUKEMIA, V26, P349, DOI 10.1038/leu.2011.204; Bret C, 2009, BRIT J HAEMATOL, V145, P350, DOI 10.1111/j.1365-2141.2009.07633.x; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Burington B, 2008, CLIN CANCER RES, V14, P4821, DOI 10.1158/1078-0432.CCR-07-4568; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Decaux O, 2008, J CLIN ONCOL, V26, P4798, DOI 10.1200/JCO.2007.13.8545; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Dutta-Simmons J, 2009, BLOOD, V114, P2699, DOI 10.1182/blood-2008-12-194290; Ferriss JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030550; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Greipp PR, 2005, J CLIN ONCOL, V23, P6281, DOI 10.1200/JCO.2005.07.904; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Haessler J, 2007, CLIN CANCER RES, V13, P7073, DOI 10.1158/1078-0432.CCR-07-0527; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hoering A, 2009, BLOOD, V114, P1299, DOI 10.1182/blood-2009-03-211953; Jacobus SJ, 2011, BRIT J HAEMATOL, V155, P340, DOI 10.1111/j.1365-2141.2011.08849.x; Kuiper R, 2012, LEUKEMIA, V26, P2406, DOI 10.1038/leu.2012.127; Kummar S, 2007, NAT REV CANCER, V7, P131, DOI 10.1038/nrc2066; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Mohty B, 2012, LEUKEMIA, V26, P73, DOI 10.1038/leu.2011.310; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Morgan GJ, 2012, HAEMATOL-HEMATOL J, V97, P442, DOI 10.3324/haematol.2011.043372; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Murgo AJ, 2008, CLIN CANCER RES, V14, P3675, DOI 10.1158/1078-0432.CCR-07-4560; Neben K, 2010, HAEMATOL-HEMATOL J, V95, P1150, DOI 10.3324/haematol.2009.016436; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Palumbo A, 2011, BLOOD, V118, P4519, DOI 10.1182/blood-2011-06-358812; R Development Core Team, 2010, R LANG ENV STAT COMP; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Samson D, 1998, BRIT J HAEMATOL, V102, P1115; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Shaughnessy JD, 2011, BLOOD, V118, P3512, DOI 10.1182/blood-2010-12-328252; Shen CL, 2005, J BIOL CHEM, V280, P35967, DOI 10.1074/jbc.M505220200; Smith SC, 2010, CANCER RES, V70, P1753, DOI 10.1158/0008-5472.CAN-09-3562; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Storm HH, 2010, ACTA ONCOL, V49, P694, DOI 10.3109/02841861003631495; Subramanian J, 2010, NAT REV CLIN ONCOL, V7, P327, DOI 10.1038/nrclinonc.2010.60; Tan YM, 2008, CANCER LETT, V271, P1, DOI 10.1016/j.canlet.2008.04.036; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; U.S. Food and Drug Administration, 2006, GUID IND INV REV EXP; van de Donk NWCJ, 2011, CANCER TREAT REV, V37, P266, DOI 10.1016/j.ctrv.2010.08.008; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Waheed S, 2011, CANCER-AM CANCER SOC, V117, P1001, DOI 10.1002/cncr.25535; Wu KL, 2007, BRIT J HAEMATOL, V136, P615, DOI 10.1111/j.1365-2141.2006.06481.x; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhou Y, 2009, LEUKEMIA, V23, P1941, DOI 10.1038/leu.2009.160	57	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83252	10.1371/journal.pone.0083252	http://dx.doi.org/10.1371/journal.pone.0083252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376673	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100102
J	Buapet, P; Rasmusson, LM; Gullstrom, M; Bjork, M				Buapet, Pimchanok; Rasmusson, Lina M.; Gullstrom, Martin; Bjork, Mats			Photorespiration and Carbon Limitation Determine Productivity in Temperate Seagrasses	PLOS ONE			English	Article							INORGANIC CARBON; CO2 ENRICHMENT; ZOSTERA-MARINA; PHOTOSYNTHETIC UTILIZATION; ULVA; MACROALGAE; PH; LIGHT; IMPACTS; OXYGEN	The gross primary productivity of two seagrasses, Zostera marina and Ruppia maritima, and one green macroalga, Ulva intestinalis, was assessed in laboratory and field experiments to determine whether the photorespiratory pathway operates at a substantial level in these macrophytes and to what extent it is enhanced by naturally occurring shifts in dissolved inorganic carbon (DIC) and O-2 in dense vegetation. To achieve these conditions in laboratory experiments, seawater was incubated with U. intestinalis in light to obtain a range of higher pH and O-2 levels and lower DIC levels. Gross photosynthetic O-2 evolution was then measured in this pretreated seawater (pH, 7.8-9.8; high to low DIC:O-2 ratio) at both natural and low O-2 concentrations (adjusted by N-2 bubbling). The presence of photorespiration was indicated by a lower gross O-2 evolution rate under natural O-2 conditions than when O-2 was reduced. In all three macrophytes, gross photosynthetic rates were negatively affected by higher pH and lower DC. However, while both seagrasses exhibited significant photorespiratory activity at increasing pH values, the macroalga U. intestinalis exhibited no such activity. Rates of seagrass photosynthesis were then assessed in seawater collected from the natural habitats (i.e., shallow bays characterized by high macrophyte cover and by low DC and high pH during daytime) and compared with open baymouth water conditions (where seawater DIC is in equilibrium with air, normal DIC, and pH). The gross photosynthetic rates of both seagrasses were significantly higher when incubated in the baymouth water, indicating that these grasses can be significantly carbon limited in shallow bays. Photorespiration was also detected in both seagrasses under shallow bay water conditions. Our findings indicate that natural carbon limitations caused by high community photosynthesis can enhance photorespiration and cause a significant decline in seagrass primary production in shallow waters.	[Buapet, Pimchanok; Rasmusson, Lina M.; Gullstrom, Martin; Bjork, Mats] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Buapet, Pimchanok] Prince Songkla Univ, Dept Biol, Hat Yai, Thailand	Stockholm University; Prince of Songkla University	Buapet, P (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	pimchanok.buapet@su.se	Björk, Mats/B-4299-2010; Rasmusson, Lina/E-6295-2019; Rasmusson, Lina/B-9367-2015	Björk, Mats/0000-0003-0363-110X; Rasmusson, Lina/0000-0003-4297-0956				Abel KM, 1989, BIOL SEAGRASSES, P760; ANDERSON DH, 1946, IND ENG CHEM, V18, P767, DOI 10.1021/i560160a011; [Anonymous], 2010, PLANT PHYSL 5 EDITIO; Beer S, 2006, AQUAT BOT, V84, P367, DOI 10.1016/j.aquabot.2005.11.007; Beer S, 1996, MAR ECOL PROG SER, V141, P199, DOI 10.3354/meps141199; Beer S, 2002, FUNCT PLANT BIOL, V29, P349, DOI 10.1071/PP01185; Beer S, 1997, AQUAT BOT, V56, P277, DOI 10.1016/S0304-3770(96)01109-6; BEER S, 1989, AQUAT BOT, V34, P153, DOI 10.1016/0304-3770(89)90054-5; Beer S, 2000, EUR J PHYCOL, V35, P69, DOI 10.1017/S0967026299002553; Bjork M, 2004, MAR ECOL PROG SER, V284, P109, DOI 10.3354/meps284109; Bjork M, 1997, MAR BIOL, V129, P363, DOI 10.1007/s002270050176; BJORK M, 1993, J PHYCOL, V29, P166, DOI 10.1111/j.0022-3646.1993.00166.x; BLACK C C JR, 1976, Australian Journal of Plant Physiology, V3, P81; Buapet P, 2013, MAR FRESHWATER RES, V64, P1040, DOI 10.1071/MF12124; Campbell JE, 2013, MAR BIOL, V160, P1465, DOI 10.1007/s00227-013-2199-3; Carr H, 2003, J PHYCOL, V39, P1125, DOI 10.1111/j.0022-3646.2003.02-077.x; CHOLLET R, 1975, BOT REV, V41, P137, DOI 10.1007/BF02860828; DOWNES RW, 1968, PLANTA, V78, P79, DOI 10.1007/BF00384860; DOWNTON W J S, 1976, Australian Journal of Plant Physiology, V3, P73; DRECHSLER Z, 1993, PLANTA, V191, P34; DRECHSLER Z, 1991, PLANT PHYSIOL, V97, P1439, DOI 10.1104/pp.97.4.1439; DROMGOOLE FI, 1978, AQUAT BOT, V4, P281, DOI 10.1016/0304-3770(78)90025-6; DURAKO MJ, 1993, MAR BIOL, V115, P373, DOI 10.1007/BF00349834; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; FROSTCHRISTENSEN H, 1992, OECOLOGIA, V91, P377, DOI 10.1007/BF00317627; Gullstrom M, 2012, MAR BIOL, V159, P413, DOI 10.1007/s00227-011-1819-z; Hellblom F, 2001, AQUAT BOT, V69, P55, DOI 10.1016/S0304-3770(00)00132-7; HOLBROOK GP, 1988, CAN J BOT, V66, P577, DOI 10.1139/b88-083; HOUGH R A, 1976, Australian Journal of Plant Physiology, V3, P63; Invers O, 1997, AQUAT BOT, V59, P185, DOI 10.1016/S0304-3770(97)00072-7; Invers O, 2001, J EXP MAR BIOL ECOL, V265, P203, DOI 10.1016/S0022-0981(01)00332-X; Kozaki A, 1996, NATURE, V384, P557, DOI 10.1038/384557a0; Larsson C, 1997, EUR J PHYCOL, V32, P49; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; Menendez M, 2001, J EXP MAR BIOL ECOL, V256, P123, DOI 10.1016/S0022-0981(00)00313-0; Mercado JM, 1998, J EXP MAR BIOL ECOL, V221, P209, DOI 10.1016/S0022-0981(97)00127-5; Middelboe AL, 2007, MAR ECOL PROG SER, V338, P107, DOI 10.3354/meps338107; Mvungi EF, 2012, AQUAT BOT, V102, P44, DOI 10.1016/j.aquabot.2012.04.007; OSMOND CB, 1995, J EXP BOT, V46, P1351, DOI 10.1093/jxb/46.special_issue.1351; Palacios SL, 2007, MAR ECOL PROG SER, V344, P1, DOI 10.3354/meps07084; Pelletier G, 1997, CO2 SYS XLS VERSION; REISKIND JB, 1989, AQUAT BOT, V34, P131, DOI 10.1016/0304-3770(89)90053-3; REISKIND JB, 1988, PLANT PHYSIOL, V87, P686, DOI 10.1104/pp.87.3.686; Riley JP, 1965, CHEM OCEANOGRAPHY, V1; Semesi IS, 2009, MAR ECOL PROG SER, V382, P41, DOI 10.3354/meps07973; SMITH FA, 1980, NEW PHYTOL, V86, P245, DOI 10.1111/j.1469-8137.1980.tb00785.x; Smith S.V., 1978, Monographs on Oceanographic Methodology, P469; Uku J, 2005, MAR BIOL, V147, P1085, DOI 10.1007/s00227-005-0019-0; VAN TK, 1976, PLANT PHYSIOL, V58, P761, DOI 10.1104/pp.58.6.761; Voss I, 2013, PLANT BIOLOGY, V15, P713, DOI 10.1111/j.1438-8677.2012.00710.x; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; Wingler A, 2000, PHILOS T R SOC B, V355, P1517, DOI 10.1098/rstb.2000.0712; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; ZIMMERMAN RC, 1989, J EXP MAR BIOL ECOL, V130, P93, DOI 10.1016/0022-0981(89)90197-4; Zimmerman RC, 1997, PLANT PHYSIOL, V115, P599, DOI 10.1104/pp.115.2.599	55	49	51	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83804	10.1371/journal.pone.0083804	http://dx.doi.org/10.1371/journal.pone.0083804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376754	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100145
J	Feng, L; Wu, H; E, LL; Wang, DS; Feng, FK; Dong, YW; Liu, HC; Wang, LL				Feng, Lin; Wu, Hao; E, Lingling; Wang, Dongsheng; Feng, Fukui; Dong, Yuwan; Liu, Hongchen; Wang, Lili			Effects of Vascular Endothelial Growth Factor 165 on Bone Tissue Engineering	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2; IN-VITRO; VEGF; GENE; EXPRESSION; ANGIOGENESIS; REGENERATION; OSTEOGENESIS; MECHANISMS	To study the relationship between vascular endothelial growth factor (VEGF) and formation and repair of engineering bone, second-generation bone marrow stromal cells (BMSCs) of New Zealand white rabbits that were separated in vitro were transfected with VEGF 165 gene vectors by adenovirus to detect gene expressions. Transfected BMSCs and beta-tricalcium phosphate material were complexed and implanted at the femoral injury sites of the study group (n = 12), and the control group (n = 12) were implanted with engineering bones that were not transfected with VEGF. Femoral recoveries of the two groups were observed on the 15th, 30th, 45th and 60th days, and their vascularization and ossification statuses were observed by immunohistochemical methods. The BMSCs transfected with VEGF highly expressed VEGF genes and excreted VEGF. The two groups both experienced increased vascularization and bone volume after implantation (t = 7.92, P<0.05), and the increases of the study group were significantly higher than those of the control group (t = 6.92, P<0.05). VEGF is clinically applicable because it can accelerate the formation and repair of engineering bone by promoting vascularization and ossification.	[Feng, Lin; Wu, Hao; E, Lingling; Wang, Dongsheng; Feng, Fukui; Dong, Yuwan; Liu, Hongchen] Chinese Peoples Liberat Army Gen Hosp, Oral Med Res Ctr, Beijing, Peoples R China; [Wang, Lili] Affiliated Stomatol Hosp LMU, Dept Prosthodont, Jinzhou, Peoples R China	Chinese People's Liberation Army General Hospital	Feng, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Oral Med Res Ctr, Beijing, Peoples R China.	fenglinomrc@163.com	wang, lili/HDL-7210-2022					Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Chung E, 2012, TISSUE ENG PT A, V18, P397, DOI [10.1089/ten.tea.2010.0414, 10.1089/ten.TEA.2010.0414]; DiMuzio P, 2007, J VASC SURG, V45, p99A, DOI 10.1016/j.jvs.2007.02.046; Ferrer FA, 1997, J UROLOGY, V157, P2329, DOI 10.1016/S0022-5347(01)64775-X; Garcia P, 2012, J BONE JOINT SURG AM, V94A, P49, DOI 10.2106/JBJS.J.00795; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; HaraIrie F, 1996, BONE, V18, P29, DOI 10.1016/8756-3282(95)00425-4; Jabbari E, 2013, CURR PHARM DESIGN, V19, P3391, DOI 10.2174/1381612811319190006; Jiang J, 2011, INT J MOL SCI, V12, P1744, DOI 10.3390/ijms12031744; L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930; Larsen M, 2010, J ORTHOP RES, V28, P1015, DOI 10.1002/jor.21098; Li R, 2009, J ORTHOP RES, V27, P8, DOI 10.1002/jor.20658; Luo T, 2012, CLIN ORAL IMPLAN RES, V23, P467, DOI 10.1111/j.1600-0501.2011.02164.x; Markel TA, 2008, AM J PHYSIOL-HEART C, V295, pH2308, DOI 10.1152/ajpheart.00565.2008; Otfinowski Janusz, 1993, Patologia Polska, V44, P133; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042; Roldan JC, 2010, J CRANIO MAXILL SURG, V38, P423, DOI 10.1016/j.jcms.2010.01.003; Sakai A, 1996, BONE, V18, P479, DOI 10.1016/8756-3282(96)00042-7; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Si HP, 2012, CHINESE MED J-PEKING, V125, P906, DOI 10.3760/cma.j.issn.0366-6999.2012.05.031; Thurston G, 2002, J ANAT, V200, P575, DOI 10.1046/j.1469-7580.2002.00061.x; Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Walters BJ, 2008, J NEUROCHEM, V106, P216, DOI 10.1111/j.1471-4159.2008.05352.x; Wang L, 2010, BIOMATERIALS, V31, P9452, DOI 10.1016/j.biomaterials.2010.08.036; Yamawaki K, 2010, J PERIODONTAL RES, V45, P421, DOI 10.1111/j.1600-0765.2009.01254.x; Zou DH, 2011, STEM CELLS, V29, P1380, DOI 10.1002/stem.693	29	16	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82945	10.1371/journal.pone.0082945	http://dx.doi.org/10.1371/journal.pone.0082945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376611	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100073
J	Lee, YM; Lee, SH; Lee, KB; Nguyen, MP; Lee, MY; Park, GH; Kwon, MJ				Lee, You Mie; Lee, Sun-Hee; Lee, Kheun Byeol; Minh Phuong Nguyen; Lee, Min-Young; Park, Gyu Hwan; Kwon, Mi Jeong			Silencing of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs Stimulates Hyperplastic Phenotypes through Activation of Epidermal Growth Factor Receptor and Hypoxia-Inducible Factor-2 alpha	PLOS ONE			English	Article							CELL-CYCLE ARREST; DOWN-REGULATION; RECK; SUPPRESSOR; EXPRESSION; INVASION; ANGIOGENESIS; HIF-2-ALPHA; INVOLVEMENT; METASTASIS	Reversion-inducing Cysteine-rich protein with Kazal motifs (RECK, a tumor suppressor) is down-regulated by the oncogenic signals and hypoxia, but the biological function of RECK in early tumorigenic hyperplastic phenotypes is largely unknown. Knockdown of RECK by small interfering RNA (siRECK) or hypoxia significantly promoted cell proliferation in various normal epithelial cells. Hypoxia as well as knockdown of RECK by siRNA increased the cell cycle progression, the levels of cyclin D1 and c-Myc, and the phosphorylation of Rb protein (p-pRb), but decreased the expression of p21(cip1), p27(kip1), and p16(ink4A) HIF-2 alpha was upregulated by knockdown of RECK, indicating HIF-2 alpha is a downstream target of RECK. As knockdown of RECK induced the activation of epidermal growth factor receptor (EGFR) and treatment of an EGFR kinase inhibitor, gefitinib, suppressed HIF-2 alpha expression induced by the silencing of RECK, we can suggest that the RECK silenicng-EGFR-HIF-2 alpha axis might be a key molecular mechanism to induce hyperplastic phenotype of epithelial cells. It was also found that shRNA of RECK induced larger and more numerous colonies than control cells in an anchorage-independent colony formation assay. Using a xenograft assay, epithelial cells with stably transfected with shFRNA of RECK formed a solid mass earlier and larger than those with control cells in nude mice. In conclusion, the suppression of RECK may promote the development of early tumorigenic hyperplastic characteristics in hypoxic stress.	[Lee, You Mie; Lee, Sun-Hee; Minh Phuong Nguyen; Lee, Min-Young; Park, Gyu Hwan; Kwon, Mi Jeong] Kyungpook Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Taegu, South Korea; [Lee, You Mie; Lee, Sun-Hee; Lee, Kheun Byeol; Minh Phuong Nguyen] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu, South Korea	Kyungpook National University; Kyungpook National University	Lee, YM (corresponding author), Kyungpook Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Taegu, South Korea.	lym@knu.ac.kr		Kwon, Mi Jeong/0000-0002-7599-878X	National Research Foundation (NRF); Korean government (MSIP) [NRF-2012R1A4A1028835]	National Research Foundation (NRF); Korean government (MSIP)	This work was supported by the National Research Foundation (NRF) grant funded by the Korean government (MSIP) (NRF-2012R1A4A1028835). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbiser JL, 2004, SEMIN CANCER BIOL, V14, P81, DOI 10.1016/j.semcancer.2003.09.013; Box AH, 2004, CARCINOGENESIS, V25, P2325, DOI 10.1093/carcin/bgh274; Chang HC, 2004, CELL SIGNAL, V16, P675, DOI 10.1016/j.cellsig.2003.11.001; Chang HC, 2007, CANCER SCI, V98, P169, DOI 10.1111/j.1349-7006.2006.00367.x; Chiavarina B, 2012, CELL CYCLE, V11, P3280, DOI 10.4161/cc.21643; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jeon HW, 2010, MOL CANCER THER, V9, P1361, DOI 10.1158/1535-7163.MCT-09-0717; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Kitajima S, 2011, ONCOGENE, V30, P737, DOI 10.1038/onc.2010.448; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Lee KJ, 2010, BBA-MOL CELL RES, V1803, P608, DOI 10.1016/j.bbamcr.2010.01.004; Lee SH, 2009, ONCOGENE, V28, P184, DOI 10.1038/onc.2008.377; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Loayza-Puch F, 2010, ONCOGENE, V29, P2638, DOI 10.1038/onc.2010.23; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Meng AX, 2005, RADIOTHER ONCOL, V76, P168, DOI 10.1016/j.radonc.2005.06.025; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; MONIER R, 1990, REPROD NUTR DEV, V30, P445, DOI 10.1051/rnd:19900319; NODA M, 1989, P NATL ACAD SCI USA, V86, P162, DOI 10.1073/pnas.86.1.162; Noda M, 2003, CANCER METAST REV, V22, P167, DOI 10.1023/A:1023043315031; Noda M, 2007, CANCER SCI, V98, P1659, DOI 10.1111/j.1349-7006.2007.00588.x; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Shi L, 2012, NEUROMOL MED, V14, P303, DOI 10.1007/s12017-012-8188-8; Shiomi T, 2010, PATHOL INT, V60, P477, DOI 10.1111/j.1440-1827.2010.02547.x; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Takeuchi T, 2004, CLIN CANCER RES, V10, P5572, DOI 10.1158/1078-0432.CCR-03-0656; Wang X, 2010, CARCINOGENESIS, V31, P1202, DOI 10.1093/carcin/bgq078; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Yoshida Y, 2012, ONCOGENE, V31, P4128, DOI 10.1038/onc.2011.570	40	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84520	10.1371/journal.pone.0084520	http://dx.doi.org/10.1371/journal.pone.0084520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376819	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100171
J	Little, S; Tan, HL; Anzak, A; Pogosyan, A; Kuhn, A; Brown, P				Little, Simon; Tan, Huiling; Anzak, Anam; Pogosyan, Alek; Kuehn, Andrea; Brown, Peter			Bilateral Functional Connectivity of the Basal Ganglia in Patients with Parkinson's Disease and Its Modulation by Dopaminergic Treatment	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; MOVEMENT-RELATED CHANGES; LOCAL-FIELD POTENTIALS; SUBTHALAMIC NUCLEUS; PATHOLOGICAL SYNCHRONIZATION; BETA-OSCILLATIONS; CEREBRAL-CORTEX; RECORDINGS; AREA	Parkinson's disease is characterised by excessive subcortical beta oscillations. However, little is known about the functional connectivity of the two basal ganglia across hemispheres and specifically the role beta plays in this. We recorded local field potentials from the subthalamic nucleus bilaterally in 23 subjects with Parkinson's disease at rest, on and off medication. We found suppression of low beta power in response to levodopa (t(22) = -4.4, p<0.001). There was significant coherence between the two sides in the beta range in 19 of the subjects. Coherence was selectively attenuated in the low beta range following levodopa (t(22) = -2.7; p = 0.01). We also separately analysed amplitude co-modulation and phase synchronisation in the beta band and found significant amplitude co-modulation and phase locking values in 17 and 16 subjects respectively, off medication. There was a dissociable effect of levodopa on these measures, with a significant suppression only in low beta phase locking value (t(22) = -2.8, p = 0.01) and not amplitude co-modulation. The absolute mean values of amplitude co-modulation (0.40+/-0.03) and phase synchronisation (0.29+/-0.02) off medication were, however, relatively low, suggesting that the two basal ganglia networks may have to be approached separately with independent sensing and stimulation during adaptive deep brain stimulation. In addition, our findings highlight the functional distinction between the lower and upper beta frequency ranges and between amplitude co-modulation and phase synchronization across subthalamic nuclei.	[Little, Simon; Tan, Huiling; Pogosyan, Alek; Brown, Peter] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Anzak, Anam] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Kuehn, Andrea] Univ Med Berlin, Charite, Dept Neurol, Berlin, Germany	University of Oxford; University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brown, P (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	peter.brown@ndcn.ox.ac.uk	Brown, Peter/J-4307-2016	Brown, Peter/0000-0002-5201-3044; Little, Simon/0000-0001-6249-6230; Tan, Huiling/0000-0001-8038-3029; Kuhn, Andrea A./0000-0002-4134-9060	Wellcome trust [093929/Z/10/Z]; Deutsche Forschungsgemeinshaft - Research unit [KFO 247]; Medical Research Council; National Institute for Health Research Oxford Bio-medical Research Centre; Rosetrees Trust; MRC [G0901503] Funding Source: UKRI; Medical Research Council [G0901503] Funding Source: researchfish	Wellcome trust(Wellcome Trust); Deutsche Forschungsgemeinshaft - Research unit(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Bio-medical Research Centre(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Simon Little is supported by the Wellcome trust with a personal grant (093929/Z/10/Z, http://www.wellcome.ac.uk). Andrea Kuhn is supported by the Deutsche Forschungsgemeinshaft - Research unit - KFO 247 (http://www.dfg.de/). Peter Brown's lab is supported by the Medical Research Council, National Institute for Health Research Oxford Bio-medical Research Centre, and the Rosetrees Trust (http://www.mrc.ac.uk, http://www.nihr.ac.uk, http://www.rosetreestrust.co.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirnovin R, 2004, J NEUROSCI, V24, P11302, DOI 10.1523/JNEUROSCI.3242-04.2004; Anzak A, 2012, BRAIN, V135, P2766, DOI 10.1093/brain/aws183; Brittain J, 2013, NEUROIMAGE; Brun Y, 2012, J NEUROPHYSIOL, V108, P1575, DOI 10.1152/jn.00254.2012; Buehlmann A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000934; CARPENTER MB, 1967, AM J ANAT, V121, P41, DOI 10.1002/aja.1001210105; CARPENTER MB, 1981, BRAIN RES, V224, P1, DOI 10.1016/0006-8993(81)91113-6; Cassidy M, 2002, BRAIN, V125, P1235, DOI 10.1093/brain/awf135; Chen CC, 2006, EXP NEUROL, V198, P214, DOI 10.1016/j.expneurol.2005.11.019; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; de Solages C, 2010, EXP NEUROL, V221, P260, DOI 10.1016/j.expneurol.2009.11.012; Doyle LMF, 2005, EUR J NEUROSCI, V21, P1403, DOI 10.1111/j.1460-9568.2005.03969.x; Eusebio A, 2011, J NEUROL NEUROSUR PS, V82, P569, DOI 10.1136/jnnp.2010.217489; Fahn G, 1987, MACMILLAN HEALTHCARE, V2, P153; Fogelson N, 2006, CEREB CORTEX, V16, P64, DOI 10.1093/cercor/bhi084; Foltynie T, 2010, EXPERT REV NEUROTHER, V10, P903, DOI 10.1586/ERN.10.68; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hanslmayr S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00074; Hirschmann J, 2011, NEUROIMAGE, V55, P1159, DOI 10.1016/j.neuroimage.2010.11.063; Kuhn AA, 2006, EUR J NEUROSCI, V23, P1956, DOI 10.1111/j.1460-9568.2006.04717.x; Kuhn AA, 2006, BRAIN, V129, P695, DOI 10.1093/brain/awh715; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Little S, 2012, EXP NEUROL, V236, P383, DOI 10.1016/j.expneurol.2012.04.024; Little S, 2013, ANN NEUROL; Little S, 2012, ANN NY ACAD SCI, V1265, P9, DOI 10.1111/j.1749-6632.2012.06650.x; Litvak V, 2012, J NEUROSCI, V32, P10541, DOI 10.1523/JNEUROSCI.0767-12.2012; Litvak V, 2011, BRAIN, V134, P359, DOI 10.1093/brain/awq332; Lopez-Azcarate J, 2010, J NEUROSCI, V30, P6667, DOI 10.1523/JNEUROSCI.5459-09.2010; Marceglia S, 2006, J PHYSIOL-LONDON, V571, P579, DOI 10.1113/jphysiol.2005.100271; Marreiros AC, 2013, NEUROIMAGE, V66, P301, DOI 10.1016/j.neuroimage.2012.10.088; Nambu A, 1996, J NEUROSCI, V16, P2671; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pogosyan A, 2010, NEUROSCIENCE, V171, P245, DOI 10.1016/j.neuroscience.2010.08.068; Priori A, 2004, EXP NEUROL, V189, P369, DOI 10.1016/j.expneurol.2004.06.001; Priori A, 2002, NEUROL SCI, V23, pS101, DOI 10.1007/s100720200089; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Silberstein P, 2005, BRAIN, V128, P1277, DOI 10.1093/brain/awh480; Takada M, 1998, BRAIN RES, V791, P335, DOI 10.1016/S0006-8993(98)00198-X; Tepper JM, 2007, PROG BRAIN RES, V160, P3, DOI 10.1016/S0079-6123(06)60001-0; Walker HC, 2011, J NEUROPHYSIOL, V105, P1112, DOI 10.1152/jn.00266.2010; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156; Yoshida F, 2010, J NEUROL NEUROSUR PS, V81, P885, DOI 10.1136/jnnp.2009.190918	44	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82762	10.1371/journal.pone.0082762	http://dx.doi.org/10.1371/journal.pone.0082762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376574	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100054
J	Maia, MF; Onyango, SP; Thele, M; Simfukwe, ET; Turner, EL; Moore, SJ				Maia, Marta Ferreira; Onyango, Sangoro Peter; Thele, Max; Simfukwe, Emmanuel Titus; Turner, Elizabeth Louise; Moore, Sarah Jane			Do Topical Repellents Divert Mosquitoes within a Community? - Health Equity Implications of Topical Repellents as a Mosquito Bite Prevention Tool	PLOS ONE			English	Article							MALARIA; BEDNETS	Objectives: Repellents do not kill mosquitoes - they simply reduce human-vector contact. Thus it is possible that individuals who do not use repellents but dwell close to repellent users experience more bites than otherwise. The objective of this study was to measure if diversion occurs from households that use repellents to those that do not use repellents. Methods: The study was performed in three Tanzanian villages using 15%-DEET and placebo lotions. All households were given LLINs. Three coverage scenarios were investigated: complete coverage (all households were given 15%-DEET), incomplete coverage (80% of households were given 15%-DEET and 20% placebo) and no coverage (all households were given placebo). A crossover study design was used and coverage scenarios were rotated weekly over a period of ten weeks. The placebo lotion was randomly allocated to households in the incomplete coverage scenario. The level of compliance was reported to be close to 100%. Mosquito densities were measured through aspiration of resting mosquitoes. Data were analysed using negative binomial regression models. Findings: Repellent-users had consistently fewer mosquitoes in their dwellings. In villages where everybody had been given 15%-DEET, resting mosquito densities were fewer than half that of households in the no coverage scenario (Incidence Rate Ratio [IRR]=0.39 (95% confidence interval [CI]: 0.25-0.60); p<0.001). Placebo-users living in a village where 80% of the households used 15%-DEET were likely to have over four-times more mosquitoes (IRR=4.17; 95% Cl: 3.08-5.65; p<0.001) resting in their dwellings in comparison to households in a village where nobody uses repellent. Conclusions: There is evidence that high coverage of repellent use could significantly reduce man-vector contact but with incomplete coverage evidence suggests that mosquitoes are diverted from households that use repellent to those that do not. Therefore, if repellents are to be considered for vector control, strategies to maximise coverage are required.	[Maia, Marta Ferreira; Moore, Sarah Jane] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Maia, Marta Ferreira; Moore, Sarah Jane] Univ Basel, Basel, Switzerland; [Maia, Marta Ferreira; Onyango, Sangoro Peter; Thele, Max; Simfukwe, Emmanuel Titus; Moore, Sarah Jane] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Bagamoyo, Pwani Region, Tanzania; [Onyango, Sangoro Peter] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Turner, Elizabeth Louise] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Turner, Elizabeth Louise] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine; Duke University; Duke University	Maia, MF (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	mmaia@ihi.or.tz	Moore, Sarah J/HGE-7143-2022; Maia, Marta/I-6003-2019	Moore, Sarah J/0000-0002-0938-6654; Maia, Marta/0000-0003-3302-5610	Bill and Melinda Gates foundation [51431]	Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation)	The funding source was the Bill and Melinda Gates foundation, award number 51431. URL: www.gatesfoundation.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne L. B., 1977, CHEM CONTROL INSECT; Carroll SP, 2006, J AM MOSQUITO CONTR, V22, P507, DOI 10.2987/8756-971X(2006)22[507:PARBMR]2.0.CO;2; CDC, 2008, SAF DAT; Chavasse DC, 1996, T ROY SOC TROP MED H, V90, P493, DOI 10.1016/S0035-9203(96)90291-6; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; Cohnstaedt LW, 2011, J VECTOR ECOL, V36, P395, DOI 10.1111/j.1948-7134.2011.00180.x; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Hill N, 2007, BMJ, V55; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; LINDSAY SW, 1992, B ENTOMOL RES, V82, P49, DOI 10.1017/S0007485300051488; Maia MF, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-124; Moore SJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-101; Moore SJ, 2007, TROP MED INT HEALTH, V12, P1, DOI DOI 10.1111/J.1365-3156.2007.01965.X.PUBMED:17445144; Rowland M, 2004, TROP MED INT HEALTH, V9, P335, DOI 10.1111/j.1365-3156.2004.01198.x; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Scott TW, 2006, AM J TROP MED HYG, V75, P231, DOI 10.4269/ajtmh.2006.75.231; Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299; WHO, 2006, WHO TECH REP SER, V936, P1	20	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84875	10.1371/journal.pone.0084875	http://dx.doi.org/10.1371/journal.pone.0084875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376852	gold, Green Published, Green Accepted			2022-12-27	WOS:000328745100191
J	Otete, EH; Ahankari, AS; Jones, H; Bolton, KJ; Jordan, CW; Boswell, TC; Wilcox, MH; Ferguson, NM; Beck, CR; Puleston, RL				Otete, Eroboghene H.; Ahankari, Anand S.; Jones, Helen; Bolton, Kirsty J.; Jordan, Caroline W.; Boswell, Tim C.; Wilcox, Mark H.; Ferguson, Neil M.; Beck, Charles R.; Puleston, Richard L.			Parameters for the Mathematical Modelling of Clostridium difficile Acquisition and Transmission: A Systematic Review	PLOS ONE			English	Review							STEM-CELL TRANSPLANTATION; PROTON PUMP INHIBITORS; RISK-FACTORS; CLINICAL CHARACTERISTICS; MOLECULAR EPIDEMIOLOGY; INFECTION; DIARRHEA; RECURRENCE; FEATURES; STRAINS	Introduction: Mathematical modelling of Clostridium difficile infection dynamics could contribute to the optimisation of strategies for its prevention and control. The objective of this systematic review was to summarise the available literature specifically identifying the quantitative parameters required for a compartmental mathematical model of Clostridium difficile transmission. Methods: Six electronic healthcare databases were searched and all screening, data extraction and study quality assessments were undertaken in duplicate. Results were synthesised using a narrative approach. Results: Fifty-four studies met the inclusion criteria. Reproduction numbers for hospital based epidemics were described in two studies with a range from 0.55 to 7. Two studies provided consistent data on incubation periods. For 62% of cases, symptoms occurred in less than 4 weeks (3-28 days) after infection. Evidence on contact patterns was identified in four studies but with limited data reported for populating a mathematical model. Two studies, including one without clinically apparent donor-recipient pairs, provided information on serial intervals for household or ward contacts, showing transmission intervals of <1 week in ward based contacts compared to up to 2 months for household contacts. Eight studies reported recovery rates of between 75% - 100% for patients who had been treated with either metronidazole or vancomycin. Forty-nine studies gave recurrence rates of between 3% and 49% but were limited by varying definitions of recurrence. No study was found which specifically reported force of infection or net reproduction numbers. Conclusions: There is currently scant literature overtly citing estimates of the parameters required to inform the quantitative modelling of Clostridium difficile transmission. Further high quality studies to investigate transmission parameters are required, including through review of published epidemiological studies where these quantitative estimates may not have been explicitly estimated, but that nonetheless contain the relevant data to allow their calculation. [Systematic review reference: CRD42012003081]	[Otete, Eroboghene H.; Ahankari, Anand S.; Jones, Helen; Beck, Charles R.; Puleston, Richard L.] Univ Nottingham, Sch Community Hlth Sci, Nottingham NG7 2RD, England; [Bolton, Kirsty J.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Bolton, Kirsty J.] Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England; [Jordan, Caroline W.] NHS England Area Team Derbyshire, Nottingham, England; [Jordan, Caroline W.] NHS England Area Team Derbyshire, Derby, Notts, England; [Boswell, Tim C.] Nottingham Univ Hosp NHS Trust, Dept Clin Microbiol, Nottingham, England; [Wilcox, Mark H.] Univ Leeds, Dept Microbiol, Leeds LS2 9JT, W Yorkshire, England; [Ferguson, Neil M.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England	University of Nottingham; University of Melbourne; University of Nottingham; Nottingham University Hospital NHS Trust; University of Leeds; Imperial College London	Puleston, RL (corresponding author), Univ Nottingham, Sch Community Hlth Sci, Nottingham NG7 2RD, England.	Richard.Puleston@nottingham.ac.uk	Ahankari, Anand/Y-2471-2018; Ferguson, Neil/B-8578-2008	Ahankari, Anand/0000-0001-8695-8938; Ferguson, Neil/0000-0002-1154-8093; Otete, Harmony/0000-0003-2467-2605; Bolton, Kirsty/0000-0003-0487-4701	NHS Nottingham City National Institute for Health Research Flexibility and Sustainability Funding; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	NHS Nottingham City National Institute for Health Research Flexibility and Sustainability Funding; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project was funded by NHS Nottingham City National Institute for Health Research Flexibility and Sustainability Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanazi A, 2012, BONE MARROW TRANSPL, V47, pS134; Alangaden GJ, 2000, CLIN INFECT DIS, V31, P280; ALJUMAILI IJ, 1984, J CLIN MICROBIOL, V19, P77, DOI 10.1128/JCM.19.1.77-78.1984; Armbruster S, 2012, MIL MED, V177, P456, DOI 10.7205/MILMED-D-11-00389; ARONSSON B, 1987, EUR J CLIN MICROBIOL, V6, P352, DOI 10.1007/BF02017639; BARANY P, 1992, CLIN NEPHROL, V38, P53; BEAUSEJOUR Y, 2010, AM J GASTR C 75 ANN, pS142; Berling A, 2009, J AM GERIATR SOC, V57, pS199; Best EL, 2010, CLIN INFECT DIS, V50, P1450, DOI 10.1086/652648; Bilgrami S, 1999, BONE MARROW TRANSPL, V23, P1039, DOI 10.1038/sj.bmt.1701773; Bouza E, 1996, REV CLIN ESP, V196, P424; Cadena J, 2010, AM J MED SCI, V339, P350, DOI 10.1097/MAJ.0b013e3181d3cdaa; Campbell RJ, 2009, INFECT CONT HOSP EP, V30, P526, DOI 10.1086/597507; Choi HK, 2011, J KOREAN MED SCI, V26, P859, DOI 10.3346/jkms.2011.26.7.859; Chung CH, 2010, J MICROBIOL IMMUNOL, V43, P119, DOI 10.1016/S1684-1182(10)60019-9; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; Cookson B, 2007, POSTGRAD MED J, V83, P291, DOI 10.1136/pgmj.2006.056143; Department of Health, 2012, UPD GUID DIAGN REP C; Donskey CJ, 2010, CLIN INFECT DIS, V50, P1458, DOI 10.1086/652649; FUJII L, 2010, AM J GASTR C 75 ANN, pS144; Garey KW, 2010, CLIN INFECT DIS, V51, P1406, DOI 10.1086/657398; GOLAN Y, 2011, GASTR C DIG DIS WEEK, pS360; Gould LH, 2010, CLIN INFECT DIS, V51, P577, DOI 10.1086/655692; GRUBE BJ, 1987, ARCH SURG-CHICAGO, V122, P655; Hamel M, 2010, AM J INFECT CONTROL, V38, P173, DOI 10.1016/j.ajic.2009.08.016; HAYEK DV, 1997, GERIATRIE FORSCHUNG, V7, P123; KASPER S, 2010, CLIN MICR C 20 ECCMI, P2008; Kelsen JR, 2011, INFLAMM BOWEL DIS, V17, P50, DOI 10.1002/ibd.21421; Keven K, 2004, Transpl Infect Dis, V6, P10, DOI 10.1111/j.1399-3062.2004.00040.x; Khan FY, 2012, TRAVEL MED INFECT DI, V10, P179, DOI 10.1016/j.tmaid.2012.06.004; Khanna S, 2009, AM J GASTROENTEROL, V104, pS544, DOI 10.14309/00000434-200910003-01448; Khanna S, 2009, AM J GASTROENTEROL, V104, pS183, DOI 10.14309/00000434-200910003-00485; Kim J, 2012, PEDIATR INFECT DIS J, V31, P134, DOI 10.1097/INF.0b013e3182352e2c; Kim JW, 2010, WORLD J GASTROENTERO, V16, P3573, DOI 10.3748/wjg.v16.i28.3573; Kim J, 2011, J KOREAN MED SCI, V26, P1258, DOI 10.3346/jkms.2011.26.10.1258; Kim JH, 2011, INFECT CONT HOSP EP, V32, P656, DOI 10.1086/660767; Kim YS, 2013, EPIDEMIOL INFECT, V141, P189, DOI 10.1017/S0950268812000581; Kim YG, 2012, J CLIN GASTROENTEROL, V46, P397, DOI 10.1097/MCG.0b013e3182431d78; Kyne L, 1998, J HOSP INFECT, V38, P101, DOI 10.1016/S0195-6701(98)90063-9; Laffan AM, 2006, J AM GERIATR SOC, V54, P1068, DOI 10.1111/j.1532-5415.2006.00768.x; Lanzas C, 2011, INFECT CONT HOSP EP, V32, P553, DOI 10.1086/660013; Lee Jin Ho, 2010, Korean J Gastroenterol, V55, P175; Lefebvre SL, 2006, EMERG INFECT DIS, V12, P1036, DOI 10.3201/eid1206.060115; Legaria MC, 2003, ANAEROBE, V9, P113, DOI 10.1016/S1075-9964(03)00088-X; Linsky A, 2010, ARCH INTERN MED, V170, P772, DOI 10.1001/archinternmed.2010.73; LU SS, 1994, AM J GASTROENTEROL, V89, P1226; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Metcalf DS, 2010, LETT APPL MICROBIOL, V51, P600, DOI 10.1111/j.1472-765X.2010.02933.x; Munoz P, 2007, J HEART LUNG TRANSPL, V26, P907, DOI 10.1016/j.healun.2007.07.010; Noren T, 2004, J CLIN MICROBIOL, V42, P3635, DOI [10.1128/JCM.42.8.3635-3643.2004, 10.1128/jcm.42.8.3635-3643.2004]; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Otten AM, 2010, EPIDEMIOL INFECT, V138, P907, DOI 10.1017/S0950268809991646; Pawar D, 2012, INFECT CONT HOSP EP, V33, P1107, DOI 10.1086/668031; Pepin J, 2012, J INFECTION, V64, P387, DOI 10.1016/j.jinf.2011.12.011; Peterson LR, 2009, ANN INTERN MED, V151, P176, DOI 10.7326/0003-4819-151-3-200908040-00005; Pizzala JE, 2012, GASTROENTEROLOGY, V142, pS601; Polivkova Sylvia, 2010, Klin Mikrobiol Infekc Lek, V16, P206; PULESTON R, 2012, EPIDEMIOLOGICAL CHAR; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Ross J, 2012, GUT, V61, pA336, DOI 10.1136/gutjnl-2012-302514d.98; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; San-Gil E, 2010, INT J INFECT DIS, V14, pE263, DOI 10.1016/j.ijid.2010.02.2071; Shaw J, 2008, AM J GASTROENTEROL, V103, pS182, DOI 10.14309/00000434-200809001-00472; SINGER DB, 1986, J PEDIATR GASTR NUTR, V5, P318; VANDERZWET WC, 2012, CLIN MICR C 22 EUR C, P652; Vesteinsdottir I, 2012, EUR J CLIN MICROBIOL, V31, P2601, DOI 10.1007/s10096-012-1603-0; Vojtilova Lenka, 2011, Klin Mikrobiol Infekc Lek, V17, P208; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Waggoner S E, 1994, Infect Dis Obstet Gynecol, V2, P154, DOI 10.1155/S1064744994000578; Walker AS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001172; Watkins ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045349; Wilcox MH, 2008, J ANTIMICROB CHEMOTH, V62, P388, DOI 10.1093/jac/dkn163; WILCOX MH, 1992, J HOSP INFECT, V22, P85, DOI 10.1016/0195-6701(92)90092-Z; Yagues L, 2001, CLIN INFECT DIS, V33, P1105	75	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84224	10.1371/journal.pone.0084224	http://dx.doi.org/10.1371/journal.pone.0084224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376797	Green Published, Green Accepted, gold			2022-12-27	WOS:000328745100160
J	Wang, DF; Shi, L; Liu, SP; Hui, SCN; Wang, YJ; Cheng, JCY; Chu, WCW				Wang, Defeng; Shi, Lin; Liu, Shangping; Hui, Steve C. N.; Wang, Yongjun; Cheng, Jack C. Y.; Chu, Winnie C. W.			Altered Topological Organization of Cortical Network in Adolescent Girls with Idiopathic Scoliosis	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; ANATOMICAL NETWORKS; CEREBRAL-CORTEX; MR-IMAGES; SEGMENTATION; THICKNESS; MODELS; VOLUME	Adolescent idiopathic scoliosis (AIS) is a multifactorial disease affecting approximately 1-4% of teenagers especially girls at the age of 10-16, but its etiopathogenesis remains uncertain, Previous study has revealed that the cortical thickness in IAS patients is different from that in normal controls. Cortical thickness measurements are known to be strongly correlated between regions that are axonally connected. Hence, a hypothesis is proposed to study the possibility to demonstrate abnormal structural network revealed by cortical thickness in IAS patients. The aim of the study is to investigate abnormalities in the organization of the brain cortical network in AIS patients. This study included 42 girls with severe idiopathic scoliosis (14.7 +/- 1.3 years old) and 41 age-matched normal controls (NC, 14.6+/-1.4 years old). The brain cortex was partitioned into 154 cortical regions based on gyral and sulcal structure. The interregional connectivity was measured as the statistical correlations between the regional mean thicknesses across the subjects. We employed the graph theoretic analysis to examine the alteration in interregional correlation, small-world efficiency, hub distribution, and regional nodal characteristics in AIS patients. We demonstrated that the cortical network of AIS patients fully preserved the small-world architecture and organization, and further verified the hemispheric asymmetry of AIS brain. Our results indicated increased central role of temporal and occipital cortex and decreased central role of limbic cortex in AIS patients compared with control. Furthermore, decreased structural connectivity between hemispheres and increased connectivity in several cortical regions were observed. The findings of the study reveal the pattern of structural network alteration in AIS brain, and would help in understanding the mechanism and etiopathogenesis of AIS.	[Wang, Defeng; Shi, Lin; Liu, Shangping; Hui, Steve C. N.; Chu, Winnie C. W.] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [Wang, Defeng; Shi, Lin; Hui, Steve C. N.; Chu, Winnie C. W.] Chinese Univ Hong Kong, Res Ctr Med Image Comp, Shatin, Hong Kong, Peoples R China; [Wang, Defeng; Chu, Winnie C. W.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Wang, Defeng] Chinese Univ Hong Kong, Dept Biomed Engn, Shatin, Hong Kong, Peoples R China; [Wang, Defeng] Chinese Univ Hong Kong, Shun Hing Inst Adv Engn, Shatin, Hong Kong, Peoples R China; [Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Cheng, Jack C. Y.] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; Chinese University of Hong Kong; Capital Medical University; Chinese University of Hong Kong	Shi, L (corresponding author), Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.	shilin@cuhk.edu.hk; winnie@med.cuhk.edu.hk	Hui, Steve CN/Q-3715-2016; Cheng, Jack/J-3878-2018; Hui, Steve/AAF-6195-2021; Chu, Winnie CW/F-8449-2014; Shi, Lin/K-5241-2014	Hui, Steve CN/0000-0002-1523-4040; Cheng, Jack/0000-0001-8153-364X; Hui, Steve/0000-0002-1523-4040; Chu, Winnie CW/0000-0003-4962-4132; Shi, Lin/0000-0003-2318-4669	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 475711, CUHK 411910, CUHK 411811]; Science, Industry, Trade and Information Commission of Shenzhen Municipality [JC201005250030A]; National Natural Science Foundation of China [81101111]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Science, Industry, Trade and Information Commission of Shenzhen Municipality; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work described in this paper was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No.: CUHK 475711, 411910, 411811), a grant from the Science, Industry, Trade and Information Commission of Shenzhen Municipality (Project No. JC201005250030A), and a grant from the National Natural Science Foundation of China (Project No. 81101111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Cohen J., 1983, APPL MULTIPLE REGRES; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Domenech J, 2011, EUR SPINE J, V20, P1069, DOI 10.1007/s00586-011-1776-8; Domenech J, 2010, EUR SPINE J, V19, P223, DOI 10.1007/s00586-009-1243-y; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Fasold O, 2002, NEUROIMAGE, V17, P1384, DOI 10.1006/nimg.2002.1241; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; GOLDBERG CJ, 1995, SPINE, V20, P1685, DOI 10.1097/00007632-199508000-00007; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Kouwenhoven JWM, 2008, SPINE, V33, P2898, DOI 10.1097/BRS.0b013e3181891751; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Liu TM, 2008, J MAGN RESON IMAGING, V27, P732, DOI 10.1002/jmri.21321; Shi L, 2009, AM J NEURORADIOL, V30, P1302, DOI 10.3174/ajnr.A1577; Shi L, 2011, NEUROIMAGE, V54, pS180, DOI 10.1016/j.neuroimage.2010.04.002; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Voges N, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/484812; Wang DF, 2012, NEUROIMAGE, V59, P935, DOI 10.1016/j.neuroimage.2011.07.097; Wang DF, 2009, NEUROIMAGE, V45, P738, DOI 10.1016/j.neuroimage.2008.12.068; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wiener-Vacher SR, 1998, J PEDIATR-US, V132, P1028, DOI 10.1016/S0022-3476(98)70403-2; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006	37	13	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83767	10.1371/journal.pone.0083767	http://dx.doi.org/10.1371/journal.pone.0083767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376742	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100137
J	Xiong, JX; He, C; Li, C; Tan, G; Li, JC; Yu, ZP; Hu, Z; Chen, F				Xiong, Jiaxiang; He, Chao; Li, Chao; Tan, Gang; Li, Jingcheng; Yu, Zhengping; Hu, Zhian; Chen, Fang			Changes of Dendritic Spine Density and Morphology in the Superficial Layers of the Medial Entorhinal Cortex Induced by Extremely Low-Frequency Magnetic Field Exposure	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SPATIAL MEMORY; HIPPOCAMPAL SPINES; COGNITIVE FUNCTION; NMDA RECEPTORS; SYNAPSES; EXPRESSION; INPUT; AMPA; REPRESENTATION	In the present study, we investigated the effects of chronic exposure (14 and 28 days) to a 0.5 mT 50 Hz extremely low-frequency magnetic field (ELM) on the dendritic spine density and shape in the superficial layers of the medial entorhinal cortex (MEC). We performed Golgi staining to reveal the dendritic spines of the principal neurons in rats. The results showed that ELM exposure induced a decrease in the spine density in the dendrites of stellate neurons and the basal dendrites of pyramidal neurons at both 14 days and 28 days, which was largely due to the loss of the thin and branched spines. The alteration in the density of mushroom and stubby spines post ELM exposure was cell-type specific. For the stellate neurons, ELM exposure slightly increased the density of stubby spines at 28 days, while it did not affect the density of mushroom spines at the same time. In the basal dendrites of pyramidal neurons, we observed a significant decrease in the mushroom spine density only at the later time point post ELM exposure, while the stubby spine density was reduced at 14 days and partially restored at 28 days post ELM exposure. ELM exposure-induced reduction in the spine density in the apical dendrites of pyramidal neurons was only observed at 28 days, reflecting the distinct vulnerability of spines in the apical and basal dendrites. Considering the changes in spine number and shape are involved in synaptic plasticity and the MEC is a part of neural network that is closely related to learning and memory, these findings may be helpful for explaining the ELM exposure-induced impairment in cognitive functions.	[Xiong, Jiaxiang; He, Chao; Li, Chao; Tan, Gang; Li, Jingcheng; Hu, Zhian; Chen, Fang] Third Mil Med Univ, Dept Physiol, Chongqing, Peoples R China; [Yu, Zhengping] Third Mil Med Univ, Dept Occupat Hlth, Chongqing, Peoples R China	Army Medical University; Army Medical University	Hu, Z (corresponding author), Third Mil Med Univ, Dept Physiol, Chongqing, Peoples R China.	zhianhu@aliyun.com; chenfang315@aliyun.com	Li, Jingcheng/AAF-8205-2019	Li, Jingcheng/0000-0001-5099-5411	National Basic Research Program of China [2011CB503700]	National Basic Research Program of China(National Basic Research Program of China)	This work was sponsored by the National Basic Research Program of China (Grant number: 2011CB503700) URL of funder's website: http://www.973.gov.cn/English/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI A, 1994, HIPPOCAMPUS, V4, P1, DOI 10.1002/hipo.450040103; Artacho-Perula E, 2007, ANAL QUANT CYTOL, V29, P1; Baiano M, 2008, SCHIZOPHR RES, V102, P171, DOI 10.1016/j.schres.2007.11.035; Beed P, 2010, NEURON, V68, P1059, DOI 10.1016/j.neuron.2010.12.009; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Chakraborti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040844; Che Y, 2007, BRAIN RES BULL, V74, P178, DOI 10.1016/j.brainresbull.2007.06.009; Crasson M, 1999, BIOELECTROMAGNETICS, V20, P474, DOI 10.1002/(SICI)1521-186X(199912)20:8<474::AID-BEM2>3.0.CO;2-M; Cui YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032196; Delhez M, 2004, BIOELECTROMAGNETICS, V25, P592, DOI 10.1002/bem.20040; Ganeshina O, 2004, J COMP NEUROL, V468, P86, DOI 10.1002/cne.10950; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hoyer C, 2012, REPROD TOXICOL, V34, P86, DOI 10.1016/j.reprotox.2012.03.006; Jadidi M, 2007, NEUROBIOL LEARN MEM, V88, P387, DOI 10.1016/j.nlm.2007.07.010; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kononenko NL, 2012, HIPPOCAMPUS, V22, P881, DOI 10.1002/hipo.20949; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Li CQ, 2008, BRAIN RES BULL, V77, P237, DOI 10.1016/j.brainresbull.2008.07.010; Li Y, 2011, HIPPOCAMPUS, V21, P265, DOI 10.1002/hipo.20745; Majewska A, 2000, J NEUROSCI, V20, P1722; Mancuso JJ, 2013, NEUROSCIENCE, V251, P129, DOI 10.1016/j.neuroscience.2012.04.010; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Preece AW, 1998, INT J RADIAT BIOL, V74, P463, DOI 10.1080/095530098141339; Sewards TV, 2003, BRAIN RES REV, V42, P243, DOI 10.1016/S0165-0173(03)00175-9; Sienkiewicz ZJ, 1998, BIOELECTROMAGNETICS, V19, P79, DOI 10.1002/(SICI)1521-186X(1998)19:2<79::AID-BEM4>3.0.CO;2-0; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Sun HY, 2010, BIOELECTROMAGNETICS, V31, P150, DOI 10.1002/bem.20540; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Van Cauter T, 2013, CEREB CORTEX, V23, P451, DOI 10.1093/cercor/bhs033; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Volfovsky N, 1999, J NEUROPHYSIOL, V82, P450, DOI 10.1152/jn.1999.82.1.450; von Bohlen und Halbach O, 2006, J NEUROSCI RES, V83, P525, DOI 10.1002/jnr.20759; Wang XS, 2013, BIOELECTROMAGNETICS, V34, P275, DOI 10.1002/bem.21775; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	47	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83561	10.1371/journal.pone.0083561	http://dx.doi.org/10.1371/journal.pone.0083561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376717	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100127
J	Zhang, XL; Yan, XY; Cheng, L; Dai, JZ; Wang, CY; Han, P; Chai, YM				Zhang, Xiongliang; Yan, Xiaoyu; Cheng, Liang; Dai, Jiezhi; Wang, Chunyang; Han, Pei; Chai, Yimin			Wound Healing Improvement with PHD-2 Silenced Fibroblasts in Diabetic Mice	PLOS ONE			English	Article							HYDROXYLASE INHIBITORS INCREASE; ENDOTHELIAL GROWTH-FACTOR; CHEMICAL-MODIFICATION; PROLYL HYDROXYLASES; RNA; SIRNAS; INTERFERENCE; ANGIOGENESIS; EXPRESSION; INDUCTION	Background: Hypoxia-inducible factor la is the central regulator of the hypoxia-induced response which results in the up-regulation of angiogenic factors. Its activity is under precise regulation of prolyl-hydroxylase domain 2. We hypothesized that PHD2 silenced fibroblasts would increase the expression of angiogenic factors, which might contribute to the improvement of the diabetic wound healing. Materials and Methods: 50 dB/db mice were employed and randomly assigned into five groups with 10 mice in each: group 1 (untreated cell), group 2 (PHD2 silenced cell), group 3 (L-mimosine treated cells), group 4 (nontargeting siRNA treated cells) and group 5 (sham control). Fibroblasts were cultivated from the dermis of mice in each group and treated with PHD2 targeting siRNA, L-mimosine and non-targeting siRNA respectively. A fraction of the fibroblasts were employed to verify the silencing rate of PHD2 after 48 hours. The autologous fibroblasts (treated and untreated) labeled with adenovirus-GFP were implanted around the wound (Phi 6mm), which was created on the dorsum of each mouse. The status of wounds was recorded periodically. Ten days postoperatively, 3 mice from each group were sacrificed and wound tissues were harvested. Molecular biological examinations were performed to evaluate the expressions of cytokines. 28 days postoperatively, the remaining mice were sacrificed. Histological examinations were performed to evaluate the densities of GFP+ cells and capillaries. Results: The expression of PHD2 reduced to 12.5%, and the expressions of HIF-1 alpha and VEGFa increased significantly after PHD2 siRNA treatment. With the increasing expressions of HIF-1 alpha and VEGFa, the time to wound closure in group 2 was less than 2 weeks. Increased numbers of GFP+ cells and capillaries were observed in group 2. Conclusion: PHD2 siRNA treatment not only increased the expression of HIF1 alpha and VEGFa, but also improved the fibroblast proliferation. These effects might contribute to the improvement of the diabetic wound healing.	[Zhang, Xiongliang; Yan, Xiaoyu; Cheng, Liang; Dai, Jiezhi; Wang, Chunyang; Han, Pei; Chai, Yimin] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Orthoped, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Chai, YM (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Orthoped, Shanghai 200030, Peoples R China.	chaiyimin@gmail.com			national natural science foundation of china [81171728]	national natural science foundation of china(National Natural Science Foundation of China (NSFC))	The present work was supported by the grants from national natural science foundation of china (Grant No. 81171728). (URL: http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agis H, 2012, J PERIODONTAL RES, V47, P165, DOI 10.1111/j.1600-0765.2011.01415.x; Apelqvist J, 2012, ENDOCRINE, V41, P384, DOI 10.1007/s12020-012-9619-x; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Choung S, 2006, BIOCHEM BIOPH RES CO, V342, P919, DOI 10.1016/j.bbrc.2006.02.049; Chung LC, 2012, AM J PHYSIOL-CELL PH, V302, pC676, DOI 10.1152/ajpcell.00180.2011; Corey DR, 2007, J CLIN INVEST, V117, P3615, DOI 10.1172/JCI33483; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Desta T, 2010, J DENT RES, V89, P609, DOI 10.1177/0022034510362960; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Hewitson KS, 2004, DRUG DISCOV TODAY, V9, P704, DOI 10.1016/S1359-6446(04)03202-7; Higuchi Y, 2010, BIODRUGS, V24, P195, DOI 10.2165/11534450-000000000-00000; Hoogwerf BJ, 2001, MED CLIN N AM, V85, P1213, DOI 10.1016/S0025-7125(05)70373-4; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; KALUCKA J, 2013, MOL CELL BIOL; Kato H, 2006, INT J CANCER, V118, P1144, DOI 10.1002/ijc.21488; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; LEE E, 2013, CELL TRANSPLANT, P94853; McLaughlin PJ, 2013, EXP BIOL MED, V238, P733, DOI 10.1177/1535370213492688; Mollenhauer M, 2012, LANGENBECK ARCH SURG, V397, P1313, DOI 10.1007/s00423-012-0998-5; Muller HD, 2012, J ENDODONT, V38, P1498, DOI 10.1016/j.joen.2012.08.003; Natarajan R, 2006, CIRC RES, V98, P133, DOI 10.1161/01.RES.0000197816.63513.27; Peters AS, 2012, EXP DERMATOL, V21, P765, DOI 10.1111/exd.12010; Scherr M, 2003, CURR MED CHEM, V10, P245, DOI 10.2174/0929867033368493; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-y; Smith TG, 2010, ANTIOXID REDOX SIGN, V12, P431, DOI 10.1089/ars.2009.2901; Steinhoff A, 2009, BIOCHEM BIOPH RES CO, V387, P705, DOI 10.1016/j.bbrc.2009.07.090; Subramanya S, 2010, EXPERT OPIN BIOL TH, V10, P201, DOI 10.1517/14712590903448158; Takahashi Y, 2009, J PHARM SCI-US, V98, P74, DOI 10.1002/jps.21398; Takeda K, 2007, HYPERTENSION, V49, P178, DOI 10.1161/01.HYP.0000251360.40838.0f; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Vogler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069128; Wang P, 2013, CELL PHYSIOL BIOCHEM, V32, P859, DOI 10.1159/000354488; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875	40	25	27	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84548	10.1371/journal.pone.0084548	http://dx.doi.org/10.1371/journal.pone.0084548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376825	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100176
J	Genini, S; Beltran, WA; Aguirre, GD				Genini, Sem; Beltran, William A.; Aguirre, Gustavo D.			Up-Regulation of Tumor Necrosis Factor Superfamily Genes in Early Phases of Photoreceptor Degeneration	PLOS ONE			English	Article							CELL-DEATH; FRAMESHIFT MUTATION; BETA-SUBUNIT; TNF-ALPHA; APOPTOSIS; MECHANISMS; EXPRESSION; ROD; ACTIVATION; PATHWAY	We used quantitative real-time PCR to examine the expression of 112 genes related to retinal function and/or belonging to known pro-apoptotic, cell survival, and autophagy pathways during photoreceptor degeneration in three early-onset canine models of human photoreceptor degeneration, rod cone dysplasia 1 (rcd1), X-linked progressive retinal atrophy 2 (xlpra2), and early retinal degeneration (erd), caused respectively, by mutations in PDE6B, RPGRORF15, and STK38L. Notably, we found that expression and timing of differentially expressed (DE) genes correlated with the cell death kinetics. Gene expression profiles of rcd1 and xlpra2 were similar; however rcd1 was more severe as demonstrated by the results of the TUNEL and ONL thickness analyses, a greater number of genes that were DE, and the identification of altered expression that occurred at earlier time points. Both diseases differed from erd, where a smaller number of genes were DE. Our studies did not highlight the potential involvement of mitochondrial or autophagy pathways, but all three diseases were accompanied by the down-regulation of photoreceptor genes, and up-regulation of several genes that belong to the TNF superfamily, the extrinsic apoptotic pathway, and pro-survival pathways. These proteins were expressed by different retinal cells, including horizontal, amacrine, ON bipolar, and Muller cells, and suggest an interplay between the dying photoreceptors and inner retinal cells. Western blot and immunohistochemistry results supported the transcriptional regulation for selected proteins. This study highlights a potential role for signaling through the extrinsic apoptotic pathway in early cell death events and suggests that retinal cells other than photoreceptors might play a primary or bystander role in the degenerative process.	[Genini, Sem; Beltran, William A.; Aguirre, Gustavo D.] Univ Penn, Sch Vet Med, Dept Clin Studies, Sect Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania	Genini, S (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, Sect Ophthalmol, Philadelphia, PA 19104 USA.	geninis@vet.upenn.edu; gda@vet.upenn.edu		Aguirre, Gustavo/0000-0002-5228-256X	Foundation Fighting Blindness (FFB), NIH [EY06855, EY017549, EY022012, 5P30EY001583-38]; Van Sloun Fund for Canine Genetic Research, Hope for Vision; Macula Vision Research Foundation; NATIONAL EYE INSTITUTE [R24EY022012, R01EY017549, R01EY006855, P30EY001583, U01EY006855] Funding Source: NIH RePORTER	Foundation Fighting Blindness (FFB), NIH; Van Sloun Fund for Canine Genetic Research, Hope for Vision; Macula Vision Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the Foundation Fighting Blindness (FFB), NIH Grants EY06855, EY017549, EY022012, and 5P30EY001583-38, the Van Sloun Fund for Canine Genetic Research, Hope for Vision, and Macula Vision Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACLAND GM, 1987, EXP EYE RES, V44, P491, DOI 10.1016/S0014-4835(87)80160-4; Baehr W, 2009, VISION RES, V49, P2636, DOI 10.1016/j.visres.2009.04.008; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Berta AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024074; Bertazza L, 2008, FRONT BIOSCI-LANDMRK, V13, P2736, DOI 10.2741/2881; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Cottet S, 2009, CURR MOL MED, V9, P375, DOI 10.2174/156652409787847155; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; FARBER DB, 1992, NEURON, V9, P349, DOI 10.1016/0896-6273(92)90173-B; Gaurnier-Hausser A, 2011, CLIN CANCER RES, V17, P4661, DOI 10.1158/1078-0432.CCR-10-3310; Genini S, 2012, ADV EXP MED BIOL, V723, P353, DOI 10.1007/978-1-4614-0631-0_46; Genini S, 2010, INVEST OPHTH VIS SCI, V51, P6038, DOI 10.1167/iovs.10-5443; Gesslein B, 2010, MOL VIS, V16, P2317; Goldstein O, 2010, GENOMICS, V96, P362, DOI 10.1016/j.ygeno.2010.09.003; Hamano R, 2011, EUR J IMMUNOL, V41, P2010, DOI 10.1002/eji.201041205; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Leonard KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000314; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Ma JJ, 2009, EUR J OBSTET GYN R B, V146, P222, DOI 10.1016/j.ejogrb.2009.06.011; Melino G, 2005, CELL DEATH DIFFER, V12, P1457, DOI 10.1038/sj.cdd.4401781; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; RAY K, 1994, INVEST OPHTH VIS SCI, V35, P4291; Rohrer B, 2004, J BIOL CHEM, V279, P41903, DOI 10.1074/jbc.M405085200; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Zacks DN, 2004, INVEST OPHTH VIS SCI, V45, P4563, DOI 10.1167/iovs.04-0598; Zadro-Lamoureux LA, 2009, INVEST OPHTH VIS SCI, V50, P1448, DOI 10.1167/iovs.08-2855; Zhang BY, 2010, J IMMUNOL, V184, P4770, DOI 10.4049/jimmunol.0902713; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993; Zhang Q, 2003, INVEST OPHTH VIS SCI, V44, P4542, DOI 10.1167/iovs.02-1202	53	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e85408	10.1371/journal.pone.0085408	http://dx.doi.org/10.1371/journal.pone.0085408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367709	Green Published, gold			2022-12-27	WOS:000328741900077
J	Ricci-Cabello, I; Ruiz-Perez, I; Rojas-Garcia, A; Pastor, G; Goncalves, DC				Ricci-Cabello, Ignacio; Ruiz-Perez, Isabel; Rojas-Garcia, Antonio; Pastor, Guadalupe; Goncalves, Daniela C.			Improving Diabetes Care in Rural Areas: A Systematic Review and Meta-Analysis of Quality Improvement Interventions in OECD Countries	PLOS ONE			English	Review							TELEMEDICINE CASE-MANAGEMENT; SELF-MANAGEMENT; OF-CARE; GLYCEMIC CONTROL; MULTIFACETED INTERVENTION; ASSOCIATION STANDARDS; ETHNICALLY DIVERSE; AFRICAN-AMERICANS; EDUCATION; STRATEGIES	Background and Aims: Despite well documented disparities in health and healthcare in rural communities, evidence in relation to quality improvement (QI) interventions in those settings is still lacking. The main goals of this work were to assess the effectiveness of QI strategies designed to improve diabetes care in rural areas, and identify characteristics associated with greater success. Methods: We conducted a systematic review and meta-analysis. Systematic electronic searches were conducted in MEDLINE, EMBASE, CINAHL, and 12 additional bibliographic sources. Experimental studies carried out in the OECD member countries assessing the effectiveness of QI interventions aiming to improve diabetes care in rural areas were included. The effect of the interventions and their impact on glycated hemoglobin was pooled using a random-effects meta-analysis. Results: Twenty-six studies assessing the effectiveness of twenty QI interventions were included. Interventions targeted patients (45%), clinicians (5%), the health system (15%), or several targets (35%), and consisted of the implementation of one or multiple QI strategies. Most of the interventions produced a positive impact on processes of care or diabetes self-management, but a lower effect on health outcomes was observed. Interventions with multiple strategies and targeting the health system and/or clinicians were more likely to be effective. Six QI interventions were included in the meta-analysis (1,496 patients), which showed a significant reduction in overall glycated hemoglobin of 0.41 points from baseline in those patients receiving the interventions (95% CI -0.75% to -0.07%). Conclusions: This work identified several characteristics associated with successful interventions to improve the quality of diabetes care in rural areas. Efforts to improve diabetes care in rural communities should focus on interventions with multiple strategies targeted at clinicians and/or the health system, rather than on traditional patientoriented interventions.	[Ricci-Cabello, Ignacio; Goncalves, Daniela C.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Ricci-Cabello, Ignacio; Ruiz-Perez, Isabel; Rojas-Garcia, Antonio] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Ruiz-Perez, Isabel; Rojas-Garcia, Antonio; Pastor, Guadalupe] Andalusian Sch Publ Hlth, Granada, Spain	University of Oxford; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Escuela Andaluza de Salud Publica	Ricci-Cabello, I (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	ignacio.riccicabello@phc.ox.ac.uk	Ricci-Cabello, Ignacio/C-5770-2012; Ricci-Cabello, Ignacio/A-6141-2017; Rojas Garcia, Antonio/GPX-8129-2022; Garcia, Antonio Rojas/AAA-1422-2021	Ricci-Cabello, Ignacio/0000-0002-4725-8274; Ricci-Cabello, Ignacio/0000-0002-4725-8274; Rojas Garcia, Antonio/0000-0002-7792-4311; Goncalves Bradley, Daniela/0000-0002-5186-3792; Ruiz-Perez, Isabel/0000-0002-9565-0502	National Institute of Health Carlos III [PS09/00747]	National Institute of Health Carlos III	Source of funding: National Institute of Health Carlos III (http://www.isciii.es/). Grant number PS09/00747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Anderson-Loftin W, 2005, DIABETES EDUCATOR, V31, P555, DOI 10.1177/0145721705278948; Anderson-Loftin W, 2002, DIABETES EDUCATOR, V28, P245, DOI 10.1177/014572170202800210; Andrus MR, 2004, J COMMUN HEALTH, V29, P29, DOI 10.1023/B:JOHE.0000007443.96138.03; Balamurugan Appathurai, 2006, Prev Chronic Dis, V3, pA15; Balamurugan A, 2009, DIABETES EDUCATOR, V35, P147, DOI 10.1177/0145721708326988; Bhattacharya G, 2012, J IMMIGR MINOR HLTH; Bray P, 2005, DIABETES EDUCATOR, V31, P712, DOI 10.1177/0145721705280830; Bray P, 2005, J RURAL HEALTH, V21, P317, DOI 10.1111/j.1748-0361.2005.tb00101.x; Brown SA, 2002, DIABETES CARE, V25, P259, DOI 10.2337/diacare.25.2.259; Clancy C, 2009, NATL HEALTHCARE DISP; Coon P, 2002, DIABETES CARE, V25, P2224, DOI 10.2337/diacare.25.12.2224; Dansky KH, 1998, J RURAL HEALTH, V14, P129, DOI 10.1111/j.1748-0361.1998.tb00614.x; Davis RM, 2010, DIABETES CARE, V33, P1712, DOI 10.2337/dc09-1919; Dettori N, 2005, J RURAL HEALTH, V21, P172, DOI 10.1111/j.1748-0361.2005.tb00078.x; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Eakin EG, 2002, DIABETES-METAB RES, V18, P26, DOI 10.1002/dmrr.266; Glazier RH, 2006, DIABETES CARE, V29, P1675, DOI 10.2337/dc05-1942; Hawthorne K, 2008, DIABETIC MED, V27, P613; Izquierdo R, 2010, DIABETES TECHNOL THE, V12, P213, DOI 10.1089/dia.2009.0102; Johnson Elizabeth A, 2005, Prev Chronic Dis, V2, pA08; Johnson JA, 2005, DIABETES CARE, V28, P783, DOI 10.2337/diacare.28.4.783; Kirkman MS, 2002, DIABETES CARE, V25, P1946, DOI 10.2337/diacare.25.11.1946; Koopman RJ, 2006, J RURAL HEALTH, V22, P63, DOI 10.1111/j.1748-0361.2006.00009.x; Kotani Kazuhiko, 2004, Aust J Rural Health, V12, P251, DOI 10.1111/j.1440-1854.2004.00626.x; Krishna S, 2010, J RURAL HEALTH, V26, P3, DOI 10.1111/j.1748-0361.2009.00259.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maddigan SL, 2004, DIABETES CARE, V27, P1306, DOI 10.2337/diacare.27.6.1306; Mainous AG, 2004, ANN FAM MED, V2, P563, DOI 10.1370/afm.119; Majumdar SR, 2003, DIABETES CARE, V26, P3061, DOI 10.2337/diacare.26.11.3061; Mayer-Davis EJ, 2004, AM J PUBLIC HEALTH, V94, P1736, DOI 10.2105/AJPH.94.10.1736; McIlhenny CV, 2011, RURAL REMOTE HEALTH, V11; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mudaliar U, 2013, DIABETES RES CLIN PR, V100, P306, DOI 10.1016/j.diabres.2013.01.010; Nelson S, 2008, CURR MED RES OPIN, V24, P3129, DOI [10.1185/03007990802467502, 10.1185/03007990802467502 ]; O'Brien T, 2008, DIABETES EDUCATOR, V34, P334, DOI 10.1177/0145721708316318; Organization for Economic, 2012, LIST OECD MEMB COUNT; Pollard C, 2009, J RURAL HEALTH, V25, P77, DOI 10.1111/j.1748-0361.2009.00202.x; Ricci-Cabello I, 2010, HEALTH SOC CARE COMM, V18, P572, DOI 10.1111/j.1365-2524.2010.00960.x; Ricci-Cabello I, 2013, DIABETES CARE, V36, P760, DOI 10.2337/dc12-1057; Seid M., 2006, QUALITY IMPROVEMENT; Shea S, 2006, J AM MED INFORM ASSN, V13, P40, DOI 10.1197/jamia.M1917; Shea S, 2009, J AM MED INFORM ASSN, V16, P446, DOI 10.1197/jamia.M3157; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Siminerio LM, 2005, DIABETES EDUCATOR, V31, P225, DOI 10.1177/0145721705275325; Smith L, 2000, DIABETES EDUCATOR, V26, P645, DOI 10.1177/014572170002600412; Stone MA, 2013, DIABETES CARE, V36, P2628, DOI 10.2337/dc12-1759; Strauss K, 2006, J GEN INTERN MED, V21, P378, DOI 10.1111/j.1525-1497.2006.00386.x; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Trief PM, 2007, DIABETES CARE, V30, P1266, DOI 10.2337/dc06-2476; Utz SW, 2006, FAM COMMUNITY HEALTH, V29, P195, DOI 10.1097/00003727-200607000-00006; Weeks WB, 2008, J RURAL HEALTH, V24, P337, DOI 10.1111/j.1748-0361.2008.00179.x; Weinstock RS, 2011, DIABETES CARE, V34, P274, DOI 10.2337/dc10-1346; Weinstock RS, 2011, AGE AGEING, V40, P98, DOI 10.1093/ageing/afq147; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Zgibor Janice C, 2011, J Diabetes Sci Technol, V5, P494; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004; Zoorob RJ, 1996, J COMMUN HEALTH, V21, P175, DOI 10.1007/BF01557997	60	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84464	10.1371/journal.pone.0084464	http://dx.doi.org/10.1371/journal.pone.0084464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HY	24367662	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900048
J	Carroll, SY; O'Mahony, SM; Grenham, S; Cryan, JF; Hyland, NP				Carroll, Siobhan Yvonne; O'Mahony, Siobhain Mary; Grenham, Susan; Cryan, John Francis; Hyland, Niall Patrick			Disodium Cromoglycate Reverses Colonic Visceral Hypersensitivity and Influences Colonic Ion Transport in a Stress-Sensitive Rat Strain	PLOS ONE			English	Article							NEONATAL MATERNAL-DEPRIVATION; CONNECTIVE-TISSUE-TYPE; LONG-TERM ALTERATIONS; MOUSE MAST-CELLS; SODIUM CROMOGLYCATE; ANTIALLERGIC COMPOUNDS; HISTAMINE-RELEASE; RESTRAINT STRESS; FIBROBLASTS; ANAPHYLAXIS	The interface between psychiatry and stress-related gastrointestinal disorders (GI), such as irritable bowel syndrome (IBS), is well established, with anxiety and depression the most frequently occurring comorbid conditions. Moreover, stress-sensitive Wistar Kyoto (WKY) rats, which display anxiety-and depressive-like behaviors, exhibit GI disturbances akin to those observed in stress-related GI disorders. Additionally, there is mounting preclinical and clinical evidence implicating mast cells as significant contributors to the development of abdominal visceral pain in IBS. In this study we examined the effects of the rat connective tissue mast cell (CTMC) stabiliser, disodium cromoglycate (DSCG) on visceral hypersensitivity and colonic ion transport, and examined both colonic and peritoneal mast cells from stress-sensitive WKY rats. DSCG significantly decreased abdominal pain behaviors induced by colorectal distension in WKY animals independent of a reduction in colonic rat mast cell mediator release. We further demonstrated that mast cell-stimulated colonic ion transport was sensitive to inhibition by the mast cell stabiliser DSCG, an effect only observed in stress-sensitive rats. Moreover, CTMC-like mast cells were significantly increased in the colonic submucosa of WKY animals, and we observed a significant increase in the proportion of intermediate, or immature, peritoneal mast cells relative to control animals. Collectively our data further support a role for mast cells in the pathogenesis of stress-related GI disorders.	[Carroll, Siobhan Yvonne; O'Mahony, Siobhain Mary; Grenham, Susan; Cryan, John Francis; Hyland, Niall Patrick] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Carroll, Siobhan Yvonne; Hyland, Niall Patrick] Natl Univ Ireland Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland; [O'Mahony, Siobhain Mary; Grenham, Susan; Cryan, John Francis] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland	University College Cork; University College Cork; University College Cork	Hyland, NP (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.	n.hyland@ucc.ie	O'Mahony, Siobhain M./AAE-9167-2021; Cryan, John F./A-6950-2013	O'Mahony, Siobhain M./0000-0002-9597-9391; Cryan, John F./0000-0001-5887-2723; Hyland, Niall/0000-0003-0060-7390	Science Foundation Ireland [02/CE/B124, 07/CE/B1368]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland through a Centre Grant to the Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland (02/CE/B124 and 07/CE/B1368). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRE F, 1983, DIGESTION, V28, P108, DOI 10.1159/000198972; ARRUZAZABALA MD, 1982, AGENTS ACTIONS, V12, P596, DOI 10.1007/BF01965066; Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055; Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Barreau F, 2008, GUT, V57, P582, DOI 10.1136/gut.2007.126680; Barreau F, 2004, GASTROENTEROLOGY, V127, P524, DOI 10.1053/j.gastro.2004.05.019; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Buhner S, 2009, GASTROENTEROLOGY, V137, P1425, DOI 10.1053/j.gastro.2009.07.005; Cenac N, 2007, J CLIN INVEST, V117, P636, DOI 10.1172/JCI29255; Collins CB, 2007, POULTRY SCI, V86, P843, DOI 10.1093/ps/86.5.843; CROSSMAN DC, 1993, J APPL PHYSIOL, V75, P167, DOI 10.1152/jappl.1993.75.1.167; DAYTON ET, 1988, P NATL ACAD SCI USA, V85, P569, DOI 10.1073/pnas.85.2.569; DIXON M, 1980, BRIT J PHARMACOL, V70, P11, DOI 10.1111/j.1476-5381.1980.tb10898.x; Dong Wen Zhu, 2004, Chin J Dig Dis, V5, P103, DOI 10.1111/j.1443-9573.2004.00168.x; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Eleno N, 1999, PULM PHARMACOL THER, V12, P55, DOI 10.1006/pupt.1999.0171; ENERBACK L, 1985, BIOCHEM J, V227, P661, DOI 10.1042/bj2270661; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P313, DOI 10.1111/apm.1966.66.3.313; Folks David G, 2004, Curr Psychiatry Rep, V6, P210, DOI 10.1007/s11920-004-0066-0; Gibney SM, 2010, NEUROSCIENCE, V165, P675, DOI 10.1016/j.neuroscience.2009.08.076; GIBSON S, 1987, IMMUNOLOGY, V62, P621; Greenwood-van Meerveld B, 2005, NEUROGASTROENT MOTIL, V17, P415, DOI 10.1111/j.1365-2982.2005.00648.x; Gunter WD, 2000, PHYSIOL BEHAV, V69, P379, DOI 10.1016/S0031-9384(99)00254-1; Hyland NP, 2009, GUT, V58, P1029, DOI 10.1136/gut.2008.167882; Inagaki N, 2001, BIOL PHARM BULL, V24, P829, DOI 10.1248/bpb.24.829; KANAKURA Y, 1988, BLOOD, V72, P877; La Jun-Ho, 2004, J Vet Sci, V5, P319; Larauche M, 2011, J NEUROGASTROENTEROL, V17, P213, DOI 10.5056/jnm.2011.17.3.213; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; LOBO B, 2009, GASTROENTEROLOGY S1, V140, pS499; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Manchanda RK, 2011, PHARMACOL REP, V63, P54, DOI 10.1016/S1734-1140(11)70398-X; Martinez V, 2007, N-S ARCH PHARMACOL, V376, P205, DOI 10.1007/s00210-007-0195-1; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Michaloudi HC, 1999, J ANAT, V195, P577, DOI 10.1046/j.1469-7580.1999.19540577.x; MILLER HRP, 1972, AM J PATHOL, V69, P195; MOSS GF, 1970, TOXICOL APPL PHARM, V17, P691, DOI 10.1016/0041-008X(70)90043-8; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nautiyal KM, 2008, P NATL ACAD SCI USA, V105, P18053, DOI 10.1073/pnas.0809479105; O'Mahony CM, 2011, PHARMACOL BIOCHEM BE, V97, P690, DOI 10.1016/j.pbb.2010.11.012; O'Mahony SM, 2010, NEUROGASTROENT MOTIL, V22, P573, DOI 10.1111/j.1365-2982.2009.01432.x; O'Mahony Siobhain M, 2012, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0940s61; O'Malley D, 2010, NEUROGASTROENT MOTIL, V22, P301, DOI 10.1111/j.1365-2982.2009.01412.x; O'Malley D, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00190; Ohashi K, 2007, J VET MED SCI, V69, P1223, DOI 10.1292/jvms.69.1223; Oka T, 2012, LAB INVEST, V92, P1472, DOI 10.1038/labinvest.2012.116; Park JH, 2006, J GASTROEN HEPATOL, V21, P71, DOI 10.1111/j.1440-1746.2005.04143.x; PEARCE FL, 1982, J IMMUNOL, V128, P2481; PEARCE FL, 1982, AGENTS ACTIONS, V12, P183, DOI 10.1007/BF01965140; PERDUE MH, 1985, J ALLERGY CLIN IMMUN, V76, P498, DOI 10.1016/0091-6749(85)90733-X; REYNOLDS DS, 1988, J BIOL CHEM, V263, P12783; Santos J, 2008, PSYCHONEUROENDOCRINO, V33, P1248, DOI 10.1016/j.psyneuen.2008.07.002; Saunders PR, 2002, DIGEST DIS SCI, V47, P208, DOI 10.1023/A:1013204612762; Schemann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052104; SCOTT RB, 1993, DIGEST DIS SCI, V38, P396, DOI 10.1007/BF01316490; SHANAHAN F, 1986, INT ARCH ALLER A IMM, V80, P424, DOI 10.1159/000234092; Sugimoto Y, 1998, GEN PHARMACOL, V31, P613, DOI 10.1016/S0306-3623(98)00063-9; Tariq Mohammad, 2006, Inflammopharmacology, V14, P163, DOI 10.1007/s10787-006-1524-6; Trezena AG, 2003, MEDIAT INFLAMM, V12, P237, DOI 10.1080/09629350310001599684; van den Wijngaard R. M., 2009, NEUROGASTROENT MOTIL, V21, P1107, DOI DOI 10.1111/J.1365-2982.2009.01339.X.PUBMED:19523146; Vergnolle N, 1998, GASTROENTEROLOGY, V114, pA429; Zuo YX, 2003, PAIN, V105, P467, DOI 10.1016/S0304-3959(03)00261-6	62	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84718	10.1371/journal.pone.0084718	http://dx.doi.org/10.1371/journal.pone.0084718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367692	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300157
J	Estrada-Sanchez, AM; Barton, SJ; Burroughs, CL; Doyle, AR; Rebec, GV				Estrada-Sanchez, Ana Maria; Barton, Scott J.; Burroughs, Courtney L.; Doyle, Amanda R.; Rebec, George V.			Dysregulated Striatal Neuronal Processing and Impaired Motor Behavior in Mice Lacking Huntingtin Interacting Protein 14 (HIP14)	PLOS ONE			English	Article							CORTICOSTRIATAL CIRCUIT DYSFUNCTION; MOUSE MODEL; SYNAPTIC PLASTICITY; NEURAL INFORMATION; NMDA RECEPTOR; BASAL GANGLIA; SPIKE TRAINS; PALMITOYLATION; TRAFFICKING; DOPAMINE	Palmitoyl acyl transferases (PATs) play a critical role in protein trafficking and function. Huntingtin interacting protein 14 (HIP14) is a PAT that acts on proteins associated with neuronal transmission, suggesting that deficient protein palmitoylation by HIP14, which occurs in the YAC128 model of Huntington's disease (HD), might have deleterious effects on neurobehavioral processing. HIP14 knockout mice show biochemical and neuropathological changes in the striatum, a forebrain region affected by HD that guides behavioral choice and motor flexibility. Thus, we evaluated the performance of these mice in two tests of motor ability: nest-building and plus maze turning behavior. Relative to wild-type controls, HIP14 knockout mice show impaired nest building and decreased turning in the plus maze. When we recorded the activity of striatal neurons during plus-maze performance, we found faster firing rates and dysregulated spike bursting in HIP14 knockouts compared to wild-type. There was also less correlated firing between simultaneously recorded neuronal pairs in the HIP14 knockouts. Overall, our results indicate that HIP14 is critically involved in behavioral modulation of striatal processing. In the absence of HIP14, striatal neurons become dysfunctional, leading to impaired motor behavior.	[Rebec, George V.] Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA; Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Rebec, GV (corresponding author), Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA.	rebec@indiana.edu	Estrada-Sánchez, Ana María/AAD-9736-2020	Estrada-Sánchez, Ana María/0000-0002-7191-4446	USPHS [NS035663, AG039818]; Indiana METACyt Initiative of Indiana University; Lilly Endowment, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039818] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Indiana METACyt Initiative of Indiana University; Lilly Endowment, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research by the authors is supported by USPHS grants NS035663 and AG039818, the Indiana METACyt Initiative of Indiana University funded in part by a major grant from the Lilly Endowment, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; ALDRIDGE JW, 1991, BRAIN RES, V543, P123; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Burns SP, 2010, J NEUROSCI, V30, P13739, DOI 10.1523/JNEUROSCI.0743-10.2010; Buzsaki G, 2005, NAT NEUROSCI, V8, P1418, DOI 10.1038/nn1105-1418; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Delint-Ramirez I, 2008, J NEUROCHEM, V106, P1658, DOI 10.1111/j.1471-4159.2008.05523.x; Delint-Ramirez I, 2011, J BIOL CHEM, V286, P32962, DOI 10.1074/jbc.M111.243899; Delint-Ramirez I, 2010, J NEUROSCI, V30, P8162, DOI 10.1523/JNEUROSCI.1792-10.2010; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Estrada-Sanchez AM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00019; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Foster JD, 2011, J BIOL CHEM, V286, P5175, DOI 10.1074/jbc.M110.187872; Fowler SC, 2009, BEHAV BRAIN RES, V202, P130, DOI 10.1016/j.bbr.2009.03.022; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Goytain A, 2008, J BIOL CHEM, V283, P33365, DOI 10.1074/jbc.M801469200; Homayoun L, 2005, J NEUROPHYSIOL, V93, P1989, DOI 10.1152/jn.00875.2004; Hong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030879; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Huang K, 2010, NEUROBIOL DIS, V40, P207, DOI 10.1016/j.nbd.2010.05.027; Huntington G, 2003, J NEUROPSYCH CLIN N, V15, P109, DOI 10.1176/appi.neuropsych.15.1.109; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Keith DJ, 2012, J NEUROSCI, V32, P7119, DOI 10.1523/JNEUROSCI.0784-12.2012; KIRKWOOD PA, 1979, J NEUROSCI METH, V1, P107, DOI 10.1016/0165-0270(79)90009-8; Kong MMC, 2011, BIOCHEM BIOPH RES CO, V405, P445, DOI 10.1016/j.bbrc.2011.01.050; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Miller BR, 2008, J NEUROPHYSIOL, V100, P2205, DOI 10.1152/jn.90606.2008; Miller BR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00026; Miller BR, 2010, FUTUR NEUROL, V5, P735, DOI 10.2217/FNL.10.41; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; NG GYK, 1994, J NEUROCHEM, V63, P1589; NG GYK, 1994, EUR J PHARM-MOLEC PH, V267, P7, DOI 10.1016/0922-4106(94)90219-4; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Rebec GV, 2006, NEUROSCIENCE, V137, P327, DOI 10.1016/j.neuroscience.2005.08.062; Rush DB, 2012, BIOCHEM J, V442, P39, DOI 10.1042/BJ20110679; Sager TN, 2010, BEHAV BRAIN RES, V208, P444, DOI 10.1016/j.bbr.2009.12.014; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Stanford JA, 2001, NEUROBIOL AGING, V22, P659, DOI 10.1016/S0197-4580(00)00257-8; Stowers RS, 2007, J NEUROSCI, V27, P12874, DOI 10.1523/JNEUROSCI.2464-07.2007; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Walker AG, 2008, J NEUROSCI, V28, P8973, DOI 10.1523/JNEUROSCI.2804-08.2008; Wichmann T, 2006, J NEUROPHYSIOL, V95, P2120, DOI 10.1152/jn.01013.2005; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Young FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036315	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84537	10.1371/journal.pone.0084537	http://dx.doi.org/10.1371/journal.pone.0084537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376823	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000155
J	Goncalves, PF; Klepac-Ceraj, V; Huang, H; Paster, BJ; Aukhil, I; Wallet, SM; Shaddox, LM				Goncalves, Patricia F.; Klepac-Ceraj, Vanja; Huang, Hong; Paster, Bruce J.; Aukhil, Ikramuddin; Wallet, Shannon M.; Shaddox, Luciana M.			Correlation of Aggregatibacter actinomycetemcomitans Detection with Clinical/Immunoinflammatory Profile of Localized Aggressive Periodontitis Using a 16S rRNA Microarray Method: A Cross-Sectional Study	PLOS ONE			English	Article							LEUKOTOXIC JP2 CLONE; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; DISEASE; HEALTH	Objective: The objective of this study was to determine whether the detection of Aggregatibacter actinomycetemcomitans (Aa) correlates with the clinical and immunoinflammatory profile of Localized Aggressive Periodontitis (LAP), as determined by by 16S rRNA gene-based microarray. Subjects and Methods: Subgingival plaque samples from the deepest diseased site of 30 LAP patients [ PD >= 5 mm, BoP and bone loss] were analyzed by 16S rRNA gene-based microarrays. Gingival crevicular fluid (GCF) samples were analyzed for 14 cyto/chemokines. Peripheral blood was obtained and stimulated in vitro with P. gingivalis and E. coli to evaluate inflammatory response profiles. Plasma lipopolysaccharide (LPS) levels were also measured. Results: Aa was detected in 56% of LAP patients and was shown to be an indicator for different bacterial community structures (p<0.01). Elevated levels of pro-inflammatory cyto/chemokines were detected in LPS-stimulated blood samples in both Aa-detected and Aa-non-detected groups (p>0.05). Clinical parameters and serum LPS levels were similar between groups. However, Aa-non-detected GCF contained higher concentration of IL-8 than Aa-detected sites (p<0.05). TNF alpha and IL1 beta were elevated upon E. coli LPS stimulation of peripheral blood cells derived from patients with Aa-detected sites. Conclusions: Our findings demonstrate that the detection of Aa in LAP affected sites, did not correlate with clinical severity of the disease at the time of sampling in this cross-sectional study, although it did associate with lower local levels of IL-8, a different subgingival bacterial profile and elevated LPS-induced levels of TNF alpha and IL1 beta.	[Goncalves, Patricia F.] Fed Univ Jequitinhonha & Mucuri Valleys, Dept Dent, Diamantina, MG, Brazil; [Goncalves, Patricia F.; Huang, Hong; Aukhil, Ikramuddin; Wallet, Shannon M.; Shaddox, Luciana M.] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32610 USA; [Klepac-Ceraj, Vanja; Paster, Bruce J.] Fortsyth Inst, Dept Microbial Ecol & Pathogenesis, Cambridge, MA USA; [Klepac-Ceraj, Vanja] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA; [Paster, Bruce J.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); State University System of Florida; University of Florida; Wellesley College; Harvard University; Harvard School of Dental Medicine	Shaddox, LM (corresponding author), Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32610 USA.	lshaddox@dental.ufl.edu	Paster, Bruce J/AAP-8559-2021	Klepac-Ceraj, Vanja/0000-0001-5387-5706	NIH/NIDCR [R01DE019456]; National Council of Technological and Scientific Development, CNPq, Brazil; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019456] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Council of Technological and Scientific Development, CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by NIH/NIDCR R01DE019456 (www.nidcr.nih.gov). PF Goncalves postdoctoral fellowship was supported by the National Council of Technological and Scientific Development, CNPq, Brazil (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Benjamini Y., 1995, J ROYAL STAT SOC B, V57; CHRISTERSSON LA, 1985, J CLIN PERIODONTOL, V12, P465, DOI 10.1111/j.1600-051X.1985.tb01382.x; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Cugini C, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.19804; Ennibi OK, 2012, ACTA ODONTOL SCAND, V70, P318, DOI 10.3109/00016357.2011.642002; Fine DH, 2007, J CLIN MICROBIOL, V45, P3859, DOI 10.1128/JCM.00653-07; Gotelli NJ, 2013, ECOSIMR 1 00; HAFFAJEE AD, 1984, J CLIN PERIODONTOL, V11, P600, DOI 10.1111/j.1600-051X.1984.tb00913.x; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Haubek D, 2010, APMIS, V118, P1, DOI 10.1111/j.1600-0463.2010.02665.x; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Hornik K, 2005, COMPUTATION STAT, V20, P197, DOI 10.1007/BF02789699; Inomata M, 2010, EUR J ORAL SCI, V118, P574, DOI 10.1111/j.1600-0722.2010.00775.x; Kaner D, 2007, J PERIODONTOL, V78, P1201, DOI 10.1902/jop.2007.060437; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Kraus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030716; Lamell CW, 2000, J CLIN MICROBIOL, V38, P1196, DOI 10.1128/JCM.38.3.1196-1199.2000; Lang NP, 1999, ANN PERIODONTOL, V4, P53, DOI DOI 10.1902/ANNALS.1999.4.1.53; Lee SH, 2006, MICROBIOL-SGM, V152, P535, DOI 10.1099/mic.0.28470-0; Leung WK, 2005, J PERIODONTAL RES, V40, P258, DOI 10.1111/j.1600-0765.2005.00805.x; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; MANDELL RL, 1986, J PERIODONTOL, V57, P94, DOI 10.1902/jop.1986.57.2.94; Mombelli A, 2002, J CLIN PERIODONTOL, V29, P10, DOI 10.1034/j.1600-051X.29.s3.1.x; MOORE WEC, 1991, J CLIN PERIODONTOL, V18, P729, DOI 10.1111/j.1600-051X.1991.tb00064.x; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Shaddox L, 2010, J DENT RES, V89, P143, DOI 10.1177/0022034509353397; Shaddox LM, 2012, J DENT RES, V91, P927, DOI 10.1177/0022034512456039; Shaddox LM, 2011, J DENT RES, V90, P1140, DOI 10.1177/0022034511413928; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; ZAMBON JJ, 1983, J PERIODONTOL, V54, P707, DOI 10.1902/jop.1983.54.12.707; Zhao JJ, 2012, INFLAMMATION, V35, P1330, DOI 10.1007/s10753-012-9446-5	33	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85066	10.1371/journal.pone.0085066	http://dx.doi.org/10.1371/journal.pone.0085066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376864	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000176
J	Lambert, JE; Ryan, EA; Thomson, ABR; Clandinin, MT				Lambert, Jennifer E.; Ryan, Edmond A.; Thomson, Alan B. R.; Clandinin, Michael T.			De Novo Lipogenesis and Cholesterol Synthesis in Humans with Long-Standing Type 1 Diabetes Are Comparable to Non-Diabetic Individuals	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; INSULIN-RESISTANCE; HIGH-CARBOHYDRATE; DEUTERATED WATER; DIETARY-FAT; CARDIOVASCULAR-DISEASE; TRIGLYCERIDE SYNTHESIS; LDL CHOLESTEROL; DEUTERIUM-OXIDE; ABSORPTION	Background: Synthesis of lipid species, including fatty acids (FA) and cholesterol, can contribute to pathological disease. The purpose of this study was to investigate FA and cholesterol synthesis in individuals with type 1 diabetes, a group at elevated risk for vascular disease, using stable isotope analysis. Methods: Individuals with type 1 diabetes (n = 9) and age-, sex-, and BMI-matched non-diabetic subjects (n = 9) were recruited. On testing day, meals were provided to standardize food intake and elicit typical feeding responses. Blood samples were analyzed at fasting (0 and 24 h) and postprandial (2, 4, 6, and 8 hours after breakfast) time points. FA was isolated from VLDL to estimate hepatic FA synthesis, whereas free cholesterol (FC) and cholesteryl ester (CE) was isolated from plasma and VLDL to estimate whole-body and hepatic cholesterol synthesis, respectively. Lipid synthesis was measured using deuterium incorporation and isotope ratio mass spectrometry. Results: Fasting total hepatic lipogenesis (3.91 +/- 0.90% vs. 5.30 +/- 1.22%; P = 0.41) was not significantly different between diabetic and control groups, respectively, nor was synthesis of myristic (28.60 +/- 4.90% vs. 26.66 +/- 4.57%; P = 0.76), palmitic (12.52 +/- 2.75% vs. 13.71 +/- 2.64%; P = 0.65), palmitoleic (3.86 +/- 0.91% vs. 4.80 +/- 1.22%; P = 0.65), stearic (5.55 +/- 1.04% vs. 6.96 +/- 0.97%; P = 0.29), and oleic acid (1.45 +/- 0.28% vs. 2.10 +/- 0.51%; P = 0.21). Postprandial lipogenesis was also not different between groups (P = 0.38). Similarly, fasting synthesis of whole-body FC (8.2 +/- 1.3% vs. 7.3 +/- 0.8%/day; P = 0.88) and CE (1.9 +/- 0.4% vs. 2.0 +/- 0.3%/day; P = 0.96) and hepatic FC (8.2 +/- 2.0% vs. 8.1 +/- 0.8%/day; P = 0.72) was not significantly different between diabetic and control subjects. Conclusions: Despite long-standing disease, lipogenesis and cholesterol synthesis was not different in individuals with type 1 diabetes compared to healthy non-diabetic humans.	[Lambert, Jennifer E.; Thomson, Alan B. R.; Clandinin, Michael T.] Univ Alberta, Alberta Inst Human Nutr, Edmonton, AB, Canada; [Ryan, Edmond A.; Thomson, Alan B. R.; Clandinin, Michael T.] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Alberta	Lambert, JE (corresponding author), Univ Alberta, Alberta Inst Human Nutr, Edmonton, AB, Canada.	jel.lambert@gmail.com			Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by the Canadian Institutes of Health Research (project funds, to MTC, and training scholarship, to JEL) (http://www.cihr-irsc.gc.ca/e/193.html) and the Natural Sciences and Engineering Research Council of Canada (to MTC) (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE S1, V35, pS4, DOI DOI 10.2337/DC12-S004; Bergman BC, 2013, J CLIN ENDOCR METAB, V98, pE40, DOI 10.1210/jc.2012-2892; Bergman BC, 2012, J CLIN ENDOCR METAB, V97, P1663, DOI 10.1210/jc.2011-3172; Berthold HK, 2010, LIPIDS, V45, P491, DOI 10.1007/s11745-010-3420-5; Bloks VW, 2004, DIABETOLOGIA, V47, P104, DOI 10.1007/s00125-003-1261-y; Browning JD, 2011, AM J CLIN NUTR, V93, P1048, DOI 10.3945/ajcn.110.007674; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Dagher F J, 1965, Adv Surg, V1, P69; DECUYPER I, 1993, CLIN CHIM ACTA, V219, P123, DOI 10.1016/0009-8981(93)90203-G; Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; FEINGOLD KR, 1990, ENDOCRINOLOGY, V127, P2247, DOI 10.1210/endo-127-5-2247; GOODMAN DS, 1980, J LIPID RES, V21, P699; Gremaud G, 2001, RAPID COMMUN MASS SP, V15, P1207, DOI 10.1002/rcm.365; Gylling H, 2004, DIABETES, V53, P2217, DOI 10.2337/diabetes.53.9.2217; Gylling H, 2007, DIABETES-METAB RES, V23, P372, DOI 10.1002/dmrr.697; Hallikainen M, 2011, ATHEROSCLEROSIS, V217, P473, DOI 10.1016/j.atherosclerosis.2011.03.041; Harding SV, 2010, J NUTR, V140, P1249, DOI 10.3945/jn.109.120311; Hudgins LC, 2000, J LIPID RES, V41, P595; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Hudgins LC, 1998, AM J CLIN NUTR, V67, P631, DOI 10.1093/ajcn/67.4.631; JONES PJH, 1990, CAN J PHYSIOL PHARM, V68, P955, DOI 10.1139/y90-145; JONES PJH, 1993, METABOLISM, V42, P1065, DOI 10.1016/0026-0495(93)90024-I; JONES PJH, 1994, ARTERIOSCLER THROMB, V14, P542, DOI 10.1161/01.ATV.14.4.542; Jones PJH, 1996, ARTERIOSCL THROM VAS, V16, P1222, DOI 10.1161/01.ATV.16.10.1222; JONES PJH, 1993, ARTERIOSCLER THROMB, V13, P247, DOI 10.1161/01.ATV.13.2.247; JUNGAS RL, 1968, BIOCHEMISTRY-US, V7, P3708, DOI 10.1021/bi00850a050; Konrad SD, 1998, BBA-LIPID LIPID MET, V1393, P143, DOI 10.1016/S0005-2760(98)00061-7; Lammert O, 2000, BRIT J NUTR, V84, P233; LEITCH CA, 1991, BIOL MASS SPECTROM, V20, P392, DOI 10.1002/bms.1200200611; Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539; Maahs DM, 2010, DIABETES, V59, P1771, DOI 10.2337/db09-1626; Maahs DM, 2005, DIABETES CARE, V28, P301, DOI 10.2337/diacare.28.2.301; MacKay D, 2011, ATHEROSCLEROSIS, V218, P253, DOI 10.1016/j.atherosclerosis.2010.04.022; Mangat R, 2011, DIABETIC MED, V28, P61, DOI 10.1111/j.1464-5491.2010.03138.x; Marques-Lopes I, 2001, AM J CLIN NUTR, V73, P253; Matthan NR, 2000, LIPIDS, V35, P1037, DOI 10.1007/s11745-000-0616-9; Mazier MJP, 1997, J NUTR, V127, P332, DOI 10.1093/jn/127.2.332; McDevitt RM, 2001, AM J CLIN NUTR, V74, P737; Miettinen TA, 2004, DIABETES CARE, V27, P53, DOI 10.2337/diacare.27.1.53; Myrie SB, 2012, AM J CLIN NUTR, V95, P837, DOI 10.3945/ajcn.111.028985; Orchard TJ, 2010, CURR DIABETES REP, V10, P48, DOI 10.1007/s11892-009-0089-3; Pappu AS, 2003, J LAB CLIN MED, V141, P250, DOI 10.1067/mlc.2003.31; Parks EJ, 2008, J NUTR, V138, P1039, DOI 10.1093/jn/138.6.1039; Pfohl M, 1998, EUR J CLIN INVEST, V28, P491; Pouteau E, 2003, ISOT ENVIRON HEALT S, V39, P247, DOI 10.1080/10256010310001621155; Raeini-Sarjaz M, 2001, AM J CLIN NUTR, V73, P262; Rideout TC, 2010, AM J CLIN NUTR, V92, P41, DOI 10.3945/ajcn.2009.29073; Rideout TC, 2010, TRANSL RES, V155, P220, DOI 10.1016/j.trsl.2009.12.005; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Schauer IE, 2011, DIABETES, V60, P306, DOI 10.2337/db10-0328; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Schwarz JM, 1995, J CLIN INVEST, V96, P2735, DOI 10.1172/JCI118342; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Sittiwet C, 2007, ATHEROSCLEROSIS, V194, P465, DOI 10.1016/j.atherosclerosis.2006.08.044; Su Jenny W, 2009, Diabetes Care, V32, pe21, DOI 10.2337/dc08-1573; Targher G, 2010, J HEPATOL, V53, P713, DOI 10.1016/j.jhep.2010.04.030; Tremblay AJ, 2010, J LIPID RES; Wilke MS, 2009, DIABETOLOGIA, V52, P1628, DOI 10.1007/s00125-009-1405-9	61	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82530	10.1371/journal.pone.0082530	http://dx.doi.org/10.1371/journal.pone.0082530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376543	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000015
J	Bustamante, HA; Rivera-Dictter, A; Cavieres, VA; Munoz, VC; Gonzalez, A; Lin, YM; Mardones, GA; Burgos, PV				Bustamante, Hianara A.; Rivera-Dictter, Andres; Cavieres, Viviana A.; Munoz, Vanessa C.; Gonzalez, Alexis; Lin, Yimo; Mardones, Gonzalo A.; Burgos, Patricia V.			Turnover of C99 is Controlled by a Crosstalk between ERAD and Ubiquitin-Independent Lysosomal Degradation in Human Neuroglioma Cells	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANS-GOLGI NETWORK; C-TERMINAL FRAGMENT; ALZHEIMERS-DISEASE; A-BETA; GAMMA-SECRETASE; APP; ACCUMULATION; PROTEASOME; GENERATION	Alzheimer's disease AD characterized by the buildup of amyloid-beta peptide (A beta) aggregates derived from proteolytic processing of the beta-amyloid precursor protein (APP). Amyloidogenic cleavage of APP by beta-secretase/BACE1 generates the C-terminal fragment C99/CTF beta that can be subsequently cleaved by gamma-secretase to produce A beta Growing evidence indicates high levels of C99/CTF beta are determinant for AD. Although it has been postulated that gamma-secretase-independent pathways must control C99/CTF beta levels, the contribution of organelles with degradative functions, such as the endoplasmic reticulum (ER) or lysosomes, is unclear. In this report, we investigated the turnover and amyloidogenic processing of C99/CTF beta in human H4 neurogliama cells, and found that C99/CTF beta is localized at the Golgi apparatus in contrast to APP, which is mostly found in endosomes. Conditions that localized C99/CTF beta to the ER resulted in its degradation in a proteasome. dependent manner that first required polyubiquitination, consistent with an active role of the ER associated degradation ERAD) in this process Furthermore, when proteasomal activity was inhibited C99/CTF beta was degraded in a chloroquine (CQ)-sensitive compartment, implicating lysosomes as alternative sites for its degradation. Our results highlight a crosstalk between degradation pathways within the ER and lysosomes to avoid protein accumulation and toxicity.	[Burgos, Patricia V.] Univ Austral Chile, Dept Physiol, Sch Med, Valdivia, Chile; Univ Austral Chile, Ctr Invest Sur Austral Enfermedades Sistema Nervi, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile	Burgos, PV (corresponding author), Univ Austral Chile, Dept Physiol, Sch Med, Valdivia, Chile.	patricia.burgos@uach.cl			Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [1100027, 1130929, 1100896]	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by Grants 1100027 (PVB), 1130929 (PVB) and 1100896 (GAM) from Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT; www.fondecyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2012, J ALZHEIMERS DIS, V31, P343, DOI 10.3233/JAD-2012-120001; Baulac S, 2003, NEUROBIOL DIS, V14, P194, DOI 10.1016/S0969-9961(03)00123-2; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Burgos PV, 2004, P NATL ACAD SCI USA, V101, P3845, DOI 10.1073/pnas.0400295101; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Guo CJ, 2011, J VIROL, V85, P6416, DOI 10.1128/JVI.01500-10; HAASS C, 1993, ANN NY ACAD SCI, V695, P109, DOI 10.1111/j.1749-6632.1993.tb23037.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Herskowitz JH, 2012, MOL BIOL CELL, V23, P2645, DOI 10.1091/mbc.E12-01-0014; Inestrosa NC, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.19; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Johannes L, 1998, TRENDS CELL BIOL, V8, P158, DOI 10.1016/S0962-8924(97)01209-9; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; KOO EH, 1994, J BIOL CHEM, V269, P17386; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Lamb CA, 2010, TRAFFIC, V11, P1445, DOI 10.1111/j.1600-0854.2010.01113.x; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Mardones GA, 2006, MOL BIOL CELL, V17, P525, DOI 10.1091/mbc.E05-05-0447; Mardones GA, 2007, MOL BIOL CELL, V18, P3486, DOI 10.1091/mbc.E07-02-0190; MARTIN BL, 1995, J BIOL CHEM, V270, P26727, DOI 10.1074/jbc.270.45.26727; Nunan J, 2003, J NEUROSCI RES, V74, P378, DOI 10.1002/jnr.10646; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Schmitz A, 2004, TRAFFIC, V5, P89, DOI 10.1111/j.1600-0854.2004.00159.x; Selivanova A, 2007, BIOCHEM BIOPH RES CO, V357, P1034, DOI 10.1016/j.bbrc.2007.04.062; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wang SY, 2011, J BIOL CHEM, V286, P29376, DOI 10.1074/jbc.M111.233346; Watanabe T, 2012, J NEUROSCI, V32, P3352, DOI 10.1523/JNEUROSCI.5659-11.2012; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957; Yuyama K, 2006, FEBS LETT, V580, P6972, DOI 10.1016/j.febslet.2006.11.072; Zhang LL, 1999, J BIOL CHEM, V274, P8966, DOI 10.1074/jbc.274.13.8966	54	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83096	10.1371/journal.pone.0083096	http://dx.doi.org/10.1371/journal.pone.0083096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376644	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100089
J	Diwakar, L; Morris, RK; Barton, P; Middleton, LJ; Kilby, MD; Roberts, TE				Diwakar, Lavanya; Morris, Rachel K.; Barton, Pelham; Middleton, Lee J.; Kilby, Mark D.; Roberts, Tracy E.			Evaluation of the Cost Effectiveness of Vesico-Amniotic Shunting in the Management of Congenital Lower Urinary Tract Obstruction (Based on Data from the PLUTO Trial)	PLOS ONE			English	Article							POSTERIOR URETHRAL VALVES; INTERVENTION	Objective: To determine the cost-effectiveness of in-utero percutaneous Vesico Amniotic Shunt (VAS) in the management of fetal lower urinary tract obstruction (LUTO) Design: Model based economic analysis using data from the randomised controlled arm of the PLUTO (percutaneous vesico-amniotic shunting for lower urinary tract obstruction) trial. Setting: Fetal medicine departments in United Kingdom, Ireland and Netherlands. Population or Sample: Pregnant women with a male, singleton fetus with LUTO. Methods: Costs and outcomes were prospectively collected in the trial; three separate base case analyses were performed using the intention to treat (ITT), per protocol and uniform prior methods. Deterministic and probabilistic sensitivity analyses were performed to explore data uncertainty. Main Outcome Measures: Survival at 28 days, 1 year and disease free survival at 1 year. Results: VAS was more expensive but appeared to result in higher rates of survival compared with conservative management in patients with LUTO. Using ITT analysis the incremental cost effectiveness ratios based on outcomes of survival at 28 days, 1 year, or 1 morbidity-free year on the VAS arm were 15,506 pound, 15,545 pound and 43,932 pound, respectively. Conclusions: VAS is a more expensive option compared to the conservative approach in the management of individuals with LUTO. Data from the RCT suggest that VAS improves neonatal survival but does not result in significant improvements in morbidity. Our analysis concludes that VAS is not likely to be cost effective in the management of these patients given the NICE (National Institute of Health and Clinical Excellence) cost threshold of 20,000 pound per QALY.	[Diwakar, Lavanya; Barton, Pelham; Roberts, Tracy E.] Univ Birmingham, Sch Hlth & Populat Sci, Hlth Econ Unit, Birmingham, W Midlands, England; [Morris, Rachel K.; Kilby, Mark D.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Middleton, Lee J.] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England; [Morris, Rachel K.; Kilby, Mark D.] Birmingham Womens Hosp NHS Fdn Trust, Fetal Med Ctr, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; Birmingham Women's Hospital	Roberts, TE (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Hlth Econ Unit, Public Hlth Bldg, Birmingham, W Midlands, England.	t.e.roberts@bham.ac.uk	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020; Diwakar, Lavanya/G-7425-2016; Roberts, Tracy/AAO-4610-2021	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; Diwakar, Lavanya/0000-0003-4369-6637; Roberts, Tracy/0000-0002-0624-0537; Middleton, Lee/0000-0003-4621-1922; Morris, Katie/0000-0003-1247-429X	NIHR HTA; Wellbeing of Women (UK); HTA; National Institute for Health Research [07/01/44] Funding Source: researchfish	NIHR HTA; Wellbeing of Women (UK)(Wellbeing of Women (WoW)); HTA; National Institute for Health Research(National Institute for Health Research (NIHR))	ISRCTN53328556. Funded by the NIHR HTA programme between September 2008 and September 2012 and by Wellbeing of Women (UK) between 2005 to 2008. HTA funding URL: http://www.hta.ac.uk/project/1732.asp. URL of this project on the Controlled Trials Website: http://www.controlled-trials.com/ ISRCTN53328556. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535; Biard JM, 2005, OBSTET GYNECOL, V106, P503, DOI 10.1097/01.AOG.0000171117.38929.eb; Clark TJ, 2003, OBSTET GYNECOL, V102, P367, DOI 10.1016/S0029-7844(03)00577-5; CROMBLEHOLME TM, 1990, AM J OBSTET GYNECOL, V162, P1239, DOI 10.1016/0002-9378(90)90026-4; Curtis L, 2015, UNIT COSTS HLTH SOCI; Department of Health, 2011, CONF PAYM RES PBR AR; Drummond MF, 2005, METHODS EC EVALUATIO, P27; HUTTON KAR, 1994, J UROLOGY, V152, P698, DOI 10.1016/S0022-5347(17)32684-8; Merrill DC, 1997, FETAL THERAPY INVASI; Morris R, PLUTO STUDY IN PRESS; Morris RK, 2010, BJOG-INT J OBSTET GY, V117, P382, DOI 10.1111/j.1471-0528.2010.02500.x; Morris RK, 2009, BJOG-INT J OBSTET GY, V116, P1290, DOI 10.1111/j.1471-0528.2009.02194.x; Morris RK, 2013, LANCET; Morris RC, 2009, TLS-TIMES LIT SUPPL, P6; NAKAYAMA DK, 1986, J PEDIATR SURG, V21, P43, DOI 10.1016/S0022-3468(86)80651-0; National Institute for Health and Care Excellence, 2006, FET VES AMN SHUNT LO; National Institute for Health and Clinical Excellence (NICE), 2008, UPD GUID METH TECHN; Ylinen E, 2004, PEDIATR NEPHROL, V19, P874, DOI 10.1007/s00467-004-1474-4	18	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82564	10.1371/journal.pone.0082564	http://dx.doi.org/10.1371/journal.pone.0082564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376546	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100038
J	Nie, Y; Liu, Q; Liu, SY				Nie, Yong; Liu, Qiao; Liu, Shiyin			Glacial Lake Expansion in the Central Himalayas by Landsat Images, 1990-2010	PLOS ONE			English	Article							MOUNT EVEREST REGION; MT. QOMOLANGMA EVEREST; MORAINE-DAMMED LAKES; OUTBURST FLOODS; VICINITY; HAZARDS; BASIN	Glacial lake outburst flood (GLOF) is a serious hazard in high, mountainous regions. In the Himalayas, catastrophic risks of GLOFs have increased in recent years because most Himalayan glaciers have experienced remarkable downwasting under a warming climate. However, current knowledge about the distribution and recent changes in glacial lakes within the central Himalaya mountain range is still limited. Here, we conducted a systematic investigation of the glacial lakes within the entire central Himalaya range by using an object-oriented image processing method based on the Landsat Thematic Mapper (TM) or Enhanced Thematic Mapper (ETM) images from 1990 to 2010. We extracted the lake boundaries for four time points (1990, 2000, 2005 and 2010) and used a time series inspection method combined with a consistent spatial resolution of Landsat images that consistently revealed lake expansion. Our results show that the glacial lakes expanded rapidly by 17.11% from 1990 to 2010. The pre-existing, larger glacial lakes, rather than the newly formed lakes, contributed most to the areal expansion. The greatest expansions occurred at the altitudinal zones between 4800 m and 5600 m at the north side of the main Himalayan range and between 4500 m and 5600 m at the south side, respectively. Based on the expansion rate, area and type of glacial lakes, we identified 67 rapidly expanding glacial lakes in the central Himalayan region that need to be closely monitored in the future. The warming and increasing amounts of light-absorbing constituents of snow and ice could have accelerated the melting that directly affected the glacial lake expansion. Across the main central Himalayas, glacial lakes at the north side show more remarkable expansion than those at the south side. An effective monitoring and warning system for critical glacial lakes is urgently needed.	[Nie, Yong; Liu, Qiao] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China; [Liu, Shiyin] Chinese Acad Sci, State Key Lab Cryosphere Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Liu, Q (corresponding author), Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China.	jackie9211@gmail.com	Liu, Shiyin/AAT-4278-2020; Liu, Qiao/S-5706-2019; Liu, Qiao/H-6525-2011	Liu, Qiao/0000-0002-7285-5425; Liu, Qiao/0000-0002-7285-5425; nie, yong/0000-0002-6075-8564	National Science and Technology Support Program of Chinese MOST [2012BAC19807]; National Natural Science Foundation of China [41101082]; Foundation of IMHE for Young Scientists	National Science and Technology Support Program of Chinese MOST; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of IMHE for Young Scientists	This study was supported by the National Science and Technology Support Program of Chinese MOST (Grant No. 2012BAC19807) and the National Natural Science Foundation of China (Grant No. 41101082) and, also supported by the Foundation of IMHE for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong R, 2011, GLIMS GLACIER DATABA; Bajracharya B, 2007, MT RES DEV, V27, P336, DOI 10.1659/mrd.0783; Bajracharya SR, 2009, ANN GLACIOL, V50, P81, DOI 10.3189/172756410790595895; Blaschke T., 2001, REMOTE SENSING SPATI, V34, P22; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Bolch T, 2010, CRYOSPHERE, V4, P419, DOI 10.5194/tc-4-419-2010; Bolch T, 2008, J GLACIOL, V54, P592, DOI 10.3189/002214308786570782; Burns P, 2014, REMOTE SENS ENVIRON, V140, P165, DOI 10.1016/j.rse.2013.08.026; Cenderelli DA, 2001, GEOMORPHOLOGY, V40, P57, DOI 10.1016/S0169-555X(01)00037-X; Che T, 2004, J GLACIOLOGY GEOCRYO, V27, P801; Che T, 2005, J GLACIOL GEOCRYOL, V27, P801; Chen XQ, 2007, GEOMORPHOLOGY, V88, P298, DOI 10.1016/j.geomorph.2006.11.012; Fujita K, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045205; Gardelle J, 2011, GLOBAL PLANET CHANGE, V75, P47, DOI 10.1016/j.gloplacha.2010.10.003; Huggel C, 2002, CAN GEOTECH J, V39, P316, DOI 10.1139/T01-099; Jarvis A, 2008, HOLE FILLED SEAMLESS; Jiang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045889; Jin X., 2007, P SPIE, V6567; Kang SC, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/015101; Komori J, 2008, QUATERN INT, V184, P177, DOI 10.1016/j.quaint.2007.09.012; Li ZX, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045404; [刘晶晶 Liu Jingjing], 2008, [灾害学, Journal of Catastrophology], V23, P55; [刘伟刚 Liu Weigang], 2006, [冰川冻土, Journal of Glaciology and Geocryology], V28, P663; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Ming J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014021; Nayar A, 2009, NATURE, V461, P1042, DOI 10.1038/4611042a; Nie Y, 2013, ENVIRON EARTH SCI, V68, P251, DOI 10.1007/s12665-012-1736-6; Nie Y, 2011, WETLANDS, V31, P875, DOI 10.1007/s13157-011-0202-7; Nie Y, 2010, J GEOGR SCI, V20, P667, DOI 10.1007/s11442-010-0803-8; Quincey DJ, 2007, GLOBAL PLANET CHANGE, V56, P137, DOI 10.1016/j.gloplacha.2006.07.013; Salerno F, 2012, GLOBAL PLANET CHANGE, V92-93, P30, DOI 10.1016/j.gloplacha.2012.04.001; Wang X, 2012, NAT HAZARD EARTH SYS, V12, P3109, DOI 10.5194/nhess-12-3109-2012; Wang X, 2012, MT RES DEV, V32, P203, DOI 10.1659/MRD-JOURNAL-D-11-00044.1; Worni R, 2013, SCI TOTAL ENV; [谢自楚 XIE Zichu], 2006, [冰川冻土, Journal of Glaciology and Geocryology], V28, P457; Xu BQ, 2009, P NATL ACAD SCI USA, V106, P22114, DOI [10.1073/pnas.0910444106, 10.1073/pnas.pnas.0910444106]; Yao XJ, 2012, J GLACIOL, V58, P753, DOI 10.3189/2012JoG11J048; Zhao DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066365	38	66	74	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83973	10.1371/journal.pone.0083973	http://dx.doi.org/10.1371/journal.pone.0083973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376778	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100150
J	Ogata, FT; Batista, WL; Sartori, A; Gesteira, TF; Masutani, H; Arai, RJ; Yodoi, J; Stern, A; Monteiro, HP				Ogata, Fernando Toshio; Batista, Wagner Luiz; Sartori, Adriano; Gesteira, Tarsis Ferreira; Masutani, Hiroshi; Arai, Roberto Jun; Yodoi, Junji; Stern, Arnold; Monteiro, Hugo Pequeno			Nitrosative/Oxidative Stress Conditions Regulate Thioredoxin-Interacting Protein (TXNIP) Expression and Thioredoxin-1 (TRX-1) Nuclear Localization	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; REDOX REGULATION; OXIDATIVE STRESS; CELL-GROWTH; BINDING; GLUCOSE; KINASE; ROLES; TRANSLOCATION; ASSOCIATION	Thioredoxin (TRX-1) is a multifunctional protein that controls the redox status of other proteins. TRX-1 can be found in the extracellular milieu, cytoplasm and nucleus, and it has distinct functions in each environment. Previously, we studied the intracellular localization of TRX-1 and its relationship with the activation of the p21Ras - ERK1/2 MAP Kinases signaling pathway. In situations where this pathway was activated by stress conditions evoked by a nitrosothiol, S-nitroso-N-acetylpenicillamine (SNAP), TRX-1 accumulated in the nuclear compartment due to nitrosylation of p21Ras and activation of downstream ERK1/2 MAP kinases. Presently, we demonstrate that ERK1/2 MAP Kinases activation and spatial distribution within cells trigger TRX-1 nuclear translocation through downregulation of the physiological inhibitor of TRX-1, Thioredoxin Interacting Protein (TXN1P). Once activated by the oxidants, SNAP and H2O2, the ERK1/2 MAP kinases migrate to the nucleus. This is correlated with down-regulation of TXN1P. In the presence of the MEK inhibitors (PD98059 or U0126), or in cells transfected with the Protein Enriched in Astrocytes (PEA-15), a cytoplasmic anchor of ERK1/2 MAP kinases, TRX-1 nuclear migration and TXNIP down-regulation are no longer observed in cells exposed to oxidants. On the other hand, over-expression of TXNIP abolishes nuclear migration of TRX-1 under nitrosative/oxidative stress conditions, whereas gene silencing of TXNIP facilitates nuclear migration even in the absence of stress conditions. Studies based on the TXNIP promoter support this regulation. In conclusion, changes in TRX-1 compartmentalization under nitrosative/oxidative stress conditions are dependent on the expression levels of TXNIP, which are regulated by cellular compartmentalization and activation of the ERK1/2 MAP kinases.	[Ogata, Fernando Toshio; Sartori, Adriano; Gesteira, Tarsis Ferreira; Monteiro, Hugo Pequeno] Univ Fed Sao Paulo, Dept Bioquim Biol Mol, Sao Paulo, Brazil; [Ogata, Fernando Toshio; Sartori, Adriano; Gesteira, Tarsis Ferreira; Monteiro, Hugo Pequeno] Univ Fed Sao Paulo, CTCMol, Ctr Cellular & Mol Therapy, Sao Paulo, Brazil; [Batista, Wagner Luiz] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil; [Masutani, Hiroshi; Yodoi, Junji] Kyoto Univ, Dept Biol Responses, Kyoto, Japan; [Arai, Roberto Jun; Stern, Arnold] NYU, Sch Med, Dept Pharmacol, New York, NY USA; Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Kyoto University; New York University; Universidade de Sao Paulo	Monteiro, HP (corresponding author), Univ Fed Sao Paulo, Dept Bioquim Biol Mol, Sao Paulo, Brazil.	hugo.monteiro@pesquisador.cnpq.br	Masutani, Hiroshi/B-5114-2014; Ogata, Fernando T/G-4366-2013; Batista, Wagner L./C-8204-2012	Ogata, Fernando T/0000-0002-1855-8358; Masutani, Hiroshi/0000-0001-7633-2827	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [07/59617-6, 09/52730-7, 12/10470-1, 06/53791-1, 09/50708-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP - Processos: 07/59617-6, 09/52730-7, and 12/10470-1 to H.P.M. Processos: 06/53791-1 and 09/50708-4 to F.T.O. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Akamatsu Y, 1997, J BIOL CHEM, V272, P14497, DOI 10.1074/jbc.272.23.14497; Arai RJ, 2006, BIOCHEM BIOPH RES CO, V348, P1254, DOI 10.1016/j.bbrc.2006.07.178; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bai J, 2003, J NEUROSCI, V23, P503, DOI 10.1523/JNEUROSCI.23-02-00503.2003; Batista WL, 2013, ANTIOXID REDOX SIGN, V18, P221, DOI 10.1089/ars.2011.4455; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Deora AA, 2000, BIOCHEMISTRY-US, V39, P9901, DOI 10.1021/bi992954b; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Ferre F, 2006, NUCLEIC ACIDS RES, V34, pW182, DOI 10.1093/nar/gkl189; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Haling JR, 2010, MOL BIOL CELL, V21, P664, DOI 10.1091/mbc.E09-08-0659; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Liyanage NPM, 2007, EXP EYE RES, V85, P270, DOI 10.1016/j.exer.2007.05.001; Masaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039900; Meuillet EJ, 2004, ARCH BIOCHEM BIOPHYS, V429, P123, DOI 10.1016/j.abb.2004.04.020; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nishizawa K, 2011, CARCINOGENESIS, V32, P1459, DOI 10.1093/carcin/bgr137; Oliveira CJR, 2008, NITRIC OXIDE-BIOL CH, V18, P241, DOI 10.1016/j.niox.2008.02.001; Oliveira CJR, 2003, FREE RADICAL BIO MED, V35, P381, DOI 10.1016/S0891-5849(03)00311-3; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Schonhoff CM, 2001, J NEUROCHEM, V78, P631, DOI 10.1046/j.1471-4159.2001.00432.x; Schulze PC, 2006, ARTERIOSCL THROM VAS, V26, P2666, DOI 10.1161/01.ATV.0000248914.21018.f1; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Stoltzman CA, 2011, J BIOL CHEM, V286, P38027, DOI 10.1074/jbc.M111.275503; Turturro F, 2007, CLIN CANCER RES, V13, P3724, DOI 10.1158/1078-0432.CCR-07-0244; Ueno M, 1999, J BIOL CHEM, V274, P35809, DOI 10.1074/jbc.274.50.35809; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Yu FX, 2009, MOL ENDOCRINOL, V23, P932, DOI 10.1210/me.2008-0383; Yu L, 2006, BIOTECHNOL PROGR, V22, P1461, DOI 10.1021/bp060102e	47	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84588	10.1371/journal.pone.0084588	http://dx.doi.org/10.1371/journal.pone.0084588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376827	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100178
J	Overall, RW; Walker, TL; Leiter, O; Lenke, S; Ruhwald, S; Kempermann, G				Overall, Rupert W.; Walker, Tara L.; Leiter, Odette; Lenke, Sina; Ruhwald, Susann; Kempermann, Gerd			Delayed and Transient Increase of Adult Hippocampal Neurogenesis by Physical Exercise in DBA/2 Mice	PLOS ONE			English	Article							DENTATE GYRUS; CELL-PROLIFERATION; GENETIC INFLUENCE; PRECURSOR CELLS; NEURONS; MOUSE; SURVIVAL; DIFFERENTIATION; STRESS	This study builds on the findings that physical activity, such as wheel running in mice, enhances cell proliferation and neurogenesis in the adult hippocampus of the common mouse strain C57BL16, and that the baseline level of neurogenesis varies by strain, being considerably lower in DBA/2. Because C57BL/6 and DBA/2 are important as the parental strains of the BXD recombinant inbred cross which allows the detection of genetic loci regulating phenotypes such as adult neurogenesis, we performed the current study to investigate the gene x environment interactions regulating neurogenesis. At equal distances and times run DBA/2J mice lacked the acute increase in precursor cell proliferation known from C57BLJ6. In DBA/2J proliferation even negatively correlated with the distance run. This was neither due to a stress response (to running itself or single housing) nor differences in estrous cycle. DBA/2 animals exhibited a delayed and weaker pro-neurogenic response with a significant increase in numbers of proliferating cells first detectable after more than a week of wheel running. The proliferative response to running was transient in both strains, the effect being undetectable by 6 weeks. There was also a small transient increase in the production of new neurons in DBA/2J, although these extra cells did not survive. These findings indicate that the comparison between C57BU6 and DBA/2, and by extension the BXD genetic reference population derived from these strains, should provide a powerful tool for uncovering the complex network of modifier genes affecting the activity-dependent regulation of adult hippocampal neurogenesis. More generally, our findings also describe how the external physical environment interacts with the internal genetic environment to produce different responses to the same behavioral stimuli.	[Overall, Rupert W.; Walker, Tara L.; Leiter, Odette; Lenke, Sina; Ruhwald, Susann; Kempermann, Gerd] Tech Univ Dresden, CRTD, D-01062 Dresden, Germany; [Kempermann, Gerd] German Ctr Neurodegenerat Dis DZNE, Dresden, Germany	Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden	Kempermann, G (corresponding author), Tech Univ Dresden, CRTD, D-01062 Dresden, Germany.	gerd.kempermann@dzne.de	Overall, Rupert W/P-3102-2016; Leiter, Odette/ABA-2678-2020; Kempermann, Gerd/F-5416-2010; Walker, Tara/C-6242-2017	Overall, Rupert W/0000-0002-3882-6073; Leiter, Odette/0000-0002-8241-6995; Kempermann, Gerd/0000-0002-5304-4061; Walker, Tara/0000-0002-8472-0245	basic institutional funds (CRTD-DFG Research Center for Regenerative Therapies at Technische Universitat Dresden and German Center for Neurodegenerative Disease (DZNE), Dresden)	basic institutional funds (CRTD-DFG Research Center for Regenerative Therapies at Technische Universitat Dresden and German Center for Neurodegenerative Disease (DZNE), Dresden)	This work was financed from basic institutional funds (CRTD-DFG Research Center for Regenerative Therapies at Technische Universitat Dresden and German Center for Neurodegenerative Disease (DZNE), Dresden). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu H, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.001.2009; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; CALIGIONI CS, 2009, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NSA04IS48.PUBMED:19575469; Clark PJ, 2011, GENES BRAIN BEHAV, V10, P345, DOI 10.1111/j.1601-183X.2010.00674.x; Clark PJ, 2012, HIPPOCAMPUS, V22, P1860, DOI 10.1002/hipo.22020; Clark PJ, 2010, BEHAV BRAIN RES, V213, P246, DOI 10.1016/j.bbr.2010.05.007; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Greenwood BN, 2012, BEHAV BRAIN RES, V233, P314, DOI 10.1016/j.bbr.2012.05.017; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2002, DEV BRAIN RES, V134, P1, DOI 10.1016/S0165-3806(01)00224-3; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Krebs J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00106, 10.3389/fnins.2011.00107]; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Leasure JL, 2009, HIPPOCAMPUS, V19, P907, DOI 10.1002/hipo.20563; Miller BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014458; Overall RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048527; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Ramirez-Rodriguez G, 2013, J NEUROSCI, V33, P5785, DOI 10.1523/JNEUROSCI.6452-11.2013; Seki T, 2002, J NEUROSCI RES, V69, P772, DOI 10.1002/jnr.10366; Snyder JS, 2009, HIPPOCAMPUS, V19, P898, DOI 10.1002/hipo.20552; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Walker TL, 2013, J NEUROSCI, V33, P3010, DOI 10.1523/JNEUROSCI.3363-12.2013; Walker TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044371; Wang LP, 2005, MOL CELL NEUROSCI, V29, P181, DOI 10.1016/j.mcn.2005.02.002; Wong EYH, 2004, EUR J NEUROSCI, V20, P2491, DOI 10.1111/j.1460-9568.2004.03717.x	40	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83797	10.1371/journal.pone.0083797	http://dx.doi.org/10.1371/journal.pone.0083797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376750	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100141
J	Timmers, I; Gentile, F; Rubio-Gozalbo, ME; Jansma, BM				Timmers, Inge; Gentile, Francesco; Rubio-Gozalbo, M. Estela; Jansma, Bernadette M.			Temporal Characteristics of Online Syntactic Sentence Planning: An Event-Related Potential Study	PLOS ONE			English	Article							TIME-COURSE; ELECTROPHYSIOLOGICAL EVIDENCE; LANGUAGE PRODUCTION; LEXICAL ACCESS; BRAIN; DYNAMICS; SPEAKING; SCOPE; COMPREHENSION; INFORMATION	During sentence production, linguistic information (semantics, syntax, phonology) of words is retrieved and assembled into a meaningful utterance. There is still debate on how we assemble single words into more complex syntactic structures such as noun phrases or sentences. In the present study, event-related potentials (ERPs) were used to investigate the time course of syntactic planning. Thirty-three volunteers described visually animated scenes using naming formats varying in syntactic complexity: from simple words ('W', e.g., "triangle', "red","square", "green", "to fly towards"), to noun phrases ('NP', e.g., "the red triangle", "the green square" "to fly towards"), to a sentence ('S', e.g., "The red triangle flies towards the green square."). Behaviourally, we observed an increase in errors and corrections with increasing syntactic complexity, indicating a successful experimental manipulation. In the ERPs following scene onset syntactic complexity variations were found in a P300-like component ('S'/'NP'>'W') and a fronto-central negativity (linear increase with syntactic complexity) In addition, the scene could display two actions - unpredictable for the participant, as the disambiguation occurred only later in the animation. Time-locked to the moment of visual disambiguation of the action and thus the verb, we observed another P300 component ('S'>'NP'/'W'). The data show for the first time evidence of sensitivity to syntactic planning within the P300 time window, time-locked to visual events critical syntactic planning We discuss the findings in the light of current syntactic planning views.	[Timmers, Inge; Gentile, Francesco; Jansma, Bernadette M.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Timmers, Inge; Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Dept Paediat, Maastricht, Netherlands; [Gentile, Francesco] Catholic Univ Louvain, Inst Res Psychol, Inst Neurosci, B-1348 Louvain, Belgium; [Gentile, Francesco; Jansma, Bernadette M.] M BIC, Maastricht, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Lab Genet Metab Dis, Maastricht, Netherlands	Maastricht University; Maastricht University; Universite Catholique Louvain; Maastricht University; Maastricht University	Timmers, I (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	inge.timmers@maastrichtuniversity.nl	Rubio-Gozalbo, M Estela/H-1833-2011	Timmers, Inge/0000-0001-7162-6623; Jansma, Bernadette M./0000-0002-2925-0244	Maastricht University	Maastricht University	This work was supported by a Maastricht University Incentive to Bernadette M. Jansma ("Women in higher positions in science") and by a Galactosemia Research Fund grant to M. Estela Rubio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alario FX, 2002, LANG COGNITIVE PROC, V17, P299, DOI 10.1080/01690960143000236; Allum PH, 2007, J EXP PSYCHOL LEARN, V33, P791, DOI 10.1037/0278-7393.33.4.791; Allum PH, 2009, J EXP PSYCHOL LEARN, V35, P1240, DOI 10.1037/a0016367; Bles M, 2007, BRAIN RES, V1150, P143, DOI 10.1016/j.brainres.2007.02.071; Bock J.K., 1994, HDB PSYCHOLINGUISTIC, P945; Bock J. K., 2004, INTERFACE LANGUAGE V, P249; Bock K., 1995, SPEECH LANGUAGE COMM, V2nd ed., P181, DOI DOI 10.1016/B978-012497770-9/50008-X; Coles M.G.H., 1995, OX PSYCH S, P1; Costa A, 2009, P NATL ACAD SCI USA, V106, P21442, DOI 10.1073/pnas.0908921106; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Elman J. L., 2009, COGNITIVE SCI, V33, P547, DOI [DOI 10.1111/j.1551-6709.2009.01023.x, DOI 10.1111/J.1551-6709.2009.01023.X]; ELMAN JL, 1991, MACH LEARN, V7, P195, DOI 10.1007/BF00114844; FERREIRA F, 1991, J MEM LANG, V30, P210, DOI 10.1016/0749-596X(91)90004-4; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Gahl S, 2006, LINGUIST REV, V23, P213, DOI 10.1515/TLR.2006.007; Ganushchak LY, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00208; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Haller S, 2005, NEUROPSYCHOLOGIA, V43, P807, DOI 10.1016/j.neuropsychologia.2004.09.007; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; Indefrey P, 2004, BRAIN LANG, V89, P312, DOI 10.1016/S0093-934X(03)00352-3; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2001, P NATL ACAD SCI USA, V98, P5933, DOI 10.1073/pnas.101118098; Janssen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033202; Kempen G, 2013, NEUROINFORMATICS; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Koester D, 2008, NEUROIMAGE, V42, P1622, DOI 10.1016/j.neuroimage.2008.06.043; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Konopka AE, 2012, J MEM LANG, V66, P143, DOI 10.1016/j.jml.2011.08.003; Langacker R.W., 1987, FDN COGNITIVE GRAMMA; Levelt W., 1989, SPEAKING INTENTION A; Makeig S., 2009, OXFORD HDB EVENT REL; Marek A, 2007, APHASIOLOGY, V21, P1147, DOI 10.1080/02687030600646577; Menenti L, 2011, PSYCHOL SCI, V22, P1173, DOI 10.1177/0956797611418347; Meyer AS, 1996, J MEM LANG, V35, P477, DOI 10.1006/jmla.1996.0026; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; Pickering MJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00238; Pickering MJ, 1999, TRENDS COGN SCI, V3, P136, DOI 10.1016/S1364-6613(99)01293-0; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 1997, P ROY SOC B-BIOL SCI, V264, P1785, DOI 10.1098/rspb.1997.0247; Rabovsky M, 2011, J COGNITIVE NEUROSCI; Rahman RA, 2003, J EXP PSYCHOL LEARN, V29, P850, DOI 10.1037/0278-7393.29.5.850; Rahman RA, 2008, PSYCHON B REV, V15, P1055, DOI 10.3758/PBR.15.6.1055; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Schiller NO, 2006, LANG COGNITIVE PROC, V21, P1011; Schmitt BM, 2000, PSYCHOPHYSIOLOGY, V37, P473, DOI 10.1017/S0048577200981782; Schmitt BM, 2001, NEUROSCI RES, V41, P293, DOI 10.1016/S0168-0102(01)00286-3; Schmitt BM, 2001, J COGNITIVE NEUROSCI, V13, P510, DOI 10.1162/08989290152001925; Segaert K, 2012, CEREB CORTEX, V22, P1662, DOI 10.1093/cercor/bhr249; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Strijkers K, 2010, CEREB CORTEX, V20, P912, DOI 10.1093/cercor/bhp153; Tomasello M., 2005, CONSTRUCTING LANGUAG; van Turennout M, 1998, SCIENCE, V280, P572, DOI 10.1126/science.280.5363.572; van Turennout M, 1999, J PSYCHOLINGUIST RES, V28, P649, DOI 10.1023/A:1023221028150; vanTurennout M, 1997, J EXP PSYCHOL LEARN, V23, P787, DOI 10.1037/0278-7393.23.4.787; Vosse TG, 2008, COGNITIVE PSYCHOL; Wagner V, 2010, J EXP PSYCHOL LEARN, V36, P423, DOI 10.1037/a0018619	58	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82884	10.1371/journal.pone.0082884	http://dx.doi.org/10.1371/journal.pone.0082884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376601	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100069
J	Ding, L; Zhang, LL; Gao, R; Chen, D; Wang, JJ; Gao, XY; Kang, YM; Zhu, GQ				Ding, Lei; Zhang, Ling-Li; Gao, Run; Chen, Dan; Wang, Jue-Jin; Gao, Xing-Ya; Kang, Yu-Ming; Zhu, Guo-Qing			Superoxide Anions in Paraventricular Nucleus Modulate Adipose Afferent Reflex and Sympathetic Activity in Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; LEPTIN SENSORS; ACTIVATION; CAPSAICIN; TISSUE; CONTRIBUTES; EPIDIDYMIS; DISMUTASE; TARGETS; MEDIATE	Background: Adipose afferent reflex (AAR) is a sympatho-excitatory reflex induced by chemical stimulation of white adipose tissue (WAT). Ionotropic glutamate receptors including NMDA receptors (NMDAR) and non-NMDA receptors (non-NMDAR) in paraventricular nucleus (PVN) mediate the AAR. Enhanced AAR contributes to sympathetic activation and hypertension in obesity rats. This study was designed to investigate the role and mechanism of superoxide anions in PVN in modulating the AAR. Methodology/Principal Findings: Renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) were recorded in anesthetized rats. AAR was evaluated by the RSNA and MAP responses to injections of capsaicin into four sites of right inguinal WAT (8.0 nmol in 8.0 mu l for each site). Microinjection of polyethylene glycol-superoxide dismutase (PEG-SOD), the superoxide anion scavenger tempol or the NAD(P)H oxidase inhibitor apocynin into the PVN decreased the baseline RSNA and MAP, and attenuated the AAR. Unilateral WAT injection of capsaicin increased superoxide anions in bilateral PVN, which was prevented by the WAT denervation. WAT injection of capsaicin increased superoxide anion level and NAD(P)H oxidase activity in the PVN, which was abolished by the PVN pretreatment with the combined NMDAR antagonist AP5 and non-NMDAR antagonist CNQX. Microinjection of the NMDAR agonist NMDA or the non-NMDAR agonist AMPA increased superoxide anion level and NAD(P)H oxidase activity in the PVN. Conclusions: NAD(P)H oxidase-derived superoxide anions in the PVN contributes to the tonic modulation of AAR. Activation of ionotropic glutamate receptors in the PVN is involved in the AAR-induced production of superoxide anions in the PVN.	[Ding, Lei; Zhang, Ling-Li; Gao, Run; Chen, Dan; Wang, Jue-Jin; Gao, Xing-Ya; Zhu, Guo-Qing] Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China; [Kang, Yu-Ming] Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Cardiovasc Res Ctr, Xian 710049, Shanxi, Peoples R China	Nanjing Medical University; Xi'an Jiaotong University	Zhu, GQ (corresponding author), Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China.	gqzhucn@njmu.edu.cn	Wang, Jue/GVU-0480-2022; Juejin, Wang/ABA-7017-2020	, Juejin/0000-0003-4921-5451; Zhu, Guo-Qing/0000-0002-3132-9592	Chinese National Natural Science fund [31171095, 31271213]; National Basic Research Program of China (973 Program) [2012CB517805]	Chinese National Natural Science fund(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by Chinese National Natural Science fund (31171095 and 31271213), National Basic Research Program of China (973 Program, No. 2012CB517805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Chen AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040748; Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041; Cui BP, 2013, ACTA PHYSIOL, V209, P45, DOI 10.1111/apha.12125; DiBona GF, 2013, HYPERTENSION, V61, P556, DOI 10.1161/HYPERTENSIONAHA.111.00633; Foster MT, 2006, AM J PHYSIOL-REG I, V291, pR1630, DOI 10.1152/ajpregu.00197.2006; Gan XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050102; Gan XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025784; Gao J, 2012, PFLUG ARCH EUR J PHY, V463, P297, DOI 10.1007/s00424-011-1036-0; Han YL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035506, 10.1371/journal.pone.0048966]; Han Y, 2011, J APPL PHYSIOL, V110, P646, DOI 10.1152/japplphysiol.00908.2010; HOLZER P, 1991, PHARMACOL REV, V43, P143; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; LIU TH, 1989, AM J PHYSIOL, V256, pH589, DOI 10.1152/ajpheart.1989.256.2.H589; Luebbert M, 2010, PFLUG ARCH EUR J PHY, V459, P737, DOI 10.1007/s00424-009-0782-8; Luo Z, 2009, BRIT J PHARMACOL, V157, P935, DOI 10.1111/j.1476-5381.2009.00259.x; MEEKER RB, 1993, BRAIN RES, V600, P112, DOI 10.1016/0006-8993(93)90408-F; Niijima A, 1999, NEUROSCI LETT, V262, P125, DOI 10.1016/S0304-3940(99)00054-3; Niijima A, 1998, J AUTONOM NERV SYST, V73, P19, DOI 10.1016/S0165-1838(98)00109-X; Nishihara M, 2012, J HYPERTENS, V30, P97, DOI 10.1097/HJH.0b013e32834e1df4; Oliveira-Sales EB, 2009, AM J HYPERTENS, V22, P484, DOI 10.1038/ajh.2009.17; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Rosc-Schluter BI, 2012, CARDIOVASC RES, V93, P454, DOI 10.1093/cvr/cvr348; Shi Z, 2012, J APPL PHYSIOL, V112, P1008, DOI 10.1152/japplphysiol.01164.2011; Shi Z, 2009, PFLUG ARCH EUR J PHY, V458, P247, DOI 10.1007/s00424-008-0627-x; Song CK, 2009, AM J PHYSIOL-REG I, V296, pR501, DOI 10.1152/ajpregu.90786.2008; Sun HH, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-649; Tanida M, 2000, NEUROSCI LETT, V293, P107, DOI 10.1016/S0304-3940(00)01490-7; Xia HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022682; Xiong XQ, 2012, HYPERTENSION, V60, P1280, DOI 10.1161/HYPERTENSIONAHA.112.198002; Xiong XQ, 2013, ACTA PHYSL OXF, DOI [10.1111/apha.12182, DOI 10.1111/APHA.12182.[]; Xue BJ, 2012, AM J PHYSIOL-HEART C, V302, pH733, DOI 10.1152/ajpheart.00873.2011; Yamada J, 2003, NEUROSCI RES, V45, P1, DOI 10.1016/S0168-0102(02)00196-7; Yu Y, 2007, PFLUG ARCH EUR J PHY, V454, P551, DOI 10.1007/s00424-007-0256-9; Yuan N, 2013, PFLUG ARCH EUR J PHY, V465, P261, DOI 10.1007/s00424-012-1173-0; Zhong BH, 2008, AM J PHYSIOL-HEART C, V295, pH728, DOI 10.1152/ajpheart.00022.2008	39	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83771	10.1371/journal.pone.0083771	http://dx.doi.org/10.1371/journal.pone.0083771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376743	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000111
J	Kuhlmann, F; Opitz, SEW; Inselsbacher, E; Ganeteg, U; Nasholm, T; Ninkovic, V				Kuhlmann, Franziska; Opitz, Sebastian E. W.; Inselsbacher, Erich; Ganeteg, Ulrika; Nasholm, Torgny; Ninkovic, Velemir			Exploring the Nitrogen Ingestion of Aphids - A New Method Using Electrical Penetration Graph and N-15 Labelling	PLOS ONE			English	Article							HOST-PLANT; PHLOEM TRANSPORT; XYLEM SAP; PREDATION; PROTEINS; CARBON; PREY	Studying plant-aphid interactions is challenging as aphid feeding is a complex process hidden in the plant tissue. Here we propose a combination of two well established methods to study nutrient acquisition by aphids focusing on the uptake of isotopically labelled nitrogen (N-15). We combined the Electrical Penetration Graph (EPG) technique that allows detailed recording of aphid feeding behaviour and stable isotope ratio mass spectrometry (IRMS) to precisely measure the uptake of nitrogen. Bird cherry-oat aphids Rhopalosiphum padi L. (Hemiptera, Aphididae) fed for 24 h on barley plants (Hordeum vulgare L., cultivar Lina, Poaceae) that were cultivated with a N-15 enriched nutrient solution. The time aphids fed in the phloem was strongly positive correlated with their N-15 uptake. All other single behavioural phases were not correlated with N-15 enrichment in the aphids, which corroborates their classification as non-feeding EPG phases. In addition, phloemfeeding and N-15 enrichment of aphids was divided into two groups. One group spent only short time in the phloem phase and was unsuccessful in nitrogen acquisition, while the other group displayed longer phloem-feeding phases and was successful in nitrogen acquisition. This suggests that several factors such as the right feeding site, time span of feeding and individual conditions play a role for the aphids to acquire nutrients successfully. The power of this combination of methods for studying plant-aphid interactions is discussed.	[Kuhlmann, Franziska; Opitz, Sebastian E. W.; Ninkovic, Velemir] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Inselsbacher, Erich; Ganeteg, Ulrika; Nasholm, Torgny] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [Nasholm, Torgny] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Umea University	Ninkovic, V (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	velemir.ninkovic@slu.se	Opitz, Sebastian Ed Wieland/AFK-4118-2022; Ninkovic, Velemir/E-7677-2011; Opitz, Sebastian Ed Wieland/AAG-2898-2022; Inselsbacher, Erich/C-3727-2012	Ninkovic, Velemir/0000-0001-9276-7169; Inselsbacher, Erich/0000-0001-5490-8768; Nasholm, Torgny/0000-0002-2275-2030	Swedish Foundation for Strategic Environmental Research (Mistra) through the PlantComMistra programme; Swedish Research Council Formas; Trees and Crops for the Future	Swedish Foundation for Strategic Environmental Research (Mistra) through the PlantComMistra programme(Swedish Foundation for Strategic Research); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Trees and Crops for the Future	This work was financially supported by the Swedish Foundation for Strategic Environmental Research (Mistra) through the PlantComMistra programme (to VN, TN and FK). This work was supported by The Swedish Research Council Formas (to TN) and Trees and Crops for the Future (to TN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUCLAIR JL, 1963, ANNU REV ENTOMOL, V8, P439, DOI 10.1146/annurev.en.08.010163.002255; CULL DC, 1977, PHYSIOL ENTOMOL, V2, P109, DOI 10.1111/j.1365-3032.1977.tb00086.x; de Vos M, 2007, BIOESSAYS, V29, P871, DOI 10.1002/bies.20624; Dinant S, 2010, CR BIOL, V333, P504, DOI 10.1016/j.crvi.2010.03.008; DOUGLAS AE, 1993, ECOL ENTOMOL, V18, P31, DOI 10.1111/j.1365-2311.1993.tb01076.x; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Douglas AE, 2007, APHIDS AS CROP PESTS, P115, DOI 10.1079/9780851998190.0115; Gaupels F, 2008, J EXP BOT, V59, P3297, DOI 10.1093/jxb/ern181; Giordanengo P, 2010, CR BIOL, V333, P516, DOI 10.1016/j.crvi.2010.03.007; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Gomez SK, 2006, ENVIRON EXP BOT, V55, P77, DOI 10.1016/j.envexpbot.2004.10.001; Gunduz EA, 2009, P ROY SOC B-BIOL SCI, V276, P987, DOI 10.1098/rspb.2008.1476; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; HEIMBACH U, 1986, J APPL ENTOMOL, V101, P396, DOI 10.1111/j.1439-0418.1986.tb00874.x; Hood-Nowotny R, 2007, ENTOMOL EXP APPL, V124, P3, DOI 10.1111/j.1570-7458.2007.00572.x; Kallarackal J, 2012, PLANTA, V236, P209, DOI 10.1007/s00425-012-1600-7; Kehr J, 2006, J EXP BOT, V57, P767, DOI 10.1093/jxb/erj087; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Leroy PD, 2011, ARTHROPOD-PLANT INTE, V5, P193, DOI 10.1007/s11829-011-9128-5; Muller C, 2006, ANNU PLANT REV, V23, P398; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nienstedt KM, 2004, ENTOMOL EXP APPL, V112, P183, DOI 10.1111/j.0013-8703.2004.00195.x; Nienstedt KM, 2004, ENTOMOL EXP APPL, V112, P191, DOI 10.1111/j.0013-8703.2004.00155.x; Nienstedt KM, 2000, ENTOMOL EXP APPL, V94, P319, DOI 10.1023/A:1003987223604; Nour-Eldin HH, 2009, PHYTOCHEM REV, V8, P53, DOI 10.1007/s11101-008-9110-8; PATE JS, 1979, PLANT PHYSIOL, V64, P1083, DOI 10.1104/pp.64.6.1083; Pettersson J, 2007, APHIDS AS CROP PESTS, P87, DOI 10.1079/9780851998190.0087; Pompon J, 2011, J INSECT PHYSIOL, V57, P1317, DOI 10.1016/j.jinsphys.2011.06.007; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Powell G, 2001, PHYSIOL ENTOMOL, V26, P194, DOI 10.1046/j.0307-6962.2001.00234.x; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; Seel WE, 1999, NEW PHYTOL, V143, P281, DOI 10.1046/j.1469-8137.1999.00461.x; SPILLER NJ, 1990, ENTOMOL EXP APPL, V55, P101, DOI 10.1007/BF00352570; Taylor SH, 2012, ENTOMOL EXP APPL, V142, P121, DOI 10.1111/j.1570-7458.2011.01206.x; Tjallingii W.F., 1995, P190; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; TJALLINGII WF, 1995, PROCEEDINGS OF THE SECTION EXPERIMENTAL AND APPLIED ENTOMOLOGY OF THE NETHERLANDS ENTOMOLOGICAL SOCIETY (N.E.V.), VOL 6, 1995, P163; Tjallingii WF, 2013, EPG SYSTEMS; Turgeon R, 2009, ANNU REV PLANT BIOL, V60, P207, DOI 10.1146/annurev.arplant.043008.092045; Van Bel AJE, 2003, PLANT CELL ENVIRON, V26, P125, DOI 10.1046/j.1365-3040.2003.00963.x; van Emden HF, 2007, APHIDS AS CROP PESTS, P447, DOI 10.1079/9780851998190.0447; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; Will T, 2009, J EXP BIOL, V212, P3305, DOI 10.1242/jeb.028514; Wilson ACC, 2011, P NATL ACAD SCI USA, V108, P10220, DOI 10.1073/pnas.1007065108; WINTER H, 1992, PLANT PHYSIOL, V99, P996, DOI 10.1104/pp.99.3.996; Yoshida Hideya, 1996, Bulletin of the Research Institute for Bioresources Okayama University, V4, P73	49	7	7	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83085	10.1371/journal.pone.0083085	http://dx.doi.org/10.1371/journal.pone.0083085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376642	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000059
J	Marin, A; Tejero, H; Nuno, JC; Montero, F				Marin, Arturo; Tejero, Hector; Carlos Nuno, Juan; Montero, Francisco			The Advantage of Arriving First: Characteristic Times in Finite Size Populations of Error-Prone Replicators	PLOS ONE			English	Article							QUASI-SPECIES EVOLUTION; HIGH MUTATION-RATES; ASEXUAL POPULATIONS; SEPARATING CAUSES; MUTATORS; CONSEQUENCES; OPTIMIZATION; ADAPTATION; THRESHOLDS; SIMULATION	We study the evolution of a finite size population formed by mutationally isolated lineages of error-prone replicators in a two-peak fitness landscape. Computer simulations are performed to gain a stochastic description of the system dynamics. More specifically, for different population sizes, we compute the probability of each lineage being selected in terms of their mutation rates and the amplification factors of the fittest phenotypes. We interpret the results as the compromise between the characteristic time a lineage takes to reach its fittest phenotype by crossing the neutral valley and the selective value of the sequences that form the lineages. A main conclusion is drawn: for finite population sizes, the survival probability of the lineage that arrives first to the fittest phenotype rises significantly.	[Marin, Arturo; Tejero, Hector; Montero, Francisco] Univ Complutense Madrid, Fac Ciencias Quim, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain; [Carlos Nuno, Juan] Univ Politecn Madrid, Escuela Tecn Super Ingenieros Montes, Dept Matemat Aplicada Recursos Nat, Madrid, Spain	Complutense University of Madrid; Universidad Politecnica de Madrid	Montero, F (corresponding author), Univ Complutense Madrid, Fac Ciencias Quim, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain.	framonte@quim.ucm.es	Nuño, Juan Carlos/H-5532-2015; Montero, Francisco/G-9850-2015; Tejero, Hector/M-1045-2014	Nuño, Juan Carlos/0000-0003-4708-980X; Montero, Francisco/0000-0003-2366-3635; Marin, Arturo/0000-0003-4074-8294; Tejero, Hector/0000-0002-4940-700X	Ministerio de Economia Y Competitividad, Gobierno de Espana [BFU2012-39816-C02-02]	Ministerio de Economia Y Competitividad, Gobierno de Espana	This work was supported by BFU2012-39816-C02-02, Ministerio de Economia Y Competitividad, Gobierno de Espana (http://www.mineco.gob.es/portal/site/mineco/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/38001; Aguirre J, 2009, J THEOR BIOL, V261, P148, DOI 10.1016/j.jtbi.2009.07.034; Andre JB, 2006, GENETICS, V172, P611, DOI 10.1534/genetics.105.046680; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; Bull JJ, 2005, PLOS COMPUT BIOL, V1, P450, DOI 10.1371/journal.pcbi.0010061; Clune J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000187; Couce A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003167; Desai MM, 2011, GENETICS, V188, P997, DOI 10.1534/genetics.111.128116; Dixit NM, 2012, J COMPUT BIOL, V19, P1176, DOI 10.1089/cmb.2012.0064; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Elena SF, 2005, J VIROL, V79, P11555, DOI 10.1128/JVI.79.18.11555-11558.2005; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Heo M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000710; Jiang XQ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-298; KIMURA M, 1967, GENET RES, V9, P23, DOI 10.1017/S0016672300010284; Llorens M, 1999, BIOPHYS J, V77, P23, DOI 10.1016/S0006-3495(99)76869-4; Marin A, 2012, J THEOR BIOL, V303, P25, DOI 10.1016/j.jtbi.2012.02.029; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Moran P., 1962, STAT PROCESSES EVOLU; NOWAK M, 1989, J THEOR BIOL, V137, P375, DOI 10.1016/S0022-5193(89)80036-0; Orr HA, 2000, GENETICS, V155, P961; Pahle J, 2009, BRIEF BIOINFORM, V10, P53, DOI 10.1093/bib/bbn050; Piedrafita G, 2012, J THEOR BIOL, V300, P143, DOI 10.1016/j.jtbi.2012.01.013; SCHUSTER P, 1988, B MATH BIOL, V50, P635, DOI 10.1016/S0092-8240(88)80059-4; Schuster P, 2012, COMPLEXITY, V17, P6, DOI 10.1002/cplx.21401; Schuster P, 2011, COMPLEXITY, V17, P5, DOI 10.1002/cplx.20399; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Sober E., 1993, NATURE SELECTION EVO; Stich M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-110; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Tejero H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-2; Tenaillon O, 1999, GENETICS, V152, P485; Traulsen A, 2007, J THEOR BIOL, V249, P617, DOI 10.1016/j.jtbi.2007.08.012; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Wylie CS, 2009, GENETICS, V181, P1595, DOI 10.1534/genetics.108.094532	38	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83142	10.1371/journal.pone.0083142	http://dx.doi.org/10.1371/journal.pone.0083142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376656	gold, Green Published, Green Accepted			2022-12-27	WOS:000328882000064
J	Meir, JU; Robinson, PW; Vilchis, LI; Kooyman, GL; Costa, DP; Ponganis, PJ				Meir, Jessica U.; Robinson, Patrick W.; Vilchis, L. Ignacio; Kooyman, Gerald L.; Costa, Daniel P.; Ponganis, Paul J.			Blood Oxygen Depletion Is Independent of Dive Function in a Deep Diving Vertebrate, the Northern Elephant Seal	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; MARINE PREDATOR; BEHAVIOR; THERMOREGULATION; PATTERNS; WHALES; COST	Although energetics is fundamental to animal ecology, traditional methods of determining metabolic rate are neither direct nor instantaneous. Recently, continuous blood oxygen (O-2) measurements were used to assess energy expenditure in diving elephant seals (Mirounga angustirostris), demonstrating that an exceptional hypoxemic tolerance and exquisite management of blood O-2 stores underlie the extraordinary diving capability of this consummate diver. As the detailed relationship of energy expenditure and dive behavior remains unknown, we integrated behavior, ecology, and physiology to characterize the costs of different types of dives of elephant seals. Elephant seal dive profiles were analyzed and O-2 utilization was classified according to dive type (overall function of dive: transit, foraging, food processing/rest). This is the first account linking behavior at this level with in vivo blood O-2 measurements in an animal freely diving at sea, allowing us to assess patterns of O-2 utilization and energy expenditure between various behaviors and activities in an animal in the wild. In routine dives of elephant seals, the blood O-2 store was significantly depleted to a similar range irrespective of dive function, suggesting that all dive types have equal costs in terms of blood O-2 depletion. Here, we present the first physiological evidence that all dive types have similarly high blood O-2 demands, supporting an energy balance strategy achieved by devoting one major task to a given dive, thereby separating dive functions into distinct dive types. This strategy may optimize O-2 store utilization and recovery, consequently maximizing time underwater and allowing these animals to take full advantage of their underwater resources. This approach may be important to optimizing energy expenditure throughout a dive bout or at-sea foraging trip and is well suited to the lifestyle of an elephant seal, which spends >90% of its time at sea submerged making diving its most "natural" state.	[Meir, Jessica U.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [Robinson, Patrick W.; Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Vilchis, L. Ignacio; Kooyman, Gerald L.; Ponganis, Paul J.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California Santa Cruz; University of California System; University of California San Diego; Scripps Institution of Oceanography	Meir, JU (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA.	jmeir@mgh.harvard.edu	Costa, Daniel/E-2616-2013	Costa, Daniel/0000-0002-0233-5782; , gerald/0000-0002-8872-2950	National Science Foundation Integrative Organismal Systems (IOS) [0641801]; Office of Naval Research [N00014-08-1-1195]	National Science Foundation Integrative Organismal Systems (IOS); Office of Naval Research(Office of Naval Research)	Funding was provided by National Science Foundation Integrative Organismal Systems (IOS) Grant # 0641801, Office of Naval Research grant # N00014-08-1-1195. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biuw M, 2003, J EXP BIOL, V206, P3405, DOI 10.1242/jeb.00583; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Butler P.J., 1993, Symposia of the Zoological Society of London, V66, P317; Crocker Daniel E., 1994, P328; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; Davis RW, 1999, J EXP BIOL, V202, P1091; Elsner R., 1983, DIVING ASPHYXIA COMP; ELSNER RW, 1964, PHYSIOLOGIST, V7, P124; Goldbogen JA, 2008, J EXP BIOL, V211, P3712, DOI 10.1242/jeb.023366; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P305, DOI 10.1016/j.cbpa.2010.09.002; Hochscheid S, 2010, J EXP BIOL, V213, P1328, DOI 10.1242/jeb.037184; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; KRAMER DL, 1988, CAN J ZOOL, V66, P89, DOI 10.1139/z88-012; Le Boeuf Burney J., 1994, P237; LEBOEUF BJ, 1992, CAN J ZOOL, V70, P786, DOI 10.1139/z92-111; LeBoeuf BJ, 1996, CAN J ZOOL, V74, P1632; LEBOEUF BJ, 1988, CAN J ZOOL, V66, P446, DOI 10.1139/z88-064; Meir JU, 2009, AM J PHYSIOL-REG I, V297, pR927, DOI 10.1152/ajpregu.00247.2009; Mitani Y, 2010, BIOL LETTERS, V6, P163, DOI 10.1098/rsbl.2009.0719; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; Noren DP, 1999, J COMP PHYSIOL B, V169, P93, DOI 10.1007/s003600050198; Oliver GW, 1998, MAR MAMMAL SCI, V14, P245, DOI 10.1111/j.1748-7692.1998.tb00714.x; Ponganis PJ, 2007, J EXP BIOL, V210, P4279, DOI 10.1242/jeb.011221; Ponganis P. J., 2003, BENNETT ELLIOTTS PHY, P211; Ponganis PJ, 2011, J EXP BIOL, V214, P3325, DOI 10.1242/jeb.031252; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Robinson PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036728; Royall R., 1997, STAT EVIDENCE LIKELI; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Sparling CE, 2007, BIOL LETTERS, V3, P94, DOI 10.1098/rsbl.2006.0566; Stockard TK, 2005, J EXP BIOL, V208, P2973, DOI 10.1242/jeb.01687; Williams CL, 2011, J EXP BIOL, V214, P1802, DOI 10.1242/jeb.052233; Williams TM, 1999, J EXP BIOL, V202, P2763; Williams TM, 2004, J EXP BIOL, V207, P973, DOI 10.1242/jeb.00822; Wilson RP, 2011, J EXP BIOL, V214, P646, DOI 10.1242/jeb.044859	35	13	13	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83248	10.1371/journal.pone.0083248	http://dx.doi.org/10.1371/journal.pone.0083248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376671	Green Published, gold			2022-12-27	WOS:000328882000075
J	Qin, XY; Wei, FF; Tanokura, M; Ishibashi, N; Shimizu, M; Moriwaki, H; Kojima, S				Qin, Xian-Yang; Wei, Feifei; Tanokura, Masaru; Ishibashi, Naoto; Shimizu, Masahito; Moriwaki, Hisataka; Kojima, Soichi			The Effect of Acyclic Retinoid on the Metabolomic Profiles of Hepatocytes and Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							TARGETING CANCER METABOLISM; 2ND PRIMARY TUMORS; GROWTH; EXPRESSION; PREVENTION; INDUCTION; APOPTOSIS; EPIDEMIOLOGY; SUPPRESSION; HEPATITIS	Background/Purpose: Acyclic retinoid (ACR) is a promising chemopreventive agent for hepatocellular carcinoma (HCC) that selectively inhibits the growth of HCC cells (JHH7) but not normal hepatic cells (Hc). To better understand the molecular basis of the selective anti-cancer effect of ACR, we performed nuclear magnetic resonance (NMR)-based and capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS)-based metabolome analyses in JHH7 and Hc cells after treatment with ACR. Methodology/Principal Findings: NMR-based metabolomics revealed a distinct metabolomic profile of JHH7 cells at 18 h after ACR treatment but not at 4 h after ACR treatment. CE-TOFMS analysis identified 88 principal metabolites in JHH7 and Hc cells after 24 h of treatment with ethanol (EtOH) or ACR. The abundance of 71 of these metabolites was significantly different between EtOH-treated control JHH7 and Hc cells, and 49 of these metabolites were significantly down-regulated in the ACR-treated JHH7 cells compared to the EtOH-treated JHH7 cells. Of particular interest, the increase in adenosine-5'-triphosphate (ATP), the main cellular energy source, that was observed in the EtOH-treated control JHH7 cells was almost completely suppressed in the ACR-treated JHH7 cells; treatment with ACR restored ATP to the basal levels observed in both EtOH-control and ACR-treated Hc cells (0.72-fold compared to the EtOH control-treated JHH7 cells). Moreover, real-time PCR analyses revealed that ACR significantly increased the expression of pyruvate dehydrogenase kinases 4 (PDK4), a key regulator of ATP production, in JHH7 cells but not in Hc cells (3.06-fold and 1.20-fold compared to the EtOH control, respectively). Conclusions/Significance: The results of the present study suggest that ACR may suppress the enhanced energy metabolism of JHH7 cells but not Hc cells; this occurs at least in part via the cancer-selective enhancement of PDK4 expression. The cancer-selective metabolic pathways identified in this study will be important targets of the anti-cancer activity of ACR.	[Qin, Xian-Yang; Kojima, Soichi] RIKEN, Ctr Life Sci Technol, Microsignaling Regulat Technol Unit, Wako, Saitama, Japan; [Wei, Feifei; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Ishibashi, Naoto] KOWA Co Ltd, Div Pharmaceut, Tokyo New Drug Res Labs, Tokyo, Japan; [Shimizu, Masahito; Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Dept Gastroenterol, Gifu, Japan; [Qin, Xian-Yang; Wei, Feifei] Japan Soc Promot Sci, Tokyo, Japan	RIKEN; University of Tokyo; Kowa Company, Ltd.; Gifu University; Japan Society for the Promotion of Science	Kojima, S (corresponding author), RIKEN, Ctr Life Sci Technol, Microsignaling Regulat Technol Unit, Wako, Saitama, Japan.	skojima@postman.riken.go.jp	Kojima, Soichi/N-7104-2015; WEI, FEIFEI/C-7985-2017; Qin, Xian-Yang/AAB-5628-2020	Kojima, Soichi/0000-0002-5252-1612; WEI, FEIFEI/0000-0002-5770-3255; Tanokura, Masaru/0000-0001-5072-2480	Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Foreign Researchers; HMT Research Grant for Young Leaders in Metabolomics from Human Metabolome Technologies Inc.; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Foreign Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); HMT Research Grant for Young Leaders in Metabolomics from Human Metabolome Technologies Inc.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Foreign Researchers. This study was also partly supported by the HMT Research Grant for Young Leaders in Metabolomics 2012 from Human Metabolome Technologies Inc. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, Gan To Kagaku Ryoho, V31 Suppl 1, P1; Beyoglu D, 2013, HEPATOLOGY, V58, P229, DOI 10.1002/hep.26350; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bronner IF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006826; Butler EB, 2013, CANCER RES, V73, P2709, DOI 10.1158/0008-5472.CAN-12-3009; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dilip A, 2013, ANTICANCER DRUGS; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; FUJISE K, 1990, HEPATO-GASTROENTEROL, V37, P457; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kagawa M, 2004, CARCINOGENESIS, V25, P979, DOI 10.1093/carcin/bgh093; Komi Y, 2010, LAB INVEST, V90, P52, DOI 10.1038/labinvest.2009.110; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Matsushima-Nishiwaki R, 2003, CARCINOGENESIS, V24, P1353, DOI 10.1093/carcin/bgg090; Matsushima-Nishiwaki R, 2001, CANCER RES, V61, P7675; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Muto Y, 1999, NEW ENGL J MED, V340, P1046, DOI 10.1056/NEJM199904013401315; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; Nakatsu N, 2007, MOL PHARMACOL, V72, P1171, DOI 10.1124/mol.107.038836; Obora A, 2002, HEPATOLOGY, V36, P1115, DOI 10.1053/jhep.2002.36369; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Okada H, 2012, CANCER RES, V72, P4459, DOI 10.1158/0008-5472.CAN-12-0028; Qin XY, 2012, NEUROTOXICOLOGY, V33, P1375, DOI 10.1016/j.neuro.2012.08.016; Qin XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036711; Qin XY, 2011, FEBS LETT, V585, P3310, DOI 10.1016/j.febslet.2011.09.017; Schoonjans K, 1996, J LIPID RES, V37, P907; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Shao RX, 2005, GASTROENTEROLOGY, V128, P86, DOI 10.1053/j.gastro.2004.09.077; Sugimoto M, 2010, ELECTROPHORESIS, V31, P2311, DOI 10.1002/elps.200900584; Suzui M, 2002, CANCER RES, V62, P3997; Tatsukawa H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-4; Vander Heiden MG, 2011, COLD SH Q B, V76, P325, DOI 10.1101/sqb.2012.76.010900; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wang JA, 2011, TUMOR BIOL, V32, P223, DOI 10.1007/s13277-010-0116-7; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wei FF, 2010, MAGN RESON CHEM, V48, P857, DOI 10.1002/mrc.2678; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Yamori Takao, 2004, Gan To Kagaku Ryoho, V31, P485	43	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82860	10.1371/journal.pone.0082860	http://dx.doi.org/10.1371/journal.pone.0082860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376596	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000034
J	Baldo, B; Soylu, R; Petersen, A				Baldo, Barbara; Soylu, Rana; Petersen, Asa			Maintenance of Basal Levels of Autophagy in Huntington's Disease Mouse Models Displaying Metabolic Dysfunction	PLOS ONE			English	Article							STRIATAL PROJECTION-NEURONS; CHAPERONE-MEDIATED AUTOPHAGY; GENE-EXPRESSION CHANGES; MUTANT HUNTINGTIN; SELECTIVE AUTOPHAGY; BECLIN 1; UBIQUITINATED TARGETS; NEUROPROTECTIVE ROLE; DIFFERENTIAL LOSS; MAMMALIAN TARGET	Huntington's disease (HD) is a fatal neurodegenerative disorder caused by an expanded polyglutamine repeat in the huntingtin protein. Neuropathology in the basal ganglia and in the cerebral cortex has been linked to the motor and cognitive symptoms whereas recent work has suggested that the hypothalamus might be involved in the metabolic dysfunction. Several mouse models of HD that display metabolic dysfunction have hypothalamic pathology, and expression of mutant huntingtin in the hypothalamus has been causally linked to the development of metabolic dysfunction in mice. Although the pathogenic mechanisms by which mutant huntingtin exerts its toxic functions in the HD brain are not fully known, several studies have implicated a role for the lysososomal degradation pathway of autophagy. Interestingly, changes in autophagy in the hypothalamus have been associated with the development of metabolic dysfunction in wildtype mice. We hypothesized that expression of mutant huntingtin might lead to changes in the autophagy pathway in the hypothalamus in mice with metabolic dysfunction. We therefore investigated whether there were changes in basal levels of autophagy in a mouse model expressing a fragment of 853 amino acids of mutant huntingtin selectively in the hypothalamus using a recombinant adeno-associate viral vector approach as well as in the transgenic BACHD mice. We performed qRT-PCR and Western blot to investigate the mRNA and protein expression levels of selected autophagy markers. Our results show that basal levels of autophagy are maintained in the hypothalamus despite the presence of metabolic dysfunction in both mouse models. Furthermore, although there were no major changes in autophagy in the striatum and cortex of BACHD mice, we detected modest, but significant differences in levels of some markers in mice at 12 months of age. Taken together, our results indicate that overexpression of mutant huntingtin in mice do not significantly perturb basal levels of autophagy.	[Baldo, Barbara; Soylu, Rana; Petersen, Asa] Lund Univ, Dept Expt Med Sci, Translat Neuroendocrine Res Unit, Lund, Sweden	Lund University	Baldo, B (corresponding author), Lund Univ, Dept Expt Med Sci, Translat Neuroendocrine Res Unit, Lund, Sweden.	Barbara.baldo@med.lu.se		Soylu Kucharz, Rana/0000-0002-7872-5322	Swedish Medical Research Council [K2011-62X-20404-05-6]; Ragnar Soderberg foundation; province of Skane state grants	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Ragnar Soderberg foundation; province of Skane state grants	This work was supported by grants from the Swedish Medical Research Council (K2011-62X-20404-05-6), the Ragnar Soderberg foundation and the province of Skane state grants. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALBIN RL, 1990, NEW ENGL J MED, V322, P1293, DOI 10.1056/NEJM199005033221807; Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Arias E, 2011, CURR OPIN CELL BIOL, V23, P184, DOI 10.1016/j.ceb.2010.10.009; Arnulf I, 2008, ARCH NEUROL-CHICAGO, V65, P482, DOI 10.1001/archneur.65.4.482; Aziz A, 2008, BRAIN PATHOL, V18, P474, DOI 10.1111/j.1750-3639.2008.00135.x; Aziz NA, 2010, EUR J NEUROL, V17, P1068, DOI 10.1111/j.1468-1331.2010.02973.x; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Block RC, 2010, J CLIN LIPIDOL, V4, P17, DOI 10.1016/j.jacl.2009.11.003; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chan EYW, 2002, HUM MOL GENET, V11, P1939, DOI 10.1093/hmg/11.17.1939; Coupe B, 2012, CELL METAB, V15, P247, DOI 10.1016/j.cmet.2011.12.016; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Deng YP, 2004, J CHEM NEUROANAT, V27, P143, DOI 10.1016/j.jchemneu.2004.02.005; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; FARRER LA, 1985, CLIN GENET, V27, P62; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Gabery S, 2010, ACTA NEUROPATHOL, V120, P777, DOI 10.1007/s00401-010-0742-6; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; Goodman AOG, 2008, EXP NEUROL, V210, P691, DOI 10.1016/j.expneurol.2007.12.026; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Halliday GM, 1998, EXP NEUROL, V154, P663, DOI 10.1006/exnr.1998.6919; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harada H, 2013, J NEUROSCI, V33, P14767, DOI 10.1523/JNEUROSCI.2954-12.2013; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; HEDREEN JC, 1991, NEUROSCI LETT, V133, P257, DOI 10.1016/0304-3940(91)90583-F; Heng MY, 2010, HUM MOL GENET, V19, P3702, DOI 10.1093/hmg/ddq285; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hult Lundh S, 2013, HUMAN MOL GENETICS; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Hult S, 2010, CURR DRUG TARGETS, V11, P1237, DOI 10.2174/1389450111007011237; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Jimenez-Sanchez M, 2012, PROG NEUROBIOL, V97, P67, DOI 10.1016/j.pneurobio.2011.08.013; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kaushik S, 2011, CELL METAB, V14, P173, DOI 10.1016/j.cmet.2011.06.008; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kelley AE, 2005, J COMP NEUROL, V493, P72, DOI 10.1002/cne.20769; Kirkin V, 2009, AUTOPHAGY, V5, P732, DOI 10.4161/auto.5.5.8566; Koga H, 2011, J NEUROSCI, V31, P18492, DOI 10.1523/JNEUROSCI.3219-11.2011; Koga H, 2011, NEUROBIOL DIS, V43, P29, DOI 10.1016/j.nbd.2010.07.006; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; KREMER HPH, 1992, ARCH NEUROL-CHICAGO, V49, P349, DOI 10.1001/archneur.1992.00530280029014; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundh SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051168; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Metcalf DJ, 2012, EXP NEUROL, V238, P22, DOI 10.1016/j.expneurol.2010.11.003; Metzger S, 2010, HUM GENET, V128, P453, DOI 10.1007/s00439-010-0873-9; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Novak MJU, 2011, INT REV NEUROBIOL, V98, P297, DOI 10.1016/B978-0-12-381328-2.00013-4; Paulsen JS, 2011, CURR NEUROL NEUROSCI, V11, P474, DOI 10.1007/s11910-011-0215-x; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Petersen A, 2001, HUM MOL GENET, V10, P1243, DOI 10.1093/hmg/10.12.1243; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Petersen A, 2012, J HUNTINGTONS DIS, V1, P5, DOI 10.3233/JHD-2012-120006; Politis M, 2008, BRAIN, V131, P2860, DOI 10.1093/brain/awn244; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; Proenca CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068357; Qi L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046834, 10.1371/journal.pone.0029572]; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Quan W, 2012, ENDOCRINOLOGY, V153, P1817, DOI 10.1210/en.2011-1882; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Roscic A, 2011, J NEUROCHEM, V119, P398, DOI 10.1111/j.1471-4159.2011.07435.x; Rosenblatt Adam, 2007, Dialogues Clin Neurosci, V9, P191; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rue L, 2013, NEUROBIOL DIS, V52, P219, DOI 10.1016/j.nbd.2012.12.008; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Singh R, 2012, ADIPOCYTE, V1, P75, DOI 10.4161/adip.18966; Soneson C, 2010, NEUROBIOL DIS, V40, P531, DOI 10.1016/j.nbd.2010.07.013; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Thomas EA, 2011, HUM MOL GENET, V20, P1049, DOI 10.1093/hmg/ddq548; Timmers HJLM, 1996, BRAIN RES, V728, P141, DOI 10.1016/0006-8993(96)00080-7; Trejo A, 2004, NUTRITION, V20, P192, DOI 10.1016/j.nut.2003.10.007; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; Weihl CC, 2013, NEUROTHERAPEUTICS, V10, P383, DOI 10.1007/s13311-013-0180-y; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; WIEGAND M, 1991, J NEUROL, V238, P203, DOI 10.1007/BF00314781; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Wu JC, 2012, ACTA PHARMACOL SIN, V33, P743, DOI 10.1038/aps.2012.14; Wu JX, 2006, BIOCHEM BIOPH RES CO, V339, P437, DOI 10.1016/j.bbrc.2005.10.211; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yamanaka T, 2010, HUM MOL GENET, V19, P2099, DOI 10.1093/hmg/ddq087; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zucker B, 2005, HUM MOL GENET, V14, P179, DOI 10.1093/hmg/ddi014	113	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83050	10.1371/journal.pone.0083050	http://dx.doi.org/10.1371/journal.pone.0083050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376631	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100082
J	Deep, K; Poddar, A; Das, SK				Deep, Kamal; Poddar, Abhijit; Das, Subrata K.			Anoxybacillus suryakundensis sp nov, a Moderately Thermophilic, Alkalitolerant Bacterium Isolated from Hot Spring at Jharkhand, India	PLOS ONE			English	Article							DEOXYRIBONUCLEIC-ACID; THIOSULFATE; OXIDATION; DATABASE	Four closely related facultative anaerobe, moderately thermophilic, Gram positive rods (JS1(T), JS5, JS11, and JS15) were isolated from sediment samples from a hot spring at Suryakund, Jharkhand, India. Colonies were pale yellow, rough surface with uneven edges on TSA after 72 h incubation. Heterotrophic growth was observed at 40-60 degrees C and pH 5.5-11.5; optimum growth occurred at 55 degrees C and pH 7.5. 16S rRNA gene sequence analysis revealed the strains belong to genus Anoxybacillus. DNA-DNA homology values among strains were above 70% and showed distinct ERIC and REP PCR profile. On the basis of morphology and biochemical characteristics, strain JS1(T) was studied further. Strain JS1(T) showed 99.30% sequence similarity with A. flavithermus subsp. yunnanensis, 99.23% with A. mongoliensis, 99.16% with A. eryuanensis, 98.74% with A. flavithermus subsp. flavithermus, 98.54% with A. tengchongensis, 98.51% with A. pushchinoensis, 97.91% with A. thermarum, 97.82% with A. kaynarcensis, 97.77% with A. ayderensis and A. kamchatkensis, 97.63% with A. salavatliensis, 97.55% with A. kestanbolensis, 97.48% with A. contaminans, 97.27% with A. gonensis and 97.17% with A. voinovskiensis. In 16S rRNA secondary structure based phylogenetic comparison, strain JS1(T) was clustered with Anoxybacillus eryuanensis, A. mongoliensis, and A. flavithermus subsp. yunnanensis and showed 15 species specific base substitutions with maximum variability in helix 6. Moreover, DNA-DNA relatedness between JS1(T) and the closely related type strains were well below 70%. The DNA G+C content was 42.1 mol%. The major fatty acids were C-15.0 iso, C-16.0 iso and C-17.0 iso. The polar lipids were a phosphatidylgylycerol, a diphosphatidylglycerol, a phosphatidylethnolamine, a phosphatidylcholine, a phosphatidyl monomethylethanolamine and four unknown lipids. Based on polyphasic approach, strain JS1(T) represent a novel species of the genus Anoxybacillus for which Anoxybacillus suryakundensis sp. nov. is proposed. The type strain is JS1(T) (= DSM 27374(T) = LMG 27616(T) = JCM19211(T)).	[Deep, Kamal; Poddar, Abhijit; Das, Subrata K.] Inst Life Sci, Dept Biotechnol, Bhubaneswar, Orissa, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Das, SK (corresponding author), Inst Life Sci, Dept Biotechnol, Bhubaneswar, Orissa, India.	subratkdas@hotmail.com	Poddar, Abhijit/B-5880-2014	Poddar, Abhijit/0000-0002-6775-1090	Department of Biotechnology, Ministry of Science and Technology, Government of India; University Grant Commission; Council of Scientific and Industrial Research, Government of India, New Delhi	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); University Grant Commission(University Grants Commission, India); Council of Scientific and Industrial Research, Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India. The authors, KD and AP acknowledge the University Grant Commission and Council of Scientific and Industrial Research, Government of India, New Delhi respectively for providing the fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bandyopadhyay S, 2013, ARCH MICROBIOL, V195, P1, DOI 10.1007/s00203-012-0840-z; Belduz AO, 2003, INT J SYST EVOL MICR, V53, P1315, DOI 10.1099/ijs.0.02473-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cihan AC, 2011, J BASIC MICROB, V51, P136, DOI 10.1002/jobm.201000115; Coman C, 2013, EXTREMOPHILES, V17, P523, DOI 10.1007/s00792-013-0537-5; Dai J, 2011, FEMS MICROBIOL LETT, V320, P72, DOI 10.1111/j.1574-6968.2011.02294.x; Das SK, 1996, INT J SYST BACTERIOL, V46, P981, DOI 10.1099/00207713-46-4-981; De Clerck E, 2004, INT J SYST EVOL MICR, V54, P941, DOI 10.1099/ijs.0.02960-0; Dulger S, 2004, INT J SYST EVOL MICR, V54, P1499, DOI 10.1099/ijs.0.02863-0; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224, DOI 10.1099/00207713-39-3-224; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gardner DP, 2012, P 2012 IEEE INT C BI, P237, DOI DOI 10.1109/BIBM.2012.6392676; HEINEN W, 1982, A VAN LEEUW J MICROB, V48, P265, DOI 10.1007/BF00400386; Hou WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053350; Inan K, 2013, J BASIC MICROB, V53, P410, DOI 10.1002/jobm.201100638; Jung YT, 2012, INT J SYST EVOL MICR, V62, P2062, DOI 10.1099/ijs.0.036582-0; Jyoti V, 2010, INT J SYST EVOL MICR, V60, P1052, DOI 10.1099/ijs.0.014035-0; Kevbrin VV, 2005, EXTREMOPHILES, V9, P391, DOI 10.1007/s00792-005-0479-7; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; Namsaraev ZB, 2010, MICROBIOLOGY+, V79, P491, DOI 10.1134/S0026261710040119; Narayan KD, 2010, CURR MICROBIOL, V61, P248, DOI 10.1007/s00284-010-9602-9; Panda SK, 2009, INT J SYST EVOL MICR, V59, P2171, DOI 10.1099/ijs.0.007120-0; Panday D, 2011, INT J SYST EVOL MICR, V61, P2632, DOI 10.1099/ijs.0.028407-0; Panday D, 2010, INT J SYST EVOL MICR, V60, P861, DOI 10.1099/ijs.0.013466-0; Pikuta E, 2003, INT J SYST EVOL MICR, V53, P1561, DOI 10.1099/ijs.0.02643-0; Pikuta E, 2000, INT J SYST EVOL MICR, V50, P2109, DOI 10.1099/00207713-50-6-2109; Poli A, 2009, EXTREMOPHILES, V13, P867, DOI 10.1007/s00792-009-0274-y; RIVERA IG, 1995, APPL ENVIRON MICROB, V61, P2898, DOI 10.1128/AEM.61.8.2898-2904.1995; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STANECK JL, 1974, APPL MICROBIOL, V28, P226, DOI 10.1128/AEM.28.2.226-231.1974; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Yumoto I, 2004, INT J SYST EVOL MICR, V54, P1239, DOI 10.1099/ijs.0.02889-0; Zhang CM, 2011, INT J SYST EVOL MICR, V61, P118, DOI 10.1099/ijs.0.020834-0	37	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85493	10.1371/journal.pone.0085493	http://dx.doi.org/10.1371/journal.pone.0085493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376881	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100203
J	Gilchrist, EJ; Sidebottom, CHD; Koh, CS; MacInnes, T; Sharpe, AG; Haughn, GW				Gilchrist, Erin J.; Sidebottom, Christine H. D.; Koh, Chu Shin; MacInnes, Tanya; Sharpe, Andrew G.; Haughn, George W.			A Mutant Brassica napus (Canola) Population for the Identification of New Genetic Diversity via TILLING and Next Generation Sequencing	PLOS ONE			English	Article							DETECT INDUCED MUTATIONS; POINT MUTATIONS; DIETARY RECOMMENDATIONS; DISCOVERY; IMPROVEMENT; RESOURCE; PLATFORM; WHEAT; TOOL	We have generated a Brassica napus (canola) population of 3,158 EMS-mutagenised lines and used TILLING to demonstrate that the population has a high enough mutation density that it will be useful for identification of mutations in genes of interest in this important crop species. TILLING is a reverse genetics technique that has been successfully used in many plant and animal species. Classical TILLING involves the generation of a mutagenised population, followed by screening of DNA samples using a mismatch-specific endonuclease that cleaves only those PCR products that carry a mutation. Polyacrylamide gel detection is then used to visualise the mutations in any gene of interest. We have used this TILLING technique to identify 432 unique mutations in 26 different genes in B. napus (canola cv. DH12075). This reflects a mutation density ranging from 1/56 kb to 1/308 kb (depending on the locus) with an average of 1/109 kb. We have also successfully verified the utility of next generation sequencing technology as a powerful approach for the identification of rare mutations in a population of plants, even in polyploid species such as B. napus. Most of the mutants we have identified are publically available.	[Gilchrist, Erin J.; MacInnes, Tanya; Haughn, George W.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Sidebottom, Christine H. D.; Koh, Chu Shin; Sharpe, Andrew G.] Natl Res Council Canada, Saskatoon, SK, Canada	University of British Columbia; National Research Council Canada	Gilchrist, EJ (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	erin.gilchrist@ubc.ca; Andrew.Sharpe@nrc-cnrc.gc.ca		Koh, ChuShin/0000-0001-7313-2125	National Research Council Genomics Health Initiative Biorenewable Oil for Food and Fuel program; Genome Canada/Genome Alberta Designing Oilseeds for Tomorrow's Markets; AVAC Ltd. Bioactive Oils Programme; Canadian Foundation for Innovation [19834]	National Research Council Genomics Health Initiative Biorenewable Oil for Food and Fuel program; Genome Canada/Genome Alberta Designing Oilseeds for Tomorrow's Markets; AVAC Ltd. Bioactive Oils Programme; Canadian Foundation for Innovation(Canada Foundation for Innovation)	Funding for this study was provided by the following grants: the National Research Council Genomics Health Initiative Biorenewable Oil for Food and Fuel program (to A.G.S.); Genome Canada/Genome Alberta Designing Oilseeds for Tomorrow's Markets (to G.W.H.); AVAC Ltd. Bioactive Oils Programme (to G.W.H.); and Canadian Foundation for Innovation project #19834 (to G.W.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BURNS PA, 1986, GENETICS, V113, P811; Bus A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-281; Byrne ME, 2006, PLOS GENET, V2, P785, DOI 10.1371/journal.pgen.0020089; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dong CM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-143; Eckardt NA, 2007, PLANT CELL, V19, P2700, DOI 10.1105/tpc.107.056226; Gady ALF, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-13; Gebauer SK, 2006, AM J CLIN NUTR, V83, p1526S, DOI 10.1093/ajcn/83.6.1526S; Gilchrist EJ, 2006, MOL ECOL, V15, P1367, DOI 10.1111/j.1365-294X.2006.02885.x; Greene EA, 2003, GENETICS, V164, P731; Harloff HJ, 2012, THEOR APPL GENET, V124, P957, DOI 10.1007/s00122-011-1760-z; Johnson GH, 2007, J AM DIET ASSOC, V107, P1726, DOI 10.1016/j.jada.2007.07.015; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Marroni F, 2011, PLANT J, V67, P736, DOI 10.1111/j.1365-313X.2011.04627.x; Martin B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-147; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Reddy TV, 2012, IND CROP PROD, V40, P324, DOI 10.1016/j.indcrop.2012.03.031; Rigola D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004761; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; STEFANSSON BR, 1975, CAN J PLANT SCI, V55, P343, DOI 10.4141/cjps75-053; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Taylor NE, 2003, NUCLEIC ACIDS RES, V31, P3808, DOI 10.1093/nar/gkg574; Till BJ, 2004, NUCLEIC ACIDS RES, V32, P2632, DOI 10.1093/nar/gkh599; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Tsai H, 2011, PLANT PHYSIOL, V156, P1257, DOI 10.1104/pp.110.169748; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Wang TL, 2012, PLANT BIOTECHNOL J, V10, P761, DOI 10.1111/j.1467-7652.2012.00708.x; Wells R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-111; Zerr T, 2005, NUCLEIC ACIDS RES, V33, P2806, DOI 10.1093/nar/gki580; Zhu QH, 2012, GENETICS, V192, P819, DOI 10.1534/genetics.112.144436	40	35	40	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84303	10.1371/journal.pone.0084303	http://dx.doi.org/10.1371/journal.pone.0084303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376800	Green Published, gold			2022-12-27	WOS:000328745100162
J	Guo, CC; Yang, B; Gu, WY; Peng, B; Xia, SQ; Yang, FQ; Wen, DY; Geng, J; Zhang, YY; Zheng, JH				Guo, Changcheng; Yang, Bin; Gu, Wenyu; Peng, Bo; Xia, Shengqiang; Yang, Fengqiang; Wen, Deyi; Geng, Jiang; Zhang, Yuanyuan; Zheng, Junhua			Intravesical Resiniferatoxin for the Treatment of Storage Lower Urinary Tract Symptoms in Patients with Either Interstitial Cystitis or Detrusor Overactivity: A Meta-Analysis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; DOUBLE-BLIND; VANILLOID RECEPTOR; EXPRESSION; TRPV1; THERAPY; FIBERS; DESENSITIZATION; CAPSAICIN; RTX	Background: While Resin-iferatoxin (RIX) has been widely used for patients with storage lower urinary tract symptoms (LUTS), its clinical efficiency hasn't yet been well evaluated. A meta-analysis was performed to evaluate the exact roles of intravesical RTX for the treatment of storage LUTS in patients with either interstitial cystitis (IC) or detrusor overactivity (DO). Methods: A meta-analysis of RTX treatment was performed through a comprehensive search of the literature. In total, 2,332 records were initially recruited, 1,907 from Elsevier, 207 from Medline and 218 from the Web of Science. No records were retrieved from the Embase or Cochrane Library. Seven trials with 355 patients were included and one trial was excluded because of the lack of extractable data. The analyses were all performed using RevMan 5.1 and MIX 2.0. Results: Bladder pain was significantly reduced after RTX therapy in patients with either IC or DO. The average decrease of the visual an alogue pain scale was 0.42 after RTX treatment (p=0.02). The maximum cystometric capacity (MCC) was significantly increased in patients with DO (MCC increase, 53.36 ml, p =0.006) but not in those with IC (MCC increase, -19.1 ml, p= 0.35). No significant improvement in urinary frequency, nocturia, incontinence or the first involuntary detrusor contraction (FDC) was noted after RTX therapy (p= 0.06, p = 0.52, p = 0.19 and p=0.41, respectively). Conclusions: RTX could significantly reduce bladder pain in patients with either IC or DO, and increase MCC in patients with DO; however, no significant improvement was observed in frequency, nocturia, incontinence or FDC. Given the limitations in the small patient size and risk of bias in the included trials, great caution should be taken when intravesical RTX is used before a large, multicenter, well-designed random control trial with a long-term follow-up is carried out to further assess the clinical efficacy of RTX in in patients with storage LUTS.	[Guo, Changcheng; Yang, Bin; Gu, Wenyu; Peng, Bo; Xia, Shengqiang; Yang, Fengqiang; Wen, Deyi; Geng, Jiang; Zheng, Junhua] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Urol, Shanghai 200092, Peoples R China; [Zhang, Yuanyuan] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA	Tongji University; Wake Forest University	Zheng, JH (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Urol, Shanghai 200092, Peoples R China.	zhengjh0471@sina.com	Wei, Li/AAE-9938-2020; zhang, yuanyuan/GYA-4428-2022; wei, li/GSD-3630-2022		National Natural Science Foundation of China [31100702/C100307]; Specialized Research Fund for the Doctoral Program of Higher Education in China [20110072120054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education in China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported in part or in whole by the National Natural Science Foundation of China (Grant No.31100702/C100307) and Specialized Research Fund for the Doctoral Program of Higher Education in China (Grant No. 20110072120054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.No additional external funding received for this study.	Apostolidis A, 2005, UROLOGY, V65, P400, DOI 10.1016/j.urology.2004.10.007; Apostolidis A, 2006, EUR UROL, V50, P1299, DOI 10.1016/j.eururo.2006.04.006; Avelino A, 2002, NEUROSCIENCE, V109, P787, DOI 10.1016/S0306-4522(01)00496-1; Avelino A, 2000, AUTON NEUROSCI-BASIC, V86, P37, DOI 10.1016/S1566-0702(00)00204-6; Avelino A, 2006, N-S ARCH PHARMACOL, V373, P287, DOI 10.1007/s00210-006-0073-2; Birder LA, 2013, ACTA PHYSIOL, V207, P123, DOI 10.1111/j.1748-1716.2012.02462.x; Birder LA, 2001, P NATL ACAD SCI USA, V98, P13396, DOI 10.1073/pnas.231243698; Brady CM, 2004, BJU INT, V93, P770, DOI 10.1111/j.1464-410X.2003.04722.x; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Chen TYH, 2005, INT UROGYNECOL J, V16, P293, DOI 10.1007/s00192-005-1307-4; Cruz CD, 2008, EXP NEUROL, V214, P301, DOI 10.1016/j.expneurol.2008.08.016; Cruz F, 2004, UROLOGY, V63, P65, DOI 10.1016/j.urology.2003.11.001; Cruz F, 2007, NEUROUROL URODYNAM, V26, P920, DOI 10.1002/nau.20479; Cruz F, 2010, EUR UROL SUPPL, V9, P472, DOI 10.1016/j.eursup.2010.04.003; de Groat WC, 1997, UROLOGY, V50, P36, DOI 10.1016/S0090-4295(97)00587-6; Dinis P, 2004, EUR UROL, V46, P88, DOI 10.1016/j.eururo.2004.01.016; Dinis P, 2008, CURR BLADDER DYSFUNC, V3, P133, DOI 10.1007/s11884-008-0021-8; Dmitrieva N, 1996, PAIN, V66, P87, DOI 10.1016/0304-3959(96)02993-4; Elliott CS, 2012, CURR UROL REP, V13, P319, DOI 10.1007/s11934-012-0264-y; Fujihara A, 2011, INT J UROL, V18, P341, DOI 10.1111/j.1442-2042.2011.02749.x; Gever JR, 2010, BRIT J PHARMACOL, V160, P1387, DOI 10.1111/j.1476-5381.2010.00796.x; Ham BK, 2012, INT NEUROUROL J, V16, P41, DOI 10.5213/inj.2012.16.1.41; Kanai A, 2010, J UROLOGY, V183, P1288, DOI 10.1016/j.juro.2009.12.060; Kim JH, 2003, J SPINAL CORD MED, V26, P358, DOI 10.1080/10790268.2003.11753706; Kuo HC, 2006, J UROLOGY, V176, P641, DOI 10.1016/j.juro.2006.03.087; Kuo HC, 2011, LUTS, V3, P2, DOI 10.1111/j.1757-5672.2011.00087.x; Kuo HC, 2003, BJU INT, V92, P597, DOI 10.1046/j.1464-410X.2003.04441.x; Kuo HC, 2003, J UROLOGY, V170, P835, DOI 10.1097/01.ju.0000081652.31524.27; Lazzeri M, 2000, J UROLOGY, V164, P676, DOI 10.1016/S0022-5347(05)67279-5; Malykhina AP, 2013, BRAIN RES, V1491, P213, DOI 10.1016/j.brainres.2012.11.003; Marchand JE, 1998, BRIT J UROL, V81, P224; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moutzouris DA, 2009, CLIN J AM SOC NEPHRO, V4, P1844, DOI 10.2215/CJN.02000309; Ni SB, 2012, EUR UROL, V61, P1142, DOI 10.1016/j.eururo.2012.02.019; Ohsawa M, 2013, NEUROSCIENCE; Ouslander JG, 2004, NEW ENGL J MED, V350, P786, DOI 10.1056/NEJMra032662; OXMAN AD, 1993, ANN NY ACAD SCI, V703, P125, DOI 10.1111/j.1749-6632.1993.tb26342.x; PANG X, 1995, BRIT J UROL, V75, P744, DOI 10.1111/j.1464-410X.1995.tb07384.x; Payne CK, 2005, J UROLOGY, V173, P1590, DOI 10.1097/01.ju.0000154631.92150.ef; Peng CH, 2007, UROL INT, V78, P78, DOI 10.1159/000096940; Reitz A, 2004, SPINAL CORD, V42, P267, DOI 10.1038/sj.sc.3101584; Rios LAS, 2007, NEUROUROL URODYNAM, V26, P773, DOI 10.1002/nau.20300; Silva C, 2000, EUR UROL, V38, P444, DOI 10.1159/000020322; Silva C, 2005, EUR UROL, V48, P650, DOI 10.1016/j.eururo.2005.04.012; Silva C, 2002, J UROLOGY, V168, P575, DOI 10.1016/S0022-5347(05)64683-6; Silva Carlos, 2007, BMC Urol, V7, P9, DOI 10.1186/1471-2490-7-9; Yokoyama T, 2004, J UROLOGY, V172, P596, DOI 10.1097/01.ju.0000132769.71014.b5; Yoshimura N, 2007, NEUROUROL URODYNAM, V26, P908, DOI 10.1002/nau.20487; Yoshimura N, 2013, INT J UROL, V20, P56, DOI 10.1111/j.1442-2042.2012.03226.x	49	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82591	10.1371/journal.pone.0082591	http://dx.doi.org/10.1371/journal.pone.0082591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376550	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100041
J	Jones, HE; Mansukhani, MM; Tong, GX; Westhoff, CL				Jones, Heidi E.; Mansukhani, Mahesh M.; Tong, Guo-Xia; Westhoff, Carolyn L.			Validity and Reliability of Using a Self-Lavaging Device for Cytology and HPV Testing for Cervical Cancer Screening: Findings from a Pilot Study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; RISK HUMAN-PAPILLOMAVIRUS; IRRIGATION SMEAR; ENDOCERVICAL STATUS; WOMEN; SPECIMENS; AGREEMENT; ABNORMALITIES; METAANALYSIS; SENSITIVITY	Self-sampling could increase cervical cancer screening uptake. While methods have been identified for human papillomavirus (HPV) testing, to date, self-sampling has not provided adequate specimens for cytology. We piloted the validity and reliability of using a self-lavaging device for cervical cytology and HPV testing. We enrolled 198 women in New York City in 2008-2009 from three ambulatory clinics where they received cervical cancer screening. All were asked to use the Delphi Screener (TM) to self-lavage 1-3 months after clinician-collected index cytological smear (100 normal; 98 abnormal). Women with abnormal cytology results from either specimen underwent colposcopy; 10 women with normal results from both specimens also underwent colposcopy. We calculated sensitivity of self-collected cytology to detect histologically confirmed high grade lesions (cervical intraepithelial neoplasia, CIN, 2+); specificity for histology-negative (CIN 1 or lower), paired cytology negative, or a third cytology negative; and kappa for paired results. One hundred and ninety-seven (99.5%) women self-collected a lavage. Seventy-five percent had moderate to excellent cellularity, two specimens were unsatisfactory for cytology. Seven of 167 (4%) women with definitive results had CIN2+; one had normal and six abnormal cytology results with the self-lavage (sensitivity = 803/o, 95% Confidence Interval, CI: 42, 100). The kappa for paired cytology was low (0.36; 95% CI: 0.25, 0.47) primarily due to clinician specimens with atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesion (LSIL) coded as normal using Screener specimens. However, three cases of HSIL were coded as ASC-US and one as normal using Screener specimens. Seventy-three women had paired high-risk HPV tests with a kappa of 0.66 (95% Cl: 0.49, 0.84). Based on these preliminary findings, a larger study to estimate the performance of the Screener for co-testing cytology and HPV or for HPV testing with cytology triage is warranted.	[Jones, Heidi E.; Westhoff, Carolyn L.] Columbia Univ, Dept Obstet & Gynecol, Med Ctr, New York, NY 10027 USA; [Jones, Heidi E.] CUNY, Sch Publ Hlth, Epidemiol & Biostat Program, New York, NY 10021 USA; [Jones, Heidi E.] CUNY Hunter Coll, New York, NY 10021 USA; [Mansukhani, Mahesh M.; Tong, Guo-Xia] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA	Columbia University; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); Columbia University	Jones, HE (corresponding author), Columbia Univ, Dept Obstet & Gynecol, Med Ctr, New York, NY 10027 USA.	hjon@hunter.cuny.edu	Jones, Heidi E/ABF-8381-2020	Jones, Heidi E/0000-0002-4285-3752	Delphi Bioscience (Scherpenzeel, Netherlands); HEJ	Delphi Bioscience (Scherpenzeel, Netherlands)(Netherlands Government); HEJ	Delphi Bioscience (Scherpenzeel, Netherlands) funded this study as a research grant to Columbia University, including salary support for HEJ. Delphi staff commented on study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CE, 2004, CYTOPATHOLOGY, V15, P256, DOI 10.1111/j.1365-2303.2004.00161.x; ANDERSON GH, 1967, CAN MED ASSOC J, V96, P268; Anderson W A, 1967, CA Cancer J Clin, V17, P102, DOI 10.3322/canjclin.17.3.102; Bidus MA, 2005, CLIN OBSTET GYNECOL, V48, P127, DOI 10.1097/01.grf.0000151569.46072.34; Bos AB, 2001, AM J CLIN PATHOL, V115, P851; BRANDTNIELSEN E, 1967, ACTA OBSTET GYN SCAN, VS 46, P85; Brink AATP, 2006, J CLIN MICROBIOL, V44, P2518, DOI 10.1128/JCM.02440-05; Byrd TL, 2007, ETHNIC DIS, V17, P129; Driggers RW, 2008, OBSTET GYN CLIN N AM, V35, P583, DOI 10.1016/j.ogc.2008.09.007; Flahault A, 2005, J CLIN EPIDEMIOL, V58, P859, DOI 10.1016/j.jclinepi.2004.12.009; Franceschi S, 2009, INT J CANCER, V125, P2246, DOI 10.1002/ijc.24634; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Jones HE, 2007, J CLIN MICROBIOL, V45, P1679, DOI 10.1128/JCM.02369-06; Jones HE, 2012, J WOMENS HEALTH, V21, P1275, DOI 10.1089/jwh.2012.3512; Knops-Dullens T, 2007, EUR J CANCER PREV, V16, P436, DOI 10.1097/01.cej.0000236250.71113.7c; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Leyden WA, 2005, JNCI-J NATL CANCER I, V97, P675, DOI 10.1093/jnci/dji115; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Mintzer M, 1999, CANCER CYTOPATHOL, V87, P113, DOI 10.1002/(SICI)1097-0142(19990625)87:3<113::AID-CNCR3>3.0.CO;2-V; MITCHELL H, 1991, LANCET, V337, P265, DOI 10.1016/0140-6736(91)90870-U; Moore D, 2009, CYTOPATHOLOGY, V20, P161, DOI 10.1111/j.1365-2303.2008.00605.x; MUSKETT JM, 1966, BRIT MED J, V2, P341, DOI 10.1136/bmj.2.5509.341; Ogilvie GS, 2005, SEX TRANSM INFECT, V81, P207, DOI 10.1136/sti.2004.011858; Petignat P, 2007, GYNECOL ONCOL, V105, P530, DOI 10.1016/j.ygyno.2007.01.023; RICHART RM, 1965, J AMER MED ASSOC, V192, P199, DOI 10.1001/jama.1965.03080160019004; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047; Wright TC, 2007, CLIN OBSTET GYNECOL, V50, P313, DOI 10.1097/GRF.0b013e31804a8285; Zhao CQ, 2008, CANCER CYTOPATHOL, V114, P242, DOI 10.1002/cncr.23598	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82115	10.1371/journal.pone.0082115	http://dx.doi.org/10.1371/journal.pone.0082115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376516	Green Published, gold			2022-12-27	WOS:000328745100017
J	Kuo, CL; Zaykin, D				Kuo, Chia-Ling; Zaykin, Dmitri			The Ranking Probability Approach and Its Usage in Design and Analysis of Large-Scale Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; POSITIVE REPORT; FALSE; DISCOVERY	In experiments with many statistical tests there is need to balance type I and type II error rates while taking multiplicity into account. In the traditional approach, the nominal a-level such as 0.05 is adjusted by the number of tests, K, i.e., as 0.05/K. Assuming that some proportion of tests represent "true signals'', that is, originate from a scenario where the null hypothesis is false, power depends on the number of true signals and the respective distribution of effect sizes. One way to define power is for it to be the probability of making at least one correct rejection at the assumed a-level. We advocate an alternative way of establishing how "well-powered'' a study is. In our approach, useful for studies with multiple tests, the ranking probability P-x,P-u is controlled, defined as the probability of making at least x correct rejections while rejecting hypotheses with u smallest P-values. The two approaches are statistically related. Probability that the smallest P-value is a true signal (i.e., P-1,P-1) is equal to the power at the level 0.5/K, to an very good excellent approximation. Ranking probabilities are also related to the false discovery rate and to the Bayesian posterior probability of the null hypothesis. We study properties of our approach when the effect size distribution is replaced for convenience by a single "typical'' value taken to be the mean of the underlying distribution. We conclude that its performance is often satisfactory under this simplification; however, substantial imprecision is to be expected when K is very large and u is small. Precision is largely restored when three values with the respective abundances are used instead of a single typical effect size value.	[Kuo, Chia-Ling] Univ Connecticut, Ctr Hlth, Ctr Quantitat Med, Farmington, CT USA; [Zaykin, Dmitri] NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA	University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zaykin, D (corresponding author), NIEHS, Biostat Branch, POB 12233, Res Triangle Pk, NC 27709 USA.	dmitri.zaykin@nih.gov	Zaykin, Dmitri/C-3752-2019	Zaykin, Dmitri/0000-0002-9444-2859	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101866] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Gail MH, 2008, BIOSTATISTICS, V9, P201, DOI 10.1093/biostatistics/kxm032; Kuo CL, 2011, GENETICS, V189, P329, DOI 10.1534/genetics.111.130542; Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071494; Lucke JE, 2009, GENET EPIDEMIOL, V33, P145, DOI 10.1002/gepi.20363; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Sackrowitz H, 1999, AM STAT, V53, P326, DOI 10.2307/2686051; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wakefield J, 2008, INT J EPIDEMIOL, V37, P641, DOI 10.1093/ije/dym257; Zaykin DV, 2005, GENETICS, V171, P813, DOI 10.1534/genetics.105.044206	11	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83079	10.1371/journal.pone.0083079	http://dx.doi.org/10.1371/journal.pone.0083079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376639	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100086
J	Melka, MG; Abrahamowicz, M; Leonard, GT; Perron, M; Richer, L; Veillette, S; Gaudet, D; Paus, T; Pausova, Z				Melka, Melkaye G.; Abrahamowicz, Michal; Leonard, Gabriel T.; Perron, Michel; Richer, Louis; Veillette, Suzanne; Gaudet, Daniel; Paus, Tomas; Pausova, Zdenka			Clustering of the Metabolic Syndrome Components in Adolescence: Role of Visceral Fat	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; NUTRITION-EXAMINATION-SURVEY; SUBCUTANEOUS ADIPOSE-TISSUE; 3RD NATIONAL-HEALTH; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CARDIOMETABOLIC RISK; SCIENTIFIC STATEMENT; BODY-FAT	Viceral fat (VF) promotes the development of metabolic syndrome (MetS) which emerges as early as in adolescence. The clustering of MetS components suggests shared etiologies, but these are largely unknown and may vary between males and females. Here, we investigated the latent structure of pre-clinical MetS in a community-based sample of 286 male and 312 female adolescents, assessing their abdominal adiposity (VF) directly with magnetic resonance imaging. Principal component analysis of the five MetS-defining variables (VF, blood pressure [BP], fasting serum triglycerides, HDL-cholesterol and glucose) identified independent two components 111 both males and females. The first component was sex-similar; it explained >30% of variance and was loaded by all but BP variables. The second component explained >20% of variance; it was loaded by BP similarly in both sexes but additional loading by metabolic variables was sex-specific. This sex-specificity was not detected in analyses that used waist circumference instead of VF. In adolescence, MetS-defining variables cluster into at least two sub-syndromes: (1) sex-similar metabolic abnormalities of obesity-induced insulin resistance and (2) sex-specific metabolic abnormalities associated with BP elevation. These results suggest that the etiology of MetS may involve more than one pathway and that some of the pathways may differ between males and females. Further, the sex-specific metabolic abnormalities associated in BP elevation suggest he need for sex-specific prevention and treatment strategies MetS.	[Melka, Melkaye G.; Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Abrahamowicz, Michal] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Leonard, Gabriel T.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Perron, Michel; Veillette, Suzanne] Cegep Jonquiere, ECOBES, Rech & Transfert, Jonquiere, PQ, Canada; [Perron, Michel; Veillette, Suzanne] Univ Quebec Chicoutimi, Dept Human Sci, Chicoutimi, PQ, Canada; [Richer, Louis] Univ Quebec Chicoutimi, Dept Psychol, Chicoutimi, PQ, Canada; [Gaudet, Daniel] Univ Montreal, Community Genom Ctr, Chicoutimi, PQ, Canada; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McGill University; University of Quebec; University of Quebec Chicoutimi; University of Quebec; University of Quebec Chicoutimi; Universite de Montreal; University of Toronto; University Toronto Affiliates; Baycrest	Pausova, Z (corresponding author), Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada.	zdenka.pausova@sickkids.ca		Abrahamowicz, Michal/0000-0002-3172-3952	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Foundation for Innovation(Canada Foundation for Innovation)	The Canadian Institutes of Health Research (ZP, TP), Heart and Stroke Foundation of Canada (ZP), and the Canadian Foundation for Innovation (ZP) support the Saguenay Youth Study. MA is a James McGill Professor of Biostatistics at McGill University. TP is the Tanenbaum Chair in Population Neuroscience at the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alvarez GE, 2002, CIRCULATION, V106, P2533, DOI 10.1161/01.CIR.0000041244.79165.25; Alvarez GE, 2004, AM J PHYSIOL-HEART C, V287, pH414, DOI 10.1152/ajpheart.01046.2003; Anand SS, 2003, CIRCULATION, V108, P420, DOI 10.1161/01.CIR.0000080884.27358.49; [Anonymous], 2004, PREV AD OV OB CAN 19; Biaggioni I, 2008, HYPERTENSION, V51, P168, DOI 10.1161/HYPERTENSIONAHA.107.090514; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Daniels SR, 1996, HYPERTENSION, V28, P37, DOI 10.1161/01.HYP.28.1.37; Demerath EW, 2008, AM J CLIN NUTR, V88, P1263, DOI 10.3945/ajcn.2008.26546; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Freedman DS, 2009, AM J CLIN NUTR, V90, P210, DOI 10.3945/ajcn.2009.27525; Gillum R F, 1982, J Natl Med Assoc, V74, P43; GREKIN RJ, 1995, HYPERTENSION, V26, P193, DOI 10.1161/01.HYP.26.1.193; Griffith TF, 2005, AM HEART J, V149, P769, DOI 10.1016/j.ahj.2005.01.037; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Haastrup AT, 1998, HYPERTENSION, V32, P693, DOI 10.1161/01.HYP.32.4.693; Hu HH, 2011, OBES REV, V12, pe504, DOI 10.1111/j.1467-789X.2010.00824.x; Johnson WD, 2009, ARCH PEDIAT ADOL MED, V163, P371, DOI 10.1001/archpediatrics.2009.3; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; KANNEL WB, 1967, ANN INTERN MED, V67, P48, DOI 10.7326/0003-4819-67-1-48; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Kraja AT, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-41; Kraja AT, 2005, HYPERTENSION, V46, P751, DOI 10.1161/01.HYP.0000184249.20016.bb; Lipscombe LL, 2009, CAN MED ASSOC J, V180, P16, DOI 10.1503/cmaj.081713; Lowenstein CJ, 2010, CURR OPIN ENDOCRINOL, V17, P166, DOI 10.1097/MED.0b013e32833727ee; McGill HC, 2003, JAMA-J AM MED ASSOC, V290, P2320, DOI 10.1001/jama.290.17.2320; Meigs JB, 2003, DIABETES, V52, P2160, DOI 10.2337/diabetes.52.8.2160; Mercuro G, 2010, J CARDIOVASC MED, V11, P207, DOI 10.2459/JCM.0b013e32833178ed; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Narkiewicz K, 2005, HYPERTENSION, V45, P522, DOI 10.1161/01.HYP.0000160318.46725.46; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Paradis G, 2004, CIRCULATION, V110, P1832, DOI 10.1161/01.CIR.0000143100.31752.B7; Pausova Z, 2007, HUM BRAIN MAPP, V28, P502, DOI 10.1002/hbm.20402; Pausova Z, 2012, HYPERTENSION, V59, P572, DOI 10.1161/HYPERTENSIONAHA.111.180372; Pimenta E, 2008, HYPERTENSION PRIMER; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Smith JD, 2012, J CLIN ENDOCR METAB, V97, P1517, DOI 10.1210/jc.2011-2550; Soran H, 2012, CURR OPIN LIPIDOL, V23, P353, DOI 10.1097/MOL.0b013e328355ca25; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Syme C, 2008, ARCH PEDIAT ADOL MED, V162, P453, DOI 10.1001/archpedi.162.5.453; TANAKA H, 1994, ACTA PAEDIATR, V83, P646; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Woolston A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034410; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; ZEIHER AM, 1994, CIRCULATION, V89, P2525, DOI 10.1161/01.CIR.89.6.2525; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102	56	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82368	10.1371/journal.pone.0082368	http://dx.doi.org/10.1371/journal.pone.0082368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376531	gold, Green Accepted, Green Published			2022-12-27	WOS:000328745100029
J	Modrego, J; Azcona, L; Martin-Palacios, N; Zamorano-Leon, JJ; Segura, A; Rodriguez, P; Guerra, R; Tamargo, J; Macaya, C; Lopez-Farre, AJ				Modrego, Javier; Azcona, Luis; Martin-Palacios, Naiara; Zamorano-Leon, Jose J.; Segura, Antonio; Rodriguez, Pablo; Guerra, Reddy; Tamargo, Juan; Macaya, Carlos; Lopez-Farre, Antonio J.			Platelet Content of Nitric Oxide Synthase 3 Phosphorylated At Serine(1177) Is Associated with the Functional Response of Platelets to Aspirin	PLOS ONE			English	Article							L-ARGININE; ASYMMETRIC DIMETHYLARGININE; SYSTEMIC INFLAMMATION; CARDIOVASCULAR EVENTS; RISK; EXPRESSION; RESISTANCE; CELLS; METAANALYSIS; INHIBITION	Objective: To analyse if platelet responsiveness to aspirin (ASA) may be associated with a different ability of platelets to generate nitric oxide (NO). Patients/Methods: Platelets were obtained from 50 patients with stable coronary ischemia and were divided into ASA-sensitive (n= 26) and ASA-resistant (n = 24) using a platelet functionality test (PFA-100). Results: ASA-sensitive platelets tended to release more NO (determined as nitrite + nitrate) than ASA-resistant platelets but it did not reach statistical significance. Protein expression of nitric oxide synthase 3 (NOS3) was higher in ASA-sensitive than in ASA-resistant platelets but there were no differences in the platelet expression of nitric oxide synthase 2 (NOS2) isoform. The highest NOS3 expression in ASA-sensitive platelets was independent of the presence of T-to-C mutation at nucleotide position -786 (T-786 -> C) in the NOS3-coding gene. However, platelet content of phosphorylated N053 at Serine (Ser)(1177), an active form of NOS3, was higher in ASA-sensitive than in ASA-resistant platelets. The level of platelet NOS3 Ser(1177) phosphorylation was positively associated with the closure time in the PFA-100 test. in vitro, collagen failed to stimulate the aggregation of ASA-sensitive platelets, determined by lumiaggregometry, and it was associated with a significant increase (p =0.018) of NOS3 phosphorylation at Ser(1177). On the contrary, collagen stimulated the aggregation of ASA-resistant platelets but did not significantly modify the platelet content of phosphorylated NOS3 Ser(1177). During collagen stimulation the release of NO from ASA-sensitive platelets was significantly enhanced but it was not modified in ASA-resistant platelets. Conclusions: Functional platelet responsiveness to ASA was associated with the platelet content of phosphorylated NOS3 at Ser(1177).	[Modrego, Javier; Azcona, Luis; Martin-Palacios, Naiara; Zamorano-Leon, Jose J.; Rodriguez, Pablo; Macaya, Carlos; Lopez-Farre, Antonio J.] Univ Complutense Madrid, Hosp Clin San Carlos, Cardiovasc Res Unit, Madrid, Spain; [Azcona, Luis; Guerra, Reddy; Macaya, Carlos] Univ Complutense Madrid, Hosp Clin San Carlos, Dept Cardiol, Hemodynam Unit, Madrid, Spain; [Segura, Antonio] Hlth Sci Inst, Talavera De La Reina, Toledo, Spain; [Tamargo, Juan] Univ Complutense Madrid, Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Dept Pharmacol,Sch Med, Madrid, Spain	Complutense University of Madrid; Hospital Clinico San Carlos; Complutense University of Madrid; Hospital Clinico San Carlos; Complutense University of Madrid; Hospital Clinico San Carlos	Lopez-Farre, AJ (corresponding author), Univ Complutense Madrid, Hosp Clin San Carlos, Cardiovasc Res Unit, Madrid, Spain.	ajlf@telefonica.net	Segura, Antonio a/Q-5696-2017; Tamargo, Juan/J-7772-2016; MODREGO, JAVIER/ABE-7818-2021; Fragoso, Antonio Segura/AAM-7995-2020	Segura, Antonio a/0000-0003-4884-2242; Tamargo, Juan/0000-0002-7979-7758; MODREGO, JAVIER/0000-0002-2200-9503; LOPEZ FARRE, ANTONIO/0000-0003-0301-067X; ZAMORANO LEON, JOSE JAVIER/0000-0003-0686-4208	Fondo de Investigaciones de la Seguridad Social (Redes tematicas de Investigacion Cooperativa (RETICs) [RD12/0042/0040]; Fondo Europeo de Desarrollo Regional (Fondos FEDER); Fondos de Investigaciones de la Seguridad Social [PI12/01818]	Fondo de Investigaciones de la Seguridad Social (Redes tematicas de Investigacion Cooperativa (RETICs); Fondo Europeo de Desarrollo Regional (Fondos FEDER); Fondos de Investigaciones de la Seguridad Social	This work was supported by Fondo de Investigaciones de la Seguridad Social (Redes tematicas de Investigacion Cooperativa (RETICs) RD12/0042/0040], Fondo Europeo de Desarrollo Regional (Fondos FEDER) and Fondos de Investigaciones de la Seguridad Social (PI12/01818).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohmer A, 2012, BLOOD, V119, P1322, DOI 10.1182/blood-2011-11-393124; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; Boo YC, 2006, FREE RADIC BIOL MED, V411, P44; Brunini TMC, 2004, CLIN EXP PHARMACOL P, V31, P738, DOI 10.1111/j.1440-1681.2004.04067.x; Cardaropoli S, 2003, J HYPERTENS, V21, P2103, DOI 10.1097/00004872-200311000-00020; Chakraborty K, 2003, PLATELETS, V14, P421, DOI 10.1080/095371032000158763; Chen LY, 1996, J CARDIOVASC PHARM, V27, P154, DOI 10.1097/00005344-199601000-00024; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dosenko Victor E, 2006, Exp Clin Cardiol, V11, P11; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; Freedman JE, 1998, CIRCULATION, V98, P1481, DOI 10.1161/01.CIR.98.15.1481; Gambaryan S, 2008, J THROMB HAEMOST, V6, P1376, DOI 10.1111/j.1538-7836.2008.03014.x; Garcia-Cardoso J, 2010, INT J IMPOT RES, V22, P68, DOI 10.1038/ijir.2009.51; Grinstein J, 2012, CLIN CARDIOL, V35, P673, DOI 10.1002/clc.22031; Homoncik M, 2000, BRIT J HAEMATOL, V111, P1250, DOI 10.1046/j.1365-2141.2000.02473.x; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kang ES, 2000, J LAB CLIN MED, V135, P444, DOI 10.1067/mlc.2000.106805; Kawasaki T, 2000, STROKE, V31, P591, DOI 10.1161/01.STR.31.3.591; Krasopoulos G, 2008, BMJ-BRIT MED J, V336, P195, DOI 10.1136/bmj.39430.529549.BE; Leming I, 2001, CIRC RES, V88, P68; Lopez-Farre AJ, 2011, PROTEOMICS, V11, P3335, DOI 10.1002/pmic.201000708; LOPEZFARRE A, 1995, CIRCULATION, V91, P2080, DOI 10.1161/01.CIR.91.7.2080; Macchi L, 2006, CURR PHARM DESIGN, V12, P251, DOI 10.2174/138161206775193064; Mateos-Caceres PJ, 2010, THROMB HAEMOSTASIS, V103, P160, DOI 10.1160/TH09-05-0290; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; MEHTA JL, 1995, J LAB CLIN MED, V125, P370; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; RADOMSKI MW, 1990, BRIT J PHARMACOL, V101, P325, DOI 10.1111/j.1476-5381.1990.tb12709.x; Reny JL, 2008, J THROMB HAEMOST, V6, P444, DOI 10.1111/j.1538-7836.2008.02897.x; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Russo I, 2004, THROMB RES, V114, P265, DOI 10.1016/j.thromres.2004.06.036; SASE K, 1995, LIFE SCI, V57, P2049, DOI 10.1016/0024-3205(95)02191-K; Schedel Angelika, 2009, V496, P273, DOI 10.1007/978-1-59745-553-4_17; Vaziri ND, 1999, HYPERTENSION, V34, P1237, DOI 10.1161/01.HYP.34.6.1237; Williams Robert H, 2004, Thromb J, V2, P11, DOI 10.1186/1477-9560-2-11; Zamorano-Leon JJ, 2010, INT J CARDIOL, V142, P206, DOI 10.1016/j.ijcard.2008.11.166; Ziegler S, 2004, ANN HEMATOL, V83, P92, DOI 10.1007/s00277-003-0789-8	37	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82574	10.1371/journal.pone.0082574	http://dx.doi.org/10.1371/journal.pone.0082574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376548	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100039
J	Mossine, VV; Waters, JK; Hannink, M; Mawhinney, TP				Mossine, Valeri V.; Waters, James K.; Hannink, Mark; Mawhinney, Thomas P.			piggyBac Transposon plus Insulators Overcome Epigenetic Silencing to Provide for Stable Signaling Pathway Reporter Cell Lines	PLOS ONE			English	Article							DENDRITIC CELLS; IN-VITRO; TRANSGENIC ADENOCARCINOMA; SLEEPING-BEAUTY; GENE-THERAPY; MODEL; THP-1; EXPRESSION; VECTOR; DIFFERENTIATION	Genetically modified hematopoietic progenitors represent an important testing platform for a variety of cell-based therapies, pharmaceuticals, diagnostics and other applications. Stable expression of a transfected gene of interest in the cells is often obstructed by its silencing. DNA transposons offer an attractive non-viral alternative of transgene integration into the host genome, but their broad applicability to leukocytes and other "transgene unfriendly" cells has not been fully demonstrated. Here we assess stability of piggyBac transposon-based reporter expression in murine prostate adenocarcinoma TRAMP-C2, human monocyte THP-1 and erythroleukemia K562 cell lines, along with macrophages and dendritic cells (DCs) that have differentiated from the THP-1 transfects. The most efficient and stable reporter activity was observed for combinations of the transposon inverted terminal repeats and one 5'- or two cHS4 core insulators flanking a green fluorescent protein reporter construct, with no detectable silencing over 10 months of continuous cell culture in absence of any selective pressure. In monocytic THP-1 cells, the functional activity of luciferase reporters for NF-kappa B, Nrf2, or HIF-1 alpha has not decreased over time and was retained following differentiation into macrophages and DCs, as well. These results imply pB as a versatile tool for gene integration in monocytic cells in general, and as a convenient access route to DC-based signaling pathway reporters suitable for high-throughput assays, in particular.	[Mossine, Valeri V.; Hannink, Mark; Mawhinney, Thomas P.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Mossine, Valeri V.; Waters, James K.; Mawhinney, Thomas P.] Univ Missouri, Expt Stn Chem Labs, Columbia, MO USA; [Mawhinney, Thomas P.] Univ Missouri, Dept Child Hlth, Columbia, MO 65201 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Mossine, VV (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	MossineV@missouri.edu		Mawhinney, Thomas/0000-0002-1807-2550	University of Missouri Agriculture Experiment Station Laboratories; National Center for Complementary and Alternative Medicines (NCCAM), the Office of Dietary Supplements (ODS) [P50AT006273]; National Cancer Institute (NCI); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT006273] Funding Source: NIH RePORTER	University of Missouri Agriculture Experiment Station Laboratories; National Center for Complementary and Alternative Medicines (NCCAM), the Office of Dietary Supplements (ODS); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in part, by the University of Missouri Agriculture Experiment Station Laboratories and by Grant P50AT006273 from the National Center for Complementary and Alternative Medicines (NCCAM), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCCAM, ODS, NCI, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade N, 2009, TOXICOL SCI, V107, P451, DOI 10.1093/toxsci/kfn243; Atkinson H, 2010, GENETICA, V138, P485, DOI 10.1007/s10709-009-9434-3; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Berges C, 2005, BIOCHEM BIOPH RES CO, V333, P896, DOI 10.1016/j.bbrc.2005.05.171; Bradburne Christopher, 2009, Genet Vaccines Ther, V7, P6, DOI 10.1186/1479-0556-7-6; Burke B, 2002, J LEUKOCYTE BIOL, V72, P417; Camoriano M, 2008, CANCER RES, V68, P4173, DOI 10.1158/0008-5472.CAN-07-6715; Conti L, 2008, IMMUNOBIOLOGY, V213, P859, DOI 10.1016/j.imbio.2008.07.017; CORSINI E, 2011, PROG NOVEL TEST STRA, P103; Di Matteo Mario, 2012, Methods Mol Biol, V859, P241, DOI 10.1007/978-1-61779-603-6_14; Emery DW, 2011, HUM GENE THER, V22, P761, DOI 10.1089/hum.2010.233; Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009; Foster BA, 1997, CANCER RES, V57, P3325; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Hansel TT, 2013, LANCET, V381, P861, DOI 10.1016/S0140-6736(12)62202-8; Holm CK, 2013, CURR OPIN IMMUNOL, V25, P13, DOI 10.1016/j.coi.2012.12.006; Jeet V, 2008, PROSTATE, V68, P548, DOI 10.1002/pros.20714; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kimber I, 2013, CUTAN OCUL TOXICOL, V32, P54, DOI 10.3109/15569527.2012.692135; Leone C, 2006, GLIA, V54, P183, DOI 10.1002/glia.20372; Li RB, 2013, DIS MODEL MECH, V6, P828, DOI 10.1242/dmm.010827; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Li ZJ, 2013, P NATL ACAD SCI USA, V110, P5004, DOI 10.1073/pnas.1218620110; Liang Q, 2009, GENESIS, V47, P404, DOI 10.1002/dvg.20508; Lindemann C, 2002, EXP HEMATOL, V30, P150, DOI 10.1016/S0301-472X(01)00778-0; Maggi A, 2005, NAT REV DRUG DISCOV, V4, P249, DOI 10.1038/nrd1661; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McCabe MT, 2006, CANCER RES, V66, P385, DOI 10.1158/0008-5472.CAN-05-2020; Meir Yaa-Jyuhn James, 2011, Chang Gung Med J, V34, P565; Michelini E, 2010, ANAL BIOANAL CHEM, V398, P227, DOI 10.1007/s00216-010-3933-z; Migliaccio AR, 2000, GENE, V256, P197, DOI 10.1016/S0378-1119(00)00353-X; Naylor LH, 1999, BIOCHEM PHARMACOL, V58, P749, DOI 10.1016/S0006-2952(99)00096-9; Owen MR, 2011, CANCER RES, V71, P2826, DOI 10.1158/0008-5472.CAN-10-2834; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Ramezani A, 2010, METHODS MOL BIOL, V614, P77, DOI 10.1007/978-1-60761-533-0_5; Recillas-Targa F, 2006, MOL BIOTECHNOL, V34, P337, DOI 10.1385/MB:34:3:337; Schnoor M, 2009, J IMMUNOL METHODS, V344, P109, DOI 10.1016/j.jim.2009.03.014; Takahashi Naoyuki, 2007, V135, P285; Vandebriel RJ, 2012, HUM VACC IMMUNOTHER, V8, P1323, DOI 10.4161/hv.21350; Voigt K, 2012, MOL THER, V20, P1852, DOI 10.1038/mt.2012.126; Yagi K, 2007, APPL MICROBIOL BIOT, V73, P1251, DOI 10.1007/s00253-006-0718-6	42	25	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85494	10.1371/journal.pone.0085494	http://dx.doi.org/10.1371/journal.pone.0085494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376882	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100204
J	Zhou, WD; Chen, YW; Liu, XY; Chu, PG; Loria, S; Wang, YF; Yen, Y; Chou, KM				Zhou, Wendi; Chen, Yih-wen; Liu, Xiyong; Chu, Peiguo; Loria, Sofia; Wang, Yafan; Yen, Yun; Chou, Kai-Ming			Expression of DNA Translesion Synthesis Polymerase eta in Head and Neck Squamous Cell Cancer Predicts Resistance to Gemcitabine and Cisplatin-Based Chemotherapy	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; SOMATIC HYPERMUTATION; PROTEIN EXPRESSION; POOR-PROGNOSIS; FANCONI-ANEMIA; LESION BYPASS; POL-ETA; REPLICATION; SURVIVAL; ADDUCTS	Purpose: The development of resistance against anticancer drugs has been a persistent clinical problem for the treatment of locally advanced malignancies in the head and neck mucosal derived squamous cell carcinoma (HNSCC). Recent evidence indicates that the DNA translesion synthesis (TLS) polymerase eta (Pol eta; hRad30a gene) reduces the effectiveness of gemcitabine/cisplatin. The goal of this study is to examine the relationship between the expression level of Pol eta and the observed resistance against these chemotherapeutic agents in HNSCC, which is currently unknown. Methods: Sixty-four mucosal derived squamous cell carcinomas of head and neck (HNSCC) from 1989 and 2007 at the City of Hope National Medical Center (Duarte, CA) were retrospectively analyzed. Pretreatment samples were immunostained with anti-Pol eta antibody and the correlation between the expression level of Pol eta and clinical outcomes were evaluated. Forty-nine cases treated with platinum (n=40) or gemcitabine (n=9) based chemotherapy were further examined for Pol eta expression level for comparison with patient response to chemotherapy. Results: The expression of Pol eta was elevated in 67% of the head and neck tumor samples. Pol eta expression level was significantly higher in grade 1 to grade 2 tumors (well to moderately differentiated). The overall benefit rate (complete response+ partial response) in patients treated with platinum and gemcitabine based chemotherapy was 79.5%, where low Pol eta level was significantly associated with high complete response rate (p=0.03), although not associated with overall survival. Furthermore, no significant correlation was observed between Pol eta expression level with gender, age, tobacco/alcohol history, tumor stage and metastatic status. Conclusions: Our data suggest that Pol eta expression may be a useful prediction marker for the effectiveness of platinum or gemcitabine based therapy for HNSCC.	[Zhou, Wendi] Columbia Univ, Coll Phys & Surg, Affiliated Hosp, Dept Pathol,St Lukes Roosevelt Hosp Ctr, New York, NY USA; [Chen, Yih-wen; Chou, Kai-Ming] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Liu, Xiyong; Wang, Yafan; Yen, Yun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA; [Chu, Peiguo; Loria, Sofia] City Hope Comprehens Canc Ctr, Dept Pathol, Duarte, CA USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Indiana University System; Indiana University Bloomington; City of Hope; Beckman Research Institute of City of Hope; City of Hope	Yen, Y (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA.	yyen@coh.org; chouk@iupui.edu	Liu, Xiyong/E-1646-2019; Yen, Yun/H-9591-2016	Liu, Xiyong/0000-0002-0259-3669; 	NIH [RO1 112446]; NATIONAL CANCER INSTITUTE [R01CA112446] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by NIH RO1 112446 for KMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2008, MOL MED REP, V1, P695, DOI 10.3892/mmr_00000015; Adelstein David J, 2009, Head Neck, V31, P1393, DOI 10.1002/hed.21269; Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; Auclair Y, 2010, DNA REPAIR, V9, P754, DOI 10.1016/j.dnarep.2010.03.013; Azuma K, 2009, LUNG CANCER, V64, P326, DOI 10.1016/j.lungcan.2008.09.002; Bartz SR, 2006, MOL CELL BIOL, V26, P9377, DOI 10.1128/MCB.01229-06; Bassett E, 2003, BIOCHEMISTRY-US, V42, P14197, DOI 10.1021/bi035359p; Burkitt K, 2007, CANCER LETT, V253, P131, DOI 10.1016/j.canlet.2007.01.017; Burkitt K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-24; Ceppi P, 2009, CLIN CANCER RES, V15, P1039, DOI 10.1158/1078-0432.CCR-08-1227; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Chen YW, 2006, MOL CANCER RES, V4, P257, DOI 10.1158/1541-7786.MCR-05-0118; Cheng L, 2011, ESSENTIALS ANATOMIC, p125p; Chin D, 2005, INT J CANCER, V113, P789, DOI 10.1002/ijc.20608; de Feraudy S, 2007, ONCOGENE, V26, P5713, DOI 10.1038/sj.onc.1210385; Duvvuri U, 2009, CURR PROB SURG, V46, P114, DOI [10.1067/j.cpsurg.2008.10.002, 10.1067/j.cpsurg.2008.10.001]; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Faili A, 2009, J IMMUNOL, V182, P6353, DOI 10.4049/jimmunol.0900177; Fernandes AM, 2008, J ORAL PATHOL MED, V37, P543, DOI 10.1111/j.1600-0714.2008.00658.x; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Furuta T, 2002, CANCER RES, V62, P4899; Gotte A, 2005, ADV OTO-RHINO-LARYNG, V62, P38; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; Hsu DSS, 2010, CLIN CANCER RES, V16, P4561, DOI 10.1158/1078-0432.CCR-10-0593; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kishi K, 2003, CLIN CANCER RES, V9, P4368; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Kusumoto R, 2002, BIOCHEMISTRY-US, V41, P6090, DOI 10.1021/bi025549k; Lawley PD, 1996, MUTAT RES-FUND MOL M, V355, P13, DOI 10.1016/0027-5107(96)00020-6; Lever W. F., 1990, HISTOPATHOLOGY SKIN; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Pan QR, 2005, CANCER LETT, V217, P139, DOI 10.1016/j.canlet.2004.07.021; Quinn JE, 2009, GYNECOL ONCOL, V113, P134, DOI 10.1016/j.ygyno.2008.12.015; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Reed E, 1998, CANCER TREAT REV, V24, P331, DOI 10.1016/S0305-7372(98)90056-1; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; Samimi G, 2000, CLIN CANCER RES, V6, P1415; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Teng KY, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-126; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; Wachters FM, 2005, LUNG CANCER-J IASLC, V50, P211, DOI 10.1016/j.lungcan.2005.06.013; Wagner JM, 2009, MOL PHARMACOL, V76, P208, DOI 10.1124/mol.109.055178; Wang D, 2009, LUNG CANCER, V66, P298, DOI 10.1016/j.lungcan.2009.02.019; Yavuz S, 2002, J IMMUNOL, V169, P3825, DOI 10.4049/jimmunol.169.7.3825; Yuan FH, 2000, J BIOL CHEM, V275, P8233, DOI 10.1074/jbc.275.11.8233; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4717, DOI 10.1093/nar/28.23.4717; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	54	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83978	10.1371/journal.pone.0083978	http://dx.doi.org/10.1371/journal.pone.0083978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376779	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100151
J	Zhu, CK; Sun, YH; Yu, XM; Tong, JG				Zhu, Chuankun; Sun, Yanhong; Yu, Xiaomu; Tong, Jingou			Centromere Localization for Bighead Carp (Aristichthys nobilis) through Half-Tetrad Analysis in Diploid Gynogenetic Families	PLOS ONE			English	Article							MICROSATELLITE LINKAGE MAP; TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; SEA-CUCUMBER; LOCI; AFLP; INTERFERENCE; DISTANCES; MARKERS	Gene-centromere (G-C) mapping provides insights into structural and behavioural properties of chromosomes. In this study, G-C mapping using microsatellite markers and meiogynogenetic (meiotic gynogenetic) families were performed in bighead carp (Aristichthys nobilis, 2N = 48), which belongs to Cyprinidae. A total of 218 microsatellites were selected across 24 linkage groups (LGs) of a recently well-defined genetic linkage map for bighead carp, with 151 being heterozygous in at least one of six dams in diploid meiogynogenetic families. After tests for Mendelian segregation in two diploid control families, 103 microsatellites were used for G-C distance calculation in 383 gynogens. The second division segregation frequency (y) was computed through half-tetrad analyses, and the values ranged from 0 to 0.97 (mean 0.40). High G-C recombination frequencies (over 0.667) were observed in 18 (17.5%) of the loci examined, which revealed a low level of chiasma interferences compared with other fishes studied previously. Distribution of G-C distances across LGs ranged from 0 cM to 48.5 cM (mean 20 cM) under the assumption of complete interference. All 24 centromeres were localized according to their closest-related microsatellites at 95% confident intervals. The average distance between centromeres and their closest-linked markers was 6.1 cM with 15 out of 24 LGs having a distance below 5 cM. Based on the centromere positions in this study, we proposed a formula of 24 m/sm+24 t/st chromosomes with 92 arms for bighead carp, which was mostly in accordance with a previously reported karyotype for bighead carp (24 m/sm+24 st). These results of centromere localization provide a basic framework and important resources for genetics and comparative genomics studies in bighead carp and its closely-related cyprinid species.	[Zhu, Chuankun; Sun, Yanhong; Yu, Xiaomu; Tong, Jingou] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Zhu, Chuankun; Sun, Yanhong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tong, JG (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	jgtong@ihb.ac.cn	Zhu, Chuankun/AFE-0407-2022		NSFC of China [31272647]; MOA of China [200903045, 2011-G12]; FEBL of China [2011FBZ20]	NSFC of China(National Natural Science Foundation of China (NSFC)); MOA of China; FEBL of China	This study was financially supported by research grants from the NSFC (31272647), MOA (200903045, 2011-G12) and FEBL (2011FBZ20) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, J HERED, V77, P307, DOI 10.1093/oxfordjournals.jhered.a110247; ALLENDORF FW, 1984, AQUACULTURE, V43, P413, DOI 10.1016/0044-8486(84)90249-7; Bastiaanssen HJM, 1996, THEOR APPL GENET, V93, P1040, DOI 10.1007/BF00230122; Danzmann RG, 2001, GENETICA, V111, P3, DOI 10.1023/A:1013713431255; deAlmeidaToledo LF, 1995, AQUACULTURE, V135, P277, DOI 10.1016/0044-8486(95)01032-7; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Guo W, 2014, ANIMAL GENE IN PRESS, P45; Guo XM, 1996, BIOL BULL-US, V191, P145, DOI 10.2307/1542916; Guyomard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-302; Haldane JBS, 1919, J GENET, V8, P299; Hubert S, 2009, AQUACULTURE, V288, P172, DOI 10.1016/j.aquaculture.2008.12.006; Ji XS, 2009, J FISH BIOL, V75, P422, DOI 10.1111/j.1095-8649.2009.02257.x; JOHNSON KR, 1987, GENETICS, V116, P579; Johnson SL, 1996, GENETICS, V142, P1277; KAUFFMAN EJ, 1995, GENOMICS, V30, P337, DOI 10.1006/geno.1995.9869; Kolar C.S., 2005, ASIAN CARPS GENUS HY; Kong Qing-liang, 2006, Sichuan Journal of Zoology, V25, P64; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lallias D, 2007, ANIM GENET, V38, P340, DOI 10.1111/j.1365-2052.2007.01611.x; Launey S, 2001, GENETICS, V159, P255; Li L, 2004, MAR BIOTECHNOL, V6, P26, DOI 10.1007/s10126-003-0001-0; Li Q, 2009, ANIM GENET, V40, P678, DOI 10.1111/j.1365-2052.2009.01900.x; Li Q, 2011, ANIMAL GENETICS, V43, P290; Li Y, 2008, MAR BIOTECHNOL, V10, P83, DOI 10.1007/s10126-007-9040-2; Liao M, 2007, ANIM GENET, V38, P364, DOI 10.1111/j.1365-2052.2007.01617.x; Lindner KR, 2000, GENOME, V43, P538, DOI 10.1139/gen-43-3-538; Liu LS, 2013, AQUAC RES, V44, P1470, DOI 10.1111/j.1365-2109.2012.03155.x; LIU LY, 1980, ACTA ZOOL SINICA, V26, P126; LIU Q, 1992, J HERED, V83, P245, DOI 10.1093/oxfordjournals.jhered.a111208; Martinez P, 2008, AQUACULTURE, V280, P81, DOI 10.1016/j.aquaculture.2008.05.011; Morishima K, 2001, GENETICA, V111, P59, DOI 10.1023/A:1013701128529; Naciri Y., 1995, Molecular Marine Biology and Biotechnology, V4, P83; Nie HT, 2011, AQUACULTURE, V319, P67, DOI 10.1016/j.aquaculture.2011.07.006; Nomura K, 2006, AQUACULTURE, V257, P53, DOI 10.1016/j.aquaculture.2006.03.011; O'Malley KG, 2003, J HERED, V94, P273, DOI 10.1093/jhered/esg067; Poompuang S, 2011, AQUAC RES, V42, P210, DOI 10.1111/j.1365-2109.2010.02613.x; Reid DP, 2007, GENETICS, V177, P1193, DOI 10.1534/genetics.107.075374; Sakamoto T, 2000, GENETICS, V155, P1331; Sambrook J., 2001, MOL CLONING LAB MANU, P463; Song WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052097; Song WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050404; STREISINGER G, 1986, GENETICS, V112, P311; THORGAARD GH, 1983, GENETICS, V103, P771; Wang ZW, 2004, PROG NAT SCI-MATER, V14, P60, DOI 10.1080/10020070412331343151; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; Yu X, 1989, CHROMOSOMES CHINESE, P59; Yue GH, 2014, FISH FISH, V15, P376, DOI 10.1111/faf.12020; Zan R.G., 1980, ACTA GENET SIN, V7, P72; Zhao HY, 1998, GENETICS, V150, P473	49	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82950	10.1371/journal.pone.0082950	http://dx.doi.org/10.1371/journal.pone.0082950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376614	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100074
J	Cook, MB; Matthews, CE; Gunja, MZ; Abid, Z; Freedman, ND; Abnet, CC				Cook, Michael B.; Matthews, Charles E.; Gunja, Munira Z.; Abid, Zaynah; Freedman, Neal D.; Abnet, Christian C.			Physical Activity and Sedentary Behavior in Relation to Esophageal and Gastric Cancers in the NIH-AARP Cohort	PLOS ONE			English	Article							BODY-MASS INDEX; SQUAMOUS-CELL CARCINOMA; POPULATION-BASED COHORT; NATIONAL DEATH INDEX; SOCIOECONOMIC-STATUS; MASTER FILE; LIFE-STYLE; RISK; OBESITY; ASSOCIATION	Introduction: Body mass index is known to be positively associated with an increased risk of adenocarcinomas of the esophagus, yet there is there limited evidence on whether physical activity or sedentary behavior affects risk of histology- and site-specific upper gastrointestinal cancers. We used the NIH-AARP Diet and Health Study to assess these exposures in relation to esophageal adenocarcinoma (EA), esophageal squamous cell carcinoma (ESCC), gastric cardia adenocarcinoma (GCA), and gastric non-cardia adenocarcinoma (GNCA). Methods: Self-administered questionnaires were used to elicit physical activity and sedentary behavior exposures at various age periods. Cohort members were followed via linkage to the US Postal Service National Change of Address database, the Social Security Administration Death Master File, and the National Death Index. Cox proportional hazards regression models were used to estimate hazard ratios (HR) and 95 percent confidence intervals (95% CI) Results: During 4.8 million person years, there were a total of 215 incident ESCCs, 631 EAs, 453 GCAs, and 501 GNCAs for analysis. Strenuous physical activity in the last 12 months (HR>(5times/week vs.never)=0.58, 95% CI: 0.39, 0.88) and typical physical activity and sports during ages 15-18 years (p for trend=0.01) were each inversely associated with GNCA risk. Increased sedentary behavior was inversely associated with EA (HR5-6 hrs/day vs. <1 hr=0.57, 95% CI: 0.36, 0.92). There was no evidence that BMI was a confounder or effect modifier of any relationship. After adjustment for multiple testing, none of these results were deemed to be statistically significant at p<0.05. Conclusions: We find evidence for an inverse association between physical activity and GNCA risk. Associations between body mass index and adenocarcinomas of the esophagus do not appear to be related to physical activity and sedentary behavior.	[Cook, Michael B.; Matthews, Charles E.; Gunja, Munira Z.; Abid, Zaynah; Freedman, Neal D.; Abnet, Christian C.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cook, MB (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	michael.cook@nih.gov	Abnet, Christian C/C-4111-2015; Cook, Michael B/A-5641-2009; matthews, Charles e/E-8073-2015; Freedman, Neal David/B-9741-2015	Abnet, Christian C/0000-0002-3008-7843; Cook, Michael B/0000-0002-0533-7302; matthews, Charles e/0000-0001-8037-3103; Freedman, Neal David/0000-0003-0074-1098	NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abrams JA, 2009, GUT, V58, P1437, DOI 10.1136/gut.2009.183285; Akiyama T, 2011, DIGESTION, V83, P142, DOI 10.1159/000321810; Ayazi S, 2009, J GASTROINTEST SURG, V13, P1440, DOI 10.1007/s11605-009-0930-7; Balbuena L, 2009, FUTURE ONCOL, V5, P1051, DOI 10.2217/FON.09.65; Batty GD, 2010, ANN EPIDEMIOL, V20, P661, DOI 10.1016/j.annepidem.2010.03.014; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair A, 2005, ANN EPIDEMIOL, V15, P279, DOI 10.1016/j.annepidem.2004.08.008; BROWNSON RC, 1991, AM J PUBLIC HEALTH, V81, P639, DOI 10.2105/AJPH.81.5.639; Campbell PT, 2007, EUR J CANCER, V43, P593, DOI 10.1016/j.ejca.2006.11.011; Dar NA, 2013, CANCER SCI, V104, P1231, DOI 10.1111/cas.12210; Derakhshan MH, 2012, GUT, V61, P337, DOI 10.1136/gutjnl-2011-300633; DOSEMECI M, 1993, CANCER CAUSE CONTROL, V4, P313, DOI 10.1007/BF00051333; Dunton GF, 2009, INT J OBESITY, V33, P1427, DOI 10.1038/ijo.2009.174; Etemadi A, 2012, ANN ONCOL, V23, P1593, DOI 10.1093/annonc/mdr494; Hassler S, 2008, EUR J EPIDEMIOL, V23, P273, DOI 10.1007/s10654-008-9232-8; Hermansen SW, 2009, AM J EPIDEMIOL, V169, P901, DOI 10.1093/aje/kwn404; Hill ME, 2001, SOC SECUR BULL, V64, P45; Hoyo C, 2012, INT J EPIDEMIOL, V41, P1706, DOI 10.1093/ije/dys176; Huang Xin-En, 2004, Asian Pac J Cancer Prev, V5, P419; Inoue M, 2008, AM J EPIDEMIOL, V168, P391, DOI 10.1093/aje/kwn146; Jurek AM, 2008, INT J EPIDEMIOL, V37, P382, DOI 10.1093/ije/dym291; Knuth AG, 2009, J PHYS ACT HEALTH, V6, P548, DOI 10.1123/jpah.6.5.548; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; Leitzmann MF, 2009, AM J PREV MED, V36, P112, DOI 10.1016/j.amepre.2008.09.033; Huerta JM, 2010, CANCER CAUSE CONTROL, V21, P657, DOI 10.1007/s10552-009-9493-x; NOMURA AMY, 1995, JPN J CANCER RES, V86, P916, DOI 10.1111/j.1349-7006.1995.tb03001.x; Osorio-Costa F, 2009, ARQ BRAS ENDOCRINOL, V53, P213, DOI 10.1590/S0004-27302009000200013; PAFFENBARGER RS, 1987, AM J CLIN NUTR, V45, P312, DOI 10.1093/ajcn/45.1.312; Pandeya N, 2011, J GASTROEN HEPATOL, V26, P1283, DOI 10.1111/j.1440-1746.2011.06726.x; Pandolfino JE, 2006, GASTROENTEROLOGY, V130, P639, DOI 10.1053/j.gastro.2005.12.016; Parent ME, 2011, CANCER EPIDEMIOL, V35, P151, DOI 10.1016/j.canep.2010.09.004; Parikh NI, 2007, AM J MED, V120, P242, DOI 10.1016/j.amjmed.2006.06.004; Pukkala E, 1993, Eur J Cancer Prev, V2, P369, DOI 10.1097/00008469-199309000-00002; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; SEVERSON RK, 1989, AM J EPIDEMIOL, V130, P522, DOI 10.1093/oxfordjournals.aje.a115366; Sjodahl K, 2008, CANCER EPIDEM BIOMAR, V17, P135, DOI 10.1158/1055-9965.EPI-07-0704; Soll-Johanning H, 2004, INT ARCH OCC ENV HEA, V77, P351, DOI 10.1007/s00420-004-0510-9; STUKONIS M, 1969, INT J CANCER, V4, P248, DOI 10.1002/ijc.2910040215; Vigen C, 2006, INT J CANCER, V118, P1004, DOI 10.1002/ijc.21419; Wannamethee SG, 2001, BRIT J CANCER, V85, P1311, DOI 10.1054/bjoc.2001.2096; Weiderpass E, 2003, J OCCUP ENVIRON MED, V45, P305, DOI 10.1097/01.jom.0000052963.43131.44; Wen XY, 2010, ASIAN PAC J CANCER P, V11, P1473; WHITTEMORE AS, 1985, JNCI-J NATL CANCER I, V74, P43; Wilson LJ, 1999, AM J GASTROENTEROL, V94, P2840, DOI 10.1111/j.1572-0241.1999.01426.x; Yun YH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-366; Zhang ZF, 1996, CANCER EPIDEM BIOMAR, V5, P761	46	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84805	10.1371/journal.pone.0084805	http://dx.doi.org/10.1371/journal.pone.0084805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367697	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900068
J	Qureshi, HY; Han, D; MacDonald, R; Paudel, HK				Qureshi, Hamid Y.; Han, Dong; MacDonald, Ryen; Paudel, Hemant K.			Overexpression of 14-3-3z Promotes Tau Phosphorylation at Ser(262) and Accelerates Proteosomal Degradation of Synaptophysin in Rat Primary Hippocampal Neurons	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; FTDP-17 MISSENSE MUTATIONS; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; PROTEASOMAL DEGRADATION; REACTIVE ASTROCYTES; RECOMBINANT TAU; LUNG-CANCER; EXPRESSION; NEURODEGENERATION	b-amyloid peptide accumulation, tau hyperphosphorylation, and synapse loss are characteristic neuropathological symptoms of Alzheimer's disease (AD). Tau hyperphosphorylation is suggested to inhibit the association of tau with microtubules, making microtubules unstable and causing neurodegeneration. The mechanism of tau phosphorylation in AD brain, therefore, is of considerable significance. Although PHF-tau is phosphorylated at over 40 Ser/Thr sites, Ser(262) phosphorylation was shown to mediate b-amyloid neurotoxicity and formation of toxic tau lesions in the brain. In vitro, PKA is one of the kinases that phosphorylates tau at Ser(262), but the mechanism by which it phosphorylates tau in AD brain is not very clear. 14-3-3z is associated with neurofibrillary tangles and is upregulated in AD brain. In this study, we show that 14-3-3z promotes tau phosphorylation at Ser(262) by PKA in differentiating neurons. When overexpressed in rat hippocampal primary neurons, 14-3-3z causes an increase in Ser(262) phosphorylation, a decrease in the amount of microtubule-bound tau, a reduction in the amount of polymerized microtubules, as well as microtubule instability. More importantly, the level of pre-synaptic protein synaptophysin was significantly reduced. Downregulation of synaptophysin in 14-3-3z overexpressing neurons was mitigated by inhibiting the proteosome, indicating that 14-3-3z promotes proteosomal degradation of synaptophysin. When 14-3-3z overexpressing neurons were treated with the microtubule stabilizing drug taxol, tau Ser(262) phosphorylation decreased and synaptophysin level was restored. Our data demonstrate that overexpression of 14-3-3z accelerates proteosomal turnover of synaptophysin by promoting the destabilization of microtubules. Synaptophysin is involved in synapse formation and neurotransmitter release. Our results suggest that 14-3-3z may cause synaptic pathology by reducing synaptophysin levels in the brains of patients suffering from AD.	[Qureshi, Hamid Y.; Han, Dong; MacDonald, Ryen; Paudel, Hemant K.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; [MacDonald, Ryen; Paudel, Hemant K.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University	Paudel, HK (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca			Canadian Institute for Health Research, and Alzheimer's Society of Canada	Canadian Institute for Health Research, and Alzheimer's Society of Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from Canadian Institute for Health Research, and Alzheimer's Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Allen B, 2002, J NEUROSCI, V22, P9340; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Angelastro JM, 2000, P NATL ACAD SCI USA, V97, P10424, DOI 10.1073/pnas.97.19.10424; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BLACK MM, 1986, J CELL BIOL, V103, P545, DOI 10.1083/jcb.103.2.545; Brennan GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054491; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Cassano S, 1996, J BIOL CHEM, V271, P29870, DOI 10.1074/jbc.271.47.29870; Cheah PS, 2012, MOL PSYCHIATR, V17, P451, DOI 10.1038/mp.2011.158; Chen XQ, 2003, GLIA, V42, P315, DOI 10.1002/glia.10185; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Daly C, 1997, J NEUROSCI, V17, P2365; Delobel P, 2002, J NEUROCHEM, V83, P412, DOI 10.1046/j.1471-4159.2002.01143.x; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fan T, 2007, CANCER RES, V67, P7901, DOI 10.1158/0008-5472.CAN-07-0090; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Han D, 2009, J BIOL CHEM, V284, P13422, DOI 10.1074/jbc.M901095200; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Hernandez F, 2004, NEUROSCI LETT, V357, P143, DOI 10.1016/j.neulet.2003.12.049; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Huff LM, 2010, CANCER RES, V70, P5870, DOI 10.1158/0008-5472.CAN-09-4281; Iijima K, 2010, HUM MOL GENET, V19, P2947, DOI 10.1093/hmg/ddq200; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Iwai A, 2000, BBA-MOL BASIS DIS, V1502, P95, DOI 10.1016/S0925-4439(00)00036-3; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Kawamoto Y, 2004, ACTA NEUROPATHOL, V108, P302, DOI 10.1007/s00401-004-0892-5; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee G, 2012, PROG MOL BIOL TRANSL, V107, P263, DOI 10.1016/B978-0-12-385883-2.00004-7; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leugers CJ, 2010, J BIOL CHEM, V285, P19125, DOI 10.1074/jbc.M110.105387; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; Lim F, 2001, MOL CELL NEUROSCI, V18, P702, DOI 10.1006/mcne.2001.1051; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; Lu YF, 2011, J BIOL CHEM, V286, P20569, DOI 10.1074/jbc.M111.220962; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Malaspina A, 2000, J NEUROCHEM, V75, P2511, DOI 10.1046/j.1471-4159.2000.0752511.x; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Paudel HK, 1999, J BIOL CHEM, V274, P8029, DOI 10.1074/jbc.274.12.8029; Paudel HK, 1997, J BIOL CHEM, V272, P1777; Perathoner A, 2005, CLIN CANCER RES, V11, P3274, DOI 10.1158/1078-0432.CCR-04-2207; Pirim I, 1998, INT J NEUROSCI, V95, P101, DOI 10.3109/00207459809000653; Preuss U, 1998, EUR J CELL BIOL, V76, P176, DOI 10.1016/S0171-9335(98)80032-0; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Qureshi HY, 2011, J BIOL CHEM, V286, P5055, DOI 10.1074/jbc.M110.178905; Ramser EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013462; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Ren QG, 2007, FEBS LETT, V581, P1521, DOI 10.1016/j.febslet.2007.02.065; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Sakaue F, 2005, J BIOL CHEM, V280, P31522, DOI 10.1074/jbc.M504792200; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Satoh J, 2004, AM J PATHOL, V165, P577, DOI 10.1016/S0002-9440(10)63322-6; Schipper HM, 1999, NEUROSCIENCE, V93, P585, DOI 10.1016/S0306-4522(99)00120-7; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Sironi JJ, 1998, FEBS LETT, V436, P471, DOI 10.1016/S0014-5793(98)01185-5; Sluchanko NN, 2011, BIOCHEMISTRY-US, V50, P9797, DOI 10.1021/bi201374s; Sobue K, 2000, J BIOL CHEM, V275, P16673, DOI 10.1074/jbc.M000784200; Song W, 2009, J NEUROCHEM, V110, P719, DOI 10.1111/j.1471-4159.2009.06165.x; Soulie C, 2004, NEUROSCI LETT, V365, P1, DOI 10.1016/j.neulet.2004.03.090; Sun W, 2002, J BIOL CHEM, V277, P11933, DOI 10.1074/jbc.M107182200; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Tanemura K, 2002, J NEUROSCI, V22, P133, DOI 10.1523/JNEUROSCI.22-01-00133.2002; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; WATANABE A, 1993, J BIOL CHEM, V268, P25712; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; YAN GZ, 1995, J NEUROSCI, V15, P6200; Yu WD, 2012, HUM MOL GENET, V21, P1384, DOI 10.1093/hmg/ddr576	101	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84615	10.1371/journal.pone.0084615	http://dx.doi.org/10.1371/journal.pone.0084615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367683	Green Submitted, Green Published, gold			2022-12-27	WOS:000328741900059
J	Somasundaram, R; Nuij, VJAA; van der Woude, CJ; Kuipers, EJ; Peppelenbosch, MP; Fuhler, GM				Somasundaram, Rajesh; Nuij, Veerle J. A. A.; van der Woude, C. Janneke; Kuipers, Ernst J.; Peppelenbosch, Maikel P.; Fuhler, Gwenny M.			Peripheral Neutrophil Functions and Cell Signalling in Crohn's Disease	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INFLAMMATORY-BOWEL-DISEASE; PROTEIN-KINASE-B; GM-CSF; PHOSPHATIDYLINOSITOL 3-KINASE; ULCERATIVE-COLITIS; REGULATED KINASE; NADPH OXIDASE; WHOLE-BLOOD; IN-VITRO	The role of the innate immunity in the pathogenesis of Crohn's disease (CD), an inflammatory bowel disease, is a subject of increasing interest. Neutrophils (PMN) are key members of the innate immune system which migrate to sites of bacterial infection and initiate the defence against microbes by producing reactive oxygen species (ROS), before undergoing apoptosis. It is believed that impaired innate immune responses contribute to CD, but it is as yet unclear whether intrinsic defects in PMN signal transduction and corresponding function are present in patients with quiescent disease. We isolated peripheral blood PMN from CD patients in remission and healthy controls (HC), and characterised migration, bacterial uptake and killing, ROS production and cell death signalling. Whereas IL8-induced migration and signalling were normal in CD, trans-epithelial migration was significantly impaired. Uptake and killing of E. coli were normal. However, an increased ROS production was observed in CD PMN after stimulation with the bacterial peptide analogue fMLP, which was mirrored by an increased fMLP-triggered ERK and AKT signal activation. Interestingly, cleavage of caspase-3 and caspase-8 during GMCSF-induced rescue from cell-death was decreased in CD neutrophils, but a reduced survival signal emanating from STAT3 and AKT pathways was concomitantly observed, resulting in a similar percentage of end stage apoptotic PMN in CD patients and HC. In toto, these data show a disturbed signal transduction activation and functionality in peripheral blood PMN from patients with quiescent CD, which point toward an intrinsic defect in innate immunity in these patients.	[Somasundaram, Rajesh; Nuij, Veerle J. A. A.; van der Woude, C. Janneke; Kuipers, Ernst J.; Peppelenbosch, Maikel P.; Fuhler, Gwenny M.] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Fuhler, GM (corresponding author), Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	g.fuhler@erasmusmc.nl	Peppelenbosch, Maikel P./U-5304-2019; Fuhler, Gwenny/AAC-7122-2019; Kuipers, Ernst J/H-3293-2019	Fuhler, Gwenny/0000-0001-9221-4855; Kuipers, Ernst J/0000-0002-0633-3098; van der Woude, C.Janneke/0000-0003-3875-6957; Peppelenbosch, Maikel/0000-0001-9112-6028	Dutch Cancer Society [2010-4737]; ECCO	Dutch Cancer Society(KWF Kankerbestrijding); ECCO	GMF is supported by the Dutch Cancer Society (grant 2010-4737). MPP is supported by a personal ECCO grant. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annabi B, 1998, AM J HUM GENET, V62, P400, DOI 10.1086/301727; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Biagioni C, 2006, EXP BIOL MED, V231, P186; Blake KM, 2004, CLIN EXP IMMUNOL, V136, P262, DOI 10.1111/j.1365-2249.2004.02429.x; Brandt E, 1998, EUR CYTOKINE NETW, V9, P647; Brazil JC, 2010, J IMMUNOL, V185, P7026, DOI 10.4049/jimmunol.1001293; Burelout C, 2007, J LEUKOCYTE BIOL, V81, P1523, DOI 10.1189/jlb.0406256; Casanova JL, 2009, J EXP MED, V206, P1839, DOI 10.1084/jem.20091683; Conway KL, 2012, J IMMUNOL, V189, P3631, DOI 10.4049/jimmunol.1103746; Crepaldi L, 2002, INT IMMUNOL, V14, P1145, DOI 10.1093/intimm/dxf079; Epling-Burnette PK, 2001, J IMMUNOL, V166, P7486, DOI 10.4049/jimmunol.166.12.7486; Faber K.N., 2012, CLIN VACCINE IMMUNOL; Fiuza C, 2002, CLIN DIAGN LAB IMMUN, V9, P433, DOI 10.1128/CDLI.9.2.433-439.2002; Fortin CF, 2007, BIOGERONTOLOGY, V8, P173, DOI 10.1007/s10522-006-9067-1; Fuhler GM, 2005, J LEUKOCYTE BIOL, V77, P257, DOI 10.1189/jlb.0504306; Fuhler GM, 2003, EXP HEMATOL, V31, P752, DOI 10.1016/S0301-472X(03)00188-7; Fuhler GM, 2003, BLOOD, V101, P1172, DOI 10.1182/blood.V101.3.1172; Fuhler GM, 2008, BLOOD, V111, P359, DOI 10.1182/blood-2006-11-060632; Fuhler GM, 2007, J LEUKOCYTE BIOL, V81, P449, DOI 10.1189/jlb.0506311; Furebring M, 2006, SCAND J IMMUNOL, V63, P208, DOI 10.1111/j.1365-3083.2006.01724.x; GIONCHETTI P, 1994, DIGEST DIS SCI, V39, P550, DOI 10.1007/BF02088341; Glasser AL, 2008, ARCH IMMUNOL THER EX, V56, P237, DOI 10.1007/s00005-008-0026-1; GRISHAM MB, 1988, DIGEST DIS SCI, V33, pS6, DOI 10.1007/BF01538126; Harbord MWN, 2006, ALIMENT PHARM THER, V24, P651, DOI 10.1111/j.1365-2036.2006.03016.x; Hayee B, 2011, DIGEST DIS SCI, V56, P1482, DOI 10.1007/s10620-010-1426-8; HOMBURG CHE, 1995, BLOOD, V85, P532; JONES SC, 1993, J GASTROEN HEPATOL, V8, P508, DOI 10.1111/j.1440-1746.1993.tb01643.x; Klionsky DJ, 2009, NEW ENGL J MED, V360, P1785, DOI 10.1056/NEJMcibr0810347; Kopprasch S, 1996, CLIN CHIM ACTA, V253, P145, DOI 10.1016/0009-8981(96)06365-6; Kotone-Miyahara Y, 2004, J LEUKOCYTE BIOL, V76, P1047, DOI 10.1189/jlb.0104048; Liu LX, 1996, ANN NY ACAD SCI, V796, P21, DOI 10.1111/j.1749-6632.1996.tb32563.x; Maiguel D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001811; Marks DJB, 2011, CURR OPIN GASTROEN, V27, P328, DOI 10.1097/MOG.0b013e3283463b45; Marks DJB, 2010, CLIN REV ALLERG IMMU, V38, P20, DOI 10.1007/s12016-009-8133-2; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; McKenzie SJ, 1996, J CLIN INVEST, V98, P136, DOI 10.1172/JCI118757; MITSUYAMA K, 1994, CLIN EXP IMMUNOL, V96, P432; MULHOLLAND MW, 1983, ANN SURG, V198, P673, DOI 10.1097/00000658-198312000-00001; Passalacqua S, 2011, J CLIN APHERESIS, V26, P332, DOI 10.1002/jca.20315; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rahman FZ, 2008, INFLAMM BOWEL DIS, V14, P1443, DOI 10.1002/ibd.20449; RHODES JM, 1983, GUT, V24, P73, DOI 10.1136/gut.24.1.73; Sakamoto C, 2003, INT J HEMATOL, V77, P60, DOI 10.1007/BF02982604; Schwarzmaier D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062761; Segal AW, 1996, MOL MED TODAY, V2, P129, DOI 10.1016/1357-4310(96)88723-5; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; Taguchi M, 1998, J EXP MED, V187, P1927, DOI 10.1084/jem.187.12.1927; Trottier MD, 2012, OBESITY, V20, P1057, DOI 10.1038/oby.2011.354; Uzel G, 2008, BLOOD, V111, P209, DOI 10.1182/blood-2007-04-082552; VERSPAGET HW, 1988, GUT, V29, P223, DOI 10.1136/gut.29.2.223; Zhou L, 2009, CELL MOL LIFE SCI, V66, P192, DOI 10.1007/s00018-008-8308-7	53	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84521	10.1371/journal.pone.0084521	http://dx.doi.org/10.1371/journal.pone.0084521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367671	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900052
J	Specogna, AV; Patten, SB; Turin, TC; Hill, MD				Specogna, Adrian V.; Patten, Scott B.; Turin, Tanvir C.; Hill, Michael D.			The Reliability and Sensitivity of the National Institutes of Health Stroke Scale for Spontaneous Intracerebral Hemorrhage in an Uncontrolled Setting	PLOS ONE			English	Article								Background and Purpose: The National Institutes of Health Stroke Scale (NIHSS) is commonly used to measure neurologic function and guide treatment after spontaneous intracerebral hemorrhage (ICH) in routine stroke clinics. We evaluated its reliability and sensitivity to detect change with consecutive and unique rater combinations in a real-world setting. Methods: Conservative measures of interrater reliability (unweighted Kappa (kappa), Intraclass Correlation Coefficient (ICC1.1) and sensitivity to detect change (Minimal Detectable Difference (MDD)) were estimated. Sixty-one repeated ratings were completed within 1 week after ICH by physicians and nurses with no investigator intervention. Results: Reliability (consistency) of the NIHSS total score was good for both physicians vs. nurses and nurses vs. nurses (ICC=0.78, 95%CI: 0.58-0.89 and ICC= 0.75, 95% CI: 0.55-0.87 respectively) in this scenario. Reliability (agreement) of items 1C and 9 were excellent (kappa>=0.61) for both rater comparisons, however, reliability was poor to fair on most remaining items (kappa:0.01-0.60), with item 11 being completely unreliable in this scenario (kappa<0.01). The MDD95 of the total NIHSS score was +/- 10 and +/- 11 points for physician vs. nurse and nurse vs. nurse comparisons. Conclusions: The reliability of the NIHSS is good overall for ICH even in an uncontrolled setting. However, on repeated measurements changes in total NIHSS score of at least >=10 points need to be observed for clinicians to be confident that real changes had occurred within 1 week after ICH.	[Specogna, Adrian V.; Patten, Scott B.; Turin, Tanvir C.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Hill, Michael D.] Foothills Prov Gen Hosp, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada	University of Calgary; University of Calgary	Specogna, AV (corresponding author), Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada.	specogna@shaw.ca	Hill, Michael D/C-9073-2012; Patten, Scott/B-4434-2011; Turin, Tanvir C/L-7617-2016	Hill, Michael D/0000-0002-6269-1543; Patten, Scott/0000-0001-9871-4041; Turin, Tanvir C/0000-0002-7499-5050	Alberta Heritage Foundation for Medical Research; University of Calgary; Tomorrow's Research Cardiovascular Health Professional training program	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); University of Calgary; Tomorrow's Research Cardiovascular Health Professional training program	Adrian V. Specogna has received salary support awards from the Alberta Heritage Foundation for Medical Research, the University of Calgary, and the Tomorrow's Research Cardiovascular Health Professional training program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Kasner SE, 2003, STROKE, V34, P568, DOI 10.1161/01.STR.0000052630.11159.25; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Portney LG, 2008, CORRELATION, V3; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Specogna Adrian V, 2004, J Knee Surg, V17, P203; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Woo D, 1999, STROKE, V30, P2355, DOI 10.1161/01.STR.30.11.2355	9	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84702	10.1371/journal.pone.0084702	http://dx.doi.org/10.1371/journal.pone.0084702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367691	Green Published, gold			2022-12-27	WOS:000328741900063
J	Bhasin, B; Lau, B; Atta, MG; Fine, DM; Estrella, MM; Schwartz, GJ; Lucas, GM				Bhasin, Bhavna; Lau, Bryan; Atta, Mohamed G.; Fine, Derek M.; Estrella, Michelle M.; Schwartz, George J.; Lucas, Gregory M.			HIV Viremia and T-Cell Activation Differentially Affect the Performance of Glomerular Filtration Rate Equations Based on Creatinine and Cystatin C	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM CREATININE; ANTIRETROVIRAL THERAPY; LYMPHOCYTE-ACTIVATION; CD38 EXPRESSION; INFECTION; MARKER; REPLICATION; POPULATION; MORTALITY	Background: Serum creatinine and cystatin C are used as markers of glomerular filtration rate (GFR). The performance of these GFR markers relative to exogenously measured GFR (mGFR) in HIV-positive individuals is not well established. Methods: We assessed the performance of the chronic kidney disease epidemiology collaboration equations based on serum concentrations of creatinine (eGFR(cr)), cystatin C (eGFR(cys)) and both biomarkers combined (eGFR(cr-cys)) in 187 HIV-positive and 98 HIV-negative participants. Measured GFR was calculated by plasma iohexol clearance. Bias and accuracy were defined as the difference between eGFR and mGFR and the percentage of eGFR observations within 30% of mGFR, respectively. Activated CD4 and CD8 T-cells (CD38+ HLA-DR+) were measured by flow cytometry. Results: The median mGFR was > 100 ml/min/1.73 m(2) in both groups. All equations tended to be less accurate in HIV-positive than in HIV-negative subjects, with eGFRcr-cys being the most accurate overall. In the HIV-positive group, eGFRcys was significantly less accurate and more biased than eGFR(cr) and eGFR(cr_cys). Additionally eGFR(cys) bias and accuracy were strongly associated with use of antiretroviral therapy, HIV RNA suppression, and percentages of activated CD4 or CD8 T-cells. Hepatitis C seropositivity was associated with larger eGFRcys bias in both HIV-positive and HIV-negative groups. In contrast, eGFRcr accuracy and bias were not associated with HIV-related factors, T-cell activation, or hepatitis C. Conclusions: The performance of eGFRcys relative to mGFR was strongly correlated with HIV treatment factors and markers of T-cell activation, which may limit its usefulness as a GFR marker in this population.	[Bhasin, Bhavna; Lau, Bryan; Atta, Mohamed G.; Fine, Derek M.; Estrella, Michelle M.; Lucas, Gregory M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Lau, Bryan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Schwartz, George J.] Univ Rochester, Sch Med, Dept Pediat, Rochester, NY 14642 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Rochester	Lucas, GM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	glucas@jhmi.edu			National Institute on Drug Abuse [R01-DA026770]; Johns Hopkins Institute for Clinical and Translational Research (ICTR); National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR 000424-06];  [P01-DK056492];  [K23DK081317]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056492, K23DK081317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026770, K24DA035684] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Johns Hopkins Institute for Clinical and Translational Research (ICTR); National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by a grant from the National Institute on Drug Abuse (R01-DA026770) and by the Johns Hopkins Institute for Clinical and Translational Research (ICTR), which is funded in part by grant number UL1 TR 000424-06 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Additional support was provided by P01-DK056492 (MGA, DMF, and GML) and by K23DK081317 (MME). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS, or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraclough K, 2009, NEPHRON CLIN PRACT, V111, pC39, DOI 10.1159/000178978; Benito JM, 2004, AIDS RES HUM RETROV, V20, P227, DOI 10.1089/088922204773004950; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beran O, 2003, ACTA VIROL, V47, P121; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Choi A, 2010, AM J KIDNEY DIS, V56, P872, DOI 10.1053/j.ajkd.2010.05.019; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Driver TH, 2013, AIDS, V27, P2291, DOI 10.1097/QAD.0b013e328362e874; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Estrella MM, 2011, JAIDS-J ACQ IMM DEF, V57, P380, DOI 10.1097/QAI.0b013e318222f461; Gagneux-Brunon A, 2013, AIDS; Gagneux-Brunon A, 2012, NEPHROL DIAL TRANSPL, V27, P1305, DOI 10.1093/ndt/gfs001; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Grubb A, 2010, CLIN CHEM LAB MED, V48, P1619, DOI 10.1515/CCLM.2010.318; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Inker LA, 2012, JAIDS-J ACQ IMM DEF, V61, P302, DOI 10.1097/QAI.0b013e31826a6c4f; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jones CY, 2008, AM J KIDNEY DIS, V51, P914, DOI 10.1053/j.ajkd.2008.01.027; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Luc G, 2006, ATHEROSCLEROSIS, V185, P375, DOI 10.1016/j.atherosclerosis.2005.06.017; Mauss S, 2008, ANTIVIR THER, V13, P1091; Mocroft A, 2009, AIDS, V23, P71, DOI 10.1097/QAD.0b013e32831cc129; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Praditpornsilpa K, 2012, AIDS, V26, P1781, DOI 10.1097/QAD.0b013e328356480d; Schwartz GJ, 2006, KIDNEY INT, V69, P2070, DOI 10.1038/sj.ki.5000385; Vlahov D, 1991, NIDA Res Monogr, V109, P75	29	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82028	10.1371/journal.pone.0082028	http://dx.doi.org/10.1371/journal.pone.0082028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376511	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000005
J	Dhar, P; Tayade, AB; Kumar, J; Chaurasia, OP; Srivastava, RB; Singh, SB				Dhar, Priyanka; Tayade, Amol B.; Kumar, Jatinder; Chaurasia, Om P.; Srivastava, Ravi B.; Singh, Shashi B.			Nutritional Profile of Phytococktail from Trans-Himalayan Plants	PLOS ONE			English	Article							WATER-SOLUBLE VITAMINS; PERFORMANCE LIQUID-CHROMATOGRAPHY; HIPPOPHAE-RHAMNOIDES L.; MONOUNSATURATED FATTY-ACIDS; UNDERIVATIZED AMINO-ACIDS; PALMITOLEIC ACID; SEQUENTIAL DETERMINATION; CHEMICAL-COMPOSITION; GAS-CHROMATOGRAPHY; LDL-CHOLESTEROL	We estimated the nutritive value, vitamin content, amino acid composition, fatty acid content, and mineral profile of a phytococktail comprising sea buckthorn (Hippophae rhamnoides), apricot (Prunus armeniaca), and roseroot (Rhodiola imbricata) from trans-Himalaya. The free vitamin forms in the phytococktail were determined by rapid resolution liquid chromatography/tandem mass spectrometry (RRLC-MS/MS). Vitamin E and B-complex vitamins were detected as the principle vitamins. Reversed-phase high performance liquid chromatography (RP-HPLC) with pre-column derivatization was used for identification and quantification of amino acids. Eight essential and eleven non-essential amino acids were quantified, and the content ranged between 76.33 and 9485.67 mu g/g. Among the essential amino acids, L-methionine, L-phenylalanine, L-lysine, L-leucine, and L-histidine were found to be the dominant contributors. We also quantified the fatty acids in the phytococktail by using gas chromatography coupled with a flame ionization detector (GC-FID) with fatty acid methyl esters (FAMEs) derivatization. The analysis revealed the presence of 4 major fatty acids contributing to the total lipid content. Palmitic acid was found to be the rich source of saturated fatty acid (SFA) and constituted,31% of the total lipid content. Among the unsaturated fatty acids (UFAs), palmitoleic acid (43.47%), oleic acid (20.89%), and linoleic acid (4.31%) were prominent. The mineral profiling was carried out by inductively coupled plasma optical emission spectrometer (ICP-OES), and it was found to contain a number of important dietary mineral elements. The harsh climatic conditions, difficult terrain, and logistic constraints at high altitude regions of Indian trans-Himalayan cold desert lead to the scarcity of fresh fruits and vegetables. Therefore, the source of multiple vitamins, essential amino acids, fatty acids, and dietary minerals from the phytococktail would provide great health benefit in the stressful environment and could be used as a high value nutritional supplement.	[Dhar, Priyanka; Tayade, Amol B.; Kumar, Jatinder; Chaurasia, Om P.; Srivastava, Ravi B.] Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India; [Singh, Shashi B.] Def Res & Dev Org, Def Inst Physiol & Allied Sci, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR); Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Chaurasia, OP (corresponding author), Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India.	dropchaurasiadihardrdo@gmail.com	Singh, Shashi Bala/AAS-9889-2021; CHAURASIA, OM/AAW-6347-2021; CHAURASIA, OM PRAKASH/AAP-3358-2021	CHAURASIA, OM PRAKASH/0000-0003-2921-2755	Defence Research and Development Organisation	Defence Research and Development Organisation(Defence Research & Development Organisation (DRDO))	This work was funded by the Defence Research and Development Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Ames JM, 1998, FOOD CHEM, V62, P431, DOI 10.1016/S0308-8146(98)00078-8; *AOAC, 2002, AOAC OFF METH AN; AOAC, 1990, FOOD COMP ADD NAT CO, V2, P1096; Arella F, 1996, FOOD CHEM, V56, P81, DOI 10.1016/0308-8146(95)00149-2; Armstrong M, 2007, RAPID COMMUN MASS SP, V21, P2717, DOI 10.1002/rcm.3124; Bai Z, 2005, CHEM NAT COMPD+, V41, P418, DOI 10.1007/s10600-005-0166-z; Ball GFM, 2006, FOOD SCI T, V156, P3; Ballabh B, 2007, CURR SCI INDIA, V92, P1664; BARNA E, 1994, J CHROMATOGR A, V668, P359, DOI 10.1016/0021-9673(94)80126-6; Bercovici D., 1995, Biotechnology in animal feeds and animal feeding., P93, DOI 10.1002/9783527615353.ch6; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; Burlingame B, 2009, ANN NUTR METAB, V55, P5, DOI 10.1159/000228993; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chang NW, 1998, LIPIDS, V33, P481, DOI 10.1007/s11745-998-0231-9; Chaurasia OP, 2011, INNOVATIONS AGROANIM, P113; Chen LiMei, 2007, Stewart Postharvest Review, V3, P2; Chen T., 1988, HIPPOPHA, V1, P19; Chen Z, 2006, ANAL CHIM ACTA, V569, P169, DOI 10.1016/j.aca.2006.03.099; CHOPRA SL, 1991, ANAL AGR CHEM, V4, P297; CHOUDHURY N, 1995, AM J CLIN NUTR, V61, P1043, DOI 10.1093/ajcn/61.5.1043; Curb JD, 2000, ARCH INTERN MED, V160, P1154, DOI 10.1001/archinte.160.8.1154; David TW, 2005, AU J TECHNOL, V9, P75; Dhar P, 2012, J FOOD SCI, V77, pC156, DOI 10.1111/j.1750-3841.2011.02523.x; Dhar P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-259; Di Maro A, 2011, AUST J CROP SCI, V5, P154; DIAZ AN, 1993, J CHROMATOGR A, V655, P39; Din JN, 2004, BMJ-BRIT MED J, V328, P30, DOI 10.1136/bmj.328.7430.30; DIONEX, 2010, 89 DIONEX, P1; Dulf FV, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-106; Dwivedi DH, 2008, ACTA HORTIC, P335, DOI 10.17660/ActaHortic.2008.765.44; Erdogan-Orhan I, 2011, FOOD RES INT, V44, P1238, DOI 10.1016/j.foodres.2010.11.014; Fabiani A, 2002, J CHROMATOGR SCI, V40, P14, DOI 10.1093/chromsci/40.1.14; Fatima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034099; Flynn A, 2003, EUR J NUTR, V42, P118, DOI 10.1007/s00394-003-0391-9; FRANE W, 1983, ANGEW BOT, V57, P77; FURST P, 1990, J CHROMATOGR, V499, P557, DOI 10.1016/S0021-9673(00)97000-6; Garcia L, 2001, ANAL CHIM ACTA, V434, P193, DOI 10.1016/S0003-2670(01)00836-4; Garg ML, 2003, J NUTR, V133, P1060, DOI 10.1093/jn/133.4.1060; Gentili A, 2008, RAPID COMMUN MASS SP, V22, P2029, DOI 10.1002/rcm.3583; Gentili A, 2011, J CHROMATOGR A, V1218, P684, DOI 10.1016/j.chroma.2010.12.001; Gilliland DL, 2012, J AOAC INT, V95, P583, DOI 10.5740/jaoacint.CS2011_13; Goldschmidt RJ, 2010, ANAL BIOANAL CHEM, V397, P471, DOI 10.1007/s00216-009-3373-9; GOPALAN C, 2000, NUTR VALUE INDIAN FO; Griel AE, 2008, J NUTR, V138, P761, DOI 10.1093/jn/138.4.761; HAEFELI RJ, 1990, FOOD SCI TECHNOL-LEB, V23, P523; Han JY, 2003, J AGR FOOD CHEM, V51, P5315, DOI 10.1021/jf0211027; Hedge J., 1962, CARBOHYDRATE CHEM, V17, P371; HEGAZI SM, 1972, J SCI FOOD AGR, V23, P497, DOI 10.1002/jsfa.2740230410; Hota KB, 2011, INNOVATIONS AGROANIM, P277; Ilisz I, 2012, J PHARMACEUT BIOMED, V69, P28, DOI 10.1016/j.jpba.2012.01.020; Indrayan AK, 2005, CURR SCI INDIA, V89, P1252; Jenkins DJA, 2010, CAN MED ASSOC J, V182, P1961, DOI 10.1503/cmaj.092128; Kallio H, 2002, J AGR FOOD CHEM, V50, P3004, DOI 10.1021/jf011556o; Kallio K., 1999, P INT S SEA BUCKTH H; Katona ZF, 1999, J CHROMATOGR A, V847, P91, DOI 10.1016/S0021-9673(99)00333-7; KHAN JK, 1994, J CHROMATOGR A, V687, P113, DOI 10.1016/0021-9673(94)00777-2; Klejdus B, 2004, ANAL CHIM ACTA, V520, P57, DOI 10.1016/j.aca.2004.02.027; Kris-Etherton PM, 1999, AM J CLIN NUTR, V70, P1009; KUSHI LH, 1995, AM J CLIN NUTR, V61, p1407S, DOI 10.1093/ajcn/61.6.1407S; Kusmenoglu S., 2008, TURK J PHARM SCI, V5, P29; Kwon S, 2000, ENZYME MICROB TECH, V26, P209, DOI 10.1016/S0141-0229(99)00134-9; Liu H, 2009, FOOD RES INT, V42, P1131, DOI 10.1016/j.foodres.2009.05.014; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu BY, 2008, J CHROMATOGR SCI, V46, P225, DOI 10.1093/chromsci/46.3.225; Man YBC, 1999, J FOOD LIPIDS, V6, P181, DOI 10.1111/j.1745-4522.1999.tb00142.x; Mandal S, 2007, INDIAN J AGR SCI, V77, P464; Matthan NR, 2009, J NUTR, V139, P215, DOI 10.3945/jn.108.099804; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Millward DJ, 1999, P NUTR SOC, V58, P249, DOI 10.1017/S0029665199000348; Mohsin S, 2008, 59897084EN AG TECHN, P1; Moreno P, 2000, J CHROMATOGR A, V870, P207, DOI 10.1016/S0021-9673(99)01021-3; Morgan NG, 2008, BIOCHEM SOC T, V36, P905, DOI 10.1042/BST0360905; Morgan NG, 2010, PROSTAG LEUKOTR ESS, V82, P231, DOI 10.1016/j.plefa.2010.02.018; Mukherjee PK, 2005, P INT C PROM DEV BOT, P457; Ndaw S, 2000, FOOD CHEM, V71, P129, DOI 10.1016/S0308-8146(00)00135-7; NG TKW, 1992, J AM COLL NUTR, V11, P383; Okamoto H, 2003, J CHROMATOGR A, V986, P153, DOI 10.1016/S0021-9673(02)01916-7; Ozcan M, 2000, ACTA ALIMENT HUNG, V29, P289, DOI 10.1556/AAlim.29.2000.3.7; Perricone N, 2002, PERRICONE PRESCRIPTI, P66; Pintea A, 2001, PHYTOCHEM ANALYSIS, V12, P293, DOI 10.1002/pca.600; Piraud M, 2005, RAPID COMMUN MASS SP, V19, P1587, DOI 10.1002/rcm.1957; Poinsot V, 2010, ELECTROPHORESIS, V31, P105, DOI 10.1002/elps.200900399; Radi M, 1997, HORTSCIENCE, V32, P1087, DOI 10.21273/HORTSCI.32.6.1087; rhamnoides H., 1989, P INT S SEA BUCKTH H, P67; ROACH D, 1970, J CHROMATOGR, V52, P393, DOI 10.1016/S0021-9673(01)96589-6; Ruan X, 2001, SPECTROSC SPECT ANAL, V21, P542; Ruiz D, 2005, J AGR FOOD CHEM, V53, P9544, DOI 10.1021/jf051539p; Ruiz D, 2005, J AGR FOOD CHEM, V53, P6368, DOI 10.1021/jf0480703; Santos J, 2012, J CHROMATOGR A, V1261, P179, DOI 10.1016/j.chroma.2012.04.067; SARWAR G, 1993, J CHROMATOGR-BIOMED, V615, P1, DOI 10.1016/0378-4347(93)80286-D; SCALIA S, 1995, J PHARM SCI, V84, P433, DOI 10.1002/jps.2600840409; Schoene RB, 1996, NUTR NEEDS COLD HIGH, P319; Seppanen-Laakso T, 2002, ANAL CHIM ACTA, V465, P39, DOI 10.1016/S0003-2670(02)00397-5; Sochor J, 2011, MOLECULES, V16, P7428, DOI 10.3390/molecules16097428; Song ZH, 2003, ANAL CHIM ACTA, V488, P71, DOI 10.1016/S0003-2670(03)00665-2; Suryakumar G, 2011, J ETHNOPHARMACOL, V138, P268, DOI 10.1016/j.jep.2011.09.024; Tayade AB, 2013, J FOOD SCI, V78, pC402, DOI 10.1111/1750-3841.12054; Tayade AB, 2013, ANAL CHIM ACTA, V789, P65, DOI 10.1016/j.aca.2013.05.062; Tayade AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052797; Teres S, 2008, P NATL ACAD SCI USA, V105, P13811, DOI 10.1073/pnas.0807500105; Tesfaldet ZO, 2004, TALANTA, V64, P1189, DOI 10.1016/j.talanta.2004.02.044; Turan S, 2007, J AGR FOOD CHEM, V55, P10787, DOI 10.1021/jf071801p; Ul'chenko NT, 2009, CHEM NAT COMPD+, V45, P314, DOI 10.1007/s10600-009-9353-7; Versari A, 2008, FOOD CHEM, V108, P334, DOI 10.1016/j.foodchem.2007.10.053; Woo KL, 2003, MOL BIOTECHNOL, V24, P69, DOI 10.1385/MB:24:1:69; Wood PL, 2006, J CHROMATOGR B, V831, P313, DOI 10.1016/j.jchromb.2005.12.031; Yang B, 2000, J NUTR BIOCHEM, V11, P338, DOI 10.1016/S0955-2863(00)00088-7; Yang BR, 2002, TRENDS FOOD SCI TECH, V13, P160, DOI 10.1016/S0924-2244(02)00136-X; Yang BR, 2002, J FOOD COMPOS ANAL, V15, P143, DOI 10.1006/jfca.2001.1041; Yang BR, 2001, J AGR FOOD CHEM, V49, P1939, DOI 10.1021/jf001059s; Yang ZH, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-120; Yoon WJ, 2010, J OLEO SCI, V59, P315, DOI 10.5650/jos.59.315; Zafra-Gomez A, 2006, J AGR FOOD CHEM, V54, P4531, DOI 10.1021/jf060346e; Zhang J., 1997, THE JOURNAL OF NUTRI, V127, P509, DOI DOI 10.1093/jn/127.3.509S; Zhang W., 1989, P INT S SEA BUCKTHOR, P96	116	14	14	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83008	10.1371/journal.pone.0083008	http://dx.doi.org/10.1371/journal.pone.0083008			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376624	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000051
J	Lin, YW; Huang, CY; Chen, YH; Shih, CM; Tsao, NW; Lin, CY; Chang, NC; Tsai, CS; Tsai, HY; Tsai, JC; Huang, PH; Li, CY; Lin, FY				Lin, Yi-Wen; Huang, Chun-Yao; Chen, Yung-Hsiang; Shih, Chun-Ming; Tsao, Nai-Wen; Lin, Cheng-Yen; Chang, Nen-Chung; Tsai, Chien-Sung; Tsai, Hsiao-Ya; Tsai, Jui-Chi; Huang, Po-Hsun; Li, Chi-Yuan; Lin, Feng-Yen			GroEL1, a Heat Shock protein 60 of Chlamydia pneumoniae, Impairs Neovascularization by Decreasing Endothelial Progenitor Cell Function	PLOS ONE			English	Article							ATHEROSCLEROTIC LESION DEVELOPMENT; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; HEAT-SHOCK PROTEINS; ADHESION MOLECULES; RECEPTOR 4; OXIDATIVE STRESS; EXPRESSION; INFECTION; PROLIFERATION	The number and function of endothelial progenitor cells (EPCs) are sensitive to hyperglycemia, hypertension, and smoking in humans, which are also associated with the development of atherosclerosis. GroEL1 from Chlamydia pneumoniae has been found in atherosclerotic lesions and is related to atherosclerotic pathogenesis. However, the actual effects of GroEL1 on EPC function are unclear. In this study, we investigate the EPC function in GroEL1-administered hind limb-ischemic C57BL/B6 and C57BL/10ScNJ (a toll-like receptor 4 (TLR4) mutation) mice and human EPCs. In mice, laser Doppler imaging, flow cytometry, and immunohistochemistry were used to evaluate the degree of neo-vasculogenesis, circulating level of EPCs, and expression of CD34, vWF, and endothelial nitric oxide synthase (eNOS) in vessels. Blood flow in the ischemic limb was significantly impaired in C57BL/B6 but not C57BL/10ScNJ mice treated with GroEL1. Circulating EPCs were also decreased after GroEL1 administration in C57BL/B6 mice. Additionally, GroEL1 inhibited the expression of CD34 and eNOS in C57BL/B6 ischemic muscle. In vitro, GroEL1 impaired the capacity of differentiation, mobilization, tube formation, and migration of EPCs. GroEL1 increased senescence, which was mediated by caspases, p38 MAPK, and ERK1/2 signaling in EPCs. Furthermore, GroEL1 decreased integrin and E-selectin expression and induced inflammatory responses in EPCs. In conclusion, these findings suggest that TLR4 and impaired NO-related mechanisms could contribute to the reduced number and functional activity of EPCs in the presence of GroEL1 from C. pneumoniae.	[Lin, Yi-Wen; Huang, Chun-Yao; Shih, Chun-Ming; Chang, Nen-Chung; Lin, Feng-Yen] Taipei Med Univ, Coll Med, Dept Internal Med, Sch Med, Taipei, Taiwan; [Lin, Yi-Wen; Huang, Chun-Yao; Shih, Chun-Ming; Chang, Nen-Chung; Tsai, Jui-Chi; Lin, Feng-Yen] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Lin, Yi-Wen; Huang, Chun-Yao; Shih, Chun-Ming; Chang, Nen-Chung; Tsai, Jui-Chi; Lin, Feng-Yen] Taipei Med Univ Hosp, Cardiovasc Res Ctr, Taipei, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Tsao, Nai-Wen] Taipei Med Univ Hosp, Div Cardiovasc Surg, Taipei, Taiwan; [Lin, Cheng-Yen] Hung Kuang Univ, Dept Comp Sci & Informat Management, Taichung, Taiwan; [Tsai, Chien-Sung; Tsai, Hsiao-Ya] Natl Def Med Ctr, Div Cardiovasc Surg, Taipei, Taiwan; [Huang, Po-Hsun] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Li, Chi-Yuan] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Li, Chi-Yuan] China Med Univ Hosp, Dept Anesthesiol, Taichung, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital; Hungkuang University; National Defense Medical Center; Taipei Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lin, FY (corresponding author), Taipei Med Univ, Coll Med, Dept Internal Med, Sch Med, Taipei, Taiwan.	g870905@tmu.edu.tw	Chen, Yung-Hsiang/K-6766-2015; Stefanadis, Christodoulos/ABH-2232-2020	Chen, Yung-Hsiang/0000-0002-8756-5113; Stefanadis, Christodoulos/0000-0001-5974-6454; Li, Chi-Yuan/0000-0003-3390-7568; Tsai, Hsaio Ya/0000-0002-5704-507X	National Science Council, Taiwan [NSC 99-2314-B-038-030-MY2, NSC101-2314-B-038-041-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was partially funded by National Science Council (NSC 99-2314-B-038-030-MY2 and NSC101-2314-B-038-041-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou I, 2006, ATHEROSCLEROSIS, V189, P247, DOI 10.1016/j.atherosclerosis.2006.06.021; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Blessing E, 2001, ATHEROSCLEROSIS, V158, P13, DOI 10.1016/S0021-9150(00)00758-9; Borel N, 2008, ATHEROSCLEROSIS, V199, P154, DOI 10.1016/j.atherosclerosis.2007.09.026; CAMPBELL LA, 2013, PATHOG DROSOPHILA IN; Chen CY, 2009, CARDIOVASC RES, V83, P768, DOI 10.1093/cvr/cvp150; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103; Di Pietro M, 2013, J BIOL REG HOMEOS AG, V27, P509; Di Pietro M, 2013, INT J MOL SCI, V14, P15105, DOI 10.3390/ijms140715105; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Ezzahiri R, 2002, CARDIOVASC RES, V56, P269, DOI 10.1016/S0008-6363(02)00544-8; Ha TZ, 2011, ANTIOXID REDOX SIGN, V15, P1875, DOI 10.1089/ars.2010.3723; He C, 2013, ARTERIOSCL THROM VAS, V33, P330, DOI 10.1161/ATVBAHA.112.300679; He J, 2010, J CELL BIOCHEM, V111, P179, DOI 10.1002/jcb.22686; Hiroki J, 2004, J MOL CELL CARDIOL, V37, P537, DOI 10.1016/j.yjmcc.2004.05.008; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hogdahl M, 2008, APMIS, V116, P1082, DOI 10.1111/j.1600-0463.2008.01145.x; Huang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042808; Huang PH, 2011, J MOL CELL CARDIOL, V51, P109, DOI 10.1016/j.yjmcc.2011.03.008; Huang PH, 2010, ATHEROSCLEROSIS, V212, P426, DOI 10.1016/j.atherosclerosis.2010.06.034; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Joshi Rajnish, 2013, N Am J Med Sci, V5, P169, DOI 10.4103/1947-2714.109178; Kalayoglu MV, 1999, J INFECT DIS, V180, P780, DOI 10.1086/314931; Kalayoglu MV, 1998, INFECT IMMUN, V66, P5067, DOI 10.1128/IAI.66.11.5067-5072.1998; KaukorantaTolvanen SSE, 1996, MICROB PATHOGENESIS, V21, P407, DOI 10.1006/mpat.1996.0071; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Kohara K, 2002, STROKE, V33, P1474, DOI 10.1161/01.STR.0000018974.05768.FB; Kol A, 1999, J CLIN INVEST, V103, P571, DOI 10.1172/JCI5310; Krull M, 1999, J IMMUNOL, V162, P4834; Kuki S, 2006, CIRC J, V70, P1076, DOI 10.1253/circj.70.1076; Lin CP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/845037; Lin FY, 2011, J IMMUNOL, V186, P4405, DOI 10.4049/jimmunol.1003116; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; Oh IY, 2007, BLOOD, V110, P3891, DOI 10.1182/blood-2006-10-048991; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ribatti D, 2007, LEUKEMIA RES, V31, P439, DOI 10.1016/j.leukres.2006.10.014; Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072; Rosell A, 2009, J CEREBR BLOOD F MET, V29, P933, DOI 10.1038/jcbfm.2009.17; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Scharner D, 2009, ARTERIOSCL THROM VAS, V29, P571, DOI 10.1161/ATVBAHA.108.182006; Schumacher A, 2002, CLIN MICROBIOL INFEC, V8, P654, DOI 10.1046/j.1469-0691.2002.00439.x; Seeger FH, 2005, CIRCULATION, V111, P1184, DOI 10.1161/01.CIR.0000157156.85397.A1; Tousoulis D, 2006, CYTOKINE GROWTH F R, V17, P225, DOI 10.1016/j.cytogfr.2006.04.003; Urbich C, 2004, TRENDS CARDIOVAS MED, V14, P318, DOI 10.1016/j.tcm.2004.10.001; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Volanen I, 2006, ARTERIOSCL THROM VAS, V26, P649, DOI 10.1161/01.ATV.0000202664.76816.bb; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Xu QB, 2003, CURR OPIN CARDIOL, V18, P245, DOI 10.1097/00001573-200307000-00001; Yoder MC, 2005, BLOOD, V105, P1846, DOI 10.1182/blood-2004-12-4743; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196; Zhang YM, 2009, AM J PHYSIOL-HEART C, V296, pH1675, DOI 10.1152/ajpheart.00665.2008; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	62	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84731	10.1371/journal.pone.0084731	http://dx.doi.org/10.1371/journal.pone.0084731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376840	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000163
J	Umemoto, E; Takeda, A; Jin, SJ; Luo, ZJ; Nakahogi, N; Hayasaka, H; Lee, CM; Tanaka, T; Miyasaka, M				Umemoto, Eiji; Takeda, Akira; Jin, Soojung; Luo, Zhijuan; Nakahogi, Naoki; Hayasaka, Haruko; Lee, Chun Man; Tanaka, Toshiyuki; Miyasaka, Masayuki			Dynamic Changes in Endothelial Cell Adhesion Molecule Nepmucin/CD300LG Expression under Physiological and Pathological Conditions	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; NONOBESE DIABETIC MICE; L-SELECTIN; LYMPHOCYTE TRAFFICKING; P-SELECTIN; IN-VITRO; VENULES; HETEROGENEITY; PROMOTER; RECEPTOR	Vascular endothelial cells often change their phenotype to adapt to their local microenvironment. Here we report that the vascular endothelial adhesion molecule nepmucin/CD300LG, which is implicated in lymphocyte binding and transmigration, shows unique expression patterns in the microvascular endothelial cells of different tissues. Under physiological conditions, nepmucin/CD300LG was constitutively and selectively expressed at the luminal surface of the small arterioles, venules, and capillaries of most tissues, but it was only weakly expressed in the microvessels of the splenic red pulp and thymic medulla. Furthermore, it was barely detectable in immunologically privileged sites such as the brain, testis, and uterus. The nepmucin/CD300LG expression rapidly decreased in lymph nodes receiving acute inflammatory signals, and this loss was mediated at least in part by TNF-alpha. It was also down-regulated in tumors and tumor-draining lymph nodes, indicating that nepmucin/CD300LG expression is negatively regulated by locally produced signals under these circumstances. In contrast, nepmucin/CD300LG was induced in the high endothelial venule-like blood vessels of chronically inflamed pancreatic islets in an animal model of non-obese diabetes. Interestingly, the activated CD4(+) T cells infiltrating the inflamed pancreas expressed high levels of the nepmucin/CD300LG ligand(s), supporting the idea that nepmucin/CD300LG and its ligand interactions are locally involved in pathological T cell trafficking. Taken together, these observations indicate that the nepmucin/CD300LG expression in microvascular endothelial cells is influenced by factor(s) that are locally produced in tissues, and that its expression is closely correlated with the level of leukocyte infiltration in certain tissues.	[Umemoto, Eiji; Takeda, Akira; Jin, Soojung; Luo, Zhijuan; Nakahogi, Naoki; Hayasaka, Haruko; Miyasaka, Masayuki] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Immunodynam, Suita, Osaka, Japan; [Umemoto, Eiji; Hayasaka, Haruko; Miyasaka, Masayuki] Osaka Univ, World Premier Int Res Ctr Initiat, Immunol Frontier Res Ctr, Lab Immunodynam, Suita, Osaka, Japan; [Lee, Chun Man] Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka, Japan; [Tanaka, Toshiyuki] Hyogo Univ Hlth Sci, Sch Pharm, Immunobiol Lab, Kobe, Hyogo, Japan	Osaka University; Osaka University; Osaka University; Immuno-Biological Laboratories Co. Ltd.	Umemoto, E (corresponding author), Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Immune Regulat, Suita, Osaka, Japan.	umemoto@ongene.med.osaka-u.ac.jp	Miyasaka, Masayuki/AAM-6343-2020; Umemoto, Eiji/AAX-6562-2021; Takeda, Akira/AAH-7892-2019	Takeda, Akira/0000-0003-4748-4543; Takeda, Akira/0000-0002-8173-9135	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590252, 24111005, 25460268, 25460603]; Grants-in-Aid for Scientific Research [25460268] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid 24590252 (to E. U.), 24111005 (to E. U. and M. M.), 25460268 (to H. H.), and 25460603 (to T. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Almendro N, 1996, J IMMUNOL, V157, P5411; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Atkins GB, 2011, ARTERIOSCL THROM VAS, V31, P1476, DOI 10.1161/ATVBAHA.111.228999; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Davis ME, 2004, J BIOL CHEM, V279, P163, DOI 10.1074/jbc.M307528200; FAVEEUW C, 1994, J IMMUNOL, V152, P5969; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; HANNINEN A, 1993, J CLIN INVEST, V92, P2509, DOI 10.1172/JCI116859; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; Izawa D, 1999, INT IMMUNOL, V11, P1989, DOI 10.1093/intimm/11.12.1989; Jin S, 2008, FEBS LETT, V582, P3018, DOI 10.1016/j.febslet.2008.07.041; Kashiwazaki M, 2003, INT IMMUNOL, V15, P1219, DOI 10.1093/intimm/dxg121; Katakai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00200; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; Kraling BM, 1996, AM J PATHOL, V148, P1181; Kunkel EJ, 1998, J IMMUNOL, V161, P2449; Lacorre DA, 2004, BLOOD, V103, P4164, DOI 10.1182/blood-2003-10-3537; Langenkamp E, 2009, CELL TISSUE RES, V335, P205, DOI 10.1007/s00441-008-0642-4; Lee CM, 2002, CANCER RES, V62, P4282; Liu J, 2011, BLOOD, V117, P342, DOI 10.1182/blood-2010-06-287987; Melder RJ, 1996, NAT MED, V2, P992, DOI 10.1038/nm0996-992; Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002; Minami T, 2002, BLOOD, V100, P4019, DOI 10.1182/blood-2002-03-0955; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; Murfee WL, 2005, MICROCIRCULATION, V12, P151, DOI 10.1080/10739680590904955; Niemela H, 2005, BLOOD, V106, P3405, DOI 10.1182/blood-2005-01-0254; Ochoa CD, 2010, SEMIN THROMB HEMOST, V36, P301, DOI 10.1055/s-0030-1253452; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; RESNICK N, 1993, P NATL ACAD SCI USA, V90, P7908, DOI 10.1073/pnas.90.16.7908-d; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; SHYY JYJ, 1995, P NATL ACAD SCI USA, V92, P8069, DOI 10.1073/pnas.92.17.8069; Stan RV, 1999, J CELL BIOL, V145, P1189, DOI 10.1083/jcb.145.6.1189; TANAKA T, 1991, J IMMUNOL, V147, P2222; Thurston G, 2000, MICROCIRCULATION, V7, P67, DOI 10.1038/sj.mn.7300155; Uchimura K, 2006, TRENDS IMMUNOL, V27, P559, DOI 10.1016/j.it.2006.10.007; Umemoto E, 2006, J EXP MED, V203, P1603, DOI 10.1084/jem.20052543; Umemoto E, 2011, CRIT REV IMMUNOL, V31, P147, DOI 10.1615/CritRevImmunol.v31.i2.40	43	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83681	10.1371/journal.pone.0083681	http://dx.doi.org/10.1371/journal.pone.0083681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376728	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000105
J	Xia, SJ; Zhang, WD; Huang, LT; Jiang, H				Xia, Sujian; Zhang, Weidong; Huang, Liting; Jiang, Hong			Comparative Efficacy and Safety of Deferoxamine, Deferiprone and Deferasirox on Severe Thalassemia: A Meta-Analysis of 16 Randomized Controlled Trials	PLOS ONE			English	Article							LONG-TERM SAFETY; MAJOR PATIENTS; MYOCARDIAL IRON; CARDIAC IRON; MAGNETIC-RESONANCE; COMBINED THERAPY; DESFERRIOXAMINE; MONOTHERAPY; CHELATION; OVERLOAD	Objective: A meta-analysis was conducted to investigate the efficacy and safety of three main iron chelators, namely, deferoxamine (DFO), deferiprone (DFP) and deferasirox (DFX) for thalassemia major (TM) patients. Methods: Randomized controlled trials comparing mono-therapy DFO, DFP, DFX and combined DFP with DFO therapy in TM patients from January 1990 to December 2012 were searched and selected. Two independent authors assessed data from extracted randomized trials for efficacy and safety in the measurements of serum ferritin (SF), live iron concentration (LIC), myocardial iron content (MIC), left ventricular ejection fraction (LVEF) and adverse events (AEs). Results: Sixteen studies were selected. In the comparison of DFP versus DFO treatment groups, a significant difference was revealed on MIC and LVEF (P = 0.01 and P = 0.007, respectively) but not on SF or LIC level (P = 0.65 and P = 0.37, respectively). In comparing combined therapy (DFP plus DFO) versus DFO, a significant difference was shown on MIC and LVEF measurements (P < 0.00001 and P = 0.003, respectively), but not on SF or LIC levels (P = 0.93 and P = 0.62, respectively). Moreover, the combined DFP with DFO treatment had significantly higher risk than DFO treatment (RR 1.46 with 95% CI 1.04 to 2.04). When comparing DFX with DFO, a significant difference was shown on the SF level (P = 0.003), and there was no difference between DFX and DFO in safety evaluation (RR 1.53 with 95% CI 0.31 to 7.49). Conclusion: Findings indicated that the most effective and safe iron chelators remains to be proven, and further large-scale, long-term studies are needed.	[Xia, Sujian; Jiang, Hong] Univ Jinan, Sch Med, Div Med Stat, Guangzhou, Guangdong, Peoples R China; [Zhang, Weidong] Novartis Pharmaceut Oncol, Beijing, Peoples R China; [Huang, Liting] Zhuhai Peoples Hosp, Zhuhai City, Guangdong, Peoples R China	Jinan University	Huang, LT (corresponding author), Zhuhai Peoples Hosp, Zhuhai City, Guangdong, Peoples R China.	ting.hwang30@gmail.com	zhang, weidong/N-1070-2014	zhang, weidong/0000-0002-8079-1185	Guangdong Medical Insurance Research Association (GDMIRA)	Guangdong Medical Insurance Research Association (GDMIRA)	The funder is Guangdong Medical Insurance Research Association (GDMIRA) http://www.gdmib.com/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis A, 1999, EUR J CLIN PHARMACOL, V55, P1, DOI 10.1007/s002280050584; Alpendurada F, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-8; Aydinok Y, 2007, HAEMATOLOGICA, V92, P1599, DOI 10.3324/haematol.11414; Aydinok Y, 2012, EUR J HAEMATOL, V88, P431, DOI 10.1111/j.1600-0609.2012.01769.x; Cappellini MD, 2007, CLIN THER, V29, P909, DOI 10.1016/j.clinthera.2007.05.007; Cappellini MD, 2006, BLOOD, V107, P3455, DOI 10.1182/blood-2005-08-3430; Caro JJ, 2002, BMC BLOOD DISORDERS, V2, P1471; Cassinerio E, 2012, ANN HEMATOL, V91, P1443, DOI 10.1007/s00277-012-1480-8; Chang HH, 2011, PEDIATR BLOOD CANCER, V56, P420, DOI 10.1002/pbc.22826; El-Beshlawy A, 2008, ANN HEMATOL, V87, P545, DOI 10.1007/s00277-008-0471-2; Eshghi P, 2011, DARU J PHARM SCI; Galanello R, 2006, HAEMATOLOGICA, V91, P1241; Galia M, 2003, HEMOGLOBIN, V27, P63, DOI 10.1081/HEM-120021538; Gomber Sunil, 2004, Indian Pediatr, V41, P21; Green D, 2012, J AUTISM DEV DISORD, V42, P1774, DOI 10.1007/s10803-011-1405-8; Ha SY, 2006, HEMOGLOBIN, V30, P263, DOI 10.1080/03630260600642617; JPT H, 2011, COCHRANE HDB SYSTEMA; Kwiatkowski JL, 2011, HEMATOL-AM SOC HEMAT, P451, DOI 10.1182/asheducation-2011.1.451; Maggio A, 2002, BLOOD CELL MOL DIS, V28, P196, DOI 10.1006/bcmd.2002.0510; Maggio A, 2009, BRIT J HAEMATOL, V145, P245, DOI 10.1111/j.1365-2141.2009.07609.x; Mamtani M, 2008, BRIT J HAEMATOL, V141, P882, DOI 10.1111/j.1365-2141.2008.07122.x; Merchant R, 2011, INDIAN PEDIATR, V48, P697, DOI 10.1007/s13312-011-0115-9; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Mourad FH, 2003, BRIT J HAEMATOL, V121, P187, DOI 10.1046/j.1365-2141.2003.04240.x; Olivieri NF, 1998, NEW ENGL J MED, V339, P417, DOI 10.1056/NEJM199808133390701; Pantalone GR, 2011, HEMOGLOBIN, V35, P206, DOI 10.3109/03630269.2011.570674; Pathare A, 2010, ANN HEMATOL, V89, P405, DOI 10.1007/s00277-009-0838-z; Peng CT, 2003, EUR J HAEMATOL, V70, P392, DOI 10.1034/j.1600-0609.2003.00071.x; Pennell DJ, 2006, BLOOD, V107, P3738, DOI 10.1182/blood-2005-07-2948; Pennell DJ, 2010, BLOOD, V115, P2364, DOI 10.1182/blood-2009-04-217455; Piga A, 2006, HAEMATOL-HEMATOL J, V91, P873; Prabhu R., 2009, J BIOSCI TECHNOL, P20; Smith GC, 2011, J CARDIOVASC MAGN R, V13, P1, DOI [10.1186/1532-429X-13-S1-M1, DOI 10.1186/1532-429X-13-S1-M1.PUBMED:21208447, DOI 10.1186/1532-429X-13-1]; Tanner MA, 2007, CIRCULATION, V115, P1876, DOI 10.1161/CIRCULATIONAHA.106.648790; VanOrden HE, 2006, ANN PHARMACOTHER, V40, P1110, DOI 10.1345/aph.1G566; Vichinsky EP, 2005, ANN NY ACAD SCI, V1054, P18, DOI 10.1196/annals.1345.003; Viprakasit V, 2009, INT J HEMATOL, V90, P435, DOI 10.1007/s12185-009-0432-0; Wood JC, 2010, BLOOD, V116, P537, DOI 10.1182/blood-2009-11-250308	38	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82662	10.1371/journal.pone.0082662	http://dx.doi.org/10.1371/journal.pone.0082662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376563	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000021
J	Xing, XJ; Yang, J; Yang, XQ; Wei, Y; Zhu, LB; Li, M				Xing, Xiaojing; Yang, Ji; Yang, Xiaoqin; Wei, Yi; Zhu, Lubing; Li, Ming			IL-17A Induces Endothelial Inflammation in Systemic Sclerosis via the ERK Signaling Pathway	PLOS ONE			English	Article							T-CELLS; LUPUS-ERYTHEMATOSUS; DISEASE; SCLERODERMA; TH17; SKIN; PATHOGENESIS; LYMPHOCYTES; ACTIVATION; PROMOTES	Recent reports have demonstrated that endothelial cells are involved in vascular inflammatory injury in systemic sclerosis (SSc) and interleukin-17A (IL-17A) plays a crucial role in the pathogenesis of SSC. However, little is known about the effects of IL-17A on endothelial cell inflammation in SSC. The aim of our study was to investigate the role of IL-17A in endothelial inflammation. Here, we showed that IL-17A mRNA and protein levels were augmented in the peripheral blood and more IL-17(+) lymphocytes infiltrated in the perivascular areas in the involved skin of SSC patients. SSC patient serum induced chemokine and adhesion molecule expression in HUVECs, which was blocked by IL-17A neutralization. IL-17A alone induced chemokine and adhesion molecule expression and promoted T cell-HUVEC adhesion. Extracellular signal-regulated kinase (ERK) inhibition and IL-17A neutralization prominently inhibited chemokine and adhesion molecule expression and blocked T cell-HUVEC adhesion. IL-17A derived from SSC patient serum mediated endothelial cells inflammation by up-regulating chemokines and adhesion molecules, which was blocked by ERK inhibition. These data imply that ERK signal pathway might play a key role in the progression of endothelial injury induced by IL-17A in SSC.	[Xing, Xiaojing; Yang, Ji; Yang, Xiaoqin; Wei, Yi; Zhu, Lubing; Li, Ming] Fudan Univ, Dept Dermatol, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University	Li, M (corresponding author), Fudan Univ, Dept Dermatol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	li.ming@zs-hospital.sh.cn			National Natural Science Foundation of China [81000693, 30872274]; Shanghai Science and Technology Committee [134119a8400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by grants from National Natural Science Foundation of China (No. 81000693 and 30872274), and Medical guide project from Shanghai Science and Technology Committee (No. 134119a8400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D., 2007, ARTHRITIS RES THER, V9, pS2, DOI DOI 10.1186/AR2228; Abraham DJ, 2005, TRENDS IMMUNOL, V26, P587, DOI 10.1016/j.it.2005.09.004; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Balbir-Gurman A, 2012, BEST PRACT RES CL RH, V26, P13, DOI 10.1016/j.berh.2012.01.011; Cerinic MM, 2003, SEMIN ARTHRITIS RHEU, V32, P285, DOI 10.1053/sarh.2002.50011; Cutolo M, 2010, NAT REV RHEUMATOL, V6, P578, DOI 10.1038/nrrheum.2010.104; Del Papa N, 2004, ARTHRITIS RHEUM-US, V50, P1296, DOI 10.1002/art.20116; Deleuran B, 2007, NAT CLIN PRACT RHEUM, V3, P682, DOI 10.1038/ncprheum0618; FREEMONT AJ, 1992, BRIT J DERMATOL, V126, P561; Hashimoto Motomu, 2012, Nihon Rinsho Meneki Gakkai Kaishi, V35, P463; Hosokawa Y, 2012, HUM IMMUNOL, V73, P26, DOI 10.1016/j.humimm.2011.10.004; Inoue D, 2006, BIOCHEM BIOPH RES CO, V347, P852, DOI 10.1016/j.bbrc.2006.06.137; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kahaleh MB, 1999, AUTOIMMUNITY, V31, P195, DOI 10.3109/08916939908994064; Kalogerou A, 2005, ANN RHEUM DIS, V64, P1233, DOI 10.1136/ard.2004.027094; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kim HR, 2007, RHEUMATOLOGY, V46, P57, DOI 10.1093/rheumatology/kel159; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; O'Reilly S, 2012, RHEUMATOLOGY, V51, P1540, DOI 10.1093/rheumatology/kes090; Okamoto Y, 2012, ARTHRITIS RHEUM-US, V64, P3726, DOI 10.1002/art.34643; Ong VH, 2010, CURR OPIN RHEUMATOL, V22, P264, DOI 10.1097/BOR.0b013e328337c3d6; Radstake TRDJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005903; Rodriguez-Reyna TS, 2012, RHEUMATOL INT, V32, P2653, DOI 10.1007/s00296-011-2056-y; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Sakkas LI, 2004, ARTHRITIS RHEUM-US, V50, P1721, DOI 10.1002/art.20315; Truchetet ME, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3486; Valentini G, 2003, ANN RHEUM DIS, V62, P901, DOI 10.1136/ard.62.9.901; Varga J, 2012, ETIOLOGY PATHOGENESI, P1343; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; WELLS AU, 1995, EUR RESPIR J, V8, P266, DOI 10.1183/09031936.95.08020266; Yang J, 2011, RHEUMATOLOGY, V50, P1366, DOI 10.1093/rheumatology/ker116; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Zepp J, 2011, TRENDS IMMUNOL, V32, P232, DOI 10.1016/j.it.2011.02.007; Zhou Y, 2007, CYTOKINE, V38, P157, DOI 10.1016/j.cyto.2007.06.002	36	54	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85032	10.1371/journal.pone.0085032	http://dx.doi.org/10.1371/journal.pone.0085032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376862	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000174
J	Yuen, CM; Kurbatova, EV; Click, ES; Cavanaugh, JS; Cegielski, JP				Yuen, Courtney M.; Kurbatova, Ekaterina V.; Click, Eleanor S.; Cavanaugh, J. Sean; Cegielski, J. Peter			Association between Mycobacterium tuberculosis Complex Phylogenetic Lineage and Acquired Drug Resistance	PLOS ONE			English	Article							SHORT-COURSE CHEMOTHERAPY; UNITED-STATES; SUSCEPTIBILITY; RELAPSE; PYRAZINAMIDE; MUTATION	Background: Development of resistance to antituberculosis drugs during treatment (i.e., acquired resistance) can lead to emergence of resistant strains and consequent poor clinical outcomes. However, it is unknown whether Mycobacterium tuberculosis complex species and lineage affects the likelihood of acquired resistance. Methods: We analyzed data from the U. S. National Tuberculosis Surveillance System and National Tuberculosis Genotyping Service for tuberculosis cases during 2004-2011 with assigned species and lineage and both initial and final drug susceptibility test results. We determined univariate associations between species and lineage of Mycobacterium tuberculosis complex bacteria and acquired resistance to isoniazid, rifamycins, fluoroquinolones, and second-line injectables. We used Poisson regression with backward elimination to generate multivariable models for acquired resistance to isoniazid and rifamycins. Results: M. bovis was independently associated with acquired resistance to isoniazid (adjusted prevalence ratio = 8.46, 95% CI 2.96-24.14) adjusting for HIV status, and with acquired resistance to rifamycins (adjusted prevalence ratio = 4.53, 95% CI 1.29-15.90) adjusting for homelessness, HIV status, initial resistance to isoniazid, site of disease, and administration of therapy. East Asian lineage was associated with acquired resistance to fluoroquinolones (prevalence ratio = 6.10, 95% CI 1.56-23.83). Conclusions: We found an association between mycobacterial species and lineage and acquired drug resistance using U. S. surveillance data. Prospective clinical studies are needed to determine the clinical significance of these findings, including whether rapid genotyping of isolates at the outset of treatment may benefit patient management.	[Yuen, Courtney M.; Kurbatova, Ekaterina V.; Click, Eleanor S.; Cavanaugh, J. Sean; Cegielski, J. Peter] US Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div TB Eliminat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Kurbatova, EV (corresponding author), US Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div TB Eliminat, Atlanta, GA 30333 USA.	EKurbatova@cdc.gov		Yuen, Courtney/0000-0002-5219-2599				An DD, 2009, ANTIMICROB AGENTS CH, V53, P4835, DOI 10.1128/AAC.00541-09; [Anonymous], 2008, GUID PROGR MAN DRUG; [Anonymous], 2006, EMERG INFECT DIS, V12, P736, DOI [10.3201/eid1205.050400, DOI 10.3201/EID1205.050400]; CDC, 2012, REP TUB US 2011; Chedore P, 2010, J CLIN MICROBIOL, V48, P300, DOI 10.1128/JCM.01775-09; Chiang CY, 2010, INT J TUBERC LUNG D, V14, P672; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; de Jong BC, 2005, J CLIN MICROBIOL, V43, P3530, DOI 10.1128/JCM.43.7.3530-3532.2005; de Steenwinkel JEM, 2012, EMERG INFECT DIS, V18, P660, DOI 10.3201/eid1804.110912; Ershova JV, 2012, CLIN INFECT DIS, V55, P1600, DOI 10.1093/cid/cis748; Fenner L, 2012, ANTIMICROB AGENTS CH, V56, P3047, DOI 10.1128/AAC.06460-11; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Hanif M, 2009, INT J TUBERC LUNG D, V13, P74; Hlavsa MC, 2008, CLIN INFECT DIS, V47, P168, DOI 10.1086/589240; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Lee SS, 2013, RESPIROLOGY; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Li JH, 2005, CLIN INFECT DIS, V41, P83, DOI 10.1086/430377; Malla B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052297; Mitchison DA, 2000, INT J TUBERC LUNG D, V4, P796; Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10; Mokdad Ali H, 2003, MMWR Recomm Rep, V52, P1; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P21, DOI 10.1093/cid/cit167; Phyu S, 2009, J CLIN MICROBIOL, V47, P335, DOI 10.1128/JCM.01812-08; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; World Health Organization, 2006, GLOB TUB CONTR WHO R; World Health Organization, 2006, GLOB PLAN STOP TB 20; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zhang Y, 2002, J MED MICROBIOL, V51, P42, DOI 10.1099/0022-1317-51-1-42	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83006	10.1371/journal.pone.0083006	http://dx.doi.org/10.1371/journal.pone.0083006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376623	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000050
J	Hubad, B; Lapanje, A				Hubad, Barbara; Lapanje, Ales			The Efficient Method for Simultaneous Monitoring of the Culturable as Well as Nonculturable Airborne Microorganisms	PLOS ONE			English	Article							WATER TREATMENT-PLANT; QUANTITATIVE PCR; BACTERIA; QUANTIFICATION; LEGIONELLAE; INHIBITION; PATHOGENS; AGAR	Cultivation-based microbiological methods are a gold standard for monitoring of airborne micro-organisms to determine the occupational exposure levels or transmission paths of a particular infectious agent. Some highly contagious microorganisms are not easily culturable but it is becoming evident that cultivation and molecular methods are complementary and in these cases highly relevant. We report a simple and efficient method for sampling and analyzing airborne bacteria with an impactor-type high-flow-rate portable air sampler, currently used for monitoring culturable bacteria or fungi. A method is reported for extraction of nucleic acids from impacted cells without prior cultivation and using agarose as a sampling matrix. The DNA extraction efficiency was determined in spiked samples and, samples taken from a wastewater treatment plant and an alpine area. The abundance, diversity and quantity of total bacteria were analysed by a quantitative polymerase chain reaction, and by construction and analysis of clone libraries. The method does not interfere with downstream PCR analysis and can cover the gap between traditional culture and molecular techniques of bioaerosol monitoring.	[Hubad, Barbara; Lapanje, Ales] Inst Microbial Sci & Technol, Domzale, Slovenia		Lapanje, A (corresponding author), Inst Microbial Sci & Technol, Domzale, Slovenia.	ales.lapanje@imst.si	Lapanje, Aleš/AAD-2618-2022	Lapanje, Aleš/0000-0002-2603-0844	European Union Social Fund [P-MR-07/55]; European Commission [261810, 312139, A-1087-RT-GC]	European Union Social Fund(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by the European Union Social Fund (grant no. P-MR-07/55) and the European Commission Seventh Framework program, projects MULTISENSE CHIP (grant no. 261810), KillSpill (grant no. 312139) and Patch (grant no. A-1087-RT-GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ AJ, 1995, APPL ENVIRON MICROB, V61, P3639, DOI 10.1128/AEM.61.10.3639-3644.1995; An HR, 2004, INDOOR AIR, V14, P385, DOI 10.1111/j.1600-0668.2004.00257.x; Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102; Bauer H, 2002, ATMOS RES, V64, P109, DOI 10.1016/S0169-8095(02)00084-4; Bauer H, 2002, WATER RES, V36, P3965, DOI 10.1016/S0043-1354(02)00121-5; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Carducci A, 2011, J HOSP INFECT, V77, P242, DOI 10.1016/j.jhin.2010.10.010; Chang CW, 2012, J AEROSOL SCI, V48, P63, DOI 10.1016/j.jaerosci.2012.02.003; Chang CW, 2012, AEROSOL SCI TECH, V46, P369, DOI 10.1080/02786826.2011.633583; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; D'Arcy N, 2012, AEROBIOLOGIA, V28, P413, DOI 10.1007/s10453-012-9251-5; Delgado-Viscogliosi P, 2005, APPL ENVIRON MICROB, V71, P4086, DOI 10.1128/AEM.71.7.4086-4096.2005; Gibb AP, 1998, J CLIN MICROBIOL, V36, P275, DOI 10.1128/JCM.36.1.275-276.1998; Han YP, 2013, J ENVIRON SCI, V25, P5, DOI 10.1016/S1001-0742(12)60018-7; He QS, 2011, J ENVIRON MONITOR, V13, P706, DOI 10.1039/c0em00559b; Hospodsky D, 2010, APPL ENVIRON MICROB, V76, P7004, DOI 10.1128/AEM.01240-10; Karra S, 2007, WATER RES, V41, P1355, DOI 10.1016/j.watres.2006.12.014; Le Goff O, 2012, ATMOS ENV; Lee JA, 2007, J OCCUP ENVIRON MED, V49, P1235, DOI 10.1097/JOM.0b013e3181568b40; Li KJ, 2011, SCI TOTAL ENVIRON, V409, P5493, DOI 10.1016/j.scitotenv.2011.09.010; Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x; Nubel U, 1996, J BACTERIOL, V178, P5636; Rinsoz T, 2008, ATMOS ENVIRON, V42, P6767, DOI 10.1016/j.atmosenv.2008.05.018; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shannon KE, 2007, SCI TOTAL ENVIRON, V382, P121, DOI 10.1016/j.scitotenv.2007.02.039; SMITH HL, 1958, J BACTERIOL, V76, P662, DOI 10.1128/JB.76.6.662-665.1958; Team RC, 2013, R LANG ENV STAT COMP; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Yamaguchi Y, 2002, BIOTECHNIQUES, V33, P282, DOI 10.2144/02332bm05; Yamamoto N, 2010, J BIOSCI BIOENG, V109, P83, DOI 10.1016/j.jbiosc.2009.06.015; Yao MS, 2006, AEROSOL SCI TECH, V40, P595, DOI 10.1080/02786820600729146; Ziros PG, 2011, VIROL J, V8, P1	33	15	16	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82186	10.1371/journal.pone.0082186	http://dx.doi.org/10.1371/journal.pone.0082186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376520	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100019
J	Nilsen, C; Paige, J; Warner, O; Mayhew, B; Sutley, R; Lam, M; Bernoff, AJ; Topaz, CM				Nilsen, Christa; Paige, John; Warner, Olivia; Mayhew, Benjamin; Sutley, Ryan; Lam, Matthew; Bernoff, Andrew J.; Topaz, Chad M.			Social Aggregation in Pea Aphids: Experiment and Random Walk Modeling	PLOS ONE			English	Article							EUCALLIPTERUS-TILIAE L; PATTERNS; DYNAMICS; BEHAVIOR; MOVEMENT; DISTANCE	From bird flocks to fish schools and ungulate herds to insect swarms, social biological aggregations are found across the natural world. An ongoing challenge in the mathematical modeling of aggregations is to strengthen the connection between models and biological data by quantifying the rules that individuals follow. We model aggregation of the pea aphid, Acyrthosiphon pisum. Specifically, we conduct experiments to track the motion of aphids walking in a featureless circular arena in order to deduce individual-level rules. We observe that each aphid transitions stochastically between a moving and a stationary state. Moving aphids follow a correlated random walk. The probabilities of motion state transitions, as well as the random walk parameters, depend strongly on distance to an aphid's nearest neighbor. For large nearest neighbor distances, when an aphid is essentially isolated, its motion is ballistic with aphids moving faster, turning less, and being less likely to stop. In contrast, for short nearest neighbor distances, aphids move more slowly, turn more, and are more likely to become stationary; this behavior constitutes an aggregation mechanism. From the experimental data, we estimate the state transition probabilities and correlated random walk parameters as a function of nearest neighbor distance. With the individual-level model established, we assess whether it reproduces the macroscopic patterns of movement at the group level. To do so, we consider three distributions, namely distance to nearest neighbor, angle to nearest neighbor, and percentage of population moving at any given time. For each of these three distributions, we compare our experimental data to the output of numerical simulations of our nearest neighbor model, and of a control model in which aphids do not interact socially. Our stochastic, social nearest neighbor model reproduces salient features of the experimental data that are not captured by the control.	[Nilsen, Christa; Paige, John; Warner, Olivia; Mayhew, Benjamin; Sutley, Ryan; Topaz, Chad M.] Macalester Coll, Dept Math Stat & Comp Sci, St Paul, MN 55105 USA; [Lam, Matthew; Bernoff, Andrew J.] Harvey Mudd Coll, Dept Math, Claremont, CA 91711 USA	Macalester College; Claremont Colleges; Harvey Mudd College	Topaz, CM (corresponding author), Macalester Coll, Dept Math Stat & Comp Sci, St Paul, MN 55105 USA.	ctopaz@macalester.edu		Paige, John/0000-0003-2683-2596; Bernoff, Andrew/0000-0001-9443-6320; Topaz, Chad/0000-0001-9977-3414	National Science Foundation [DMS-1009633]; Macalester College's Data Scholars Program; Howard Hughes Medical Institute's Precollege and Undergraduate Science Education Program; Howard Hughes Medical Institute Undergraduate Science Education Program award [52006301]; Direct For Mathematical & Physical Scien [1009633] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Macalester College's Data Scholars Program; Howard Hughes Medical Institute's Precollege and Undergraduate Science Education Program; Howard Hughes Medical Institute Undergraduate Science Education Program award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation grant DMS-1009633 to CT. CN and OW were supported though Macalester College's Data Scholars Program, funded by a grant from the Howard Hughes Medical Institute's Precollege and Undergraduate Science Education Program. ML was supported by the Howard Hughes Medical Institute Undergraduate Science Education Program award 52006301 to Harvey Mudd College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bernoff AJ, 2011, SIAM J APPL DYN SYST, V10, P212, DOI 10.1137/100804504; Bonabeu E, 1999, SANTA FE I STUDIES S; BREDER CM, 1954, ECOLOGY, V35, P361, DOI 10.2307/1930099; Brisson JA, 2010, PHILOS T R SOC B, V365, P605, DOI 10.1098/rstb.2009.0255; Camazine S., 2020, SELF ORG BIOL SYSTEM; CAPPUCCINO N, 1987, ECOLOGY, V68, P1634, DOI 10.2307/1939856; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; D'Orsogna MR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.104302; Dixon AFG, 1958, T R ENT S LOND, P319; Eastop V, 1971, B BR MUS NAT HIST EN, V26; Eftimie R, 2007, B MATH BIOL, V69, P1537, DOI 10.1007/s11538-006-9175-8; Eftimie R, 2007, P NATL ACAD SCI USA, V104, P6974, DOI 10.1073/pnas.0611483104; Fetecau RC, 2011, NONLINEARITY, V24, P2681, DOI 10.1088/0951-7715/24/10/002; Fetecau R.C., 2012, PHYSICA D; Fisher NI, 1995, STAT ANAL CIRCULAR D; Flierl G, 1999, J THEOR BIOL, V196, P397, DOI 10.1006/jtbi.1998.0842; Gautrais J, 2009, J MATH BIOL, V58, P429, DOI 10.1007/s00285-008-0198-7; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; KIDD NAC, 1976, OECOLOGIA, V25, P175, DOI 10.1007/BF00368852; KIDD NAC, 1976, OECOLOGIA, V22, P299, DOI 10.1007/BF00344799; KISLOW CJ, 1972, NATURE, V235, P108, DOI 10.1038/235108a0; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Kolokolnikov T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.015203; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Leverentz AJ, 2009, SIAM J APPL DYN SYST, V8, P880, DOI 10.1137/090749037; Levine H, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.017101; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; M. J. WAY, 1970, Animal populations in relation to their food resources. A symposium of the British Ecological Society, Aberdeen 24-28 March 1969., P229; Mogilner A, 2003, J MATH BIOL, V47, P353, DOI 10.1007/s00285-003-0209-7; Mogilner A, 1999, J MATH BIOL, V38, P534, DOI 10.1007/s002850050158; Mondor EB, 2000, J CHEM ECOL, V26, P2875, DOI 10.1023/A:1026402229440; Okubo A., 2001, DIFFUSION ECOLOGICAL, P10; Okubo Akira, 2001, P197; Parrish J., 1997, ANIMAL GROUPS 3 DIME; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Passino K., 2005, BIOMIMICRY OPTIMIZAT; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; ROITBERG BD, 1979, J ANIM ECOL, V48, P111, DOI 10.2307/4104; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shlesinger M. F., 1995, LECT NOTES PHYS, V450; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; STRONG FE, 1967, ENTOMOL EXP APPL, V10, P463, DOI 10.1111/j.1570-7458.1967.tb02466.x; Tilman D., 2018, SPATIAL ECOLOGY ROLE; Topaz CM, 2008, EUR PHYS J-SPEC TOP, V157, P93, DOI 10.1140/epjst/e2008-00633-y; Topaz CM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002642; Topaz CM, 2004, SIAM J APPL MATH, V65, P152, DOI 10.1137/S0036139903437424; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; Turchin Peter, 1998; van Emden H, 2007, APHIDS AS CROP PESTS, pXXI; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0	53	13	13	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83343	10.1371/journal.pone.0083343	http://dx.doi.org/10.1371/journal.pone.0083343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376691	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100114
J	Rohde, J; Amann, R; Rziha, HJ				Rohde, Joerg; Amann, Ralf; Rziha, Hanns-Joachim			New Orf Virus (Parapoxvirus) Recombinant Expressing H5 Hemagglutinin Protects Mice against H5N1 and H1N1 Influenza A Virus	PLOS ONE			English	Article							CD4(+) T-CELLS; CROSS-CLADE PROTECTION; DNA VACCINE; MONOCLONAL-ANTIBODIES; PSEUDORABIES VIRUS; CELLULAR-IMMUNITY; INFECTION; NUCLEOPROTEIN; GLYCOPROTEIN; TRANSMISSION	Previously we demonstrated the versatile utility of the Parapoxvirus Orf virus (ORFV) as a vector platform for the development of potent recombinant vaccines. In this study we present the generation of new ORFV recombinants expressing the hemagglutinin (HA) or nucleoprotein (NP) of the highly pathogenic avian influenza virus (HPAIV) H5N1. Correct foreign gene expression was examined in vitro by immunofluorescence, Western blotting and flow cytometry. The protective potential of both recombinants was evaluated in the mouse challenge model. Despite adequate expression of NP, the recombinant D1701-V-NPh5 completely failed to protect mice from lethal challenge. However, the H5 HA-expressing recombinant D1701-V-HAh5n mediated solid protection in a dose-dependent manner. Two intramuscular (i.m.) injections of the HA-expressing recombinant protected all animals from lethal HPAIV infection without loss of body weight. Notably, the immunized mice resisted cross-clade H5N1 and heterologous H1N1 (strain PR8) influenza virus challenge. In vivo antibody-mediated depletion of CD4-positive and/or CD8-posititve T-cell subpopulations during immunization and/or challenge infection implicated the relevance of CD4-positive T-cells for induction of protective immunity by D1701-V-HAh5n, whereas the absence of CD8-positive T-cells did not significantly influence protection. In summary, this study validates the potential of the ORFV vectored vaccines also to combat HPAIV.	[Rohde, Joerg; Amann, Ralf; Rziha, Hanns-Joachim] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany	Friedrich Loeffler Institute	Rziha, HJ (corresponding author), Univ Tubingen, Dept Immunol, Interfac Inst Cell Biol, Tubingen, Germany.	achim.rziha@fli.bund.de			Pfizer Animal Health	Pfizer Animal Health	Part of the work was financially supported by Pfizer Animal Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R, 2013, J VIROL, V87, P1618, DOI 10.1128/JVI.02470-12; Barrett PN, 2010, CURR OPIN MOL THER, V12, P21; Bodewes R, 2010, VIRUSES-BASEL, V2, P166, DOI 10.3390/v2010166; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; Buttner M, 2002, J VET MED B, V49, P7, DOI 10.1046/j.1439-0450.2002.00539.x; Chen JR, 2011, TRENDS BIOTECHNOL, V29, P426, DOI 10.1016/j.tibtech.2011.04.007; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Chen Y, 2010, VIROLOGY, V405, P15, DOI 10.1016/j.virol.2010.05.024; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; Czerny CP, 1997, ARCH VIROL, V142, P807, DOI 10.1007/s007050050120; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Dory D, 2006, VACCINE, V24, P6256, DOI 10.1016/j.vaccine.2006.05.078; Droebner K, 2008, VACCINE, V26, P6965, DOI 10.1016/j.vaccine.2008.09.051; El Sahlyt HM, 2008, EXPERT REV VACCINES, V7, P241, DOI 10.1586/14760584.7.2.241; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Fischer T, 2003, J VIROL, V77, P9312, DOI 10.1128/JVI.77.17.9312-9323.2003; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gillim-Ross L, 2006, CLIN MICROBIOL REV, V19, P614, DOI 10.1128/CMR.00005-06; Guo HL, 2011, J VIROL, V85, P448, DOI 10.1128/JVI.01812-10; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Haig DM, 2006, CURR OPIN INFECT DIS, V19, P127, DOI 10.1097/01.qco.0000216622.75326.ef; Harder TC, 2010, VET IMMUNOL IMMUNOP, V134, P54, DOI 10.1016/j.vetimm.2009.10.009; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Henkel M, 2005, J VIROL, V79, P314, DOI 10.1128/JVI.79.1.314-325.2005; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hessel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016247; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Karaca K, 2005, CLIN DIAGN LAB IMMUN, V12, P1340, DOI 10.1128/CDLI.12.11.1340-1342.2005; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Kreijtz JHCM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007790; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Kyriakis CS, 2009, VACCINE, V27, P2258, DOI 10.1016/j.vaccine.2009.02.006; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; LEGROS GS, 1984, IMMUNOLOGY, V51, P103; Li Q, 2012, P NATL ACAD SCI USA, V109, P18897, DOI 10.1073/pnas.1211037109; Mayrhofer J, 2009, J VIROL, V83, P5192, DOI 10.1128/JVI.02081-08; Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636; Osterhaus A, 2011, PHILOS T R SOC B, V366, P2766, DOI 10.1098/rstb.2011.0102; Ozawa M, 2011, VIRUS RES, V162, P8, DOI 10.1016/j.virusres.2011.09.035; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Poon LLM, 2009, J IMMUNOL, V182, P3063, DOI 10.4049/jimmunol.0803467; Pushko P, 2011, VACCINE, V29, P5911, DOI 10.1016/j.vaccine.2011.06.068; Rao SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009812; Rimmelzwaan GF, 2009, VACCINE, V27, P6363, DOI 10.1016/j.vaccine.2009.01.016; Rohde J, 2011, VACCINE, V29, P9256, DOI 10.1016/j.vaccine.2011.09.121; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Rziha HJ, 2000, J BIOTECHNOL, V83, P137, DOI 10.1016/S0168-1656(00)00307-2; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stittelaar KJ, 2010, VACCINE, V28, P4970, DOI 10.1016/j.vaccine.2010.05.028; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Tang XC, 2010, VACCINE, V28, P6821, DOI 10.1016/j.vaccine.2010.08.040; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tumpey TM, 2009, ANNU REV MICROBIOL, V63, P79, DOI 10.1146/annurev.micro.091208.073359; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; van Rooij EMA, 2010, VACCINE, V28, P1808, DOI 10.1016/j.vaccine.2009.12.004; Voigt H, 2007, VACCINE, V25, P5915, DOI 10.1016/j.vaccine.2007.05.035; Weber O, 2013, EUR J CLIN MICROBIOL, V32, P451, DOI 10.1007/s10096-012-1780-x; Xu K, 2011, VIRAL IMMUNOL, V24, P45, DOI 10.1089/vim.2010.0056	69	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83802	10.1371/journal.pone.0083802	http://dx.doi.org/10.1371/journal.pone.0083802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376753	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100144
J	Stafford, JH; Hao, GY; Best, AM; Sun, XK; Thorpe, PE				Stafford, Jason H.; Hao, Guiyang; Best, Anne M.; Sun, Xiankai; Thorpe, Philip E.			Highly Specific PET Imaging of Prostate Tumors in Mice with an Iodine-124-Labeled Antibody Fragment That Targets Phosphatidylserine	PLOS ONE			English	Article							ANNEXIN-V SCINTIGRAPHY; ANIONIC PHOSPHOLIPIDS; MONOCLONAL-ANTIBODY; INCREASED EXPOSURE; IN-VITRO; CHEMOTHERAPY; APOPTOSIS; SURFACE; PHOSPHATIDYLETHANOLAMINE; AGENT	Phosphatidylserine (PS) is an attractive target for imaging agents that identify tumors and assess their response to therapy. PS is absent from the surface of most cell types, but becomes exposed on tumor cells and tumor vasculature in response to oxidative stresses in the tumor microenvironment and increases in response to therapy. To image exposed PS, we used a fully human PS-targeting antibody fragment, PGN635 F(ab')2, that binds to complexes of PS and beta 2-glycoprotein I. PGN635 F(ab')(2) was labeled with the positron-emitting isotope iodine-124 (I-124) and the resulting probe was injected into nude mice bearing subcutaneous or orthotopic human PC3 prostate tumors. Biodistribution studies showed that I-124-PGN635 F(ab')(2) localized with remarkable specificity to the tumors with little uptake in other organs, including the liver and kidneys. Clear delineation of the tumors was achieved by PET 48 hours after injection. Radiation of the tumors with 15 Gy or systemic treatment of the mice with 10 mg/kg docetaxel increased localization in the tumors. Tumor-to-normal (T/N) ratios were inversely correlated with tumor growth measured over 28 days. These data indicate that I-124-PGN635 F(ab')(2) is a promising new imaging agent for predicting tumor response to therapy.	[Stafford, Jason H.; Best, Anne M.; Thorpe, Philip E.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA; [Hao, Guiyang; Sun, Xiankai] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dept Radiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Stafford, JH (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA.	jason006@stanford.edu	Hao, Guiyang/D-5312-2011	Hao, Guiyang/0000-0001-6695-5123	NIH [U24 CA126608]; Cancer Center [5P30 CA 142543-03]; Gillson Longenbaugh Foundation; Peregrine Pharmaceuticals Inc., Tustin, CA; NATIONAL CANCER INSTITUTE [P30CA142543, U24CA126608] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; Gillson Longenbaugh Foundation; Peregrine Pharmaceuticals Inc., Tustin, CA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH (U24 CA126608) for the Small Animal Imaging Research Program at UTSW, Cancer Center Support Grant (5P30 CA 142543-03), the Gillson Longenbaugh Foundation, and a sponsored research agreement with Peregrine Pharmaceuticals Inc., Tustin, CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhasan MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046106; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Bauwens M, 2011, NUCL MED BIOL, V38, P381, DOI 10.1016/j.nucmedbio.2010.09.008; Belhocine T, 2003, ANN NY ACAD SCI, V1010, P525, DOI 10.1196/annals.1299.097; Belhocine T, 2002, CLIN CANCER RES, V8, P2766; Belov VV, 2011, MOL PHARMACEUT, V8, P736, DOI 10.1021/mp100358f; BITBOL M, 1987, BIOCHIM BIOPHYS ACTA, V904, P268, DOI 10.1016/0005-2736(87)90376-2; Blankenberg F, 2002, CLIN CANCER RES, V8, P2757; Boswell CA, 2004, J MED CHEM, V47, P1465, DOI 10.1021/jm030383m; Capila I, 2001, STRUCTURE, V9, P57, DOI 10.1016/S0969-2126(00)00549-9; Carrasquillo JA, 2011, J NUCL MED, V52, P1173, DOI 10.2967/jnumed.110.086165; Collingridge DR, 2003, BRIT J CANCER, V89, P1327, DOI 10.1038/sj.bjc.6601262; COVELL DG, 1986, CANCER RES, V46, P3969; Czernin J, 2004, J NUCL MED, V45, p1S; Divgi CR, 2007, LANCET ONCOL, V8, P304, DOI 10.1016/S1470-2045(07)70044-X; Emonds KM, 2009, METHODS, V48, P193, DOI 10.1016/j.ymeth.2009.03.021; Gambhir SS, 2001, J NUCL MED, V42, p1S; He J, 2007, CLIN CANCER RES, V13, P5211, DOI 10.1158/1078-0432.CCR-07-0793; He J, 2009, CLIN CANCER RES, V15, P6871, DOI 10.1158/1078-0432.CCR-09-1499; Hoebers FJP, 2008, EUR J NUCL MED MOL I, V35, P509, DOI 10.1007/s00259-007-0624-x; Huang XM, 2005, CANCER RES, V65, P4408, DOI 10.1158/0008-5472.CAN-05-0031; Jennewein M, 2008, CLIN CANCER RES, V14, P1377, DOI 10.1158/1078-0432.CCR-07-1516; Kartachova M, 2007, J CLIN ONCOL, V25, P2534, DOI 10.1200/JCO.2006.10.1337; Kemerink GJ, 2003, J NUCL MED, V44, P947; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Loose D, 2008, EUR J NUCL MED MOL I, V35, P47, DOI 10.1007/s00259-007-0577-0; Luster TA, 2006, J BIOL CHEM, V281, P29863, DOI 10.1074/jbc.M605252200; Marconescu A, 2008, BBA-BIOMEMBRANES, V1778, P2217, DOI 10.1016/j.bbamem.2008.05.006; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Ogasawara A, 2013, NUCL MED BIOL, V40, P15, DOI 10.1016/j.nucmedbio.2012.09.001; Orlova A, 2009, J NUCL MED, V50, P417, DOI 10.2967/jnumed.108.057919; Pentlow KS, 1996, J NUCL MED, V37, P1557; Ran S, 2002, CANCER RES, V62, P6132; Riedl S, 2011, BBA-BIOMEMBRANES, V1808, P2638, DOI 10.1016/j.bbamem.2011.07.026; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Smith BA, 2010, J AM CHEM SOC, V132, P67, DOI 10.1021/ja908467y; Stafford JH, 2011, NEOPLASIA, V13, P299, DOI 10.1593/neo.101366; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Vanderheyden JL, 2006, NUCL MED BIOL, V33, P135, DOI 10.1016/j.nucmedbio.2005.09.002; Verroust PJ, 2002, KIDNEY INT, V62, P745, DOI 10.1046/j.1523-1755.2002.00501.x; WAHL RL, 1983, J NUCL MED, V24, P316; Wall JS, 2006, J NUCL MED, V47, P2016; Wang F, 2008, NUCL MED BIOL, V35, P359, DOI 10.1016/j.nucmedbio.2007.12.007; Wang F, 2011, J NUCL MED, V52, P592, DOI 10.2967/jnumed.110.081588; WILLIAMSON P, 1994, MOL MEMBR BIOL, V11, P199, DOI 10.3109/09687689409160430; Wu AM, 2009, J NUCL MED, V50, P2, DOI 10.2967/jnumed.108.056887; Yagle KJ, 2005, J NUCL MED, V46, P658; Zhao DW, 2011, TRANSL ONCOL, V4, P355, DOI 10.1593/tlo.11178; ZULUETA JJ, 1995, AM J RESP CELL MOL, V12, P41, DOI 10.1165/ajrcmb.12.1.7529030	50	20	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84864	10.1371/journal.pone.0084864	http://dx.doi.org/10.1371/journal.pone.0084864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367699	gold, Green Submitted, Green Published			2022-12-27	WOS:000328741900070
J	Dong, HB; Wang, SQ; Jia, YY; Ni, YD; Zhang, YS; Zhuang, S; Shen, XZ; Zhao, RQ				Dong, Haibo; Wang, Shaoqing; Jia, Yuanyuan; Ni, Yingdong; Zhang, Yuanshu; Zhuang, Su; Shen, Xiangzhen; Zhao, Ruqian			Long-Term Effects of Subacute Ruminal Acidosis (SARA) on Milk Quality and Hepatic Gene Expression in Lactating Goats Fed a High-Concentrate Diet	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ACUTE-PHASE PROTEINS; DAIRY-COWS; LIPID-METABOLISM; CHEWING ACTIVITY; NERVOUS-SYSTEM; RUMEN PH; GLUCOSE; STRESS; LIPOPOLYSACCHARIDE	Purpose: The mechanism underlying the decline in milk quality during periods of feeding high-concentrate diets to dairy ruminants is not well documented. The aim of this study was to investigate the metabolic changes in the liver that contribute to the input of substrate precursors to the mammary gland after feeding a high-concentrate diet to lactating goats for a long period. Experimental Design: Eight mid-lactating goats with rumen cannulas were randomly assigned to two groups. For 9 weeks, the treatment group was fed a high-concentrate diet (60% concentrate of dry matter, HC) and the control group was fed a low-concentrate diet (40% concentrate of dry matter, LC). Ruminal fluid, plasma, and liver tissues were sampled, microarray techniques and real-time polymerase chain reaction were used to evaluate metabolic parameters and gene expression in liver. Results: Feeding a 60%-concentrate diet for 9 weeks resulted in a significant decrease in rumen pH. Changes in fat and protein content also occurred, which negatively affected milk quality. Plasma levels of leptin (p = 0.058), non-esterified fatty acid (p = 0.071), and glucose (p = 0.014) increased markedly in HC group. Plasma cortisol concentration was significantly elevated in the treatment group (p<0.05). Expression of the glucocorticoid receptor protein gene was significantly down-regulated (p<0.05) in the liver. The expression of genes for interleukin 1 beta, serum amyloid A, C-reactive protein, and haptoglobin mRNA was significantly increased (p<0.05) in the HC group. GeneRelNet analysis showed that gene expression involved in inflammatory responses and the metabolism of lipids, protein, and carbohydrate were significantly altered by feeding a high-concentrate diet for 9 weeks. Conclusions: Activation of the acute phase response and the inflammatory response may contribute to nutrient partitioning and re-distribution of energy in the liver, and ultimately lead to a decline in milk quality.	[Dong, Haibo; Wang, Shaoqing; Jia, Yuanyuan; Ni, Yingdong; Zhang, Yuanshu; Zhao, Ruqian] Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China; [Zhuang, Su] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Shen, Xiangzhen] Nanjing Agr Univ, Coll Vet Med, Inst Small Anim Dis, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Agricultural University	Ni, YD (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	niyingdong@njau.edu.cn		Dong, Haibo/0000-0001-6520-3739	National Basic Research Program of China [2011CB100802]; National Nature Science Foundation of China [31272470]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (Project No. 2011CB100802) and National Nature Science Foundation of China (Project No. 31272470) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSEMGEEST SPM, 1995, VET QUART, V17, P9, DOI 10.1080/01652176.1995.9694521; AlZahal O, 2007, J ANIM SCI, V85, P213, DOI 10.2527/jas.2006-095; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bannerman DD, 2004, J DAIRY SCI, V87, P2420, DOI 10.3168/jds.S0022-0302(04)73365-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Beauchemin KA, 2003, J DAIRY SCI, V86, P630, DOI 10.3168/jds.S0022-0302(03)73641-8; Boden G, 2007, DIABETES, V56, P248, DOI 10.2337/db06-0481; Bryson JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE417, DOI 10.1152/ajpendo.1999.277.3.E417; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chen GL, 2012, AM J MED GENET B, V159B, P152, DOI 10.1002/ajmg.b.32023; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Dong GZ, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-48; Duffield T, 2004, J DAIRY SCI, V87, P59, DOI 10.3168/jds.S0022-0302(04)73142-2; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Emmanuel DGV, 2008, J DAIRY SCI, V91, P606, DOI 10.3168/jds.2007-0256; Fairfield AM, 2007, J DAIRY SCI, V90, P937, DOI 10.3168/jds.S0022-0302(07)71577-1; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Garrett EF, 1999, J DAIRY SCI, V82, P1170, DOI 10.3168/jds.S0022-0302(99)75340-3; GN G, 2005, SUBACUTE RUMINAL ACI; Gozho GN, 2005, J DAIRY SCI, V88, P1399, DOI 10.3168/jds.S0022-0302(05)72807-1; Grum DE, 1996, J DAIRY SCI, V79, P1836, DOI 10.3168/jds.S0022-0302(96)76552-9; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Johnson RW, 1997, J ANIM SCI, V75, P1244; Kabaroff LC, 2006, VET IMMUNOL IMMUNOP, V113, P113, DOI 10.1016/j.vetimm.2006.04.003; Karrow NA, 2006, BRAIN BEHAV IMMUN, V20, P144, DOI 10.1016/j.bbi.2005.05.003; Keunen JE, 2002, J DAIRY SCI, V85, P3304, DOI 10.3168/jds.S0022-0302(02)74419-6; Khafipour E, 2009, J DAIRY SCI, V92, P1712, DOI 10.3168/jds.2008-1656; Khafipour E, 2009, J DAIRY SCI, V92, P1060, DOI 10.3168/jds.2008-1389; Kleen JL, 2003, J VET MED A, V50, P406, DOI 10.1046/j.1439-0442.2003.00569.x; Li S, 2012, J DAIRY SCI, V95, P294, DOI 10.3168/jds.2011-4447; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; MILLS SE, 1979, J ANIM SCI, V48, P961, DOI 10.2527/jas1979.484961x; MINTON JE, 1994, J ANIM SCI, V72, P1891, DOI 10.2527/1994.7271891x; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Nocek JE, 1997, J DAIRY SCI, V80, P1005, DOI 10.3168/jds.S0022-0302(97)76026-0; Nukina K, 2001, J NEUROIMMUNOL, V115, P46, DOI 10.1016/S0165-5728(01)00260-0; Oba M, 2000, J DAIRY SCI, V83, P1350, DOI 10.3168/jds.S0022-0302(00)75002-8; Plaizier JC, 2008, VET J, V176, P21, DOI 10.1016/j.tvjl.2007.12.016; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Salisbury J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007479; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Sohn MJ, 2008, BIOCHEM PHARMACOL, V75, P923, DOI 10.1016/j.bcp.2007.10.021; Steele MA, 2012, J DAIRY SCI, V95, P6072, DOI 10.3168/jds.2011-4864; Steele MA, 2011, AM J PHYSIOL-REG I, V300, pR1515, DOI 10.1152/ajpregu.00120.2010; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Taguchi Y, 1998, P ASSOC AM PHYSICIAN, V110, P559; Xiao CT, 2005, J DAIRY SCI, V88, P2794, DOI 10.3168/jds.S0022-0302(05)72959-3; Yang WZ, 2006, J DAIRY SCI, V89, P217, DOI 10.3168/jds.S0022-0302(06)72086-0; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zunszain PA, 2011, PROG NEURO-PSYCHOPH, V35, P722, DOI 10.1016/j.pnpbp.2010.04.011	56	42	52	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82850	10.1371/journal.pone.0082850	http://dx.doi.org/10.1371/journal.pone.0082850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376594	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000033
J	Dumoux, M; Le Gall, SM; Habbeddine, M; Delarbre, C; Hayward, RD; Kanellopoulos-Langevin, C; Verbeke, P				Dumoux, Maud; Le Gall, Sylvain M.; Habbeddine, Mohamed; Delarbre, Christiane; Hayward, Richard D.; Kanellopoulos-Langevin, Colette; Verbeke, Philippe			Penicillin Kills Chlamydia following the Fusion of Bacteria with Lysosomes and Prevents Genital Inflammatory Lesions in C. muridarum-Infected Mice	PLOS ONE			English	Article							SULBACTAM AMPICILLIN; III SECRETION; IFN-GAMMA; IN-VITRO; ULTRASTRUCTURAL ANALYSIS; TRACHOMATIS PERSISTENCE; MEMBRANE-PROTEINS; CELL-CULTURE; MURINE MODEL; AMOXICILLIN	The obligate intracellular bacterium Chlamydia exists as two distinct forms. Elementary bodies (EBs) are infectious and extracellular, whereas reticulate bodies (RBs) replicate within a specialized intracellular compartment termed an 'inclusion'. Alternative persistent intra-cellular forms can be induced in culture by diverse stimuli such as IFN gamma or adenosine/EHNA. They do not grow or divide but revive upon withdrawal of the stimulus and are implicated in several widespread human diseases through ill-defined in vivo mechanisms. beta-lactam antibiotics have also been claimed to induce persistence in vitro. The present report shows that upon penicillin G (pG) treatment, inclusions grow as fast as those in infected control cells. After removal of pG, Chlamydia do not revert to RBs. These effects are independent of host cell type, serovar, biovar and species of Chlamydia. Time-course experiments demonstrated that only RBs were susceptible to pG. pG-treated bacteria lost their control over host cell apoptotic pathways and no longer expressed pre-16S rRNA, in contrast to persistent bacteria induced with adenosine/EHNA. Confocal and live-video microscopy showed that bacteria within the inclusion fused with lysosomal compartments in pG-treated cells. That leads to recruitment of cathepsin D as early as 3 h post pG treatment, an event preceding bacterial death by several hours. These data demonstrate that pG treatment of cultured cells infected with Chlamydia results in the degradation of the bacteria. In addition we show that pG is significantly more efficient than doxycycline at preventing genital inflammatory lesions in C. muridarum-C57Bl/6 infected mice. These in vivo results support the physiological relevance of our findings and their potential therapeutic applications.	[Dumoux, Maud; Le Gall, Sylvain M.; Habbeddine, Mohamed; Delarbre, Christiane; Kanellopoulos-Langevin, Colette; Verbeke, Philippe] CNRS, Inst Jacques Monod, UMR 7592, Lab Inflammat Gestn & Autoimmun, Paris, France; [Dumoux, Maud; Le Gall, Sylvain M.; Habbeddine, Mohamed; Delarbre, Christiane; Kanellopoulos-Langevin, Colette; Verbeke, Philippe] Univ Paris Diderot, Paris, France; [Hayward, Richard D.] Univ London, Univ Coll London & Birkbeck, Inst Struct & Mol Biol, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of London; Birkbeck University London; University College London	Kanellopoulos-Langevin, C (corresponding author), Univ Paris Diderot, INSERM U699, Fac Med Xavier Bichat, Paris, France.	colette.kanellopoulos@inserm.fr; philippe.verbeke@inserm.fr		Dumoux, Maud/0000-0002-1732-1041; Hayward, Richard David/0000-0002-1710-2172				BEALE AS, 1994, ANTIMICROB AGENTS CH, V38, P1937, DOI 10.1128/AAC.38.9.1937; BEATTY WL, 1994, INFECT IMMUN, V62, P4059, DOI 10.1128/IAI.62.9.4059-4062.1994; BEATTY WL, 1995, INFECT IMMUN, V63, P199, DOI 10.1128/IAI.63.1.199-205.1995; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P15971, DOI 10.1073/pnas.2535394100; BRUHAT MA, 1986, DRUGS, V31, P7, DOI 10.2165/00003495-198600312-00002; CEVENINI R, 1988, FEMS MICROBIOL LETT, V56, P41; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; CROMBLEHOLME W, 1986, DRUGS, V31, P11, DOI 10.2165/00003495-198600312-00003; CSANGO PA, 1985, SEX TRANSM DIS, V12, P93, DOI 10.1097/00007435-198504000-00009; Dean D, 2001, INFECT IMMUN, V69, P2442, DOI 10.1128/IAI.69.4.2442-2447.2001; Dong F, 2005, INFECT IMMUN, V73, P1861, DOI 10.1128/IAI.73.3.1861-1864.2005; Gerard HC, 1997, MOL GEN GENET, V255, P637, DOI 10.1007/s004380050538; Goellner S, 2006, INFECT IMMUN, V74, P4801, DOI 10.1128/IAI.01487-05; Hemsell D L, 1993, Infect Dis Obstet Gynecol, V1, P123, DOI 10.1155/S1064744993000286; HEMSELL DL, 1988, DRUGS, V35, P39, DOI 10.2165/00003495-198800357-00010; Heuer D, 2003, CELL MICROBIOL, V5, P315, DOI 10.1046/j.1462-5822.2003.00278.x; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; HOW SJ, 1985, J ANTIMICROB CHEMOTH, V15, P399, DOI 10.1093/jac/15.4.399; Huston WM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-190; JOHNSON FWA, 1977, J ANTIMICROB CHEMOTH, V3, P49, DOI 10.1093/jac/3.1.49; Kacmar J, 2001, Infect Dis Obstet Gynecol, V9, P197, DOI 10.1155/S1064744901000321; Kleba B, 2008, INFECT IMMUN, V76, P4842, DOI 10.1128/IAI.00715-08; Klos A, 2009, FEMS MICROBIOL LETT, V291, P120, DOI 10.1111/j.1574-6968.2008.01446.x; KOSSEIM M, 1991, ANTIMICROB AGENTS CH, V35, P1651, DOI 10.1128/AAC.35.8.1651; KRAMER MJ, 1979, J INFECT DIS, V139, P717, DOI 10.1093/infdis/139.6.717; KRAMER MJ, 1971, INFECT IMMUN, V3, P333, DOI 10.1128/IAI.3.2.333-341.1971; KUO CC, 1977, ANTIMICROB AGENTS CH, V12, P80, DOI 10.1128/AAC.12.1.80; Lambden PR, 2006, MICROBIOL-SGM, V152, P2573, DOI 10.1099/mic.0.29032-0; Lugert R, 2004, MED MICROBIOL IMMUN, V193, P163, DOI 10.1007/s00430-003-0206-x; MAGAT AH, 1993, OBSTET GYNECOL, V81, P745; MATSUMOTO A, 1970, J BACTERIOL, V101, P278, DOI 10.1128/JB.101.1.278-285.1970; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Mpiga P, 2006, MICROBIOL RES, V161, P9, DOI 10.1016/j.micres.2005.04.004; Nagarajan UM, 2012, J IMMUNOL, V188, P2866, DOI 10.4049/jimmunol.1103461; OBWEGESER J, 1989, J ANTIMICROB CHEMOTH, V24, P165, DOI 10.1093/jac/24.suppl_B.165; Ouellette SP, 2012, MOL MICROBIOL, V85, P164, DOI 10.1111/j.1365-2958.2012.08100.x; PAAVONEN J, 1989, AM J OBSTET GYNECOL, V161, P128, DOI 10.1016/0002-9378(89)90249-4; Pavelka MS, 2007, TRENDS MICROBIOL, V15, P147, DOI 10.1016/j.tim.2007.02.003; Peters J, 2005, CELL MICROBIOL, V7, P1099, DOI 10.1111/j.1462-5822.2005.00534.x; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; PETERSON HB, 1990, REV INFECT DIS, V12, pS656; Pettengill MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008299; Pirbhai M, 2006, J BIOL CHEM, V281, P31495, DOI 10.1074/jbc.M602796200; Prantner D, 2011, INFECT IMMUN, V79, P3922, DOI 10.1128/IAI.00140-11; Ridgway GL, 1997, J ANTIMICROB CHEMOTH, V40, P311, DOI 10.1093/jac/40.3.311; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; SARDINIA LM, 1988, J GEN MICROBIOL, V134, P997; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schramm N, 1996, INFECT IMMUN, V64, P1208, DOI 10.1128/IAI.64.4.1208-1214.1996; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Scidmore MA, 2005, CURR PROTOC MICROBIO; Singh CR, 2006, J IMMUNOL, V177, P3250, DOI 10.4049/jimmunol.177.5.3250; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Storey C, 2001, ANTIMICROB AGENTS CH, V45, P303, DOI 10.1128/AAC.45.1.303-305.2001; Su H, 1999, J INFECT DIS, V180, P1252, DOI 10.1086/315046; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Wang J, 2011, MICROBIOL-SGM, V157, P2759, DOI 10.1099/mic.0.044917-0; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Wolf K, 2000, INFECT IMMUN, V68, P2379, DOI 10.1128/IAI.68.4.2379-2385.2000; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394	64	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83511	10.1371/journal.pone.0083511	http://dx.doi.org/10.1371/journal.pone.0083511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376710	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000328882000091
J	Lal, A; Ikeda, T; French, N; Baker, MG; Hales, S				Lal, Aparna; Ikeda, Takayoshi; French, Nigel; Baker, Michael G.; Hales, Simon			Climate Variability, Weather and Enteric Disease Incidence in New Zealand: Time Series Analysis	PLOS ONE			English	Article							NINO-SOUTHERN-OSCILLATION; SEA-SURFACE TEMPERATURE; AMBIENT-TEMPERATURE; EL-NINO; ATMOSPHERIC CIRCULATION; RISK-FACTORS; CAMPYLOBACTER INFECTION; SALMONELLA-TYPHIMURIUM; SUBTROPICAL REGIONS; EUROPEAN COUNTRIES	Background: Evaluating the influence of climate variability on enteric disease incidence may improve our ability to predict how climate change may affect these diseases. Objectives: To examine the associations between regional climate variability and enteric disease incidence in New Zealand. Methods: Associations between monthly climate and enteric diseases (campylobacteriosis, salmonellosis, cryptosporidiosis, giardiasis) were investigated using Seasonal Auto Regressive Integrated Moving Average (SARIMA) models. Results: No climatic factors were significantly associated with campylobacteriosis and giardiasis, with similar predictive power for univariate and multivariate models. Cryptosporidiosis was positively associated with average temperature of the previous month (beta = 0.130, SE = 0.060, p <0.01) and inversely related to the Southern Oscillation Index (SOI) two months previously (beta = -0.008, SE = 0.004, p <0.05). By contrast, salmonellosis was positively associated with temperature (beta = 0.110, SE = 0.020, p <0.001) of the current month and SOI of the current (beta = 0.005, SE = 0.002, p<0.050) and previous month (beta = 0.005, SE = 0.002, p<0.05). Forecasting accuracy of the multivariate models for cryptosporidiosis and salmonellosis were significantly higher. Conclusions: Although spatial heterogeneity in the observed patterns could not be assessed, these results suggest that temporally lagged relationships between climate variables and national communicable disease incidence data can contribute to disease prediction models and early warning systems.	[Lal, Aparna; Baker, Michael G.; Hales, Simon] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Ikeda, Takayoshi] Univ Otago, Deans Dept, Wellington, New Zealand; [French, Nigel] Massey Univ, Hopkirk Res Inst, Mol Epidemiol & Publ Hlth Lab, Palmerston North, New Zealand	University of Otago; University of Otago; Massey University	Lal, A (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, New Zealand.	aparnal49@gmail.com	French, Nigel/F-5725-2011	French, Nigel/0000-0002-6334-0657; Hales, Simon/0000-0002-4529-7595; lal, aparna/0000-0001-7062-1468	University of Otago Postgraduate Research Scholarship	University of Otago Postgraduate Research Scholarship	This work was supported by a University of Otago Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arshad MM, 2007, FOODBORNE PATHOG DIS, V4, P16, DOI 10.1089/fpd.2006.48; ATHERTON F, 1995, EPIDEMIOL INFECT, V115, P123, DOI 10.1017/S0950268800058180; Basher RE, 1996, INT J CLIMATOL, V16, P405, DOI 10.1002/(SICI)1097-0088(199604)16:4<405::AID-JOC14>3.0.CO;2-T; Bentham G, 2001, INT J BIOMETEOROL, V45, P22, DOI 10.1007/s004840000083; Bi P, 2008, J INFECTION, V57, P317, DOI 10.1016/j.jinf.2008.08.004; Britton E, 2010, J WATER HEALTH, V8, P561, DOI 10.2166/wh.2010.049; Britton E, 2010, AUST NZ J PUBL HEAL, V34, P126, DOI 10.1111/j.1753-6405.2010.00495.x; Cash BA, 2010, J CLIMATE, V23, P2817, DOI 10.1175/2009JCLI2512.1; Checkley W, 2000, LANCET, V355, P442, DOI 10.1016/S0140-6736(00)82010-3; Clare GR, 2002, INT J CLIMATOL, V22, P107, DOI 10.1002/joc.722; Clark RG, 2004, NEW ZEAL VET J, V52, P26, DOI 10.1080/00480169.2004.36387; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; D'Souza RM, 2004, EPIDEMIOLOGY, V15, P86, DOI 10.1097/01.ede.0000101021.03453.3e; de Souza D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009927; Doorduyn Y, 2006, EPIDEMIOL INFECT, V134, P617, DOI 10.1017/S0950268805005406; Doorduyn Y, 2010, EPIDEMIOL INFECT, V138, P1391, DOI 10.1017/S095026881000052X; Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Eberhart-Phillips J, 1997, J EPIDEMIOL COMMUN H, V51, P686, DOI 10.1136/jech.51.6.686; Fitzharris B, 2007, NEW ZEAL GEOGR, V63, P160, DOI 10.1111/j.1745-7939.2007.00119.x; Fleury M, 2006, INT J BIOMETEOROL, V50, P385, DOI 10.1007/s00484-006-0028-9; Ford TE, 2009, EMERG INFECT DIS, V15, P1341, DOI 10.3201/eid1509.081334; Franklin LJ, 2009, EPIDEMIOL INFECT, V137, P434, DOI 10.1017/S095026880800109X; GORDON ND, 1985, J ROY SOC NEW ZEAL, V15, P137, DOI 10.1080/03036758.1985.10416840; Gordon ND, 1986, SO OSCILLATION NZ WE; Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364; Hall GV, 2002, MED J AUSTRALIA, V177, P614, DOI 10.5694/j.1326-5377.2002.tb04984.x; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Helfenstein U, 1996, Stat Methods Med Res, V5, P3, DOI 10.1177/096228029600500102; Hoque ME, 2002, NEW ZEAL MED J, V115, P121; Hoque ME, 2001, LANCET, V357, P1017, DOI 10.1016/S0140-6736(00)04251-3; Hu WN, 2007, ANN EPIDEMIOL, V17, P679, DOI 10.1016/j.annepidem.2007.03.020; Hu WB, 2010, INT J BIOMETEOROL, V54, P433, DOI 10.1007/s00484-009-0294-4; IPCC, 2012, MAN RISKS EXTR EV DI; IRI/LDEO CDL, 2007, MEAN SURF CLIM DAT G; Jofre J, 2010, HANDB ENVIRON CHEM, V8, P147, DOI 10.1007/698_2009_22; Jore S, 2010, PREV VET MED, V93, P33, DOI 10.1016/j.prevetmed.2009.09.015; Kessel A S, 2001, Commun Dis Public Health, V4, P171; Kovats RS, 2005, INT J BIOMETEOROL, V49, P207, DOI 10.1007/s00484-004-0241-3; Kovats RS, 2004, EPIDEMIOL INFECT, V132, P443, DOI 10.1017/S0950268804001992; Lake IR, 2008, EPIDEMIOL INFECT, V136, P1383, DOI 10.1017/S0950268807009922; Lake IR, 2009, EPIDEMIOL INFECT, V137, P1538, DOI 10.1017/S0950268809002477; Lake Iain R., 2005, Journal of Water and Health, V3, P469; Lake R, 2010, SHORT REPORT DIS PYR; Lal A, 2011, EPIDEMIOLOGY INFECT, P1; Lal A, 2012, PLOS ONE PUBLIC LIB, Ve31883; Learmonth J, 2001, J EUKARYOT MICROBIOL, p34S; Lloyd SJ, 2007, CLIM RES, V34, P119, DOI 10.3354/cr034119; Louis VR, 2005, APPL ENVIRON MICROB, V71, P85, DOI 10.1128/AEM.71.1.85-92.2005; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; MACKEY BM, 1987, LETT APPL MICROBIOL, V4, P13, DOI 10.1111/j.1472-765X.1987.tb01571.x; Mccarthy ND, 2012, EPIDEMIOLOGY INFECT, P1; McKerchar AI, 2003, HYDROLOG SCI J, V48, P637, DOI 10.1623/hysj.48.4.637.51412; Miller WA, 2007, APPL ENVIRON MICROB, V73, P6972, DOI 10.1128/AEM.00100-07; Mosley MP, 2000, HYDROLOG SCI J, V45, P249, DOI 10.1080/02626660009492323; Mullan AB, 1998, INT J CLIMATOL, V18, P817, DOI 10.1002/(SICI)1097-0088(19980630)18:8&lt;817::AID-JOC261&gt;3.0.CO;2-E; Mullan AB, 1995, INT J CLIMATOL, V15, P1365, DOI 10.1002/joc.3370151205; Mullner P, 2010, EPIDEMIOL INFECT, V138, P1372, DOI 10.1017/S0950268809991579; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; Nylen G, 2002, EPIDEMIOL INFECT, V128, P383, DOI 10.1017/S0950268802006830; Panackal A, 2012, J EARTH SCI CLIMATIC, pe102; Parry M.L., 2007, CONTRIBUTION WORKING; Patz JA, 2002, P NATL ACAD SCI USA, V99, P12506, DOI 10.1073/pnas.212467899; Phungamngoen C, 2011, INT J FOOD MICROBIOL, V147, P127, DOI 10.1016/j.ijfoodmicro.2011.03.019; Pires SM, 2010, FOODBORNE PATHOG DIS, V7, P143, DOI 10.1089/fpd.2009.0369; Plummer N, 1999, CLIMATIC CHANGE, V42, P183, DOI 10.1023/A:1005472418209; Poveda G, 2001, ENVIRON HEALTH PERSP, V109, P489, DOI 10.2307/3454707; Ravel A, 2010, FOODBORNE PATHOG DIS, V7, P785, DOI 10.1089/fpd.2009.0460; Rind E, 2010, EPIDEMIOL INFECT, V138, P1359, DOI 10.1017/S095026881000018X; Salinger MJ, 1999, INT J CLIMATOL, V19, P1049, DOI [10.1002/(SICI)1097-0088(199908)19:10<1049::AID-JOC417>3.0.CO;2-Z, 10.1002/(SICI)1097-0088(199908)19:10&lt;1049::AID-JOC417&gt;3.0.CO;2-Z]; Scarsbrook MR, 2003, J AM WATER RESOUR AS, V39, P1435, DOI 10.1111/j.1752-1688.2003.tb04429.x; Sears A, 2011, EMERG INFECT DIS, V17, P1007, DOI [10.3201/eid/1706.101272, 10.3201/eid1706.101272]; Shaman J, 2013, P NATL ACAD SCI USA, V110, P3689, DOI 10.1073/pnas.1107485109; Singh RBK, 2001, ENVIRON HEALTH PERSP, V109, P155, DOI 10.2307/3434769; Snel SJ, 2009, EPIDEMIOL INFECT, V137, P1641, DOI 10.1017/S0950268809002465; Spencer SEF, 2011, EPIDEMIOLOGY INFECT, P1; Statistics New Zealand A, 2010, HIST POP EST; Stefanoglannis N, 2001, NEW ZEAL MED J, V114, P519; Sumner J, 2004, INT J FOOD MICROBIOL, V92, P199, DOI 10.1016/j.ijfoodmicro.2003.10.003; Tirado MC, 2010, FOOD RES INT, V43, P1745, DOI 10.1016/j.foodres.2010.07.003; Uhlmann S, 2009, J WATER HEALTH, V7, P692, DOI 10.2166/wh.2009.108; Ummenhofer CC, 2007, J CLIMATE, V20, P5418, DOI 10.1175/2007JCLI1430.1; Watkiss P, 2012, CLIMATIC CHANGE, V112, P101, DOI 10.1007/s10584-011-0342-z; Wilson Nick, 2011, Reviews on Environmental Health, V26, P93, DOI 10.1515/REVEH.2011.013; Zhang BS, 2007, CLIMATIC CHANGE, V84, P203, DOI 10.1007/s10584-007-9245-4; Zhang Y, 2008, INT J BIOMETEOROL, V52, P179, DOI 10.1007/s00484-007-0109-4; Zhang Y, 2012, ENVIRON INT, V44, P26, DOI 10.1016/j.envint.2012.01.007; Zhang Y, 2010, SCI TOTAL ENVIRON, V408, P524, DOI 10.1016/j.scitotenv.2009.10.068	90	45	46	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83484	10.1371/journal.pone.0083484	http://dx.doi.org/10.1371/journal.pone.0083484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376707	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000090
J	Nakayama, M; Shichinohe, S; Itoh, Y; Ishigaki, H; Kitano, M; Arikata, M; Pham, VL; Ishida, H; Kitagawa, N; Okamatsu, M; Sakoda, Y; Ichikawa, T; Tsuchiya, H; Nakamura, S; Le, QM; Ito, M; Kawaoka, Y; Kida, H; Ogasawara, K				Nakayama, Misako; Shichinohe, Shintaro; Itoh, Yasushi; Ishigaki, Hirohito; Kitano, Mitsutaka; Arikata, Masahiko; Van Loi Pham; Ishida, Hideaki; Kitagawa, Naoko; Okamatsu, Masatoshi; Sakoda, Yoshihiro; Ichikawa, Takaya; Tsuchiya, Hideaki; Nakamura, Shinichiro; Quynh Mai Le; Ito, Mutsumi; Kawaoka, Yoshihiro; Kida, Hiroshi; Ogasawara, Kazumasa			Protection against H5N1 Highly Pathogenic Avian and Pandemic (H1N1) 2009 Influenza Virus Infection in Cynomolgus Monkeys by an Inactivated H5N1 Whole Particle Vaccine	PLOS ONE			English	Article							CROSS-PROTECTION; IMMUNITY; CHALLENGE; ORIGIN; CELLS; SWINE; PIGS; EFFICACY; STRAINS	H5N1 highly pathogenic avian influenza virus (HPAIV) infection has been reported in poultry and humans with expanding clade designations. Therefore, a vaccine that induces immunity against a broad spectrum of H5N1 viruses is preferable for pandemic preparedness. We established a second H5N1 vaccine candidate, A/duck/Hokkaido/Vac-3/2007 (Vac-3), in our virus library and examined the efficacy of inactivated whole particles of this strain against two clades of H5N1 HPAIV strains that caused severe morbidity in cynomolgus macaques. Virus propagation in vaccinated macaques infected with either of the H5N1 HPAIV strains was prevented compared with that in unvaccinated macaques. This vaccine also prevented propagation of a pandemic (H1N1) 2009 virus in macaques. In the vaccinated macaques, neutralization activity, which was mainly shown by anti-hemagglutinin antibody, against H5N1 HPAIVs in plasma was detected, but that against H1N1 virus was not detected. However, neuraminidase inhibition activity in plasma and T-lymphocyte responses in lymph nodes against H1N1 virus were detected. Therefore, cross-clade and heterosubtypic protective immunity in macaques consisted of humoral and cellular immunity induced by vaccination with Vac-3.	[Nakayama, Misako; Itoh, Yasushi; Ishigaki, Hirohito; Kitano, Mitsutaka; Arikata, Masahiko; Van Loi Pham; Ishida, Hideaki; Kitagawa, Naoko; Ogasawara, Kazumasa] Shiga Univ Med Sci, Dept Pathol, Div Pathol & Dis Regulat, Otsu, Shiga 52021, Japan; [Arikata, Masahiko] Shiga Univ Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Otsu, Shiga 52021, Japan; [Tsuchiya, Hideaki; Nakamura, Shinichiro] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Otsu, Shiga 52021, Japan; [Shichinohe, Shintaro; Okamatsu, Masatoshi; Sakoda, Yoshihiro; Ichikawa, Takaya; Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Microbiol Lab, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Quynh Mai Le] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Ito, Mutsumi; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin Madison, Dept Pathobiol Sci, Madison, WI USA	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Hokkaido University; Hokkaido University; National Institute of Hygiene & Epidemiology (NIHE); University of Tokyo; University of Wisconsin System; University of Wisconsin Madison	Itoh, Y (corresponding author), Shiga Univ Med Sci, Dept Pathol, Div Pathol & Dis Regulat, Otsu, Shiga 52021, Japan.	yasushii@belle.shiga-med.ac.jp	Ishigaki, Hirohito/AAO-7458-2020; Shichinohe, Shintaro/C-7937-2017	Ishigaki, Hirohito/0000-0002-5249-8598; Shichinohe, Shintaro/0000-0002-8783-2103; Nakayama, Misako/0000-0001-8611-0662; Itoh, Yasushi/0000-0001-7462-2193	Regional Research and Development Resources Utilization Program, Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Initiative for Global Research Network on Infectious Diseases	Regional Research and Development Resources Utilization Program, Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Regional Research and Development Resources Utilization Program, Japan Science and Technology Agency, the Grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan, for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University and the Japan Initiative for Global Research Network on Infectious Diseases. The funders had no role in study design, data collecton and analysis, decision to publish, or preparation of the manuscript.	Arikata M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037220; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Bethell D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059674; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; Crowe BA, 2010, VACCINE, V29, P166, DOI 10.1016/j.vaccine.2010.10.065; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; FUJIMOTO K, 1990, J MED PRIMATOL, V19, P21; Gustin KM, 2011, J INFECT DIS, V204, P1491, DOI 10.1093/infdis/jir596; Harada Y, 2011, VACCINE, V29, P8330, DOI 10.1016/j.vaccine.2011.08.091; Hayashi K, 2003, AM J PATHOL, V162, P1721, DOI 10.1016/S0002-9440(10)64306-4; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Itoh Y, 2008, VACCINE, V26, P562, DOI 10.1016/j.vaccine.2007.11.031; Itoh Y, 2010, VACCINE, V28, P780, DOI 10.1016/j.vaccine.2009.10.067; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kida H, 2006, DEV BIOLOGICALS, V124, P69; KIDA H, 1987, VIROLOGY, V159, P109, DOI 10.1016/0042-6822(87)90353-9; KIDA H, 1983, ARCH VIROL, V76, P91, DOI 10.1007/BF01311693; KIDA H, 1988, VIROLOGY, V162, P160, DOI 10.1016/0042-6822(88)90405-9; Le QM, 2010, J GEN VIROL, V91, P2485, DOI 10.1099/vir.0.021659-0; Marcelin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026335; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Miyake T, 2010, J MED PRIMATOL, V39, P58, DOI 10.1111/j.1600-0684.2009.00395.x; Murakami S, 2008, VACCINE, V26, P6398, DOI 10.1016/j.vaccine.2008.08.053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; Okamatsu M, 2010, VIRUS GENES, V41, P351, DOI 10.1007/s11262-010-0530-3; Sakoda Y, 2012, J GEN VIROL, V93, P541, DOI 10.1099/vir.0.037572-0; Schwartz JA, 2011, J VIROL, V85, P4602, DOI 10.1128/JVI.02491-10; Shichinohe S, 2013, VET MICROBIOL, V164, P39, DOI 10.1016/j.vetmic.2013.01.041; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Soda K, 2008, JPN J VET RES, V55, P93; SUGITA S, 1991, J MOL EVOL, V32, P16, DOI 10.1007/BF02099924; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; Topham DJ, 1997, J IMMUNOL, V159, P5197; Pham VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075910; VIRELIZIER JL, 1975, J IMMUNOL, V115, P434; Wan HQ, 2013, J VIROL, V87, P9290, DOI 10.1128/JVI.01203-13; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Yang PH, 2010, VET MICROBIOL, V146, P17, DOI 10.1016/j.vetmic.2010.03.024; YASUDA J, 1991, J GEN VIROL, V72, P2007, DOI 10.1099/0022-1317-72-8-2007	43	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82740	10.1371/journal.pone.0082740	http://dx.doi.org/10.1371/journal.pone.0082740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376571	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000025
J	Sfara, V; Mougabure-Cueto, GA; Zerba, EN; Alzogaray, RA				Sfara, Valeria; Mougabure-Cueto, Gaston A.; Zerba, Eduardo N.; Alzogaray, Raul A.			Locomotor Behaviour of Blattella germanica Modified by DEET	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; AGGREGATION PHEROMONE; L DICTYOPTERA; INSECT; COCKROACH; REPELLENCY; TARGETS; DIPTERA; MUTANT; NYMPHS	N,N-diethyl-3-methylbenzamide (DEET) is the active principle of most insect repellents used worldwide. However, its toxicity on insects has not been widely studied. The aim of this work is to study the effects of DEET on the locomotor activity of Blattella germanica. DEET has a dose-dependent repellent activity on B. germanica. Locomotor activity was significantly lower when insects were pre-exposed to 700 mu g/cm(2) of DEET for 20 or 30 minutes, but it did not change when pre-exposure was shorter. Locomotor activity of insects that were pre-exposed to 2.000 mu g/cm(2) of DEET for 10 minutes was significantly lower than the movement registered in controls. No differences were observed when insects were pre-exposed to lower concentrations of DEET. A 30-minute pre-exposure to 700 mu g/cm(2) of DEET caused a significant decrease in locomotor activity. Movement was totally recovered 24 h later. The locomotor activity measured during the exposure to different concentrations of DEET remained unchanged. Insects with decreased locomotor activity were repelled to the same extent than control insects by the same concentration of DEET. We demonstrated that the repellency and modification of locomotor activity elicited by DEET are non-associated phenomena. We also suggested that the reduction in locomotor activity indicates toxicity of DEET, probably to insect nervous system.	[Sfara, Valeria; Mougabure-Cueto, Gaston A.; Zerba, Eduardo N.; Alzogaray, Raul A.] Ctr Invest Plagas & Insecticidas CIPEIN UNIDEF CI, Buenos Aires, DF, Argentina; [Sfara, Valeria; Zerba, Eduardo N.; Alzogaray, Raul A.] Univ Nacl San Martin, Inst Invest & Ingn Ambiental 3IA, Buenos Aires, DF, Argentina		Sfara, V (corresponding author), Ctr Invest Plagas & Insecticidas CIPEIN UNIDEF CI, Buenos Aires, DF, Argentina.	vale_sfara@hotmail.com			Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina [PIP 2010-0887]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The financial support for this research was provided by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina (PIP 2010-0887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzogaray RA, 1997, ARCH INSECT BIOCHEM, V35, P323, DOI 10.1002/(SICI)1520-6327(199705)35:3<323::AID-ARCH6>3.0.CO;2-U; Alzogaray RA, 2000, MED VET ENTOMOL, V14, P6, DOI 10.1046/j.1365-2915.2000.00213.x; [Anonymous], 1982, INSECTICIDE MODE ACT; BENOIT M, 1986, PESTIC BIOCHEM PHYS, V26, P284, DOI 10.1016/0048-3575(86)90070-2; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Brenner Richard J., 1995, P77; BROWNE LB, 1977, CHEM CONTROL INSECT, P117; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; DAVIS EE, 1972, J ECON ENTOMOL, V65, P1058, DOI 10.1093/jee/65.4.1058; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; DETHIER VG, 1960, J ECON ENTOMOL, V53, P134, DOI 10.1093/jee/53.1.134; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Frances S. P., 2007, INSECT REPELLENTS PR, P311; GAMMON DW, 1978, PESTIC SCI, V9, P79, DOI 10.1002/ps.2780090115; KENNEDY JS, 1978, PHYSIOL ENTOMOL, V3, P91, DOI 10.1111/j.1365-3032.1978.tb00138.x; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; Rivault C, 1998, J INSECT PHYSIOL, V44, P909, DOI 10.1016/S0022-1910(98)00062-6; ROBBINS PJ, 1986, J TOXICOL ENV HEALTH, V18, P503, DOI 10.1080/15287398609530891; Ruigt G.S.F., 1985, P183; SAKUMA M, 1991, APPL ENTOMOL ZOOL, V26, P223, DOI 10.1303/aez.26.223; SAKUMA M, 1990, APPL ENTOMOL ZOOL, V25, P355, DOI 10.1303/aez.25.355; Sanford JL, 2013, NATURWISSENSCHAFTEN, V100, P269, DOI 10.1007/s00114-013-1021-x; Sfara V, 2008, ARCH INSECT BIOCHEM, V67, P1, DOI 10.1002/arch.20210; Sfara V, 2011, J INSECT PHYSIOL, V57, P1431, DOI 10.1016/j.jinsphys.2011.07.009; Soderlund David M., 1995, P217; Stanczyk NM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054438, DOI 10.1371/J0URNAL.P0NE.0054438]; Sudakin DL, 2003, J TOXICOL-CLIN TOXIC, V41, P831, DOI 10.1081/CLT-120025348; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105	31	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83433	10.1371/journal.pone.0083433	http://dx.doi.org/10.1371/journal.pone.0083433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376701	Green Published, gold			2022-12-27	WOS:000328882000087
J	Sommet, N; Pulfrey, C; Butera, F				Sommet, Nicolas; Pulfrey, Caroline; Butera, Fabrizio			Did My MD Really Go to University to Learn? Detrimental Effects of Numerus Clausus on Self-Efficacy, Mastery Goals and Learning	PLOS ONE			English	Article							PERCEIVED BEHAVIORAL-CONTROL; HIGHER-EDUCATION; STEREOTYPE-THREAT; ACHIEVEMENT GOALS; MEDICAL-STUDENTS; PERFORMANCE; COMPETITION; MEDIATION; SELECTION; COLLEGE	Exams with numerus clausus are very common in Medicine, Business Administration and Law. They are intended to select a predefined number of academic candidates on the basis of their rank rather than their absolute performance. Various scholars and politicians believe that numerus clausus policies are a vector of academic excellence. We argue, however, that they could have ironic epistemic effects. In comparison with selective policies based on criterion-based evaluations, selection via numerus clausus creates negative interdependence of competence (i.e., the success of some students comes at the expense of the others). Thus, we expect it to impair students' sense of self-efficacy and-by extension-the level of mastery goals they adopt, as well as their actual learning. Two field studies respectively reported that presence (versus absence) and awareness (versus ignorance) of numerus clausus policies at University was associated with a decreased endorsement of mastery goals; this effect was mediated by a reduction in self-efficacy beliefs. Moreover, an experimental study revealed that numerus clausus negatively predicted learning; this effect was, again, mediated by a reduction in self-efficacy beliefs. Practical implications for the selection procedures in higher education are discussed.	[Sommet, Nicolas; Pulfrey, Caroline; Butera, Fabrizio] Univ Lausanne, Social Sci Inst, Lausanne, Switzerland	University of Lausanne	Butera, F (corresponding author), Univ Lausanne, Social Sci Inst, Lausanne, Switzerland.	Fabrizio.Butera@unil.ch	Sommet, Nicolas/K-7412-2016	Sommet, Nicolas/0000-0001-8585-1274; Butera, Fabrizio/0000-0002-8856-4374	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding provided by Swiss National Science Foundation http://www.snf.ch/E/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; ANESTAPS, 2012, CAPEPS EXT 2012 32 R; Artoisenet C, 2006, LOUVAIN MED, V125, P4; Attal-Toubert K, 2009, DREES ETUDES RESULTA, V679, P1; BANDURA A, 1993, EDUC PSYCHOL, V28, P117, DOI 10.1207/s15326985ep2802_3; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bennett M, 2000, AUST J PSYCHOL, V52, P23, DOI 10.1080/00049530008255363; Bourgueil Y, 2006, HLTH POLICY DEV, V7/8, P1; Burgoon JM., 2008, THESIS U N CAROLINA; BUTERA F, 1995, EUR J SOC PSYCHOL, V25, P457, DOI 10.1002/ejsp.2420250408; Cassidy S., 2002, Journal of Educational Computing Research, V26, P133, DOI 10.2190/JGJR-0KVL-HRF7-GCNV; Chirkov V, 2007, INT J INTERCULT REL, V31, P199, DOI 10.1016/j.ijintrel.2006.03.002; Cribari-Neto F, 2004, COMPUT STAT DATA AN, V45, P215, DOI 10.1016/S0167-9473(02)00366-3; Darnon C., 2005, LANNEE PSYCHOLOGIQUE, V105, P105, DOI DOI 10.3406/PSY.2005.3821; Darnon C, 2009, J PERS SOC PSYCHOL, V96, P119, DOI 10.1037/a0012824; De Paola M, 2011, EMPIR ECON, V41, P227, DOI 10.1007/s00181-010-0372-9; Deutsch M, 1949, HUM RELAT, V2, P199, DOI 10.1177/001872674900200301; Dimmitt C, 2003, PROFESSIONAL SCH COU, V6, P340; Diseth A, 2012, EDUC PSYCHOL-UK, V32, P335, DOI 10.1080/01443410.2012.657159; Diseth A, 2011, LEARN INDIVID DIFFER, V21, P191, DOI 10.1016/j.lindif.2011.01.003; Doan Bui Dang Ha, 2004, Cah Sociol Demogr Med, V44, P101; Dompnier B, 2009, PSYCHOL SCI, V20, P939, DOI 10.1111/j.1467-9280.2009.02384.x; DWECK CS, 1986, AM PSYCHOL, V41, P1040, DOI 10.1037/0003-066X.41.10.1040; Elliot AJ, 2001, J PERS SOC PSYCHOL, V80, P501, DOI 10.1037//0022-3514.80.3.501; Ford HH, 2009, PSYCHOL CLASSROOM LE, P645; Haase CM, 2007, THESIS U JENA GERMAN; Hansgen K-D, 1997, EXAMEN APTITUDE ETUD, P3; Harackiewicz JM, 2002, J EDUC PSYCHOL, V94, P562, DOI 10.1037//0022-0663.94.3.562; Hardy-Dubernet AC, 2006, DISCRIMINATIONS MOND, P25; Hardy-Dubernet AC, 2008, EUR J EDUC, V43, P331, DOI [10.1111/j.1465-3435.2008.00361.x, DOI 10.1111/J.1465-3435.2008.00361.X]; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hayes AF, 2007, BEHAV RES METHODS, V39, P709, DOI 10.3758/BF03192961; Hsieh PH, 2007, J ADV ACAD, V18, P454, DOI 10.4219/jaa-2007-500; Huang L, 2005, THESIS STOCKHOLM U S; Hulsman RL, 2007, MED EDUC, V41, P369, DOI 10.1111/j.1365-2929.2007.02708.x; Iacobucci D, 2007, J CONSUM PSYCHOL, V17, P139, DOI 10.1016/S1057-7408(07)70020-7; Janssen PJ, 1997, EXAMEN APTITUDE ETUD, P57; Johnson, 1989, COOPERATION COMPETIT; Johnson DW, 2005, GENET SOC GEN PSYCH, V131, P285, DOI 10.3200/MONO.131.4.285-358; Johnson DW, 2007, EDUC PSYCHOL REV, V19, P15, DOI 10.1007/s10648-006-9038-8; Johnson DW, 2009, EDUC RESEARCHER, V38, P37, DOI 10.3102/0013189X08330540; Johnson Valen E, 2003, GRADE INFLATION CRIS; JUNGE ME, 1995, GIFTED CHILD QUART, V39, P22, DOI 10.1177/001698629503900104; KAUFMAN NH, 1994, J LEGAL EDUC, V44, P415; Louryan S, 2009, Rev Med Brux, V30, P205; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Mann P., 2003, APPEARANCE REALITY S; Manstead ASR, 1998, J APPL SOC PSYCHOL, V28, P1375, DOI 10.1111/j.1559-1816.1998.tb01682.x; Martin L, 2012, GUY VALLANCIEN VRAI, P23; MCDONOUGH PM, 1994, J HIGH EDUC, V65, P427, DOI 10.2307/2943854; MICHAELS JW, 1977, REV EDUC RES, V47, P87, DOI 10.3102/00346543047001087; Michalopoulos D, 2006, CAUC REV INT AFF, V1, P65; Middleton MJ, 1997, J EDUC PSYCHOL, V89, P710, DOI 10.1037/0022-0663.89.4.710; Midgley C., 2000, MANUAL PATTERNS ADAP; Pajares F, 2000, CONTEMP EDUC PSYCHOL, V25, P406, DOI 10.1006/ceps.1999.1027; PAJARES F, 1994, J EDUC PSYCHOL, V86, P193, DOI 10.1037/0022-0663.86.2.193; Pajares F, 2002, THEOR PRACT, V41, P116, DOI 10.1207/s15430421tip4102_8; Pechar H, 1998, EUR J EDUC, V33, P41; Pechar H, 2009, J ADULT CONTINUING E, V15, P142; Pechar H, 2007, CAN J HIGH EDUC, V37, P109; Pecresse, 2008, COMMUNICATION; Picard P, 2011, BEGINNING TEACHERS C, P119; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; PREMFORS R, 1982, POLICY SCI, V14, P365, DOI 10.1007/BF00137397; PREMFORS R, 1980, COMP EDUC REV, V24, P302, DOI 10.1086/446150; Pulfrey C, 2011, J EDUC PSYCHOL, V103, P683, DOI 10.1037/a0023911; Regner I, 2010, PSYCHOL SCI, V21, P1646, DOI 10.1177/0956797610386619; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; RICHTER I, 1988, COMP EDUC, V24, P53, DOI 10.1080/0305006880240105; Schunk D. H., 2012, MOTIVATION SELF REGU; SCHUNK DH, 1991, EDUC PSYCHOL, V26, P207, DOI 10.1207/s15326985ep2603&4_2; SHUELL TJ, 1986, REV EDUC RES, V56, P411, DOI 10.3102/00346543056004411; Sins PHM, 2008, CONTEMP EDUC PSYCHOL, V33, P58, DOI 10.1016/j.cedpsych.2006.12.004; Smith JL, 2004, EDUC PSYCHOL REV, V16, P177, DOI 10.1023/B:EDPR.0000034020.20317.89; SPENCE J, 1981, COMP EDUC, V17, P285, DOI 10.1080/0305006810170305; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Stanne MB, 1999, PSYCHOL BULL, V125, P133, DOI 10.1037/0033-2909.125.1.133; TERRY DJ, 1995, BRIT J SOC PSYCHOL, V34, P199, DOI 10.1111/j.2044-8309.1995.tb01058.x; Tukey JW, 1977, EXPLORATORY DATA ANA; Tyson W, 2007, J EDUC STUDENTS PLAC, V12, P243, DOI 10.1080/10824660701601266; Urlings-Strop LC, 2011, MED EDUC, V45, P1032, DOI 10.1111/j.1365-2923.2011.04031.x; Urlings-Strop LC, 2009, MED EDUC, V43, P175, DOI 10.1111/j.1365-2923.2008.03267.x; Wallach D, 2011, NUMERUS CLAUSUS POUR; Whiston SC, 1998, J COUNS DEV, V76, P412, DOI 10.1002/j.1556-6676.1998.tb02700.x; Wigfield A, 2000, CONTEMP EDUC PSYCHOL, V25, P68, DOI 10.1006/ceps.1999.1015; Wilson R. J., 1985, INTRO GRAPH THEORY; Yzerbyt VY, 2004, J EXP SOC PSYCHOL, V40, P424, DOI 10.1016/j.jesp.2003.10.001; Zimmerman BJ, 2000, CONTEMP EDUC PSYCHOL, V25, P82, DOI 10.1006/ceps.1999.1016	89	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84178	10.1371/journal.pone.0084178	http://dx.doi.org/10.1371/journal.pone.0084178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	278IG	24376794	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000142
J	Theunissen, LM; Durr, V				Theunissen, Leslie M.; Duerr, Volker			Insects Use Two Distinct Classes of Steps during Unrestrained Locomotion	PLOS ONE			English	Article							INTER-LEG COORDINATION; STICK INSECT; WALKING INSECT; CORRECTIVE RESPONSES; CARAUSIUS-MOROSUS; GROUND SUPPORT; COCKROACH; MECHANISMS; MOVEMENT; PATTERNS	Background: Adaptive, context-dependent control of locomotion requires modulation of centrally generated rhythmic motor patterns through peripheral control loops and postural reflexes. Thus assuming that the modulation of rhythmic motor patterns accounts for much of the behavioural variability observed in legged locomotion, investigating behavioural variability is a key to the understanding of context-dependent control mechanisms in locomotion. To date, the variability of unrestrained locomotion is poorly understood, and virtually nothing is known about the features that characterise the natural statistics of legged locomotion. In this study, we quantify the natural variability of hexapedal walking and climbing in insects, drawing from a database of several thousand steps recorded over two hours of walking time. Results: We show that the range of step length used by unrestrained climbing stick insects is large, showing that step length can be changed substantially for adaptive locomotion. Step length distributions were always bimodal, irrespective of leg type and walking condition, suggesting the presence of two distinct classes of steps: short and long steps. Probability density of step length was well-described by a gamma distribution for short steps, and a logistic distribution for long steps. Major coefficients of these distributions remained largely unaffected by walking conditions. Short and long steps differed concerning their spatial occurrence on the walking substrate, their timing within the step sequence, and their prevalent swing direction. Finally, ablation of structures that serve to improve foothold increased the ratio of short to long steps, indicating a corrective function of short steps. Conclusions: Statistical and functional differences suggest that short and long steps are physiologically distinct classes of leg movements that likely reflect distinct control mechanisms at work.	[Theunissen, Leslie M.; Duerr, Volker] Univ Bielefeld, Dept Biol Cybernet, D-33615 Bielefeld, Germany; [Theunissen, Leslie M.; Duerr, Volker] Univ Bielefeld, Cognit Interact Technol Ctr Excellence, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Durr, V (corresponding author), Univ Bielefeld, Dept Biol Cybernet, D-33615 Bielefeld, Germany.	volker.duerr@uni-bielefeld.de	Dürr, Volker/Y-5036-2019	Dürr, Volker/0000-0001-9239-4964	EU project EMICAB (FP7-ICT) [270182]; German Excellence Initiative	EU project EMICAB (FP7-ICT); German Excellence Initiative	This work was supported by the EU project EMICAB (FP7-ICT, No. 270182) to VD, and by the Cluster of Excellence 277 CITEC funded in the framework of the German Excellence Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Blaesing B, 2004, J EXP BIOL, V207, P1273, DOI 10.1242/jeb.00888; Blasing B, 2004, J COMP PHYSIOL A, V190, P173, DOI 10.1007/s00359-003-0482-3; Buschges A, 2008, BRAIN RES REV, V57, P162, DOI 10.1016/j.brainresrev.2007.06.028; Buschges A, 2012, CURR OPIN NEUROBIOL, V22, P602, DOI 10.1016/j.conb.2012.02.003; Bullock JMR, 2008, J EXP BIOL, V211, P3333, DOI 10.1242/jeb.020941; Buschges A, 2005, J NEUROPHYSIOL, V93, P1127, DOI 10.1152/jn.00615.2004; Busshardt P, 2011, J EXP BIOL, V214, P1676, DOI 10.1242/jeb.051953; CRUSE H, 1982, J EXP BIOL, V101, P161; CRUSE H, 1976, J COMP PHYSIOL, V112, P235, DOI 10.1007/BF00606541; CRUSE H, 1988, J EXP BIOL, V138, P455; CRUSE H, 1979, PHYSIOL ENTOMOL, V4, P121, DOI 10.1111/j.1365-3032.1979.tb00186.x; CRUSE H, 1984, J COMP PHYSIOL, V154, P695, DOI 10.1007/BF01350223; Cruse H, 1998, NEURAL NETWORKS, V11, P1435, DOI 10.1016/S0893-6080(98)00067-7; DEAN J, 1992, PHYSIOL ENTOMOL, V17, P331, DOI 10.1111/j.1365-3032.1992.tb01031.x; DEAN J, 1983, J EXP BIOL, V103, P75; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Durr V, 2005, J EXP BIOL, V208, P2237, DOI 10.1242/jeb.01637; Durr V, 2005, J EXP BIOL, V208, P2253, DOI 10.1242/jeb.01638; Durr V, 2004, ARTHROPOD STRUCT DEV, V33, P237, DOI 10.1016/j.asd.2004.05.004; Ebeling W, 2006, J EXP BIOL, V209, P2199, DOI 10.1242/jeb.02251; Frazier SF, 1999, J COMP PHYSIOL A, V185, P157, DOI 10.1007/s003590050374; Fuchs E, 2012, J EXP BIOL, V215, P1884, DOI 10.1242/jeb.067488; GORASSINI MA, 1994, J NEUROPHYSIOL, V71, P603, DOI 10.1152/jn.1994.71.2.603; Grabowska M, 2012, J EXP BIOL, V215, P4255, DOI 10.1242/jeb.073643; Harley CM, 2009, J EXP BIOL, V212, P1463, DOI 10.1242/jeb.028381; HIEBERT GW, 1994, J NEUROPHYSIOL, V71, P611, DOI 10.1152/jn.1994.71.2.611; Holtje M, 2003, J EXP BIOL, V206, P2715, DOI 10.1242/jeb.00492; Larsen GS, 1997, J COMP PHYSIOL A, V180, P683, DOI 10.1007/s003590050083; Mu LY, 2005, J COMP PHYSIOL A, V191, P1037, DOI 10.1007/s00359-005-0029-x; MUCKE A, 1991, ZOOMORPHOLOGY, V110, P175, DOI 10.1007/BF01633002; Niven JE, 2010, CURR BIOL, V20, P86, DOI 10.1016/j.cub.2009.10.079; Patla AE, 1997, GAIT POSTURE, V5, P54, DOI 10.1016/S0966-6362(96)01109-5; PEARSON KG, 1984, INT J ROBOT RES, V3, P101, DOI 10.1177/027836498400300209; Pick S, 2005, CURR BIOL, V15, P1473, DOI 10.1016/j.cub.2005.07.022; Rietdyk S, 1998, EXP BRAIN RES, V119, P251, DOI 10.1007/s002210050339; Rietdyk S, 2010, J MOTOR BEHAV, V42, P37, DOI 10.1080/00222890903303309; Ritzmann RE, 2007, CURR OPIN NEUROBIOL, V17, P629, DOI 10.1016/j.conb.2008.01.001; Rosano H, 2007, BIOL CYBERN, V97, P229, DOI 10.1007/s00422-007-0170-4; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Roth LM, 1952, J EXPT ZOOLOGY, P486; SCHMITZ J, 1989, J EXP BIOL, V143, P373; Schutz C, 2011, PHILOS T R SOC B, V366, P2996, DOI 10.1098/rstb.2011.0126; Sinety R. De, 1901, Cellule, Vxix, P118; Watson JT, 2002, J COMP PHYSIOL A, V188, P39, DOI 10.1007/s00359-002-0277-y; WENDLER G, 1964, Z VERGL PHYSIOL, V48, P198, DOI 10.1007/BF00297860; WILSON DM, 1966, ANNU REV ENTOMOL, V11, P103, DOI 10.1146/annurev.en.11.010166.000535; Wosnitza A, 2013, J EXP BIOL, V216, P480, DOI 10.1242/jeb.078139; Zehr EP, 1999, PROG NEUROBIOL, V58, P185, DOI 10.1016/S0301-0082(98)00081-1; Zill S, 2004, ARTHROPOD STRUCT DEV, V33, P273, DOI 10.1016/j.asd.2004.05.005; Zill SN, 2011, J COMP PHYSIOL A, V197, P851, DOI 10.1007/s00359-011-0647-4; Zill SN, 2010, J COMP PHYSIOL A, V196, P407, DOI 10.1007/s00359-010-0526-4	52	27	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85321	10.1371/journal.pone.0085321	http://dx.doi.org/10.1371/journal.pone.0085321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376877	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000182
J	Liu, H; Sun, Y; Ramos, KRM; Nisola, GM; Valdehuesa, KNG; Lee, WK; Park, SJ; Chung, WJ				Liu, Huaiwei; Sun, Yuanzhang; Ramos, Kristine Rose M.; Nisola, Grace M.; Valdehuesa, Kris Nino G.; Lee, Won-Keun; Park, Si Jae; Chung, Wook-Jin			Combination of Entner-Doudoroff Pathway with MEP Increases Isoprene Production in Engineered Escherichia coli	PLOS ONE			English	Article							GLUCONATE METABOLISM; MEVALONATE PATHWAY; PRECURSOR; ACID; YEAST; YIELD	Embden-Meyerhof pathway (EMP) in tandem with 2-C-methyl-D-erythritol 4-phosphate pathway (MEP) is commonly used for isoprenoid biosynthesis in E. coli. However, this combination has limitations as EMP generates an imbalanced distribution of pyruvate and glyceraldehyde-3-phosphate (G3P). Herein, four glycolytic pathways-EMP, Entner-Doudoroff Pathway (EDP), Pentose Phosphate Pathway (PPP) and Dahms pathway were tested as MEP feeding modules for isoprene production. Results revealed the highest isoprene production from EDP containing modules, wherein pyruvate and G3P were generated simultaneously; isoprene titer and yield were more than three and six times higher than those of the EMP module, respectively. Additionally, the PPP module that generates G3P prior to pyruvate was significantly more effective than the Dahms pathway, in which pyruvate production precedes G3P. In terms of precursor generation and energy/reducing-equivalent supply, EDP+PPP was found to be the ideal feeding module for MEP. These findings may launch a new direction for the optimization of MEP-dependent isoprenoid biosynthesis pathways.	[Liu, Huaiwei; Sun, Yuanzhang; Ramos, Kristine Rose M.; Nisola, Grace M.; Valdehuesa, Kris Nino G.; Park, Si Jae; Chung, Wook-Jin] Myongji Univ, Dept Energy & Biotechnol, Energy & Environm Fus Technol Ctr, Yongin, Gyeonggi Do, South Korea; [Lee, Won-Keun] Myongji Univ, Div Biosci & Bioinformat, Yongin, Gyeonggi Do, South Korea	Myongji University; Myongji University	Chung, WJ (corresponding author), Myongji Univ, Dept Energy & Biotechnol, Energy & Environm Fus Technol Ctr, Yongin, Gyeonggi Do, South Korea.	wjc0828@gmail.com	NISOLA, GRACE MASBATE/AAW-1888-2021; Valdehuesa, Kris Niño G./I-3718-2018; NISOLA, GRACE MASBATE/AFV-6332-2022	NISOLA, GRACE MASBATE/0000-0002-1125-9785; Valdehuesa, Kris Niño G./0000-0002-4472-548X; NISOLA, GRACE MASBATE/0000-0002-1125-9785; Ramos, Kristine Rose/0000-0002-5978-2604	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education [2009-0093816]	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant number: 2009-0093816). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Charusanti P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001186; Choi HS, 2010, APPL ENVIRON MICROB, V76, P3097, DOI 10.1128/AEM.00115-10; Danner H, 2011, PHYTOCHEMISTRY, V72, P897, DOI 10.1016/j.phytochem.2011.03.014; EISENBERG RC, 1967, J BACTERIOL, V93, P941, DOI 10.1128/JB.93.3.941-949.1967; Farmer WR, 2001, BIOTECHNOL PROGR, V17, P57, DOI 10.1021/bp000137t; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Fong SS, 2006, J BIOL CHEM, V281, P8024, DOI 10.1074/jbc.M510016200; FRAENKEL DG, 1967, J BACTERIOL, V93, P1571, DOI 10.1128/JB.93.5.1571-1578.1967; Frost JW, 2008, Patent No. [2008091288 A2, 2008091288, WO 2008/091288 A2]; Jiang X, 2009, NANOBIO PROTOCOL GEN; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Liu HW, 2013, APPL MICROBIOL BIOT, V97, P3409, DOI 10.1007/s00253-012-4618-7; Liu H, 2012, BIORESOURCE TECHNOL, V115, P244, DOI 10.1016/j.biortech.2011.08.065; Lv XM, 2013, APPL MICROBIOL BIOT, V97, P2357, DOI 10.1007/s00253-012-4485-2; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Misawa N, 2011, CURR OPIN BIOTECH, V22, P627, DOI 10.1016/j.copbio.2011.01.002; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109; Xue JF, 2011, APPL ENVIRON MICROB, V77, P2399, DOI 10.1128/AEM.02341-10; Yadav VG, 2012, METAB ENG, V14, P233, DOI 10.1016/j.ymben.2012.02.001; Yang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033509; Zhao J, 2004, APPL MICROBIOL BIOT, V64, P91, DOI 10.1007/s00253-003-1458-5; Zhou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047513; Zurbriggen A, 2012, BIOENERG RES, V5, P814, DOI 10.1007/s12155-012-9192-4	29	55	58	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83290	10.1371/journal.pone.0083290	http://dx.doi.org/10.1371/journal.pone.0083290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376679	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100106
J	Marcq, I; Nyga, R; Cartier, F; Amrathlal, RS; Ossart, C; Ouled-Haddou, H; Ghamlouch, H; Galmiche, A; Chatelain, D; Lamotte, L; Debuysscher, V; Fuentes, V; Eric, NK; Regimbeau, JM; Marolleau, JP; Latour, S; Bouhlal, H				Marcq, Ingrid; Nyga, Remy; Cartier, Flora; Amrathlal, Rabbind Singh; Ossart, Christele; Ouled-Haddou, Hakim; Ghamlouch, Hussein; Galmiche, Antoine; Chatelain, Denis; Lamotte, Luciane; Debuysscher, Veronique; Fuentes, Vincent; Eric Nguyen-Khac; Regimbeau, Jean-Marc; Marolleau, Jean-Pierre; Latour, Sylvain; Bouhlal, Hicham			Identification of SLAMF3 (CD229) as an Inhibitor of Hepatocellular Carcinoma Cell Proliferation and Tumour Progression	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SIGNAL-TRANSDUCTION; BCL-2 FAMILY; TUBEROUS SCLEROSIS; EXPRESSION; SAP; PROTEINS; RECEPTOR; LIVER; ACTIVATION	Although hepatocellular carcinoma (HCC) is one of the most common malignancies and constitutes the third leading cause of cancer-related deaths, the underlying molecular mechanisms are not fully understood. In the present study, we demonstrate for the first time that hepatocytes express signalling lymphocytic activation molecule family member 3 (SLAMF3/CD229) but not other SLAMF members. We provide evidence to show that SLAMF3 is involved in the control of hepatocyte proliferation and in hepatocellular carcinogenesis. SLAMF3 expression is significantly lower in primary human HCC samples and HCC cell lines than in human healthy primary hepatocytes. In HCC cell lines, the restoration of high levels of SLAMF3 expression inhibited cell proliferation and migration and enhanced apoptosis. Furthermore, SLAMF3 expression was associated with inhibition of HCC xenograft progression in the nude mouse model. The restoration of SLAMF3 expression levels also decreased the phosphorylation of MAPK ERK1/2, JNK and mTOR. In samples from resected HCC patients, SLAMF3 expression levels were significantly lower in tumorous tissues than in peritumoral tissues. Our results identify SLAMF3 as a specific marker of normal hepatocytes and provide evidence for its potential role in the control of proliferation of HCC cells.	[Marcq, Ingrid; Nyga, Remy; Cartier, Flora; Amrathlal, Rabbind Singh; Ouled-Haddou, Hakim; Ghamlouch, Hussein; Lamotte, Luciane; Debuysscher, Veronique; Fuentes, Vincent; Marolleau, Jean-Pierre; Bouhlal, Hicham] Univ Picardie Jules Verne, INSERM, UMR925, Amiens, France; [Marcq, Ingrid; Nyga, Remy; Cartier, Flora; Amrathlal, Rabbind Singh; Ouled-Haddou, Hakim; Ghamlouch, Hussein; Lamotte, Luciane; Debuysscher, Veronique; Fuentes, Vincent; Marolleau, Jean-Pierre; Bouhlal, Hicham] Univ Picardie Jules Verne, EA UFR Med 4666, CAP Sante FED 4231, Amiens, France; [Cartier, Flora] Univ Bordeaux Segalen, INSERM, Lab Physiol Canc Foie, U1053, Bordeaux, France; [Ossart, Christele; Marolleau, Jean-Pierre; Bouhlal, Hicham] Ctr Hosp Univ Sud, Serv Hematol Clin & Therapie Cellulaire, Amiens, France; [Galmiche, Antoine] Ctr Hosp Univ Sud, Serv Biochim, Amiens, France; [Chatelain, Denis] Ctr Hosp Univ Sud, Serv Anat Pathol, Amiens, France; [Fuentes, Vincent] Ctr Hosp Univ Sud, Serv Immunol, Amiens, France; [Eric Nguyen-Khac] Ctr Hosp Univ Sud, Serv Hepatogastroenterol, Amiens, France; [Regimbeau, Jean-Marc] Ctr Hosp Univ Sud, Serv Chirurg Digest, Amiens, France; [Latour, Sylvain] Hop Necker Enfants Malad, IRNEM, U768, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Bouhlal, H (corresponding author), Univ Picardie Jules Verne, INSERM, UMR925, Amiens, France.	hicham.bouhlal@u-picardie.fr	; Latour, Sylvain/H-3652-2017	Ghamlouch, Hussein/0000-0002-2932-1081; Latour, Sylvain/0000-0001-8238-4391	Picardy Regional Council (CRP); CRP	Picardy Regional Council (CRP)(Region Hauts-de-France); CRP	This work was funded by the Picardy Regional Council (CRP) (grant reference: Imm-VHC). RN received a fellowship from the CRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexia C, 2004, BIOCHEM PHARMACOL, V68, P1003, DOI 10.1016/j.bcp.2004.05.029; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Bao JJ, 1996, HUM GENE THER, V7, P355, DOI 10.1089/hum.1996.7.3-355; Beerheide W, 2000, BIOCHEM BIOPH RES CO, V273, P54, DOI 10.1006/bbrc.2000.2891; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen Wong L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P575, DOI 10.2174/156801105774574649; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Del Valle JM, 2003, J BIOL CHEM, V278, P17430, DOI 10.1074/jbc.M301569200; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Duan XX, 2005, WORLD J GASTROENTERO, V11, P4740, DOI 10.3748/wjg.v11.i30.4740; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608; Feng DY, 2001, WORLD J GASTROENTERO, V7, P33; Frenzel A, 2009, APOPTOSIS, V14, P584, DOI 10.1007/s10495-008-0300-z; Galmiche A, 2010, MOL CANCER RES, V8, P1116, DOI 10.1158/1541-7786.MCR-10-0029; Gonzalez-Carmona MA, 2008, HEPATOLOGY, V48, P157, DOI 10.1002/hep.22296; Graham DB, 2006, J IMMUNOL, V176, P291, DOI 10.4049/jimmunol.176.1.291; He X, 2008, CANCER RES, V68, P5591, DOI 10.1158/0008-5472.CAN-08-0025; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Hwang YH, 2004, HEPATOL RES, V29, P113, DOI 10.1016/j.hepres.2004.02.009; Ito T, 2000, HEPATOLOGY, V31, P1080, DOI 10.1053/he.2000.6496; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; Iyoda K, 2003, CANCER-AM CANCER SOC, V97, P3017, DOI 10.1002/cncr.11425; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Lang H, 2008, J HEPATOL, V8, P3; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Lee SH, 2001, HUM PATHOL, V32, P250, DOI 10.1053/hupa.2001.22769; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Martin M, 2001, J IMMUNOL, V167, P3668, DOI 10.4049/jimmunol.167.7.3668; Martin M, 2005, J IMMUNOL, V174, P5977, DOI 10.4049/jimmunol.174.10.5977; Mott JL, 2007, HEPATOLOGY, V46, P906, DOI 10.1002/hep.21812; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Roberts LR, 2005, SEMIN LIVER DIS, V25, P212, DOI 10.1055/s-2005-871200; Sahin F, 2004, CLIN CANCER RES, V10, P8421, DOI 10.1158/1078-0432.CCR-04-0941; Sakai H, 2009, CANCER SCI, V10, P1975; Sandrin MS, 1996, IMMUNOGENETICS, V43, P13; Schuierer MM, 2006, ONCOL REP, V16, P451; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Simonin Y, 2009, HEPATOLOGY, V50, P1370, DOI 10.1002/hep.23169; Sintes J, 2013, J IMMUNOL, V190, P21, DOI 10.4049/jimmunol.1202435; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Veillette A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002469; Veillette A, 2009, IMMUNOL REV, V232, P229, DOI 10.1111/j.1600-065X.2009.00824.x; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yamanaka T, 2000, HEPATOLOGY, V32, P482, DOI 10.1053/jhep.2000.16266; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Yoshida T, 2006, ONCOGENE, V25, P6056, DOI 10.1038/sj.onc.1209635	59	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82918	10.1371/journal.pone.0082918	http://dx.doi.org/10.1371/journal.pone.0082918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376606	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100072
J	Xiao, ZJ; Rodriguez, PQ; He, LQ; Betsholtz, C; Tryggvason, K; Patrakka, J				Xiao, Zhijie; Rodriguez, Patricia Q.; He, Liqun; Betsholtz, Christer; Tryggvason, Karl; Patrakka, Jaakko			Wtip- and Gadd45a-Interacting Protein Dendrin Is Not Crucial for the Development or Maintenance of the Glomerular Filtration Barrier	PLOS ONE			English	Article							EXPRESSION; NEPHRIN; MOUSE	Glomerular podocyte cells are critical for the function of the renal ultrafiltration barrier. Especially, the highly specialized cell cell junction of podocytes, the slit diaphragm, has a central role in the filtration barrier. This is highlighted by the fact that mutations in molecular components of the slit diaphragm, inclucling nephrin and Cd2-associated protein (Cd2ap), result in proteinuric diseases in man. Dendrin is a poorly characterized cytosalic component of the slit diaphragm in where it interact h nephrin and Cd2ap. Dendrin is highly specific for the podocyte slit diaphragm, suggesting that it has a dedicated role in glomerular filtration barrier. In this study, we have generated a dendrin knockout mouse line and explored the molecular interactions of dendrin. Dendrin-deficient mice were viable, fertile, and had a normal life span. Morphologically, the glomerulogenesis proceeded normally and adult dendrin-deficient mice showed normal glomerular histology. No significant protainuria was observed. Fallowing glomerular injury, lack of dendrin did not affect the severity of the damage or h recovery process. Yeast two-hybrid screen and co-immunoprecipitation experiments showed that dendrin binds to interacting protein (Wtip) and growth arrest and DNA-damage-inducible 45 alpha (Gadd45a). Wtip and Gadd45a mediate gene transcription in the nucleus, suggesting that dendrin may have similar functions in podacytes In line with this, we observed he relocation of dendrin to nucleus in adriamycin nephropathy model. Our results indicate that dendrin is dispensable forth unction of the normal glomerular filtration barrier and that dendrin interacts with Wtip and Gadd45a.	[Xiao, Zhijie; Rodriguez, Patricia Q.; Tryggvason, Karl; Patrakka, Jaakko] Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden; [He, Liqun; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden; [He, Liqun; Betsholtz, Christer] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Tryggvason, Karl] Duke NUS, Cardiovasc & Metab Disorders Program, Singapore, Singapore	Karolinska Institutet; Karolinska Institutet; Uppsala University; National University of Singapore	Patrakka, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden.	jaakko.patrakka@ki.se	Patrakka, Jaakko/AAG-8796-2019	He, Liqun/0000-0003-2127-7597	Knut and Alice Wallenberg Foundation; Swedish Research Council; Swedish Child Diabetes Foundation; Diabetesfonden (the Diabetes Foundation)	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Child Diabetes Foundation; Diabetesfonden (the Diabetes Foundation)	The study was supported by the Knut and Alice Wallenberg Foundation (CB and KT), the Swedish Research Council (CB, KT, and JP), the Swedish Child Diabetes Foundation (JP), and Diabetesfonden (the Diabetes Foundation) (JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Duner F, 2008, NEPHROL DIAL TRANSPL, V23, P2504, DOI 10.1093/ndt/gfn100; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Jefferson JA, 2011, AM J KIDNEY DIS, V58, P666, DOI 10.1053/j.ajkd.2011.05.032; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kawachi H, 2009, CLIN EXP NEPHROL, V13, P275, DOI 10.1007/s10157-009-0162-x; Kim JH, 2010, J BIOL CHEM, V285, P9995, DOI 10.1074/jbc.M109.061671; Kodama F, 2013, NEPHROL DIAL TRANSPL, V28, P1762, DOI 10.1093/ndt/gfs500; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; NeunerJehle M, 1996, J NEUROSCI RES, V46, P138, DOI 10.1002/(SICI)1097-4547(19961015)46:2<138::AID-JNR2>3.0.CO;2-I; Patrakka J, 2007, J AM SOC NEPHROL, V18, P689, DOI 10.1681/ASN.2006060675; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Sistani L, 2011, KIDNEY INT, V80, P1045, DOI 10.1038/ki.2011.231; Sun Y, 2009, AM J NEPHROL, V29, P558, DOI 10.1159/000191469; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Xiao ZJ, 2011, NEPHRON EXP NEPHROL, V118, pE39, DOI 10.1159/000320382; Xu KF, 2011, IMMUNOBIOLOGY, V216, P871, DOI 10.1016/j.imbio.2011.02.005; Yaddanapudi S, 2011, J CLIN INVEST, V121, P3965, DOI 10.1172/JCI58552	22	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83133	10.1371/journal.pone.0083133	http://dx.doi.org/10.1371/journal.pone.0083133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376653	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100095
J	Mattern, T; Ellenberg, U; Houston, DM; Lamare, M; Davis, LS; van Heezik, Y; Seddon, PJ				Mattern, Thomas; Ellenberg, Ursula; Houston, David M.; Lamare, Miles; Davis, Lloyd S.; van Heezik, Yolanda; Seddon, Philip J.			Straight Line Foraging in Yellow-Eyed Penguins: New Insights into Cascading Fisheries Effects and Orientation Capabilities of Marine Predators	PLOS ONE			English	Article							FOVEAUX STRAIT; GPS-TRACKING; PARAPERCIS-COLIAS; BLUE COD; NAVIGATION; DIET; RESOLUTION; BEHAVIOR; ANIMALS; SUCCESS	Free-ranging marine predators rarely search for prey along straight lines because dynamic ocean processes usually require complex search strategies. If linear movement patterns occur they are usually associated with travelling events or migratory behaviour. However, recent fine scale tracking of flying seabirds has revealed straight-line movements while birds followed fishing vessels. Unlike flying seabirds, penguins are not known to target and follow fishing vessels. Yet yellow-eyed penguins from New Zealand often exhibit directed movement patterns while searching for prey at the seafloor, a behaviour that seems to contradict common movement ecology theories. While deploying GPS dive loggers on yellow-eyed penguins from the Otago Peninsula we found that the birds frequently followed straight lines for several kilometres with little horizontal deviation. In several cases individuals swam up and down the same line, while some of the lines were followed by more than one individual. Using a remote operated vehicle (ROV) we found a highly visible furrow on the seafloor most likely caused by an otter board of a demersal fish trawl, which ran in a straight line exactly matching the trajectory of a recent line identified from penguin tracks. We noted high abundances of benthic scavengers associated with fisheries-related bottom disturbance. While our data demonstrate the acute way-finding capabilities of benthic foraging yellow-eyed penguins, they also highlight how hidden cascading effects of coastal fisheries may alter behaviour and potentially even population dynamics of marine predators, an often overlooked fact in the examination of fisheries' impacts.	[Mattern, Thomas; Ellenberg, Ursula; Davis, Lloyd S.; van Heezik, Yolanda; Seddon, Philip J.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Houston, David M.] Dept Conservat Sci & Capabil, Auckland, New Zealand; [Lamare, Miles] Univ Otago, Dept Marine Sci, Dunedin, New Zealand	University of Otago; University of Otago	Mattern, T (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	t.mattern@eudyptes.net	Ellenberg, Ursula/B-4519-2015; Seddon, Philip/G-8659-2011; Mattern, Thomas/AAJ-6325-2020; van Heezik, Yolanda/I-2744-2019; Ellenberg, Ursula/AAF-7317-2020	Ellenberg, Ursula/0000-0002-3100-6742; Seddon, Philip/0000-0001-9076-9566; Mattern, Thomas/0000-0003-0745-8180; van Heezik, Yolanda/0000-0003-0494-5311; Ellenberg, Ursula/0000-0002-3100-6742; Lamare, Miles/0000-0001-8656-7240	Leiden Conservation Foundation; Otago University	Leiden Conservation Foundation; Otago University	The Leiden Conservation Foundation provided financial support for the Polaris II cruise. All other expenses were covered by Otago University research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GOOGL EARTH VERS 7 1; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; Browne T, 2011, AUSTRAL ECOL, V36, P99, DOI 10.1111/j.1442-9993.2010.02125.x; Carbines G, 2004, AQUAT CONSERV, V14, P491, DOI 10.1002/aqc.608; Cheung A, 2008, BIOL CYBERN, V99, P197, DOI 10.1007/s00422-008-0251-z; Clement & associates Ltd, 2008, NZ INSH TRAWL GEAR O; Cranfield HJ, 1999, AQUAT CONSERV, V9, P461, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<461::AID-AQC353>3.0.CO;2-Z; Ellenberg U, 2012, YELLOW EYED PENGUIN; Ellenberg U, 2007, GEN COMP ENDOCR, V152, P54, DOI 10.1016/j.ygcen.2007.02.022; Engel J, 1998, CONSERV BIOL, V12, P1204, DOI 10.1046/j.1523-1739.1998.0120061204.x; Granadeiro JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017467; Horton TW, 2011, BIOL LETTERS, V7, P674, DOI 10.1098/rsbl.2011.0279; Houston D. M., 2005, New Zealand Journal of Zoology, V32, P267; Humborstad OB, 2004, ICES J MAR SCI, V61, P53, DOI 10.1016/j.icesjms.2003.10.001; IUCN, 2013, IUCN RED LIST THREAT; Jiang WM, 2002, AQUAT CONSERV, V12, P257, DOI 10.1002/aqc.495; Jillett J, 2003, NATURAL HIST SO NZ U, P318; KAISER MJ, 1994, MAR ECOL PROG SER, V112, P41, DOI 10.3354/meps112041; King SD, 2012, MAR ECOL PROG SER, V467, P233, DOI 10.3354/meps09969; LEE JE, 1985, J WILDLIFE MANAGE, V49, P658, DOI 10.2307/3801690; Lipp HP, 2004, CURR BIOL, V14, P1239, DOI 10.1016/j.cub.2004.07.024; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Lokkebord S, 2005, FAO FISHERIES TECHNI; Luschi Paolo, 2013, ISRN Zoology, P1; Mann K.H., 2005, DYNAMICS MARINE ECOS, V3rd ed., P163; Mattern T, 2007, MAR ECOL PROG SER, V343, P295, DOI 10.3354/meps06954; Ministry for Primary Industries, 2013, NAT AQ BIOD INF SYST; Miskelly Colin M., 2008, Notornis, V55, P117; Moore P. J., 1997, Marine Ornithology, V25, P17; Moore P. J., 1999, Marine Ornithology, V27, P49; Moore PJ, 1994, WHAT IS BAD SEASON Y; Moore PJ, 1995, SCI RES SERIES; Mutch P.G., 1983, THESIS U AUCKLAND; Nevitt GA, 2005, BIOL LETT-UK, V1, P303, DOI 10.1098/rsbl.2005.0350; Papi F, 2006, MAR FRESHW BEHAV PHY, V39, P3, DOI 10.1080/10236240600563057; R Core Team, 2021, R LANGUAGE ENV STAT; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Schwinghamer P, 1998, CONSERV BIOL, V12, P1251; Seddon PJ, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P91; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Tew-Kai E, 2013, J APPL ECOL, V50, P659, DOI 10.1111/1365-2664.12086; Tillin HM, 2006, MAR ECOL PROG SER, V318, P31, DOI 10.3354/meps318031; Torres LG, 2011, MAR ECOL PROG SER, V428, P289, DOI 10.3354/meps09068; Trathan PN, 2008, MAR ECOL PROG SER, V370, P285, DOI 10.3354/meps07638; VANHEEZIK Y, 1990, NEW ZEAL J ZOOL, V17, P201, DOI 10.1080/03014223.1990.10422597; VANHEEZIK Y, 1990, IBIS, V132, P354; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wilson RP, 2013, ECOL LETT, V16, P1145, DOI 10.1111/ele.12149; Wilson RP, 1997, WILDLIFE SOC B, V25, P101	51	23	23	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84381	10.1371/journal.pone.0084381	http://dx.doi.org/10.1371/journal.pone.0084381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367656	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300139
J	Aitkin, CD; Santos, EM; Kowler, E				Aitkin, Cordelia D.; Santos, Elio M.; Kowler, Eileen			Anticipatory Smooth Eye Movements in Autism Spectrum Disorder	PLOS ONE			English	Article							SLOW OCULOMOTOR CONTROL; PURSUIT INITIATION; VOLUNTARY CONTROL; OCULAR PURSUIT; MOTION; TARGET; EXPECTATIONS; PERCEPTION; DEFICITS; MICROSACCADES	Smooth pursuit eye movements are important for vision because they maintain the line of sight on targets that move smoothly within the visual field. Smooth pursuit is driven by neural representations of motion, including a surprisingly strong influence of high-level signals representing expected motion. We studied anticipatory smooth eye movements (defined as smooth eye movements in the direction of expected future motion) produced by salient visual cues in a group of high-functioning observers with Autism Spectrum Disorder (ASD), a condition that has been associated with difficulties in either generating predictions, or translating predictions into effective motor commands. Eye movements were recorded while participants pursued the motion of a disc that moved within an outline drawing of an inverted Y-shaped tube. The cue to the motion path was a visual barrier that blocked the untraveled branch (right or left) of the tube. ASD participants showed strong anticipatory smooth eye movements whose velocity was the same as that of a group of neurotypical participants. Anticipatory smooth eye movements appeared on the very first cued trial, indicating that trial-by-trial learning was not responsible for the responses. These results are significant because they show that anticipatory capacities are intact in high-functioning ASD in cases where the cue to the motion path is highly salient and unambiguous. Once the ability to generate anticipatory pursuit is demonstrated, the study of the anticipatory responses with a variety of types of cues provides a window into the perceptual or cognitive processes that underlie the interpretation of events in natural environments or social situations.	[Aitkin, Cordelia D.; Santos, Elio M.; Kowler, Eileen] Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Kowler, E (corresponding author), Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA.	kowler@rci.rutgers.edu		Santos, Elio M./0000-0002-9739-7512	NJ Governor's Council for medical research and treatment of autism [10-403-SCH-E-0]	NJ Governor's Council for medical research and treatment of autism	This work was supported by grant 10-403-SCH-E-0 from the NJ Governor's Council for medical research and treatment of autism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila MT, 2006, J NEUROPHYSIOL, V95, P593, DOI 10.1152/jn.00369.2005; Badler JB, 2006, J NEUROSCI, V26, P4519, DOI 10.1523/JNEUROSCI.3739-05.2006; Badler J, 2010, J NEUROSCI, V30, P10517, DOI 10.1523/JNEUROSCI.1733-10.2010; BARNES GR, 1991, J PHYSIOL-LONDON, V439, P439, DOI 10.1113/jphysiol.1991.sp018675; Barnes GR, 2000, J NEUROPHYSIOL, V84, P2340, DOI 10.1152/jn.2000.84.5.2340; BOMAN DK, 1988, VISION RES, V28, P1157, DOI 10.1016/0042-6989(88)90142-3; Brieber S, 2010, NEUROPSYCHOLOGIA, V48, P1644, DOI 10.1016/j.neuropsychologia.2010.02.007; COLLEWIJN H, 1984, J PHYSIOL-LONDON, V351, P217, DOI 10.1113/jphysiol.1984.sp015242; Collewijn H, 2008, J VISION, V8, DOI 10.1167/8.14.20; DALLOS PJ, 1963, IEEE T AUTOMAT CONTR, P218; de Hemptinne C, 2006, J NEUROPHYSIOL, V95, P3770, DOI 10.1152/jn.00007.2006; de Hemptinne C, 2008, J NEUROSCI, V28, P4298, DOI 10.1523/JNEUROSCI.5678-07.2008; Dodge R, 1930, ARCH NEURO PSYCHIATR, V24, P21, DOI 10.1001/archneurpsyc.1930.02220130024002; Eggert T, 2009, EXP BRAIN RES, V196, P205, DOI 10.1007/s00221-009-1840-3; Falck-Ytter T, 2010, BIOL LETTERS, V6, P375, DOI 10.1098/rsbl.2009.0897; Foss-Feig JH, 2013, J NEUROSCI, V33, P8243, DOI 10.1523/JNEUROSCI.1608-12.2013; Goldberg MC, 2002, NEUROPSYCHOLOGIA, V40, P2039, DOI 10.1016/S0028-3932(02)00059-3; Gomot M, 2012, INT J PSYCHOPHYSIOL, V83, P240, DOI 10.1016/j.ijpsycho.2011.09.017; Gowen E, 2013, J AUTISM DEV DISORD, V43, P323, DOI 10.1007/s10803-012-1574-0; Grinter EJ, 2010, BRAIN RES BULL, V82, P147, DOI 10.1016/j.brainresbull.2010.02.016; Hafed ZM, 2011, J NEUROSCI, V31, P15219, DOI 10.1523/JNEUROSCI.3106-11.2011; HEINEN SJ, 1995, EXP BRAIN RES, V104, P357; Heinen SJ, 2003, VISUAL NEUROSCIENCES, P333; Hong LE, 2008, BIOL PSYCHIAT, V63, P458, DOI 10.1016/j.biopsych.2007.06.004; Jarrett CB, 2002, COGNITIVE BRAIN RES, V14, P383, DOI 10.1016/S0926-6410(02)00140-4; Joseph RM, 2009, DEVELOPMENTAL SCI, V12, P1083, DOI 10.1111/j.1467-7687.2009.00855.x; Kaiser MD, 2009, PSYCHON B REV, V16, P761, DOI 10.3758/PBR.16.5.761; KAO GW, 1994, VISION RES, V34, P3027, DOI 10.1016/0042-6989(94)90276-3; Kerzel D, 2008, VISION RES, V48, P958, DOI 10.1016/j.visres.2008.01.015; KHURANA B, 1987, VISION RES, V27, P1603, DOI 10.1016/0042-6989(87)90168-4; Kim CY, 2007, SPATIAL VISION, V20, P545, DOI 10.1163/156856807782758395; KNOWLER E, 1978, VISION RES, V18, P603, DOI 10.1016/0042-6989(78)90211-0; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; KOWLER E, 1989, VISION RES, V29, P1049, DOI 10.1016/0042-6989(89)90052-7; KOWLER E, 1979, VISION RES, V19, P633, DOI 10.1016/0042-6989(79)90239-6; KOWLER E, 1984, VISION RES, V24, P197, DOI 10.1016/0042-6989(84)90122-6; Kowler E, 2011, VISION RES, V51, P1457, DOI 10.1016/j.visres.2010.12.014; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Ladda J, 2007, EXP BRAIN RES, V182, P343, DOI 10.1007/s00221-007-0988-y; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Missal M, 2004, J NEUROPHYSIOL, V92, P1257, DOI 10.1152/jn.01255.2003; Missal M, 2001, J NEUROPHYSIOL, V86, P2413, DOI 10.1152/jn.2001.86.5.2413; Moates AF, 2012, BIOL PSYCHIAT, V72, P752, DOI 10.1016/j.biopsych.2012.03.030; Nackaerts E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044473; Nowinski CV, 2005, PSYCHIAT RES, V137, P11, DOI 10.1016/j.psychres.2005.07.005; PUCKETT JDW, 1969, VISION RES, V9, P695; Robertson CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048173; Santos EM, 2012, J VISION, V12, DOI 10.1167/12.11.1; Schlack A, 2007, NEURON, V53, P881, DOI 10.1016/j.neuron.2007.02.028; Souto D, 2013, J VISION, V13, DOI 10.1167/13.2.9; Spering M, 2011, VISION RES, V51, P836, DOI 10.1016/j.visres.2010.10.017; STEINMAN RM, 1967, SCIENCE, V155, P1577, DOI 10.1126/science.155.3769.1577; STEINMAN RM, 1969, VISION RES, V9, P1167, DOI 10.1016/0042-6989(69)90054-6; Takarae Y, 2004, BRAIN, V127, P2584, DOI 10.1093/brain/awh307; Takarae Y, 2008, J INT NEUROPSYCH SOC, V14, P980, DOI 10.1017/S1355617708081277; Takarae Y, 2007, PSYCHIAT RES-NEUROIM, V156, P117, DOI 10.1016/j.pscychresns.2007.03.008; Wells SG, 1998, EXP BRAIN RES, V120, P129, DOI 10.1007/s002210050385; WESTHEIMER G, 1954, AMA ARCH OPHTHALMOL, V52, P932; Yang SN, 2010, J NEUROPHYSIOL, V103, P2458, DOI 10.1152/jn.00215.2009; Yang Y, 2010, J NEUROPHYSIOL, V104, P2850, DOI 10.1152/jn.00761.2010	60	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83230	10.1371/journal.pone.0083230	http://dx.doi.org/10.1371/journal.pone.0083230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	278IG	24376667	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000071
J	Browning, DF; Matthews, SA; Rossiter, AE; Sevastsyanovich, YR; Jeeves, M; Mason, JL; Wells, TJ; Wardius, CA; Knowles, TJ; Cunningham, AF; Bavro, VN; Overduin, M; Henderson, IR				Browning, Douglas F.; Matthews, Sophie A.; Rossiter, Amanda E.; Sevastsyanovich, Yanina R.; Jeeves, Mark; Mason, Jessica L.; Wells, Timothy J.; Wardius, Catherine A.; Knowles, Timothy J.; Cunningham, Adam F.; Bavro, Vassiliy N.; Overduin, Michael; Henderson, Ian R.			Mutational and Topological Analysis of the Escherichia coli BamA Protein	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; TRIMERIC AUTOTRANSPORTER; SEQUENCE; COMPLEX; FHAC; FLEXIBILITY; MECHANISM; INSERTION; RESIDUES; REQUIRES	The multi-protein beta-barrel assembly machine (BAM) of Escherichia coli is responsible for the folding and insertion of beta-barrel containing integral outer membrane proteins (OMPs) into the bacterial outer membrane. An essential component of this complex is the BamA protein, which binds unfolded beta-barrel precursors via the five polypeptide transport-associated (POTRA) domains in its N-terminus. The C-terminus of BamA contains a beta-barrel domain, which tethers BamA to the outer membrane and is also thought to be involved in OMP insertion. Here we mutagenize BamA using linker scanning mutagenesis and demonstrate that all five POTRA domains are essential for BamA protein function in our experimental system. Furthermore, we generate a homology based model of the BamA beta-barrel and test our model using insertion mutagenesis, deletion analysis and immunofluorescence to identify beta-strands, periplasmic turns and extracellular loops. We show that the surface-exposed loops of the BamA beta-barrel are essential.	[Browning, Douglas F.; Matthews, Sophie A.; Rossiter, Amanda E.; Sevastsyanovich, Yanina R.; Mason, Jessica L.; Wells, Timothy J.; Wardius, Catherine A.; Cunningham, Adam F.; Bavro, Vassiliy N.; Henderson, Ian R.] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Jeeves, Mark; Wells, Timothy J.; Overduin, Michael] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Browning, DF (corresponding author), Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.	D.F.Browning@bham.ac.uk; I.R.Henderson@bham.ac.uk	Bavro, Vassiliy/I-4846-2019; Henderson, Ian/AAD-5369-2019; Wells, Timothy/AAG-3311-2021; Overduin, Michael/AAG-3632-2020; Wells, Timothy/M-2025-2016	Bavro, Vassiliy/0000-0003-2330-8924; Overduin, Michael/0000-0002-3114-6585; Browning, Douglas/0000-0003-4672-3514; Wells, Timothy/0000-0001-7766-5404; Henderson, Ian/0000-0002-9954-4977; Jeeves, Mark/0000-0001-9736-0990; Knowles, Tim/0000-0002-6632-0985; Cunningham, Adam/0000-0003-0248-964X; Wardius, Catherine/0000-0002-3588-8113	Medical Research Council; BBSRC; BBSRC [BB/I020756/1, BB/G022054/1, BB/F000472/1] Funding Source: UKRI; MRC [G0801209] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I020756/1, BB/G022054/1, BB/F000472/1] Funding Source: researchfish; Medical Research Council [G0801209] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was generously supported by funding from the Medical Research Council and BBSRC (D. F. B., I. R. H. and M.O.). V.N.B. is a Birmingham University Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwari K, 2012, MOL MICROBIOL, V84, P832, DOI 10.1111/j.1365-2958.2012.08059.x; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Bennion D, 2010, MOL MICROBIOL, V77, P1153, DOI 10.1111/j.1365-2958.2010.07280.x; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Delattre AS, 2010, FEBS J, V277, P4755, DOI 10.1111/j.1742-4658.2010.07881.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Lehr U, 2010, MOL MICROBIOL, V78, P932, DOI 10.1111/j.1365-2958.2010.07377.x; Leonard-Rivera M, 2012, J BACTERIOL, V194, P4662, DOI 10.1128/JB.00825-12; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Leyton DL, 2011, J BIOL CHEM, V286, P42283, DOI 10.1074/jbc.M111.306118; Marani P, 2006, PROTEIN SCI, V15, P884, DOI 10.1110/ps.051889506; Meli AC, 2006, J BIOL CHEM, V281, P158, DOI 10.1074/jbc.M508524200; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Oberhettinger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047069; Patel GJ, 2013, BIOCHEMISTRY-US, V52, P3974, DOI 10.1021/bi400103t; Raghunathan D, 2011, INFECT IMMUN, V79, P4342, DOI 10.1128/IAI.05592-11; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Rossiter AE, 2011, J BACTERIOL, V193, P4250, DOI 10.1128/JB.00192-11; Rossiter AE, 2011, MOL MICROBIOL, V81, P179, DOI 10.1111/j.1365-2958.2011.07685.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruiz N, 2006, ACS CHEM BIOL, V1, P385, DOI 10.1021/cb600128v; Sambrook J., 2001, MOL CLONING LAB MANU; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Schrodinger L., 2020, PYMOL; Squire DJP, 2009, BIOCHEM J, V420, P249, DOI 10.1042/BJ20090183; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Tellez R, 2012, J BACTERIOL, V194, P317, DOI 10.1128/JB.06192-11; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Zhang H, 2011, ACTA CRYSTALLOGR F, V67, P734, DOI 10.1107/S1744309111014254	43	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84512	10.1371/journal.pone.0084512	http://dx.doi.org/10.1371/journal.pone.0084512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376817	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000328882000154
J	Chakrabarti, L; Wang, BD; Lee, NH; Sandler, AD				Chakrabarti, Lina; Wang, Bi-Dar; Lee, Norman H.; Sandler, Anthony D.			A Mechanism Linking Id2-TGF beta Crosstalk to Reversible Adaptive Plasticity in Neuroblastoma	PLOS ONE			English	Article							CANCER STEM-CELLS; GROWTH-FACTOR-BETA; TGF-BETA; ID PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR PROGRESSION; CLONAL EVOLUTION; EPITHELIAL-CELLS; MATRIX ADHESION; PROLIFERATION	The ability of high-risk neuroblastoma to survive unfavorable growth conditions and multimodal therapy has produced an elusive childhood cancer with remarkably poor prognosis. A novel phenomenon enabling neuroblastoma to survive selection pressure is its capacity for reversible adaptive plasticity. This plasticity allows cells to transition between highly proliferative anchorage dependent (AD) and slow growing, anoikis-resistant anchorage independent (AI) phenotypes. Both phenotypes are present in established mouse and human tumors. The differential gene expression profile of the two cellular phenotypes in the mouse Neuro2a cell line delineated pathways of proliferation in AD cells or tyrosine kinase activation/apoptosis inhibition in AI cells. A 20 fold overexpression of inhibitor of differentiation 2 (Id2) was identified in AD cells while up-regulation of genes involved in anoikis resistance like PI3K/Akt, Erk, Bcl2 and integrins was observed in AI cells. Similarly, differential expression of Id2 and other genes of interest were also observed in the AD and AI phenotypes of human neuroblastoma cell lines, SK-N-SH and IMR-32; as well as in primary human tumor specimens. Forced down-regulation of Id2 in AD cells or overexpression in AI cells induced the cells to gain characteristics of the other phenotype. Id2 binds both TGF beta and Smad2/3 and appears critical for maintaining the proliferative phenotype at least partially through negative regulation of the TGFb/Smad pathway. Simultaneously targeting the differential molecular pathways governing reversible adaptive plasticity resulted in 50% cure of microscopic disease and delayed tumor growth in established mouse neuroblastoma tumors. We present a mechanism that accounts for reversible adaptive plasticity and a molecular basis for combined targeted therapies in neuroblastoma.	[Chakrabarti, Lina; Sandler, Anthony D.] Childrens Natl Med Ctr, Joseph E Robert Ctr Surg Care, Washington, DC 20010 USA; [Chakrabarti, Lina; Sandler, Anthony D.] Childrens Natl Med Ctr, Sheikh Zayed Inst Pediat Surg Innovat, Washington, DC 20010 USA; [Wang, Bi-Dar; Lee, Norman H.] George Washington Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20037 USA	Children's National Health System; Children's National Health System; George Washington University	Sandler, AD (corresponding author), Childrens Natl Med Ctr, Joseph E Robert Ctr Surg Care, Washington, DC 20010 USA.	asandler@childrensnational.org		Sandler, Anthony/0000-0001-9440-2964; Wang, Bi-Dar/0000-0002-2530-7020	Sheikh Zayed Institute for Pediatric Surgical Innovation; Michael Sandler Cancer Research Fund;  [R01-CA120316];  [R01-DK056108]; NATIONAL CANCER INSTITUTE [R01CA120316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056108] Funding Source: NIH RePORTER	Sheikh Zayed Institute for Pediatric Surgical Innovation; Michael Sandler Cancer Research Fund; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the Sheikh Zayed Institute for Pediatric Surgical Innovation and the Michael Sandler Cancer Research Fund (ADS) and R01-CA120316 and R01-DK056108 (NHL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1990, CANCER RES, V50, P6757; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Burnier JV, 2011, ONCOGENE, V30, P3766, DOI 10.1038/onc.2011.89; Chai H, 2010, INT J CLIN EXP PATHO, V3, P408; Chakrabarti Lina, 2012, Front Oncol, V2, P82, DOI 10.3389/fonc.2012.00082; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Choudhury SR, 2010, INVEST NEW DRUG, V28, P812, DOI 10.1007/s10637-009-9324-7; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Diaz-Montero CM, 2006, EUR J CANCER, V42, P1491, DOI 10.1016/j.ejca.2006.03.007; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Duxbury MS, 2004, CANCER RES, V64, P3987, DOI 10.1158/0008-5472.CAN-04-0424; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Edsjo A, 2007, SEMIN CANCER BIOL, V17, P248, DOI 10.1016/j.semcancer.2006.04.005; Fan LX, 2012, KIDNEY INT, V81, P76, DOI 10.1038/ki.2011.296; Giannoni E, 2008, CELL DEATH DIFFER, V15, P867, DOI 10.1038/cdd.2008.3; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; HEPPNER GH, 1984, CANCER RES, V44, P2259; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Jones J, 1997, J ORAL PATHOL MED, V26, P63, DOI 10.1111/j.1600-0714.1997.tb00023.x; Kakodkar NC, 2012, PEDIATR BLOOD CANCER, V59, P642, DOI 10.1002/pbc.24004; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lasorella A, 2002, CANCER RES, V62, P301; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Ling MT, 2002, BBA-GEN SUBJECTS, V1570, P145, DOI 10.1016/S0304-4165(02)00189-7; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; NEVINS JR, 1991, COLD SPRING HARB SYM, V56, P157; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; NOWELL PC, 1986, CANCER RES, V46, P2203; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Stover DG, 2007, J CELL BIOCHEM, V101, P851, DOI 10.1002/jcb.21149	52	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83521	10.1371/journal.pone.0083521	http://dx.doi.org/10.1371/journal.pone.0083521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376712	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000093
J	Georges, A; Cambisano, N; Ahariz, N; Karim, L; Georges, M				Georges, Anouk; Cambisano, Nadine; Ahariz, Naima; Karim, Latifa; Georges, Michel			A Genome Scan Conducted in a Multigenerational Pedigree with Convergent Strabismus Supports a Complex Genetic Determinism	PLOS ONE			English	Article							HAPLOTYPE SHARING ANALYSIS; AFFECTED INDIVIDUALS; SUSCEPTIBILITY LOCI; MAP	A genome-wide linkage scan was conducted in a Northern-European multigenerational pedigree with nine of 40 related members affected with concomitant strabismus. Twenty-seven members of the pedigree including all affected individuals were genotyped using a SNP array interrogating > 300,000 common SNPs. We conducted parametric and non-parametric linkage analyses assuming segregation of an autosomal dominant mutation, yet allowing for incomplete penetrance and phenocopies. We detected two chromosome regions with near-suggestive evidence for linkage, respectively on chromosomes 8 and 18. The chromosome 8 linkage implied a penetrance of 0.80 and a rate of phenocopy of 0.11, while the chromosome 18 linkage implied a penetrance of 0.64 and a rate of phenocopy of 0. Our analysis excludes a simple genetic determinism of strabismus in this pedigree.	[Georges, Anouk] Univ Liege CHU, Fac Med, Dept Ophtalmol, Liege, Belgium; [Cambisano, Nadine; Ahariz, Naima; Georges, Michel] Univ Liege B34, Unit Anim Genom GIGA R, Liege, Belgium; [Cambisano, Nadine; Ahariz, Naima; Georges, Michel] Univ Liege B34, Fac Vet Med, Liege, Belgium; [Karim, Latifa] Univ Liege B34, GIGA R Genotranscript Core Facl, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Georges, M (corresponding author), Univ Liege B34, Unit Anim Genom GIGA R, Liege, Belgium.	michel.georges@ulg.ac.be		Georges, Michel/0000-0003-4124-2375	Unit of Animal Genomics.GIGA-R & Faculty of Veterinary Medicine, University of Liege (B34), 1 Avenue de l'Hopital, Lege, Belgium	Unit of Animal Genomics.GIGA-R & Faculty of Veterinary Medicine, University of Liege (B34), 1 Avenue de l'Hopital, Lege, Belgium	The work was funded by the Unit of Animal Genomics.GIGA-R & Faculty of Veterinary Medicine, University of Liege (B34), 1 Avenue de l'Hopital, 4000-Lege, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann L, 2005, HUM HERED, V59, P67, DOI 10.1159/000085221; Bourgain C, 2001, AM J HUM GENET, V68, P154, DOI 10.1086/316933; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Durkin K, 2012, NATURE, V482, P81, DOI 10.1038/nature10757; Engle EC, 2007, ARCH OPHTHALMOL-CHIC, V125, P189, DOI 10.1001/archopht.125.2.189; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujiwara H, 2003, ACTA MED OKAYAMA, V57, P109; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Parikh V, 2003, P NATL ACAD SCI USA, V100, P12283, DOI 10.1073/pnas.2035118100; Rice A, 2009, INVEST OPHTH VIS SCI, V50, P3210, DOI 10.1167/iovs.07-1631; Shaaban S, 2009, INVEST OPHTH VIS SCI, V50, P654, DOI 10.1167/iovs.08-2437; Thomas A, 2008, ANN HUM GENET, V72, P279, DOI 10.1111/j.1469-1809.2007.00406.x; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Van der Meulen MA, 1997, GENET EPIDEMIOL, V14, P915, DOI 10.1002/(SICI)1098-2272(1997)14:6<915::AID-GEPI59>3.0.CO;2-P	16	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83574	10.1371/journal.pone.0083574	http://dx.doi.org/10.1371/journal.pone.0083574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376720	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000098
J	Gerard, C; Novak, B				Gerard, Claude; Novak, Bela			microRNA as a Potential Vector for the Propagation of Robustness in Protein Expression and Oscillatory Dynamics within a ceRNA Network	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; NEGATIVE FEEDBACK; MAMMALIAN MICRORNAS; CIRCADIAN-CLOCK; MESSENGER-RNAS; NOISE; MECHANISMS; FAMILY; IMPACT	microRNAs (miRNAs) are small noncoding RNAs that are important post-transcriptional regulators of gene expression. miRNAs can induce thresholds in protein synthesis. Such thresholds in protein output can be also achieved by oligomerization of transcription factors (TF) for the control of gene expression. First, we propose a minimal model for protein expression regulated by miRNA and by oligomerization of TF. We show that miRNA and oligomerization of TF generate a buffer, which increases the robustness of protein output towards molecular noise as well as towards random variation of kinetics parameters. Next, we extend the model by considering that the same miRNA can bind to multiple messenger RNAs, which accounts for the dynamics of a minimal competing endogenous RNAs (ceRNAs) network. The model shows that, through common miRNA regulation, TF can control the expression of all proteins formed by the ceRNA network, even if it drives the expression of only one gene in the network. The model further suggests that the threshold in protein synthesis mediated by the oligomerization of TF can be propagated to the other genes, which can increase the robustness of the expression of all genes in such ceRNA network. Furthermore, we show that a miRNA could increase the time delay of a "Goodwin-like" oscillator model, which may favor the occurrence of oscillations of large amplitude. This result predicts important roles of miRNAs in the control of the molecular mechanisms leading to the emergence of biological rhythms. Moreover, a model for the latter oscillator embedded in a ceRNA network indicates that the oscillatory behavior can be propagated, via the shared miRNA, to all proteins formed by such ceRNA network. Thus, by means of computational models, we show that miRNAs could act as vectors allowing the propagation of robustness in protein synthesis as well as oscillatory behaviors within ceRNA networks.	[Gerard, Claude; Novak, Bela] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Oxford	Gerard, C (corresponding author), Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium.	claude.gerard@uclouvain.be	Novak, Bela/D-5365-2009	Novak, Bela/0000-0002-6961-1366	EC FP7 MitoSys [241548]; Foundation Philippe Wiener - Maurice Anspach	EC FP7 MitoSys; Foundation Philippe Wiener - Maurice Anspach	This research was supported by EC FP7 MitoSys (241548) and by the Foundation Philippe Wiener - Maurice Anspach. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ansel J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000049; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonev B, 2012, CELL REPORTS, V2, P10, DOI 10.1016/j.celrep.2012.05.017; Borenstein E, 2006, P NATL ACAD SCI USA, V103, P6593, DOI 10.1073/pnas.0510600103; Bosia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066609; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen RM, 2013, CURR BIOL, V23, P1959, DOI 10.1016/j.cub.2013.08.005; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng HYM, 2007, CELL CYCLE, V6, P3034, DOI 10.4161/cc.6.24.5106; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Drakaki A, 2009, CURR GENOMICS, V10, P35, DOI 10.2174/138920209787581299; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Figliuzzi M, 2013, BIOPHYS J, V104, P1203, DOI 10.1016/j.bpj.2013.01.012; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Ghim CM, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-94; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Goldbeter A, 2012, FEBS LETT, V586, P2955, DOI 10.1016/j.febslet.2012.07.041; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gursky VV, 2012, BIOSYSTEMS, V109, P329, DOI 10.1016/j.biosystems.2012.05.013; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hansen KF, 2011, GENOME MED, V3, DOI 10.1186/gm224; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Ji N, 2013, CELL, V155, P869, DOI 10.1016/j.cell.2013.09.060; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KELLER AD, 1995, J THEOR BIOL, V172, P169, DOI 10.1006/jtbi.1995.0014; Kim DH, 2013, NAT GENET, V45, P1337, DOI 10.1038/ng.2763; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Laudadio I, 2012, GASTROENTEROLOGY, V142, P119, DOI 10.1053/j.gastro.2011.09.001; Lebrecht D, 2005, P NATL ACAD SCI USA, V102, P13176, DOI 10.1073/pnas.0506462102; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu KH, 2012, J THEOR BIOL, V304, P103, DOI 10.1016/j.jtbi.2012.03.037; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Noorbakhsh J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072676; Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Poliseno L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002858; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; Rue P, 2013, ANNU REV BIOPHYS, V42, P605, DOI 10.1146/annurev-biophys-083012-130335; Ruoff P, 1999, J BIOL RHYTHM, V14, P469, DOI 10.1177/074873099129001037; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Shomron N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000397; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Strange K, 2012, CURR BIOL, V22, pR1000, DOI 10.1016/j.cub.2012.10.024; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Woller A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032722; Xie ZR, 2007, BIOCHEM BIOPH RES CO, V358, P722, DOI 10.1016/j.bbrc.2007.04.207; Zhang JS, 2012, CANCER METAST REV, V31, P653, DOI 10.1007/s10555-012-9368-6	87	11	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83372	10.1371/journal.pone.0083372	http://dx.doi.org/10.1371/journal.pone.0083372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376695	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000084
J	Li, MX; Jirapatnakul, A; Biancardi, A; Riccio, ML; Weiss, RS; Reeves, AP				Li, Minxing; Jirapatnakul, Artit; Biancardi, Alberto; Riccio, Mark L.; Weiss, Robert S.; Reeves, Anthony P.			Growth Pattern Analysis of Murine Lung Neoplasms by Advanced Semi-Automated Quantification of Micro-CT Images	PLOS ONE			English	Article							SMALL PULMONARY NODULES; TUMOR MEASUREMENTS; MOUSE MODELS; SOLID TUMORS; VARIABILITY; SEGMENTATION; PROGRESSION; KINETICS; SIZE; RATES	Computed tomography (CT) is a non-invasive imaging modality used to monitor human lung cancers. Typically, tumor volumes are calculated using manual or semi-automated methods that require substantial user input, and an exponential growth model is used to predict tumor growth. However, these measurement methodologies are time-consuming and can lack consistency. In addition, the availability of datasets with sequential images of the same tumor that are needed to characterize in vivo growth patterns for human lung cancers is limited due to treatment interventions and radiation exposure associated with multiple scans. In this paper, we performed micro-CT imaging of mouse lung cancers induced by overexpression of ribonucleotide reductase, a key enzyme in nucleotide biosynthesis, and developed an advanced semi-automated algorithm for efficient and accurate tumor volume measurement. Tumor volumes determined by the algorithm were first validated by comparison with results from manual methods for volume determination as well as direct physical measurements. A longitudinal study was then performed to investigate in vivo murine lung tumor growth patterns. Individual mice were imaged at least three times, with at least three weeks between scans. The tumors analyzed exhibited an exponential growth pattern, with an average doubling time of 57.08 days. The accuracy of the algorithm in the longitudinal study was also confirmed by comparing its output with manual measurements. These results suggest an exponential growth model for lung neoplasms and establish a new advanced semi-automated algorithm to measure lung tumor volume in mice that can aid efforts to improve lung cancer diagnosis and the evaluation of therapeutic responses.	[Li, Minxing; Weiss, Robert S.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA; [Jirapatnakul, Artit; Biancardi, Alberto; Reeves, Anthony P.] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY USA; [Riccio, Mark L.] Cornell Univ, Inst Biotechnol & Life Sci Technol, Ithaca, NY USA	Cornell University; Cornell University; Cornell University	Weiss, RS (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA.	rsw26@cornell.edu; reeves@ece.cornell.edu	Jirapatnakul, Artit/J-4044-2014	Jirapatnakul, Artit/0000-0003-2730-1615	NIH [CA108773, CA163255]; Cornell University Institute for Biotechnology & Life Science Technologies; NATIONAL CANCER INSTITUTE [R01CA163255, R01CA108773] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell University Institute for Biotechnology & Life Science Technologies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by NIH R01 grants CA108773 and CA163255 (RSW) and an Innovation Grant from the Cornell University Institute for Biotechnology & Life Science Technologies (RSW and APR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artaechevarria X, 2009, PHYS MED BIOL, V54, P7009, DOI 10.1088/0031-9155/54/22/017; Artaechevarria X, 2011, EUR RADIOL, V21, P954, DOI 10.1007/s00330-010-1982-5; Artaechevarria X, 2010, EUR RADIOL, V20, P2600, DOI 10.1007/s00330-010-1853-0; Bahri MA, 2012, IEEE NUCL SCI CONF R, P3783; BRUNTON GF, 1978, CELL TISSUE KINET, V11, P161, DOI 10.1111/j.1365-2184.1978.tb00884.x; Cavanaugh Dawn, 2004, Mol Imaging, V3, P55, DOI 10.1162/153535004773861723; Cody DD, 2005, INVEST RADIOL, V40, P263, DOI 10.1097/01.rli.0000160070.67270.05; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ford NL, 2007, J APPL PHYSIOL, V102, P2046, DOI 10.1152/japplphysiol.00629.2006; Fushiki H, 2009, CANCER SCI, V100, P1544, DOI 10.1111/j.1349-7006.2009.01199.x; Gerlee P, 2013, CANCER RES, V73, P2407, DOI 10.1158/0008-5472.CAN-12-4355; Gietema HA, 2007, RADIOLOGY, V245, P888, DOI 10.1148/radiol.2452061054; Goodman LR, 2006, AM J ROENTGENOL, V186, P989, DOI 10.2214/AJR.04.1821; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; Haines BB, 2009, NEOPLASIA, V11, P39, DOI 10.1593/neo.81030; Henschke CI, 2012, RADIOLOGY, V263, P578, DOI 10.1148/radiol.12102489; Herman AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022973; Holdsworth DW, 2002, TRENDS BIOTECHNOL, V20, pS34, DOI 10.1016/S0167-7799(02)02004-8; Hori Y, 2008, CANCER SCI, V99, P1774, DOI 10.1111/j.1349-7006.2008.00889.x; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; James K, 1999, J NATL CANCER I, V91, P523, DOI 10.1093/jnci/91.6.523; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kostis WJ, 2003, IEEE T MED IMAGING, V22, P1259, DOI 10.1109/TMI.2003.817785; Marten K, 2006, EUR RADIOL, V16, P781, DOI 10.1007/s00330-005-0036-x; Munoz-Barrutia A, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/734734; Namati E, 2006, PHYS MED BIOL, V51, P6061, DOI 10.1088/0031-9155/51/23/008; Namati E, 2010, MED PHYS, V37, P4793, DOI 10.1118/1.3476454; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Oxnard GR, 2011, J CLIN ONCOL, V29, P3114, DOI 10.1200/JCO.2010.33.7071; Reeves AP, 2007, ACAD RADIOL, V14, P1475, DOI 10.1016/j.acra.2007.09.005; Reeves AP, 2006, IEEE T MED IMAGING, V25, P435, DOI 10.1109/TMI.2006.871548; Reeves AP, 2009, 2 INT WORKSH PULM IM, P353; RETSKY MW, 1990, MED HYPOTHESES, V33, P95, DOI 10.1016/0306-9877(90)90186-I; REYNOLDS SH, 1991, ENVIRON HEALTH PERSP, V93, P145, DOI 10.2307/3431182; REYNOLDS SH, 1992, PROG CLIN BIOL RES, V376, P303; Rodriguez-Brenes IA, 2013, TRENDS ECOLOGY EVOLU; Rodt T, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-15; Ross JC, 2007, ACAD RADIOL, V14, P1382, DOI 10.1016/j.acra.2007.08.004; Rudyanto RD, 2013, MED IMAGE ANAL, V17, P1095, DOI 10.1016/j.media.2013.07.002; SCHWARTZ M, 1961, CANCER, V14, P1272, DOI 10.1002/1097-0142(196111/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H; SPRATT JS, 1995, J SURG ONCOL, V60, P137, DOI 10.1002/jso.2930600216; Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Zhao BS, 2009, RADIOLOGY, V252, P263, DOI 10.1148/radiol.2522081593	46	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83806	10.1371/journal.pone.0083806	http://dx.doi.org/10.1371/journal.pone.0083806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376755	gold, Green Accepted, Green Published			2022-12-27	WOS:000328882000115
J	Lindinger, MI; Leung, MJ; Hawke, TJ				Lindinger, Michael I.; Leung, Matthew J.; Hawke, Thomas J.			Inward Flux of Lactate(-) through Monocarboxylate Transporters Contributes to Regulatory Volume Increase in Mouse Muscle Fibres	PLOS ONE			English	Article							LACTIC-ACID EFFLUX; SKELETAL-MUSCLE; CELL-VOLUME; EXERCISE; MCT1; EXPRESSION; K+; PERMEABILITY; PROTEINS; CAPACITY	Mouse and rat skeletal muscles are capable of a regulatory volume increase (RVI) after they shrink (volume loss resultant from exposure to solutions of increased osmolarity) and that this RVI occurs mainly by a Na-K-Cl-Cotransporter (NKCC) - dependent mechanism. With high-intensity exercise, increased extracellular osmolarity is accompanied by large increases in extracellular [lactate(-)]. We hypothesized that large increases in [lactate(-)] and osmolarity augment the NKCC-dependent RVI response observed with a NaCl (or sucrose) - induced increase in osmolarity alone; a response that is dependent on lactate(-) influx through monocarboxylate transporters (MCTs). Single mouse muscle fibres were isolated and visualized under light microscopy under varying osmolar conditions. When solution osmolarity was increased by adding NaLac by 30 or 60 mM, fibres lost significantly less volume and regained volume sooner compared to when NaCl was used. Phloretin (MCT1 inhibitor) accentuated the volume loss compared to both NaLac controls, supporting a role for MCT1 in the RVI response in the presence of elevated [lactate(-)]. Inhibition of MCT4 (with pCMBS) resulted in a volume loss, intermediate to that seen with phloretin and NaLac controls. Bumetanide (NKCC inhibitor), in combination with pCMBS, reduced the magnitude of volume loss, but volume recovery was complete. While combined phloretin-bumetanide also reduced the magnitude of the volume loss, it also largely abolished the cell volume recovery. In conclusion, RVI in skeletal muscle exposed to raised tonicity and [lactate(-)] is facilitated by inward flux of solute by NKCC- and MCT1-dependent mechanisms. This work demonstrates evidence of a RVI response in skeletal muscle that is facilitated by inward flux of solute by MCT-dependent mechanisms. These findings further expand our understanding of the capacities for skeletal muscle to volume regulate, particularly in instances of raised tonicity and lactate(-) concentrations, as occurs with high intensity exercise.	[Lindinger, Michael I.; Leung, Matthew J.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Hawke, Thomas J.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	University of Guelph; McMaster University	Lindinger, MI (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	mi.lindinger@gmail.com	Lindinger, PhD, Michael Ivan/AFV-0958-2022; Lindinger, Michael Ivan/N-7575-2018	Lindinger, PhD, Michael Ivan/0000-0003-1001-4302; Lindinger, Michael Ivan/0000-0003-1001-4302; Hawke, Thomas/0000-0003-4974-4820	Natural Sciences and Engineering Research Council of Canada; Canadian foundation for Innovation; Ontario Ministry of Research and Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian foundation for Innovation(Canada Foundation for Innovation); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	MI Lindinger, Natural Sciences and Engineering Research Council of Canada. TJ Hawke, Canadian foundation for Innovation; Ontario Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonen A, 2000, MED SCI SPORT EXER, V32, P778, DOI 10.1097/00005768-200004000-00010; Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516; Bonen A, 1998, AM J PHYSIOL-ENDOC M, V274, pE102, DOI 10.1152/ajpendo.1998.274.1.E102; Bonen A, 2006, APPL PHYSIOL NUTR ME, V31, P31, DOI 10.1139/H05-002; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; CHIN ER, 1991, AM J PHYSIOL, V261, pR98, DOI 10.1152/ajpregu.1991.261.1.R98; CONWAY EJ, 1946, NATURE, V157, P715, DOI 10.1038/157715a0; de Paoli FV, 2010, J PHYSIOL-LONDON, V588, P4785, DOI 10.1113/jphysiol.2010.196568; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571; Foppen RJG, 2002, J PHYSIOL-LONDON, V542, P181, DOI 10.1113/jphysiol.2001.013298; Foppen RJG, 2001, COMP BIOCHEM PHYS A, V130, P533, DOI 10.1016/S1095-6433(01)00430-5; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Fraser JA, 2011, J PHYSIOL-LONDON, V589, P5555, DOI 10.1113/jphysiol.2011.218313; Gosmanov AR, 2003, NEWS PHYSIOL SCI, V18, P196, DOI 10.1152/nips.01446.2003; Hawke TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1636, DOI 10.1152/ajpcell.00124.2007; Hawke TJ, 2003, J BIOL CHEM, V278, P4015, DOI 10.1074/jbc.M209200200; HODGKIN AL, 1957, J PHYSIOL-LONDON, V137, pP30; Juel C, 2001, EUR J APPL PHYSIOL, V86, P12, DOI 10.1007/s004210100517; Kitaoka Y, 2011, J PHYSIOL SCI, V61, P467, DOI 10.1007/s12576-011-0167-6; Kristensen M, 2006, AM J PHYSIOL-REG I, V290, pR766, DOI 10.1152/ajpregu.00534.2004; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LINDINGER MI, 1995, J APPL PHYSIOL, V78, P765, DOI 10.1152/jappl.1995.78.3.765; LINDINGER MI, 1994, AM J PHYSIOL, V266, pR1896, DOI 10.1152/ajpregu.1994.266.6.R1896; Lindinger MI, 2001, CAN J PHYSIOL PHARM, V79, P996, DOI 10.1139/cjpp-79-12-996; Lindinger MI, 2011, J PHYSIOL-LONDON, V589, P2887, DOI 10.1113/jphysiol.2011.206730; LUNDVALL J, 1970, Acta Physiologica Scandinavica, V80, p31A, DOI 10.1111/j.1748-1716.1970.tb04854.x; LUNDVALL J, 1972, ACTA PHYSIOL SCAND, V85, P258, DOI 10.1111/j.1748-1716.1972.tb05259.x; LUNDVALL J, 1972, ACTA PHYSIOL SCAND, P1; MASON MJ, 1988, J PHYSIOL-LONDON, V400, P459, DOI 10.1113/jphysiol.1988.sp017132; Miller BF, 2002, J PHYSIOL-LONDON, V544, P963, DOI 10.1113/jphysiol.2002.027128; Nissar AA, 2012, AM J PHYSIOL-CELL PH, V302, pC220, DOI 10.1152/ajpcell.00298.2011; O'Neill WC, 1999, AM J PHYSIOL-CELL PH, V276, pC995, DOI 10.1152/ajpcell.1999.276.5.C995; Pedersen TH, 2009, J GEN PHYSIOL, V134, P323, DOI 10.1085/jgp.200910291; Robinson RA, 1942, T FARADAY SOC, V38, P0063, DOI 10.1039/tf9423800063; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; SITDIKOV R F, 1989, Byulleten' Eksperimental'noi Biologii i Meditsiny, V108, P563; Skelton MS, 1988, MED SCI SPORTS EXERC, V30, P536; Thomas C, 2005, J APPL PHYSIOL, V98, P804, DOI 10.1152/japplphysiol.01057.2004; Thomas C, 2012, AM J PHYSIOL-REG I, V302, pR1, DOI 10.1152/ajpregu.00250.2011; Urazaev A. Kh, 1998, Uspekhi Fiziologicheskikh Nauk, V29, P12; Usher-Smith JA, 2009, BIOL REV, V84, P143, DOI 10.1111/j.1469-185X.2008.00066.x; VANHOEK AN, 1990, BIOCHIM BIOPHYS ACTA, V1030, P203, DOI 10.1016/0005-2736(90)90296-Z; vanMil HGJ, 1997, BRIT J PHARMACOL, V120, P39, DOI 10.1038/sj.bjp.0700887; Wilson MC, 1998, J BIOL CHEM, V273, P15920, DOI 10.1074/jbc.273.26.15920; Yang BX, 2000, AM J PHYSIOL-CELL PH, V278, pC1108, DOI 10.1152/ajpcell.2000.278.6.C1108; Yang Z, 1991, THESIS U GUELPH; Yoshida Y, 2004, J APPL PHYSIOL, V97, P527, DOI 10.1152/japplphysiol.01347.2003	49	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84451	10.1371/journal.pone.0084451	http://dx.doi.org/10.1371/journal.pone.0084451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376811	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000149
J	McGirr, AA; Tuite, AR; Fisman, DN				McGirr, Ashleigh A.; Tuite, Ashleigh R.; Fisman, David N.			Estimation of the Underlying Burden of Pertussis in Adolescents and Adults in Southern Ontario, Canada	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; UNITED-STATES; VACCINE; EPIDEMIOLOGY; TRANSMISSION; IMMUNITY; RESURGENCE; INFECTION; EFFICACY; RECOMMENDATIONS	Despite highly successful vaccination programs and high vaccine uptake, both endemic pertussis and periodic pertussis outbreaks continue to occur. The under-recognized role of adolescents and adults in disease transmission, due to waning immunity following natural infection and vaccination, and reduced likelihood of correct diagnosis, may contribute to pertussis persistence. We constructed a mathematical model to describe the transmission of pertussis in Southern Ontario in both pre-vaccine and vaccine eras, to estimate the underlying burden of pertussis in the population. The model was well calibrated using the best available data on pertussis in the pre-vaccination (1880-1929) and vaccination (1993-2004) eras in Ontario. Pertussis under-reporting by age group was estimated by comparing model-projected incidence to reported laboratory-confirmed cases for Greater Toronto. Best-fit model estimates gave a basic reproductive number of approximately 10.6, (seasonal range 9.9 to 11.5). Under-reporting increased with age, and approximately >95% of infections in children were caused by infections in persons with waning immunity to pertussis following prior infection or vaccination. A well-calibrated model suggests that under-recognized cases of pertussis in older individuals are likely to be an important driver of ongoing pertussis outbreaks in children. Model projections strongly support enhancement of booster vaccination efforts in adults.	[McGirr, Ashleigh A.; Tuite, Ashleigh R.; Fisman, David N.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto	Fisman, DN (corresponding author), Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	david.fisman@utoronto.ca			Novartis; Sanofi-Pasteur; GlaxoSmithKline vaccine divisions	Novartis(Novartis); Sanofi-Pasteur; GlaxoSmithKline vaccine divisions	The authors have read the journal's policy and have the following conflicts: Dr. Fisman has received research funding from Novartis, Sanofi-Pasteur, and GlaxoSmithKline vaccine divisions. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anderson R M, 1990, Lancet, V335, P641; [Anonymous], 2009, N S W Public Health Bull, V20, P31; Arinaminpathy N, 2012, P NATL ACAD SCI USA, V109, P20154, DOI 10.1073/pnas.1209683109; Bamberger ES, 2008, EUR J PEDIATR, V167, P133, DOI 10.1007/s00431-007-0548-2; Barret AS, 2010, EUROSURVEILLANCE, V15; Blackwood JC, 2013, P NATL ACAD SCI USA, V110, P9595, DOI 10.1073/pnas.1220908110; Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; Broutin H, 2010, P ROY SOC B-BIOL SCI, V277, P3239, DOI 10.1098/rspb.2010.0994; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Cherry JD, 2003, PEDIATRICS, V112, P405, DOI 10.1542/peds.112.2.405; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; De Serres G, 2000, Can Commun Dis Rep, V26, P1; Emerson H, 1937, AM J PUBLIC HLTH S, V27; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Greenberg DP, 2009, PEDIATR INFECT DIS J, V28, P521, DOI 10.1097/INF.0b013e318199d2fc; Halperin SA, 2005, PEDIATR INFECT DIS J, V24, pS141, DOI 10.1097/01.inf.0000166163.02135.8b; HALPERIN SA, 1989, J PEDIATR-US, V115, P686, DOI 10.1016/S0022-3476(89)80643-2; Halperin SA, 2008, HARRISONS PRINCIPLES, P933; Lavine JS, 2012, VACCINE, V30, P544, DOI 10.1016/j.vaccine.2011.11.065; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; Lievano FA, 2002, J CLIN MICROBIOL, V40, P2801, DOI 10.1128/JCM.40.8.2801-2805.2002; LONG SS, 1990, J INFECT DIS, V161, P480, DOI 10.1093/infdis/161.3.480; Macey R., 2000, BERKELEY MADONNA; Macey R., 2009, BERKELEY MADONNA USE; McWha L, 2004, Can Commun Dis Rep, V30, P37; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nguyen HTH, 2008, J R SOC INTERFACE, V5, P403, DOI 10.1098/rsif.2007.1168; Orenstein WA, 2005, HEALTH AFFAIR, V24, P599, DOI 10.1377/hlthaff.24.3.599; Preziosi MP, 2003, VACCINE, V21, P1853, DOI 10.1016/S0264-410X(03)00007-0; Raguckas SE, 2007, PHARMACOTHERAPY, V27, P41, DOI 10.1592/phco.27.1.41; Ross MA, 1932, CAN PUBLIC HLTH J IN, P331; Scheifele D, 1997, 23 NACI CAN COMM DIS; Schmitt HJ, 1996, JAMA-J AM MED ASSOC, V275, P37, DOI 10.1001/jama.275.1.37; Smith C, 2000, EUR J PEDIATR, V159, P898, DOI 10.1007/PL00008365; Stefanoff P, 2013, EPIDEMIOL INFECT, P1; SUTTER RW, 1992, JAMA-J AM MED ASSOC, V267, P386, DOI 10.1001/jama.267.3.386; TARANGER J, 1994, PEDIATR INFECT DIS J, V13, P936, DOI 10.1097/00006454-199410000-00020; Tozzi AE, 2003, PEDIATRICS, V112, P1069, DOI 10.1542/peds.112.5.1069; van Boven M, 2004, TRENDS MICROBIOL, V12, P116, DOI 10.1016/j.tim.2004.01.002; van Boven M, 2000, MATH BIOSCI, V164, P161, DOI 10.1016/S0025-5564(00)00009-2; VONKONIG CHW, 1995, LANCET, V346, P1326, DOI 10.1016/S0140-6736(95)92343-8; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Wearing HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000647; Weir E, 2002, CAN MED ASSOC J, V167, P1146; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Winter K., 2010, Morbidity and Mortality Weekly Report, V59, P817; Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010; World Health Organization, 2003, WHO REC SURV STAND P; WRIGHT SW, 1995, JAMA-J AM MED ASSOC, V273, P1044, DOI 10.1001/jama.273.13.1044	53	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83850	10.1371/journal.pone.0083850	http://dx.doi.org/10.1371/journal.pone.0083850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376767	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000127
J	Perdue, KL; Diamond, SG				Perdue, Katherine L.; Diamond, Solomon Gilbert			Effects of Spatial Pattern Scale of Brain Activity on the Sensitivity of DOT, fMRI, EEG and MEG	PLOS ONE			English	Article							DIFFUSE OPTICAL TOMOGRAPHY; NEAR-INFRARED SPECTROSCOPY; FUNCTIONAL CONNECTIVITY; WHOLE-HEAD; QUANTITATIVE ASSESSMENT; CORTICAL SOURCES; CEREBRAL-CORTEX; VISUAL-CORTEX; MAGNETOENCEPHALOGRAPHY; LOCALIZATION	The objective of this work is to quantify how patterns of cortical activity at different spatial scales are measured by noninvasive functional neuroimaging sensors. We simulated cortical activation patterns at nine different spatial scales in a realistic head model and propagated this activity to magnetoencephalography (MEG), electroencephalography (EEG), diffuse optical tomography (DOT), and functional magnetic resonance imaging (fMRI) sensors in arrangements that are typically used in functional neuroimaging studies. We estimated contrast transfer functions (CTF), correlation distances in sensor space, and the minimum resolvable spatial scale of cortical activity for each modality. We found that CTF decreases as the spatial extent of cortical activity decreases, and that correlations between nearby sensors depend on the spatial extent of cortical activity. For cortical activity on the intermediate spatial scale of 6.7 cm(2), the correlation distances (r>0.5) were 1.0 cm for fMRI, 2.0 cm for DOT, 12.8 for EEG, 9.5 cm for MEG magnetometers and 9.7 cm for MEG gradiometers. The resolvable spatial pattern scale was found to be 1.43 cm(2) for MEG magnetometers, 0.88 cm(2) for MEG gradiometers, 376 cm(2) for EEG, 0.75 cm(2) for DOT, and 0.072 cm(2) for fMRI. These findings show that sensitivity to cortical activity varies substantially as a function of spatial scale within and between the different imaging modalities. This information should be taken into account when interpreting neuroimaging data and when choosing the number of nodes for network analyses in sensor space.	[Perdue, Katherine L.; Diamond, Solomon Gilbert] Thayer Sch Engn Dartmouth, Hanover, NH USA	Dartmouth College	Perdue, KL (corresponding author), Thayer Sch Engn Dartmouth, Hanover, NH USA.	Katherine.Perdue@childrens.harvard.edu	Perdue, Katherine/D-4306-2013	Perdue, Katherine/0000-0003-2846-3149; Diamond, Solomon/0000-0002-7589-2942	National Science Foundation; National Institutes of Health [5R01EB006385]; Institute for Quantitative Biomedical Sciences; Thayer School of Engineering at Dartmouth; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033256] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Quantitative Biomedical Sciences; Thayer School of Engineering at Dartmouth; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Partial funding was provided by National Science Foundation (Graduate Research Fellowship to KLP), National Institutes of Health (5R01EB006385), a Director's DISCOVERY grant from the Institute for Quantitative Biomedical Sciences, and the Thayer School of Engineering at Dartmouth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnour F, 2009, PHYS MED BIOL, V54, P6383, DOI 10.1088/0031-9155/54/20/023; Ahlfors SP, 2010, BRAIN TOPOGR, V23, P227, DOI 10.1007/s10548-010-0154-x; Ahlfors SP, 2010, HUM BRAIN MAPP, V31, P140, DOI 10.1002/hbm.20851; Aubert-Broche B, 2006, IEEE T MED IMAGING, V25, P1410, DOI 10.1109/TMI.2006.883453; Boas DA, 2005, APPL OPTICS, V44, P1957, DOI 10.1364/AO.44.001957; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cooper RJ, 2012, NEUROIMAGE, V62, P1999, DOI 10.1016/j.neuroimage.2012.05.031; Cottereau B, 2007, NEUROIMAGE, V38, P439, DOI 10.1016/j.neuroimage.2007.07.046; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Eggebrecht AT, 2012, NEUROIMAGE, V61, P1120, DOI 10.1016/j.neuroimage.2012.01.124; Fang QQ, 2010, BIOMED OPT EXPRESS, V1, P165, DOI 10.1364/BOE.1.000165; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Formisano E, 2012, NEUROIMAGE, V62, P1249, DOI 10.1016/j.neuroimage.2012.02.078; Freeman WJ, 2009, INT J PSYCHOPHYSIOL, V73, P43, DOI 10.1016/j.ijpsycho.2008.12.019; Goldenholz DM, 2009, HUM BRAIN MAPP, V30, P1077, DOI 10.1002/hbm.20571; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Habermehl C, 2012, NEUROIMAGE, V59, P3201, DOI 10.1016/j.neuroimage.2011.11.062; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Hopfinger JB, 2000, NEUROIMAGE, V11, P326, DOI 10.1006/nimg.2000.0549; Irimia A, 2012, NEUROIMAGE, V59, P2464, DOI 10.1016/j.neuroimage.2011.08.104; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Liu AK, 1998, P NATL ACAD SCI USA, V95, P8945, DOI 10.1073/pnas.95.15.8945; Mesquita RC, 2010, BIOMED OPT EXPRESS, V1, P324, DOI 10.1364/BOE.1.000324; Molins A, 2008, NEUROIMAGE, V42, P1069, DOI 10.1016/j.neuroimage.2008.05.064; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Mur M, 2009, SOC COGN AFFECT NEUR, V4, P101, DOI 10.1093/scan/nsn044; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Nunez P.L., 2005, ELECT FIELDS BRAIN N; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Ou WM, 2009, NEUROIMAGE, V46, P624, DOI 10.1016/j.neuroimage.2009.03.008; Parkes LM, 2005, MAGN RESON MED, V54, P1465, DOI 10.1002/mrm.20712; Perdue KL, 2012, PHYS MED BIOL, V57, P2857, DOI 10.1088/0031-9155/57/10/2857; Phillips C, 2002, NEUROIMAGE, V16, P678, DOI 10.1006/nimg.2002.1143; Rosa MJ, 2010, J INTEGR NEUROSCI, V9, P453, DOI 10.1142/S0219635210002512; Saad ZS, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P1510; Sasai S, 2011, NEUROIMAGE, V56, P252, DOI 10.1016/j.neuroimage.2010.12.075; Shmuel A, 2007, NEUROIMAGE, V35, P539, DOI 10.1016/j.neuroimage.2006.12.030; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Swisher JD, 2010, J NEUROSCI, V30, P325, DOI 10.1523/JNEUROSCI.4811-09.2010; Takeuchi M, 2009, BRAIN TOPOGR, V22, P197, DOI 10.1007/s10548-009-0109-2; Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; White BR, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3368999; Wu L, 2010, NEUROIMAGE, V52, P1252, DOI 10.1016/j.neuroimage.2010.05.053; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zeff BW, 2007, P NATL ACAD SCI USA, V104, P12169, DOI 10.1073/pnas.0611266104	55	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83299	10.1371/journal.pone.0083299	http://dx.doi.org/10.1371/journal.pone.0083299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376684	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000079
J	Brodel, AK; Sonnabend, A; Roberts, LO; Stech, M; Wustenhagen, DA; Kubick, S				Broedel, Andreas K.; Sonnabend, Andrei; Roberts, Lisa O.; Stech, Marlitt; Wuestenhagen, Doreen A.; Kubick, Stefan			IRES-Mediated Translation of Membrane Proteins and Glycoproteins in Eukaryotic Cell-Free Systems	PLOS ONE			English	Article							INTERNAL RIBOSOME ENTRY; INITIATION-FACTORS; SITE; RNA; VIRUS; DICISTROVIRIDAE; MECHANISMS; ELONGATION; EXPRESSION; REGION	Internal ribosome entry site (IRES) elements found in the 5' untranslated region of mRNAs enable translation initiation in a cap-independent manner, thereby representing an alternative to cap-dependent translation in cell-free protein expression systems. However, IRES function is largely species-dependent so their utility in cell-free systems from different species is rather limited. A promising approach to overcome these limitations would be the use of IRESs that are able to recruit components of the translation initiation apparatus from diverse origins. Here, we present a solution to this technical problem and describe the ability of a number of viral IRESs to direct efficient protein expression in different eukaryotic cell-free expression systems. The IRES from the intergenic region (IGR) of the Cricket paralysis virus (CrPV) genome was shown to function efficiently in four different cell-free systems based on lysates derived from cultured Sf21, CHO and K562 cells as well as wheat germ. Our results suggest that the CrPV IGR IRES-based expression vector is universally applicable for a broad range of eukaryotic cell lysates. 5121, CHO and K562 cell-free expression systems are particularly promising platforms for the production of glycoproteins and membrane proteins since they contain endogenous microsomes that facilitate the incorporation of membrane-spanning proteins and the formation of post-translational modifications. We demonstrate the use of the CrPV IGR RES-based expression vector for the enhanced synthesis of various target proteins including the glycoprotein erythropoietin and the membrane proteins heparin-binding EGF-like growth factor receptor as well as epidermal growth factor receptor in the above mentioned eukaryotic cell-free systems. CrPV IGR RES-mediated translation will facilitate the development of novel eukaryotic cell-free expression platforms as well as the high-yield synthesis of desired proteins in already established systems.	[Broedel, Andreas K.; Sonnabend, Andrei; Stech, Marlitt; Wuestenhagen, Doreen A.; Kubick, Stefan] Fraunhofer Inst Biomed Engn IBMT, Branch Potsdam Golm, Potsdam, Germany; [Roberts, Lisa O.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	Fraunhofer Gesellschaft; University of Surrey	Kubick, S (corresponding author), Fraunhofer Inst Biomed Engn IBMT, Branch Potsdam Golm, Potsdam, Germany.	stefan.kubick@ibmt.fraunhofer.de		Brodel, Andreas/0000-0002-8639-9782	German Ministry of Education and Research (BMBF) [0312039]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Ministry of Education and Research (BMBF number 0312039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Brodel AK, 2013, J BIOTECHNOL, V163, P301, DOI 10.1016/j.jbiotec.2012.11.001; Carlson ED, 2011, BIOTECHNOLOGY ADV; Cevallos RC, 2005, J VIROL, V79, P677, DOI 10.1128/JVI.79.2.677-683.2005; Deniz N, 2009, RNA, V15, P932, DOI 10.1261/rna.1315109; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hertz MI, 2011, NUCLEIC ACIDS RES, V39, P7276, DOI 10.1093/nar/gkr427; Hertz MI, 2011, VIROLOGY, V411, P355, DOI 10.1016/j.virol.2011.01.005; HIGUCHI M, 1992, J BIOL CHEM, V267, P7703; Hohn T, 2000, DEV PL GEN, V5, P126; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Kobayashi T, 2007, J VIROL METHODS, V142, P182, DOI 10.1016/j.jviromet.2007.01.026; Kobayashi T, 2011, J BIOCHEM, V150, P423, DOI 10.1093/jb/mvr072; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Kubick S, 2003, CELL-FREE PROTEIN EXPRESSION, P209; Kubick S, 2009, CURR TOP MEMBR, V63, P25, DOI 10.1016/S1063-5823(09)63002-7; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Li HJ, 2009, CURR OPIN BIOTECH, V20, P678, DOI 10.1016/j.copbio.2009.10.009; Li J, 2010, N LINKED PROTEIN GLY, P227; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; Mikami S, 2006, PROTEIN EXPRES PURIF, V46, P348, DOI 10.1016/j.pep.2005.09.021; Mureev S, 2009, NAT BIOTECHNOL, V27, P747, DOI 10.1038/nbt.1556; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; Orth JHC, 2011, TOXICON, V57, P199, DOI 10.1016/j.toxicon.2010.11.011; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pisarev AV, 2005, CR BIOL, V328, P589, DOI 10.1016/j.crvi.2005.02.004; Sachse R, 2013, ENG LIFE SCI, V13, P39, DOI 10.1002/elsc.201100235; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stech M, 2013, J BIOTECHNOL, V164, P220, DOI 10.1016/j.jbiotec.2012.08.020; Swartz JR, 2009, NAT BIOTECHNOL, V27, P731, DOI 10.1038/nbt0809-731; Terenin IM, 2005, MOL CELL BIOL, V25, P7879, DOI 10.1128/MCB.25.17.7879-7888.2005; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Woolaway KE, 2001, J VIROL, V75, P10244, DOI 10.1128/JVI.75.21.10244-10249.2001; Zeenko VV, 2008, RNA, V14, P593, DOI 10.1261/rna.825008	43	49	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82234	10.1371/journal.pone.0082234	http://dx.doi.org/10.1371/journal.pone.0082234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376523	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100021
J	Chen, JJ; Jing, J; Zhan, ZX; Zhang, T; Zhang, CY; Piao, ZY				Chen, Jingjing; Jing, Jing; Zhan, Zhongxiang; Zhang, Teng; Zhang, Chunyu; Piao, Zhongyun			Identification of Novel QTLs for Isolate-Specific Partial Resistance to Plasmodiophora brassicae in Brassica rapa	PLOS ONE			English	Article							CLUBROOT-RESISTANCE; CHINESE-CABBAGE; ARABIDOPSIS-THALIANA; COMPARATIVE GENOMICS; LINKAGE MAPS; DISEASE; MARKERS; GENE; LOCI; MICROSATELLITES	Plasmodiophora brassicae, the causal agent of clubroot disease of the Brassica crops, is widespread in the world. Quantitative trait loci (QTLs) for partial resistance to 4 different isolates of P. brassicae (Pb2, Pb4, Pb7, and Pb10) were investigated using a BC1F1 population from a cross between two subspecies of Brassica rapa, i.e. Chinese cabbage inbred line C59-1 as a susceptible recurrent parent and turnip inbred line ECD04 as a resistant donor parent. The BC1F2 families were assessed for resistance under controlled conditions. A linkage map constructed with simple sequence repeats (SSR), unigene-derived microsatellite (UGMS) markers, and specific markers linked to published clubroot resistance (CR) genes of B. rapa was used to perform QTL mapping. A total of 6 QTLs residing in 5 CR QTL regions of the B. rapa chromosomes A01, A03, and A08 were identified to account for 12.2 to 35.2% of the phenotypic variance. Two QTL regions were found to be novel except for 3 QTLs in the respective regions of previously identified Crr1, Crr2, and Crr3. QTL mapping results indicated that 1 QTL region was common for partial resistance to the 2 isolates of Pb2 and Pb7, whereas the others were specific for each isolate. Additionally, synteny analysis between B. rapa and Arabidopsis thaliana revealed that all CR QTL regions were aligned to a single conserved crucifer blocks (U, F, and R) on 3 Arabidopsis chromosomes where 2 CR QTLs were detected in A. thaliana. These results suggest that some common ancestral genomic regions were involved in the evolution of CR genes in B. rapa.	[Chen, Jingjing; Jing, Jing; Zhang, Teng; Piao, Zhongyun] Shenyang Agr Univ, Coll Hort, Shenyang 110161, Peoples R China; [Zhan, Zhongxiang; Zhang, Chunyu] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Zhan, Zhongxiang; Zhang, Chunyu] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Shenyang Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Zhang, CY (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	zhchy@mail.hzau.edu.cn; zypiao@syau.edu.cn	Zhang, Chun-yu/HDP-5776-2022; chen, JJ/HGB-6029-2022		National Natural Scientific Foundation of China [31171967]; Natural Science Foundation of Liaoning Province of China [20102199]; Research Fund for the Doctoral Program of Higher Education of China [20132103110010]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province of China(Natural Science Foundation of Liaoning Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by grants from the National Natural Scientific Foundation of China, Project No. 31171967, the Natural Science Foundation of Liaoning Province of China, Project No. 20102199, and the Research Fund for the Doctoral Program of Higher Education of China, Project No. 20132103110010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeiter A., 2002, Plant Protection Science, V38, P519; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; Botella MA, 1997, PLANT J, V12, P1197, DOI 10.1046/j.1365-313X.1997.12051197.x; BUCZACKI ST, 1975, T BRIT MYCOL SOC, V65, P295, DOI 10.1016/S0007-1536(75)80013-1; Choi SR, 2007, THEOR APPL GENET, V115, P777, DOI 10.1007/s00122-007-0608-z; CHURCHILL GA, 1994, GENETICS, V138, P963; Cowling WA, 2009, CROP PASTURE SCI, V60, P1009, DOI 10.1071/CP08223; CRISP P, 1989, EUPHYTICA, V42, P215; CRUTE IR, 1986, PLANT PATHOL, V35, P15, DOI 10.1111/j.1365-3059.1986.tb01975.x; CRUTE IR, 1983, PLANT PATHOL, V32, P405, DOI 10.1111/j.1365-3059.1983.tb02855.x; Devos S, 2005, NEW PHYTOL, V166, P241, DOI 10.1111/j.1469-8137.2004.01304.x; Diederichsen E, 1996, PLANT BREEDING, V115, P5, DOI 10.1111/j.1439-0523.1996.tb00862.x; Doerge RW, 1996, GENETICS, V142, P285; Fuchs H, 1996, MOL PLANT MICROBE IN, V9, P91, DOI 10.1094/MPMI-9-0091; Hatakeyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054745; Hayashida N, 2008, J JPN SOC HORTIC SCI, V77, P150, DOI 10.2503/jjshs1.77.150; Hirai M, 2004, THEOR APPL GENET, V108, P639, DOI 10.1007/s00122-003-1475-x; Hirai M, 2006, BREEDING SCI, V56, P223, DOI 10.1270/jsbbs.56.223; Jubault M, 2008, THEOR APPL GENET, V117, P191, DOI 10.1007/s00122-008-0765-8; Karling J.S., 1968, PLASMODIOPHORALES IN, V2nd ed.; Kim H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-432; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kuginuki Y, 1999, EUR J PLANT PATHOL, V105, P327, DOI 10.1023/A:1008705413127; Kuginuki Y, 1997, EUPHYTICA, V98, P149, DOI 10.1023/A:1003147815692; Li XN, 2013, DNA RES, V20, P1, DOI 10.1093/dnares/dss029; Li X, 2010, GENOME, V53, P939, DOI 10.1139/G10-054; Manzanares MJ, 1996, ACTA HORTIC, P411, DOI 10.17660/ActaHortic.1996.407.52; Manzanares-Dauleux MJ, 2000, THEOR APPL GENET, V101, P885, DOI 10.1007/s001220051557; Matsumoto E, 1998, EUPHYTICA, V104, P79, DOI 10.1023/A:1018370418201; McMullen MD, 1995, MOL PLANT MICROBE IN, V8, P811, DOI 10.1094/MPMI-8-0811; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagaoka T, 2010, THEOR APPL GENET, V120, P1335, DOI 10.1007/s00122-010-1259-z; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parida SK, 2010, GENOME, V53, P55, DOI [10.1139/G09-084, 10.1139/g09-084]; Piao Zhong Yun, 2007, Horticulture Environment and Biotechnology, V48, P148; Piao ZY, 2009, J PLANT GROWTH REGUL, V28, P252, DOI 10.1007/s00344-009-9093-8; Piao ZY, 2004, THEOR APPL GENET, V108, P1458, DOI 10.1007/s00122-003-1577-5; Ramchiary N, 2011, DNA RES, V18, P305, DOI 10.1093/dnares/dsr017; Richter TE, 2000, PLANT MOL BIOL, V42, P195, DOI 10.1023/A:1006388223475; Saito M, 2006, THEOR APPL GENET, V114, P81, DOI 10.1007/s00122-006-0412-1; Sakamoto K, 2008, THEOR APPL GENET, V117, P759, DOI 10.1007/s00122-008-0817-0; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Suwabe K, 2003, THEOR APPL GENET, V107, P997, DOI 10.1007/s00122-003-1309-x; Suwabe K, 2002, THEOR APPL GENET, V104, P1092, DOI 10.1007/s00122-002-0875-7; Suwabe K, 2006, GENETICS, V173, P309, DOI 10.1534/genetics.104.038968; Tanaka Shuhei, 2006, Journal of General Plant Pathology, V72, P205, DOI 10.1007/s10327-006-0276-x; Ueno H, 2012, PLANT MOL BIOL, V80, P621, DOI 10.1007/s11103-012-9971-5; Van Ooijen JW, 2001, JOINT MAP VERSION 3; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S., 2007, WINDOWS QTL CARTOGRA; Werner S, 2008, THEOR APPL GENET, V116, P363, DOI 10.1007/s00122-007-0674-2; WILLIAMS PH, 1966, PHYTOPATHOLOGY, V56, P624; WIT F, 1964, EUPHYTICA, V13, P9, DOI 10.1007/BF00037512; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yoshikawa H., 1993, B NATL RES I VEG ORN, V7, P1	56	52	63	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85307	10.1371/journal.pone.0085307	http://dx.doi.org/10.1371/journal.pone.0085307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376876	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100201
J	Li, W; Huang, Y; Li, YP; Chen, X				Li, Wei; Huang, Yue; Li, Yapeng; Chen, Xi			Brain Network Evolution after Stroke Based on Computational Experiments	PLOS ONE			English	Article							AGE-RELATED-CHANGES; FUNCTIONAL CONNECTIVITY; GLOBAL OPTIMIZATION; MOTOR RECOVERY; COMMUNICATION; CONSEQUENCES; ORGANIZATION; DYNAMICS; CORTEX; MODEL	Stroke is a frequently-occurring disease threatening the human nervous system. As a serious debilitation affecting a large-scale, hierarchical, and vastly complex electrochemical system, stroke remains relatively misunderstood. Rehabilitation mechanisms and means have suffered from this lack of systematic understanding. Here we propose an evolution model to simulate the dynamic actual evolvement process of functional brain networks computationally in an effort to address current shortcomings in the state of the field. According to simulation results, we conclude that the brain networks of patients following acute stroke were characterized by lower small worldness and lower quantity of long-distance connections compared with the healthy condition. Moreover, distance penalization may be used to describe the general mechanism of brain network evolution in the acute period after stroke.	[Li, Wei; Huang, Yue; Li, Yapeng; Chen, Xi] Educ Minist China, Image Proc & Intelligent Control Key Lab, Wuhan, Peoples R China; [Li, Wei; Huang, Yue; Li, Yapeng] Huazhong Univ Sci & Technol, Dept Intelligent Sci & Technol, Wuhan 430074, Peoples R China; [Chen, Xi] Huazhong Univ Sci & Technol, Dept Syst Sci & Engn, Coll Automat, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, X (corresponding author), Educ Minist China, Image Proc & Intelligent Control Key Lab, Wuhan, Peoples R China.	chenxi@mail.hust.edu.cn			Natural Science Foundation of China [60905024, 70903026]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Natural Science Foundation of China (No. 60905024 and No. 70903026) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Bloch AF, 2013, CEREB CORTEX, V23, P127, DOI 10.1093/cercor/bhr388; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BANKES S, 1993, OPER RES, V41, P435, DOI 10.1287/opre.41.3.435; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bosnell RA, 2011, NEUROREHAB NEURAL RE, V25, P607, DOI 10.1177/1545968311405675; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Buma FE, 2010, NEUROREHAB NEURAL RE, V24, P589, DOI 10.1177/1545968310364058; Buzsaki G., 2006, RHYTHMS BRAIN, V34, P448, DOI [1204.92017, DOI 10.1093/ACPROF:OSO/9780195301069.001.0001, 10.1093/acprof:oso/9780195301069.001.0001]; Carhart-Harris RL, 2010, BRAIN, V133, P1265, DOI 10.1093/brain/awq010; Carter AR, 2012, NEUROREHAB NEURAL RE, V26, P7, DOI 10.1177/1545968311411054; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Cherniak C, 2004, P NATL ACAD SCI USA, V101, P1081, DOI 10.1073/pnas.0305212101; De Vico Fallani F, 2013, NEUROIMAGE; Downes JH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002522; Fallani FDV, 2008, IEEE T NEUR SYS REH, V16, P442, DOI 10.1109/TNSRE.2008.2006196; Fallani FDV, 2007, HUM BRAIN MAPP, V28, P1334, DOI 10.1002/hbm.20353; Fallani FD, 2009, ANAT REC, V292, P2023, DOI 10.1002/ar.20965; Finger S., 2001, ORIGINS NEUROSCIENCE; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gao W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025278; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Lai SM, 2002, STROKE, V33, P1840, DOI 10.1161/01.STR.0000019289.15440.F2; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Li X, 2003, PHYSICA A, V328, P287, DOI 10.1016/S0378-4371(03)00567-3; Li X, 2003, PHYSICA A, V328, P274, DOI 10.1016/S0378-4371(03)00604-6; Liu ZH, 2002, PHYS LETT A, V303, P337, DOI 10.1016/S0375-9601(02)01317-8; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Mintzopoulos D, 2009, NEUROIMAGE, V47, pT90, DOI 10.1016/j.neuroimage.2009.03.007; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Portillo IJG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006863; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tsirka V, 2011, INT J PSYCHOPHYSIOL, V79, P89, DOI 10.1016/j.ijpsycho.2010.09.006; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Vertes PE, 2012, P NATL ACAD SCI USA, V109, P5868, DOI 10.1073/pnas.1111738109; Wang Fei-yue, 2004, Journal of System Simulation, V16, P893; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westlake KP, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00008; Xuan Q, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036105; Zhu CP, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/023006	54	11	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82845	10.1371/journal.pone.0082845	http://dx.doi.org/10.1371/journal.pone.0082845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376592	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100065
J	Ma, CZ; Cao, W; Liu, WH; Gui, R; Jia, Y				Ma, Chengzhang; Cao, Wei; Liu, Wangheng; Gui, Rong; Jia, Ya			Direct Sum Matrix Game with Prisoner's Dilemma and Snowdrift Game	PLOS ONE			English	Article							TIT-FOR-TAT; EVOLUTIONARY GAMES; COOPERATION; STRATEGY; INVASION	A direct sum form is proposed for constructing a composite game from two 2 x 2 games, prisoner's dilemma and snowdrift game. This kind of direct sum form game is called a multiple roles game. The replicator dynamics of the multiple roles game h will-mixed populations is explored. The dynamical behaviors on square lattice are investigated by numerical simulation found that the dynamical behaviors of population on square lattice depend on the mixing proportion of the two simple games. Mixing SD activities to pure PD population inhibits the proportion of cooperators in PD, and mixing PD activities to pure SD population stimulates the proportion of cooperators in SD. Besides spatial reciprocity, our results show hat there are roles reciprocities between different types of individuals.	[Ma, Chengzhang; Cao, Wei; Liu, Wangheng; Gui, Rong; Jia, Ya] Huazhong Normal Univ, Dept Phys, Wuhan 430070, Peoples R China; [Ma, Chengzhang; Cao, Wei; Liu, Wangheng; Gui, Rong; Jia, Ya] Huazhong Normal Univ, Inst Biophys, Wuhan, Peoples R China; [Ma, Chengzhang; Cao, Wei; Gui, Rong] Huazhong Agr Univ, Coll Sci, Dept Appl Phys, Wuhan, Peoples R China	Central China Normal University; Central China Normal University; Huazhong Agricultural University	Jia, Y (corresponding author), Huazhong Normal Univ, Dept Phys, Wuhan 430070, Peoples R China.	jiay@phy.ccnu.edu.cn	Jia, Ya/J-6121-2017	Jia, Ya/0000-0002-2818-9074; Chengzhang, Ma/0000-0003-2742-1174	National Natural Science Foundation of China [11175068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under 11175068 (YJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R, 1984, EVOLUTION THEORY GAM; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Chen XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043724, 10.1371/journal.pone.0036895]; Colman AM, 2013, GAME THEORY ITS APPL; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Fu F, 2010, J THEOR BIOL, V266, P358, DOI 10.1016/j.jtbi.2010.06.042; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; HELBING D, 1992, PHYSICA A, V181, P29, DOI 10.1016/0378-4371(92)90195-V; KERR NL, 1983, J PERS SOC PSYCHOL, V45, P819, DOI 10.1037/0022-3514.45.4.819; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; Liu YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030689; Lotem A, 1999, NATURE, V400, P226, DOI 10.1038/22247; Maynard Smith J., 1982, pi; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ohtsuki H, 2006, J THEOR BIOL, V239, P435, DOI 10.1016/j.jtbi.2005.08.008; Ohtsuki H, 2006, P ROY SOC B-BIOL SCI, V273, P2249, DOI 10.1098/rspb.2006.3576; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026104; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wang J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016101; Wang SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001917; Wang XF, 2012, SCI REP-UK, V2, DOI 10.1038/srep00740; WILSON DS, 1983, ANNU REV ECOL SYST, V14, P159, DOI 10.1146/annurev.es.14.110183.001111; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143	40	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e81855	10.1371/journal.pone.0081855	http://dx.doi.org/10.1371/journal.pone.0081855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376505	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100009
J	Wang, SK; Wang, Y; Wu, HJ; Hu, LK				Wang, Shikun; Wang, Yang; Wu, Haijian; Hu, Likuan			RBP2 Induces Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							HISTONE DEMETHYLASE RBP2; E-CADHERIN EXPRESSION; H3 LYSINE 4; BREAST-CANCER; N-CADHERIN; TUMOR PROGRESSION; METASTASIS; INVASION; METHYLATION; GENE	RBP2 has been found to actively participate in cancer progression. It inhibits the senescence of cancer cells, mediates cancer cell proliferation and promotes cancer metastasis. It is also essential to drug tolerance. However, the effects of RBP2 on epithelial-mesenchymal transition are still unknown. In this study, we analyzed the effects of RBP2 on epithelial-mesenchymal transition in non-small cell lung cancer. The results showed that RBP2 down-regulated the expression of E-cadherin by inhibiting the promoter activity of E-cadherin and up-regulated the expression of N-cadherin and snail via the activation of Akt signaling, and the overexpression of RBP2 induced epithelial-rnesenchymal transition in non-small cell lung cancer cells. Our study further indicated thatRBP2 may be a potential target for anti-lung cancer therapy.	[Wang, Shikun; Wang, Yang; Wu, Haijian; Hu, Likuan] Shandong Univ, Qilu Hosp, Dept Radiat Oncol, Jinan 250100, Shandong, Peoples R China	Shandong University	Hu, LK (corresponding author), Shandong Univ, Qilu Hosp, Dept Radiat Oncol, Jinan 250100, Shandong, Peoples R China.	hulikuan_2013@163.com			Natural Science Foundation of Shandong Province [Z2005C02]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the Natural Science Foundation of Shandong Province [Z2005C02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Cheng SF, 2003, AM J PATHOL, V162, P1937, DOI 10.1016/S0002-9440(10)64327-1; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Esteller M, 2005, EMBO REP, V6, P624, DOI 10.1038/sj.embor.7400456; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Huang PH, 2011, MOL PHARMACOL, V79, P197, DOI 10.1124/mol.110.067702; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lawrence MG, 2007, CELLS TISSUES ORGANS, V185, P111, DOI 10.1159/000101311; Li SH, 2009, WORLD J SURG, V33, P1876, DOI 10.1007/s00268-009-0119-y; Lin WC, 2011, P NATL ACAD SCI USA, V108, P13379, DOI 10.1073/pnas.1110104108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Montenegro RC, 2013, TOXICOL IN VITRO, V27, P2076, DOI 10.1016/j.tiv.2013.07.011; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Teng YC, 2013, CANCER RES, V73, P4711, DOI 10.1158/0008-5472.CAN-12-3165; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Wang H, 2013, CANC PLOS ONE, V8, DOI [10.1371/journal.pone.0056664, DOI 10.1371/J0URNAL.P0NE.0056664]; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045622; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058915; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942	42	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84735	10.1371/journal.pone.0084735	http://dx.doi.org/10.1371/journal.pone.0084735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376841	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100184
J	Zhang, XX; Tang, YJ; Ma, QB; Yang, CY; Mu, YH; Suo, HC; Luo, LH; Nian, H				Zhang, Xiu-xiang; Tang, Yu-juan; Ma, Qi-bin; Yang, Cun-yi; Mu, Ying-hui; Suo, Hai-cui; Luo, Lai-hui; Nian, Hai			OsDREB2A, a Rice Transcription Factor, Significantly Affects Salt Tolerance in Transgenic Soybean	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; DNA-BINDING PROTEINS; CIS-ACTING ELEMENT; FUNCTIONAL-CHARACTERIZATION; PROLINE BIOSYNTHESIS; DROUGHT TOLERANCE; STRESS RESPONSES; ABIOTIC STRESSES; OVER-EXPRESSION; LOW-TEMPERATURE	The dehydration responsive element binding (DREB) transcription factors play an important role in regulating stress-related genes. OsDREB2A, a member of the DREBP subfamily of AP2/ERF transcription factors in rice (Oryza sativa), is involved in the abiotic stress response. OsDREB2A expression is induced by drought, low-temperature and salt stresses. Here, we report the ability of OsDREB2A to regulate high-salt response in transgenic soybean. Overexpressing OsDREB2A in soybeans enhanced salt tolerance by accumulating osmolytes, such as soluble sugars and free proline, and improving the expression levels of some stress-responsive transcription factors and key genes. The phenotypic characterization of transgenic soybean were significantly better than those of wild-type (WT). Electrophoresis mobility shift assay (EMSA) revealed that the OsDREB2A can bind to the DRE core element in vitro. These results indicate that OsDREB2A may participate in abiotic stress by directly binding with DRE element to regulate the expression of downstream genes. Overexpression of OsDREB2A in soybean might be used to improve tolerance to salt stress.	[Zhang, Xiu-xiang; Tang, Yu-juan; Ma, Qi-bin; Yang, Cun-yi; Mu, Ying-hui; Suo, Hai-cui; Nian, Hai] South China Agr Univ, State Key Lab Agr & Biol Resources Protect & Util, Guangdong Subctr, Natl Ctr Soybean Improvement,Coll Agr, Guangzhou, Guangdong, Peoples R China; [Luo, Lai-hui] Jiaying Univ, Sch Life Sci, Meizhou, Peoples R China	South China Agricultural University; Jiaying University	Zhang, XX (corresponding author), South China Agr Univ, State Key Lab Agr & Biol Resources Protect & Util, Guangdong Subctr, Natl Ctr Soybean Improvement,Coll Agr, Guangzhou, Guangdong, Peoples R China.	xiuxiangzh@scau.edu.cn; hnian@scau.edu.cn	ma, qibin/HDO-2133-2022		National Key Project for Research on Transgenic Biology in China [2014ZX0800921B-002, 2011ZX08004-002-003]; China Agricultural Research System [CARS-04-PS09]; Scientific and Technological Planning Project of Guandong Province [2009A020102004]	National Key Project for Research on Transgenic Biology in China; China Agricultural Research System; Scientific and Technological Planning Project of Guandong Province	This work was supported, in part, by grants from National Key Project for Research on Transgenic Biology in China (2014ZX0800921B-002), the China Agricultural Research System (CARS-04-PS09), National Key Project for Research on Transgenic Biology in China (2011ZX08004-002-003) and the Scientific and Technological Planning Project of Guandong Province (2009A020102004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An G, 1988, BINARY VECTORS, P1; Angkinand N, 2000, PLANT PHYSL LAB; Anoop N, 2003, J PLANT BIOCHEM BIOT, V12, P109, DOI 10.1007/BF03263170; Armengaud P, 2004, PHYSIOL PLANTARUM, V120, P442, DOI 10.1111/j.0031-9317.2004.00251.x; Barrero JM, 2006, PLANT CELL ENVIRON, V29, P2000, DOI 10.1111/j.1365-3040.2006.01576.x; Chen JQ, 2008, BIOTECHNOL LETT, V30, P2191, DOI 10.1007/s10529-008-9811-5; Chen M, 2007, BIOCHEM BIOPH RES CO, V353, P299, DOI 10.1016/j.bbrc.2006.12.027; Cong L, 2008, BIOCHEM BIOPH RES CO, V371, P702, DOI 10.1016/j.bbrc.2008.04.126; Cui M, 2011, PLANT PHYSIOL BIOCH, V49, P1384, DOI 10.1016/j.plaphy.2011.09.012; DELAUNEY AJ, 1990, MOL GEN GENET, V221, P299, DOI 10.1007/BF00259392; Di R, 1996, PLANT CELL REP, V15, P746, DOI 10.1007/BF00232220; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Vendruscolo ECG, 2007, J PLANT PHYSIOL, V164, P1367, DOI 10.1016/j.jplph.2007.05.001; Gutha LR, 2008, PLANT MOL BIOL, V68, P533, DOI 10.1007/s11103-008-9391-8; Hao DY, 1998, J BIOL CHEM, V273, P26857, DOI 10.1074/jbc.273.41.26857; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hmida-Sayari A, 2005, PLANT SCI, V169, P746, DOI 10.1016/j.plantsci.2005.05.025; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jiang C, 1996, PLANT MOL BIOL, V30, P679, DOI 10.1007/BF00049344; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Li XP, 2005, THEOR APPL GENET, V110, P1355, DOI 10.1007/s00122-004-1867-6; Liu N, 2007, PLANTA, V226, P827, DOI 10.1007/s00425-007-0529-8; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu W, 2010, ONCOGENE, V29, P4914, DOI 10.1038/onc.2010.237; Mito T, 2011, PLANT BIOTECHNOL J, V9, P736, DOI 10.1111/j.1467-7652.2010.00578.x; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Riechmann JL, 1998, BIOL CHEM, V379, P633; Saltzmann KD, 2008, J CHEM ECOL, V34, P1401, DOI 10.1007/s10886-008-9544-x; Shen YG, 2003, THEOR APPL GENET, V107, P155, DOI 10.1007/s00122-003-1226-z; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Su J, 2004, PLANT SCI, V166, P941, DOI 10.1016/j.plantsci.2003.12.004; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tang MJ, 2007, PLANT MOL BIOL, V63, P419, DOI 10.1007/s11103-006-9098-7; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Xiong YW, 2006, PLANTA, V224, P878, DOI 10.1007/s00425-006-0273-5; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zeng P, 2004, PLANT CELL REP, V22, P478, DOI 10.1007/s00299-003-0712-8; Zhao JS, 2007, PLANT CELL REP, V26, P1521, DOI 10.1007/s00299-007-0362-3	45	50	63	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83011	10.1371/journal.pone.0083011	http://dx.doi.org/10.1371/journal.pone.0083011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376625	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100078
J	Carleton, RD; Heard, SB; Silk, PJ				Carleton, R. Drew; Heard, Stephen B.; Silk, Peter J.			A Simulation Approach to Assessing Sampling Strategies for Insect Pests: An Example with the Balsam Gall Midge	PLOS ONE			English	Article							SPRUCE BUDWORM DEFOLIATION; EVOLUTIONARY RADIATIONS; FOLIAGE WEIGHT; GROWTH LOSS; PARAMETER; FIR; AGGREGATION; LIKELIHOOD; SELECTION; BEHAVIOR	Estimation of pest density is a basic requirement for integrated pest management in agriculture and forestry, and efficiency in density estimation is a common goal. Sequential sampling techniques promise efficient sampling, but their application can involve cumbersome mathematics and/or intensive warm-up sampling when pests have complex within-or between-site distributions. We provide tools for assessing the efficiency of sequential sampling and of alternative, simpler sampling plans, using computer simulation with "pre-sampling'' data. We illustrate our approach using data for balsam gall midge (Paradiplosis tumifex) attack in Christmas tree farms. Paradiplosis tumifex proved recalcitrant to sequential sampling techniques. Midge distributions could not be fit by a common negative binomial distribution across sites. Local parameterization, using warm-up samples to estimate the clumping parameter k for each site, performed poorly: k estimates were unreliable even for samples of n similar to 100 trees. These methods were further confounded by significant within-site spatial autocorrelation. Much simpler sampling schemes, involving random or belt-transect sampling to preset sample sizes, were effective and efficient for P. tumifex. Sampling via belt transects (through the longest dimension of a stand) was the most efficient, with sample means converging on true mean density for sample sizes of n similar to 25-40 trees. Pre-sampling and simulation techniques provide a simple method for assessing sampling strategies for estimating insect infestation. We suspect that many pests will resemble P. tumifex in challenging the assumptions of sequential sampling methods. Our software will allow practitioners to optimize sampling strategies before they are brought to real-world applications, while potentially avoiding the need for the cumbersome calculations required for sequential sampling methods.	[Carleton, R. Drew; Silk, Peter J.] Nat Resources Canada, Atlantic Forestry Ctr, Canadian Forest Serv, Fredericton, NB, Canada; [Carleton, R. Drew] Forest Protect Ltd, Lincoln, NB, Canada; [Heard, Stephen B.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada	Natural Resources Canada; Canadian Forest Service; University of New Brunswick	Carleton, RD (corresponding author), Nat Resources Canada, Atlantic Forestry Ctr, Canadian Forest Serv, Fredericton, NB, Canada.	Drew.Carleton@nrcan-rncan.gc.ca			Canadian Agricultural Adaption Program; Natural Resources Canada, Canadian Forest Service; Forest Protection Limited; Natural Sciences and Engineering Research Council of Canada	Canadian Agricultural Adaption Program; Natural Resources Canada, Canadian Forest Service(Natural Resources CanadaCanadian Forest Service); Forest Protection Limited; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Canadian Agricultural Adaption Program; Natural Resources Canada, Canadian Forest Service; Forest Protection Limited; Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT MS, 1946, P CAMB PHILOS SOC, V42, P239, DOI 10.1017/S0305004100022994; Binns MR, 1994, HDB SAMPLING METHODS, P175; Burgio G, 2012, B INSECTOL, V65, P123; Carleton RD, 2012, CANADIAN EN IN PRESS; CLARK SJ, 1989, BIOMETRICS, V45, P309, DOI 10.2307/2532055; Denno R.F., 1983, VARIABLE PLANTS HERB; DePalma E, 2012, J ECON ENTOMOL, V105, P1077, DOI 10.1603/EC11199; Edgington E.S., 2007, RANDOMIZATION TESTS; GIESE RONALD L., 1959, FOREST SCI, V5, P193; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Heard SB, 1998, OIKOS, V81, P187, DOI 10.2307/3546480; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; IWAO S, 1975, Researches on Population Ecology (Tokyo), V16, P281, DOI 10.1007/BF02511067; Johns RC, 2009, ENTOMOL EXP APPL, V132, P264, DOI 10.1111/j.1570-7458.2009.00890.x; Kotze DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040923; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; OSGOOD EA, 1978, ANN ENTOMOL SOC AM, V71, P85, DOI 10.1093/aesa/71.1.85; Pedigo LP., 1994, HDB SAMPLING METHODS; PIEGORSCH WW, 1990, BIOMETRICS, V46, P863, DOI 10.2307/2532104; Piene H, 1999, FOREST ECOL MANAG, V123, P115, DOI 10.1016/S0378-1127(99)00023-7; Piene H, 2003, FOREST ECOL MANAG, V179, P37, DOI 10.1016/S0378-1127(02)00484-X; QUIRING DT, 1993, ECOL ENTOMOL, V18, P353, DOI 10.1111/j.1365-2311.1993.tb01112.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Reynolds DR, 2002, COMPUT ELECTRON AGR, V35, P271, DOI 10.1016/S0168-1699(02)00023-6; Shah PK, 2009, J ECON ENTOMOL, V102, P1070; Statistics Canada ITD, 2012, CHRISTM TREES NUMB; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Wald A., 1947, SEQUENTIAL ANAL; WILLSON LJ, 1984, BIOMETRICS, V40, P109, DOI 10.2307/2530749; Zhang ZP, 2012, J AGR BIOL ENVIR ST, V17, P265, DOI 10.1007/s13253-012-0089-7	34	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82618	10.1371/journal.pone.0082618	http://dx.doi.org/10.1371/journal.pone.0082618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376556	Green Submitted, gold, Green Published			2022-12-27	WOS:000328882000018
J	Cherry, JJ; Rietz, A; Malinkevich, A; Liu, YQ; Xie, M; Bartolowits, M; Davisson, VJ; Baleja, JD; Androphy, EJ				Cherry, Jonathan J.; Rietz, Anne; Malinkevich, Anna; Liu, Yuqi; Xie, Meng; Bartolowits, Matthew; Davisson, V. Jo; Baleja, James D.; Androphy, Elliot J.			Structure Based Identification and Characterization of Flavonoids That Disrupt Human Papillomavirus-16 E6 Function	PLOS ONE			English	Article							PRIMARY HUMAN KERATINOCYTES; MAMMARY EPITHELIAL-CELLS; TYPE-16 E6; E6-MEDIATED DEGRADATION; MUTATIONAL ANALYSIS; ACCURATE DOCKING; E7 ONCOPROTEINS; PROTEIN; P53; CANCER	Expression and function of the human papillomavirus (HPV) early protein 6 (E6) is necessary for viral replication and oncogenesis in cervical cancers. HPV E6 targets the tumor suppressor protein p53 for degradation. To achieve this, "high-risk" HPV E6 proteins bind to and modify the target specificity of the ubiquitin ligase E6AP (E6 associated protein). This E6-dependent loss of p53 enables the virus to bypass host cell defenses and facilitates virally induced activation of the cell cycle progression during viral replication. Disruption of the interaction between E6 and E6AP and stabilization of p53 should decrease viability and proliferation of HPV positive cells. A new in vitro high-throughput binding assay was developed to assay binding between HPV-16 E6 and E6AP and to identify compounds that inhibit this interaction. The compound luteolin emerged from the screen and a library of novel flavones based on its structure was synthesized and characterized using this in vitro binding assay. The compounds identified in this study disrupt the E6/E6AP interaction, increase the levels of p53 and p21(Cip1/Waf1), and decrease proliferation of HPV positive cell lines. The new class of flavonoid E6 inhibitors displays a high degree of specificity for HPV positive cells. Docking analyses suggest that these compounds bind in a hydrophobic pocket at the interface between E6 and E6AP and mimic the leucines in the conserved a-helical motif of E6AP. The activity and specificity of these compounds represent a promising new lead for development as an antiviral therapy in the treatment of HPV infection and cervical cancer.	[Cherry, Jonathan J.; Malinkevich, Anna; Xie, Meng; Androphy, Elliot J.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Cherry, Jonathan J.; Rietz, Anne; Xie, Meng; Androphy, Elliot J.] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Liu, Yuqi; Baleja, James D.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Bartolowits, Matthew; Davisson, V. Jo] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	University of Massachusetts System; University of Massachusetts Worcester; Indiana University System; Indiana University Bloomington; Tufts University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Androphy, EJ (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	eandro@iu.edu			NIH [R01 CA119904, R01 CA107394]; Indiana University Simon Cancer Center ITRAC; NATIONAL CANCER INSTITUTE [R01CA119904, R01CA107394] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Simon Cancer Center ITRAC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R01 CA119904 and R01 CA107394 and Indiana University Simon Cancer Center ITRAC grants to EJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baleja JD, 2006, ANTIVIR RES, V72, P49, DOI 10.1016/j.antiviral.2006.03.014; Be XB, 2001, BIOCHEMISTRY-US, V40, P1293, DOI 10.1021/bi0019592; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boulet G, 2007, INT J BIOCHEM CELL B, V39, P2006, DOI 10.1016/j.biocel.2007.07.004; BUTZ K, 1995, ONCOGENE, V10, P927; Chahar Maheep K, 2011, Pharmacogn Rev, V5, P1, DOI 10.4103/0973-7847.79093; Chen JJ, 1998, J BIOL CHEM, V273, P13537, DOI 10.1074/jbc.273.22.13537; Dalal S, 1996, J VIROL, V70, P683, DOI 10.1128/JVI.70.2.683-688.1996; Das K, 2000, J VIROL, V74, P812, DOI 10.1128/JVI.74.2.812-816.2000; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Fradet-Turcotte A, 2007, ANTIVIR THER, V12, P431; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P10978, DOI 10.1073/pnas.97.20.10978; Grm HS, 2004, J GEN VIROL, V85, P2815, DOI 10.1099/vir.0.80035-0; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hall WS, 1997, VIRUS RES, V51, P183, DOI 10.1016/S0168-1702(97)00095-6; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; HUDSON JB, 1990, J VIROL, V64, P519, DOI 10.1128/JVI.64.2.519-526.1990; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Kho EY, 2013, P NATL ACAD SCI USA, V110, P7542, DOI 10.1073/pnas.1304855110; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Kranz JK, 2011, METHOD ENZYMOL, V493, P277, DOI 10.1016/B978-0-12-381274-2.00011-X; Kuballa P, 2007, J BIOL CHEM, V282, P65, DOI 10.1074/jbc.M605117200; Lee HG, 2005, J ETHNOPHARMACOL, V98, P339, DOI 10.1016/j.jep.2005.01.054; Lewis DA, 2010, ONCOGENE, V29, P1475, DOI 10.1038/onc.2009.440; Liu Y, 1999, J VIROL, V73, P7297, DOI 10.1128/JVI.73.9.7297-7307.1999; Liu YQ, 2004, BIOCHEMISTRY-US, V43, P7421, DOI 10.1021/bi049552a; Liu YQ, 2009, J MOL BIOL, V386, P1123, DOI 10.1016/j.jmb.2009.01.018; Matta CF, 2010, EUR J MED CHEM, V45, P1868, DOI 10.1016/j.ejmech.2010.01.025; McKaig RG, 1998, HEAD NECK-J SCI SPEC, V20, P250, DOI 10.1002/(SICI)1097-0347(199805)20:3<250::AID-HED11>3.0.CO;2-O; MUNGER K, 1989, J VIROL, V63, P4417; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Park RB, 2002, J VIROL, V76, P11359, DOI 10.1128/JVI.76.22.11359-11364.2002; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Schrodinger L, 2011, LIGPREP; Schru┬dinger L, 2011, MAESTR; Sekaric P, 2008, J VIROL, V82, P71, DOI 10.1128/JVI.01776-07; Sidi AOMO, 2011, PROTEIN EXPRES PURIF, V80, P8, DOI 10.1016/j.pep.2011.06.013; Song S, 2000, VIROLOGY, V267, P141, DOI 10.1006/viro.1999.0106; Stoppler H, 1997, J BIOL CHEM, V272, P13332, DOI 10.1074/jbc.272.20.13332; Thomas M, 1999, ONCOGENE, V18, P7690, DOI 10.1038/sj.onc.1202953; Tungteakkhun SS, 2008, ARCH VIROL, V153, P397, DOI 10.1007/s00705-007-0022-5; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; Wise-Draper TM, 2008, FRONT BIOSCI-LANDMRK, V13, P1003, DOI 10.2741/2739; Yamabhai M, 2001, METHOD ENZYMOL, V332, P88; Yuan CH, 2012, BIOORG MED CHEM LETT, V22, P2125, DOI 10.1016/j.bmcl.2011.12.145; Zanier K, 2005, J MOL BIOL, V349, P401, DOI 10.1016/j.jmb.2005.03.071; Zanier K, 2007, PROTEIN EXPRES PURIF, V51, P59, DOI 10.1016/j.pep.2006.07.029; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	59	52	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84506	10.1371/journal.pone.0084506	http://dx.doi.org/10.1371/journal.pone.0084506			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376816	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000153
J	Hayashida, N; Imaizumi, M; Shimura, H; Okubo, N; Asari, Y; Nigawara, T; Midorikawa, S; Kotani, K; Nakaji, S; Otsuru, A; Akamizu, T; Kitaoka, M; Suzuki, S; Taniguchi, N; Yamashita, S; Takamura, N				Hayashida, Naomi; Imaizumi, Misa; Shimura, Hiroki; Okubo, Noriyuki; Asari, Yasushi; Nigawara, Takeshi; Midorikawa, Sanae; Kotani, Kazuhiko; Nakaji, Shigeyuki; Otsuru, Akira; Akamizu, Takashi; Kitaoka, Masafumi; Suzuki, Shinichi; Taniguchi, Nobuyuki; Yamashita, Shunichi; Takamura, Noboru		Invest Comm Proportion Thyroid	Thyroid Ultrasound Findings in Children from Three Japanese Prefectures: Aomori, Yamanashi and Nagasaki	PLOS ONE			English	Article							SONOGRAPHIC APPEARANCE; PREVALENCE; THYMUS; INCIDENTALOMAS; POPULATION; CHERNOBYL	Due to the likelihood of physical and mental health impacts following the unprecedented accident at the Fukushima Daiichi Nuclear Power Plant, the Fukushima prefectural government decided to conduct the Fukushima Health Management Survey to assist in the long-term health management of residents. This included thyroid ultrasound examination for all children in Fukushima. For appropriate evaluation of ultrasound screening of the thyroid, it is important to understand its reference data of thyroid findings in children in general. In order to analyze the frequencies of specific thyroid findings, we conducted ultrasound screening of the thyroid by the same procedures as used in Fukushima in 4,365 children, aged 3 to 18 years, from three Japanese prefectures. Overall, thyroid cysts were identified in 56.88% and thyroid nodules in 1.65% of the participants. Thyroid cysts and nodules with a maximum diameter of more than 5 mm were identified in 4.58% and 1.01%, respectively, and age-adjusted prevalences were 3.82% and 0.99%, respectively. Although the prevalence of cysts and nodules varied among the examination areas, no significant differences were observed among the three examination areas in the prevalence of cysts and nodules with a maximum diameter of more than 5 mm. Also, the prevalence of thyroid cysts and nodules, especially those with a maximum diameter of more than 5 mm, significantly increased with age, and showed a female predominance. We also identified ectopic thymus (1.95%), diffuse goiter (1.40%), ultimobranchial body (0.73%), lymph node swelling (0.21%) and thyroid agenesis (0.05%). This is the first ultrasound description of the age-adjusted prevalence of thyroid cysts and nodules, or of the prevalence of abnormalities other than cysts and nodules, such as ectopic thymus, in relation to age, in the general Japanese child population. We contend that this can provide relevant information for the Fukushima Health Management Survey and future population studies.	[Hayashida, Naomi; Takamura, Noboru] Nagasaki Univ, Dept Global Hlth Med & Welf, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Yamashita, Shunichi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki 852, Japan; [Imaizumi, Misa] Radiat Effects Res Fdn, Dept Clin Studies, Nagasaki, Japan; [Okubo, Noriyuki; Nakaji, Shigeyuki] Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori, Japan; [Asari, Yasushi] Hirosaki Univ, Grad Sch Med, Dept Emergency & Disaster Med, Hirosaki, Aomori, Japan; [Nigawara, Takeshi] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori, Japan; [Shimura, Hiroki] Fukushima Med Univ, Dept Lab Med, Fukushima, Japan; [Midorikawa, Sanae; Otsuru, Akira] Fukushima Med Univ, Dept Radiat Hlth Management, Fukushima, Japan; [Suzuki, Shinichi] Fukushima Med Univ, Dept Thyroid & Endocrinol, Fukushima, Japan; [Yamashita, Shunichi] Fukushima Med Univ, Radiat Med Sci Ctr Fukushima Hlth Management Surv, Fukushima, Japan; [Kotani, Kazuhiko; Taniguchi, Nobuyuki] Jichi Med Univ, Dept Clin Lab Med, Shimotsuke, Tochigi, Japan; [Akamizu, Takashi] Wakayama Med Univ, Dept Med 1, Wakayama, Japan; [Kitaoka, Masafumi] Showa Gen Hosp, Div Endocrinol & Metab, Tokyo, Japan	Nagasaki University; Nagasaki University; Radiation Effects Research Foundation - Japan; Hirosaki University; Hirosaki University; Hirosaki University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Jichi Medical University; Wakayama Medical University	Hayashida, N (corresponding author), Nagasaki Univ, Dept Global Hlth Med & Welf, Atom Bomb Dis Inst, Nagasaki 852, Japan.	naomin@nagasaki-u.ac.jp	Yamashita, Shunichi/GVS-9508-2022	Akamizu, Takashi/0000-0003-4960-8271; Yamashita, Shunichi/0000-0001-6399-6261; Takamura, Noboru/0000-0002-5552-3234	Ministry of Environment of Japan	Ministry of Environment of Japan(Ministry of the Environment, Japan)	This study was funded by the Ministry of Environment of Japan (funder's website: http://www.env.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa K, 1997, J CLIN ENDOCR METAB, V82, P3430, DOI 10.1210/jc.82.10.3430; Avula S, 2010, PEDIATR RADIOL, V40, P1774, DOI 10.1007/s00247-010-1684-9; BRANDER A, 1991, RADIOLOGY, V181, P683, DOI 10.1148/radiology.181.3.1947082; Gimm O, 1997, J PEDIATR SURG, V32, P1241, DOI 10.1016/S0022-3468(97)90691-6; Ishigaki K, 2001, ENDOCR J, V48, P591, DOI 10.1507/endocrj.48.591; Kang HW, 2004, THYROID, V14, P29, DOI 10.1089/105072504322783812; Kim HG, 2012, J CLIN ULTRASOUND, V40, P266, DOI 10.1002/jcu.21898; Megremis S, 2008, J CLIN ULTRASOUND, V36, P443, DOI 10.1002/jcu.20463; O'Brien RT, 2007, CLIN TECH SMALL AN P, V22, P93, DOI 10.1053/j.ctsap.2007.05.003; Reiners C, 2004, THYROID, V14, P926, DOI 10.1089/thy.2004.14.926; Souchkevitch GN, 1997, HLTH CONS CHERN ACC; Statistics Bureau Ministry of Internal Affairs and Communications, 2012, 2010 POP CENS REF TA; Taira Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045816; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; Taniguchi N, 2013, J MED ULTRASON, V40, P219, DOI 10.1007/s10396-013-0456-1; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, SOURC EFF ION RAD 20, VII; YAMASHITA S, 1997, CHERNOBYL DECADE; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105	18	55	60	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83220	10.1371/journal.pone.0083220	http://dx.doi.org/10.1371/journal.pone.0083220			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376666	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000070
J	Kalra, S; Puniya, BL; Kulshreshtha, D; Kumar, S; Kaur, J; Ramachandran, S; Singh, K				Kalra, Shikha; Puniya, Bhanwar Lal; Kulshreshtha, Deepika; Kumar, Sunil; Kaur, Jagdeep; Ramachandran, Srinivasan; Singh, Kashmir			De Novo Transcriptome Sequencing Reveals Important Molecular Networks and Metabolic Pathways of the Plant, Chlorophytum borivilianum	PLOS ONE			English	Article							14 ALPHA-DEMETHYLASE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; ISOPRENOID BIOSYNTHESIS; FUNCTIONAL EXPRESSION; CAMELLIA-SINENSIS; FLAVONOL SYNTHASE; CHALCONE SYNTHASE; ESCHERICHIA-COLI; COPTIS-JAPONICA	Chlorophytum borivilianum, an endangered medicinal plant species is highly recognized for its aphrodisiac properties provided by saponins present in the plant. The transcriptome information of this species is limited and only few hundred expressed sequence tags (ESTs) are available in the public databases. To gain molecular insight of this plant, high throughput transcriptome sequencing of leaf RNA was carried out using Illumina's HiSeq 2000 sequencing platform. A total of 22,161,444 single end reads were retrieved after quality filtering. Available (e. g., De-Bruijn/Eulerian graph) and in-house developed bioinformatics tools were used for assembly and annotation of transcriptome. A total of 101,141 assembled transcripts were obtained, with coverage size of 22.42 Mb and average length of 221 bp. Guanine-cytosine (GC) content was found to be 44%. Bioinformatics analysis, using non-redundant proteins, gene ontology (GO), enzyme commission (EC) and kyoto encyclopedia of genes and genomes (KEGG) databases, extracted all the known enzymes involved in saponin and flavonoid biosynthesis. Few genes of the alkaloid biosynthesis, along with anticancer and plant defense genes, were also discovered. Additionally, several cytochrome P450 (CYP450) and glycosyltransferase unique sequences were also found. We identified simple sequence repeat motifs in transcripts with an abundance of di-nucleotide simple sequence repeat (SSR; 43.1%) markers. Large scale expression profiling through Reads per Kilobase per Million mapped reads (RPKM) showed major genes involved in different metabolic pathways of the plant. Genes, expressed sequence tags (ESTs) and unique sequences from this study provide an important resource for the scientific community, interested in the molecular genetics and functional genomics of C. borivilianum.	[Kalra, Shikha; Kumar, Sunil; Kaur, Jagdeep; Singh, Kashmir] Panjab Univ, Dept Biotechnol, Chandigarh 160014, India; [Puniya, Bhanwar Lal; Kulshreshtha, Deepika; Ramachandran, Srinivasan] CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr, New Delhi, India	Panjab University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Singh, K (corresponding author), Panjab Univ, Dept Biotechnol, Chandigarh 160014, India.	kashmirbio@pu.ac.in	Singh, Kashmir/ABA-3329-2020; Puniya, Bhanwar Lal/K-6295-2016	Singh, Kashmir/0000-0002-9646-9043; Puniya, Bhanwar Lal/0000-0001-7528-3568; Kaur, Jagdeep/0000-0002-2252-2489	Council of Scientific and Industrial Research (CSIR), India [38(1338)/12/EMRII]	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Funding came from the Council of Scientific and Industrial Research (CSIR), India (csirhrdg.res.in). Grant number: 38(1338)/12/EMRII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya D, 2009, J NAT PROD, V72, P177, DOI 10.1021/np800559z; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bak S, 1997, PLANT J, V11, P191, DOI 10.1046/j.1365-313X.1997.11020191.x; Bordia P, 1995, ADV HORTICULTURE, V11, P429; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Brain KR, 1975, PRACTICAL EVALUATION, P78; CabelloHurtado F, 1997, BIOCHEM BIOPH RES CO, V230, P381, DOI 10.1006/bbrc.1996.5873; CAPORALE LH, 1995, P NATL ACAD SCI USA, V92, P75, DOI 10.1073/pnas.92.1.75; Carels N, 1998, J MOL EVOL, V46, P45, DOI 10.1007/PL00006282; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; COREY EJ, 1993, P NATL ACAD SCI USA, V90, P11628, DOI 10.1073/pnas.90.24.11628; Deore S. L., 2010, Annals of Biological Research, V1, P36; Duvold T, 1997, TETRAHEDRON LETT, V38, P4769, DOI 10.1016/S0040-4039(97)01045-9; Eisenreich W, 1998, CHEM BIOL, V5, pR221, DOI 10.1016/S1074-5521(98)90002-3; FACCHINI PJ, 1994, J BIOL CHEM, V269, P26684; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Geetha K. A., 2001, Journal of Tropical Medicinal Plants, V2, P287; Ghawana Sanjay, 2011, BMC Res Notes, V4, P85, DOI 10.1186/1756-0500-4-85; GOFF SA, 1990, EMBO J, V9, P2517, DOI 10.1002/j.1460-2075.1990.tb07431.x; Haralampidis K, 2002, ADV BIOCHEM ENG BIOT, V75, P31; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Herrera JBR, 1998, PHYTOCHEMISTRY, V49, P1905, DOI 10.1016/S0031-9422(98)00366-5; HIRAYAMA T, 1992, PLANT MOL BIOL, V20, P653, DOI 10.1007/BF00046450; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Kalra S, 2013, MOL BIOTECHNOL, V54, P944, DOI 10.1007/s12033-012-9645-1; Kaushik Nutan, 2005, Phytochemistry Reviews, V4, P191, DOI 10.1007/s11101-005-2607-5; KAWALLECK P, 1993, J BIOL CHEM, V268, P2189; KREUZALER F, 1983, P NATL ACAD SCI-BIOL, V80, P2591, DOI 10.1073/pnas.80.9.2591; Kumar M, 2010, ASIAN PAC J CANCER P, V11, P327; Kumar S, 2012, GENE, V511, P79, DOI 10.1016/j.gene.2012.09.046; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Li Q, 2009, ONCOLOGY-BASEL, V77, P335, DOI 10.1159/000264627; Li ZS, 1998, PLANT CELL, V10, P383, DOI 10.1105/tpc.10.3.383; Lin GZ, 2007, PROTEIN EXPRES PURIF, V55, P287, DOI 10.1016/j.pep.2007.05.013; MaldonadoMendoza IE, 1996, PLANT PHYSIOL, V110, P43, DOI 10.1104/pp.110.1.43; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; Manjunatha G, 2004, SAFED MUSLI WHITE GO; Manning K, 1998, PLANTA, V205, P622, DOI 10.1007/s004250050365; MARQUES IA, 1988, PLANT PHYSIOL, V88, P46, DOI 10.1104/pp.88.1.46; MEIJER AH, 1993, PLANT MOL BIOL, V22, P379, DOI 10.1007/BF00014944; Moriguchi T, 2002, PHYSIOL PLANTARUM, V114, P251, DOI 10.1034/j.1399-3054.2002.1140211.x; Morikawa T, 2006, PLANT CELL, V18, P1008, DOI 10.1105/tpc.105.036012; Morishige T, 2000, J BIOL CHEM, V275, P23398, DOI 10.1074/jbc.M002439200; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Narasimhan S, 2006, PLANTA MED, V72, P1421, DOI 10.1055/s-2006-951705; Ohyama K, 2009, P NATL ACAD SCI USA, V106, P725, DOI 10.1073/pnas.0807675106; Park Jong Dae, 2005, Phytochemistry Reviews, V4, P159, DOI 10.1007/s11101-005-2835-8; Parkinson J, 2009, METHODS MOL BIOL, V533; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qiu SX, 2000, PLANTA MED, V66, P587, DOI 10.1055/s-2000-8600; Qureshi N, 1981, BIOSYNTHESIS ISOPREN, V1; Rohdich F, 2001, CURR OPIN CHEM BIOL, V5, P535, DOI 10.1016/S1367-5931(00)00240-4; Rohmer M, 2003, PURE APPL CHEM, V75, P375, DOI 10.1351/pac200375020375; Rudd S, 2003, TRENDS PLANT SCI, V8, P321, DOI 10.1016/S1360-1385(03)00131-6; RUEFFER M, 1987, Z NATURFORSCH C, V42, P319; SATO F, 1994, EUR J BIOCHEM, V225, P125, DOI 10.1111/j.1432-1033.1994.00125.x; SCHMELZER E, 1989, PLANT CELL, V1, P993, DOI 10.1105/tpc.1.10.993; Schuhr Christoph A., 2003, Phytochemistry Reviews, V2, P3, DOI 10.1023/B:PHYT.0000004180.25066.62; Senthilvel S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-119; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shibuya M, 2010, FEBS LETT, V584, P2258, DOI 10.1016/j.febslet.2010.03.037; SHIRLEY BW, 1992, PLANT CELL, V4, P333, DOI 10.1105/tpc.4.3.333; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; STADLER R, 1987, TETRAHEDRON LETT, V28, P1251, DOI 10.1016/S0040-4039(00)95338-3; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; TAKEUCHI A, 1994, PLANT CELL PHYSIOL, V35, P1011; Tansakul P, 2006, FEBS LETT, V580, P5143, DOI 10.1016/j.febslet.2006.08.044; Thakur M, 2008, J COMPLEMENTARY INTE, V5, P1; TREZZINI GF, 1993, PLANT MOL BIOL, V21, P385, DOI 10.1007/BF00019954; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Visavadiya NP, 2010, DRUG CHEM TOXICOL, V33, P173, DOI 10.3109/01480540903311068; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wise ML, 1998, COMPREHENSIVE NATURA, V2; Yu O, 2005, ADV AGRON, V86, P147, DOI 10.1016/S0065-2113(05)86003-1; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	81	55	62	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83336	10.1371/journal.pone.0083336	http://dx.doi.org/10.1371/journal.pone.0083336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376689	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000080
J	Zheng, DQ; Zhang, K; Gao, KH; Liu, ZW; Zhang, X; Li, O; Sun, JG; Zhang, XY; Du, FG; Sun, PY; Qu, AM; Wu, XC				Zheng, Daoqiong; Zhang, Ke; Gao, Kehui; Liu, Zewei; Zhang, Xing; Li, Ou; Sun, Jianguo; Zhang, Xiaoyang; Du, Fengguang; Sun, Peiyong; Qu, Aimin; Wu, Xuechang			Construction of Novel Saccharomyces cerevisiae Strains for Bioethanol Active Dry Yeast (ADY) Production	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; RESISTANCE; TOLERANCE; TREHALOSE; MEMBRANE; LEADS	The application of active dry yeast (ADY) in bioethanol production simplifies operation processes and reduces the risk of bacterial contamination. In the present study, we constructed a novel ADY strain with improved stress tolerance and ethanol fermentation performances under stressful conditions. The industrial Saccharomyces cerevisiae strain ZTW1 showed excellent properties and thus subjected to a modified whole-genome shuffling (WGS) process to improve its ethanol titer, proliferation capability, and multiple stress tolerance for ADY production. The best-performing mutant, Z3-86, was obtained after three rounds of WGS, producing 4.4% more ethanol and retaining 2.15-fold higher viability than ZTW1 after drying. Proteomics and physiological analyses indicated that the altered expression patterns of genes involved in protein metabolism, plasma membrane composition, trehalose metabolism, and oxidative responses contribute to the trait improvement of Z3-86. This work not only successfully developed a novel S. cerevisiae mutant for application in commercial bioethanol production, but also enriched the current understanding of how WGS improves the complex traits of microbes.	[Zheng, Daoqiong; Zhang, Ke; Gao, Kehui; Liu, Zewei; Zhang, Xing; Li, Ou; Sun, Jianguo; Wu, Xuechang] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xiaoyang; Du, Fengguang; Sun, Peiyong; Qu, Aimin] Tianguan Grp Co Ltd, State Key Lab Motor Vehicle Biofuel Technol, Nanyang, Henan, Peoples R China	Zhejiang University	Wu, XC (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	mblab@zju.edu.cn			Postdoctoral Science Foundation of China [2013M531450]; Zhejiang Province Postdoctoral Foundation [BSH1301026]; State Key Laboratory of Motor Vehicle Biofuels Technology of China [2013013]	Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Zhejiang Province Postdoctoral Foundation; State Key Laboratory of Motor Vehicle Biofuels Technology of China	This work was financially supported by Postdoctoral Science Foundation of China (2013M531450; http://res.chinapostdoctor.org.cn/Program/Main.html), Zhejiang Province Postdoctoral Foundation (BSH1301026; http://www.zjhrss.gov.cn/), and State Key Laboratory of Motor Vehicle Biofuels Technology of China (2013013; http://www.tianguan.com.cn/jituan/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2009, BBA-BIOMEMBRANES, V1788, P743, DOI 10.1016/j.bbamem.2008.12.002; Allen SA, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-2; Amorim HV, 2011, APPL MICROBIOL BIOT, V91, P1267, DOI 10.1007/s00253-011-3437-6; Bellissimi E, 2005, PROCESS BIOCHEM, V40, P2205, DOI 10.1016/j.procbio.2004.09.002; Beney L, 2001, APPL MICROBIOL BIOT, V57, P34; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; Della-Bianca BE, 2013, APPL MICROBIOL BIOT, V97, P979, DOI 10.1007/s00253-012-4631-x; Dupont S, 2011, BBA-BIOMEMBRANES, V1808, P1520, DOI 10.1016/j.bbamem.2010.11.012; Espindola AD, 2003, CRYOBIOLOGY, V47, P236, DOI 10.1016/j.cryobiol.2003.10.003; GADD GM, 1987, FEMS MICROBIOL LETT, V48, P249, DOI 10.1016/0378-1097(87)90171-6; Garre E, 2010, INT J FOOD MICROBIOL, V136, P295, DOI 10.1016/j.ijfoodmicro.2009.10.018; Gomez-Pastor R, 2012, APPL MICROBIOL BIOT, V94, P773, DOI 10.1007/s00253-011-3738-9; Gomez-Pastor R, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-9; Gong JX, 2009, BIOTECHNOL ADV, V27, P996, DOI 10.1016/j.biotechadv.2009.05.016; Jimenez-Marti E, 2011, INT J FOOD MICROBIOL, V145, P211, DOI 10.1016/j.ijfoodmicro.2010.12.023; Kasavi C, 2012, BIOMASS BIOENERG, V45, P230, DOI 10.1016/j.biombioe.2012.06.013; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; Kollaras A, 2011, BIORESOURCE TECHNOL, V102, P7521, DOI 10.1016/j.biortech.2011.04.094; Lemetais G, 2012, APPL MICROBIOL BIOT, V96, P471, DOI 10.1007/s00253-012-4014-3; Lewis JA, 2010, GENETICS, V186, P1197, DOI 10.1534/genetics.110.121871; Litwin I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003640; Liu JD, 2013, J APPL MICROBIOL, V114, P482, DOI 10.1111/jam.12046; Mahmud SA, 2012, J BIOSCI BIOENG, V113, P526, DOI 10.1016/j.jbiosc.2011.11.028; Mentre P, 2001, INT REV CYTOL, V201, P1, DOI 10.1016/S0074-7696(01)01001-4; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Pagnotta SE, 2010, J PHYS CHEM B, V114, P4904, DOI 10.1021/jp911940h; Patnaik R, 2002, NAT BIOTECHNOL, V20, P707, DOI 10.1038/nbt0702-707; Perez-Torrado R, 2009, APPL MICROBIOL BIOT, V81, P951, DOI 10.1007/s00253-008-1722-9; Pinel D, 2011, APPL ENVIRON MICROB, V77, P4736, DOI 10.1128/AEM.02769-10; Sarkar N, 2012, RENEW ENERG, V37, P19, DOI 10.1016/j.renene.2011.06.045; Shi DJ, 2009, J IND MICROBIOL BIOT, V36, P139, DOI 10.1007/s10295-008-0481-z; Talebnia F, 2010, BIORESOURCE TECHNOL, V101, P4744, DOI 10.1016/j.biortech.2009.11.080; Tao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031235; Trofimova Y, 2010, FEMS MICROBIOL LETT, V308, P55, DOI 10.1111/j.1574-6968.2010.01989.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaudano E, 2009, INT J FOOD MICROBIOL, V129, P30, DOI 10.1016/j.ijfoodmicro.2008.10.027; Wang PM, 2012, BIORESOURCE TECHNOL, V108, P203, DOI 10.1016/j.biortech.2011.12.147; WOOD JS, 1982, MOL CELL BIOL, V2, P1080, DOI 10.1128/MCB.2.9.1080; Zhang YX, 2002, NATURE, V415, P644, DOI 10.1038/415644a; Zheng DQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-479; Zheng DQ, 2011, BIORESOURCE TECHNOL, V102, P3020, DOI 10.1016/j.biortech.2010.09.122	41	10	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85022	10.1371/journal.pone.0085022	http://dx.doi.org/10.1371/journal.pone.0085022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376860	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000172
J	Champredon, D; Bellan, S; Dushoff, J				Champredon, David; Bellan, Steve; Dushoff, Jonathan			HIV Sexual Transmission Is Predominantly Driven by Single Individuals Rather than Discordant Couples: A Model-Based Approach	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV-1-DISCORDANT COUPLES; ANTIRETROVIRAL THERAPY; PARTNERSHIPS; INFECTION; SPREAD; COHORT; RISK; SEROCONVERSION; PREVALENCE	Understanding the relative contribution to HIV transmission from different social groups is important for public-health policy. Information about the importance of stable serodiscordant couples (when one partner is infected but not the other) relative to contacts outside of stable partnerships in spreading disease can aid in designing and targeting interventions. However, the overall importance of within-couple transmission, and the determinants and correlates of this importance, are not well understood. Here, we explore how mechanistic factors - like partnership dynamics and rates of extra-couple transmission - affect various routes of transmission, using a compartmental model with parameters based on estimates from Sub-Saharan Africa. Under our assumptions, when sampling model parameters within a realistic range, we find that infection of uncoupled individuals is usually the predominant route (median 0.62, 2.5%-97.5% quantiles: 0.26-0.88), while transmission within discordant couples is usually important, but rarely represents the majority of transmissions (median 0.33, 2.5%-97.5% quantiles: 0.10-0.67). We find a strong correlation between long-term HIV prevalence and the contact rate of uncoupled individuals, implying that this rate may be a key driver of HIV prevalence. For a given level of prevalence, we find a negative correlation between the proportion of discordant couples and the within-couple transmission rate, indicating that low discordance in a population may reflect a relatively high rate of within-couple transmission. Transmission within or outside couples and among uncoupled individuals are all likely to be important in sustaining heterosexual HIV transmission in Sub-Saharan Africa. Hence, intervention policies should be broadly targeted when practical.	[Champredon, David] McMaster Univ, Sch Computat Sci & Engn, Hamilton, ON, Canada; [Bellan, Steve] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Dushoff, Jonathan] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University; University of Texas System; University of Texas Austin; McMaster University	Champredon, D (corresponding author), McMaster Univ, Sch Computat Sci & Engn, Hamilton, ON, Canada.	champrd@math.mcmaster.ca	Bellan, Steven/D-6368-2013	Bellan, Steven/0000-0002-4110-272X; Champredon, David/0000-0002-7090-8757	James S. McDonnell Foundation; Canadian Institutes of Health Research; Canadian Natural Sciences and Engineering Research Council; National Institute of General Medical Sciences MIDAS grant [U01GM087719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institute of General Medical Sciences MIDAS grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DC and JD were supported by grants from the James S. McDonnell Foundation, the Canadian Institutes of Health Research, and the Canadian Natural Sciences and Engineering Research Council. SEB was supported by a National Institute of General Medical Sciences MIDAS grant U01GM087719 to Lauren A. Meyers and Alison P. Galvani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Bellan SE, 2013, LANCET, V381, P1561, DOI 10.1016/S0140-6736(12)61960-6; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Cassels S, 2008, JAIDS-J ACQ IMM DEF, V47, pS34, DOI 10.1097/QAI.0b013e3181605da3; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Chemaitelly H, 2012, SEX TRANSM INFECT, V88, P51, DOI 10.1136/sextrans-2011-050114; Coburn BJ, 2011, LANCET INFECT DIS, V11, P263, DOI 10.1016/S1473-3099(11)70080-9; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; De Walque D, 2007, POPUL DEV REV, V33, P501, DOI 10.1111/j.1728-4457.2007.00182.x; DIETZ K, 1988, J MATH BIOL, V26, P1, DOI 10.1007/BF00280169; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Hargrove JW, 2011, EPIDEMICS-NETH, V3, P88, DOI 10.1016/j.epidem.2011.02.004; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Ndase P, 2012, JAIDS-J ACQ IMM DEF, V59, P65, DOI 10.1097/QAI.0b013e318237b864; Robinson NJ, 1999, INT J STD AIDS, V10, P718, DOI 10.1258/0956462991913394; SERWADDA D, 1995, AIDS, V9, P745, DOI 10.1097/00002030-199507000-00012; Shelton JD, 2010, LANCET, V375, P964, DOI 10.1016/S0140-6736(10)60416-3; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002	30	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82906	10.1371/journal.pone.0082906	http://dx.doi.org/10.1371/journal.pone.0082906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376602	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100070
J	Giri, H; Chandel, S; Dwarakanath, LS; Sreekumar, S; Dixit, M				Giri, Hemant; Chandel, Shivam; Dwarakanath, Linga S.; Sreekumar, Sooriyakala; Dixit, Madhulika			Increased Endothelial Inflammation, sTie-2 and Arginase Activity in Umbilical Cords Obtained from Gestational Diabetic Mothers	PLOS ONE			English	Article							E-SELECTIN; INTERNATIONAL ASSOCIATION; SUBCLINICAL INFLAMMATION; VASCULAR DYSFUNCTION; WOMEN; PREGNANCY; MELLITUS; ANGIOPOIETIN-2; RECEPTOR; GROWTH	Objective: The aim of this study was to determine subclinical inflammation in umbilical vein derived endothelial cells (HUVECs) obtained from Asian Indian subjects with gestational diabetes (GDM) and to determine levels of angiogenic factors and arginase activity in their cord blood. Methods: This case-control study included 38 control and 30 GDM subjects. Subjects were confirmed as GDM based on 75g oral glucose tolerance test (OGTT) conducted in the second trimester of pregnancy. Angiogenic markers and arginase activity were measured in cord blood by ELISA and colorimetric methods respectively. Endothelial inflammation was assessed through adhesion of PKH26-labelled leukocytes onto HUVEC monolayer obtained from the study groups. Gene and surface expression of adhesion molecules were confirmed via reverse transcription polymerase chain reaction (RT-PCR) and flow cytometry respectively. Results: The study revealed increased adhesion of leukocytes to HUVECs isolated from GDM subjects compared to controls. HUVECs of babies born to GDM mothers had increased surface and mRNA expression of E-selectin. sTie2 levels were significantly higher in the cord blood for GDM subjects (3869 +/- 370 ng/L) compared to controls (3045 +/- 296 ng/L). Furthermore, arginase activity was higher in cord blood of GDM mothers as opposed to the control group (7.75 +/- 2.4 mu moles of urea/ml/hour vs 2.88 +/- 0.49 mu moles of urea/ml/hour; p-value= 0.019). Spearman's correlation analysis revealed positive correlation of cord blood arginase activity with glucose intolerance (p=0.596, p=0.004) and post load glucose values (p=0.472, p=0.031) of mothers observed during the second trimester of pregnancy. Conclusions: HUVECs derived from Asian Indian GDM mothers, exhibit signs of sub-clinical endothelial inflammation along with increased levels of sTie2 and arginase activity in their cord blood serum.	[Giri, Hemant; Chandel, Shivam; Dixit, Madhulika] Indian Inst Technol, Dept Biotechnol, Lab Vasc Biol, Madras 600036, Tamil Nadu, India; [Dwarakanath, Linga S.; Sreekumar, Sooriyakala] Sooriya Hosp, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Dixit, M (corresponding author), Indian Inst Technol, Dept Biotechnol, Lab Vasc Biol, Madras 600036, Tamil Nadu, India.	mdixit@iitm.ac.in	Giri, Hemant/Y-8093-2019		Department of Science and Technology (DST), Government of India [SR/SO/HS-88/2007]	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	The work was funded by Department of Science and Technology (DST), Government of India sponsored grant (SR/SO/HS-88/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE S1, V35, pS4, DOI DOI 10.2337/DC12-S004; Bairagi S, 2012, HUM REPROD, V27, P844, DOI 10.1093/humrep/der457; Balaji V, 2011, Indian J Endocrinol Metab, V15, P187, DOI 10.4103/2230-8210.83403; Bautch VL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006452; BEISCHER NA, 1991, DIABETES, V40, P35, DOI 10.2337/diab.40.2.S35; Bjelakovic G., 2009, Journal of Basic and Clinical Physiology and Pharmacology, V20, P319; Boztosun A, 2012, GINEKOL POL, V83, P749; Buhimschi CS, 2010, J CLIN ENDOCR METAB, V95, P3428, DOI 10.1210/jc.2009-2829; BUSSE R, 1991, N-S ARCH PHARMACOL, V344, P126; Carpintero A, 1996, CLIN CHIM ACTA, V255, P153, DOI 10.1016/0009-8981(96)06403-0; Carr DB, 2006, DIABETES CARE, V29, P2078, DOI 10.2337/dc05-2482; Chang SC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/457971; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; DORNHORST A, 1992, DIABETIC MED, V9, P820, DOI 10.1111/j.1464-5491.1992.tb01900.x; Eklund L, 2013, EXP CELL RES, V319, P1271, DOI 10.1016/j.yexcr.2013.03.011; Eren MA, 2012, GYNECOL ENDOCRINOL, V28, P1010, DOI 10.3109/09513590.2012.705371; Farah Nadine, 2012, J Reprod Infertil, V13, P95; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Giri H, 2012, ARTERIOSCL THROM VAS, V32, P1943, DOI 10.1161/ATVBAHA.111.239251; Grabner R, 2000, CYTOMETRY, V40, P238, DOI 10.1002/1097-0320(20000701)40:3<238::AID-CYTO9>3.0.CO;2-3; Heitritter SM, 2005, J CLIN ENDOCR METAB, V90, P3983, DOI 10.1210/jc.2004-2494; Hiden U, 2012, J CLIN ENDOCR METAB, V97, P3613, DOI 10.1210/jc.2012-1212; Hwang SJ, 1997, CIRCULATION, V96, P4219; Ishizaka M, 2007, VASC PHARMACOL, V47, P272, DOI 10.1016/j.vph.2007.08.001; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866; Jung C, 2010, CARDIOVASC RES, V85, P147, DOI 10.1093/cvr/cvp303; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim I, 2001, CIRC RES, V89, P477, DOI 10.1161/hh1801.097034; Kirshon B, 1990, Tex Med, V86, P88; Kropf P, 2007, EUR J IMMUNOL, V37, P935, DOI 10.1002/eji.200636542; Kvietys PR, 2012, FREE RADICAL BIO MED, V52, P556, DOI 10.1016/j.freeradbiomed.2011.11.002; Leiva A, 2011, EXP DIABETES RES, DOI 10.1155/2011/349286; Luke B, 2005, J REPROD MED, V50, P241; Mendez JD, 2002, REPROD TOXICOL, V16, P809, DOI 10.1016/S0890-6238(02)00057-6; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Ming XF, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000992; Mordwinkin NM, 2013, J MATERN-FETAL NEO M, V26, P507, DOI 10.3109/14767058.2012.736564; Morris CR, 2004, AM J RESP CRIT CARE, V170, P148, DOI 10.1164/rccm.200309-1304OC; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mrizak I, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-93; Papayianni A, 2002, NEPHROL DIAL TRANSPL, V17, P435, DOI 10.1093/ndt/17.3.435; Park JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055699; Polat MF, 2003, SURG TODAY, V33, P655, DOI 10.1007/s00595-002-2563-2; RASANEN J, 1987, ACTA OBSTET GYN SCAN, V66, P349, DOI 10.3109/00016348709103651; Rasul S, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-55; Reusch Petra, 2001, Angiogenesis, V4, P123, DOI 10.1023/A:1012226627813; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Salmi AA, 2012, VASA, V41, P96, DOI 10.1024/0301-1526/a000171; Schiessl B, 2009, PLACENTA, V30, P79, DOI 10.1016/j.placenta.2008.10.004; Scholl TO, 2001, AM J EPIDEMIOL, V154, P514, DOI 10.1093/aje/154.6.514; Shroff RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056273; Sokup A, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/278050; Stark AR, 2006, PEDIATRICS, V117, P1444, DOI 10.1542/peds.2006-0325; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Walker JD, 2008, DIABETIC MED, V25, P1025, DOI 10.1111/j.1464-5491.2008.02532.x; Westra J, 2011, RHEUMATOLOGY, V50, P665, DOI 10.1093/rheumatology/keq378; Winzer C, 2004, DIABETES CARE, V27, P1721, DOI 10.2337/diacare.27.7.1721; Xiao J, 2013, MOL MED REP, V8, P267, DOI 10.3892/mmr.2013.1478; Yabkowitz R, 1999, BLOOD, V93, P1969, DOI 10.1182/blood.V93.6.1969.406k14_1969_1979; Yousefzadeh Gholamreza, 2012, J Tehran Heart Cent, V7, P156; Zhang EG, 2001, MOL MED, V7, P624, DOI 10.1007/BF03401869	65	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84546	10.1371/journal.pone.0084546	http://dx.doi.org/10.1371/journal.pone.0084546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376824	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100175
J	Holloway, SR; Naniez, JE; Seitz, AR				Holloway, Steven R.; Naniez, Jose E., Sr.; Seitz, Aaron R.			Word-Decoding as a Function of Temporal Processing in the Visual System	PLOS ONE			English	Article							TOP-DOWN FACILITATION; CONTRAST SENSITIVITY; MOTION DETECTION; AREA MT; MACAQUE; PERCEPTION; DYSLEXIA; IMPAIRMENT; RESPONSES; PATHWAYS	This study explored the relation between visual processing and word-decoding ability in a normal reading population. Forty participants were recruited at Arizona State University. Flicker fusion thresholds were assessed with an optical chopper using the method of limits by a 1-deg diameter green (543 nm) test field. Word decoding was measured using reading-word and nonsense-word decoding tests. A non-linguistic decoding measure was obtained using a computer program that consisted of Landolt C targets randomly presented in four cardinal orientations, at 3-radial distances from a focus point, for eight compass points, in a circular pattern. Participants responded by pressing the arrow key on the keyboard that matched the direction the target was facing. The results show a strong correlation between critical flicker fusion thresholds and scores on the reading-word, nonsense-word, and non-linguistic decoding measures. The data suggests that the functional elements of the visual system involved with temporal modulation and spatial processing may affect the ease with which people read.	[Holloway, Steven R.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Naniez, Jose E., Sr.] Arizona State Univ, Dept Social & Behav Sci, Phoenix, AZ USA; [Seitz, Aaron R.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Downtown Phoenix; University of California System; University of California Riverside	Holloway, SR (corresponding author), Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA.	srh@asu.edu	Holloway, Steven R/O-3032-2013	Holloway, Steven R/0000-0001-8900-5315				Ahlfors SP, 1999, J NEUROPHYSIOL, V82, P2545, DOI 10.1152/jn.1999.82.5.2545; Allen PA, 2009, ATTEN PERCEPT PSYCHO, V71, P281, DOI 10.3758/APP.71.2.281; Au A, 2007, PERCEPT PSYCHOPHYS, V69, P1344, DOI 10.3758/BF03192951; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Buchholz J, 2004, DYSLEXIA, V10, P24, DOI 10.1002/dys.263; Cohen L, 2008, NEUROIMAGE, V40, P353, DOI 10.1016/j.neuroimage.2007.11.036; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; CORNELISSEN P, 1995, VISION RES, V35, P1483, DOI 10.1016/0042-6989(95)98728-R; Cornelissen PL, 1998, ANN DYSLEXIA, V48, P155, DOI 10.1007/s11881-998-0008-3; Demb JB, 1998, J NEUROSCI, V18, P6939; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; Graves RE, 1999, NEUROPSYCHOLOGY, V13, P575; Halstead W.C., 1947, BRAIN INTELLIGENCE Q; Kveraga K, 2007, J NEUROSCI, V27, P13232, DOI 10.1523/JNEUROSCI.3481-07.2007; LAPRAY M, 1969, J READING, V12, P305; Liederman J, 2003, BRAIN LANG, V85, P140, DOI 10.1016/S0093-934X(02)00550-3; Lisberger SG, 1999, J NEUROSCI, V19, P2224; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; MARTIN F, 1987, PERCEPTION, V16, P215, DOI 10.1068/p160215; MERIGAN WH, 1991, J NEUROSCI, V11, P3422; MISHKIN M, 1959, J COMP PHYSIOL PSYCH, V52, P660, DOI 10.1037/h0038577; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; SCHILLER PH, 1991, NEUROPSYCHOLOGIA, V29, P433, DOI 10.1016/0028-3932(91)90003-Q; Seitz AR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000028; Seitz AR, 2005, HUM PSYCHOPHARM CLIN, V20, P55, DOI 10.1002/hup.661; Smith Jr CF, 1983, 5 ANN M GREAT LAK RE; Solomon SG, 2002, VISION RES, V42, P2893, DOI 10.1016/S0042-6989(02)00414-5; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Talcott JB, 2000, P NATL ACAD SCI USA, V97, P2952, DOI 10.1073/pnas.040546597; Talcott JB, 1998, NEURO-OPHTHALMOLOGY, V20, P187, DOI 10.1076/noph.20.4.187.3931; Talcott JB, 2000, NEUROPSYCHOLOGIA, V38, P935, DOI 10.1016/S0028-3932(00)00020-8; Vidyasagar TR, 1999, NEUROREPORT, V10, P1283, DOI 10.1097/00001756-199904260-00024; Wells EF, 2001, EXP BRAIN RES, V139, P106, DOI 10.1007/s002210100721; Whitney C, 2005, J RES READ, V28, P274, DOI 10.1111/j.1467-9817.2005.00270.x; WOLF M, 1991, READ RES QUART, V26, P123, DOI 10.2307/747978; Wolf M, 1999, ANN DYSLEXIA, V49, P3	40	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84010	10.1371/journal.pone.0084010	http://dx.doi.org/10.1371/journal.pone.0084010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376782	Green Published, gold			2022-12-27	WOS:000328745100153
J	Luo, YM; Jackson, T; Wang, XG; Huang, XT				Luo, Yangmei; Jackson, Todd; Wang, Xiaogang; Huang, Xiting			Neural Correlates of Self-Appraisals in the Near and Distant Future: An Event-Related Potential Study	PLOS ONE			English	Article							NEGATIVITY BIAS; TIME; ANTICIPATION; OPTIMISM; THINKING; STIMULI; SELVES; WORDS; BRAIN	To investigate perceptual and neural correlates of future self-appraisals as a function of temporal distance, event-related potentials (ERPs) were recorded while participants (11 women, eight men) made judgments about the applicability of trait adjectives to their near future selves (i.e., one month from now) and their distant future selves (i.e., three years from now). Behavioral results indicated people used fewer positive adjectives, more negative adjectives, recalled more specific events coming to mind and felt more psychologically connected to the near future self than the distant future self. Electrophysiological results demonstrated that negative trait adjectives elicited more positive ERP deflections than did positive trait adjectives in the interval between 550 and 800 ms (late positive component) within the near future self condition. However, within the same interval, there were no significant differences between negative and positive traits adjectives in the distant future self condition. The results suggest that negative emotional processing in future self-appraisals is modulated by temporal distance, consistent with predictions of construal level theory.	[Luo, Yangmei; Jackson, Todd; Wang, Xiaogang; Huang, Xiting] China Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Luo, Yangmei; Jackson, Todd; Wang, Xiaogang; Huang, Xiting] Southwest Univ, Fac Psychol, Chongqing, Peoples R China	Southwest University - China	Huang, XT (corresponding author), China Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China.	xthuang@swu.edu.cn		Luo, Yangmei/0000-0002-4440-6980	Fundamental Research Funds for the Central Universities [SWU1209469]; National 211 Project, China [NSKD11001]; Faculty of Psychology in Southwest University [TR201201-1]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National 211 Project, China; Faculty of Psychology in Southwest University	This study was supported by "the Fundamental Research Funds for the Central Universities" (SWU1209469) to the first author, the Key Discipline Fund of the National 211 Project, China (NSKD11001), and the Research Team's Construction Project from the Faculty of Psychology in Southwest University (2012) "The Mechanism and Application of Range-Synthesis Model of Time" (TR201201-1) to the corresponding author and research fellow. Study design, data collection and analysis were supported by The Fundamental Research Funds for the Central Universities (SWU1209469) and the Key Discipline Fund of the National 211 Project, China (NSKD11001). The Research Team's Construction Project from the Faculty of Psychology in Southwest University (2012) "The Mechanism and Application of Range-Synthesis Model of Time" (TR201201-1) has roles in preparation of the manuscript and, decision to publish.	D'Argembeau A, 2008, NEUROIMAGE, V40, P398, DOI 10.1016/j.neuroimage.2007.11.025; D'Argembeau A, 2008, SOC COGN AFFECT NEUR, V3, P244, DOI 10.1093/scan/nsn020; Ersner-Hershfield H, 2009, SOC COGN AFFECT NEUR, V4, P85, DOI 10.1093/scan/nsn042; Ersner-Hershfield H, 2009, JUDGM DECIS MAK, V4, P280; Gable PA, 2010, EMOTION, V10, P441, DOI 10.1037/a0018425; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Heller D, 2011, J EXP SOC PSYCHOL, V47, P610, DOI 10.1016/j.jesp.2011.01.010; Helweg-Larsen M, 2001, PERS SOC PSYCHOL REV, V5, P74, DOI 10.1207/S15327957PSPR0501_5; Huang YX, 2006, NEUROSCI LETT, V398, P91, DOI 10.1016/j.neulet.2005.12.074; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Kanten AB, 2008, EUR J SOC PSYCHOL, V38, P343, DOI 10.1002/ejsp.457; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Kong FC, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-49; Li HJ, 2012, J RES PERS, V46, P459, DOI 10.1016/j.jrp.2012.02.010; Luo YM, 2010, NEUROSCI LETT, V475, P69, DOI 10.1016/j.neulet.2010.03.042; MacLeod AK, 2005, COGNITION EMOTION, V19, P357, DOI 10.1080/02699930441000247; MacLeod AK, 1996, J ABNORM PSYCHOL, V105, P286, DOI 10.1037/0021-843X.105.2.286; MacLeod AK, 2007, COGNITION EMOTION, V21, P1114, DOI 10.1080/02699930601109507; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Newby-Clark IR, 2003, PERS SOC PSYCHOL B, V29, P807, DOI 10.1177/0146167203029007001; Nussbaum S, 2006, J EXP PSYCHOL GEN, V135, P152, DOI 10.1037/0096-3445.135.2.152; Oyserman D, 2002, J ADOLESCENCE, V25, P313, DOI 10.1006/jado.2002.0474; Peetz J, 2008, SOC PERSONAL PSYCHOL, V2, P2090, DOI 10.1111/j.1751-9004.2008.00150.x; Robinson MD, 1999, PERS SOC PSYCHOL B, V25, P595; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schacter DL, 2008, ANN NY ACAD SCI, V1124, P39, DOI 10.1196/annals.1440.001; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Sedikides C, 2009, SOC PERSONAL PSYCHOL, V3, P899, DOI 10.1111/j.1751-9004.2009.00231.x; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Shestyuk AY, 2010, AM J PSYCHIAT, V167, P536, DOI 10.1176/appi.ajp.2009.06091444; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Wakslak CJ, 2008, J PERS SOC PSYCHOL, V95, P757, DOI 10.1037/a0012939; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; Wilson AE, 2001, J PERS SOC PSYCHOL, V80, P572, DOI 10.1037//0022-3514.80.4.572; Wilson AE, 2012, EUR J SOC PSYCHOL, V42, P342, DOI 10.1002/ejsp.1863; Yuan JJ, 2008, NEUROSCIENCE, V157, P524, DOI 10.1016/j.neuroscience.2008.09.023; Yuan JJ, 2011, BIOL PSYCHOL, V87, P17, DOI 10.1016/j.biopsycho.2011.01.004	42	4	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84332	10.1371/journal.pone.0084332	http://dx.doi.org/10.1371/journal.pone.0084332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376803	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100164
J	N'Guyen, S; Moulin-Frier, C; Droulez, J				N'Guyen, Steve; Moulin-Frier, Clement; Droulez, Jacques			Decision Making under Uncertainty: A Quasimetric Approach	PLOS ONE			English	Article							SEARCH	We propose a new approach for solving a class of discrete decision making problems under uncertainty with positive cost. This issue concerns multiple and diverse fields such as engineering, economics, artificial intelligence, cognitive science and many others. Basically, an agent has to choose a single or series of actions from a set of options, without knowing for sure their consequences. Schematically, two main approaches have been followed: either the agent learns which option is the correct one to choose in a given situation by trial and error, or the agent already has some knowledge on the possible consequences of his decisions; this knowledge being generally expressed as a conditional probability distribution. In the latter case, several optimal or suboptimal methods have been proposed to exploit this uncertain knowledge in various contexts. In this work, we propose following a different approach, based on the geometric intuition of distance. More precisely, we define a goal independent quasimetric structure on the state space, taking into account both cost function and transition probability. We then compare precision and computation time with classical approaches.	[N'Guyen, Steve; Moulin-Frier, Clement; Droulez, Jacques] CNRS, Coll France, UMR 7152, Lab Physiol Percept & Act, Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS)	N'Guyen, S (corresponding author), CNRS, Coll France, UMR 7152, Lab Physiol Percept & Act, Paris, France.	steve.nguyen@college-de-france.fr		Moulin-Frier, Clement/0000-0002-7258-7256	ROMEO project (Ile de France district, Paris city); ROMEO project (DGCIS); RoboSoM EU project [ICT-2009.2.1]	ROMEO project (Ile de France district, Paris city); ROMEO project (DGCIS); RoboSoM EU project	This project has been founded by the ROMEO project (Ile de France district, Paris city and DGCIS) and the RoboSoM EU project (ICT-2009.2.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTROM KJ, 1965, J MATH ANAL APPL, V10, P174, DOI 10.1016/0022-247X(65)90154-X; Barry JL, 2011, P INT JOINT C ART IN; BARTO AG, 1995, ARTIF INTELL, V72, P81, DOI 10.1016/0004-3702(94)00011-O; Bellman R., 1957, DYNAMIC PROGRAMMING; Bertsekas D. P., 1995, DYNAMIC PROGRAMMING, V2; Bonet B., 2003, Proceedings, Thirteenth International Conference on Automated Planning and Scheduling, P12; Boutilier C, 1999, J ARTIF INTELL RES, V11, P1; Buffet O, 2006, P 5 INT PLANN COMP I; Dietterich T. G., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P118; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Drake A. W., 1962, THESIS MIT; DUBINS LE, 1957, AM J MATH, V79, P497, DOI 10.2307/2372560; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; FREDMAN ML, 1987, J ACM, V34, P596, DOI 10.1145/28869.28874; Givan R., 2007, ICAPS, P352; Hansen EA, 2001, ARTIF INTELL, V129, P35, DOI 10.1016/S0004-3702(01)00106-0; HART PE, 1968, IEEE T SYST SCI CYB, VSSC4, P100, DOI 10.1109/TSSC.1968.300136; Hauskrecht M., 1998, Uncertainty in Artificial Intelligence. Proceedings of the Fourteenth Conference (1998), P220; Howard R. A., 1960, DYNAMIC PROGRAMMING; Kaelbling L, 2011, IROS WORKSH KNOWL RE; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Kappen HJ, 2005, J STAT MECH-THEORY E, P1; Keyder E, 2008, 6 INT PLANN COMP BOO; Kocsis L, 2006, LECT NOTES COMPUT SC, V4212, P282, DOI 10.1007/11871842_29; Kolobov A, 2012, WORKSH HEUR SEARCH D; Kolobov A, 2010, AAAI CONF ARTIF INTE, P1108; Kolobov A, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P1746; Laumond J. P., 1998, Robot motion planning and control, P1, DOI 10.1007/BFb0036070; Little I., 2007, ICAPS WORKSH IPC PRE; Littman M. L., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P394; Peret L, 2004, FRONT ARTIF INTEL AP, V110, P530; Puterman ML., 2014, MARKOV DECISION PROC; ROY B, 1959, CR HEBD ACAD SCI, V249, P216; Soueres P., 1998, Robot motion planning and control, P93, DOI 10.1007/BFb0036072; Stengel Robert F, 1986, STOCHASTIC OPTIMAL C; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Teichteil-Konigsbuch F., 2010, P 9 INT C AUT AG MUL, P1231; Teichteil-Konigsbuch F., 2011, P 25 AAAI C ART INT; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Todorov E, 2009, P NATL ACAD SCI USA, V106, P11478, DOI 10.1073/pnas.0710743106; WARSHALL S, 1962, J ACM, V9, P11, DOI 10.1145/321105.321107; Yoon S., 2008, AAAI, P1010	43	2	2	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83411	10.1371/journal.pone.0083411	http://dx.doi.org/10.1371/journal.pone.0083411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376697	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100116
J	Sundararajan, R; Kalkonde, Y; Gokhale, C; Greenough, PG; Bang, A				Sundararajan, Radhika; Kalkonde, Yogeshwar; Gokhale, Charuta; Greenough, P. Gregg; Bang, Abhay			Barriers to Malaria Control among Marginalized Tribal Communities: A Qualitative Study	PLOS ONE			English	Article							INDIA; PREVENTION	Background: Malaria infection accounts for over one million deaths worldwide annually. India has the highest number of malaria deaths outside Africa, with half among Indian tribal communities. Our study sought to identify barriers to malaria control within tribal populations in malaria-endemic Gadchiroli district, Maharashtra. Methods and Findings: This qualitative study was conducted via focus groups and interviews with 84 participants, and included tribal villagers, traditional healers, community health workers (CHWs), medical officers, and district officials. Questions assessed knowledge about malaria, behavior during early stages of infection, and experiences with prevention among tribal villagers and traditional healers. CHWs, medical officers, and district officials were asked about barriers to treating and preventing malaria among tribal populations. Data were inductively analyzed and assembled into broader explanation linking barriers to geographical, cultural and social factors. Findings indicate lack of knowledge regarding malaria symptoms and transmission. Fever cases initially present to traditional healers or informal providers who have little knowledge of malaria or high-risk groups such as children and pregnant women. Tribal adherence with antimalarial medications is poor. Malaria prevention is inadequate, with low-density and inconsistent use of insecticide-treated nets (ITNs). Malaria educational materials are culturally inappropriate, relying on dominant language literacy. Remote villages and lack of transport complicate surveillance by CHWs. Costs of treating malaria outside the village are high. Conclusions: Geographic, cultural, and social factors create barriers to malaria control among tribal communities in India. Efforts to decrease malaria burden among these populations must consider such realities. Our results suggest improving community-level knowledge about malaria using culturally-appropriate health education materials; making traditional healers partners in malaria control; promoting within-village rapid diagnosis and treatment; increasing ITN distribution and promoting their use as potential strategies to decrease infection rates in these communities. These insights may be used to shape malaria control programs among marginalized populations.	[Sundararajan, Radhika; Greenough, P. Gregg] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kalkonde, Yogeshwar; Gokhale, Charuta; Bang, Abhay] SEARCH, Gadchiroli, Maharashtra, India	Harvard University; Brigham & Women's Hospital	Bang, A (corresponding author), SEARCH, Gadchiroli, Maharashtra, India.	search@satyam.net.in	Kalkonde, Yogeshwar/O-2926-2019	Kalkonde, Yogeshwar/0000-0003-3543-3618; Sundararajan, Radhika/0000-0002-8451-2243	Brigham and Women's Department of Emergency Medicine; Partners Centers of Expertise Global Health Division; SEARCH	Brigham and Women's Department of Emergency Medicine; Partners Centers of Expertise Global Health Division; SEARCH	This project was made possible by financial support from the Brigham and Women's Department of Emergency Medicine as well as a grant from The Partners Centers of Expertise Global Health Division. YK, AB, and other SEARCH staff were supported by SEARCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dhiman RC, 2005, CURR SCI INDIA, V88, P475; Directorate of the National Vector Borne Disease Control Programme, 2009, OP MAN IMPL MAL PROG; Dutta-Bergman MJ, 2005, HEALTH COMMUN, V18, P103, DOI 10.1207/s15327027hc1802_1; Government of India, 2013, OV MIN TRIB AFF; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Kleinman A, 1999, DAEDALUS-US, V128, P69; Kleinman Arthur, 2006, WHAT REALLY MATTERS; Krippendorff K., 2012, CONTENT ANAL INTRO I; Mwenesi HA, 2005, ACTA TROP, V95, P292, DOI 10.1016/j.actatropica.2005.06.004; National Vector Borne Disease Control Programme, 2013, SUPP PROJ WORLD BANK; National Vector Borne Disease Control Programme, 2013, MAL CONTR STRAT; National Vector Borne Disease Control Programme, 2013, MAL SIT 2008 2012; National Vector Borne Disease Control Programme, 2013, LIST CHLOR RES AR; Official Website for District Collectorate Gadchiroli, 2013, PEOPL THEIR CULT; Official Website for District Collectorate Gadchiroli, 2013, AB DISTR; Patton M. Q., 1990, QUALITATIVE EVALUATI; Sabin LL, 2010, AM J TROP MED HYG, V82, P1010, DOI 10.4269/ajtmh.2010.09-0339; Sood RD, 2010, J VECTOR DIS, V47, P243; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978; Vijayakumar KN, 2009, ACTA TROP, V112, P137, DOI 10.1016/j.actatropica.2009.07.011; von Furer-Haimendorf C, 1992, TRIBES INDIA STRUGGL; Vora P, 2011, INT J CRIM JUSTICE S, V6, P358; World Health Organization, 2007, EST MAL DIS BURD IND; World Health Organization, 2013, MAL BURD SEA REG	24	31	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e81966	10.1371/journal.pone.0081966	http://dx.doi.org/10.1371/journal.pone.0081966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376507	gold, Green Published			2022-12-27	WOS:000328745100011
J	Devillers, A; Courjol, F; Fradin, C; Coste, A; Poulain, D; Pipy, B; Bernardes, ES; Jouault, T				Devillers, Audrey; Courjol, Flavie; Fradin, Chantal; Coste, Agnes; Poulain, Daniel; Pipy, Bernard; Bernardes, Emerson Soares; Jouault, Thierry			Deficient Beta-Mannosylation of Candida albicans Phospholipomannan Affects the Proinflammatory Response in Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NLRP3 INFLAMMASOME; BETA-1,2-LINKED OLIGOMANNOSIDES; BAD PHOSPHORYLATION; IN-VITRO; GALECTIN-3; FAMILY; IDENTIFICATION; RECOGNITION; ASSOCIATION	Candida albicans produces a complex glycosphingolipid called phospholipomannan (PLM), which is present on the cell-wall surface of yeast and shed upon contact with host cells. The glycan moiety of PLM is composed of beta-mannosides with degrees of polymerization up to 19 in C. albicans serotype A. PLM from serotype B strains displays a twofold decrease in the length of the glycan chains. In this study we compared the proinflammatory activities of PLMs purified from C. albicans serotype A and serotype B strains and from a bmt6 Delta mutant of C. albicans, whose PLM is composed of short truncated oligomannosidic chain. We found that PLMs activate caspase-1 in murine macrophage cell line J774 independent of the glycan chain length although IL-1 beta secretion is more intense with long glycan chain. None of the tested PLMs stimulate ROS production, indicating that caspase-1 activation may occur through a ROS-independent pathway. On the other hand, only long-chain oligomannosides present on PLM from serotype A strain (PLM-A) are able to induce TNF-alpha production in macrophages, a property that is not affect by blocking endocytosis through latrunculin A treatment. Finally, we demonstrate that soluble and not cell surface-bound galectin-3, is able to potentiate PLM-A-induced TNF-alpha production in macrophages. PLMs from C. albicans serotype B and from bmt6 Delta mutant are not able to induce TNF-alpha production and galectin-3 pretreatment does not interfere with this result. In conclusion, we show here that PLMs are able to evoke a proinflammatory state in macrophage, which is in part dependent on their glycosylation status. Long-glycan chains favor interaction with soluble galectin-3 and help amplify inflammatory response.	[Devillers, Audrey; Courjol, Flavie; Fradin, Chantal; Poulain, Daniel; Jouault, Thierry] Inserm U995, Team 2, Lille, France; [Devillers, Audrey; Courjol, Flavie; Fradin, Chantal; Poulain, Daniel; Jouault, Thierry] Univ Lille Nord France, Lille, France; [Devillers, Audrey; Courjol, Flavie; Fradin, Chantal; Poulain, Daniel; Jouault, Thierry] Univ Lille 2, Lille, France; [Coste, Agnes; Pipy, Bernard] Univ Toulouse 3, Polarisat Macrophages & Recepteurs Nucl Path Infl, UMR MD3, F-31062 Toulouse, France; [Coste, Agnes; Pipy, Bernard] Univ Toulouse 3, UMR 152, F-31062 Toulouse, France; [Bernardes, Emerson Soares] Canc Inst State Sao Paulo, Sao Paulo, Brazil	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Jouault, T (corresponding author), Inserm U995, Team 2, Lille, France.	thierry.jouault@univ-lille2.fr	Poulain, Daniel/C-8683-2014; Fradin, Chantal/N-2382-2018; Jouault, Thierry/I-1071-2018; Agnès, Coste/AAK-9408-2020; Bernardes, Emerson Soares/D-3711-2017; Poulain, Daniel/I-6095-2018	Fradin, Chantal/0000-0002-3883-4401; Jouault, Thierry/0000-0003-1988-8647; Bernardes, Emerson Soares/0000-0002-0029-7313; Coste, Agnes/0000-0001-7781-3323; Pipy, Bernard/0000-0001-8060-7029; Poulain, Daniel/0000-0002-0729-5468	Inserm and by the European Community [HEALTH-F2-2010-260338]; ANR [09-MIEN-031-01]	Inserm and by the European Community; ANR(French National Research Agency (ANR))	This work was supported by Inserm and by the European Community's Seventh Framework Program (FP7-2007-2013) under grant agreement no. HEALTH-F2-2010-260338 'ALLFUN'. AD was supported by ANR 09-MIEN-031-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dalle F, 2003, INFECT IMMUN, V71, P7061, DOI 10.1128/IAI.71.12.7061-7068.2003; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; Fermino ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026004; Feuk-Lagerstedt E, 1999, J IMMUNOL, V163, P5592; Fradin C, 2000, INFECT IMMUN, V68, P4391, DOI 10.1128/IAI.68.8.4391-4398.2000; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Goins TL, 2000, J CLIN MICROBIOL, V38, P2862, DOI 10.1128/JCM.38.8.2862-2869.2000; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Ibata-Ombetta S, 2003, J BIOL CHEM, V278, P13086, DOI 10.1074/jbc.M210680200; Ibata-Ombetta S, 2003, ANN NY ACAD SCI, V1010, P573, DOI 10.1196/annals.1299.107; Ibata-Ombetta S, 2001, J LEUKOCYTE BIOL, V70, P149; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Jouault T, 1998, J INFECT DIS, V178, P792, DOI 10.1086/515361; JOUAULT T, 1994, IMMUNOLOGY, V83, P268; JOUAULT T, 1995, INFECT IMMUN, V63, P2378, DOI 10.1128/IAI.63.6.2378-2381.1995; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; KOBAYASHI H, 1990, ARCH BIOCHEM BIOPHYS, V278, P195, DOI 10.1016/0003-9861(90)90248-W; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Mille C, 2004, J BIOL CHEM, V279, P47952, DOI 10.1074/jbc.M405534200; Mille C, 2008, J BIOL CHEM, V283, P9724, DOI 10.1074/jbc.M708825200; Mille C, 2012, GLYCOBIOLOGY, V22, P1332, DOI 10.1093/glycob/cws097; Poulain D, 2002, INFECT IMMUN, V70, P4323, DOI 10.1128/IAI.70.8.4323-4328.2002; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Trinel PA, 2005, MOL MICROBIOL, V58, P984, DOI 10.1111/j.1365-2958.2005.04890.x; Trinel PA, 2002, J BIOL CHEM, V277, P37260, DOI 10.1074/jbc.M202295200; TRINEL PA, 1993, INFECT IMMUN, V61, P4398, DOI 10.1128/IAI.61.10.4398-4405.1993; Trinel PA, 1999, J BIOL CHEM, V274, P30520, DOI 10.1074/jbc.274.43.30520; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725	31	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84771	10.1371/journal.pone.0084771	http://dx.doi.org/10.1371/journal.pone.0084771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367694	Green Published, gold			2022-12-27	WOS:000328741900065
J	Guo, W; Pleitner, JM; Saupe, KW; Greaser, ML				Guo, Wei; Pleitner, Jonathan M.; Saupe, Kurt W.; Greaser, Marion L.			Pathophysiological Defects and Transcriptional Profiling in the RBM20(-/-) Rat Model	PLOS ONE			English	Article							TITIN ISOFORM EXPRESSION; TISSUE GROWTH-FACTOR; GIANT PROTEIN TITIN; CARDIAC TITIN; DIASTOLIC DYSFUNCTION; MYOCARDIAL STIFFNESS; PASSIVE STIFFNESS; FACTOR-BETA; HUMAN HEART; GENE	Our recent study indicated that RNA binding motif 20 (Rbm20) alters splicing of titin and other genes. The current goals were to understand how the Rbm20(-/-) rat is related to physiological, structural, and molecular changes leading to heart failure. We quantitatively and qualitatively compared the expression of titin isoforms between Rbm20(-/-) and wild type rats by real time RT-PCR and SDS agarose electrophoresis. Isoform changes were linked to alterations in transcription as opposed to translation of titin messages. Reduced time to exhaustion with running in knockout rats also suggested a lower maximal cardiac output or decreased skeletal muscle performance. Electron microscopic observations of the left ventricle from knockout animals showed abnormal myofibril arrangement, Z line streaming, and lipofuscin deposits. Mutant skeletal muscle ultrastructure appeared normal. The results suggest that splicing alterations in Rbm20(-/-) rats resulted in pathogenic changes in physiology and cardiac ultrastructure. Secondary changes were observed in message levels for many genes whose splicing was not directly affected. Gene and protein expression data indicated the activation of pathophysiological and muscle stress-activated pathways. These data provide new insights on Rbm20 function and how its malfunction leads to cardiomyopathy.	[Guo, Wei; Pleitner, Jonathan M.; Greaser, Marion L.] Univ Wisconsin, Muscle Biol Lab, Madison, WI 53706 USA; [Saupe, Kurt W.] Univ Wisconsin, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Greaser, ML (corresponding author), Univ Wisconsin, Muscle Biol Lab, Madison, WI 53706 USA.	mgreaser@ansci.wisc.edu			National Institutes of Health [HL77196]; National Institute of Food and Agriculture; United States Department of Agriculture [WIS01556]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (HL77196)(MLG) and the National Institute of Food and Agriculture, United States Department of Agriculture (ID number WIS01556 to MLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Barta P, 2002, J HYPERTENS, V20, P1115, DOI 10.1097/00004872-200206000-00022; Bell SP, 2000, CIRC RES, V87, P235, DOI 10.1161/01.RES.87.3.235; Borg TK, 1996, TRENDS CARDIOVAS MED, V6, P65, DOI 10.1016/1050-1738(96)00005-9; Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Brenner DA, 2001, CIRCULATION, V104, P221, DOI 10.1161/01.CIR.104.2.221; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Crean JK, 2004, FASEB J, V18, P1541, DOI 10.1096/fj.04-1546fje; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Giehl K, 2008, AM J PHYSIOL-RENAL, V294, pF407, DOI 10.1152/ajprenal.00093.2007; GOLDSPINK G, 1971, J CELL SCI, V9, P123; Granzier HL, 2009, CIRC RES, V105, P557, DOI 10.1161/CIRCRESAHA.109.200964; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Greaser ML, 2008, J MOL CELL CARDIOL, V44, P983, DOI 10.1016/j.yjmcc.2008.02.272; Greaser ML, 2005, J MUSCLE RES CELL M, V26, P325, DOI 10.1007/s10974-005-9039-0; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Guo W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/753675; Gupta A, 2010, LAB INVEST, V90, P520, DOI 10.1038/labinvest.2010.43; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Hugo C, 2003, NEPHROL DIAL TRANSPL, V18, P1241, DOI 10.1093/ndt/gfg159; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lahmers S, 2004, CIRC RES, V94, P505, DOI 10.1161/01.RES.0000115522.52554.86; LeWinter MM, 2007, CLIN CHIM ACTA, V375, P1, DOI 10.1016/j.cca.2006.06.035; Li DX, 2010, CTS-CLIN TRANSL SCI, V3, P90, DOI 10.1111/j.1752-8062.2010.00198.x; Linke WA, 2008, CARDIOVASC RES, V77, P637, DOI 10.1016/j.cardiores.2007.03.029; Linke WA, 2010, PHYSIOLOGY, V25, P186, DOI 10.1152/physiol.00005.2010; Makarenko I, 2004, CIRC RES, V95, P708, DOI 10.1161/01.RES.0000143901.37063.2f; MARON BJ, 1975, CIRCULATION, V52, P926, DOI 10.1161/01.CIR.52.5.926; MARON BJ, 1975, J MOL CELL CARDIOL, V7, P697, DOI 10.1016/0022-2828(75)90146-7; Mateja RD, 2013, BBA-MOL CELL RES, V1833, P804, DOI 10.1016/j.bbamcr.2012.08.011; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Mitov MI, 2009, ELECTROPHORESIS, V30, P848, DOI 10.1002/elps.200800583; Muhle-Goll C, 2001, J MOL BIOL, V313, P431, DOI 10.1006/jmbi.2001.5017; Muto M, 2001, INT J CARDIOL, V81, P189, DOI 10.1016/S0167-5273(01)00566-6; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Neagoe C, 2003, J MUSCLE RES CELL M, V24, P175, DOI 10.1023/A:1026053530766; Neagoe C, 2002, CIRCULATION, V106, P1333, DOI 10.1161/01.CIR.0000029803.93022.93; Opitz CA, 2004, CIRC RES, V94, P967, DOI 10.1161/01.RES.0000124301.48193.E1; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Patel JR, 2012, AM J PHYSIOL-HEART C, V302, pH697, DOI 10.1152/ajpheart.00800.2011; PATTERSON S, 1976, J CELL SCI, V22, P607; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PLEITNER JM, 2013, THESIS U WISCONSIN M, P1012; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; Raskin A, 2012, J BIOL CHEM, V287, P29273, DOI 10.1074/jbc.M112.372839; Refaat MM, 2012, HEART RHYTHM, V9, P390, DOI 10.1016/j.hrthm.2011.10.016; SCHAPER J, 1991, CIRCULATION, V83, P504, DOI 10.1161/01.CIR.83.2.504; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; Wahab NA, 2005, DIABETOLOGIA, V48, P2650, DOI 10.1007/s00125-005-0006-5; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Warren CM, 2004, MECH DEVELOP, V121, P1301, DOI 10.1016/j.mod.2004.07.003; Warren CM, 2003, CARDIOVASC RES, V59, P86, DOI 10.1016/S0008-6363(03)00328-6; Wu LJ, 2006, MOL CELL BIOCHEM, V284, P65, DOI 10.1007/s11010-005-9014-5; Wu YM, 2007, J MOL CELL CARDIOL, V42, P186, DOI 10.1016/j.yjmcc.2006.09.017; Wu YM, 2002, J CARD FAIL, V8, pS276, DOI 10.1054/jcaf.2002.129278; Wu YM, 2002, CIRCULATION, V106, P1384, DOI 10.1161/01.CIR.0000029804.61510.02; Ye P, 2003, CLIN EXP PHARMACOL P, V30, P930, DOI 10.1111/j.1440-1681.2003.03937.x	60	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84281	10.1371/journal.pone.0084281	http://dx.doi.org/10.1371/journal.pone.0084281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367651	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900043
J	Massot, C; Bancel, D; Lauri, FL; Truffault, V; Baldet, P; Stevens, R; Gautier, H				Massot, Capucine; Bancel, Doriane; Lauri, Felicie Lopez; Truffault, Vincent; Baldet, Pierre; Stevens, Rebecca; Gautier, Helene			High Temperature Inhibits Ascorbate Recycling and Light Stimulation of the Ascorbate Pool in Tomato despite Increased Expression of Biosynthesis Genes	PLOS ONE			English	Article							L-GALACTOSE GUANYLTRANSFERASE; VITAMIN-C LEVELS; GLUTATHIONE-REDUCTASE; FRUIT-DEVELOPMENT; GROWING TEMPERATURES; RIBES-NIGRUM; ACID; PLANT; METABOLISM; PATHWAY	Understanding how the fruit microclimate affects ascorbate (AsA) biosynthesis, oxidation and recycling is a great challenge in improving fruit nutritional quality. For this purpose, tomatoes at breaker stage were harvested and placed in controlled environment conditions at different temperatures (12, 17, 23, 27 and 31 degrees C) and irradiance regimes (darkness or 150 mu mol m(-2) s(-1)). Fruit pericarp tissue was used to assay ascorbate, glutathione, enzymes related to oxidative stress and the AsA/glutathione cycle and follow the expression of genes coding for 5 enzymes of the AsA biosynthesis pathway (GME, VTC2, GPP, L-GalDH, GLDH). The AsA pool size in pericarp tissue was significantly higher under light at temperatures below 27 degrees C. In addition, light promoted glutathione accumulation at low and high temperatures. At 12 degrees C, increased AsA content was correlated with the enhanced expression of all genes of the biosynthesis pathway studied, combined with higher DHAR and MDHAR activities and increased enzymatic activities related to oxidative stress (CAT and APX). In contrast, at 31 degrees C, MDHAR and GR activities were significantly reduced under light indicating that enzymes of the AsA/glutathione cycle may limit AsA recycling and pool size in fruit pericarp, despite enhanced expression of genes coding for AsA biosynthesis enzymes. In conclusion, this study confirms the important role of fruit microclimate in the regulation of fruit pericarp AsA content, as under oxidative conditions (12 degrees C, light) total fruit pericarp AsA content increased up to 71%. Moreover, it reveals that light and temperature interact to regulate both AsA biosynthesis gene expression in tomato fruits and AsA oxidation and recycling.	[Massot, Capucine; Bancel, Doriane; Truffault, Vincent; Gautier, Helene] INRA, UR Plantes & Syst Cultures Hort 1115, Avignon, France; [Lauri, Felicie Lopez] Univ Avignon, EA4279, Avignon, France; [Baldet, Pierre] France Univ Bordeaux, INRA, UMR Biol Fruit & Pathol 1332, Bordeaux, France; [Stevens, Rebecca] INRA, UR 1052, F-84143 Montfavet, France	INRAE; Avignon Universite; INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE	Massot, C (corresponding author), INRA, UR Plantes & Syst Cultures Hort 1115, Avignon, France.	massot.capucine@gmail.com; helene.gautier@avignon.inra.fr		Baldet, Pierre/0000-0001-7351-1803; Stevens, Rebecca/0000-0003-4401-7923	Plantinov'Ser fundings (Pays de Loire, France); PHD grant for Capucine Massot	Plantinov'Ser fundings (Pays de Loire, France); PHD grant for Capucine Massot	This work was supported by Plantinov'Ser fundings (Pays de Loire, France). INRA and Region Provence Alpes Cote d'Azur co-funded a PHD grant for Capucine Massot. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Alimohammadi M, 2012, J EXP BOT, V63, P825, DOI 10.1093/jxb/err306; Atkinson CJ, 2013, ANN BOT-LONDON, V111, P703, DOI 10.1093/aob/mct026; Badejo AA, 2012, J EXP BOT, V63, P229, DOI 10.1093/jxb/err275; Benard C, 2009, J AGR FOOD CHEM, V57, P4112, DOI 10.1021/jf8036374; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Chen Z, 2008, J BIOL CHEM, V283, P21347, DOI 10.1074/jbc.M802601200; Conklin PL, 2001, PLANT CELL ENVIRON, V24, P383, DOI 10.1046/j.1365-3040.2001.00686.x; CRIBB AE, 1989, ANAL BIOCHEM, V183, P195, DOI 10.1016/0003-2697(89)90188-7; Davey MW, 2000, J SCI FOOD AGR, V80, P825, DOI [10.1002/(SICI)1097-0010(20000515)80:7<825::AID-JSFA598>3.0.CO;2-6, 10.1002/(SICI)1097-0010(20000515)80:7&lt;825::AID-JSFA598&gt;3.0.CO;2-6]; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Dumas Y, 2003, J SCI FOOD AGR, V83, P369, DOI 10.1002/jsfa.1370; Faria T, 1996, TREE PHYSIOL, V16, P115; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Gallie DR, 2013, J EXP BOT, V64, P433, DOI 10.1093/jxb/ers330; Garchery C, 2013, PLANT CELL ENVIRON, V36, P159, DOI 10.1111/j.1365-3040.2012.02564.x; Garg N, 2011, SCI HORTIC-AMSTERDAM, V131, P29, DOI 10.1016/j.scienta.2011.09.024; Gautier H, 2005, CAN J PLANT SCI, V85, P439, DOI 10.4141/P03-163; Gautier H, 2005, J SCI FOOD AGR, V85, P1009, DOI 10.1002/jsfa.2060; Gautier H, 2009, ANN BOT-LONDON, V103, P495, DOI 10.1093/aob/mcn233; Gautier H, 2008, J AGR FOOD CHEM, V56, P1241, DOI 10.1021/jf072196t; Gest N, 2013, J EXP BOT, V64, P33, DOI 10.1093/jxb/ers297; Gomez R, 1998, J FOOD QUALITY, V21, P329, DOI 10.1111/j.1745-4557.1998.tb00526.x; Green MA, 2005, NATURE, V433, P83, DOI 10.1038/nature03172; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Hancock RD, 2007, FUNCT PLANT BIOL, V34, P1080, DOI 10.1071/FP07221; Ioannidi E, 2009, J EXP BOT, V60, P663, DOI 10.1093/jxb/ern322; Kang HM, 2002, POSTHARVEST BIOL TEC, V24, P49, DOI 10.1016/S0925-5214(01)00129-6; Koo LC, 1996, DIET LUNG CANC 20 YE, P22; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Lechaudel M, 2013, J PLANT PHYSIOL, V170, P567, DOI 10.1016/j.jplph.2012.11.009; Leferink NGH, 2009, PLANT PHYSIOL, V150, P596, DOI 10.1104/pp.109.136929; Li MJ, 2009, PLANTA, V230, P39, DOI 10.1007/s00425-009-0925-3; Li Y, 2007, J NUTR, V137, P2171, DOI 10.1093/jn/137.10.2171; Li Y, 2007, MED HYPOTHESES, V68, P1315, DOI 10.1016/j.mehy.2006.10.035; Linster CL, 2008, J BIOL CHEM, V283, P18483, DOI 10.1074/jbc.M802594200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN BA, 1979, PLANT PHYSIOL, V63, P486, DOI 10.1104/pp.63.3.486; Massot C, 2012, PLANTA, V235, P153, DOI 10.1007/s00425-011-1493-x; Massot C, 2010, PLANT PHYSIOL BIOCH, V48, P751, DOI 10.1016/j.plaphy.2010.06.001; Melino VJ, 2011, J SCI FOOD AGR, V91, P1712, DOI 10.1002/jsfa.4376; Murshed R, 2008, ANAL BIOCHEM, V383, P320, DOI 10.1016/j.ab.2008.07.020; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Ogweno JO, 2008, J PLANT GROWTH REGUL, V27, P49, DOI 10.1007/s00344-007-9030-7; Ogweno JO, 2009, SCI HORTIC-AMSTERDAM, V123, P17, DOI 10.1016/j.scienta.2009.07.011; Parsons HT, 2011, BIOCHEM J, V440, P375, DOI 10.1042/BJ20110939; Poiroux-Gonord F, 2010, J AGR FOOD CHEM, V58, P12065, DOI 10.1021/jf1037745; Richardson AC, 2004, PLANT CELL ENVIRON, V27, P423, DOI 10.1111/j.1365-3040.2003.01161.x; Rivero RM, 2004, J HORTIC SCI BIOTECH, V79, P560, DOI 10.1080/14620316.2004.11511805; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Stevens R, 2007, PLANT PHYSIOL, V143, P1943, DOI 10.1104/pp.106.091413; Stevens R, 2006, J AGR FOOD CHEM, V54, P6159, DOI 10.1021/jf061241e; Tamaoki M, 2003, PLANT SCI, V164, P1111, DOI 10.1016/S0168-9452(03)00122-5; Toor RK, 2006, J FOOD COMPOS ANAL, V19, P1, DOI 10.1016/j.jfca.2004.11.008; Torres CA, 2006, J EXP BOT, V57, P1933, DOI 10.1093/jxb/erj136; Wang J, 2013, PLANT CELL, V25, P625, DOI 10.1105/tpc.112.106880; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Yabuta Y, 2007, J EXP BOT, V58, P2661, DOI 10.1093/jxb/erm124	63	40	45	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84474	10.1371/journal.pone.0084474	http://dx.doi.org/10.1371/journal.pone.0084474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367665	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900049
J	Viljoen, AJ; Kirsten, CJ; Baker, B; van Helden, PD; Wiid, IJF				Viljoen, Albertus J.; Kirsten, Catriona J.; Baker, Bienyameen; van Helden, Paul D.; Wiid, Ian J. F.			The Role of Glutamine Oxoglutarate Aminotransferase and Glutamate Dehydrogenase in Nitrogen Metabolism in Mycobacterium bovis BCG	PLOS ONE			English	Article							TUBERCULOSIS; GENE; GROWTH; ELECTROPORATION; SYNTHETASE; GLNE; KEGG	Recent evidence suggests that the regulation of intracellular glutamate levels could play an important role in the ability of pathogenic slow-growing mycobacteria to grow in vivo. However, little is known about the in vitro requirement for the enzymes which catalyse glutamate production and degradation in the slow-growing mycobacteria, namely; glutamine oxoglutarate aminotransferase (GOGAT) and glutamate dehydrogenase (GDH), respectively. We report that allelic replacement of the Mycobacterium bovis BCG gltBD-operon encoding for the large (gltB) and small (gltD) subunits of GOGAT with a hygromycin resistance cassette resulted in glutamate auxotrophy and that deletion of the GDH encoding-gene (gdh) led to a marked growth deficiency in the presence of L-glutamate as a sole nitrogen source as well as reduction in growth when cultured in an excess of L-asparagine.	[Viljoen, Albertus J.; Kirsten, Catriona J.; Baker, Bienyameen; van Helden, Paul D.; Wiid, Ian J. F.] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,MRC Ctr Mol, Cape Town, South Africa	National Research Foundation - South Africa; Stellenbosch University	Viljoen, AJ (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,MRC Ctr Mol, Cape Town, South Africa.	ajvil@sun.ac.za	Baker, Bienyameen/F-9150-2015; Viljoen, Albertus/O-6794-2019	Baker, Bienyameen/0000-0002-2158-6763; Viljoen, Albertus/0000-0001-8949-7401	Department of Biomedical Sciences, Division of Molecular Biology and Human Genetics, Stellenbosch University; National Research Foundation (DAAD-NRF)	Department of Biomedical Sciences, Division of Molecular Biology and Human Genetics, Stellenbosch University; National Research Foundation (DAAD-NRF)	The study was supported financially by the Department of Biomedical Sciences, Division of Molecular Biology and Human Genetics, Stellenbosch University. AJV received a bursary from the the National Research Foundation (DAAD-NRF). The financial assistance of the National Research Foundation (DAAD-NRF) towards this research is hereby acknowledged. Opinions expressed and conclusions arrived at, are those of the author and are not necessarily to be attributed to the DAAD-NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon J, 2010, FEMS MICROBIOL REV, V34, P588, DOI 10.1111/j.1574-6976.2010.00216.x; BISHOP P J, 1970, Tubercle, V51, P196; Camardella L, 2002, COMP BIOCHEM PHYS A, V131, P559, DOI 10.1016/S1095-6433(01)00507-4; Carroll P, 2008, J BACTERIOL, V190, P4894, DOI 10.1128/JB.00166-08; Chen JM, 2003, INFECT IMMUN, V71, P708, DOI 10.1128/IAI.71.2.708-716.2003; Cheung Y. W., 2011, Hong Kong Medical Journal, V17, P32; COHN ML, 1968, AM REV RESPIR DIS, V98, P295; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Harper C, 2008, IUBMB LIFE, V60, P643, DOI 10.1002/iub.100; Harth G, 1997, J BIOL CHEM, V272, P22728, DOI 10.1074/jbc.272.36.22728; Hinds J, 1999, MICROBIOL-UK, V145, P519, DOI 10.1099/13500872-145-3-519; JAYARAM HN, 1968, ARCH BIOCHEM BIOPHYS, V126, P165, DOI 10.1016/0003-9861(68)90570-5; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kawakami R, 2007, J BACTERIOL, V189, P5626, DOI 10.1128/JB.00496-07; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lu CD, 2001, J BACTERIOL, V183, P490, DOI 10.1128/JB.183.2.490-499.2001; LYON RH, 1974, J BACTERIOL, V117, P151, DOI 10.1128/JB.117.1.151-156.1974; Machowski EE, 2007, J BACTERIOL, V189, P2190, DOI 10.1128/JB.01647-06; Minambres B, 2000, J BIOL CHEM, V275, P39529, DOI 10.1074/jbc.M005136200; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Parish T, 2000, J BACTERIOL, V182, P5715, DOI 10.1128/JB.182.20.5715-5720.2000; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Pashley CA, 2006, MICROBIOL-SGM, V152, P2727, DOI 10.1099/mic.0.28942-0; SAMBROOK J, 2000, MOL CLONING LAB MANU; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SORU E, 1972, CAN J BIOCHEM CELL B, V50, P1149, DOI 10.1139/o72-157; Tullius MV, 2003, INFECT IMMUN, V71, P3927, DOI 10.1128/IAI.71.7.3927-3936.2003; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wards BJ, 1996, FEMS MICROBIOL LETT, V145, P101, DOI 10.1016/0378-1097(96)00394-1; Warren RM, 2000, MOL MICROBIOL, V37, P1405, DOI 10.1046/j.1365-2958.2000.02090.x; WEBSTER ADB, 1981, J ROY SOC MED, V74, P163, DOI 10.1177/014107688107400215	36	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84452	10.1371/journal.pone.0084452	http://dx.doi.org/10.1371/journal.pone.0084452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367660	Green Submitted, Green Published, gold			2022-12-27	WOS:000328741900047
J	Belnoue, E; Fontannaz, P; Rochat, AF; Tougne, C; Bergthaler, A; Lambert, PH; Pinschewer, DD; Siegrist, CA				Belnoue, Elodie; Fontannaz, Paola; Rochat, Anne-Francoise; Tougne, Chantal; Bergthaler, Andreas; Lambert, Paul-Henri; Pinschewer, Daniel D.; Siegrist, Claire-Anne			Functional Limitations of Plasmacytoid Dendritic Cells Limit Type I Interferon, T Cell Responses and Virus Control in Early Life	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; RESPIRATORY SYNCYTIAL VIRUS; TRANSCRIPTION FACTOR E2-2; CHRONIC VIRAL-INFECTION; NEONATAL MICE; FLT3 LIGAND; CORD BLOOD; AUTOIMMUNE-DISEASES; CLONAL EXPANSION; IMMUNE-RESPONSES	Infant mortality from viral infection remains a major global health concern: viruses causing acute infections in immunologically mature hosts often follow a more severe course in early life, with prolonged or persistent viral replication. Similarly, the WE strain of lymphocytic choriomeningitis virus (LCMV-WE) causes acute self-limiting infection in adult mice but follows a protracted course in infant animals, in which LCMV-specific CD8(+) T cells fail to expand and control infection. By disrupting type I IFNs signaling in adult mice or providing IFN-alpha supplementation to infant mice, we show here that the impaired early life T cell responses and viral control result from limited early type I IFN responses. We postulated that plasmacytoid dendritic cells (pDC), which have been identified as one major source of immediate-early IFN-I, may not exert adult-like function in vivo in the early life microenvironment. We tested this hypothesis by studying pDC functions in vivo during LCMV infection and identified a coordinated downregulation of infant pDC maturation, activation and function: despite an adult-like in vitro activation capacity of infant pDCs, the expression of the E2-2 pDC master regulator (and of critical downstream antiviral genes such as MyD88, TLR7/TLR9, NF-kappa B, IRF7 and IRF8) is downregulated in vivo at baseline and during LCMV infection. A similar pattern was observed in response to ssRNA polyU, a model ligand of the TLR7 viral sensor. This suggests that the limited T cell-mediated defense against early life viral infections is largely attributable to / regulated by infant pDC responses and provides incentives for novel strategies to supplement or stimulate immediate-early IFN-alpha responses.	[Belnoue, Elodie] Univ Geneva, World Hlth Org Collaborating Ctr Vaccinol & Neona, Dept Pathol Immunol, Geneva, Switzerland; Univ Geneva, World Hlth Org Collaborating Ctr Vaccinol & Neona, Dept Pediat, Geneva, Switzerland	University of Geneva; World Health Organization; University of Geneva; World Health Organization	Belnoue, E (corresponding author), Univ Geneva, World Hlth Org Collaborating Ctr Vaccinol & Neona, Dept Pathol Immunol, Geneva, Switzerland.	elodie.belnoue@unige.ch	Bergthaler, Andreas/ABG-5047-2020	Bergthaler, Andreas/0000-0003-0597-1976; Pinschewer, Daniel/0000-0002-1594-3189				Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Badovinac VP, 2006, J IMMUNOL, V177, P999, DOI 10.4049/jimmunol.177.2.999; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Basler Christopher F, 2002, Int Rev Immunol, V21, P305; Belnoue E, 2007, J VIROL, V81, P7338, DOI 10.1128/JVI.00062-07; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Charrier E, 2012, CELL IMMUNOL, V276, P114, DOI 10.1016/j.cellimm.2012.04.010; Cho HJ, 2002, J IMMUNOL, V168, P4907, DOI 10.4049/jimmunol.168.10.4907; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dakic A, 2004, J IMMUNOL, V172, P1018, DOI 10.4049/jimmunol.172.2.1018; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; De Wit D, 2003, J AUTOIMMUN, V21, P277, DOI 10.1016/j.jaut.2003.08.003; Fernandez MA, 2008, EUR J IMMUNOL, V38, P102, DOI 10.1002/eji.200636945; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gold MC, 2006, PEDIATR RES, V60, P34, DOI 10.1203/01.pdr.0000220352.13547.f4; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Heidema J, 2007, J IMMUNOL, V179, P8410, DOI 10.4049/jimmunol.179.12.8410; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Jung A, 2008, J VIROL, V82, P196, DOI 10.1128/JVI.01640-07; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Lande R, 2010, ANN NY ACAD SCI, V1183, P89, DOI 10.1111/j.1749-6632.2009.05152.x; Lang PA, 2009, BLOOD, V113, P1045, DOI 10.1182/blood-2007-10-117861; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Lee LN, 2009, J IMMUNOL, V182, P7178, DOI 10.4049/jimmunol.0802526; LEVEY RH, 1963, SCIENCE, V142, P483; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lines JL, 2010, J IMMUNOL, V185, P2980, DOI 10.4049/jimmunol.0903075; Lopez CB, 2003, J INFECT DIS, V187, P1126, DOI 10.1086/368381; Lukaszewski RA, 2000, J VIROL, V74, P5006, DOI 10.1128/JVI.74.11.5006-5015.2000; Lukens MV, 2010, J VIROL, V84, P2374, DOI 10.1128/JVI.01807-09; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; Macal M, 2012, CELL HOST MICROBE, V11, P617, DOI 10.1016/j.chom.2012.04.017; Montoya M, 2005, J IMMUNOL, V174, P1851, DOI 10.4049/jimmunol.174.4.1851; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Ohm-Smith MJ, 2004, J CLIN MICROBIOL, V42, P2996, DOI 10.1128/JCM.42.7.2996-2999.2004; Olitsky PK, 1936, J EXP MED, V64, P723, DOI 10.1084/jem.64.5.723; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Rajagopal D, 2010, BLOOD, V115, P1949, DOI 10.1182/blood-2009-08-238543; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Traub E, 1936, J EXP MED, V63, P533, DOI 10.1084/jem.63.4.533; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Upham JW, 2009, J ALLERGY CLIN IMMUN, V124, P707, DOI 10.1016/j.jaci.2009.07.009; Vollstedt S, 2004, EUR J IMMUNOL, V34, P1849, DOI 10.1002/eji.200324443; Vollstedt S, 2003, J EXP MED, V197, P575, DOI 10.1084/jem.20021900; Vollstedt S, 2006, EUR J IMMUNOL, V36, P1231, DOI 10.1002/eji.200535759; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Welsh RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002352; Wiesel M, 2011, J IMMUNOL, V186, P754, DOI 10.4049/jimmunol.1003166; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; WILSON CB, 1992, AM J REPROD IMMUNOL, V28, P132, DOI 10.1111/j.1600-0897.1992.tb00774.x; Zhang XM, 2007, J EXP MED, V204, P1107, DOI 10.1084/jem.20062013; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052003; Zhou SH, 2012, J VIROL, V86, P11254, DOI 10.1128/JVI.00576-12; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10	73	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85302	10.1371/journal.pone.0085302	http://dx.doi.org/10.1371/journal.pone.0085302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376875	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000181
J	Boutin, S; Bernatchez, L; Audet, C; Derome, N				Boutin, Sebastien; Bernatchez, Louis; Audet, Celine; Derome, Nicolas			Network Analysis Highlights Complex Interactions between Pathogen, Host and Commensal Microbiota	PLOS ONE			English	Article							CHARR SALVELINUS-FONTINALIS; BROOK CHARR; ARTEMIA-FRANCISCANA; STRESS; FISH; COMMUNITIES; SKIN; PROPIONIBACTERIA; RESISTANCE; PROBIOTICS	Interactions between bacteria and their host represent a full continuum from pathogenicity to mutualism. From an evolutionary perspective, host-bacteria relationships are no longer considered a two-component system but rather a complex network. In this study, we focused on the relationship between brook charr (Salvelinus fontinalis) and bacterial communities developing on skin mucus. We hypothesized that stressful conditions such as those occurring in aquaculture production induce shifts in the bacterial community of healthy fish, thus allowing pathogens to cause infections. The results showed that fish skin mucus microbiota taxonomical structure is highly specific, its diversity being partly influenced by the surrounding water bacterial community. Two types of taxonomic co-variation patterns emerged across 121 contrasted communities' samples: one encompassing four genera well known for their probiotic properties, the other harboring five genera mostly associated with pathogen species. The homeostasis of fish bacterial community was extensively disturbed by induction of physiological stress in that both: 1) the abundance of probiotic-like bacteria decreased after stress exposure; and 2) pathogenic bacteria increased following stress exposure. This study provides further insights regarding the role of mutualistic bacteria as a primary host protection barrier.	[Boutin, Sebastien; Bernatchez, Louis; Derome, Nicolas] Univ Laval, Dept Biol, IBIS, Quebec City, PQ G1K 7P4, Canada; [Audet, Celine] Univ Quebec Rimouski UQAR, Inst Sci Rimouski ISMER, Rimouski, PQ, Canada	Laval University; University of Quebec; Universite du Quebec a Rimouski	Boutin, S (corresponding author), Univ Laval, Dept Biol, IBIS, Quebec City, PQ G1K 7P4, Canada.	sebastien.boutin.1@ulaval.ca	Boutin, Sébastien/AAX-5334-2021; Audet, Celine/F-5192-2011	Boutin, Sébastien/0000-0002-0499-2460; Bernatchez, Louis/0000-0002-8085-9709	"Natural Sciences and Engineering Research Council" (NSERC); "Collaborative REsearch And Training Experience" program (CREATE)	"Natural Sciences and Engineering Research Council" (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); "Collaborative REsearch And Training Experience" program (CREATE)	This work was financially supported by a Partnership grant (Strategic program) of the "Natural Sciences and Engineering Research Council" (NSERC) to LB, ND and CA and the "Collaborative REsearch And Training Experience" program (CREATE). This is a contribution to the research program of Ressources Aquatiques du Quebec (RAQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Austin B, 2006, THESCIENTIFICWORLDJO, V6, P931, DOI 10.1100/tsw.2006.181; Austin B., 2012, BACTERIAL FISH PATHO, DOI DOI 10.1007/978-94-007-4884-2; Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; BOUTIN S, 2013, CAN J MICROBIOL; Boutin S, 2012, MOL ECOL RESOUR, V12, P1027, DOI 10.1111/j.1755-0998.2012.03166.x; Boutin S, 2012, VET MICROBIOL, V155, P355, DOI 10.1016/j.vetmic.2011.09.002; CAHILL MM, 1990, MICROB ECOL, V19, P21, DOI 10.1007/BF02015051; Chaia AP, 1999, LAIT, V79, P175, DOI 10.1051/lait:1999114; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Champigneulle A., 1984, BULLETIN FRANCAIS DE PISCICULTURE, P52; Claireaux G, 2000, J FISH BIOL, V56, P347; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crespel A, 2011, J FISH BIOL, V79, P2019, DOI 10.1111/j.1095-8649.2011.03149.x; Curtis TP, 2006, PHILOS T R SOC B, V361, P2023, DOI 10.1098/rstb.2006.1921; DeAngelis KM, 2010, ENVIRON MICROBIOL, V12, P3137, DOI 10.1111/j.1462-2920.2010.02286.x; Defoirdt T, 2007, ENVIRON MICROBIOL, V9, P445, DOI 10.1111/j.1462-2920.2006.01161.x; Dillon R, 2002, RES MICROBIOL, V153, P503, DOI 10.1016/S0923-2508(02)01361-X; Easy RH, 2009, COMP BIOCHEM PHYS D, V4, P159, DOI 10.1016/j.cbd.2009.02.001; Espelid S, 1996, FISH SHELLFISH IMMUN, V6, P95, DOI 10.1006/fsim.1996.0011; ESTY WW, 1986, ANN STAT, V14, P1257, DOI 10.1214/aos/1176350066; Fahrbach M, 2008, INT J SYST EVOL MICR, V58, P2215, DOI 10.1099/ijs.0.65342-0; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Freilich S, 2010, NUCLEIC ACIDS RES, V38, P3857, DOI 10.1093/nar/gkq118; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Halet D, 2007, FEMS MICROBIOL ECOL, V60, P363, DOI 10.1111/j.1574-6941.2007.00305.x; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hickman C. S., 2005, INFLUENCE COOPERATIV, P3; Hisar O, 2002, ISR J AQUACULT-BAMID, V54, P189; IGER Y, 1995, GEN COMP ENDOCR, V97, P188, DOI 10.1006/gcen.1995.1018; Jezbera J, 2011, ENVIRON MICROBIOL, V13, P922, DOI 10.1111/j.1462-2920.2010.02396.x; Laplante K, 2013, EVOL APPL, V6, P643, DOI 10.1111/eva.12050; Le Moullac G, 1998, FISH SHELLFISH IMMUN, V8, P621, DOI 10.1006/fsim.1998.0166; Lucentini L, 2006, MOL ECOL NOTES, V6, P257, DOI 10.1111/j.1471-8286.2005.01142.x; MantereAlhonen S, 1995, LAIT, V75, P447, DOI 10.1051/lait:19954-534; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Rakers S, 2010, EXP DERMATOL, V19, P313, DOI 10.1111/j.1600-0625.2009.01059.x; Ramsey MM, 2009, P NATL ACAD SCI USA, V106, P1578, DOI 10.1073/pnas.0809533106; Roling WFM, 2010, CURR OPIN BIOTECH, V21, P532, DOI 10.1016/j.copbio.2010.06.007; Sauvage C, 2012, G3-GENES GENOM GENET, V2, P379, DOI 10.1534/g3.111.001867; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Stecher B, 2013, NAT REV MICROBIOL, V11, P277, DOI 10.1038/nrmicro2989; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Thiel A, 2004, ITAL J FOOD SCI, V16, P245; Trivedi Bijal, 2012, Nature, V492, pS60, DOI 10.1038/492S60a; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Verbrugghe E, 2012, VET MICROBIOL, V155, P115, DOI 10.1016/j.vetmic.2011.09.012; White DC, 1996, CURR OPIN BIOTECH, V7, P301, DOI 10.1016/S0958-1669(96)80034-6; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	54	126	133	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84772	10.1371/journal.pone.0084772	http://dx.doi.org/10.1371/journal.pone.0084772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376845	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000165
J	den Dekker, MAM; Zwiers, M; van den Heuvel, ER; de Vos, LC; Smit, AJ; Zeebregts, CJ; Oudkerk, M; Vliegenthart, R; Lefrandt, JD; Mulder, DJ				den Dekker, Martijn A. M.; Zwiers, Marjan; van den Heuvel, Edwin R.; de Vos, Lisanne C.; Smit, Andries J.; Zeebregts, Clark J.; Oudkerk, Matthijs; Vliegenthart, Rozemarijn; Lefrandt, Joop D.; Mulder, Douwe J.			Skin Autofluorescence, a Non-Invasive Marker for AGE Accumulation, Is Associated with the Degree of Atherosclerosis	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INTIMA-MEDIA THICKNESS; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; SOLUBLE RECEPTOR; ENDPRODUCTS; RISK; PENTOSIDINE; COMPLICATIONS; INDIVIDUALS	Introduction: Advanced glycation endproducts (AGEs) may be involved in the development of atherosclerosis, beyond diabetes and renal disease. Skin autofluorescence (AF) is a non-invasive marker for AGEs. We examined whether skin AF is increased in (subclinical) atherosclerosis and associated with the degree of atherosclerosis independent of diabetes and renal function. Methods: A cross-sectional study of 223 patients referred for primary (n = 163) or secondary (n = 60) prevention between 2006 and 2012 was performed. Skin AF was measured using the AGE-Reader. Ultrasonography was used to assess plaques in carotid and femoral arteries and computed tomography for the calculation of the coronary artery calcium score (CACS; in primary prevention only). Primary prevention patients were divided into a group with subclinical atherosclerosis defined as >1 plaque or CACS >100 (n = 67; age 53 year [interquartile range 48-56]; 49% male) and without (controls; 96; 43 [38-51]; 55%). Secondary prevention were patients with peripheral arterial disease (60; 64 [58-70]; 73%). Results: Skin AF was higher in subclinical and clinical atherosclerosis compared with controls (skin AF 2.11 [interquartile range 1.83-2.46] and 2.71 [2.15-3.27] vs. 1.87 [1.68-2.12] respectively; P = 0.005 and <0.001). In a multivariate analysis, the association of skin AF with the atherosclerosis categories was independent of age, sex, diabetes, presence of the metabolic syndrome, Framingham Risk Score, and renal function. Skin AF correlated with most cardiovascular risk factors, Framingham risk score, and IMT and CACS. Conclusions: Skin AF is increased in documented subclinical and clinical atherosclerosis, independent of known risk factors such as diabetes and renal disease. These data suggest that AGEs may be associated with the burden of atherosclerosis and warrant a prospective study to investigate its clinical usability as a risk assessment tool for primary prevention.	[den Dekker, Martijn A. M.; Oudkerk, Matthijs; Vliegenthart, Rozemarijn] Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging North East Netherlands, Groningen, Netherlands; [Vliegenthart, Rozemarijn] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Zwiers, Marjan; de Vos, Lisanne C.; Smit, Andries J.; Lefrandt, Joop D.; Mulder, Douwe J.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Vasc Med, Groningen, Netherlands; [van den Heuvel, Edwin R.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Zeebregts, Clark J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Vasc Surg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Mulder, DJ (corresponding author), Univ Groningen, Dept Internal Med, Div Vasc Med, Univ Med Ctr Groningen, Groningen, Netherlands.	d.j.mulder@umcg.nl		Oudkerk, Matthijs/0000-0003-2800-4110				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Bierhaus A, 1998, CARDIOVASC RES, V37, P586, DOI 10.1016/S0008-6363(97)00233-2; Conway BN, 2012, DIABETES CARE, V35, P2331, DOI 10.2337/dc12-0053; de Leeuw K, 2007, RHEUMATOLOGY, V46, P1551, DOI 10.1093/rheumatology/kem215; de Vos LC, 2013, ARTERIOSCL THROM VAS, V33, P131, DOI 10.1161/ATVBAHA.112.300016; den Hollander NC, 2007, J INHERIT METAB DIS, V30, P916, DOI 10.1007/s10545-007-0507-0; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P177, DOI 10.1161/ATVBAHA.108.173609; Groen JM, 2008, INT J CARDIOVAS IMAG, V24, P547, DOI 10.1007/s10554-007-9282-0; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; Hricik DE, 1996, CLIN TRANSPLANT, V10, P568; Ishibashi Y, 2012, METABOLISM, V61, P1067, DOI 10.1016/j.metabol.2012.01.006; Januszewski AS, 2012, DIABETIC MED, V29, P726, DOI 10.1111/j.1464-5491.2011.03562.x; KUME S, 1995, AM J PATHOL, V147, P654; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lutgers HL, 2010, EUR J CLIN INVEST, V40, P812, DOI 10.1111/j.1365-2362.2010.02329.x; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Meerwaldt R, 2007, DIABETES CARE, V30, P107, DOI 10.2337/dc06-1391; Meerwaldt R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-29; MITCHELL J R, 1962, Br Med J, V1, P1293; Mulder DJ, 2009, NETH HEART J, V17, P162, DOI 10.1007/BF03086239; Mulder DJ, 2008, ATHEROSCLEROSIS, V197, P217, DOI 10.1016/j.atherosclerosis.2007.03.027; Mulder DJ, 2006, DIABETES TECHNOL THE, V8, P523, DOI 10.1089/dia.2006.8.523; Noordzij MJ, 2012, INT J CARDIOVAS IMAG, V28, P431, DOI 10.1007/s10554-011-9805-6; Oudkerk M, 2008, INT J CARDIOVAS IMAG, V24, P645, DOI 10.1007/s10554-008-9319-z; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Roman MJ, 2012, HYPERTENSION, V59, P29, DOI 10.1161/HYPERTENSIONAHA.111.181925; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Smit AJ, 2010, CURR OPIN NEPHROL HY, V19, P527, DOI 10.1097/MNH.0b013e32833e9259; Tanaka K, 2012, DIABETIC MED, V29, P492, DOI 10.1111/j.1464-5491.2011.03448.x; Tanaka K, 2010, THER APHER DIAL, V14, P334, DOI 10.1111/j.1744-9987.2009.00782.x; Terpstra WF, 2004, J HYPERTENS, V22, P1309, DOI 10.1097/01.hjh.0000125412.50839.b5; Touboul PJ, 2004, CEREBROVASC DIS, V18, P346, DOI 10.1159/000081812; Urios P, 2007, DIABETES RES CLIN PR, V77, P337, DOI 10.1016/j.diabres.2006.12.024; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	39	46	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83084	10.1371/journal.pone.0083084	http://dx.doi.org/10.1371/journal.pone.0083084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376641	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000058
J	Erb, WM; Hodges, JK; Hammerschmidt, K				Erb, Wendy M.; Hodges, J. Keith; Hammerschmidt, Kurt			Individual, Contextual, and Age-Related Acoustic Variation in Simakobu (Simias concolor) Loud Calls	PLOS ONE			English	Article							SEX-RELATED VARIATIONS; REFLECT BODY-SIZE; RED DEER; ALARM CALLS; VOCAL COMMUNICATION; PRESBYTIS-JOHNII; MALE QUALITY; MONKEYS; IDENTITY; VOCALIZATIONS	Primate loud calls have the potential to encode information about the identity, arousal, age, or physical condition of the caller, even at long distances. In this study, we conducted an analysis of the acoustic features of the loud calls produced by a species of Asian colobine monkey (simakobu, Simias concolor). Adult male simakobu produce loud calls spontaneously and in response to loud sounds and other loud calls, which are audible more than 500 m. Individual differences in calling rates and durations exist, but it is unknown what these differences signal and which other acoustic features vary among individuals. We aimed to describe the structure and usage of calls and to examine acoustic features that vary within and among individuals. We determined the context of 318 loud calls and analyzed 170 loud calls recorded from 10 adult males at an undisturbed site, Pungut, Siberut Island, Indonesia. Most calls (53%) followed the loud call of another male, 31% were spontaneous, and the remaining 16% followed a loud environmental disturbance. The fundamental frequency (F0) decreased while inter-unit intervals (IUI) increased over the course of loud call bouts, possibly indicating caller fatigue. Discriminant function analysis indicated that calls were not well discriminated by context, but spontaneous calls had higher peak frequencies, suggesting a higher level of arousal. Individual calls were distinct and individuals were mainly discriminated by IUI, call duration, and F0. Loud calls of older males had shorter IUI and lower F0, while middle-aged males had the highest peak frequencies. Overall, we found that calls were individually distinct and may provide information about the age, stamina, and arousal of the calling male, and could thus be a way for males and females to assess competitors and mates from long distances.	[Erb, Wendy M.] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08903 USA; [Hodges, J. Keith] German Primate Ctr, Reprod Biol Unit, Gottingen, Germany; [Hammerschmidt, Kurt] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany	Rutgers State University New Brunswick; Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ)	Erb, WM (corresponding author), Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08903 USA.	erbivorous@gmail.com	Erb, Wendy M/I-5555-2019	Erb, Wendy M/0000-0001-5714-9496	American Society of Primatologists; Margot Marsh Biodiversity Fund; NSF DDIG [BCS-0752504]; Primate Action Fund; Primate Conservation, Inc.; Stony Brook University (Interdepartmental Doctoral Program in Anthropological Sciences)	American Society of Primatologists; Margot Marsh Biodiversity Fund; NSF DDIG(National Science Foundation (NSF)); Primate Action Fund; Primate Conservation, Inc.; Stony Brook University (Interdepartmental Doctoral Program in Anthropological Sciences)	This work was supported by the American Society of Primatologists; Margot Marsh Biodiversity Fund; an NSF DDIG (BCS-0752504); the Primate Action Fund; Primate Conservation, Inc.; and Stony Brook University (Interdepartmental Doctoral Program in Anthropological Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 1998, PRINCIPLES ANIMAL CO; Arnold K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065660; Bouchet H, 2012, J COMP PSYCHOL, V126, P45, DOI 10.1037/a0025018; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; Delgado RA, 2006, INT J PRIMATOL, V27, P5, DOI 10.1007/s10764-005-9001-4; Erb WM, 2012, INT J PRIMATOL, V33, P1406, DOI 10.1007/s10764-012-9630-3; Erb WM, 2012, AM J PRIMATOL, V74, P580, DOI 10.1002/ajp.22010; Erb WM, 2012, PUBLICATION STATE U; Ey E, 2007, PRIMATES, V48, P253, DOI 10.1007/s10329-006-0033-y; Ey E, 2007, INT J PRIMATOL, V28, P947, DOI 10.1007/s10764-007-9139-3; Fichtel C, 2002, ETHOLOGY, V108, P763, DOI 10.1046/j.1439-0310.2002.00816.x; Fichtel C, 2001, BEHAVIOUR, V138, P97, DOI 10.1163/15685390151067094; Fischer J, 2004, BEHAV ECOL SOCIOBIOL, V56, P140, DOI 10.1007/s00265-003-0739-4; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; FITCH WT, 1995, AM J PRIMATOL, V37, P191, DOI 10.1002/ajp.1350370303; Harris TR, 2006, BEHAVIOUR, V143, P197, DOI 10.1163/156853906775900702; HAUSER MD, 1997, EVOLUTION COMMUNICAT; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; HOHMANN G, 1990, FOLIA PRIMATOL, V55, P200, DOI 10.1159/000156518; HOHMANN G, 1989, FOLIA PRIMATOL, V52, P27, DOI 10.1159/000156380; HOHMANN G, 1991, INT J PRIMATOL, V12, P503, DOI 10.1007/BF02547636; INOUE M, 1988, FOLIA PRIMATOL, V51, P76, DOI 10.1159/000156359; Kamilar JM, 2010, BIOL LETTERS, V6, P736, DOI 10.1098/rsbl.2010.0348; Kitchen DM, 2003, BEHAV ECOL SOCIOBIOL, V53, P374, DOI 10.1007/s00265-003-0588-1; Maciej P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023015; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; MCCOMB K, 1993, P ROY SOC B-BIOL SCI, V252, P59, DOI 10.1098/rspb.1993.0046; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; Meise K, 2011, J ACOUST SOC AM, V129, P1631, DOI 10.1121/1.3531944; Mitani JC, 1998, PRIMATES, V39, P171, DOI 10.1007/BF02557729; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Oliveira DAG, 2004, AN ACAD BRAS CIENC, V76, P393, DOI 10.1590/S0001-37652004000200031; Palacios V, 2007, J MAMMAL, V88, P606, DOI 10.1644/06-MAMM-A-151R1.1; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 1999, CR ACAD SCI III-VIE, V322, P271, DOI 10.1016/S0764-4469(99)80063-8; Reby D, 2010, P ROY SOC B-BIOL SCI, V277, P2747, DOI 10.1098/rspb.2010.0467; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Riede T, 2007, J ACOUST SOC AM, V121, P1758, DOI 10.1121/1.2427115; Ripmeester EAP, 2007, ETHOLOGY, V113, P1021, DOI 10.1111/j.1439-0310.2007.01398.x; RUBENSTEIN DI, 1992, EVOL ECOL, V6, P254, DOI 10.1007/BF02214165; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Soltis J, 2009, J COMP PSYCHOL, V123, P222, DOI 10.1037/a0015223; Spillmann B, 2010, ETHOLOGY, V116, P385, DOI 10.1111/j.1439-0310.2010.01744.x; Steenbeek R, 1998, FOLIA PRIMATOL, V69, P77, DOI 10.1159/000021566; Tabachnick B. G., 2001, USING MULTIVARIATE S; Teichroeb JA, 2010, ETHOLOGY, V116, P366, DOI 10.1111/j.1439-0310.2010.01752.x; TENAZA RR, 1989, PRIMATES, V30, P199, DOI 10.1007/BF02381304; Theis KR, 2007, BEHAVIOUR, V144, P557, DOI 10.1163/156853907780713046; TILSON RL, 1977, J MAMMAL, V58, P202, DOI 10.2307/1379577; Vannoni E, 2009, ANIM BEHAV, V78, P3, DOI 10.1016/j.anbehav.2009.03.015; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; WASER PM, 1977, Z TIERPSYCHOL, V43, P239; WATANABE K, 1981, Primates, V22, P145, DOI 10.1007/BF02382606; Whitten A.J., 1982, International Journal of Primatology, V3, P445, DOI 10.1007/BF02693743; Wich SA, 2003, INT J PRIMATOL, V24, P1251, DOI 10.1023/B:IJOP.0000005991.97232.2a; Wich SA, 2003, ETHOLOGY, V109, P1, DOI 10.1046/j.1439-0310.2003.00837.x; Wich SA, 2002, BEHAVIOUR, V139, P79, DOI 10.1163/15685390252902292; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; Wyman MT, 2008, ANIM BEHAV, V76, P1625, DOI 10.1016/j.anbehav.2008.05.032; Zuberbuehler Klaus, 2002, P289; [No title captured]; [No title captured]	68	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83131	10.1371/journal.pone.0083131	http://dx.doi.org/10.1371/journal.pone.0083131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376651	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000061
J	Giefing, M; Winoto-Morbach, S; Sosna, J; Doring, C; Klapper, W; Kuppers, R; Bottcher, S; Adam, D; Siebert, R; Schuetze, S				Giefing, Maciej; Winoto-Morbach, Supandi; Sosna, Justyna; Doering, Claudia; Klapper, Wolfram; Kueppers, Ralf; Boettcher, Sebastian; Adam, Dieter; Siebert, Reiner; Schuetze, Stefan			Hodgkin-Reed-Sternberg Cells in Classical Hodgkin Lymphoma Show Alterations of Genes Encoding the NADPH Oxidase Complex and Impaired Reactive Oxygen Species Synthesis Capacity	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; EXPRESSION; ACTIVATION; IDENTIFICATION; SUPEROXIDE; MECHANISMS; PRODUCTS; PATHWAY; DISEASE	The membrane bound NADPH oxidase involved in the synthesis of reactive oxygen species (ROS) is a multi-protein enzyme encoded by CYBA, CYBB, NCF1, NCF2 and NCF4 genes. Growing evidence suggests a role of ROS in the modulation of signaling pathways of non-phagocytic cells, including differentiation and proliferation of B-cell progenitors. Transcriptional downregulation of the CYBB gene has been previously reported in cell lines of the B-cell derived classical Hodgkin lymphoma (cHL). Thus, we explored functional consequences of CYBB downregulation on the NADPH complex. Using flow cytometry to detect and quantify superoxide anion synthesis in cHL cell lines we identified recurrent loss of superoxide anion production in all stimulated cHL cell lines in contrast to stimulated non-Hodgkin lymphoma cell lines. As CYBB loss proved to exert a deleterious effect on the NADPH oxidase complex in cHL cell lines, we analyzed the CYBB locus in Hodgkin and Reed-Sternberg (HRS) cells of primary cHL biopsies by in situ hybridisation and identified recurrent deletions of the gene in 8/18 cases. Immunohistochemical analysis to 14 of these cases revealed a complete lack of detectable CYBB protein expression in all HRS cells in all cases studied. Moreover, by microarray profiling of cHL cell lines we identified additional alterations of NADPH oxidase genes including CYBA copy number loss in 3/7 cell lines and a significant downregulation of the NCF1 transcription (p=0.006) compared to normal B-cell subsets. Besides, NCF1 protein was significantly downregulated (p<0.005) in cHL compared to other lymphoma cell lines. Together this findings show recurrent alterations of the NADPH oxidase encoding genes that result in functional inactivation of the enzyme and reduced production of superoxide anion in cHL.	[Giefing, Maciej; Siebert, Reiner; Schuetze, Stefan] Univ Kiel, Inst Human Genet, Kiel, Germany; [Giefing, Maciej; Winoto-Morbach, Supandi; Sosna, Justyna; Adam, Dieter; Schuetze, Stefan] Univ Hosp Schleswig Holstein, Kiel, Germany; [Winoto-Morbach, Supandi; Sosna, Justyna; Adam, Dieter; Schuetze, Stefan] Univ Kiel, Inst Immunol, Kiel, Germany; [Doering, Claudia] Goethe Univ Frankfurt, Sch Med, Senckenberg Inst Pathol, D-60054 Frankfurt, Germany; [Klapper, Wolfram] Hematopathol Sect & Lymph Node Registry, Dept Pathol, Kiel, Germany; [Kueppers, Ralf] Univ Duisburg Essen, Fac Med, Inst Cell Biol Canc Res, Essen, Germany; [Boettcher, Sebastian] Univ Hosp Schleswig Holstein, Dept Med 2, Kiel, Germany; [Giefing, Maciej] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Goethe University Frankfurt; University of Duisburg Essen; University of Kiel; Schleswig Holstein University Hospital; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences	Giefing, M (corresponding author), Univ Kiel, Inst Human Genet, Campus Kiel, Kiel, Germany.	giefingm@man.poznan.pl	Siebert, Reiner/A-8049-2010; Klapper, Wolfram/S-6314-2016; Giefing, Maciej/D-2568-2009; Sosna, Justyna/I-5682-2019; Adam, Dieter/E-9763-2010	Adam, Dieter/0000-0002-5668-5032; Kuppers, Ralf/0000-0002-6691-7191; Giefing, Maciej/0000-0002-4760-8246	Deutsche Krebshilfe [107748]; Wilhelm Sander Stiftung [2005.168.2]; Deutsche Forschungsgemeinschaft [KU-1315/7-1, SFB 877]; Kinderkrebsinitiative Buchholz/Holm-Seppensen; Federation of Biochemical Societies; Polish Ministry of Science and Higher Education; German Academic Exchange Service (DAAD) [A/08/79433]	Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm Sander Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kinderkrebsinitiative Buchholz/Holm-Seppensen; Federation of Biochemical Societies; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The authors would like to thank Deutsche Krebshilfe that supported the project through the grant (107748), the Wilhelm Sander Stiftung (2005.168.2) the Deutsche Forschungsgemeinschaft (KU-1315/7-1 and SFB 877, projects B1 to SS and B2 to DA and SS) and the Kinderkrebsinitiative Buchholz/Holm-Seppensen (infrastructure to MG, WK and RS), the Federation of Biochemical Societies (Long-Term fellowship to MG), the Polish Ministry of Science and Higher Education (Support for International Mobility of Scientists fellowship to MG), the German Academic Exchange Service (DAAD) (fellowship A/08/79433 to JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Ammerpohl O, 2012, LEUKEMIA, V26, P185, DOI 10.1038/leu.2011.194; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Cerchietti L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018436; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Crotzer VL, 2012, J IMMUNOL, V189, P3800, DOI 10.4049/jimmunol.1103080; DIEHL V, 1981, J CANCER RES CLIN, V101, P111, DOI 10.1007/BF00405072; Ehlers A, 2008, LEUKEMIA, V22, P835, DOI 10.1038/leu.2008.12; FEDYK ER, 1994, INT J IMMUNOPHARMACO, V16, P533, DOI 10.1016/0192-0561(94)90105-8; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; FISCHER P, 1988, BLOOD, V72, P234; Giefing M, 2008, BRIT J HAEMATOL, V142, P916, DOI 10.1111/j.1365-2141.2008.07262.x; Giefing Maciej, 2013, Methods Mol Biol, V971, P227, DOI 10.1007/978-1-62703-269-8_13; Hoffmann M, 2010, CANCER RES, V70, P2328, DOI 10.1158/0008-5472.CAN-09-2388; Horie R, 2002, ONCOGENE, V21, P2493, DOI 10.1038/sj.onc.1205337; Johnston RB, 2001, CURR OPIN HEMATOL, V8, P17, DOI 10.1097/00062752-200101000-00004; Jurkowska M, 2004, ARCH IMMUNOL THER EX, V52, P113; KOBAYASHI S, 1995, J BIOCHEM, V117, P758, DOI 10.1093/oxfordjournals.jbchem.a124773; KOBAYASHI S, 1990, BLOOD, V75, P458; Kuppers R, 2003, J CLIN INVEST, V111, P529, DOI 10.1172/JC1200316624; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lan Q, 2007, HUM GENET, V121, P161, DOI 10.1007/s00439-006-0288-9; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li Q, 2009, ANTIOXID REDOX SIGN, V11, P1249, DOI 10.1089/ARS.2008.2407; Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x; Mader A, 2007, CYTOGENET GENOME RES, V119, P204, DOI 10.1159/000112062; Martin-Subero JI, 2002, AM J PATHOL, V161, P413, DOI 10.1016/S0002-9440(10)64197-1; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Ni W, 2007, CIRC RES, V101, P985, DOI 10.1161/CIRCRESAHA.107.152439; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Otto C, 2012, BRIT J HAEMATOL, V157, P702, DOI 10.1111/j.1365-2141.2012.09113.x; Overbeck BM, 2012, HAEMATOL-HEMATOL J, V97, P1612, DOI 10.3324/haematol.2012.061770; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Pearse DD, 2008, AM J PHYSIOL-RENAL, V294, pF1094, DOI 10.1152/ajprenal.00458.2007; POPPEMA S, 1985, CANCER, V55, P683, DOI 10.1002/1097-0142(19850215)55:4<683::AID-CNCR2820550402>3.0.CO;2-O; Richards S, 2008, IMMUNOL REV, V224, P183, DOI 10.1111/j.1600-065X.2008.00652.x; Rossi D, 2009, LEUKEMIA, V23, P1118, DOI 10.1038/leu.2008.398; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Schumacher MA, 2010, HAEMATOL-HEMATOL J, V95, P153, DOI 10.3324/haematol.2009.010157; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	42	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84928	10.1371/journal.pone.0084928	http://dx.doi.org/10.1371/journal.pone.0084928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376854	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000168
J	Kurata, A; Kawaguchi, N; Kido, T; Inoue, K; Suzuki, J; Ogimoto, A; Funada, J; Higaki, J; Miyagawa, M; Vembar, M; Mochizuki, T				Kurata, Akira; Kawaguchi, Naoto; Kido, Teruhito; Inoue, Katsuji; Suzuki, Jun; Ogimoto, Akiyoshi; Funada, Jun-ichi; Higaki, Jitsuo; Miyagawa, Masao; Vembar, Mani; Mochizuki, Teruhito			Qualitative and Quantitative Assessment of Adenosine Triphosphate Stress Whole-Heart Dynamic Myocardial Perfusion Imaging Using 256-Slice Computed Tomography	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; DUAL-SOURCE CT; DIAGNOSTIC-ACCURACY; BLOOD-FLOW; ANGIOGRAPHY; INFARCTION; QUANTIFICATION; SCINTIGRAPHY; PREDICTION; PLAQUES	Background: The aim of this study was to investigate the correlation of the qualitative transmural extent of hypoperfusion areas (HPA) using stress dynamic whole-heart computed tomography perfusion (CTP) imaging by 256-slice CT with CTP-derived myocardial blood flow (MBF) for the estimation of the severity of coronary artery stenosis. Methods and Results: Eleven patients underwent adenosine triphosphate (0.16 mg/kg/min, 5 min) stress dynamic CTP by 256-slice CT (coverage: 8 cm, 0.27 s/rotation), and 9 of the 11 patients underwent coronary angiography (CAG). Stress dynamic CTP (whole-heart datasets over 30 consecutive heart beats in systole without spatial and temporal gaps) was acquired with prospective ECG gating (effective radiation dose: 10.4 mSv). The extent of HPAs was visually graded using a 3-point score (normal, subendocardial, transmural). MBF (ml/100g/min) was measured by deconvolution. Differences in MBF (mean +/- standard error) according to HPA and CAG results were evaluated. In 27 regions (3 major coronary territories in 9 patients), 11 coronary stenoses (> 50% reduction in diameter) were observed. In 353 myocardial segments, HPA was significantly related to MBF (P < 0.05; normal 295 +/- 94; subendocardial 186 +/- 67; and transmural 80 +/- 53). Coronary territory analysis revealed a significant relationship between coronary stenosis severity and MBF (P < 0.05; non-significant stenosis [< 50%], 284 +/- 97; moderate stenosis [50-70%], 184 +/- 74; and severe stenosis [> 70%], 119 +/- 69). Conclusion: The qualitative transmural extent of HPA using stress whole-heart dynamic CTP imaging by 256-slice CT exhibits a good correlation with quantitative CTP-derived MBF and may aid in assessing the hemodynamic significance of coronary artery disease.	[Kurata, Akira; Kawaguchi, Naoto; Kido, Teruhito; Miyagawa, Masao; Mochizuki, Teruhito] Ehime Univ, Dept Diagnost & Therapeut Radiol, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Inoue, Katsuji; Suzuki, Jun; Ogimoto, Akiyoshi; Higaki, Jitsuo] Ehime Univ, Dept Integrated Med & Informat, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Funada, Jun-ichi] Ehime Natl Hosp, Dept Cardiol, Natl Hosp Org, Matsuyama, Ehime, Japan; [Vembar, Mani] Philips Healthcare, CT Clin Sci, Cleveland, OH USA	Ehime University; Ehime University; Philips; Philips Healthcare	Kurata, A (corresponding author), Ehime Univ, Dept Diagnost & Therapeut Radiol, Grad Sch Med, Matsuyama, Ehime 790, Japan.							Austen W G, 1975, Circulation, V51, P5; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Cury RC, 2010, AM J CARDIOL, V106, P310, DOI 10.1016/j.amjcard.2010.03.025; Dwivedi G, 2012, CIRC J, V76, P544, DOI 10.1253/circj.CJ-11-1427; Eastwood JD, 2002, RADIOLOGY, V222, P227, DOI 10.1148/radiol.2221010471; Funama Y, 2011, J COMPUT ASSIST TOMO, V35, P480, DOI 10.1097/RCT.0b013e31821fee94; George RT, 2009, CIRC-CARDIOVASC IMAG, V2, P174, DOI 10.1161/CIRCIMAGING.108.813766; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Ho KT, 2010, JACC-CARDIOVASC IMAG, V3, P811, DOI 10.1016/j.jcmg.2010.05.009; Hosokawa K, 2011, CIRC J, V75, P1905, DOI 10.1253/circj.CJ-10-1144; Iriart X, 2007, EUR RADIOL, V17, P2581, DOI 10.1007/s00330-007-0665-3; Jahnke C, 2007, CIRCULATION, V115, P1769, DOI 10.1161/CIRCULATIONAHA.106.652016; Kido T, 2008, CIRC J, V72, P1086, DOI 10.1253/circj.72.1086; Koyama Y, 2005, RADIOLOGY, V235, P804, DOI 10.1148/radiol.2353030441; Kurata A, 2005, CIRC J, V 69, P550, DOI 10.1253/circj.69.550; MEIER P, 1954, J APPL PHYSIOL, V6, P731, DOI 10.1152/jappl.1954.6.12.731; MIYAGAWA M, 1995, J AM COLL CARDIOL, V26, P1196, DOI 10.1016/0735-1097(95)00304-5; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Nakajima K, 2012, CIRC J, V76, P1313, DOI 10.1253/circj.CJ-12-0260; Nakauchi Y, 2012, HEART, V98, P566, DOI 10.1136/heartjnl-2011-300915; Nieman K, 2008, RADIOLOGY, V247, P49, DOI 10.1148/radiol.2471070332; PALMAS W, 1995, J AM COLL CARDIOL, V25, P1024, DOI 10.1016/0735-1097(94)00523-S; Porter TR, 2011, CIRC-CARDIOVASC IMAG, V4, P628, DOI 10.1161/CIRCIMAGING.111.966341; Primak AN, 2007, MED PHYS, V34, P4726, DOI 10.1118/1.2805476; Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056; Rossi A, 2013, EUR HEART J-CARD IMG, V14, P331, DOI 10.1093/ehjci/jes150; Sakuma H, 2005, AM J ROENTGENOL, V185, P95, DOI 10.2214/ajr.185.1.01850095; So A, 2012, EUR RADIOL, V22, P39, DOI 10.1007/s00330-011-2260-x; Ueshima H, 2006, CIRC J, V70, P1249; Wang YN, 2012, AM J ROENTGENOL, V198, P521, DOI 10.2214/AJR.11.7830; Wolff SD, 2004, CIRCULATION, V110, P732, DOI 10.1161/01.CIR.0000138106.84335.62	32	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83950	10.1371/journal.pone.0083950	http://dx.doi.org/10.1371/journal.pone.0083950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376774	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000133
J	Lu, ZH; Kaliberov, S; Sohn, RE; Kaliberova, L; Curiel, DT; Arbeit, JM				Lu, Zhi Hong; Kaliberov, Sergey; Sohn, Rebecca E.; Kaliberova, Lyudmila; Curiel, David T.; Arbeit, Jeffrey M.			Transcriptional Targeting of Primary and Metastatic Tumor Neovasculature by an Adenoviral Type 5 Roundabout4 Vector in Mice	PLOS ONE			English	Article							CONDITIONALLY REPLICATING ADENOVIRUS; ENDOTHELIAL GROWTH-FACTOR; GENE-THERAPY; MAGIC ROUNDABOUT; ROBO4 PROMOTER; EXPRESSION; ANGIOGENESIS; CELLS; RECEPTOR; DELIVERY	New approaches targeting metastatic neovasculature are needed. Payload capacity, cellular transduction efficiency, and first-pass cellular uptake following systemic vector administration, motivates persistent interest in tumor vascular endothelial cell (EC) adenoviral (Ad) vector targeting. While EC transductional and transcriptional targeting has been accomplished, vector administration approaches of limited clinical utility, lack of tumor-wide EC expression quantification, and failure to address avid liver sequestration, challenged prior work. Here, we intravenously injected an Ad vector containing 3 kb of the human roundabout4 (ROBO4) enhancer/promoter transcriptionally regulating an enhanced green fluorescent protein (EGFP) reporter into immunodeficient mice bearing 786-O renal cell carcinoma subcutaneous (SC) xenografts and kidney orthotopic (KO) tumors. Initial experiments performed in human coxsackie virus and adenovirus receptor (hCAR) transgenic:Rag2 knockout mice revealed multiple ECs with high-level Ad5ROBO4-EGFP expression throughout KO and SC tumors. In contrast, Ad5CMV-EGFP was sporadically expressed in a few tumor vascular ECs and stromal cells. As the hCAR transgene also facilitated Ad5ROBO4 and control Ad5CMV vector EC expression in multiple host organs, follow-on experiments engaged warfarin-mediated liver vector detargeting in hCAR non-transgenic mice. Ad5ROBO4-mediated EC expression was undetectable in most host organs, while the frequencies of vector expressing intratumoral vessels and whole tumor EGFP protein levels remained elevated. In contrast, AdCMV vector expression was only detectable in one or two stromal cells throughout the whole tumor. The Ad5ROBO4 vector, in conjunction with liver detargeting, provides tractable genetic access for in-vivo EC genetic engineering in malignancies.	[Lu, Zhi Hong; Sohn, Rebecca E.; Arbeit, Jeffrey M.] Washington Univ, St Louis Med Sch, Div Urol, St Louis, MO USA; [Lu, Zhi Hong; Sohn, Rebecca E.; Arbeit, Jeffrey M.] Washington Univ, St Louis Med Sch, Dept Surg, St Louis, MO USA; [Kaliberov, Sergey; Kaliberova, Lyudmila; Curiel, David T.] Washington Univ, Dept Radiat Oncol, St Louis Med Sch, St Louis, MO 63130 USA; [Kaliberov, Sergey; Kaliberova, Lyudmila; Curiel, David T.] Washington Univ, St Louis Med Sch, Biol Therapeut Ctr, St Louis, MO USA; [Curiel, David T.; Arbeit, Jeffrey M.] Washington Univ, St Louis Med Sch, Siteman Canc Ctr, St Louis, MO USA; [Arbeit, Jeffrey M.] Washington Univ, Dept Cell Biol, St Louis Med Sch, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Curiel, DT (corresponding author), Washington Univ, Dept Radiat Oncol, St Louis Med Sch, St Louis, MO 63130 USA.	dcuriel@radonc.wustl.edu; arbeitj@wustl.edu	Arbeit, Jeffrey/K-6920-2019		National Institutes of Health (NIH) [R01CA159959, R01CA154697]; NATIONAL CANCER INSTITUTE [R01CA159959, R01CA154697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (NIH) grant numbers: R01CA159959 to JMA and R01CA154697 to DTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026; Avci ME, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-392; Bachtarzi H, 2011, J CONTROL RELEASE, V150, P196, DOI 10.1016/j.jconrel.2010.10.011; Baker AH, 2005, EXP PHYSIOL, V90, P27, DOI 10.1113/expphysiol.2004.028126; Ballard MS, 2012, ADV CANCER RES, V114, P187, DOI 10.1016/B978-0-12-386503-8.00005-3; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brenner A, 2013, CLIN CANC RES; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Cook KM, 2010, CA-CANCER J CLIN, V60, P222, DOI 10.3322/caac.20075; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dong ZH, 2009, ADV DRUG DELIVER REV, V61, P542, DOI 10.1016/j.addr.2009.02.006; Duffy MR, 2012, NANOMEDICINE-UK, V7, P271, DOI [10.2217/nnm.11.186, 10.2217/NNM.11.186]; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2010, CURR OPIN HEMATOL, V17, P219, DOI 10.1097/MOH.0b013e3283386660; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Goto-Koshino Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050849; Greenberger S, 2004, J CLIN INVEST, V113, P1017, DOI 10.1172/JCI200420007; Grone J, 2006, ONCOL REP, V15, P1437; Haisma HJ, 2010, INT J PHARMACEUT, V391, P155, DOI 10.1016/j.ijpharm.2010.02.032; Heusschen R, 2010, BBA-REV CANCER, V1805, P87, DOI 10.1016/j.bbcan.2009.09.005; Hidaka C, 1999, J CLIN INVEST, V103, P579, DOI 10.1172/JCI5309; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kaliberov SA, 2013, VIROLOGY; Khare R, 2011, CURR GENE THER, V11, P241, DOI 10.2174/156652311796150363; Koch AW, 2011, DEV CELL, V20, P33, DOI 10.1016/j.devcel.2010.12.001; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Lindemann D, 2009, THROMB HAEMOSTASIS, V102, P1135, DOI 10.1160/TH09-10-0724; Lyle C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-148; Marlow R, 2010, P NATL ACAD SCI USA, V107, P10520, DOI 10.1073/pnas.1001896107; Mavria G, 2005, J GENE MED, V7, P263, DOI 10.1002/jgm.662; Mavria G, 2000, GENE THER, V7, P368, DOI 10.1038/sj.gt.3301093; Nettelbeck DM, 2001, MOL THER, V3, P882, DOI 10.1006/mthe.2001.0342; Okada Y, 2008, BLOOD, V112, P2336, DOI 10.1182/blood-2008-01-135079; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Peled M, 2009, CLIN CANCER RES, V15, P1664, DOI 10.1158/1078-0432.CCR-08-1670; Preuss Meredith A, 2008, Open Gene Ther J, V1, P7, DOI 10.2174/1875037000801010007; Reynolds PN, 2000, MOL THER, V2, P562, DOI 10.1006/mthe.2000.0205; Sakurai F, 2011, FRONT BIOSCI-LANDMRK, V16, P2389, DOI 10.2741/3861; Savontaus MJ, 2002, GENE THER, V9, P972, DOI 10.1038/sj.gt.3301747; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Sheldon H, 2009, FASEB J, V23, P513, DOI 10.1096/fj.07-098269; Shinozaki K, 2006, GENE THER, V13, P52, DOI 10.1038/sj.gt.3302598; Short JJ, 2010, MOL CANCER THER, V9, P2536, DOI 10.1158/1535-7163.MCT-10-0332; Smith JG, 2010, CURR TOP MICROBIOL, V343, P195, DOI 10.1007/82_2010_16; Smith-Berdan S, 2011, CELL STEM CELL, V8, P72, DOI 10.1016/j.stem.2010.11.030; Song W, 2008, CANCER GENE THER, V15, P667, DOI 10.1038/cgt.2008.38; Stinski MF, 1999, GENE EXPRESSION SYSTEMS, P211, DOI 10.1016/B978-012253840-7/50009-2; Stoff-Khalili MA, 2008, BREAST CANCER RES TR, V108, P43, DOI 10.1007/s10549-007-9587-7; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Takayama K, 2007, CANCER GENE THER, V14, P105, DOI 10.1038/sj.cgt.7700991; Tallone T, 2001, P NATL ACAD SCI USA, V98, P7910, DOI 10.1073/pnas.141223398; Varda-Bloom N, 2001, GENE THER, V8, P819, DOI 10.1038/sj.gt.3301472; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Yang WY, 2006, WORLD J GASTROENTERO, V12, P5331, DOI 10.3748/wjg.v12.i33.5331; Yoshikawa M, 2013, BLOOD, V121, P2804, DOI 10.1182/blood-2012-12-468363; Zhang X., 2012, P INT C MICR MILL WA, V2, P1; Zheng W, 2012, CEREB CORTEX, V22, P2587, DOI 10.1093/cercor/bhr330; Zhu TS, 2011, CANCER RES, V71, P6061, DOI 10.1158/0008-5472.CAN-10-4269	67	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83933	10.1371/journal.pone.0083933	http://dx.doi.org/10.1371/journal.pone.0083933			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376772	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000132
J	Mabood, F; Khan, WA; Ismail, AIM				Mabood, Fazle; Khan, Waqar A.; Ismail, Ahmad Izani Md.			Optimal Homotopy Asymptotic Method for Flow and Heat Transfer of a Viscoelastic Fluid in an Axisymmetric Channel with a Porous Wall	PLOS ONE			English	Article							NON-NEWTONIAN FLUID; NONLINEAR EQUATIONS; BOUNDARY	In this article, an approximate analytical solution of flow and heat transfer for a viscoelastic fluid in an axisymmetric channel with porous wall is presented. The solution is obtained through the use of a powerful method known as Optimal Homotopy Asymptotic Method (OHAM). We obtained the approximate analytical solution for dimensionless velocity and temperature for various parameters. The influence and effect of different parameters on dimensionless velocity, temperature, friction factor, and rate of heat transfer are presented graphically. We also compared our solution with those obtained by other methods and it is found that OHAM solution is better than the other methods considered. This shows that OHAM is reliable for use to solve strongly nonlinear problems in heat transfer phenomena.	[Mabood, Fazle; Ismail, Ahmad Izani Md.] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia; [Khan, Waqar A.] Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan	Universiti Sains Malaysia; National University of Sciences & Technology - Pakistan	Khan, WA (corresponding author), Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan.	wkhan_2000@yahoo.com	Mabood, Fazle/AAE-5840-2021; Khan, Waqar/H-3886-2013	Mabood, Fazle/0000-0003-2698-8427; Khan, Waqar/0000-0002-8328-850X				Abbasbandy S, 2006, PHYS LETT A, V360, P109, DOI 10.1016/j.physleta.2006.07.065; Abu-Hijleh BAK, 2000, INT J HEAT MASS TRAN, V43, P2727, DOI 10.1016/S0017-9310(99)00301-4; Akcay M, 1999, ARCH APPL MECH, V69, P215, DOI 10.1007/s004190050215; Babaelahi M, 2010, MECCANICA, V45, P817, DOI 10.1007/s11012-010-9290-3; DEBRUGE LL, 1972, J HEAT TRANSF, V94, P385, DOI 10.1115/1.3449956; Esmaeilpour M, 2010, COMMUN NONLINEAR SCI, V15, P2424, DOI 10.1016/j.cnsns.2009.10.004; Ghoreishi M, 2011, MATH METHOD APPL SCI, V34, P1833, DOI 10.1002/mma.1483; Gul R, 2009, HT2008: PROCEEDINGS OF THE ASME SUMMER HEAT TRANSFER CONFERENCE, VOL 1, P311; Herisanu N, 2010, COMPUT MATH APPL, V60, P1607, DOI 10.1016/j.camwa.2010.06.042; Idrees M, 2012, MATH COMPUT MODEL, V55, P1324, DOI 10.1016/j.mcm.2011.10.010; Islam S, 2008, J POROUS MEDIA, V11, P669, DOI 10.1615/JPorMedia.v11.i7.50; Islam S, 2007, J POROUS MEDIA, V10, P401, DOI 10.1615/JPorMedia.v10.i4.60; Islam S, 2010, INT J NONLIN SCI NUM, V11, P389; Kechil SA, 2007, PHYS LETT A, V363, P110, DOI 10.1016/j.physleta.2006.11.054; Khan N, 2013, HEAT TRANSF RES, V44, P1; Khan ZH, 2009, HT2008: PROCEEDINGS OF THE ASME SUMMER HEAT TRANSFER CONFERENCE, VOL 1, P301, DOI 10.1115/HT2008-56448; Khan ZH, 2008, NUST J ENG SCI, V1, P40; Kurtcebe C, 2002, INT COMMUN HEAT MASS, V29, P971, DOI 10.1016/S0735-1933(02)00417-7; Mabood F, 2013, HEAT TRANSF IN PRESS; Marinca V., 2011, NONLINEAR DYNAMICAL; Marinca V, 2008, CENT EUR J PHYS, V6, P648, DOI [10.2478/s11534-008-0061-x, 10.2478/S11534-008-0061-x]; Marinca V, 2008, INT COMMUN HEAT MASS, V35, P710, DOI 10.1016/j.icheatmasstransfer.2008.02.010; Marinca V, 2010, J SOUND VIB, V329, P1450, DOI 10.1016/j.jsv.2009.11.005; Marinca V, 2009, APPL MATH LETT, V22, P245, DOI 10.1016/j.aml.2008.03.019; Nemoda S, 2004, THERM SCI, V8, P3; Nield DA, 2000, INT J HEAT MASS TRAN, V43, P4119, DOI 10.1016/S0017-9310(00)00025-9; Pilevne E, 2006, P 4 WSEAS INT C HEAT, V21-23, P287; RIVLIN RS, 1955, J RATION MECH ANAL, V4, P323; Sheikholeslami M, 2012, SAINS MALAYS, V41, P1281; Shin S, 1999, INT J HEAT MASS TRAN, V42, P2935, DOI 10.1016/S0017-9310(98)00358-5; TERRILL RM, 1965, AERONAUT QUART, V16, P323, DOI 10.1017/S0001925900003565; Trimis D, 2000, FLUIDS C EXH DENV; VAFAI K, 1981, INT J HEAT MASS TRAN, V24, P195, DOI 10.1016/0017-9310(81)90027-2; WHITE JL, 1965, AICHE J, V11, P324, DOI 10.1002/aic.690110225; Yuan S., 1956, T AM SOC MECH ENG, V78, P719	35	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83581	10.1371/journal.pone.0083581	http://dx.doi.org/10.1371/journal.pone.0083581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376722	Green Published, gold			2022-12-27	WOS:000328882000100
J	Monteoliva, D; McCarthy, CB; Diambra, L				Monteoliva, Diana; McCarthy, Christina B.; Diambra, Luis			Noise Minimisation in Gene Expression Switches	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; FLUCTUATING ENVIRONMENTS; STOCHASTICITY; INFORMATION; VARIABILITY; DIFFERENTIATION; CONSEQUENCES; POPULATIONS; NETWORKS; CASCADES	Gene expression is subject to stochastic variation which leads to fluctuations in the rate of protein production. Recently, a study in yeast at a genomic scale showed that, in some cases, gene expression variability alters phenotypes while, in other cases, these remain unchanged despite fluctuations in the expression of other genes. These studies suggested that noise in gene expression is a physiologically relevant trait and, to prevent harmful stochastic variation in the expression levels of some genes, it can be subject to minimisation. However, the mechanisms for noise minimisation are still unclear. In the present work, we analysed how noise expression depends on the architecture of the cis-regulatory system, in particular on the number of regulatory binding sites. Using analytical calculations and stochastic simulations, we found that the fluctuation level in noise expression decreased with the number of regulatory sites when regulatory transcription factors interacted with only one other bound transcription factor. In contrast, we observed that there was an optimal number of binding sites when transcription factors interacted with many bound transcription factors. This finding suggested a new mechanism for preventing large fluctuations in the expression of genes which are sensitive to the concentration of regulators.	[Diambra, Luis] Univ Nacl La Plata, Lab Biol Sistemas, Ctr Reg Estudios Genom, Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina; [McCarthy, Christina B.] Univ Nacl La Plata, Lab Metagen Microorganismos, Ctr Reg Estudios Genom, Fac Ciencias Exactas, Florencio Varela, Argentina; [McCarthy, Christina B.] Univ Nacl Noroeste Prov Buenos Aires, Dept Informat & Tecnol, Pergamino, Buenos Aires, Argentina; [Monteoliva, Diana] Univ Nacl La Plata, Inst Fis, La Plata, Buenos Aires, Argentina	National University of La Plata; National University of La Plata; Universidad Nacional del Noroeste de la Provincia de Buenos Aires; National University of La Plata	Diambra, L (corresponding author), Univ Nacl La Plata, Lab Biol Sistemas, Ctr Reg Estudios Genom, Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina.	ldiambra@gmail.com	L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880; McCarthy, Christina Beryl/0000-0001-9725-5285				Bayer Travis S, 2009, J Biol Eng, V3, P1, DOI 10.1186/1754-1611-3-1; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Burger A, 2010, P NATL ACAD SCI USA, V107, P4016, DOI 10.1073/pnas.0915138107; Carey LB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001528; Celani A, 2010, P NATL ACAD SCI USA, V107, P1391, DOI 10.1073/pnas.0909673107; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chubukov V, 2012, P NATL ACAD SCI USA, V109, P5127, DOI 10.1073/pnas.1114235109; Francois P, 2010, DEVELOPMENT, V137, P2385, DOI 10.1242/dev.048033; Francois P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026009; Gerland U, 2009, P NATL ACAD SCI USA, V106, P8841, DOI 10.1073/pnas.0808500106; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Gutierrez PS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011914; Gutierrez PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044812; Holloway DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001069; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; Levin MD, 2003, FEBS LETT, V550, P135, DOI 10.1016/S0014-5793(03)00857-3; Lu T, 2007, P NATL ACAD SCI USA, V104, P18982, DOI 10.1073/pnas.0706115104; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Neildez-Nguyen TMA, 2008, DIFFERENTIATION, V76, P33, DOI 10.1111/j.1432-0436.2007.00219.x; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paldi A, 2003, CELL MOL LIFE SCI, V60, P1775, DOI 10.1007/s00018-003-23147-z; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rieckh G, 2013, ARXIV13078075, P1; Sanchez A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001100; Saunders TE, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041902; SAVAGEAU MA, 1977, P NATL ACAD SCI USA, V74, P5647, DOI 10.1073/pnas.74.12.5647; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Smith MCA, 2007, MOL MICROBIOL, V66, P699, DOI 10.1111/j.1365-2958.2007.05951.x; Sokolowski TR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002654; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Tostevin F, 2007, PLOS COMPUT BIOL, V3, P763, DOI 10.1371/journal.pcbi.0030078; Walczak AM, 2009, P NATL ACAD SCI USA, V106, P6529, DOI 10.1073/pnas.0811999106	46	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84020	10.1371/journal.pone.0084020	http://dx.doi.org/10.1371/journal.pone.0084020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376783	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000136
J	Funari, VA; Winkler, M; Brown, J; Dimitrijevich, SD; Ljubimov, AV; Saghizadeh, M				Funari, Vincent A.; Winkler, Michael; Brown, Jordan; Dimitrijevich, Slobodan D.; Ljubimov, Alexander V.; Saghizadeh, Mehrnoosh			Differentially Expressed Wound Healing-Related microRNAs in the Human Diabetic Cornea	PLOS ONE			English	Article							HUMAN COLORECTAL-CARCINOMA; INNATE IMMUNE-RESPONSES; GROWTH-FACTOR RECEPTOR; C-MET GENE; TUMOR-SUPPRESSOR; PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA; EPITHELIAL-CELLS; GLIOMA-CELLS; MOUSE EYE	MicroRNAs are powerful gene expression regulators, but their corneal repertoire and potential changes in corneal diseases remain unknown. Our purpose was to identify miRNAs altered in the human diabetic cornea by microarray analysis, and to examine their effects on wound healing in cultured telomerase-immortalized human corneal epithelial cells (HCEC) in vitro. Total RNA was extracted from age-matched human autopsy normal (n=6) and diabetic (n=6) central corneas, Flash Tag end-labeled, and hybridized to Affymetrix (R) GeneChip (R) miRNA Arrays. Select miRNAs associated with diabetic cornea were validated by quantitative RT-PCR (Q-PCR) and by in situ hybridization (ISH) in independent samples. HCEC were transfected with human pre-miRm (TM) miRNA precursors (h-miR) or their inhibitors (antagomirs) using Lipofectamine 2000. Confluent transfected cultures were scratch-wounded with P200 pipette tip. Wound closure was monitored by digital photography. Expression of signaling proteins was detected by immunostaining and Western blot. Using microarrays, 29 miRNAs were identified as differentially expressed in diabetic samples. Two miRNA candidates showing the highest fold increased in expression in the diabetic cornea were confirmed by Q-PCR and further characterized. HCEC transfection with h-miR-146a or h-miR-424 significantly retarded wound closure, but their respective antagomirs significantly enhanced wound healing vs. controls. Cells treated with h-miR-146a or h-miR-424 had decreased p-p38 and p-EGFR staining, but these increased over control levels close to the wound edge upon antagomir treatment. In conclusion, several miRNAs with increased expression in human diabetic central corneas were found. Two such miRNAs inhibited cultured corneal epithelial cell wound healing. Dysregulation of miRNA expression in human diabetic cornea may be an important mediator of abnormal wound healing.	[Funari, Vincent A.; Brown, Jordan] Cedars Sinai Med Ctr, Genom Core, Los Angeles, CA 90048 USA; [Funari, Vincent A.; Ljubimov, Alexander V.] Univ Calif Los Angeles, Los Angeles, CA USA; [Winkler, Michael; Ljubimov, Alexander V.; Saghizadeh, Mehrnoosh] Cedars Sinai Med Ctr, Dept Biomed Sci, Regenerat Med Inst, Eye Program, Los Angeles, CA 90048 USA; [Dimitrijevich, Slobodan D.] Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, Ft Worth, TX USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; University of North Texas System; University of North Texas Health Science Center	Saghizadeh, M (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Regenerat Med Inst, Eye Program, Los Angeles, CA 90048 USA.	ghiamm@cshs.org	Ljubimov, Alexander/CAE-9130-2022; Ljubimov, Alexander V/E-5883-2013	Ljubimov, Alexander/0000-0003-2398-5319	NIH [R21 EY022771, R01 EY13431]; Cedars-Sinai Regenerative Medicine Institute; NATIONAL EYE INSTITUTE [R01EY013431, R01EY025377, R21EY022771] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Regenerative Medicine Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by NIH R21 EY022771, R01 EY13431, and Cedars-Sinai Regenerative Medicine Institute grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bertero T, 2011, FASEB J, V25, P1, DOI [10.1096/fj.11-0101ufm, DOI 10.1096/FJ.11-0101UFM.]; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cavallerano J, 1992, Optom Clin, V2, P93; Chen G, 2013, ASIAN PAC J CANCER P, V14, P3871, DOI 10.7314/APJCP.2013.14.6.3871; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060317; Chen YQ, 2013, J BIOSCIENCES, V38, P523, DOI 10.1007/s12038-013-9351-6; Chous PA, 2003, DIABETIC EYE DIS, P87; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cory G, 2011, METHODS MOL BIOL, V769, P25, DOI 10.1007/978-1-61779-207-6_2; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Deacon DC, 2010, DEVELOPMENT, V137, P1887, DOI 10.1242/dev.050526; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Dimitrijevich SD, 2008, INVEST OPHTHALMOL VI, V49; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Ganesan J, 2013, CIRCULATION, V127, P2097, DOI 10.1161/CIRCULATIONAHA.112.000882; Garofalo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067581; Gattolliat CH, 2011, BRIT J CANCER, V105, P1352, DOI 10.1038/bjc.2011.388; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Guo HY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-77; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hong L, 2013, EXPERT OPIN THER TAR, V17, P1073, DOI 10.1517/14728222.2013.819853; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hutchison ER, 2013, GLIA, V61, P1018, DOI 10.1002/glia.22483; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kenchegowda S, 2011, INVEST OPHTH VIS SCI, V52, P2240, DOI 10.1167/iovs.10-6199; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Kong D, 2012, ONCOGENE, V31, P3949, DOI 10.1038/onc.2011.558; Lee SKW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021249; Li Jun, 2010, Chinese Medical Sciences Journal, V25, P65, DOI 10.1016/S1001-9294(10)60024-7; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Li Y, 2009, DEV DYNAM, V238, P2388, DOI 10.1002/dvdy.22056; Lin DH, 2013, INVEST OPHTH VIS SCI, V54, P6167, DOI 10.1167/iovs.12-11577; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Liu N, 2012, EMBO J, V31, P2365, DOI 10.1038/emboj.2012.88; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Ljubimov AV, 2013, INVEST OPHTHALMOL VI, V54; Long XH, 2013, EXP THER MED, V5, P1048, DOI 10.3892/etm.2013.959; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Majid S, 2013, CLIN CANCER RES, V19, P73, DOI 10.1158/1078-0432.CCR-12-2952; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Meng O, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016132, DOI 10.1371/JOURNAL.PONE.0016132.]; Murray AR, 2013, INVEST OPHTH VIS SCI, V54, P1689, DOI 10.1167/iovs.12-10921; Nagaoka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065127; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Nowakowski TJ, 2013, P NATL ACAD SCI USA, V110, P7056, DOI 10.1073/pnas.1219385110; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Paik JH, 2011, CLIN CANCER RES, V17, P4761, DOI 10.1158/1078-0432.CCR-11-0494; Pan SJ, 2012, INT J IMMUNOPATH PH, V25, P871, DOI 10.1177/039463201202500405; Pignot G, 2013, INT J CANCER, V132, P2479, DOI 10.1002/ijc.27949; Poliseno L, 2012, J INVEST DERMATOL, V132, P1860, DOI 10.1038/jid.2011.451; Qian NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068004; Qiu TZ, 2013, INT J MOL MED, V32, P593, DOI 10.3892/ijmm.2013.1439; Ramachandran S, 2013, AM J RESP CELL MOL, V49, P544, DOI 10.1165/rcmb.2012-0430OC; Rani SB, 2013, NEURO-ONCOLOGY, V15, P1302, DOI 10.1093/neuonc/not090; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Roy S, 2011, PHYSIOL GENOMICS, V43, P557, DOI 10.1152/physiolgenomics.00160.2010; Ryan D, 2006, MOL VIS, V12, P1175; Saghizadeh M, 2011, MOL VIS, V17, P2177; Saghizadeh M, 2010, INVEST OPHTH VIS SCI, V51, P1970, DOI 10.1167/iovs.09-4569; Saghizadeh M, 2010, BRAIN RES BULL, V81, P262, DOI 10.1016/j.brainresbull.2009.10.007; Sanchez-Thorin JC, 1998, INT OPHTHALMOL CLIN, V38, P19, DOI 10.1097/00004397-199838020-00004; Schultz R O, 1981, Trans Am Ophthalmol Soc, V79, P180; Semaan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019827; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Skrzypek K, 2013, ANTIOXID REDOX SIGN, V19, P644, DOI 10.1089/ars.2013.5184; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Testa U, 2012, J HEMATOL ONCOL, V27, P5; Veltman K, 2012, INT J BIOCHEM CELL B, V44, P341, DOI 10.1016/j.biocel.2011.11.006; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Xi SC, 2013, J CLIN INVEST, V123, P1241, DOI 10.1172/JCI61271; Xiao FQ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-195; Xu B, 2012, PROSTATE, V72, P1171, DOI 10.1002/pros.22466; Xu K, 2012, BIOCHEM J, V446, P291, DOI 10.1042/BJ20120386; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Xu KP, 2011, INVEST OPHTH VIS SCI, V52, P3301, DOI 10.1167/iovs.10-5670; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Xu SB, 2009, PROG RETIN EYE RES, V28, P87, DOI 10.1016/j.preteyeres.2008.11.003; Xu WD, 2013, EXPERT OPIN THER TAR, V17, P659, DOI 10.1517/14728222.2013.773311; Xu ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053146; Yang HP, 2013, J CLIN INVEST, V123, P285, DOI 10.1172/JCI63861; Yang Y, 2013, FEBS J, V280, P5109, DOI 10.1111/febs.12485; Yi C, 2012, ONCOGENE, V31, P4421, DOI 10.1038/onc.2011.629; Yin J, 2011, INVEST OPHTH VIS SCI, V52, P6589, DOI 10.1167/iovs.11-7709; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zhang Y, 2013, ONCOL REP, V30, P1976, DOI 10.3892/or.2013.2633; Zhong H, 2010, INT J HEMATOL, V92, P129, DOI 10.1007/s12185-010-0626-5; Zieske JD, 2000, INVEST OPHTH VIS SCI, V41, P1346	100	64	68	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84425	10.1371/journal.pone.0084425	http://dx.doi.org/10.1371/journal.pone.0084425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376808	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100168
J	Gong, JY; Sun, YH				Gong, Jian-Yang; Sun, Ye-Huan			Association of VEGF Gene Polymorphisms with Diabetic Retinopathy: A Meta-Analysis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RISK; HETEROGENEITY; PROGRESSION; VARIANTS; PROMOTER	Background: Studies on the association of vascular endothelial growth factor (VEGF) gene -460T/C and -2578C/A polymorphisms with diabetic retinopathy (DR) have reported conflicting results. The aim of the present study was to assess the association by using meta-analysis. Methods: A systematic search of electronic databases (PubMed, EMBASE, Elsevier Science Direct, ISI Web of Science, CBM, CNKI and VIP) was carried out until Sept 18, 2013. The pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were used to assess the strength of the association. Results: Eleven studies (-460T/C: 6 studies including 932 cases and 722 controls; -2578C/A: 6 studies including 1,071 cases and 1,137 controls) were involved in this meta-analysis. Significant association was found for -460T/C polymorphism (C versus T: OR=1.48, 95% CI=1.07-2.05, P=0.02; TC+CC versus TT: OR=1.78, 95% CI=1.02-3.12, P=0.04; CC versus TT+TC: OR=1.76, 95% CI=1.10-2.81, P=0.02), but not for -2578C/A polymorphism (P>0.05). Similar results were found in the subgroup analysis. Conclusions: This meta-analysis demonstrates that DR is associated with VEGF gene -460T/C polymorphism, but not -2578C/A polymorphism. Further case-control studies based on larger sample size are still needed, especially for -2578C/A polymorphism.	[Gong, Jian-Yang; Sun, Ye-Huan] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China; [Gong, Jian-Yang] Anhui Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Sun, YH (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China.	yhsun_ahmu_edu@yeah.net						Abhary S, 2009, INVEST OPHTH VIS SCI, V50, P5552, DOI 10.1167/iovs.09-3694; Abhary S, 2009, DIABETES, V58, P2137, DOI 10.2337/db09-0059; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Al-Kateb H, 2007, DIABETES, V56, P2161, DOI 10.2337/db07-0376; Aldebasi YH, 2013, INT J CLIN EXP MED, V6, P239; Awata T, 2005, BIOCHEM BIOPH RES CO, V333, P679, DOI 10.1016/j.bbrc.2005.05.167; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; BARNETT A H, 1991, American Journal of Medicine, V90, p67S, DOI 10.1016/0002-9343(91)90421-S; Brogan IJ, 1999, HUM IMMUNOL, V60, P1245, DOI 10.1016/S0198-8859(99)00132-9; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chun MY, 2010, J CLIN ENDOCR METAB, V95, P3547, DOI 10.1210/jc.2009-2719; Churchill AJ, 2008, INVEST OPHTH VIS SCI, V49, P3611, DOI 10.1167/iovs.07-1383; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duh E, 1999, DIABETES, V48, P1899, DOI 10.2337/diabetes.48.10.1899; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FRANK RN, 1994, NEW ENGL J MED, V331, P1519, DOI 10.1056/NEJM199412013312212; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kangas-Kontio T, 2009, BRIT J OPHTHALMOL, V93, P1401, DOI 10.1136/bjo.2009.159012; Khan Zia Ali, 2003, Exp Diabesity Res, V4, P287, DOI 10.1155/EDR.2003.287; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; MALECAZE F, 1994, ARCH OPHTHALMOL-CHIC, V112, P1476, DOI 10.1001/archopht.1994.01090230090028; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Nakamura S, 2009, GRAEF ARCH CLIN EXP, V247, P21, DOI 10.1007/s00417-008-0915-3; Paine SK, 2012, MOL VIS, V18, P2749; Patel S, 2008, CURR DIABETES REP, V8, P257, DOI 10.1007/s11892-008-0046-6; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Shah CA, 2008, INDIAN J MED SCI, V62, P500, DOI DOI 10.4103/0019-5359.48562.PUBMED:19265246; Stevens A, 2003, CANCER RES, V63, P812; Suganthalakshmi B, 2006, MOL VIS, V12, P336; Szaflik JP, 2008, GRAEF ARCH CLIN EXP, V246, P39, DOI 10.1007/s00417-007-0674-6; [王晓梅 WANG Xiaomei], 2008, [中国糖尿病杂志, Chinese Journal of Diabetes], V16, P462; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105; Xu B, 2010, MED ONCOL, V27, P1031, DOI 10.1007/s12032-009-9329-2; Yang XF, 2011, MOL VIS, V17, P3088	38	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84069	10.1371/journal.pone.0084069	http://dx.doi.org/10.1371/journal.pone.0084069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376787	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100156
J	Jain, N; Bhasne, K; Hemaswasthi, M; Mukhopadhyay, S				Jain, Neha; Bhasne, Karishma; Hemaswasthi, M.; Mukhopadhyay, Samrat			Structural and Dynamical Insights into the Membrane-Bound alpha-Synuclein	PLOS ONE			English	Article							CONFORMATIONAL PLASTICITY; BROKEN HELIX; PROTEIN; BINDING; FLUORESCENCE; DISEASE; VESICLE; CHAMELEON; MUTATION; BILAYER	Membrane-induced disorder-to-helix transition of alpha-synuclein, a presynaptic protein, has been implicated in a number of important neuronal functions as well as in the etiology of Parkinson's disease. In order to obtain structural insights of membrane-bound alpha-synuclein at the residue-specific resolution, we took advantage of the fact that the protein is devoid of tryptophan and incorporated single tryptophan at various residue positions along the sequence. These tryptophans were used as site-specific markers to characterize the structural and dynamical aspects of alpha-synuclein on the negatively charged small unilamellar lipid vesicles. An array of site-specific fluorescence readouts, such as the spectral-shift, quenching efficiency and anisotropy, allowed us to discern various features of the conformational rearrangements occurring at different locations of alpha-synuclein on the lipid membrane. In order to define the spatial localization of various regions of the protein near the membrane surface, we utilized a unique and sensitive indicator, namely, red-edge excitation shift (REES), which originates when a fluorophore is located in a highly ordered micro-environment. The extent of REES observed at different residue positions allowed us to directly identify the residues that are localized at the membrane-water interface comprising a thin (15 A) layer of motionally restrained water molecules and enabled us to construct a dynamic hydration map of the protein. The combination of site-specific fluorescence readouts allowed us to unravel the intriguing molecular details of -synuclein on the lipid membrane in a direct model-free fashion. Additionally, the combination of methodologies described here are capable of distinguishing subtle but important structural alterations of alpha-synuclein bound to different negatively charged lipids with varied head-group chemistry. We believe that the structural modulations of alpha-synuclein on the membrane could potentially be related to its physiological functions as well as to the onset of Parkinson's diseases.	[Jain, Neha; Bhasne, Karishma; Mukhopadhyay, Samrat] Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, India; [Hemaswasthi, M.; Mukhopadhyay, Samrat] Indian Inst Sci Educ & Res, Dept Chem Sci, Mohali, India	Indian Institute of Science Education & Research (IISER) - Mohali; Indian Institute of Science Education & Research (IISER) - Mohali	Mukhopadhyay, S (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, India.	mukhopadhyay@iisermohali.ac.in	Bhasne, Karishma/HGE-5686-2022	Bhasne, Karishma/0000-0002-6422-8544; Mukhopadhyay, Samrat/0000-0003-1242-9958	IISER Mohali; Council of Scientific and Industrial Research; Department of Science and Technology (INSPIRE fellowship)	IISER Mohali; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (INSPIRE fellowship)(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	This work was funded by IISER Mohali, the Council of Scientific and Industrial Research (to SM) and the Department of Science and Technology (INSPIRE fellowship to KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chattopadhyay A, 2014, ACCOUNTS CHEM RES, V47, P12, DOI 10.1021/ar400006z; Christine CJ, 2004, P NATL ACAD SCI USA, V101, P8331; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Deleersnijder A, 2013, TRENDS MOL MED, V19, P368, DOI 10.1016/j.molmed.2013.04.002; Demchenko AP, 2008, METHOD ENZYMOL, V450, P59, DOI 10.1016/S0076-6879(08)03404-6; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Drescher M, 2012, CHEMBIOCHEM, V13, P761, DOI 10.1002/cbic.201200059; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ferreon ACM, 2007, BIOCHEMISTRY-US, V46, P4499, DOI 10.1021/bi602461y; Ferreon ACM, 2010, ANGEW CHEM INT EDIT, V49, P3469, DOI 10.1002/anie.201000378; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Haldar S, 2011, J PHYS CHEM B, V115, P5693, DOI 10.1021/jp200255e; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Kim YS, 2006, J MOL BIOL, V360, P386, DOI 10.1016/j.jmb.2006.05.004; Kjaer L, 2009, BIOPHYS J, V96, P2857, DOI 10.1016/j.bpj.2008.12.3940; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lee JC, 2004, P NATL ACAD SCI USA, V101, P16466, DOI 10.1073/pnas.0407307101; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Pal SK, 2004, CHEM REV, V104, P2099, DOI 10.1021/cr020689l; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Tamamizu-Kato S, 2006, BIOCHEMISTRY-US, V45, P10947, DOI 10.1021/bi060939i; Tompa P., 2010, STRUCTURE FUNCTION I; Tory MC, 2002, BBA-BIOMEMBRANES, V1564, P435, DOI 10.1016/S0005-2736(02)00493-5; Tosatto L, 2010, BIOCHIM BIOPHYS ACTA, V1818, P2876; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Ullman O, 2011, J AM CHEM SOC, V133, P19536, DOI 10.1021/ja208657z; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Vamvaca K, 2009, J MOL BIOL, V389, P413, DOI 10.1016/j.jmb.2009.03.021; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; Veldhuis G, 2009, CHEMBIOCHEM, V10, P436, DOI 10.1002/cbic.200800644; Wang GF, 2010, PROTEIN SCI, V19, P1686, DOI 10.1002/pro.449; Watson JB, 2009, NEUROSCIENCE, V159, P501, DOI 10.1016/j.neuroscience.2009.01.021; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wietek J, 2013, FEBS LETT, V587, P2572, DOI 10.1016/j.febslet.2013.06.034; [No title captured], DOI DOI 10.1002/9783527619498.CH41	62	33	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83752	10.1371/journal.pone.0083752	http://dx.doi.org/10.1371/journal.pone.0083752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376740	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100135
J	Long, JH; Arshavsky, VY; Burns, ME				Long, James H.; Arshavsky, Vadim Y.; Burns, Marie E.			Absence of Synaptic Regulation by Phosducin in Retinal Slices	PLOS ONE			English	Article							ROD PHOTORECEPTORS; TRANSDUCIN; PHOTOTRANSDUCTION; PHOSPHOPROTEIN; EXPRESSION; BINDING; PROTEIN; SIGNALS; CELLS	Phosducin is an abundant photoreceptor protein that binds G-protein B gamma subunits and plays a role in modulating synaptic transmission at photorceptor synapeses under both dark-adapted and light-adapted conditions in vivo. To examine the role of phosducin at the rod-to-rod bipolar cell (RBC) synapse, we used whole-cell voltage clamp recordings to measure the light-evoked currents from both wild-type (WT) and phosducin knockout (Pd-/-) RBCs, in dark- and light-adapted retinal slices. Pd-/- RBCs showed smaller dim flash responses and steeper intensity response relationships than WT RBCs, consistent with the smaller rod responses being selectively filtered out by the non-linear threshold at the rod-to-rod bipolar synapse. In addition, Pd-/- RBCs showed a marked delay in the onset of the light-evoked currents, similar to that of a WT response to an effectively dimmer flash. Comparison of the changes in flash sensitivity in the presence of steady adapting light revealed that Pd-/- RBCs desensitized less than WT RBCs to the same intensity. These results are quantitatively consistent with the smaller single photon responses of Pd-/- rods, owing to the known reduction in rod G-protein expression levels in this line. The absence of an additional synaptic phenotype in these experiments suggests that the function of phosducin at the photoreceptor synapse is abolished by the conditions of retinal slice recordings.	[Long, James H.; Burns, Marie E.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Arshavsky, Vadim Y.] Duke Univ, Ctr Eye, Dept Ophthalmol, Durham, NC 27710 USA; [Arshavsky, Vadim Y.] Duke Univ, Ctr Eye, Dept Pharmacol, Durham, NC USA; [Burns, Marie E.] Univ Calif Davis, Dept Ophthalmol & Vis Sci, Davis, CA 95616 USA; [Burns, Marie E.] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	University of California System; University of California Davis; Duke University; Duke University; University of California System; University of California Davis; University of California System; University of California Davis	Burns, ME (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	meburns@ucdavis.edu			NIH [R01 EY14047, EY10336]; Vision Training Grant [NIH T32 EY15387]; Research to Prevent Blindness; Achievement Rewards for College Scientists; NATIONAL EYE INSTITUTE [R01EY014047, R01EY010336, T32EY015387, P30EY005722] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vision Training Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Achievement Rewards for College Scientists; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by NIH R01 EY14047 to MEB, EY10336 to VYA and the Vision Training Grant (NIH T32 EY15387) to JHL and CF, Research to Prevent Blindness, and Achievement Rewards for College Scientists to JHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo AW, 2011, J NEUROSCI, V31, P3670, DOI 10.1523/JNEUROSCI.4750-10.2011; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Gross OP, 2010, J NEUROSCI, V30, P3450, DOI 10.1523/JNEUROSCI.5391-09.2010; Krispel CM, 2007, J GEN PHYSIOL, V130, P303, DOI 10.1085/jgp.200709812; LEE RH, 1987, BIOCHEMISTRY-US, V26, P3983, DOI 10.1021/bi00387a036; LEE RH, 1984, BIOCHEMISTRY-US, V23, P1972, DOI 10.1021/bi00304a014; LEE RH, 1988, EXP EYE RES, V46, P829, DOI 10.1016/S0014-4835(88)80035-6; Muller S, 1996, J BIOL CHEM, V271, P11781, DOI 10.1074/jbc.271.20.11781; Nakano K, 2001, P NATL ACAD SCI USA, V98, P4693, DOI 10.1073/pnas.071067198; Okawa H, 2010, J PHYSIOL-LONDON, V588, P1947, DOI 10.1113/jphysiol.2010.188573; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Thulin CD, 1999, MOL VIS, V5, pU13; Wu SM, 2010, INVEST OPHTH VIS SCI, V51, P1264, DOI 10.1167/iovs.09-4396; YOSHIDA T, 1994, J BIOL CHEM, V269, P24050	16	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83970	10.1371/journal.pone.0083970	http://dx.doi.org/10.1371/journal.pone.0083970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376776	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100148
J	Underbjerg, M; George, MS; Thorsen, P; Kesmodel, US; Mortensen, EL; Manly, T				Underbjerg, Mette; George, Melanie S.; Thorsen, Poul; Kesmodel, Ulrik S.; Mortensen, Erik L.; Manly, Tom			Separable Sustained and Selective Attention Factors Are Apparent in 5-Year-Old Children	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; PREFRONTAL CORTEX; EVERYDAY ATTENTION; UNILATERAL NEGLECT; SPATIAL AWARENESS; NEURAL MECHANISMS; VISUAL-SEARCH; TEA-CH; ADHD; BRAIN	In adults and older children, evidence consistent with relative separation between selective and sustained attention, superimposed upon generally positive inter-test correlations, has been reported. Here we examine whether this pattern is detectable in 5-year-old children from the healthy population. A new test battery (TEA-Ch(J)) was adapted from measures previously used with adults and older children and administered to 172 5-year-olds. Test-retest reliability was assessed in 60 children. Ninety-eight percent of the children managed to complete all measures. Discrimination of visual and auditory stimuli were good. In a factor analysis, the two TEA-Ch(J) selective attention tasks (one visual, one auditory) loaded onto a common factor and diverged from the two sustained attention tasks (one auditory, one motor), which shared a common loading on the second factor. This pattern, which suggests that the tests are indeed sensitive to underlying attentional capacities, was supported by the relationships between the TEA-Ch(J) factors and Test of Everyday Attention for Children subtests in the older children in the sample. It is possible to gain convincing performance-based estimates of attention at the age of 5 with the results reflecting a similar factor structure to that obtained in older children and adults. The results are discussed in light of contemporary models of attention function. Given the potential advantages of early intervention for attention difficulties, the findings are of clinical as well as theoretical interest.	[Underbjerg, Mette; Kesmodel, Ulrik S.] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Underbjerg, Mette] Vejlefjord Rehabil Ctr, Childrens Neuroctr, Stouby, Denmark; [George, Melanie S.; Manly, Tom] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Thorsen, Poul] Lillebaelt Hosp, Dept Obstet & Gynaecol, Kolding, Denmark; [Kesmodel, Ulrik S.] Aarhus Univ Hosp, Dept Obstet & Gynaecol, DK-8000 Aarhus, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen; University of Copenhagen	Underbjerg, M (corresponding author), Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark.	MU@SOCI.AU.DK		Mortensen, Erik Lykke/0000-0002-6985-451X	North Atlantic Neuro Epidemiology Alliances/Aarhus University Medical Research Council [MRC MC-A060-5PQ20]; MRC [MC_U105559837] Funding Source: UKRI; Medical Research Council [MC_U105559837] Funding Source: researchfish	North Atlantic Neuro Epidemiology Alliances/Aarhus University Medical Research Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by North Atlantic Neuro Epidemiology Alliances/Aarhus University Medical Research Council (MRC MC-A060-5PQ20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson V, 2005, J INT NEUROPSYCH SOC, V11, P817, DOI 10.1017/S1355617705051052; Atkinson J, 2007, PROG BRAIN RES, V164, P123, DOI 10.1016/S0079-6123(07)64007-2; BACHOROWSKI JA, 1990, J PERS SOC PSYCHOL, V58, P512, DOI 10.1037/0022-3514.58.3.512; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Dehaene S, 2001, ANN NY ACAD SCI, V929, P152; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dobler VB, 2005, J CHILD PSYCHOL PSYC, V46, P1230, DOI 10.1111/j.1469-7610.2005.00421.x; Dobler VB, 2003, DEV MED CHILD NEUROL, V45, P282, DOI 10.1017/S0012162203000537; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; George M, 2005, BRAIN COGNITION, V57, P264, DOI 10.1016/j.bandc.2004.09.003; Hampshire A, 2009, COGN AFFECT BEHAV NE; Heaton SC, 2001, CHILD NEUROPSYCHOL, V7, P251, DOI 10.1076/chin.7.4.251.8736; Karmiloff-Smith A, 2003, CORTEX, V39, P161, DOI 10.1016/S0010-9452(08)70091-1; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T, 1997, NEUROCASE, V3, P19, DOI 10.1080/13554799708404031; McCourt ME, 1997, NEUROPSYCHOLOGIA, V35, P369, DOI 10.1016/S0028-3932(96)00143-1; Miller E. K., 2001, ANN REV NEUROSCIENCE, V24; Moore D.R., 2006, AUDIOLOGICAL MED, V4, P4, DOI [DOI 10.1080/16513860600568573, 10.1080/16513860600568573]; Nigg JT, 1997, NEUROPSYCHOLOGIA, V35, P165, DOI 10.1016/S0028-3932(96)00070-X; Parasuraman R, 1987, ERGONOMICS HUMAN FAC; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; ROBERTSON IH, 1996, J INT NEUROPSYCH SOC, V2, P523; Scerif G, 2004, DEVELOPMENTAL SCI, V7, P116, DOI 10.1111/j.1467-7687.2004.00327.x; Shallice T, 1993, ATTENTION SELECTION, P171; Sheppard DM, 1999, J NEUROL NEUROSUR PS, V66, P57, DOI 10.1136/jnnp.66.1.57; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sutcliffe P. A., 2006, ED PSYCHOL, V26, P325, DOI [10.1080/01443410500341031, DOI 10.1080/01443410500341031]; Weschler D, 1989, WECHSLER PRESCHOOL P; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8	38	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82843	10.1371/journal.pone.0082843	http://dx.doi.org/10.1371/journal.pone.0082843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376591	gold, Green Published			2022-12-27	WOS:000328745100064
J	Rattray, I; Smith, EJ; Crum, WR; Walker, TA; Gale, R; Bates, GP; Modo, M				Rattray, Ivan; Smith, Edward J.; Crum, William R.; Walker, Thomas A.; Gale, Richard; Bates, Gillian P.; Modo, Michel			Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the R6/1 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							ELECTRON-MICROSCOPIC CHARACTERIZATION; PITUITARY-ADRENAL AXIS; CELLULAR PATHOLOGY; MUTANT HUNTINGTIN; GENE-EXPRESSION; FLUID REGISTRATION; STRIATAL NEURONS; TRANSGENIC MICE; PHENOTYPE; HDH(Q92)	Huntington's disease (HD) is caused by the expansion of a CAG repeat in the huntingtin (HTT) gene. The R6 mouse models of HD express a mutant version of exon 1 HTT and typically develop motor and cognitive impairments, a widespread huntingtin (HTT) aggregate pathology and brain atrophy. Unlike the more commonly used R6/2 mouse line, R6/1 mice have fewer CAG repeats and, subsequently, a less rapid pathological decline. Compared to the R6/2 line, fewer descriptions of the progressive pathologies exhibited by R6/1 mice exist. The association between the molecular and cellular neuropathology with brain atrophy, and with the development of behavioral phenotypes remains poorly understood in many models of HD. In attempt to link these factors in the R6/1 mouse line, we have performed detailed assessments of behavior and of regional brain abnormalities determined through longitudinal, in vivo magnetic resonance imaging (MRI), as well as an end-stage, ex vivo MRI study and histological assessment. We found progressive decline in both motor and non-motor related behavioral tasks in R6/1 mice, first evident at 11 weeks of age. Regional brain volumes were generally unaffected at 9 weeks, but by 17 weeks there was significant grey matter atrophy. This age-related brain volume loss was validated using a more precise, semi-automated Tensor Based morphometry assessment. As well as these clear progressive phenotypes, mutant HTT (mHTT) protein, the hallmark of HD molecular pathology, was widely distributed throughout the R6/1 brain and was accompanied by neuronal loss. Despite these seemingly concomitant, robust pathological phenotypes, there appeared to be little correlation between the three main outcome measures: behavioral performance, MRI-detected brain atrophy and histopathology. In conclusion, R6/1 mice exhibit many features of HD, but the underlying mechanisms driving these clear behavioral disturbances and the brain volume loss, still remain unclear.	[Rattray, Ivan; Smith, Edward J.; Modo, Michel] Kings Coll London, Inst Psychiat, Dept Neurosci, London, England; [Rattray, Ivan; Smith, Edward J.; Walker, Thomas A.; Gale, Richard; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London, England; [Crum, William R.] Kings Coll London, Dept Neuroimaging, Inst Psychiat, London, England; [Modo, Michel] Univ Pittsburgh, Dept Radiol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA	University of London; King's College London; University of London; King's College London; University of London; King's College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Modo, M (corresponding author), Kings Coll London, Inst Psychiat, Dept Neurosci, London, England.	modomm@upmc.edu	Crum, William R/C-4891-2008; Bates, Gillian/E-1146-2012	Crum, William R/0000-0001-9369-2197; Modo, Michel/0000-0003-4436-735X; Bates, Gillian/0000-0002-4041-6305	Medical Research Council [G0800846]; CHDI Foundation; MRC [G0800846] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CHDI Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council (G0800846) and the CHDI Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada YSK, 2013, BEHAV BRAIN RES, V238, P243, DOI 10.1016/j.bbr.2012.10.039; Aylward EH, 2012, BIOL PSYCHIAT, V71, P822, DOI 10.1016/j.biopsych.2011.07.030; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P104, DOI 10.1016/j.brainresbull.2011.07.009; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P189, DOI 10.1016/j.brainresbull.2011.03.014; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P137, DOI 10.1016/j.brainresbull.2011.05.005; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P171, DOI 10.1016/j.brainresbull.2011.03.013; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Bissonette GB, 2012, NEUROPHARMACOLOGY, V62, P1168, DOI 10.1016/j.neuropharm.2011.03.011; Bjorkqvist M, 2006, HUM MOL GENET, V15, P1713, DOI 10.1093/hmg/ddl094; Bolivar VJ, 2004, BRAIN RES, V1005, P29, DOI 10.1016/j.brainres.2004.01.021; Brooks S, 2012, BRAIN RES BULL, V88, P182, DOI 10.1016/j.brainresbull.2010.05.004; Brooks S, 2012, BRAIN RES BULL, V88, P148, DOI 10.1016/j.brainresbull.2010.05.003; Brooks S, 2012, BRAIN RES BULL, V88, P113, DOI 10.1016/j.brainresbull.2010.05.005; Brooks SP, 2012, BRAIN RES BULL, V88, P130, DOI 10.1016/j.brainresbull.2011.06.008; Brooks SP, 2012, BRAIN RES BULL, V88, P121, DOI 10.1016/j.brainresbull.2011.05.010; Brooks SP, 2012, BRAIN RES BULL, V88, P94, DOI 10.1016/j.brainresbull.2011.01.010; Crum WR, 2013, J NEUROSCI METH, V218, P170, DOI 10.1016/j.jneumeth.2013.05.009; Crum WR, 2013, J NEUROSCI METH, V216, P62, DOI 10.1016/j.jneumeth.2013.03.015; Crum WR, 2005, PHYS MED BIOL, V50, P5153, DOI 10.1088/0031-9155/50/21/014; CRUM WR, 2013, J NEUROSCIENCE METHO, P1012; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Delmaire C, 2013, HUM BRAIN MAPP, V34, P2141, DOI 10.1002/hbm.22055; Dominguez JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074131; Du X, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.58; El-Akabawy G, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-97; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Freeborough PA, 1998, J COMPUT ASSIST TOMO, V22, P838, DOI 10.1097/00004728-199809000-00031; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giles P, 2012, BRAIN RES BULL, V88, P199, DOI 10.1016/j.brainresbull.2011.10.001; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hickey MA, 2005, NEUROBIOL DIS, V20, P1, DOI 10.1016/j.nbd.2005.01.024; Hodges A, 2008, GENES BRAIN BEHAV, V7, P288, DOI 10.1111/j.1601-183X.2007.00350.x; Hong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047026; Hong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030879; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kusakabe M, 2001, J COMP NEUROL, V430, P485, DOI 10.1002/1096-9861(20010219)430:4<485::AID-CNE1045>3.0.CO;2-6; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Ma L, 2003, GLIA, V43, P274, DOI 10.1002/glia.10261; Macbeth AH, 2009, NAT PROTOC, V4, P1574, DOI 10.1038/nprot.2009.141; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/S0278-5846(84)80032-9; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mazarakis NK, 2005, J NEUROSCI, V25, P3059, DOI 10.1523/JNEUROSCI.4320-04.2005; Menalled LB, 2002, J NEUROSCI, V22, P8266; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Miller BR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00026; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Mouton PR, 2011, UNBIASED STEREOLOGY; Naver B, 2003, NEUROSCIENCE, V122, P1049, DOI 10.1016/j.neuroscience.2003.08.053; Olsson IAS, 2003, APPL ANIM BEHAV SCI, V81, P245, DOI 10.1016/S0168-1591(02)00285-X; Pardon MC, 2008, NEUROSCI BIOBEHAV R, V32, P1103, DOI 10.1016/j.neubiorev.2008.03.005; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rattray I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060012; Rebec GV, 2006, NEUROSCIENCE, V137, P327, DOI 10.1016/j.neuroscience.2005.08.062; Ruocco HH, 2008, J NEUROL NEUROSUR PS, V79, P130, DOI 10.1136/jnnp.2007.116244; Sadikot AF, 1997, J COMP NEUROL, V389, P193; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Smith KM, 2006, BBA-MOL BASIS DIS, V1762, P616, DOI 10.1016/j.bbadis.2006.03.004; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Stout JC, 2012, J NEUROL NEUROSUR PS, V83, P687, DOI 10.1136/jnnp-2011-301940; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Trueman RC, 2012, BRAIN RES BULL, V88, P163, DOI 10.1016/j.brainresbull.2011.10.019; Trueman RC, 2012, BRAIN RES BULL, V88, P156, DOI 10.1016/j.brainresbull.2011.03.012; Vernon AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017269; Walker AG, 2008, J NEUROSCI, V28, P8973, DOI 10.1523/JNEUROSCI.2804-08.2008; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004	76	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84726	10.1371/journal.pone.0084726	http://dx.doi.org/10.1371/journal.pone.0084726			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367693	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000328741900064
J	Ryland, LK; Doshi, UA; Shanmugavelandy, SS; Fox, TE; Aliaga, C; Broeg, K; Baab, KT; Young, M; Khan, O; Haakenson, JK; Jarbadan, NR; Liao, J; Wang, HG; Feith, DJ; Loughran, TP; Liu, X; Kester, M				Ryland, Lindsay K.; Doshi, Ushma A.; Shanmugavelandy, Sriram S.; Fox, Todd E.; Aliaga, Cesar; Broeg, Kathleen; Baab, Kendall Thomas; Young, Megan; Khan, Osman; Haakenson, Jeremy K.; Jarbadan, Nancy Ruth; Liao, Jason; Wang, Hong-Gang; Feith, David J.; Loughran, Thomas P., Jr.; Liu, Xin; Kester, Mark			C6-Ceramide Nanoliposomes Target the Warburg Effect in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							SHORT-CHAIN CERAMIDE; GENE-EXPRESSION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CELL-DEATH; CANCER; PROTEIN; SURVIVAL; FLUDARABINE; GENERATION; INHIBITION	Ceramide is a sphingolipid metabolite that induces cancer cell death. When C6-ceramide is encapsulated in a nanoliposome bilayer formulation, cell death is selectively induced in tumor models. However, the mechanism underlying this selectivity is unknown. As most tumors exhibit a preferential switch to glycolysis, as described in the "Warburg effect", we hypothesize that ceramide nanoliposomes selectively target this glycolytic pathway in cancer. We utilize chronic lymphocytic leukemia (CLL) as a cancer model, which has an increased dependency on glycolysis. In CLL cells, we demonstrate that C6-ceramide nanoliposomes, but not control nanoliposomes, induce caspase 3/7-independent necrotic cell death. Nanoliposomal ceramide inhibits both the RNA and protein expression of GAPDH, an enzyme in the glycolytic pathway, which is overexpressed in CLL. To confirm that ceramide targets GAPDH, we demonstrate that downregulation of GAPDH potentiates the decrease in ATP after ceramide treatment and exogenous pyruvate treatment as well as GAPDH overexpression partially rescues ceramide-induced necrosis. Finally, an in vivo murine model of CLL shows that nanoliposomal C6-ceramide treatment elicits tumor regression, concomitant with GAPDH downregulation. We conclude that selective inhibition of the glycolytic pathway in CLL cells with nanoliposomal C6-ceramide could potentially be an effective therapy for leukemia by targeting the Warburg effect.	[Ryland, Lindsay K.; Doshi, Ushma A.; Shanmugavelandy, Sriram S.; Fox, Todd E.; Young, Megan; Haakenson, Jeremy K.; Wang, Hong-Gang; Kester, Mark] Penn State Coll Med, Dept Pharmacol, Hershey, PA USA; [Ryland, Lindsay K.; Aliaga, Cesar; Broeg, Kathleen; Baab, Kendall Thomas; Young, Megan; Khan, Osman; Jarbadan, Nancy Ruth; Liao, Jason; Wang, Hong-Gang; Feith, David J.; Loughran, Thomas P., Jr.; Liu, Xin; Kester, Mark] Penn State Coll Med, Penn State Hershey Canc Inst, Hershey, PA USA; [Loughran, Thomas P., Jr.; Liu, Xin] Penn State Coll Med, Dept Med, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kester, M (corresponding author), Penn State Coll Med, Dept Pharmacol, Hershey, PA USA.	mkester@psu.edu	Kester, Mark/ABG-4615-2020; Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Young, Megan/0000-0003-1751-9979	National Institutes of Health [CA133525, CA098472]; Pennsylvania Tobacco Settlement Fund [R01HL76789]; NATIONAL CANCER INSTITUTE [R01CA133525, P01CA171983, R01CA098472] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Settlement Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant nos. CA133525 and CA098472 (to T. P. L.) and Pennsylvania Tobacco Settlement Fund, R01HL76789 (to M. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Bagnara D, 2011, BLOOD, V117, P5463, DOI 10.1182/blood-2010-12-324210; Biswal SS, 2000, TOXICOLOGY, V154, P45, DOI 10.1016/S0300-483X(00)00296-1; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chapman JV, 2010, BIOCHEM PHARMACOL, V80, P308, DOI 10.1016/j.bcp.2010.04.001; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; FOON KA, 1990, ANN INTERN MED, V113, P525, DOI 10.7326/0003-4819-113-7-525; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Geschwind JFH, 2002, CANCER RES, V62, P3909; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hetz CA, 2002, J CELL SCI, V115, P4671, DOI 10.1242/jcs.00153; Hofheinz RD, 2005, ANTI-CANCER DRUG, V16, P691, DOI 10.1097/01.cad.0000167902.53039.5a; Huttmann A, 2006, LEUKEMIA, V20, P1774, DOI 10.1038/sj.leu.2404363; Jiang YX, 2011, CANCER BIOL THER, V12, P574, DOI 10.4161/cbt.12.7.15971; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kueck A, 2007, GYNECOL ONCOL, V107, P450, DOI 10.1016/j.ygyno.2007.07.065; Kumagai S, 2008, BIOCHEM BIOPH RES CO, V365, P362, DOI 10.1016/j.bbrc.2007.10.199; Lavallard VJ, 2009, CANCER RES, V69, P3013, DOI 10.1158/0008-5472.CAN-08-2731; Liu X, 2010, BLOOD, V116, P4192, DOI 10.1182/blood-2010-02-271080; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loisel S, 2005, LEUKEMIA RES, V29, P1347, DOI 10.1016/j.leukres.2005.04.017; MELO JV, 1986, INT J CANCER, V38, P531, DOI 10.1002/ijc.2910380413; Mengubas K, 1999, ONCOGENE, V18, P2499, DOI 10.1038/sj.onc.1202622; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Ramos B, 2003, MOL PHARMACOL, V64, P502, DOI 10.1124/mol.64.2.502; Rathmell JC, 2007, CELL, V129, P861, DOI 10.1016/j.cell.2007.05.030; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Rivenzon-Segal D, 2000, AM J PHYSIOL-ENDOC M, V279, pE508, DOI 10.1152/ajpendo.2000.279.3.E508; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Shanmugam M, 2009, CURR OPIN ONCOL, V21, P531, DOI 10.1097/CCO.0b013e32832f57ec; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Song SW, 2007, NAT CELL BIOL, V9, P869, DOI 10.1038/ncb0807-869; Stover TC, 2005, CLIN CANCER RES, V11, P3465, DOI 10.1158/1078-0432.CCR-04-1770; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; Tran MA, 2008, CLIN CANCER RES, V14, P3571, DOI 10.1158/1078-0432.CCR-07-4881; Veldurthy A, 2008, BLOOD, V112, P1443, DOI 10.1182/blood-2007-11-123984; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watson DG, 2013, CELL SIGNAL, V25, P1011, DOI 10.1016/j.cellsig.2013.01.002; Yang J, 2010, BLOOD, V115, P51, DOI 10.1182/blood-2009-06-223719; Yeluri S, 2009, J CANCER RES CLIN, V135, P867, DOI 10.1007/s00432-009-0590-8; Zhao XB, 2008, J PHARM SCI-US, V97, P1508, DOI 10.1002/jps.21046	48	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84648	10.1371/journal.pone.0084648	http://dx.doi.org/10.1371/journal.pone.0084648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367685	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900060
J	Bonnet, M; Baudin, E; Jani, IV; Nunes, E; Verhoustraten, F; Calmy, A; Bastos, R; Bhatt, NB; Michon, C				Bonnet, Maryline; Baudin, Elisabeth; Jani, Ilesh V.; Nunes, Elizabete; Verhoustraten, Francois; Calmy, Alexandra; Bastos, Rui; Bhatt, Nilesh B.; Michon, Christophe			Incidence of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome and Impact on Patient Outcome	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; RESTORATION DISEASE; RISK-FACTORS; MORTALITY	Objectives and Design: We used data from a randomized trial of HIV-tuberculosis co-infected patients in Mozambique to determine the incidence and predictors of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (IRIS) occurring within 12 weeks of starting antiretroviral therapy, and to evaluate its association with patient outcome at 48 weeks. Methods: HIV-tuberculosis co-infected and antiretroviral therapy-naive adults with less than 250 CD4/mm3 were randomized to a nevirapine or efavirenz-based antiretroviral therapy initiated 4 to 6 weeks after starting tuberculosis treatment, and were then followed for 48 weeks. Tuberculosis cases were diagnosed using WHO guidelines, and tuberculosis-IRIS by case definitions of the International Network for the Study of HIV-associated IRIS. Results: The 573 HIV-tuberculosis co-infected patients who initiated antiretroviral therapy had a median CD4 count of 92 cells/mm(3) and HIV-1 RNA of 5.6 log(10) copies/mL. Mortality at week 48 was 6.1% (35/573). Fifty-three (9.2%) patients presented a tuberculosis-IRIS within 12 weeks of starting antiretroviral therapy. Being female and having a low CD4 count, high HIV-1 RNA load, low body mass index and smear-positive pulmonary tuberculosis were independently associated with tuberculosis-IRIS. After adjustment for baseline body mass index, CD4 count and hemoglobin, occurrence of tuberculosis-IRIS was independently associated with 48-week mortality (aOR 2.72 95%CI 1.14-6.54). Immunological and HIV-1 virological responses and tuberculosis treatment outcomes were not different between patients with and without tuberculosis-IRIS. Conclusion: In this large prospective cohort, tuberculosis-IRIS occurrence within 12 weeks of starting antiretroviral therapy was independently associated with the mortality of HIV-tuberculosis co-infected patients at 48 weeks post antiretroviral therapy initiation.	[Bonnet, Maryline; Baudin, Elisabeth] Epicentre, Paris, France; [Jani, Ilesh V.; Bhatt, Nilesh B.] Inst Nacl Saude, Maputo, Mozambique; [Nunes, Elizabete; Bastos, Rui] Cent Hosp, Maputo, Mozambique; [Verhoustraten, Francois] Med Sans Frontieres, Geneva, Switzerland; [Calmy, Alexandra] Univ Hosp Geneva, Geneva, Switzerland; [Michon, Christophe] Annecy Hosp, Annecy, France	Doctors Without Borders; University of Geneva; Centre Hospitalier Annecy Genevois	Bonnet, M (corresponding author), Epicentre, Paris, France.	maryline.bonnet@geneva.msf.org		Jani, Ilesh/0000-0002-6880-6655; Baudin, Elisabeth/0000-0002-6575-6971	French Research Agency for HIV/AIDS and hepatitis (ANRS) [12146]; Medecins sans Frontiere, Operational Center Geneva	French Research Agency for HIV/AIDS and hepatitis (ANRS); Medecins sans Frontiere, Operational Center Geneva	The study was funded by a grant from the French Research Agency for HIV/AIDS and hepatitis (ANRS) No 12146 and co-funding by Medecins sans Frontiere, Operational Center Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastard M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-27; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Bonnet M, 2013, LANCET INFECT DIS, V13, P303, DOI 10.1016/S1473-3099(13)70007-0; Burman W, 2007, INT J TUBERC LUNG D, V11, P1282; Colebunders R, 2006, INT J TUBERC LUNG D, V10, P946; De D, 2011, BRAZ J INFECT DIS, V15, P553, DOI 10.1590/S1413-86702011000600009; Eshun-Wilson Ingrid, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P104, DOI 10.1177/1545109710361537; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; French MAH, 2012, MED J AUSTRALIA, V196, P318, DOI 10.5694/mja12.10089; Gengiah TN, 2011, EXPERT OPIN DRUG SAF, V10, P559, DOI 10.1517/14740338.2011.546783; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Gupta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055824; Haddow LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040623; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hoyo-Ulloa I, 2011, INT J INFECT DIS, V15, pE408, DOI 10.1016/j.ijid.2011.02.007; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karmakar S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/239021; Kumarasamy N, 2013, J Int Assoc Provid AIDS Care, V12, P28, DOI 10.1177/1545109712457711; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Manosuthi W, 2006, J INFECTION, V53, P357, DOI 10.1016/j.jinf.2006.01.002; Manosuthi W, 2009, AIDS, V23, P2467, DOI 10.1097/QAD.0b013e32832f7b59; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2012, CURR HIV-AIDS REP, V9, P238, DOI 10.1007/s11904-012-0129-5; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Naidoo K, 2012, ANN INTERN MED, V157, P313, DOI 10.7326/0003-4819-157-5-201209040-00004; Novak RM, 2012, AIDS, V26, P721, DOI 10.1097/QAD.0b013e3283511e91; Straetemans M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015241; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; Worodria W, 2012, ANTIVIR THER, V17, P841, DOI 10.3851/IMP2108; Worodria W, 2011, JAIDS-J ACQ IMM DEF, V58, P32, DOI 10.1097/QAI.0b013e3182255dc2	33	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84585	10.1371/journal.pone.0084585	http://dx.doi.org/10.1371/journal.pone.0084585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367678	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300149
J	Deletre, E; Martin, T; Campagne, P; Bourguet, D; Cadin, A; Menut, C; Bonafos, R; Chandre, F				Deletre, Emilie; Martin, Thibaud; Campagne, Pascal; Bourguet, Denis; Cadin, Andy; Menut, Chantal; Bonafos, Romain; Chandre, Fabrice			Repellent, Irritant and Toxic Effects of 20 Plant Extracts on Adults of the Malaria Vector Anopheles gambiae Mosquito	PLOS ONE			English	Article							THROUGHPUT SCREENING SYSTEM; ESSENTIAL OILS; AEDES-AEGYPTI; SPATIAL REPELLENT; CONTACT IRRITANT; BURKINA-FASO; INSECT; PEST; DIPTERA; IDENTIFICATION	Pyrethroid insecticides induce an excito-repellent effect that reduces contact between humans and mosquitoes. Insecticide use is expected to lower the risk of pathogen transmission, particularly when impregnated on long-lasting treated bednets. When applied at low doses, pyrethroids have a toxic effect, however the development of pyrethroid resistance in several mosquito species may jeopardize these beneficial effects. The need to find additional compounds, either to kill disease-carrying mosquitoes or to prevent mosquito contact with humans, therefore arises. In laboratory conditions, the effects (i. e., repellent, irritant and toxic) of 20 plant extracts, mainly essential oils, were assessed on adults of Anopheles gambiae, a primary vector of malaria. Their effects were compared to those of DEET and permethrin, used as positive controls. Most plant extracts had irritant, repellent and/or toxic effects on An. gambiae adults. The most promising extracts, i. e. those combining the three types of effects, were from Cymbopogon winterianus, Cinnamomum zeylanicum and Thymus vulgaris. The irritant, repellent and toxic effects occurred apparently independently of each other, and the behavioural response of adult An. gambiae was significantly influenced by the concentration of the plant extracts. Mechanisms underlying repellency might, therefore, differ from those underlying irritancy and toxicity. The utility of the efficient plant extracts for vector control as an alternative to pyrethroids may thus be envisaged.	[Deletre, Emilie; Martin, Thibaud; Cadin, Andy] Cirad, UR Hortsys, Montpellier, France; [Martin, Thibaud; Campagne, Pascal] ICIPE, Plant Hlth Dept, Nairobi, Kenya; [Bourguet, Denis] INRA CIRAD IRD Montpellier SupAgro, UMR CBGP, Montpellier, France; [Menut, Chantal] Fac Pharm Montpellier, Inst Biomol Max Mousseron, Montpellier, France; [Bonafos, Romain] USAE, Montpellier SupAgro, Montpellier, France; [Chandre, Fabrice] IRD CNRS UM1 UM2, UMR MiVEGEC, Montpellier, France	CIRAD; International Centre of Insect Physiology & Ecology (ICIPE); CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Deletre, E (corresponding author), Cirad, UR Hortsys, Montpellier, France.	emilie.deletre@cirad.fr	Chandre, Fabrice/Q-3429-2019	Chandre, Fabrice/0000-0002-1994-9705; Bourguet, Denis/0000-0002-2109-5323	Mutavie fundation; IRD; CIRAD	Mutavie fundation; IRD; CIRAD	This study was financed by Mutavie fundation (grant Agreement). The authors also thank IRD, CIRAD for financial support. The funding sources had no involvement at any stage in the preparation of this paper and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164; Achee NL, 2009, J AM MOSQUITO CONTR, V25, P156, DOI 10.2987/08-5831.1; Amer A, 2006, PARASITOL RES, V99, P466, DOI 10.1007/s00436-006-0182-3; [Anonymous], [No title captured]; Awolola T., 2012, MALAR CONTROL ELIMIN, V1; Barnard DR, 1999, J MED ENTOMOL, V36, P625, DOI 10.1093/jmedent/36.5.625; Bourguet D, 2013, TRENDS ECOL EVOL, V28, P110, DOI 10.1016/j.tree.2012.09.001; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; Dabire KR, 2009, TROP MED INT HEALTH, V14, P396, DOI 10.1111/j.1365-3156.2009.02243.x; DAVIS EE, 1976, J COMP PHYSIOL, V105, P43, DOI 10.1007/BF01380052; de Boer H, 2010, J MED ENTOMOL, V47, P400, DOI 10.1603/ME09273; Dekker T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-183; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; Djogbenou L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-70; Dusfour I, 2009, J VECTOR ECOL, V34, P232, DOI [10.3376/038.034.0209, 10.1111/j.1948-7134.2009.00031.x]; Foster SP, 1997, ANNU REV ENTOMOL, V42, P123, DOI 10.1146/annurev.ento.42.1.123; Grieco JP, 2005, J AM MOSQUITO CONTR, V21, P404, DOI 10.2987/8756-971X(2006)21[404:ANHSST]2.0.CO;2; Harrewijn Paul, 1995, Chemoecology, V5-6, P55, DOI 10.1007/BF01259434; Hilje L, 2006, ADV PHYTOMED, V3, P379; HOLM S, 1979, SCAND J STAT, V6, P65; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Ramirez GIJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048698; Licciardi S, 2006, MED VET ENTOMOL, V20, P288, DOI 10.1111/j.1365-2915.2006.00630.x; Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11; Matthews, 1978, INSECT BEHAV; Specos MMM, 2010, T ROY SOC TROP MED H, V104, P653, DOI 10.1016/j.trstmh.2010.06.004; Moretti AN, 2013, J MED ENTOMOL, V50, P1046, DOI 10.1603/ME12248; Namountougou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048412; NARAHASHI T, 1971, B WORLD HEALTH ORGAN, V44, P337; Pickett JA, 2008, P NATL ACAD SCI USA, V105, P13195, DOI 10.1073/pnas.0807167105; Pridgeon JW, 2009, J AM MOSQUITO CONTR, V25, P168, DOI 10.2987/08-5837.1; R Development Core Team, 2012, R LANG ENV STAT COMP; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008; Regnault-Roger C., 1997, INTEGR PEST MANAG RE, V2, P25, DOI [10.1023/A:1018472227889, DOI 10.1023/A:1018472227889]; Regnault-Roger C, 2002, BIOPESTICIDE ORIGINE; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; Said SH, 2009, J AM MOSQUITO CONTR, V25, P436, DOI 10.2987/09-5895.1; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Tawatsin A, 2001, J VECTOR ECOL, V26, P76; Temu EA, 2013, PLOS ONE, V7, P9, DOI DOI 10.1371/J0URNAL.-P0NE.0044986; Thanispong K, 2010, J MED ENTOMOL, V47, P833, DOI 10.1603/ME09246; White GB, 2007, INSECT REPELLENTS PR, P31; WHO, 2011, WORLD MALARIA REPORT 2011, P1; *WHO, 1993, WHO TECHN REP SER, V839; WHO, 2008, WORLD MAL REP 2008, P10; WHO UNICEF, 2005, WORLD MALARIA REPORT; World Health Organisation, 1998, TEST PROC INS RES MO; World Health Organisation, 2013, GUID EFF TEST SPAT R; Yadouleton A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-60; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x; Zoubiri S, J SAUDI CHE IN PRESS	58	46	48	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82103	10.1371/journal.pone.0082103	http://dx.doi.org/10.1371/journal.pone.0082103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376515	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000006
J	Dobricki, M; de la Rosa, S				Dobricki, Martin; de la Rosa, Stephan			The Structure of Conscious Bodily Self-Perception during Full-Body Illusions	PLOS ONE			English	Article							MULTISENSORY MECHANISMS; COMPONENTS; OWNERSHIP; NUMBER; AGENCY; TOUCH	Previous research suggests that bodily self-identification, bodily self-localization, agency, and the sense of being present in space are critical aspects of conscious full-body self-perception. However, none of the existing studies have investigated the relationship of these aspects to each other, i.e., whether they can be identified to be distinguishable components of the structure of conscious full-body self-perception. Therefore, the objective of the present investigation is to elucidate the structure of conscious full-body self-perception. We performed two studies in which we stroked the back of healthy individuals for three minutes while they watched the back of a distant virtual body being synchronously stroked with a virtual stick. After visuo-tactile stimulation, participants assessed changes in their bodily self-perception with a custom made self-report questionnaire. In the first study, we investigated the structure of conscious full-body self-perception by analyzing the responses to the questionnaire by means of multidimensional scaling combined with cluster analysis. In the second study, we then extended the questionnaire and validated the stability of the structure of conscious full-body self-perception found in the first study within a larger sample of individuals by performing a principle components analysis of the questionnaire responses. The results of the two studies converge in suggesting that the structure of conscious full-body self-perception consists of the following three distinct components: bodily self-identification, space-related self-perception (spatial presence), and agency.	[Dobricki, Martin; de la Rosa, Stephan] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Dobricki, M (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	martin.dobricki@tuebingen.mpg.de		Dobricki, Martin/0000-0001-8347-0005; de la Rosa, Stephan/0000-0003-2759-9589	Swiss National Science Foundation [PA00P1_134133]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The first author was supported by a fellowship for advanced researchers (Grant No. PA00P1_134133) from the Swiss National Science Foundation (www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRINDELL WA, 1985, APPL PSYCH MEAS, V9, P165, DOI 10.1177/014662168500900205; Aspell JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006488; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Cooksey RW, 2006, ORGAN RES METHODS, V9, P78, DOI 10.1177/1094428105283939; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Guterstam A, 2012, CONSCIOUS COGN, V21, P1037, DOI 10.1016/j.concog.2012.01.018; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Kannape OA, 2010, NEUROPSYCHOLOGIA, V48, P1628, DOI 10.1016/j.neuropsychologia.2010.02.005; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lenggenhager B, 2009, CONSCIOUS COGN, V18, P110, DOI 10.1016/j.concog.2008.11.003; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Palluel E, 2012, NEUROREPORT, V23, P354, DOI 10.1097/WNR.0b013e328351db14; Perez-Marcos D, 2012, COGN NEURODYNAMICS, V6, P295, DOI 10.1007/s11571-011-9178-5; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; REVELLE W, 1979, MULTIVAR BEHAV RES, V14, P57, DOI 10.1207/s15327906mbr1401_4; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Tajadura-Jimenez A, 2012, CONSCIOUS COGN, V21, P1725, DOI 10.1016/j.concog.2012.10.004; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; Usoh M, 2000, PRESENCE-TELEOP VIRT, V9, P497, DOI 10.1162/105474600566989; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; Wirth W., 2008, BRUCKE ZWISCHEN THEO, P70; Wissmath B, 2011, CONSCIOUS COGN, V20, P1808, DOI 10.1016/j.concog.2011.05.008	33	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83840	10.1371/journal.pone.0083840	http://dx.doi.org/10.1371/journal.pone.0083840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	278IG	24376765	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000125
J	Gomez-Pastor, R; Garre, E; Perez-Torrado, R; Matallana, E				Gomez-Pastor, Rocio; Garre, Elena; Perez-Torrado, Roberto; Matallana, Emilia			Trx2p-dependent Regulation of Saccharomyces cerevisiae Oxidative Stress Response by the Skn7p Transcription Factor under Respiring Conditions	PLOS ONE			English	Article							THIOREDOXIN DEFICIENCY; REDOX REGULATION; GENE-EXPRESSION; YEAST-CELLS; YAP1; GLUTATHIONE; PROTEINS; ACTIVATION; DAMAGE; TRX2	The whole genome analysis has demonstrated that wine yeasts undergo changes in promoter regions and variations in gene copy number, which make them different to lab strains and help them better adapt to stressful conditions during winemaking, where oxidative stress plays a critical role. Since cytoplasmic thioredoxin II, a small protein with thiol-disulphide oxidoreductase activity, has been seen to perform important functions under biomass propagation conditions of wine yeasts, we studied the involvement of Trx2p in the molecular regulation of the oxidative stress transcriptional response on these strains. In this study, we analyzed the expression levels of several oxidative stress-related genes regulated by either Yap1p or the co-operation between Yap1p and Skn7p. The results revealed a lowered expression for all the tested Skn7p dependent genes in a Trx2p-deficient strain and that Trx2p is essential for the oxidative stress response during respiratory metabolism in wine yeast. Additionally, activity of Yap1p and Skn7p dependent promoters by beta-galactosidase assays clearly demonstrated that Skn7p-dependent promoter activation is affected by TRX2 gene deficiency. Finally we showed that deleting the TRX2 gene causes Skn7p hyperphosphorylation under oxidative stress conditions. We propose Trx2p to be a new positive efector in the regulation of the Skn7p transcription factor that controls phosphorylation events and, therefore, modulates the oxidative stress response in yeast.	[Gomez-Pastor, Rocio; Garre, Elena; Matallana, Emilia] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain; [Perez-Torrado, Roberto; Matallana, Emilia] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, E-46010 Valencia, Spain	University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Matallana, E (corresponding author), Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain.	emilia.matallana@uv.es	Matallana, Emilia/L-4619-2014; Perez Torrado, Roberto/E-7613-2012	Matallana, Emilia/0000-0002-3889-0454; Perez Torrado, Roberto/0000-0002-3118-6755	Spanish Ministry of Education and Science (MEC) [AGL 2008-00060, AGL2011-24353]; FPI program from the MEC (Spanish Ministry of Education); I3P program from the CSIC (Spanish National Research Council); JAEDOC program from the CSIC	Spanish Ministry of Education and Science (MEC)(Spanish Government); FPI program from the MEC (Spanish Ministry of Education); I3P program from the CSIC (Spanish National Research Council); JAEDOC program from the CSIC	This work has been supported by grants AGL 2008-00060 and AGL2011-24353 from the Spanish Ministry of Education and Science (MEC) to EM. EG was a predoctoral fellow of the FPI program from the MEC (Spanish Ministry of Education). RG-P was a predoctoral fellow of the I3P program from the CSIC (Spanish National Research Council). RP-T was a postdoctoral fellow of the JAEDOC program from the CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Charizanis C, 1999, MOL GEN GENET, V261, P740, DOI 10.1007/s004380050017; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Demasi APD, 2006, FEBS J, V273, P805, DOI 10.1111/j.1742-4658.2006.05116.x; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Espindola AD, 2003, CRYOBIOLOGY, V47, P236, DOI 10.1016/j.cryobiol.2003.10.003; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Fomenko DE, 2011, P NATL ACAD SCI USA, V108, P2729, DOI 10.1073/pnas.1010721108; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Gomez-Pastor R, 2012, APPL MICROBIOL BIOT, V94, P773, DOI 10.1007/s00253-011-3738-9; Gomez-Pastor R, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-4; Gomez-Pastor R, 2010, FEMS YEAST RES, V10, P870, DOI 10.1111/j.1567-1364.2010.00667.x; Gomez-Pastor R, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-9; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Gulshan K, 2011, J BIOL CHEM, V286, P34071, DOI 10.1074/jbc.M111.251298; He XJ, 2009, EUKARYOT CELL, V8, P768, DOI 10.1128/EC.00021-09; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Izawa S, 1999, J BIOL CHEM, V274, P28459, DOI 10.1074/jbc.274.40.28459; Jakubowski W, 2000, FREE RADICAL BIO MED, V28, P659, DOI 10.1016/S0891-5849(99)00266-X; Koc A, 2006, J BIOL CHEM, V281, P15058, DOI 10.1074/jbc.M601968200; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu JMY, 2003, EUKARYOT CELL, V2, P1304, DOI 10.1128/EC.2.6.1304-1314.2003; Macierzynska E, 2007, CELL MOL BIOL LETT, V12, P448, DOI 10.2478/s11658-007-0017-y; Mason JT, 2006, BIOCHEMISTRY-US, V45, P13409, DOI 10.1021/bi061136y; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; Moye-Rowley WS, 2002, ANTIOXID REDOX SIGN, V4, P123, DOI 10.1089/152308602753625915; Mulford KE, 2011, EUKARYOT CELL, V10, P761, DOI 10.1128/EC.00328-10; MULLER EGD, 1991, J BIOL CHEM, V266, P9194; OCONGARRIDO E, 2002, MOL MICROBIOL, V43, P993, DOI DOI 10.1046/J.1365-2958.2002.02795.X; Perez-Torrado R, 2009, APPL MICROBIOL BIOT, V81, P951, DOI 10.1007/s00253-008-1722-9; Puig S, 1998, J AGR FOOD CHEM, V46, P1689, DOI 10.1021/jf9706538; Querol A, 2003, INT J FOOD MICROBIOL, V86, P3, DOI 10.1016/S0168-1605(03)00244-7; QUEROL A, 1992, APPL ENVIRON MICROB, V58, P2948, DOI 10.1128/AEM.58.9.2948-2953.1992; Raitt DC, 2000, MOL BIOL CELL, V11, P2335, DOI 10.1091/mbc.11.7.2335; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Trotter EW, 2002, MOL MICROBIOL, V46, P869, DOI 10.1046/j.1365-2958.2002.03216.x; Tsuzi D, 2004, FEBS LETT, V565, P148, DOI 10.1016/j.febslet.2004.03.091; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790	52	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85404	10.1371/journal.pone.0085404	http://dx.doi.org/10.1371/journal.pone.0085404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376879	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000183
J	Liu, LM; Zhao, Y; Xie, KM; Sun, XD; Gao, YZ; Wang, ZF				Liu, Limin; Zhao, Ying; Xie, Keming; Sun, Xiaodong; Gao, Yuzhen; Wang, Zufeng			Estrogen-Induced Nongenomic Calcium Signaling Inhibits Lipopolysaccharide-Stimulated Tumor Necrosis Factor alpha Production in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; ANTIINFLAMMATORY CYTOKINES; MEDIATED ACTIVATION; GENE-EXPRESSION; RECEPTOR-ALPHA; SEX STEROIDS; TNF-ALPHA; PATHWAY; ESTRADIOL; KINASE	Estrogen is traditionally thought to exert genomic actions through members of the nuclear receptor family. Here, we investigated the rapid nongenomic effects of 17 beta-estradiol (E-2) on tumor necrosis factor alpha (TNF-alpha) production following lipopolysaccharide (LPS) stimulation in mouse bone marrow-derived macrophages (BMMs). We found that LPS induced TNF-alpha production in BMMs via phosphorylation of p38 mitogen-activated protein kinase (MAPK). E-2 itself did not affect the MAPK pathway, although it attenuated LPS-induced TNF-alpha production through suppression of p38 MAPK activation. Recently, G protein-coupled receptor 30 (GPR30) was suggested to be a membrane estrogen receptor (mER) that can mediate nongenomic estradiol signaling. We found that BMMs expressed both intracellular estrogen receptors (iER) and mER GPR30. The specific GPR30 antagonist G-15 significantly blocked effects of estradiol on LPS-induced TNF-alpha production, whereas an iER antagonist did not. Moreover, E-2 induced a rapid rise in intracellular free Ca2+ that was due to the influx of extracellular Ca2+ and was not inhibited by an iER antagonist or silencing of iER. Ca2+ influx was also induced by an impermeable E-2 conjugated to BSA (E-2-BSA), which has been used to investigate the nongenomic effects of estrogen. Consequently, Ca2+, a pivotal factor in E-2-stimulated nongenomic action, was identified as the key mediator. The inhibitory effects of E-2 on LPS-induced TNF-alpha production and p38 MAPK phosphorylation were dependent on E-2-triggered Ca2+ influx because BAPTA, an intracellular Ca2+ chelator, prevented these effects. Taken together, these data indicate that E-2 can down-regulate LPS-induced TNF-alpha production via blockade of p38 MAPK phosphorylation through the mER-mediated nongenomic Ca2+ signaling pathway in BMMs.	[Liu, Limin; Zhao, Ying; Xie, Keming; Sun, Xiaodong] Soochow Univ, Coll Med, Dept Pathol & Pathophysiol, Suzhou, Jiangsu, Peoples R China; [Gao, Yuzhen; Wang, Zufeng] Soochow Univ, Coll Med, Dept Forens Med, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Gao, YZ (corresponding author), Soochow Univ, Coll Med, Dept Forens Med, Suzhou, Jiangsu, Peoples R China.	yuzhengao@suda.edu.cn; zufengwang@suda.edu.cn	liu, li/HGC-0900-2022; Zhao, Ying/C-3916-2011; Zhao, Ying/AAS-7970-2021		National Natural Science Foundation of China [31000630]; Natural Science Foundation of Jiangsu Province [BK2010217]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study is supported by grants from National Natural Science Foundation of China (No. 31000630) and Natural Science Foundation of Jiangsu Province (No. BK2010217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bondar G, 2009, J NEUROSCI, V29, P15323, DOI 10.1523/JNEUROSCI.2107-09.2009; Bouskine A, 2008, ENDOCRINOLOGY, V149, P565, DOI 10.1210/en.2007-1318; Arroyo IC, 2011, CURR TOP MED CHEM, V11, P1661; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; Fujiwara N, 2005, INFLAMM ALLERGY DRUG, V4, P281, DOI [DOI 10.2174/1568010054022024, 10.2174/1568010054022024]; Gambino YP, 2010, BIOL REPROD, V83, P42, DOI 10.1095/biolreprod.110.083535; Ghisletti S, 2005, MOL CELL BIOL, V25, P2957, DOI 10.1128/MCB.25.8.2957-2968.2005; Guma M, 2012, ARTHRITIS RHEUM-US, V64, P2887, DOI 10.1002/art.34489; Harkonen PL, 2006, ANN NY ACAD SCI, V1089, P218, DOI 10.1196/annals.1386.045; Hsieh YC, 2007, AM J PATHOL, V170, P1210, DOI 10.2353/ajpath.2007.060883; Jaubert AM, 2007, ENDOCRINOLOGY, V148, P2444, DOI 10.1210/en.2006-1329; Kim KN, 2010, EUR J PHARMACOL, V649, P369, DOI 10.1016/j.ejphar.2010.09.032; Kulpa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041076; Kuo J, 2010, J NEUROSCI, V30, P12950, DOI 10.1523/JNEUROSCI.1158-10.2010; Lelu K, 2010, EUR J IMMUNOL, V40, P3489, DOI 10.1002/eji.201040678; Liu LM, 2006, PARASITOL RES, V99, P189, DOI 10.1007/s00436-006-0168-1; Martocchia A, 2011, CURR TOP MED CHEM, V11, P1668; Montagna P, 2010, ANN NY ACAD SCI, V1193, P30, DOI 10.1111/j.1749-6632.2009.05298.x; Murphy AJ, 2010, J IMMUNOL, V184, P5029, DOI 10.4049/jimmunol.0903463; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Rettew JA, 2010, MOL CELL ENDOCRINOL, V328, P87, DOI 10.1016/j.mce.2010.07.017; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Russo C, 2005, CLIN SCI, V109, P135, DOI 10.1042/CS20050038; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Stevis PE, 1999, ENDOCRINOLOGY, V140, P5455, DOI 10.1210/en.140.11.5455; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Suzuki T, 2008, J CELL PHYSIOL, V214, P662, DOI 10.1002/jcp.21255; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Wang YJ, 2006, INT J BIOCHEM CELL B, V38, P170, DOI 10.1016/j.biocel.2005.08.004; Xing DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036890; Zhang LL, 2009, J CELL BIOCHEM, V106, P553, DOI 10.1002/jcb.22017; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764	36	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83072	10.1371/journal.pone.0083072	http://dx.doi.org/10.1371/journal.pone.0083072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376635	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000055
J	Lopez-Cortes, LE; Galvez-Acebal, J; del Toro, MD; Velasco, C; de Cueto, M; Caballero, FJ; Muniain, MA; Pascual, A; Rodriguez-Bano, J				Lopez-Cortes, Luis E.; Galvez-Acebal, Juan; del Toro, Maria D.; Velasco, Carmen; de Cueto, Marina; Caballero, Francisco J.; Muniain, Miguel A.; Pascual, Alvaro; Rodriguez-Bano, Jesus			Effect of Statin Therapy in the Outcome of Bloodstream Infections Due to Staphylococcus aureus: A Prospective Cohort Study	PLOS ONE			English	Article							SEVERE SEPSIS; IN-VITRO; BACTEREMIA; MORTALITY; MANAGEMENT; IMPACT; CONSULTATION; ENDOCARDITIS; GUIDELINES; CARE	Introduction: Statins have pleiotropic effects that could influence the prevention and outcome of some infectious diseases. There is no information about their specific effect on Staphylococcus aureus bacteremia (SAB). Methods: A prospective cohort study including all SAB diagnosed in patients aged >= 18 years admitted to a 950-bed tertiary hospital from March 2008 to January 2011 was performed. The main outcome variable was 14-day mortality, and the secondary outcome variables were 30-day mortality, persistent bacteremia (PB) and presence of severe sepsis or septic shock at diagnosis of SAB. The effect of statin therapy at the onset of SAB was studied by multivariate logistic regression and Cox regression analysis, including a propensity score for statin therapy. Results: We included 160 episodes. Thirty-three patients (21.3%) were receiving statins at the onset of SAB. 14-day mortality was 21.3%. After adjustment for age, Charlson index, Pitt score, adequate management, and high risk source, statin therapy had a protective effect on 14-day mortality (adjusted OR = 0.08; 95% CI: 0.01-0.66; p = 0.02), and PB (OR = 0.89; 95% CI: 0.27-1.00; p = 0.05) although the effect was not significant on 30-day mortality (OR = 0.35; 95% CI: 0.10-1.23; p = 0.10) or presentation with severe sepsis or septic shock (adjusted OR = 0.89; CI 95%: 0.27-2.94; p = 0.8). An effect on 30-day mortality could neither be demonstrated on Cox analysis (adjusted HR = 0.5; 95% CI: 0.19-1.29; p = 0.15). Conclusions: Statin treatment in patients with SAB was associated with lower early mortality and PB. Randomized studies are necessary to identify the role of statins in the treatment of patients with SAB.	[Lopez-Cortes, Luis E.; Galvez-Acebal, Juan; del Toro, Maria D.; de Cueto, Marina; Muniain, Miguel A.; Pascual, Alvaro; Rodriguez-Bano, Jesus] Hosp Univ Virgen Macarena, Unidad Clin Enfermedades Infecciosas & Microbiol, Seville, Spain; [Galvez-Acebal, Juan; del Toro, Maria D.; Velasco, Carmen; de Cueto, Marina; Caballero, Francisco J.; Muniain, Miguel A.; Pascual, Alvaro; Rodriguez-Bano, Jesus] Inst Salud Carlos III, Spanish Network Res Infect Dis, Madrid, Spain; [Velasco, Carmen; Pascual, Alvaro] Univ Seville, Dept Microbiol, Seville, Spain; [Galvez-Acebal, Juan; del Toro, Maria D.; Muniain, Miguel A.; Rodriguez-Bano, Jesus] Univ Seville, Dept Med, Seville, Spain	Hospital Universitario Virgen Macarena; Instituto de Salud Carlos III; University of Sevilla; University of Sevilla	Rodriguez-Bano, J (corresponding author), Hosp Univ Virgen Macarena, Unidad Clin Enfermedades Infecciosas & Microbiol, Seville, Spain.	jesusrb@us.es	Gálvez-Acebal, Juan/K-6462-2013; Velasco, Carmen/C-6469-2016; Pascual, Alvaro/Y-5854-2018; Rodríguez-Baño, Jesús/F-2453-2011	Gálvez-Acebal, Juan/0000-0002-5294-4957; Velasco, Carmen/0000-0002-0657-3200; Pascual, Alvaro/0000-0002-8672-5891; Rodríguez-Baño, Jesús/0000-0001-6732-9001; Toro Lopez, Maria Dolores del/0000-0002-4935-8754; Lopez-Cortes, Luis Eduardo/0000-0002-9347-527X; Cueto-Lopez, Marina/0000-0001-6778-5488	Pfizer; Wyeth; Novartis	Pfizer(Pfizer); Wyeth(Wyeth); Novartis(Novartis)	JRB has served as consultant and speaker for Pfizer, Roche, Astellas, Novartis and Merck. A. P. has been a consultant for Pfizer; has served as speaker for Wyeth, and Pfizer; and has received research support from Pfizer, Wyeth, and Novartis. All other authors had no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Almog Y, 2007, CRIT CARE MED, V35, P372, DOI 10.1097/01.CCM.0000253397.42079.D5; Bellosta S, 1998, ATHEROSCLEROSIS, V137, pS101, DOI 10.1016/S0021-9150(97)00319-5; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chang FY, 2003, MEDICINE, V82, P322, DOI 10.1097/01.md.0000091185.93122.40; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dobesh PP, 2009, PHARMACOTHERAPY, V29, P621, DOI 10.1592/phco.29.6.621; Fernandez R, 2006, INTENS CARE MED, V32, P160, DOI 10.1007/s00134-005-2743-9; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Gasch O, 2013, J ANTIMICROB CHEMOTH, V68, P1423, DOI 10.1093/jac/dkt016; Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455; Horn MP, 2008, J PHARMACOL EXP THER, V326, P135, DOI 10.1124/jpet.108.137927; Hsu J, 2009, EUR J CLIN MICROBIOL, V28, P1343, DOI 10.1007/s10096-009-0787-4; Janda Surinder, 2010, J Crit Care, V25, DOI 10.1016/j.jcrc.2010.02.013; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Johnson JR, 2008, ARCH INTERN MED, V168, P772, DOI 10.1001/archinte.168.7.772; Khatib R, 2006, SCAND J INFECT DIS, V38, P7, DOI 10.1080/00365540500372846; Khatib R, 2009, SCAND J INFECT DIS, V41, P4, DOI 10.1080/00365540802441711; Kim SH, 2003, CLIN INFECT DIS, V37, P794, DOI 10.1086/377540; Koh KK, 2000, CARDIOVASC RES, V47, P648, DOI 10.1016/S0008-6363(00)00146-2; Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y; Lahey T, 2009, MEDICINE, V88, P263, DOI 10.1097/MD.0b013e3181b8fccb; Lesens O, 2003, INFECT CONT HOSP EP, V24, P890, DOI 10.1086/502156; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Martin CP, 2007, PHARMACOTHERAPY, V27, P20, DOI 10.1592/phco.27.1.20; McGregor JC, 2007, CLIN INFECT DIS, V45, P329, DOI 10.1086/519283; Pruefer D, 2002, CIRCULATION, V106, P2104, DOI 10.1161/01.CIR.0000034048.38910.91; RAAD II, 1992, CLIN INFECT DIS, V14, P75, DOI 10.1093/clinids/14.1.75; Retamar P, 2012, ANTIMICROB AGENTS CH, V56, P472, DOI 10.1128/AAC.00462-11; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; Rodriguez-Bano J, 2010, CLIN MICROBIOL INFEC, V16, P1408, DOI [10.1111/j.1469-0691.2010.03089.x, 10.1111/j.1469-0691.2009.03089.x]; Rodriguez-Bano J, 2010, EXPERT REV ANTI-INFE, V8, P815, DOI [10.1586/eri.10.49, 10.1586/ERI.10.49]; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Viasus D, 2010, EUR J CLIN MICROBIOL, V29, P143, DOI 10.1007/s10096-009-0835-0; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xiong YQ, 2009, J INFECT DIS, V199, P201, DOI 10.1086/595738; Yang KC, 2007, AM J EMERG MED, V25, P494, DOI 10.1016/j.ajem.2006.09.011; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120; Yoon YK, 2010, J ANTIMICROB CHEMOTH, V65, P1015, DOI 10.1093/jac/dkq050	43	29	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82958	10.1371/journal.pone.0082958	http://dx.doi.org/10.1371/journal.pone.0082958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376617	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000047
J	Malyshevskaya, O; Shiraishi, Y; Kimura, F; Yamamoto, N				Malyshevskaya, Olga; Shiraishi, Yoshihiro; Kimura, Fumitaka; Yamamoto, Nobuhiko			Role of Electrical Activity in Horizontal Axon Growth in the Developing Cortex: A Time-Lapse Study Using Optogenetic Stimulation	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; INTRINSIC CONNECTIONS; PYRAMIDAL NEURONS; AUDITORY-CORTEX; FUNCTIONAL ARCHITECTURE; BEHAVIORAL-RESPONSES; EXCITABLE CELLS; NEURAL ACTIVITY; OPTICAL CONTROL	During development, layer 2/3 neurons in the neocortex extend their axons horizontally, within the same layers, and stop growing at appropriate locations to form branches and synaptic connections. Firing and synaptic activity are thought to be involved in this process, but how neuronal activity regulates axonal growth is not clear. Here, we studied axonal growth of layer 2/3 neurons by exciting cell bodies or axonal processes in organotypic slice cultures of the rat cortex. For neuronal stimulation and morphological observation, plasmids encoding channelrhodopsin-2 (ChR2) and DsRed were coelectroporated into a small number of layer 2/3 cells. Firing activity induced by photostimulation (475 nm) was confirmed by whole-cell patch recording. Axonal growth was observed by time-lapse confocal microscopy, using a different excitation wavelength (560 nm), at 10-20-min intervals for several hours. During the first week in vitro, when spontaneous neuronal activity is low, DsRed-and ChR2-expressing axons grew at a constant rate. When high-frequency photostimulation (4 or 10 Hz) for 1 min was applied to the soma or axon, most axons paused in their growth. In contrast, lower-frequency stimulation did not elicit this pause behavior. Moreover, in the presence of tetrodotoxin, even high-frequency stimulation did not cause axonal growth to pause. These results indicate that increasing firing activity during development suppresses axon growth, suggesting the importance of neuronal activity for the formation of horizontal connections.	[Malyshevskaya, Olga; Shiraishi, Yoshihiro; Yamamoto, Nobuhiko] Osaka Univ, Grad Sch Frontier Biosci, Lab Cellular & Mol Neurobiol, Suita, Osaka, Japan; [Kimura, Fumitaka] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan	Osaka University; Osaka University	Yamamoto, N (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Lab Cellular & Mol Neurobiol, Suita, Osaka, Japan.	nobuhiko@fbs.osaka-u.ac.jp		Malyshevskaya, Olga/0000-0002-7454-0195; Yamamoto, Nobuhiko/0000-0002-1916-932X	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23115102]; Japan Society for the Promotion of Science [20300110, 23300118]; Grants-in-Aid for Scientific Research [25115721] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research on Innovative Areas "Mesoscopic Neurocircuitry" (number 23115102) of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to N.Y., and for Scientific Research (B) (numbers 20300110 and 23300118) of the Japan Society for the Promotion of Science to NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Bosking WH, 1997, J NEUROSCI, V17, P2112; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bruno RM, 2009, J NEUROSCI, V29, P3172, DOI 10.1523/JNEUROSCI.5911-08.2009; BURKHALTER A, 1990, J COMP NEUROL, V302, P920, DOI 10.1002/cne.903020417; CALLAWAY EM, 1991, P NATL ACAD SCI USA, V88, P745, DOI 10.1073/pnas.88.3.745; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; Callaway EM, 1998, J NEUROSCI, V18, P1505; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; COHAN CS, 1986, SCIENCE, V232, P1638, DOI 10.1126/science.3715470; COHAN CS, 1987, J NEUROSCI, V7, P3588; Diefenbach TJ, 2000, J NEUROSCI, V20, P1484; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; FIELDS RD, 1990, J NEUROSCI, V10, P2950; Flint AC, 1997, J NEUROPHYSIOL, V78, P1990, DOI 10.1152/jn.1997.78.4.1990; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Galuske RAW, 1996, CEREB CORTEX, V6, P417, DOI 10.1093/cercor/6.3.417; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Ibarretxe G, 2007, J NEUROSCI, V27, P7684, DOI 10.1523/JNEUROSCI.1070-07.2007; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KATZ LC, 1991, EUR J NEUROSCI, V3, P1, DOI 10.1111/j.1460-9568.1991.tb00805.x; KELLER A, 1993, J COMP NEUROL, V336, P229, DOI 10.1002/cne.903360206; Kisvarday ZF, 1997, CEREB CORTEX, V7, P605, DOI 10.1093/cercor/7.7.605; LOHMANN H, 1994, J COMP NEUROL, V344, P543, DOI 10.1002/cne.903440405; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Malach R, 1997, CEREB CORTEX, V7, P386, DOI 10.1093/cercor/7.4.386; MATSUBARA JA, 1988, J COMP NEUROL, V268, P38, DOI 10.1002/cne.902680105; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; Melchitzky DS, 1998, J COMP NEUROL, V390, P211, DOI 10.1002/(SICI)1096-9861(19980112)390:2<211::AID-CNE4>3.0.CO;2-4; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Mire E, 2012, NAT NEUROSCI, V15, P1134, DOI 10.1038/nn.3160; MIRMIRAN M, 1982, DEV BRAIN RES, V3, P37, DOI 10.1016/0165-3806(82)90074-8; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nirenberg S, 2012, P NATL ACAD SCI USA, V109, P15012, DOI 10.1073/pnas.1207035109; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohnami S, 2008, J NEUROSCI, V28, P9117, DOI 10.1523/JNEUROSCI.1731-08.2008; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Read HL, 2001, P NATL ACAD SCI USA, V98, P8042, DOI 10.1073/pnas.131591898; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; ROCKLAND KS, 1982, J COMP NEUROL, V209, P41, DOI 10.1002/cne.902090105; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Schwartz TH, 1998, NEURON, V20, P541, DOI 10.1016/S0896-6273(00)80993-9; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Sincich LC, 2001, J NEUROSCI, V21, P4416, DOI 10.1523/JNEUROSCI.21-12-04416.2001; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Szebenyi G, 1998, J NEUROSCI, V18, P7930; Tanigawa H, 2005, CEREB CORTEX, V15, P1887, DOI 10.1093/cercor/bhi067; TSO DY, 1986, J NEUROSCI, V6, P1160; Uesaka N, 2005, J NEUROSCI, V25, P1, DOI 10.1523/JNEUROSCI.3855-04.2005; Van Brederode JFM, 2000, NEUROSCIENCE, V101, P851, DOI 10.1016/S0306-4522(00)00430-9; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Wyatt RM, 2012, NAT NEUROSCI, V15, P949, DOI 10.1038/nn.3134; Yabuta NH, 1998, VISUAL NEUROSCI, V15, P1007, DOI 10.1017/S0952523898156018; Yamamoto N, 1997, J NEUROSCI, V17, P3653; YAMAMOTO N, 1992, NEURON, V9, P217, DOI 10.1016/0896-6273(92)90161-6; YAMAMOTO N, 1989, SCIENCE, V245, P192, DOI 10.1126/science.2749258; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	65	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82954	10.1371/journal.pone.0082954	http://dx.doi.org/10.1371/journal.pone.0082954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376616	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000046
J	Manea, SA; Todirita, A; Manea, A				Manea, Simona-Adriana; Todirita, Andra; Manea, Adrian			High Glucose-Induced Increased Expression of Endothelin-1 in Human Endothelial Cells Is Mediated by Activated CCAAT/Enhancer-Binding Proteins	PLOS ONE			English	Article							GENE-EXPRESSION; NITRIC-OXIDE; C/EBP-BETA; TRANSCRIPTIONAL REGULATION; NADPH OXIDASE; KAPPA-B; MACROPHAGES; APOPTOSIS; RECRUITMENT; DYSFUNCTION	High glucose-induced endothelial dysfunction is partially mediated by the down-stream pathophysiological effects triggered by increased expression of endothelin-1 (ET-1). The molecular control mechanisms of ET-1 synthesis are yet to be discovered. Members of the CCAAT/enhancer-binding proteins (C/EBP) family are important regulators of key metabolic processes, cellular differentiation and proinflammatory genes. In this study, we aimed at elucidating the role of C/EBP in mediating the high glucose effect on ET-1 expression in human endothelial cells (EC). Human umbilical vein cells (EAhy926) and primary cultures of human aortic EC were exposed to high levels of glucose (16.5-25 mM). Real-time PCR, Western blot, enzyme-linked immunosorbent assay, ET-1 promoter-luciferase reporter analysis, and chromatin immunoprecipitation assays were employed to investigate ET-1 regulation. High glucose activated C/EBP alpha, C/EBP beta, and C/EBP delta in a dose-dependent manner. It also promoted significant increases in ET-1 gene and peptide expression. Chemical inhibition of JNK, p38MAPK and ERK1/2 diminished significantly the high glucose-induced nuclear translocation of C/EBP and ET-1 expression. Silencing of C/EBP alpha, C/EBP beta or C/EBP delta greatly reduced the high glucose-induced upregulation of ET-1 mRNA, pre-pro-ET-1, and ET-1 secretion. The expression of various C/EBP isoforms was selectively downregulated by siRNA-mediated gene silencing. In silico analysis indicated the existence of typical C/EBP elements within human ET-1 gene promoter. Transient overexpression of C/EBP alpha, C/EBP beta or C/EBP delta upregulated the luciferase level controlled by the ET-1 gene promoter. The direct interaction of C/EBP alpha, C/EBP beta or C/EBP delta proteins with the ET-1 promoter in high glucose-exposed EC was confirmed by chromatin immunoprecipitation assay. High glucose-induced ET-1 expression is mediated through multiple mechanisms. We present evidence that members of the C/EBP proinflammatory transcription factors are important regulators of ET-1 in high glucose-exposed human endothelial cells. High glucose-induced activation of C/EBP-related signaling pathways may induce excessive ET-1 synthesis, thus promoting vasoconstriction and dysfunction of the vascular wall cells in diabetes.	[Manea, Simona-Adriana; Todirita, Andra; Manea, Adrian] Romanian Acad, Inst Cellular Biol & Pathol Nicolae Simionescu, Bucharest, Romania	Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology	Manea, SA (corresponding author), Romanian Acad, Inst Cellular Biol & Pathol Nicolae Simionescu, Bucharest, Romania.	simona.manea@icbp.ro	Manea, Adrian/C-4279-2011		Romanian National Authority for Scientific Research (CNCS - UEFISCDI) [PN-II-RU-TE-2011-3-0142]; CARDIOPRO [143/2009]; Romanian Academy	Romanian National Authority for Scientific Research (CNCS - UEFISCDI)(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); CARDIOPRO; Romanian Academy(Romanian Academy of Sciences)	This study was financially supported by grants of the Romanian National Authority for Scientific Research (CNCS - UEFISCDI, http://uefiscdi.gov.ro), project PN-II-RU-TE-2011-3-0142 and co-financed project 143/2009 - CARDIOPRO and by the Romanian Academy (http://www.acad.ro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourque SL, 2011, AM J PHYSIOL-REG I, V300, pR1288, DOI 10.1152/ajpregu.00397.2010; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caivano M, 2001, J BIOL CHEM, V276, P48693, DOI 10.1074/jbc.M108282200; Heltianu C, 2011, TYPE, V1, P3; Heltianu C, 2008, CENT EUR J BIOL, V3, P243, DOI 10.2478/s11535-008-0019-4; Heltianu C, 2009, CENT EUR J BIOL, V4, P521, DOI 10.2478/s11535-009-0051-z; Hong S, 2011, J LEUKOCYTE BIOL, V90, P643, DOI 10.1189/jlb.0111043; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Kalani M, 2008, VASC HEALTH RISK MAN, V4, P1061, DOI 10.2147/VHRM.S3920; Kelkenberg U, 2002, ARTERIOSCL THROM VAS, V22, P949, DOI 10.1161/01.ATV.0000017198.16727.27; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067009; Lauth M, 2000, J MOL MED-JMM, V78, P441, DOI 10.1007/s001090000129; LEE ME, 1991, J BIOL CHEM, V266, P19034; Lee YH, 1997, MOL CELL BIOL, V17, P2038, DOI 10.1128/MCB.17.4.2038; Li H, 2007, CELL MOL IMMUNOL, V4, P407; Luscher TF, 2000, CIRCULATION, V102, P2434, DOI 10.1161/01.CIR.102.19.2434; LUSCHER TF, 1991, TRENDS CARDIOVAS MED, V1, P179, DOI 10.1016/1050-1738(91)90034-C; Manea A, 2008, ARTERIOSCL THROM VAS, V28, P878, DOI 10.1161/ATVBAHA.108.163592; Manea A, 2012, FREE RADICAL BIO MED, V52, P1497, DOI 10.1016/j.freeradbiomed.2012.02.018; Manea SA, 2011, BIOCHEM BIOPH RES CO, V407, P486, DOI 10.1016/j.bbrc.2011.03.043; Manea SA, 2010, CELL TISSUE RES, V340, P71, DOI 10.1007/s00441-010-0936-1; Ohicita M, 2012, J PHARMACOL SCI, V119, P302, DOI 10.1254/jphs.12R01CR; Osada S, 1996, J BIOL CHEM, V271, P3891; Pernow J, 2012, LIFE SCI, V91, P507, DOI 10.1016/j.lfs.2012.03.029; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Potenza MA, 2009, CURR MED CHEM, V16, P94, DOI 10.2174/092986709787002853; Quehenberger P, 2000, DIABETES, V49, P1561, DOI 10.2337/diabetes.49.9.1561; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Roy SK, 2002, P NATL ACAD SCI USA, V99, P7945, DOI 10.1073/pnas.122075799; SHEFFIELD JB, 1987, ANAL BIOCHEM, V166, P49, DOI 10.1016/0003-2697(87)90544-6; Simionescu M, 2007, ARTERIOSCL THROM VAS, V27, P266, DOI 10.1161/01.ATV.0000253884.13901.e4; Tawfik A, 2005, VASC PHARMACOL, V43, P320, DOI 10.1016/j.vph.2005.08.018; Tsukano H, 2010, ARTERIOSCL THROM VAS, V30, P1925, DOI 10.1161/ATVBAHA.110.206094; Undem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046303; Vignon-Zellweger N, 2012, LIFE SCI, V91, P490, DOI 10.1016/j.lfs.2012.03.026; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Xia CL, 1997, INT J BIOCHEM CELL B, V29, P1525, DOI 10.1016/S1357-2725(97)00083-6; YAMAUCHI T, 1990, FEBS LETT, V267, P16, DOI 10.1016/0014-5793(90)80276-O; Yao ST, 2013, J ATHEROSCLER THROMB, V20, P94, DOI 10.5551/jat.13425; Yin LY, 2005, MOL CELL ENDOCRINOL, V245, P43, DOI 10.1016/j.mce.2005.10.002	43	24	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84170	10.1371/journal.pone.0084170	http://dx.doi.org/10.1371/journal.pone.0084170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376792	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000140
J	Schaap, MWH; van Oostrom, H; Doornenbal, A; van 't Klooster, J; Baars, AM; Arndt, SS; Hellebrekers, LJ				Schaap, Manon W. H.; van Oostrom, Hugo; Doornenbal, Arie; van 't Klooster, Jose; Baars, Annemarie M.; Arndt, Saskia S.; Hellebrekers, Ludo J.			Nociception and Conditioned Fear in Rats: Strains Matter	PLOS ONE			English	Article							SOMATOSENSORY-EVOKED POTENTIALS; FAWN-HOODED RAT; MEMORY RETRIEVAL; HOT-PLATE; ANIMAL-MODELS; C-FOS; EXPRESSION; BEHAVIOR; PAIN; EXTINCTION	When using rats in pain research, strain-related differences in outcomes of tests for pain and nociception are acknowledged. However, very little is known about the specific characteristics of these strain differences. In this study four phylogenetically distant inbred rat strains, i.e. Wistar Kyoto (WKY), Fawn Hooded (FH), Brown Norway (BN) and Lewis (LE), were investigated in different tests related to pain and nociception. During Pavlovian fear conditioning, the LE and WKY showed a significantly longer duration of freezing behaviour than the FH and BN. Additionally, differences in c-Fos expression in subregions of the prefrontal cortex and amygdala between rat strains during retrieval and expression of conditioned fear were found. For example, the BN did not show recruitment of the basolateral amygdala, whereas the WKY, FH and LE did. During the hot plate test, the WKY and LE showed a lower thermal threshold compared to the BN and FH. In a follow-up experiment, the two most contrasting strains regarding behaviour during the hot plate test and Pavlovian fear conditioning (i.e. FH and WKY) were selected and the hot plate test, Von Frey test and somatosensory-evoked potential (SEP) were investigated. During the Von Frey test, the WKY showed a lower mechanical threshold compared to the FH. When measuring the SEP, the FH appeared to be less reactive to increasing stimulus intensities when considering both peak amplitudes and latencies. Altogether, the combined results indicate various differences between rat strains in Pavlovian fear conditioning, nociception related behaviours and nociceptive processing. These findings demonstrate the necessity of using multiple rat strains when using tests including noxious stimuli and suggest that the choice of rat strains should be considered. When selecting a strain for a particular study it should be considered how this strain behaves during the tests used in that study.	[Schaap, Manon W. H.; van Oostrom, Hugo; Doornenbal, Arie; Hellebrekers, Ludo J.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Schaap, Manon W. H.; van Oostrom, Hugo; Arndt, Saskia S.; Hellebrekers, Ludo J.] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands; [van 't Klooster, Jose; Baars, Annemarie M.; Arndt, Saskia S.] Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University	Schaap, MWH (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	m.schaap@uu.nl		Peeters-Schaap, Manon/0000-0001-6147-1226				Allen JW, 2004, METH MOLEC MED, P11; ANNAU Z, 1961, J COMP PHYSIOL PSYCH, V54, P428, DOI 10.1037/h0042199; Banoub M, 2003, ANESTHESIOLOGY, V99, P716, DOI 10.1097/00000542-200309000-00029; Bromm B, 1998, ELECTROEN CLIN NEURO, V107, P227, DOI 10.1016/S0013-4694(98)00075-3; Canzian F, 1997, GENOME RES, V7, P262, DOI 10.1101/gr.7.3.262; CARTER RB, 1991, PAIN, V47, P211, DOI 10.1016/0304-3959(91)90207-E; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Christina AJM, 2004, J Circadian Rhythms, V2, P2, DOI 10.1186/1740-3391-2-2; ESPEJO EF, 1993, BEHAV BRAIN RES, V56, P171, DOI 10.1016/0166-4328(93)90035-O; FANSELOW MS, 1982, ANIM LEARN BEHAV, V10, P448, DOI 10.3758/BF03212284; FANSELOW MS, 1979, J COMP PHYSIOL PSYCH, V93, P736, DOI 10.1037/h0077609; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Gagliese L, 2000, NEUROSCI BIOBEHAV R, V24, P843, DOI 10.1016/S0149-7634(00)00041-5; Garelick MG, 2005, P NATL ACAD SCI USA, V102, P9091, DOI 10.1073/pnas.0504017102; Gunn A, 2011, J PAIN, V12, P222, DOI 10.1016/j.jpain.2010.06.011; Hall J, 2001, EUR J NEUROSCI, V13, P1453, DOI 10.1046/j.0953-816x.2001.01531.x; Huang ACW, 2013, BEHAV BRAIN RES, V237, P23, DOI 10.1016/j.bbr.2012.09.024; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jarome TJ, 2010, BEHAV GENET, V40, P85, DOI 10.1007/s10519-009-9297-5; KOLPAKOV VG, 1977, BEHAVIOUR, V62, P190, DOI 10.1163/156853977X00108; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; KUIJPERS MHM, 1986, J HYPERTENS, V4, pS41; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lehner M, 2006, BEHAV BRAIN RES, V171, P189, DOI 10.1016/j.bbr.2006.03.044; Lieberman DA, 2000, LEARNING BEHAV COGNI, P50; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mogil JS, 2000, NEUROSCI BIOBEHAV R, V24, P375, DOI 10.1016/S0149-7634(00)00015-4; Murrell JC, 2006, J VET PHARMACOL THER, V29, P325, DOI 10.1111/j.1365-2885.2006.00758.x; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; RAYMOND SL, 1975, THROMB DIATH HAEMOST, V33, P361, DOI 10.1055/s-0038-1647888; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Schaap MWH, 2011, ILAR J, V52, P32; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Stienen PJ, 2005, BRAIN RES BULL, V67, P269, DOI 10.1016/j.brainresbull.2005.06.038; Stienen PJ, 2004, BRAIN RES, V1030, P256, DOI 10.1016/j.brainres.2004.10.014; Stienen PJ, 2003, J NEUROSCI METH, V126, P79, DOI 10.1016/S0165-0270(03)00070-0; Stohr T, 2000, PHARMACOL BIOCHEM BE, V67, P809, DOI 10.1016/S0091-3057(00)00426-3; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strekalova T, 2003, GENES BRAIN BEHAV, V2, P3, DOI 10.1034/j.1601-183X.2003.00001.x; van der Staay FJ, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-50; van Oostrom H, 2005, BRAIN RES PROTOC, V15, P14, DOI 10.1016/j.brainresprot.2005.02.001; van Oostrom H, 2007, BRAIN RES BULL, V71, P404, DOI 10.1016/j.brainresbull.2006.10.009; van Oostrom H, 2011, VET J, V190, P338, DOI 10.1016/j.tvjl.2010.11.025; vanderStaay FJ, 1996, PHYSIOL BEHAV, V60, P97; WECHSLER B, 1995, APPL ANIM BEHAV SCI, V43, P123, DOI 10.1016/0168-1591(95)00557-9	46	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83339	10.1371/journal.pone.0083339	http://dx.doi.org/10.1371/journal.pone.0083339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376690	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000081
J	Shen, TT; Ma, J; Zhang, L; Yu, XF; Liu, MM; Hou, YL; Wang, YY; Ma, C; Li, SZ; Zhu, DL				Shen, Tingting; Ma, Jun; Zhang, Lei; Yu, Xiufeng; Liu, Mengmeng; Hou, Yunlong; Wang, Yanyan; Ma, Cui; Li, Shuzhen; Zhu, Daling			Positive Feedback-Loop of Telomerase Reverse Transcriptase and 15-Lipoxygenase-2 Promotes Pulmonary Hypertension	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELL; ARTERIAL-HYPERTENSION; 15-HYDROXYEICOSATETRAENOIC ACID; CANCER-CELLS; LIFE-SPAN; IN-VITRO; HYPOXIA; GROWTH; PROLIFERATION; EXPRESSION	Objective: Pulmonary hypertension (PH) is characterized with pulmonary vasoconstriction and vascular remodeling mediated by 15-lipoxygenase (15-LO)/15-hydroxyeicosatetraenoic acid (15-HETE) according to our previous studies. Meanwhile, telomerase reverse transcriptase (TERT) activity is highly correlated with vascular injury and remodeling, suggesting that TERT may be an essential determinant in the development of PH. The aim of this study was to determine the contribution and molecular mechanisms of TERT in the pathogenesis of PH. Approach and Results: We measured the right ventricular systolic pressure (RVSP) and ventricular weight, analyzed morphometric change of the pulmonary vessels in the hypoxia or monocrotaline treated rats. Bromodeoxyuridine incorporation, transwell assay and flow cytometry in pulmonary smooth muscle cells were performed to investigate the roles and relationship of TERT and 15-LO/15-HETE in PH. We revealed that the expression of TERT was increased in pulmonary vasculature of patients with PH and in the monocrotaline or hypoxia rat model of PH. The up-regulation of TERT was associated with experimental elevated RVSP and pulmonary vascular remodeling. Coimmunoprecipitation experiments identified TERT as a novel interacting partner of 15-LO-2. TERT and 15-LO-2 augmented protein expression of each other. In addition, the proliferation, migration and cell-cycle transition from G(0)/G(1) phase to S phase induced by hypoxia were inhibited by TERT knockdown, which were rescued by 15-HETE addition. Conclusions: These results demonstrate that TERT regulates pulmonary vascular remodeling. TERT and 15-LO-2 form a positive feedback loop and together promote proliferation and migration of pulmonary artery smooth muscle cells, creating a self-amplifying circuit which propels pulmonary hypertension.	[Shen, Tingting; Ma, Jun; Zhang, Lei; Yu, Xiufeng; Liu, Mengmeng; Wang, Yanyan; Ma, Cui; Zhu, Daling] Harbin Med Univ Daqing, Coll Pharm, Dept Biopharmaceut Sci, Daqing, Heilongjiang Pr, Peoples R China; [Li, Shuzhen; Zhu, Daling] Harbin Med Univ, Biopharmaceut Key Lab Heilongjiang Prov, Harbin, Heilongjiang Pr, Peoples R China; [Hou, Yunlong] Harbin Med Univ, Key Lab Cardiovasc Res, State Prov Key Labs Biomed Pharmaceut China, Dept Pharmacol,Minist Educ, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhu, DL (corresponding author), Harbin Med Univ Daqing, Coll Pharm, Dept Biopharmaceut Sci, Daqing, Heilongjiang Pr, Peoples R China.	dalingz@yahoo.com			National Natural Science Foundation of China [31071007, 30370578]; Science and technique Foundation of Education Department of Heilongjiang Province [11531248]; Science and Technique Foundation of Harbin [2008AA3AS097, 2006RFXXS029, 2010RFQQS056]; Certificate of China Postdoctoral Science Foundation [2012M510999]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technique Foundation of Education Department of Heilongjiang Province; Science and Technique Foundation of Harbin; Certificate of China Postdoctoral Science Foundation	This work was supported by grants from the National Natural Science Foundation of China (No. 31071007, 30370578), Science and technique Foundation of Education Department of Heilongjiang Province (No. 11531248), Science and Technique Foundation of Harbin (No. 2008AA3AS097, 2006RFXXS029, 2010RFQQS056) and Certificate of China Postdoctoral Science Foundation Grant (No. 2012M510999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; Amsellem V, 2011, AM J RESP CRIT CARE, V184, P1358, DOI 10.1164/rccm.201105-0802OC; Anwar A, 2012, AM J PHYSIOL-LUNG C, V303, pL1, DOI 10.1152/ajplung.00050.2012; Arteaga S, 2005, J ETHNOPHARMACOL, V98, P231, DOI 10.1016/j.jep.2005.02.002; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bu DX, 2010, ARTERIOSCL THROM VAS, V30, P2604, DOI 10.1161/ATVBAHA.110.213074; Cao Ying, 2002, FASEB Journal, V16, P96; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Falchetti A, 2005, J BONE MINER RES, V20, P410, DOI 10.1359/JBMR.041123; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Gizard F, 2008, CIRC RES, V103, P1155, DOI 10.1161/CIRCRESAHA.108.186205; Guo L, 2008, EUR J PHARMACOL, V587, P187, DOI 10.1016/j.ejphar.2008.02.031; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Humer J, 2008, MELANOMA RES, V18, P314, DOI 10.1097/CMR.0b013e32830aaaa6; Jeffery TK, 2001, PHARMACOL THERAPEUT, V92, P1, DOI 10.1016/S0163-7258(01)00157-7; Jeng KS, 2011, HEPATO-GASTROENTEROL, V58, P2091, DOI 10.5754/hge11087; Landberg G, 1997, CANCER RES, V57, P549; Li P, 2004, J APPL PHYSIOL, V97, P1550, DOI 10.1152/japplphysiol.01311.2003; Liu KB, 2001, J IMMUNOL, V166, P4826, DOI 10.4049/jimmunol.166.8.4826; Ma C, 2011, HYPERTENSION, V58, P679, DOI 10.1161/HYPERTENSIONAHA.111.171561; Ma J, 2012, J LIPID RES, V53, P1093, DOI 10.1194/jlr.M024398; Ma J, 2010, J CELL PHYSIOL, V222, P82, DOI 10.1002/jcp.21923; Maier KG, 2000, AM J PHYSIOL-HEART C, V279, pH863, DOI 10.1152/ajpheart.2000.279.2.H863; Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045; Melana SM, 1998, CLIN CANCER RES, V4, P693; Minamino T, 2001, CIRC RES, V89, P237, DOI 10.1161/hh1501.094267; Minamino T, 2001, MOL CELL BIOL, V21, P3336, DOI 10.1128/MCB.21.10.3336-3342.2001; Mouraret N G-BG, 2012, AM J RESP CRIT CARE, V185, pA5288; Nakayama JI, 1997, CELL, V88, P875, DOI 10.1016/S0092-8674(00)81933-9; Nozaki Y, 2000, AM J RESP CELL MOL, V23, P460, DOI 10.1165/ajrcmb.23.4.3958; PATERLINI P, 1993, CANCER RES, V53, P235; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Sahara M, 2007, CIRCULATION, V115, P509, DOI 10.1161/CIRCULATIONAHA.106.655837; SIGAL E, 1988, BIOCHEM BIOPH RES CO, V157, P457, DOI 10.1016/S0006-291X(88)80271-7; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; THYBERG J, 1990, ARTERIOSCLEROSIS, V10, P966, DOI 10.1161/01.ATV.10.6.966; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Tsujiuchi T, 1998, CANCER LETT, V122, P115, DOI 10.1016/S0304-3835(97)00378-9; Zhang L, 2012, CELL SIGNAL, V24, P1931, DOI 10.1016/j.cellsig.2012.06.007; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zhou QG, 2011, J NEUROSCI, V31, P12258, DOI 10.1523/JNEUROSCI.0805-11.2011; Zhu DL, 2003, CIRC RES, V92, P992, DOI 10.1161/01.RES.0000070881.65194.8F; Zhu XL, 1996, P NATL ACAD SCI USA, V93, P6091, DOI 10.1073/pnas.93.12.6091	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83132	10.1371/journal.pone.0083132	http://dx.doi.org/10.1371/journal.pone.0083132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376652	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000062
J	Shleeva, M; Goncharenko, A; Kudykina, Y; Young, D; Young, M; Kaprelyants, A				Shleeva, Margarita; Goncharenko, Anna; Kudykina, Yuliya; Young, Danielle; Young, Michael; Kaprelyants, Arseny			Cyclic Amp-Dependent Resuscitation of Dormant Mycobacteria by Exogenous Free Fatty Acids	PLOS ONE			English	Article							NON-CULTURABLE CELLS; PROMOTING FACTOR; PEPTIDOGLYCAN FRAGMENTS; SPORE GERMINATION; STATIONARY-PHASE; TUBERCULOSIS; GROWTH; CAMP; SMEGMATIS; GENE	One third of the world population carries a latent tuberculosis (TB) infection, which may reactivate leading to active disease. Although TB latency has been known for many years it remains poorly understood. In particular, substances of host origin, which may induce the resuscitation of dormant mycobacteria, have not yet been described. In vitro models of dormant ("non-culturable") cells of Mycobacterium smegmatis (mc(2) 155) and Mycobacterium tuberculosis H37Rv were used. We found that the resuscitation of dormant M. smegmatis and M. tuberculosis cells in liquid medium was stimulated by adding free unsaturated fatty acids (FA), including arachidonic acid, at concentrations of 1.6-10 mu M. FA addition enhanced cAMP levels in reactivating M. smegmatis cells and exogenously added cAMP (3-10 mM) or dibutyryl-cAMP (0.5-1 mM) substituted for FA, causing resuscitation of M. smegmatis and M. tuberculosis dormant cells. A M. smegmatis null-mutant lacking MSMEG_4279, which encodes a FA-activated adenylyl cyclase (AC), could not be resuscitated by FA but it was resuscitated by cAMP. M. smegmatis and M. tuberculosis cells hyper-expressing AC were unable to form non-culturable cells and a specific inhibitor of AC (8-bromo-cAMP) prevented FA-dependent resuscitation. RT-PCR analysis revealed that rpfA (coding for resuscitation promoting factor A) is up-regulated in M. smegmatis in the beginning of exponential growth following the cAMP increase in lag phase caused by FA-induced cell activation. A specific Rpf inhibitor(4-benzoyl-2-nitrophenylthiocyanate) suppressed FA-induced resuscitation. We propose a novel pathway for the resuscitation of dormant mycobacteria involving the activation of adenylyl cyclase MSMEG_4279 by FAs resulted in activation of cellular metabolism followed later by increase of RpfA activity which stimulates cell multiplication in exponential phase. The study reveals a probable role for lipids of host origin in the resuscitation of dormant mycobacteria, which may function during the reactivation of latent TB.	[Shleeva, Margarita; Goncharenko, Anna; Kudykina, Yuliya; Kaprelyants, Arseny] Russian Acad Sci, Bach Inst Biochem, Moscow, Russia; [Young, Danielle; Young, Michael] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	Research Center of Biotechnology RAS; Russian Academy of Sciences; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Kaprelyants, A (corresponding author), Russian Acad Sci, Bach Inst Biochem, Moscow, Russia.	arseny@inbi.ras.ru	Biryukova, Yulia K/D-8577-2014; Shleeva, Margarita/ADL-9159-2022	Biryukova, Yulia K/0000-0002-5804-4001; 	Program of Presidium of RAS "Molecular and Cellular Biology," RFBR [11-04-01440-a, 11-04-00713-a]	Program of Presidium of RAS "Molecular and Cellular Biology," RFBR	This work was supported by the Program of Presidium of RAS "Molecular and Cellular Biology," RFBR (www.rfbr.ru) (grants 11-04-01440-a, 11-04-00713-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Bai G, 2011, CELL MICROBIOL, V13, P349, DOI 10.1111/j.1462-5822.2010.01562.x; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; Barthe P, 2010, STRUCTURE, V18, P606, DOI 10.1016/j.str.2010.02.013; Bishai W, 2000, NATURE, V406, P683, DOI 10.1038/35021159; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; CARSON DD, 1980, J BACTERIOL, V141, P1122, DOI 10.1128/JB.141.3.1122-1126.1980; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Demina GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008174; Derouaux A, 2004, J BACTERIOL, V186, P3282, DOI 10.1128/JB.186.10.3282.2004; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Dhillon J, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-51; DICKINSON JM, 1981, AM REV RESPIR DIS, V123, P367; DOWNARD J, 1995, MOL MICROBIOL, V16, P171, DOI 10.1111/j.1365-2958.1995.tb02290.x; DUBOS RJ, 1946, J EXP MED, V83, P409, DOI 10.1084/jem.83.5.409; Dworkin J, 2010, NAT REV MICROBIOL, V8, P890, DOI 10.1038/nrmicro2453; GERSCH D, 1979, EXPERIENTIA, V35, P749, DOI 10.1007/BF01968222; Golyshevskaya V I, 1986, Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol, V35, P263; Gupta RK, 2010, MICROBIOL-SGM, V156, P2714, DOI 10.1099/mic.0.037622-0; Jungwirth B, 2008, FEMS MICROBIOL LETT, V281, P190, DOI 10.1111/j.1574-6968.2008.01098.x; Kana BD, 2010, FEMS IMMUNOL MED MIC, V58, P39, DOI 10.1111/j.1574-695X.2009.00606.x; KERWIN JL, 1982, J GEN MICROBIOL, V128, P2179; Kudykina Yu K, 2011, Mikrobiologiia, V80, P625; Lillebaek T, 2002, APMIS, V110, P625, DOI 10.1034/j.1600-0463.2002.1100905.x; Man J. C. de, 1975, European Journal of Applied Microbiology, V1, P67; Motaal AA, 2006, FEBS J, V273, P4219, DOI 10.1111/j.1742-4658.2006.05420.x; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; Mukamolova GV, 2002, MOL MICROBIOL, V46, P623, DOI 10.1046/j.1365-2958.2002.03184.x; Nazarova EV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P636, DOI 10.1134/S0006297911060034; Nikitushkin VD, 2013, ANTON LEEUW INT J G, V103, P37, DOI 10.1007/s10482-012-9784-1; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Raychaudhuri S, 1998, MICROBIOL-UK, V144, P2131, DOI 10.1099/00221287-144-8-2131; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Schaloske RH, 2007, J BIOSCIENCES, V32, P1281, DOI 10.1007/s12038-007-0137-6; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Shleeva M, 2004, MICROBIOL-SGM, V150, P1687, DOI 10.1099/mic.0.26893-0; Shleeva MO, 2011, TUBERCULOSIS, V91, P146, DOI 10.1016/j.tube.2010.12.006; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; Susstrunk U, 1998, MOL MICROBIOL, V30, P33, DOI 10.1046/j.1365-2958.1998.01033.x; SVETLICHNYI V A, 1983, Mikrobiologiya, V52, P33; Tran SL, 2005, MICROBIOL-SGM, V151, P665, DOI 10.1099/mic.0.27624-0; Tufariello JM, 2006, INFECT IMMUN, V74, P2985, DOI 10.1128/IAI.74.5.2985-2995.2006; Virdy KJ, 1999, MICROBIOL-UK, V145, P1883, DOI 10.1099/13500872-145-8-1883; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WHEELER PR, 1992, J GEN MICROBIOL, V138, P825, DOI 10.1099/00221287-138-4-825; Zhang Y, 2001, BIOCHEM BIOPH RES CO, V284, P542, DOI 10.1006/bbrc.2001.4993	51	45	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82914	10.1371/journal.pone.0082914	http://dx.doi.org/10.1371/journal.pone.0082914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376605	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000038
J	Yan, Q; Chen, P; Lu, AL; Zhao, P; Gu, AH				Yan, Qing; Chen, Pin; Lu, Ailin; Zhao, Peng; Gu, Aihua			Association between CTLA-4 60G/A and-1661A/G Polymorphisms and the Risk of Cancers: A Meta-Analysis	PLOS ONE			English	Article							GENE POLYMORPHISMS; SUSCEPTIBILITY; VARIANTS; HAPLOTYPES; CARCINOMA; MELANOMA; P53	Purpose: CTLA-4 is one of the most fundamental immunosuppressive cotykines which belongs to the immunoglobulin super-family, and is expressed mainly on activated T cells. Previous studies have reported the existence of CTLA4 60G/A and CTLA4-1661A/G polymorphism in cancers. However, the effects remain conflicting. Hence, we performed a meta-analysis to investigate the association between these polymorphisms and cancer risk. Methods: We searched the Pubmed and Web of Science databases until October 24, 2013 to obtain relevant published studies. Pooled odds ratios (ORs) and corresponding 95% confidence intervals (CIs) for the relationship between CTLA4 gene polymorphisms and cancer susceptibility were calculated by stata 11 software. Heterogeneity tests, sensitivity analyses and publication bias assessments were also performed in our meta-analysis. Results: A total of 22 articles comprising 31 case-control studies concerning the CTLA-4 60G/A and CTLA-4 -1661A/G polymorphisms were included in the meta-analysis. The pooled results suggested the CTLA-4 60G/A polymorphism was significantly associated with an increased skin cancer risk (AA vs. GG: OR = 1.32, 95%CI = 1.09-1.59; AA vs. GA+GG: OR = 1.26, 95%CI = 1.07-1.48). For CTLA-4 -1661 A/G polymorphism, the results showed that the CTLA-4 -1661A/G polymorphism was significantly associated with an increased cancer risk (GA vs. AA: OR = 1.44, 95%CI = 1.13-1.82; GA+GG vs. AA: OR = 1.35, 95%CI = 1.07-1.69; G vs. A: OR = 1.21, 95%CI = 1.01-1.47), especially in gastric cancer, breast cancer, other cancers and in Asians population subgroups. Conclusion: Our meta-analysis suggests that the CTLA-4 -1661A/G polymorphism is a potential factor for the susceptibility of cancer, especially in gastric cancer, breast cancer and other cancers, and the CTLA-4 60G/A polymorphism is significantly associated with increased skin cancer risk. The effect of the CTLA-4 -1661A/G polymorphism on cancer susceptibility especially exists in Asians and population based subjects.	[Yan, Qing; Chen, Pin; Lu, Ailin; Zhao, Peng] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Gu, Aihua] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhao, P (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	zhaopeng@njmu.edu.cn; aihuagu@njmu.edu.cn	Zhao, Peng/HDO-7507-2022		National Natural Science Foundation of China [81172694]; Grant for the 135 Key Medical Project of Jiangsu Province [XK201117]; practice innovation training program projects for the Jiangsu College students [2012JSSPTTP1018]; Jiangsu Province's Qinglan project [JX2161015124]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grant for the 135 Key Medical Project of Jiangsu Province; practice innovation training program projects for the Jiangsu College students; Jiangsu Province's Qinglan project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Natural Science Foundation of China (Grant No. 81172694), the Grant for the 135 Key Medical Project of Jiangsu Province (No. XK201117), the practice innovation training program projects for the Jiangsu College students (2012JSSPTTP1018), the Jiangsu Province's Qinglan project (JX2161015124), the project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Beissert S, 1999, J IMMUNOL, V163, P6725; Bharti V, 2013, HUM IMMUNOL, V74, P348, DOI 10.1016/j.humimm.2012.12.008; Bouwhuis MG, 2010, CANCER IMMUNOL IMMUN, V59, P303, DOI 10.1007/s00262-009-0751-2; Cheng TY, 2006, J CLIN ONCOL, V24, P3483, DOI 10.1200/JCO.2005.05.5434; Cheng XL, 2011, HEPATO-GASTROENTEROL, V58, P432; Chuang WY, 2005, ANN NEUROL, V58, P644, DOI 10.1002/ana.20577; COOPER JD, 1975, J THORAC CARDIOV SUR, V69, P905; Cozar JM, 2007, HUM IMMUNOL, V68, P698, DOI 10.1016/j.humimm.2007.05.002; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Erfani N, 2012, IRAN J IMMUNOL, V9, P188; Espenschied J, 2003, J IMMUNOL, V170, P3401, DOI 10.4049/jimmunol.170.6.3401; Feng DP, 2013, GENET TEST MOL BIOMA, V17, P458, DOI 10.1089/gtmb.2012.0488; Hadinia A, 2007, J GASTROEN HEPATOL, V22, P2283, DOI 10.1111/j.1440-1746.2007.04862.x; Hernandez J, 2001, J IMMUNOL, V166, P3908, DOI 10.4049/jimmunol.166.6.3908; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hou RP, 2010, MOL BIOL REP, V37, P515, DOI 10.1007/s11033-009-9705-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kammerer PW, 2010, ORAL ONCOL, V46, P543, DOI 10.1016/j.oraloncology.2010.03.025; Karabon L, 2012, PATHOL ONCOL RES, V18, P219, DOI 10.1007/s12253-011-9431-6; Karabon L, 2011, HUM IMMUNOL, V72, P947, DOI 10.1016/j.humimm.2011.05.010; Khaghanzadeh N, 2010, CANCER GENET CYTOGEN, V196, P171, DOI 10.1016/j.cancergencyto.2009.09.001; Khorshied MM, 2013, LEUK LYMPHOMA; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Li DL, 2012, MOL CELL BIOCHEM, V364, P283, DOI 10.1007/s11010-012-1228-8; Li Heng, 2008, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V24, P282; Liu J, 2013, CANC EPIDEMIOL; Liu Y, 2011, DNA CELL BIOL, V30, P1051, DOI 10.1089/dna.2011.1269; MANTEL N, 1959, J NATL CANCER I, V22, P719; Menard C, 2008, CLIN CANCER RES, V14, P5242, DOI 10.1158/1078-0432.CCR-07-4797; O'Day SJ, 2007, CANCER-AM CANCER SOC, V110, P2614, DOI 10.1002/cncr.23086; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Rahimifar S, 2010, GYNECOL ONCOL, V119, P136, DOI 10.1016/j.ygyno.2010.06.006; Scheipers P, 1998, P NATL ACAD SCI USA, V95, P10083, DOI 10.1073/pnas.95.17.10083; Sun T, 2009, CANCER RES, V69, P6011, DOI 10.1158/0008-5472.CAN-09-0176; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Walunas TL, 2011, J IMMUNOL, V187, P3466; Wang LH, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-173; Welsh MM, 2009, CANCER RES, V69, P6158, DOI 10.1158/0008-5472.CAN-09-0415	45	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83710	10.1371/journal.pone.0083710	http://dx.doi.org/10.1371/journal.pone.0083710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376736	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000109
J	Maccari, M; Amat, F; Gomez, A				Maccari, Marta; Amat, Francisco; Gomez, Africa			Origin and Genetic Diversity of Diploid Parthenogenetic Artemia in Eurasia	PLOS ONE			English	Article							SALINE LAKES; ASEXUALITY; HYBRIDIZATION; BRANCHIOPODA; CRUSTACEA; SUBUNIT; ROUTES; SPREAD; TIBET	There is wide interest in understanding how genetic diversity is generated and maintained in parthenogenetic lineages, as it will help clarify the debate of the evolution and maintenance of sexual reproduction. There are three mechanisms that can be responsible for the generation of genetic diversity of parthenogenetic lineages: contagious parthenogenesis, repeated hybridization and microorganism infections (e. g. Wolbachia). Brine shrimps of the genus Artemia (Crustacea, Branchiopoda, Anostraca) are a good model system to investigate evolutionary transitions between reproductive systems as they include sexual species and lineages of obligate parthenogenetic populations of different ploidy level, which often co-occur. Diploid parthenogenetic lineages produce occasional fully functional rare males, interspecific hybridization is known to occur, but the mechanisms of origin of asexual lineages are not completely understood. Here we sequenced and analysed fragments of one mitochondrial and two nuclear genes from an extensive set of populations of diploid parthenogenetic Artemia and sexual species from Central and East Asia to investigate the evolutionary origin of diploid parthenogenetic Artemia, and geographic origin of the parental taxa. Our results indicate that there are at least two, possibly three independent and recent maternal origins of parthenogenetic lineages, related to A. urmiana and Artemia sp. from Kazakhstan, but that the nuclear genes are very closely related in all the sexual species and parthenogegetic lineages except for A. sinica, who presumable took no part on the origin of diploid parthenogenetic strains. Our data cannot rule out either hybridization between any of the very closely related Asiatic sexual species or rare events of contagious parthenogenesis via rare males as the contributing mechanisms to the generation of genetic diversity in diploid parthenogenetic Artemia lineages.	[Maccari, Marta; Gomez, Africa] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Maccari, Marta; Amat, Francisco] CSIC, Inst Acuicultura Torre Sal, Castellon de La Plana, Spain	University of Hull; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS)	Maccari, M (corresponding author), Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	martamaccari@gmail.com	Gomez, A/L-6505-2014	Gomez, A/0000-0002-1297-4502	Plan Nacional project [CGL2008-03277]; Spanish Government MICIN; National Environment Research Council (NERC) Advanced Fellowship [NE/B501298/1]; JAE Program from CSIC; European Social Fund; Natural Environment Research Council [NE/B501298/1] Funding Source: researchfish	Plan Nacional project; Spanish Government MICIN; National Environment Research Council (NERC) Advanced Fellowship; JAE Program from CSIC; European Social Fund(European Social Fund (ESF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study has been funded by the Plan Nacional CGL2008-03277 project to Francisco Amat, sponsored by Spanish Government MICIN. Africa Gomez was supported by a National Environment Research Council (NERC) Advanced Fellowship (NE/B501298/1). Marta Maccari was supported by a fellowship of the JAE Program from CSIC and European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzopoulos TJ, 2009, INT REV HYDROBIOL, V94, P560, DOI 10.1002/iroh.200911147; Abatzopoulos TJ, 2002, BIOL J LINN SOC, V75, P333, DOI 10.1111/j.1095-8312.2002.tb02074.x; ABATZOPOULOS TJ, 2002, ARTEMIA BASIC APPL B; AMAT F, 1995, J BIOGEOGR, V22, P49, DOI 10.2307/2846072; Baxevanis AD, 2006, MOL PHYLOGENET EVOL, V40, P724, DOI 10.1016/j.ympev.2006.04.010; Bengtsson B, 2009, LOST SEX; BLACKMAN RL, 1972, B ENTOMOL RES, V62, P281, DOI 10.1017/S0007485300047726; CAI Y, 1989, Wasmann Journal of Biology, V47, P105; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; D'Souza TG, 2010, J HERED, V101, pS34, DOI 10.1093/jhered/esq005; Delmotte F, 2001, P ROY SOC B-BIOL SCI, V268, P2291, DOI 10.1098/rspb.2001.1778; Eads BD, 2012, P NATL ACAD SCI USA, V109, P858, DOI 10.1073/pnas.1119667109; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hou L, 2006, AQUAC RES, V37, P671, DOI 10.1111/j.1365-2109.2006.01480.x; INNES DJ, 1988, EVOLUTION, V42, P1024, DOI 10.1111/j.1558-5646.1988.tb02521.x; Kappas I, 2009, MOL PHYLOGENET EVOL, V52, P192, DOI 10.1016/j.ympev.2009.03.012; Kearney M, 2005, TRENDS ECOL EVOL, V20, P495, DOI 10.1016/j.tree.2005.06.005; Kearney M, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P447, DOI 10.1007/978-90-481-2770-2_21; Librado P, 2009, BIOINFORMATICS; Litvinenko LI, 2008, INLAND WATER BIOL, V1, P37, DOI 10.1007/s12212-008-1007-0; Lunt DH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-194; Lutes AA, 2011, P NATL ACAD SCI USA, V108, P9910, DOI 10.1073/pnas.1102811108; Lynch M, 2008, GENETICS, V180, P317, DOI 10.1534/genetics.107.084657; Maccari M, 2013, J EVOLUTION BIOL, V26, P1934, DOI 10.1111/jeb.12191; Manaffar R, 2011, MOL ECOL RESOUR, V11, P211, DOI 10.1111/j.1755-0998.2010.02908.x; Maniatsi S, 2011, MOL PHYLOGENET EVOL, V58, P353, DOI 10.1016/j.ympev.2010.11.029; Maniatsi S, 2010, HYDROBIOLOGIA, V651, P317, DOI 10.1007/s10750-010-0306-8; Miller M.A., 2010, P GAT COMP ENV WORKS; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Morgan-Richards M, 2005, MOL ECOL, V14, P2133, DOI 10.1111/j.1365-294X.2005.02575.x; MORITZ C, 1983, SCIENCE, V220, P735, DOI 10.1126/science.220.4598.735; Munoz J, 2008, MOL ECOL, V17, P3160, DOI 10.1111/j.1365-294X.2008.03818.x; Munoz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011932; Neiman M, 2012, HEREDITY, V109, P57, DOI 10.1038/hdy.2012.13; PILLA EJS, 1994, HEREDITY, V73, P47, DOI 10.1038/hdy.1994.97; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sandrock C, 2011, CURR BIOL, V21, P433, DOI 10.1016/j.cub.2011.01.070; Schon I, 2000, HEREDITY, V84, P161, DOI 10.1046/j.1365-2540.2000.00647.x; Schwander T, 2011, CURR BIOL, V21, P1129, DOI 10.1016/j.cub.2011.05.026; Shoen I, 2009, LOST SEX EVOLUTIONAR; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Triantaphyllidis GV, 1997, MAR BIOL, V129, P477, DOI 10.1007/s002270050188; Van Stappen G, 2003, HYDROBIOLOGIA, V500, P179, DOI 10.1023/A:1024658604530; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Wen Z, 2005, HYDROBIOLOGIA, V541, P189, DOI 10.1007/s10750-004-5707-0; WILLIAMS WD, 1991, HYDROBIOLOGIA, V210, P39, DOI 10.1007/BF00014322; Xu S, 2013, MOL ECOL, V22, P4549, DOI 10.1111/mec.12407	49	22	22	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83348	10.1371/journal.pone.0083348	http://dx.doi.org/10.1371/journal.pone.0083348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376692	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100115
J	Rabani, A; Ariel, G; Be'er, A				Rabani, Amit; Ariel, Gil; Be'er, Avraham			Collective Motion of Spherical Bacteria	PLOS ONE			English	Article							GIANT NUMBER FLUCTUATIONS; GLIDING MOTILITY; SALMONELLA-TYPHIMURIUM; SWARMING MOTILITY; SURFACE; GROWTH; MYXOBACTERIA; PATTERNS; COLONIES; FLAGELLA	A large variety of motile bacterial species exhibit collective motions while inhabiting liquids or colonizing surfaces. These collective motions are often characterized by coherent dynamic clusters, here hundreds of cells move in correlated whirl and jets. Previously, all species that were known to form such motion had a rod-shaped structure, which enhances the order through steric and hydrodynamic interactions. Here we show that the spherical motile bacteria Serratia rnarcescens exhibit robust collective dynamics and correlated coherent motion while grown in suspensions. As cells migrate to the upper surface of a drop, they form a monolayer, and move collectively in whirls and jets. At all concentrations, the distribution of the bacterial speed was approximately Rayleigh with an average that depends on concentration in a non-monotonic way. Other dynamical parameters such as vorticity and correlation functions are also analyzed and compared to rod-shaped bacteria from the same strain Our results demonstrate that self-propelled spherical objects do form complex ordered collective motion. This opens a door for a new perspective on the role of cell aspect ratio and alignment of cells with collective motion in nature.	[Rabani, Amit; Be'er, Avraham] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Zuckerberg Inst Water Res, Midreshet Ben Gurion, Israel; [Ariel, Gil] Bar Ilan Univ, Dept Math, Ramat Gan, Israel	Ben Gurion University; Bar Ilan University	Be'er, A (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Zuckerberg Inst Water Res, Sede Boqer Campus, Midreshet Ben Gurion, Israel.	beera@bgu.ac.il			EU; People Programme of the European Union [321777]; ISRAEL SCIENCE FOUNDATION [337/12]	EU(European Commission); People Programme of the European Union; ISRAEL SCIENCE FOUNDATION(Israel Science Foundation)	The research has been partially supported by an EU Marie-Curie IRG grant. The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no [321777]. This research was supported by THE ISRAEL SCIENCE FOUNDATION (grant No. 337/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranson IS, 2008, SCIENCE, V320, P612, DOI 10.1126/science.1153456; Baskaran A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.268101; Be'er A, 2013, J BACTERIOL, V195, P2709, DOI 10.1128/JB.00080-13; Be'er A, 2011, BIOPHYS J, V101, P1017, DOI 10.1016/j.bpj.2011.07.019; Be'er A, 2009, J BACTERIOL, V191, P5758, DOI 10.1128/JB.00660-09; Ben Jacob E, 2004, TRENDS MICROBIOL, V12, P366, DOI 10.1016/j.tim.2004.06.006; Ben-Jacob E, 1998, ANNU REV MICROBIOL, V52, P779, DOI 10.1146/annurev.micro.52.1.779; BLACKHART BD, 1985, P NATL ACAD SCI USA, V82, P8767, DOI 10.1073/pnas.82.24.8767; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Chen X, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.148101; Cisneros LH, 2007, EXP FLUIDS, V43, P737, DOI 10.1007/s00348-007-0387-y; Cisneros LH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061907; Copeland MF, 2010, APPL ENVIRON MICROB, V76, P1241, DOI 10.1128/AEM.02153-09; Copeland MF, 2009, SOFT MATTER, V5, P1174, DOI 10.1039/b812146j; Daniels R, 2006, P NATL ACAD SCI USA, V103, P14965, DOI 10.1073/pnas.0511037103; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; Grossman D, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/023036; Gyrya V, 2010, B MATH BIOL, V72, P148, DOI 10.1007/s11538-009-9442-6; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; Hernandez-Ortiz JP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.204501; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Igoshin OA, 2004, P NATL ACAD SCI USA, V101, P4256, DOI 10.1073/pnas.0400704101; Ingham CJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-36; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; MATSUYAMA T, 1992, J BACTERIOL, V174, P1769, DOI 10.1128/jb.174.6.1769-1776.1992; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; Peruani F, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030904; Sokolov A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158102; Sokolov A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248109; Sokolov A, 2010, P NATL ACAD SCI USA, V107, P969, DOI 10.1073/pnas.0913015107; Sokolov A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.148101; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Turner L, 2010, J BACTERIOL, V192, P3259, DOI 10.1128/JB.00083-10; Tuson HH, 2013, J BACTERIOL, V195, P368, DOI 10.1128/JB.01537-12; Tuval I, 2005, P NATL ACAD SCI USA, V102, P2277, DOI 10.1073/pnas.0406724102; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; Wensink HH, 2012, P NATL ACAD SCI USA, V109, P14308, DOI 10.1073/pnas.1202032109; Wu YL, 2011, P NATL ACAD SCI USA, V108, P4147, DOI 10.1073/pnas.1016693108; Wu YL, 2009, P NATL ACAD SCI USA, V106, P1222, DOI 10.1073/pnas.0811662106; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Yu R, 2007, MOL MICROBIOL, V63, P454, DOI 10.1111/j.1365-2958.2006.05536.x; Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107; Zhang HP, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48011	48	38	38	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83760	10.1371/journal.pone.0083760	http://dx.doi.org/10.1371/journal.pone.0083760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376741	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100136
J	Rauter, G; Sigrist, R; Koch, C; Crivelli, F; van Raai, M; Riener, R; Wolf, P				Rauter, Georg; Sigrist, Roland; Koch, Claudio; Crivelli, Francesco; van Raai, Mark; Riener, Robert; Wolf, Peter			Transfer of Complex Skill Learning from Virtual to Real Rowing	PLOS ONE			English	Article							SIMULATION TECHNOLOGY; PERFORMANCE; ENVIRONMENTS; DISPLAYS	Simulators are commonly used to train complex tasks. In particular, simulators are applied to train dangerous tasks, to save costs, and to investigate the impact of different factors on task performance. However, in most cases, the transfer of simulator training to the real task has not been investigated. Without a proof for successful skill transfer, simulators might not be helpful at all or even counter-productive for learning the real task. In this paper, the skill transfer of complex technical aspects trained on a scull rowing simulator to sculling on water was investigated. We assume if a simulator provides high fidelity rendering of the interactions with the environment even without augmented feedback, training on such a realistic simulator would allow similar skill gains as training in the real environment. These learned skills were expected to transfer to the real environment. Two groups of four recreational rowers participated. One group trained on water, the other group trained on a simulator. Within two weeks, both groups performed four training sessions with the same licensed rowing trainer. The development in performance was assessed by quantitative biomechanical performance measures and by a qualitative video evaluation of an independent, blinded trainer. In general, both groups could improve their performance on water. The used biomechanical measures seem to allow only a limited insight into the rowers' development, while the independent trainer could also rate the rowers' overall impression. The simulator quality and naturalism was confirmed by the participants in a questionnaire. In conclusion, realistic simulator training fostered skill gains to a similar extent as training in the real environment and enabled skill transfer to the real environment. In combination with augmented feedback, simulator training can be further exploited to foster motor learning even to a higher extent, which is subject to future work.	[Rauter, Georg; Sigrist, Roland; Koch, Claudio; Crivelli, Francesco; van Raai, Mark; Riener, Robert; Wolf, Peter] ETH, Sensory Motor Syst SMS Lab, IRIS, Zurich, Switzerland; [Rauter, Georg; Sigrist, Roland; Koch, Claudio; Crivelli, Francesco; van Raai, Mark; Riener, Robert; Wolf, Peter] Univ Zurich, Fac Med, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; University of Zurich	Rauter, G (corresponding author), ETH, Sensory Motor Syst SMS Lab, IRIS, Zurich, Switzerland.	georg.rauter@hest.ethz.ch	Riener, Robert/B-9868-2016	Rauter, Georg/0000-0001-9089-8181	ETH Zurich; Swiss National Science Foundation [CR22I2_135105]	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by ETH Zurich and the Swiss National Science Foundation (Grant ":"Impact of Different Feedback Modalities on Complex Skill Learning", fund number CR22I2_135105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg D, 2008, HDB RUDERTRAINING; [Anonymous], 2008, SPORTS TECHNOL, DOI DOI 10.1080/19346182.2008.9648483; Azcueta R, 2002, SHIP TECHNOLOGY RES, V49, P46; Bell HH, 1998, INT J AVIAT PSYCHOL, V8, P223, DOI 10.1207/s15327108ijap0803_4; Bronkhorst AW, 1996, HUM FACTORS, V38, P23, DOI 10.1518/001872096778940859; Cabrera D, 2006, HUM MOVEMENT SCI, V25, P192, DOI 10.1016/j.humov.2005.11.002; Carraro G. U., 1998, Proceedings. VRML 98 Third Symposium on the Virtual Reality Modeling Language, P63, DOI 10.1145/271897.274372; Drobny Dieter, 2010, CHI 10 EXTENDED ABST, P3793, DOI DOI 10.1145/1753846.1754058; Frisoli A., 2008, P 2008 AMB SYS WORKS, P1; G_obel S., 2010, PROC INT C ADV VIS I, P337, DOI DOI 10.1145/1842993.1843056; GABA DM, 1988, ANESTHESIOLOGY, V69, P387, DOI 10.1097/00000542-198809000-00017; Gopher D, 2012, WORK, V41, P2284, DOI 10.3233/WOR-2012-0452-2284; Govil A, 2000, P 8 ACM INT C MULT, P489; Henry Jonathon C., 1995, Journal of Sports Sciences, V13, P199, DOI 10.1080/02640419508732228; Issenberg SB, 1999, JAMA-J AM MED ASSOC, V282, P861, DOI 10.1001/jama.282.9.861; Ito S, 2010, PROCEDIA ENGINEER, V2, P2649, DOI 10.1016/j.proeng.2010.04.046; Johard L, 2011, INT C SKILLS, V1; Kelly A., 2000, SPORTS ENG, V3, P13, DOI DOI 10.1046/J.1460-2687.2000.00037.X>; Kleshnev V, 2009, ROWING BIOMACHNICS N; Kleshnev V, 2011, ROWING BIOMECHANICS; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Liu YC, 2001, ERGONOMICS, V44, P425, DOI 10.1080/00140130010011369; Marchal-Crespo L, 2012, P IEEE BIOROB; Mestre DR, 2011, PRESENCE-VIRTUAL AUG, V20, P1, DOI 10.1162/pres_a_00031; Miles HC, 2012, COMPUT GRAPH-UK, V36, P714, DOI 10.1016/j.cag.2012.04.007; Multon F, 2007, VRST 2007: ACM SYMPOSIUM ON VIRTUAL REALITY SOFTWARE AND TECHNOLOGY, PROCEEDINGS, P77; Nakamura A., 2005, CHI 2005 EXTENDED AB, P1685, DOI DOI 10.1145/1056808.1056997; O'Toole RV, 1999, J AM COLL SURGEONS, V189, P114, DOI 10.1016/S1072-7515(99)00076-9; Oosterhout G, 1993, EP Patent, Patent No. [0,376,403, 0376403]; Pew R., 1998, MODELING HUMAN ORG B; Rauter G, 2012, COMPUT METHOD BIOMEC, V15, P815, DOI 10.1080/10255842.2011.561794; Rauter G, 2008, THESIS GRAZ U TECHNO; Rauter G, 2010, P IEEE RAS-EMBS INT, P82, DOI 10.1109/BIOROB.2010.5627788; Riener R, 2012, VIRTUAL REALITY MED, DOI DOI 10.1007/978-1-4471-4011-5; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Rolfe J.M., 1988, FLIGHT SIMULATION, V1; Ruffaldi E., 2009, P 5 IEEE INT C MECH; Rycroft M, 1999, ACTA ASTRONAUT, V44, P303, DOI 10.1016/S0094-5765(98)00188-X; Salansky W, 1993, EP Patent, Patent No. [0,383,892, 0383892]; Scalese RJ, 2008, J GEN INTERN MED, V23, P46, DOI 10.1007/s11606-007-0283-4; Schmidt R. A., 2008, MOTOR LEARNING PERFO; Sigrist R, 2013, J MOTOR BEHAV; Sigrist R, 2013, PSYCHON B REV, V20, P21, DOI 10.3758/s13423-012-0333-8; Tang J, 2006, SYMPOSIUM ON HAPTICS INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS 2006, PROCEEDINGS, P281; Tannen RS, 2004, INT J AVIAT PSYCHOL, V14, P297, DOI 10.1207/s15327108ijap1403_5; Theeuwes J., 1996, TRANSPORT RES REC, V1550, P30, DOI DOI 10.1177/0361198196155000105; v. Zitzewitz Joachim, 2009, 2009 IEEE International Conference on Robotics and Automation (ICRA), P313, DOI 10.1109/ROBOT.2009.5152219; von Zitzewitz J, 2010, IEEE INT C INT ROBOT, P2289, DOI 10.1109/IROS.2010.5649255; Wachtel J, 1985, FUTURE NUCL POWER PL; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Wolpert DM, 2010, CURR BIOL, V20, pR467, DOI 10.1016/j.cub.2010.04.035; Wulf G, 2002, PSYCHON B REV, V9, P185, DOI 10.3758/BF03196276; Zitzewitz von J, 2012, ROBOTICA, V18, P687	53	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82145	10.1371/journal.pone.0082145	http://dx.doi.org/10.1371/journal.pone.0082145			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376518	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100018
J	Riley, JP; Kulkarni, A; Mehrotra, P; Koh, B; Perumal, NB; Kaplan, MH; Goenka, S				Riley, Jonathan P.; Kulkarni, Aishwarya; Mehrotra, Purvi; Koh, Byunghee; Perumal, Narayanan B.; Kaplan, Mark H.; Goenka, Shreevrat			PARP-14 Binds Specific DNA Sequences to Promote Th2 Cell Gene Expression	PLOS ONE			English	Article							SIGNAL-TRANSDUCER; TRANSCRIPTION FACTOR; STAT6 GENE; IL-4; POLY(ADP-RIBOSE); INTERLEUKIN-21; T-HELPER-1; ACTIVATOR; ASTHMA; DIFFERENTIATION	PARP-14, a member of the poly ADP-ribose polymerase super family, promotes T helper cell 2 (Th2) differentiation by regulating interleukin-4 (IL-4) and STAT6-dependent transcription. Yet, whether PARP-14 globally impacts gene regulation has not been determined. In this report, using an RNA pol II ChlP-seq approach, we identify genes in Th2 cells that are regulated by PARP-14 and either dependent or independent of ADP-ribosyltransferase catalytic activity. Our data on rate that PARP-14 enhances the expression of Th2 genes as it represses the expression of Th1-associated genes. Among the relevant targets are Signal Transducer and Activator of Transcription genes required for polarizing Th1 and Th2 To define a mechanism for PARP-14 function, we use an informatics approach to identify putative PARP-14 DNA binding sites. Two putative PARP-14 binding motifs are identified in multiple Th2 cytokine genes, and we demonstrate that PARP-14 interacts with each motif using in vitro binding assays. Taken together our results indicate that PARP-14 is an important factor for T helper cell differentiation and it binds to specific DNA sequences to mediate its function.	[Riley, Jonathan P.; Kulkarni, Aishwarya; Mehrotra, Purvi; Koh, Byunghee; Kaplan, Mark H.; Goenka, Shreevrat] Indiana Univ Sch Med, HB Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Koh, Byunghee; Kaplan, Mark H.; Goenka, Shreevrat] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Kulkarni, Aishwarya; Perumal, Narayanan B.] Indiana Univ Purdue Univ, Sch Informat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Kaplan, MH (corresponding author), Indiana Univ Sch Med, HB Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA.	mkaplan2@iupui.edu			National Institutes of Health [HL093105, Al095282]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health Grants (HL093105 and Al095282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Amoli MM, 2002, GENES IMMUN, V3, P220, DOI 10.1038/sj.gene.6363872; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Datta R, 2011, ALLERGY, V66, P853, DOI 10.1111/j.1398-9995.2011.02549.x; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Duetsch G, 2002, HUM MOL GENET, V11, P613, DOI 10.1093/hmg/11.6.613; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Gao PS, 2004, J MED GENET, V41, P535, DOI 10.1136/jmg.2003.015842; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Goenka S, 2003, J BIOL CHEM, V278, P50362, DOI 10.1074/jbc.M305854200; Goenka S, 2007, J BIOL CHEM, V282, P18732, DOI 10.1074/jbc.M611283200; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jabeen R, 2013, J CLIN INVE IN PRESS; Jagtap P, 2002, CRIT CARE MED, V30, P1071, DOI 10.1097/00003246-200205000-00019; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Leonard WJ, 2008, J LEUKOCYTE BIOL, V84, P348, DOI 10.1189/jlb.0308149; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; Lund RJ, 2007, J IMMUNOL, V178, P3648, DOI 10.4049/jimmunol.178.6.3648; Mehrotra P, 2012, J ALLERGY CLIN IMMUN; Mehrotra P, 2011, J BIOL CHEM, V286, P1767, DOI 10.1074/jbc.M110.157768; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Nagarkatti R, 2004, AM J RESP CELL MOL, V31, P317, DOI 10.1165/rcmb.2003-0128OC; Nagarkatti R, 2002, J HUM GENET, V47, P684, DOI 10.1007/s100380200105; Nelson N, 1996, J IMMUNOL, V156, P3711; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Schedel M, 2004, J ALLERGY CLIN IMMUN, V114, P1100, DOI 10.1016/j.jaci.2004.07.048; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shinnakasu R, 2006, J IMMUNOL, V177, P5801, DOI 10.4049/jimmunol.177.9.5801; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	47	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83127	10.1371/journal.pone.0083127	http://dx.doi.org/10.1371/journal.pone.0083127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376650	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100094
J	Sebastian, K; Detro-Dassen, S; Rinis, N; Fahrenkamp, D; Muller-Newen, G; Merk, HF; Schmalzing, G; Zwadlo-Klarwasser, G; Baron, JM				Sebastian, Katrin; Detro-Dassen, Silvia; Rinis, Natalie; Fahrenkamp, Dirk; Mueller-Newen, Gerhard; Merk, Hans F.; Schmalzing, Guenther; Zwadlo-Klarwasser, Gabriele; Baron, Jens Malte			Characterization of SLCO5A1/OATP5A1, a Solute Carrier Transport Protein with Non-Classical Function	PLOS ONE			English	Article							OATP/SLCO SUPERFAMILY; DENDRITIC CELLS; ONCOSTATIN M; EXPRESSION; POLYPEPTIDES; IDENTIFICATION; MATURATION; SUBUNITS; STOICHIOMETRY; BACTERIAL	Organic anion transporting polypeptides (OATP/SLCO) have been identified to mediate the uptake of a broad range of mainly amphipathic molecules. Human OATP5A1 was found to be expressed in the epithelium of many cancerous and non-cancerous tissues throughout the body but protein characterization and functional analysis have not yet been performed. This study focused on the biochemical characterization of OATP5A1 using Xenopus laevis oocytes and Flp-In T-REx-HeLa cells providing evidence regarding a possible OATP5A1 function. SLCO5A1 is highly expressed in mature dendritic cells compared to immature dendritic cells (similar to 6.5-fold) and SLCO5A1 expression correlates with the differentiation status of primary blood cells. A core-and complex-N-glycosylated polypeptide monomer of similar to 105 kDa and similar to 130 kDa could be localized in intracellular membranes and on the plasma membrane, respectively. Inducible expression of SLCO5A1 in HeLa cells led to an inhibitory effect of similar to 20% after 96 h on cell proliferation. Gene expression profiling with these cells identified immunologically relevant genes (e. g. CCL20) and genes implicated in developmental processes (e.g. TGM2). A single nucleotide polymorphism leading to the exchange of amino acid 33 (L -> F) revealed no differences regarding protein expression and function. In conclusion, we provide evidence that OATP5A1 might be a non-classical OATP family member which is involved in biological processes that require the reorganization of the cell shape, such as differentiation and migration.	[Sebastian, Katrin; Merk, Hans F.; Baron, Jens Malte] Univ Hosp RWTH Aachen, Dept Dermatol & Allergol, Aachen, Germany; [Detro-Dassen, Silvia; Schmalzing, Guenther] Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany; [Rinis, Natalie; Fahrenkamp, Dirk; Mueller-Newen, Gerhard] Rhein Westfal TH Aachen, Fac Med, Inst Biochem & Mol Biol, Aachen, Germany; [Zwadlo-Klarwasser, Gabriele] Rhein Westfal TH Aachen, Fac Med, Interdisciplinary Ctr Clin Res IZKF, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Sebastian, K (corresponding author), Univ Hosp RWTH Aachen, Dept Dermatol & Allergol, Aachen, Germany.	ksebastian@ukaachen.de	Baron, Jens M/N-2934-2016	Baron, Jens M/0000-0002-1174-6946	BMBF [0315226]	BMBF(Federal Ministry of Education & Research (BMBF))	This research project was supported by a grant from the BMBF (ref. no. 0315226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama Y, 2009, EXP DERMATOL, V18, P404, DOI 10.1111/j.1600-0625.2008.00814.x; Baron JM, 2008, CURR MED CHEM, V15, P2258, DOI 10.2174/092986708785747535; Clarke JD, 2012, EXPERT OPIN DRUG MET, V8, P349, DOI 10.1517/17425255.2012.656087; Compton ELR, 2011, J BIOL CHEM, V286, P27058, DOI 10.1074/jbc.M111.244533; de Jager M, 2013, NEUROBIOL AGING, V34, P1159, DOI 10.1016/j.neurobiolaging.2012.10.005; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Dreuw A, 2005, J INVEST DERMATOL, V124, P28, DOI 10.1111/j.0022-202X.2004.23499.x; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; GLOOR S, 1995, GENE, V160, P213, DOI 10.1016/0378-1119(95)00226-V; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Jacobs JJL, 2006, EXP DERMATOL, V15, P432, DOI 10.1111/j.0906-6705.2006.00420.x; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Jung ID, 2010, BIOCHEM BIOPH RES CO, V394, P272, DOI 10.1016/j.bbrc.2010.02.153; Kindla J, 2011, CANCER BIOL THER, V11, P584, DOI 10.4161/cbt.11.6.14533; Kock K, 2010, J BIOL CHEM, V285, P11336, DOI 10.1074/jbc.M109.056457; Konig J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Le Vee M, 2011, BIOCHEM PHARMACOL, V82, P304, DOI 10.1016/j.bcp.2011.04.017; Lee TK, 2003, AM J PHYSIOL-GASTR L, V285, pG371, DOI 10.1152/ajpgi.00358.2002; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liedauer R, 2009, ONCOL REP, V22, P1485, DOI 10.3892/or_00000591; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Meier-Abt F, 2005, J MEMBRANE BIOL, V208, P213, DOI 10.1007/s00232-005-7004-x; Mio K, 2008, J BIOL CHEM, V283, P1137, DOI 10.1074/jbc.M702681200; Niemi M, 2004, PHARMACOGENETICS, V14, P429, DOI 10.1097/01.fpc.0000114750.08559.32; Niemi M, 2007, PHARMACOGENOMICS, V8, P787, DOI 10.2217/14622416.8.7.787; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; Okabe M, 2008, MOL CANCER THER, V7, P3081, DOI 10.1158/1535-7163.MCT-08-0539; Olszewski-Hamilton U, 2011, Biomark Cancer, V3, P31, DOI 10.4137/BIC.S7151; Ott H, 2010, SKIN PHARMACOL PHYS, V23, P213, DOI 10.1159/000313897; Ouwehand K, 2012, EUR J CELL BIOL, V91, P765, DOI 10.1016/j.ejcb.2012.06.004; Pizzagalli F, 2003, J CLIN ENDOCR METAB, V88, P3902, DOI 10.1210/jc.2003-030174; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schiffer R, 2003, J INVEST DERMATOL, V120, P285, DOI 10.1046/j.1523-1747.2003.12031.x; SCHMALZING G, 1991, BIOCHEM J, V279, P329, DOI 10.1042/bj2790329; SCHMALZING G, 1992, J BIOL CHEM, V267, P20212; Schmalzing G, 1997, P NATL ACAD SCI USA, V94, P1136, DOI 10.1073/pnas.94.4.1136; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shin S, 2013, J VASC SURG, V57, P1362, DOI 10.1016/j.jvs.2012.09.062; Shumilina E, 2011, AM J PHYSIOL-CELL PH, V300, pC1205, DOI 10.1152/ajpcell.00039.2011; Skazik C, 2008, EXP DERMATOL, V17, P739, DOI 10.1111/j.1600-0625.2008.00745.x; Skazik C, 2011, ARCH BIOCHEM BIOPHYS, V508, P212, DOI 10.1016/j.abb.2011.01.013; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Svoboda M, 2011, CURR DRUG METAB, V12, P139, DOI 10.2174/138920011795016863; Tirona RG, 2007, DRUG TRANSPORTERS, P75; Wang Z, 2012, AMINO ACIDS, V42, P939, DOI 10.1007/s00726-011-1008-x; Wlcek K, 2008, CANCER BIOL THER, V7, P1452, DOI 10.4161/cbt.7.9.6282; Wlcek K, 2011, CANCER BIOL THER, V11, P801, DOI 10.4161/cbt.11.9.15176; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	54	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83257	10.1371/journal.pone.0083257	http://dx.doi.org/10.1371/journal.pone.0083257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376674	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100103
J	Keeley, T; Al-Janabi, H; Lorgelly, P; Coast, J				Keeley, Thomas; Al-Janabi, Hareth; Lorgelly, Paula; Coast, Joanna			A Qualitative Assessment of the Content Validity of the ICECAP-A and EQ-5D-5L and Their Appropriateness for Use in Health Research	PLOS ONE			English	Article							STANDARD EQ-5D; CONSTRUCT-VALIDITY; 5-LEVEL VERSION; 3-LEVEL SYSTEM; CAPABILITY	Purpose: The ICECAP-A and EQ-5D-5L are two index measures appropriate for use in health research. Assessment of content validity allows understanding of whether a measure captures the most relevant and important aspects of a concept. This paper reports a qualitative assessment of the content validity and appropriateness for use of the eq-5D-5L and ICECAP-A measures, using novel methodology. Methods: In-depth semi-structured interviews were conducted with research professionals in the UK and Australia. Informants were purposively sampled based on their professional role. Data were analysed in an iterative, thematic and constant comparative manner. A two stage investigation - the comparative direct approach - was developed to address the methodological challenges of the content validity research and allow rigorous assessment. Results: Informants viewed the ICECAP-A as an assessment of the broader determinants of quality of life, but lacking in assessment of health-related determinants. The eq-5D-5L was viewed as offering good coverage of health determinants, but as lacking in assessment of these broader determinants. Informants held some concerns about the content or wording of the Self-care, Pain/Discomfort and Anxiety/Depression items ( EQ-5D-5L) and the Enjoyment, Achievement and attachment items ( ICECAP-A). Conclusion: Using rigorous qualitative methodology the results suggest that the ICECAP-A and EQ-5D-5L hold acceptable levels of content validity and are appropriate for use in health research. This work adds expert opinion to the emerging body of research using patients and public to validate these measures.	[Keeley, Thomas] Univ Birmingham, MRC Midlands Hub Trials Methodol Res, Birmingham, W Midlands, England; [Keeley, Thomas; Al-Janabi, Hareth; Coast, Joanna] Univ Birmingham, Hlth Econ Unit, Birmingham, W Midlands, England; [Lorgelly, Paula] Monash Univ, Ctr Hlth Econ, Victoria, Australia	University of Birmingham; University of Birmingham; Monash University	Keeley, T (corresponding author), Univ Birmingham, MRC Midlands Hub Trials Methodol Res, Birmingham, W Midlands, England.	TJK962@bham.ac.uk		Coast, Joanna/0000-0002-3537-5166; Lorgelly, Paula/0000-0002-8990-9514; Al-Janabi, Hareth/0000-0002-3691-8310	Medical Research Council Midlands Hub for Trials Methodology Research; MRC [G0701027, G0800808] Funding Source: UKRI; Medical Research Council [G0701027, G0800808] Funding Source: researchfish	Medical Research Council Midlands Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work is funded through the Medical Research Council Midlands Hub for Trials Methodology Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Janabi H, 2013, QUAL LIFE RES, V22, P1831, DOI 10.1007/s11136-012-0293-5; Al-Janabi H, 2013, SOC SCI MED, V87, P116, DOI 10.1016/j.socscimed.2013.03.035; Al-Janabi H, 2012, QUAL LIFE RES, V21, P167, DOI 10.1007/s11136-011-9927-2; Brod M, 2009, QUAL LIFE RES, V18, P1263, DOI 10.1007/s11136-009-9540-9; Carmines E. G., 1979, RELIABILITY VALIDITY, DOI DOI 10.4135/9781412985642; Coast J, 2008, SOC SCI MED, V67, P1190, DOI 10.1016/j.socscimed.2008.06.027; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Janssen MF, 2008, QUAL LIFE RES, V17, P463, DOI 10.1007/s11136-008-9318-5; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Janssen MF, 2008, VALUE HEALTH, V11, P275, DOI 10.1111/j.1524-4733.2007.00230.x; Kim SH, 2011, VALUE HEALTH, V14, pA171, DOI 10.1016/j.jval.2011.02.947; Kim TH, 2013, QUAL LIFE RES, V22, P2245, DOI 10.1007/s11136-012-0331-3; Lasch KE, 2010, QUAL LIFE RES, V19, P1087, DOI 10.1007/s11136-010-9677-6; Legard R., 2009, QUALITATIVE RES PRAC, P138; Magasi S, 2012, QUAL LIFE RES, V21, P739, DOI 10.1007/s11136-011-9990-8; Pickard AS, 2007, MED CARE, V45, P259, DOI 10.1097/01.mlr.0000254515.63841.81; Ritchie J, 2009, QUALITATIVE RES PRAC, P77; Ritchie J, 2009, QUALITATIVE RES PRAC, P219; Scalone L, 2013, QUAL LIFE RES, V22, P1707, DOI 10.1007/s11136-012-0318-0; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Sen A, 1992, INEQUALITY RE EXAMIN; Sen A., 1993, QUALITY LIFE, P30, DOI [10.1093/0198287976.003.0003, DOI 10.1093/0198287976.003.0003]; Sen A, 1980, CHOICE WELFARE MEASU; Sireci SG, 1998, SOC INDIC RES, V45, P83, DOI 10.1023/A:1006985528729; Spencer L, 2009, QUALITATIVE RES PRAC, P199	26	54	54	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e85287	10.1371/journal.pone.0085287	http://dx.doi.org/10.1371/journal.pone.0085287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367708	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900076
J	Junghans, AF; Evers, C; De Ridder, DTD				Junghans, Astrid F.; Evers, Catharine; De Ridder, Denise T. D.			Eat Me If You Can: Cognitive Mechanisms Underlying the Distance Effect	PLOS ONE			English	Article							OBJECTS; LANGUAGE; CUES; FMRI	Proximal objects provide affordances that activate the motor information involved in interacting with the objects. This effect has previously been shown for artifacts but not for natural objects, such as food. This study examined whether the sight of proximal food, compared to distant food activates eating-related information. In two experiments reaction times to verbal labels following the sight of proximal and distant objects (food and toys) were measured. Verbal labels included function words that were compatible with one object category (eating and playing) and observation words compatible with both object categories. The sight of food was expected to activate eating-related information when presented at proximity but not at distance, as reflected by faster reaction times to proximal than distant compatible eating words and no difference between reaction times to proximal and distant food for observation words (Experiment 1). Experiment 2 additionally compared the reaction times to wrapped and unwrapped food. The distance effect was expected to occur only for unwrapped food because only unwrapped food is readily edible. As expected, Experiment 1 and 2 revealed faster responses to compatible eating words at proximity than at distance. In Experiment 2 this distance effect occurred only for readily edible, unwrapped food but not for wrapped food. For observation words no difference in response times between the distances was found. These findings suggest that the sight of proximal food activates eating-related information, which could explain people's differential behavioral responses to reachable versus distant food. The activation of eating-related information upon sight of accessible food could provide a cognition-based explanation for mindless eating.	[Junghans, Astrid F.; Evers, Catharine; De Ridder, Denise T. D.] Univ Utrecht, Dept Clin & Hlth Psychol, NL-3508 TC Utrecht, Netherlands	Utrecht University	Junghans, AF (corresponding author), Univ Utrecht, Dept Clin & Hlth Psychol, NL-3508 TC Utrecht, Netherlands.	a.f.junghans@uu.nl			European Commission's Framework Programme 7, People Action, through the Marie Curie Initial Training Network CONsumer COmpetence Research Training (CONCORT)	European Commission's Framework Programme 7, People Action, through the Marie Curie Initial Training Network CONsumer COmpetence Research Training (CONCORT)	This research was funded by the European Commission's Framework Programme 7, People Action, through the Marie Curie Initial Training Network CONsumer COmpetence Research Training (CONCORT) (www.concort-project.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSINI E, 2011, EUROPEAN PERSPECTIVE; Ambrosini E, 2013, EXP BRAIN RES, V229, P197, DOI 10.1007/s00221-013-3607-0; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bub DN, 2010, J EXP PSYCHOL HUMAN, V36, P341, DOI 10.1037/a0017606; Cardellicchio P, 2011, NEUROPSYCHOLOGIA, V49, P1369, DOI 10.1016/j.neuropsychologia.2011.01.021; Costantini M, 2011, PSYCHON B REV, V18, P302, DOI 10.3758/s13423-011-0054-4; Costantini M, 2010, EXP BRAIN RES, V207, P95, DOI 10.1007/s00221-010-2435-8; De Stefani E, 2012, EXP BRAIN RES, V218, P539, DOI 10.1007/s00221-012-3047-2; Fedoroff IC, 1997, APPETITE, V28, P33, DOI 10.1006/appe.1996.0057; Ferri F, 2011, NEUROPSYCHOLOGIA, V49, P3519, DOI 10.1016/j.neuropsychologia.2011.09.001; Gallivan JP, 2009, J NEUROSCI, V29, P4381, DOI 10.1523/JNEUROSCI.0377-09.2009; Geyskens K, 2008, J CONSUM RES, V35, P600, DOI 10.1086/591106; Gibson J.J., 1986, ECOLOGICAL APPROACH; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; HERMAN CP, 1975, J ABNORM PSYCHOL, V84, P666, DOI 10.1037/0021-843X.84.6.666; Lowe MR, 2009, APPETITE, V53, P114, DOI 10.1016/j.appet.2009.05.016; Maas J, 2012, PSYCHOL HEALTH, V27, P59, DOI 10.1080/08870446.2011.565341; MICHAELS CF, 1988, J EXP PSYCHOL HUMAN, V14, P231, DOI 10.1037/0096-1523.14.2.231; Pinel JPJ, 2000, AM PSYCHOL, V55, P1105, DOI 10.1037//0003-066X.55.10.1105; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Ranganathan R, 2011, HUM MOVEMENT SCI, V30, P1102, DOI 10.1016/j.humov.2010.11.012; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; ter Horst AC, 2011, EXP BRAIN RES, V212, P635, DOI 10.1007/s00221-011-2748-2; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Wansink B, 2006, INT J OBESITY, V30, P871, DOI 10.1038/sj.ijo.0803217; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12; Waugh C, 2008, MOTIV EMOTION, V32, P323, DOI 10.1007/s11031-008-9104-2; WILF M, 2013, FRONT PSYCHOL, V4, P1; WMO, 2012, CENTR COMM RES INV H	32	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84643	10.1371/journal.pone.0084643	http://dx.doi.org/10.1371/journal.pone.0084643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367684	Green Published, gold			2022-12-27	WOS:000328740300152
J	Coze, F; Gilard, F; Tcherkez, G; Virolle, MJ; Guyonvarch, A				Coze, Fabien; Gilard, Francoise; Tcherkez, Guillaume; Virolle, Marie-Joelle; Guyonvarch, Armel			Carbon-Flux Distribution within Streptomyces coelicolor Metabolism: A Comparison between the Actinorhodin-Producing Strain M145 and Its Non-Producing Derivative M1146	PLOS ONE			English	Article							FMN-DEPENDENT MONOOXYGENASE; BIOSYNTHETIC GENE CLUSTERS; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; GLUCOSE KINASE; PHOSPHOENOLPYRUVATE CARBOXYLASE; HETEROLOGOUS EXPRESSION; CORYNEBACTERIUM-GLUTAMICUM; ANTIBIOTIC PRODUCTION; THEORETICAL-ANALYSIS	Metabolic Flux Analysis is now viewed as essential to elucidate the metabolic pattern of cells and to design appropriate genetic engineering strategies to improve strain performance and production processes. Here, we investigated carbon flux distribution in two Streptomyces coelicolor A3 (2) strains: the wild type M145 and its derivative mutant M1146, in which gene clusters encoding the four main antibiotic biosynthetic pathways were deleted. Metabolic Flux Analysis and C-13-labeling allowed us to reconstruct a flux map under steady-state conditions for both strains. The mutant strain M1146 showed a higher growth rate, a higher flux through the pentose phosphate pathway and a higher flux through the anaplerotic phosphoenolpyruvate carboxylase. In that strain, glucose uptake and the flux through the Krebs cycle were lower than in M145. The enhanced flux through the pentose phosphate pathway in M1146 is thought to generate NADPH enough to face higher needs for biomass biosynthesis and other processes. In both strains, the production of NADPH was higher than NADPH needs, suggesting a key role for nicotinamide nucleotide transhydrogenase for redox homeostasis. ATP production is also likely to exceed metabolic ATP needs, indicating that ATP consumption for maintenance is substantial. Our results further suggest a possible competition between actinorhodin and triacylglycerol biosynthetic pathways for their common precursor, acetyl-CoA. These findings may be instrumental in developing new strategies exploiting S. coelicolor as a platform for the production of bio-based products of industrial interest.	[Coze, Fabien; Virolle, Marie-Joelle; Guyonvarch, Armel] Univ Paris 11, Inst Genet & Microbiol, Unite Mixte Rech 8621, F-91405 Orsay, France; [Gilard, Francoise; Tcherkez, Guillaume] Univ Paris 11, Inst Biotechnol Plantes, Unite Mixte Rech 8618, F-91405 Orsay, France; [Coze, Fabien; Gilard, Francoise; Tcherkez, Guillaume; Virolle, Marie-Joelle; Guyonvarch, Armel] Ctr Natl Rech Sci, Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Guyonvarch, A (corresponding author), Univ Paris 11, Inst Genet & Microbiol, Unite Mixte Rech 8621, F-91405 Orsay, France.	armel@igmors.u-psud.fr	Tcherkez, Guillaume/L-1300-2015; Gilard, Francoise/C-8022-2016	Gilard, Francoise/0000-0001-9314-1555; virolle, marie-joelle/0000-0001-9509-4115	French National Center for Scientific Research [ABG-25680/BDI SDV24]	French National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS))	Fabien Coze was supported by a grant (Grant ABG-25680/BDI SDV24) from the French National Center for Scientific Research (http://cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-202; ALVES AMCR, 1994, J BACTERIOL, V176, P6827, DOI 10.1128/JB.176.22.6827-6835.1994; ANDERSEN KB, 1980, J BACTERIOL, V144, P114, DOI 10.1128/JB.144.1.114-123.1980; Antoniewicz MR, 2006, METABOLOMICS, V2, P41, DOI 10.1007/s11306-006-0018-2; Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Arabolaza A, 2008, APPL ENVIRON MICROB, V74, P2573, DOI 10.1128/AEM.02638-07; Bailey J.E., 1986, BIOCH ENG FUNDAMENTA; Barreteau H, 2009, J CHROMATOGR B, V877, P213, DOI 10.1016/j.jchromb.2008.12.010; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bibb M, 1996, MICROBIOL-SGM, V142, P1335, DOI 10.1099/13500872-142-6-1335; Bibb M, 2009, METHOD ENZYMOL, V458, P93, DOI 10.1016/S0076-6879(09)04804-6; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Borodina I, 2005, GENOME RES, V15, P820, DOI 10.1101/gr.3364705; Borodina I, 2008, J BIOL CHEM, V283, P25186, DOI 10.1074/jbc.M803105200; Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAMWELL H, 1993, BIOCHEM J, V293, P131, DOI 10.1042/bj2930131; Bruheim P, 2002, J IND MICROBIOL BIOT, V28, P103, DOI 10.1038/sj/jim/7000219; Bruheim P, 2002, APPL MICROBIOL BIOT, V58, P735, DOI 10.1007/s00253-002-0969-9; BUSHELL ME, 1983, J GEN MICROBIOL, V129, P1733; CALHOUN MW, 1993, J BACTERIOL, V175, P3020, DOI 10.1128/JB.175.10.3020-3025.1993; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Chohnan S, 1997, APPL ENVIRON MICROB, V63, P553, DOI 10.1128/AEM.63.2.553-560.1997; Christiansen P., 1970, THESIS U GOTTINGEN G; Daae EB, 1999, METAB ENG, V1, P153, DOI 10.1006/mben.1998.0112; Das A, 2009, ACCOUNTS CHEM RES, V42, P631, DOI 10.1021/ar8002249; DEKLEVA ML, 1988, CAN J MICROBIOL, V34, P1235, DOI 10.1139/m88-217; DEKLEVA ML, 1988, CAN J MICROBIOL, V34, P1241, DOI 10.1139/m88-218; DENOYA CD, 1995, J BACTERIOL, V177, P3504, DOI 10.1128/jb.177.12.3504-3511.1995; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Dominguez H, 1998, EUR J BIOCHEM, V254, P96, DOI 10.1046/j.1432-1327.1998.2540096.x; DOULL JL, 1990, APPL MICROBIOL BIOT, V32, P449, DOI 10.1007/BF00903781; EGLI T, 1981, J GEN MICROBIOL, V123, P365; ERICKSON LE, 1979, BIOTECHNOL BIOENG, V21, P575, DOI 10.1002/bit.260210405; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fischer M, 2008, ARCH BIOCHEM BIOPHYS, V474, P252, DOI 10.1016/j.abb.2008.02.008; Flinspach K, 2010, BIOPOLYMERS, V93, P823, DOI 10.1002/bip.21493; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; Gottschalk G., 1986, BACTERIAL METABOLISM; Guzman S, 2005, MICROBIOL-SGM, V151, P1717, DOI 10.1099/mic.0.27557-0; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hay J, 2011, PLANT J, V67, P513, DOI 10.1111/j.1365-313X.2011.04611.x; He J, 2001, MICROBIOL-SGM, V147, P2817, DOI 10.1099/00221287-147-10-2817; Heide L, 2009, NAT PROD REP, V26, P1241, DOI 10.1039/b808333a; HOBBS G, 1992, J BACTERIOL, V174, P1487, DOI 10.1128/jb.174.5.1487-1494.1992; Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5; HOLMS WH, 1986, CURR TOP CELL REGUL, V28, P69; Hong K, 1999, APPL MICROBIOL BIOT, V51, P523, DOI 10.1007/s002530051427; IKEDA H, 1984, MOL GEN GENET, V196, P501, DOI 10.1007/BF00436199; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Ingraham J. L., 1983, GROWTH BACTERIAL CEL; Jones AC, 2012, FEBS J, V279, P1243, DOI 10.1111/j.1742-4658.2012.08517.x; Jonsbu E, 2001, APPL MICROBIOL BIOT, V56, P93, DOI 10.1007/s002530100613; Kana BD, 2001, J BACTERIOL, V183, P7076, DOI 10.1128/JB.183.24.7076-7086.2001; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kaysser L, 2010, CHEMBIOCHEM, V11, P191, DOI 10.1002/cbic.200900637; Kim HB, 2004, METAB ENG, V6, P313, DOI 10.1016/j.ymben.2004.04.001; Kiviharju K, 2007, APPL MICROBIOL BIOT, V73, P1267, DOI 10.1007/s00253-006-0607-z; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Lange HC, 2001, BIOTECHNOL BIOENG, V75, P334, DOI 10.1002/bit.10054; Lautru S., 2012, ANGEW CHEM INT EDIT, V51, P1; Lautru S, 2007, MICROBIOL-SGM, V153, P1405, DOI 10.1099/mic.0.2006/003145-0; Leighty RW, 2011, METAB ENG, V13, P745, DOI 10.1016/j.ymben.2011.09.010; Lin H, 2004, BIOTECHNOL PROGR, V20, P1599, DOI 10.1021/bp049843a; Mahajan Girish Badrinath, 2012, Front Biosci (Elite Ed), V4, P240; MATSUBARA H, 1969, BIOCHEM BIOPH RES CO, V35, P175, DOI 10.1016/0006-291X(69)90263-0; Matsuhashi M, 1947, J BIOL CHEM, V242, P3191; Melzoch K, 1997, BIOTECHNOL BIOENG, V54, P577; Mo S, 2008, CHEM BIOL, V15, P137, DOI 10.1016/j.chembiol.2007.11.015; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; MULDER MM, 1986, BIOCHIM BIOPHYS ACTA, V851, P223, DOI 10.1016/0005-2728(86)90129-5; NACHLAS MM, 1963, J LAB CLIN MED, V62, P148; Naeimpoor F, 2000, METAB ENG, V2, P140, DOI 10.1006/mben.2000.0146; Neidhardt F.C., 1987, ESCHERICHIA COLI SAL, VI; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Nelson D.L., 2004, PRINCIPLES BIOCH, V4th; Nemeria N, 1998, BIOCHEMISTRY-US, V37, P911, DOI 10.1021/bi9722251; Nicholls D., 2002, BIOENERGETICS, V3; NIEDERPR.D, 1961, J BACTERIOL, V81, P557, DOI 10.1128/JB.81.4.557-563.1961; Nieselt K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-10; Noh K, 2011, APPL MICROBIOL BIOT, V91, P1247, DOI 10.1007/s00253-011-3390-4; Norris J., 1970, METHODS MICROBIOLOGY, V3; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; OLUKOSHI ER, 1994, MICROBIOL-SGM, V140, P931, DOI 10.1099/00221287-140-4-931; PLASKITT KA, 1995, PHILOS T R SOC B, V347, P105, DOI 10.1098/rstb.1995.0016; Ramos I, 2004, RES MICROBIOL, V155, P267, DOI 10.1016/j.resmic.2004.01.004; Roels JA, 2009, BIOTECHNOL BIOENG, V103, P2, DOI 10.1002/bit.22325; ROLLIN C, 1995, EUR J BIOCHEM, V227, P488, DOI 10.1111/j.1432-1033.1995.tb20414.x; Rossa CA, 2002, METAB ENG, V4, P138, DOI 10.1006/mben.2001.0217; Roubos JA, 2002, BIOTECHNOL PROGR, V18, P451, DOI 10.1021/bp020294n; RUSSELL JB, 1979, APPL ENVIRON MICROB, V37, P537, DOI 10.1128/AEM.37.3.537-543.1979; SALAS JA, 1984, FEMS MICROBIOL LETT, V22, P229; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; SCHULZE KL, 1964, ARCH MIKROBIOL, V48, P1, DOI 10.1007/BF00406595; Shahab N, 1996, MICROBIOL-SGM, V142, P1927, DOI 10.1099/13500872-142-8-1927; Shin JH, 2011, J BACTERIOL, V193, P75, DOI 10.1128/JB.00965-10; Siebenberg S, 2011, CHEMBIOCHEM, V12, P2677, DOI 10.1002/cbic.201100494; Stanier R.Y., 1986, THE MICROBIAL WORLD; STOUTHAMER AH, 1975, ARCH MICROBIOL, V102, P187, DOI 10.1007/BF00428367; Stryer L., 1988, BIOCHEMISTRY-US; SUGIMOTO S, 1987, AGR BIOL CHEM TOKYO, V51, P1257, DOI 10.1080/00021369.1987.10868215; SUGIMOTO SI, 1987, AGR BIOL CHEM TOKYO, V51, P101, DOI 10.1080/00021369.1987.10868001; TEMPEST DW, 1984, ANNU REV MICROBIOL, V38, P459, DOI 10.1146/annurev.mi.38.100184.002331; Thomas L, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013797; TSAO SW, 1985, J ANTIBIOT, V38, P128, DOI 10.7164/antibiotics.38.128; VALLINO JJ, 1993, BIOTECHNOL BIOENG, V41, P633, DOI 10.1002/bit.260410606; Valton J, 2006, J BIOL CHEM, V281, P27, DOI 10.1074/jbc.M506146200; Valton J, 2004, J BIOL CHEM, V279, P44362, DOI 10.1074/jbc.M407722200; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; van Wezel GP, 2007, J MOL MICROB BIOTECH, V12, P67, DOI 10.1159/000096461; van Wezel GP, 2005, MOL MICROBIOL, V55, P624, DOI 10.1111/j.1365-2958.2004.04413.x; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Verleyen T, 2001, J AM OIL CHEM SOC, V78, P981, DOI 10.1007/s11746-001-0375-z; Wiechert W, 1997, BIOTECHNOL BIOENG, V55, P118, DOI 10.1002/(SICI)1097-0290(19970705)55:1<118::AID-BIT13>3.0.CO;2-I; Williams TCR, 2010, PLANT PHYSIOL, V154, P311, DOI 10.1104/pp.110.158535; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531; Worthington AS, 2007, ACS CHEM BIOL, V2, P152, DOI 10.1021/cb700053g; WRIGHT LF, 1976, J GEN MICROBIOL, V96, P289, DOI 10.1099/00221287-96-2-289; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; ZARETSKAYA MS, 1987, ANTIBIOT MED BIOTEK, V32, P529; Zhou M, 2012, FEMS MICROBIOL LETT, V333, P169, DOI 10.1111/j.1574-6968.2012.02609.x; Zhu K, 2005, MICROBIOL-SGM, V151, P615, DOI 10.1099/mic.0.27634-0	127	33	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84151	10.1371/journal.pone.0084151	http://dx.doi.org/10.1371/journal.pone.0084151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376790	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000138
J	Denkinger, CM; Kalantri, Y; Schumacher, SG; Michael, JS; Shankar, D; Saxena, A; Sriram, N; Balamugesh, T; Luo, R; Pollock, NR; Pai, M; Christopher, DJ				Denkinger, Claudia M.; Kalantri, Yatiraj; Schumacher, Samuel G.; Michael, Joy S.; Shankar, Deepa; Saxena, Arvind; Sriram, Natarajan; Balamugesh, Thangakunam; Luo, Robert; Pollock, Nira R.; Pai, Madhukar; Christopher, Devasahayam J.			Challenges in the Development of an Immunochromatographic Interferon-Gamma Test for Diagnosis of Pleural Tuberculosis	PLOS ONE			English	Article							ADENOSINE-DEAMINASE; XPERT MTB/RIF; EFFUSION; ASSAY	Existing diagnostic tests for pleural tuberculosis (TB) have inadequate accuracy and/or turnaround time. Interferongamma (IFNg) has been identified in many studies as a biomarker for pleural TB. Our objective was to develop a lateral flow, immunochromatographic test (ICT) based on this biomarker and to evaluate the test in a clinical cohort. Because IFNg is commonly present in non-TB pleural effusions in low amounts, a diagnostic IFNg-threshold was first defined with an enzyme-linked immunosorbent assay (ELISA) for IFNg in samples from 38 patients with a confirmed clinical diagnosis (cut-off of 300pg/ml; 94% sensitivity and 93% specificity). The ICT was then designed; however, its achievable limit of detection (5000pg/ml) was over 10-fold higher than that of the ELISA. After several iterations in development, the prototype ICT assay for IFNg had a sensitivity of 69% (95% confidence interval (CI): 50-83) and a specificity of 94% (95% CI: 81-99%) compared to ELISA on frozen samples. Evaluation of the prototype in a prospective clinical cohort (72 patients) on fresh pleural fluid samples, in comparison to a composite reference standard (including histopathological and microbiologic test results), showed that the prototype had 65% sensitivity (95% CI: 44-83) and 89% specificity (95% CI: 74-97). Discordant results were observed in 15% of samples if testing was repeated after one freezing and thawing step. Inter-rater variability was limited (3%; 1out of 32). In conclusion, despite an iterative development and optimization process, the performance of the IFNg ICT remained lower than what could be expected from the published literature on IFNg as a biomarker in pleural fluid. Further improvements in the limit of detection of an ICT for IFNg, and possibly combination of IFNg with other biomarkers such as adenosine deaminase, are necessary for such a test to be of value in the evaluation of pleural tuberculosis.	[Denkinger, Claudia M.; Pollock, Nira R.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Denkinger, Claudia M.; Schumacher, Samuel G.; Pai, Madhukar] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Denkinger, Claudia M.; Schumacher, Samuel G.; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Kalantri, Yatiraj; Saxena, Arvind; Sriram, Natarajan] Tulip Diagnost, Goa, India; [Michael, Joy S.] Christian Med Coll & Hosp, Dept Microbiol, Vellore, Tamil Nadu, India; [Shankar, Deepa; Balamugesh, Thangakunam; Christopher, Devasahayam J.] Christian Med Coll & Hosp, Dept Pulm Med, Vellore, Tamil Nadu, India; [Luo, Robert] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Pollock, Nira R.] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; McGill University; McGill University; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Stanford University; Harvard University; Boston Children's Hospital	Denkinger, CM (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	claudia.denkinger@mail.mcgill.ca	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021; Christopher, DJ/R-1479-2019; Thangakunam, Balamugesh/H-4931-2019	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Thangakunam, Balamugesh/0000-0001-6799-065X; Schumacher, Samuel G/0000-0002-6136-206X	Grand Challenges Canada award [0026-01-04-01-01]; Canadian Institutes of Health Research [MOP-89918]; European and Developing Countries Clinical Trials Partnership (EDCTP - TBNEAT grant); Fonds de recherche du Quebec - Sante (FRQS); Richard Tomlinson Fellowship at McGill University; Burroughs-Wellcome Fund from the American Society of Tropical Medicine and Hygiene; Quebec Respiratory Health Training Program (QRHTP); NIH [K23 AI074638-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI074638] Funding Source: NIH RePORTER	Grand Challenges Canada award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European and Developing Countries Clinical Trials Partnership (EDCTP - TBNEAT grant); Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); Richard Tomlinson Fellowship at McGill University; Burroughs-Wellcome Fund from the American Society of Tropical Medicine and Hygiene; Quebec Respiratory Health Training Program (QRHTP); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grand Challenges Canada award (0026-01-04-01-01), and by a grant from the Canadian Institutes of Health Research (grants MOP-89918). MP is supported by the European and Developing Countries Clinical Trials Partnership (EDCTP - TBNEAT grant) and the Fonds de recherche du Quebec - Sante (FRQS). CMD is supported by a Richard Tomlinson Fellowship at McGill University and a fellowship of the Burroughs-Wellcome Fund from the American Society of Tropical Medicine and Hygiene. SGS is supported by the Quebec Respiratory Health Training Program (QRHTP). NRP is supported by NIH K23 AI074638-01A2. The funders had no role in the analysis of data and decision to publish.	Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; BUEL E, 1981, PREP BIOCHEM, V11, P363, DOI 10.1080/00327488108065529; Christopher DJ, 2013, EUR RESPIR J, V42, P1427, DOI 10.1183/09031936.00103213; Denkinger CM, 2012, J CLIN MICROBIOL, V50, P2455, DOI 10.1128/JCM.00842-12; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Friedrich SO, 2011, J CLIN MICROBIOL, V49, P4341, DOI 10.1128/JCM.05454-11; Goto M, 2003, ANN CLIN BIOCHEM, V40, P374, DOI 10.1258/000456303766477011; Greco S, 2003, INT J TUBERC LUNG D, V7, P777; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273; Klarkowski DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004351; Lee VJ, 2007, JAIDS-J ACQ IMM DEF, V45, P449, DOI 10.1097/QAI.0b013e318095a3f3; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Pai M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-6; Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1; Perez-Rodriguez E, 1999, RESP MED, V93, P816, DOI 10.1016/S0954-6111(99)90267-6; Porcel JM, 2009, LUNG, V187, P263, DOI 10.1007/s00408-009-9165-3; Porcel Jose Manuel, 2003, Med Sci Monit, V9, pCR175; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; SEIBERT AF, 1991, CHEST, V99, P883, DOI 10.1378/chest.99.4.883; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; Udwadia ZF, 2010, CURR OPIN PULM MED, V16, P399, DOI 10.1097/MCP.0b013e328339cf6e; UNGERER JPJ, 1992, CLIN CHEM, V38, P1322; Villegas MV, 2000, CHEST, V118, P1355, DOI 10.1378/chest.118.5.1355	27	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85447	10.1371/journal.pone.0085447	http://dx.doi.org/10.1371/journal.pone.0085447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376880	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000184
J	Frith, JE; Titmarsh, DM; Padmanabhan, H; Cooper-White, JJ				Frith, Jessica E.; Titmarsh, Drew M.; Padmanabhan, Harish; Cooper-White, Justin J.			Microbioreactor Array Screening of Wnt Modulators and Microenvironmental Factors in Osteogenic Differentiation of Mesenchymal Progenitor Cells	PLOS ONE			English	Article							HUMAN BONE-MARROW; STEM-CELLS; STROMAL CELLS; GENE-EXPRESSION; PROMOTES PROLIFERATION; OSTEOBLAST; MINERALIZATION; DISRUPTION; CULTURES; CANCER	Cellular microenvironmental conditions coordinate to regulate stem cell populations and their differentiation. Mesenchymal precursor cells (MPCs), which have significant potential for a wide range of therapeutic applications, can be expanded or differentiated into osteo- chondro- and adipogenic lineages. The ability to establish, screen, and control aspects of the microenvironment is paramount if we are to elucidate the complex interplay of signaling events that direct cell fate. Whilst modulation of Wnt signaling may be useful to direct osteogenesis in MPCs, there is still significant controversy over how the Wnt signaling pathway influences osteogenesis. In this study, we utilised a full-factorial microbioreactor array (MBA) to rapidly, combinatorially screen several Wnt modulatory compounds (CHIR99021, IWP-4 and IWR-1) and characterise their effects upon osteogenesis. The MBA screening system showed excellent consistency between donors and experimental runs. CHIR99021 (a Wnt agonist) had a profoundly inhibitory effect upon osteogenesis, contrary to expectations, whilst the effects of the IWP-4 and IWR-1 (Wnt antagonists) were confirmed to be inhibitory to osteogenesis, but to a lesser extent than observed for CHIR99021. Importantly, we demonstrated that these results were translatable to standard culture conditions. Using RT-qPCR of osteogenic and Wnt pathway markers, we showed that CHIR exerted its effects via inhibition of ALP and SPP1 expression, even though other osteogenic markers (RUNX2, MSX2, DLX, COL1A1) were upregulated. Lastly, this MBA platform, due to the continuous provision of medium from the first to the last of ten serially connected culture chambers, permitted new insight into the impacts of paracrine signaling on osteogenic differentiation in MPCs, with factors secreted by the MPCs in upstream chambers enhancing the differentiation of cells in downstream chambers. Insights provided by this cell-based assay system will be key to better understanding signaling mechanisms, as well as optimizing MPC growth and differentiation conditions for therapeutic applications.	[Frith, Jessica E.; Titmarsh, Drew M.; Padmanabhan, Harish; Cooper-White, Justin J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia; [Cooper-White, Justin J.] Univ Queensland, Sch Chem Engn, St Lucia, Qld, Australia; [Cooper-White, Justin J.] CSIRO, Mat Sci & Engn Div, Clayton, Vic 3168, Australia	University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Cooper-White, JJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia.	j.cooperwhite@uq.edu.au	Titmarsh, Drew M/F-9546-2011; Frith, Jessica/J-6873-2017	Titmarsh, Drew M/0000-0001-8379-6136; Frith, Jessica/0000-0002-6558-5412; Cooper-White, Justin/0000-0002-1920-8229	Australian Research Council Discovery Grants Scheme [DP1095429, DP110104446]	Australian Research Council Discovery Grants Scheme(Australian Research Council)	The authors would like to acknowledge the Australian Research Council Discovery Grants Scheme (DP1095429 and DP110104446) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Barreto JF, 2011, J TISSUE ENG REGEN M, V5, P464, DOI 10.1002/term.338; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Beck GR, 1998, J CELL BIOCHEM, V68, P269, DOI 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Dun XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-247; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Frith J, 2008, TRANSFUS MED HEMOTH, V35, P216, DOI [10.1159/000127448, 000127448]; Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI 10.1089/ten.TEC.2009.0432; Frith JE, 2012, STEM CELLS DEV, V21, P2442, DOI 10.1089/scd.2011.0615; GREEN E, 1990, EUR J BIOCHEM, V188, P147, DOI 10.1111/j.1432-1033.1990.tb15382.x; GRONTHOS S, 1995, BLOOD, V85, P929, DOI 10.1182/blood.V85.4.929.bloodjournal854929; Gronthos S, 2003, J CELL SCI; Gronthos S, 2007, STEM CELLS DEV, V16, P953, DOI 10.1089/scd.2007.0069; Gronthos S, 2009, STEM CELLS DEV, V18, P1253, DOI 10.1089/scd.2008.0400; Gwak J, 2012, CELL RES, V22, P237, DOI 10.1038/cr.2011.127; Hudson J, 2012, STEM CELLS DEV, V21, P1513, DOI 10.1089/scd.2011.0254; Jansen BJH, 2010, STEM CELLS DEV, V19, P481, DOI 10.1089/scd.2009.0288; Krause U, 2010, P NATL ACAD SCI USA, V107, P4147, DOI 10.1073/pnas.0914360107; Krugluger W, 2007, GRAEF ARCH CLIN EXP, V245, P1543, DOI 10.1007/s00417-007-0635-0; Kurata H, 2007, TISSUE ENG, V13, P1513, DOI 10.1089/ten.2006.0374; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Long X-DaW, 2008, TOXICOL LETT, V181, P47; Maxson S, 2008, J TISSUE ENG REGEN M, V2, P147, DOI 10.1002/term.76; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McCoy RJ, 2010, TISSUE ENG PART B-RE, V16, P587, DOI [10.1089/ten.teb.2010.0370, 10.1089/ten.TEB.2010.0370]; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; Monahan J, 2001, ANAL CHEM, V73, P3193, DOI 10.1021/ac001426z; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Subramaniam N, 2012, CANCER PREV RES, V5, P553, DOI 10.1158/1940-6207.CAPR-12-0053; Titmarsh D, 2009, BIOTECHNOL BIOENG, V104, P1240, DOI 10.1002/bit.22504; Titmarsh DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052405; Torensma R, 2012, STEM CELLS DEV; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	45	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82931	10.1371/journal.pone.0082931	http://dx.doi.org/10.1371/journal.pone.0082931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376608	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000040
J	Lit, L; Belanger, JM; Boehm, D; Lybarger, N; Oberbauer, AM				Lit, Lisa; Belanger, Janelle M.; Boehm, Debby; Lybarger, Nathan; Oberbauer, Anita M.			Differences in Behavior and Activity Associated with a Poly(A) Expansion in the Dopamine Transporter in Belgian Malinois	PLOS ONE			English	Article							ANIMAL-MODELS; SEROTONIN; POLYMORPHISMS; GENES; MICE	In Belgian Malinois dogs, a 38-base pair variable number tandem repeat in the dopamine transporter gene (SLC6A3) is associated with behavior changes in Malinois. By additional sequencing in SLC6A3, we identified an intronic 12-nucleotide poly(A) insertion ("PolyA(22)") before the terminal exon that was associated with seizure, "glazing over" behaviors, and episodic biting behaviors in a sample of 138 Malinois. We next investigated whether PolyA(22) was associated with 1) increased locomotor activity and 2) response to novelty. Using a sample of 22 Malinois and 25 dogs of other breeds, dogs' activity was monitored in a novel and non-novel environment while wearing activity monitoring collars. All dogs were more active in novel compared with non-novel environments, and Malinois were more active overall than other breeds. There was an effect of PolyA(22) genotype on activity levels, and this effect appeared to underlie the difference detected between Malinois and other breeds. There was no effect of PolyA(22) genotype on the relative decrease in activity between novel and non-novel environments for either group or all dogs considered together. In addition to an association between PolyA(22) and owner reports of seizure, "glazing over" behaviors, and episodic biting behaviors, these findings support an effect of PolyA(22) on dopamine transporter function related to activity. Further investigation is required to confirm mechanistic effects of PolyA(22) on SLC6A3. The complex polygenic nature of behavior and the range of behaviors associated with this insertion predict that effects are likely also modified by additional genetic and environmental factors.	[Lit, Lisa; Belanger, Janelle M.; Oberbauer, Anita M.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Boehm, Debby] Precis Canine, Phoenix, AZ USA; [Lybarger, Nathan] Left Coast K9, Marysville, CA USA	University of California System; University of California Davis	Lit, L (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	llit@ucdavis.edu			Morris Foundation [D12CA-054]	Morris Foundation	This study was funded by grant #D12CA-054 from Morris Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Belgian Malinois Club, IS MAL RIGHT YOU; Center for Disease Control and Prevention, 2009, CTR DIS CONTR PREV D; Fox MA, 2013, PSYCHOPHARMACOLOGY, V227, P685, DOI 10.1007/s00213-013-2988-x; Garcia-Garcia M, 2010, NEUROPSYCHOLOGIA, V48, P4136, DOI 10.1016/j.neuropsychologia.2010.10.005; Goncalves VF, 2012, NEUROSCI LETT, V519, P9, DOI 10.1016/j.neulet.2012.04.027; Hall NJ, 2012, GENES BRAIN BEHAV, V11, P889, DOI 10.1111/j.1601-183X.2012.00851.x; Hejjas K, 2007, MAMM GENOME, V18, P871, DOI 10.1007/s00335-007-9070-0; IBM, SPSS STAT VERS 21; Jucaite A, 2005, BIOL PSYCHIAT, V57, P229, DOI 10.1016/j.biopsych.2004.11.009; Lit L, 2013, ANIM GENET, V44, P604, DOI 10.1111/age.12040; Lit L, 2012, PHARMACOGENOMICS J, V12, P368, DOI 10.1038/tpj.2011.23; Lit L, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-45; Morice E, 2004, EUR J NEUROSCI, V20, P120, DOI 10.1111/j.1460-9568.2004.03465.x; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Oberbauer AM, 2003, VET RES COMMUN, V27, P27, DOI 10.1023/A:1022006606796; Patel BD, 2013, PSYCHIAT QUART, V84, P407, DOI 10.1007/s11126-013-9253-7; Perona MTG, 2008, BEHAV PHARMACOL, V19, P566, DOI 10.1097/FBP.0b013e32830cd80f; Rao A, 2013, SYNAPSE, V67, P668, DOI 10.1002/syn.21671; Rehfeld Anders, 2013, Front Endocrinol (Lausanne), V4, P53, DOI 10.3389/fendo.2013.00053; TIIHONEN J, 1995, NAT MED, V1, P654, DOI 10.1038/nm0795-654; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Vage J, 2010, GENES BRAIN BEHAV, V9, P372, DOI 10.1111/j.1601-183X.2010.00568.x; Viggiano D, 2003, NEUROSCI BIOBEHAV R, V27, P623, DOI 10.1016/j.neubiorev.2003.08.006; Wan M, 2013, ANIM GENET, V44, P717, DOI 10.1111/age.12058	25	7	7	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82948	10.1371/journal.pone.0082948	http://dx.doi.org/10.1371/journal.pone.0082948			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376613	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000044
J	Yi, JY; Cai, Y; Yao, ZJ; Lin, JP				Yi, Jiayong; Cai, Yu; Yao, Zhenjun; Lin, Jianping			Genetic Analysis of the Relationship between Bone Mineral Density and Low-Density Lipoprotein Receptor-Related Protein 5 Gene Polymorphisms	PLOS ONE			English	Article							LARGE-SCALE ANALYSIS; LRP5 GENE; OSTEOPOROTIC FRACTURES; A1330V POLYMORPHISM; ASSOCIATION; MASS; VARIANTS; MUTATION; LOW-DENSITY-LIPOPROTEIN-RECEPTOR-RELATED-PROTEIN-5; POPULATION	Background: A number of studies have examined the association between the polymorphisms of the low-density lipoprotein receptor-related protein 5 gene (LRP5), but previous results have been inconclusive. Thus we performed a meta-analysis of studies on the association between the LRP5 polymorphisms and bone mineral density (BMD) to assess their pooled effects. Methods: Published literature from PubMed, EMBASE and ISI web of science were searched for eligible publications. Weighted mean difference (WMD) and 95% confidence interval (CI) was calculated using fixed-or random-effects model. Results: A total of 19 studies with 25773 subjects were considered in this meta-analysis. Of them, 17 examined the association between the A1330V polymorphism and BMD, 8 were focused on the V667M polymorphism, and 2 analyzed the Q89R polymorphism. Individuals with the A1330V AA genotype showed significantly higher BMD than those with the AV/VV genotypes [at lumbar spine (LS): WMD = 0.02g/cm(2), 95% CI = 0.01-0.03, P < 10(-4); at femur neck (FN): WMD = 0.01g/cm(2), 95% CI = 0.00-0.02, P = 0.01] or VV genotype (at LS: WMD = 0.02g/cm(2), 95% CI = 0.01-0.04, P = 0.01). Significant associations were also detected in the analysis for V667M (VV vs. VM/MM: WMD at LS = 0.02g/cm(2), 95% CI = 0.02-0.03, P < 10(-5); WMD at FN = 0.01g/cm(2), 95% CI = 0.01-0.02, P = 0.0002). As for Q89R, subjects with the QQ genotype tended to have higher BMD than those with the QR/RR genotypes at FN (WMD = 0.03g/cm(2), 95% CI = 0.01-0.05, P = 0.005). Conclusion: This meta-analysis demonstrated that the LRP5 polymorphisms may be modestly associated with BMD of LS and FN.	[Yi, Jiayong; Yao, Zhenjun; Lin, Jianping] Fudan Univ, Zhongshan Hosp, Dept Orthoped, Shanghai 200433, Peoples R China; [Cai, Yu] Fudan Univ, Dept Gastroenterol, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Lin, JP (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Orthoped, Shanghai 200433, Peoples R China.	jplin0806@126.com						Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brixen K, 2007, CALCIFIED TISSUE INT, V81, P421, DOI 10.1007/s00223-007-9088-z; Davey SG, 1997, LANCET, V350, P1182, DOI DOI 10.1016/S0140-6736(05)63833-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ezura Y, 2007, BONE, V40, P997, DOI 10.1016/j.bone.2005.06.025; Fang Y, 2005, AM J HUM GENET, V77, P807, DOI 10.1086/497438; Ferrari SL, 2004, AM J HUM GENET, V74, P866, DOI 10.1086/420771; Giroux S, 2008, OSTEOPOROSIS INT, V19, P1769, DOI 10.1007/s00198-008-0617-z; Giroux S, 2007, BONE, V40, P1299, DOI 10.1016/j.bone.2007.01.004; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grundberg E, 2008, OSTEOPOROSIS INT, V19, P829, DOI 10.1007/s00198-007-0512-z; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Jiang XY, 2010, EXP CLIN ENDOCR DIAB, V118, P388, DOI 10.1055/s-0029-1225613; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Koh JM, 2004, J KOREAN MED SCI, V19, P407, DOI 10.3346/jkms.2004.19.3.407; Koller DL, 2005, J BONE MINER RES, V20, P75, DOI 10.1359/JBMR.041019; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Kruk M, 2009, CALCIFIED TISSUE INT, V84, P171, DOI 10.1007/s00223-008-9207-5; Langdahl BL, 2008, BONE, V42, P969, DOI 10.1016/j.bone.2007.11.007; Lee YH, 2009, RHEUMATOL INT, V29, P539, DOI 10.1007/s00296-008-0745-y; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; MANTEL N, 1959, J NATL CANCER I, V22, P719; Markatseli AE, 2011, MATURITAS, V70, P188, DOI 10.1016/j.maturitas.2011.07.016; Massart F, 2013, JOINT BONE SPINE, V80, P414, DOI 10.1016/j.jbspin.2012.10.020; Mencej-Bedrac S, 2009, CALCIFIED TISSUE INT, V85, P501, DOI 10.1007/s00223-009-9306-y; Mizuguchi T, 2004, J HUM GENET, V49, P80, DOI 10.1007/s10038-003-0111-6; Modder UI, 2012, J CELL BIOCHEM, V113, P2248, DOI 10.1002/jcb.24095; Noh T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005438; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Riancho JA, 2011, EUR J ENDOCRINOL, V164, P123, DOI 10.1530/EJE-10-0582; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Saarinen A, 2007, BONE, V40, P1006, DOI 10.1016/j.bone.2006.11.010; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Stathopoulou MG, 2010, J AM DIET ASSOC, V110, P1078, DOI 10.1016/j.jada.2010.04.007; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013217; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tran BNH, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-55; Twells RCJ, 2003, GENOME RES, V13, P845, DOI 10.1101/gr.563703; Uitterlinden AG, 1998, NEW ENGL J MED, V338, P1016, DOI 10.1056/NEJM199804093381502; Urano T, 2004, J BONE MINER METAB, V22, P341, DOI 10.1007/s00774-003-0492-9; van Meurs JBJ, 2006, J BONE MINER RES, V21, P141, DOI 10.1359/JBMR.050904; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Yu JB, 2010, ACTA PHARMACOL SIN, V31, P1464, DOI 10.1038/aps.2010.92; Zhang ZL, 2005, ACTA PHARMACOL SIN, V26, P1111, DOI 10.1111/j.1745-7254.2005.00173.x	54	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85052	10.1371/journal.pone.0085052	http://dx.doi.org/10.1371/journal.pone.0085052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376863	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000175
J	Ameis, HM; Drenckhan, A; von Loga, K; Escherich, G; Wenke, K; Izbicki, JR; Reinshagen, K; Gros, SJ				Ameis, Helen M.; Drenckhan, Astrid; von Loga, Katharina; Escherich, Gabriele; Wenke, Katharina; Izbicki, Jakob R.; Reinshagen, Konrad; Gros, Stephanie J.			PGK1 as Predictor of CXCR4 Expression, Bone Marrow Metastases and Survival in Neuroblastoma	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; PHOSPHOGLYCERATE KINASE 1; GASTRIC-CANCER; TUMOR-METASTASIS; PROSTATE-CANCER; PERITONEAL DISSEMINATION; NOD/SCID MICE; BREAST-CANCER; MOUSE MODEL; FACTOR-I	Background and Aim: A close relationship between phosphoglycerate kinase 1 (PGK1) and the CXCR4/SDF1 axis (chemokine receptor 4/stromal cell derived factor 1) has been shown for several cancers. However, the role of PGK1 has not been investigated for neuroblastoma, and PGK1 might be a therapeutic target for this tumor entity. The aim of the current study was to evaluate the role of PGK1 expression in neuroblastoma patients, to determine the impact of PGK1 expression levels on survival, and to correlate PGK1 expression with CXCR4 expression and bone marrow dissemination. Materials and Methods: Samples from 22 patients with neuroblastoma that were surgically treated at the University Medical Center Hamburg-Eppendorf were evaluated for expression of PGK1 and CXCR4 using immunohistochemistry. Results were correlated with clinical parameters, metastases and outcome of patients. Immunocytochemistry, proliferation and expression analysis of CXCR4 and PGK1 were performed in neuroblastoma cell lines. Results: PGK1 is expressed in neuroblastoma cells. PGK1 expression is significantly positively correlated with CXCR4 expression and tumor dissemination to the bone marrow. Moreover the expression of PGK1 is significantly associated with a negative impact on survival in patients with neuroblastoma. PGK1 is downregulated by inhibition of CXCR4 in neuroblastoma cells. Conclusion: PGK1 appears to play an important role for neuroblastoma, predicting survival and tumor dissemination. Further in vivo studies outstanding, it is a candidate target for novel therapeutic strategies.	[Ameis, Helen M.; Wenke, Katharina; Reinshagen, Konrad] Altona Childrens Hosp, Univ Med Ctr Hamburg Eppendorf, Dept Pediat Surg, Hamburg, Germany; [Drenckhan, Astrid; Izbicki, Jakob R.; Gros, Stephanie J.] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [von Loga, Katharina] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany; [Escherich, Gabriele] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Gros, SJ (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany.	sgros@uke.de	Reinshagen, Konrad/P-2824-2019					Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Arscott WT, 2009, ONCOGENE, V28, P479, DOI 10.1038/onc.2008.402; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Castleberry RP, 1997, EUR J CANCER, V33, P2113, DOI 10.1016/S0959-8049(97)00202-5; CICCARONE V, 1989, CANCER RES, V49, P219; Daly EB, 2004, BBA-MOL CELL RES, V1691, P17, DOI 10.1016/j.bbamcr.2003.11.004; Detterbeck FC, 2004, CHEST, V125, P2300, DOI 10.1378/chest.125.6.2300; Fukuda M, 2001, J PEDIAT HEMATOL ONC, V23, P10, DOI 10.1097/00043426-200101000-00004; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Gros SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047287; Gros SJ, 2012, IN VIVO, V26, P711; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hero B, 2000, MED PEDIATR ONCOL, V35, P683, DOI 10.1002/1096-911X(20001201)35:6<683::AID-MPO43>3.0.CO;2-F; HUGHES M, 1974, CANCER, V34, P1706, DOI 10.1002/1097-0142(197411)34:5<1706::AID-CNCR2820340519>3.0.CO;2-J; Kaifi JT, 2005, J NATL CANCER I, V97, P1840, DOI 10.1093/jnci/dji431; Liberman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043665; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lutz W, 1998, ONCOGENE, V17, P339, DOI 10.1038/sj.onc.1200201; Lutz W, 1996, ONCOGENE, V13, P803; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Meier R, 2007, PLOS ONE, V2, pe1016, DOI [10.1371/journal.pone.0001016, DOI 10.1371/J0URNAL.P0NE.0001016]; Migita T, 2001, CLIN CANCER RES, V7, P2750; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; Mosadegh B, 2008, BIOTECHNOL BIOENG, V100, P1205, DOI 10.1002/bit.21851; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; NICOLSON GL, 1992, ONCOL RES, V4, P389; Oonakahara K, 2004, AM J RESP CELL MOL, V30, P671, DOI 10.1165/rcmb.2003-0340OC; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peyruchaud O, 2003, J BIOL CHEM, V278, P45826, DOI 10.1074/jbc.M309024200; Pinkerton CR, 2000, EUR J CANCER, V36, P1808, DOI 10.1016/S0959-8049(00)00189-1; Russell HV, 2004, J PEDIATR SURG, V39, P1506, DOI 10.1016/j.jpedsurg.2004.06.019; Sanz-Rodriguez F, 2001, BLOOD, V97, P346, DOI 10.1182/blood.V97.2.346; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Seeger RC, 2000, J CLIN ONCOL, V18, P4067, DOI 10.1200/JCO.2000.18.24.4067; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Taichman RS, 2002, CANCER RES, V62, P1832; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Wang JH, 2007, CANCER RES, V67, P149, DOI 10.1158/0008-5472.CAN-06-2971; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinstein JL, 2003, ONCOLOGIST, V8, P278, DOI 10.1634/theoncologist.8-3-278; Woelfle U, 2003, CANCER RES, V63, P5679; Yasumoto K, 2006, CANCER RES, V66, P2181, DOI 10.1158/0008-5472.CAN-05-3393; YEATMAN TJ, 1993, SEMIN SURG ONCOL, V9, P256; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhang LB, 2007, NEOPLASIA, V9, P36, DOI 10.1593/neo.06670; Zieker D, 2008, CELL PHYSIOL BIOCHEM, V21, P429, DOI 10.1159/000129635; Zieker D, 2010, CELL PHYSIOL BIOCHEM, V26, P147, DOI 10.1159/000320545; Zieker D, 2010, INT J CANCER, V126, P1513, DOI 10.1002/ijc.24835; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	55	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83701	10.1371/journal.pone.0083701	http://dx.doi.org/10.1371/journal.pone.0083701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376734	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100131
J	Castillo, P; Pietrantonio, PV				Castillo, Paula; Pietrantonio, Patricia V.			Differences in sNPF Receptor-Expressing Neurons in Brains of Fire Ant (Solenopsis invicta Buren) Worker Subcastes: Indicators for Division of Labor and Nutritional Status?	PLOS ONE			English	Article							SHORT NEUROPEPTIDE-F; DROSOPHILA CENTRAL COMPLEX; CENTRAL-NERVOUS-SYSTEM; BEE MUSHROOM BODIES; HONEY-BEE; SOCIAL-BEHAVIOR; APIS-MELLIFERA; FORAGING EXPERIENCE; FEEDING-BEHAVIOR; PHEIDOLE-DENTATA	In the red imported fire ant, Solenopsis invicto Buren, the neuronal and molecular mechanisms related to worker division of labor are poorly understood. Workers from different subcastes (major, medium and minors) perform different tasks, which are loosely associated with their size. We hypothesized that the short neuropeptide F (sNPF) signaling system (NPY-like) could be involved in mechanisms of worker division of labor and sensing or responding to colony nutritional requirements. Thus, we investigated the expression of the short neuropeptide F receptor (sNPFR) in the brain and subesophageal ganglion (SEG) of workers from colonies with and without brood. Across worker subcastes a total of 9 clusters of immunoreactive sNPFR cells were localized in the brain and the subesophageal ganglion (SEG); some of these cells were similar to those observed previously in the queen. Worker brain sNPFR cell clusters were found in the protocerebrum near mushroom bodies, in the central complex and in the lateral horn. Other sNPFR immunoreactive cells were found at the edge of the antennal lobes. Across subcastes, we observed both a constant and a differential pattern of sNPFR clusters, with a higher number of sNPFR cells found in minor than in major workers. Those sNPFR cells detected in all worker subcastes appear to be involved in olfaction or SEG functions. The differential expression of clusters in subcastes suggests that sNPFR signaling is involved in regulating behaviors associated with specific subcastes and thus, division of labor. Some sNPFR cells appear to be involved in nutrient sensing and/or brood care, feeding behavior and locomotion. In colonies without brood, workers showed a lower cluster number, and an overall reduced sNPFR signal Our results suggest the sNPF signaling system is a candidate for the neurobiological control of worker division of labor and sensing brood presence, perhaps correlating with protein requirements and availability.	[Castillo, Paula; Pietrantonio, Patricia V.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Pietrantonio, PV (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	p-pietrantonio@tamu.edu			Fire ant research and management project, Texas Agri Life Research;  [NSF-105-1257837]	Fire ant research and management project, Texas Agri Life Research; 	Funding for this research was from the Fire ant research and management project, Texas Agri Life Research, and by grant NSF-105-1257837 to PVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament SA, 2011, INSECT MOL BIOL, V20, P335, DOI 10.1111/j.1365-2583.2011.01068.x; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Audsley N, 2009, GEN COMP ENDOCR, V162, P93, DOI 10.1016/j.ygcen.2008.08.003; Brockmann A, 2009, P NATL ACAD SCI USA, V106, P2383, DOI 10.1073/pnas.0813021106; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; Cassill DL, 1999, J INSECT BEHAV, V12, P307, DOI 10.1023/A:1020835304713; Chen ME, 2006, ARCH INSECT BIOCHEM, V61, P195, DOI 10.1002/arch.20103; Choi MY, 2009, CELL TISSUE RES, V335, P431, DOI 10.1007/s00441-008-0721-6; Cook SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025407; Dobrin SE, 2012, J INSECT PHYSIOL, V58, P228, DOI 10.1016/j.jinsphys.2011.11.009; Dolezal AG, 2013, J INSECT PHYSIOL, V59, P519, DOI 10.1016/j.jinsphys.2013.02.008; Ehmer B, 2004, J COMP NEUROL, V469, P198, DOI 10.1002/cne.11014; Garczynski SF, 2006, PEPTIDES, V27, P575, DOI 10.1016/j.peptides.2005.06.029; Giraldo YM, 2013, NEUROSCI LETT, V534, P107, DOI 10.1016/j.neulet.2012.11.057; GRISS C, 1991, J INSECT PHYSIOL, V37, P477, DOI 10.1016/0022-1910(91)90023-S; Gronenberg W, 1996, J EXP BIOL, V199, P2011; Gronenberg W, 1999, J COMP NEUROL, V412, P229, DOI 10.1002/(SICI)1096-9861(19990920)412:2<229::AID-CNE4>3.0.CO;2-E; Gronenberg W, 1999, BRAIN BEHAV EVOLUT, V54, P85, DOI 10.1159/000006615; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; HOWARD DF, 1981, PHYSIOL ENTOMOL, V6, P297, DOI 10.1111/j.1365-3032.1981.tb00274.x; Kahsai L, 2012, NEUROSCIENCE, V208, P11, DOI 10.1016/j.neuroscience.2012.02.007; Kahsai L, 2011, J COMP NEUROL, V519, P290, DOI 10.1002/cne.22520; Kahsai L, 2010, J EXP BIOL, V213, P2256, DOI 10.1242/jeb.043190; Kapan N, 2012, CELL MOL LIFE SCI, V69, P4051, DOI 10.1007/s00018-012-1097-z; Langkilde T, 2009, ECOLOGY, V90, P208, DOI 10.1890/08-0355.1; LeBoeuf' AC, 2013, CURR OPIN NEUROBIOL, V23, P3, DOI 10.1016/j.conb.2012.08.008; Libbrecht R, 2013, EVOLUTION, V67, P517, DOI 10.1111/j.1558-5646.2012.01792.x; Ligon RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022578; Lu HL, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-57; Lutz CC, 2012, DEV NEUROBIOL, V72, P153, DOI 10.1002/dneu.20929; Maleszka J, 2009, J COMP PHYSIOL A, V195, P733, DOI 10.1007/s00359-009-0449-0; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Miller DG, 2001, INSECT SOC, V48, P178, DOI 10.1007/PL00001762; MIRENDA JT, 1981, ANIM BEHAV, V29, P410, DOI 10.1016/S0003-3472(81)80100-5; Mitchell BK, 1999, MICROSC RES TECHNIQ, V47, P401, DOI 10.1002/(SICI)1097-0029(19991215)47:6<401::AID-JEMT4>3.0.CO;2-7; Muscedere ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031618; Mysore K, 2010, ARTHROPOD STRUCT DEV, V39, P310, DOI 10.1016/j.asd.2010.04.003; Mysore K, 2009, ARTHROPOD STRUCT DEV, V38, P485, DOI 10.1016/j.asd.2009.06.001; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; NASSEL DR, 1993, CELL TISSUE RES, V273, P1, DOI 10.1007/BF00304608; O'Donnell S, 2004, NEUROSCI LETT, V356, P159, DOI 10.1016/j.neulet.2003.11.053; Page RE, 2012, ANNU REV GENET, V46, P97, DOI 10.1146/annurev-genet-110711-155610; Paul J, 2002, J INSECT PHYSIOL, V48, P255, DOI 10.1016/S0022-1910(01)00171-8; PETRALIA RS, 1980, CELL TISSUE RES, V206, P145, DOI 10.1007/BF00233615; Seid MA, 2008, DEV NEUROBIOL, V68, P1325, DOI 10.1002/dneu.20663; Seid MA, 2008, J COMP NEUROL, V507, P1102, DOI 10.1002/cne.21600; Simola DF, 2013, GENOME RES, V23, P486, DOI 10.1101/gr.148361.112; Sinakevitch I, 2005, J COMP NEUROL, V488, P233, DOI 10.1002/cne.20572; Sinakevitch I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014536; Smith CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042433; SORENSEN AA, 1981, INSECT SOC, V28, P129, DOI 10.1007/BF02223701; SORENSEN AA, 1981, INSECT SOC, V28, P383, DOI 10.1007/BF02224195; SORENSEN AA, 1983, PHYSIOL ENTOMOL, V8, P83, DOI 10.1111/j.1365-3032.1983.tb00336.x; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Toth AL, 2007, TRENDS GENET, V23, P334, DOI 10.1016/j.tig.2007.05.001; Tschinkel WR, 2006, FIRE ANTS; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Wilder SM, 2013, OECOLOGIA, V172, P197, DOI 10.1007/s00442-012-2477-7; WILSON E O, 1978, Journal of the Kansas Entomological Society, V51, P615; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9	62	11	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83966	10.1371/journal.pone.0083966	http://dx.doi.org/10.1371/journal.pone.0083966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376775	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100147
J	Charlton, RA; Snowball, JM; Bloomfield, K; de Vries, CS				Charlton, Rachel A.; Snowball, Julia M.; Bloomfield, Katherine; de Vries, Corinne S.			Colorectal Cancer Risk Reduction following Macrogol Exposure: A Cohort and Nested Case Control Study in the UK	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; ABERRANT CRYPT FOCI; POLYETHYLENE-GLYCOL; COLON CARCINOGENESIS; ENDOMETRIAL CANCER; PRIMARY-CARE; CHEMOPREVENTION; METAANALYSIS; MORTALITY; ASPIRIN	Background and Aims:Animal studies have demonstrated macrogol laxatives may reduce colorectal cancer (CRC) risk. This study aimed to investigate the association between macrogol prescribing and CRC risk. Methods: A case-control study nested within a cohort of laxative users was conducted using data from the UK General Practice Research Database. Six controls per case were identified and to account for the lead time of CRC, additional control sets were selected on the index date backdated by 1 to 5 years. Exposure to macrogols and covariate status before each of the backdated index dates was established. Conditional logistic regression was used to calculate the risk of CRC following macrogol prescribing adjusted for potential confounders. Results: 4734 incident CRC cases were identified; 2722, 2195, 1789, 1481 and 1214 had received a laxative prescription before the index dates backdated by 1 to 5 years. A suggestion of a non-significant reduction in CRC risk associated with 'macrogol after other laxative' prescribing was observed when the index date was backdated by 1 and 2 years, ORadj = 0.87 (CI(95)0.74-1.03) and ORadj = 0.80 (CI(95)0.65-1.00) compared to non-macrogol laxative exposure. The odds ratios reduced further and were significant when backdated by 3, 4 and 5 years, ORadj = 0.68 (CI(95)0.50-0.92), ORadj = 0.60 (CI(95)0.40-0.90) and ORadj = 0.30 (CI(95)0.14-0.64) respectively. This reduction in risk was not observed, however, for 'macrogol only' and 'macrogol before other laxative' exposure categories. Conclusions: In this study we observed a reduced CRC risk associated with macrogol prescribing after accounting for the lead time for CRC. Further studies are required to determine whether the association is causal and whether it can partly be explained by selective prescribing.	[Charlton, Rachel A.; Snowball, Julia M.; Bloomfield, Katherine; de Vries, Corinne S.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Bloomfield, Katherine] Univ Auckland, Dept Geriatr Med, Auckland 1, New Zealand	University of Bath; University of Auckland	Charlton, RA (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.	r.a.charlton@bath.ac.uk		Snowball, Julia/0000-0002-8454-9046	Norgine Ltd.	Norgine Ltd.	This study was funded by Norgine Ltd. The study design, analysis and interpretation were carried out independent of the funding source and the authors had contractual freedom to publish. An employee of the funder (Dr Chris Hewson) did, however, contribute to the introduction section of the manuscript, which we have acknowledged. The funders had no role in study design, data collection and analysis and decision to publish.	Attar A, 1999, GUT, V44, P226, DOI 10.1136/gut.44.2.226; Azoulay L, 2010, CANC EPIDEMIOL BIOMA; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Beral V, 2005, LANCET, V365, P1543, DOI 10.1016/S0140-6736(05)66455-0; Bertagnolli MM, 2009, CANCER PREV RES, V2, P310, DOI 10.1158/1940-6207.CAPR-08-0206; Boggon R, 2013, PHARMACOEPIDEM DR S, V22, P168, DOI 10.1002/pds.3374; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; Charlton R, 2012, PHARMACOEPIDEM DR S, V21, P775, DOI 10.1002/pds.3236; Corpet DE, 2000, CANCER RES, V60, P3160; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; de Vries CS, 2005, DRUG SAFETY, V28, P241, DOI 10.2165/00002018-200528030-00005; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Dorval E, 2006, GASTROEN CLIN BIOL, V30, P1196, DOI 10.1016/S0399-8320(06)73511-4; Dregan A, 2012, CANCER EPIDEMIOL, V36, P425, DOI 10.1016/j.canep.2012.05.013; Higgins PDR, 2004, AM J GASTROENTEROL, V99, P750, DOI 10.1111/j.1572-0241.2004.04114.x; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Langman M, 1998, GUT, V43, P578, DOI 10.1136/gut.43.4.578; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Liang PS, 2009, INT J CANCER, V124, P2406, DOI 10.1002/ijc.24191; MHRA, 2009, GEN PRACT RES DAT; Midgley R, 1999, LANCET, V353, P391, DOI 10.1016/S0140-6736(98)07127-X; Moskal A, 2007, INT J CANCER, V120, P664, DOI 10.1002/ijc.22299; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parnaud G, 1999, CANCER RES, V59, P5143; Parnaud G, 2001, INT J CANCER, V92, P63, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1158>3.3.CO;2-#; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Roy HK, 2006, MOL CANCER THER, V5, P2060, DOI 10.1158/1535-7163.MCT-06-0054; Roy HK, 2011, INT J ONCOL, V38, P529, DOI 10.3892/ijo.2010.875; Roy HK, 2001, FEBS LETT, V496, P143, DOI 10.1016/S0014-5793(01)02420-6; StataCorp, 2021, STATA STAT SOFTWARE; Tache S, 2006, SCAND J GASTROENTERO, V41, P730, DOI 10.1080/00365520500380668; Wali RK, 2008, MOL CANCER THER, V7, P3103, DOI 10.1158/1535-7163.MCT-08-0434; Wood L, 2004, DRUG SAFETY, V27, P871, DOI 10.2165/00002018-200427120-00004; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011	36	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83203	10.1371/journal.pone.0083203	http://dx.doi.org/10.1371/journal.pone.0083203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376663	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100099
J	Figarola, JL; Singhal, P; Rahbar, S; Gugiu, BG; Awasthi, S; Singhal, SS				Figarola, James Lester; Singhal, Preeti; Rahbar, Samuel; Gugiu, Bogdan Gabriel; Awasthi, Sanjay; Singhal, Sharad S.			COH-SR4 Reduces Body Weight, Improves Glycemic Control and Prevents Hepatic Steatosis in High Fat Diet-Induced Obese Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; LIPID DYSREGULATION; INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; CATALYTIC SUBUNIT; AMPK ACTIVATION; IN-VIVO; METABOLISM; TARGET	Obesity is a chronic metabolic disorder caused by imbalance between energy intake and expenditure, and is one of the principal causative factors in the development of metabolic syndrome, diabetes and cancer. COH-SR4 ("SR4") is a novel investigational compound that has anti-cancer and anti-adipogenic properties. In this study, the effects of SR4 on metabolic alterations in high fat diet (HFD)-induced obese C57BUJ6 mice were investigated. Oral feeding of SR4 (5 mg/kg body weight.) in HFD mice for 6 weeks significantly reduced body weight, prevented hyperlipidemia and improved glycemic control without affecting food intake. These changes were associated with marked decreases in epididymal fat mass, adipocyte hypertrophy, increased plasma adiponectin and reduced leptin levels. SR4 treatment also decreased liver triglycerides, prevented hepatic steatosis, and normalized liver enzymes. Western blots demonstrated increased AMPK activation in liver and adipose tissues of SR4-treated HFD obese mice, while gene analyses by real time PCR showed COH-SR4 significantly suppressed the mRNA expression of lipogenic genes such as sterol regulatory element binding protein-1c (Srebf1), acetyl-Coenzyme A carboxylase (Acaca), peroxisome proliferator-activated receptor gamma (Pparg), fatty acid synthase (Fasn), stearoyl-Coenzyme A desaturase 1 (Scd1), carnitine palmitoyltransferase la (Cpt1a) and 3-hydroxy-3-methyl-glutaryl-CoA reductase (Hmgcr), as well as gluconeogenic genes phosphoenolpyruvate carboxykinase 1 (Pck1) and glucose-6-phosphatase (G6pc) in the liver of obese mice. In vitro, SR4 activates AMPK independent of upstream kinases liver kinase B1 (LKB1) and Ca2+/calmodulin-dependent protein kinase kinase 3 (CaMKK beta). Together, these data suggest that SR4, a novel AMPK activator, may be a promising therapeutic compound for treatment of obesity, fatty liver disease, and related metabolic disorders.	[Figarola, James Lester; Singhal, Preeti; Rahbar, Samuel; Awasthi, Sanjay; Singhal, Sharad S.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet, Duarte, CA 91010 USA; [Figarola, James Lester; Singhal, Preeti; Rahbar, Samuel; Awasthi, Sanjay; Singhal, Sharad S.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Metab Dis Res, Duarte, CA 91010 USA; [Gugiu, Bogdan Gabriel] City Hope Natl Med Ctr, Beckman Res Inst, Immunol & Mass Spectrometry & Prote Core, Duarte, CA 91010 USA; [Awasthi, Sanjay] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Singhal, SS (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet, Duarte, CA 91010 USA.	ssinghal@coh.org	Awasthi, Sanjay/R-4904-2019	Awasthi, Sanjay/0000-0002-5214-5717	National Institutes of Health [77495]; Department's Chair; Beckman Research Institute of the City of Hope; NATIONAL CANCER INSTITUTE [P30CA033572, R01CA077495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department's Chair; Beckman Research Institute of the City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant (CA 77495). The authors wish to thank Isaac and Jacquelin Moradi for their generous financial support. Funding from Department's Chair (Prof. Arthur Riggs) and Beckman Research Institute of the City of Hope is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Boden G, 2004, DIABETES CARE, V27, P2253, DOI 10.2337/diacare.27.9.2253; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Choi YK, 2013, MOL CELLS, V36, P279, DOI 10.1007/s10059-013-0169-8; Coletta DK, 2009, DIABETOLOGIA, V52, P723, DOI 10.1007/s00125-008-1256-9; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Do GM, 2012, MOL NUTR FOOD RES, V56, P1282, DOI 10.1002/mnfr.201200067; Figarola JL, 2013, INT J MOL MED, V31, P1166, DOI 10.3892/ijmm.2013.1313; Figarola JL, 2012, INVEST NEW DRUG, V30, P1413, DOI 10.1007/s10637-011-9711-8; Fogarty S, 2009, BIOCHIM BIOPHYS ACTA, V1804, P581; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Garg SK, 2014, DIABETES OBES METAB, V16, P97, DOI 10.1111/dom.12124; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Harvey AE, 2011, ANN NY ACAD SCI, V1229, P45, DOI 10.1111/j.1749-6632.2011.06096.x; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Jeon Sang-Min, 2012, Cell Logist, V2, P197; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kim HS, 2012, BIOCHEM PHARMACOL, V83, P385, DOI 10.1016/j.bcp.2011.11.008; Kim WS, 2009, AM J PHYSIOL-ENDOC M, V296, pE812, DOI 10.1152/ajpendo.90710.2008; Lee JW, 2012, J LIPID RES, V53, P1277, DOI 10.1194/jlr.M022897; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lin JN, 2010, J AGR FOOD CHEM, V58, P1584, DOI 10.1021/jf9035782; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Shang J, 2008, ACTA PHARMACOL SIN, V29, P698, DOI 10.1111/j.1745-7254.2008.00807.x; Shirai T, 2011, BIOCHEM BIOPH RES CO, V414, P287, DOI 10.1016/j.bbrc.2011.08.120; Singhal SS, 2012, BIOCHEM PHARMACOL, V84, P1419, DOI 10.1016/j.bcp.2012.08.020; Singhal SS, 2013, BIOCH PHARM IN PRESS; Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882; Taube A, 2012, AM J PHYSIOL-HEART C, V302, pH2148, DOI 10.1152/ajpheart.00907.2011; Um MY, 2013, BASIC CLIN PHARMACOL, V113, P152, DOI 10.1111/bcpt.12076; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Zhang WY, 2012, DIABETES, V61, P3114, DOI 10.2337/db11-1373; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	50	22	22	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83801	10.1371/journal.pone.0083801	http://dx.doi.org/10.1371/journal.pone.0083801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376752	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100143
J	Harron, K; Goldstein, H; Wade, A; Muller-Pebody, B; Parslow, R; Gilbert, R				Harron, Katie; Goldstein, Harvey; Wade, Angie; Muller-Pebody, Berit; Parslow, Roger; Gilbert, Ruth			Linkage, Evaluation and Analysis of National Electronic Healthcare Data: Application to Providing Enhanced Blood-Stream Infection Surveillance in Paediatric Intensive Care	PLOS ONE			English	Article							RECORD LINKAGE	Background: Linkage of risk-factor data for blood-stream infection (BSI) in paediatric intensive care (PICU) with bacteraemia surveillance data to monitor risk-adjusted infection rates in PICU is complicated by a lack of unique identifiers and under-ascertainment in the national surveillance system. We linked, evaluated and performed preliminary analyses on these data to provide a practical guide on the steps required to handle linkage of such complex data sources. Methods: Data on PICU admissions in England and Wales for 2003-2010 were extracted from the Paediatric Intensive Care Audit Network. Records of all positive isolates from blood cultures taken for children <16 years and captured by the national voluntary laboratory surveillance system for 2003-2010 were extracted from the Public Health England database, LabBase2. "Gold-standard" datasets with unique identifiers were obtained directly from three laboratories, containing microbiology reports that were eligible for submission to LabBase2 (defined as "clinically significant" by laboratory microbiologists). Reports in the gold-standard datasets were compared to those in LabBase2 to estimate ascertainment in LabBase2. Linkage evaluated by comparing results from two classification methods (highest-weight classification of match weights and prior-informed imputation using match probabilities) with linked records in the gold-standard data. BSI rate was estimated as the proportion of admissions associated with at least one BSI. Results: Reporting gaps were identified in 548/2596 lab-months of LabBase2. Ascertainment of clinically significant BSI in the remaining months was approximately 80-95%. Prior-informed imputation provided the least biased estimate of BSI rate (5.8% of admissions). Adjusting for ascertainment, the estimated BSI rate was 6.1-7.3%. Conclusion: Linkage of PICU admission data with national BSI surveillance provides the opportunity for enhanced surveillance but analyses based on these data need to take account of biases due to ascertainment and linkage error. This study provides a generalisable guide for linkage, evaluation and analysis of complex electronic healthcare data.	[Harron, Katie; Goldstein, Harvey; Wade, Angie; Gilbert, Ruth] UCL, Inst Child Hlth, London, England; [Goldstein, Harvey] Univ Bristol, Grad Sch Educ, Bristol, Avon, England; [Muller-Pebody, Berit] Publ Hlth England, Healthcare Associated Infect & Antimicrobial Resi, London, England; [Parslow, Roger] Univ Leeds, Div Epidemiol, Leeds, W Yorkshire, England	University of London; University College London; University of Bristol; Public Health England; University of Leeds	Harron, K (corresponding author), UCL, Inst Child Hlth, London, England.	Katie.harron.10@ucl.ac.uk	Parslow, Roger/AAV-1477-2020	Harron, Katie/0000-0002-3418-2856; Gilbert, Ruth/0000-0001-9347-2709; Goldstein, Harvey/0000-0003-3878-4122; Parslow, Roger/0000-0002-3945-5294; Muller-Pebody, Berit/0000-0002-8874-480X	National Institute for Health Research Health Technology Assessment (NIHR HTA) programme [08/13/47]; National Clinical Audit and Patient Outcomes Programme via Healthcare Quality Improvement Partnership (HQIP); Health Commission Wales Specialised Services; NHS Lothian / National Service Division NHS Scotland; Royal Belfast Hospital for Sick Children; Our Lady's Children's Hospital, Crumlin; Children's University Hospital, Temple Street; Harley Street Clinic, London	National Institute for Health Research Health Technology Assessment (NIHR HTA) programme(National Institute for Health Research (NIHR)); National Clinical Audit and Patient Outcomes Programme via Healthcare Quality Improvement Partnership (HQIP); Health Commission Wales Specialised Services; NHS Lothian / National Service Division NHS Scotland; Royal Belfast Hospital for Sick Children; Our Lady's Children's Hospital, Crumlin; Children's University Hospital, Temple Street; Harley Street Clinic, London	This work was supported by funding from the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme [project number 08/13/47]. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS or the Department of Health. PICANet is funded by the National Clinical Audit and Patient Outcomes Programme via Healthcare Quality Improvement Partnership (HQIP), Health Commission Wales Specialised Services, NHS Lothian / National Service Division NHS Scotland, the Royal Belfast Hospital for Sick Children, Our Lady's Children's Hospital, Crumlin, Children's University Hospital, Temple Street and The Harley Street Clinic, London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez LG, 2011, J HOSP INFECT, V79, P231, DOI 10.1016/j.jhin.2011.06.016; Bohensky MA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-346; Charlton CMJ, 2012, STATJR SOFTWARE; Clark DE, 2004, INJURY PREV, V10, P186, DOI 10.1136/ip.2003.004580; DuVall SL, 2010, J BIOMED INFORM, V43, P24, DOI 10.1016/j.jbi.2009.08.004; Elward AM, 2005, PEDIATRICS, V115, P868, DOI 10.1542/peds.2004-0256; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Ford JB, 2006, PAEDIATR PERINAT EP, V20, P329, DOI 10.1111/j.1365-3016.2006.00715.x; Goldstein H, 2012, STAT MED, V31, P3481, DOI 10.1002/sim.5508; Harron K, 2013, INTENS CARE MED, V39, P1080, DOI 10.1007/s00134-013-2841-z; Harron K, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech-2012-201376; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Lariscy JT, 2011, J AGING HEALTH, V23, P1263, DOI 10.1177/0898264311421369; Nosocomial Infection National Surveillance Service, 2007, SURV HOSP ACQ BACT E, P1997; Pearson A, 2009, J ANTIMICROB CHEMOTH, V64, P11, DOI 10.1093/jac/dkp260; Rubin DB, 2004, MULTIPLE IMPUTATION; Schmidlin K, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-1; Universities of Leeds and Leicester, 2012, PAED INT CAR AUD NET; Urrea M, 2003, PEDIATR INFECT DIS J, V22, P490, DOI 10.1097/00006454-200306000-00002; Wilson J, 2011, CLIN MICROBIOL INFEC, V17, P451, DOI 10.1111/j.1469-0691.2010.03262.x; Yogaraj JS, 2002, PEDIATRICS, V110, P481, DOI 10.1542/peds.110.3.481	22	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85278	10.1371/journal.pone.0085278	http://dx.doi.org/10.1371/journal.pone.0085278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376874	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000328745100200
J	Huang, SY; Fang, CY; Wu, CC; Tsai, CH; Lin, SF; Chen, JY				Huang, Sheng-Yen; Fang, Chih-Yeu; Wu, Chung-Chun; Tsai, Ching-Hwa; Lin, Su-Fang; Chen, Jen-Yang			Reactive Oxygen Species Mediate Epstein-Barr Virus Reactivation by N-Methyl-N'-Nitro-N-Nitrosoguanidine	PLOS ONE			English	Article							EARLY PROTEINS BZLF1; HIGH-RISK AREAS; NASOPHARYNGEAL CARCINOMA; OXIDATIVE STRESS; LYTIC CYCLE; RHEUMATOID-ARTHRITIS; LIPID-PEROXIDATION; SALTED FISH; RTA PROTEIN; P53	N-nitroso compounds (NOCs) and Epstein-Barr virus (EBV) reactivation have been suggested to play a role in the development of nasopharyngeal carcinoma (NPC). Although chemicals have been shown to be a risk factor contributing to the carcinogenesis of NPC, the underlying mechanism is not fully understood. We demonstrated recently that N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) enhances the genomic instability and tumorigenicity of NPC cells via induction of EBV reactivation. However, the mechanisms that trigger EBV reactivation from latency remain unclear. Here, we address the role of ROS in induction of EBV reactivation under MNNG treatment. EBV reactivation was induced in over 70% of EBV-positive NA cells and the promoter of Rta (Rp) was activated after MNNG treatment. Inhibitor experiments revealed ATM, p38 MAPK and JNK were activated by ROS and involved in MNNG-induced EBV reactivation. Significantly, ROS scavengers N-acetyl-L-cysteine (NAC), catalase and reduced glutathione inhibited EBV reactivation under MNNG and H2O2 treatment, suggesting ROS mediate EBV reactivation. The p53 was essential for EBV reactivation and the Rp activation by MNNG. Moreover, the p53 was phosphorylated, translocated into nucleus, and bound to Rp following ROS stimulation. The results suggest ROS play an important role in initiation of EBV reactivation by MNNG through a p53-dependent mechanism. Our findings demonstrate novel signaling mechanisms used by NOCs to induce EBV reactivation and provide a novel insight into NOCs link the EBV reactivation in the contribution to the development of NPC. Notably, this study indicates that antioxidants might be effective for inhibiting N-nitroso compound-induced EBV reactivation and therefore could be promising preventive and therapeutic agents for EBV reactivation-associated malignancies.	[Huang, Sheng-Yen; Chen, Jen-Yang] Natl Tsing Hua Univ, Grad Program Biotechnol Med, Hsinchu, Taiwan; [Huang, Sheng-Yen; Chen, Jen-Yang] Natl Hlth Res Inst, Hsinchu, Taiwan; [Huang, Sheng-Yen] Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Hsinchu, Taiwan; [Tsai, Ching-Hwa; Chen, Jen-Yang] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Huang, Sheng-Yen; Fang, Chih-Yeu; Wu, Chung-Chun; Lin, Su-Fang; Chen, Jen-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Miaoli County, Taiwan	National Tsing Hua University; National Health Research Institutes - Taiwan; National Tsing Hua University; National Taiwan University; National Health Research Institutes - Taiwan	Chen, JY (corresponding author), Natl Tsing Hua Univ, Grad Program Biotechnol Med, Hsinchu, Taiwan.	cjy@nhri.org.tw	Fang, Chih-Yeu/AAH-5170-2021; Lin, Su-Fang/B-2666-2010; Chen, Jen-Yang/D-2085-2010	Fang, Chih-Yeu/0000-0002-8280-3012; Lin, Su-Fang/0000-0001-8706-2439	National Health Research Institutes; National Science Council, Taiwan [N5C98-3112-B-400-002, N5C99-3112-B-400-009, NSC101-2325-B-400-023, NSC102-2325-B-400-021]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by National Health Research Institutes and National Science Council, Taiwan (N5C98-3112-B-400-002, N5C99-3112-B-400-009, NSC101-2325-B-400-023, NSC102-2325-B-400-021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; Adamson AL, 2000, J VIROL, V74, P1224, DOI 10.1128/JVI.74.3.1224-1233.2000; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; BARTSCH H, 1989, FREE RADICAL BIO MED, V7, P637, DOI 10.1016/0891-5849(89)90144-5; BARTSCH H, 1984, CARCINOGENESIS, V5, P1381, DOI 10.1093/carcin/5.11.1381; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; BOUVIER G, 1991, IARC SCI PUBL, V105, P204; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Cerimele F, 2005, P NATL ACAD SCI USA, V102, P175, DOI 10.1073/pnas.0408381102; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang SS, 2008, J VIROL, V82, P7745, DOI 10.1128/JVI.02717-07; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; Chang Y, 2004, J GEN VIROL, V85, P1371, DOI 10.1099/vir.0.79886-0; CHEN JY, 1989, J MED VIROL, V27, P269, DOI 10.1002/jmv.1890270403; CHEN JY, 1985, J MED VIROL, V16, P99, DOI 10.1002/jmv.1890160202; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; Chiu LY, 2011, BIOCHEM PHARMACOL, V81, P459, DOI 10.1016/j.bcp.2010.10.016; Chiu YF, 2007, J GEN VIROL, V88, P2463, DOI 10.1099/vir.0.82881-0; Chua HH, 2012, J MED VIROL, V84, P1279, DOI 10.1002/jmv.23316; COUNTRYMAN J, 1985, P NATL ACAD SCI USA, V82, P4085, DOI 10.1073/pnas.82.12.4085; Crawford D, 2004, EPSTEIN BARR VIRUS W, P123; Darr CD, 2001, J VIROL, V75, P6135, DOI 10.1128/JVI.75.13.6135-6142.2001; de-The G, 1982, EPIDEMIOLOGY EPSTEIN, P25; DEVATHAIRE F, 1988, INT J CANCER, V42, P176, DOI 10.1002/ijc.2910420206; Duckett DR, 1999, P NATL ACAD SCI USA, V96, P12384, DOI 10.1073/pnas.96.22.12384; EADIE JS, 1984, NATURE, V308, P201, DOI 10.1038/308201a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044810; Farrow DC, 1998, INT J CANCER, V78, P675, DOI 10.1002/(SICI)1097-0215(19981209)78:6&lt;675::AID-IJC2&gt;3.0.CO;2-J; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Gao X, 2001, VIROLOGY, V286, P91, DOI 10.1006/viro.2001.0965; Gargouri B, 2009, BIOL TRACE ELEM RES, V132, P27, DOI 10.1007/s12011-009-8384-z; Gargouri B, 2009, MOL CELL BIOCHEM, V324, P55, DOI 10.1007/s11010-008-9984-1; Gohler T, 2002, J BIOL CHEM, V277, P41192, DOI 10.1074/jbc.M202344200; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; Hagemeier SR, 2012, J VIROL, V86, P13360, DOI 10.1128/JVI.01850-12; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hebels DGAJ, 2010, TOXICOL SCI, V116, P194, DOI 10.1093/toxsci/kfq121; Hebels DGAJ, 2009, TOXICOL SCI, V108, P290, DOI 10.1093/toxsci/kfp035; HENLE W, 1977, INT J CANCER, V20, P663, DOI 10.1002/ijc.2910200504; HIRAYAMA T, 1981, PREV MED, V10, P614, DOI 10.1016/0091-7435(81)90051-7; Huang SY, 2010, CHEM-BIOL INTERACT, V188, P623, DOI 10.1016/j.cbi.2010.09.020; IARC, 1997, EPST BARR VIR KAP HE; IARC International Agency for Research on Cancer, 2013, AG CLASS IARC MON; Inoue T, 2001, FEBS LETT, V490, P196, DOI 10.1016/S0014-5793(01)02123-8; Jaiswal AS, 2002, MUTAT RES-FUND MOL M, V500, P17, DOI 10.1016/S0027-5107(01)00296-2; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LaJeunesse DR, 2005, BIOCHEM BIOPH RES CO, V333, P438, DOI 10.1016/j.bbrc.2005.05.120; Lassoued S, 2008, MOL CELL BIOCHEM, V313, P179, DOI 10.1007/s11010-008-9755-z; Lassoued S, 2010, BIOL TRACE ELEM RES, V137, P13, DOI 10.1007/s12011-009-8555-y; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lijinsky W, 1999, MUTAT RES-GEN TOX EN, V443, P129, DOI 10.1016/S1383-5742(99)00015-0; LIN CT, 1990, LAB INVEST, V62, P713; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; LYNN T, 1973, JPN J EXP MED, V43, P121; MIRVISH SS, 1995, CANCER LETT, V93, P17, DOI 10.1016/0304-3835(95)03786-V; Mitacek EJ, 1999, CARCINOGENESIS, V20, P133, DOI 10.1093/carcin/20.1.133; Moller P, 1998, MUTAT RES-REV MUTAT, V410, P271, DOI 10.1016/S1383-5742(97)00041-0; Niedobitek G, 1997, J PATHOL, V182, P151, DOI 10.1002/(SICI)1096-9896(199706)182:2<151::AID-PATH824>3.0.CO;2-3; OKANO M, 1988, Clinical Microbiology Reviews, V1, P300; Parkin DM, 2002, CANC INCIDENCE 5 CON; Peterhans E, 1997, BIOL TRACE ELEM RES, V56, P107, DOI 10.1007/BF02778986; POIRIER S, 1987, INT J CANCER, V39, P293, DOI 10.1002/ijc.2910390305; Price TO, 2005, BRAIN RES, V1045, P57, DOI 10.1016/j.brainres.2005.03.031; Ragoczy T, 1999, J VIROL, V73, P9858, DOI 10.1128/JVI.73.12.9858-9866.1999; Ragoczy T, 1998, J VIROL, V72, P7978, DOI 10.1128/JVI.72.10.7978-7984.1998; ROONEY CM, 1989, J VIROL, V63, P3109, DOI 10.1128/JVI.63.7.3109-3116.1989; Sarban S, 2005, CLIN BIOCHEM, V38, P981, DOI 10.1016/j.clinbiochem.2005.08.003; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; SHAO YM, 1988, CARCINOGENESIS, V9, P1455, DOI 10.1093/carcin/9.8.1455; SINCLAIR AJ, 1991, J VIROL, V65, P2237, DOI 10.1128/JVI.65.5.2237-2244.1991; Stuff JE, 2009, J FOOD COMPOS ANAL, V22, pS42, DOI 10.1016/j.jfca.2009.01.008; Su XH, 2013, NAT REV CANCER, V13, P136, DOI 10.1038/nrc3446; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Toussirot E, 2007, JOINT BONE SPINE, V74, P418, DOI 10.1016/j.jbspin.2007.05.001; Tricker AR, 1997, EUR J CANCER PREV, V6, P226, DOI 10.1097/00008469-199706000-00003; Tsai CH, 1997, J BIOMED SCI, V4, P69, DOI 10.1007/BF02255596; TSAI CHA, 1991, INTERVIROLOGY, V32, P376, DOI 10.1159/000150221; Ye FC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002054; YU MC, 1986, CANCER RES, V46, P956; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; Zdzalik M, 2010, CELL CYCLE, V9, P4584, DOI 10.4161/cc.9.22.13871; ZENG Y, 1985, INT J CANCER, V36, P545, DOI 10.1002/ijc.2910360505; ZENG Y, 1985, ADV CANCER RES, V44, P121, DOI 10.1016/S0065-230X(08)60027-5; Zhu KQ, 2003, WORLD J GASTROENTERO, V9, P2073, DOI 10.3748/wjg.v9.i9.2073; ZONG YS, 1992, CANCER, V69, P3, DOI 10.1002/1097-0142(19920101)69:1&lt;3::AID-CNCR2820690104&gt;3.0.CO;2-7; ZOU XN, 1994, INT J CANCER, V59, P155, DOI 10.1002/ijc.2910590202	93	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84919	10.1371/journal.pone.0084919	http://dx.doi.org/10.1371/journal.pone.0084919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376853	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100192
J	Li, W; Okuda, A; Yamamoto, H; Yamanishi, K; Terada, N; Yamanishi, H; Tanaka, Y; Okamura, H				Li, Wen; Okuda, Akico; Yamamoto, Hideyuki; Yamanishi, Kyosuke; Terada, Nobuyuki; Yamanishi, Hiromichi; Tanaka, Yoshimasa; Okamura, Haruki			Regulation of Development of CD56(bright)CD11c(+) NK-like Cells with Helper Function by IL-18	PLOS ONE			English	Article							DELTA-T-CELLS; DENDRITIC CELLS; INTERLEUKIN-18; IMMUNOTHERAPY; STIMULATION; ZOLEDRONATE; CYTOTOXICITY; INFLAMMATION; ENHANCEMENT; LYMPHOCYTES	Human gamma delta Tcells augment host defense against tumors and infections, and might have a therapeutic potential in immunotherapy. However, mechanism of gamma delta T cell proliferation is unclear, and therefore is difficult numbers of gamma delta T cells for clinical immunotherapy. Recently, natural killer (NK)-like CD56(bright)CD11c(+) promote the proliferation of gamma delta T cells in an IL-18-dependent manner. In this study, we demonstrated that the NK-like CD56(bright)CD11c(+) cells could directly interact with gamma delta T cells to promote their sustained expansionm while conventional dendritic cells (DCs), IFN-alpha-induced DCs, plasmacytoid DCs or monocytes did not. We also examined the cellular mechanism underlying the regulation of CD56(bright)CD11c(+) cells. CD14(+) monocytes pre-incubated with IL-2/IL-18 formed intensive nteractions with CD56(int)CD11c(+) cells to promote their differentiation to CD56(bright)CD11c(+) cells with helper function. The development of CD56(brigh)tCD11c(+) cells was suppressed in an IFN-alpha dependent manner. These results indicate that CD14(+) monocytes pretreated with IL-2/IL-18, but neither DCs nor monocytes, play a determining role on the development and proliferation of CD56(bright)CD11c(+) cells which in turn modulate the expansion of gamma delta T cells. CD56(bright)CD11c(+) NK-like cells may be a novel target for immunotherapy Litilizing gamma T cells, by overcoming he limitation of gamma delta T cells proliferation.	[Li, Wen; Okuda, Akico; Yamamoto, Hideyuki; Yamanishi, Kyosuke; Okamura, Haruki] Hyogo Coll Med, Lab Tumor Immunol & Cell Therapy, Nishinomiya, Hyogo, Japan; [Okuda, Akico; Terada, Nobuyuki] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo, Japan; [Yamanishi, Kyosuke] Hyogo Coll Med, Dept Neuropsychiat, Nishinomiya, Hyogo, Japan; [Yamanishi, Hiromichi] Hirakata Gen Hosp Dev Disorders, Hirakata, Osaka, Japan; [Tanaka, Yoshimasa] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan	Hyogo College of Medicine; Hyogo College of Medicine; Hyogo College of Medicine; Kyoto University	Okamura, H (corresponding author), Hyogo Coll Med, Lab Tumor Immunol & Cell Therapy, Nishinomiya, Hyogo, Japan.	haruoka@hyo-med.ac.jp	Yamanishi, Kyosuke/GQH-4743-2022	Tanaka, Yoshimasa/0000-0002-5024-0614	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT; Astellas Pharma Inc. through the "Formation of Innovation Center for Fusion of Advanced Technologies" program	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Pharma Inc. through the "Formation of Innovation Center for Fusion of Advanced Technologies" program	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), by "Coordination, Support, and Training Program for Translational Research" from MEXT, and by "Special Coordination Funds for Promoting Science and Technology" from MEXT and Astellas Pharma Inc. through the "Formation of Innovation Center for Fusion of Advanced Technologies" program. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beetz S, 2008, IMMUNOBIOLOGY, V213, P173, DOI 10.1016/j.imbio.2007.10.006; Capietto AH, 2011, CELL MOL LIFE SCI, V68, P2433, DOI 10.1007/s00018-011-0705-7; Champagne E, 2011, ARCH IMMUNOL THER EX, V59, P117, DOI 10.1007/s00005-011-0118-1; Chien YH, 2007, IMMUNOL REV, V215, P46, DOI 10.1111/j.1600-065X.2006.00470.x; Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Devilder MC, 2009, J IMMUNOL, V183, P3625, DOI 10.4049/jimmunol.0901571; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Dinarello CA, 2012, EUR J IMMUNOL, V42, P1385, DOI 10.1002/eji.201242635; Eberl M, 2009, PLOS PATHOG, V5, P1; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Gregori S, 2011, TISSUE ANTIGENS, V77, P89, DOI 10.1111/j.1399-0039.2010.01615.x; Gruenbacher G, 2009, BLOOD, V114, P4422, DOI 10.1182/blood-2009-06-227256; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hodge DL, 2006, J INTERF CYTOK RES, V26, P706, DOI 10.1089/jir.2006.26.706; Kunzmann V, 2004, IMMUNOLOGY, V112, P369, DOI 10.1111/j.1365-2567.2004.01908.x; Li W, 2007, J LEUKOCYTE BIOL, V82, P142, DOI 10.1189/jlb.0706431; Li W, 2010, J IMMUNOTHER, V33, P287, DOI 10.1097/CJI.0b013e3181c80ffa; Mailliard RB, 2005, J EXP MED, V202, P941, DOI 10.1084/hem.20050128; Martino A, 2007, CURR MOL MED, V7, P658, DOI 10.2174/156652407782564345; Meraviglia S, 2010, CLIN EXP IMMUNOL, V161, P290, DOI 10.1111/j.1365-2249.2010.04167.x; Meraviglia S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/587315; Miyagawa F, 2001, J IMMUNOL, V166, P5508, DOI 10.4049/jimmunol.166.9.5508; Mohty M, 2003, J IMMUNOL, V171, P3385, DOI 10.4049/jimmunol.171.7.3385; Moser B, 2007, IMMUNOL REV, V215, P89, DOI 10.1111/j.1600-065X.2006.00472.x; Moser B, 2011, CELL MOL LIFE SCI, V68, P2443, DOI 10.1007/s00018-011-0706-6; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Papewalis C, 2008, J IMMUNOL, V180, P1462, DOI 10.4049/jimmunol.180.3.1462; Roelofs AJ, 2009, BRIT J HAEMATOL, V144, P245, DOI 10.1111/j.1365-2141.2008.07435.x; Saito A, 2007, J CLIN EXP HEMATOP, V47, P61, DOI 10.3960/jslrt.47.61; Santini D, 2009, CANCER IMMUNOL IMMUN, V58, P31, DOI 10.1007/s00262-008-0521-6; Scotet E, 2008, FRONT BIOSCI-LANDMRK, V13, P6872, DOI 10.2741/3195; Thedrez A, 2007, IMMUNOL REV, V215, P123, DOI 10.1111/j.1600-065X.2006.00468.x; Troseid M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-11; Tsuda J, 2011, J IMMUNOL, V186, P2003, DOI 10.4049/jimmunol.1001919; Volin MV, 2011, J INTERF CYTOK RES, V31, P745, DOI 10.1089/jir.2011.0050; Watanabe N, 2006, CYTOTHERAPY, V8, P118, DOI 10.1080/14653240600620200; Wong JL, 2013, CANCER RES, V73, P4653, DOI 10.1158/0008-5472.CAN-12-4366; Wong JL, 2011, J IMMUNOTHER, V34, P270, DOI 10.1097/CJI.0b013e31820b370b; Zhang RJ, 2006, J IMMUNOL, V176, P2610, DOI 10.4049/jimmunol.176.4.2610	40	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82586	10.1371/journal.pone.0082586	http://dx.doi.org/10.1371/journal.pone.0082586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376549	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100040
J	Santiago, JA; Potashkin, JA				Santiago, Jose A.; Potashkin, Judith A.			Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes	PLOS ONE			English	Article							AMYLOID-BETA; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; RISK; PRIORITIZATION; GENES; HETEROGENEITY; REPLICATION; BIOMARKERS; FEATURES	Background: Shared dysregulated pathways may contribute to Parkinson's disease and type 2 diabetes, chronic diseases that afflict millions of people worldwide. Despite the evidence provided by epidemiological and gene profiling studies, the molecular and functional networks implicated in both diseases, have not been fully explored. In this study, we used an integrated network approach to investigate the extent to which Parkinson's disease and type 2 diabetes are linked at the molecular level. Methods and Findings: Using a random walk algorithm within the human functional linkage network we identified a molecular cluster of 478 neighboring genes closely associated with confirmed Parkinson's disease and type 2 diabetes genes. Biological and functional analysis identified the protein serine-threonine kinase activity, MAPK cascade, activation of the immune response, and insulin receptor and lipid signaling as convergent pathways. Integration of results from microarrays studies identified a blood signature comprising seven genes whose expression is dysregulated in Parkinson's disease and type 2 diabetes. Among this group of genes, is the amyloid precursor protein (APP), previously associated with neurodegeneration and insulin regulation. Quantification of RNA from whole blood of 192 samples from two independent clinical trials, the Harvard Biomarker Study (HBS) and the Prognostic Biomarker Study (PROBE), revealed that expression of APP is significantly upregulated in Parkinson's disease patients compared to healthy controls. Assessment of biomarker performance revealed that expression of APP could distinguish Parkinson's disease from healthy individuals with a diagnostic accuracy of 80% in both cohorts of patients. Conclusions: These results provide the first evidence that Parkinson's disease and diabetes are strongly linked at the molecular level and that shared molecular networks provide an additional source for identifying highly sensitive biomarkers. Further, these results suggest for the first time that increased expression of APP in blood may modulate the neurodegenerative phenotype in type 2 diabetes patients.	[Santiago, Jose A.; Potashkin, Judith A.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Cellular & Mol Pharmacol Dept, N Chicago, IL USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Potashkin, JA (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Cellular & Mol Pharmacol Dept, N Chicago, IL USA.	judy.potashkin@rosalindfranklin.edu	Santiago, Jose A./CAJ-2999-2022	Santiago, Jose A./0000-0002-1431-5789	US Army Medical Research and Materiel Command [W81XWH-09-0708, W81XWH-13-1-0025]	US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This study was funded by the US Army Medical Research and Materiel Command under awards number W81XWH-09-0708 and W81XWH-13-1-0025 to J.A.P. Opinions, conclusions, interpretations and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 2013, J NEUROL NEUROSUR PS, V84, P537, DOI 10.1136/jnnp-2012-303808; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Aviles-Olmos I, 2013, BRAIN, V136, P374, DOI 10.1093/brain/aws009; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bosco D, 2012, J NEUROL SCI, V315, P39, DOI 10.1016/j.jns.2011.12.008; Buongiorno M, 2011, J NEUROL SCI, V310, P25, DOI 10.1016/j.jns.2011.06.046; Cereda E, 2012, NEUROLOGY, V78, P1507, DOI 10.1212/WNL.0b013e3182553cc9; Cereda E, 2011, DIABETES CARE, V34, P2614, DOI 10.2337/dc11-1584; Ding HL, 2011, MOVEMENT DISORD, V26, P2283, DOI 10.1002/mds.23934; Le DH, 2012, COMPUT BIOL CHEM, V37, P17, DOI 10.1016/j.compbiolchem.2012.02.004; Edwards YJK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016917; Furlong LI, 2013, TRENDS GENET, V29, P150, DOI 10.1016/j.tig.2012.11.004; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hardy J, 2009, CURR OPIN GENET DEV, V19, P254, DOI 10.1016/j.gde.2009.03.008; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Jain D, 2012, J MOL CELL BIOL, V4, P221, DOI 10.1093/jmcb/mjs025; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Liu M, 2007, PLOS GENET, V3, P958, DOI 10.1371/journal.pgen.0030096; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Molochnikov L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-26; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Palacios N, 2011, MOVEMENT DISORD, V26, P2253, DOI 10.1002/mds.23855; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Potashkin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043595; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Santiago JA, MOV DISORD IN PRESS; Santiago JA, 2013, TRENDS MOL MED, V19, P176, DOI 10.1016/j.molmed.2013.01.002; Scheele C, 2007, FASEB J, V21, P3653, DOI 10.1096/fj.07-8520com; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Sharma M, 2012, NEUROLOGY, V79, P659, DOI 10.1212/WNL.0b013e318264e353; Shehadeh LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009104; Tu ZD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003107; Wahlqvist ML, 2012, PARKINSONISM RELAT D, V18, P753, DOI 10.1016/j.parkreldis.2012.03.010; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Westmark CJ, 2013, MOL PSYCHIATR, V18, P425, DOI 10.1038/mp.2012.122	41	50	52	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83940	10.1371/journal.pone.0083940	http://dx.doi.org/10.1371/journal.pone.0083940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376773	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100146
J	Szeto, K; Latulippe, DR; Ozer, A; Pagano, JM; White, BS; Shalloway, D; Lis, JT; Craighead, HG				Szeto, Kylan; Latulippe, David R.; Ozer, Abdullah; Pagano, John M.; White, Brian S.; Shalloway, David; Lis, John T.; Craighead, Harold G.			RAPID-SELEX for RNA Aptamers	PLOS ONE			English	Article							IN-VITRO SELECTION; VASCULAR-PERMEABILITY; SYSTEMATIC EVOLUTION; LIGANDS; PROTEIN; BIND; NUCLEOTIDE; ENRICHMENT	Aptamers are high-affinity ligands selected from DNA or RNA libraries via SELEX, a repetitive in vitro process of sequential selection and amplification step. RNA SELEX is more complicated than DNA SELEX because of the additional transcription and reverse transcription steps. Here, we report a new selection scheme, RAPID-SELEX (RNA Aptamer isolation via Dual-cycles SELEX), that simplifies this process by systematically skipping unnecessary amplification steps. Using affinity microcolumns, we were able to complete a multiplex selection for protein targets, CHK2 and UBLCP1, in a third of the time required for analogous selections using a conventional SELEX Approach. High-throughput sequencing of the encriched pools from both RAPID and SELEX revealed many identical candiate aptamers from the starting pool of 5x10(15) sequences. For CHK2, the same sequence was preferentially enriched in both selections as the top candiate and was found to bind to ists respectiv3e target. These results demonstrate the efficiency and, most importantly, the roubustness of our selection scheme. RAPID provides a generalized approach that can be used with any selection technology to accelerate the rate of aptamer discovery, without compromising selection performance.	[Szeto, Kylan; Latulippe, David R.; Craighead, Harold G.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Ozer, Abdullah; Pagano, John M.; White, Brian S.; Shalloway, David; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA	Cornell University; Cornell University	Craighead, HG (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	hgc1@cornell.edu			National Institutes of Health [GM090320, DA030329]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the National Institutes of Health grants GM090320 and DA030329. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley J, 2012, ELECTROPHORESIS, V33, P2783, DOI 10.1002/elps.201200032; Berezovski M, 2006, J AM CHEM SOC, V128, P1410, DOI 10.1021/ja056943j; Burke DH, 1997, NUCLEIC ACIDS RES, V25, P2020, DOI 10.1093/nar/25.10.2020; Burmeister PE, 2005, CHEM BIOL, V12, P25, DOI 10.1016/j.chembiol.2004.10.017; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; CIESIOLKA J, 1995, RNA, V1, P538; Cox JC, 1998, BIOTECHNOL PROGR, V14, P845, DOI 10.1021/bp980097h; Cox JC, 2001, BIOORGAN MED CHEM, V9, P2525, DOI 10.1016/S0968-0896(01)00028-1; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Ditzler MA, 2013, NUCLEIC ACIDS RES, V41, P1873, DOI 10.1093/nar/gks1190; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Geiger A, 1996, NUCLEIC ACIDS RES, V24, P1029, DOI 10.1093/nar/24.6.1029; Gevertz J, 2005, RNA, V11, P853, DOI 10.1261/rna.7271405; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gong Q, 2012, ANAL CHEM, V84, P5365, DOI 10.1021/ac300873p; GREEN LS, 1995, CHEM BIOL, V2, P683, DOI 10.1016/1074-5521(95)90032-2; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Jensen KB, 1995, P NATL ACAD SCI USA, V92, P12220, DOI 10.1073/pnas.92.26.12220; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; LATHAM JA, 1994, NUCLEIC ACIDS RES, V22, P2817, DOI 10.1093/nar/22.14.2817; Latulippe DR, 2013, ANAL CHEM; Mendonsa SD, 2004, ANAL CHEM, V76, P5387, DOI 10.1021/ac049857v; Nitsche A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-48; Ozer A, 2013, NUCL ACIDS RES; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Park SM, 2009, LAB CHIP, V9, P1206, DOI 10.1039/b814993c; Peng L, 2007, MICROSC RES TECHNIQ, V70, P372, DOI 10.1002/jemt.20421; Raddatz MSL, 2008, ANGEW CHEM INT EDIT, V47, P5190, DOI 10.1002/anie.200800216; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Schutze T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029604; Thiel WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043836; Thiel WH, 2011, NUCLEIC ACID THER, V21, P253, DOI 10.1089/nat.2011.0288; Tok J, 2010, ELECTROPHORESIS, V31, P2055, DOI 10.1002/elps.200900543; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Zimmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009169	38	46	47	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82667	10.1371/journal.pone.0082667	http://dx.doi.org/10.1371/journal.pone.0082667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376564	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100050
J	Wright, ND; Symmonds, M; Morris, LS; Dolan, RJ				Wright, Nicholas D.; Symmonds, Mkael; Morris, Laurel S.; Dolan, Raymond J.			Dissociable Influences of Skewness and Valence on Economic Choice and Neural Activity	PLOS ONE			English	Article							DECISION-MAKING; RISK; REWARD; PROBABILITY; PREFERENCES; UNCERTAINTY; VARIANCE	Asymmetry in distributions of potential outcomes (i.e. skewness), and whether those potential outcomes reflect gains or losses (i.e. their valence), both exert a powerful influence on value-based choice. How valence affects the impact of skewness on choice is unknown. Here by orthogonally manipulating the skewness and valence of economic stimuli we show that both have an influence on choice. We show that the influence of skewness on choice is independent of valence, both across and within subjects. fMRI data revealed skew-related activity in bilateral anterior insula and dorsomedial prefrontal cortex, which shows no interaction with valence. Further, the expression of skew-related activity depends on an individual's preference for skewness, and this was again independent of valence-related preference. Our findings highlight the importance of skewness in choice and show that its influence, both behaviourally and neurally, is distinct from an influence of valence.	[Wright, Nicholas D.; Symmonds, Mkael; Morris, Laurel S.; Dolan, Raymond J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Symmonds, Mkael] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England	University of London; University College London; University of Oxford	Wright, ND (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	nick@nicholasdwright.com	Morris, Laurel/AAS-4655-2021; Wright, Nicholas/HHY-7227-2022	Dolan, Ray/0000-0001-9356-761X; Morris, Laurel S./0000-0002-5862-6650	Wellcome Trust Programme Grant [078865/Z/05/Z]; Wellcome Trust [091593/Z/10/Z]	Wellcome Trust Programme Grant(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Programme Grant 078865/Z/05/Z to RJD. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. Funder's URL: http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERFER CP, 1970, J BUS, V43, P341, DOI 10.1086/295286; Bossaerts P, 2010, BRAIN STRUCT FUNCT, V214, P645, DOI 10.1007/s00429-010-0253-1; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Burke CJ, 2011, J NEUROPHYSIOL, V106, P2415, DOI 10.1152/jn.00471.2011; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; CARACO T, 1984, ANIM BEHAV, V32, P76, DOI 10.1016/S0003-3472(84)80326-7; COOMBS CH, 1960, J EXP PSYCHOL, V60, P265, DOI 10.1037/h0041444; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Golec J, 1998, J POLIT ECON, V106, P205, DOI 10.1086/250007; Guitart-Masip M, 2011, J NEUROSCI, V31, P7867, DOI 10.1523/JNEUROSCI.6376-10.2011; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahnt T, 2011, NEUROIMAGE, V56, P709, DOI 10.1016/j.neuroimage.2010.05.058; LICHTENSTEIN S, 1965, J EXP PSYCHOL, V69, P162, DOI 10.1037/h0021570; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; LOPES LL, 1984, J EXP PSYCHOL HUMAN, V10, P465, DOI 10.1037/0096-1523.10.4.465; Lovallo D, 2000, J BEHAV DECIS MAKING, V13, P179, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<179::AID-BDM332>3.0.CO;2-J; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sortino F.A., 1994, J INVEST, V3, P59, DOI [10.3905/joi.3.3.59, DOI 10.3905/JOI.3.3.59]; Symmonds M, 2011, NEUROIMAGE, V58, P1139, DOI 10.1016/j.neuroimage.2011.06.087; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Viard A, 2011, J NEUROSCI, V31, P4613, DOI 10.1523/JNEUROSCI.4640-10.2011; Wright ND, 2012, J NEUROSCI, V32, P7009, DOI 10.1523/JNEUROSCI.0049-12.2012; Wu CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016838	31	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83454	10.1371/journal.pone.0083454	http://dx.doi.org/10.1371/journal.pone.0083454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376705	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100121
J	Yu, X; Li, Z; Shen, JX; Wu, WKK; Liang, JQ; Weng, XS; Qiu, GX				Yu, Xin; Li, Zheng; Shen, Jianxiong; Wu, William K. K.; Liang, Jinqian; Weng, Xisheng; Qiu, Guixing			MicroRNA-10b Promotes Nucleus Pulposus Cell Proliferation through RhoC-Akt Pathway by Targeting HOXD10 in Intervetebral Disc Degeneration	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; BREAST-CANCER; SIGNALING PATHWAY; UP-REGULATION; EXPRESSION; INVASION; MIR-B-10; GROWTH; TRANSFORMATION; METASTASIS	Aberrant proliferation of nucleus pulposus cell is implicated in the pathogenesis of intervertebral disc degeneration. Recent findings revealed that microRNAs, a class of small noncoding RNAs, could regulate cell proliferation in many pathological conditions. Here, we showed that miR-10b was dramatically upregulated in degenerative nucleus pulposus tissues when compared with nucleus pulposus tissues isolated from patients with idiopathic scoliosis. Moreover, miR-10b levels were associated with disc degeneration grade and downregulation of HOXD10. In cultured nucleus pulposus cells, miR-10b overexpression stimulated cell proliferation with concomitant translational inhibition of HOXD10 whereas restored expression of HOXD10 reversed the mitogenic effect of miR-10b. MiR-10b-mediated downregulation of HOXD10 led to increased RhoC expression and Akt phosphorylation. Either knockdown of RhoC or inhibition of Akt abolished the effect of miR-10b on nucleus pulposus cell proliferation. Taken together, aberrant miR-10b upregulation in intervertebral disc degeneration could contribute to abnormal nucleus pulposus cell proliferation through derepressing the RhoC-Akt pathway by targeting HOXD10. Our study also underscores the potential of miR-10b and the RhoC-Akt pathway as novel therapeutic targets in intervertebral disc degeneration.	[Yu, Xin; Li, Zheng; Shen, Jianxiong; Liang, Jinqian; Weng, Xisheng; Qiu, Guixing] Beijing Union Med Coll Hosp, Dept Orthopaed Surg, Peking Union Med Coll, Beijing, Peoples R China; [Yu, Xin] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Yu, Xin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, William K. K.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Wu, William K. K.] Chinese Univ Hong Kong, State Key Lab Digest Dis, LKS Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Wu, William K. K.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Shen, JX (corresponding author), Beijing Union Med Coll Hosp, Dept Orthopaed Surg, Peking Union Med Coll, Beijing, Peoples R China.	shenjianxiong@medmail.com.cn	Wu, William K.K./A-3277-2009; wu, william/HII-5817-2022; Shen, Jianxiong/AAH-6200-2019	Wu, William K.K./0000-0002-5662-5240; Weng, Xisheng/0000-0002-6021-1462; Qiu, Guixing/0000-0002-4597-9350	National Natural Science Foundation of P.R. China [81272053, 81330044, 81301596]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of P.R. China (Grant Number: 81272053,81330044, and 81301596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker A, 2011, SPINE PHILA PA 1976; Biagioni F, 2012, EMBO MOL MED, V4, P1214, DOI 10.1002/emmm.201201483; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Frampton AE, 2012, SURGERY; FRYMOYER JW, 1991, ORTHOP CLIN N AM, V22, P263; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Ha Tai-You, 2011, Immune Netw, V11, P309, DOI 10.4110/in.2011.11.6.309; Hangai M, 2008, SPINE J, V8, P732, DOI 10.1016/j.spinee.2007.07.392; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Johnson WEB, 2001, CONNECT TISSUE RES, V42, P197, DOI 10.3109/03008200109005650; Lau MT, 2012, CANCER LETT, V326, P191, DOI 10.1016/j.canlet.2012.08.016; Li QJ, 2012, TUMOR BIOL, V33, P1455, DOI 10.1007/s13277-012-0396-1; Li R, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-169; Li Z, 2013, J ORTHOP RES, V31, P847, DOI 10.1002/jor.22308; Li Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053176; Liu Z, 2012, INT J ONCOL, V40, P1553, DOI 10.3892/ijo.2012.1342; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2720; Masuda K, 2004, SPINE, V29, P2757, DOI 10.1097/01.brs.0000146048.14946.af; McCullough DF, 2010, BIOCHEM SOC T, V38, P1565, DOI 10.1042/BST0381565; Mussnich P, 2013, MOL ONCOL, V7, P531, DOI 10.1016/j.molonc.2013.01.002; Nakayama I, 2013, INT J ONCOL, V43, P63, DOI 10.3892/ijo.2013.1935; Nicolas Francisco E, 2010, Recent Pat DNA Gene Seq, V4, P142; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Preis M, 2011, CLIN CANCER RES, V17, P5812, DOI 10.1158/1078-0432.CCR-11-0695; Roy S, 2011, PHYSIOL GENOMICS, V43, P557, DOI 10.1152/physiolgenomics.00160.2010; Ruepp Andreas, 2012, Methods Mol Biol, V822, P249, DOI 10.1007/978-1-61779-427-8_17; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Sun LH, 2011, BRAIN RES, V1389, P9, DOI 10.1016/j.brainres.2011.03.013; Teplyuk NM, 2012, NEURO-ONCOLOGY, V14, P689, DOI 10.1093/neuonc/nos074; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Van Wynsberghe PM, 2011, METHOD CELL BIOL, V106, P219, DOI 10.1016/B978-0-12-544172-8.00008-6; Wu M, 2010, CANCER-AM CANCER SOC, V116, P2768, DOI 10.1002/cncr.25181; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048917; Zhang BH, 2009, ENVIRON HEALTH PERSP, V117, P231, DOI 10.1289/ehp.11841; Zhao CQ, 2008, SPINE, V33, pE858, DOI 10.1097/BRS.0b013e31818338e5; Zhao FL, 2012, J INT MED RES, V40, P859, DOI 10.1177/147323001204000304	39	150	158	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83080	10.1371/journal.pone.0083080	http://dx.doi.org/10.1371/journal.pone.0083080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376640	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100087
J	Chen, XF; Radany, EH; Wong, P; Ma, SL; Wu, K; Wang, B; Wong, JYC				Chen, Xufeng; Radany, Eric H.; Wong, Patty; Ma, Shenglin; Wu, Kan; Wang, Bing; Wong, Jeffrey Y. C.			Suberoylanilide Hydroxamic Acid Induces Hypersensitivity to Radiation Therapy in Acute Myelogenous Leukemia Cells Expressing Constitutively Active FLT3 Mutants	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TOTAL-BODY IRRADIATION; DOUBLE-STRAND BREAKS; TOTAL-MARROW IRRADIATION; HISTONE DEACETYLASE INHIBITORS; INTERNAL TANDEM DUPLICATIONS; TYROSINE KINASE; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; CONDITIONING REGIMEN	Histone deacetylase inhibitors (HDIs) have shown promise as candidate radiosensitizer for many types of cancers. However, the mechanisms of action are not well understood, and whether they could have clinical impact on radiotherapy for leukemia is unclear. In this study, we demonstrate that suberoylanilide hydroxamic acid (SAHA) can increase radiosensitivity of acute myeloid leukemia (AML) cells through posttranslational modification of Rad51 protein responses and selective inhibition of the homology-directed repair (HDR) pathway. Our data also showed that AML cells with mutant, constitutively active FMS-like tyrosine kinase-3 (FLT3) were more radiation sensitive, caused by compromised non-homologous end joining (NHEJ) repair. Furthermore, SAHA-induced radiosensitization were enhanced in AML cells with expression of these FLT3 mutants. The results of this study suggest that SAHA, a recently approved HDI in clinical trials, may act as a candidate component for novel conditioning regimens to improve efficacy for AML patients undergoing radiotherapy and chemotherapy.	[Chen, Xufeng; Radany, Eric H.; Wong, Patty; Wong, Jeffrey Y. C.] City Hope Natl Med Ctr, Ctr Canc, Dept Radiat Oncol, Duarte, CA USA; [Ma, Shenglin; Wu, Kan; Wang, Bing] First People s Hosp, Hangzhou Med Grp, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China	City of Hope; Hangzhou Medical College	Wong, JYC (corresponding author), City Hope Natl Med Ctr, Ctr Canc, Dept Radiat Oncol, Duarte, CA USA.	jwong@coh.org						Advani AS, 2005, CURR PHARM DESIGN, V11, P3449, DOI 10.2174/138161205774370807; Appelbaum FR, 2009, BEST PRACT RES CL HA, V22, P543, DOI 10.1016/j.beha.2009.10.004; Banath JP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-4; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Blaise D, 2001, BLOOD, V97, P3669, DOI 10.1182/blood.V97.11.3669; Brandts CH, 2005, CANCER RES, V65, P9643, DOI 10.1158/0008-5472.CAN-05-0422; Brunet S, 2012, J CLIN ONCOL; Chen XF, 2012, MOL CANCER RES, V10, P1052, DOI 10.1158/1541-7786.MCR-11-0587; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; CLIFT RA, 1991, BLOOD, V77, P1660; Collis SJ, 2001, NUCLEIC ACIDS RES, V29, P1534, DOI 10.1093/nar/29.7.1534; Dikomey E, 2000, INT J RADIAT ONCOL, V46, P481, DOI 10.1016/S0360-3016(99)00335-1; Doepfner KT, 2007, CRIT REV ONCOL HEMAT, V63, P215, DOI 10.1016/j.critrevonc.2007.05.005; DUSENBERY KE, 1995, INT J RADIAT ONCOL, V31, P119, DOI 10.1016/0360-3016(94)00335-I; Fan JS, 2010, BLOOD, V116, P5298, DOI 10.1182/blood-2010-03-272591; Garcia-Manero G, 2012, J CLIN ONCOL, V30, P2204, DOI 10.1200/JCO.2011.38.3265; Gilliland DG, 2002, CURR OPIN HEMATOL, V9, P274, DOI 10.1097/00062752-200207000-00003; Govedarovic N, 2011, J BUON, V16, P108; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Gunn A, 2011, J BIOL CHEM, V286, P42470, DOI 10.1074/jbc.M111.309252; HAROUSSEAU JL, 1989, J CLIN ONCOL, V7, P45, DOI 10.1200/JCO.1989.7.1.45; Hine CM, 2012, MOL THER, V20, P347, DOI 10.1038/mt.2011.215; Kadia TM, 2010, BRIT J HAEMATOL, V150, P72, DOI 10.1111/j.1365-2141.2010.08211.x; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kuroda S, 2012, ACTA MED OKAYAMA, V66, P83; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Li L, 2011, BLOOD, V117, P3131, DOI 10.1182/blood-2010-05-286070; Li YZ, 2002, BIOCHEM BIOPH RES CO, V299, P697, DOI 10.1016/S0006-291X(02)02692-X; Majhail NS, 2008, BIOL BLOOD MARROW TR, V14, P282, DOI 10.1016/j.bbmt.2007.12.488; Martinez-Iglesias O, 2008, CLIN TRANSL ONCOL, V10, P395, DOI 10.1007/s12094-008-0221-x; Mukherjee B, 2010, SEMIN RADIAT ONCOL, V20, P250, DOI 10.1016/j.semradonc.2010.05.002; Needham LA, 2011, J PHARMACOL EXP THER, V339, P132, DOI 10.1124/jpet.111.183640; Petruccelli LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020987; Raderschall E, 2002, CANCER RES, V62, P219; Romanski A, 2012, CELL CYCLE, V11, P3219, DOI 10.4161/cc.21565; Sak A, 2005, BRIT J CANCER, V92, P1089, DOI 10.1038/sj.bjc.6602457; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Seedhouse CH, 2006, LEUKEMIA, V20, P2130, DOI 10.1038/sj.leu.2404439; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Sheikhha Mohammad Hasan, 2003, Hematol J, V4, P41, DOI 10.1038/sj.thj.6200224; Shimizu H, 2009, BIOCHEM BIOPH RES CO, V382, P286, DOI 10.1016/j.bbrc.2009.03.020; Shulman LN, 1998, INT J RADIAT ONCOL, V42, P1113, DOI 10.1016/S0360-3016(98)00344-7; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; Subramanian C, 2005, P NATL ACAD SCI USA, V102, P4842, DOI 10.1073/pnas.0408351102; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; Weisberg E, 2009, DRUG RESIST UPDATE, V12, P81, DOI 10.1016/j.drup.2009.04.001; Wong JYC, 2013, INT J RADIAT ONCOL, V85, P148, DOI 10.1016/j.ijrobp.2012.03.033; Wong JYC, 2009, INT J RADIAT ONCOL, V73, P273, DOI 10.1016/j.ijrobp.2008.04.071; Wong JYC, 2006, BIOL BLOOD MARROW TR, V12, P306, DOI 10.1016/j.bbmt.2005.10.026; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434	56	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84515	10.1371/journal.pone.0084515	http://dx.doi.org/10.1371/journal.pone.0084515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367670	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900051
J	Cox, JH; Hussell, S; Sondergaard, H; Roepstorff, K; Bui, JV; Deer, JR; Zhang, J; Li, ZG; Lamberth, K; Kvist, PH; Padkjaer, S; Haase, C; Zahn, S; Odegard, VH				Cox, Jennifer H.; Hussell, Scott; Sondergaard, Henrik; Roepstorff, Kirstine; Bui, John-Vu; Deer, Jen Running; Zhang, Jun; Li, Zhan-Guo; Lamberth, Kasper; Kvist, Peter Helding; Padkjaer, Soren; Haase, Claus; Zahn, Stefan; Odegard, Valerie H.			Antibody-Mediated Targeting of the Orai1 Calcium Channel Inhibits T Cell Function	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; CRAC CHANNEL; INTRACELLULAR CALCIUM; STORE DEPLETION; ION SELECTIVITY; IMMUNE; IMMUNODEFICIENCY; STIM1; CYCLOSPORINE; LYMPHOCYTES	Despite the attractiveness of ion channels as therapeutic targets, there are no examples of monoclonal antibodies directed against ion channels in clinical development. Antibody-mediated inhibition of ion channels could offer a directed, specific therapeutic approach. To investigate the potential of inhibiting ion channel function with an antibody, we focused on Orai1, the pore subunit of the calcium channel responsible for store-operated calcium entry (SOCE) in T cells. Effector T cells are key drivers of autoimmune disease pathogenesis and calcium signaling is essential for T cell activation, proliferation, and cytokine production. We show here the generation of a specific anti-human Orai1 monoclonal antibody (mAb) against an extracellular loop of the plasma membrane-spanning protein. The anti-Orai1 mAb binds native Orai1 on lymphocytes and leads to cellular internalization of the channel. As a result, T cell proliferation, and cytokine production is inhibited in vitro. In vivo, anti-Orai1 mAb is efficacious in a human T cell-mediated graft-versus host disease (GvHD) mouse model. This study demonstrates the feasibility of antibody-mediated inhibition of Orai1 function and, more broadly, reveals the possibility of targeting ion channels with biologics for the treatment of autoimmunity and other diseases.	[Cox, Jennifer H.; Hussell, Scott; Bui, John-Vu; Odegard, Valerie H.] Novo Nordisk Res Ctr, Dept Cellular Immunol, Seattle, WA USA; [Sondergaard, Henrik; Haase, Claus] Novo Nordisk AS, Dept Immunopharmacol, Malov, Denmark; [Roepstorff, Kirstine; Kvist, Peter Helding] Novo Nordisk AS, Dept Histol, Malov, Denmark; [Deer, Jen Running] Novo Nordisk Res Ctr, Dept Mol Immunol, Seattle, WA USA; [Zhang, Jun] Beijing Novo Nordisk Pharmaceut Sci & Technol Co, Dept Cell Biol, Beijing, Peoples R China; [Li, Zhan-Guo] Beijing Univ Peoples Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China; [Lamberth, Kasper] Novo Nordisk AS, Dept Screening & Cell Technol, Malov, Denmark; [Padkjaer, Soren] Novo Nordisk AS, Dept Prot Struct & Biophys, Malov, Denmark; [Zahn, Stefan] Novo Nordisk AS, Dept Antibody Technol, Malov, Denmark	Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk	Odegard, VH (corresponding author), Novo Nordisk Res Ctr, Dept Cellular Immunol, Seattle, WA USA.	VALO@novonordisk.com			Novo Nordisk	Novo Nordisk(Novo Nordisk)	Funding was received from Novo Nordisk, a commercial source, and all authors are current employees or collaborators of Novo Nordisk and have no additional conflicting financial interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; Kuchroo VK, 2012, NAT MED, V18, P42, DOI 10.1038/nm.2621; LEDEIST F, 1995, BLOOD, V85, P1053, DOI 10.1182/blood.V85.4.1053.bloodjournal8541053; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; Lin FF, 2013, J PHARMACOL EXP THER, V345, P225, DOI 10.1124/jpet.112.202788; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; McCarl CA, 2010, J IMMUNOL, V185, P5845, DOI 10.4049/jimmunol.1001796; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PRESENT DH, 1994, DIGEST DIS SCI, V39, P374, DOI 10.1007/BF02090211; Rao A, 2009, IMMUNOL REV, V231, P5, DOI 10.1111/j.1600-065X.2009.00823.x; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Sondergaard H, CLIN EXPT I IN PRESS; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Yang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036379; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108	36	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82944	10.1371/journal.pone.0082944	http://dx.doi.org/10.1371/journal.pone.0082944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376610	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000042
J	Deja, S; Dawiskiba, T; Balcerzak, W; Orczyk-Pawilowicz, M; Glod, M; Pawelka, D; Mlynarz, P				Deja, Stanislaw; Dawiskiba, Tomasz; Balcerzak, Waldemar; Orczyk-Pawilowicz, Magdalena; Glod, Mateusz; Pawelka, Dorota; Mlynarz, Piotr			Follicular Adenomas Exhibit a Unique Metabolic Profile. H-1 NMR Studies of Thyroid Lesions	PLOS ONE			English	Article							PROTON-MAGNETIC-RESONANCE; NEEDLE-ASPIRATION BIOPSY; BREAST-CANCER; COLON TUMORS; NMR; NODULES; GENE; SPECTROSCOPY; EXPRESSION; DIAGNOSIS	Thyroid cancer is the most common endocrine malignancy. However, more than 90% of thyroid nodules are benign. It remains unclear whether thyroid carcinoma arises from preexisting benign nodules. Metabolomics can provide valuable and comprehensive information about low molecular weight compounds present in living systems and further our understanding of the biology regulating pathological processes. Herein, we applied H-1 NMR-based metabolic profiling to identify the metabolites present in aqueous tissue extracts of healthy thyroid tissue (H), non-neoplastic nodules (NN), follicular adenomas (FA) and malignant thyroid cancer (TC) as an alternative way of investigating cancer lesions. Multivariate statistical methods provided clear discrimination not only between healthy thyroid tissue and pathological thyroid tissue but also between different types of thyroid lesions. Potential biomarkers common to all thyroid lesions were identified, namely, alanine, methionine, acetone, glutamate, glycine, lactate, tyrosine, phenylalanine and hypoxanthine. Metabolic changes in thyroid cancer were mainly related to osmotic regulators (taurine and scyllo-and myo-inositol), citrate, and amino acids supplying the TCA cycle. Thyroid follicular adenomas were found to display metabolic features of benign non-neoplastic nodules and simultaneously displayed a partial metabolic profile associated with malignancy. This finding allows the discrimination of follicular adenomas from benign non-neoplastic nodules and thyroid cancer with similar accuracy. Moreover, the presented data indicate that follicular adenoma could be an individual stage of thyroid cancer development.	[Deja, Stanislaw] Opole Univ, Fac Chem, Opole, Poland; [Dawiskiba, Tomasz] Wroclaw Med Univ, Dept Vasc Gen & Transplantat Surg, Wroclaw, Poland; [Balcerzak, Waldemar; Glod, Mateusz; Pawelka, Dorota] Wroclaw Med Univ, Dept & Clin Gen Gastroenterol & Endocrinol Surg 1, Wroclaw, Poland; [Orczyk-Pawilowicz, Magdalena] Wroclaw Med Univ, Dept Chem & Immunochem, Wroclaw, Poland; [Mlynarz, Piotr] Wroclaw Univ Technol, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland	University of Opole; Wroclaw Medical University; Wroclaw Medical University; Wroclaw Medical University; Wroclaw University of Science & Technology	Mlynarz, P (corresponding author), Wroclaw Univ Technol, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland.	piotr.mlynarz@pwr.wroc.pl	Orczyk-Pawiłowicz, Magdalena/AAV-9298-2021; Deja, Stanislaw/AAI-7526-2020	Deja, Stanislaw/0000-0002-7714-2547; Pawelka, Dorota/0000-0003-2077-7629; Dawiskiba, Tomasz/0000-0003-2329-2918; Mlynarz, Piotr/0000-0002-8502-4022	National Science Centre [N N403 154640]; European Social Fund	National Science Centre(National Science Centre, Poland); European Social Fund(European Social Fund (ESF))	National Science Centre grant nr N N403 154640 "Design of peptide libraries and metabolomics studies as a tool in the diagnosis of thyroid cancer". Stanislaw Deja is a recipient of a Ph.D. scholarship under a project funded by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N, 2008, WORLD J SURG, V32, P1237, DOI 10.1007/s00268-008-9484-1; Barden CB, 2003, CLIN CANCER RES, V9, P1792; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Budczies J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-334; Camacho D, 2005, METABOLOMICS, V1, P53, DOI 10.1007/s11306-005-1107-3; DeFeo EM, 2011, NAT REV UROL, V8, P301, DOI 10.1038/nrurol.2011.53; DELBRIDGE L, 1994, WORLD J SURG, V18, P512, DOI 10.1007/BF00353751; DeLellis R, 2004, PATHOLOGY GENETICS T; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Eszlinger M, 2010, MOL CELL ENDOCRINOL, V322, P29, DOI 10.1016/j.mce.2010.01.010; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fischer S, 2008, ARCH PATHOL LAB MED, V132, P359, DOI 10.1043/1543-2165(2008)132[359:AOITTN]2.0.CO;2; Gao HC, 2012, J CANCER RES CLIN, V138, P753, DOI 10.1007/s00432-011-1134-6; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Jimenez B, 2013, J PROTEOME RES, V12, P959, DOI 10.1021/pr3010106; Jordan KW, 2011, ACTA CYTOL, V55, P584, DOI 10.1159/000333271; Kouniavsky G, 2012, J SURG ONCOL, V105, P438, DOI 10.1002/jso.21935; LEAN CL, 1995, J CLIN ENDOCR METAB, V80, P1306, DOI 10.1210/jc.80.4.1306; Miccoli P, 2012, SURGERY, V152, P1118, DOI 10.1016/j.surg.2012.08.037; MORENO A, 1993, NMR BIOMED, V6, P111, DOI 10.1002/nbm.1940060202; Moreno A, 1996, NMR BIOMED, V9, P33, DOI 10.1002/(SICI)1099-1492(199602)9:1<33::AID-NBM391>3.0.CO;2-G; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nikiforov YE, 2011, ARCH PATHOL LAB MED, V135, P569, DOI 10.1043/2010-0664-RAIR.1; Ong E. S., 2010, MOL CELL PROTEOMICS, DOI [10.1074/mcp.M900551-MCP200., DOI 10.1074/MCP.M900551-MCP200, 10.1074/mcp.M900551-MCP200]; Rocha CM, 2010, J PROTEOME RES, V9, P319, DOI 10.1021/pr9006574; RUSSELL P, 1994, AM J MED, V96, P383, DOI 10.1016/0002-9343(94)90071-X; Sakorafas GH, 2010, SURG ONCOL, V19, pE130, DOI 10.1016/j.suronc.2010.06.003; Salabe GB, 2001, BIOMED PHARMACOTHER, V55, P39, DOI 10.1016/S0753-3322(00)00010-X; Sapio MR, 2007, ENDOCR-RELAT CANCER, V14, P1089, DOI 10.1677/ERC-07-0147; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Schmid KW, 2006, VIRCHOWS ARCH, V448, P385, DOI 10.1007/s00428-006-0162-0; Serra S, 2008, ENDOCR PATHOL, V19, P156, DOI 10.1007/s12022-008-9031-5; Silwood CJL, 2002, J DENT RES, V81, P422, DOI 10.1177/154405910208100613; Sinclair AJ, 2010, NMR BIOMED, V23, P123, DOI 10.1002/nbm.1428; Tessem MB, 2010, J PROTEOME RES, V9, P3664, DOI 10.1021/pr100176g; Torregrossa L, 2012, J PROTEOME RES, V11, P3317, DOI 10.1021/pr300105e; Trovato M, 2003, HISTOL HISTOPATHOL, V18, P393, DOI 10.14670/HH-18.393; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329; Yao ZZ, 2011, MOL BIOSYST, V7, P2608, DOI 10.1039/c1mb05029j; Zhang J, 2012, BBA-MOL BASIS DIS, V1822, P1807, DOI 10.1016/j.bbadis.2012.08.001; Zhao JM, 2008, ONCOL REP, V19, P329	46	46	51	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84637	10.1371/journal.pone.0084637	http://dx.doi.org/10.1371/journal.pone.0084637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376829	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000156
J	Jacobs, JE; Wagner, M; Dhahbi, J; Boffelli, D; Martin, DIK				Jacobs, James E.; Wagner, Mark; Dhahbi, Joseph; Boffelli, Dario; Martin, David I. K.			Deficiency of MIWI2 (Piwil4) Induces Mouse Erythroleukemia Cell Differentiation, but Has No Effect on Hematopoiesis In Vivo	PLOS ONE			English	Article							DNA METHYLATION; SMALL RNAS; MILI; PROTEIN; GENES; MAINTENANCE; EXPRESSION; HOMOLOG; FAMILY; TESTES	Piwi proteins and their small non-coding RNA partners are involved in the maintenance of stem cell character and genome integrity in the male germ cells of mammals. MIWI2, one of the mouse Piwi-like proteins, is expressed in the prepachytene phase of spermatogenesis during the period of de novo methylation. Absence of this protein leads to meiotic defects and a progressive loss of germ cells. There is an accumulation of evidence that Piwi proteins may be active in hematopoietic tissues. Thus, MIWI2 may have a role in hematopoietic stem and/or progenitor cell self-renewal and differentiation, and defects in MIWI2 may lead to abnormal hematopoiesis. MIWI2 mRNA can be detected in a mouse erythroblast cell line by RNA-seq, and shRNA-mediated knockdown of this mRNA causes the cells to take on characteristics of differentiated erythroid precursors. However, there are no detectable hematopoietic abnormalities in a MIWI2-deficient mouse model. While subtle, non-statistically significant changes were noted in the hematopoietic function of mice without a functional MIWI2 gene when compared to	[Jacobs, James E.; Wagner, Mark; Dhahbi, Joseph; Boffelli, Dario; Martin, David I. K.] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Jacobs, JE (corresponding author), Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA.	jjacobs@chori.org			California Institute for Regenerative Medicine; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES016581] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded through the California Institute for Regenerative Medicine (http://www.cirm.ca.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cichocki F, 2010, J IMMUNOL, V185, P2009, DOI 10.4049/jimmunol.1000855; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Darricarrere N, 2013, P NATL ACAD SCI USA, V110, P1297, DOI 10.1073/pnas.1213283110; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kanathezhath B, 2011, EXP BIOL MED, V236, P492, DOI 10.1258/ebm.2011.010216; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Nolde MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071950; Ro S, 2007, RNA, V13, P1693, DOI 10.1261/rna.640307; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Ruscetti SK, 1999, INT J BIOCHEM CELL B, V31, P1089, DOI 10.1016/S1357-2725(99)00074-6; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Wagner MW, 2008, J BIOL CHEM, V283, P21382, DOI 10.1074/jbc.M709953200; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	28	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82573	10.1371/journal.pone.0082573	http://dx.doi.org/10.1371/journal.pone.0082573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376547	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000016
J	Sand, JM; Larsen, L; Hogaboam, C; Martinez, F; Han, ML; Larsen, MR; Nawrocki, A; Zheng, QL; Karsdal, MA; Leeming, DJ				Sand, Jannie Marie; Larsen, Lise; Hogaboam, Cory; Martinez, Fernando; Han, MeiLan; Larsen, Martin Rossel; Nawrocki, Arkadiusz; Zheng, Qinlong; Karsdal, Morten Asser; Leeming, Diana Julie			MMP Mediated Degradation of Type IV Collagen Alpha 1 and Alpha 3 Chains Reflects Basement Membrane Remodeling in Experimental and Clinical Fibrosis - Validation of Two Novel Biomarker Assays	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; ENZYME-IMMUNOASSAY; LIVER FIBROSIS; GELATINASE-A; SERUM; SEQUENCE; PEPTIDE; LAMININ; UNIQUE; MARKER	Objectives: Fibrosis is characterized by excessive tissue remodeling resulting from altered expression of various growth factors, cytokines and proteases. We hypothesized that matrix metalloproteinase (MMP) mediated degradation of type IV collagen, a main component of the basement membrane, will release peptide fragments (neo-epitopes) into the circulation. Here we present the development of two competitive enzyme-linked immunosorbent assays (ELISAs) for assessing the levels of specific fragments of type IV collagen alpha 1 (C4M12a1) and alpha 3 (C4M12a3) chains in serum as indicators of fibrosis. Methods: Fragments of type IV collagen cleaved in vitro by MMP-12 were identified by mass spectrometry, and two were chosen for ELISA development due to their unique sequences. The assays were evaluated using samples from a carbon tetrachloride (CCl4) rat model of liver fibrosis and from patients with idiopathic pulmonary fibrosis (IPF) or chronic obstructive pulmonary disease (COPD). Results: Two technically robust ELISAs were produced using neo-epitope specific monoclonal antibodies. Mean serum C4M12a1 levels were significantly elevated in CCl4-treated rats compared with controls in weeks 12, 16, and 20, with a maximum increase of 102% at week 16 (p < 0.0001). Further, C4M12a1 levels correlated with the total collagen content of the liver in CCl4-treated rats (r = 0.43, p = 0.003). Mean serum C4M12a3 levels were significantly elevated in patients with mild, moderate, and severe IPF, and COPD relative to healthy controls, with a maximum increase of 321% in COPD (p < 0.0001). Conclusions: Two assays measuring C4M12a1 and C4M12a3 enabled quantification of MMP mediated degradation of type IV collagen in serum. C4M12a1 was elevated in a pre-clinical model of liver fibrosis, and C4M12a3 was elevated in IPF and COPD patients. This suggests the use of these assays to investigate pathological remodeling of the basement membrane in different organs. However, validations in larger clinical settings are needed.	[Sand, Jannie Marie; Larsen, Lise; Karsdal, Morten Asser; Leeming, Diana Julie] Nordic, Fibrosis Biol & Biomarkers, Biosci, Herlev, Denmark; [Hogaboam, Cory] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Martinez, Fernando; Han, MeiLan] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Larsen, Martin Rossel; Nawrocki, Arkadiusz] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Zheng, Qinlong] Nord Biosci Beijing, Beijing, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Southern Denmark; Nordic Bioscience	Sand, JM (corresponding author), Nordic, Fibrosis Biol & Biomarkers, Biosci, Herlev, Denmark.	jsa@nordicbioscience.com	ZHENG, Qin/T-2925-2019; hogaboam, cory/M-3578-2014; Hogaboam, Cory M./AAI-1433-2021; Larsen, Martin Rossel/F-1411-2015	Hogaboam, Cory M./0000-0003-3366-4850; Sand, Jannie Marie Bulow/0000-0002-3239-0934; Karsdal, Morten/0000-0001-5026-8740; Larsen, Martin Rossel/0000-0001-6203-0123	Danish Research Foundation (Den Danske Forskningsfond)	Danish Research Foundation (Den Danske Forskningsfond)	The authors gratefully acknowledge the funding from the Danish Research Foundation (Den Danske Forskningsfond) supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billinghurst RC, 2010, METHODS MOL BIOL, V622, P349, DOI 10.1007/978-1-60327-299-5_21; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; Chandler S, 1996, BIOCHEM BIOPH RES CO, V228, P421, DOI 10.1006/bbrc.1996.1677; Claria J, 1999, ASCITES AND RENAL DYSFUNCTION IN LIVER DISEASE, P379; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Corbel M, 2001, INFLAMM RES, V50, P129, DOI 10.1007/s000110050736; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; GEFTER ML, 1977, SOMAT CELL GENET, V3, P231, DOI 10.1007/BF01551818; Gioia M, 2010, J BIOL INORG CHEM, V15, P1219, DOI 10.1007/s00775-010-0680-8; Gioia M, 2009, J MOL BIOL, V386, P419, DOI 10.1016/j.jmb.2008.12.021; Han YP, 2006, J GASTROEN HEPATOL, V21, pS88, DOI 10.1111/j.1440-1746.2006.04586.x; Henriksen K, 2011, DRUG DISCOV TODAY, V16, P967, DOI 10.1016/j.drudis.2011.06.010; HOGEMANN B, 1984, CLIN CHIM ACTA, V144, P1, DOI 10.1016/0009-8981(84)90254-7; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kalluri R, 1997, J CLIN INVEST, V99, P2470, DOI 10.1172/JCI119431; Karsdal MA, 2011, CLIN BIOCHEM, V44, P1278, DOI 10.1016/j.clinbiochem.2011.08.1135; Karsdal MA, 2010, CLIN BIOCHEM, V43, P793, DOI 10.1016/j.clinbiochem.2010.03.015; Kasuga I, 1996, Respirology, V1, P277, DOI 10.1111/j.1440-1843.1996.tb00043.x; KAWAMURA M, 1994, THORAX, V49, P144, DOI 10.1136/thx.49.2.144; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kisseleva Tatiana, 2008, Proc Am Thorac Soc, V5, P338, DOI 10.1513/pats.200711-168DR; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Lagente V, 2005, BRAZ J MED BIOL RES, V38, P1521, DOI 10.1590/S0100-879X2005001000009; Leeming DJ, 2011, BIOMARKERS, V16, P616, DOI 10.3109/1354750X.2011.620628; Leeming DJ, 2010, CLIN BIOCHEM, V43, P1249, DOI 10.1016/j.clinbiochem.2010.07.025; Leeming DJ, 2012, HEPATOL RES, V42, P482, DOI 10.1111/j.1872-034X.2011.00946.x; Luo YQ, 2010, CLIN CHIM ACTA, V411, P510, DOI 10.1016/j.cca.2010.01.001; MACKAY AR, 1990, J BIOL CHEM, V265, P21929; Salazar LM, 2011, LUNG, V189, P101, DOI 10.1007/s00408-011-9279-2; MARIYAMA M, 1994, J BIOL CHEM, V269, P23013; MATSUMOTO E, 1989, ACTA PATHOL JAPON, V39, P23; MATSUMOTO E, 1989, ACTA PATHOL JAPON, V39, P217; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Monaco S, 2006, PROTEIN SCI, V15, P2805, DOI 10.1110/ps.062430706; MORRISON KE, 1991, AM J HUM GENET, V49, P545; Munoz-Luque J, 2008, J PHARMACOL EXP THER, V324, P475, DOI 10.1124/jpet.107.131896; Murawaki Y, 1996, J HEPATOL, V24, P148, DOI 10.1016/S0168-8278(96)80023-7; Neubauer K, 1999, J HEPATOL, V31, P692, DOI 10.1016/S0168-8278(99)80350-X; NIEMELA O, 1985, EUR J CLIN INVEST, V15, P132, DOI 10.1111/j.1365-2362.1985.tb00156.x; O'Reilly PJ, 2008, CURR OPIN PHARMACOL, V8, P242, DOI 10.1016/j.coph.2008.02.003; OBATA K, 1989, CLIN CHIM ACTA, V181, P293, DOI 10.1016/0009-8981(89)90235-0; Pardo A, 2008, INT J BIOCHEM CELL B, V40, P1141, DOI 10.1016/j.biocel.2007.11.020; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; RISTELI J, 1981, ANAL BIOCHEM, V113, P372, DOI 10.1016/0003-2697(81)90091-9; Rosenquist C, 1998, CLIN CHEM, V44, P2281; Ruiz S, 1999, J LEUKOCYTE BIOL, V66, P416, DOI 10.1002/jlb.66.3.416; SCHUPPAN D, 1986, J CLIN INVEST, V78, P241, DOI 10.1172/JCI112557; Segovia-Silvestre T, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-19; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shipley JM, 1996, P NATL ACAD SCI USA, V93, P3942, DOI 10.1073/pnas.93.9.3942; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Thingholm Tine E., 2009, V527, P57, DOI 10.1007/978-1-60327-834-8_5; Veidal SS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-22; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	62	119	124	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84934	10.1371/journal.pone.0084934	http://dx.doi.org/10.1371/journal.pone.0084934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376856	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000170
J	Thaitrong, N; Charlermroj, R; Himananto, O; Seepiban, C; Karoonuthaisiri, N				Thaitrong, Numrin; Charlermroj, Ratthaphol; Himananto, Orawan; Seepiban, Channarong; Karoonuthaisiri, Nitsara			Implementation of Microfluidic Sandwich ELISA for Superior Detection of Plant Pathogens	PLOS ONE			English	Article							VIRUS; AMPLIFICATION; CITRULLI; PHYSICS; ASSAY	Rapid and economical screening of plant pathogens is a high-priority need in the seed industry. Crop quality control and disease surveillance demand early and accurate detection in addition to robustness, scalability, and cost efficiency typically required for selective breeding and certification programs. Compared to conventional bench-top detection techniques routinely employed, a microfluidic-based approach offers unique benefits to address these needs simultaneously. To our knowledge, this work reports the first attempt to perform microfluidic sandwich ELISA for Acidovorax citrulli (Ac), watermelon silver mottle virus (WSMoV), and melon yellow spot virus (MYSV) screening. The immunoassay occurs on the surface of a reaction chamber represented by a microfluidic channel. The capillary force within the microchannel draws a reagent into the reaction chamber as well as facilitates assay incubation. Because the underlying pad automatically absorbs excess fluid, the only operation required is sequential loading of buffers/reagents. Buffer selection, antibody concentrations, and sample loading scheme were optimized for each pathogen. Assay optimization reveals that the 20-folds lower sample volume demanded by the microchannel structure outweighs the 2- to 4-folds higher antibody concentrations required, resulting in overall 5-10 folds of reagent savings. In addition to cutting the assay time by more than 50%, the new platform offers 65% cost savings from less reagent consumption and labor cost. Our study also shows 12.5-, 2-, and 4-fold improvement in assay sensitivity for Ac, WSMoV, and MYSV, respectively. Practical feasibility is demonstrated using 19 real plant samples. Given a standard 96-well plate format, the developed assay is compatible with commercial fluorescent plate readers and readily amendable to robotic liquid handling systems for completely hand-free assay automation.	[Thaitrong, Numrin; Charlermroj, Ratthaphol; Himananto, Orawan; Seepiban, Channarong; Karoonuthaisiri, Nitsara] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Klongluang, Pathum Thani, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Thaitrong, N (corresponding author), Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Klongluang, Pathum Thani, Thailand.	numrin.tha@biotec.or.th						Anidrunddha P, 2010, J IMMUNOL, V144, P18; ARUNASALAM G, 1989, J PHYTOPATHOL, V126, P160, DOI 10.1111/j.1439-0434.1989.tb01099.x; Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916; Blow N, 2007, NAT METHODS, V4, P665, DOI 10.1038/nmeth0807-665; Charlermroj R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062344; Chen H, 2008, LAB CHIP, V8, P826, DOI 10.1039/b719846a; Chen TC, 2010, ARCH VIROL, V155, P1085, DOI 10.1007/s00705-010-0688-y; Chiemsombat P, 2008, ARCH VIROL, V153, P571, DOI 10.1007/s00705-007-0024-3; Coutts BA, 2009, PHYTOPATHOLOGY, V99, P1156, DOI 10.1094/PHYTO-99-10-1156; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Gervais T, 2006, CHEM ENG SCI, V61, P1102, DOI 10.1016/j.ces.2005.06.024; Gitaitis R, 2007, ANNU REV PHYTOPATHOL, V45, P371, DOI 10.1146/annurev.phyto.45.062806.094321; Hadersdorfer J, 2011, ANN APPL BIOL, V159, P456, DOI 10.1111/j.1744-7348.2011.00510.x; Herman RA, 2011, IMMUNOASSAYS AGR BIO, P208; Himananto O, 2011, PLANT DIS, V95, P1172, DOI 10.1094/PDIS-12-10-0889; Hopkins DL, 2002, HORTSCIENCE, V37, P924, DOI 10.21273/HORTSCI.37.6.924; Kai JH, 2012, LAB CHIP, V12, P4257, DOI 10.1039/c2lc40585g; Kato K, 2000, PHYTOPATHOLOGY, V90, P422, DOI 10.1094/PHYTO.2000.90.4.422; Keinath AP, 2011, HORTSCIENCE, V46, P532, DOI 10.21273/HORTSCI.46.4.532; Kerpedjieva SS, 2012, STEM CELLS DEV, V21, P2541, DOI 10.1089/scd.2011.0711; Kim J, 2011, BIOANALYSIS, V3, P227, DOI 10.4155/BIO.10.172; Lakkis M, 2012, TRANSLATIONAL MED; Larsen RC, 2003, PLANT DIS, V87, P1366, DOI 10.1094/PDIS.2003.87.11.1366; Li BJ, 2013, EUR J PLANT PATHOL, V135, P903, DOI 10.1007/s10658-012-0136-9; Lopez MM, 2003, INT MICROBIOL, V6, P233, DOI 10.1007/s10123-003-0143-y; Minc N, 2004, CR PHYS, V5, P565, DOI 10.1016/j.crhy.2004.04.003; Ohno K, 2008, ELECTROPHORESIS, V29, P4443, DOI 10.1002/elps.200800121; Ravindran A, 2012, PHYTOPATHOLOGY, V102, P899, DOI 10.1094/PHYTO-03-12-0055-R; Seepiban C, 2011, ARCH VIROL, V156, P263, DOI 10.1007/s00705-010-0856-0; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Szemes M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni069; Thomma BPHJ, 2003, MOL PLANT PATHOL, V4, P225, DOI 10.1046/J.1364-3703.2003.00173.X; Walcott RR, 2003, HORTTECHNOLOGY, V13, P40, DOI 10.21273/HORTTECH.13.1.0040; Wang L, 2007, J AGR FOOD CHEM, V55, P10509, DOI 10.1021/jf0721242	35	18	18	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83231	10.1371/journal.pone.0083231	http://dx.doi.org/10.1371/journal.pone.0083231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376668	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000072
J	van Abeelen, AFM; Elias, SG; de Jong, PA; Grobbee, DE; Bossuyt, PMM; van der Schouw, YT; Roseboom, TJ; Uiterwaal, CSPM				van Abeelen, Annet F. M.; Elias, Sjoerd G.; de Jong, Pim A.; Grobbee, Diederick E.; Bossuyt, Patrick M. M.; van der Schouw, Yvonne T.; Roseboom, Tessa J.; Uiterwaal, Cuno S. P. M.			Famine in the Young and Risk of Later Hospitalization for COPD and Asthma	PLOS ONE			English	Article							LUNG-FUNCTION; MECHANICS; DISEASE	Background: Undernutrition during critical periods of growth and development may permanently affect lung physiology and function. Objectives: To investigate whether acute undernutrition in childhood or young adulthood increases the risk of later hospitalization for obstructive airways disease, chronic obstructive pulmonary disease (COPD), or asthma. Methods: We studied 7,841 women from Prospect-EPIC who experienced the 1944-45 Dutch famine between ages 0 and 21. Pulmonary outcomes were measured by registered hospital admissions and exposure-blinded computed tomography (CT) in a subgroup of 295 women. With Cox proportional hazard regression we explored effects of famine exposure on risk of hospitalization for obstructive airways disease, COPD, and asthma. With logistic regression we explored effects of famine on risk of CT evidence of pulmonary disease. Results: Risks of hospitalization for obstructive airways disease, COPD, and asthma were increased after moderate famine exposure, and significantly increased after severe famine exposure: hazard ratios for obstructive airways disease were 1.31 (95% CI: 0.97 to 1.77) and 1.57 (95% CI: 1.10 to 2.23) respectively. Associations between famine exposure and hospitalization for COPD were stronger in ever-smokers than in never-smokers. Conclusions: Acute undernutrition in childhood or young adulthood is associated with an increased risk of later COPD and asthma hospitalization, possibly through increased sensitivity for tobacco smoke.	[van Abeelen, Annet F. M.; Elias, Sjoerd G.; Grobbee, Diederick E.; van der Schouw, Yvonne T.; Uiterwaal, Cuno S. P. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van Abeelen, Annet F. M.; Bossuyt, Patrick M. M.; Roseboom, Tessa J.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Roseboom, Tessa J.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	van Abeelen, AFM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	annetvanabeelen@gmail.com	de Jong, Pim A/G-7220-2014; Grobbee, Diederick/C-7651-2014; Elias, Sjoerd G/E-6057-2011; van der Schouw, Yvonne T./F-8327-2014; Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016	de Jong, Pim A/0000-0003-4840-6854; Grobbee, Diederick/0000-0003-4472-4468; Elias, Sjoerd G/0000-0003-3903-4024; van der Schouw, Yvonne T./0000-0002-4605-435X; Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128; Roseboom, Tessa/0000-0003-0564-5994	"Europe Against Cancer'' Program of the European Commission (SANCO); Dutch Ministry of Health; Dutch Cancer Society; ZonMw; Netherlands Organization for Health Research and Development; World Cancer Research Fund (WCRF)	"Europe Against Cancer'' Program of the European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Health; Dutch Cancer Society(KWF Kankerbestrijding); ZonMw(Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF))	The Prospect-EPIC study was supported by "Europe Against Cancer'' Program of the European Commission (SANCO); the Dutch Ministry of Health; the Dutch Cancer Society; ZonMw, the Netherlands Organization for Health Research and Development; World Cancer Research Fund (WCRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 1998, MOTHERS BABIES DIS L; Bogin B., 1999, PATTERNS HUMAN GROWT, V2nd ed.; Boker LK, 2001, EUR J EPIDEMIOL, V17, P1047, DOI 10.1023/A:1020009325797; Burger G, 1948, TUSSEN ONS VOLK HONG; Cameron N, 2002, YEARB PHYS ANTHROPOL, V45, P159, DOI 10.1002/ajpa.10183; Coxson HO, 2004, AM J RESP CRIT CARE, V170, P748, DOI 10.1164/rccm.200405-651OC; Dias CM, 2004, J APPL PHYSIOL, V97, P1888, DOI 10.1152/japplphysiol.00091.2004; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Elias SG, 2004, J NATL CANCER I, V96, P539, DOI 10.1093/jnci/djh087; Jones A, 2008, EUR HEART J, V29, P2164, DOI 10.1093/eurheartj/ehn292; Jong Loe de, 1981, KONINKRIJK NEDERLAND; Lawlor DA, 2005, THORAX, V60, P851, DOI 10.1136/thx.2005.042408; Lopuhaa CE, 2000, THORAX, V55, P555, DOI 10.1136/thorax.55.7.555; Mataloun MMGB, 2009, BRAZ J MED BIOL RES, V42, P606, DOI 10.1590/S0100-879X2009000700004; Narayanan M, 2012, AM J RESP CRIT CARE, V185, P186, DOI 10.1164/rccm.201107-1348OC; Riboli E, 1997, INT J EPIDEMIOL S1, V26, pS6; Ryter Stefan W, 2010, Proc Am Thorac Soc, V7, P13, DOI 10.1513/pats.200909-101JS; SAHEBJAMI H, 1979, AM REV RESPIR DIS, V119, P443; Statistics Netherlands, DOODS UITG LIJST LEE; Statistics Netherlands, BEV GESL LEEFT BURG; Statistics Netherlands, 2020, BEV HUISH BEV VAN 18; Trienekens GM., 1985, TUSSEN ONS VOLK HONG; United Nations Food and Agriculture Organization FAO, 2010, FOOD COMES 1 FAO 8 M; World Health Organization, 2011, NCD MORT MORB	24	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82636	10.1371/journal.pone.0082636	http://dx.doi.org/10.1371/journal.pone.0082636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376558	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000019
J	Zhou, JW; Wang, W; Gao, ZH; Peng, XL; Chen, XL; Chen, W; Xu, WY; Xu, HX; Lin, MC; Jiang, SS				Zhou, Jianwen; Wang, Wei; Gao, Zhenhua; Peng, Xueling; Chen, Xulin; Chen, Wei; Xu, Weiyi; Xu, Haixiong; Lin, Marie C.; Jiang, Songshan			MicroRNA-155 Promotes Glioma Cell Proliferation via the Regulation of MXI1	PLOS ONE			English	Article							VIRUS-INDUCED LYMPHOMAS; HUMAN GLIOBLASTOMA CELLS; GENE-EXPRESSION; NONCODING RNA; PROSTATE-CANCER; DOWN-REGULATION; C-MYC; MUTATION; GROWTH; TUMORS	Gliomas are the most common and aggressive primary tumors in the central nervous system. Recently, Max interactor-1 (MXI1), an antagonist of c-Myc that is involved in brain tumor progression, has been reported to be deregulated in a variety of tumors including glioma. However, the mechanism of MXI1 deregulation in gliomas remains unclear. In this study, we show that the relative expression level of MXI1 is markedly down-regulated in glioma cell lines. Using integrated bioinformatic analysis and experimental confirmation, we identified several miRNAs by screening a panel of predicted miRNAs that may regulate the MXI1 3'UTR. The strongest inhibitory miRNA, miR-155, can attenuate the activity of a luciferase reporter gene that is fused with the MXI1 3'UTR and decrease the expression levels of MXI1 mRNA and protein in U87 glioma cells. The potential role of miR-155 in promoting glioma cell proliferation by targeting MXI1 was confirmed in various glioma cell lines by rescue experiments using MTT assays, EdU incorporation assay, and cell counting experiments. In addition, we determined that the level of MXI1 mRNA was inversely correlated with the expression of miR-155 in 18 sets of glioblastoma multiforme specimens. These findings reveal for the first time that the targeting of MXI1 by miR-155 may result in a reduction in MXI1 expression and promote glioma cell proliferation; this result suggests a novel function of miR-155 in targeting MXI1 in glioma-genesis.	[Zhou, Jianwen; Peng, Xueling; Xu, Weiyi; Jiang, Songshan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Jianwen; Chen, Xulin; Jiang, Songshan] Sun Yat Sen Univ, Sch Life Sci, Key Lab Gene Engn, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wei] PLA, Guangzhou Command, Guangzhou Gen Hosp, Epilepsy Ctr,Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Gao, Zhenhua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Wei] Guangzhou Med Univ, Affiliated Hosp 2, Dept Gynecol, Guangzhou, Guangdong, Peoples R China; [Xu, Haixiong] Sun Yat Sen Univ, Affiliated Shantou Hosp, Dept Neurosurg, Shantou, Peoples R China; [Lin, Marie C.] Kunming Med Univ, Biomed Eng Res Ctr, Kunming, Peoples R China; [Zhou, Jianwen] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wei] HuaBo Biopharmaceut Inst Guangzhou, Guangzhou, Guangdong, Peoples R China; [Peng, Xueling] Shenzhen State High Tech Ind Innovat Ctr, Shenzhen, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Kunming Medical University; Sun Yat Sen University	Jiang, SS (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	jiangssh@mail.sysu.edu.cn			National Natural Science Foundation of China [81272773]; Natural Science Foundation of Guangdong Province [S2013010012170]; Scientific and Technological Planning of Guangzhou [2012J4100082]; Fundamental Research Funds for the Central Universities [10lgpy23]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Scientific and Technological Planning of Guangzhou; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by grants from the National Natural Science Foundation of China (Grant no. 81272773); Natural Science Foundation of Guangdong Province (Grant no. S2013010012170); the Scientific and Technological Planning of Guangzhou(Grant no. 2012J4100082) and the Fundamental Research Funds for the Central Universities (Grant no. 10lgpy23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; EAGLE LR, 1995, NAT GENET, V9, P249, DOI 10.1038/ng0395-249; EDELHOFF S, 1994, ONCOGENE, V9, P665; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fults D, 1998, INT J ONCOL, V12, P905; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kawamata N, 1996, PROSTATE, V29, P191, DOI 10.1002/1097-0045(199609)29:3<191::AID-PROS2990290305>3.0.CO;2-1; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Lages E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020600; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lavon I, 2010, NEURO-ONCOLOGY, V12, P422, DOI 10.1093/neuonc/nop061; Lee TC, 1999, J BIOL CHEM, V274, P595, DOI 10.1074/jbc.274.2.595; Li XJ, 1999, JPN J CANCER RES, V90, P740, DOI 10.1111/j.1349-7006.1999.tb00809.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Manni I, 2002, BRIT J CANCER, V86, P477, DOI 10.1038/sj.bjc.6600065; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Prochownik EV, 1998, GENE CHROMOSOME CANC, V22, P295, DOI 10.1002/(SICI)1098-2264(199808)22:4<295::AID-GCC5>3.0.CO;2-Q; Rao SAM, 2010, MODERN PATHOL, V23, P1404, DOI 10.1038/modpathol.2010.135; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schreiber-Agus N, 1998, NATURE, V393, P483, DOI 10.1038/31008; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Skotheim RI, 2002, CANCER RES, V62, P2359; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Teng G, 2009, PHILOS T R SOC B, V364, P631, DOI 10.1098/rstb.2008.0209; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang DY, 2000, PATHOL INT, V50, P373, DOI 10.1046/j.1440-1827.2000.01057.x; WECHSLER DS, 1994, GENOMICS, V21, P669, DOI 10.1006/geno.1994.1336; Wechsler DS, 1997, CANCER RES, V57, P4905; Wuchty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014681; Xu WY, 2013, INT J ONCOL, V42, P757, DOI 10.3892/ijo.2012.1742; Xu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041470; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang Y, 2012, FRONT BIOSCI-LANDMRK, V17, P700, DOI 10.2741/3952; Zhou P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068204; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	47	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83055	10.1371/journal.pone.0083055	http://dx.doi.org/10.1371/journal.pone.0083055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376632	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000054
J	Chen, SM; Fan, CC; Chiue, MS; Chou, C; Chen, JH; Hseu, RS				Chen, Szu-Ming; Fan, Chi-Chen; Chiue, Ming-Shivan; Chou, Chi; Chen, Jyh-Horng; Hseu, Ruey-Shyang			Hemodynamic and Neuropathological Analysis in Rats with Aluminum Trichloride-Induced Alzheimer's Disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; TRANSGENIC MICE; BRAIN-BARRIER; INDUCED IMPAIRMENT; SENILE PLAQUES; DRINKING-WATER; IN-VIVO; CELLS; MICROCIRCULATION; PARAMETERS	Background and Aims: Hemodynamic normality is crucial to maintaining the integrity of cerebral vessels and, therefore, preserving the cognitive functions of Alzheimer's disease patients. This study investigates the implications of the hemodynamic changes and the neuropathological diversifications of AlCl3-induced AD. Methods: The experimental animals were 8- to 12-wk-old male Wistar rats. The rats were randomly divided into 2 groups: a control group and a (+)control group. Food intake, water intake, and weight changes were recorded daily for 22 wk. Synchronously, the regional cerebral blood flow (rCBF) of the rats with AlCl3-induced AD were measured using magnetic resonance imaging (MRI). The hemorheological parameters were analyzed using a computerized auto-rotational rheometer. The brain tissue of the subjects was analyzed using immunohistological chemical (IHC) staining to determine the beta-amyloid (A beta) levels. Results: The results of hemodynamic analysis revealed that the whole blood viscosity (WBV), fibrinogen, plasma viscosity and RBC aggregation index (RAI) in (+)control were significantly higher than that of control group, while erythrocyte electrophoresis (El) of whole blood in (+)control were significantly lower than that of control group. The results of acetylcholinesterase-RBC (AChE-RBC)in the (+)control group was significantly higher than that of the control group. The results also show that the reduction of rCBF in rats with AlCl3-induced AD was approximately 50% to 60% that of normal rats. IHC stain results show that significantly more A beta plaques accumulated in the hippocampus and cortex of the (+)control than in the control group. Conclusion: The results accentuate the importance of hemorheology and reinforce the specific association between hemodynamic and neuropathological changes in rats with AlCl3-induced AD. Hemorheological parameters, such as WBV and fibrinogen, and AChE-RBC were ultimately proven to be useful biomarkers of the severity and progression of AD patients. In addition, the parameters can be substituted for invasive inspection in therapeutic intervention.	[Chen, Szu-Ming; Hseu, Ruey-Shyang] Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Chen, Szu-Ming; Fan, Chi-Chen] Yuanpei Univ, Dept Med Lab Sci & Biotechnol, Hsinchu, Taiwan; [Chiue, Ming-Shivan; Chen, Jyh-Horng] Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan; [Chiue, Ming-Shivan; Chen, Jyh-Horng] Natl Taiwan Univ, Mol Imaging Ctr, Taipei 10764, Taiwan; [Chiue, Ming-Shivan] Natl Taiwan Univ, Grad Inst Biomed Engn, Taipei 10764, Taiwan; [Fan, Chi-Chen; Chou, Chi] Mackay Mem Hosp, Dept Physiol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Mackay Memorial Hospital	Chen, JH (corresponding author), Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan.	jyhhchen2@gmail.com; rshseu@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013		Taiwan Sigma Biotech Corp.; Central Lab.	Taiwan Sigma Biotech Corp.; Central Lab.	This work was supported by Taiwan Sigma Biotech Corp. and Central Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmani RS, 2000, NEUROBIOL AGING, V21, P257, DOI 10.1016/S0197-4580(00)00118-4; AKAMA K, 1994, ARTIF CELL BLOOD SUB, V22, P901, DOI 10.3109/10731199409117928; BANKS WA, 1989, NEUROSCI BIOBEHAV R, V13, P47, DOI 10.1016/S0149-7634(89)80051-X; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Campbell A, 2004, J NEUROSCI RES, V75, P565, DOI 10.1002/jnr.10877; Castorina A, 2010, CELL BIOL TOXICOL, V26, P367, DOI 10.1007/s10565-009-9149-3; Chang CY, 2007, MICROCIRCULATION, V14, P627, DOI 10.1080/10739680701411056; Chien S., 2006, HEMODILUTION THEORET, P1; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; DELATORRE JC, 1993, NEUROL RES, V15, P146; DELATORRE JC, 1994, NEUROSCI BIOBEHAV R, V18, P397, DOI 10.1016/0149-7634(94)90052-3; Deschaintre Y, 2009, NEUROLOGY, V73, P674, DOI 10.1212/WNL.0b013e3181b59bf3; Di Patre PL, 1999, ARCH NEUROL-CHICAGO, V56, P1254, DOI 10.1001/archneur.56.10.1254; Erazi H, 2010, CR BIOL, V333, P23, DOI 10.1016/j.crvi.2009.09.016; Flaten TP, 2001, BRAIN RES BULL, V55, P187, DOI 10.1016/S0361-9230(01)00459-2; Gong Qi-hai, 2006, Chin J Integr Med, V12, P37; Goodman SR, 2007, EXP BIOL MED, V232, P1391, DOI 10.3181/0706-MR-156; Grammas P, 2011, INT J CLIN EXP PATHO, V4, P616; HANTSON P, 1995, J TOXICOL-CLIN TOXIC, V33, P645, DOI 10.3109/15563659509010622; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HIGUCHI Y, 1987, JPN J PSYCHIAT NEUR, V41, P283; Inestrosa NC, 1996, NEURON, V16, P881, DOI 10.1016/S0896-6273(00)80108-7; Inestrose Nibaldo C., 2004, Current Alzheimer Research, V1, P249, DOI 10.2174/1567205043332063; Jones KR, 1998, J NEUROCYTOL, V27, P59, DOI 10.1023/A:1006939020525; Jones RS, 2004, NEUROL RES, V26, P488, DOI 10.1179/016164104225017640; Kanaya K, 2012, PSYCHOGERIATRICS, V12, P172, DOI 10.1111/j.1479-8301.2011.00399.x; Lee CL, 2007, J NEUROSCI RES, V85, P3171, DOI 10.1002/jnr.21428; Li WJ, 2012, NEUROIMAGE, V60, P1083, DOI 10.1016/j.neuroimage.2011.12.077; Liang RF, 2012, IND HEALTH, V50, P428, DOI 10.2486/indhealth.MS1330; Low TY, 2002, PROTEOMICS, V2, P1229, DOI 10.1002/1615-9861(200209)2:9<1229::AID-PROT1229>3.0.CO;2-N; Mattson MP, 1997, BRAIN RES, V771, P147, DOI 10.1016/S0006-8993(97)00824-X; MIYAKAWA T, 1989, ANN MED, V21, P99, DOI 10.3109/07853898909149193; MIYAKAWA T, 1979, ACTA NEUROPATHOL, V48, P153, DOI 10.1007/BF00691158; Mohanty JG, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-11; Ogunshola OO, 2009, CELL MOL LIFE SCI, V66, P3555, DOI 10.1007/s00018-009-0141-0; Ravi LB, 2004, NEUROL RES, V26, P579, DOI 10.1179/016164104225016227; Rondeau V, 2000, AM J EPIDEMIOL, V152, P59, DOI 10.1093/aje/152.1.59; Rusina R, 2011, NEUROTOX RES, V20, P329, DOI 10.1007/s12640-011-9246-y; Samukawa K, 2008, BIORHEOLOGY, V45, P689, DOI 10.3233/BIR-2008-0516; Smith MM, 2009, CLIN HEMORHEOL MICRO, V41, P229, DOI 10.3233/CH-2009-1174; Solerte SB, 2000, NEUROBIOL AGING, V21, P271, DOI 10.1016/S0197-4580(00)00105-6; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Suo ZM, 1998, NEUROSCI LETT, V257, P77, DOI 10.1016/S0304-3940(98)00814-3; Tang Z, 2012, AM J ALZHEIMERS DIS, V27, P267, DOI 10.1177/1533317512447885; Toledano A., 2004, Current Alzheimer Research, V1, P189, DOI 10.2174/1567205043332117; Tomljenovic L, 2011, J ALZHEIMERS DIS, V23, P567, DOI 10.3233/JAD-2010-101494; Velcheva I, 2008, CLIN HEMORHEOL MICRO, V39, P391, DOI 10.3233/CH-2008-1107; Wang ZQ, 2009, ACTA RADIOL, V50, P312, DOI 10.1080/02841850802709219; Wen ZY, 2000, CLIN HEMORHEOL MICRO, V22, P261; Xu W, 2010, J NEUROSCI RES, V88, P3155, DOI 10.1002/jnr.22479; Yokel RA, 2006, J ALZHEIMERS DIS, V10, P223; Yoshiura T, 2009, AM J NEURORADIOL, V30, P1388, DOI 10.3174/ajnr.A1562; Zatta P, 2002, BRAIN RES BULL, V59, P41, DOI 10.1016/S0361-9230(02)00836-5; Zhang LD, 2012, AM J NUCL MED MOLEC, V2, P386; Zhang ZJ, 2003, LIFE SCI, V73, P2443, DOI 10.1016/S0024-3205(03)00649-0; Zheng W, 2001, J TOXICOL-CLIN TOXIC, V39, P711, DOI 10.1081/CLT-100108512; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	59	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82561	10.1371/journal.pone.0082561	http://dx.doi.org/10.1371/journal.pone.0082561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376545	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100037
J	Dominoni, DM; Quetting, M; Partecke, J				Dominoni, Davide M.; Quetting, Michael; Partecke, Jesko			Long-Term Effects of Chronic Light Pollution on Seasonal Functions of European Blackbirds (Turdus merula)	PLOS ONE			English	Article							CHRONIC STRESS; NIGHT; STARLINGS; PHOTOREFRACTORINESS; CORTICOSTERONE; REPRODUCTION; MELATONIN; RHYTHMS; BIRDS; URBAN	Light pollution is known to affect important biological functions of wild animals, including daily and annual cycles. However, knowledge about long-term effects of chronic exposure to artificial light at night is still very limited. Here we present data on reproductive physiology, molt and locomotor activity during two-year cycles of European blackbirds (Turdus merula) exposed to either dark nights or 0.3 lux at night. As expected, control birds kept under dark nights exhibited two regular testicular and testosterone cycles during the two-year experiment. Control urban birds developed testes faster than their control rural conspecifics. Conversely, while in the first year blackbirds exposed to light at night showed a normal but earlier gonadal cycle compared to control birds, during the second year the reproductive system did not develop at all: both testicular size and testosterone concentration were at baseline levels in all birds. In addition, molt sequence in light-treated birds was more irregular than in control birds in both years. Analysis of locomotor activity showed that birds were still synchronized to the underlying light-dark cycle. We suggest that the lack of reproductive activity and irregular molt progression were possibly the results of i) birds being stuck in a photorefractory state and/or ii) chronic stress. Our data show that chronic low intensities of light at night can dramatically affect the reproductive system. Future studies are needed in order to investigate if and how urban animals avoid such negative impact and to elucidate the physiological mechanisms behind these profound long-term effects of artificial light at night. Finally we call for collaboration between scientists and policy makers to limit the impact of light pollution on animals and ecosystems.	[Dominoni, Davide M.; Quetting, Michael; Partecke, Jesko] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Dominoni, Davide M.; Partecke, Jesko] Univ Konstanz, Dept Biol, Constance, Germany; [Dominoni, Davide M.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	Max Planck Society; University of Konstanz; University of Glasgow	Dominoni, DM (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.	ddominoni@orn.mpg.de	Dominoni, Davide Michelangelo/E-9092-2016	Dominoni, Davide Michelangelo/0000-0003-2063-9955	Volkswagen Foundation ('Initiative Evolutionary Biology'); International Max Planck Research School for Organismal Biology	Volkswagen Foundation ('Initiative Evolutionary Biology'); International Max Planck Research School for Organismal Biology	J.P. was funded by the Volkswagen Foundation ('Initiative Evolutionary Biology'). Additional funding to D.D. was provided by the International Max Planck Research School for Organismal Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2007, ANAL LINGUISTIC DATA; Bates DM, 2007, LME4 LINEAR MIXED EF; Bird BL, 2004, CONSERV BIOL, V18, P1435, DOI 10.1111/j.1523-1739.2004.00349.x; Crowley SJ, 2003, J BIOL RHYTHM, V18, P513, DOI 10.1177/0748730403258422; Cyr NE, 2007, GEN COMP ENDOCR, V151, P82, DOI 10.1016/j.ygcen.2006.12.003; Davies TW, 2012, BIOL LETTERS, V8, P764, DOI 10.1098/rsbl.2012.0216; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2004, IBIS, V146, P493, DOI 10.1111/j.1474-919x.2004.00290.x; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Dawson A, 2007, GEN COMP ENDOCR, V153, P378, DOI 10.1016/j.ygcen.2007.01.043; Dominoni D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3017; Dominoni DM, 2014, J ANIM ECOL, V83, P681, DOI 10.1111/1365-2656.12150; Dominoni DM, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-60; FOLLETT BK, 1974, P NATL ACAD SCI USA, V71, P1666, DOI 10.1073/pnas.71.5.1666; Fonken Laura K, 2011, F1000 Med Rep, V3, P18, DOI 10.3410/M3-18; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; GWINNER E, 1982, J COMP PHYSIOL, V146, P419, DOI 10.1007/BF00609438; Gwinner E., 1986, CIRCANNUAL RHYTHMS, Vfirst; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; Honryo T, 2014, AQUAC RES, V45, P1109, DOI 10.1111/are.12059; IUCN, 2012, WORLD URB PROSP 2011; Jenni L., 1994, BIOL MOULT BIRDS; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Kantermann T, 2010, SLEEP BIOL RHYTHMS, V8, P95, DOI 10.1111/j.1479-8425.2010.00432.x; Kempenaers B, 2010, CURR BIOL, V20, P1735, DOI 10.1016/j.cub.2010.08.028; Kirby ED, 2009, P NATL ACAD SCI USA, V106, P11324, DOI 10.1073/pnas.0901176106; NEWTON I, 1966, IBIS, V108, P41, DOI 10.1111/j.1474-919X.1966.tb07251.x; NICHOLLS TJ, 1988, PHYSIOL REV, V68, P133, DOI 10.1152/physrev.1988.68.1.133; Partecke J, 2005, J AVIAN BIOL, V36, P295, DOI 10.1111/j.0908-8857.2005.03344.x; Pauley SM, 2004, MED HYPOTHESES, V63, P588, DOI 10.1016/j.mehy.2004.03.020; Poot H, 2008, ECOL SOC, V13; Retana-Marquez S, 2003, HORM BEHAV, V44, P327, DOI 10.1016/j.yhbeh.2003.04.001; Rich C., 2006, ECOLOGICAL CONSEQUEN; RIVIER C, 1986, SCIENCE, V231, P607, DOI 10.1126/science.3003907; Rowan W, 1938, P ZOOL SOC LOND A-GE, V108, P51; Santos CD, 2010, ACTA OECOL, V36, P166, DOI 10.1016/j.actao.2009.11.008; Schmid B, 2011, J BIOL RHYTHM, V26, P464, DOI 10.1177/0748730411414264; Schoech SJ, 2013, J EXP ZOOL PART A, V319, P527, DOI 10.1002/jez.1816; Shuboni D, 2010, NEUROSCIENCE, V170, P1172, DOI 10.1016/j.neuroscience.2010.08.009; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Te Marvelde L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035617, DOI 10.1371/J0URNAL.P0NE.0035617.PUBMED:22545123]; Titulaer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037377; Van Dongen HPA, 1999, J BIOL RHYTHM, V14, P617, DOI 10.1177/074873099129000984; WINGFIELD JC, 1976, CONDOR, V78, P570, DOI 10.2307/1367117; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	46	60	63	4	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85069	10.1371/journal.pone.0085069	http://dx.doi.org/10.1371/journal.pone.0085069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376865	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000328745100195
J	Glavind, J; Henriksen, TB; Kindberg, SF; Uldbjerg, N				Glavind, Julie; Henriksen, Tine Brink; Kindberg, Sara Fevre; Uldbjerg, Niels			Randomised Trial of Planned Caesarean Section Prior to Versus after 39 Weeks: Unscheduled Deliveries and Facility Logistics - A Secondary Analysis	PLOS ONE			English	Article							MATERNAL COMPLICATIONS; RESPIRATORY MORBIDITY; TERM; RISK; TIME; PREGNANCY; DURATION; OUTCOMES; IMPACT	Objectives: To compare the impact of scheduling caesarean section prior to versus after 39 completed weeks of gestation on the occurrence of unscheduled caesarean section and rescheduling of the procedure. Methods: Secondary analysis from a multicentre randomised open-label trial including singleton pregnant women with a healthy foetus and a reliable due date. Women were allocated by computerized telephone randomisation to planned caesarean section at 38 weeks and three days or 39 weeks and three days. The outcomes were unscheduled deliveries with provided reasons, such as spontaneous labour onset or supervening complications, and any changes in the scheduled delivery date. Statistical analyses were according to intention-to-treat using Fisher's exact test. Results: From March 2009 to June 2011 1,274 women were included. Median difference in gestational age at delivery was six days. Compared to the 38 weeks group, the women in the 39 weeks group were more likely to have an unscheduled caesarean section (15.2% vs. 9.3%; RR 1.64, 95% CI 1.21; 2.22), to deliver between 6 pm and 8 am (10 % vs. 6%; RR 1.68, 95% Cl 1.14; 2.47), or to have the procedure rescheduled (36.7% vs. 23%; RR 1.6, 95% CI 1.34;1.90). Conclusions: Scheduling caesarean section after 39 weeks leads to a 60% increase in unscheduled caesarean sections and a 70% increase in delivery outside regular work hours as compared to scheduling of the procedure prior to 39 weeks.	[Glavind, Julie; Kindberg, Sara Fevre; Uldbjerg, Niels] Aarhus Univ Hosp, Inst Clin Med, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark; [Glavind, Julie; Henriksen, Tine Brink] Aarhus Univ Hosp, Inst Clin Med, Perinatal Epidemiol Res Unit, DK-8000 Aarhus, Denmark; [Henriksen, Tine Brink] Aarhus Univ Hosp, Inst Clin Med, Dept Pediat, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Glavind, J (corresponding author), Aarhus Univ Hosp, Inst Clin Med, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark.	julie.glavind@dadlnet.dk	Glavind, Julie/AAQ-2408-2020; Uldbjerg, Niels/O-2038-2016	Glavind, Julie/0000-0002-9856-6621; Uldbjerg, Niels/0000-0002-6449-6426	Danish Council For Independent Research; Medical sciences (FSS); Health Research Fund of Central Denmark Region; Philanthropic Foundation TrygFonden; Aase and Ejnar Danielsen's Foundation; Sophus Jacobsen's Foundation; Dagmar Marshall's Foundation; Marie Dorthea and Holger From, Haderslev's Foundation	Danish Council For Independent Research(Det Frie Forskningsrad (DFF)); Medical sciences (FSS)(Danish Medical Research Council); Health Research Fund of Central Denmark Region; Philanthropic Foundation TrygFonden; Aase and Ejnar Danielsen's Foundation; Sophus Jacobsen's Foundation; Dagmar Marshall's Foundation; Marie Dorthea and Holger From, Haderslev's Foundation	The study was supported by grants from The Danish Council For Independent Research (www.fi.dk) vertical bar Medical sciences (FSS), Health Research Fund of Central Denmark Region, The Philanthropic Foundation TrygFonden (vvww.trygfonden.dk), Aase and Ejnar Danielsen's Foundation (www.danielsensfond.dk), Sophus Jacobsen's Foundation, Dagmar Marshall's Foundation, Marie Dorthea and Holger From, Haderslev's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen VM, 2005, BJOG-INT J OBSTET GY, V112, P986, DOI 10.1111/j.1471-0528.2005.00615.x; Bailit JL, 2006, AM J OBSTET GYNECOL, V195, P1132, DOI 10.1016/j.ajog.2006.06.009; Balchin I, 2008, OBSTET GYNECOL, V111, P659, DOI 10.1097/AOG.0b013e318163cd55; Bergholt T, 2003, ACTA OBSTET GYN SCAN, V82, P251, DOI 10.1034/j.1600-0412.2003.00095.x; Bergsjo P, 1990, ACTA OBSTET GYN SCAN, V69, P197, DOI 10.3109/00016349009028681; Chiossi G, 2013, OBSTET GYNECOL, V121, P561, DOI 10.1097/AOG.0b013e3182822193; Ertugrul S, 2013, J OBSTET GYNAECOL RE, V39, P105, DOI 10.1111/j.1447-0756.2012.01951.x; Glavind J, 2013, BJOG-INT J OBSTET GY, V120, P1123, DOI 10.1111/1471-0528.12278; Gould JB, 2005, OBSTET GYNECOL, V106, P352, DOI 10.1097/01.AOG.0000168627.33566.3c; Gurol-Urganci I, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-43; Hansen AK, 2008, BMJ-BRIT MED J, V336, P85, DOI 10.1136/bmj.39405.539282.BE; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; National Institute for Health and Clinical Excellence (NICE), 2011, CAES SECT 2012; Ojidu J. I., 1999, Journal of Obstetrics and Gynaecology (Abingdon), V19, P142; Pallasmaa N, 2010, ACTA OBSTET GYN SCAN, V89, P896, DOI 10.3109/00016349.2010.487893; Peled Y, 2011, J MATERN-FETAL NEO M, V24, P1051, DOI 10.3109/14767058.2010.545913; Reddy UM, 2011, OBSTET GYNECOL, V117, P1279, DOI 10.1097/AOG.0b013e3182179e28; Richardson BS, 2005, AM J OBSTET GYNECOL, V192, P219, DOI 10.1016/j.ajog.2004.06.034; Smith GCS, 2001, HUM REPROD, V16, P1497, DOI 10.1093/humrep/16.7.1497; Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267; vanHam MAPC, 1997, EUR J OBSTET GYN R B, V74, P1, DOI 10.1016/S0301-2115(97)02725-5; Wetta L, 2012, OBSTET GYN CLIN N AM, V39, P89, DOI 10.1016/j.ogc.2011.12.002; Wilmink FA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.052; Zanardo V, 2004, ACTA PAEDIATR, V93, P643, DOI [10.1080/08035250410026671, 10.1111/j.1651-2227.2004.tb02990.x]	25	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84744	10.1371/journal.pone.0084744	http://dx.doi.org/10.1371/journal.pone.0084744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376842	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100185
J	Kim, HS; Sung, JS; Yang, SJ; Kwon, NJ; Jin, L; Kim, ST; Park, KH; Shin, SW; Kim, HK; Kang, JH; Kim, JO; Park, JY; Choi, JE; Yoon, H; Park, CK; Yang, KS; Seo, JS; Kim, YH				Kim, Hye Sook; Sung, Jae Sook; Yang, Song-Ju; Kwon, Nak-Jung; Jin, LiHua; Kim, Seung Tae; Park, Kyong Hwa; Shin, Sang Won; Kim, Han Kyeom; Kang, Jin-Hyoung; Kim, Jeong-Oh; Park, Jae Yong; Choi, Jin Eun; Yoon, HyoungKyu; Park, Chan Kwon; Yang, Kap-Seok; Seo, Jeong-Sun; Kim, Yeul Hong			Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; GENE MUTATION; CANCER; GEFITINIB; HETEROGENEITY; ERLOTINIB	Direct sequencing remains the most widely used method for the detection ofepidermal growth factor receptor (EGFR)mutations in lung cancerl however, its relatively low sensitivity limits its clinical use. The objective of this study was toinvestigate the sensitivity of detecting an epidermal growth factor receptor (EGFR) mutation from peptide nucleic acid-locked nucleic acid polyrnerase chain reaction (PNA-LNA PCR) clamp and Ion Torrent Personal Genome Machine (PGM)techniques compared to that by direct sequencing. Furthermore, the predictive efficacy of EGFR mutations detected by PNA-LNA PCR clamp was evaluated. EGFR mutational status was assessed by direct sequencing, PNA-LNA PCR clamp, and Ion Torrent PGM in 57 patients with non-small cell lung cancer (NSCLC). We evaluated the predictive efficacy of PNIA-LNAPCR clamp on the EGFR-TKI treatment in 36 patients with advanced NSCLC retrospectively. Compared to direct sequencing (16/57, 28.1%), PNA-LNA PCR clamp (27/57, 47.4%) and Ion Torrent PGNI (26/57, 45.6%) detected more EGFR mutations. EGFR mutant patients had significantly longer progressive free survival (14.31 vs. 21.61 months, P=0.003) than that of EGFR wild patients when tested with PNA-LNIA PR clamp. However, no difference in response rate to EGFR TKIs (75.0% vs. 82.4% P=0.195) or overall survival (34.39 vs. 44.10 months, P=0.422) was observed between the EGFR mutations by direct sequencing or PNA-LNA PCR clamp. Our results demonstrate firstly that patients with EGFR mutations were detected more frequently by PNA-LNA PCR clamp and Ion Torrent PGM than those by direct sequencing. EGFR mutations detected by PNA-LNA PCR clamp may be as a predicative factor for EGFR TKI response in patients with NSCLC	[Kim, Hye Sook; Kim, Seung Tae; Park, Kyong Hwa; Shin, Sang Won; Kim, Yeul Hong] Korea Univ, Coll Med, Dept Internal Med, Div Oncol Hematol, Seoul 136705, South Korea; [Sung, Jae Sook; Jin, LiHua; Kim, Yeul Hong] Korea Univ, Canc Res Inst, Seoul, South Korea; [Yang, Song-Ju; Kwon, Nak-Jung; Yang, Kap-Seok; Seo, Jeong-Sun] Macroge Inc, Seoul, South Korea; [Kim, Han Kyeom] Korea Univ, Coll Med, Dept Pathol, Seoul 136705, South Korea; [Kang, Jin-Hyoung] Catholic Univ Korea, Seoul St Marys Hosp, Div Med Oncol, Seoul, South Korea; [Kim, Jeong-Oh] Catholic Univ Korea, Res Inst Med Sci, Lab Med Oncol, Seoul, South Korea; [Park, Jae Yong] Kyungpook Natl Univ, Med Ctr, Lung Canc Ctr, Taegu, South Korea; [Choi, Jin Eun] Kyungpook Natl Univ, Sch Med, Dept Biochem, Taegu, South Korea; [Yoon, HyoungKyu; Park, Chan Kwon] Catholic Univ Korea, Coll Med, St Marys Hosp, Div Pulmonol,Dept Internal Med, Seoul, South Korea; [Seo, Jeong-Sun] Seoul Natl Univ, Med Res Ctr, GMI, Seoul, South Korea; [Seo, Jeong-Sun] Seoul Natl Univ, Coll Med, Dept Biochem, Seoul, South Korea; [Seo, Jeong-Sun] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Kyungpook National University; Kyungpook National University; Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Seo, JS (corresponding author), Macroge Inc, Seoul, South Korea.	jeongsun@snu.ac.kr; yhk0215@korea.ac.kr	Seo, Jeong-Sun/J-2763-2012; Sung, Jae Sook/AAA-3882-2021	Kim, Yeul Hong/0000-0002-2555-2333; PARK, KYONG HWA/0000-0002-2464-7920	National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea [A111218-11-GM04]	National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea	This study was supported by a grant of the National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea (A111218-11-GM04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano H, 2006, CLIN CANCER RES, V12, P43, DOI 10.1158/1078-0432.CCR-05-0934; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Costa DB, 2008, CLIN CANCER RES, V14, P7060, DOI 10.1158/1078-0432.CCR-08-1455; Endo K, 2005, LUNG CANCER, V50, P375, DOI 10.1016/j.lungcan.2005.08.009; Gu D, 2007, HUM MUTAT, V28, P760, DOI 10.1002/humu.20512; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kimura H, 2006, CANCER SCI, V97, P642, DOI 10.1111/j.1349-7006.2006.00216.x; Laurie SA, 2013, J CLIN ONCOL, V31, P1061, DOI 10.1200/JCO.2012.43.4522; Liu YH, 2011, LOCATION, LOCALIZATION, AND LOCALIZABILITY: LOCATION-AWARENESS TECHNOLOGY FOR WIRELESS NETWORKS, P111, DOI 10.1007/978-1-4419-7371-9_8; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Meldrum Cliff, 2011, Clin Biochem Rev, V32, P177; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Sakurada A, 2008, J THORAC ONCOL, V3, P527, DOI 10.1097/JTO.0b013e318168be93; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Tanaka T, 2007, CANCER SCI, V98, P246, DOI 10.1111/j.1349-7006.2006.00377.x; Tougeron D, 2013, ANN ONCOL; Won YW, 2011, J CLIN PATHOL, V64, P947, DOI 10.1136/jclinpath-2011-200169; Wu JY, 2008, CLIN CANCER RES, V14, P4877, DOI 10.1158/1078-0432.CCR-07-5123	23	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e81975	10.1371/journal.pone.0081975	http://dx.doi.org/10.1371/journal.pone.0081975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376508	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100012
J	Noda, T; Kanzaki, R; Takahashi, H				Noda, Takahiro; Kanzaki, Ryohei; Takahashi, Hirokazu			Stimulus Phase Locking of Cortical Oscillation for Auditory Stream Segregation in Rats	PLOS ONE			English	Article							PERCEPTUAL ORGANIZATION; NEURONAL OSCILLATIONS; NEURAL ADAPTATION; TONE SEQUENCES; CORTEX; SOUND; FREQUENCY; REPRESENTATION; SYNCHRONIZATION; POTENTIALS	The phase of cortical oscillations contains rich information and is valuable for encoding sound stimuli. Here we hypothesized that oscillatory phase modulation, instead of amplitude modulation, is a neural correlate of auditory streaming. Our behavioral evaluation provided compelling evidences for the first time that rats are able to organize auditory stream. Local field potentials (LFPs) were investigated in the cortical layer IV or deeper in the primary auditory cortex of anesthetized rats. In response to ABA-sequences with different inter-tone intervals and frequency differences, neurometric functions were characterized with phase locking as well as the band-specific amplitude evoked by test tones. Our results demonstrated that under large frequency differences and short inter-tone intervals, the neurometric function based on stimulus phase locking in higher frequency bands, particularly the gamma band, could better describe van Noorden's perceptual boundary than the LFP amplitude. Furthermore, the gamma-band neurometric function showed a build-up-like effect within around 3 seconds from sequence onset. These findings suggest that phase locking and amplitude have different roles in neural computation, and support our hypothesis that temporal modulation of cortical oscillations should be considered to be neurophysiological mechanisms of auditory streaming, in addition to forward suppression, tonotopic separation, and multi-second adaptation.	[Noda, Takahiro; Kanzaki, Ryohei; Takahashi, Hirokazu] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan; [Kanzaki, Ryohei; Takahashi, Hirokazu] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Mechanoinformat, Tokyo, Japan; [Takahashi, Hirokazu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Takahashi, H (corresponding author), Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan.	takahashi@i.u-tokyo.ac.jp			SCOPE [121803022]; Kakenhi [24650252, 23135507]	SCOPE; Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present work was supported in part by SCOPE (121803022) and Kakenhi (24650252, 23135507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2007, HEARING RES, V229, P225, DOI 10.1016/j.heares.2007.01.011; Alkire M, 2008, SCIENCE, V322; Allen FH, 1991, AUTOMATED CONFORMATI; Arnott SR, 2011, BRAIN RES, V1387, P116, DOI 10.1016/j.brainres.2011.02.062; Bee MA, 2004, J NEUROPHYSIOL, V92, P1088, DOI 10.1152/jn.00884.2003; Bee MA, 2010, J COMP PHYSIOL A, V196, P543, DOI 10.1007/s00359-010-0542-4; Bidet-Caulet A, 2007, J NEUROSCI, V27, P9252, DOI 10.1523/JNEUROSCI.1402-07.2007; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; Brosch M, 2008, EXP BRAIN RES, V184, P349, DOI 10.1007/s00221-007-1109-7; Busch NA, 2010, P NATL ACAD SCI USA, V107, P16048, DOI 10.1073/pnas.1004801107; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Chandrasekaran C, 2010, J NEUROSCI, V30, P13919, DOI 10.1523/JNEUROSCI.3174-10.2010; Cheung SW, 2001, HEARING RES, V156, P115, DOI 10.1016/S0378-5955(01)00272-6; Chimoto S, 2002, BRAIN RES, V934, P34, DOI 10.1016/S0006-8993(02)02316-8; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cusack R, 2005, J COGNITIVE NEUROSCI, V17, P641, DOI 10.1162/0898929053467541; Dean I, 2008, J NEUROSCI, V28, P6430, DOI 10.1523/JNEUROSCI.0470-08.2008; Deike S, 2004, NEUROREPORT, V15, P1511, DOI 10.1097/01.wnr.0000132919.12990.34; Deike S, 2010, HEARING RES, V265, P30, DOI 10.1016/j.heares.2010.03.005; Eggermont JJ, 2002, J NEUROPHYSIOL, V87, P305, DOI 10.1152/jn.00490.2001; Eggermont JJ, 2001, HEARING RES, V157, P1, DOI 10.1016/S0378-5955(01)00259-3; Elhilali M, 2009, NEURON, V61, P317, DOI 10.1016/j.neuron.2008.12.005; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; FRIBERG A, 1995, J ACOUST SOC AM, V98, P2524, DOI 10.1121/1.413218; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gielen S, 2010, BIOL CYBERN, V103, P151, DOI 10.1007/s00422-010-0390-x; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; Hudetz AG, 2011, ANESTHESIOLOGY, V114, P588, DOI 10.1097/ALN.0b013e31820ad3f9; Itatani N, 2009, J NEUROPHYSIOL, V101, P3212, DOI 10.1152/jn.91333.2008; Kanwal JS, 2003, NETWORK-COMP NEURAL, V14, P413, DOI 10.1088/0954-898X/14/3/303; Kondo HM, 2009, J NEUROSCI, V29, P12695, DOI 10.1523/JNEUROSCI.1549-09.2009; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; LAMPL I, 1993, J NEUROPHYSIOL, V70, P2181, DOI 10.1152/jn.1993.70.5.2181; Lipp R, 2010, NEUROPSYCHOLOGIA, V48, P1417, DOI 10.1016/j.neuropsychologia.2010.01.009; Luo H, 2013, CURR BIOL, V23, P968, DOI 10.1016/j.cub.2013.04.031; Marella S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041918; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Muller D, 2005, PSYCHOPHYSIOLOGY, V42, P668, DOI 10.1111/j.1469-8986.2005.00355.x; NAKAJIMA Y, 1980, PSYCHOL RES-PSYCH FO, V41, P335, DOI 10.1007/BF00308878; Noda T, 2013, NEUROSCI RE IN PRESS; Palva S, 2005, J NEUROSCI, V25, P5248, DOI 10.1523/JNEUROSCI.0141-05.2005; Palva S, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-04-j0003.2002; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Peng Y, 2010, NEUROSCIENCE, V169, P1403, DOI 10.1016/j.neuroscience.2010.05.047; Ponjavic-Conte KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053953; POVEL DJ, 1984, PSYCHOL RES-PSYCH FO, V45, P315, DOI 10.1007/BF00309709; Pressnitzer D, 2008, CURR BIOL, V18, P1124, DOI 10.1016/j.cub.2008.06.053; Pressnitzer D, 2006, CURR BIOL, V16, P1351, DOI 10.1016/j.cub.2006.05.054; Rahne T, 2008, BRAIN RES, V1220, P118, DOI 10.1016/j.brainres.2007.08.011; Rauschecker JP, 2005, ANN NY ACAD SCI, V1060, P125, DOI 10.1196/annals.1360.009; Rutkowski RG, 2003, HEARING RES, V181, P116, DOI 10.1016/S0378-5955(03)00182-5; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Schadwinkel S, 2010, CEREB CORTEX, V20, P2863, DOI 10.1093/cercor/bhq037; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Scott A MacDougall-Shackleton SHH, 1998, J ACOUST SOC AM, V103, P7; Silva A, 2010, ANESTHESIOLOGY, V112, P355, DOI 10.1097/ALN.0b013e3181ca3196; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Snyder JS, 2007, CEREB CORTEX, V17, P501, DOI 10.1093/cercor/bhj175; Snyder JS, 2007, PSYCHOL BULL, V133, P780, DOI 10.1037/0033-2909.133.5.780; Sussman E, 1999, PSYCHOPHYSIOLOGY, V36, P22, DOI 10.1017/S0048577299971056; Takahashi H, 2005, HEARING RES, V210, P9, DOI 10.1016/j.heares.2005.05.014; Takahashi H, 2011, NEUROSCIENCE, V199, P243, DOI 10.1016/j.neuroscience.2011.09.046; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Teki S, 2011, J NEUROSCI, V31, P164, DOI 10.1523/JNEUROSCI.3788-10.2011; Tomita M, 2005, J NEUROPHYSIOL, V93, P378, DOI 10.1152/jn.00643.2004; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; van Noorden L.P.A.S., 1975, TEMPORAL COHERENCE P; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00060; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wilson EC, 2007, J NEUROPHYSIOL, V97, P2230, DOI 10.1152/jn.00788.2006; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006	81	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83544	10.1371/journal.pone.0083544	http://dx.doi.org/10.1371/journal.pone.0083544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376715	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100125
J	Onitilo, AA; Onesti, JK; Single, RM; Engel, JM; James, TA; Bowles, EJA; Feigelson, HS; Barney, T; McCahill, LE				Onitilo, Adedayo A.; Onesti, Jill K.; Single, Richard M.; Engel, Jessica M.; James, Ted A.; Bowles, Erin J. Aiello; Feigelson, Heather Spencer; Barney, Tom; McCahill, Laurence E.			Utilization of Neoadjuvant Chemotherapy Varies in the Treatment of Women with Invasive Breast Cancer	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; CONSERVING SURGERY; MASTECTOMY RATES; THERAPY; QUALITY; RECOMMENDATIONS; CHOICE	Background: Treatment with neoadjuvant chemotherapy (NAG) has made it possible for some women to be successfully treated with breast conservation therapy (BCT) who were initially considered ineligible. Factors related to current practice patterns of NAC use are important to understand particularly as the surgical treatment of invasive breast cancer has changed. The goal of this study was to determine variations in neoadjuvant chemotherapy use in a large multi-center national database of patients with breast cancer. Methods: We evaluated NAC use in patients with initially operable invasive breast cancer and potential impact on breast conservation rates. Records of 2871 women ages 18-years and older diagnosed with 2907 invasive breast cancers from January 2003 to December 2008 at four institutions across the United States were examined using the Breast Cancer Surgical Outcomes (BRCASO) database. Main outcome measures included NAC use and association with pre-operatively identified clinical factors, surgical approach (partial mastectomy [PM] or total mastectomy [TM]), and BCT failure (initial PM followed by subsequent TM). Results: Overall, NAC utilization was 3.8%l. Factors associated with NAC use included younger age, pre-operatively known positive nodal status, and increasing clinical tumor size. NAC use and BCT failure rates increased with clinical tumor size, and there was significant variation in NAC use across institutions. Initial TM frequency approached initial PM frequency for tumors >30-40mm; BCT failure rate was 22.7% for tumors >40mm. Only 2.7% of patients undergoing initial PM and 7.2% undergoing initial TM received NAC. Conclusions: NAC use in this study was infrequent and varied among institutions. Infrequent NAC use in patients suggests that NAC may be underutilized in eligible patients desiring breast conservation.	[Onitilo, Adedayo A.] Marshfield Clin Fdn Med Res & Educ, Dept Hematol & Oncol, Weston, WI USA; [Onitilo, Adedayo A.] Univ Queensland, Sch Populat Hlth, Clin Epidemiol Unit, Brisbane, Qld, Australia; [Onesti, Jill K.] Grand Rapids Med Educ Partners, Grand Rapids, MI USA; [Single, Richard M.] Univ Vermont, Burlington, VT USA; [Engel, Jessica M.] St Michaels Hosp, Marshfield Clin Canc Care, Stevens Point, WI USA; [James, Ted A.] Univ Vermont, Coll Med, Burlington, VT USA; [Bowles, Erin J. Aiello] Grp Hlth Cooperat Puget Sound, Res Inst, Seattle, WA 98121 USA; [Feigelson, Heather Spencer] Kaiser Permanente Colorado, Denver, CO USA; [Barney, Tom; McCahill, Laurence E.] Van Andel Res Inst, Grand Rapids, MI USA	University of Queensland; University of Vermont; University of Vermont; Group Health Cooperative; Kaiser Permanente; Van Andel Institute	Onitilo, AA (corresponding author), Marshfield Clin Fdn Med Res & Educ, Dept Hematol & Oncol, Weston, WI USA.	onitilo.adedayo@marshfieldclinic.org			National Institute of Health	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded under the American recovery and Reinvestment Act of 2009 by National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonadonna G, 1998, J CLIN ONCOL, V16, P93, DOI 10.1200/JCO.1998.16.1.93; Bowles EJA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-136; Caldon LJM, 2007, EUR J CANCER, V43, P1662, DOI 10.1016/j.ejca.2007.04.021; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Damle S, 2011, ANN SURG ONCOL, V18, P1356, DOI 10.1245/s10434-010-1434-0; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Foster JA, 2009, J NATL COMPR CANC NE, V7, P697, DOI 10.6004/jnccn.2009.0049; Gilligan MA, 2002, MED CARE, V40, P181; Gomez SL, 2004, ETHNIC DIS, V14, P134; Gralow JR, 2008, J CLIN ONCOL, V26, P814, DOI 10.1200/JCO.2007.15.3510; Habermann EB, 2010, J CLIN ONCOL, V28, P3437, DOI 10.1200/JCO.2009.27.6774; HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391; James TA, 2010, J CLIN ONCOL, V28; James T, 2009, BREAST J, V15, P524, DOI 10.1111/j.1524-4741.2009.00771.x; James TA, 2010, J CLIN ONCOL, V28, pE364, DOI 10.1200/JCO.2009.27.9703; Jatoi I, 2005, AM J CLIN ONCOL-CANC, V28, P289, DOI 10.1097/01.coc.0000156922.58631.d7; Kaufmann M, 2007, ANN ONCOL, V18, P1927, DOI 10.1093/annonc/mdm201; Kaufmann M, 2010, CANCER-AM CANCER SOC, V116, P1184, DOI 10.1002/cncr.24874; McCahill LE, 2009, ARCH SURG-CHICAGO, V144, P455, DOI 10.1001/archsurg.2009.56; McCahill LE, 2009, AM J SURG, V197, P216, DOI 10.1016/j.amjsurg.2007.12.056; McGuire KP, 2009, ANN SURG ONCOL, V16, P2682, DOI 10.1245/s10434-009-0635-x; Mieog JSD, 2007, BRIT J SURG, V94, P1189, DOI 10.1002/bjs.5894; Moreno-Aspitia A, 2012, CRIT REV ONCOL HEMAT, V82, P187, DOI 10.1016/j.critrevonc.2011.04.013; Nattinger AB, 2001, J NATL CANCER I, V93, P1344, DOI 10.1093/jnci/93.17.1344; Peintinger F, 2006, CANCER-AM CANCER SOC, V107, P1248, DOI 10.1002/cncr.22111; Poggi MM, 2003, CANCER, V98, P697, DOI 10.1002/cncr.11580; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Roth SL, 2010, STRAHLENTHER ONKOL, V186, P299, DOI 10.1007/s00066-010-2143-0; Temple WJ, 2006, J CLIN ONCOL, V24, P3367, DOI 10.1200/JCO.2005.02.7771; Thomas A, 2006, ANTICANCER RES, V26, P1677	31	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84535	10.1371/journal.pone.0084535	http://dx.doi.org/10.1371/journal.pone.0084535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376822	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100174
J	Pelekanou, V; Notas, G; Kampa, M; Tsentelierou, E; Stathopoulos, EN; Tsapis, A; Castanas, E				Pelekanou, Vassiliki; Notas, George; Kampa, Marilena; Tsentelierou, Eleftheria; Stathopoulos, Efstathios N.; Tsapis, Andreas; Castanas, Elias			BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 Proteins Are Related to Human Glioma Tumor Grade: Immunohistochemistry and Public Microarray Data Meta-Analysis	PLOS ONE			English	Article							PROLIFERATION-INDUCING LIGAND; NECROSIS-FACTOR FAMILY; CENTRAL-NERVOUS-SYSTEM; TRAIL-INDUCED APOPTOSIS; CELL-ACTIVATING FACTOR; FACTOR-KAPPA-B; WEAK INDUCER; STEM-CELLS; TNF FAMILY; ASTROCYTE PROLIFERATION	Gliomas are common and lethal tumors of the central nervous system (CNS). Genetic alterations, inflammatory and angiogenic processes have been identified throughout tumor progression; however, treatment still remains palliative for most cases. Biological research on parameters influencing cell survival, invasion and tumor heterogeneity identified several cytokines interfering in CNS inflammation, oxidative stress and malignant transformation, including TNF-superfamily (TNFSF) members. In this report we performed a meta-analysis of public gene-array data on the expression of a group of TNFSF ligands (BAFF, APRIL, TWEAK) and their receptors (BAFF-R, TACI, BCMA, Fn14) in gliomas. In addition, we investigated by immunohistochemistry (IHC) the tumor cells' expression of these ligands and receptors in a series of 56 gliomas of different grade. We show that in IHC, BAFF and APRIL as well as their cognate receptors (BCMA, TACI) and Fn14 expression correlate with tumor grade. This result was not evidenced in micro-arrays meta-analysis. Finally, we detected for the first time Fn14, BAFF, BCMA and TACI in glioma-related vascular endothelium. Our data, combined with our previous report in glioma cell lines, suggest a role for these receptors and ligands in glioma biology and advance these molecules as potential markers for the classification of these tumors to the proliferative, angiogenic or stem-like molecular subtype.	[Pelekanou, Vassiliki; Notas, George; Kampa, Marilena; Tsapis, Andreas; Castanas, Elias] Univ Crete, Sch Med, Labs Expt Endocrinol, Iraklion, Greece; [Pelekanou, Vassiliki; Tsentelierou, Eleftheria; Stathopoulos, Efstathios N.] Univ Crete, Sch Med, Labs Pathol, Iraklion, Greece; [Tsapis, Andreas] Hop St Louis, INSERM, U976, Paris, France; Univ Paris Diderot, Paris, France	University of Crete; University of Crete; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Pelekanou, V (corresponding author), Univ Crete, Sch Med, Labs Expt Endocrinol, Iraklion, Greece.	pelekanou@med.uoc.gr; castanas@med.uoc.gr	Pelekanou, Vasiliki/AAB-9735-2021; Notas, George/K-3709-2019; Castanas, Elias/E-7007-2010	Pelekanou, Vasiliki/0000-0002-8431-1927; Notas, George/0000-0002-2506-5252; Castanas, Elias/0000-0002-8370-1835; Tsentelierou, Eleftheria/0000-0001-7215-4453	European Union-FP7 Marie Curie Actions-Career Reintegration Grants [PCIG-GA-2011-303723]; University of Crete Research Committee funds	European Union-FP7 Marie Curie Actions-Career Reintegration Grants; University of Crete Research Committee funds	This work was partially supported by the European Union-FP7 Marie Curie Actions-Career Reintegration Grants PCIG-GA-2011-303723 (to VP) and the University of Crete Research Committee funds to EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaoui SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033609; Alexaki VI, 2012, ENDOCRINOLOGY, V153, P739, DOI 10.1210/en.2011-1504; Alexaki VI, 2009, J IMMUNOL, V183, P5948, DOI 10.4049/jimmunol.0901186; Benson MJ, 2008, IMMUNOL CELL BIOL, V86, P485, DOI 10.1038/icb.2008.35; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Cols M, 2012, J IMMUNOL, V188, P6071, DOI 10.4049/jimmunol.1102066; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deshayes F, 2004, ONCOGENE, V23, P3005, DOI 10.1038/sj.onc.1207350; Desplat-Jego S, 2005, CLIN IMMUNOL, V117, P15, DOI 10.1016/j.clim.2005.06.005; Desplat-Jego S, 2002, J NEUROIMMUNOL, V133, P116, DOI 10.1016/S0165-5728(02)00368-5; Desplat-Jego S, 2009, J LEUKOCYTE BIOL, V85, P132, DOI 10.1189/jlb.0608347; Dillon SR, 2006, NAT REV DRUG DISCOV, V5, P235, DOI 10.1038/nrd1982; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; George-Chandy A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2484; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Haile WB, 2010, NEUROSCIENCE, V171, P1256, DOI 10.1016/j.neuroscience.2010.10.029; Hamill CA, 2007, J NEUROSCI RES, V85, P3535, DOI 10.1002/jnr.21443; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; Hatzoglou A, 2000, J IMMUNOL, V165, P1322, DOI 10.4049/jimmunol.165.3.1322; Hawkins CJ, 2004, VITAM HORM, V67, P427; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Hosomi N, 2005, J CEREBR BLOOD F MET, V25, P959, DOI 10.1038/sj.jcbfm.9600086; Ilzecka J, 2006, EUR CYTOKINE NETW, V17, P276; Inta I, 2008, J NEUROL SCI, V275, P117, DOI 10.1016/j.jns.2008.08.005; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jakubowski A, 2002, J CELL SCI, V115, P267; Kaplan MJ, 2000, J IMMUNOL, V164, P2897, DOI 10.4049/jimmunol.164.6.2897; Kargiotis O, 2006, J NEURO-ONCOL, V78, P281, DOI 10.1007/s11060-005-9097-6; Kauer TM, 2012, NAT NEUROSCI, V15, P197, DOI 10.1038/nn.3019; Kesari S, 2011, SEMIN ONCOL, V38, pS2, DOI 10.1053/j.seminoncol.2011.09.005; Killeen PR, 2005, PSYCHOL SCI, V16, P345, DOI 10.1111/j.0956-7976.2005.01538.x; Kitange GJ, 2003, CURR OPIN ONCOL, V15, P197, DOI 10.1097/00001622-200305000-00003; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Kuijlen JMA, 2010, NEUROPATH APPL NEURO, V36, P168, DOI 10.1111/j.1365-2990.2010.01069.x; Langat DL, 2008, AM J PATHOL, V172, P1303, DOI 10.2353/ajpath.2008.071139; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Maia S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020787; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; McCoy MK, 2008, MOL THER, V16, P1572, DOI 10.1038/mt.2008.146; Montgomery SL, 2012, J NEUROIMMUNE PHARM, V7, P42, DOI 10.1007/s11481-011-9287-2; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Notas G, 2012, J IMMUNOL, V189, P4748, DOI 10.4049/jimmunol.1102891; Oldenhuis CNAM, 2008, CURR OPIN PHARMACOL, V8, P433, DOI 10.1016/j.coph.2008.06.011; Paulino VM, 2010, MOL CANCER RES, V8, P1558, DOI 10.1158/1541-7786.MCR-10-0334; Pelekanou V, 2011, ANAL CELL PATHOL, V34, P49, DOI [10.3233/ACP-2011-0001, 10.1155/2011/108631]; Pelekanou V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-76; Petty RD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-434; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Phillips TA, 2003, J LEUKOCYTE BIOL, V74, P81, DOI 10.1189/jlb.0103033; Polavarapu R, 2005, J NEUROSCI, V25, P10094, DOI 10.1523/JNEUROSCI.3382-05.2005; Potrovita I, 2004, J NEUROSCI, V24, P8237, DOI 10.1523/JNEUROSCI.1089-04.2004; Puduvalli VK, 2005, APOPTOSIS, V10, P233, DOI 10.1007/s10495-005-6078-3; Roth W, 2001, CELL DEATH DIFFER, V8, P403, DOI 10.1038/sj.cdd.4400827; Rousseau A, 2008, CURR OPIN NEUROL, V21, P720, DOI 10.1097/WCO.0b013e328312c3a7; Rousselet E, 2012, MOL PHARMACOL, V82, P948, DOI 10.1124/mol.112.079608; Saas P, 2000, GLIA, V32, P102, DOI 10.1002/1098-1136(200010)32:1<102::AID-GLIA100>3.0.CO;2-U; Sandberg WJ, 2009, THROMB HAEMOSTASIS, V102, P704, DOI 10.1160/TH08-10-0665; Scholzke MN, 2011, MOL CELL NEUROSCI, V46, P325, DOI 10.1016/j.mcn.2010.10.004; Serafini B, 2008, J NEUROPATH EXP NEUR, V67, P1137, DOI 10.1097/NEN.0b013e31818dab90; Shah K, 2003, ONCOGENE, V22, P6865, DOI 10.1038/sj.onc.1206748; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Strojnik T, 2009, ANTICANCER RES, V29, P3269; Sun BL, 2009, EXP LUNG RES, V35, P486, DOI 10.1080/01902140902759274; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070924; Thangarajh M, 2007, SCAND J IMMUNOL, V65, P92, DOI 10.1111/j.1365-3083.2006.01867.x; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Watanabe K, 1997, LAB INVEST, V76, P277; Wislet-Gendebien S, 2005, BRAIN RES BULL, V68, P95, DOI 10.1016/j.brainresbull.2005.08.016; Yamanaka R, 2006, ONCOGENE, V25, P5994, DOI 10.1038/sj.onc.1209585; Yepes M, 2007, FRONT BIOSCI-LANDMRK, V12, P2272; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802; Zhang JX, 2010, DEV COMP IMMUNOL, V34, P1199, DOI 10.1016/j.dci.2010.06.015; Zhang X, 2005, INT IMMUNOL, V17, P779, DOI 10.1093/intimm/dxh259	93	22	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83250	10.1371/journal.pone.0083250	http://dx.doi.org/10.1371/journal.pone.0083250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376672	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100101
J	Rao, KD; Ryan, M; Shroff, Z; Vujicic, M; Ramani, S; Berman, P				Rao, Krishna D.; Ryan, Mandy; Shroff, Zubin; Vujicic, Marko; Ramani, Sudha; Berman, Peter			Rural Clinician Scarcity and Job Preferences of Doctors and Nurses in India: A Discrete Choice Experiment	PLOS ONE			English	Article							HEALTH-WORKERS; NONPHYSICIAN CLINICIAN; SURGERY; QUALITY	The scarcity of rural doctors has undermined the ability of health systems in low and middle-income countries like India to provide quality services to rural populations. This study examines job preferences of doctors and nurses to inform what works in terms of rural recruitment strategies. Job acceptance of different strategies was compared to identify policy options for increasing the availability of clinical providers in rural areas. In 2010 a Discrete Choice Experiment was conducted in India. The study sample included final year medical and nursing students, and in-service doctors and nurses serving at Primary Health Centers. Eight job attributes were identified and a D-efficient fractional factorial design was used to construct pairs of job choices. Respondent acceptance of job choices was analyzed using multi-level logistic regression. Location mattered; jobs in areas offering urban amenities had a high likelihood of being accepted. Higher salary had small effect on doctor, but large effect on nurse, acceptance of rural jobs. At five times current salary levels, 13% (31%) of medical students (doctors) were willing to accept rural jobs. At half this level, 61% (52%) of nursing students (nurses) accepted a rural job. The strategy of reserving seats for specialist training in exchange for rural service had a large effect on job acceptance among doctors, nurses and nursing students. For doctors and nurses, properly staffed and equipped health facilities, and housing had small effects on job acceptance. Rural upbringing was not associated with rural job acceptance. Incentivizing doctors for rural service is expensive. A broader strategy of substantial salary increases with improved living, working environment, and education incentives is necessary. For both doctors and nurses, the usual strategies of moderate salary increases, good facility infrastructure, and housing will not be effective. Non-physician clinicians like nurse-practitioners offer an affordable alternative for delivering rural health care.	[Rao, Krishna D.] Publ Hlth Fdn India, New Delhi, India; [Ryan, Mandy] Univ Aberdeen, Inst Appl Hlth Sci, Hlth Econ Res Unit, Aberdeen, Scotland; [Shroff, Zubin; Berman, Peter] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Vujicic, Marko] Amer Dent Assoc, Chicago, IL USA; [Ramani, Sudha] Indian Inst Publ Hlth Hyderabad, Hyderabad, Andhra Pradesh, India	Public Health Foundation of India; University of Aberdeen; Harvard University; Harvard T.H. Chan School of Public Health	Rao, KD (corresponding author), Publ Hlth Fdn India, New Delhi, India.	kd.rao@phfi.org			World Bank	World Bank(The World Bank India)	The study was funded by a grant from the World Bank. Two of the authors were members of the World Bank at the time of this study. The funders (World Bank) participated in the study design, decision to publish, and preparation of the manuscript.	Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; [Anonymous], 2011, STAT STAT SOFTW REL; Blaauw D, 2010, B WORLD HEALTH ORGAN, V88, P350, DOI 10.2471/BLT.09.072918; Cheng J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-15; Dolea C, 2010, B WORLD HEALTH ORGAN, V88, P379, DOI 10.2471/BLT.09.070607; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Guo G, 2000, ANNU REV SOCIOL, V26, P441, DOI 10.1146/annurev.soc.26.1.441; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huicho L, 2008, LANCET, V372, P910, DOI 10.1016/S0140-6736(08)61401-4; Miranda JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050567; Kalantri S P, 2007, Indian J Med Ethics, V4, P152; Khandpur N, 2010, INDIA RESULTS QUALIT; Kokho P, 2013, SOC SCI MED, DOI [10.1016/j.socs-cimed.2013.02.018, DOI 10.1016/J.SOCS-CIMED.2013.02.018]; Kolstad JR, 2011, HEALTH ECON, V20, P196, DOI 10.1002/hec.1581; Kruk ME, 2010, B WORLD HEALTH ORGAN, V88, P333, DOI 10.2471/BLT.09.072892; Kuhfeld W.F., 2010, SAS; Lagarde M, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-62; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Mangham LJ, 2009, HEALTH POLICY PLANN, V24, P151, DOI 10.1093/heapol/czn047; McCord C, 2009, HEALTH AFFAIR, V28, pW876, DOI 10.1377/hlthaff.28.5.w876; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Opuni M, 2010, AIDS BEHAV, V14, P807, DOI 10.1007/s10461-009-9584-4; Rao KD, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-19; Shroff Zubin C, 2013, Indian J Community Med, V38, P27, DOI 10.4103/0970-0218.106624; Sundararaman T, 2011, B WORLD HEALTH ORGAN, V89, P73, DOI 10.2471/BLT.09.070862; Vujicic M., 2010, ATTRACTING DOCTORS M; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; WHO Geneva Switzerland, 2012, CONDUCT DISCRETE CHO; Wilhelm TJ, 2011, TROP DOCT, V41, P71, DOI 10.1258/td.2010.100272; Wooldridge J., 2002, ECONOMETRIC ANAL CRO	30	30	30	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82984	10.1371/journal.pone.0082984	http://dx.doi.org/10.1371/journal.pone.0082984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376621	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100076
J	Tam, CHT; Ho, JSK; Wang, Y; Lam, VKL; Lee, HM; Jiang, GZ; Lau, ESH; Kong, APS; Fan, XD; Woo, JLF; Tsui, SKW; Ng, MCY; So, WY; Chan, JCN; Ma, RCW				Tam, Claudia H. T.; Ho, Janice S. K.; Wang, Ying; Lam, Vincent K. L.; Lee, Heung Man; Jiang, Guozhi; Lau, Eric S. H.; Kong, Alice P. S.; Fan, Xiaodan; Woo, Jean L. F.; Tsui, Stephen K. W.; Ng, Maggie C. Y.; So, Wing Yee; Chan, Juliana C. N.; Ma, Ronald C. W.			Use of Net Reclassification Improvement (NRI) Method Confirms The Utility of Combined Genetic Risk Score to Predict Type 2 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELL FUNCTION; HONG-KONG CHINESE; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; COMMON VARIANTS; JAPANESE POPULATION; FASTING GLUCOSE; HAN CHINESE; OBESITY	Background: Recent genome-wide association studies (GWAS) identified more than 70 novel loci for type 2 diabetes (T2D), some of which have been widely replicated in Asian populations. In this study, we investigated their individual and combined effects on T2D in a Chinese population. Methodology: We selected 14 single nucleotide polymorphisms (SNPs) in T2D genes relating to beta-cell function validated in Asian populations and genotyped them in 5882 Chinese T2D patients and 2569 healthy controls. A combined genetic score (CGS) was calculated by summing up the number of risk alleles or weighted by the effect size for each SNP under an additive genetic model. We tested for associations by either logistic or linear regression analysis for T2D and quantitative traits, respectively. The contribution of the CGS for predicting T2D risk was evaluated by receiver operating characteristic (ROC) analysis and net reclassification improvement (NRI). Results: We observed consistent and significant associations of IGF2BP2, WFS1, CDKAL1, SLC30A8, CDKN2A/B, HHEX, TCF7L2 and KCNQ1 (8.5x10(-18)<P<8.5x10(-3)), as well as nominal associations of NOTCH2, JAZF1, KCNJ11 and HNF1B (0.05<P<0.1) with T2D risk, which yielded odds ratios ranging from 1.07 to 2.09. The 8 significant SNPs exhibited joint effect on increasing T2D risk, fasting plasma glucose and use of insulin therapy as well as reducing HOMA-beta, BMI, waist circumference and younger age of diagnosis of T2D. The addition of CGS marginally increased AUC (2%) but significantly improved the predictive ability on T2D risk by 11.2% and 11.3% for unweighted and weighted CGS, respectively using the NRI approach (P<0.001). Conclusion: In a Chinese population, the use of a CGS of 8 SNPs modestly but significantly improved its discriminative ability to predict T2D above and beyond that attributed to clinical risk factors (sex, age and BMI).	[Tam, Claudia H. T.; Ho, Janice S. K.; Wang, Ying; Lam, Vincent K. L.; Lee, Heung Man; Jiang, Guozhi; Lau, Eric S. H.; Kong, Alice P. S.; Woo, Jean L. F.; So, Wing Yee; Chan, Juliana C. N.; Ma, Ronald C. W.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Kong, Alice P. S.; So, Wing Yee; Chan, Juliana C. N.; Ma, Ronald C. W.] Chinese Univ Hong Kong, Hong Kong Inst Diabet & Obes, Hong Kong, Hong Kong, Peoples R China; [Kong, Alice P. S.; So, Wing Yee; Chan, Juliana C. N.; Ma, Ronald C. W.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Fan, Xiaodan] Chinese Univ Hong Kong, Dept Stat, Hong Kong, Hong Kong, Peoples R China; [Tsui, Stephen K. W.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Ng, Maggie C. Y.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Ctr Diabet Res, Winston Salem, NC USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Wake Forest University	Ma, RCW (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	rcwma@cuhk.edu	Chan, Juliana/B-7918-2016; Lau, Eric S.H./AGZ-2920-2022; Ma, Ronald/C-2788-2009; Tsui, Stephen Kwok-Wing/E-4385-2015; Kong, Alice/P-3703-2015; Woo, Jean/K-2625-2014; Fan, Xiaodan/Q-2208-2018	Chan, Juliana/0000-0003-1325-1194; Ma, Ronald/0000-0002-1227-803X; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Kong, Alice/0000-0001-8927-6764; Woo, Jean/0000-0001-7593-3081; Fan, Xiaodan/0000-0002-2744-9030; Lau, Eric S.H./0000-0003-1581-5643	Hong Kong Foundation for Research and Development in Diabetes under the Chinese University of Hong Kong; Liao Wun Yuk Diabetes Research Memorial Fund; Hong Kong Governments Research Grant Committee Central Allocation Scheme [CUHK 1/04C]; Research Grants Council Earmarked Research Grant [CUHK4727/0M]; Innovation and Technology Fund [ITS/088/08, ITS/487/09FP]; Focused Investment Fund of the Chinese University; Chinese University Direct Grant; Research Fund of the Department of Medicine and Therapeutics; Diabetes and Endocrine Research Fund of the Chinese University of Hong Kong; National Institutes of Health Grant NIH-RFA from the National Institutes of Diabetes and Digestive and Kidney Diseases [DK-085545-01]	Hong Kong Foundation for Research and Development in Diabetes under the Chinese University of Hong Kong; Liao Wun Yuk Diabetes Research Memorial Fund; Hong Kong Governments Research Grant Committee Central Allocation Scheme; Research Grants Council Earmarked Research Grant; Innovation and Technology Fund; Focused Investment Fund of the Chinese University; Chinese University Direct Grant; Research Fund of the Department of Medicine and Therapeutics; Diabetes and Endocrine Research Fund of the Chinese University of Hong Kong; National Institutes of Health Grant NIH-RFA from the National Institutes of Diabetes and Digestive and Kidney Diseases	This study was supported by the Hong Kong Foundation for Research and Development in Diabetes established under the auspices of the Chinese University of Hong Kong, the Liao Wun Yuk Diabetes Research Memorial Fund, the Hong Kong Governments Research Grant Committee Central Allocation Scheme (CUHK 1/04C), Research Grants Council Earmarked Research Grant (CUHK4727/0M), the Innovation and Technology Fund (ITS/088/08 and ITS/487/09FP), Focused Investment Fund of the Chinese University, a Chinese University Direct Grant, the Research Fund of the Department of Medicine and Therapeutics, the Diabetes and Endocrine Research Fund of the Chinese University of Hong Kong, and National Institutes of Health Grant NIH-RFA DK-085545-01 (from the National Institutes of Diabetes and Digestive and Kidney Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Billings LK, 2011, ANN NY ACAD SCI, V1212, P59; Cauchi S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-45; Chan JCN, 2011, CURR CARDIOVASC RISK, V5, P230, DOI 10.1007/s12170-011-0172-6; Cheurfa N, 2011, DIABETOLOGIA, V54, P554, DOI 10.1007/s00125-010-1989-0; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gupta V, 2012, DIABETOLOGIA, V55, P349, DOI 10.1007/s00125-011-2355-6; Haupt A, 2009, DIABETOLOGIA, V52, P457, DOI 10.1007/s00125-008-1250-2; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Janipalli CS, 2012, DIABETIC MED, V29, P121, DOI 10.1111/j.1464-5491.2011.03438.x; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Kahn SE, 2012, DIABETES OBES METAB, V14, P46, DOI 10.1111/j.1463-1326.2012.01650.x; Ko GTC, 2007, INT J OBESITY, V31, P254, DOI 10.1038/sj.ijo.0803389; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Linder K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038224; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Ma RC, 2013, DIABETOLOGIA; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy MI, 2008, DIABETES, V57, P2889, DOI 10.2337/db08-0343; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Miyake K, 2009, J HUM GENET, V54, P236, DOI 10.1038/jhg.2009.17; Ng MCY, 2010, DIABETIC MED, V27, P1443, DOI 10.1111/j.1464-5491.2010.03124.x; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; Omori S, 2009, DIABETOLOGIA, V52, P1554, DOI 10.1007/s00125-009-1397-5; Ozaki R, 2007, ARCH DIS CHILD, V92, P224, DOI 10.1136/adc.2006.100453; Pascoe L, 2008, DIABETOLOGIA, V51, P1989, DOI 10.1007/s00125-008-1124-7; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi Q, 2010, DIABETOLOGIA, V53, P2163, DOI 10.1007/s00125-010-1826-5; Ruchat SM, 2010, DIABETOLOGIA, V53, P679, DOI 10.1007/s00125-009-1630-2; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Stancakova A, 2009, DIABETES, V58, P2129, DOI 10.2337/db09-0117; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; 't Hart LM, 2010, DIABETES, V59, P287, DOI 10.2337/db09-0736; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tam CHT, 2009, DIABETES, V58, P765, DOI 10.2337/db08-1277; Tam CHT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011428; Tang NLS, 2010, BONE, V46, P543, DOI 10.1016/j.bone.2009.09.012; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wray NR, 2008, CURR OPIN GENET DEV, V18, P257, DOI 10.1016/j.gde.2008.07.006; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Yamakawa-Kobayashi K, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-11; Yang XL, 2008, ARCH INTERN MED, V168, P451, DOI 10.1001/archinte.168.5.451; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yu W, 2011, CLIN PHARMACOL THER, V89, P437, DOI 10.1038/clpt.2010.351; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou DZ, 2010, J HUM GENET, V55, P810, DOI 10.1038/jhg.2010.117	67	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83093	10.1371/journal.pone.0083093	http://dx.doi.org/10.1371/journal.pone.0083093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376643	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100088
J	Heylmann, D; Bauer, M; Becker, H; van Gool, S; Bacher, N; Steinbrink, K; Kaina, B				Heylmann, Daniel; Bauer, Martina; Becker, Huong; van Gool, Stefaan; Bacher, Nicole; Steinbrink, Kerstin; Kaina, Bernd			Human CD4+CD25+Regulatory T Cells Are Sensitive to Low Dose Cyclophosphamide: Implications for the Immune Response	PLOS ONE			English	Article							MULTIPLE-MYELOMA; CANCER-PATIENTS; DNA; REPAIR; IMMUNOTHERAPY; INHIBITION; TUMORS; BLOOD	Regulatory T cells (Treg) play a pivotal role in the immune system since they inhibit the T cell response. It is well known that cyclophosphamide applied at low dose is able to stimulate the immune response while high dose cyclophosphamide exerts inhibitory activity. Data obtained in mice indicate that cyclophosphamide provokes a reduction in the number of Treg and impairs their suppressive activity, resulting in immune stimulation. Here, we addressed the question of the sensitivity of human Treg to cyclophosphamide, comparing Treg with cytotoxic T cells (CTL) and T helper cells (Th). We show that Treg are more sensitive than CTL and Th to mafosfamide, which is an active derivative of cyclophosphamide, which does not need metabolic activation. The high sensitivity of Treg was due to the induction of apoptosis. Treg compared to CTL and Th were not more sensitive to the alkylating drugs temozolomide and nimustine and also not to mitomycin C, indicating a specific Treg response to mafosfamide. The high sensitivity of Treg to mafosfamide resulted not only in enhanced cell death, but also in impaired Treg function as demonstrated by a decline in the suppressor activity of Treg in a co-culture model with Th and Helios positive Treg. Treatment of Treg with mafosfamide gave rise to a high level of DNA crosslinks, which were not repaired to the same extent as observed in Th and CTL. Also, Treg showed a low level of gamma H2AX foci up to 6 h and a high level 24 h after treatment, indicating alterations in the DNA damage response. Overall, this is the first demonstration that human Treg are, in comparison with Th and CTL, hypersensitive to cyclophosphamide, which is presumably due to a DNA repair defect.	[Heylmann, Daniel; Bauer, Martina; Becker, Huong; Kaina, Bernd] Univ Med Ctr, Dept Toxicol, Mainz, Germany; [van Gool, Stefaan] Univ Hosp, Louvain, Belgium; [Bacher, Nicole; Steinbrink, Kerstin] Univ Med Ctr, Dept Dermatol, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Kaina, B (corresponding author), Univ Med Ctr, Dept Toxicol, Mainz, Germany.	kaina@uni-mainz.de	Kaina, Bernd/AAE-4692-2020	Heylmann, Daniel/0000-0002-8335-2313	Deutsche Forschungsgemeinschaft, DFG [KA724/20-1]	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft, DFG KA724/20-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Bauer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039956; Bauer M, 2011, P NATL ACAD SCI USA, V108, P21105, DOI 10.1073/pnas.1111919109; Beissert S, 2006, J INVEST DERMATOL, V126, P15, DOI 10.1038/sj.jid.5700004; Cai J, 2009, CHEM RES TOXICOL, V22, P708, DOI 10.1021/tx800465m; Emadi A, 2009, NAT REV CLIN ONCOL, V6, P638, DOI 10.1038/nrclinonc.2009.146; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Ge YZ, 2012, CANCER IMMUNOL IMMUN, V61, P353, DOI 10.1007/s00262-011-1106-3; Ghiringhelli F, 2004, EUR J IMMUNOL, V34, P336, DOI 10.1002/eji.200324181; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Goldstein M, 2008, TOXICOL APPL PHARM, V229, P20, DOI 10.1016/j.taap.2008.01.001; Joy MS, 2012, BRIT J CLIN PHARMACO, V74, P445, DOI 10.1111/j.1365-2125.2012.04223.x; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lefrere F, 1999, BONE MARROW TRANSPL, V24, P463, DOI 10.1038/sj.bmt.1701910; Liotta F, 2011, BJU INT, V107, P1500, DOI 10.1111/j.1464-410X.2010.09555.x; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; MATTHIAS M, 1984, ONKOLOGIE, V7, P48, DOI 10.1159/000215401; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sharabi A, 2011, BONE MARROW RES, DOI 10.1155/2011/269519; Sharabi A, 2010, CANCER PREV RES, V3, P1265, DOI 10.1158/1940-6207.CAPR-10-0138; Tomasz M, 1997, PHARMACOL THERAPEUT, V76, P73, DOI 10.1016/S0163-7258(97)00088-0; Usanova S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-248; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wainwright DA, 2011, NEURO-ONCOLOGY, V13, P1308, DOI 10.1093/neuonc/nor134; Walter S., 2012, NAT MED; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5; Zhao J, 2010, CANCER RES, V70, P4850, DOI 10.1158/0008-5472.CAN-10-0283	28	62	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83384	10.1371/journal.pone.0083384	http://dx.doi.org/10.1371/journal.pone.0083384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376696	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000085
J	Honda, S; Shirotani-Ikejima, H; Tadokoro, S; Tomiyama, Y; Miyata, T				Honda, Shigenori; Shirotani-Ikejima, Hiroko; Tadokoro, Seiji; Tomiyama, Yoshiaki; Miyata, Toshiyuki			The Integrin-Linked Kinase-PINCH-Parvin Complex Supports Integrin alpha IIb beta 3 Activation	PLOS ONE			English	Article							FOCAL ADHESION PROTEIN; CELL-ADHESION; TALIN HEAD; PLATELET-AGGREGATION; ILK; DOMAIN; BINDING; LOCALIZATION; INTERACTS; PATHWAY	Integrin-linked kinase (ILK) is an important signaling regulator that assembles into the heteroternary complex with adaptor proteins PINCH and parvin (termed the IPP complex). We recently reported that ILK is important for integrin activation in a Chinese hamster ovary (CHO) cell system. We previously established parental CHO cells expressing a constitutively active chimeric integrin (alpha IIb alpha 6B beta 3) and mutant CHO cells expressing inactive alpha IIb alpha 6B beta 3 due to ILK deficiency. In this study, we further investigated the underlying mechanisms for ILK-dependent integrin activation. ILK-deficient mutant cells had trace levels of PINCH and alpha-parvin, and transfection of ILK cDNA into the mutant cells increased not only ILK but also PINCH and alpha-parvin, resulting in the restoration of alpha IIb alpha 6B beta 3 activation. In the parental cells expressing active alpha IIb alpha 6B beta 3, ILK, PINCH, and alpha-parvin were co-immunoprecipitated, indicating the formation of the IPP complex. Moreover, short interfering RNA (siRNA) experiments targeting PINCH-1 or both alpha- and beta-parvin mRNA in the parent cells impaired the alpha IIb alpha 6B beta 3 activation as well as the expression of the other components of the IPP complex. In addition, ILK mutants possessing defects in either PINCH or parvin binding failed to restore alpha IIb alpha 6B beta 3 activation in the mutant cells. Kindlin-2 siRNA in the parental cells impaired alpha IIb alpha 6B beta 3 activation without disturbing the expression of ILK. For CHO cells stably expressing wild-type alpha IIb alpha 6B beta 3 that is an inactive form, overexpression of a talin head domain (THD) induced alpha IIb beta 3 activation and the THD-induced alpha IIb alpha 6B beta 3 activation was impaired by ILK siRNA through a significant reduction in the expression of the IPP complex. In contrast, overexpression of all IPP components in the alpha IIb alpha 6B beta 3-expressing CHO cells further augmented THD-induced alpha IIb beta 3 activation, whereas they did not induce alpha IIb alpha 6B beta 3 activation without THD. These data suggest that the IPP complex rather than ILK plays an important role and supports integrin activation probably through stabilization of the active conformation.	[Honda, Shigenori; Shirotani-Ikejima, Hiroko; Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan; [Tadokoro, Seiji; Tomiyama, Yoshiaki] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka, Japan; [Tomiyama, Yoshiaki] Osaka Univ Hosp, Dept Blood Transfus, Suita, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; Osaka University; Osaka University	Honda, S (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan.	shige@ncvc.go.jp		Tomiyama, Yoshiaki/0000-0001-7645-0989	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Health, Labor, and Welfare of Japan; and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Braun A, 2003, EXP CELL RES, V284, P239, DOI 10.1016/S0014-4827(02)00039-3; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chen K, 2008, J BIOL CHEM, V283, P2508, DOI 10.1074/jbc.M707307200; Chiswell BP, 2010, J STRUCT BIOL, V170, P157, DOI 10.1016/j.jsb.2009.12.002; Chu HY, 2006, MOL CELL BIOL, V26, P1817, DOI 10.1128/MCB.26.5.1817-1825.2006; Dittrich M, 2008, ARTERIOSCL THROM VAS, V28, P1326, DOI 10.1161/ATVBAHA.107.161000; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Friedrich EB, 2004, MOL CELL BIOL, V24, P8134, DOI 10.1128/MCB.24.18.8134-8144.2004; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801; Hannigan GE, 2011, ONCOGENE, V30, P4375, DOI 10.1038/onc.2011.177; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Honda S, 2009, BLOOD, V113, P5304, DOI 10.1182/blood-2008-07-169136; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li FG, 1999, J CELL SCI, V112, P4589; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Pasquet JM, 2002, THROMB HAEMOSTASIS, V88, P115; Qadota H, 2012, J BIOL CHEM, V287, P28537, DOI 10.1074/jbc.M112.354852; Qin J, 2012, CURR OPIN CELL BIOL, V24, P607, DOI 10.1016/j.ceb.2012.06.003; Ramos JW, 1998, J BIOL CHEM, V273, P33897, DOI 10.1074/jbc.273.51.33897; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Stevens JM, 2004, J THROMB HAEMOST, V2, P1443, DOI 10.1111/j.1538-7836.2004.00870.x; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Tucker KL, 2008, BLOOD, V112, P4523, DOI 10.1182/blood-2008-03-148502; Vouret-Craviari V, 2004, J CELL SCI, V117, P4559, DOI 10.1242/jcs.01331; Widmaier M, 2012, J CELL SCI, V125, P1839, DOI 10.1242/jcs.093864; Yamaji S, 2002, BIOCHEM BIOPH RES CO, V297, P1324, DOI 10.1016/S0006-291X(02)02381-1; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Zent R, 2000, J BIOL CHEM, V275, P5059, DOI 10.1074/jbc.275.7.5059; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200	51	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85498	10.1371/journal.pone.0085498	http://dx.doi.org/10.1371/journal.pone.0085498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376884	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000185
J	Katari, VS; van Esdonk, L; Goringer, HU				Katari, Venkata Subbaraju; van Esdonk, Lea; Goeringer, H. Ulrich			Molecular Crowding Inhibits U-Insertion/Deletion RNA Editing In Vitro: Consequences for the In Vivo Reaction	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; TRYPANOSOMA-BRUCEI; MITOCHONDRIAL TRANSLATION; DNA DUPLEX; STABILIZATION; ASSOCIATION; STABILITY; IDENTIFICATION; CONFINEMENT; COMPLEXES	Mitochondrial pre-mRNAs in African trypanosomes are edited to generate functional transcripts. The reaction is typified by the insertion and deletion of U nucleotides and is catalyzed by a macromolecular complex, the editosome. Editosomes bind pre-edited mRNA/gRNA pairs and the reaction can be recapitulated in vitro by using pre-mRNA- and gRNA-mimicking oligoribonucleotides together with enriched editosome preparations. Although the in vitro assay has been instrumental in unraveling the basic steps of the editing cycle it is performed at dilute solvent conditions. This ignores the fact that editing takes place inside the highly crowded mitochondria. Here we investigate the effects of molecular crowding on RNA editing. By using neutral, macromolecular cosolutes we generate defined dilute, semidilute and crowded solvent properties and we demonstrate different thermodynamic stabilities of the pre-mRNA/gRNA hybrid RNAs at these conditions. Crowded conditions stabilize the RNAs by -30 kJ/mol. Furthermore, we show that the rate constants for the association and dissociation (k(ass)/k(diss)) of substrate RNAs to editosomes decrease, ultimately inhibiting the in vitro reaction. The data demonstrate that the current RNA editing in vitro system is sensitive to molecular crowding, which suggests that the in vivo reaction cannot rely on a diffusion-controlled, collision-based mechanism. Possible non-diffusional reaction pathways are discussed.	[Katari, Venkata Subbaraju; van Esdonk, Lea; Goeringer, H. Ulrich] Tech Univ Darmstadt, Dept Mol Genet, Darmstadt, Germany	Technical University of Darmstadt	Goringer, HU (corresponding author), Tech Univ Darmstadt, Dept Mol Genet, Darmstadt, Germany.	goringer@bio.tu-darmstadt.de			Illing Foundation for Molecular Chemistry; German Research Council [DFG-SFB902]	Illing Foundation for Molecular Chemistry; German Research Council(German Research Foundation (DFG))	This work was supported by the Illing Foundation for Molecular Chemistry (http://dr.illing-stiftungen.de) and the German Research Council (DFG-SFB902) (http://www.dfg.de) to HUG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; Batra J, 2009, BIOPHYS J, V97, P906, DOI 10.1016/j.bpj.2009.05.032; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Bohm C, 2012, J BIOL CHEM, V287, P26268, DOI 10.1074/jbc.M112.365916; Breslauer K J, 1994, Methods Mol Biol, V26, P347; BRUN R, 1979, ACTA TROP, V36, P289; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Cruz-Reyes J, 2002, MOL CELL BIOL, V22, P4652, DOI 10.1128/MCB.22.13.4652-4660.2002; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Denesyuk NA, 2011, J AM CHEM SOC, V133, P11858, DOI 10.1021/ja2035128; Dieteren CEJ, 2011, P NATL ACAD SCI USA, V108, P8657, DOI 10.1073/pnas.1017581108; Elcock AH, 2010, CURR OPIN STRUC BIOL, V20, P196, DOI 10.1016/j.sbi.2010.01.008; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Fujimoto T, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/857149; Goringer HU, 2012, ANNU REV MICROBIOL, V66, P65, DOI 10.1146/annurev-micro-092611-150150; Golas MM, 2009, EMBO J, V28, P766, DOI 10.1038/emboj.2009.19; GORINGER HU, 1994, P NATL ACAD SCI USA, V91, P1776, DOI 10.1073/pnas.91.5.1776; Grams J, 2000, EMBO J, V19, P5525, DOI 10.1093/emboj/19.20.5525; Grams J, 2002, J BIOL CHEM, V277, P16952, DOI 10.1074/jbc.M200662200; Harve KS, 2010, NUCLEIC ACIDS RES, V38, P172, DOI 10.1093/nar/gkp884; Hauser R, 1996, J CELL SCI, V109, P517; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Igo RP, 2002, EUKARYOT CELL, V1, P112, DOI 10.1128/EC.1.1.112-118.2002; Karimata Hisae, 2004, Nucleic Acids Symp Ser (Oxf), P107, DOI 10.1093/nass/48.1.107; Karimata Hisae, 2006, Nucleic Acids Symp Ser (Oxf), P81; Kilburn D, 2010, J AM CHEM SOC, V132, P8690, DOI 10.1021/ja101500g; Koslowsky Donna J, 2004, RNA Biol, V1, P28; Koumoto K, 2008, CHEM LETT, V37, P864, DOI 10.1246/cl.2008.864; Kozer N, 2004, J MOL BIOL, V336, P763, DOI 10.1016/j.jmb.2003.12.008; Kozer N, 2007, BIOPHYS J, V92, P2139, DOI 10.1529/biophysj.106.097717; Lambert D, 2007, J MOL BIOL, V370, P993, DOI 10.1016/j.jmb.2007.03.080; Lambert D, 2010, J MOL BIOL, V404, P138, DOI 10.1016/j.jmb.2010.09.043; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; MARZUKI S, 1986, BIOCHIM BIOPHYS ACTA, V866, P120, DOI 10.1016/0167-4781(86)90108-9; McManus MT, 2001, RNA, V7, P167, DOI 10.1017/S1355838201002072; Minton AP, 1998, METHOD ENZYMOL, V295, P127; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Miyoshi D, 2002, BIOCHEMISTRY-US, V41, P15017, DOI 10.1021/bi020412f; Miyoshi Daisuke, 2009, Nucleic Acids Symp Ser (Oxf), P59, DOI 10.1093/nass/nrp030; Muhuri S, 2009, J AM CHEM SOC, V131, P9268, DOI 10.1021/ja900744e; Nakano S, 2004, J AM CHEM SOC, V126, P14330, DOI 10.1021/ja0463029; Nakano S, 2009, J AM CHEM SOC, V131, P16881, DOI 10.1021/ja9066628; Nashimoto M, 2000, EUR J BIOCHEM, V267, P2738, DOI 10.1046/j.1432-1327.2000.01294.x; ODOM OW, 1980, BIOCHEMISTRY-US, V19, P5947, DOI 10.1021/bi00567a001; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Panigrahi AK, 2007, METHOD ENZYMOL, V424, P3, DOI 10.1016/S0076-6879(07)24001-7; Pincus DL, 2008, J AM CHEM SOC, V130, P7364, DOI 10.1021/ja078326w; Pramanik S, 2011, J PHYS CHEM B, V115, P13862, DOI 10.1021/jp207856p; Pusnik M, 2007, MOL CELL BIOL, V27, P6876, DOI 10.1128/MCB.00708-07; READ LK, 1992, J BIOL CHEM, V267, P1123; Reifur L, 2008, RNA, V14, P2195, DOI 10.1261/rna.1144508; Sharma MR, 2009, P NATL ACAD SCI USA, V106, P9637, DOI 10.1073/pnas.0901631106; Spink CH, 1995, J AM CHEM SOC, V117, P12887, DOI 10.1021/ja00156a038; SRERE PA, 1980, TRENDS BIOCHEM SCI, V5, P120, DOI 10.1016/0968-0004(80)90051-1; Stuart Kenneth, 2004, Methods Mol Biol, V265, P251; Wang YZ, 2010, SOFT MATTER, V6, P3318, DOI 10.1039/c001342k; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou Huan-Xiang, 2013, Biophys Rev, V5, P207, DOI 10.1007/s12551-013-0101-7; Zhou HX, 2008, ARCH BIOCHEM BIOPHYS, V469, P76, DOI 10.1016/j.abb.2007.07.013; ZIMMERMAN SB, 1988, NUCLEIC ACIDS RES, V16, P6309, DOI 10.1093/nar/16.14.6309	63	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83796	10.1371/journal.pone.0083796	http://dx.doi.org/10.1371/journal.pone.0083796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376749	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000114
J	van den Broeke, EN; Koeslag, L; Arendsen, LJ; Nienhuijs, SW; Rosman, C; van Rijn, CM; Wilder-Smith, OHG; van Goor, H				van den Broeke, Emanuel N.; Koeslag, Lonneke; Arendsen, Laura J.; Nienhuijs, Simon W.; Rosman, Camiel; van Rijn, Clementina M.; Wilder-Smith, Oliver H. G.; van Goor, Harry			Altered Cortical Responsiveness to Pain Stimuli after High Frequency Electrical Stimulation of the Skin in Patients with Persistent Pain after Inguinal Hernia Repair	PLOS ONE			English	Article							LONG-TERM POTENTIATION; HUMANS; LTP; FACILITATION; SYSTEM	Background: High Frequency electrical Stimulation (HFS) of the skin induces enhanced brain responsiveness expressed as enhanced Event-Related Potential (ERP) N1 amplitude to stimuli applied to the surrounding unconditioned skin in healthy volunteers. The aim of the present study was to investigate whether this enhanced ERP N1 amplitude could be a potential marker for altered cortical sensory processing in patients with persistent pain after surgery. Materials and Methods: Nineteen male patients; 9 with and 10 without persistent pain after inguinal hernia repair received HFS. Before, directly after and thirty minutes after HFS evoked potentials and the subjective pain intensity were measured in response to electric pain stimuli applied to the surrounding unconditioned skin. Results: The results show that, thirty minutes after HFS, the ERP N1 amplitude observed at the conditioned arm was statistically significantly larger than the amplitude at the control arm across all patients. No statistically significant differences were observed regarding ERP N1 amplitude between patients with and without persistent pain. However, thirty minutes after HFS we did observe statistically significant differences of P2 amplitude at the conditioned arm between the two groups. The P2 amplitude decreased in comparison to baseline in the group of patients with pain. Conclusion: The ERP N1 effect, induced after HFS, was not different between patients with vs. without persistent pain. The decreasing P2 amplitude was not observed in the patients without pain and also not in the previous healthy volunteer study and thus might be a marker for altered cortical sensory processing in patients with persistent pain after surgery.	[van den Broeke, Emanuel N.; Arendsen, Laura J.; Wilder-Smith, Oliver H. G.] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands; [Koeslag, Lonneke; van Goor, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6525 ED Nijmegen, Netherlands; [Nienhuijs, Simon W.] Catharina Hosp, Dept Surg, Eindhoven, Netherlands; [Rosman, Camiel] Canisius Wilhelmina Hosp, Dept Surg, Nijmegen, Netherlands; [van Rijn, Clementina M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Catharina Hospital; Canisius-Wilhelmina Hospital; Radboud University Nijmegen	van den Broeke, EN (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands.	Emanuelvandenbroeke@hotmail.com	Nienhuijs, Simon/H-7505-2019; van Goor, H./H-8035-2014; rosman, camiel/F-9059-2016; Wilder-Smith, Oliver H.G./E-7541-2012; van Rijn, Clementina/D-5828-2012	van Goor, H./0000-0003-0323-4876; rosman, camiel/0000-0002-9152-3987; Wilder-Smith, Oliver H.G./0000-0003-4390-2381; van Rijn, Clementina/0000-0002-1103-6338; Arendsen, Laura/0000-0002-9160-3282				Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Fabiani M., 2000, HDB PSYCHOPHYSIOLOGY, P53; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hansen N, 2007, J NEUROPHYSIOL, V97, P2559, DOI 10.1152/jn.01125.2006; Iannetti GD, 2013, J NEUROPHYS IN PRESS; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ikeda H, 2009, NEUROSCI RES, V64, P133, DOI 10.1016/j.neures.2009.03.004; Katsarava Z, 2006, HEADACHE, V46, P1511, DOI 10.1111/j.1526-4610.2006.00446.x; Klein T, 2004, J NEUROSCI, V24, P964, DOI 10.1523/JNEUROSCI.1222-03.2004; Klein T, 2008, PAIN, V139, P507, DOI 10.1016/j.pain.2008.06.001; Klein T, 2006, J NEUROPHYSIOL, V96, P3551, DOI 10.1152/jn.00755.2006; Landolt HP, 2004, NEUROPSYCHOPHARMACOL, V29, P1933, DOI 10.1038/sj.npp.1300526; Lang S, 2007, PAIN, V128, P254, DOI 10.1016/j.pain.2006.09.026; LeBars D, 1991, ACUPUNCT MED, V9, P47, DOI DOI 10.1136/AIM.9.2.47; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Maihofner C, 2010, EUR J PAIN, V14, P64, DOI 10.1016/j.ejpain.2009.02.007; Mouraux A, 2010, PAIN, V150, P199, DOI 10.1016/j.pain.2010.04.026; Nienhuijs SW, 2005, BRIT J SURG, V92, P33, DOI 10.1002/bjs.4702; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; Valeriani M, 2003, CLIN NEUROPHYSIOL, V114, P1879, DOI 10.1016/S1388-2457(03)00180-9; Van den Broeke EN, 2012, J NEUROPHYSIOL, V108, P2276, DOI 10.1152/jn.00391.2012; van den Broeke EN, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-28; van den Broeke EN, 2010, J NEUROPHYSIOL, V103, P2107, DOI 10.1152/jn.00979.2009; Van Den Broeke EN, 2013, EUR J PAIN IN PRESS; Van Seventer R, 2010, EUR J PAIN, V14, P58, DOI 10.1016/j.ejpain.2009.01.005	29	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82701	10.1371/journal.pone.0082701	http://dx.doi.org/10.1371/journal.pone.0082701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376568	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000023
J	Chen, BF; Zhang, B; Zhu, CC; Ye, ZR; Wang, CG; Ma, DH; Ye, MH; Kong, M; Jin, J; Lin, J; Wu, CL; Wang, Z; Ye, JH; Zhang, J; Hu, QT				Chen, Baofu; Zhang, Bo; Zhu, Chengchu; Ye, Zhongrui; Wang, Chunguo; Ma, Dehua; Ye, Minhua; Kong, Min; Jin, Jiang; Lin, Jiang; Wu, Chunlei; Wang, Zheng; Ye, Jiahong; Zhang, Jian; Hu, Quanteng			Modified McKeown Minimally Invasive Esophagectomy for Esophageal Cancer: A 5-Year Retrospective Study of 142 Patients in a Single Institution	PLOS ONE			English	Article							ASSISTED THORACOSCOPIC ESOPHAGECTOMY; OUTCOMES; MORTALITY; EXPERIENCE; VOLUME; METAANALYSIS; MORBIDITY; POSITION; ENGLAND	Background: To achieve decreased invasiveness and lower morbidity, minimally invasive esophagectomy (ME) was introduced in 1997 for localized esophageal cancer. The combined thoracoscopic-laparoscopic esophagectomy (left neck anastomosis, defined as the McKeown ME procedure) has been performed since 2007 at our institution. From 2007 to 2011, our institution subsequently evolved as a high-volume MIE center in China. We aim to share our experience with MIE, and have evaluated the outcomes of 142 patients. Methods: We retrospectively reviewed 142 consecutive patients who had presented with esophageal cancer undergoing McKeown ME from July 2007 to December 2011. The procedure, surgical outcomes, disease-free and overall survival of these cases were assessed. Results: The average total procedure time was 270.5 +/- 28.1 min. The median operation time for thoracoscopy was 81.5 +/- 14.6 min and for laparoscopy was 63.81 +/- 9.1 min. The average blood loss associated with thoracoscopy was 123.8 +/- 39.2 ml, and for laparoscopic procedures was 49.9 +/- 14.3 ml. The median number of lymph nodes retrieved was 22.8. The 30 day mortality rate was 0.7%. Major surgical complications occurred in 24.6% and major non-surgical complications occurred in 18.3% of these patients. The median DFS and OS were 36.0 +/- 2.6 months and 43.0 +/- 3.4 months respectively. Conclusions: Surgical and oncological outcomes following McKeown MIE for esophageal cancer were acceptable and comparable with those of open-McKeown esophagectomy. The procedure was both feasible and safe properties that can be consolidated by experience.	[Chen, Baofu; Zhang, Bo; Zhu, Chengchu; Ye, Zhongrui; Wang, Chunguo; Ma, Dehua; Ye, Minhua; Kong, Min; Jin, Jiang; Lin, Jiang; Wu, Chunlei; Wang, Zheng; Ye, Jiahong; Zhang, Jian; Hu, Quanteng] Taizhou Hosp, Wenzhou Med Coll, Dept Thorac Surg, Linhai, Zhejiang, Peoples R China	Wenzhou Medical University	Zhu, CC (corresponding author), Taizhou Hosp, Wenzhou Med Coll, Dept Thorac Surg, Linhai, Zhejiang, Peoples R China.	zhucc669266@163.com			Zhejiang Provincial Science and Technology Major Projects [2011C13039-2]; Zhejiang Provincial Science and Technology Innovation Team Projects [2011R09040-03]	Zhejiang Provincial Science and Technology Major Projects; Zhejiang Provincial Science and Technology Innovation Team Projects	This work was supported by Zhejiang Provincial Science and Technology Major Projects (Grant No. 2011C13039-2) and Zhejiang Provincial Science and Technology Innovation Team Projects (Grant No. 2011R09040-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avital S, 2005, AM J SURG, V190, P69, DOI 10.1016/j.amjsurg.2004.12.004; Bailey SH, 2003, ANN THORAC SURG, V75, P217, DOI 10.1016/S0003-4975(02)04368-0; Ben-David K, 2011, ANN SURG ONCOL, V18, P3324, DOI 10.1245/s10434-011-1702-7; Biere SSAY, 2009, MINERVA CHIR, V64, P121; Birkmeyer JD, 2006, ANN SURG, V243, P411, DOI 10.1097/01.sla.0000201800.45264.51; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bizekis C, 2006, ANN THORAC SURG, V82, P402, DOI 10.1016/j.athoracsur.2006.02.052; Butler N, 2011, SURG ENDOSC, V25, P2071, DOI 10.1007/s00464-010-1511-2; Chen Bao-fu, 2010, Zhonghua Wai Ke Za Zhi, V48, P1206; Decker G, 2009, EUR J CARDIO-THORAC, V35, P13, DOI 10.1016/j.ejcts.2008.09.024; Hayden JD, 2007, DIS ESOPHAGUS, V20, P251, DOI 10.1111/j.1442-2050.2007.00644.x; Hulscher JBF, 2001, ANN THORAC SURG, V72, P306, DOI 10.1016/S0003-4975(00)02570-4; Jarral OA, 2012, SURG ENDOSC, V26, P2095, DOI 10.1007/s00464-012-2172-0; Karl RC, 2000, ANN SURG, V231, P635, DOI 10.1097/00000658-200005000-00003; Kawahara K, 1999, SURG ENDOSC-ULTRAS, V13, P218, DOI 10.1007/s004649900948; Kinjo Y, 2012, SURG ENDOSC, V26, P381, DOI 10.1007/s00464-011-1883-y; Law S, 1997, SURGERY, V122, P8, DOI 10.1016/S0039-6060(97)90257-9; Lazzarino AI, 2010, ANN SURG, V252, P292, DOI 10.1097/SLA.0b013e3181dd4e8c; Levy Ryan M, 2010, Adv Surg, V44, P101; Luketich JD, 2012, ANN SURG, V256, P95, DOI 10.1097/SLA.0b013e3182590603; Luketich JD, 2003, ANN SURG, V238, P486, DOI 10.1097/01.sla.0000089858.40725.68; Luketich JD, 2000, SURG ENDOSC, V14, P700, DOI 10.1007/s004640000222; Mamidanna R, 2012, ANN SURG, V255, P197, DOI 10.1097/SLA.0b013e31823e39fa; MCANENA OJ, 1994, BRIT J SURG, V81, P236, DOI 10.1002/bjs.1800810225; Nagpal K, 2010, SURG ENDOSC, V24, P1621, DOI 10.1007/s00464-009-0822-7; Ninomiya I, 2010, DIS ESOPHAGUS, V23, P618, DOI 10.1111/j.1442-2050.2010.01075.x; Noshiro H, 2010, SURG ENDOSC, V24, P2965, DOI 10.1007/s00464-010-1072-4; Osugi H, 2002, SURG ENDOSC, V16, P1588, DOI 10.1007/s00464-002-9019-z; Pennathur A, 2010, ANN THORAC SURG, V89, pS2159, DOI 10.1016/j.athoracsur.2010.03.069; Puntambekar SP, 2010, SURG ENDOSC, V24, P2407, DOI 10.1007/s00464-010-0963-8; Smithers BM, 2001, SURG ENDOSC-ULTRAS, V15, P176, DOI 10.1007/s004640000307; Swisher SG, 2000, J THORAC CARDIOV SUR, V119, P1126, DOI 10.1067/mtc.2000.105644; Zhu Cheng-chu, 2005, Zhonghua Wai Ke Za Zhi, V43, P628	33	19	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82428	10.1371/journal.pone.0082428	http://dx.doi.org/10.1371/journal.pone.0082428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376537	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100032
J	Geiger, BM; Gras-Miralles, B; Ziogas, DC; Karagiannis, AKA; Zhen, A; Fraenkel, P; Kokkotou, E				Geiger, Brenda M.; Gras-Miralles, Beatriz; Ziogas, Dimitrios C.; Karagiannis, Apostolos K. A.; Zhen, Aileen; Fraenkel, Paula; Kokkotou, Efi			Intestinal Upregulation of Melanin-Concentrating Hormone in TNBS-Induced Enterocolitis in Adult Zebrafish	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INNATE IMMUNE-RESPONSE; EXPRESSION; MICE; MODEL; EVOLUTIONARY; GENES; MICROBIOTA; RECEPTOR; GHRELIN	Background: Melanin-concentrating hormone (MCH), an evolutionarily conserved appetite-regulating neuropeptide, has been recently implicated in the pathogenesis of inflammatory bowel disease (IBD). Expression of MCH is upregulated in inflamed intestinal mucosa in humans with colitis and MCH-deficient mice treated with trinitrobenzenesulfonic acid (TNBS) develop an attenuated form of colitis compared to wild type animals. Zebrafish have emerged as a new animal model of IBD, although the majority of the reported studies concern zebrafish larvae. Regulation MCH expression in the adult zebrafish intestine remains unknown. Methods: In the present study we induced enterocolitis in adult zebrafish by intrarectal administration of TNBS. Follow-up included survival analysis, histological assessment of changes in intestinal architecture, and assessment of intestinal infiltration by myeloperoxidase positive cells and cytokine transcript levels. Results: Treatment with TNBS dose-dependently reduced fish survival. This response required the presence of an intact microbiome, since fish pre-treated with vancomycin developed less severe enterocolitis. At 6 hours post-challenge, we detected a significant influx of myeloperoxidase positive cells in the intestine and upregulation of both proinflammatory and anti-inflammatory cytokines. Most importantly, and in analogy to human IBD and TNBS-induced mouse experimental colitis, we found increased intestinal expression of MCH and its receptor in TNBS-treated zebrafish. Conclusions: Taken together these findings not only establish a model of chemically-induced experimental enterocolitis in adult zebrafish, but point to effects of MCH in intestinal inflammation that are conserved across species.	[Geiger, Brenda M.; Gras-Miralles, Beatriz; Ziogas, Dimitrios C.; Karagiannis, Apostolos K. A.; Kokkotou, Efi] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA; [Zhen, Aileen; Fraenkel, Paula] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Fraenkel, P (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.	pfraenke@bidmc.harvard.edu; ekokkoto@bidmc.harvard.edu		Fraenkel, Paula/0000-0001-8894-0117; Ziogas, Dimitrios C./0000-0003-2620-4004; Gras-Miralles, Beatriz/0000-0002-5943-7755	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [R01 DK080058, R01 DK 085250]; Department of Defense Congressionally Directed Medical Research Programs [W81XWH-11-1-0656]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085250, R01DK080058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083198] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Defense Congressionally Directed Medical Research Programs(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants R01 DK080058 and R01 DK 085250 from National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, and W81XWH-11-1-0656 award from Department of Defense Congressionally Directed Medical Research Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amole N, 2009, GEN COMP ENDOCR, V161, P133, DOI 10.1016/j.ygcen.2008.11.002; Berman JR, 2009, J COMP NEUROL, V517, P695, DOI 10.1002/cne.22171; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Brautigam L, 2010, J COMP NEUROL, V518, P2978, DOI 10.1002/cne.22375; Brugman S, 2009, GASTROENTEROLOGY, V137, P1757, DOI 10.1053/j.gastro.2009.07.069; Chandrasekharan B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003304; Chaniotou Z, 2010, GASTROENTEROLOGY, V139, P2083, DOI 10.1053/j.gastro.2010.08.024; Dasgupta S, 2013, INFLAMM BOWEL DIS, V19, P2478, DOI 10.1097/MIB.0b013e318297d884; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Faro A, 2009, ZEBRAFISH, V6, P361, DOI 10.1089/zeb.2009.0617; Fleming A, 2010, INFLAMM BOWEL DIS, V16, P1162, DOI 10.1002/ibd.21200; Forlano PM, 2007, J COMP NEUROL, V505, P235, DOI 10.1002/cne.21447; Gay J, 2008, ENDOCRINOLOGY, V149, P3403, DOI 10.1210/en.2007-1703; Goldsmith JR, 2013, DIS MODEL MECH, V6, P146, DOI 10.1242/dmm.009852; Gross KJ, 2007, INFLAMM BOWEL DIS, V13, P918, DOI 10.1002/ibd.20129; HERVIEU G, 1995, NEUROENDOCRINOLOGY, V61, P348, DOI 10.1159/000126857; Hill J, 2001, J BIOL CHEM, V276, P20125, DOI 10.1074/jbc.M102068200; Hosomi S, 2008, INFLAMM BOWEL DIS, V14, P1205, DOI 10.1002/ibd.20477; Karmiris K, 2006, INFLAMM BOWEL DIS, V12, P100, DOI 10.1097/01.MIB.0000200345.38837.46; KAWAUCHI H, 1983, NATURE, V305, P321, DOI 10.1038/305321a0; Kokkotou E, 2005, AM J PHYSIOL-REG I, V289, pR117, DOI 10.1152/ajpregu.00861.2004; Kokkotou E, 2008, P NATL ACAD SCI USA, V105, P10613, DOI 10.1073/pnas.0804536105; Kokkotou E, 2006, J IMMUNOL, V177, P3355, DOI 10.4049/jimmunol.177.5.3355; Kolakowski LF, 1996, FEBS LETT, V398, P253, DOI 10.1016/S0014-5793(96)01160-X; Konnengiesser K, 2008, INFLAMM BOWEL DIS, V14, P324, DOI 10.1002/ibd.20334; Lakaye B, 2009, PEPTIDES, V30, P2076, DOI 10.1016/j.peptides.2009.05.004; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lieschke GJ, 2009, CURR BIOL, V19, pR678, DOI 10.1016/j.cub.2009.06.068; Logan DW, 2003, GENOMICS, V81, P184, DOI 10.1016/S0888-7543(02)00037-x; Love DR, 2007, EXPERT REV MOL DIAGN, V7, P177, DOI 10.1586/14737159.7.2.177; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Macneil Douglas J, 2013, Front Endocrinol (Lausanne), V4, P49, DOI 10.3389/fendo.2013.00049; Mione M, 2009, ZEBRAFISH, V6, P445, DOI 10.1089/zeb.2009.0638; Mizusawa K, 2009, PEPTIDES, V30, P1990, DOI 10.1016/j.peptides.2009.04.010; Musson MC, 2011, REGUL PEPTIDES, V171, P26, DOI 10.1016/j.regpep.2011.06.001; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Novoa B, 2012, ADV EXP MED BIOL, V946, P253, DOI 10.1007/978-1-4614-0106-3_15; OEHLERS SH, DIS MODEL J MECH, V5, P457; Oehlers SH, 2013, ZEBRAFISH, V10, P184, DOI 10.1089/zeb.2012.0824; Oehlers SH, 2011, DEV DYNAM, V240, P288, DOI 10.1002/dvdy.22519; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Silva AB, 2006, IMMUNOLOGY, V118, P131, DOI 10.1111/j.1365-2567.2006.02351.x; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wittamer V, 2011, BLOOD, V117, P7126, DOI 10.1182/blood-2010-11-321448; Zhang DC, 2005, J BIOCHEM MOL BIOL, V38, P571	49	22	24	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83194	10.1371/journal.pone.0083194	http://dx.doi.org/10.1371/journal.pone.0083194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376661	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100098
J	Luo, XY; Xie, HL; Long, XL; Zhou, M; Xu, ZB; Shi, BZ; Jiang, H; Li, ZH				Luo, Xiaoying; Xie, Hailong; Long, Xiaolan; Zhou, Min; Xu, Zhibin; Shi, Bizhi; Jiang, Hua; Li, Zonghai			EGFRvIII Mediates Hepatocellular Carcinoma Cell Invasion by Promoting S100 Calcium Binding Protein A11 Expression	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER-CELLS; VARIANT III; COLORECTAL-CANCER; DOWN-REGULATION; BRAIN-TUMORS; EGF RECEPTOR; METASTASIS; CARCINOGENESIS	Epidermal growth factor receptor (EGFR) is frequently aberrantly expressed in cancer, and abnormal signalling downstream of this receptor contributes to tumour growth. EGFR variant III (EGFRvIII) is the most commonly altered form of EGFR and contains a truncated ligand-binding domain. Aberrant signalling downstream of this receptor contributes to tumour invasion. We previously reported that EGFRvIII can promote hepatocellular carcinoma (HCC) invasion. However, little is known concerning the mechanisms underlying EGFRvIII-mediated increases in cell motility and invasion in HCC. In this study, we observed that S100A11 was significantly upregulated in Huh-7 cells that overexpressed EGFRvIII. Moreover, S100A11 expression was elevated in HCC tissue samples (68.6%; 35/51), and this elevation was correlated with EGFRvIII expression (p = 0.0020; n = 20). Furthermore, the overexpression of S100A11 can promote HCC cell invasiveness, whereas siRNA against S100A11 can suppress the invasiveness of HCC cells stably transfected with EGFRvIII. Additionally, STAT3 inhibitors can block S100A11 expression and S100A11 promoter activity in HCC cells with stable overexpression of EGFRvIII. Furthermore, mutation in STATx binding sites could abolish the S1000A11 promoter activity stimulation by EGFRvIII. Taken together, the results demonstrate that the EGFRvIII-STAT3 pathway promotes cell migration and invasion by upregulating S100A11.	[Luo, Xiaoying; Zhou, Min; Xu, Zhibin; Shi, Bizhi; Jiang, Hua; Li, Zonghai] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China; [Xie, Hailong; Long, Xiaolan] Univ South China, Canc Res Inst, Hengyang, Hunan, Peoples R China	Shanghai Jiao Tong University; University of South China	Li, ZH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China.	zonghaili@shsmu.edu.cn			Key Program of the Shanghai Science and Technology Committee [10431903700]; Supporting Program of the "Twelfth Five-Year Plan'' for Science & Technology Research of China [2012ZX10002015-007]; National Natural Science Foundation of China [81071746]; State Key Laboratory of Oncogenes and Related Genes [91-11-03/05]; Shanghai Science and Technology Committee [10431903700]	Key Program of the Shanghai Science and Technology Committee; Supporting Program of the "Twelfth Five-Year Plan'' for Science & Technology Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Oncogenes and Related Genes; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by the Key Program of the Shanghai Science and Technology Committee (No. 10431903700), the Supporting Program of the "Twelfth Five-Year Plan'' for Science & Technology Research of China (2012ZX10002015-007), the National Natural Science Foundation of China (No. 81071746), and the research fund of the State Key Laboratory of Oncogenes and Related Genes (91-11-03/05). This work was supported by the Key Program of the Shanghai Science and Technology Committee (No. 10431903700), the Supporting Program of the "Twelfth Five-Year Plan'' for Science & Technology Research of China (2012ZX10002015-007), the National Natural Science Foundation of China (No. 81071746), and the research fund of the State Key Laboratory of Oncogenes and Related Genes (91-11-03/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2009, MOL CELL BIOL, V29, P2372, DOI 10.1128/MCB.01505-08; Bailey VJ, 2009, GENOME RES, V19, P1455, DOI 10.1101/gr.088831.108; Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; CHAFFANET M, 1992, EUR J CANCER, V28A, P11, DOI 10.1016/0959-8049(92)90374-B; Del Vecchio CA, 2012, CANCER RES, V72, P2657, DOI 10.1158/0008-5472.CAN-11-2656; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Frederick L, 2000, CANCER RES, V60, P1383; Heimberger AB, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-38; Ho R, 2005, CANCER RES, V65, P9868, DOI 10.1158/0008-5472.CAN-04-2426; Jiang H, 2011, J BIOL CHEM, V286, P5913, DOI 10.1074/jbc.M110.192252; Lankiewicz S, 2008, CELL ONCOL, V30, P463, DOI 10.3233/CLO-2008-0432; Liang K, 2003, INT J RADIAT ONCOL, V57, P246, DOI 10.1016/S0360-3016(03)00511-X; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Melle C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003767; Micallef J, 2009, CANCER RES, V69, P7548, DOI 10.1158/0008-5472.CAN-08-4783; Miyazaki M, 2004, CANCER RES, V64, P4155, DOI 10.1158/0008-5472.CAN-03-2750; Modjtahedi H, 2009, ANTI-CANCER DRUG, V20, P851, DOI 10.1097/CAD.0b013e3283330590; Mori M, 2004, ONCOL REP, V11, P1287; Moscatello DK, 1996, ONCOGENE, V13, P85; Ning Y, 2005, CANCER RES, V65, P9280, DOI 10.1158/0008-5472.CAN-05-0407; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Ou Chao, 2005, Ai Zheng, V24, P166; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; PANDIELLA A, 1989, ONCOGENE, V4, P1299; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Pines G, 2010, ONCOGENE, V29, P5850, DOI 10.1038/onc.2010.313; Rahimi M, 2011, CANCER LETT, V306, P43, DOI 10.1016/j.canlet.2011.02.024; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Steffensen KD, 2008, CLIN CANCER RES, V14, P3278, DOI 10.1158/1078-0432.CCR-07-4171; Tang P, 1997, J NEURO-ONCOL, V35, P303, DOI 10.1023/A:1005824802617; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wheeler SE, 2010, ONCOGENE, V29, P5135, DOI 10.1038/onc.2009.279; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yang YQ, 2012, NEOPLASIA, V14, P509, DOI 10.1593/neo.12328; Zhou M, 2010, LIVER INT, V30, P925, DOI 10.1111/j.1478-3231.2010.02233.x; Zhu AX, 2006, ONCOLOGIST, V11, P790, DOI 10.1634/theoncologist.11-7-790	38	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83332	10.1371/journal.pone.0083332	http://dx.doi.org/10.1371/journal.pone.0083332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376686	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100111
J	Saad, E; Silvanto, J				Saad, Elyana; Silvanto, Juha			Contrast and Strength of Visual Memory and Imagery Differentially Affect Visual Perception	PLOS ONE			English	Article							WORKING-MEMORY; MECHANISMS	Visual short-ter memory (VSTM) and visual imagery have been shown to modulate visual perception. However, how the subjective experience of VSTIVI/imagery and its contrast modulate this process has not been investigated. We addressed this issue by asking participants to detect brief masked targets while they were engaged either in VSTIVI or visual imagery. Subjective experience of memory/imagery (strength scale), and the visual contrast of the memory/mental image (contrast scale) were assessed on a trial-by-trial basis. For both VSTIVI and imagery, contrast of the memory/mental image was positively associated with reporting target presence. Consequently, at the sensory level, both VSTIVI and imagery facilitated visual perception. However, subjective strength of VSTM was positively associated with visual detection whereas the opposite pattern was found for imagery. Thus the relationship between subjective strength of memory/imagery and visual detection are qualitatively different for VSTM and visual imagery, although their impact at the sensory level appears similar. Our results furthermore demonstrate that imagery and VSTM are partly dissociable processes.	[Saad, Elyana; Silvanto, Juha] Aalto Univ, Sch Sci, OV Lounasmaa Lab, Brain Res Unit, Espoo, Finland; [Saad, Elyana] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Silvanto, Juha] Univ Westminster, Fac Sci & Technol, Dept Psychol, London W1R 8AL, England	Aalto University; University of Helsinki; University of Westminster	Silvanto, J (corresponding author), Aalto Univ, Sch Sci, OV Lounasmaa Lab, Brain Res Unit, Espoo, Finland.	J.Silvanto@westminster.ac.uk		Silvanto, Juha/0000-0001-6044-5296	Academy of Finland [137485]; Aalto Starting Grant; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Aalto Starting Grant; Emil Aaltonen Foundation	Funding provided by Academy of Finland (137485), Aalto Starting Grant and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Cattaneo Z, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00029; CRAVERLEMLEY C, 1992, PSYCHOL REV, V99, P633, DOI 10.1037/0033-295X.99.4.633; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; FARAH MJ, 1989, J EXP PSYCHOL HUMAN, V15, P203, DOI 10.1037/0096-1523.15.2.203; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Segal, 1971, IMAGERY CURRENT COGN, P73; SEGAL SJ, 1970, J EXP PSYCHOL, V83, P458, DOI 10.1037/h0028840; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Soto D, 2012, J NEUROSCI, V32, P3447, DOI 10.1523/JNEUROSCI.6243-11.2012; Soto D, 2010, J EXP PSYCHOL LEARN, V36, P441, DOI 10.1037/a0018686; Sparing R, 2002, BRAIN RES, V938, P92, DOI 10.1016/S0006-8993(02)02478-2	16	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84827	10.1371/journal.pone.0084827	http://dx.doi.org/10.1371/journal.pone.0084827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376849	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000328745100189
J	Borghgraef, P; Menuet, C; Theunis, C; Louis, JV; Devijver, H; Maurin, H; Smet-Nocca, C; Lippens, G; Hilaire, G; Gijsen, H; Moechars, D; Van Leuven, F				Borghgraef, Peter; Menuet, Clement; Theunis, Clara; Louis, Justin V.; Devijver, Herman; Maurin, Herve; Smet-Nocca, Caroline; Lippens, Guy; Hilaire, Gerard; Gijsen, Harrie; Moechars, Dieder; Van Leuven, Fred			Increasing Brain Protein O-GlcNAc-ylation Mitigates Breathing Defects and Mortality of Tau.P301L Mice	PLOS ONE			English	Article							X-CHROMOSOME; TAU; TAUOPATHY; GLYCOSYLATION	The microtubule associated protein tau causes primary and secondary tauopathies by unknown molecular mechanisms. Post-translational O-GlcNAc-ylation of brain proteins was demonstrated here to be beneficial for Tau.P301L mice by pharmacological inhibition of O-GlcNAc-ase. Chronic treatment of ageing Tau.P301L mice mitigated their loss in body-weight and improved their motor deficits, while the survival was 3-fold higher at the pre-fixed study endpoint at age 9.5 months. Moreover, O-GlcNAc-ase inhibition significantly improved the breathing parameters of Tau.P301L mice, which underpinned pharmacologically the close correlation of mortality and upper-airway defects. O-GlcNAc-ylation of brain proteins increased rapidly and stably by systemic inhibition of O-GlcNAc-ase. Conversely, biochemical evidence for protein Tau.P301L to become O-GlcNAc-ylated was not obtained, nor was its phosphorylation consistently or markedly affected. We conclude that increasing O-GlcNAc-ylation of brain proteins improved the clinical condition and prolonged the survival of ageing Tau.P301L mice, but not by direct biochemical action on protein tau. The pharmacological effect is proposed to be located downstream in the pathological cascade initiated by protein Tau.P301L, opening novel venues for our understanding, and eventually treating the neurodegeneration mediated by protein tau.	[Borghgraef, Peter; Theunis, Clara; Louis, Justin V.; Devijver, Herman; Maurin, Herve; Van Leuven, Fred] KULeuven, Expt Genet Grp LEGTEGG, Louvain, Belgium; [Menuet, Clement; Hilaire, Gerard] CNRS, MP3 Respirat, UMR 6231, Fac St Jerome, Marseille, France; [Smet-Nocca, Caroline; Lippens, Guy] Univ Lille, Grp RMN Glycobiol, CNRS, Villeneuve Dascq, France; [Gijsen, Harrie; Moechars, Dieder] Janssen Res & Dev, Dept Neurosci, Beerse, Belgium	KU Leuven; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Johnson & Johnson; Janssen Pharmaceuticals	Van Leuven, F (corresponding author), KULeuven, Expt Genet Grp LEGTEGG, Louvain, Belgium.	fred.vanleuven@med.kuleuven.be	Smet-Nocca, Caroline/G-2868-2012; Smet-Nocca, Caroline/U-3427-2019	Smet-Nocca, Caroline/0000-0002-9793-0882; Smet-Nocca, Caroline/0000-0002-9793-0882; Lippens, Guy/0000-0002-8236-0901; Menuet, Clement/0000-0002-7419-6427	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen); Instituut Wetenschap Techniek (IWT); EEC; de Rooms-fund; KULeuven-Research Fund; KULeuven- ResearchDevelopment; Laboratory Excellence program (LABEX, France); Development of Innovative Strategies for Transdisciplinary approach to Alzheimer's disease (DISTALZ, France)	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen)(FWO); Instituut Wetenschap Techniek (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); EEC; de Rooms-fund; KULeuven-Research Fund(KU Leuven); KULeuven- ResearchDevelopment; Laboratory Excellence program (LABEX, France); Development of Innovative Strategies for Transdisciplinary approach to Alzheimer's disease (DISTALZ, France)	The investigations were made possible by funding and infrastructural support from the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen), Instituut Wetenschap & Techniek (IWT), EEC 6th & 7th Framework Programs, "de Rooms-fund", KULeuven-Research Fund, and KULeuven- Research&Development. GL and CS were supported by the Laboratory Excellence program (LABEX, France) and by Development of Innovative Strategies for Transdisciplinary approach to Alzheimer's disease (DISTALZ, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Davies GJ, 2010, BIOCHEM SOC T, V38, P1179, DOI 10.1042/BST0381179; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Dutschmann M, 2010, J NEUROSCI, V30, P1810, DOI 10.1523/JNEUROSCI.5261-09.2010; Duyckaerts C, 2008, ACTA NEUROPATHOL, V118, P5; Gotz J, 2010, BBA-MOL BASIS DIS, V1802, P860, DOI 10.1016/j.bbadis.2009.09.008; Golks A, 2008, EMBO REP, V9, P748, DOI 10.1038/embor.2008.129; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Home G, 2011, DRUG DISCOV TODAY, V16, P107, DOI 10.1016/j.drudis.2010.08.017; Jaworski T, 2010, INT J ALZHEIMERS DIS; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Krzeslak A, 2011, ONCOL REP, V26, P743, DOI 10.3892/or.2011.1333; Lazarus BD, 2009, INT J BIOCHEM CELL B, V41, P2134, DOI 10.1016/j.biocel.2009.03.008; Martinez-Fleites C, 2010, BBA-GEN SUBJECTS, V1800, P122, DOI 10.1016/j.bbagen.2009.07.019; Menuet C, 2011, RESP PHYSIOL NEUROBI, V178, P290, DOI 10.1016/j.resp.2011.06.030; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Smet-Nocca C, 2011, MOL BIOSYST, V7, P1420, DOI 10.1039/c0mb00337a; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang JZ, 1996, NAT MED, V2, P871, DOI 10.1038/nm0896-871; Yu CH, 2008, BIOCHEM BIOPH RES CO, V375, P59, DOI 10.1016/j.bbrc.2008.07.101; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Yuzwa SA, 2011, AMINO ACIDS, V40, P857, DOI 10.1007/s00726-010-0705-1	32	65	65	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84442	10.1371/journal.pone.0084442	http://dx.doi.org/10.1371/journal.pone.0084442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376810	gold, Green Published			2022-12-27	WOS:000328882000148
J	Del Fabbro, C; Scalabrin, S; Morgante, M; Giorgi, FM				Del Fabbro, Cristian; Scalabrin, Simone; Morgante, Michele; Giorgi, Federico M.			An Extensive Evaluation of Read Trimming Effects on Illumina NGS Data Analysis	PLOS ONE			English	Article							RNA-SEQ; DIFFERENTIAL GENE; SEQUENCE; GENOME; ASSEMBLIES; EXPRESSION; EFFICIENT; ALIGNMENT; RESOURCE; FORMAT	Next Generation Sequencing is having an extremely strong impact in biological and medical research and diagnostics, with applications ranging from gene expression quantification to genotyping and genome reconstruction. Sequencing data is often provided as raw reads which are processed prior to analysis 1 of the most used preprocessing procedures is read trimming, which aims at removing low quality portions while preserving the longest high quality part of a NGS read. In the current work, we evaluate nine different trimming algorithms in four datasets and three common NGS-based applications (RNA-Seq, SNP calling and genome assembly). Trimming is shown to increase the quality and reliability of the analysis, with concurrent gains in terms of execution time and computational resources needed.	[Del Fabbro, Cristian; Morgante, Michele; Giorgi, Federico M.] Inst Appl Genom, Udine, Italy; [Scalabrin, Simone] IGA Technol Serv, Udine, Italy; [Giorgi, Federico M.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA	Columbia University	Giorgi, FM (corresponding author), Inst Appl Genom, Udine, Italy.	fmg2117@columbia.edu	Giorgi, Federico M./AAD-5797-2020; Del Fabbro, Cristian/C-5523-2014	Giorgi, Federico M./0000-0002-7325-9908; Del Fabbro, Cristian/0000-0001-8189-6192; MORGANTE, Michele/0000-0003-2591-2156	IGA Technology Services	IGA Technology Services	This work was funded by IGA Technology Services (http://www.igatechnology.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal V, 2008, BIOINFORMATICS, V24, pI153, DOI 10.1093/bioinformatics/btn298; Biesecker LG, 2012, NAT REV GENET, V13, P818, DOI 10.1038/nrg3357; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Dunham I, 2012, INTEGRATED ENCY DNA; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Giorgi FM, 2013, BIOINFORMATICS, V29, P717, DOI 10.1093/bioinformatics/btt053; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Pireddu L, 2011, BIOINFORMATICS, V27, P2159, DOI 10.1093/bioinformatics/btr325; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schott T, 2012, GENOME BIOL EVOL, V4, P1310, DOI 10.1093/gbe/evs107; Schuster S. C., 2007, NATURE, V200; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vicedomini R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S6; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	43	239	244	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85024	10.1371/journal.pone.0085024	http://dx.doi.org/10.1371/journal.pone.0085024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376861	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000173
J	Fuchsl, AM; Langgartner, D; Reber, SO				Fuechsl, Andrea M.; Langgartner, Dominik; Reber, Stefan O.			Mechanisms Underlying the Increased Plasma ACTH Levels in Chronic Psychosocially Stressed Male Mice	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PITUITARY-ADRENAL RESPONSES; MINERALOCORTICOID-RECEPTORS; ANTERIOR-PITUITARY; HPA AXIS; VASOPRESSIN; BRAIN; CORTICOSTERONE; RAT	Mice exposed to chronic subordinate colony housing (CSC, 19 days), an established paradigm for chronic psychosocial stress, show unaffected basal morning plasma corticosterone (CORT) concentrations, despite enlarged adrenal glands and an increased CORT response to an acute heterotypic stressor. In the present study we investigate the mechanisms underlying these phenomena at the level of the pituitary. We show that both basal and acute stressor-induced (forced swim (FS), 6 min) plasma adrenocorticotropic hormone (ACTH) concentrations, the number of total and corticotroph pituitary cells, and relative protein expression of pituitary mineralocorticoid receptor and FK506-binding protein 51 was increased in CSC compared with single-housed control (SHC) mice, while relative corticotropin releasing hormone (CRH) receptor 1 (CRH-R1) and glucocorticoid receptor protein expression was down-regulated. Relative pituitary pro-opiomelanocortin and arginine vasopressin (AVP) receptor 1b (AVPR-1b) protein expression, FS (6 min)-induced ACTH secretion in dexamethasone-blocked mice, and the number of AVP positive magnocellular and parvocellular neurons in the paraventricular hypothalamic nucleus (PVN) was unaffected following CSC. Taken together, the data of the present study indicate that 19 days of CSC result in pituitary hyperactivity, under both basal and acute heterotypic stress conditions. Although further studies have to assess this in detail, an increased number of pituitary corticotrophs together with unaffected relative pituitary AVPR-1b and decreased CRH-R1 protein expression following CSC suggests that pituitary hyperdrive is mediated by newly formed corticotrophs that are more sensitive to AVP than CRH. Moreover, our data indicate that changes in PVN AVP and negative feedback inhibition seem not to play a major role in pituitary hyperactivity following CSC.	[Fuechsl, Andrea M.; Langgartner, Dominik; Reber, Stefan O.] Univ Regensburg, Dept Behav & Mol Neurobiol, D-93053 Regensburg, Germany; [Langgartner, Dominik; Reber, Stefan O.] Univ Ulm, Lab Mol Psychosomat, Clin Psychosomat Med & Psychotherapy, D-89069 Ulm, Germany	University of Regensburg; Ulm University	Reber, SO (corresponding author), Univ Regensburg, Dept Behav & Mol Neurobiol, D-93053 Regensburg, Germany.	stefan.reber@uniklinik-ulm.de			German Research Foundation (DFG) [RE2911/5-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support from the German Research Foundation (DFG Project RE2911/5-1) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA G, 1994, FRONT NEUROENDOCRIN, V15, P321, DOI 10.1006/frne.1994.1013; Bartolomucci A, 2007, FRONT NEUROENDOCRIN, V28, P28, DOI 10.1016/j.yfrne.2007.02.001; Bhatnagar S, 2003, HORM BEHAV, V43, P158, DOI 10.1016/S0018-506X(02)00011-9; Bhatnagar S, 1998, NEUROSCIENCE, V84, P1025, DOI 10.1016/S0306-4522(97)00577-0; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Datson NA, 2001, EUR J NEUROSCI, V14, P675, DOI 10.1046/j.0953-816x.2001.01685.x; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x; Feldman S, 1999, BRAIN RES, V821, P33, DOI 10.1016/S0006-8993(99)01054-9; Fuchsl AM, 2013, STRESS, V16, P461, DOI 10.3109/10253890.2013.793303; Garner B, 2005, BIOL PSYCHIAT, V58, P417, DOI 10.1016/j.biopsych.2005.04.018; GILLIES GE, 1982, NATURE, V299, P355, DOI 10.1038/299355a0; Harris AP, 2013, PSYCHONEUROENDOCRINO, V38, P648, DOI 10.1016/j.psyneuen.2012.08.007; HAUGER RL, 1987, ENDOCRINOLOGY, V120, P1527, DOI 10.1210/endo-120-4-1527; HAUGER RL, 1990, BRAIN RES, V532, P34, DOI 10.1016/0006-8993(90)91738-3; Hawtin SR, 2001, BIOCHEM J, V357, P73, DOI 10.1042/0264-6021:3570073; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; John C, 2002, ENDOCRINOLOGY, V143, P3060, DOI 10.1210/en.143.8.3060; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Kadar A, 2010, J COMP NEUROL, V518, P3948, DOI 10.1002/cne.22432; KOVACS KJ, 1988, BRAIN RES, V474, P205, DOI 10.1016/0006-8993(88)90435-0; KROZOWSKI Z, 1981, ENDOCRINOLOGY, V109, P1811, DOI 10.1210/endo-109-6-1811; Kudielka BM, 2006, BIOL PSYCHOL, V72, P147, DOI 10.1016/j.biopsycho.2005.09.001; Ma XM, 1999, ENDOCRINOLOGY, V140, P3623, DOI 10.1210/en.140.8.3623; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MILLER AH, 1992, BIOL PSYCHIAT, V32, P850, DOI 10.1016/0006-3223(92)90175-Y; Neumann ID, 2000, REGUL PEPTIDES, V96, P31, DOI 10.1016/S0167-0115(00)00197-X; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; OITZL MS, 1995, PSYCHONEUROENDOCRINO, V20, P655, DOI 10.1016/0306-4530(95)00003-7; Pariante CM, 2005, NEUROPSYCHOPHARMACOL, V30, P1923, DOI 10.1038/sj.npp.1300766; Pariante CM, 2001, BIOL PSYCHIAT, V49, P391, DOI 10.1016/S0006-3223(00)01088-X; Paxinos G, 2001, MOUSE BRAIN STEREOTA, Vxxv; Peters S, 2012, STRESS, V15, P403, DOI 10.3109/10253890.2011.631232; Rabadan-Diehl C, 2007, J NEUROENDOCRINOL, V19, P309, DOI 10.1111/j.1365-2826.2007.01533.x; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Reber SO, 2008, ANN NY ACAD SCI, V1148, P184, DOI 10.1196/annals.1410.003; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; RIVIER C, 1983, ENDOCRINOLOGY, V113, P939, DOI 10.1210/endo-113-3-939; SAKAKURA M, 1982, TOHOKU J EXP MED, V137, P191, DOI 10.1620/tjem.137.191; Sasse SK, 2008, STRESS, V11, P425, DOI 10.1080/10253890801887453; SAWCHENKO PE, 1984, P NATL ACAD SCI-BIOL, V81, P1883, DOI 10.1073/pnas.81.6.1883; Schmidt D, 2010, BRAIN BEHAV IMMUN, V24, P1097, DOI 10.1016/j.bbi.2010.04.014; Singewald GM, 2009, STRESS, V12, P58, DOI 10.1080/10253890802042082; Slattery DA, 2012, PSYCHONEUROENDOCRINO, V37, P702, DOI 10.1016/j.psyneuen.2011.09.002; SPENCER RL, 1991, BRAIN RES, V549, P236, DOI 10.1016/0006-8993(91)90463-6; Uschold-Schmidt N, 2012, PSYCHONEUROENDOCRINO, V37, P1676, DOI 10.1016/j.psyneuen.2012.02.015; Veenema AH, 2008, ENDOCRINOLOGY, V149, P2727, DOI 10.1210/en.2007-1469; VERNIKOS J, 1982, ENDOCRINOLOGY, V110, P413, DOI 10.1210/endo-110-2-413; Wagner KV, 2012, NEUROPSYCHOPHARMACOL; Weiser MJ, 2011, J NEUROENDOCRINOL, V23, P1231, DOI 10.1111/j.1365-2826.2011.02217.x; WHITNALL MH, 1985, NATURE, V317, P248, DOI 10.1038/317248a0; WHITNALL MH, 1985, J NEUROSCI, V5, P98; Yeung CM, 2006, INT J BIOCHEM CELL B, V38, P1441, DOI 10.1016/j.biocel.2006.02.012; Yoshii T, 2008, NEUROSCIENCE, V156, P466, DOI 10.1016/j.neuroscience.2008.07.049; Zelena D, 2003, AM J PHYSIOL-ENDOC M, V285, pE1110, DOI 10.1152/ajpendo.00219.2003	59	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84161	10.1371/journal.pone.0084161	http://dx.doi.org/10.1371/journal.pone.0084161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376791	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000139
J	Jiang, HB; Xie, NH; Cao, BB; Tan, L; Fan, YZ; Zhang, F; Yao, ZZ; Liu, L; Nie, SF				Jiang, Hongbo; Xie, Nianhua; Cao, Beibei; Tan, Li; Fan, Yunzhou; Zhang, Fan; Yao, Zhongzhao; Liu, Li; Nie, Shaofa			Determinants of Progression to AIDS and Death Following HIV Diagnosis: A Retrospective Cohort Study in Wuhan, China	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INJECTING DRUG-USERS; UNITED-STATES; HIV-1-INFECTED PATIENTS; DISEASE PROGRESSION; INFECTED ADULTS; HONG-KONG; MORTALITY; SURVIVAL; HAART	Objective: To identify determinants associated with disease progression and death following human immunodeficiency virus (HIV) diagnosis. Methods: Disease progression data from the diagnosis of HIV infection or acquiring immunodeficiency syndrome (AIDS) to February 29, 2012 were retrospectively collected from the national surveillance system databases and the national treatment database in Wuhan, China. Kaplan-Meier method, Logistic regression and Cox proportional hazards model were applied to identify the related factors of progression to AIDS or death following HIV diagnosis. Results: By the end of February 2012, 181 of 691 HIV infectors developed to AIDS, and 129 of 470 AIDS patients died among whom 289 cases received concurrent HIV/AIDS diagnosis. Compared with men infected through homosexual behavior, injection drug users possessed sharply decreased hazard ratio (HR) for progression to AIDS following HIV diagnosis [HR = 0.31, 95% confidence interval (CI), 0.18-0.54, P = 4.01 x 10(-5)]. HIV infectors at least 60 years presented 1.15-fold (HR = 2.15, 95% CI, 1.15-4.03, P = 0.017) increased risk to develop AIDS when compared with those aged 17-29 years. Similarly, AIDS patients with diagnosis ages between 50 and 59 years were at a 1.60-fold higher risk of death (HR = 2.60, 95% CI, 1.18-5.72, P = 0.017) compared to those aged 19-29 years. AIDS patients with more CD4(+) T-cells within 6 months at diagnosis (cell/mL) presented lower risk of death (HR = 0.29 for 50-vs <50, 95% CI, 0.15-0.59, P = 0.001). The highly active antiretroviral therapy (HAART) delayed progression to AIDS from HIV diagnosis (HR = 0.15, 95% CI, 0.07-0.34, P = 6.46 x 10(-6)) and reduced the risk of death after AIDS diagnosis (HR = 0.02, 95% CI, 0.01-0.04, P = 7.25 x 10(-25)). Conclusions: Progression to AIDS and death following HIV diagnosis differed in age at diagnosis, transmission categories, CD4+ T-cell counts and HAART. Effective interventions should target those at higher risk for morbidity or mortality, ensuring early diagnosis and timely treatment to slow down the disease progression.	[Jiang, Hongbo; Cao, Beibei; Tan, Li; Fan, Yunzhou; Zhang, Fan; Liu, Li; Nie, Shaofa] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Jiang, Hongbo; Cao, Beibei; Tan, Li; Fan, Yunzhou; Zhang, Fan; Liu, Li; Nie, Shaofa] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Key Lab Environm & Hlth,Minist Educ, Wuhan 430074, Peoples R China; [Xie, Nianhua; Yao, Zhongzhao] Wuhan Ctr Dis Control & Prevent, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, L (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	gracefulliuly@gmail.com; sf_nie@mails.tjmu.edu.cn	Fan, Yunzhou/P-8829-2014	Jiang, Hongbo/0000-0002-0631-4460				[Anonymous], 1994, Pediatrics, V94, P815; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Braga P, 2007, AIDS PATIENT CARE ST, V21, P321, DOI 10.1089/apc.2006.0111; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; Chan KCW, 2006, HIV MED, V7, P186, DOI 10.1111/j.1468-1293.2006.00352.x; Chinese Ministry of Health, 2012, 2012 CHIN AIDS RESP; Couturier E, 1998, AIDS, V12, P795, DOI 10.1097/00002030-199807000-00016; COX DR, 1972, J R STAT SOC B, V34, P187; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Cunningham WE, 1999, MED CARE, V37, P1270, DOI 10.1097/00005650-199912000-00010; Dou Zhi-hui, 2008, Zhonghua Yufang Yixue Zazhi, V42, P879; Dou ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022707; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ewings FM, 2008, AIDS, V22, P89, DOI 10.1097/QAD.0b013e3282f3915e; Gao XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044881; Girardi E, 2000, J ACQ IMMUN DEF SYND, V25, P71, DOI 10.1097/00126334-200009010-00010; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Hall HI, 2006, ANN EPIDEMIOL, V16, P824, DOI 10.1016/j.annepidem.2006.01.009; Hocking JS, 2000, INT J STD AIDS, V11, P503, DOI 10.1258/0956462001916407; Holtgrave DR, 2005, INT J STD AIDS, V16, P777, DOI 10.1258/095646205774988109; Hubei Province: Department of Health, 2006, ASS REP HUB PROV HLT; Jia ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025671; Joy R, 2008, JAIDS-J ACQ IMM DEF, V47, P500, DOI 10.1097/QAI.0b013e3181648dfd; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; Li XH, 2009, J HUAZHONG U SCI-MED, V29, P580, DOI 10.1007/s11596-009-0510-9; Lima VD, 2008, J INFECT DIS, V198, P51, DOI 10.1086/588675; Lutalo T, 2007, AIDS, V21, pS15, DOI 10.1097/01.aids.0000299406.44775.de; Ma Y, 2010, INT J EPIDEMIOL, V39, P973, DOI 10.1093/ije/dyp233; Malta M, 2009, JAIDS-J ACQ IMM DEF, V52, P629, DOI 10.1097/QAI.0b013e3181b31b8a; Manfredi R, 2002, DRUG AGING, V19, P647, DOI 10.2165/00002512-200219090-00003; McMahon J, 2011, AIDS BEHAV, V15, P1503, DOI 10.1007/s10461-010-9759-z; Monge S, 2011, SEX TRANSM INFECT, V87, P571, DOI 10.1136/sextrans-2011-050125; Nyirenda M, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000299413.82893.2b; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Pehrson P, 1997, AIDS, V11, P1007, DOI 10.1097/00002030-199708000-00009; Perez-Hoyos S, 2007, J WOMENS HEALTH, V16, P1052, DOI 10.1089/jwh.2007.0437; Pezzotti Patrizio, 2003, Epidemiol Prev, V27, P348; PHILLIPS AN, 1991, J ACQ IMMUN DEF SYND, V4, P970; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Serraino D, 2009, JAIDS-J ACQ IMM DEF, V52, P99, DOI 10.1097/QAI.0b013e3181a4f663; Settle Edmund, 2003, AIDS CHINA ANNOTATED; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Skiest DJ, 1996, AM J MED, V101, P605, DOI 10.1016/S0002-9343(96)00329-4; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Villasis-Keever A, 2001, ARCH MED RES, V32, P62, DOI 10.1016/S0188-4409(00)00263-0; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wong KH, 2004, CLIN INFECT DIS, V39, P853, DOI 10.1086/423183; Wutoh AK, 2003, JAIDS-J ACQ IMM DEF, V33, pS106, DOI 10.1097/00126334-200306012-00007; Zaba B, 2007, AIDS, V21, pS87, DOI 10.1097/01.aids.0000299415.67646.26; Zhang F., 2005, CHINA FREE ART MANUA; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zoufaly A, 2012, HIV MED, V13, P172, DOI 10.1111/j.1468-1293.2011.00958.x	59	13	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83078	10.1371/journal.pone.0083078	http://dx.doi.org/10.1371/journal.pone.0083078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376638	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000057
J	Lidzba, K; Ebner, K; Hauser, TK; Wilke, M				Lidzba, Karen; Ebner, Kathina; Hauser, Till-Karsten; Wilke, Marko			Complex Visual Search in Children and Adolescents: Effects of Age and Performance on fMRI Activation	PLOS ONE			English	Article							VISUOSPATIAL FUNCTIONS; SPATIAL ATTENTION; WORKING-MEMORY; PARIETAL INVOLVEMENT; NEURAL ACTIVITY; BRAIN; TASK; CORTEX; LATERALIZATION; INTEGRATION	Complex visuospatial processing relies on distributed neural networks involving occipital, parietal and frontal brain regions. Effects of physiological maturation (during normal brain development) and proficiency on tasks requiring complex visuospatial processing have not yet been studied extensively, as they are almost invariably interrelated. We therefore aimed at dissociating the effects of age and performance on functional MRI (fMRI) activation in a complex visual search task. In our cross-sectional study, healthy children and adolescents (n = 43, 19 females, 7-17 years) performed a complex visual search task during fMRI. Resulting activation was analysed with regard to the differential effects of age and performance. Our results are compatible with an increase in the neural network's efficacy with age: within occipital and parietal cortex, the core regions of the visual exploration network, activation increased with age, and more so in the right than in the left hemisphere. Further, activation outside the visual search network decreased with age, mainly in left inferior frontal, middle temporal, and inferior parietal cortex. High-performers had stronger activation in right superior parietal cortex, suggesting a more mature visual search network. We could not see effects of age or performance in frontal cortex. Our results show that effects of physiological maturation and effects of performance, while usually intertwined, can be successfully disentangled and investigated using fMRI in children and adolescents.	[Lidzba, Karen; Ebner, Kathina; Wilke, Marko] Childrens Hosp Univ Tubingen, Tubingen, Germany; [Hauser, Till-Karsten] Univ Tubingen, Radiol Clin, Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Lidzba, K (corresponding author), Childrens Hosp Univ Tubingen, Tubingen, Germany.	karen.lidzba@med.uni-tuebingen.de		Lidzba, Karen/0000-0002-0716-1953	German Research Foundation [DFG WI3630/1-1]; European Social Fund; Ministry of Science and the Arts: Margarete-von-Wrangell Programme for Women	German Research Foundation(German Research Foundation (DFG)); European Social Fund(European Social Fund (ESF)); Ministry of Science and the Arts: Margarete-von-Wrangell Programme for Women	German Research Foundation: DFG WI3630/1-1 to Marko Wilke (www.dfg.de). European Social Fund and Ministry of Science and the Arts: Margarete-von-Wrangell Programme for Women to Karen Lidzba (www.margarete-von-wrangell.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSHOOMOFF NA, 1995, NEUROPSYCHOLOGY, V9, P364, DOI 10.1037/0894-4105.9.3.364; Anderson EJ, 2007, EXP BRAIN RES, V180, P289, DOI 10.1007/s00221-007-0860-0; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bryce D, 2011, NEUROIMAGE, V57, P671, DOI 10.1016/j.neuroimage.2010.12.006; Bunge SA, 2007, CURR OPIN NEUROBIOL, V17, P243, DOI 10.1016/j.conb.2007.02.005; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, NEUROIMAGE, V8, P176, DOI 10.1006/nimg.1998.0354; Crone EA, 2006, J NEUROSCI, V26, P11239, DOI 10.1523/JNEUROSCI.2165-06.2006; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Dekker T, 2011, NEUROIMAGE, V57, P659, DOI 10.1016/j.neuroimage.2010.11.005; Durston S, 2006, NEUROPSYCHOLOGIA, V44, P2149, DOI 10.1016/j.neuropsychologia.2005.10.010; Ebner K, 2011, NEUROIMAGE, V58, P923, DOI 10.1016/j.neuroimage.2011.06.048; Everts R, 2009, HUM BRAIN MAPP, V30, P473, DOI 10.1002/hbm.20523; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Groen MA, 2011, NEUROPSYCHOLOGIA, V49, P3265, DOI 10.1016/j.neuropsychologia.2011.07.031; Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hayakawa T, 2006, NEUROIMAGE, V33, P296, DOI 10.1016/j.neuroimage.2006.06.034; Himmelbach M, 2006, NEUROIMAGE, V32, P1747, DOI 10.1016/j.neuroimage.2006.04.221; Jansen-Osmann P, 2007, NEUROREPORT, V18, P175, DOI 10.1097/WNR.0b013e328010ff6b; Karnath HO, 2012, NEUROPSYCHOLOGIA, V50, P1010, DOI 10.1016/j.neuropsychologia.2011.06.027; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; Lee PS, 2007, NEUROIMAGE, V38, P184, DOI 10.1016/j.neuroimage.2007.07.013; Leonards U, 2000, J COGNITIVE NEUROSCI, V12, P61, DOI 10.1162/089892900564073; Lidzba K, 2006, NEUROREPORT, V17, P929, DOI 10.1097/01.wnr.0000221841.12632.d6; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Makino Y, 2004, NEUROIMAGE, V23, P525, DOI 10.1016/j.neuroimage.2004.06.026; Manjaly ZM, 2007, NEUROIMAGE, V35, P283, DOI 10.1016/j.neuroimage.2006.11.036; Manjaly ZM, 2003, NEUROIMAGE, V19, P674, DOI 10.1016/S1053-8119(03)00095-8; Marsh R, 2006, HUM BRAIN MAPP, V27, P848, DOI 10.1002/hbm.20225; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; Muggleton NG, 2003, J NEUROPHYSIOL, V89, P3340, DOI 10.1152/jn.01086.2002; Nagahama Y, 1999, NEUROIMAGE, V10, P193, DOI 10.1006/nimg.1999.0451; Nobre AC, 2003, NEUROIMAGE, V18, P91, DOI 10.1006/nimg.2002.1329; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; PETERSEN SE, 1994, CAN J EXP PSYCHOL, V48, P319, DOI 10.1037/1196-1961.48.2.319; PEZDEK K, 1986, J EXP PSYCHOL LEARN, V12, P530, DOI 10.1037/0278-7393.12.4.530; POSNER MI, 1984, J NEUROSCI, V4, P1863; Reimold M, 2006, J CEREBR BLOOD F MET, V26, P751, DOI 10.1038/sj.jcbfm.9600231; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Rubia K, 2010, NEUROIMAGE, V51, P817, DOI 10.1016/j.neuroimage.2010.02.058; Scherf KS, 2006, J COGNITIVE NEUROSCI, V18, P1045, DOI 10.1162/jocn.2006.18.7.1045; Shipp S, 2011, NEUROPSYCHOLOGIA, V49, P2630, DOI 10.1016/j.neuropsychologia.2011.05.011; Silk TJ, 2010, NEUROIMAGE, V53, P718, DOI 10.1016/j.neuroimage.2010.06.068; Smith SE, 2008, ARCH NEUROL-CHICAGO, V65, P1284, DOI 10.1001/archneur.65.10.1284; Szaflarski JP, 2012, NEUROIMAGE, V63, P1188, DOI 10.1016/j.neuroimage.2012.08.049; Tamber-Rosenau BJ, 2011, J COGNITIVE NEUROSCI, V23, P2905, DOI 10.1162/jocn.2011.21608; Walter E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020742; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Wilke M, 2006, NEUROIMAGE, V33, P522, DOI 10.1016/j.neuroimage.2006.07.010; Wilke M, 2012, NEUROIMAGE, V59, P2062, DOI 10.1016/j.neuroimage.2011.10.043; WITKIN HA, 1950, J PERS, V19, P1, DOI 10.1111/j.1467-6494.1950.tb01084.x; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Yovel G, 2001, J EXP PSYCHOL HUMAN, V27, P1369, DOI 10.1037/0096-1523.27.6.1369	68	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85168	10.1371/journal.pone.0085168	http://dx.doi.org/10.1371/journal.pone.0085168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376871	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000179
J	Tang, XL; Feng, HX; Zhang, JH; Chen, WN				Tang, Xiaoling; Feng, Huixing; Zhang, Jianhua; Chen, Wei Ning			Comparative Proteomics Analysis of Engineered Saccharomyces cerevisiae with Enhanced Biofuel Precursor Production	PLOS ONE			English	Article							OXIDATIVE STRESS; GLYOXYLATE CYCLE; METABOLISM; TOLERANCE; RESPONSES; GLUCOSE; ENZYMES; GENES	The yeast Saccharomyces cerevisiae was metabolically modified for enhanced biofuel precursor production by knocking out genes encoding mitochondrial isocitrate dehydrogenase and over-expression of a heterologous ATP-citrate lyase. A comparative iTRAQ-coupled 2D LC-MS/MS analysis was performed to obtain a global overview of ubiquitous protein expression changes in S. cerevisiae engineered strains. More than 300 proteins were identified. Among these proteins, 37 were found differentially expressed in engineered strains and they were classified into specific categories based on their enzyme functions. Most of the proteins involved in glycolytic and pyruvate branchpoint pathways were found to be up-regulated and the proteins involved in respiration and glyoxylate pathway were however found to be down-regulated in engineered strains. Moreover, the metabolic modification of S. cerevisiae cells resulted in a number of up-regulated proteins involved in stress response and differentially expressed proteins involved in amino acid metabolism and protein biosynthesis pathways. These LC-MS/MS based proteomics analysis results not only offered extensive information in identifying potential protein-protein interactions, signal pathways and ubiquitous cellular changes elicited by the engineered pathways, but also provided a meaningful biological information platform serving further modification of yeast cells for enhanced biofuel production.	[Tang, Xiaoling; Feng, Huixing; Zhang, Jianhua; Chen, Wei Ning] Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chen, WN (corresponding author), Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore 639798, Singapore.	wnchen@ntu.edu.sg		, Yang/0000-0002-6620-8897	CRP research grant from the National Research Foundation of Singapore	CRP research grant from the National Research Foundation of Singapore(National Research Foundation, Singapore)	This research is supported by a CRP research grant from the National Research Foundation of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011935; Beopoulos A, 2011, APPL MICROBIOL BIOT, V90, P1193, DOI 10.1007/s00253-011-3212-8; De la Fuente IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030162; delaFuente JM, 1997, SCIENCE, V276, P1566, DOI 10.1126/science.276.5318.1566; Dunlop MJ, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-32; Flikweert MT, 1997, APPL ENVIRON MICROB, V63, P3399, DOI 10.1128/AEM.63.9.3399-3404.1997; Gomez-Pastor R, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-31; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; HONES I, 1983, Z ALLG MIKROBIOL, V23, P163, DOI 10.1002/jobm.3630230304; Iraqui I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000524; Isken S, 1998, EXTREMOPHILES, V2, P229, DOI 10.1007/s007920050065; Kostadinova N, 2011, BIOTECHNOL BIOTEC EQ, V25, P50, DOI 10.5504/bbeq.2011.0122; Lee YJ, 2011, YEAST, V28, P153, DOI 10.1002/yea.1828; Lehmann M, 2009, MOL PLANT, V2, P390, DOI 10.1093/mp/ssn080; Lin AP, 2011, J BIOL CHEM, V286, P33737, DOI 10.1074/jbc.M111.266890; Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081; Mao SM, 2010, J PROTEOME RES, V9, P3046, DOI 10.1021/pr9012078; Meher LC, 2006, RENEW SUST ENERG REV, V10, P248, DOI 10.1016/j.rser.2004.09.002; Michell RH, 2011, ADV ENZYME REGUL, V51, P84, DOI 10.1016/j.advenzreg.2010.10.002; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; Sivagnanam K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-66; Suslu KG, 2011, GENET MOL RES, V10, P4041, DOI 10.4238/2011.November.8.4; Tang XL, 2013, METAB ENG, V16, P95, DOI 10.1016/j.ymben.2013.01.003; Taylor Mark, 2008, Biotechnology Journal, V3, P1388, DOI 10.1002/biot.200800158; Thornley P, 2008, RENEW ENERG, V33, P1922, DOI 10.1016/j.renene.2007.11.011; Tolonen AC, 2011, MOL SYST BIOL, V7, DOI [10.1038/msb.2010.116, 10.1038/MSB.2010.116]; WILLS C, 1990, CRIT REV BIOCHEM MOL, V25, P245, DOI 10.3109/10409239009090611; Xu RNX, 2007, J PHARMACEUT BIOMED, V44, P342, DOI 10.1016/j.jpba.2007.02.006; You KM, 2003, APPL ENVIRON MICROB, V69, P1499, DOI 10.1128/AEM.69.3.1499-1503.2003	30	9	9	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84661	10.1371/journal.pone.0084661	http://dx.doi.org/10.1371/journal.pone.0084661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376832	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000158
J	Amanzada, A; Kopp, W; Spengler, U; Ramadori, G; Mihm, S				Amanzada, Ahmad; Kopp, Waltraut; Spengler, Ulrich; Ramadori, Giuliano; Mihm, Sabine			Interferon- lambda(4) (IFNL4) Transcript Expression in Human Liver Tissue Samples	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GENE-EXPRESSION; HUMAN HEPATOCYTES; INTERLEUKIN 28B; INNATE IMMUNITY; IL28B GENOTYPE; INFECTION; CLEARANCE; RIBAVIRIN; ASSOCIATION	Eradication of hepatitis C virus (HCV) infection, both spontaneous and treatment-induced, is marked by the wildtype allele C of a single nucleotide polymorphism upstream of the IL28B gene, rs12979860. This favorable allele was recently described to be in linkage disequilibrium with the wildtype allele TT of a dinucleotide polymorphism, ss469415590, located within a new protein-coding gene. While the TT allele introduces a frame-shift and disrupts the open reading frame, only the variant allele, Delta G, creates a novel type III interferon (IFN) protein, IFN-lambda(4)/IFNL4. Absence of IFNL4 is thus supposed to favor resolution of HCV infection. As to date IFNL4 mRNA transcription has only been investigated in polyl:C-stimulated primary human hepatocytes and not yet in HCV infection in vivo, this study analyzed IFNL4 mRNA expression in human liver biopsy specimens. Samples were obtained from patients with a broad panel of disorders including no liver disease, liver diseases of non-viral etiology, chronic hepatitis B and chronic hepatitis C. Hepatic IFNL4 transcripts were detectable exclusively in a subgroup of chronic hepatitis C patients (24/45). Their amounts were positively related to liver HCV RNA copy numbers (p = 0.0023, r = 0.56) suggesting that the hepatic viral load influences IFNL4 transcription irrespective of IFNL4 governing genotype. Both, the IFNL4 creating allele Delta G (p<0.0001) and actual IFNL4 transcription (p = 0.0015) were found to be correlated to the activation of IFN stimulatory genes (ISGs). By contrast, IFNL4 ss469415590 genotypes were not found to be related to IFN-lambda(2/3)/IL28 or IFN-lambda(1)/IL29 gene expression. In conclusion, this study is the first report on intrahepatic transcript levels of the recently discovered IFNL4 gene. Data indicate that HCV infection in particular might activate IFNL4 transcription in the liver. It provides a possible explanation as to why hepatitis C patients show ISG stimulation in their livers in the apparent absence of an induction of other IFN subtypes.	[Amanzada, Ahmad; Kopp, Waltraut; Ramadori, Giuliano; Mihm, Sabine] Univ Med Ctr Goettingen, Dept Gastroenterol & Endocrinol, Gottingen, Germany; [Spengler, Ulrich] Univ Hosp Bonn, Dept Gen Internal Med, Bonn, Germany	University of Gottingen; University of Bonn	Mihm, S (corresponding author), Univ Med Ctr Goettingen, Dept Gastroenterol & Endocrinol, Gottingen, Germany.	smihm@med.uni-goettingen.de			Deutsche Forschungsgemeinschaft [MI 474/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [grant number MI 474/1-1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aka PV, 2014, J INFECT DIS, V209, P350, DOI 10.1093/infdis/jit433; Amanzada A, 2012, DIGESTION, V86, P218, DOI 10.1159/000339879; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Heim MH, 2009, VIRUSES-BASEL, V1, P1073, DOI 10.3390/v1031073; Hennig H, 2001, TRANSFUSION, V41, P1100, DOI 10.1046/j.1537-2995.2001.41091100.x; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Iizuka N, 2002, CANCER RES, V62, P3939; Jouan L, 2010, J HEPATOL, V52, P167, DOI 10.1016/j.jhep.2009.11.011; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Mihm S, 2004, LAB INVEST, V84, P1148, DOI 10.1038/labinvest.3700135; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Patzwahl R, 2001, J VIROL, V75, P1332, DOI 10.1128/JVI.75.3.1332-1338.2001; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912	30	44	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84026	10.1371/journal.pone.0084026	http://dx.doi.org/10.1371/journal.pone.0084026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376784	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100154
J	Dhiraj, DK; Chrysanthou, E; Mallucci, GR; Bushell, M				Dhiraj, Dalbir K.; Chrysanthou, Elvina; Mallucci, Giovanna R.; Bushell, Martin			miRNAs-19b,-29b-2*and-339-5p Show an Early and Sustained Up-Regulation in Ischemic Models of Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NEURONAL CELL-DEATH; TRANSGENIC MICE PROTECTS; CYTOCHROME-C; INDUCED APOPTOSIS; ARTERY OCCLUSION; HEART-DISEASE; BCL-2 GENE; IN-VITRO; ACTIVATION	Stroke, the loss of neurons after ischemic insult to the brain, is one of the leading causes of death and disability worldwide. Despite its prevalence and severity, current therapy is extremely limited, highlighting the importance of further understanding the molecular events underlying ischemia-induced neuronal cell death. An ischemic area can be subdivided into two separate pathophysiological regions: the rapidly dying necrotic core, and the potentially salvageable apoptotic penumbra. Understanding molecular events occurring in the apoptotic ischemic penumbra may give greater insight into mechanisms controlling this salvageable tissue. miRNAs are known to have key roles in the regulation of gene expression in numerous pathological conditions, including the modulation of distinct pathways in stroke. However, previous studies have profiled miRNAs in the whole ischemic infarct, and do not differentiate between miRNA regulation in the necrotic core versus the apoptotic penumbra. We asked if there were unique miRNAs that are differentially regulated following ischemic insults in the salvageable apoptotic penumbra. miRNA expression profiles were compared in the whole infarct from in vivo stroke models, using the three vessel occlusion approach, to an in vitro model of the ischemic penumbra, prior to apoptotic induction. Multiple miRNAs were found to be differentially regulated following ischemic insults in each system. However, miR-19b, miR-29b-2* and miR-339-5p were significantly up-regulated in both model systems. Further, we confirmed these results in a neuroblastoma cell line subjected to a penumbra-like ischemic insult that induced the apoptotic cell death pathway. The data show that miR-19b, miR-29b-2* and miR-339-5p are up-regulated following ischemic insults and may be regulating gene expression to control important cellular pathways in the salvageable ischemic penumbra. Further investigation of their role and mRNA target identification may lead to new insights into the molecular mechanisms taking place in the salvageable apoptotic penumbra.	[Dhiraj, Dalbir K.; Chrysanthou, Elvina; Mallucci, Giovanna R.; Bushell, Martin] MRC, MRC Toxicol Unit, Leicester, Leics, England		Bushell, M (corresponding author), MRC, MRC Toxicol Unit, Leicester, Leics, England.	mb446@le.ac.uk		Mallucci, Giovanna/0000-0001-8504-1191	Medical Research Council Toxicology [5T520]; Medical Research Council [MC_UP_A600_1024, MC_U132692719, MC_EX_G0902052, MC_U123160654] Funding Source: researchfish; MRC [MC_EX_G0902052, MC_UP_A600_1024, MC_U123160654, MC_U132692719] Funding Source: UKRI	Medical Research Council Toxicology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is funded by Medical Research Council Toxicology, 5T520 (ITTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonawich FJ, 1998, J CEREBR BLOOD F MET, V18, P882, DOI 10.1097/00004647-199808000-00008; Asahi M, 1997, J CEREBR BLOOD F MET, V17, P11, DOI 10.1097/00004647-199701000-00003; Back T, 2004, J NEUROL, V251, P388, DOI 10.1007/s00415-004-0399-y; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belayev L, 1997, J CEREBR BLOOD F MET, V17, P1266, DOI 10.1097/00004647-199712000-00002; Bicker S, 2008, J CELL MOL MED, V12, P1466, DOI 10.1111/j.1582-4934.2008.00400.x; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao GD, 2004, J NEUROSCI, V24, P6189, DOI 10.1523/JNEUROSCI.1426-04.2004; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Concannon CG, 2008, J NEUROCHEM, V105, P891, DOI 10.1111/j.1471-4159.2007.05187.x; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Ferrer I, 2003, J NEUROPATH EXP NEUR, V62, P329, DOI 10.1093/jnen/62.4.329; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Ginsberg MD, 1997, AM J NEURORADIOL, V18, P1435; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Goldstein LB, 2007, CIRCULATION, V116, P1504, DOI 10.1161/CIRCULATIONAHA.106.670885; Gottron FJ, 1997, MOL CELL NEUROSCI, V9, P159, DOI 10.1006/mcne.1997.0618; Green AR, 2003, TRENDS PHARMACOL SCI, V24, P402, DOI 10.1016/S0165-6147(03)00192-5; GWAG BJ, 1995, NEUROSCIENCE, V68, P615, DOI 10.1016/0306-4522(95)00232-8; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Harada J, 1999, BRAIN RES, V842, P311, DOI 10.1016/S0006-8993(99)01808-9; Harms C, 2000, FASEB J, V14, P1814, DOI 10.1096/fj.99-0899com; Hata R, 1999, METAB BRAIN DIS, V14, P117, DOI 10.1023/A:1020709814456; Hermann DM, 2001, NEUROSCIENCE, V104, P947, DOI 10.1016/S0306-4522(01)00125-7; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kalda A, 1998, NEUROSCI LETT, V240, P21, DOI 10.1016/S0304-3940(97)00914-2; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Krantic S, 2007, PROG NEUROBIOL, V81, P179, DOI 10.1016/j.pneurobio.2006.12.002; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Le DA, 2002, P NATL ACAD SCI USA, V99, P15188, DOI 10.1073/pnas.232473399; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; LINNIK MD, 1995, STROKE, V26, P1670, DOI 10.1161/01.STR.26.9.1670; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; MEMEZAWA H, 1992, STROKE, V23, P552, DOI 10.1161/01.STR.23.4.552; Minnerup J, 2009, NEUROTHERAPEUTICS, V6, P43, DOI 10.1016/j.nurt.2008.10.032; Namura S, 1998, J NEUROSCI, V18, P3659; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Ouyang YB, 1999, J CEREBR BLOOD F MET, V19, P1126, DOI 10.1097/00004647-199910000-00009; Paciaroni M, 2009, EUR NEUROL, V61, P321, DOI 10.1159/000210544; Plesnila N, 2002, EUR SURG RES, V34, P37, DOI 10.1159/000048885; Rami A, 2003, NEUROCHEM INT, V43, P79, DOI 10.1016/S0197-0186(02)00194-8; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosenbaum DM, 2000, J NEUROSCI RES, V61, P686, DOI 10.1002/1097-4547(20000915)61:6<686::AID-JNR12>3.0.CO;2-7; Saito A, 2003, J NEUROSCI, V23, P1710; Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108; Sims NR, 2009, BIOCHIM BIOPHYS ACTA; Sugawara T, 2002, FASEB J, V16, P1997, DOI 10.1096/fj.02-0251fje; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang WX, 2008, EXPRESSION MICRORNA; Webster KA, 2006, ANTIOXID REDOX SIGN, V8, P1667, DOI 10.1089/ars.2006.8.1667; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yamamoto H, 2003, EXP NEUROL, V182, P261, DOI 10.1016/S0014-4886(03)00116-X; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021; Yin XM, 2002, J BIOL CHEM, V277, P42074, DOI 10.1074/jbc.M204991200; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343; Zhang M, 2003, ACTA BIOCH BIOPH SIN, V35, P561	81	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83717	10.1371/journal.pone.0083717	http://dx.doi.org/10.1371/journal.pone.0083717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376737	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000328745100133
J	Guan, NY; Zhang, X; Luo, ZG; Tao, DC; Yang, XJ				Guan, Naiyang; Zhang, Xiang; Luo, Zhigang; Tao, Dacheng; Yang, Xuejun			Discriminant Projective Non-Negative Matrix Factorization	PLOS ONE			English	Article							IMAGE; VARIABLES	Projective non-negative matrix factorization (PNMF) projects high-dimensional non-negative examples X onto a lower-dimensional subspace spanned by a non-negative basis W and considers W-T X as their coefficients, i.e., X approximate to WWT X. Since PNMF learns the natural parts-based representation Wof X, it has been widely used in many fields such as pattern recognition and computer vision. However, PNMF does not perform well in classification tasks because it completely ignores the label information of the dataset. This paper proposes a Discriminant PNMF method (DPNMF) to overcome this deficiency. In particular, DPNMF exploits Fisher's criterion to PNMF for utilizing the label information. Similar to PNMF, DPNMF learns a single non-negative basis matrix and needs less computational burden than NMF. In contrast to PNMF, DPNMF maximizes the distance between centers of any two classes of examples meanwhile minimizes the distance between any two examples of the same class in the lower-dimensional subspace and thus has more discriminant power. We develop a multiplicative update rule to solve DPNMF and prove its convergence. Experimental results on four popular face image datasets confirm its effectiveness comparing with the representative NMF and PNMF algorithms.	[Guan, Naiyang; Zhang, Xiang; Luo, Zhigang] Natl Univ Def Technol, Sch Comp Sci, Natl Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China; [Tao, Dacheng] Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia; [Tao, Dacheng] Univ Technol Sydney, Fac Engn & Informat Technol, Sydney, NSW 2007, Australia; [Yang, Xuejun] Natl Univ Def Technol, State Key Lab High Performance Comp, Changsha, Hunan, Peoples R China	National University of Defense Technology - China; University of Technology Sydney; University of Technology Sydney; National University of Defense Technology - China	Luo, ZG (corresponding author), Natl Univ Def Technol, Sch Comp Sci, Natl Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China.	zgluo@nudt.edu.cn; Dacheng.Tao@uts.edu.au			Scientific Research Plan Project of National University of Defense Technology [JC13-06-01]; Australian Research Council Discovery Project [120103730]	Scientific Research Plan Project of National University of Defense Technology; Australian Research Council Discovery Project(Australian Research Council)	This work was partially supported by Scientific Research Plan Project of National University of Defense Technology (No. JC13-06-01) and Australian Research Council Discovery Project (120103730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Bengio Y, 2003, OUT OF SAMPLE EXTENS; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Graham D., 1998, FACE RECOGNITION, V163, P446, DOI DOI 10.1007/978-3-642-72201-1_25; Guan N., 2012, ARXIV12073438V1; Guan NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077162; Guan NY, 2012, IEEE T NEUR NET LEAR, V23, P1087, DOI 10.1109/TNNLS.2012.2197827; Guan NY, 2012, IEEE T SIGNAL PROCES, V60, P2882, DOI 10.1109/TSP.2012.2190406; Guan NY, 2011, IEEE T NEURAL NETWOR, V22, P1218, DOI 10.1109/TNN.2011.2157359; Guan NY, 2011, IEEE T IMAGE PROCESS, V20, P2030, DOI 10.1109/TIP.2011.2105496; He XF, 2005, IEEE I CONF COMP VIS, P1208; He XF, 2004, ADV NEUR IN, V16, P153; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Hu L, 2013, INT J COMPUTER SCI I, V10, P127; Kong DG, 2012, IEEE DATA MINING, P942, DOI 10.1109/ICDM.2012.111; Kuhn H. W., 1951, P 2 BERK S MATH STAT, P481, DOI DOI 10.1007/BF01582292; Lee CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048238; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li J, 2013, INT J C ART INT, P1466; Li J, 2013, IEEE T NEUR NET LEAR, V24, P964, DOI 10.1109/TNNLS.2013.2245341; Li J, 2013, IEEE T NEUR NET LEAR, V24, P485, DOI 10.1109/TNNLS.2012.2234134; Li J, 2012, IEEE T IMAGE PROCESS, V21, P4830, DOI 10.1109/TIP.2012.2211372; Liu XB, 2010, IEEE T IMAGE PROCESS, V19, P1126, DOI 10.1109/TIP.2009.2039050; Murrell B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028898; Pauca VP, 2004, SIAM PROC S, P452; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Song ML, 2013, IEEE T IMAGE PROCESS, V22, P3283, DOI 10.1109/TIP.2013.2261307; Song ML, 2012, IEEE T IMAGE PROCESS, V21, P2887, DOI 10.1109/TIP.2012.2183882; Song ML, 2010, IEEE T PATTERN ANAL, V32, P1537, DOI 10.1109/TPAMI.2009.74; Tao DC, 2007, IEEE DATA MINING, P302, DOI 10.1109/ICDM.2007.105; Tao DC, 2007, IEEE T PATTERN ANAL, V29, P1700, DOI 10.1109/TPAMI.2007.1096; Taslaman L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046331; Wang SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066647; Wang SJ, 2012, IEEE T NEUR NET LEAR, V23, P876, DOI 10.1109/TNNLS.2012.2191620; Wang SJ, 2011, NEUROCOMPUTING, V74, P2142, DOI 10.1016/j.neucom.2011.01.024; Wang SJ, 2011, IEEE T IMAGE PROCESS, V20, P2490, DOI 10.1109/TIP.2011.2121084; Wen JH, 2013, IEEE J-STARS, V6, P759, DOI 10.1109/JSTARS.2012.2210276; Yan SC, 2007, IEEE T PATTERN ANAL, V29, P40, DOI 10.1109/TPAMI.2007.250598; Yang ZR, 2010, IEEE T NEURAL NETWOR, V21, P734, DOI 10.1109/TNN.2010.2041361; Yuan Z., 2004, SPRINGER LECT NOTES, V3195, P1; Zafeiriou S, 2006, IEEE T NEURAL NETWOR, V17, P683, DOI 10.1109/TNN.2006.873291; Zafeiriou S, 2010, IEEE T IMAGE PROCESS, V19, P1050, DOI 10.1109/TIP.2009.2038816; Zhang H, 2012, LECT NOTES COMPUT SC, V7665, P277, DOI 10.1007/978-3-642-34487-9_34; Zhang TH, 2009, IEEE T KNOWL DATA EN, V21, P1299, DOI 10.1109/TKDE.2008.212	46	16	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83291	10.1371/journal.pone.0083291	http://dx.doi.org/10.1371/journal.pone.0083291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376680	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100107
J	Liu, DD; Liang, F; Wang, X; Cao, J; Qin, WT; Sun, BW				Liu, Dadong; Liang, Feng; Wang, Xu; Cao, Jie; Qin, Weiting; Sun, Bingwei			Suppressive Effect of CORM-2 on LPS-Induced Platelet Activation by Glycoprotein Mediated HS1 Phosphorylation Interference	PLOS ONE			English	Article							MONOXIDE-RELEASING MOLECULES; DEPENDENT PROTEIN-KINASE; CARBON-MONOXIDE; OXIDATIVE STRESS; LEUKOCYTES SEQUESTRATION; INFLAMMATORY RESPONSES; CO; OXYGENASE-1; HEME; EXPRESSION	In recent years, it has been discovered that septic patients display coagulation abnormalities. Platelets play a major role in coagulation system. Studies have confirmed that carbon monoxide (CO) has important cytoprotective and ant inflammatory function. However, whether CO could alter abnormal activation of platelets and coagulation and thereby duce the incidence of mortality during sepsis has not been defined. In this report, we have used CO-releasing molecules (CORM-2) to determine whether CO inhibits LPS-induced abnormal activation of platelets and have explored the potential mechanisms. LPS was used to induce activation of platelets in vitro, which were purified from the peripheral venous blood healthy adult donors. CORM-2 was applied as a potential therapeutic agent. CORM-2 preconditioning and delayed treatment were also studied. We found that in the LPS groups, the function of platelets such as spreading, aggregation and lease were enhanced abnormally. By contrast, the platelets in the CORM-2 group were gently activated Fur her showed that the expression of platelet membrane glycoproteins increased in the LPS group. C hematopoietic lineage cell-specific protein 1 and its phosphorylated form also increased dramatically. These phenomena less dramatically seen in the CORM-2 groups. Taken together, we conclude that during LPS stimulation, platelets were abnormally activated, and this functional state may be associated with the signal that is transmitted between membrane glycoproteins and HS1. CORM-released CO suppresses the abnormal activation of platelets by interfering with glycoprotein mediated HS1 phosphorylation.	[Liu, Dadong; Liang, Feng; Wang, Xu; Cao, Jie; Qin, Weiting; Sun, Bingwei] Jiangsu Univ, Affiliated Hosp, Dept Burn & Plast Surg, Zhenjiang, Peoples R China	Jiangsu University	Sun, BW (corresponding author), Jiangsu Univ, Affiliated Hosp, Dept Burn & Plast Surg, Zhenjiang, Peoples R China.	sunbinwe@hotmail.com			National Natural Science Foundation of China [30772256, 81071546, 81272148]; Jiangsu Provincial Natural Science Foundation [BK2012703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (No. 30772256, 81071546 and 81272148 http://www.nsfc.gov.cn/ Portal0/default152.htm), and Jiangsu Provincial Natural Science Foundation (No. BK2012703, http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tamimi M, 2012, THROMB HAEMOSTASIS, V107, P648, DOI 10.1160/TH11-10-0745; Romaniuk MA, 2010, BIOCHEM J, V432, P535, DOI 10.1042/BJ20100538; Arthur JF, 2005, THROMB HAEMOSTASIS, V93, P716, DOI 10.1160/TH04-09-0584; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Bigalke B, 2011, CURR DRUG TARGETS, V12, P1821, DOI 10.2174/138945011797635867; Cepinskas G, 2008, AM J PHYSIOL-GASTR L, V294, pG184, DOI 10.1152/ajpgi.00348.2007; Clemetson KJ, 2007, BLOOD, V109, P393, DOI 10.1182/blood-2006-10-053462; Cranmer SL, 2011, BLOOD, V117, P2718, DOI 10.1182/blood-2010-07-296194; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Fei DS, 2012, TRANSL RES, V159, P99, DOI 10.1016/j.trsl.2011.10.009; Frezza D, 2012, ANN RHEUM DIS, V71, P1309, DOI 10.1136/ard.2010.147025; Frezzato F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039902; Gu MY, 1999, J CELL BIOL, V147, P1085, DOI 10.1083/jcb.147.5.1085; Kahner BN, 2007, BLOOD, V110, P2449, DOI 10.1182/blood-2006-11-056069; Kahner BN, 2008, PLATELETS, V19, P614, DOI 10.1080/09537100802351057; KITAMURA D, 1989, NUCLEIC ACIDS RES, V17, P9367; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Levi M, 1999, THROMB HAEMOSTASIS, V82, P695; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Li SF, 2010, ASIAN J ANDROL, V12, P247, DOI 10.1038/aja.2009.78; Li ZY, 2011, THROMB RES, V127, P184, DOI 10.1016/j.thromres.2010.10.010; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Maruyama K, 2012, THROMB RES, V130, pE188, DOI 10.1016/j.thromres.2012.07.002; Mizuguchi S, 2009, AM J PHYSIOL-HEART C, V297, pH920, DOI 10.1152/ajpheart.00305.2009; Motterlini R, 2003, CURR PHARM DESIGN, V9, P2525, DOI 10.2174/1381612033453785; Nurden A, 2011, J THROMB HAEMOST, V9, P76, DOI 10.1111/j.1538-7836.2011.04274.x; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Senzel L, 2009, CURR OPIN HEMATOL, V16, P329, DOI 10.1097/MOH.0b013e32832e9dc6; Song H, 2011, J PERIODONTAL RES, V46, P48, DOI 10.1111/j.1600-0765.2010.01307.x; Soni HM, 2012, INDIAN J PHARM SCI, V74, P281, DOI 10.4103/0250-474X.107047; Soni H, 2011, TOXICOL APPL PHARM, V253, P70, DOI 10.1016/j.taap.2011.03.013; Stokes KY, 2012, J PHYSIOL-LONDON, V590, P1023, DOI 10.1113/jphysiol.2011.225417; Sun BW, 2009, CELL MOL LIFE SCI, V66, P365, DOI 10.1007/s00018-008-8487-2; Sun BW, 2007, J BURN CARE RES, V28, P173, DOI 10.1097/BCR.0b013E31802CA491; Sun BW, 2008, INT J BIOL SCI, V4, P270; Sun BW, 2008, INT J BIOL SCI, V4, P176; Sun BW, 2007, J SURG RES, V139, P128, DOI 10.1016/j.jss.2006.08.032; Tsoyi K, 2010, SHOCK, V34, P608, DOI 10.1097/SHK.0b013e3181e46f15; Tsoyi K, 2009, INFLAMMATION, V32, P364, DOI 10.1007/s10753-009-9144-0; Tsoyi K, 2009, MOL PHARMACOL, V76, P173, DOI 10.1124/mol.109.055137; Tyml K, 2011, MICROCIRCULATION, V18, P152, DOI 10.1111/j.1549-8719.2010.00080.x; van Velzen JF, 2012, THROMB RES, V130, P92, DOI 10.1016/j.thromres.2012.02.041; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Wang X, 2012, WORLD J GASTROENTERO, V18, P5719, DOI 10.3748/wjg.v18.i40.5719; Wenzel RP, 2002, NEW ENGL J MED, V347, P966, DOI 10.1056/NEJMp020096; Yin H, 2008, BLOOD, V111, P658, DOI 10.1182/blood-2007-04-085514; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; Zhang Y, 2011, CELL MOL LIFE SCI, V68, P3771, DOI 10.1007/s00018-011-0678-6; Zheng M, 2013, AM J PHYSIOL-ENDOC M, V304, pE780, DOI 10.1152/ajpendo.00466.2012	52	14	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83112	10.1371/journal.pone.0083112	http://dx.doi.org/10.1371/journal.pone.0083112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376647	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100092
J	Lubovac-Pilav, Z; Borras, DM; Ponce, E; Louie, MC				Lubovac-Pilav, Zelmina; Borras, Daniel M.; Ponce, Esmeralda; Louie, Maggie C.			Using Expression Profiling to Understand the Effects of Chronic Cadmium Exposure on MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							DNA-BINDING DOMAIN; NOBLE NBL/CR RAT; GENE-EXPRESSION; CYCLIN B1; PROLIFERATIVE LESIONS; ZINC-FINGER; E-CADHERIN; IN-VIVO; ESTROGEN; OVEREXPRESSION	Cadmium a metalloestrogen known to activate the estrogen receptor and promote breast cancer cell growth. Previous studies have implicated cadmium in the development of more malignant tumors; however the molecular mechanisms behind this cadmium-induced malignancy remain elusive. Using clonal cell lines derived from exposing breast cancer cells to cadmium for over 6 months (MCF-7-Cd4, -Cd6, -Cd7, -Cd8 and -Cd12), this study aims to identify gene expression signatures associated with chronic cadmium exposure. Our results demonstrate that prolonged cadmium exposure does not merely result in the deregulation of genes but actually leads to a distinctive expression profile. The genes deregulated in cadmium-exposed cells are involved in multiple biological processes i.e. cell growth, apoptosis, etc.) and molecular functions (i.e. cadmium/metal ion binding, transcription factor activity, etc.). Hierarchical clustering demonstrates that the five clonal cadmium cell lines share a common gene expression signature of breast cancer associated genes, clearly differentiating control cells from cadmium exposed cells. The results presented in this study offer insights into the cellular and molecular impacts of cadmium on breast cancer and emphasize the importance of studying chronic cadmium exposure as one possible mechanism of promoting breast cancer progression.	[Lubovac-Pilav, Zelmina; Borras, Daniel M.] Univ Skovde, Sch Biosci, Syst Biol Res Ctr Bioinformat, Skovde, Sweden; [Ponce, Esmeralda; Louie, Maggie C.] Dominican Univ Calif, Dept Nat Sci & Math, San Rafael, CA USA; [Louie, Maggie C.] Touro Univ Calif, Coll Pharm, Vallejo, CA USA	University of Skovde; Touro University California	Lubovac-Pilav, Z (corresponding author), Univ Skovde, Sch Biosci, Syst Biol Res Ctr Bioinformat, Skovde, Sweden.	zelmina.lubovac@his.se; maggie.louie@dominican.edu	Pilav, Zelmina Lubovac/E-9956-2016	Pilav, Zelmina Lubovac/0000-0001-6427-0315	National Cancer Institute [CA121983-02, CA121983-02S1]; Magnus Bergvall stiftelse; AG fonden; NATIONAL CANCER INSTITUTE [R15CA121983] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Magnus Bergvall stiftelse; AG fonden; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Cancer Institute (CA121983-02 to MCL and CA121983-02S1 to EP), and from Magnus Bergvall stiftelse and AG fonden to ZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanzar WE, 2001, CANCER RES, V61, P455; Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; Ali I, 2010, ENVIRON HEALTH PERSP, V118, P1389, DOI 10.1289/ehp.1001967; Alonso-Gonzalez C, 2007, J PINEAL RES, V42, P403, DOI 10.1111/j.1600-079X.2007.00434.x; Antila E, 1996, SCI TOTAL ENVIRON, V186, P251, DOI 10.1016/0048-9697(96)05119-4; Benbrahim-Tallaa L, 2009, ENVIRON HEALTH PERSP, V117, P1847, DOI 10.1289/ehp.0900999; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertucci F, 2006, OMICS, V10, P429, DOI 10.1089/omi.2006.10.429; Bredenberg J, 2002, PROTEINS, V49, P24, DOI 10.1002/prot.10195; Buchko GW, 2000, CARCINOGENESIS, V21, P1051, DOI 10.1093/carcin/21.5.1051; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Byrne C, 2009, TOXICOL APPL PHARM, V238, P266, DOI 10.1016/j.taap.2009.03.025; CANTOR KP, 1995, J OCCUP ENVIRON MED, V37, P336, DOI 10.1097/00043764-199503000-00011; Chan TA, 2000, GENE DEV, V14, P1584; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; D'Angiolella V, 2013, TRENDS CELL BIOL, V23, P135, DOI 10.1016/j.tcb.2012.10.011; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Francois E, 2003, BIOTECHNOL ADV, V22, P17, DOI 10.1016/j.biotechadv.2003.08.005; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; Garrett SH, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S2; Haga A, 1996, EUR J CANCER, V32A, P2342, DOI 10.1016/S0959-8049(96)00349-8; Hofer N, 2009, TOXICOL LETT, V191, P123, DOI 10.1016/j.toxlet.2009.08.014; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Ionescu JG, 2006, NEUROENDOCRINOL LETT, V27, P36; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JIN TY, 1992, TOXICOLOGY, V75, P29, DOI 10.1016/0300-483X(92)90123-V; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Kayaalti Z, 2011, TOXICOL APPL PHARM, V256, P1, DOI 10.1016/j.taap.2011.06.023; KEYOMARSI K, 1995, ONCOGENE, V11, P941; Kong M, 2000, EMBO J, V19, P1378, DOI 10.1093/emboj/19.6.1378; Korenaga D, 2002, SURGERY, V131, pS114, DOI 10.1067/msy.2002.119362; Liu ZW, 2008, TOXICOL APPL PHARM, V228, P286, DOI 10.1016/j.taap.2007.12.017; Low LY, 2002, J MOL BIOL, V319, P87, DOI 10.1016/S0022-2836(02)00236-X; Lu J, 2001, CELL STRESS CHAPERON, V6, P97, DOI 10.1379/1466-1268(2001)006<0097:MGEIPL>2.0.CO;2; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Martin MB, 2003, ENDOCRINOLOGY, V144, P2425, DOI 10.1210/en.2002-221054; McElroy JA, 2006, JNCI-J NATL CANCER I, V98, P869, DOI 10.1093/jnci/djj233; Mosca E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-76; National Toxicology Program, 2011, Rep Carcinog, V12, P80; Nordberg M, 1992, IARC Sci Publ, P293; Nordberg M, 2000, CELL MOL BIOL, V46, P451; Ponce E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072639; PREDKI PF, 1992, J BIOL CHEM, V267, P5842; PREDKI PF, 1994, ENVIRON HEALTH PERSP, V102, P195, DOI 10.2307/3431786; PROZIALECK WC, 1991, BIOCHEM BIOPH RES CO, V181, P1118, DOI 10.1016/0006-291X(91)92054-N; Prozialeck WC, 2000, TOXICOL APPL PHARM, V164, P231, DOI 10.1006/taap.2000.8905; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Schwartz GG, 2000, CANCER EPIDEM BIOMAR, V9, P139; Siewit CL, 2010, MOL ENDOCRINOL, V24, P981, DOI 10.1210/me.2009-0410; Sirchia R, 2008, BIOCHIMIE, V90, P1578, DOI 10.1016/j.biochi.2008.06.011; Soria JC, 2000, CANCER RES, V60, P4000; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Strumylaite L, 2011, BREAST CANCER RES TR, V125, P511, DOI 10.1007/s10549-010-1007-8; Tekin D, 2012, J APPL TOXICOL, V32, P270, DOI 10.1002/jat.1661; Tully DB, 2000, TOXICOL APPL PHARM, V168, P79, DOI 10.1006/taap.2000.9014; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venet D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051013; Waalkes MP, 1999, CARCINOGENESIS, V20, P65, DOI 10.1093/carcin/20.1.65; Waalkes MP, 2000, TOXICOL SCI, V54, P110, DOI 10.1093/toxsci/54.1.110; Waalkes MP, 1999, J TOXICOL ENV HEAL A, V58, P199, DOI 10.1080/009841099157296; Waalkes MP, 1999, TOXICOL SCI, V52, P154, DOI 10.1093/toxsci/52.2.154; WHO INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V58, P119; Yasuda M, 2002, J CANCER RES CLIN, V128, P412, DOI 10.1007/s00432-002-0359-9; Yu XY, 2010, TOXICOL APPL PHARM, V245, P83, DOI 10.1016/j.taap.2010.02.005; Zhao YS, 2009, BREAST CANCER RES TR, V117, P141, DOI 10.1007/s10549-008-0228-6; Zhou T, 1999, TOXICOLOGY, V142, P1, DOI 10.1016/S0300-483X(99)00115-8	75	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84646	10.1371/journal.pone.0084646	http://dx.doi.org/10.1371/journal.pone.0084646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376830	Green Published, gold			2022-12-27	WOS:000328745100180
J	Miki, D; Ochi, H; Takahashi, A; Hayes, CN; Urabe, Y; Abe, H; Kawaoka, T; Tsuge, M; Hiraga, N; Imamura, M; Kawakami, Y; Aikata, H; Takahashi, S; Akuta, N; Suzuki, F; Ikeda, K; Kumada, H; Karino, Y; Toyota, J; Tsunoda, T; Kubo, M; Kamatani, N; Nakamura, Y; Chayama, K				Miki, Daiki; Ochi, Hidenori; Takahashi, Atsushi; Hayes, C. Nelson; Urabe, Yuji; Abe, Hiromi; Kawaoka, Tomokazu; Tsuge, Masataka; Hiraga, Nobuhiko; Imamura, Michio; Kawakami, Yoshiiku; Aikata, Hiroshi; Takahashi, Shoichi; Akuta, Norio; Suzuki, Fumitaka; Ikeda, Kenji; Kumada, Hiromitsu; Karino, Yoshiyasu; Toyota, Joji; Tsunoda, Tatsuhiko; Kubo, Michiaki; Kamatani, Naoyuki; Nakamura, Yusuke; Chayama, Kazuaki			HLA-DQB1*03 Confers Susceptibility to Chronic Hepatitis C in Japanese: A Genome-Wide Association Study	PLOS ONE			English	Article							VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; GENETIC-VARIATION; HLA; INTERFERON; CLEARANCE; IL28B; LOCUS; VARIANTS	Hepatitis C virus (HCV) establishes a chronic infection in 70-80% of infected individuals. Many researchers have examined the effect of human leukocyte antigen (HLA) on viral persistence because of its critical role in the immune response against exposure to HCV, but almost all studies have proven to be inconclusive. To identify genetic risk factors for chronic HCV infection, we analyzed 458,207 single nucleotide polymorphisms (SNPs) in 481 chronic HCV patients and 2,963 controls in a Japanese cohort. Next, we performed a replication study with an independent panel of 4,358 cases and 1,114 controls. We further confirmed the association in 1,379 cases and 25,817 controls. In the GWAS phase, we found 17 SNPs that showed suggestive association (P < 1 x 10(-5)). After the first replication study, we found one intronic SNP in the HLA-DQ locus associated with chronic HCV infection, and when we combined the two studies, the association reached the level of genome-wide significance. In the second replication study, we again confirmed the association (P-combined = 3.59 x 10(-16), odds ratio [OR] = 0.79). Subsequent analysis revealed another SNP, rs1130380, with a stronger association (OR=0.72). This nucleotide substitution causes an amino acid substitution (R55P) in the HLA-DQB1 protein specific to the DQB1*03 allele, which is common worldwide. In addition, we confirmed an association with the previously reported IFNL3-IFNL4 locus and propose that the effect of DQB1*03 on HCV persistence might be affected by the IFNL4 polymorphism. Our findings suggest that a common amino acid substitution in HLA-DQB1 affects susceptibility to chronic infection with HCV in the Japanese population and may not be independent of the IFNL4 genotype.	[Miki, Daiki; Ochi, Hidenori; Hayes, C. Nelson; Abe, Hiromi; Kawaoka, Tomokazu; Hiraga, Nobuhiko; Imamura, Michio; Kawakami, Yoshiiku; Aikata, Hiroshi; Chayama, Kazuaki] RIKEN, Ctr Integrat Med Sci, Lab Digest Dis, Hiroshima, Japan; [Miki, Daiki; Ochi, Hidenori; Hayes, C. Nelson; Urabe, Yuji; Abe, Hiromi; Kawaoka, Tomokazu; Hiraga, Nobuhiko; Imamura, Michio; Kawakami, Yoshiiku; Aikata, Hiroshi; Takahashi, Shoichi; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan; [Miki, Daiki; Ochi, Hidenori; Hayes, C. Nelson; Kawaoka, Tomokazu; Tsuge, Masataka; Hiraga, Nobuhiko; Imamura, Michio; Kawakami, Yoshiiku; Aikata, Hiroshi; Takahashi, Shoichi; Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Tsuge, Masataka] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Akuta, Norio; Suzuki, Fumitaka; Ikeda, Kenji; Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan; [Karino, Yoshiyasu; Toyota, Joji] Sapporo Kosei Gen Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan; [Tsunoda, Tatsuhiko] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan	RIKEN; Hiroshima University; Hiroshima University; RIKEN; Hiroshima University; Toranomon Hospital; Sapporo Kosei General Hospital; RIKEN; RIKEN; University of Tokyo	Chayama, K (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Digest Dis, Hiroshima, Japan.	chayama@hiroshima-u.ac.jp	Tsunoda, Tatsuhiko/K-2061-2014; Abe-Chayama, Hiromi/M-8256-2019; Tsuge, Masataka/G-5246-2019; Chayama, Kazuaki/B-2493-2016; Hayes, C. Nelson N/G-4596-2019; Miki, Daiki/L-5069-2018; Kubo, Michiaki/N-7947-2015	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Tsuge, Masataka/0000-0001-7591-8287; Miki, Daiki/0000-0002-6505-9826; Chayama, Kazuaki/0000-0002-5530-5341	Ministry of Health, Labor and Welfar; Ministry of Education Culture Sports Science and Technology; Government of Japan; Grants-in-Aid for Scientific Research [25670369] Funding Source: KAKEN	Ministry of Health, Labor and Welfar; Ministry of Education Culture Sports Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Government of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by Grants-in-Aid for scientific research and development from the Ministry of Health, Labor and Welfare (http:// www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/) and Ministry of Education Culture Sports Science and Technology (http:// www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm), Government of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakr I, 2006, GUT, V55, P1183, DOI [10.1136/gut.2005.078147, 10.1136/gut.2006.078147]; BARRERA JM, 1995, HEPATOLOGY, V21, P639, DOI 10.1016/0270-9139(95)90511-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cangussu LOF, 2011, SCAND J IMMUNOL, V74, P282, DOI 10.1111/j.1365-3083.2011.02568.x; Chayama K, 2013, J GASTROENTEROL, V48, P1, DOI 10.1007/s00535-012-0714-9; Chayama K, 2012, HEPATOL RES, V42, P841, DOI 10.1111/j.1872-034X.2012.01002.x; Duggal P, 2013, ANN INTERN MED, V158, P235, DOI 10.7326/0003-4819-158-4-201302190-00003; Haydon GH, 1997, GUT, V40, P128, DOI 10.1136/gut.40.1.128; Hiraga N, 2009, J HEPATOL, V51, P1046, DOI 10.1016/j.jhep.2009.09.002; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Kawaoka T, 2011, J HEPATOL, V54, P408, DOI 10.1016/j.jhep.2010.07.032; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Kuzushita N, 1998, HEPATOLOGY, V27, P240, DOI 10.1002/hep.510270136; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Ochi H, 2011, J GEN VIROL, V92, P1071, DOI 10.1099/vir.0.029124-0; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; PRIETO M, 1995, HEPATOLOGY, V22, P413, DOI 10.1016/0270-9139(95)90559-6; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Siebold C, 2004, P NATL ACAD SCI USA, V101, P1999, DOI 10.1073/pnas.0308458100; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Tanaka J, 2004, INTERVIROLOGY, V47, P32, DOI 10.1159/000076640; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; VANDERZWAN A, 2002, IHWG TECHNICAL MANUA; Welzel TM, 2009, HEPATOLOGY, V49, P1847, DOI 10.1002/hep.22877; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yoshizawa K, 2003, TISSUE ANTIGENS, V61, P159, DOI 10.1034/j.1399-0039.2003.00015.x	36	32	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84226	10.1371/journal.pone.0084226	http://dx.doi.org/10.1371/journal.pone.0084226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376798	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100161
J	Qureshi, SR; Khan, WA; Prosser, R				Qureshi, Shafiq R.; Khan, Waqar A.; Prosser, Robert			Behaviour of a Premixed Flame Subjected to Acoustic Oscillations	PLOS ONE			English	Article								In this paper, a one dimensional premixed laminar methane flame is subjected to acoustic oscillations and studied. The purpose of this analysis is to investigate the effects of acoustic perturbations on the reaction rates of different species, with a view to their respective contribution to thermoacoustic instabilities. Acoustically transparent non reflecting boundary conditions are employed. The flame response has been studied with acoustic waves of different frequencies and amplitudes. The integral values of the reaction rates, the burning velocities and the heat release of the acoustically perturbed flame are compared with the unperturbed case. We found that the flame's sensitivity to acoustic perturbations is greatest when the wavelength is comparable to the flame thickness. Even in this case, the perturbations are stable with time. We conclude that acoustic fields acting on the chemistry do not contribute significantly to the emergence of large amplitude pressure oscillations.	[Qureshi, Shafiq R.; Khan, Waqar A.] Natl Univ Sci & Technol, Pakistan Navy Engn Coll, Dept Engn Sci, Karachi, Pakistan; [Prosser, Robert] Univ Manchester, Sch MACE, Manchester, Lancs, England	National University of Sciences & Technology - Pakistan; University of Manchester	Khan, WA (corresponding author), Natl Univ Sci & Technol, Pakistan Navy Engn Coll, Dept Engn Sci, Karachi, Pakistan.	wkhan_2000@yahoo.com	Khan, Waqar/H-3886-2013	Khan, Waqar/0000-0002-8328-850X; Prosser, Robert/0000-0001-5591-2056				Abbott M.B., 1989, COMPUTATIONAL FLUID; Bauer H, 1973, PHYS FLUIDS, V16; Baukal CE., 2003, IND BURNERS HDB, DOI 10.1201/9780203488805; Baum M, 1994, J COMPUTATIONAL PHYS, V116; Bilger R, 2000, PROGR ENERGY COMBUST, V26; Clarke JF, 1964, DYNAMICS REAL GASES; Clarke JF, 1978, ACTA ASTR, V5; Culick F.E., 2006, UNSTEADY MOTIONS COM; Dowling A. P., 1983, SOUND SOURCES SOUND; Ducruix S., 2003, J PROPULSION POWER, V19; Durox D, 1997, J FLUID MECH, V350; Eckstein J, 2006, T ASME, V128; Elaine SO, 1985, PROGR ENERGY COMBUST, V11; Hanson J, 1999, J GEOPHYS RES, V104; Kee R. J., 1990, TECHNICAL REPORT; Klein R, 1995, J COMPUTATIONAL PHYS, V121; Kuo K K., 1986, PRINCIPLES COMBUSTIO; Lefebvre A. H., 1998, GAS TURBINE COMBUSTI; Lieuwen TC, 2003, ASME TURB EXP 2003 A; McIntosh A, 1991, COMB SCI TECHNOL, V75; McIntosh A, 1999, PHIL T R SOC LONDON, V357; Melvin A, 1971, COMBUSTION SCI TECHN, V4; Poinsot T, 1987, J FLUID MECH, V177; Poinsot TJ, 1992, J COMPUTATIONAL PHYS, V101; Pope SB, 1987, ANN REV FLUID MECH, V19; Prosser R, 2007, J COMPUTATIONAL PHYS, V222; Prosser R, 2005, J COMPUTATIONAL PHYS, V207; Putname AA, 1953, T ASME; Raun RL, 1993, PROGR ENERGY COMBUST, V19; ROCHE M, 1989, SIAM J NUMER ANAL, V26, P963, DOI 10.1137/0726053; Scarinci T, 2000, ASME TURBO EXPO; Shimmer H, 1977, COMBUSTION FLAME, V28; Srinivasan J, 1976, PHYS FLUIDS, V18; Strahle WC, 1978, PROG ENERGY COMBUST, V4; Sutherland J, 2003, J COMPUTATIONAL PHYS, V191; Teerling OJ, 2007, COMBUSTION THEORY MO, V11; THOMPSON KW, 1987, J COMPUT PHYS, V68, P1, DOI 10.1016/0021-9991(87)90041-6; Toong TY, 1972, COMBUSTION FLAME, V18; Truffaut JM, 1998, COMBUST THEORY MODEL, V2; Turns S.R., 1996, INTRO COMBUSTION CON; Wray AA, 1989, IUTAM S TOP FLUID ME, P95; Yu KH, 1991, J FLUID MECH, V232	42	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e81659	10.1371/journal.pone.0081659	http://dx.doi.org/10.1371/journal.pone.0081659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376501	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100005
J	Sahana, G; Nielsen, US; Aamand, GP; Lund, MS; Guldbrandtsen, B				Sahana, Goutam; Nielsen, Ulrik Sander; Aamand, Gert Pedersen; Lund, Mogens Sando; Guldbrandtsen, Bernt			Novel Harmful Recessive Haplotypes Identified for Fertility Traits in Nordic Holstein Cattle	PLOS ONE			English	Article								Using genomic data, lethal recessives may be discovered from haplotypes that are common in the population but never occur in the homozygote state in live animals. This approach only requires genotype data from phenotypically normal (i.e. live) individuals and not from the affected embryos that die. A total of 7,937 Nordic Holstein animals were genotyped with BovineSNP50 BeadChip and haplotypes including 25 consecutive markers were constructed and tested for absence of homozygotes states. We have identified 17 homozygote deficient haplotypes which could be loosely clustered into eight genomic regions harboring possible recessive lethal alleles. Effects of the identified haplotypes were estimated on two fertility traits: non-return rates and calving interval. Out of the eight identified genomic regions, six regions were confirmed as having an effect on fertility. The information can be used to avoid carrier-by-carrier mattings in practical animal breeding. Further, identification of causative genes/polymorphisms responsible for lethal effects will lead to accurate testing of the individuals carrying a lethal allele.	[Sahana, Goutam; Lund, Mogens Sando; Guldbrandtsen, Bernt] Aarhus Univ, Dept Mol Biol & Genet, Ctr Quantitat Genet & Genom, Tjele, Denmark; [Nielsen, Ulrik Sander] Knowledge Ctr Agr, Aarhus, Denmark; [Aamand, Gert Pedersen] Nord Cattle Genet Evaluat, Aarhus, Denmark	Aarhus University	Sahana, G (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Ctr Quantitat Genet & Genom, Tjele, Denmark.	Goutam.Sahana@agrsci.dk	Sahana, Goutam/K-7613-2014; Lund, Mogens S/I-4321-2016; Sahana, Goutam/AAI-7579-2021	Sahana, Goutam/0000-0001-7608-7577; Sahana, Goutam/0000-0001-7608-7577; Aamand, Gert Pedersen/0000-0003-1885-3290	Danish Directorate for Food, Fisheries and Agri Business; VikingGenetics; Nordic Cattle Genetic Evaluation; Aarhus University;  [3412-08-02253];  [3401-04-00853]	Danish Directorate for Food, Fisheries and Agri Business; VikingGenetics; Nordic Cattle Genetic Evaluation; Aarhus University; ; 	This work was performed in the projects 'Genomic Selection from function to efficient utilization in cattle breeding' (grant no. 3412-08-02253), funded by the Danish Directorate for Food, Fisheries and Agri Business, VikingGenetics, Nordic Cattle Genetic Evaluation, and Aarhus University, and 'DNA based selection to improve disease resistance, fertility, calf survival and production in Danish cattle' (grant no. 3401-04-00853), funded by the Danish Directorate for Food, Fisheries and Agri Business. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2006, J VET DIAGN INVEST, V18, P418, DOI 10.1177/104063870601800421; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Charlier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043085; Fritz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065550; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; VanRaden PM, 2011, J DAIRY SCI, V94, P5673, DOI 10.3168/jds.2011-4500; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	8	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82909	10.1371/journal.pone.0082909	http://dx.doi.org/10.1371/journal.pone.0082909			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376603	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100071
J	Yang, Y; Takeda, A; Yoshimura, T; Oshima, Y; Sonoda, KH; Ishibashi, T				Yang, Yang; Takeda, Atsunobu; Yoshimura, Takeru; Oshima, Yuji; Sonoda, Koh-Hei; Ishibashi, Tatsuro			IL-10 Is Significantly Involved in HSP70-Regulation of Experimental Subretinal Fibrosis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; TUMOR-NECROSIS-FACTOR; IN-VITRO; HEAT-SHOCK-PROTEIN-70; EXPRESSION; HSP70; ACTIVATION; PATHWAY; INFLAMMATION; INDUCTION	Subretinal fibrosis is directly related to severe visual loss, especially if occurs in the macula, and is frequently observed in advanced age-related macular degeneration and other refractory eye disorders such as diabetic retinopathy and uveitis. In this study, we analyzed the immunosuppressive mechanism of subretinal fibrosis using the novel animal model recently demonstrated. Both TLR2 and TLR4 deficient mice showed significant enlargement of subretinal fibrotic area as compared with wild-type mice. A single intraocular administration of heat shock protein 70 (HSP70), which is an endogenous ligand for TLR2 and TLR4, inhibited subretinal fibrosis in wild-type mice but not in TLR2 and TLR4-deficient mice. Additionally, HSP70 induced IL-10 production in eyes from wild-type mice but was impaired in both TLR2- and TLR4-deficient mice, indicating that HSP70-TLR2/TLR4 axis plays an immunomodulatory role in subretinal fibrosis. Thus, these results suggest that HSP70-TLR2/TLR4 axis is a new therapeutic target for subretinal fibrosis due to prognostic CNV.	[Yang, Yang; Takeda, Atsunobu; Yoshimura, Takeru; Oshima, Yuji; Ishibashi, Tatsuro] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka 812, Japan; [Sonoda, Koh-Hei] Yamaguchi Univ, Sch Med, Dept Ophthalmol, Ube, Yamaguchi 755, Japan	Kyushu University; Yamaguchi University	Yoshimura, T (corresponding author), Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka 812, Japan.	takeruy@med.kyushu-u.ac.jp		Yoshimura, Takeru/0000-0002-5983-7193	Grants-in-Aid for Scientific Research [23689071] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Asea A, 2000, CELL STRESS CHAPERON, V5, P425, DOI 10.1379/1466-1268(2000)005<0425:HPBAPN>2.0.CO;2; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Bobryshev YV, 2002, J VASC SURG, V35, P368, DOI 10.1067/mva.2002.121067; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; De AK, 2000, J IMMUNOL, V165, P3951, DOI 10.4049/jimmunol.165.7.3951; Dybdahl B, 2002, CIRCULATION, V105, P685, DOI 10.1161/hc0602.103617; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Guzhova I, 2001, BRAIN RES, V914, P66, DOI 10.1016/S0006-8993(01)02774-3; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Jo YJ, 2011, INVEST OPHTH VIS SCI, V52, P6089, DOI 10.1167/iovs.10-5189; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Ludwig D, 1999, DIGEST DIS SCI, V44, P1440, DOI 10.1023/A:1026616221950; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Mansilla MJ, 2012, HEAT SHOCK PROTEIN 7; Matsumura N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039890; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miller JW, 2010, JPN J OPHTHALMOL, V54, P523, DOI 10.1007/s10384-010-0863-4; Missotten GS, 2003, INVEST OPHTH VIS SCI, V44, P3059, DOI 10.1167/iovs.02-1038; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Prakken BJ, 2001, J IMMUNOL, V167, P4147, DOI 10.4049/jimmunol.167.8.4147; Quintana FJ, 2005, J IMMUNOL, V175, P2777, DOI 10.4049/jimmunol.175.5.2777; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Satoh M, 2006, EUR J HEART FAIL, V8, P810, DOI 10.1016/j.ejheart.2006.03.004; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; SIMON MM, 1995, J CLIN INVEST, V95, P926, DOI 10.1172/JCI117800; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Sugita S, 2003, J EXP MED, V198, P161, DOI 10.1084/jem.20030097; Tanaka KI, 2010, BIOCHEM PHARMACOL, V80, P920, DOI 10.1016/j.bcp.2010.05.025; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Yoo BC, 1999, J NEURAL TRANSM-SUPP, P315; Zanin-Zhorov A, 2005, J IMMUNOL, V174, P3227, DOI 10.4049/jimmunol.174.6.3227; Zhou J, 2005, IMMUNOLOGY, V114, P522, DOI 10.1111/j.1365-2567.2004.02112.x	43	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e80288	10.1371/journal.pone.0080288	http://dx.doi.org/10.1371/journal.pone.0080288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376495	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100002
J	Duran, A; Meyer, ALS; Pie, MR				Duran, Andressa; Meyer, Andreas L. S.; Pie, Marcio R.			Climatic Niche Evolution in New World Monkeys (Platyrrhini)	PLOS ONE			English	Article							PHYLOGENETIC SIGNAL; ECOLOGICAL NICHES; CONSERVATISM; RADIATION; SPACE; SPP.; SIZE	Despite considerable interest in recent years on species distribution modeling and phylogenetic niche conservatism, little is known about the way in which climatic niches change over evolutionary time. This knowledge is of major importance to understand the mechanisms underlying limits of species distributions, as well as to infer how different lineages might be affected by anthropogenic climate change. In this study we investigate the tempo and mode climatic niche evolution in New World monkeys (Platyrrhini). Climatic conditions found throughout the distribution of 140 primate species were investigated using a principal component analysis, which indicated that mean temperature (particularly during the winter) is the most important climatic correlate of platyrrhine geographical distributions, accounting for nearly half of the interspecific variation in climatic niches. The effects of precipitation were associated with the second principal component, particularly with respect to the dry season. When models of trait evolution were fit to scores on each of the principal component axes, significant phylogenetic signal was detected for PC1 scores, but not for PC2 scores. Interestingly, although all platyrrhine families occupied comparable regions of climatic space, some aotid species such as Aotus lemurinus, A. jorgehernandezi, and A. miconax show highly distinctive climatic niches associated with drier conditions (high PC2 scores). This shift might have been made possible by their nocturnal habits, which could serve as an exaptation that allow them to be less constrained by humidity during the night. These results underscore the usefulness of investigating explicitly the tempo and mode of climatic niche evolution and its role in determining species distributions.	[Duran, Andressa; Meyer, Andreas L. S.; Pie, Marcio R.] Univ Fed Parana, Lab Dinam Evolut & Sistemas Complexos, Dept Zool, Ctr Politecn, BR-80060000 Curitiba, Parana, Brazil; [Meyer, Andreas L. S.; Pie, Marcio R.] Univ Fed Parana, Programa Posgrad Zool, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana	Pie, MR (corresponding author), Univ Fed Parana, Lab Dinam Evolut & Sistemas Complexos, Dept Zool, Ctr Politecn, BR-80060000 Curitiba, Parana, Brazil.	pie@ufpr.br	Meyer, Andreas L S/M-6301-2017	Meyer, Andreas L S/0000-0001-8870-5192; Duran, Andressa/0000-0003-4611-7557	CAPES (Ministry of Education - Brazilian Government); CNPq (Ministry of Science and Technology - Brazilian Government)	CAPES (Ministry of Education - Brazilian Government)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Ministry of Science and Technology - Brazilian Government)	This study was funded through a graduate scholarship to ALSM by CAPES (Ministry of Education - Brazilian Government) and a research fellowship by CNPq (Ministry of Science and Technology - Brazilian Government) to MRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bowler M, 2009, AM J PRIMATOL, V71, P976, DOI 10.1002/ajp.20740; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Cooper N, 2010, J EVOLUTION BIOL, V23, P2529, DOI 10.1111/j.1420-9101.2010.02144.x; Cooper N, 2011, P ROY SOC B-BIOL SCI, V278, P2384, DOI 10.1098/rspb.2010.2207; Dormann CF, 2010, BIOL LETTERS, V6, P229, DOI 10.1098/rsbl.2009.0688; ESRI, 2012, ARCGIS 9 3; Evans MEK, 2009, AM NAT, V173, P225, DOI 10.1086/595757; Fernandez-Duque E, 2001, AM J PRIMATOL, V53, P99, DOI 10.1002/1098-2345(200103)53:3<99::AID-AJP1>3.0.CO;2-N; Fernandez-Duque E., 2007, PRIMATES PERSPECTIVE, P139; Fleagle JG, 2006, DEV PRIMATOL, P375; Glor RE, 2011, EVOLUTION, V65, P673, DOI 10.1111/j.1558-5646.2010.01177.x; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Greene H. W., 1986, FIELDIANA ZOOLOGY, V31, P1; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harmon L, 2009, GEIGER ANAL EVOLUTIO; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof C, 2010, ECOGRAPHY, V33, P242, DOI 10.1111/j.1600-0587.2010.06309.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kamilar JM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0341; Kamilar JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011073; Lehman SM., 2006, PRIMATE BIOGEOGRAPHY; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lozier JD, 2009, J BIOGEOGR, V36, P1623, DOI 10.1111/j.1365-2699.2009.02152.x; Marroig G, 2005, EVOLUTION, V59, P1128; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; MASON WA, 1974, FOLIA PRIMATOL, V22, P1, DOI 10.1159/000155614; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olalla-Tarraga MA, 2011, J BIOGEOGR, V38, P2237, DOI 10.1111/j.1365-2699.2011.02570.x; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; PATTERSON B. D., 2007, DIGITAL DISTRIBUTION; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Perez DM, 2012, BIOL J LINN SOC, V106, P307, DOI 10.1111/j.1095-8312.2012.01860.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Pie MR, 2013, ECOL MODEL, V250, P165, DOI 10.1016/j.ecolmodel.2012.10.019; R Development Core Team, 2012, R LANG ENV STAT COMP; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Rosenberger Alfred L., 2009, P69, DOI 10.1007/978-0-387-78705-3_4; Rylands Anthony B., 2009, P23, DOI 10.1007/978-0-387-78705-3_2; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Strier KB, 1997, FOLIA PRIMATOL, V68, P120, DOI 10.1159/000157242; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2008, ECOL LETT, V11, P1004, DOI 10.1111/j.1461-0248.2008.01238.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wilkinson RD, 2010, SYST BIOL, V59, P1	56	23	23	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83684	10.1371/journal.pone.0083684	http://dx.doi.org/10.1371/journal.pone.0083684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376729	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000106
J	Fawcett, JA; Kado, T; Sasaki, E; Takuno, S; Yoshida, K; Sugino, RP; Kosugi, S; Natsume, S; Mitsuoka, C; Uemura, A; Takagi, H; Abe, A; Ishii, T; Terauchi, R; Innan, H				Fawcett, Jeffrey A.; Kado, Tomoyuki; Sasaki, Eriko; Takuno, Shohei; Yoshida, Kentaro; Sugino, Ryuichi P.; Kosugi, Shunichi; Natsume, Satoshi; Mitsuoka, Chikako; Uemura, Aiko; Takagi, Hiroki; Abe, Akira; Ishii, Takashige; Terauchi, Ryohei; Innan, Hideki			QTL Map Meets Population Genomics: An Application to Rice	PLOS ONE			English	Article							ORYZA-SATIVA; TRANSCRIPTION FACTORS; ARTIFICIAL SELECTION; GENETIC DIVERSITY; SSP JAPONICA; DOMESTICATION; EXPRESSION; REVEALS; POLYMORPHISM; ARABIDOPSIS	Genes involved in the transition from wild to cultivated crop species should be of great agronomic importance. Population genomic approaches utilizing genome resequencing data have been recently applied for this purpose, although it only reports a large list of candidate genes with no biological information. Here, by resequencing more than 30 genomes altogether of wild rice Oryza rufipogon and cultivated rice O. sativa, we identified a number of regions with clear footprints of selection during the domestication process. We then focused on identifying candidate domestication genes in these regions by utilizing the wealth of QTL information in rice. We were able to identify a number of interesting candidates such as transcription factors that should control key domestication traits such as shattering, awn length, and seed dormancy. Other candidates include those that might have been related to the improvement of grain quality and those that might have been involved in the local adaptation to dry conditions and colder environments. Our study shows that population genomic approaches and QTL mapping information can be used together to identify genes that might be of agronomic importance.	[Fawcett, Jeffrey A.; Kado, Tomoyuki; Sasaki, Eriko; Takuno, Shohei; Sugino, Ryuichi P.; Innan, Hideki] Grad Univ Adv Studies, Hayama, Kanagawa, Japan; [Yoshida, Kentaro; Kosugi, Shunichi; Natsume, Satoshi; Mitsuoka, Chikako; Uemura, Aiko; Takagi, Hiroki; Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Abe, Akira] Iwate Agr Res Ctr, Kitakami, Iwate 0240003, Japan; [Ishii, Takashige] Kobe Univ, Fac Agr, Kobe, Hyogo 657, Japan	Graduate University for Advanced Studies - Japan; Iwate Biotechnology Research Center; Kobe University	Terauchi, R (corresponding author), Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan.	terauchi@ibrc.or.jp; innan_hideki@soken.ac.jp	Ishii, Takashige/AAG-1486-2021; Terauchi, Ryohei/Y-2992-2019	Terauchi, Ryohei/0000-0002-0095-4651; Takuno, Shohei/0000-0001-9538-7487; Kosugi, Shunichi/0000-0002-5882-9255; Fawcett, Jeffrey/0000-0003-3907-2135; Yoshida, Kentaro/0000-0002-3614-1759; Innan, Hideki/0000-0001-6375-9231	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) from the Bio-oriented Technology Research Advancement Institution in Japan; Grants-in-Aid for Scientific Research [22510217] Funding Source: KAKEN	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) from the Bio-oriented Technology Research Advancement Institution in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) from the Bio-oriented Technology Research Advancement Institution in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Barrero JM, 2010, PLANT J, V61, P611, DOI 10.1111/j.1365-313X.2009.04088.x; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chapman MA, 2008, PLANT CELL, V20, P2931, DOI 10.1105/tpc.108.059808; Counce PA, 2006, CROP SCI, V46, P1501, DOI 10.2135/cropsci2005.0240; Doebley J, 1998, PLANT CELL, V10, P1075, DOI 10.1105/tpc.10.7.1075; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Falush D, 2003, GENETICS, V164, P1567; Fujino K, 2010, MOL GENET GENOMICS, V284, P137, DOI 10.1007/s00438-010-0555-2; Gao LZ, 2008, GENETICS, V179, P965, DOI 10.1534/genetics.106.068072; Gibbings JG, 2003, PLANT BIOTECHNOL J, V1, P271, DOI 10.1046/j.1467-7652.2003.00026.x; Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008; Han Long-Zhi, 2006, Acta Genetica Sinica, V33, P998, DOI 10.1016/S0379-4172(06)60135-2; Harris JC, 2011, NEW PHYTOL, V190, P823, DOI 10.1111/j.1469-8137.2011.03733.x; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Imbe T, 2004, SAKUMOTSU KENKYUJO K, V5, P35; Innan H, 2008, GENETICS, V179, P1713, DOI 10.1534/genetics.108.086835; Ishikawa R, 2010, GENES GENET SYST, V85, P265, DOI 10.1266/ggs.85.265; Izawa T, 2007, J EXP BOT, V58, P3091, DOI 10.1093/jxb/erm159; Izawa T, 2009, CURR OPIN PLANT BIOL, V12, P185, DOI 10.1016/j.pbi.2009.01.004; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Kim KN, 2003, PLANT MOL BIOL, V52, P1191, DOI 10.1023/B:PLAN.0000004330.62660.a2; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Malz S, 1999, PLANT MOL BIOL, V40, P985, DOI 10.1023/A:1006265528015; Matsumura H, 1999, PLANT J, V20, P719, DOI 10.1046/j.1365-313X.1999.00640.x; Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Ni JJ, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap005; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Oka H. I., 1988, Origin of cultivated rice.; OKA HI, 1967, EVOLUTION, V21, P249, DOI [10.2307/2406673, 10.1111/j.1558-5646.1967.tb00153.x]; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Rakshit S, 2007, THEOR APPL GENET, V114, P731, DOI 10.1007/s00122-006-0473-1; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Sakai H, 2011, GENOME BIOL EVOL, V3, P1357, DOI 10.1093/gbe/evr111; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; TAJIMA F, 1983, GENETICS, V105, P437; Takahashi Y, 2011, GENES GENET SYST, V86, P175, DOI 10.1266/ggs.86.175; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xiang Y, 2007, PLANT PHYSIOL, V144, P1416, DOI 10.1104/pp.107.101295; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yadav R, 1997, THEOR APPL GENET, V94, P619, DOI 10.1007/s001220050459; Youens-Clark K, 2011, NUCLEIC ACIDS RES, V39, pD1085, DOI 10.1093/nar/gkq1148; Zhou Y, 2012, PLANT CELL, V24, P1034, DOI 10.1105/tpc.111.094383	63	9	10	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83720	10.1371/journal.pone.0083720	http://dx.doi.org/10.1371/journal.pone.0083720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376738	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000110
J	Franks, B; Champagne, FA; Higgins, ET				Franks, Becca; Champagne, Frances A.; Higgins, E. Tory			How Enrichment Affects Exploration Trade-Offs in Rats: Implications for Welfare and Well-Being	PLOS ONE			English	Article							ANIMAL EMOTION; MOTIVATION; LIVES; STATE; MONEY	We propose that a comparative approach to well-being could be the key to understanding 'the good life.' Inspired by current theories of human well-being and animal welfare, we designed a novel test of exploration behavior. Environmentally and socially enriched Long-Evans female rats (N = 60) were trained in four simultaneously presented arms of an eight-arm radial-maze. They learned to expect successes in two arms and failures in the other two. After training, 20 animals remained in enriched housing (enrichment-maintenance) while 40 animals were re-housed in standard, isolated conditions (enrichment-removal). Two weeks later, all animals were re-tested in the maze, initially with access to the four familiar arms only. In the final minute, they also had access to the unfamiliar ambiguous-arms. Though both groups showed significant interest in the ambiguous-arms (P<.0001), the enrichment-maintenance group showed a significantly greater exploratory tendency (P<.01) despite having equivalent levels of activity (P>.3). Thus, we show not only that rats will abandon known rewards and incur risk in order to explore, indicating that exploration is valuable in its own right, but also that individuals with (vs. without) enriched housing conditions are more likely to engage in such exploratory behavior. This novel test contributes to the body of knowledge examining the importance of exploration in humans and other animals; implications for animal welfare and human well-being are discussed.	[Franks, Becca; Champagne, Frances A.; Higgins, E. Tory] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Columbia University	Franks, B (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	beccafranks@gmail.com	Champagne, Frances Anne/Q-1220-2018	Champagne, Frances Anne/0000-0002-3922-084X	Office of the Director, United States National Institutes of Health [DP2OD001674]; United States National Institute of Mental Health [39429]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001674] Funding Source: NIH RePORTER	Office of the Director, United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research reported in this paper was supported by Grant DP2OD001674 from the Office of the Director, United States National Institutes of Health, to Frances A. Champagne and Grant 39429 from the United States National Institute of Mental Health to E. Tory Higgins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateson M., 2007, ANIM WELF; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Bauer MA, 2012, PSYCHOL SCI, V23, P517, DOI 10.1177/0956797611429579; BERLYNE DE, 1966, SCIENCE, V153, P25, DOI 10.1126/science.153.3731.25; Burman OHP, 2008, BIOL LETTERS, V4, P330, DOI 10.1098/rsbl.2008.0113; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; D'Eath RB, 2009, ANIM BEHAV, V77, P275, DOI 10.1016/j.anbehav.2008.10.028; DAWKINS MS, 1990, BEHAV BRAIN SCI, V13, P1, DOI 10.1017/S0140525X00077104; Diener E, 2002, SOC INDIC RES, V57, P119, DOI 10.1023/A:1014411319119; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; Elmore MRP, 2012, J APPL ANIM WELF SCI, V15, P254, DOI 10.1080/10888705.2012.683982; Franks B, 2013, ZOO BIOL, V9, P1, DOI DOI 10.1002/Z00.21075; Franks B, 2012, J COMP PSYCHOL, V126, P347, DOI 10.1037/a0027244; Franks B, 2012, ADV EXP SOC PSYCHOL, V46, P285, DOI 10.1016/B978-0-12-394281-4.00006-4; Frattaroli J, 2006, PSYCHOL BULL, V132, P823, DOI 10.1037/0033-2909.132.6.823; Fredrickson BL, 2008, J PERS SOC PSYCHOL, V95, P1045, DOI 10.1037/a0013262; Fredrickson BL, 2013, ADV EXP SOC PSYCHOL, V47, P1, DOI 10.1016/B978-0-12-407236-7.00001-2; Hagen K, 2004, APPL ANIM BEHAV SCI, V85, P203, DOI 10.1016/j.applanim.2003.11.007; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; HARLOW HF, 1950, J EXP PSYCHOL, V40, P228, DOI 10.1037/h0056906; Higgins E. T., 2012, PLEASURE PAIN MOTIVA; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; KASSER T, 1993, J PERS SOC PSYCHOL, V65, P410, DOI 10.1037/0022-3514.65.2.410; Langbein J, 2009, APPL ANIM BEHAV SCI, V120, P150, DOI 10.1016/j.applanim.2009.07.006; Latham N, 2010, BEHAV BRAIN RES, V211, P96, DOI 10.1016/j.bbr.2010.03.018; Mason GJ, 2001, NATURE, V410, P35, DOI 10.1038/35065157; Meehan CL, 2007, APPL ANIM BEHAV SCI, V102, P246, DOI 10.1016/j.applanim.2006.05.031; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Patterson-Kane EG, 2004, ANIM WELFARE, V13, pS209; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Sorensen DB, 2004, ANIM WELFARE, V13, P193; Spinka M, 2011, ANIMAL WELFARE; Watters JV, 2009, ZOO BIOL, V28, P609, DOI 10.1002/zoo.20284; Weiss A, 2011, BIOL LETTERS, V7, P872, DOI 10.1098/rsbl.2011.0543; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358	36	27	27	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83578	10.1371/journal.pone.0083578	http://dx.doi.org/10.1371/journal.pone.0083578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376721	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000099
J	Franzoni, G; Kurkure, NV; Essler, SE; Pedrera, M; Everett, HE; Bodman-Smith, KB; Crooke, HR; Graham, SP				Franzoni, Giulia; Kurkure, Nitin V.; Essler, Sabine E.; Pedrera, Miriam; Everett, Helen E.; Bodman-Smith, Kikki B.; Crooke, Helen R.; Graham, Simon P.			Proteome-Wide Screening Reveals Immunodominance in the CD8 T Cell Response against Classical Swine Fever Virus with Antigen-Specificity Dependent on MHC Class I Haplotype Expression	PLOS ONE			English	Article							ESCAPE MUTATION; DENGUE VIRUS; IDENTIFICATION; PROTECTION; LYMPHOCYTES; EPITOPES; CSFV; VACCINATION; PROTEINS; VACCINES	Vaccination with live attenuated classical swine fever virus (CSFV) vaccines induces a rapid onset of protection which has been associated with virus-specific CD8 T cell IFN-gamma responses. In this study, we assessed the specificity of this response, by screening a peptide library spanning the CSFV C-strain vaccine polyprotein to identify and characterise CD8 T cell epitopes. Synthetic peptides were pooled to represent each of the 12 CSFV proteins and used to stimulate PBMC from four pigs rendered immune to CSFV by C-strain vaccination and subsequently challenged with the virulent Brescia strain. Significant IFN-gamma expression by CD8 T cells, assessed by flow cytometry, was induced by peptide pools representing the core, E2, NS2, NS3 and NS5A proteins. Dissection of these antigenic peptide pools indicated that, in each instance, a single discrete antigenic peptide or pair of overlapping peptides was responsible for the IFN-gamma induction. Screening and titration of antigenic peptides or truncated derivatives identified the following antigenic regions: core(241-255) PESRKKLEKALLAWA and NS3(1902-1912) VEYSFIFLDEY, or minimal length antigenic peptides: E2(996-1003) YEPRDSYF, NS2(1223-1230) STVTGIFL and NS5A(3070-3078) RVDNALLKF. The epitopes are highly conserved across CSFV strains and variable sequence divergence was observed with related pestiviruses. Characterisation of epitope-specific CD8 T cells revealed evidence of cytotoxicity, as determined by CD107a mobilisation, and a significant proportion expressed TNF-alpha in addition to IFN-gamma. Finally, the variability in the antigen-specificity of these immunodominant CD8 T cell responses was confirmed to be associated with expression of distinct MHC class I haplotypes. Moreover, recognition of NS2(1223-1230) STVTGIFL and NS3(1902-1912) VEYSFIFLDEY by a larger group of C-strain vaccinated animals showed that these peptides could be restricted by additional haplotypes. Thus the antigenic regions and epitopes identified represent attractive targets for evaluation of their vaccine potential against CSFV.	[Franzoni, Giulia; Kurkure, Nitin V.; Pedrera, Miriam; Everett, Helen E.; Crooke, Helen R.; Graham, Simon P.] Anim Hlth & Vet Labs, Dept Virol, Addlestone, Surrey, England; [Franzoni, Giulia; Bodman-Smith, Kikki B.] Univ Surrey, Dept Microbial & Cellular Sci, Guildford GU2 5XH, Surrey, England; [Kurkure, Nitin V.] Maharashtra Anim & Fishery Sci Univ, Nagpur Vet Coll, Nagpur, Maharashtra, India; [Essler, Sabine E.] Univ Vet Med Vienna, Dept Pathobiol, Vienna, Austria	University of Surrey; Maharashtra Animal & Fishery Sciences University; Nagpur Veterinary College; University of Veterinary Medicine Vienna	Graham, SP (corresponding author), Anim Hlth & Vet Labs, Dept Virol, Addlestone, Surrey, England.	Simon.Graham@ahvla.gsi.gov.uk	Franzoni, Giulia/AAY-1088-2020; Crooke, Helen/D-6710-2011; Everett, Helen E/D-7123-2011; Graham, Simon P/C-8337-2011	Franzoni, Giulia/0000-0003-0987-3863; Graham, Simon P/0000-0003-4852-405X; Pedrera, Miriam/0000-0003-4868-6630; Crooke, Helen/0000-0003-1237-6542; Everett, Helen/0000-0002-1233-4265	Department for Environment, Food and Rural Affairs of the United Kingdom [SE0796]; Ministry of Science & Technology, Government of India; Alfonso Martin Escudero Foundation, Spain	Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Ministry of Science & Technology, Government of India; Alfonso Martin Escudero Foundation, Spain	This study was supported by project (SE0796) from the Department for Environment, Food and Rural Affairs of the United Kingdom. Dr. Nitin V. Kurkure's contribution to the study was facilitated by a DBT CREST Award from the Ministry of Science & Technology, Government of India. Dr. Miriam Pedrera's contribution was supported by a Research Grant for Foreign Universities or Research Centres 2011 from the Alfonso Martin Escudero Foundation, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AHVLA has no commercial connection with the manufacturer of the vaccine used in this study, Riemser Arzneimittel AG, Germany.	Ammaranond P, 2005, AIDS RES HUM RETROV, V21, P395, DOI 10.1089/aid.2005.21.395; Armengol E, 2002, J GEN VIROL, V83, P551, DOI 10.1099/0022-1317-83-3-551; Beer M, 2007, VACCINE, V25, P5665, DOI 10.1016/j.vaccine.2006.12.036; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Ceppi M, 2005, J GEN VIROL, V86, P2525, DOI 10.1099/vir.0.80907-0; Chen WS, 2006, ADV CANCER RES, V95, P203, DOI 10.1016/S0065-230X(06)95006-4; Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685; Drew TW, 2008, OIE MANUAL DIAGNOSTI, V2.6, P1092; Essler SE, 2013, ANIM GENET, V44, P202, DOI 10.1111/j.1365-2052.2012.02375.x; Everett H, 2010, VET MICROBIOL, V142, P26, DOI 10.1016/j.vetmic.2009.09.039; Franzoni G, 2013, CLIN VACCINE IMMUNOL, V20, P1604, DOI 10.1128/CVI.00415-13; Gao GP, 2008, HUM GENE THER, V19, P927, DOI 10.1089/hum.2008.011; Gerner W, 2009, DEV COMP IMMUNOL, V33, P310, DOI 10.1016/j.dci.2008.06.003; Graham SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029310; Graham SP, 2012, VACCINE, V30, P2742, DOI 10.1016/j.vaccine.2012.02.029; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Koenig P, 2007, VACCINE, V25, P3391, DOI 10.1016/j.vaccine.2006.12.052; Kuhs KAL, 2012, MOL THER, V20, P669, DOI 10.1038/mt.2011.188; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Lunney JK, 2009, DEV COMP IMMUNOL, V33, P362, DOI 10.1016/j.dci.2008.07.002; Mikkelsen M, 2011, J IMMUNOL, V186, P2355, DOI 10.4049/jimmunol.1001877; Moennig V, 2000, VET MICROBIOL, V73, P93, DOI 10.1016/S0378-1135(00)00137-1; Monso M, 2011, J PEPT SCI, V17, P24, DOI 10.1002/psc.1292; Oukka M, 1996, J IMMUNOL, V157, P3039; Parchariyanon S, 2000, DEUT TIERARZTL WOCH, V107, P236; Patch JR, 2011, CLIN VACCINE IMMUNOL, V18, P280, DOI 10.1128/CVI.00417-10; PAULY T, 1995, J GEN VIROL, V76, P3039, DOI 10.1099/0022-1317-76-12-3039; Pedersen LE, 2013, ANIM GENET, V44, P251, DOI 10.1111/j.1365-2052.2012.02400.x; Rau H, 2006, VET RES, V37, P155, DOI 10.1051/vetres:2005049; Renson P, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-9; Reutner K, 2012, DEV COMP IMMUNOL, V38, P321, DOI 10.1016/j.dci.2012.06.011; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; Sandvik T, 2000, VET REC, V147, P251; Schlaphoff V, 2007, VACCINE, V25, P6793, DOI 10.1016/j.vaccine.2007.06.026; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Suradhat S, 2005, VET IMMUNOL IMMUNOP, V106, P197, DOI 10.1016/j.vetimm.2005.02.017; Tarradas J, 2010, VET MICROBIOL, V142, P51, DOI 10.1016/j.vetmic.2009.09.043; Tarradas J, 2012, VET IMMUNOL IMMUNOP, V150, P36, DOI 10.1016/j.vetimm.2012.08.006; THIEL HJ, 1991, J VIROL, V65, P4705, DOI 10.1128/JVI.65.9.4705-4712.1991; Tian J, 2012, INT IMMUNOL, V24, P207, DOI 10.1093/intimm/dxr115; Toledo JR, 2010, VACCINE, V28, P7907, DOI 10.1016/j.vaccine.2010.09.073; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432; Whelan AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029194; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	46	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84246	10.1371/journal.pone.0084246	http://dx.doi.org/10.1371/journal.pone.0084246			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376799	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000144
J	Meynard, D; Sun, CC; Wu, QF; Chen, WJ; Chen, SZ; Nelson, CN; Waters, MJ; Babitt, JL; Lin, HY				Meynard, Delphine; Sun, Chia Chi; Wu, Qifang; Chen, Wenjie; Chen, Shanzhuo; Nelson, Caroline N.; Waters, Michael J.; Babitt, Jodie L.; Lin, Herbert Y.			Inflammation Regulates TMPRSS6 Expression via STAT5	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; MATRIPTASE-2 TMPRSS6; HEPCIDIN; BINDING; CELLS; FERROPORTIN; PROTEINS; PROMOTER; BMP6	TMPRSS6 is a regulated gene, with a crucial role in the regulation of iron homeostasis by inhibiting hepcidin expression. The main regulator of iron homeostasis, the antimicrobial peptide hepcidin, which also has a role in immunity, is directly upregulated by inflammation. In this study, we analyzed whether inflammation is also a modulator of TMPRSS6 expression in vitro and in vivo and we determined the mechanism of this regulation A Human Hepatoma cell line was treated with interleukin-6 and mice were injected with lipopolysaccharide and TMPRSS6 expression and the regulatory mechanism were addressed. In this study, we demonstrate that inflammation downregulates TMPRSS6 expression in vitro and in vivo. The downregulation of Tmprss6 by inflammation in mice is not dependent on the Bmp-Smad pathway but occurs through a decrease in Stat5 phosphorylation. Moreover, Stat5 positively regulates Tmprss6 expression directly by binding to a Stat5 element located on the Tmprss6 promoter. Importantly, our results highlight the functional role of inflammatory modulation of TMPRSS6 expression in the regulation of hepcidin. TMPRSS6 inhibition via decreased STAT5 phosphorylation may be an additional mechanism by which inflammation stimulates hepcidin expression to regulate iron homeostasis and immunity.	[Meynard, Delphine; Sun, Chia Chi; Wu, Qifang; Chen, Wenjie; Chen, Shanzhuo; Babitt, Jodie L.; Lin, Herbert Y.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Membrane Biol, Program Anemia Signaling Res,Div Nephrol,Ctr Syst, Boston, MA 02115 USA; [Nelson, Caroline N.; Waters, Michael J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Queensland	Meynard, D (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Membrane Biol, Program Anemia Signaling Res,Div Nephrol,Ctr Syst, Boston, MA 02115 USA.	meynard-sautet.delphine@mgh.harvard.edu; Lin.Herbert@mgh.harvard.edu	meynard, delphine/B-4236-2014; waters, michael j/C-9582-2014	meynard, delphine/0000-0002-9927-5535; 	MGH Fund for Medical Discovery; National Institutes of Health (NIH) [RO1 DK087727]; Massachusetts General Hospital; NIH [RO1 DK-069533, RO1 DK-071837]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069533, R01DK087727, R01DK071837] Funding Source: NIH RePORTER	MGH Fund for Medical Discovery; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital(General Electric); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	DM was supported by a Postdoctoral Fellowship Award from the MGH Fund for Medical Discovery, JLB was supported in part by National Institutes of Health (NIH) grant RO1 DK087727, and by Claflin Distinguished Scholar and Howard Goodman Fellowship Awards from the Massachusetts General Hospital. HYL was supported in part by NIH grants RO1 DK-069533 and RO1 DK-071837. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Casanovas G, 2009, J MOL MED, V87, P471, DOI 10.1007/s00109-009-0447-2; De Domenico I, 2010, J CLIN INVEST, V120, P2395, DOI 10.1172/JCI42011; Deschemin JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061050; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Grigorov I, 2001, MOL BIOL REP, V28, P217, DOI 10.1023/A:1015749109119; Kerenyi MA, 2008, BLOOD, V112, P3878, DOI 10.1182/blood-2008-02-138339; Maurer E, 2012, BIOL CHEM, V393, P535, DOI 10.1515/hsz-2011-0221; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nai A, 2012, BLOOD; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Peng H, 2010, BRIT J HAEMATOL, V151, P106, DOI 10.1111/j.1365-2141.2010.08306.x; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Sasaki Y, 2012, INT J HEMATOL, V96, P692, DOI 10.1007/s12185-012-1217-4; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Sun CC, 2012, AM J HEMATOL, V87, P392, DOI 10.1002/ajh.23110; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Zhang AS, 2010, BLOOD	27	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82127	10.1371/journal.pone.0082127	http://dx.doi.org/10.1371/journal.pone.0082127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376517	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000007
J	Townsend, KN; Spowart, JE; Huwait, H; Eshragh, S; West, NR; Elrick, MA; Kalloger, SE; Anglesio, M; Watson, PH; Huntsman, DG; Lum, JJ				Townsend, Katelin N.; Spowart, Jaeline E.; Huwait, Hassan; Eshragh, Sima; West, Nathan R.; Elrick, Mary A.; Kalloger, Steve E.; Anglesio, Michael; Watson, Peter H.; Huntsman, David G.; Lum, Julian J.			Markers of T Cell Infiltration and Function Associate with Favorable Outcome in Vascularized High-Grade Serous Ovarian Carcinoma	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PROGNOSTIC-SIGNIFICANCE; CANCER; STAGE; LYMPHOCYTES; EXPRESSION; INDUCTION; RELEVANCE; PHENOTYPE; AUTOPHAGY	Background: When T cells infiltrate the tumor environment they encounter a myriad of metabolic stressors including hypoxia. Overcoming the limitations imposed by an inadequate tumor vasculature that contributes to these stressors may be a crucial step to immune cells mounting an effective anti-tumor response. We sought to determine whether the functional capacity of tumor infiltrating lymphocytes (TIL) could be influenced by the tumor vasculature and correlated this with survival in patients with ovarian cancer. Methodology and Principal Findings: In 196 high-grade serous ovarian tumors, we confirmed that the tumor vascularity as measured by the marker CD31 was associated with improved patient disease-specific survival. We also found that tumors positive for markers of TIL (CD8, CD4 and forkhead box P3 (FoxP3)) and T cell function (granzyme B and T-cell restricted intracellular antigen-1 (TIA-1)) correlated significantly with elevated vascularity. In vitro, hypoxic CD8 T cells showed reduced cytolytic activity, secreted less effector cytokines and upregulated autophagy. Survival analysis revealed that patients had a significant improvement in disease-specific survival when FoxP3 expressing cells were present in CD31-high tumors compared to patients with FoxP3 expressing cells in CD31-low tumors [HR: 2.314 (95% CI 1.049-5.106); p = 0.0377]. Patients with high vascular endothelial growth factor (VEGF) expressing tumors containing granzyme B positive cells had improved survival compared to patients with granzyme B positive cells in VEGF-low tumors [HR: 2.522 (95% CI 1.097-5.799); p = 0.0294]. Significance: Overall, this data provides a rationale for developing strategies aimed at improving the adaptability and function of TIL to hypoxic tumor conditions.	[Townsend, Katelin N.; Spowart, Jaeline E.; West, Nathan R.; Elrick, Mary A.; Watson, Peter H.; Lum, Julian J.] British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada; [Townsend, Katelin N.; Spowart, Jaeline E.; West, Nathan R.; Watson, Peter H.; Lum, Julian J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Huwait, Hassan] Vancouver Gen Hosp, Vancouver, BC, Canada; [Eshragh, Sima; Kalloger, Steve E.; Anglesio, Michael; Watson, Peter H.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Elrick, Mary A.; Lum, Julian J.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Huntsman, David G.] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada	British Columbia Cancer Agency; University of Victoria; University of British Columbia; University of British Columbia; University of Victoria; British Columbia Cancer Agency	Lum, JJ (corresponding author), British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada.	jjlum@bccancer.bc.ca	Huntsman, David/ABE-6082-2020	Anglesio, Michael/0000-0003-1639-5003; Watson, Peter/0000-0002-1642-0638; Lum, Julian/0000-0002-5624-3541; West, Nathaniel/0000-0001-9991-0503; Huwait, Hassan/0000-0002-0336-7639	Canadian Institutes of Health Research [MSH191375, MOP201945]; Ovarian Cancer Canada (Teal Heart Scholarship); University of Victoria; British Columbia Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ovarian Cancer Canada (Teal Heart Scholarship); University of Victoria; British Columbia Cancer Foundation	This study was funded by the Canadian Institutes of Health Research (MSH191375, MOP201945), Ovarian Cancer Canada (Teal Heart Scholarship), the University of Victoria (Graduate Fellowship and two Graduate Awards), and the British Columbia Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2008, BLOOD, V112, P4953, DOI 10.1182/blood-2008-06-163048; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Clarke B, 2009, MODERN PATHOL, V22, P393, DOI 10.1038/modpathol.2008.191; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Daponte A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-335; DeLisser HM, 1997, TRENDS CARDIOVAS MED, V7, P203, DOI 10.1016/S1050-1738(97)00049-2; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Hemdan NYA, 2013, IMMUNOL LETT, V149, P123, DOI 10.1016/j.imlet.2012.11.002; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Kaanders JHAM, 2002, CANCER RES, V62, P7066; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Li XF, 2007, CANCER RES, V67, P7646, DOI 10.1158/0008-5472.CAN-06-4353; Lukashev D, 2006, J IMMUNOL, V177, P4962, DOI 10.4049/jimmunol.177.8.4962; Mackay HJ, 2010, INT J GYNECOL CANCER, V20, P945, DOI 10.1111/IGC.0b013e3181dd0110; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Nadkarni NJ, 2013, CANCER LETT, V331, P99, DOI 10.1016/j.canlet.2012.12.016; Noman MZ, 2009, J IMMUNOL, V182, P3510, DOI 10.4049/jimmunol.0800854; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Prat J, 2012, VIRCHOWS ARCH, V460, P237, DOI 10.1007/s00428-012-1203-5; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schlie Katrin, 2011, Int J Cell Biol, V2011, P470597, DOI 10.1155/2011/470597; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Spowart JE, 2012, J PATHOL, V228, P437, DOI 10.1002/path.4090; VANDIEST PJ, 1995, PATHOL RES PRACT, V191, P25, DOI 10.1016/S0344-0338(11)80918-0; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524; Woo EY, 2001, CANCER RES, V61, P4766; Yang MX, 2009, IMMUNOLOGY, V128, pe237, DOI 10.1111/j.1365-2567.2008.02954.x; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhao D, 2003, NEOPLASIA, V5, P308, DOI 10.1016/S1476-5586(03)80024-6	45	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82406	10.1371/journal.pone.0082406	http://dx.doi.org/10.1371/journal.pone.0082406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376535	Green Submitted, gold, Green Published			2022-12-27	WOS:000328882000011
J	Chen, J; Liao, YX; Li, ZT; Tian, Y; Yang, SS; He, C; Tu, DH; Sun, XY				Chen, Juan; Liao, Yixing; Li, Zhuoting; Tian, Ye; Yang, Shuaishuai; He, Chao; Tu, Dahong; Sun, Xinying			Determinants of Salt-Restriction-Spoon Using Behavior in China: Application of the Health Belief Model	PLOS ONE			English	Article							REDUCED DIETARY-SODIUM; BLOOD-PRESSURE; HYPERTENSION; METAANALYSIS; REDUCTION; ADVICE	Background: The two-gram salt-restriction-spoons, which can be used to reduce the salt intake of people, had been handed out for free by the Chinese government to the citizens several years ago, but only a small fraction of residents use such a spoon currently. Since no studies have been conducted to investigate relevant influencing factors, this study was designed to explore the determinants of salt-restriction-spoon using behavior (SRB) in China. Methods: This cross-sectional study was conducted in Beijing, China. Altogether 269 rural residents and 244 urban residents aged over 18 were selected by convenience sampling method in 2012. Variables measured in a questionnaire designed according to the Health Belief Model (HBM) included socio-demographics, perceived susceptibility, perceived severity, perceived benefits, perceived objective barriers, perceived subjective barriers, self-efficacy, knowledge of hypertension, cues to action, and SRB. Answers to the questionnaire were obtained from all the participants, and 24-hour urine samples were collected to determine the 24-hour urinary sodium excretion (24HUNa). Path analyses were used to explore the determinants of SRB. Results: Approximately 22.7% and 45.3% of residents used a salt-restriction-spoon everyday in the rural and urban areas, respectively. The average 24HUNa was 211.19 +/- 98.39 mmol for rural residents and 109.22 +/- 58.18 mmol for urban residents. Path analyses shown that perceived objective barriers, perceived benefits, perceived severity, knowledge and age were related to SRB and 24HUNa for both rural and urban participants, among which perceived objective barrier (beta = - 0.442 and beta = - 0.543, respectively) was the most important determinant. Conclusion: Improvement of the current salt-restriction-spoon and education on the right usage of the salt-restriction-spoon, the severity of hypertension, and the benefit of salt reduction are necessary, especially among those who are relatively young but at risk of hypertension, those who have lower education levels, and those who live in the rural areas.	[Chen, Juan; Liao, Yixing; Yang, Shuaishuai; Sun, Xinying] Peking Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China; [Li, Zhuoting] Peking Union Med Coll Hosp, VIP Med Serv Dept, Beijing, Peoples R China; [Tian, Ye] Peking Univ, Sch Publ Hlth, China Ctr Hlth Dev Studies, Beijing 100871, Peoples R China; [He, Chao] Shun Yi Ctr Dis Prevent & Control, Dept Hlth Educ, Beijing, Peoples R China; [Tu, Dahong] Beijing Shijitan Hosp, Community Med Ctr, Beijing, Peoples R China	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking University	Sun, XY (corresponding author), Peking Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China.	xysun@bjmu.edu.cn		Sun, Xinying/0000-0001-6638-1473	National Natural Science Foundation of China [81102176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (Project No. 81102176). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 2011, CHIN J HYPERTENS; Boylan S, 2012, OBES REV, V13, P606, DOI 10.1111/j.1467-789X.2012.00989.x; Center for Disease Control and Prevention, 2012, MON REP CHRON DIS RE; EVERS SE, 1987, PREV MED, V16, P213, DOI 10.1016/0091-7435(87)90085-5; Guansheng L, 2005, J SHANDONG U TECHNOL, V21, P55; HARRISON JA, 1992, HEALTH EDUC RES, V7, P107, DOI 10.1093/her/7.1.107; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jun Y, 2007, CHIN J PHM, V23, P542; Kapsak WR, 2011, J AM DIET ASSOC, V111, P804, DOI 10.1016/j.jada.2011.04.003; Kewen M, 2010, KABP INVESTIGATION R, P125; Kline RB, 2005, PRINCIPLES PRACTICE; Lee JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027236; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Li YQ., 2008, CHINESE J HLTH ED, V24, P501; Macedo TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058635; MACGREGOR GA, 1987, BMJ-BRIT MED J, V294, P531, DOI 10.1136/bmj.294.6571.531; McManus RJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e181; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; Neyses L, 1985, J Hypertens Suppl, V3, pS87; NUGENT CA, 1984, ARCH INTERN MED, V144, P1415, DOI 10.1001/archinte.144.7.1415; Ohta Y, 2004, HYPERTENS RES, V27, P243, DOI 10.1291/hypres.27.243; Qi Y, 2010, MED INFORM, P341; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Sheng J, 2011, TOO FEW PEOPLE USE S; Sun XY, 2006, J NUTR EDUC BEHAV, V38, P276, DOI [10.1016/j.jneb.2006.04.144, 10.1016/J.JNEB.2006.04.144]; Vassallo M, 2009, APPETITE, V52, P452, DOI 10.1016/j.appet.2008.12.008; Wenlan D, 2011, CHINESE J PREVENTIVE, V10, P952; WHO, 2012, GUID SOD INT AD CHIL; Wrobel MJ, 2011, J AM SOC HYPERTENS, V5, P208, DOI 10.1016/j.jash.2011.05.003; Yuqing L, 2008, CHINESE J HLTH ED, V5, P345	35	11	12	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83262	10.1371/journal.pone.0083262	http://dx.doi.org/10.1371/journal.pone.0083262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376675	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100104
J	Gedefaw, A; Astatkie, A; Tessema, GA				Gedefaw, Abel; Astatkie, Ayalew; Tessema, Gizachew Assefa			The Prevalence of Precancerous Cervical Cancer Lesion among HIV-Infected Women in Southern Ethiopia: A Cross-Sectional Study	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS; RISK-FACTORS; AFRICA; PREVENTION; ACCURACY; DIAGNOSIS; NEOPLASIA; PROGRAMS	Introduction: The magnitude of precancerous cervical cancer lesions as well as invasive cervical cancer is higher in HIV-infected women than non HIV-infected women. Thus, screening targeting HIV-infected women is being undertaken in developing countries, including Ethiopia. However, data on the prevalence and determinants of precancerous cervical cancer lesion among HIV-infected women in southern Ethiopia is lacking. Thus, this study aimed to assess the prevalence of and factors associated with precancerous cervical cancer lesion among HIV-infected women in southern Ethiopia. Methods: A hospital-based cross-sectional study was conducted from October 2012 to February 2013 among HIV-infected women in Southern Ethiopia. Four hundred forty eight HIV-infected women who had been screened and treated for precancerous cervical cancer lesion were included in the study. Data were collected by using structured and pretested questionnaire. Visual inspection with acetic acid was applied for screening and treatment. SPSS version 16.0 was used for data entry and analysis. Logistic regression analysis was fitted and odds ratios with 95% Confidence intervals and p-values were computed to identify factors associated with precancerous cervical cancer lesion. Results: Out of 448 study participants, 99 (22.1%) were found to be positive for precancerous cervical cancer. Being currently on highly active antiretroviral treatment (AOR=0.52, 95%CI: 0.35, 0.92), history of sexually transmitted disease (AOR=2.30, 95%CI: 1.23, 4.29) and having only one lifetime sexual partner (AOR=0.33, 95%CI: 0.20, 0.56) were factors associated with precancerous cervical cancer lesion. Conclusions: The prevalence of precancerous cervical cancer lesion among HIV-infected women in southern Ethiopia was found to be high. Intervention to access all HIV-infected women like scaling up the limited services and awareness creation should be undertaken. Measures aimed at preventing the acquisition and transmission of sexually transmitted diseases and reducing the number of sexual partners are required. Besides, early initiation of highly active antiretroviral treatment is important.	[Gedefaw, Abel] Hawassa Univ, Coll Med & Hlth Sci, Dept Gynecol & Obstet, Hawassa, Ethiopia; [Astatkie, Ayalew] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ & Environm Hlth, Hawassa, Ethiopia; [Tessema, Gizachew Assefa] Univ Gondar, Inst Publ Hlth, Dept Reprod Hlth, Gondar, Ethiopia	Hawassa University; Hawassa University; University of Gondar	Gedefaw, A (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Dept Gynecol & Obstet, Hawassa, Ethiopia.	abel.gedefaw@yahoo.com	Astatkie, Ayalew/I-1167-2019; Tessema, Gizachew A/J-9235-2018	Astatkie, Ayalew/0000-0002-4840-9601; Tessema, Gizachew A/0000-0002-4784-8151	Hawassa University College of Medicine and Health Sciences	Hawassa University College of Medicine and Health Sciences	Hawassa University College of Medicine and Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1994, CANCER-AM CANCER SOC, V73, P140, DOI 10.1002/1097-0142(19940101)73:1<140::AID-CNCR2820730124>3.0.CO;2-2; Alemayehu Y, 2008, CANC THREAT EHIOPIA; Anderson J, 2011, P 18 C RETR OPP INF; Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Bekele L, 2000, EVALUATION SEROLOGIC; Biggar RJ, 2007, J NATL CANCER I, V99, P962, DOI 10.1093/jnci/djm010; Blossom DB, 2007, J MED VIROL, V79, P758, DOI 10.1002/jmv.20817; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; CSA [Ethiopia] and ICF International, 2012, ETH DEM HLTH SURV RE; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; Denny L, 2006, VACCINE, V24, P71, DOI 10.1016/j.vaccine.2006.05.121; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Federal Democratic Republic of Ethiopia Population census commission and UNFPA, 2008, SUMM STAT REP 2007; Ferlay J., 2010, IARC CANC BASE; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Gaffikin L, 1999, LANCET, V353, P869; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Getahun F, 2013, BMC CANCER, V13, P1471; Heard I, 1998, AIDS, V12, P1459, DOI 10.1097/00002030-199812000-00007; International Agency for Research on Cancer (IARC) World Health Organisation (WHO), 2005, CERV CANC SCREEN, V10; Kapiga SH, 1999, INT J GYNECOL OBSTET, V67, P87, DOI 10.1016/S0020-7292(99)00125-3; La Ruche G, 1999, J CLIN EPIDEMIOL, V52, P953, DOI 10.1016/S0895-4356(99)00081-5; Leroy V, 1999, SEX TRANSM INFECT, V75, P103, DOI 10.1136/sti.75.2.103; Mbulaiteye SM, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-16; Memiah P, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/953743; Moodley JR, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-275; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Mwanahamuntu MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001032; Ononogbu U, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-582; Parham GP, 2006, GYNECOL ONCOL, V103, P1017, DOI 10.1016/j.ygyno.2006.06.015; Ramachandran S, 2007, 24 INT PAP C BEIJ CH; Ramogola-Masire D, 2012, JAIDS-J ACQ IMM DEF, V59, P308, DOI 10.1097/QAI.0b013e3182426227; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Sasco AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008621; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Villa LL, 2006, INT J GYNECOL OBSTET, V94, pS71, DOI 10.1016/S0020-7292(07)60013-7; Waktola EA, 2005, GYNECOL ONCOL, V99, pS201, DOI 10.1016/j.ygyno.2005.07.083; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WHO/ICO, 2010, ETH HUM PAP REL CANC; WHO/ICO, 2009, HUM PAP VIR REL CANC; Wittet S, 2008, B WORLD HEALTH ORGAN, V86, P488, DOI 10.2471/BLT.07.050450	44	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84519	10.1371/journal.pone.0084519	http://dx.doi.org/10.1371/journal.pone.0084519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376818	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100170
J	Gibbons, CJ; Kenning, C; Coventry, PA; Bee, P; Bundy, C; Fisher, L; Bower, P				Gibbons, Chris J.; Kenning, Cassandra; Coventry, Peter A.; Bee, Penny; Bundy, Christine; Fisher, Louise; Bower, Peter			Development of a Multimorbidity Illness Perceptions Scale (MULTIPIeS)	PLOS ONE			English	Article							COMMON-SENSE MODEL; HOSPITAL ANXIETY; DEPRESSION; CARE; INTERVENTIONS; PREVALENCE; MANAGEMENT; PEOPLE; EDUCATION	Background: Illness perceptions are beliefs about the cause, nature and management of illness, which enable patients to make sense of their conditions. These perceptions can predict adjustment and quality of life in patients with single conditions. However, multimorbidity (i.e. patients with multiple long-term conditions) is increasingly prevalent and a key challenge for future health care delivery. The objective of this research was to develop a valid and reliable measure of illness perceptions for multimorbid patients. Methods: Candidate items were derived from previous qualitative research with multimorbid patients. Questionnaires were posted to 1500 patients with two or more exemplar long-term conditions (depression, diabetes, osteoarthritis, coronary heart disease and chronic obstructive pulmonary disease). Data were analysed using factor analysis and Rasch analysis. Rasch analysis is a modern psychometric technique for deriving unidimensional and intervally-scaled questionnaires. Results: Questionnaires from 490 eligible patients (32.6% response) were returned. Exploratory factor analysis revealed five potential subscales 'Emotional representations', 'Treatment burden', 'Prioritising conditions', 'Causal links' and 'Activity limitations'. Rasch analysis led to further item reduction and the generation of a summary scale comprising of items from all scales. All scales were unidimensional and free from differential item functioning or local independence of items. All scales were reliable, but for each subscale there were a number of patients who scored at the floor of the scale. Conclusions: The MULTIPIeS measure consists of five individual subscales and a 22-item summary scale that measures the perceived impact of multimorbidity. All scales showed good fit to the Rasch model and preliminary evidence of reliability and validity. A number of patients scored at floor of each subscale, which may reflect variation in the perception of multimorbidity. The MULTIPIeS measure will facilitate research into the impact of illness perceptions on adjustment, clinical outcomes, quality of life, and costs in patients with multimorbidity.	[Gibbons, Chris J.; Coventry, Peter A.] Univ Manchester, NIHR Collaborat Leadership Appl Hlth Res & Care G, Manchester, Lancs, England; [Gibbons, Chris J.; Kenning, Cassandra; Coventry, Peter A.; Fisher, Louise; Bower, Peter] Univ Manchester, NIHR Sch Primary Care Res, NIHR Greater Manchester Primary Care Patient Safe, MAHSC, Manchester, Lancs, England; [Bee, Penny] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Bundy, Christine] Univ Manchester, Inst Inflammat & Repair, Manchester Ctr Hlth Psychol, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Gibbons, CJ (corresponding author), Univ Manchester, NIHR Collaborat Leadership Appl Hlth Res & Care G, Manchester, Lancs, England.	chris.gibbons@manchester.ac.uk	Bundy, Chrstine/I-4286-2015; Bower, Peter/A-1508-2011; Coventry, Peter/H-6714-2014; Bee, Penny E/O-8822-2014; Coventry, Peter/AAA-9344-2019; Sidey-Gibbons, Chris/G-3101-2014	Bundy, Chrstine/0000-0002-5981-3984; Bower, Peter/0000-0001-9558-3349; Coventry, Peter/0000-0003-0625-3829; Bee, Penny E/0000-0002-5600-0400; Coventry, Peter/0000-0003-0625-3829; Kenning, Cassandra/0000-0001-6041-4051; Sidey-Gibbons, Chris/0000-0002-4732-7305	National Institute of Health Research (NIHR); NIHR School for Primary Care Research	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR School for Primary Care Research	CJG and PAC are funded by the National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care for Greater Manchester. The research funded by the NIHR School for Primary Care Research. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The views expressed in this article are those of the authors and not necessarily those of the NIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrich D, 2010, RASCH MODELS MEASURE; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bayliss Elizabeth A, 2005, Health Qual Life Outcomes, V3, P51; Bower P, 2012, PSYCHOL HEALTH, P1; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Burt J, 2012, J HEALTH SERV RES PO, V17, P64, DOI 10.1258/jhsrp.2011.010172; Cameron L., 2010, HLTH PSYCHOL 2E, P149; Chopin B, 1983, 196 U CAL GRAD SCH E; Coventry PA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-139; Croyle R., 1993, INT REV HLTH PSYCHOL, V2, P29; de Ridder D, 2008, LANCET, V372, P246, DOI 10.1016/S0140-6736(08)61078-8; Department for Communities and Local Government, 2010, ENGL IND DEPR; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636; Gibbons CJ, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-101; Gibbons CJ, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-82; Gulliford M, 2011, J HEALTH SERV RES PO, V16, P67, DOI 10.1258/jhsrp.2010.010015; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Holland P, 1995, DIFFERENTIAL ITEM FU; Karabatsos G, 2001, J Appl Meas, V2, P389; Klein R.B., 2005, PRINCIPLES PRACTICE; Leventhal H, 2003, SELF REGULATION HLTH, P42, DOI DOI 10.1093/RHEUMATOLOGY/KEM060; Linacre JM, 1994, RASCH MEASURE T, V7, P28; Lyness JM, 2006, PSYCHOSOMATICS, V47, P435, DOI 10.1176/appi.psy.47.5.435; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McAndrew LM, 2008, BRIT J HEALTH PSYCH, V13, P195, DOI 10.1348/135910708X295604; Mercer SW, 2007, ANN FAM MED, V5, P503, DOI 10.1370/afm.778; Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020; Mills RJ, 2010, HEALTH QUAL LIFE OUT, V12, P8; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; National Institute for Clinical Excellence, 2009, NAT I HLTH CLIN EXC; Nerenz, 1980, CONTRIBUTIONS MED PS, V2, P7, DOI DOI 10.1093/GERONJ/46.4.P181; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Rasch G., 1960, PROBABILISTIC MODELS; Rick J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-293; Roland M, 2009, BRIT MED J, V339; SPSS Inc, 2010, SPSS; Streiner DL., 2001, HLTH MEASUREMENT SCA, V2nd; Tennant A., 2006, RASCH MEAS T, V20, P1048; Tourangeau R, 1987, COGNITIVE ASPECTS SU; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; Watkins M, 2000, MONTE CARLO PCA PARR; Wearden A, 2008, BRIT J HEALTH PSYCH, V13, P189, DOI 10.1348/135910708X295613; West SG, 1995, STRUCTURAL EQUATION; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Wong SY, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-119; Wu M.L, 2010, STRUCTURAL EQUATION; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	52	53	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e81852	10.1371/journal.pone.0081852	http://dx.doi.org/10.1371/journal.pone.0081852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376504	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100008
J	Jiang, JL; Shan, ZJ; Xu, WL; Wang, XR; Zhou, JY; Kong, DY; Xu, J				Jiang, Jinlin; Shan, Zhengjun; Xu, Weili; Wang, Xiaorong; Zhou, Junying; Kong, Deyang; Xu, Jing			Microcystin-LR Induced Reactive Oxygen Species Mediate Cytoskeletal Disruption and Apoptosis of Hepatocytes in Cyprinus carpio L.	PLOS ONE			English	Article							FRESH-WATER FISH; OXIDATIVE STRESS; SECONDARY METABOLITES; CARASSIUS-AURATUS; SILVER CARP; BIOACCUMULATION; CELLS; RR; ACCUMULATION; INHIBITION	Microcystins (MCs) are a group of cyclic hepatotoxic Peptides produced by cyanobacteria. Microcystin R (MC-LR) contains Letacine (L) and Arginine (R) in the variable positions, and is one of the most common and potently toxic peptides. MC-LR can inhibit Protein phosphatase type 1 and type 2A (PP1 and PP2A) activities and induce excessive production of reactive oxygen species (ROS). The underlying mechanism of the inhibition of PP1 and PP2A has been extensively studied. The over-production of ROS is considered to be another main mechanism behind MC-LR toxicity however, the detailed toxicological mechanism involved in over-production of ROS in carp (Cyprinus car pi remains largely unclear. In our present study, the hydroxyl radical (center dot OH) was significantly induced in the liver of carp after a relatively short-term exposure to MC-LR. The elevated reactive oxygen species (ROS) production may play an important role in the disruption of microtubule structure. Pre-injection of the antioxidant N-acetyl-cysteine (NAC) provided significant protection to the cytoskeleton, however buthionine sulfoximine (BSO) exacerbated cytoskeletal destruction. In addition, the elevated ROS formation induced the expression of apoptosis-related genes, including p38 JNka and bcl-2. A significant increase in apoptotic cells was observed at 12 - 48 hours. Our study further supports evidence that ROS are involved in MC-LR induced damage to liver cells in carp and indicates the need for further study of the molecular mechanisms behind MC-LR toxicity.	[Jiang, Jinlin; Shan, Zhengjun; Xu, Weili; Zhou, Junying; Kong, Deyang; Xu, Jing] Minist Environm Protect, Nanjing Inst Environm Sci, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaorong] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Jiang, JL (corresponding author), Minist Environm Protect, Nanjing Inst Environm Sci, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing, Jiangsu, Peoples R China.	jjl@nies.org	Xu, Weili/AAB-6530-2020; Jiang, Jinlin/GQB-2974-2022		National Key Technology RD Program [2011BAE06B09-5]; National Environmental Protection Public Welfare Science and Technology Research Program of China [201009033]	National Key Technology RD Program(National Key Technology R&D Program); National Environmental Protection Public Welfare Science and Technology Research Program of China	This research was supported by the National Key Technology R&D Program (Grant number 2011BAE06B09-5) and the National Environmental Protection Public Welfare Science and Technology Research Program of China (Grant number 201009033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LL, 2010, ENVIRON INT, V36, P226, DOI 10.1016/j.envint.2009.10.010; Ashton T, 1998, EUR J APPL PHYSIOL O, V77, P498, DOI 10.1007/s004210050366; Blaha L, 2004, ACTA VET BRNO, V73, P477, DOI 10.2754/avb200473040477; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Cazenave J, 2006, AQUAT TOXICOL, V76, P1, DOI 10.1016/j.aquatox.2005.08.011; Chen YM, 2006, TOXICON, V47, P742, DOI 10.1016/j.toxicon.2006.01.026; Cheng SA, 2003, CHEMOSPHERE, V52, P1797, DOI 10.1016/S0045-6535(03)00369-2; de Figueiredo DR, 2004, ECOTOX ENVIRON SAFE, V59, P151, DOI 10.1016/j.ecoenv.2004.04.006; de Magalhaes VF, 2001, TOXICON, V39, P1077; Dietrich D, 2005, TOXICOL APPL PHARM, V203, P273, DOI 10.1016/j.taap.2004.09.005; Ding WX, 2001, BIOCHEM BIOPH RES CO, V285, P1155, DOI 10.1006/bbrc.2001.5309; Ding WX, 2000, ENVIRON HEALTH PERSP, V108, P605, DOI 10.2307/3434879; Gehringer MM, 2004, FEBS LETT, V557, P1, DOI 10.1016/S0014-5793(03)01447-9; Jiang JL, 2012, COMP BIOCHEM PHYS C, V155, P483, DOI 10.1016/j.cbpc.2011.12.008; Jiang JL, 2011, ECOTOXICOLOGY, V20, P1000, DOI 10.1007/s10646-011-0646-9; Jiang JL, 2011, J HAZARD MATER, V190, P188, DOI 10.1016/j.jhazmat.2011.03.023; Li XY, 2005, COMP BIOCHEM PHYS C, V141, P292, DOI 10.1016/j.cca.2005.07.004; Li XY, 2003, TOXICON, V42, P85, DOI 10.1016/S0041-0101(03)00104-1; Li YA, 2009, AQUACULTURE, V289, P154, DOI 10.1016/j.aquaculture.2008.12.029; Livingstone DR, 2001, MAR POLLUT BULL, V42, P656, DOI 10.1016/S0025-326X(01)00060-1; Luo Y, 2005, ENVIRON TOXICOL CHEM, V24, P2145, DOI 10.1897/04-640R.1; Magalhaes VF, 2003, TOXICON, V42, P289, DOI 10.1016/S0041-0101(03)00144-2; Malbrouck C, 2003, COMP BIOCHEM PHYS C, V135, P39, DOI 10.1016/S1532-0456(03)00047-4; Malbrouck C, 2006, ENVIRON TOXICOL CHEM, V25, P72, DOI 10.1897/05-029R.1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prieto AI, 2006, AQUAT TOXICOL, V77, P314, DOI 10.1016/j.aquatox.2005.12.012; Wei YN, 2008, APOPTOSIS, V13, P1031, DOI 10.1007/s10495-008-0237-2; WICKSTROM ML, 1995, TOXICOL PATHOL, V23, P326, DOI 10.1177/019262339502300309; Wiegand C, 2005, TOXICOL APPL PHARM, V203, P201, DOI 10.1016/j.taap.2004.11.002; Xie LQ, 2007, TOXICON, V49, P646, DOI 10.1016/j.toxicon.2006.11.004; Xie LQ, 2005, ENVIRON TOXICOL, V20, P293, DOI 10.1002/tox.20120; Xie LQ, 2004, ENVIRON POLLUT, V127, P431, DOI 10.1016/j.envpol.2003.08.011; YOSHIZAWA S, 1990, J CANCER RES CLIN, V116, P609, DOI 10.1007/BF01637082; Zegura B, 2008, TOXICON, V51, P615, DOI 10.1016/j.toxicon.2007.11.009	35	21	22	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84768	10.1371/journal.pone.0084768	http://dx.doi.org/10.1371/journal.pone.0084768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376844	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100186
J	Lu, Y; Mo, CJ; Zeng, ZY; Chen, SY; Xie, YT; Peng, QL; He, Y; Deng, Y; Wang, J; Xie, L; Zeng, J; Li, S; Qin, X				Lu, Yu; Mo, Cuiju; Zeng, Zhiyu; Chen, Siyuan; Xie, Yantong; Peng, Qiliu; He, Yu; Deng, Yan; Wang, Jian; Xie, Li; Zeng, Jie; Li, Shan; Qin, Xue			CYP2D6*4 Allele Polymorphism Increases the Risk of Parkinson's Disease: Evidence from Meta-Analysis	PLOS ONE			English	Article							HYDROXYLASE GENE POLYMORPHISM; CYP2D6 POLYMORPHISM; CYTOCHROME-P450 2D6; ALZHEIMERS-DISEASE; ASSOCIATION; FREQUENCIES; 4-HYDROXYLATION; POPULATION; METABOLISM; DEMENTIA	Background: Many epidemiological studies have been conducted to explore the association between a single CYP2D6 gene polymorphism and Parkinson's disease (PD) susceptibility. However, the results remain controversial. Objectives: To clarify the effects of a single CYP2D6 gene polymorphism on the risk of PD, a meta-analysis of all available studies relating to CYP2D6*4 polymorphism and the risk of PD was conducted. Methods: A comprehensive literature search of PubMed, EMBASE, and the China National Knowledge Infrastructure (CNKI) up to September 1, 2013 was conducted. Data were extracted by two independent authors and pooled odds ratio (OR) with 95% confidence interval (CI) were calculated. Meta-regression, Galbraith plots, subgroup analysis, sensitivity analysis, and publication bias analysis were also performed. Results: Twenty-two separate comparisons consisting of 2,629 patients and 3,601 controls were included in our meta-analysis. The pooled analyses showed a significant association between CYP2D6*4G/A polymorphism and PD risk in all of the comparisons (A vs. G allele: OR = 1.28, 95% CI = 1.14-1.43, P = 0.001; AA vs. GG: OR = 1.43, 95% CI = 1.06-1.93, P = 0.018; AG vs. GG: OR = 1.22, 95% CI = 1.06-1.40, P = 0.006; AG+AA vs. GG: OR = 1.26, 95% CI = 1.10-1.44, P = 0.001; AA vs. AG+GG: OR = 1.37, 95% CI = 1.02-1.83, P = 0.036). In subgroup analysis stratified by ethnicity, significant associations were also demonstrated in Caucasians but not in Asians. No significant association was found in subgroup analysis stratified by age of onset or disease form. Conclusions: We concluded that the CYP2D6*4G/A polymorphism denotes an increased genetic susceptibility to PD in the overall population, especially in Caucasians. Further large and well-designed studies are needed to confirm this association.	[Lu, Yu; Mo, Cuiju; Peng, Qiliu; He, Yu; Deng, Yan; Wang, Jian; Xie, Li; Li, Shan; Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Zeng, Zhiyu] Guangxi Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanning, Guangxi, Peoples R China; [Chen, Siyuan; Xie, Yantong] Guangxi Med Univ, Nanning, Guangxi, Peoples R China; [Zeng, Jie] Liuzhou City Peoples Hosp, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, S (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	lis8858@126.com; qinxue919@126.com			National Natural Science Foundation of China [81260302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (No. 81260302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUNDEZ JAG, 1994, CLIN PHARMACOL THER, V55, P412, DOI 10.1038/clpt.1994.50; AGUNDEZ JAG, 1995, CLIN PHARMACOL THER, V57, P291, DOI 10.1016/0009-9236(95)90154-X; AKHMEDOVA SN, 1995, BIOCHEM MOL MED, V54, P88, DOI 10.1006/bmme.1995.1012; ARMSTRONG M, 1992, LANCET, V339, P1017, DOI 10.1016/0140-6736(92)90537-D; Atkinson A, 1999, PHARMACOGENETICS, V9, P31, DOI 10.1097/00008571-199902000-00005; BARBEAU A, 1985, LANCET, V2, P1213; Bordet R, 1996, CLIN NEUROPHARMACOL, V19, P213, DOI 10.1097/00002826-199619030-00003; Bordet R, 1996, ADV NEUROL, V69, P97; Chan DKY, 1998, J NEUROL NEUROSUR PS, V65, P781, DOI 10.1136/jnnp.65.5.781; Chen SQ, 1999, ACTA PHARMACOL SIN, V20, P585; Chen X, 1996, NEUROLOGY, V47, P779, DOI 10.1212/WNL.47.3.779; Chida M, 1999, PHARMACOGENETICS, V9, P601; CHOLERTON S, 1992, TRENDS PHARMACOL SCI, V13, P434, DOI 10.1016/0165-6147(92)90140-2; Corrigan FM, 1998, EXP NEUROL, V150, P339, DOI 10.1006/exnr.1998.6776; Corrigan FM, 2000, J TOXICOL ENV HEAL A, V59, P229, DOI 10.1080/009841000156907; DALY AK, 1994, ENVIRON HEALTH PERSP, V102, P55, DOI 10.1289/ehp.94102s955; Diederich N, 1996, ANN NEUROL, V40, P463, DOI 10.1002/ana.410400319; Duric Gordana, 2007, Vojnosanit Pregl, V64, P25; Elbaz A, 2004, ANN NEUROL, V55, P430, DOI 10.1002/ana.20051; FONNEPFISTER R, 1987, BIOCHEM BIOPH RES CO, V148, P1144, DOI 10.1016/S0006-291X(87)80252-8; Gasser T, 1996, J NEUROL NEUROSUR PS, V61, P518, DOI 10.1136/jnnp.61.5.518; Golab-Janowska M, 2007, NEUROL NEUROCHIR POL, V41, P113; HANIOKA N, 1990, AM J HUM GENET, V47, P994; Hubble JP, 1998, NEUROEPIDEMIOLOGY, V17, P96, DOI 10.1159/000026159; Ingelman-Sundberg M, 1999, TRENDS PHARMACOL SCI, V20, P342, DOI 10.1016/S0165-6147(99)01363-2; Joost O, 1999, MOVEMENT DISORD, V14, P590, DOI 10.1002/1531-8257(199907)14:4<590::AID-MDS1007>3.0.CO;2-2; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; KURTH MC, 1993, AM J MED GENET, V48, P166, DOI 10.1002/ajmg.1320480311; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lucotte G, 1996, AM J MED GENET, V67, P361, DOI 10.1002/(SICI)1096-8628(19960726)67:4<361::AID-AJMG8>3.0.CO;2-P; McCann SJ, 1997, J NEUROL SCI, V153, P50, DOI 10.1016/S0022-510X(97)00179-2; Nicholl DJ, 1999, NEUROLOGY, V53, P1415, DOI 10.1212/WNL.53.7.1415; Pang CP, 1998, MOVEMENT DISORD, V13, P529, DOI 10.1002/mds.870130324; Payami H, 2001, NEUROLOGY, V56, P1363, DOI 10.1212/WNL.56.10.1363; PLANTEBORDENEUVE V, 1994, J NEUROL NEUROSUR PS, V57, P911, DOI 10.1136/jnnp.57.8.911; Qin X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056070; Rostami-Hodjegan A, 1998, PHARMACOGENETICS, V8, P227, DOI 10.1097/00008571-199806000-00005; Sachse C, 1997, AM J HUM GENET, V60, P284; Singh M, 2010, DIS MARKERS, V28, P87, DOI [10.1155/2010/282130, 10.3233/DMA-2010-0688]; SMITH CAD, 1992, LANCET, V339, P1375, DOI 10.1016/0140-6736(92)91196-F; STACY M, 1992, PARKINSONS DIS NEURO, P10; Stefanovic M, 2000, CLIN CHEM LAB MED, V38, P929, DOI 10.1515/CCLM.2000.136; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; SUZUKI T, 1992, FASEB J, V6, P771, DOI 10.1096/fasebj.6.2.1537468; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Woo SI, 2001, PSYCHIAT CLIN NEUROS, V55, P373, DOI 10.1046/j.1440-1819.2001.00877.x	46	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84413	10.1371/journal.pone.0084413	http://dx.doi.org/10.1371/journal.pone.0084413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376807	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100167
J	Wang, XG; Hargrove, MS				Wang, Xiaoguang; Hargrove, Mark S.			Nitric Oxide in Plants: The Roles of Ascorbate and Hemoglobin	PLOS ONE			English	Article							ALFALFA ROOT CULTURES; MONODEHYDROASCORBATE REDUCTASE; NITRATE REDUCTASE; FLOODING INTOLERANCE; CYTOPLASMIC ACIDOSIS; CLASS-1 HEMOGLOBIN; GLUTATHIONE CYCLE; IN-VITRO; NO; METABOLISM	Ascorbic acid and hemoglobins have been linked to nitric oxide metabolism in plants. It has been hypothesized that ascorbic acid directly reduces plant hemoglobin in support of NO scavenging, producing nit e and monodehydroascorbate. In this scenario, monodehydroascorbate reductase uses NADH. reduce monodehydroascorbate back to ascorbate to sustain the cycle. To test this hypothesis rates of rice nonsymbiotic hemoglobin reduction by ascorbate were measured directly, in the presence and absence of purified rice monodehydroascorbate reductase and NADH. Solution NO scavenging was also measured methodically in the Presence and absence of rice nonsymbiotic hemoglobin and monodehydroascorbate reductase, under hypoxic and normoxic conditions, in an effort to gauge the likelihood of these proteins affecting NO metabolism in plant tissues. Our results indicate that ascorbic acid slowly reduces rice nonsymbiotic hemoglobin at a rate identical to myoglobin reduction. The product of the reaction is monodehydroascorbate, which can be efficiently reduced back to ascorbate in the presence of monodehydroascorbate reductase and NADH. However, our NO scavenging results suggest that the direct reduction of plant hemoglobin by ascorbic acid is unlikely to serve as a significant factor in NO metabolism, even in the presence of monodehydroascorbate reductase. Finally, the possibility that the direct reaction of nitrite/nitrous acid and ascorbic acid produces NO was measured at various pH values mimicking hypoxic plant cells. Our results suggest that this reaction is a likely source of NO a h plant cell pH drops below 7, and as nitrite concentrations rise to levels during hypoxia.	[Wang, Xiaoguang; Hargrove, Mark S.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Hargrove, MS (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	msh@iastate.edu						Aliverti A, 1999, METH MOL B, V131, P9; ANDERSON JW, 1983, PLANTA, V158, P442, DOI 10.1007/BF00397738; Biemelt S, 1998, PLANT PHYSIOL, V116, P651, DOI 10.1104/pp.116.2.651; Blokhina O, 2010, PHYSIOL PLANTARUM, V138, P447, DOI 10.1111/j.1399-3054.2009.01340.x; BUETTNER GR, 1993, FREE RADICAL BIO MED, V14, P49, DOI 10.1016/0891-5849(93)90508-R; Bustos-Sanmamed P, 2011, NEW PHYTOL, V189, P765, DOI 10.1111/j.1469-8137.2010.03527.x; Carlsson S, 2001, NITRIC OXIDE-BIOL CH, V5, P580, DOI 10.1006/niox.2001.0371; Dordas C, 2003, PLANT J, V35, P763, DOI 10.1046/j.1365-313X.2003.01846.x; Drew DP, 2007, PLANTA, V225, P945, DOI 10.1007/s00425-006-0394-x; FERRARI TE, 1971, PLANT PHYSIOL, V47, P790, DOI 10.1104/pp.47.6.790; Foyer C. H., 1993, ANTIOXIDANTS HIGHER, P31; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gentiloni Silveri N, 2001, Minerva Med, V92, P167; GRODEN D, 1979, BIOCHIM BIOPHYS ACTA, V546, P426, DOI 10.1016/0005-2728(79)90078-1; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; Hargrove MS, 2000, STRUCTURE, V8, P1005, DOI 10.1016/S0969-2126(00)00194-5; Hebelstrup KH, 2012, J EXP BOT, V63, P5581, DOI 10.1093/jxb/ers210; Hollenbeck C, 1953, PRCAMI 5 C, P106; Honikel KO, 2008, MEAT SCI, V78, P68, DOI 10.1016/j.meatsci.2007.05.030; HOSSAIN MA, 1985, J BIOL CHEM, V260, P2920; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; Huang CY, 2010, BOT STUD, V51, P37; Igamberdiev A, 2006, PLANTA, V223, P1041, DOI 10.1007/s00425-005-0145-4; Igamberdiev AU, 2006, PLANTA, V223, P1033, DOI 10.1007/s00425-005-0146-3; Igamberdiev AU, 2004, PLANTA, V219, P95, DOI 10.1007/s00425-003-1192-3; Inglett P.W., 2005, ENCY SOILS ENV, P71, DOI [10.1016/B0-12-348530-4/00178-8, DOI 10.1016/B0-12-348530-4/00178-8]; Jimenez A, 1998, PLANT PHYSIOL, V118, P1327, DOI 10.1104/pp.118.4.1327; Jimenez A, 1997, PLANT PHYSIOL, V114, P275, DOI 10.1104/pp.114.1.275; Kaiser WM, 2002, J EXP BOT, V53, P875, DOI 10.1093/jexbot/53.370.875; KELLY GJ, 1979, NATURWISSENSCHAFTEN, V66, P617, DOI 10.1007/BF00405128; Kundu S, 2003, BIOPHYS J, V84, P3931, DOI 10.1016/S0006-3495(03)75121-2; Kurz CR, 2003, FREE RADICAL BIO MED, V35, P1529, DOI 10.1016/j.freeradbiomed.2003.08.012; Kytzia A, 2006, CHEM-EUR J, V12, P8786, DOI 10.1002/chem.200600405; LEWIS RS, 1994, CHEM RES TOXICOL, V7, P568, DOI 10.1021/tx00040a013; LUNDBERG JON, 1994, GUT, V35, P1543, DOI 10.1136/gut.35.11.1543; Mur LAJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls052; Ohwaki Y, 2005, PLANT CELL PHYSIOL, V46, P324, DOI 10.1093/pcp/pci030; Perazzolli M, 2004, PLANT CELL, V16, P2785, DOI 10.1105/tpc.104.025379; Planchet E, 2006, PLANT SIGNAL BEHAV, V1, P46, DOI 10.4161/psb.1.2.2435; Rasmusson AG, 2004, ANNU REV PLANT BIOL, V55, P23, DOI 10.1146/annurev.arplant.55.031903.141720; RAUTENKRANZ AAF, 1994, PLANT PHYSIOL, V106, P187, DOI 10.1104/pp.106.1.187; ROBERTS JKM, 1985, PLANT PHYSIOL, V77, P492, DOI 10.1104/pp.77.2.492; ROBERTS JKM, 1984, P NATL ACAD SCI-BIOL, V81, P6029, DOI 10.1073/pnas.81.19.6029; Rockel P, 2002, J EXP BOT, V53, P103, DOI 10.1093/jexbot/53.366.103; Sainz M, 2013, PLANT J; Seregelyes C, 2004, FEBS LETT, V571, P61, DOI 10.1016/j.febslet.2004.06.055; Smagghe BJ, 2009, BIOPOLYMERS, V91, P1083, DOI 10.1002/bip.21256; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; Smirnoff N, 1996, ANN BOT-LONDON, V78, P661, DOI 10.1006/anbo.1996.0175; Smirnoff N, 2000, CRIT REV PLANT SCI, V19, P267, DOI 10.1016/S0735-2689(00)80005-2; Sturms R, 2011, BIOCHEMISTRY-US, V50, P10829, DOI 10.1021/bi201425f; Sturms R, 2011, BIOCHEMISTRY-US, V50, P3873, DOI 10.1021/bi2004312; Takahama Umeo, 2004, Phytochemistry Reviews, V3, P207, DOI 10.1023/B:PHYT.0000047805.08470.e3; Tiso M, 2012, BIOCHEMISTRY-US, V51, P5285, DOI 10.1021/bi300570v; Yamasaki H, 2000, FEBS LETT, V468, P89, DOI 10.1016/S0014-5793(00)01203-5; Yamasaki H, 1999, TRENDS PLANT SCI, V4, P128, DOI 10.1016/S1360-1385(99)01393-X; Zechmann B, 2011, PLANTA, V233, P1, DOI 10.1007/s00425-010-1275-x	60	21	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82611	10.1371/journal.pone.0082611	http://dx.doi.org/10.1371/journal.pone.0082611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376554	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100044
J	Zhou, ZF; Li, B; Dong, ZW; Liu, F; Zhang, Y; Yu, Y; Shang, FQ; Wu, LZ; Wang, XJ; Jin, Y				Zhou, Zhifei; Li, Bei; Dong, Zhiwei; Liu, Fen; Zhang, Yu; Yu, Yang; Shang, Fengqing; Wu, Lizheng; Wang, Xiaojing; Jin, Yan			Nicotine Deteriorates the Osteogenic Differentiation of Periodontal Ligament Stem Cells through alpha 7 Nicotinic Acetylcholine Receptor Regulating wnt Pathway	PLOS ONE			English	Article							INFLAMMATORY MICROENVIRONMENTS; KAPPA-B; HUMAN MONOCYTES; SMOKING; STIMULATION; MAINTENANCE; EXPRESSION; SWINE; IL-8	Aims: Cigarette smoking is one of the high risk factors of adult chronic periodontitis and nicotine is the well established toxic substance in cigarette. However, the mechanism of nicotine induced periodontitis is still unknown. Here we studied whether nicotine impaired the osteogenic differentiation of human periodontal ligament stem cells (hPDLSCs) through activating alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR). Methods: hPDLSCs with multi differentiation potential and surface makers for mesenchymal stem cells were harvested by limiting dilution technique. The level of mineralized nodule formation was assessed by alizarin red S staining. Expression level of ostegenic related genes and proteins were detected by real-time PCR and western blot analysis. The expression of alpha 7 nAChR and its downstream signaling pathway were examined by western blot. The role of the receptor and related signaling pathway in nicotine impairing the osteogenic potential of hPDLSCs were also studied in different levels. Results: Nicotine deteriorated the ostegenic differentiation of hPDLSCs in a dose dependent manner. Activation of alpha 7 nAChR by nicotine treatment activated wnt/beta-catenin signaling pathway, leading to osteogenic deficiency of hPDLSCs. Blockage of alpha 7 nAChR and wnt pathway inhibitor treatment rescued nicotine induced osteogenic differentiation deficiency. Conclusions: These data suggested that nicotine activated alpha 7 nAChR expressed on PDLSCs and further activated writ signaling downstream, thus deteriorating the osteogenic potential of PDLSCs. The impairment of osteogenic differentiation of PDLSCs by nicotine might lead to cigarette smoking related periodontitis.	[Zhou, Zhifei; Liu, Fen; Zhang, Yu; Wu, Lizheng; Wang, Xiaojing] Fourth Mil Med Univ, Sch Stomatol, Dept Pediat Dent, Xian 710032, Shaanxi, Peoples R China; [Zhou, Zhifei; Li, Bei; Zhang, Yu; Yu, Yang; Shang, Fengqing; Jin, Yan] Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Xian 710032, Shaanxi, Peoples R China; [Li, Bei; Jin, Yan] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Histol & Pathol, Xian 710032, Shaanxi, Peoples R China; [Dong, Zhiwei] Shenyang Mil Area Command, Dept Oral & Maxillofacial Surg, Gen Hosp, Shenyang, Liaoning, Peoples R China; [Liu, Fen] Maternal & Child Care Hosp, Dept Oral Med, Xian, Shaanxi, Peoples R China; [Shang, Fengqing] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wang, XJ (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Pediat Dent, Xian 710032, Shaanxi, Peoples R China.	wxjingpd@hotmail.com; yanjin@fmmu.edu.cn	Jin, Yan/I-4204-2013		National Major Scientific Research Program of China [2010CB944800, 2011CB964700]; Natural Science Foundation of China [81170964, 31030033, 81020108019]	National Major Scientific Research Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Major Scientific Research Program of China http://program.most.gov.cn/ (2010CB944800 and 2011CB964700) and the Natural Science Foundation of China http://www.nsfc.gov.cn/Portal0/default152.htm (81170964, 31030033 and 81020108019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bergstrom Jan, 2004, Odontology, V92, P1; Calsina G, 2002, J CLIN PERIODONTOL, V29, P771; Chambrone L, 2010, J CLIN PERIODONTOL, V37, P675, DOI 10.1111/j.1600-051X.2010.01587.x; Chen SC, 2006, J PERIODONTAL RES, V41, P547, DOI 10.1111/j.1600-0765.2006.00904.x; Chen X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.14; Grando SA, 2003, LIFE SCI, V72, P2009, DOI 10.1016/S0024-3205(03)00063-8; Gronthos S, 2006, CALCIFIED TISSUE INT, V79, P310, DOI 10.1007/s00223-006-0040-4; Hamano R, 2006, SHOCK, V26, P358, DOI 10.1097/01.shk.0000228168.86845.60; Iho S, 2003, J LEUKOCYTE BIOL, V74, P942, DOI 10.1189/jlb.1202626; Ivanovski S, 2006, ORAL DIS, V12, P358, DOI 10.1111/j.1601-0825.2006.01253.x; Kashiwagi Y, 2012, ARCH ORAL BIOL, V57, P483, DOI 10.1016/j.archoralbio.2011.10.007; Kong XW, 2013, BBA-GEN SUBJECTS, V1830, P5119, DOI 10.1016/j.bbagen.2013.07.027; Li B, 2012, ORAL DIS, V18, P285, DOI 10.1111/j.1601-0825.2011.01878.x; Liu C, 2008, CELL, V108, P837; Liu N, 2011, J BONE MINER RES, V26, P2082, DOI 10.1002/jbmr.440; Liu YF, 2010, J PERIODONTAL RES, V45, P714, DOI 10.1111/j.1600-0765.2010.01290.x; Liu YL, 2011, STEM CELLS, V29, P1804, DOI 10.1002/stem.728; Liu Y, 2008, STEM CELLS, V26, P1065, DOI 10.1634/stemcells.2007-0734; Ma ZF, 2008, TISSUE ENG PT A, V14, P2059, DOI 10.1089/ten.tea.2008.0021; Makino A, 2008, FEMS IMMUNOL MED MIC, V52, P282, DOI 10.1111/j.1574-695X.2007.00373.x; Sakurai R, 2011, EXP LUNG RES, V37, P144, DOI 10.3109/01902148.2010.490288; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Tanaka H, 2005, LIFE SCI, V77, P2273, DOI 10.1016/j.lfs.2005.02.022; Luzz LIT, 2007, J APPL ORAL SCI, V15, P512, DOI 10.1590/S1678-77572007000600011; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Wada N, 2009, J CELL PHYSIOL, V219, P667, DOI 10.1002/jcp.21710; Wan CP, 2009, J CLIN PERIODONTOL, V36, P229, DOI 10.1111/j.1600-051X.2008.01371.x; Wang L, 2011, TISSUE ENG PT A, V17, P1015, DOI 10.1089/ten.tea.2010.0140; Wang XJ, 2010, CELL TISSUE RES, V340, P347, DOI 10.1007/s00441-010-0949-9; Yang ZH, 2009, TISSUE ENG PART C-ME, V15, P571, DOI 10.1089/ten.tec.2008.0561; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x; Zhang J, 2012, BIOMATERIALS, V33, P6974, DOI 10.1016/j.biomaterials.2012.06.032; Zhang WB, 2009, METHODS, V47, P122, DOI 10.1016/j.ymeth.2008.09.004	37	31	34	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83102	10.1371/journal.pone.0083102	http://dx.doi.org/10.1371/journal.pone.0083102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376645	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100090
J	Lum, M; Attridge, SR; Morona, R				Lum, Mabel; Attridge, Stephen R.; Morona, Renato			Impact of Dynasore an Inhibitor of Dynamin II on Shigella flexneri Infection	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; ACTIN-BINDING PROTEIN; ANTIGEN CHAIN-LENGTH; TO-CELL SPREAD; O-ANTIGEN; UNIPOLAR LOCALIZATION; INTERCELLULAR SPREAD; MEDIATED ENDOCYTOSIS; CRYSTAL-STRUCTURE; EPITHELIAL-CELLS	Shigella flexneri remains a significant human pathogen due to high morbidity among children < 5 years in developing countries. One of the key features of Shigella infection is the ability of the bacterium to initiate actin tail polymerisation to disseminate into neighbouring cells. Dynamin II is associated with the old pole of the bacteria that is associated with F-actin tail formation. Dynamin II inhibition with dynasore as well as siRNA knockdown significantly reduced Shigella cell to cell spreading in vitro. The ocular mouse Sereny model was used to determine if dynasore could delay the progression of Shigella infection in vivo. While dynasore did not reduce ocular inflammation, it did provide significant protection against weight loss. Therefore dynasore's effects in vivo are unlikely to be related to the inhibition of cell spreading observed in vitro. We found that dynasore decreased S. flexneri-induced HeLa cell death in vitro which may explain the protective effect observed in vivo. These results suggest the administration of dynasore or a similar compound during Shigella infection could be a potential intervention strategy to alleviate disease symptoms.	[Lum, Mabel; Attridge, Stephen R.; Morona, Renato] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Morona, R (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	renato.morona@adelaide.edu.au	Morona, Renato/B-7746-2013	Morona, Renato/0000-0001-7009-7440; Lum, Mabel/0000-0002-4712-0603	National Health and Medical Research Council (NHMRC) of Australia [565526]; NHMRC	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by a Program Grant (565526) from the National Health and Medical Research Council (NHMRC) of Australia. ML was the recipient of the Australian Postgraduate Award from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusci P, 2013, NAT STRUCT MOL BIOL, V20, P99, DOI 10.1038/nsmb.2452; Ambrosi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049625; Ashida H, 2011, CURR OPIN IMMUNOL, V23, P448, DOI 10.1016/j.coi.2011.06.001; Baker SJ, 1999, MICROBIOL-SGM, V145, P367, DOI 10.1099/13500872-145-2-367; Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; Barman S, 2011, FEMS IMMUNOL MED MIC, V62, P304, DOI 10.1111/j.1574-695X.2011.00810.x; Barry EM, 2013, NAT REV GASTRO HEPAT, V10, P245, DOI 10.1038/nrgastro.2013.12; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Bishai EA, 2013, CELL MICROBIOL, V15, P353, DOI 10.1111/cmi.12051; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Burger KNJ, 2000, BIOCHEMISTRY-US, V39, P12485, DOI 10.1021/bi000971r; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Egile C, 1997, MOL MICROBIOL, V23, P1063, DOI 10.1046/j.1365-2958.1997.2871652.x; Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Francis MS, 1996, J MED MICROBIOL, V45, P323, DOI 10.1099/00222615-45-5-323; Fukumatsu M, 2012, CELL HOST MICROBE, V11, P325, DOI 10.1016/j.chom.2012.03.001; Gao DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060967; GOLDBERG MB, 1993, J BACTERIOL, V175, P2189, DOI 10.1128/JB.175.8.2189-2196.1993; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; Heindl JE, 2010, INFECT IMMUN, V78, P193, DOI 10.1128/IAI.00252-09; Hong M, 1997, MOL MICROBIOL, V24, P779, DOI 10.1046/j.1365-2958.1997.3731744.x; Jeong KI, 2010, J INFECT DIS, V201, P903, DOI 10.1086/650995; KADURUGAMUWA JL, 1991, INFECT IMMUN, V59, P3463, DOI 10.1128/IAI.59.10.3463-3471.1991; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Kotloff KL, 1996, INFECT IMMUN, V64, P4542, DOI 10.1128/IAI.64.11.4542-4548.1996; Lagendijk EL, 2010, FEMS MICROBIOL LETT, V305, P81, DOI 10.1111/j.1574-6968.2010.01916.x; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; LETT MC, 1989, J BACTERIOL, V171, P353, DOI 10.1128/jb.171.1.353-359.1989; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Morona R, 2003, MICROBIOL-SGM, V149, P925, DOI 10.1099/mic.0.26141-0; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; MURAYAMA SY, 1986, INFECT IMMUN, V51, P696, DOI 10.1128/IAI.51.2.696-698.1986; OAKS EV, 1985, INFECT IMMUN, V48, P124, DOI 10.1128/IAI.48.1.124-129.1985; OKAMURA N, 1983, INFECT IMMUN, V39, P505, DOI 10.1128/IAI.39.2.505-513.1983; Prunier AL, 2007, MICROBIOL-SGM, V153, P2363, DOI 10.1099/mic.0.2007/006916-0; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; RABBANI GH, 1995, INFECT IMMUN, V63, P4350, DOI 10.1128/IAI.63.11.4350-4357.1995; Rajabian T, 2009, NAT CELL BIOL, V11, P1212, DOI 10.1038/ncb1964; SANDLIN RC, 1995, INFECT IMMUN, V63, P229, DOI 10.1128/IAI.63.1.229-237.1995; Sandlin RC, 1996, MOL MICROBIOL, V22, P63, DOI 10.1111/j.1365-2958.1996.tb02656.x; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; SANSONETTI PJ, 1994, CELL, V76, P829, DOI 10.1016/0092-8674(94)90358-1; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Schuch R, 1999, MOL MICROBIOL, V34, P675, DOI 10.1046/j.1365-2958.1999.01627.x; Senerovic L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.124; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; Suzuki T, 2002, CELL MICROBIOL, V4, P223, DOI 10.1046/j.1462-5822.2002.00185.x; Suzuki T, 2006, J IMMUNOL, V177, P4709, DOI 10.4049/jimmunol.177.7.4709; Terada N, 2009, CELL TISSUE RES, V337, P91, DOI 10.1007/s00441-009-0804-z; Van Nhieu GT, 2003, NAT CELL BIOL, V5, P720, DOI 10.1038/ncb1021; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; YANG JY, 2013, J INFECT DIS; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	70	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84975	10.1371/journal.pone.0084975	http://dx.doi.org/10.1371/journal.pone.0084975			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367704	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900073
J	Steel, JJ; Franz, AWE; Sanchez-Vargas, I; Olson, KE; Geiss, BJ				Steel, J. Jordan; Franz, Alexander W. E.; Sanchez-Vargas, Irma; Olson, Ken E.; Geiss, Brian J.			Subgenomic Reporter RNA System for Detection of Alphavirus Infection in Mosquitoes	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; VIRUS TRANSDUCING SYSTEM; SINDBIS-VIRUS; AEDES-AEGYPTI; GENE-EXPRESSION; MINUS-STRAND; GENOME; REPLICATION; RESISTANCE; PROMOTERS	Current methods for detecting real-time alphavirus (Family Togaviridae) infection in mosquitoes require the use of recombinant viruses engineered to express a visibly detectable reporter protein. These altered viruses expressing fluorescent proteins, usually from a duplicated viral subgenomic reporter, are effective at marking infection but tend to be attenuated due to the modification of the genome. Additionally, field strains of viruses cannot be visualized using this approach unless infectious clones can be developed to insert a reporter protein. To circumvent these issues, we have developed an insect cell-based system for detecting wild-type sindbis virus infection that uses a virus inducible promoter to express a fluorescent reporter gene only upon active virus infection. We have developed an insect expression system that produces sindbis virus minigenomes containing a subgenomic promoter sequence, which produces a translatable RNA species only when infectious virus is present and providing viral replication proteins. This subgenomic reporter RNA system is able to detect wild-type Sindbis infection in cultured mosquito cells. The detection system is relatively species specific and only detects closely related viruses, but can detect low levels of alphavirus specific replication early during infection. A chikungunya virus detection system was also developed that specifically detects chikungunya virus infection. Transgenic Aedes aegypti mosquito families were established that constitutively express the sindbis virus reporter RNA and were found to only express fluorescent proteins during virus infection. This virus inducible reporter system demonstrates a novel approach for detecting non-recombinant virus infection in mosquito cell culture and in live transgenic mosquitoes.	[Steel, J. Jordan; Sanchez-Vargas, Irma; Olson, Ken E.; Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Geiss, Brian J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Franz, Alexander W. E.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Colorado State University; Colorado State University; University of Missouri System; University of Missouri Columbia	Geiss, BJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Brian.Geiss@colostate.edu	Geiss, Brian/J-3021-2017	Geiss, Brian/0000-0001-8180-5772; Steel, James Jordan/0000-0002-1256-2639	National Institutes of Health [AI046435]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grant #AI046435 to KEO and BJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2004, TRANSGENIC RES, V13, P411, DOI 10.1007/s11248-004-6067-2; Adelman ZN, 2002, MOL BIOCHEM PARASIT, V121, P1, DOI 10.1016/S0166-6851(02)00028-2; Anderson MAE, 2010, INSECT MOL BIOL, V19, P441, DOI 10.1111/j.1365-2583.2010.01005.x; Atkins GJ., 2013, ISRN VIROL, V2013, P1, DOI [10.5402/2013/861912, DOI 10.5402/2013/861912]; Atkinson PW, 2001, ANNU REV ENTOMOL, V46, P317, DOI 10.1146/annurev.ento.46.1.317; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Carpenetti TLG, 2012, INSECT MOL BIOL, V21, P97, DOI 10.1111/j.1365-2583.2011.01116.x; Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49; Coates CJ, 2000, INSECT BIOCHEM MOLEC, V30, P1003, DOI 10.1016/S0965-1748(00)00110-7; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Fabbrini MS, 1997, BIOCHEM J, V322, P719, DOI 10.1042/bj3220719; Foy BD, 2004, INSECT MOL BIOL, V13, P89, DOI 10.1111/j.1365-2583.2004.00464.x; Foy BD, 2008, ADV EXP MED BIOL, V627, P19, DOI 10.1007/978-0-387-78225-6_2; Franz AWE, 2011, INSECT MOL BIOL, V20, P587, DOI 10.1111/j.1365-2583.2011.01089.x; Franz AWE, 2009, INSECT MOL BIOL, V18, P661, DOI 10.1111/j.1365-2583.2009.00908.x; FRANZ AW, 2006, ENG RNA INTERFERENCE, P37508; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Frolov I, 2001, RNA, V7, P1638, DOI 10.1017/S135583820101010X; Geiss BJ, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-112; HAHN CS, 1992, P NATL ACAD SCI USA, V89, P2679, DOI 10.1073/pnas.89.7.2679; Hardy RW, 2005, J VIROL, V79, P4630, DOI 10.1128/JVI.79.8.4630-4639.2005; JARVIS DL, 1990, BIO-TECHNOL, V8, P950, DOI 10.1038/nbt1090-950; JASINSKIENE N, 2007, MICROINJECTION A AEG, P1012; Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130; KIM JY, 2013, NEUROBIOLOGY DIS, P1012; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Li JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033007; LUSTIG S, 1988, J VIROL, V62, P2329, DOI 10.1128/JVI.62.7.2329-2336.1988; Marimoutou C, 2012, MEDICINE, V91, P212, DOI 10.1097/MD.0b013e318260b604; Mossel EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060427; Myles KM, 2004, J MED ENTOMOL, V41, P95, DOI 10.1603/0022-2585-41.1.95; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; OLIVO PD, 1994, VIROLOGY, V198, P381, DOI 10.1006/viro.1994.1046; Olivo PD, 1996, CLIN MICROBIOL REV, V9, P321, DOI 10.1128/CMR.9.3.321; Patel RK, 2013, VIROLOGY, V441, P171, DOI 10.1016/j.virol.2013.03.022; PHILLIPS A, 2010, JOVE-J VIS EXP, pR1, DOI DOI 10.3791/2363.PUBMED:21178952; Pierro DJ, 2008, J VIROL, V82, P2966, DOI 10.1128/JVI.02060-07; Pierro DJ, 2003, INSECT MOL BIOL, V12, P107, DOI 10.1046/j.1365-2583.2003.00392.x; Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515; Seabaugh RC, 1998, VIROLOGY, V243, P99, DOI 10.1006/viro.1998.9034; Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12; Steel JJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-356; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; WEAVER SC, 1993, VIROLOGY, V197, P375, DOI 10.1006/viro.1993.1599; Wiley MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013924	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84930	10.1371/journal.pone.0084930	http://dx.doi.org/10.1371/journal.pone.0084930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367703	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900072
J	Liu, F; Archer, SR; Gelwick, F; Bai, E; Boutton, TW; Wu, XYB				Liu, Feng; Archer, Steven R.; Gelwick, Frances; Bai, Edith; Boutton, Thomas W.; Wu, Xinyuan Ben			Woody Plant Encroachment into Grasslands: Spatial Patterns of Functional Group Distribution and Community Development	PLOS ONE			English	Article							CANONICAL CORRESPONDENCE-ANALYSIS; SUBTROPICAL SAVANNA; SOIL INTERACTIONS; SHRUB ENCROACHMENT; ECOSYSTEM CARBON; WATER-USE; PARKLAND; VEGETATION; INVASION; SUCCESSION	Woody plant encroachment into grasslands has been globally widespread. The woody species invading grasslands represent a variety of contrasting plant functional groups and growth forms. Are some woody plant functional types (PFTs) better suited to invade grasslands than others? To what extent do local patterns of distribution and abundance of woody PFTs invading grasslands reflect intrinsic topoedaphic properties versus plant-induced changes in soil properties? We addressed these questions in the Southern Great Plains, United States at a subtropical grassland known to have been encroached upon by woody species over the past 50-100 years. A total of 20 woody species (9 tree-statured; 11 shrub-statured) were encountered along a transect extending from an upland into a playa basin. About half of the encroaching woody plants were potential N-2-fixers (55% of species), but they contributed only 7% to 16 % of the total basal area. Most species and the PFTs they represent were ubiquitously distributed along the topoedaphic gradient, but with varying abundances. Overstory-understory comparisons suggest that while future species composition of these woody communities is likely to change, PFT composition is not. Canonical correspondence analysis (CCA) ordination and variance partitioning (Partial CCA) indicated that woody species and PFT composition in developing woody communities was primarily influenced by intrinsic landscape location variables (e. g., soil texture) and secondarily by plant-induced changes in soil organic carbon and total nitrogen content. The ubiquitous distribution of species and PFTs suggests that woody plants are generally well-suited to a broad range of grassland topoedaphic settings. However, here we only examined categorical and non-quantitative functional traits. Although intrinsic soil properties exerted more control over the floristics of grassland-to-woodland succession did plant modifications of soil carbon and nitrogen concentrations, the latter are likely to influence productivity and nutrient cycling and may, over longer time-frames, feed back to influence PFT distributions.	[Liu, Feng] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China; [Liu, Feng; Boutton, Thomas W.; Wu, Xinyuan Ben] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX USA; [Archer, Steven R.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA; [Gelwick, Frances] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Bai, Edith] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Texas A&M University System; Texas A&M University College Station; University of Arizona; Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Liu, F (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China.	liufeng@wbgcas.cn	Liu, Feng/A-1410-2014; Wu, X. Ben/E-3772-2010; Noojipady, Praveen/B-2511-2010; Boutton, Thomas W./C-5821-2016	Liu, Feng/0000-0003-3383-7598; Wu, X. Ben/0000-0001-5947-3118; Boutton, Thomas W./0000-0002-7522-5728	National Science Foundation Ecosystem Studies Program [DEB-9981723]; CAS Hundred Talends Program	National Science Foundation Ecosystem Studies Program; CAS Hundred Talends Program	Funding for this research was provided by National Science Foundation Ecosystem Studies Program (Grant DEB-9981723) and partly by the CAS Hundred Talends Program to Feng Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, TREES SHRUBS CACTI S; ARCHER S, 1995, ECOSCIENCE, V2, P83, DOI 10.1080/11956860.1995.11682272; ARCHER S, 1988, ECOL MONOGR, V58, P111, DOI 10.2307/1942463; Archer S., 2001, GLOBAL BIOGEOCHEM CY, P115; Archer S.R., 2010, WILD RANGELANDS CONS, P53, DOI DOI 10.1002/9781444317091.CH4; Asner G.P., 2009, LIVESTOCK CHANGING L, P69; Bai E, 2008, OECOLOGIA, V156, P479, DOI 10.1007/s00442-008-1003-4; Bai E, 2012, ORG GEOCHEM, V42, P1512, DOI 10.1016/j.orggeochem.2010.11.004; Barger NN, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001506; Barnes PW, 1999, J VEG SCI, V10, P525, DOI 10.2307/3237187; Barnes PW, 1996, OECOLOGIA, V105, P493, DOI 10.1007/BF00330012; Biederman LA, 2009, SOIL BIOL BIOCHEM, V41, P1943, DOI 10.1016/j.soilbio.2009.06.019; BLAIR WF, 1950, J SCI, V2, P93; Boo R. M., 1991, B SOCIEDAD ARGENTINA, V27, P135; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Boutton T.W., 2009, SOIL CARBON SEQUESTR, P181; Boutton TW, 1999, RAPID COMMUN MASS SP, V13, P1263, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1263::AID-RCM653>3.0.CO;2-J; Boutton TW, 1998, GEODERMA, V82, P5, DOI 10.1016/S0016-7061(97)00095-5; BOUTTON TW, 2010, BIOGEOSCIENCES, V115, P3019; BROWN JR, 1990, OIKOS, V57, P366, DOI 10.2307/3565966; BROWN JR, 1988, VEGETATIO, V73, P73, DOI 10.1007/BF00031854; Browning DM, 2008, ECOL APPL, V18, P928, DOI 10.1890/07-1559.1; Burke IC, 1998, BIOGEOCHEMISTRY, V42, P121, DOI 10.1023/A:1005987807596; COFFEY CR, 1986, FLORISTIC STUDY LA C; Dickie IA, 2011, J APPL ECOL, V48, P926, DOI 10.1111/j.1365-2664.2011.01980.x; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Garcia C, 2005, GEODERMA, V124, P193, DOI 10.1016/j.geoderma.2004.04.013; Hibbard KA, 2003, ECOL APPL, V13, P911, DOI 10.1890/1051-0761(2003)13[911:GTWTIC]2.0.CO;2; Hibbard KA, 2001, ECOLOGY, V82, P1999, DOI 10.1890/0012-9658(2001)082[1999:BCAWPE]2.0.CO;2; Higgins SI, 2012, J ECOL, V100, P1400, DOI 10.1111/j.1365-2745.2012.02026.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Jurena PN, 2003, ECOLOGY, V84, P907, DOI 10.1890/0012-9658(2003)084[0907:WPEASH]2.0.CO;2; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; Kurokawa H, 2010, FUNCT ECOL, V24, P513, DOI 10.1111/j.1365-2435.2009.01676.x; Laungani R, 2009, P NATL ACAD SCI USA, V106, P12400, DOI 10.1073/pnas.0900921106; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; McCune B., 2011, PC ORD MULTIVARIATE; MCLENDON T, 1991, TEX J SCI, V43, P13; Midgley JJ, 2001, J TROP ECOL, V17, P871, DOI 10.1017/S026646740100164X; Midwood AJ, 1998, PLANT SOIL, V205, P13, DOI 10.1023/A:1004355423241; Naito AT, 2011, PROG PHYS GEOG, V35, P423, DOI 10.1177/0309133311403538; Nelson JA, 2002, PLANT ECOL, V160, P193, DOI 10.1023/A:1015828604444; O'Grady AP, 2009, OECOLOGIA, V160, P643, DOI 10.1007/s00442-009-1332-y; Okland RH, 2003, J VEG SCI, V14, P693, DOI 10.1111/j.1654-1103.2003.tb02201.x; OKLAND RH, 1994, J VEG SCI, V5, P117, DOI 10.2307/3235645; Okland RH, 1999, J VEG SCI, V10, P131, DOI 10.2307/3237168; PARKER AL, 2010, J ARID ENVIRON, P1487; Qian H, 2003, J VEG SCI, V14, P173, DOI 10.1658/1100-9233(2003)014[0173:UVIBPM]2.0.CO;2; Ratajczak Z, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00212.1; REID N, 1990, J VEG SCI, V1, P529, DOI 10.2307/3235787; Rossi BE, 2003, J VEG SCI, V14, P543, DOI 10.1658/1100-9233(2003)014[0543:EOPFOS]2.0.CO;2; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Schlesinger WH, 1998, BIOGEOCHEMISTRY, V42, P169, DOI 10.1023/A:1005939924434; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SCIFRES CJ, 1975, J RANGE MANAGE, V28, P279, DOI 10.2307/3897776; Soil Survey Staff, 2004, 42 SOIL SURV STAFF; Stokes CJ, 2010, ECOLOGY, V91, P1152, DOI 10.1890/08-1105.1; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Van Breemen N, 1998, BIOGEOCHEMISTRY, V42, P1, DOI 10.1023/A:1005962124317; VETAAS OR, 1992, J VEG SCI, V3, P337, DOI 10.2307/3235758; Wakeling JL, 2011, OIKOS, V120, P1448, DOI 10.1111/j.1600-0706.2011.19957.x; WATTS SE, 1993, ROOTING PATTERNS COO; Weltzin JF, 1997, ECOLOGY, V78, P751, DOI 10.1890/0012-9658(1997)078[0751:SMROVS]2.0.CO;2; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x; Zitzer SF, 1996, J APPL ECOL, V33, P1125, DOI 10.2307/2404692; Zou CB, 2005, OECOLOGIA, V145, P32, DOI 10.1007/s00442-005-0110-8	70	19	20	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84364	10.1371/journal.pone.0084364	http://dx.doi.org/10.1371/journal.pone.0084364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367655	Green Published, gold			2022-12-27	WOS:000328740300138
J	Huang, PR; Niu, WQ; Ni, ZT; Wang, RZ; Sun, XD				Huang, Peirong; Niu, Wenquan; Ni, Zhentian; Wang, Renzuo; Sun, Xiaodong			A Meta-Analysis of Anti-Vascular Endothelial Growth Factor Remedy for Macular Edema Secondary to Central Retinal Vein Occlusion	PLOS ONE			English	Article							VISUAL-ACUITY; PERMEABILITY	Background: Central retinal vein occlusion (CRVO) associates with severe vision outcome and no proven beneficial treatment. Our meta-analysis intended to appraise the efficacy and safety of anti-vascular endothelial growth factor (anti-VEGF) agents in macular edema (ME) following CRVO. Methods: Data were collected and analyzed by Review Manager 5.2.1. We employed a random-effects model to eliminate between-study heterogeneity. N-fs (called fail-safe number) was calculated to evaluate the publication bias. Results: We included 5 trials consisting 323 cases and 281 controls. Primary outcomes showed that overall comparison of anti-VEGF agents with placebo control yielded a 374% and 136% increased tendency for a gain of 15 letters or more on Early Treatment Diabetic Retinopathy Study (ETDRS) chart (95% confidence interval [95% CI]: 2.43-9.23; P < 0.00001; I-2 = 59%, 95% CI: 1.60-3.49; P < 0.0001; I-2 = 0%, respectively) at 6 and 12 months. Secondary outcomes showed that a 90% and 77% decreased risk at 6 and 12 months for a loss of 15 letters or more. The overall mean difference showed a statistically significance in best-corrected visual acuity (BCVA) on each time point. However, changes of central retinal thickness (CRT) lost significance at 12 months after 6-month as-needed treatment. The incidence of adverse events (AEs) had no statistical difference between anti-VEGF and placebo groups. Subgroup analyses indicated that patients receiving Aflibercept got the highest tendency to gain 15 letters or more (OR = 9.78; 95% CI: 4.43-21.56; P < 0.00001). Age controlled analysis suggested a weaken tendency of BCVA improvement in age over 50 (MD = 12.26; 95% CI: 7.55-16.98; P < 0.00001). Subgroup analysis by clinical classification showed a strengthen difference of BCVA changes at 6 months in ischemic type (MD = 19.65 letters, 95% CI: 13.15 to 26.14 letters, P < 0.00001). Conclusions: Our results showed that anti-VEGF agents were superior to placebo in CRVO-ME treatment with no statistically significant AEs, especially in younger people and for ischemic type.	[Huang, Peirong; Sun, Xiaodong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Sun, Xiaodong] Shanghai Jiao Tong Univ, Eye Res Inst, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hypertens, Shanghai 200030, Peoples R China; [Ni, Zhentian; Wang, Renzuo] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, XD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China.	xdsun@sjtu.edu.cn	Wang, Ruzhu/A-6727-2012; NI, ZHENTIAN/GSJ-2311-2022	Wang, Ruzhu/0000-0003-3586-5728; 	National Basic Research Program of China P-RHa [2011CB707506]; National Natural Science Foundation of China [81271030, 81170861]; Shanghai Key Basic Research [11JC141601]; Shanghai Scholar Leadship [12XD1404100]	National Basic Research Program of China P-RHa(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Basic Research; Shanghai Scholar Leadship	This study was supported by the National Basic Research Program of China P-RHa longer-te(2011CB707506), the National Natural Science Foundation of China Grant (81271030 and 81170861), Shanghai Key Basic Research Grant (11JC141601), Shanghai Scholar Leadship Grant (12XD1404100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Beck RW, 2007, OPHTHALMOLOGY, V114, P1804, DOI 10.1016/j.ophtha.2007.06.047; Boyd SR, 2002, ARCH OPHTHALMOL-CHIC, V120, P1644; Boyer D, 2010, OPHTHALMOLOGY, V117, P1860, DOI 10.1016/j.ophtha.2010.02.022; Braithwaite T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007325.pub2; Brown DM, 2013, AM J OPHTHALMOL, V155, P429, DOI 10.1016/j.ajo.2012.09.026; Browning DJ, 2007, OPHTHALMOLOGY, V114, P525, DOI 10.1016/j.ophtha.2006.06.052; Campochiaro PA, 2011, OPHTHALMOLOGY, V118, P2041, DOI 10.1016/j.ophtha.2011.02.038; Ciulla TA, 2009, CURR OPIN OPHTHALMOL, V20, P166, DOI 10.1097/ICU.0b013e328329d173; CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1425; CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1434; Crowther M, 2010, BLOOD, V116, P3140, DOI 10.1182/blood-2010-05-280883; Epstein DLJ, 2012, OPHTHALMOLOGY, V119, P1184, DOI 10.1016/j.ophtha.2012.01.022; FONG ACO, 1993, SURV OPHTHALMOL, V37, P393, DOI 10.1016/0039-6257(93)90138-W; GUTMAN FA, 1983, OPHTHALMOLOGY, V90, P481; Haller JA, 2010, OPHTHALMOLOGY, V117, P1134, DOI 10.1016/j.ophtha.2010.03.032; HAYREH SS, 1994, AM J OPHTHALMOL, V117, P429, DOI 10.1016/S0002-9394(14)70001-7; Hayreh SS, 2005, PROG RETIN EYE RES, V24, P493, DOI 10.1016/j.preteyeres.2004.12.001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ip MS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1101, DOI 10.1001/archophthalmol.2009.234; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kinge B, 2010, AM J OPHTHALMOL, V150, P310, DOI 10.1016/j.ajo.2010.03.028; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P513, DOI 10.1001/archopht.126.4.513; Lahey JM, 2002, OPHTHALMOLOGY, V109, P126, DOI 10.1016/S0161-6420(01)00842-9; London NJS, 2011, CURR OPIN OPHTHALMOL, V22, P159, DOI 10.1097/ICU.0b013e3283459737; McAllister IL, 2012, CLIN EXP OPHTHALMOL, V40, P48, DOI 10.1111/j.1442-9071.2011.02713.x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Niu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024266; Niu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017052; Niu WQ, 2009, HYPERTENS RES, V32, P1060, DOI 10.1038/hr.2009.164; ORTH DH, 1978, SURV OPHTHALMOL, V22, P357, DOI 10.1016/0039-6257(78)90132-7; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; ROSENBERG N, 1986, ARCH OPHTHALMOL-CHIC, V104, P34; Sakamoto A, 2009, CLIN EXP OPHTHALMOL, V37, P208, DOI 10.1111/j.1442-9071.2009.01914.x; Scott IU, 2009, OPHTHALMOLOGY, V116, P504, DOI 10.1016/j.ophtha.2008.10.017; Shahid H, 2006, BRIT J OPHTHALMOL, V90, P627, DOI 10.1136/bjo.2005.068668; Shahsuvaryan ML, 2003, EUR J OPHTHALMOL, V13, P445, DOI 10.1177/112067210301300505; Wroblewski JJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P374, DOI 10.1001/archophthalmol.2009.14; Xue P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045849	39	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82454	10.1371/journal.pone.0082454	http://dx.doi.org/10.1371/journal.pone.0082454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376538	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000013
J	Lee, HS; Lee, J; Kim, SO; Song, JS; Lee, JH; Lee, SI; Jung, HS; Choi, BJ				Lee, Hyo-Seol; Lee, Jongeun; Kim, Seong-Oh; Song, Je-Seon; Lee, Jae-Ho; Lee, Syng-Ill; Jung, Han-Sung; Choi, Byung-Jai			Comparative Gene-Expression Analysis of the Dental Follicle and Periodontal Ligament in Humans	PLOS ONE			English	Article							STEM-CELLS; BONE SIALOPROTEIN; CDNA MICROARRAY; TISSUE; DIFFERENTIATION; LOCALIZATION; OSTEOPONTIN; PROFILE; GROWTH; PULP	The human dental follicle partially differentiates into the periodontal ligament (PDL), but their biological functions are different. The gene-expression profiles of the dental follicle and PDL were compared using the cDNA microarray technique. Microarray analysis identified 490 genes with a twofold or greater difference in expression, 365 and 125 of which were more abundant in the dental follicle and PDL, respectively. The most strongly expressed genes in the dental follicle were those related to bone development and remodeling (EGFL6, MMP8, FRZB, and NELL1), apoptosis and chemotaxis (Nox4, CXCL13, and CCL2), and tooth and embryo development (WNT2, PAX3, FGF7, AMBN, AMTN, and SLC4A4), while in the PDL it was the tumor-suppressor gene WIF1. Genes related to bone development and remodeling (STMN2, IBSP, BMP8A, BGLAP, ACP5, OPN, BMP3, and TM7SF4) and wound healing (IL1, IL8, MMP3, and MMP9) were also more strongly expressed in the PDL than in the dental follicle. In selected genes, a comparison among cDNA microarray, real-time reverse-transcription polymerase chain reaction, and immunohistochemical staining confirmed similar relative gene expressions. The gene-expression profiles presented here identify candidate genes that may enable differentiation between the dental follicle and PDL.	[Lee, Hyo-Seol; Lee, Jongeun; Kim, Seong-Oh; Song, Je-Seon; Lee, Jae-Ho; Choi, Byung-Jai] Yonsei Univ, Dept Pediat Dent, Coll Dent, Seoul 120749, South Korea; [Kim, Seong-Oh; Song, Je-Seon; Lee, Jae-Ho; Choi, Byung-Jai] Yonsei Univ, Oral Sci Res Ctr, Coll Dent, Seoul 120749, South Korea; [Lee, Syng-Ill] Yonsei Univ, Div Oral Physiol, Dept Oral Biol, Coll Dent, Seoul 120749, South Korea; [Jung, Han-Sung] Yonsei Univ, Div Anat & Dev Biol, Dept Oral Biol, Coll Dent, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, BJ (corresponding author), Yonsei Univ, Dept Pediat Dent, Coll Dent, Seoul 120749, South Korea.	bjchoi@yuhs.ac	Jung, Han-Sung/I-3848-2012	Jung, Han-Sung/0000-0003-2795-531X; Kim, Seong Oh/0000-0002-8620-1377; Song, Je Seon/0000-0001-8620-5629; lee, jaeho/0000-0002-1556-3485	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0022160, 2012R1A1A2041910]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0022160 and 2012R1A1A2041910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amft N, 2001, ARTHRITIS RHEUM-US, V44, P2633, DOI 10.1002/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9; Baba S, 2011, ARCH ORAL BIOL, V56, P466, DOI 10.1016/j.archoralbio.2010.11.010; Cate ART, 1997, PERIODONTOL 2000, V13, P9, DOI 10.1111/j.1600-0757.1997.tb00093.x; Chan SL, 2007, LAB INVEST, V87, P644, DOI 10.1038/labinvest.3700547; Chen F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024638; CHEN JK, 1993, ARCH ORAL BIOL, V38, P241, DOI 10.1016/0003-9969(93)90034-J; Chiellini C, 2008, BIOCHEM BIOPH RES CO, V374, P64, DOI 10.1016/j.bbrc.2008.06.121; Chim SM, 2011, J BIOL CHEM, V286, P22035, DOI 10.1074/jbc.M110.187633; EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853; Fujita K, 2012, NAT MED, V18, P589, DOI 10.1038/nm.2659; Han X, 2002, J DENT RES, V81, P399, DOI 10.1177/154405910208100609; Heikinheimo K, 2002, J DENT RES, V81, P525, DOI 10.1177/154405910208100805; Kayed H, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-83; Kemoun P, 2007, TISSUE CELL, V39, P257, DOI 10.1016/j.tice.2007.06.001; Kubota T, 2008, J PERIODONTOL, V79, P166, DOI [10.1902/jop.2008.070159, 10.1902/jop.2008.070159 ]; Lee YH, 2007, J PERIODONTOL, V78, P446, DOI 10.1902/jop.2007.060240; McCulloch CA, 2006, PERIODONTOL 2000, V40, P173, DOI 10.1111/j.1600-0757.2005.00135.x; McLachlan JL, 2005, BBA-MOL BASIS DIS, V1741, P271, DOI 10.1016/j.bbadis.2005.03.007; Moriguchi M, 2010, ANAT SCI INT, V85, P92, DOI 10.1007/s12565-009-0061-y; Morsczeck C, 2008, CLIN ORAL INVEST, V12, P113, DOI 10.1007/s00784-007-0170-8; Paakkonen V, 2008, INT ENDOD J, V41, P117; Paakkonen V, 2005, EUR J ORAL SCI, V113, P369, DOI 10.1111/j.1600-0722.2005.00237.x; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Qu Y, 2008, J CANCER RES CLIN, V134, P353, DOI 10.1007/s00432-007-0291-0; ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738; Saugspier M, 2010, STEM CELLS DEV, V19, P707, DOI [10.1089/scd.2010.0027, 10.1089/scd.2009.0027]; Silverio KG, 2012, J PERIODONTAL RES, V47, P309, DOI 10.1111/j.1600-0765.2011.01433.x; Song JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061231; Suomalainen M, 2010, DEV DYNAM, V239, P364, DOI 10.1002/dvdy.22106	29	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84201	10.1371/journal.pone.0084201	http://dx.doi.org/10.1371/journal.pone.0084201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376796	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000143
J	Luckerath, K; Lapa, C; Spahmann, A; Jorg, G; Samnick, S; Rosenwald, A; Einsele, H; Knop, S; Buck, AK				Luckerath, Katharina; Lapa, Constantin; Spahmann, Annika; Joerg, Gerhard; Samnick, Samuel; Rosenwald, Andreas; Einsele, Herrmann; Knop, Stefan; Buck, Andreas K.			Targeting Paraprotein Biosynthesis for Non-Invasive Characterization of Myeloma Biology	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MULTIPLE-MYELOMA; IMAGING TECHNIQUES; IN-VIVO; C-11-METHIONINE PET/CT; FDG PET/CT; PATHOGENESIS; ANTIBODY; CELLS; MANAGEMENT	Purpose: Multiple myeloma is a hematologic malignancy originating from clonal plasma cells. Despite effective therapies, outcomes are highly variable suggesting marked disease heterogeneity. The role of functional imaging for therapeutic management of myeloma, such as positron emission tomography with 2-deoxy-2-[F-18]fluoro-D-glucose (F-18-FDG-PET), remains to be determined. Although some studies already suggested a prognostic value of F-18-FDG-PET, more specific tracers addressing hallmarks of myeloma biology, e. g. paraprotein biosynthesis, are needed. This study evaluated the amino acid tracers L-methyl-[C-11]-methionine (C-11-MET) and [F-18]-fluoroethyl-L-tyrosine (F-18-Fet) for their potential to image myeloma and to characterize tumor heterogeneity. Experimental Design: To study the utility of C-11-MET, F-18-Fet and F-18-FDG for myeloma imaging, time activity curves were compared in various human myeloma cell lines (INA-6, MM1.S, OPM-2) and correlated to cell-biological characteristics, such as marker gene expression and immunoglobulin levels. Likewise, patient-derived CD138(+) plasma cells were characterized regarding uptake and biomedical features. Results: Using myeloma cell lines and patient-derived CD138(+) plasma cells, we found that the relative uptake of C-11-MET exceeds that of F-18-FDG 1.5- to 5-fold and that of F-18-Fet 7- to 20-fold. Importantly, C-11-MET uptake significantly differed between cell types associated with worse prognosis (e. g. t(4;14) in OPM-2 cells) and indolent ones and correlated with intracellular immunoglobulin light chain and cell surface CD138 and CXCR4 levels. Direct comparison of radiotracer uptake in primary samples further validated the superiority of C-11-MET. Conclusion: These data suggest that C-11-MET might be a versatile biomarker for myeloma superior to routine functional imaging with F-18-FDG regarding diagnosis, risk stratification, prognosis and discrimination of tumor subtypes.	[Luckerath, Katharina; Lapa, Constantin; Spahmann, Annika; Joerg, Gerhard; Samnick, Samuel; Buck, Andreas K.] Univ Wurzburg, Med Ctr, Dept Nucl Med, Wurzburg, Germany; [Einsele, Herrmann; Knop, Stefan] Univ Wurzburg, Med Ctr, Dept Hematol & Oncol, Wurzburg, Germany; [Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Luckerath, K (corresponding author), Univ Wurzburg, Med Ctr, Dept Nucl Med, Wurzburg, Germany.	Lueckerath_K@ukw.de	Lueckerath, Katharina/AAF-8598-2019; Lueckerath, Katharina/S-5882-2018; Lapa, Constantin/GLV-0441-2022	Lueckerath, Katharina/0000-0001-6109-2066; Lueckerath, Katharina/0000-0001-6109-2066; Lapa, Constantin/0000-0001-7536-2207; Buck, Andreas/0000-0002-6447-0613	German Research Foundation (DFG) [105022/5-1 FUGG]; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was supported by the German Research Foundation (DFG) (105022/5-1 FUGG; http://www.dfg.de; funding was granted for establishment of a cyclotron and related laboratories) and the Open Access Publishing funding programme from the German Research Foundation (DFG) and the University of Wuerzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2013, AM J ROENTGENOL, V200, P884, DOI 10.2214/AJR.12.9653; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Bannas P, 2013, ROFO-FORTSCHR RONTG, V185, P26, DOI 10.1055/s-0032-1325405; Bartel TB, 2009, BLOOD, V114, P2068, DOI 10.1182/blood-2009-03-213280; Bourdier T, 2011, NUCL MED BIOL, V38, P645, DOI 10.1016/j.nucmedbio.2011.01.001; Burger R., 1994, BRIT J HAEMATOL, V87, P4212; Dankerl A, 2007, RADIOLOGY, V242, P498, DOI 10.1148/radiol.2422051980; Delcommenne Marc, 2012, Human Antibodies, V21, P29, DOI 10.3233/HAB-2012-0259; Diamond P, 2009, J BONE MINER RES, V24, P1150, DOI [10.1359/jbmr.090210, 10.1359/JBMR.090210]; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; Dispenzieri A, 2009, LEUKEMIA, V23, P215, DOI 10.1038/leu.2008.307; Durie BGM, 2002, J NUCL MED, V43, P1457; Durie BGM, 2006, EUR J CANCER, V42, P1539, DOI 10.1016/j.ejca.2005.11.037; Finno CJ, 2013, J VET INTERN MED, V27, P177, DOI 10.1111/jvim.12015; Gomzina N A, 2011, Bioorg Khim, V37, P216; Harris SM, 2013, J NUCL MED; Hillengass J, 2013, LEUKEMIA LYMPHOMA, V54, P1355, DOI 10.3109/10428194.2012.740559; Hillner BE, 2008, J NUCL MED, V49, P1928, DOI 10.2967/jnumed.108.056713; ISHIWATA K, 1988, J NUCL MED, V29, P1419; Iwama K, 2013, EUR J HAEMATOL, V90, P134, DOI 10.1111/ejh.12050; Jager PL, 2001, J NUCL MED, V42, P432; Kim HY, 2010, CANCER RES TREAT, V42, P225, DOI 10.4143/crt.2010.42.4.225; Kniess T, 2008, APPL RADIAT ISOTOPES, V66, P482, DOI 10.1016/j.apradiso.2007.06.005; Kuehl WM, 2012, J CLIN INVEST, V122, P3456, DOI 10.1172/JCI61188; Kuhne MR, 2013, CLIN CANCER RES, V19, P357, DOI 10.1158/1078-0432.CCR-12-2333; Magrangeas F, 2013, LEUKEMIA, V27, P473, DOI 10.1038/leu.2012.226; Magrangeas F, 2003, BLOOD, V101, P4998, DOI 10.1182/blood-2002-11-3385; Morgan GJ, 2012, HEMATOL-AM SOC HEMAT, P342, DOI 10.1182/asheducation-2012.1.342; Nakamoto Y, 2013, EUR J NUCL MED MOL I, V40, P708, DOI 10.1007/s00259-012-2333-3; Okubo S, 2010, J NEURO-ONCOL, V99, P217, DOI 10.1007/s11060-010-0117-9; Phekoo KJ, 2004, BRIT J HAEMATOL, V127, P299, DOI 10.1111/j.1365-2141.2004.05207.x; Regelink JC, 2013, BRIT J HAEMATOL, V162, P50, DOI 10.1111/bjh.12346; Reijmers RM, 2013, FEBS J, V280, P2180, DOI 10.1111/febs.12180; Rousseau C, 2012, TUMOR BIOL, V33, P679, DOI 10.1007/s13277-012-0362-y; Salamon J, 2013, EUR J NUCL MED MOL I, V40, P685, DOI 10.1007/s00259-012-2314-6; Schirrmeister H, 2003, CANCER BIOTHER RADIO, V18, P841, DOI 10.1089/108497803770418382; Shortt CP, 2009, AM J ROENTGENOL, V192, P980, DOI 10.2214/AJR.08.1633; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stessman HA, 2013, LEUKEMIA; Terpos E, 2011, J CLIN ONCOL, V29, P1907, DOI 10.1200/JCO.2010.32.5449; Udi J, 2013, BRIT J HAEMATOL, V161, P104, DOI 10.1111/bjh.12226; Zamagni E, 2011, BLOOD, V118, P5989, DOI 10.1182/blood-2011-06-361386	42	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84840	10.1371/journal.pone.0084840	http://dx.doi.org/10.1371/journal.pone.0084840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376850	Green Published, gold			2022-12-27	WOS:000328882000167
J	Azouzi, S; Gueroult, M; Ripoche, P; Genetet, S; Colin Aronovicz, Y; Le Van Kim, C; Etchebest, C; Mouro-Chanteloup, I				Azouzi, Slim; Gueroult, Marc; Ripoche, Pierre; Genetet, Sandrine; Colin Aronovicz, Yves; Le Van Kim, Caroline; Etchebest, Catherine; Mouro-Chanteloup, Isabelle			Energetic and Molecular Water Permeation Mechanisms of the Human Red Blood Cell Urea Transporter B	PLOS ONE			English	Article							URINARY CONCENTRATING ABILITY; PROTON EXCLUSION; UT-B; DYNAMICS SIMULATIONS; MEMBRANE-PROTEIN; AMMONIA CHANNEL; AQUAPORIN-1; ERYTHROCYTES; LIPOSOMES; PERMEABILITY	Urea transporter B (UT-B) is a passive membrane channel that facilitates highly efficient permeation of urea. In red blood cells (RBC), while the major function of UT-B is to transport urea, it is assumed that this protein is able to conduct water. Here, we have revisited this last issue by studying RBCs and ghosts from human variants with defects of aquaporin 1 (AQP1) or UT-B. We found that UT-B's osmotic water unit permeability (pf(unit)) is similar to that of AQP1. The determination of diffusional permeability coefficient (P-d) allowed the calculation of the P-f/P-d ratio, which is consistent with a single-file water transport. Molecular dynamic simulations of water conduction through human UT-B confirmed the experimental finding. From these results, we propose an atomistic description of water-protein interactions involved in this permeation. Inside the UT-B pore, five water molecules were found to form a single-file and move rapidly along a channel by hydrogen bond exchange involving two critical threonines. We further show that the energy barrier for water located in the central region coincides with a water dipole reorientation, which can be related to the proton exclusion observed experimentally. In conclusion, our results indicate that UT-B should be considered as a new member of the water channel family.	[Azouzi, Slim; Gueroult, Marc; Ripoche, Pierre; Genetet, Sandrine; Colin Aronovicz, Yves; Le Van Kim, Caroline; Etchebest, Catherine; Mouro-Chanteloup, Isabelle] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Azouzi, Slim; Gueroult, Marc; Ripoche, Pierre; Genetet, Sandrine; Colin Aronovicz, Yves; Le Van Kim, Caroline; Etchebest, Catherine; Mouro-Chanteloup, Isabelle] INSERM, UMR S665, Paris, France; [Azouzi, Slim; Gueroult, Marc; Ripoche, Pierre; Genetet, Sandrine; Colin Aronovicz, Yves; Le Van Kim, Caroline; Etchebest, Catherine; Mouro-Chanteloup, Isabelle] Univ Paris Diderot, Paris, France; [Azouzi, Slim; Gueroult, Marc; Ripoche, Pierre; Genetet, Sandrine; Colin Aronovicz, Yves; Le Van Kim, Caroline; Etchebest, Catherine; Mouro-Chanteloup, Isabelle] Lab Excellence GR Ex, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mouro-Chanteloup, I (corresponding author), Inst Natl Transfus Sanguine, F-75015 Paris, France.	isabelle.mouro-chanteloup@inserm.fr	etchebest, catherine/O-2485-2019; Isabelle, Mouro-Chanteloup/M-9750-2018; colin, yves/O-1910-2017; azouzi, slim/E-9295-2013; le van kim, caroline/O-7030-2017	etchebest, catherine/0000-0002-5871-2372; Isabelle, Mouro-Chanteloup/0000-0002-6368-9904; colin, yves/0000-0001-5196-4254; azouzi, slim/0000-0001-5519-4031; GENETET, Sandrine/0000-0001-8497-0087; Gueroult, Marc/0000-0003-1036-7490; le van kim, caroline/0000-0002-3251-1310	Grand Equipement National de Calcul Intensif (GENCI)-Centre Informatique National de l'Enseignement Superieur (CINES) [2012-076948, 2013-076948]	Grand Equipement National de Calcul Intensif (GENCI)-Centre Informatique National de l'Enseignement Superieur (CINES)	This work was supported by Grand Equipement National de Calcul Intensif (GENCI)-Centre Informatique National de l'Enseignement Superieur (CINES) Grant 2012-076948 and 2013-076948. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1993, AM J PHYSIOL, V265, pF463; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bankir L, 2004, AM J PHYSIOL-RENAL, V286, pF144, DOI 10.1152/ajprenal.00205.2003; Beckstein O, 2003, P NATL ACAD SCI USA, V100, P7063, DOI 10.1073/pnas.1136844100; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Burykin A, 2003, BIOPHYS J, V85, P3696, DOI 10.1016/S0006-3495(03)74786-9; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chakrabarti N, 2004, STRUCTURE, V12, P65, DOI 10.1016/j.str.2003.11.017; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; de Groot BL, 2003, J MOL BIOL, V333, P279, DOI 10.1016/j.jmb.2003.08.003; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; DENKER BM, 1988, J BIOL CHEM, V263, P15634; ECHEVARRIA M, 1993, J GEN PHYSIOL, V101, P827, DOI 10.1085/jgp.101.6.827; FROHLICH O, 1991, AM J PHYSIOL, V260, pC778, DOI 10.1152/ajpcell.1991.260.4.C778; Fu D, 2007, MOL MEMBR BIOL, V24, P366, DOI 10.1080/09687680701446965; Genetet S, 2012, AM J PHYSIOL-CELL PH, V302, pC419, DOI 10.1152/ajpcell.00092.2011; Geyer RR, 2013, AM J PHYSIOL-RENAL, V304, pF1447, DOI 10.1152/ajprenal.00609.2012; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Hub Jochen S, 2009, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-540-79885-9_3; Ilan B, 2004, PROTEINS, V55, P223, DOI 10.1002/prot.20038; Jensen MO, 2008, P NATL ACAD SCI USA, V105, P14430, DOI 10.1073/pnas.0802401105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Ko YJ, 2008, PROTEINS, V70, P1442, DOI 10.1002/prot.21696; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Levin EJ, 2012, P NATL ACAD SCI USA, V109, P11194, DOI 10.1073/pnas.1207362109; Levin EJ, 2009, NATURE, V462, P757, DOI 10.1038/nature08558; Li H, 2011, J MOL BIOL, V407, P607, DOI 10.1016/j.jmb.2011.01.036; Lucien N, 2002, J BIOL CHEM, V277, P34101, DOI 10.1074/jbc.M205073200; MACEY RI, 1984, AM J PHYSIOL, V246, pC195, DOI 10.1152/ajpcell.1984.246.3.C195; MacIver B, 2008, AM J PHYSIOL-RENAL, V294, pF956, DOI 10.1152/ajprenal.00229.2007; Mamonov AB, 2007, J GEN PHYSIOL, V130, P111, DOI 10.1085/jgp.200709810; MANNUZZU LM, 1993, J MEMBRANE BIOL, V133, P85; Mathai JC, 1996, J BIOL CHEM, V271, P1309, DOI 10.1074/jbc.271.3.1309; Mouro-Chanteloup I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008921; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nakhoul NL, 2001, AM J PHYSIOL-RENAL, V281, pF255, DOI 10.1152/ajprenal.2001.281.2.F255; OLIVES B, 1995, J BIOL CHEM, V270, P15607, DOI 10.1074/jbc.270.26.15607; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Qiu H, 2010, BBA-BIOMEMBRANES, V1798, P318, DOI 10.1016/j.bbamem.2009.11.015; Ray A, 2010, BIOINFORMATICS, V26, P3067, DOI 10.1093/bioinformatics/btq581; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; Saison C, 2012, VOX SANG, V103, P137, DOI 10.1111/j.1423-0410.2012.01590.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANDS JM, 1992, J AM SOC NEPHROL, V2, P1689; Sidoux-Walter F, 1999, J BIOL CHEM, V274, P30228, DOI 10.1074/jbc.274.42.30228; Tieleman DP, 2006, J PHYS-CONDENS MAT, V18, pS1221, DOI 10.1088/0953-8984/18/28/S07; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605; WISTOW GJ, 1991, TRENDS BIOCHEM SCI, V16, P170, DOI 10.1016/0968-0004(91)90065-4; Yang BX, 1998, J BIOL CHEM, V273, P9369, DOI 10.1074/jbc.273.16.9369; Yang BX, 2005, AM J PHYSIOL-RENAL, V288, pF881, DOI 10.1152/ajprenal.00367.2004; Yang BX, 2002, J BIOL CHEM, V277, P36782, DOI 10.1074/jbc.M206948200; YE RG, 1989, BIOCHEMISTRY-US, V28, P824, DOI 10.1021/bi00428a062; Zhao D, 2007, BBA-BIOMEMBRANES, V1768, P1815, DOI 10.1016/j.bbamem.2007.04.010; Zhu FQ, 2004, BIOPHYS J, V86, P50, DOI 10.1016/S0006-3495(04)74082-5	61	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82338	10.1371/journal.pone.0082338	http://dx.doi.org/10.1371/journal.pone.0082338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376529	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100027
J	Chiang, AWT; Shaw, GTW; Hwang, MJ				Chiang, Austin W. T.; Shaw, Grace T. W.; Hwang, Ming-Jing			Partitioning the Human Transcriptome Using HKera, a Novel Classifier of Housekeeping and Tissue-Specific Genes	PLOS ONE			English	Article							EXPRESSION; IDENTIFICATION; COMPENDIUM; PROFILES; ONTOLOGY; TOOL	High-throughput transcriptomic experiments have made it possible to classify genes that are ubiquitously expressed as housekeeping (HK) genes and those expressed only in selective tissues as tissue-specific (TS) genes. Although partitioning a transcriptome into HK and TS genes is conceptually problematic owing to the lack of precise definitions and gene expression profile criteria for the two, information whether a gene is an HK or a TS gene can provide an initial clue to its cellular and/or functional role. Consequently, the development of new and novel HK (TS) classification methods has been a topic of considerable interest in post-genomics research. Here, we report such a development. Our method, called HKera, differs from the others by utilizing a novel property of HK genes that we have previously uncovered, namely that the ranking order of their expression levels, as opposed to the expression levels themselves, tends to be preserved from one tissue to another. Evaluated against multiple benchmark sets of human HK genes, including one recently derived from second generation sequencing data, HKera was shown to perform significantly better than five other classifiers that use different methodologies. An enrichment analysis of pathway and gene ontology annotations showed that HKera-predicted HK and TS genes have distinct functional roles and, together, cover most of the ontology categories. These results show that HKera is a good transcriptome partitioner that can be used to search for, and obtain useful expression and functional information for, novel HK (TS) genes.	[Chiang, Austin W. T.; Hwang, Ming-Jing] Acad Sinica, Taiwan Int Grad Program, Bioinformat Program, Taipei 115, Taiwan; [Chiang, Austin W. T.; Shaw, Grace T. W.; Hwang, Ming-Jing] Natl Yang Ming Univ, Inst BioMed Informat, Taipei 112, Taiwan; [Chiang, Austin W. T.; Shaw, Grace T. W.; Hwang, Ming-Jing] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Hwang, MJ (corresponding author), Acad Sinica, Taiwan Int Grad Program, Bioinformat Program, Taipei 115, Taiwan.	mjhwang@ibms.sinica.edu.tw	Chiang, Austin W.T./AAF-8376-2019; Hwang, Ming-jing/E-9210-2012	Chiang, Austin W.T./0000-0001-6514-5612; Hwang, Ming-jing/0000-0002-9657-5663	National Science Council of Taiwan (NSC) [101-2311-B-001-026-MY3]	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported in part by a grant from the National Science Council of Taiwan (NSC grant no. 101-2311-B-001-026-MY3). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Cardoso JS, 2007, J MACH LEARN RES, V8, P1393; Cardoso JS, 2012, MACHINE LEARNING APP, V1; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022859; Chikina MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000417; Chu W, 2005, J MACH LEARN RES, V6, P1019; De Ferrari L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-277; Dong B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021012; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eller CD, 2007, GENE, V390, P153, DOI 10.1016/j.gene.2006.09.018; Farre D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r140; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Green DM, 1966, SIGNAL DETECTION THE; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Henson R, 2005, ENCY GENETICS GENOMI; Hild KE, 2006, IEEE T PATTERN ANAL, V28, P1385, DOI 10.1109/TPAMI.2006.186; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang PI, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-439; Kadota K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-294; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kotsiantis SB, 2007, INFORM-J COMPUT INFO, V31, P249; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Lehner B, 2004, TRENDS GENET, V20, P468, DOI 10.1016/j.tig.2004.08.002; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Shaw GTW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029314; She XW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-269; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Watson J. D., 1987, MOL BIOL GENE; WILLIAMS T, 1988, P NATL ACAD SCI USA, V85, P3527, DOI 10.1073/pnas.85.10.3527; Wu CH, 2003, NUCLEIC ACIDS RES, V31, P345, DOI 10.1093/nar/gkg040; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83040	10.1371/journal.pone.0083040	http://dx.doi.org/10.1371/journal.pone.0083040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376628	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100080
J	Dybowski, R; McKinley, TJ; Mastroeni, P; Restif, O				Dybowski, Richard; McKinley, Trevelyan J.; Mastroeni, Pietro; Restif, Olivier			Nested Sampling for Bayesian Model Comparison in the Context of Salmonella Disease Dynamics	PLOS ONE			English	Article							MONTE-CARLO METHODS; INFECTION; ENTERICA; COMPUTATION; INFERENCE; EFFICIENT; SPREAD; DEATH	Understanding the mechanisms underlying the observed dynamics of complex biological systems requires the statistical assessment and comparison of multiple alternative models. Although this has traditionally been done using maximum likelihood-based methods such as Akaike's Information Criterion (AIC), Bayesian methods have gained in popularity because they provide more informative output in the form of posterior probability distributions. However, comparison between multiple models in a Bayesian framework is made difficult by the computational cost of numerical integration over large parameter spaces. A new, efficient method for the computation of posterior probabilities has recently been proposed and applied to complex problems from the physical sciences. Here we demonstrate how nested sampling can be used for inference and model comparison in biological sciences. We present a reanalysis of data from experimental infection of mice with Salmonella enterica showing the distribution of bacteria in liver cells. In addition to confirming the main finding of the original analysis, which relied on AIC, our approach provides: (a) integration across the parameter space, (b) estimation of the posterior parameter distributions (with visualisations of parameter correlations), and (c) estimation of the posterior predictive distributions for goodness-of-fit assessments of the models. The goodness-of-fit results suggest that alternative mechanistic models and a relaxation of the quasi-stationary assumption should be considered.	[Dybowski, Richard; McKinley, Trevelyan J.; Mastroeni, Pietro; Restif, Olivier] Univ Cambridge, Dept Vet, Cambridge, England	University of Cambridge	Dybowski, R (corresponding author), Univ Cambridge, Dept Vet, Cambridge, England.	rd460@cam.ac.uk	, orestif/AAA-1532-2019	, orestif/0000-0001-9158-853X; Mastroeni, Pietro/0000-0003-3838-4962	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I002189/1, BB/I012192/1]; Royal Society; Biotechnology and Biological Sciences Research Council [BB/I002189/1, BB/I012192/1, BBS/B/02266] Funding Source: researchfish; BBSRC [BB/I012192/1, BB/I002189/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RD was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (grant number BB/I002189/1). TJM was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (grant number BB/I012192/1). OR was funded by the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1974, IEEE T AUTOMATIC CON, V19, P195; Anderson D. R., 2008, MODEL BASED INFERENC; Bishop C. M, 2006, PATTERN RECOGNITION; Brown SP, 2006, PLOS BIOL, V4, P2091, DOI 10.1371/journal.pbio.0040349; Brown ST, 2006, CINEMA ANIME, P1; Charleston B, 2011, SCIENCE, V332, P726, DOI 10.1126/science.1199884; Chopin N, 2010, BIOMETRIKA, V97, P741, DOI 10.1093/biomet/asq021; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; DUDEWICZ EJ, 1988, MODERN MATH STAT; Feroz F, 2008, MON NOT R ASTRON SOC, V384, P449, DOI 10.1111/j.1365-2966.2007.12353.x; Feroz F, 2009, MON NOT R ASTRON SOC, V398, P1601, DOI 10.1111/j.1365-2966.2009.14548.x; Garcia-Perez MA, 1999, BEHAV RES METH INS C, V31, P701, DOI 10.3758/BF03200749; Gelman Andrew, 1995, BAYESIAN DATA ANAL; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Grant AJ, 2008, IMMUNOLOGY, V125, P28, DOI 10.1111/j.1365-2567.2008.02814.x; Grant AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003070; Grant AJ, 2009, INFECT IMMUN, V77, P5608, DOI 10.1128/IAI.00827-09; Jasa T, 2012, J ACOUST SOC AM, V132, P3251, DOI 10.1121/1.4754550; Kimmel M., 2002, BRANCHING PROCESSES; Larson H., 1982, INTRO PROBABILITY TH; Mastroeni P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001840; Mastroeni P, 2009, NAT REV MICROBIOL, V7, P73, DOI 10.1038/nrmicro2034; MENG XL, 1994, ANN STAT, V22, P1142, DOI 10.1214/aos/1176325622; Miller MR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000946; Mukherjee P, 2006, ASTROPHYS J, V638, pL51, DOI 10.1086/501068; Mulholland EK, 2005, NEW ENGL J MED, V352, P75, DOI 10.1056/NEJMe048306; Murray I, 2006, ADV NEURAL INFORM PR, V19, P947; Ng KM, 2002, THESIS STANFORD U ST; O'Neill PD, 2002, MATH BIOSCI, V180, P103, DOI 10.1016/S0025-5564(02)00109-8; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sheppard M, 2003, CELL MICROBIOL, V5, P593, DOI 10.1046/j.1462-5822.2003.00296.x; Sivia Devinderjit, 2006, DATA ANAL BAYESIAN T, DOI DOI 10.1007/10201161_90; Skilling J, 2004, AIP CONF PROC, V735, P395, DOI 10.1063/1.1835238; Skilling J, 2006, BAYESIAN ANAL, V1, P833, DOI 10.1214/06-BA127; Sokal RR, 1995, BIOMETRY	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82317	10.1371/journal.pone.0082317	http://dx.doi.org/10.1371/journal.pone.0082317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376528	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100026
J	Gao, L; Wu, GJ; Liu, B; Shen, MZ; Pan, TJ; Yu, CG; Wang, QH; Ru, Y; Liu, XP; Niu, TS; Wang, GD; Wei, M; Li, RX; Yao, LB; Wang, H; Li, X				Gao, Lei; Wu, Guo-jun; Liu, Bei; Shen, Ming-zhi; Pan, Tie-jun; Yu, Chui-gong; Wang, Qin-hao; Ru, Yi; Liu, Xi-ping; Niu, Tian-shui; Wang, Guo-dong; Wei, Ming; Li, Rui-xiao; Yao, Libo; Wang, He; Li, Xia			Up-Regulation of pVHL along with Down-Regulation of HIF-l alpha by NDRG2 Expression Attenuates Proliferation and Invasion in Renal Cancer Cells	PLOS ONE			English	Article							LINDAU TUMOR-SUPPRESSOR; GROWTH-FACTOR; CARCINOMA; PROTEIN; HYDROXYLATION; INSIGHTS; MUTATION; BIOLOGY; TARGET; OXYGEN	The majority of renal cell carcinomas (RCCs) are characterized by loss of function of he tumor suppressor gene von Hippel Lindau (VHL), which acts as ubiquitin ligase for hypoxia-inducible factor-l alpha (HIF-1 alpha). In the absence of VHL, HIF-l alpha Protein becomes stabilized and contributes to tumorigenesis. Recent data demonstrate the antitumor efficacy of VHL promoter in RCC cells. This study demonstrates that N-Myc downstream-regulated gene 2 (NDFRG2) is a potential regulator of VHL. NDRG2 is involved in proliferation and invasion of cancer cell, furthermore it is frequently down-regulated in renal cell carcinoma. Herein we evaluated the effect of NDRG2 overexpression on proliferation and invasion in human renal cancer cells. The human renal cancer cell line 786-O and A498 were infected with Ad-NDRG2 or Ad-LacZ. Overexpression of NDRG2 not only inhibited the growth of the cells, but also suppressed the invasion. Further study showed that the tumor suppressor gene VHL were up-regulated, whereas transcription factor HIF-1a and vascular endothelial growth factor (VEGF) were down-regulated in 786-O cells infected by Ad-NDRG2. Finally, in a nude mouse model, intratumoral injections of Ad-NDRG2 every 3 days for a total of seven times significantly inhibited the growth and angiogenesis of xenografted 786-O tumors. In conclusion, these data indicate that NDRG2 may be involved in proliferation and invasion by impacting the expression of VHL and HIF-l alpha. NDRG2 may be an attractive therapeutic target for renal cell carcinoma.	[Gao, Lei; Wang, Qin-hao; Ru, Yi; Liu, Xi-ping; Niu, Tian-shui; Li, Xia] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Gao, Lei; Wang, Guo-dong; Li, Rui-xiao; Yao, Libo; Wang, He] Fourth Mil Med Univ, Dept Urol, Tangdu Hosp, Xian 710032, Peoples R China; [Gao, Lei; Pan, Tie-jun] Guangzhou Command PLA, Wuhan Gen Hosp, Dept Urol, Wuhan, Peoples R China; [Wu, Guo-jun; Wei, Ming] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China; [Liu, Bei] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Liu, Bei] Fourth Mil Med Univ, Tangdu Hosp, Inst Funct Brain Disorders, Xian 710032, Peoples R China; [Shen, Ming-zhi] Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Cardiol, Sanya, Peoples R China; [Yu, Chui-gong] Armed Police Gen Hosp, Dept Urol, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital	Wang, H (corresponding author), Fourth Mil Med Univ, Dept Urol, Tangdu Hosp, Xian 710032, Peoples R China.	dusxjhw@fmmu.edu.cn; lixia@fmmu.edu.cn			National Natural Science Foundation of China [81230043, 81272812]; Chinese National Key Basic Research & Development Program [2009CB521704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Basic Research & Development Program(National Basic Research Program of China)	Funding provided by National Natural Science Foundation of China (No. 81230043 and No. 81272812) and Chinese National Key Basic Research & Development Program (2009CB521704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth S, 1999, CANCER RES, V59, P2210; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Baumunk D, 2013, WORLD J UROL, V31, P1191, DOI 10.1007/s00345-012-0874-5; Caceres W, 2011, P R HEALTH SCI J, V30, P73; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gao L, 2011, CANCER LETT, V310, P94, DOI 10.1016/j.canlet.2011.06.015; Haase VH, 2012, EXP CELL RES, V318, P1057, DOI 10.1016/j.yexcr.2012.02.026; Hegele A, 2002, UROL RES, V30, P126, DOI 10.1007/s00240-002-0245-6; Hu XL, 2004, WORLD J GASTROENTERO, V10, P3518; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kim A, 2009, CARCINOGENESIS, V30, P927, DOI 10.1093/carcin/bgp072; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kim YJ, 2009, CARCINOGENESIS, V30, P598, DOI 10.1093/carcin/bgp047; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Li LJ, 2011, HEMATOL ONCOL CLIN N, V25, P667, DOI 10.1016/j.hoc.2011.04.004; Liang ZL, 2012, ANN SURG ONCOL, V19, P2763, DOI 10.1245/s10434-011-2204-3; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; Lusis EA, 2005, CANCER RES, V65, P7121, DOI 10.1158/0008-5472.CAN-05-0043; Ma J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032368; Ma JJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-103; Ma JJ, 2008, BIOL PHARM BULL, V31, P1316, DOI 10.1248/bpb.31.1316; Mitropoulos D, 2004, UROL RES, V32, P317, DOI 10.1007/s00240-003-0360-z; Montani M, 2010, AM J SURG PATHOL, V34, P806, DOI 10.1097/PAS.0b013e3181ddf54d; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Qi H, 2003, CANCER RES, V63, P7076; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Shoji K, 2013, AM J PATHOL, V182, P2191, DOI 10.1016/j.ajpath.2013.02.024; Siegel R, 2012, CA-CANCER J CLIN, V62, DOI 10.3322/caac.21153; Sjolund J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023057; Struckmann K, 2008, J PATHOL, V214, P464, DOI 10.1002/path.2310; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V317, P358, DOI 10.1016/j.bbrc.2004.03.050; Xu L, 2012, CANCER SCI, V103, P1253, DOI 10.1111/j.1349-7006.2012.02291.x; Yu CG, 2011, CANCER BIOL THER, V12, P304, DOI 10.4161/cbt.12.4.16382	42	8	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84127	10.1371/journal.pone.0084127	http://dx.doi.org/10.1371/journal.pone.0084127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376788	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100157
J	Lehner, S; Gahle, M; Dierks, C; Stelter, R; Gerber, J; Brehm, R; Distl, O				Lehner, Stefanie; Gaehle, Marion; Dierks, Claudia; Stelter, Ricarda; Gerber, Jonathan; Brehm, Ralph; Distl, Ottmar			Two-Exon Skipping within MLPH Is Associated with Coat Color Dilution in Rabbits	PLOS ONE			English	Article							LAVENDER PLUMAGE COLOR; MYOSIN-VA; POLYPYRIMIDINE TRACT; GRISCELLI-SYNDROME; SPLICE-SITE; MELANOSOME TRANSPORT; JAPANESE-QUAIL; POINT-MUTATION; GENE; MELANOPHILIN	Coat color dilution turns black coat color to blue and red color to cream and is a characteristic in many mammalian species. Matings among Netherland Dwarf, Loh, and Lionhead Dwarf rabbits over two generations gave evidence for a monogenic autosomal recessive inheritance of coat colour dilution. Histological analyses showed non-uniformly distributed, large, agglomerating melanin granules in the hair bulbs of coat color diluted rabbits. We sequenced the cDNA of MLPH in two dilute and one black rabbit for polymorphism detection. In both color diluted rabbits, skipping of exons 3 and 4 was present resulting in altered amino acids at p.QGL[37-39]QWA and a premature stop codon at p.K40*. Sequencing of genomic DNA revealed a c.111-5C>A splice acceptor mutation within the polypyrimidine tract of intron 2 within MLPH. This mutation presumably causes skipping of exons 3 and 4. In 14/15 dilute rabbits, the c. 111-5C>A mutation was homozygous and in a further dilute rabbit heterozygous and in combination with a homozygous frame shift mutation within exon 6 (c.585delG). In conclusion, our results demonstrated a colour dilution associated MLPH splice variant causing a strongly truncated protein (p,Q37QfsX4). An involvement of further MLPH-associated mutations needs further investigations.	[Lehner, Stefanie; Dierks, Claudia; Stelter, Ricarda; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Gaehle, Marion; Gerber, Jonathan; Brehm, Ralph] Univ Vet Med Hannover, Inst Anat, Hannover, Germany; [Stelter, Ricarda] Univ Vet Med Hannover, Clin Pets Reptiles & Pet & Feral Birds, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de		Dierks, Claudia/0000-0003-1299-6063	University of Veterinary Medicine Hannover	University of Veterinary Medicine Hannover	The project has been supported by internal funds of the University of Veterinary Medicine Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anistoroaei R, 2007, CYTOGENET GENOME RES, V116, P316, DOI 10.1159/000100417; Aoshima M, 1996, BLOOD, V88, P1841; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bed'hom B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-442; BELDJORD C, 1988, NUCLEIC ACIDS RES, V16, P4927, DOI 10.1093/nar/16.11.4927; BRADBURY MW, 1988, J HERED, V79, P133, DOI 10.1093/oxfordjournals.jhered.a110471; Brooks SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000909; Clarke LA, 2000, GENE CHROMOSOME CANC, V29, P367, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1051>3.3.CO;2-M; David A, 2010, EUR J ENDOCRINOL, V162, P37, DOI 10.1530/EJE-09-0583; Drogemuueller C, 2007, J HERED, V98, P468, DOI 10.1093/jhered/esm021; Fang LJ, 2001, J MOL BIOL, V307, P1261, DOI 10.1006/jmbi.2001.4561; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; GERRITS PO, 1983, J MICROSC-OXFORD, V132, P81, DOI 10.1111/j.1365-2818.1983.tb04711.x; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; Haire RN, 1997, AM J HUM GENET, V60, P798; HANSTEDE JG, 1983, J MICROSC-OXFORD, V131, P79, DOI 10.1111/j.1365-2818.1983.tb04233.x; Hori T, 2013, HUM MUTAT, V34, P473, DOI 10.1002/humu.22258; Hume AN, 2006, MOL BIOL CELL, V17, P4720, DOI 10.1091/mbc.E06-05-0457; Ishida Y, 2006, GENOMICS, V88, P698, DOI 10.1016/j.ygeno.2006.06.006; Kim Jae Hoon, 2005, J Vet Sci, V6, P259; KRAWCZAK M, 1992, HUM GENET, V90, P41; MARKERT CL, 1956, GENETICS, V41, P429; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; Minvielle F, 2009, ANIM GENET, V40, P971, DOI 10.1111/j.1365-2052.2009.01929.x; MURRU S, 1991, BLOOD, V77, P1342; Nagashima K, 2002, FEBS LETT, V517, P233, DOI 10.1016/S0014-5793(02)02634-0; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Pap E., 1921, Zs indukt Abstammgslehre, V26, P185, DOI 10.1007/BF02124487; Pastural E, 1999, NAT GENET, V23, P373, DOI 10.1038/15565; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Perego R, 2009, CAN VET J, V50, P511; Philipp U, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-34; PRIEUR DJ, 1981, J HERED, V72, P178, DOI 10.1093/oxfordjournals.jhered.a109468; Quadros L, 2008, HAEMOPHILIA, V14, P628, DOI 10.1111/j.1365-2516.2008.01704.x; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; Romeis B, 1989, ROMEIS MIKROSKOPISCH, P657; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; RUSSELL ES, 1948, GENETICS, V33, P228; Sanal O, 2002, J CLIN IMMUNOL, V22, P237, DOI 10.1023/A:1016045026204; SCHNEIDER S, 1993, HUM GENET, V91, P599; SEBILLON P, 1995, NUCLEIC ACIDS RES, V23, P3419, DOI 10.1093/nar/23.17.3419; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Takahara K, 2002, AM J HUM GENET, V71, P451, DOI 10.1086/342099; Vaez M, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-7; Van Gele M, 2009, PIGM CELL MELANOMA R, V22, P268, DOI 10.1111/j.1755-148X.2009.00558.x; von Bomhard W, 2006, VET DERMATOL, V17, P182, DOI 10.1111/j.1365-3164.2006.00517.x; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yamada K, 2007, MOL GENET METAB, V90, P291, DOI 10.1016/j.ymgme.2006.10.010	53	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84525	10.1371/journal.pone.0084525	http://dx.doi.org/10.1371/journal.pone.0084525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376820	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100172
J	Li, N; Liu, EQ; Guo, J; Pan, L; Li, BJ; Wang, P; Liu, J; Wang, Y; Liu, GS; Baccarelli, AA; Hou, LF; Hu, G				Li, Nan; Liu, Enqing; Guo, Jia; Pan, Lei; Li, Baojuan; Wang, Ping; Liu, Jin; Wang, Yue; Liu, Gongshu; Baccarelli, Andrea A.; Hou, Lifang; Hu, Gang			Maternal Prepregnancy Body Mass Index and Gestational Weight Gain on Pregnancy Outcomes	PLOS ONE			English	Article							LONGITUDINAL CHANGES; GLUCOSE-TOLERANCE; OBESITY; WOMEN; ASSOCIATIONS; TRENDS; CHINA; RISK	Objective:The aim of the present study was to evaluate the single and joint associations of maternal prepregnancy body mass index (BMI) and gestational weight gain (GWG) with pregnancy outcomes in Tianjin, China. Methods: Between June 2009 and May 2011, health care records of 33,973 pregnant women were collected and their children were measured for birth weight and birth length. The independent and joint associations of prepregnancy BMI and GWG based on the Institute of Medicine (IOM) guidelines with the risks of pregnancy and neonatal outcomes were examined by using Logistic Regression. Results: After adjustment for all confounding factors, maternal prepregnancy BMI was positively associated with risks of gestational diabetes mellitus (GDM), pregnancy-induced hypertension, caesarean delivery, preterm delivery, large-for-gestational age infant (LGA), and macrosomia, and inversely associated with risks of small-for-gestational age infant (SGA) and low birth weight. Maternal excessive GWG was associated with increased risks of pregnancy-induced hypertension, caesarean delivery, LGA, and macrosomia, and decreased risks of preterm delivery, SGA, and low birth weight. Maternal inadequate GWG was associated with increased risks of preterm delivery and SGA, and decreased risks of LGA and macrosomia, compared with maternal adequate GWG. Women with both prepregnancy obesity and excessive GWG had 2.2-5.9 folds higher risks of GDM, pregnancy-induced hypertension, caesarean delivery, LGA, and macrosomia compared with women with normal prepregnancy BMI and adequate GWG. Conclusions: Maternal prepregnancy obesity and excessive GWG were associated with greater risks of pregnancy-induced hypertension, caesarean delivery, and greater infant size at birth. Health care providers should inform women to start the pregnancy with a BMI in the normal weight category and limit their GWG to the range specified for their prepregnancy BMI.	[Li, Nan; Liu, Enqing; Guo, Jia; Pan, Lei; Li, Baojuan; Wang, Ping; Liu, Jin; Wang, Yue; Liu, Gongshu; Hu, Gang] Tianjin Womens & Childrens Hlth Ctr, Tianjin, Peoples R China; [Li, Nan; Hu, Gang] Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, Baton Rouge, LA 70808 USA; [Baccarelli, Andrea A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Baccarelli, Andrea A.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Northwestern University; Feinberg School of Medicine	Hu, G (corresponding author), Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gang.hu@pbrc.edu	Hu, Gang/V-7947-2019; Hu, Gang/N-1971-2017	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017; Baccarelli, Andrea/0000-0002-3436-0640	Tianjin Women's and Children's Health Center	Tianjin Women's and Children's Health Center	All phases of this study were supported by Tianjin Women's and Children's Health Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Catalano PM, 1998, AM J OBSTET GYNECOL, V179, P156, DOI 10.1016/S0002-9378(98)70267-4; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Feng XL, 2012, B WORLD HEALTH ORGAN, V90, P30, DOI 10.2471/BLT.11.090399; Fortner RT, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.021; Frederick IO, 2008, MATERN CHILD HLTH J, V12, P557, DOI 10.1007/s10995-007-0276-2; Frederick IO, 2006, EPIDEMIOLOGY, V17, P428, DOI 10.1097/01.ede.0000221028.33245.0b; Frias AE, 2012, SEMIN REPROD MED, V30, P472, DOI 10.1055/s-0032-1328875; Gibson KS, 2012, OBSTET GYNECOL, V119, P560, DOI 10.1097/AOG.0b013e31824758e0; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Hull HR, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.004; Institute of Medicine, 2009, WEIFHT GAIN PREGN RE; Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03; Kabiru W, 2004, AM J OBSTET GYNECOL, V191, P928, DOI 10.1016/j.ajog.2004.06.051; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Leung TY, 2008, BJOG-INT J OBSTET GY, V115, P1529, DOI 10.1111/j.1471-0528.2008.01931.x; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077809; Liu YY, 2012, ARCH GYNECOL OBSTET, V286, P905, DOI 10.1007/s00404-012-2403-6; Macdonald-Wallis C, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.042; Mamun AA, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-62; Murakami Maki, 2005, Archives of Gynecology and Obstetrics, V271, P311, DOI 10.1007/s00404-004-0629-7; National Center for Health Statistics, 2013, PREGN NUTR SURV; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Okereke NC, 2004, AM J PHYSIOL-ENDOC M, V287, pE472, DOI 10.1152/ajpendo.00589.2003; Saldana TM, 2006, AM J OBSTET GYNECOL, V195, P1629, DOI 10.1016/j.ajog.2006.05.017; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Stotland NE, 2006, OBSTET GYNECOL, V108, P635, DOI 10.1097/01.AOG.0000228960.16678.bd; Taler SJ, 2004, AM J HYPERTENS, V17, p25A; Tianjin Women's and Children's Health Center, 2010, 2010 TIANJ WOM CHILD; Tsai IH, 2012, ASIA PAC J CLIN NUTR, V21, P82; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; WHO / IDF, 2006, DEF DIAGN DIAB MELL; Yang Yan-dong, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P646; Young TK, 2002, AM J OBSTET GYNECOL, V187, P312, DOI 10.1067/mob.2002.126200; Zhang F, 2011, DIABETIC MED, V28, P652, DOI 10.1111/j.1464-5491.2010.03205.x; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	37	205	223	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82310	10.1371/journal.pone.0082310	http://dx.doi.org/10.1371/journal.pone.0082310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376527	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100025
J	Ma, ZR; Axtell, MJ				Ma, Zhaorong; Axtell, Michael J.			Long-Range Genomic Enrichment, Sequencing, and Assembly to Determine Unknown Sequences Flanking a Known microRNA	PLOS ONE			English	Article							MULTIPLEX AMPLIFICATION; DISCOVERY; DNA; SELECTION; TRANSCRIPTION; EVOLUTION; ELEMENTS; CAPTURE; MOTIFS	Conserved plant microRNAs (miRNAS) modulate important biological processes but little is known about conserved cis-regulatory elements (CREs) surrounding MIRNA genes. We developed a solution-based targeted genomic enrichment methodology to capture, enrich, and sequence flanking genomic regions surrounding conserved MIRNA genes with a locked-nucleic acid (LNA)-modified, biotinylated probe complementary to the mature miRNA sequence. Genomic DNA bound by the probe is captured by streptavidin-coated magnetic beads, amplified, sequenced and assembled de novo to obtain genomic DNA sequences flanking MIRNA locus of interest. We demonstrate the sensitivity and specificity of this enrichment methodology in Arabidopsis thaliana to enrich targeted regions spanning 10-20 kb surrounding known MIR166 and MIR165 loci. Assembly of the sequencing reads successfully recovered all targeted loci. While further optimization for larger, more complex genomes is needed, this method may enable determination of flanking genomic DNA sequence surrounding a known core (like a conserved mature (miRNA) from multiple species that currently don't have a full genome assembly available.	[Axtell, Michael J.] Penn State Univ, Huck Inst Life Sci, Integrat Biosci PhD Program Bioinformat & Genom, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Axtell, MJ (corresponding author), Penn State Univ, Huck Inst Life Sci, Integrat Biosci PhD Program Bioinformat & Genom, University Pk, PA 16802 USA.	mja18@psu.edu			US National Science Foundation (NSF) [0964859]	US National Science Foundation (NSF)(National Science Foundation (NSF))	This study was funded by US National Science Foundation (NSF) award 0964859 to MJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; D'Ascenzo M, 2009, MAMM GENOME, V20, P424, DOI 10.1007/s00335-009-9200-y; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Ettwiller L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r104; Fu Y, 2010, PLANT J, V62, P898, DOI 10.1111/j.1365-313X.2010.04196.x; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Krishnakumar S, 2008, P NATL ACAD SCI USA, V105, P9296, DOI 10.1073/pnas.0803240105; Kurtz S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-517; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Megraw M, 2006, RNA, V12, P1612, DOI 10.1261/rna.130506; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Missirian V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-287; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; OCHMAN H, 1988, GENETICS, V120, P621; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Thomas MC, 2008, GEN TRANSCRIPTION MA, DOI DOI 10.1080/10409230600648736.ACCESSED; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716	37	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83721	10.1371/journal.pone.0083721	http://dx.doi.org/10.1371/journal.pone.0083721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376739	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100134
J	Sellwood, W; Morrison, AP; Beck, R; Heffernan, S; Law, H; Bentall, RP				Sellwood, William; Morrison, Anthony P.; Beck, Rosie; Heffernan, Suzanne; Law, Heather; Bentall, Richard P.			Subjective Cognitive Complaints in Schizophrenia: Relation to Antipsychotic Medication Dose, Actual Cognitive Performance, Insight and Symptoms	PLOS ONE			English	Article							CALGARY-DEPRESSION-SCALE; ULTRA-HIGH RISK; NEGATIVE SYMPTOMS; OBJECTIVE MEASURES; RATING-SCALE; DYSFUNCTION; BELIEFS; REPLICATION; RELIABILITY; OUTPATIENTS	Background: Subjective cognitive complaints are prevalent in those affected by functional psychoses and a variety of possible associated factors have been investigated. However, few studies have examined these potential factors within single studies or analyses. Methods: Patients with a history of a schizophrenia spectrum disorder (n = 115) and a non-clinical comparison group (n = 45) completed the Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS) and the Brief Assessment of Cognition in Schizophrenia (BACS). The patient group also completed the Positive and Negative Syndromes Scale (PANSS), the Birchwood Insight Scale (IS), and the Hospital Anxiety and Depression Scale (HADS). Results: The BACS and SSTICS scores were associated in the non-clinical comparison group, but not in the patient group. In the patient group worse subjective cognition was associated positively with good insight, greater dysphoria and greater positive symptoms. Linear regression revealed that, once other variables had been accounted for, dysphoria (HADS anxiety and depression factor) was the only significant predictor of SSTICS scores. Conclusions: Subjective cognitive impairment in patients with psychosis in the absence of formal testing should not be taken as evidence of impaired cognitive functioning. Mood should be investigated when patients present with subjective cognitive complaints.	[Sellwood, William; Beck, Rosie; Bentall, Richard P.] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Morrison, Anthony P.; Law, Heather] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Heffernan, Suzanne] Univ Lancaster, Div Hlth Res, Lancaster, England	University of Liverpool; University of Manchester; Lancaster University	Sellwood, W (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England.	sellwood@liverpool.ac.uk		Morrison, Anthony/0000-0002-4389-2091; Sellwood, William/0000-0001-8260-9503; Law, Heather/0000-0002-1889-9179	National Institute for Health Research (NIHR), UK [RP-PG-0606-1086]; National Institute for Health Research [RP-PG-0606-1086] Funding Source: researchfish	National Institute for Health Research (NIHR), UK(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research commissioned by the National Institute for Health Research (NIHR), UK under its Programme Grants for Applied Research scheme (RP-PG-0606-1086). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington D, 1996, SCHIZOPHR RES, V19, P205, DOI 10.1016/0920-9964(95)00070-4; ADDINGTON D, 1993, BRIT J PSYCHIAT, V163, P39, DOI 10.1192/S0007125000292581; ADDINGTON D, 1994, SCHIZOPHR RES, V11, P239, DOI 10.1016/0920-9964(94)90017-5; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Bayard S, 2009, EUR PSYCHIAT, V24, P251, DOI 10.1016/j.eurpsy.2008.12.010; Beck A.T., 1988, MANUAL BECK HOPELESS; BECK AT, 1990, AM J PSYCHIAT, V147, P190; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Seco RB, 2010, REV PSIQUIATR SALUD, V3, P55, DOI 10.1016/j.rpsm.2010.03.002; BIRCHWOOD M, 1994, ACTA PSYCHIAT SCAND, V89, P62, DOI 10.1111/j.1600-0447.1994.tb01487.x; CartwrightHatton S, 1997, J ANXIETY DISORD, V11, P279, DOI 10.1016/S0887-6185(97)00011-X; Chan RCK, 2008, SCHIZOPHR RES, V103, P229, DOI 10.1016/j.schres.2008.02.019; Grant PM, 2009, SCHIZOPHRENIA BULL, V35, P798, DOI 10.1093/schbul/sbn008; Harvey PD, 2011, SCHIZOPHR RES, V127, P188, DOI 10.1016/j.schres.2011.01.004; Johnson I, 2011, COMPR PSYCHIAT, V52, P688, DOI 10.1016/j.comppsych.2010.12.008; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2008, SCHIZOPHR RES, V102, P108, DOI 10.1016/j.schres.2008.03.024; Keefe RSE, 2006, AM J PSYCHIAT, V163, P426, DOI 10.1176/appi.ajp.163.3.426; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Kim JH, 2008, PARKINSONISM RELAT D, V14, P239, DOI 10.1016/j.parkreldis.2007.07.009; Kim JH, 2007, J CLIN PHARM THER, V32, P461, DOI 10.1111/j.1365-2710.2007.00848.x; LINDENMAYER JP, 1995, SCHIZOPHR RES, V14, P229, DOI 10.1016/0920-9964(94)00041-6; Lysaker PH, 2007, ACTA PSYCHIAT SCAND, V116, P290, DOI 10.1111/j.1600-0447.2007.01067.x; Lysaker PH, 2011, BRIT J CLIN PSYCHOL, V50, P412, DOI 10.1111/j.2044-8260.2010.02003.x; Mezulis AH, 2004, PSYCHOL BULL, V130, P711, DOI 10.1037/0033-2909.130.5.711; Moritz S, 2002, PSYCHOPATHOLOGY, V35, P367, DOI 10.1159/000068592; Moritz S, 2002, INT CLIN PSYCHOPHARM, V17, P41, DOI 10.1097/00004850-200201000-00007; Morrison AP, 2007, BEHAV RES THER, V45, P2241, DOI 10.1016/j.brat.2007.01.002; PERALTA V, 1992, COMPR PSYCHIAT, V33, P202, DOI 10.1016/0010-440X(92)90031-K; Perivoliotis D, 2009, PSYCHOPATHOLOGY, V42, P375, DOI 10.1159/000236909; Prouteau A, 2004, SCHIZOPHR RES, V69, P85, DOI 10.1016/j.schres.2003.08.011; Sabbag S, 2011, SCHIZOPHR RES, V131, P250, DOI 10.1016/j.schres.2011.05.003; Stip E, 2003, COMPR PSYCHIAT, V44, P331, DOI 10.1016/S0010-440X(03)00086-5; VANDENBOSCH RJ, 1993, COMPR PSYCHIAT, V34, P130, DOI 10.1016/0010-440X(93)90058-C; Ventura J, 2008, SCHIZOPHR RES, V106, P59, DOI 10.1016/j.schres.2007.07.025; Yilmaz AE, 2011, J ANXIETY DISORD, V25, P389, DOI 10.1016/j.janxdis.2010.11.001; Zanello A, 2001, PSYCHOPATHOLOGY, V34, P153, DOI 10.1159/000049299; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83774	10.1371/journal.pone.0083774	http://dx.doi.org/10.1371/journal.pone.0083774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376745	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000328745100138
J	Chislock, EM; Pendergast, AM				Chislock, Elizabeth M.; Pendergast, Ann Marie			Abl Family Kinases Regulate Endothelial Barrier Function In Vitro and in Mice	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; GROWTH-FACTOR RECEPTORS; TYROSINE KINASE; VE-CADHERIN; VASCULAR-PERMEABILITY; CELL PERMEABILITY; MICROVASCULAR PERMEABILITY; DIFFERENTIAL REGULATION; ADHERENS JUNCTIONS; INDUCED INCREASE	The maintenance of endothelial barrier function is essential for normal physiology, and increased vascular permeability is a feature of a wide variety of pathological conditions, leading to complications including edema and tissue damage. Use of the pharmacological inhibitor imatinib, which targets the Abl family of non-receptor tyrosine kinases (Abl and Arg), as well as other tyrosine kinases including the platelet-derived growth factor receptor (PDGFR), Kit, colony stimulating factor 1 receptor (CSF1R), and discoidin domain receptors, has shown protective effects in animal models of inflammation, sepsis, and other pathologies characterized by enhanced vascular permeability. However, the imatinib targets involved in modulation of vascular permeability have not been well-characterized, as imatinib inhibits multiple tyrosine kinases not only in endothelial cells and pericytes but also immune cells important for disorders associated with pathological inflammation and abnormal vascular permeability. In this work we employ endothelial Abl knockout mice to show for the first time a direct role for Abl in the regulation of vascular permeability in vivo. Using both Abl/Arg-specific pharmacological inhibition and endothelial Abl knockout mice, we demonstrate a requirement for Abl kinase activity in the induction of endothelial permeability by vascular endothelial growth factor both in vitro and in vivo. Notably, Abl kinase inhibition also impaired endothelial permeability in response to the inflammatory mediators thrombin and histamine. Mechanistically, we show that loss of Abl kinase activity was accompanied by activation of the barrier-stabilizing GTPases Rac1 and Rap1, as well as inhibition of agonist-induced Ca2+ mobilization and generation of acto-myosin contractility. In all, these findings suggest that pharmacological targeting of the Abl kinases may be capable of inhibiting endothelial permeability induced by a broad range of agonists and that use of Abl kinase inhibitors may have potential for the treatment of disorders involving pathological vascular leakage.	[Chislock, Elizabeth M.; Pendergast, Ann Marie] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Pendergast, AM (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	ann.pendergast@duke.edu		Chislock, Elizabeth/0000-0002-9776-4271; Pendergast, Ann Marie/0000-0002-1250-6880	Pharmaceutical Research and Manufacturers of America Foundation; American Heart Association; National Institutes of Health [CA155160, CA070940, HL084102, AI056266]; NATIONAL CANCER INSTITUTE [R01CA155160, R01CA070940] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056266] Funding Source: NIH RePORTER	Pharmaceutical Research and Manufacturers of America Foundation; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Pharmaceutical Research and Manufacturers of America Foundation (www.phrmafoundation.org) Predoctoral Fellowship in Pharmacology/Toxicology (to EMC), an American Heart Association (www.heart.org) Predoctoral Fellowship (to EMC), and National Institutes of Health (www.nih.gov) Grants CA155160, CA070940, HL084102, and AI056266 (to AMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman J, 2012, CIRCULATION, V126, P2728, DOI 10.1161/CIRCULATIONAHA.112.134304; Amerongen GPV, 2002, VASC PHARMACOL, V39, P257, DOI 10.1016/S1537-1891(03)00014-4; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Anselmi F, 2012, ANGIOGENESIS, V15, P187, DOI 10.1007/s10456-012-9252-6; Becker PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1500, DOI 10.1152/ajplung.2001.281.6.L1500; Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chislock EM, 2013, P NATL ACAD SCI USA, V110, P12432, DOI 10.1073/pnas.1304188110; Choi Y, 2009, J BIOL CHEM, V284, P29005, DOI 10.1074/jbc.M109.026633; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Di Lorenzo A, 2013, J CELL SCI; Dudek SM, 2010, MOL BIOL CELL, V21, P4042, DOI 10.1091/mbc.E09-10-0876; Dvorak AM, 1996, J LEUKOCYTE BIOL, V59, P100, DOI 10.1002/jlb.59.1.100; Esser S, 1998, J CELL SCI, V111, P1853; Fujii E, 1997, N-S ARCH PHARMACOL, V356, P475, DOI 10.1007/PL00005079; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gavard J, 2008, J BIOL CHEM, V283, P29888, DOI 10.1074/jbc.M803880200; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gavard J, 2009, FEBS LETT, V583, P1, DOI 10.1016/j.febslet.2008.11.032; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Groeneveld ABJ, 2002, VASC PHARMACOL, V39, P247, DOI 10.1016/S1537-1891(03)00013-2; Gu JJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002632; Huang XD, 2008, J CELL BIOL, V183, P711, DOI 10.1083/jcb.200801192; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Kim IK, 2013, CRIT CARE, V17, DOI 10.1186/cc12786; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Kurimoto N, 2004, AM J PHYSIOL-HEART C, V287, pH100, DOI 10.1152/ajpheart.00922.2003; Lampugnani MG, 1997, CURR OPIN CELL BIOL, V9, P674, DOI 10.1016/S0955-0674(97)80121-4; Le Q, 1998, J IMMUNOL, V160, P3330; Li R, 2011, CURR BIOL, V21, P1534, DOI 10.1016/j.cub.2011.08.023; McLaughlin J, 2007, P NATL ACAD SCI USA, V104, P20501, DOI 10.1073/pnas.0710532105; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Pietras K, 2001, CANCER RES, V61, P2929; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Smith-Pearson PS, 2010, J BIOL CHEM, V285, P40201, DOI 10.1074/jbc.M110.147330; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vlahovic G, 2007, BRIT J CANCER, V97, P735, DOI 10.1038/sj.bjc.6603941; Vlahovic G, 2006, BRIT J CANCER, V95, P1013, DOI 10.1038/sj.bjc.6603366; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Yuan SY, 2002, VASC PHARMACOL, V39, P213, DOI 10.1016/S1537-1891(03)00010-7; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	71	52	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e85231	10.1371/journal.pone.0085231	http://dx.doi.org/10.1371/journal.pone.0085231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367707	Green Submitted, Green Published, gold			2022-12-27	WOS:000328741900075
J	Tanninen, SE; Morrissey, MD; Takehara-Nishiuchi, K				Tanninen, Stephanie E.; Morrissey, Mark D.; Takehara-Nishiuchi, Kaori			Unilateral Lateral Entorhinal Inactivation Impairs Memory Expression in Trace Eyeblink Conditioning	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; VENTRAL HIPPOCAMPUS; DORSAL HIPPOCAMPUS; ACQUISITION; CONSOLIDATION; RETRIEVAL; AMYGDALA; LESIONS; MICROINJECTION; PROJECTIONS	Memory in trace eyeblink conditioning is mediated by an inter-connected network that involves the hippocampus (HPC), several neocortical regions, and the cerebellum. This network reorganizes after learning as the center of the network shifts from the HPC to the medial prefrontal cortex (mPFC). Despite the network reorganization, the lateral entorhinal cortex (LEC) plays a stable role in expressing recently acquired HPC-dependent memory as well as remotely acquired mPFC-dependent memory. Entorhinal involvement in recent memory expression may be attributed to its previously proposed interactions with the HPC. In contrast, it remains unknown how the LEC participates in memory expression after the network disengages from the HPC. The present study tested the possibility that the LEC and mPFC functionally interact during remote memory expression by examining the impact of pharmacological inactivation of the LEC in one hemisphere and the mPFC in the contralateral hemisphere on memory expression in rats. Memory expression one day and one month after learning was significantly impaired after LEC-mPFC inactivation; however, the degree of impairment was comparable to that after unilateral LEC inactivation. Unilateral mPFC inactivation had no effect on recent or remote memory expression. These results suggest that the integrity of the LEC in both hemispheres is necessary for memory expression. Functional interactions between the LEC and mPFC should therefore be tested with an alternative design.	[Tanninen, Stephanie E.; Morrissey, Mark D.; Takehara-Nishiuchi, Kaori] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Tanninen, Stephanie E.; Morrissey, Mark D.; Takehara-Nishiuchi, Kaori] Univ Toronto, Program Neurosci, Toronto, ON, Canada; [Takehara-Nishiuchi, Kaori] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Takehara-Nishiuchi, K (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	takehara@psych.utoronto.ca	Takehara-Nishiuchi, Kaori/Q-9053-2019; Takehara, Kaori/ABD-2977-2020	Takehara-Nishiuchi, Kaori/0000-0002-7282-7838; Takehara, Kaori/0000-0002-7282-7838; Morrissey, Mark/0000-0002-3300-162X	National Sciences and Engineering Research Council of Canada (NSERC) [386683]; Canadian Foundation for Innovation Leaders [25026]; NSERC	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation Leaders; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding sources: National Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant 386683 (K.T.-N); Canadian Foundation for Innovation Leaders Opportunity Grant 25026 (K.T.-N.); NSERC Canadian Graduate Scholarship D (M. D. M.); NSERC Canadian Graduate Scholarship M (S. E. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agster KL, 2009, HIPPOCAMPUS, V19, P1159, DOI 10.1002/hipo.20578; Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Cimadevilla JM, 2005, COGNITIVE BRAIN RES, V25, P741, DOI 10.1016/j.cogbrainres.2005.09.001; ColemanMesches K, 1996, BEHAV BRAIN RES, V77, P175, DOI 10.1016/0166-4328(95)00231-6; ColemanMesches K, 1997, BEHAV BRAIN RES, V86, P17, DOI 10.1016/S0166-4328(96)02211-5; Coutureau E, 2009, PROG NEURO-PSYCHOPH, V33, P753, DOI 10.1016/j.pnpbp.2009.03.038; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Esclassan F, 2009, J NEUROSCI, V29, P8087, DOI 10.1523/JNEUROSCI.0543-09.2009; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; FENTON AA, 1993, BEHAV NEUROSCI, V107, P552, DOI 10.1037/0735-7044.107.4.552; Gilmartin MR, 2012, NEUROBIOL LEARN MEM, V97, P452, DOI 10.1016/j.nlm.2012.03.009; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Insausti R, 1997, HIPPOCAMPUS, V7, P146, DOI 10.1002/(SICI)1098-1063(1997)7:2<146::AID-HIPO4>3.0.CO;2-L; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Jones BF, 2007, HIPPOCAMPUS, V17, P957, DOI 10.1002/hipo.20330; KIM JJ, 1995, BEHAV NEUROSCI, V109, P195, DOI 10.1037/0735-7044.109.2.195; Lorenzini CA, 1996, BRAIN RES, V730, P32, DOI 10.1016/0006-8993(96)00427-1; MARKOWITSCH HJ, 1983, BRAIN RES BULL, V10, P805, DOI 10.1016/0361-9230(83)90212-5; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; Morrissey MD, 2012, J NEUROSCI, V32, P5356, DOI 10.1523/JNEUROSCI.5227-11.2012; Moyer JR, 1996, J NEUROSCI, V16, P5536; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; Oswald BB, 2008, BEHAV NEUROSCI, V122, P841, DOI 10.1037/0735-7044.122.4.841; Oswald BB, 2010, NEUROBIOL LEARN MEM, V93, P37, DOI 10.1016/j.nlm.2009.08.001; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Ryou JW, 2001, NEUROBIOL LEARN MEM, V75, P121, DOI 10.1006/nlme.2000.3966; Simon B, 2005, J NEUROSCI, V25, P10740, DOI 10.1523/JNEUROSCI.3003-05.2005; Suter EE, 2013, LEARN MEMORY, V20, P80, DOI 10.1101/lm.028894.112; Takehara K, 2002, BRAIN RES, V951, P183, DOI 10.1016/S0006-8993(02)03159-1; Takehara K, 2003, J NEUROSCI, V23, P9897; Takehara-Nishiuchi K, 2005, LEARN MEMORY, V12, P606, DOI 10.1101/lm.5905; Takehara-Nishiuchi K, 2006, J NEUROSCI, V26, P5049, DOI 10.1523/JNEUROSCI.4381-05.2006; Takehara-Nishiuchi K, 2012, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00090; Thompson LT, 1997, J PHARMACOL EXP THER, V281, P928; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Weible AP, 2006, NEUROSCIENCE, V141, P1123, DOI 10.1016/j.neuroscience.2006.04.065; Weiss C, 1999, BEHAV BRAIN RES, V99, P123, DOI 10.1016/S0166-4328(98)00096-5; Wilson DI, 2013, HIPPOCAMPUS, V23, P352, DOI 10.1002/hipo.22095; Yoon T, 2007, NEUROBIOL LEARN MEM, V87, P464, DOI 10.1016/j.nlm.2006.12.006	40	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84543	10.1371/journal.pone.0084543	http://dx.doi.org/10.1371/journal.pone.0084543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367674	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900054
J	Li, CY; Zhang, SY; Lu, Y; Zhang, Y; Wang, EH; Cui, ZS				Li, Chunyan; Zhang, Siyang; Lu, Yao; Zhang, Ying; Wang, Enhua; Cui, Zeshi			The Roles of Notch3 on the Cell Proliferation and Apoptosis Induced by CHIR99021 in NSCLC Cell Lines: A Functional Link between Wnt and Notch Signaling Pathways	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PANCREATIC-CANCER CELLS; HUMAN LUNG CANCERS; CARCINOMA-CELLS; PROTEIN-KINASE; BETA-CATENIN; INHIBITION; GROWTH; ACTIVATION; CYCLE	Wnt and Notch signaling pathways both play essential roles and interact closely in development and carcinogenesis, but their interaction in non-small-cell lung cancer (NSCLC) is poorly unknown. Here we investigated the effects of CHIR99021, a Wnt signaling agonist, or Notch3-shRNA, or the combined application of CHIR99021 and Notch3-shRNA on cell proliferation and apoptosis, as well as the expressions of Notch3, its downstream genes, cyclinA and caspase-3. Our results showed that CHIR99021 up-regulated the expression of Notch3 protein and HES1 and HEYL mRNA. CHIR99021 promoted cell proliferation and the expression of cyclinA, which were inhibited by Notch3-shRNA in these three cell lines. Moreover, Notch3-shRNA significantly attenuated the positive effects of CHIR99021 on cell proliferation and cyclinA in H460 and H157. As for apoptosis, Notch3-shRNA induced cell apoptosis and increased the expression of caspase-3, whereas CHIR99021 showed the different effects in these three cell lines. The inhibitory effect of CHIR99021 on apoptosis was significantly weakened by Notch3-shRNA only in H460. Overall, although the effects of CHIR99021 and the combined application of CHIR99021 and Notch3-shRNA on the cell proliferation and apoptosis aren't completely similar in the three cell lines, our findings still indicate that Notch3 signaling can be activated by canonical Wnt signaling and a functional link between Wnt and Notch signaling pathways exists in NSCLC, at least, which partially is associated with their regulations on the expressions of cyclinA and caspase-3.	[Li, Chunyan; Zhang, Siyang; Lu, Yao; Zhang, Ying; Cui, Zeshi] China Med Univ, Ctr Lab Technol & Expt Med, Shenyang, Peoples R China; [Wang, Enhua] China Med Univ, Dept Pathol, Shenyang, Peoples R China	China Medical University; China Medical University	Li, CY (corresponding author), China Med Univ, Ctr Lab Technol & Expt Med, Shenyang, Peoples R China.	chyli@mail.cmu.edu.cn			Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [20091001]; Liaoning Nature Science Project [201102258]	Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Liaoning Nature Science Project	The Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (to Chunyan Li, No. 20091001), Liaoning Nature Science Project (to Chunyan Li, No. 201102258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bertrand FE, 2012, CELL CYCLE, V11, P4344, DOI 10.4161/cc.22134; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Gaujoux S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055743; Grottkau BE, 2009, INT J ORAL SCI, V1, P81, DOI 10.4248/ijos.08025; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Katoh M, 2006, INT J MOL MED, V18, P517; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Lee JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036520; Li CY, 2011, J CANCER RES CLIN, V137, P771, DOI 10.1007/s00432-010-0934-4; Lin LP, 2010, CANCER RES, V70, P632, DOI 10.1158/0008-5472.CAN-09-3293; Liu YL, 2011, CURR CANCER DRUG TAR, V11, P1098, DOI 10.2174/156800911798073041; Marchand B, 2012, CARCINOGENESIS, V33, P529, DOI 10.1093/carcin/bgr309; Mazieres J, 2004, CANCER RES, V64, P4717, DOI 10.1158/0008-5472.CAN-04-1389; Mizugaki H, 2012, BRIT J CANCER, V106, P1953, DOI 10.1038/bjc.2012.178; Mori M, 2012, HUM CELL, V25, P9, DOI 10.1007/s13577-011-0038-8; Peng XR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-196; Shapiro M, 2013, ANN SURG, V257, P548, DOI 10.1097/SLA.0b013e31826d81fd; Sineva GS, 2010, BIOL CELL, V102, P549, DOI 10.1042/BC20100016; Subramaniam D, 2011, MOL CANCER THER, V10, P2146, DOI 10.1158/1535-7163.MCT-11-0399; Wang XH, 2009, CELL CYCLE, V8, P1567, DOI 10.4161/cc.8.10.8489; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Wei Q, 2008, LUNG CANCER, V62, P181, DOI 10.1016/j.lungcan.2008.06.018; Xu X, 2011, J THORAC ONCOL, V6, P716, DOI 10.1097/JTO.0b013e31820c5189; Yang LL, 2012, CARCINOGENESIS, V33, P1863, DOI 10.1093/carcin/bgs226; Zhou M, 2013, ONCOL LETT, V5, P499, DOI 10.3892/ol.2012.1033	30	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84659	10.1371/journal.pone.0084659	http://dx.doi.org/10.1371/journal.pone.0084659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367688	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300154
J	Ross, RL; Burns, JE; Taylor, CF; Mellor, P; Anderson, DH; Knowles, MA				Ross, Rebecca L.; Burns, Julie E.; Taylor, Claire F.; Mellor, Paul; Anderson, Deborah H.; Knowles, Margaret A.			Identification of Mutations in Distinct Regions of p85 Alpha in Urothelial Cancer	PLOS ONE			English	Article							INVASIVE BLADDER-CANCER; REGULATORY SUBUNIT P85-ALPHA; INTEGRATED GENOMIC ANALYSIS; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; ENDOMETRIAL CANCER; CATALYTIC SUBUNIT; HIGH-FREQUENCY; CARCINOMA; PTEN	Bladder cancers commonly show genetic aberrations in the phosphatidylinositol 3-kinase signaling pathway. Here we have screened for mutations in PIK3R1, which encodes p85 alpha, one of the regulatory subunits of PI3K. Two hundred and sixty-four bladder tumours and 41 bladder tumour cell lines were screened and 18 mutations were detected. Thirteen mutations were in C-terminal domains and are predicted to interfere with the interaction between p85 alpha and p110 alpha. Five mutations were in the BH domain of PIK3R1. This region has been implicated in p110 alpha-independent roles of p85 alpha, such as binding to and altering the activities of PTEN, Rab4 and Rab5. Expression of these mutant BH-p85 alpha forms in mouse embryonic fibroblasts with p85 alpha knockout indicated that all forms, except the truncation mutants, could bind and stabilize p110 alpha but did not increase AKT phosphorylation, suggesting that BH mutations function independently of p110 alpha. In a panel of 44 bladder tumour cell lines, 80% had reduced PIK3R1 mRNA expression relative to normal urothelial cells. This, along with mutation of PIK3R1, may alter BH domain functioning. Our findings suggest that mutant forms of p85 alpha may play an oncogenic role in bladder cancer, not only via loss of ability to regulate p110 alpha but also via altered function of the BH domain.	[Ross, Rebecca L.; Burns, Julie E.; Knowles, Margaret A.] St James Univ Hosp, Leeds Inst Canc & Pathol, Sect Expt Oncol, Leeds, W Yorkshire, England; [Taylor, Claire F.] St James Univ Hosp, Leeds Inst Canc & Pathol, Leeds Canc Res United Kingdom Ctr Genom Facil, Leeds, W Yorkshire, England; [Mellor, Paul; Anderson, Deborah H.] Saskatchewan Canc Agcy, Canc Res Unit, Saskatoon, SK, Canada; [Mellor, Paul; Anderson, Deborah H.] Univ Saskatchewan, Saskatoon, SK, Canada	Saint James's University Hospital; Saint James's University Hospital; University of Saskatchewan; University of Saskatchewan	Knowles, MA (corresponding author), St James Univ Hosp, Leeds Inst Canc & Pathol, Sect Expt Oncol, Leeds, W Yorkshire, England.	m.a.knowles@leeds.ac.uk		Burns, Julie/0000-0003-1238-8826; Knowles, Margaret/0000-0002-9363-8657	Yorkshire Cancer Research; University of Leeds MRC studentship; Canadian Institutes of Health Research [MOP84277]; Saskatchewan Health Research Foundation Fellowship	Yorkshire Cancer Research; University of Leeds MRC studentship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation Fellowship	Financial support provided by Yorkshire Cancer Research (http://yorkshirecancerresearch.org.uk/) (L362) and University of Leeds MRC studentship (MK, RR), Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (MOP84277)(DA), and Saskatchewan Health Research Foundation Fellowship (http://shrf.ca/)(PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; Aveyard JS, 1999, BRIT J CANCER, V80, P904, DOI 10.1038/sj.bjc.6690439; Brachmann SA, 2005, MOL CELL BIOL, V25, P2593, DOI 10.1128/MCB.25.7.2593-2606.2005; Cairns P, 1998, ONCOGENE, V16, P3215, DOI 10.1038/sj.onc.1201855; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chamberlain MD, 2008, J BIOL CHEM, V283, P15861, DOI 10.1074/jbc.M800941200; Chamberlain MD, 2010, CELL SIGNAL, V22, P1562, DOI 10.1016/j.cellsig.2010.05.025; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Chapman EJ, 2009, GENE CHROMOSOME CANC, V48, P694, DOI 10.1002/gcc.20672; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Hurst CD, 2012, CLIN CANCER RES, V18, P5865, DOI 10.1158/1078-0432.CCR-12-1807; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Jucker M, 2002, LEUKEMIA, V16, P894, DOI 10.1038/sj.leu.2402484; Knowles MA, 2003, CANCER RES, V63, P7652; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Luo J, 2005, P NATL ACAD SCI USA, V102, P10238, DOI 10.1073/pnas.0504378102; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Mellor P, 2012, BIOCHEM J, V441, P23, DOI 10.1042/BJ20111164; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Mizoguchi M, 2004, BRAIN PATHOL, V14, P372, DOI 10.1111/j.1750-3639.2004.tb00080.x; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Philp AJ, 2001, CANCER RES, V61, P7426; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Ross RL, 2013, ONCOGENE, V32, P768, DOI 10.1038/onc.2012.87; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; Simon R, 2000, INT J ONCOL, V17, P1025; Sjodahl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018583; Sun MH, 2010, P NATL ACAD SCI USA, V107, P15547, DOI 10.1073/pnas.1009652107; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Taylor CF, 2009, BIOCHEM SOC T, V37, P433, DOI 10.1042/BST0370433; Tomlinson DC, 2005, CANCER RES, V65, P10441, DOI 10.1158/0008-5472.CAN-05-1718; *UICC, 1978, TNM CLASS MAL TUM BL, P113; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; Wang DS, 2000, INT J CANCER, V88, P620, DOI 10.1002/1097-0215(20001115)88:4<620::AID-IJC16>3.0.CO;2-Z; WHO, 1973, HIST TYP UR BLADD TU; Wu HY, 2009, P NATL ACAD SCI USA, V106, P20258, DOI 10.1073/pnas.0902369106; Yu JH, 1998, J BIOL CHEM, V273, P30199, DOI 10.1074/jbc.273.46.30199; Zieger K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-149	49	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84411	10.1371/journal.pone.0084411	http://dx.doi.org/10.1371/journal.pone.0084411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367658	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300140
J	Warszycki, D; Mordalski, S; Kristiansen, K; Kafel, R; Sylte, I; Chilmonczyk, Z; Bojarski, AJ				Warszycki, Dawid; Mordalski, Stefan; Kristiansen, Kurt; Kafel, Rafal; Sylte, Ingebrigt; Chilmonczyk, Zdzislaw; Bojarski, Andrzej J.			A Linear Combination of Pharmacophore Hypotheses as a New Tool in Search of New Active Compounds - An Application for 5-HT1A Receptor Ligands	PLOS ONE			English	Article							HIGH-AFFINITY; DERIVATIVES; INHIBITORS; DISCOVERY; MODEL; AGENTS; CONFORMATION; TRANSPORTER; ANALOGS; BINDING	This study explores a new approach to pharmacophore screening involving the use of an optimized linear combination of models instead of a single hypothesis. The implementation and evaluation of the developed methodology are performed for a complete known chemical space of 5-HT1AR ligands (3616 active compounds with K-i < 100 nM) acquired from the ChEMBL database. Clusters generated from three different methods were the basis for the individual pharmacophore hypotheses, which were assembled into optimal combinations to maximize the different coefficients, namely, MCC, accuracy and recall, to measure the screening performance. Various factors that influence filtering efficiency, including clustering methods, the composition of test sets (random, the most diverse and cluster population-dependent) and hit mode (the compound must fit at least one or two models from a final combination) were investigated. This method outmatched both single hypothesis and random linear combination approaches.	[Warszycki, Dawid; Mordalski, Stefan; Kafel, Rafal; Bojarski, Andrzej J.] Polish Acad Sci, Inst Pharmacol, Dept Med Chem, Krakow, Poland; [Kristiansen, Kurt; Sylte, Ingebrigt] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Tromso, Norway; [Chilmonczyk, Zdzislaw] Natl Med Inst, Dept Cell Biol, Warsaw, Poland	Polish Academy of Sciences; UiT The Arctic University of Tromso; National Medicines Institute Lekow (NIL)	Bojarski, AJ (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Med Chem, Krakow, Poland.	bojarski@if-pan.krakow.pl	Bojarski, Andrzej/GSO-0213-2022; Warszycki, Dawid/T-9712-2017	Bojarski, Andrzej/0000-0003-1417-6333; Mordalski, Stefan/0000-0003-4089-6369; Sylte, Ingebrigt/0000-0002-3290-3736; Warszycki, Dawid/0000-0002-2393-4709; Chilmonczyk, Zdzislaw/0000-0002-5871-4458	European Union from the European Fund of Regional Development (EFRD); Norway Grants within the Polish-Norwegian Research Programme [Pol-Nor/198887/73/2013];  [UDA-POIG. 01.03.01-12-063/09-00 Prokog]	European Union from the European Fund of Regional Development (EFRD); Norway Grants within the Polish-Norwegian Research Programme; 	This study was supported by the project UDA-POIG. 01.03.01-12-063/09-00 Prokog, which is co-financed by the European Union from the European Fund of Regional Development (EFRD) and by Norway Grants within the Polish-Norwegian Research Programme, grant no. Pol-Nor/198887/73/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL A, 1993, J MED CHEM, V36, P4006, DOI 10.1021/jm00077a003; [Anonymous], 2011, PHAS VERS 3 3; [Anonymous], 2011, CANV VERS 1 4; Bojarski AJ, 2005, BIOORGAN MED CHEM, V13, P2293, DOI 10.1016/j.bmc.2004.12.041; Bojarski AJ, 2006, CURR TOP MED CHEM, V6, P2005, DOI 10.2174/156802606778522186; Caliendo G, 2005, CURR MED CHEM, V12, P1721, DOI 10.2174/0929867054367220; CHIDESTER CG, 1993, J MED CHEM, V36, P1301, DOI 10.1021/jm00062a001; Chilmonczyk Z, 1997, ARCH PHARM, V330, P146, DOI 10.1002/ardp.19973300507; Chiu TL, 2012, J CHEM INF MODEL, V52, P1886, DOI 10.1021/ci300121p; Durdagi S, 2011, J CHEM INF MODEL, V51, P463, DOI 10.1021/ci100409y; Franchini S, 2010, BIOORG MED CHEM LETT, V20, P2017, DOI 10.1016/j.bmcl.2010.01.030; Guner Osman F., 2002, Current Topics in Medicinal Chemistry, V2, P1321, DOI 10.2174/1568026023392940; HIBERT MF, 1988, J MED CHEM, V31, P1087, DOI 10.1021/jm00401a007; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; KELLY JL, 1956, IRE T INFORM THEOR, V2, P185, DOI 10.1109/TIT.1956.1056803; Kurczab R, 2010, BIOORG MED CHEM LETT, V20, P2465, DOI 10.1016/j.bmcl.2010.03.012; Lanfumey L, 2004, CNS NEUROL DISORD-DR, V3, P1, DOI 10.2174/1568007043482570; LANGLOIS M, 1993, EUR J PHARM-MOLEC PH, V244, P77, DOI 10.1016/0922-4106(93)90061-D; Lepailleur A, 2005, J CHEM INF MODEL, V45, P1075, DOI 10.1021/ci050045p; Lopez-Rodriguez ML, 2002, CURR MED CHEM, V9, P443, DOI 10.2174/0929867023371030; Manepalli S, 2011, J CHEM INF MODEL, V51, P2417, DOI 10.1021/ci200280m; MELLIN C, 1991, J MED CHEM, V34, P497, DOI 10.1021/jm00106a004; MOKROSZ MJ, 1995, BIOORGAN MED CHEM, V3, P533, DOI 10.1016/0968-0896(95)00039-J; Ngo T, 2013, J COMPUT AID MOL DES, V27, P305, DOI 10.1007/s10822-013-9647-5; Nowak M, 2006, J MED CHEM, V49, P205, DOI 10.1021/jm050826h; Oh SJ, 2001, CURR MED CHEM, V8, P999, DOI 10.2174/0929867013372599; Olivier B, 1999, Prog Drug Res, V52, P103; Orus L, 2002, J MED CHEM, V45, P4128, DOI 10.1021/jm0111200; Paluchowska MH, 1999, J MED CHEM, V42, P4952, DOI 10.1021/jm991045h; Paluchowska MH, 2002, EUR J MED CHEM, V37, P273, DOI 10.1016/S0223-5234(01)01312-5; Ren JX, 2011, J CHEM INF MODEL, V51, P1364, DOI 10.1021/ci100464b; Sanders MPA, 2012, J CHEM INF MODEL, V52, P1607, DOI 10.1021/ci2005274; Sanders MPA, 2011, J CHEM INF MODEL, V51, P2277, DOI 10.1021/ci200088d; Sastry M, 2010, J CHEM INF MODEL, V50, P771, DOI 10.1021/ci100062n; SLEIGHT AJ, 1991, N-S ARCH PHARMACOL, V343, P109, DOI 10.1007/BF00168596; Svegelj MB, 2011, J CHEM INF MODEL, V51, P1716, DOI 10.1021/ci2001499; Svensson F, 2012, J CHEM INF MODEL, V52, P225, DOI 10.1021/ci2004835; van Drie JH, 2003, CURR PHARM DESIGN, V9, P1649, DOI 10.2174/1381612033454568; VANSTEEN BJ, 1994, J MED CHEM, V37, P2761, DOI 10.1021/jm00043a015; Weber KC, 2010, EUR J MED CHEM, V45, P1508, DOI 10.1016/j.ejmech.2009.12.059; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Zajdel P, 2012, EUR J MED CHEM, V56, P348, DOI 10.1016/j.ejmech.2012.07.043	43	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84510	10.1371/journal.pone.0084510	http://dx.doi.org/10.1371/journal.pone.0084510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367669	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300146
J	Xi, M; Liu, SL; Zhao, L; Shen, JX; Zhang, L; Zhang, P; Liu, MZ				Xi, Mian; Liu, Shi-Liang; Zhao, Lei; Shen, Jing-Xian; Zhang, Li; Zhang, Peng; Liu, Meng-Zhong			Prognostic Factors and Survival in Patients with Radiation-Related Second Malignant Neoplasms Following Radiotherapy for Nasopharyngeal Carcinoma	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; PRIMARY CANCERS; INDUCED SARCOMA; PRIMARY TUMORS; PRIMARY HEAD; NECK; RISK; RECURRENT	Purpose: To analyze the clinicopathological characteristics, treatment modalities, and potential prognostic factors of radiation-related second malignant neoplasms (SMNs) in a large group of nasopharyngeal carcinoma (NPC) cases. Methods and Materials: Institutional electronic medical records of 39,118 patients with NPC treated by definitive radiotherapy between February 1964 and December 2003 were reviewed. A total of 247 patients with confirmed SMN attributable to radiotherapy were included. Results: Median latency between radiotherapy for NPC and the diagnosis of SMN was 9.5 years (range, 3.1-36.8 years). Squamous cell carcinoma was the most common histologic type, followed by fibrosarcoma and adenocarcinoma. Median progression-free survival and overall survival (OS) of the 235 patients who underwent treatment were 17.3 months and 28.5 months, respectively. The 5-year OS rates were 42.9%, 23.7%, and 0% for the surgery, radiotherapy, and chemotherapy groups, respectively. The independent prognostic factors associated with survival were sex, histologic type, and treatment modality in both the early stage subgroup and the advanced stage subgroup of SMN. Conclusions: Sex, histologic type, and treatment modality were the significant prognostic factors for SMN. Complete resection offers the best chance for long-term survival. In select patients with locally advanced and unresectable SMN, reirradiation should be strongly considered as a curative option.	[Xi, Mian; Liu, Shi-Liang; Zhao, Lei; Shen, Jing-Xian; Zhang, Li; Zhang, Peng; Liu, Meng-Zhong] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Xi, Mian; Liu, Shi-Liang; Zhao, Lei; Zhang, Li; Zhang, Peng; Liu, Meng-Zhong] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Xi, Mian; Liu, Shi-Liang; Zhao, Lei; Shen, Jing-Xian; Zhang, Li; Zhang, Peng; Liu, Meng-Zhong] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Shen, Jing-Xian] Sun Yat Sen Univ, Ctr Canc, Imaging Diag & Intervent Ctr, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Liu, MZ (corresponding author), State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China.	liumengzhong@126.com			National Natural Science Foundation of China [NSFC 81201748]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81201748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrigo JM, 2009, EUR RADIOL, V19, P1197, DOI 10.1007/s00330-008-1265-6; Amemiya K, 2005, BRIT J RADIOL, V78, P1028, DOI 10.1259/bjr/86352309; ARLEN M, 1971, CANCER-AM CANCER SOC, V28, P1087, DOI 10.1002/1097-0142(1971)28:5<1087::AID-CNCR2820280502>3.0.CO;2-F; Boussen H, 2004, Ann Otolaryngol Chir Cervicofac, V121, P282; BRADY MS, 1992, ARCH SURG-CHICAGO, V127, P1379; Cahan WG, 1998, CANCER-AM CANCER SOC, V82, P8, DOI 10.1002/(SICI)1097-0142(19980101)82:1<8::AID-CNCR3>3.0.CO;2-W; Cha C, 2004, ANN SURG, V239, P903, DOI 10.1097/01.sla.0000128686.51815.8b; Chen AM, 2011, INT J RADIAT ONCOL, V80, P669, DOI 10.1016/j.ijrobp.2010.02.023; Chen MC, 2008, ANN ONCOL, V19, P1180, DOI 10.1093/annonc/mdn003; de Gonzalez AB, 2011, LANCET ONCOL, V12, P353, DOI 10.1016/S1470-2045(11)70061-4; Gao X, 2003, INT J RADIAT ONCOL, V56, P427, DOI 10.1016/S0360-3016(02)04613-8; Goggins WB, 2010, CANCER CAUSE CONTROL, V21, P1461, DOI 10.1007/s10552-010-9574-x; Jia WH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-178; JONES AS, 1995, CANCER, V75, P1343, DOI 10.1002/1097-0142(19950315)75:6<1343::AID-CNCR2820750617>3.0.CO;2-T; King AD, 2000, CLIN RADIOL, V55, P684, DOI 10.1053/crad.2000.0503; Kong L, 2006, CANCER-AM CANCER SOC, V107, P1287, DOI 10.1002/cncr.22119; Kuttesch JF, 1996, J CLIN ONCOL, V14, P2818, DOI 10.1200/JCO.1996.14.10.2818; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Liu WW, 2005, LARYNGOSCOPE, V115, P1574, DOI 10.1097/01.mlg.0000173166.48440.e4; Lo WC, 2008, LARYNGOSCOPE, V118, P2151, DOI 10.1097/MLG.0b013e3181839b8c; Malone JP, 2002, SKULL BASE-INTERD AP, V12, P87, DOI 10.1055/s-2002-31576-1; MARK RJ, 1993, CANCER, V72, P887, DOI 10.1002/1097-0142(19930801)72:3<887::AID-CNCR2820720338>3.0.CO;2-5; MIN HQ, 1994, INT J RADIAT ONCOL, V30, P1037; Palazzi M, 2009, INT J RADIAT ONCOL, V74, P774, DOI 10.1016/j.ijrobp.2008.08.068; Scelo G, 2007, CANCER CAUSE CONTROL, V18, P269, DOI 10.1007/s10552-006-0101-z; Sher DJ, 2010, CANCER-AM CANCER SOC, V116, P4761, DOI 10.1002/cncr.25305; Teo PML, 1999, EUR J CANCER, V35, P219, DOI 10.1016/S0959-8049(98)00386-4; TESHIMA T, 1992, Strahlentherapie und Onkologie, V168, P213; Tham IWK, 2009, INT J RADIAT ONCOL, V75, P1481, DOI 10.1016/j.ijrobp.2009.01.018; Tubiana M, 2009, RADIOTHER ONCOL, V91, P4, DOI 10.1016/j.radonc.2008.12.016; Wang CC, 2000, INT J CANCER, V87, P228, DOI 10.1002/1097-0215(20000715)87:2&lt;228::AID-IJC12&gt;3.0.CO;2-T; Wong SJ, 2012, SEMIN RADIAT ONCOL, V22, P214, DOI 10.1016/j.semradonc.2012.03.006; Xi MA, 2010, CANCER-AM CANCER SOC, V116, P5479, DOI 10.1002/cncr.25329; Xu XG, 2008, PHYS MED BIOL, V53, pR193, DOI 10.1088/0031-9155/53/13/R01	34	6	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84586	10.1371/journal.pone.0084586	http://dx.doi.org/10.1371/journal.pone.0084586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367679	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300150
J	Cerosaletti, K; Schneider, A; Schwedhelm, K; Frank, I; Tatum, M; Wei, S; Whalen, E; Greenbaum, C; Kita, M; Buckner, J; Long, SA				Cerosaletti, Karen; Schneider, Anya; Schwedhelm, Katharine; Frank, Ian; Tatum, Megan; Wei, Shan; Whalen, Elizabeth; Greenbaum, Carla; Kita, Mariko; Buckner, Jane; Long, S. Alice			Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4(+)CD25(hi) T Cells of Type 1 Diabetic and Multiple Sclerosis Patients	PLOS ONE			English	Article							GRAVES-DISEASE; INTERLEUKIN-2; TOLERANCE; CD25; ACTIVATION; EXPRESSION; MICE	IL-2 receptor (IL-2R) signaling is essential for optimal stability and function of CD4(+)CD25(hi)FOXP3(+) regulatory T cells (Treg); a cell type that plays an integral role in maintaining tolerance. Thus, we hypothesized that decreased response to IL-2 may be a common phenotype of subjects who have autoimmune diseases associated with variants in the IL2RA locus, including T1D and MS, particularly in cells expressing the high affinity IL-2R alpha chain (IL-2RA or CD25). To examine this question we used phosphorylation of STAT5 (pSTAT5) as a downstream measure of IL-2R signaling, and found a decreased response to IL-2 in CD4(+)CD25(hi) T cells of T1D and MS, but not SLE patients. Since the IL2RArs2104286 haplotype is associated with T1D and MS, we measured pSTAT5 in controls carrying the rs2104286 risk haplotype to test whether this variant contributed to reduced IL-2 responsiveness. Consistent with this, we found decreased pSTAT5 in subjects carrying the rs2104286 risk haplotype. Reduced IL-2R signaling did not result from lower CD25 expression on CD25(hi) cells; instead we detected increased CD25 expression on naive Treg from controls carrying the rs2104286 risk haplotype, and subjects with T1D and MS. However the rs2104286 risk haplotype correlated with increased soluble IL-2RA levels, suggesting that shedding of the IL-2R may account in part for the reduced IL-2R signaling associated with the rs2104286 risk haplotype. In addition to risk variants in IL2RA, we found that the T1D-associated risk variant of PTPN2rs1893217 independently contributed to diminished IL-2R signaling. However, even when holding genotype constant at IL2RA and PTPN2, we still observed a significant signaling defect in T1D and MS patients. Together, these data suggest that multiple mechanisms converge in disease leading to decreased response to IL-2, a phenotype that may eventually lead to loss of tolerance and autoimmunity.	[Cerosaletti, Karen; Schneider, Anya; Schwedhelm, Katharine; Frank, Ian; Tatum, Megan; Wei, Shan; Kita, Mariko; Buckner, Jane; Long, S. Alice] Virginia Mason, Translat Res, Benaroya Res Inst, Seattle, WA USA; [Whalen, Elizabeth] Virginia Mason, Bioinformat, Benaroya Res Inst, Seattle, WA USA; [Greenbaum, Carla] Virginia Mason, Diabet Res, Benaroya Res Inst, Seattle, WA USA	Benaroya Research Institute; Virginia Mason Medical Center; Benaroya Research Institute; Virginia Mason Medical Center; Benaroya Research Institute; Virginia Mason Medical Center	Long, SA (corresponding author), Virginia Mason, Translat Res, Benaroya Res Inst, Seattle, WA USA.	along@benaroyaresearch.org			Juvenile Diabetes Research Foundation [2-2012-205]; BRI JDRF Center; JDRF [33-2008-398]; NIH [AI101990-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101990] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); BRI JDRF Center; JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Juvenile Diabetes Research Foundation (www.JDRF.org) grants including a Career Development Grant (2-2012-205) to SAL, BRI JDRF Center grant and JDRF (33-2008-398) to JHB. An NIH (www.niaid.org) grant (AI101990-01) to JHB also funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki CA, 2006, J AUTOIMMUN, V27, P50, DOI 10.1016/j.jaut.2006.04.005; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Brusko TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007980; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butter F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002982; Carr EJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-22; Chistiakov DA, 2011, SCAND J IMMUNOL, V74, P496, DOI 10.1111/j.1365-3083.2011.02608.x; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Fehervari Z, 2006, TRENDS IMMUNOL, V27, P109, DOI 10.1016/j.it.2006.01.005; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Garg G, 2012, J IMMUNOL, V188, P4644, DOI 10.4049/jimmunol.1100272; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hulme MA, 2012, DIABETES, V61, P14, DOI 10.2337/db11-1213; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Long SA, 2011, GENES IMMUN, V12, P116, DOI 10.1038/gene.2010.54; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Maier LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000322; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Matesanz F, 2007, J NEUROL, V254, P682, DOI 10.1007/s00415-006-0416-4; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Park MJ, 2011, STEM CELL REV REP, V7, P381, DOI 10.1007/s12015-010-9203-9; Pekalski ML, 2013, J IMMUNOL, V190, P2554, DOI 10.4049/jimmunol.1202914; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Qu HQ, 2009, J IMMUNOL, V183, P5158, DOI 10.4049/jimmunol.0901337; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; RUBIN L A, 1990, Cytokine, V2, P330, DOI 10.1016/1043-4666(90)90062-X; Russell SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047748; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Strieder TGA, 2006, AUTOIMMUNITY, V39, P93, DOI 10.1080/08916930500508092; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9	41	72	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83811	10.1371/journal.pone.0083811	http://dx.doi.org/10.1371/journal.pone.0083811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376757	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000117
J	Chen, C; Naidoo, N; Er, B; Cheong, A; Fong, NP; Tay, CY; Chan, KM; Tan, BY; Menon, E; Ee, CH; Lee, KK; Ng, YS; Teo, YY; Koh, GCH				Chen, Cynthia; Naidoo, Nasheen; Er, Benjamin; Cheong, Angela; Fong, Ngan Phoon; Tay, Choo Yian; Chan, Kin Ming; Tan, Boon Yeow; Menon, Edward; Ee, Chye Hua; Lee, Kok Keng; Ng, Yee Sien; Teo, Yik Ying; Koh, Gerald C. H.			Factors Associated with Nursing Home Placement of All Patients Admitted for Inpatient Rehabilitation in Singapore Community Hospitals from 1996 to 2005: A Disease Stratified Analysis	PLOS ONE			English	Article							STROKE REHABILITATION; CARE UTILIZATION; HIP FRACTURE; RISK; OUTCOMES; INSTITUTIONALIZATION; POPULATION; ADMISSIONS; MORTALITY; SERVICES	Objectives: To (1) identify social and rehabilitation predictors of nursing home placement, (2) investigate the association between effectiveness and efficiency in rehabilitation and nursing home placement of patients admitted for inpatient rehabilitation from 1996 to 2005 by disease in Singapore. Design: National data were retrospectively extracted from medical records of community hospital. Data Sources: There were 12,506 first admissions for rehabilitation in four community hospitals. Of which, 8,594 (90.3%) patients were discharged home and 924 (9.7%) patients were discharged to a nursing home. Other discharge destinations such as sheltered home (n = 37), other community hospital (n = 31), death in community hospital (n = 12), acute hospital (n = 1,182) and discharge against doctor's advice (n = 24) were excluded. Outcome Measure: Nursing home placement. Results: Those who were discharged to nursing home had 33% lower median rehabilitation effectiveness and 29% lower median rehabilitation efficiency compared to those who were discharged to nursing homes. Patients discharged to nursing homes were significantly older (mean age: 77 vs. 73 years), had lower mean Bathel Index scores (40 vs. 48), a longer median length of stay (40 vs. 33 days) and a longer time to rehabilitation (19 vs. 15 days), had a higher proportion without a caregiver (28 vs. 7%), being single (21 vs. 7%) and had dementia (23 vs. 10%). Patients admitted for lower limb amputation or falls had an increased odds of being discharged to a nursing home by 175% (p < 0.001) and 65% (p = 0.043) respectively compared to stroke patients. Conclusions: In our study, the odds of nursing home placement was found to be increased in Chinese, males, single or widowed or separated/divorced, patients in high subsidy wards for hospital care, patients with dementia, without caregivers, lower functional scores at admission, lower rehabilitation effectiveness or efficiency at discharge and primary diagnosis groups such as fractures, lower limb amputation and falls in comparison to strokes.	[Chen, Cynthia; Naidoo, Nasheen; Er, Benjamin; Cheong, Angela; Fong, Ngan Phoon; Teo, Yik Ying; Koh, Gerald C. H.] Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Tay, Choo Yian] Agcy Integrated Care, Planning Div, Singapore, Singapore; [Chan, Kin Ming] Ang Mo Kio Thye Hua Kwan Hosp, Med Serv, Singapore, Singapore; [Tan, Boon Yeow] St Lukes Hosp, Med Serv, Singapore, Singapore; [Menon, Edward] St Andrews Community Hosp, Med Serv, Singapore, Singapore; [Ee, Chye Hua; Lee, Kok Keng] Bright Vis Hosp, Singapore, Singapore; [Ng, Yee Sien] Singapore Gen Hosp, Dept Rehabil Med, Singapore, Singapore; [Teo, Yik Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore	National University of Singapore; Singapore General Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore	Koh, GCH (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	Gerald_Koh@nuhs.edu.sg	CHEN, CYNTHIA/O-6203-2016; /AAR-5357-2020	Koh, Choon Huat Gerald/0000-0002-6453-6897; Naidoo, Nasheen/0000-0001-8613-4808; Ng, Yee-Sien/0000-0003-1377-5852	National University of Singapore (NUS) Start-Up Grant; NUS Provost Matching Grant; NUS Academic Research Fund; Ministry of Health (Singapore) Health Services Research Competitive Research [HSRG/0006/2013]	National University of Singapore (NUS) Start-Up Grant(National University of Singapore); NUS Provost Matching Grant; NUS Academic Research Fund; Ministry of Health (Singapore) Health Services Research Competitive Research(Ministry of Health-Singapore)	This study was supported by a National University of Singapore (NUS) Start-Up Grant, the NUS Provost Matching Grant, the NUS Academic Research Fund, and Ministry of Health (Singapore) Health Services Research Competitive Research Grant Number HSRG/0006/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari VK, 2005, ARCH PHYS MED REHAB, V86, P2081, DOI 10.1016/j.apmr.2005.05.008; Carter GM HO, 2003, CASE MIX CERTIFICATI; Coward RT, 1996, J GERONTOL B-PSYCHOL, V51, pS258, DOI 10.1093/geronb/51B.5.S258; CRYSTAL S, 1989, SOC WORK, V34, P277, DOI 10.1093/sw/34.3.277-a; Department of Statistics (DOS), 2012, KEY ANN IND; Department of Statistics Singapore, 2011, SING CENS POP 2010; Elderly and Continuing Care Division; Ministry of Health (Singapore), 2004, HEALTHC SERV ELD INF; Foley D J, 1992, J Aging Health, V4, P155, DOI 10.1177/089826439200400201; Gan KY, 2012, COMMUNICATION; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Goh SN, 2011, ASIA PAC J SOC WORK, V21, P31, DOI 10.1080/21650993.2011.9756095; Graham JE, 2008, J GERONTOL A-BIOL, V63, P860, DOI 10.1093/gerona/63.8.860; HEINEMANN AW, 1987, ARCH NEUROL-CHICAGO, V44, P1167, DOI 10.1001/archneur.1987.00520230051013; JETTE AM, 1992, GERONTOLOGIST, V32, P634, DOI 10.1093/geront/32.5.634; Kane RA, 1987, LONG TERM CARE PRINC; Koh GCH, 2012, ANN ACAD MED SINGAP, V41, P494; Koh GCH, 2012, INT J STROKE, V7, P606, DOI 10.1111/j.1747-4949.2011.00612.x; Lee T, 2001, PUBLIC HEALTH NURS, V18, P443, DOI 10.1046/j.1525-1446.2001.00443.x; Levy PS, 2000, STAT METHODS MED RES, V9, P41, DOI 10.1191/096228000666554731; Lim ES, 2009, AUST SOC WORK, V62, P90, DOI 10.1080/03124070802626901; Lum TY, 2005, J GERONTOL SOC WORK, V45, P3, DOI 10.1300/J083v45n04_02; MILLER B, 1994, J GERONTOL, V49, pS14, DOI 10.1093/geronj/49.1.S14; Miller EA, 2000, MED CARE RES REV, V57, P259, DOI 10.1177/107755870005700301; Ministry of Health (MOH), 2013, HOSP SERV; Ministry of Health (MOH), 2012, SING HEALTHC SYST SE; Ministry of Health (MOH), 2012, NURSING HOMES; Ministry of Health (MOH), 2004, HEALTHC SERV ELD INF; National Population And Talent Division (NPTD), 2012, PROJ FOR MANP DEM HE; Ng TP, 2006, J AM GERIATR SOC, V54, P21, DOI 10.1111/j.1532-5415.2005.00533.x; OECD, 2011, HELP WANTED PROVIDIN; Ottenbacher KJ, 2003, MED CARE, V41, P232, DOI 10.1097/00005650-200302000-00005; PEARLMAN DN, 1992, GERONTOLOGIST, V32, P527, DOI 10.1093/geront/32.4.527; Scharlach AE, 2006, J GERONTOL SOC WORK, V47, P133, DOI 10.1300/J083v47n01_09; SHAH S, 1990, STROKE, V21, P241, DOI 10.1161/01.STR.21.2.241; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHAPIRO E, 1988, GERONTOLOGIST, V28, P237, DOI 10.1093/geront/28.2.237; Smith GE, 2000, J AM GERIATR SOC, V48, P519, DOI 10.1111/j.1532-5415.2000.tb04998.x; STEINBACH U, 1992, J GERONTOL, V47, pS183, DOI 10.1093/geronj/47.4.S183; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; WINGARD DL, 1987, GERONTOLOGIST, V27, P156, DOI 10.1093/geront/27.2.156; Yap L. K. P., 2003, SMJ Singapore Medical Journal, V44, P065	41	10	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82697	10.1371/journal.pone.0082697	http://dx.doi.org/10.1371/journal.pone.0082697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	278IG	24376567	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000022
J	Dong, P; Jiang, LJ; Liu, JY; Wu, ZM; Guo, SJ; Zhang, ZL; Zhou, FJ; Liu, ZW				Dong, Pei; Jiang, Lijuan; Liu, Jianye; Wu, Zhiming; Guo, Shengjie; Zhang, Ziling; Zhou, Fangjian; Liu, Zhuowei			Induction of Paclitaxel Resistance by ER alpha Mediated Prohibitin Mitochondrial-Nuclear Shuttling	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; PROSTATE-CANCER CELLS; ANDROGEN DEPRIVATION THERAPY; BREAST-CANCER; GROWTH; EXPRESSION; REPRESSION; BETA; PROLIFERATION; SENSITIVITY	Paclitaxel is a drug within one of the most promising classes of anticancer agents. Unfortunately, clinical success of this drug has been limited by the insurgence of cellular resistance. To address this, Paclitaxel resistance was modeled in an in vitro system using estrogen treated prostate cancer cells. This study demonstrates that emerging resistance to clinically relevant doses of Paclitaxel is associated with 17-beta-estradiol (E2) treatment in PC-3 cells, but not in LNCaP cells. We found that small interfering RNA mediated knockdown of ER alpha lead to a decrease in E2 induced Paclitaxel resistance in androgen-independent cells. We also showed that ER alpha mediated the effects of estrogen, thereby suppressing androgen-independent cell proliferation and mediating Paclitaxel resistance. Furthermore, E2 promoted Prohibitin (PHB) mitochondrial-nucleus translocation via directly mediation of ER alpha, leading to an inhibition of cellular proliferation by PHB. Additionally, restoration of Paclitaxel sensitivity by ER alpha knockdown could be overcome by PHB overexpression and, conversely, PHB knockdown decreased E2 induced Paclitaxel resistance. These findings demonstrate that PHB lies downstream of ER alpha and mediates estrogen-dependent Paclitaxel resistance signaling cascades.	[Dong, Pei; Jiang, Lijuan; Liu, Jianye; Wu, Zhiming; Guo, Shengjie; Zhang, Ziling; Zhou, Fangjian; Liu, Zhuowei] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Dong, Pei] Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou Medical University	Liu, ZW (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Dept Urol, Guangzhou 510275, Guangdong, Peoples R China.	liuzhw@sysucc.org.cn			National Natural Science Foundation of China [81202035, 81202013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default166.htm) (Grant No. 81202035, 81202013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 2003, ENDOCR J, V50, P281, DOI 10.1507/endocrj.50.281; Barone I, 2010, CLIN CANCER RES, V16, P2702, DOI 10.1158/1078-0432.CCR-09-1753; Bonkhoff H, 1999, AM J PATHOL, V155, P641, DOI 10.1016/S0002-9440(10)65160-7; Cannata DH, 2012, J CLIN ENDOCR METAB, V97, P360, DOI 10.1210/jc.2011-2353; CARRUBA G, 1994, CANCER RES, V54, P1190; Carruba G, 2006, ANN NY ACAD SCI, V1089, P201, DOI 10.1196/annals.1386.027; Carruba G, 2007, J CELL BIOCHEM, V102, P899, DOI 10.1002/jcb.21529; Devlin HL, 2009, CANCER LETT, V274, P177, DOI 10.1016/j.canlet.2008.06.007; Dong P, 2010, J CELL BIOCHEM, V111, P1367, DOI 10.1002/jcb.22865; Doyle-Lindrud S, 2012, CLIN J ONCOL NURS, V16, P286, DOI 10.1188/12.CJON.286-291; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; Gregory-Bass RC, 2008, INT J CANCER, V122, P1923, DOI 10.1002/ijc.23351; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kathiria AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031231; Lau KM, 2000, CANCER RES, V60, P3175; Leake RE, 1987, STEROID HORMONE RECE; MAEHARA Y, 1990, EUR SURG RES, V22, P50, DOI 10.1159/000129082; Montgomery B, BMC CANC, V10, P244; Patel N, 2010, P NATL ACAD SCI USA, V107, P2503, DOI 10.1073/pnas.0910649107; Powell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030993; Prins GS, 2008, STEROIDS, V73, P233, DOI 10.1016/j.steroids.2007.10.013; Ricke WA, 2008, FASEB J, V22, P1512, DOI 10.1096/fj.07-9526com; Rodriguez-Antona C, 2010, PHARMACOGENOMICS, V11, P621, DOI 10.2217/PGS.10.32; Seruga B, 2011, J CLIN ONCOL, V29, P3686, DOI 10.1200/JCO.2010.34.3996; Shapiro E, 2005, J UROLOGY, V174, P2051, DOI 10.1097/01.ju.0000176472.90432.5b; Small EJ, 1997, J CLIN ONCOL, V15, P382, DOI 10.1200/JCO.1997.15.1.382; Sripathi SR, 2011, BIOCHEMISTRY-US, V50, P8342, DOI 10.1021/bi2008933; Theiss AL, 2010, BIOCHIM BIOPHYS ACTA, V1813, P1137; Wang S, 2002, EMBO J, V21, P3019, DOI 10.1093/emboj/cdf302; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Wilson WH, 1997, BLOOD, V89, P601, DOI 10.1182/blood.V89.2.601; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754; Zhu BB, 2006, CANCER RES, V66, P8640, DOI 10.1158/0008-5472.CAN-06-1443	37	15	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83519	10.1371/journal.pone.0083519	http://dx.doi.org/10.1371/journal.pone.0083519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376711	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000092
J	Hsiao, SH; Liu, HE; Lee, HL; Lin, CL; Chen, WY; Wu, ZH; Lin, SE; Chiang, LL; Chung, CL				Hsiao, Shih-Hsin; Liu, H. Eugene; Lee, Hsin-Lun; Lin, Chii-Lan; Chen, Wei-Yu; Wu, Zhung-Han; Lin, Sey-En; Chiang, Ling-Ling; Chung, Chi-Li			Distinct Clinical Outcomes of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor (EGFR) Mutations Treated with EGFR Tyrosine Kinase Inhibitors: Non-Responders versus Responders	PLOS ONE			English	Article							1ST-LINE TREATMENT; OPEN-LABEL; CHEMOTHERAPY; MULTICENTER; RESISTANCE; GEFITINIB; ERLOTINIB; THERAPY; PHASE-3	Introduction: Treatment with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) has been associated with favorable progression free survival (PFS) in patients with non-small cell lung cancers (NSCLC) harboring EGFR mutations. However, a subset of this population doesn't respond to EGFR-TKI treatment. Therefore, the present study aimed to elucidate survival outcome in NSCLC EGFR-mutant patients who were treated with EGFR TKIs. Methods: Among the 580 consecutive NSCLC patients who were treated at our facility between 2008 and 2012, a total of 124 treatment-naive, advanced NSCLC, EGFR-mutant patients treated with EGFR TKIs were identified and grouped into non-responders and responders for analyses. Results: Of 124 patients, 104 (84%) responded to treatment, and 20 (16%) did not; and the overall median PFS was 9.0 months. Notably, the PFS, overall survival (OS) and survival rates were significantly unfavorable in non-responders (1.8 vs. 10.3 months, hazard ratio (HR) = 29.2, 95% confidence interval (CI), 13.48-63.26, P<0.0001; 9.4 vs. 17.3 months, HR = 2.74, 95% CI, 1.52-4.94, P = 0.0008; and 58% vs. 82% in 6, 37% vs. 60% in 12, and 19 vs. 40% at 24 months, respectively). In multivariate analysis, treatment efficacy strongly affected PFS and OS, independent of covariates (HR = 47.22, 95% CI, 17.88-124.73, P<0.001 and HR = 2.74, 95% CI, 1.43-5.24, P = 0.002, respectively). However, none of the covariates except of the presence of EGFR exon 19 deletion in the tumors was significantly associated with better treatment efficacy. Conclusions: A subset of NSCLC EGFR-mutant patients displayed unfavorable survival despite EGFR TKI administration. This observation reinforces the urgent need for biomarkers effectively predicting the non-responders and for drug development overcoming primary resistance to EGFR TKIs. In addition, optimal therapeutic strategies to prolong the survival of non-responders need to be investigated.	[Hsiao, Shih-Hsin; Wu, Zhung-Han; Chung, Chi-Li] Taipei Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Liu, H. Eugene] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Hematol & Oncol, Taipei, Taiwan; [Lee, Hsin-Lun] Taipei Med Univ, Wan Fang Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Lin, Chii-Lan] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chen, Wei-Yu] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Lin, Sey-En] Taipei Med Univ Hosp, Dept Pathol, Taipei, Taiwan; [Chiang, Ling-Ling; Chung, Chi-Li] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Lin, SE (corresponding author), Taipei Med Univ Hosp, Dept Pathol, Taipei, Taiwan.	hayasi@tmu.edu.tw		Chiang, Ling-Ling/0000-0002-6482-6907; Lin, Sey-En/0000-0002-8994-9452	Taipei Medical University and Hospital [TMU100-TMUH-17]	Taipei Medical University and Hospital	This work was supported by Taipei Medical University and Hospital (TMU100-TMUH-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Ohashi K, 2013, J CLIN ONCOL, V31, P1070, DOI 10.1200/JCO.2012.43.3912; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Salto-Tellez M, 2011, J THORAC ONCOL, V6, P1663, DOI 10.1097/JTO.0b013e318227816a; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	12	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83266	10.1371/journal.pone.0083266	http://dx.doi.org/10.1371/journal.pone.0083266			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376677	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000077
J	Kim, MS; Yamamoto, Y; Kim, K; Kamei, N; Shimada, T; Liu, L; Moore, K; Woo, JR; Shoelson, SE; Lee, J				Kim, Myung-Sunny; Yamamoto, Yasuhiko; Kim, Kyungjin; Kamei, Nozomu; Shimada, Takeshi; Liu, Libin; Moore, Kristin; Woo, Ju Rang; Shoelson, Steven E.; Lee, Jongsoon			Regulation of Diet-Induced Adipose Tissue and Systemic Inflammation by Salicylates and Pioglitazone	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; BLOOD-CELL COUNT; DIABETES-MELLITUS; RANDOMIZED-TRIAL; IKK-BETA; OBESITY; MONOCYTES; MACROPHAGES; SALSALATE; DISEASE	It is increasingly accepted that chronic inflammation participates in obesity-induced insulin resistance and type 2 diabetes (T2D). Salicylates and thiazolidinediones (TZDs) both have anti-inflammatory and anti-hyperglycemic properties. The present study compared the effects of these drugs on obesity-induced inflammation in adipose tissue (AT) and AT macrophages (ATMs), as well as the metabolic and immunological phenotypes of the animal models. Both drugs improved high fat diet (HFD)-induced insulin resistance. However, salicylates did not affect AT and ATM inflammation, whereas Pioglitazone improved these parameters. Interestingly, HFD and the drug treatments all modulated systemic inflammation as assessed by changes in circulating immune cell numbers and activation states. HFD increased the numbers of circulating white blood cells, neutrophils, and a pro-inflammatory monocyte subpopulation (Ly6C(hi)), whereas salicylates and Pioglitazone normalized these cell numbers. The drug treatments also decreased circulating lymphocyte numbers. These data suggest that obesity induces systemic inflammation by regulating circulating immune cell phenotypes and that antidiabetic interventions suppress systemic inflammation by normalizing circulating immune phenotypes.	[Kim, Myung-Sunny; Yamamoto, Yasuhiko; Kim, Kyungjin; Kamei, Nozomu; Shimada, Takeshi; Liu, Libin; Moore, Kristin; Woo, Ju Rang; Shoelson, Steven E.; Lee, Jongsoon] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Kim, Myung-Sunny; Yamamoto, Yasuhiko; Kim, Kyungjin; Kamei, Nozomu; Shimada, Takeshi; Liu, Libin; Moore, Kristin; Woo, Ju Rang; Shoelson, Steven E.; Lee, Jongsoon] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kim, Myung-Sunny] Korea Food Res Inst, Songnam, South Korea; [Yamamoto, Yasuhiko] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Korea Food Research Institute (KFRI); Kanazawa University	Shoelson, SE (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA.	steven.shoelson@joslin.harvard.edu; jongsoon.lee@joslin.harvard.edu	Lee, Jongsoon/AAG-1674-2020	Kamei, Nozomu/0000-0002-7686-437X; Lee, Jongsoon/0000-0002-0891-5059	National Institutes of Health (NIH) [R21 DK80380, P30 DK046200]; American Diabetes Association [RA 110BS97]; NIH [R01 DK45943, R37 DK51729, R01 DK73547, P30 DK36836]; Helen and Morton Adler Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R21DK080380, R01DK045943, R37DK051729, R01DK051729, R01DK073547, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen and Morton Adler Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institutes of Health (NIH) R21 DK80380 and P30 DK046200 (Pilot and Feasibility awards from the Boston Obesity Nutrition Research Center) and the American Diabetes Association grant RA 110BS97 to J.L.; NIH R01 DK45943, R37 DK51729, and R01 DK73547 to S.E.S.; NIH P30 DK36836 (Joslin Diabetes Research Center), and the Helen and Morton Adler Chair (S.E.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, AM J PHYSIOL-RENAL, V290, pF600, DOI 10.1152/ajprenal.00289.2005; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bays Harold, 2007, Diab Vasc Dis Res, V4, P181; Berria R, 2007, CLIN PHARMACOL THER, V82, P275, DOI 10.1038/sj.clpt.6100146; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P1275, DOI 10.1056/NEJM197406062902302; Gillum RF, 2005, ANN EPIDEMIOL, V15, P266, DOI 10.1016/j.annepidem.2004.08.009; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Kiermayer C, 2007, GENESIS, V45, P11, DOI 10.1002/dvg.20244; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kullo IJ, 2002, AM J CARDIOL, V89, P1441, DOI 10.1016/S0002-9149(02)02366-4; Lee BC, 2013, BIOCH BIOPH IN PRESS; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	30	20	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82847	10.1371/journal.pone.0082847	http://dx.doi.org/10.1371/journal.pone.0082847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5FG	24376593	Green Published, Green Submitted, gold			2022-12-27	WOS:000339881300001
J	Kuan, YH; Huang, FM; Lee, SS; Li, YC; Chang, YC				Kuan, Yu-Hsiang; Huang, Fu-Mei; Lee, Shiuan-Shinn; Li, Yi-Ching; Chang, Yu-Chao			Bisgma Stimulates Prostaglandin E2 Production in Macrophages via Cyclooxygenase-2, Cytosolic Phospholipase A2, and Mitogen-Activated Protein Kinases Family	PLOS ONE			English	Article							GROUP-IVA; EXPRESSION; A(2); CYTOTOXICITY; CELLS; INFLAMMATION; APOPTOSIS; PATHWAYS; ALPHA; LUNG	Background: Bisphenol A-glycidyl-methacrylate (BisGMA) employs as a monomer in dental resins. The leakage of BisGMA from composite resins into the peripheral environment can result in inflammation via macrophage activation. Prostaglandin E2 (PGE2) is a key regulator of immunopathology in inflammatory reactions. Little is known about the mechanisms of BisGMA-induced PGE2 expression in macrophage. The aim of this study was to evaluate the signal transduction pathways of BisGMA-induced PGE2 production in murine RAW264.7 macrophages. Methodology/Principal Findings: Herein, we demonstrate that BisGMA can exhibit cytotoxicity to RAW264.7 macrophages in a dose-and time-dependent manner (p<0.05). In addition, PGE2 production, COX-2 expression, and cPLA2 phosphorylation were induced by BisGMA on RAW264.7 macrophages in a dose-and time-dependent manner (p<0.05). Moreover, BisGMA could induce the phosphorylation of ERK1/2 pathway (MEK1/2, ERK1/2, and Elk), p38 pathway (MEK3/6, p38, and MAPKAPK2), and JNK pathway (MEK4, JNK, and c-Jun) in a dose-and time-dependent manner (p<0.05). Pretreatment with AACOCF3, U0126, SB203580, and SP600125 significantly diminished the phosphorylation of cPLA2, ERK1/2, p38, and JNK stimulated by BisGMA, respectively (p<0.05). BisGMA-induced cytotoxicity, cPLA2 phosphorylation, PGE2 generation, and caspases activation were reduced by AACOCF3, U0126, SB203580, and SP600125, respectively (p<0.05). Conclusions: These results suggest that BisGMA induced-PGE2 production may be via COX-2 expression, cPLA2 phosphorylation, and the phosphorylation of MAPK family. Cytotoxicity mediated by BisGMA may be due to caspases activation through the phosphorylation of cPLA2 and MAPKs family.	[Kuan, Yu-Hsiang; Li, Yi-Ching] Chung Shan Med Univ, Dept Pharmacol, Taichung, Taiwan; [Huang, Fu-Mei; Chang, Yu-Chao] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Lee, Shiuan-Shinn] Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Chang, Yu-Chao] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Chang, YC (corresponding author), Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan.	cyc@csmu.edu.tw	Kuan, Yu-Hsiang/R-1181-2019; Liaw, Yung Po/AAV-6746-2021	Kuan, Yu-Hsiang/0000-0002-8991-6394	NSC [100-2314-B-040-006]	NSC(Ministry of Science and Technology, Taiwan)	This study was supported by NSC 100-2314-B-040-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437; Bonventre JV, 2002, ADV EXP MED BIOL, V507, P25; Casas J, 2009, J IMMUNOL, V183, P2767, DOI 10.4049/jimmunol.0901530; Chang MC, 2012, ACTA BIOMATER, V8, P1380, DOI 10.1016/j.actbio.2011.09.011; Chang MC, 2010, BIOMATERIALS, V31, P8164, DOI 10.1016/j.biomaterials.2010.07.049; Chang MC, 2009, BIOMATERIALS, V30, P4070, DOI 10.1016/j.biomaterials.2009.04.034; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Duan L, 2001, J IMMUNOL, V166, P7469, DOI 10.4049/jimmunol.166.12.7469; Hasturk H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00118; Hebling J, 1999, J DENT, V27, P557, DOI 10.1016/S0300-5712(99)00034-2; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Khatri CA, 2003, DENT MATER, V19, P584, DOI 10.1016/S0109-5641(02)00108-2; Kim BH, 2008, ACTA PHARMACOL SIN, V29, P113, DOI 10.1111/j.1745-7254.2008.00725.x; Kirschnek S, 2006, INFECT IMMUN, V74, P850, DOI 10.1128/IAI.74.2.850-860.2006; Kuan YH, 2012, INT ENDOD J, V45, P619, DOI 10.1111/j.1365-2591.2012.02017.x; Kuan YH, 2012, FOOD CHEM TOXICOL, V50, P4003, DOI 10.1016/j.fct.2012.08.019; Kuo MY, 2011, FOOD CHEM TOXICOL, V49, P2660, DOI 10.1016/j.fct.2011.07.012; Li YC, 2012, INT ENDOD J, V45, P499, DOI 10.1111/j.1365-2591.2011.02001.x; Li YC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/383608; Lucas KK, 2005, BRIT J PHARMACOL, V144, P940, DOI 10.1038/sj.bjp.0706116; Matsuura M, 1999, INFECT IMMUN, V67, P6286; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Porto Isabel Cristina Celerino de Moraes, 2009, Braz. Dent. J., V20, P195, DOI 10.1590/S0103-64402009000300004; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Ruiperez V, 2009, J IMMUNOL, V182, P3877, DOI 10.4049/jimmunol.0804003; Said SI, 2000, REGUL PEPTIDES, V93, P21, DOI 10.1016/S0167-0115(00)00174-9; Sideridou I, 2002, BIOMATERIALS, V23, P1819, DOI 10.1016/S0142-9612(01)00308-8; Van Landuyt KL, 2011, DENT MATER, V27, P723, DOI 10.1016/j.dental.2011.05.001; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Wang MT, 2007, CANCER METAST REV, V26, P525, DOI 10.1007/s10555-007-9096-5; Yap AUJ, 2004, OPER DENT, V29, P448; Yeh CH, 2014, ENVIRON TOXICOL, V29, P1162, DOI 10.1002/tox.21847	34	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82942	10.1371/journal.pone.0082942	http://dx.doi.org/10.1371/journal.pone.0082942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376609	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000041
J	Roman, M; Rue, M; Sala, M; Ascunce, N; Bare, M; Baroja, A; De la Vega, M; Galceran, J; Natal, C; Salas, D; Sanchez-Jacob, M; Zubizarreta, R; Castells, X				Roman, Marta; Rue, Montse; Sala, Maria; Ascunce, Nieves; Bare, Marisa; Baroja, Araceli; De la Vega, Mariola; Galceran, Jaume; Natal, Carmen; Salas, Dolores; Sanchez-Jacob, Mercedes; Zubizarreta, Raquel; Castells, Xavier		Cumulative False Positive Risk Grp	Trends in Detection of Invasive Cancer and Ductal Carcinoma In Situ at Biennial Screening Mammography in Spain: A Retrospective Cohort Study	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; ESTROGEN PLUS PROGESTIN; BREAST-CANCER; INCIDENCE RATES; FILM MAMMOGRAPHY; DECREASE; WOMEN; OVERDIAGNOSIS; PERFORMANCE; MORTALITY	Background: Breast cancer incidence has decreased in the last decade, while the incidence of ductal carcinoma in situ (DCIS) has increased substantially in the western world. The phenomenon has been attributed to the widespread adaption of screening mammography. The aim of the study was to evaluate the temporal trends in the rates of screen detected invasive cancers and DCIS, and to compare the observed trends with respect to hormone replacement therapy (HRT) use along the same study period. Methods: Retrospective cohort study of 1,564,080 women aged 45-69 years who underwent 4,705,681 screening mammograms from 1992 to 2006. Age-adjusted rates of screen detected invasive cancer, DCIS, and HRT use were calculated for first and subsequent screenings. Poisson regression was used to evaluate the existence of a change-point in trend, and to estimate the adjusted trends in screen detected invasive breast cancer and DCIS over the study period. Results: The rates of screen detected invasive cancer per 100.000 screened women were 394.0 at first screening, and 229.9 at subsequent screen. The rates of screen detected DCIS per 100.000 screened women were 66.8 at first screen and 43.9 at subsequent screens. No evidence of a change point in trend in the rates of DCIS and invasive cancers over the study period were found. Screen detected DCIS increased at a steady 2.5% per year (95% CI: 1.3; 3.8), while invasive cancers were stable. Conclusion: Despite the observed decrease in breast cancer incidence in the population, the rates of screen detected invasive cancer remained stable during the study period. The proportion of DCIS among screen detected breast malignancies increased from 13% to 17% throughout the study period. The rates of screen detected invasive cancer and DCIS were independent of the decreasing trend in HRT use observed among screened women after 2002.	[Roman, Marta; Sala, Maria; Castells, Xavier] Hosp del Mar Med Res Inst IMIM, Dept Epidemiol & Evaluat, Barcelona, Spain; [Roman, Marta; Rue, Montse; Sala, Maria; Castells, Xavier] Network Res Healthcare Chron Dis REDISECC, Madrid, Spain; [Rue, Montse] Univ Lleida, Biomed Res Inst Lleida IRBLLEIDA, Basic Med Sci Dept, Lleida, Spain; [Sala, Maria; Castells, Xavier] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Ascunce, Nieves] Inst Publ Hlth, Navarra Breast Canc Screening Programme, Navarra, Spain; [Bare, Marisa] UAB, Corp Sanitaria Parc Tauli, Inst Univ Parc Tauli, Oficina Tecn Cribratge, Barcelona, Spain; [Baroja, Araceli] Fdn Rioja Salud, La Rioja Breast Canc Screening Programme, Logrono, La Rioja, Spain; [De la Vega, Mariola] Serv Canario Salud, Consejeria Sanidad, Direcc Gen Programas Asistenci, Tenerife, Santa Cruz De T, Spain; [Galceran, Jaume] Pere Virgili Hlth Res Inst, Fdn Soc Canc Res & Prevent, Tarragona, Spain; [Natal, Carmen] Hlth Off, Program & Anal Unit, Oviedo, Principado De A, Spain; [Salas, Dolores] Gen Directorate Publ Hlth, Valencia, Comunidad Valen, Spain; [Salas, Dolores] Ctr Publ Hlth Res, Valencia, Comunidad Valen, Spain; [Sanchez-Jacob, Mercedes] Consejeria Sanidad, Serv Promoc Salud, Valladolid, Spain; [Sanchez-Jacob, Mercedes] Consejeria Sanidad, Programas Preventivos, Valladolid, Spain; [Zubizarreta, Raquel] Hlth Off, Publ Hlth & Planning Directorate, Galician Breast Canc Screening Programme, La Coruna, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Universitat de Lleida; Autonomous University of Barcelona; Public Health Institute of Navarra; Autonomous University of Barcelona; Parc Tauli Hospital Universitari	Castells, X (corresponding author), Hosp del Mar Med Res Inst IMIM, Dept Epidemiol & Evaluat, Barcelona, Spain.	xcastells@parcdesalutmar.cat	Castells, Xavier/S-7798-2016; SalasTrejo, Dolores/S-1139-2017; Bare, Marisa/H-4806-2011; Serra, Maria Sala/O-9420-2019; Sala, Maria/H-2562-2013; , 0000-0001-8085-2833/ABI-7466-2020; Rue, Montserrat/B-5663-2009	Castells, Xavier/0000-0002-2528-0382; Bare, Marisa/0000-0001-8085-2833; Serra, Maria Sala/0000-0002-9955-8746; Sala, Maria/0000-0002-9955-8746; , 0000-0001-8085-2833/0000-0001-8085-2833; Rue, Montserrat/0000-0002-7862-9365; Sala Serra, Maria/0000-0002-5516-5967; Roman, Marta/0000-0001-9076-8918	Instituto de Salud Carlos III-FEDER [PI11/01296, PI09/90251]	Instituto de Salud Carlos III-FEDER(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from the Instituto de Salud Carlos III-FEDER (PI11/01296 and PI09/90251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand H, 2008, B CANCER, V95, P11, DOI 10.1684/bdc.2008.0556; Ascunce N, 2010, ANN ONCOL, V21, piii43; Barbaglia G, 2009, MENOPAUSE, V16, P1061, DOI 10.1097/gme.0b013e3181a02b44; Barchielli A, 2005, EUR J CANCER, V41, P1045, DOI 10.1016/j.ejca.2004.12.032; Bluekens AMJ, 2012, RADIOLOGY, V265, P707, DOI 10.1148/radiol.12111461; Broeders MJM, 2005, EUR J CANCER PREV, V14, P107, DOI 10.1097/00008469-200504000-00006; Canfell K, 2008, MED J AUSTRALIA, V188, P641, DOI 10.5694/j.1326-5377.2008.tb01821.x; Castells X, 2007, DESCRIPCION CRIBADO; Chlebowski RT, 2013, JNCI-J NATL CANCER I, V105, P526, DOI 10.1093/jnci/djt043; de Gelder R, 2011, PREV MED, V53, P134, DOI 10.1016/j.ypmed.2011.06.009; Domingo L, 2011, EUR RADIOL, V21, P2020, DOI 10.1007/s00330-011-2143-1; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; Evans WP, 1997, RADIOLOGY, V204, P489, DOI 10.1148/radiology.204.2.9240541; Ferlay J, 2010, IARC CANCERBASE; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Gunsoy NB, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3365; Katalinic A, 2008, BREAST CANCER RES TR, V107, P427, DOI 10.1007/s10549-007-9566-z; Kerlikowske K, 2007, JNCI-J NATL CANCER I, V99, P1335, DOI 10.1093/jnci/djm111; Kliewer EV, 2007, NEW ENGL J MED, V357, P509; Kricker A, 2004, BRIT J CANCER, V90, P1382, DOI 10.1038/sj.bjc.6601677; Kumle M, 2008, LANCET, V372, P608, DOI 10.1016/S0140-6736(08)61255-6; Li CI, 2007, CANCER EPIDEM BIOMAR, V16, P2773, DOI 10.1158/1055-9965.EPI-07-0546; Li CI, 2005, CANCER EPIDEM BIOMAR, V14, P1008, DOI 10.1158/1055-9965.EPI-04-0849; Ministerio de Sanidad y Consumo and I.N.E, 2006, ENC NAC SAL ESP 2006; Nederend J, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3091; Paci E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1625; Pastor-Barriuso R, 2003, STAT MED, V22, P1141, DOI 10.1002/sim.1045; Perry N., 2006, EUROPEAN GUIDELINES; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Pollan M, 2010, ANN ONCOL, V21, piii97, DOI 10.1093/annonc/mdq095; Pollan M, 2009, JNCI-J NATL CANCER I, V101, P1584, DOI 10.1093/jnci/djp358; Ponti A, 2007, J NATL CANCER I, V99, P1817, DOI 10.1093/jnci/djm225; Puig-Vives M, 2012, BREAST, V21, P646, DOI 10.1016/j.breast.2012.01.014; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rodriguez MB, 2002, MED CLIN-BARCELONA, V119, P4, DOI 10.1016/S0025-7753(02)73296-X; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schneider HPG, 1997, INT J FERTIL WOMEN M, V42, P365; Segura JM, 2000, J CLIN EPIDEMIOL, V53, P595, DOI 10.1016/S0895-4356(99)00201-2; Sorum R, 2010, BREAST, V19, P499, DOI 10.1016/j.breast.2010.05.014; van Steenbergen LN, 2009, BREAST CANCER RES TR, V115, P181, DOI 10.1007/s10549-008-0067-5; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482	42	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83121	10.1371/journal.pone.0083121	http://dx.doi.org/10.1371/journal.pone.0083121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376649	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000060
J	Somenahally, AC; Mosher, JJ; Yuan, T; Podar, M; Phelps, TJ; Brown, SD; Yang, ZK; Hazen, TC; Arkin, AP; Palumbo, AV; Van Nostrand, JD; Zhou, JZ; Elias, DA				Somenahally, Anil C.; Mosher, Jennifer J.; Yuan, Tong; Podar, Mircea; Phelps, Tommy J.; Brown, Steven D.; Yang, Zamin K.; Hazen, Terry C.; Arkin, Adam P.; Palumbo, Anthony V.; Van Nostrand, Joy D.; Zhou, Jizhong; Elias, Dwayne A.			Hexavalent Chromium Reduction under Fermentative Conditions with Lactate Stimulated Native Microbial Communities	PLOS ONE			English	Article							URANIUM; CR(VI); RESISTANCE; BIOREDUCTION; METALS	Microbial reduction of toxic hexavalent chromium (Cr(VI)) in-situ is a plausible bioremediation strategy in electron-acceptor limited environments. However, higher [Cr(VI)] may impose stress on syntrophic communities and impact community structure and function. The study objectives were to understand the impacts of Cr(VI) concentrations on community structure and on the Cr(VI)-reduction potential of groundwater communities at Hanford, WA. Steady state continuous flow bioreactors were used to grow native communities enriched with lactate (30 mM) and continuously amended with Cr(VI) at 0.0 (No-Cr), 0.1 (Low-Cr) and 3.0 (High-Cr) mg/L. Microbial growth, metabolites, Cr(VI), 16S rRNA gene sequences and GeoChip based functional gene composition were monitored for 15 weeks. Temporal trends and differences in growth, metabolite profiles, and community composition were observed, largely between Low-Cr and High-Cr bioreactors. In both High-Cr and Low-Cr bioreactors, Cr(VI) levels were below detection from week 1 until week 15. With lactate enrichment, native bacterial diversity substantially decreased as Pelosinus spp., and Sporotalea spp., became the dominant groups, but did not significantly differ between Cr concentrations. The Archaea diversity also substantially decreased after lactate enrichment from Methanosaeta (35%), Methanosarcina (17%) and others, to mostly Methanosarcina spp. (95%). Methane production was lower in High-Cr reactors suggesting some inhibition of methanogens. Several key functional genes were distinct in Low-Cr bioreactors compared to High-Cr. Among the Cr resistant microbes, Burkholderia vietnamiensis, Comamonas testosterone and Ralstonia pickettii proliferated in Cr amended bioreactors. In-situ fermentative conditions facilitated Cr(VI) reduction, and as a result 3.0 mg/L Cr(VI) did not impact the overall bacterial community structure.	[Somenahally, Anil C.; Mosher, Jennifer J.; Podar, Mircea; Phelps, Tommy J.; Brown, Steven D.; Yang, Zamin K.; Hazen, Terry C.; Arkin, Adam P.; Palumbo, Anthony V.; Van Nostrand, Joy D.; Zhou, Jizhong; Elias, Dwayne A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, ENIGMA Ecosyst & Networks Integrated Genes & Mol, Berkeley, CA 94720 USA; [Somenahally, Anil C.; Mosher, Jennifer J.; Yuan, Tong; Phelps, Tommy J.; Brown, Steven D.; Yang, Zamin K.; Hazen, Terry C.; Palumbo, Anthony V.; Elias, Dwayne A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Hazen, Terry C.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN USA; [Hazen, Terry C.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA; [Hazen, Terry C.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Phelps, Tommy J.; Brown, Steven D.; Hazen, Terry C.; Palumbo, Anthony V.; Elias, Dwayne A.] Univ Tennessee, Joint Biol Sci Inst, Knoxville, TN USA; [Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Yuan, Tong; Van Nostrand, Joy D.; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Dept Bot, Norman, OK 73019 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Oklahoma System; University of Oklahoma - Norman	Elias, DA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, ENIGMA Ecosyst & Networks Integrated Genes & Mol, Berkeley, CA 94720 USA.	eliasda@ornl.gov	Palumbo, Anthony V/A-4764-2011; Podar, Mircea/B-7299-2012; Arkin, Adam/M-9941-2019; 吴, 昊/AAB-1620-2020; Elias, Dwayne/GZL-8202-2022; Van Nostrand, Joy D/F-1740-2016; Arkin, Adam P/A-6751-2008; Hazen, Terry C/C-1076-2012; Brown, Steven D/A-6792-2011	Palumbo, Anthony V/0000-0002-1102-3975; Podar, Mircea/0000-0003-2776-0205; Arkin, Adam/0000-0002-4999-2931; Van Nostrand, Joy D/0000-0001-9548-6450; Arkin, Adam P/0000-0002-4999-2931; Hazen, Terry C/0000-0002-2536-9993; Brown, Steven D/0000-0002-9281-3898; Mosher, Jennifer/0000-0001-6976-2036; , ENIGMA/0000-0002-0894-2831	Office of Science, Office of Biological and Environmental Research, of the U. S. Department of Energy [DE-AC02-05CH11231]; Department of Energy [DE-AC05-00OR22725]	Office of Science, Office of Biological and Environmental Research, of the U. S. Department of Energy(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE))	This work conducted by ENIGMA- Ecosystems and Networks Integrated with Genes and Molecular Assemblies (http://enigma.lbl.gov), a Scientific Focus Area Program at Lawrence Berkeley National Laboratory, was supported by the Office of Science, Office of Biological and Environmental Research, of the U. S. Department of Energy under Contract No. DE-AC02-05CH11231. Oak Ridge National Laboratory is managed by University of Tennessee UT-Battelle LLC for the Department of Energy under contract number DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abken HJ, 1998, J BACTERIOL, V180, P2027, DOI 10.1128/JB.180.8.2027-2032.1998; Alvarez AH, 1999, J BACTERIOL, V181, P7398, DOI 10.1128/JB.181.23.7398-7400.1999; Beller HR, 2013, APPL ENVIRON MICROB, V79, P63, DOI 10.1128/AEM.02496-12; Bencheikh-Latmani R, 2007, ENVIRON SCI TECHNOL, V41, P214, DOI 10.1021/es0622655; Brodie EL, 2011, CHEMOSPHERE, V85, P660, DOI 10.1016/j.chemosphere.2011.07.021; Burkhardt EM, 2010, ENVIRON SCI TECHNOL, V44, P177, DOI 10.1021/es902038e; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cervantes C, 2001, FEMS MICROBIOL REV, V25, P335, DOI 10.1111/j.1574-6976.2001.tb00581.x; Chaudhary PP, 2011, J MICROBIOL, V49, P558, DOI 10.1007/s12275-011-1052-y; Dogan NM, 2011, ENVIRON SCI TECHNOL, V45, P2278, DOI 10.1021/es102095t; Elias DA, 2004, APPL ENVIRON MICROB, V70, P413, DOI 10.1128/AEM.70.1.413-420.2004; Elias DA, 2003, J MICROBIOL METH, V53, P343, DOI 10.1016/S0167-7012(02)00252-X; Faybishenko B, 2008, ENVIRON SCI TECHNOL, V42, P8478, DOI 10.1021/es801383r; Gihring TM, 2011, APPL ENVIRON MICROB, V77, P5955, DOI 10.1128/AEM.00220-11; Gu BH, 2005, ENVIRON SCI TECHNOL, V39, P5268, DOI 10.1021/es050350r; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hubbard SS, 2008, ENVIRON SCI TECHNOL, V42, P3757, DOI 10.1021/es071702s; Jasso-Chavez R, 2010, AQUAT TOXICOL, V100, P329, DOI 10.1016/j.aquatox.2010.08.006; KUHN W, 1983, FEMS MICROBIOL LETT, V20, P407; Lira-Silva E, 2011, J HAZARD MATER, V193, P216, DOI 10.1016/j.jhazmat.2011.07.056; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Madden AS, 2009, J ENVIRON QUAL, V38, P53, DOI 10.2134/jeq2008.0071; Mosher JJ, 2012, AQUAT MICROB ECOL, V66, P271, DOI 10.3354/ame01563; Mosher JJ, 2012, APPL ENVIRON MICROB, V78, P2082, DOI 10.1128/AEM.07165-11; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramirez-Diaz MI, 2008, BIOMETALS, V21, P321, DOI 10.1007/s10534-007-9121-8; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Senko JM, 2008, ISME J, V2, P1134, DOI 10.1038/ismej.2008.60; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Sheik CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040059; Vishnivetskaya TA, 2011, APPL ENVIRON MICROB, V77, P302, DOI 10.1128/AEM.01715-10; Walker CB, 2009, J BACTERIOL, V191, P5793, DOI 10.1128/JB.00356-09; Warnes GR, 2008, GPLOTS VARIOUS R PRO; WEIMER PJ, 1978, ARCH MICROBIOL, V119, P49, DOI 10.1007/BF00407927; Xu Mark, 2010, International Journal of Strategic Information Technology and Applications, V1, P1, DOI 10.4018/jsita.2010100101; Zhang CL, 1996, APPL BIOCHEM BIOTECH, V57-8, P923, DOI 10.1007/BF02941773	38	22	24	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83909	10.1371/journal.pone.0083909	http://dx.doi.org/10.1371/journal.pone.0083909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376771	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000131
J	Stevenson, J; Krycer, JR; Phan, L; Brown, AJ				Stevenson, Julian; Krycer, James R.; Lisa Phan; Brown, Andrew J.			A Practical Comparison of Ligation-Independent Cloning Techniques	PLOS ONE			English	Article							MUTAGENESIS; GENOMICS; RECEPTOR; PROTEIN; DNA	The precise assembly of specific DNA sequences is a critical technique in molecular biology. Traditional cloning techniques use restriction enzymes and ligation of DNA in vitro, which can be hampered by a lack of appropriate restriction-sites and inefficient enzymatic steps. A number of ligation-independent cloning techniques have been developed, including polymerase incomplete primer extension (PIPE) cloning, sequence and ligation-independent cloning (SLIC), and overlap extension cloning (OEC). These strategies rely on the generation of complementary overhangs by DNA polymerase, without requiring specific restriction sites or ligation, and achieve high efficiencies in a fraction of the time at low cost. Here, we outline and optimise these techniques and identify important factors to guide cloning project design, including avoiding PCR artefacts such as primer-dimers and vector plasmid background. Experiments made use of a common reporter vector and a set of modular primers to clone DNA fragments of increasing size. Overall, PIPE achieved cloning efficiencies of similar to 95% with few manipulations, whereas SLIC provided a much higher number of transformants, but required additional steps. Our data suggest that for small inserts (<1.5 kb), OEC is a good option, requiring only two new primers, but performs poorly for larger inserts. These ligation-independent cloning approaches constitute an essential part of the researcher's molecular-tool kit.	[Stevenson, Julian; Krycer, James R.; Lisa Phan; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Krycer, James R.] Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW, Australia	University of New South Wales Sydney; Garvan Institute of Medical Research	Stevenson, J (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	j.stevenson@unsw.edu.au; j.krycer@garvan.org.au; aj.brown@unsw.edu.au		Krycer, James/0000-0003-1536-7270	National Health and Medical Research Council [1008081]; National Heart Foundation of Australia [G11S5757]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was supported by the National Health and Medical Research Council (1008081, www.nhmrc.gov.au/); and the National Heart Foundation of Australia (G11S5757, http://www.heartfoundation.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Jenster G, 1997, P NATL ACAD SCI USA, V94, P7879, DOI 10.1073/pnas.94.15.7879; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Krycer JR, 2011, J BIOL CHEM, V286, P20637, DOI 10.1074/jbc.M111.227082; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Sanchis J, 2008, APPL MICROBIOL BIOT, V81, P387, DOI 10.1007/s00253-008-1678-9; Thieme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020556; Tillett D, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e26; Tseng WC, 2008, ANAL BIOCHEM, V375, P376, DOI 10.1016/j.ab.2007.12.013; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899	14	39	45	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83888	10.1371/journal.pone.0083888	http://dx.doi.org/10.1371/journal.pone.0083888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376768	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000128
J	Beleoken, E; Leh, H; Arnoux, A; Ducot, B; Nogues, C; De Martin, E; Johanet, C; Samuel, D; Mustafa, MZ; Duclos-Vallee, JC; Buckle, M; Ballot, E				Beleoken, Elvire; Leh, Herve; Arnoux, Armelle; Ducot, Beatrice; Nogues, Claude; De Martin, Eleonora; Johanet, Catherine; Samuel, Didier; Mustafa, Mohammad Zahid; Duclos-Vallee, Jean-Charles; Buckle, Malcolm; Ballot, Eric			SPRi-Based Strategy to Identify Specific Biomarkers in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Autoimmune Hepatitis	PLOS ONE			English	Article							NUCLEAR RIBONUCLEOPROTEIN A2; RNA-BINDING PROTEINS; HNRNP A2; AUTOANTIBODIES; RECOGNITION; DISEASE; ANTIBODIES; IDENTIFICATION; AUTOANTIGEN; MICRORNAS	Background: Heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 is a target for antinuclear autoantibodies in systemic Lupus erythematosus (SLE), rheumatoid arthritis (RA), and autoimmune hepatitis (AIH). Aim: To monitor molecular interactions between peptides spanning the entire sequence of hnRNP A2/B1 and sera from patients and healthy controls. Methods: Sera from 8 patients from each pathology and controls were passed across a surface plasmon resonance Imagery (SPRi) surface containing 39 overlapping peptides of 17 mers covering the human hnRNP B1. Interactions involving the immobilised peptides were followed in real time and dissociation rate constants k(off) for each interaction were calculated. Results: Several significant interactions were observed: i) high stability (lower K-off values) between P55-70 and the AIH sera compared to controls (p= 0.003); ii) lower stability (higher k(off) values) between P118-133 and P262-277 and SLE sera, P145-160 and RA sera compared to controls (p=0.006, p=0.002, p=0.007). The binding curves and k(off), values observed after the formation of complexes with anti-IgM and anti-IgG antibodies and after nuclease treatment of the serum indicate that i) IgM isotypes are prevalent and ii) nucleic acids participate in the interaction between anti-hnRNAP B1 and P55-70 and also between controls and the peptides studied. Conclusions: These results indicate that P55-70 of hnRNP B1 is a potential biomarker for AIH in immunological tests and suggest the role of circulating nucleic acids, (eg miRNA), present or absent according to the autoimmune disorders and involved in antigen-antibody stability.	[Beleoken, Elvire; De Martin, Eleonora; Johanet, Catherine; Samuel, Didier; Mustafa, Mohammad Zahid; Duclos-Vallee, Jean-Charles; Ballot, Eric] INSERM, Res Unit 785, Villejuif, France; [Beleoken, Elvire; Ducot, Beatrice; De Martin, Eleonora; Samuel, Didier; Mustafa, Mohammad Zahid; Duclos-Vallee, Jean-Charles; Ballot, Eric] Univ Paris 11, Fac Med, Villejuif, France; [Leh, Herve; Nogues, Claude; Buckle, Malcolm] ENS Cachan, CNRS, Lab Biol & Pharmacol Appl, Cachan, France; [Ducot, Beatrice] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, F-94275 Le Kremlin Bicetre, France; [Arnoux, Armelle] Hop Bicetre, AP HP, Unite Rech Clin, Le Kremlin Bicetre, France; [De Martin, Eleonora; Johanet, Catherine; Ballot, Eric] Hop St Antoine, AP HP, Lab Immunol, F-75571 Paris, France; [Johanet, Catherine] Univ Paris 06, Fac Med, UFR 967, Paris, France; [Samuel, Didier; Duclos-Vallee, Jean-Charles] Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Ballot, E (corresponding author), INSERM, Res Unit 785, Villejuif, France.	eric.ballot@sat.aphp.fr	De Martin, Eleonora/T-6835-2018; ARNOUX, Armelle GUENEGOU/AAL-8094-2021	ARNOUX, Armelle GUENEGOU/0000-0003-3427-7086				Avalos AM, 2010, AUTOIMMUNITY, V43, P76, DOI 10.3109/08916930903374618; Avrameas S, 2007, J AUTOIMMUN, V29, P213, DOI 10.1016/j.jaut.2007.07.010; Backes C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-340; Belver L, 2010, IMMUNITY, V33, P713, DOI 10.1016/j.immuni.2010.11.010; Bouffartigues E, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm030; BURD CG, 1989, P NATL ACAD SCI USA, V86, P9788, DOI 10.1073/pnas.86.24.9788; Ceribelli A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3377; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; ENGVALL E, 1972, J IMMUNOL, V109, P129; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Hoffmann MH, 2011, J AUTOIMMUN, V36, P288, DOI 10.1016/j.jaut.2011.02.007; Huguet S, 2004, PROTEOMICS, V4, P1341, DOI 10.1002/pmic.200300757; Jakymiw A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1959; KOZU T, 1995, GENOMICS, V25, P365, DOI 10.1016/0888-7543(95)80035-K; Landsberg MJ, 2006, BIOCHEMISTRY-US, V45, P3943, DOI 10.1021/bi052440e; Moran-Jones K, 2005, NUCLEIC ACIDS RES, V33, P486, DOI 10.1093/nar/gki203; MURRAY JS, 1990, CLIN EXP IMMUNOL, V81, P286; Nogues C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044287; Nogues C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012152; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Schett G, 2009, ANN RHEUM DIS, V68, P729, DOI 10.1136/ard.2007.087502; Siapka S, 2007, AUTOIMMUNITY, V40, P223, DOI 10.1080/08916930701352357; Skriner K, 1997, J CLIN INVEST, V100, P127, DOI 10.1172/JCI119504; Steiner G, 1996, MOL BIOL REP, V23, P167, DOI 10.1007/BF00351165; Sun KH, 2003, RHEUMATOLOGY, V42, P154, DOI 10.1093/rheumatology/keg060; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Xu RM, 1997, STRUCTURE, V5, P559, DOI 10.1016/S0969-2126(97)00211-6	28	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84600	10.1371/journal.pone.0084600	http://dx.doi.org/10.1371/journal.pone.0084600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376828	gold, Green Published			2022-12-27	WOS:000328745100179
J	Cardani, R; Bugiardini, E; Renna, LV; Rossi, G; Colombo, G; Valaperta, R; Novelli, G; Botta, A; Meola, G				Cardani, Rosanna; Bugiardini, Enrico; Renna, Laura V.; Rossi, Giulia; Colombo, Graziano; Valaperta, Rea; Novelli, Giuseppe; Botta, Annalisa; Meola, Giovanni			Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2	PLOS ONE			English	Article							NUCLEAR FOCI; CTG REPEAT; BINDING PROTEIN; IN-VIVO; RNA; ZNF9; EXPRESSION; EXPANSION; RECEPTOR; DM2	Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are progressive multisystemic disorders caused by similar mutations a two different genetic loci. The common key feature of DM pathogenesis is nuclear accumulation of mutant RNA which causes aberrant alternative splicing of specific pre-mRNAs by altering the functions of two RNA binding proteins, MBNL1 and CUGBP1. However, DM1 and DM2 show disease-specific features that make them clearly separate diseases suggesting that other cellular and molecular pathways may be involved. In this study we have analysed the histopathological, and biomolecular features of skeletal muscle biopsies from DM1 and DM2 patients in relation to presenting phenotypes to better define the molecular pathogenesis. Particularly, the expression of CUGBP1 protein has been examined to clarify if this factor may act as modifier of disease-specific manifestations in DM. The results indicate that the splicing and muscle pathological alterations observed are related to the clinical phenotype both in DM1 and in DM2 and that CUGBP1 seems to play a role in classic DM1 but not in DM2. In conclusion, our results indicate that multisystemic disease spectrum of DM pathologies may not be explained only by spliceopathy thus confirming that the molecular pathomechanism of DM is more complex than that actually suggested.	[Cardani, Rosanna; Meola, Giovanni] IRCCS Policlin San Donato, Lab Muscle Histopathol & Mol Biol, Milan, Italy; [Bugiardini, Enrico; Meola, Giovanni] Univ Milan, IRCCS Policlin San Donato, Dept Neurol, Milan, Italy; [Renna, Laura V.; Colombo, Graziano] Univ Milan, Dept Biosci, Milan, Italy; [Rossi, Giulia; Botta, Annalisa] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Valaperta, Rea] IRCCS Policlin San Donato, Res Labs Mol Biol, Milan, Italy; [Novelli, Giuseppe] IRCCS Neuromed, Pozzilli, Isernia, Italy	IRCCS Policlinico San Donato; IRCCS Policlinico San Donato; University of Milan; University of Milan; University of Rome Tor Vergata; IRCCS Policlinico San Donato; IRCCS Neuromed	Meola, G (corresponding author), IRCCS Policlin San Donato, Lab Muscle Histopathol & Mol Biol, Milan, Italy.	giovanni.meola@unimi.it	BOTTA, ANNALISA/AAD-1581-2022; Renna, Laura Valentina/ABH-7699-2020; Novelli, Giuseppe/GQB-3329-2022; Meola, Giovanni/K-4775-2016; botta, annalisa/AAB-8680-2019; cardani, rosanna/ABH-6525-2020; Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/T-8822-2019	BOTTA, ANNALISA/0000-0003-4031-5624; Renna, Laura Valentina/0000-0003-1316-7478; Novelli, Giuseppe/0000-0002-7781-602X; Meola, Giovanni/0000-0001-6396-717X; cardani, rosanna/0000-0001-8858-4327; Novelli, Giuseppe/0000-0002-7781-602X; COLOMBO, GRAZIANO/0000-0001-8663-735X; bugiardini, enrico/0000-0002-9709-6699	FMM-Fondazione Malattie Miotoniche; AFM-Association Francaise contre les Myopathies; Agenzia Spaziale Italiana (ASI)	FMM-Fondazione Malattie Miotoniche; AFM-Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI))	This research was funded by FMM-Fondazione Malattie Miotoniche, AFM-Association Francaise contre les Myopathies and Agenzia Spaziale Italiana (ASI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachinski LL, 2009, NEUROLOGY, V72, P490, DOI 10.1212/01.wnl.0000333665.01888.33; Bassez G, 2008, J NEUROPATH EXP NEUR, V67, P319, DOI 10.1097/NEN.0b013e31816b4acc; Bonifazi E, 2004, DIAGN MOL PATHOL, V13, P164; Botta A, 2008, J MED GENET, V45, P639, DOI 10.1136/jmg.2008.058909; Botta A, 2006, BBA-MOL BASIS DIS, V1762, P329, DOI 10.1016/j.bbadis.2005.11.004; Botta A, 2007, GENE EXPRESSION, V13, P339; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Cardani R, 2004, EUR J HISTOCHEM, V48, P437; Cardani R, 2012, J NEUROL, V259, P2090, DOI 10.1007/s00415-012-6462-1; Chen W, 2007, J MOL BIOL, V368, P8, DOI 10.1016/j.jmb.2007.01.088; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; Dubowitz V, 1985, PRACTICAL APPROACH, P19; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; FARKASBARGETON E, 1988, J NEUROL SCI, V83, P145, DOI 10.1016/0022-510X(88)90064-0; Gates DP, 2011, J BIOL CHEM, V286, P34224, DOI 10.1074/jbc.M111.236547; Gonzalez I, 2000, NEUROLOGY, V54, P1218; Harper PS, 2001, MYOTONIC DYSTROPHY; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Huichalaf C, 2009, J NEUROSCI, V29, P9042, DOI 10.1523/JNEUROSCI.1983-09.2009; JACOBS AEM, 1990, BIOCHIM BIOPHYS ACTA, V1096, P14, DOI 10.1016/0925-4439(90)90006-B; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Kino Y, 2009, NUCLEIC ACIDS RES, V37, P6477, DOI 10.1093/nar/gkp681; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Kuyumcu-Martinez NM, 2006, PROG MOLEC, V44, P133; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Machuca-Tzili L, 2005, MUSCLE NERVE, V32, P1, DOI 10.1002/mus.20301; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2005, CIRC RES, V97, P1152, DOI 10.1161/01.RES.0000193598.89753.e3; Mankodi A, 2003, ANN NEUROL, V54, P760, DOI 10.1002/ana.10763; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Margolis JM, 2006, HUM MOL GENET, V15, P1808, DOI 10.1093/hmg/ddl103; Massa R, 2010, NEUROPATH APPL NEURO, V36, P275, DOI 10.1111/j.1365-2990.2010.01068.x; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; Meola G, 2009, RNA BINDING PROTEINS, P153; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moxley Richard T 3rd, 2002, Neuromuscul Disord, V12, P306, DOI 10.1016/S0960-8966(01)00284-X; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Orengo JP, 2011, ANN NEUROL, V69, P681, DOI 10.1002/ana.22278; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Pelletier R, 2009, NEUROBIOL DIS, V36, P181, DOI 10.1016/j.nbd.2009.07.009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pisani V, 2008, MUSCLE NERVE, V38, P1405, DOI 10.1002/mus.21122; Raheem O, 2010, AM J PATHOL, V177, P3025, DOI 10.2353/ajpath.2010.100179; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; RICKER K, 1994, NEUROLOGY, V44, P1448, DOI 10.1212/WNL.44.8.1448; Rotondo G, 2005, EUR J NEUROL, V12, P160, DOI 10.1111/j.1468-1331.2004.01032.x; Salisbury E, 2008, EXP CELL RES, V314, P2266, DOI 10.1016/j.yexcr.2008.04.018; Salisbury E, 2009, AM J PATHOL, V175, P748, DOI 10.2353/ajpath.2009.090047; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P466, DOI 10.1001/archneur.1976.00500070008002; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Schara Ulrike, 2006, Semin Pediatr Neurol, V13, P71; Schoser B, 2010, CURR GENOMICS, V11, P77, DOI 10.2174/138920210790886844; Schoser BGH, 2004, MUSCLE NERVE, V29, P275, DOI 10.1002/mus.10545; Sen S, 2010, J BIOL CHEM, V285, P25426, DOI 10.1074/jbc.M109.095224; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; THORNTON CA, 1994, ANN NEUROL, V35, P269, DOI 10.1002/ana.410350305; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Udd B, 2003, Neuromuscul Disord, V13, P589, DOI 10.1016/S0960-8966(03)00092-0; Udd B, 1997, NEUROMUSCULAR DISORD, V7, P217, DOI 10.1016/S0960-8966(97)00041-2; Vihola A, 2003, NEUROLOGY, V60, P1854, DOI 10.1212/01.WNL.0000065898.61358.09; Ward AJ, 2010, HUM MOL GENET, V19, P3614, DOI 10.1093/hmg/ddq277	72	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83777	10.1371/journal.pone.0083777	http://dx.doi.org/10.1371/journal.pone.0083777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376746	Green Published, gold			2022-12-27	WOS:000328745100139
J	Cembranelli, SBS; Souto, FO; Ferreira-Paim, K; Richinho, TT; Nunes, PL; Nascentes, GAN; Ferreira, TB; Correia, D; Lages-Silva, E				Cembranelli, Sibeli B. S.; Souto, Fernanda O.; Ferreira-Paim, Kennio; Richinho, Tulio T.; Nunes, Poliana L.; Nascentes, Gabriel A. N.; Ferreira, Thatiana B.; Correia, Daimo; Lages-Silva, Eliane			First Evidence of Genetic Intraspecific Variability and Occurrence of Entamoeba gingivalis in HIV(+)/AIDS	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ORAL LESIONS; HISTOLYTICA; CHOLESTEROL; DISEASE; PREVALENCE; ABSCESS; HIV-1; DNA	Entamoeba gingivalis is considered an oral commensal but demonstrates a pathogenic potential associated with periodontal disease in immunocompromised individuals. Therefore, this study evaluated the occurrence, opportunistic conditions, and intraspecific genetic variability of E. gingivalis in HIV(+)/AIDS patients. Entamoeba gingivalis was studied using fresh examination (FE), culture, and PCR from bacterial plaque samples collected from 82 HIV(+)/AIDS patients. Genetic characterization of the lower ribosomal subunit of region 18S (18S-SSU rRNA) was conducted in 9 positive samples using low-stringency single specific primer PCR (LSSP-PCR) and sequencing analysis. Entamoeba gingivalis was detected in 63.4% (52/82) of the samples. No association was detected between the presence of E. gingivalis and the CD4(+) lymphocyte count (<= 200 cells/mm(3) (p = 0.912) or viral load (p = 0.429). The LSSP-PCR results helped group E. gingivalis populations into 2 polymorphic groups (68.3% similarity): group I, associated with 63.6% (7/11) of the samples, and group II, associated with 36.4% (4/11) of the samples, which shared 74% and 83.7% similarity and association with C and E isolates from HIV(-) individuals, respectively. Sequencing of 4 samples demonstrated 99% identity with the reference strain ATCC 30927 and also showed 2 divergent clusters, similar to those detected by LSSP-PCR. Opportunistic behavior of E. gingivalis was not detected, which may be related to the use of highly active antiretroviral therapy by all HIV(+)/AIDS patients. The high occurrence of E. gingivalis in these patients can be influenced by multifactorial components not directly related to the CD4(+) lymphocyte counts, such as cholesterol and the oral microbiota host, which could mask the potential opportunistic ability of E. gingivalis. The identification of the 18S SSU-rRNA polymorphism by LSSP-PCR and sequencing analysis provides the first evidence of genetic variability in E. gingivalis isolated from HIV patients.	[Cembranelli, Sibeli B. S.] Univ Fed Triangulo Mineiro, Infect & Parasit Dis Unit, Uberaba, MG, Brazil; Univ Fed Triangulo Mineiro, Parasitol Unit, Uberaba, MG, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal do Triangulo Mineiro	Cembranelli, SBS (corresponding author), Univ Fed Triangulo Mineiro, Infect & Parasit Dis Unit, Uberaba, MG, Brazil.	sibelibs@hotmail.com	Ferreira-Paim, Kennio/A-8194-2013	Ferreira-Paim, Kennio/0000-0002-6035-8392; LUCENA-NUNES, POLIANA/0000-0001-5792-1474	Fundacao de Amparo a Pesquisa de Minas Gerais-FAPEMIG [APQ -02224-11]	Fundacao de Amparo a Pesquisa de Minas Gerais-FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Fundacao de Amparo a Pesquisa de Minas Gerais-FAPEMIG APQ -02224-11 [to E.L.S.]. http://www.fapemig.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saeed WM, 2003, AL RAFIDAIN DENT J, V3, P70; ALEY SB, 1980, J EXP MED, V152, P391, DOI 10.1084/jem.152.2.391; Bergquist R, 2009, PERIODONTOL 2000, V49, P96, DOI 10.1111/j.1600-0757.2008.00294.x; Bhaijee F, 2011, CASE REP MED, V2011, DOI 10.1155/2011/357301; BLANC DS, 1992, J PROTOZOOL, V39, P471, DOI 10.1111/j.1550-7408.1992.tb04834.x; Bolscher JGM, 2002, EUR J ORAL SCI, V110, P149, DOI 10.1034/j.1600-0722.2002.11175.x; BROWN M, 1991, AIDS, V5, P93, DOI 10.1097/00002030-199101000-00014; Chen Jin-fu, 2000, Chinese Journal of Parasitology and Parasitic Diseases, V18, P84; Chen Jinfu, 1999, Chinese Journal of Parasitology and Parasitic Diseases, V17, P209; Chomicz L, 2001, Wiad Parazytol, V47, P559; Clark CG, 1997, J EUKARYOT MICROBIOL, V44, P142, DOI 10.1111/j.1550-7408.1997.tb05951.x; CLARK CG, 1992, AM J TROP MED HYG, V46, P158, DOI 10.4269/ajtmh.1992.46.158; CLAYTON JP, 1954, J PARASITOL, V40, P347, DOI 10.2307/3273749; Cutler C W, 2006, Adv Dent Res, V19, P49; DAS SR, 1976, ANN TROP MED PARASIT, V70, P439, DOI 10.1080/00034983.1976.11687144; El-Sadr W, 2005, HIV MED, V6, P114, DOI 10.1111/j.1468-1293.2005.00273.x; Favoreto Junior S, 1995, Rev Soc Bras Med Trop, V28, P379, DOI 10.1590/S0037-86821995000400012; Fuentes Cuevas R, 2008, REV ADM, V65, P259; GANNON JT, 1989, MICROBIOS, V58, P95; Ghabanchi J, 2010, Indian J Dent Res, V21, P89, DOI 10.4103/0970-9290.62821; Gharavi MJ, 2006, IRAN J PARASITOL, V1, P43; Gros G., 1849, B SOC NAT MOSCOU, V22, P549; Habte HH, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-99; JASKOSKI BENEDICT J., 1963, TRANS AMER MICROSCOP SOC, V82, P418, DOI 10.2307/3224205; Jian B, 2008, CYTOJOURNAL, V5, DOI 10.4103/1742-6413.43179; KATIYAR SK, 1987, ANN TROP MED PARASIT, V81, P201, DOI 10.1080/00034983.1987.11812113; Khairnar K, 2008, J HEALTH POPUL NUTR, V26, P418; Kikuta N, 1996, CAN J MICROBIOL, V42, P1248, DOI 10.1139/m96-161; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kroidl A, 2005, EUR J MED RES, V10, P448; Liu G Y, 2001, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V19, P229; Lucht E, 1998, CLIN INFECT DIS, V27, P471, DOI 10.1086/514709; Margiotta V, 1999, J ORAL PATHOL MED, V28, P173; Melvin DM, 1971, METODOS LAB DIAGNOST; Nocito-Mendoza I, 2003, RCOE, V8, P19; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Patel M, 2003, ORAL MICROBIOL IMMUN, V18, P199, DOI 10.1034/j.1399-302X.2003.00064.x; Patton LL, 2000, ORAL SURG ORAL MED O, V89, P299, DOI 10.1016/S1079-2104(00)70092-8; Pena SDJ, 1996, LABORATORY PROTOCOLS FOR MUTATION DETECTION, P42; Perez-Jaffe L, 1998, DIAGN CYTOPATHOL, V18, P458, DOI 10.1002/(SICI)1097-0339(199806)18:6<458::AID-DC15>3.0.CO;2-G; PINDAK FF, 1989, GENITOURIN MED, V65, P366; Rendon-Maldonado J, 2003, J EUKARYOT MICROBIOL, V50, P43, DOI 10.1111/j.1550-7408.2003.tb00104.x; Roberts AD, 1999, CLIN INFECT DIS, V29, P441, DOI 10.1086/520231; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAMBROOK J, 2000, MOL CLONING LAB MANU; Schmidt-Westhausen AM, 2000, J ORAL PATHOL MED, V29, P336, DOI 10.1034/j.1600-0714.2000.290708.x; Serrano-Luna J, 2010, CAN J MICROBIOL, V56, P987, DOI 10.1139/W10-088; Silva-Boghossian CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075898; TACHIBANA H, 1991, J INFECT DIS, V164, P825, DOI 10.1093/infdis/164.4.825; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trim RD, 2011, PARASITOL RES, V109, P857, DOI 10.1007/s00436-011-2312-9; Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3; Vernon LT, 2009, COMMUNITY DENT ORAL, V37, P427, DOI 10.1111/j.1600-0528.2009.00485.x; WANTLAND WW, 1970, J DENT RES, V49, P293, DOI 10.1177/00220345700490021601; WILLIAMS DM, 1993, J ORAL PATHOL MED, V22, P289, DOI 10.1111/j.1600-0714.1993.tb01074.x; YAMAMOTO A, 1995, MICROBIOL IMMUNOL, V39, P185, DOI 10.1111/j.1348-0421.1995.tb02187.x	56	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82864	10.1371/journal.pone.0082864	http://dx.doi.org/10.1371/journal.pone.0082864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376598	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100068
J	Zhu, FF; Yoh, M; Gilliam, FS; Lu, XK; Mo, JM				Zhu, Feifei; Yoh, Muneoki; Gilliam, Frank S.; Lu, Xiankai; Mo, Jiangming			Nutrient Limitation in Three Lowland Tropical Forests in Southern China Receiving High Nitrogen Deposition: Insights from Fine Root Responses to Nutrient Additions	PLOS ONE			English	Article							SIMULATED N DEPOSITION; SPRUCE PICEA-ABIES; PHOSPHORUS AVAILABILITY; SUBTROPICAL FORESTS; INORGANIC NITROGEN; DYNAMICS; GROWTH; TREE; FERTILIZATION; DECOMPOSITION	Elevated nitrogen (N) deposition to tropical forests may accelerate ecosystem phosphorus (P) limitation. This study examined responses of fine root biomass, nutrient concentrations, and acid phosphatase activity (APA) of bulk soil to five years of N and P additions in one old-growth and two younger lowland tropical forests in southern China. The old-growth forest had higher N capital than the two younger forests from long-term N accumulation. From February 2007 to July 2012, four experimental treatments were established at the following levels: Control, N-addition (150 kg N ha(-1) yr(-1)) P-addition (150 kg P ha(-1) yr(-1)) and N+P-addition (150 kg N ha(-1) yr(-1) plus 150 kg P ha(-1) yr(-1)). We hypothesized that fine root growth in the N-rich old-growth forest would be limited by P availability, and in the two younger forests would primarily respond to N additions due to large plant N demand. Results showed that five years of N addition significantly decreased live fine root biomass only in the old-growth forest (by 31%), but significantly elevated dead fine root biomass in all the three forests (by 64% to 101%), causing decreased live fine root proportion in the old-growth and the pine forests. P addition significantly increased live fine root biomass in all three forests (by 20% to 76%). The combined N and P treatment significantly increased live fine root biomass in the two younger forests but not in the old-growth forest. These results suggest that fine root growth in all three study forests appeared to be P-limited. This was further confirmed by current status of fine root N:P ratios, APA in bulk soil, and their responses to N and P treatments. Moreover, N addition significantly increased APA only in the old-growth forest, consistent with the conclusion that the old-growth forest was more P-limited than the younger forests.	[Zhu, Feifei; Lu, Xiankai; Mo, Jiangming] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Zhu, Feifei] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Tokyo, Japan; [Yoh, Muneoki] Tokyo Univ Agr & Technol, Inst Agr, Tokyo, Japan; [Gilliam, Frank S.] Marshall Univ, Dept Biol Sci, Huntington, WV USA; [Zhu, Feifei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; Marshall University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Mo, JM (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	mojm@scib.ac.cn	Yoh, Muneoki/C-2047-2013; Gilliam, Frank S./M-9767-2019	Yoh, Muneoki/0000-0002-5378-1459; Gilliam, Frank S./0000-0002-5525-0766	National Science Foundation of China [41273143]; National Key Basic Research 973 Program [2010CB833502]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research 973 Program(National Basic Research Program of China)	This study was funded by National Science Foundation of China(NO.41273143) and National Key Basic Research 973 Program (2010CB833502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Clare S, 2013, ECOLOGY, V94, P1540, DOI 10.1890/12-2128.1; [Anonymous], 1982, TROP SUBTROP ECOSYS; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Braun S, 2010, ENVIRON POLLUT, V158, P2043, DOI 10.1016/j.envpol.2009.11.030; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Blanes MC, 2012, SOIL BIOL BIOCHEM, V48, P51, DOI 10.1016/j.soilbio.2012.01.012; CLEMENSSONLINDELL A, 1995, PLANT SOIL, V173, P147, DOI 10.1007/BF00155526; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Compton JE, 1998, FOREST ECOL MANAG, V110, P101, DOI 10.1016/S0378-1127(98)00278-3; Cusack DF, 2011, BIOGEOCHEMISTRY, V104, P203, DOI 10.1007/s10533-010-9496-4; Fang YT, 2008, BIOGEOSCIENCES, V5, P339, DOI 10.5194/bg-5-339-2008; Fang YT, 2006, J ENVIRON SCI, V18, P752; Fang YT, 2009, FOREST ECOL MANAG, V257, P332, DOI 10.1016/j.foreco.2008.09.004; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Garrish V, 2010, J EXP BOT, V61, P3735, DOI 10.1093/jxb/erq183; Godbold DL, 2003, TREE PHYSIOL, V23, P915, DOI 10.1093/treephys/23.13.915; Gordon WS, 2000, ECOLOGY, V81, P275, DOI 10.1890/0012-9658(2000)081[0275:NCIFR]2.0.CO;2; Gress SE, 2007, ECOLOGY, V88, P119, DOI 10.1890/0012-9658(2007)88[119:NLISED]2.0.CO;2; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; He J., 1982, TROP SUBTROP ECOSYS, V1, P25; Hendricks JJ, 2006, J ECOL, V94, P40, DOI 10.1111/j.1365-2745.2005.01067.x; Homeier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047128; Huang Z. L, 1994, ACTA PHYTOECOLOGICA, V18, P194; Liu G., 1996, SOIL PHYS CHEM ANAL; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061188; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Lu XK, 2009, PEDOSPHERE, V19, P189, DOI 10.1016/S1002-0160(09)60108-9; Lu XK, 2012, BIOTROPICA, V44, P302, DOI 10.1111/j.1744-7429.2011.00831.x; Lu XK, 2010, GLOBAL CHANGE BIOL, V16, P2688, DOI 10.1111/j.1365-2486.2010.02174.x; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Majdi H, 1997, ECOSCIENCE, V4, P199, DOI 10.1080/11956860.1997.11682396; Majdi H, 1994, THESIS SWEDISH U AGR; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1007/BF01007574; Mirmanto E, 1999, PHILOS T ROY SOC B, V354, P1825, DOI 10.1098/rstb.1999.0524; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Mo JM, 2006, PLANT SOIL, V282, P135, DOI 10.1007/s11104-005-5446-7; Nadelhoffer KJ, 2000, NEW PHYTOL, V147, P131, DOI 10.1046/j.1469-8137.2000.00677.x; Naples BK, 2010, BIOGEOCHEMISTRY, V97, P109, DOI 10.1007/s10533-009-9354-4; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Ostertag R, 2001, ECOLOGY, V82, P485, DOI 10.1890/0012-9658(2001)082[0485:EONAPA]2.0.CO;2; RAICH JW, 1994, CAN J FOREST RES, V24, P2135, DOI 10.1139/x94-274; Schneider K, 2001, BIOL FERT SOILS, V34, P151, DOI 10.1007/s003740100387; SINSABAUGH RL, 1993, ECOLOGY, V74, P1586, DOI 10.2307/1940086; Tanner EVJ, 1998, ECOLOGY, V79, P10, DOI 10.1890/0012-9658(1998)079[0010:EIONLO]2.0.CO;2; Treseder KK, 2001, ECOLOGY, V82, P946, DOI 10.1890/0012-9658(2001)082[0946:EOSNAO]2.0.CO;2; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; [王晖 WANG Hui], 2008, [生态学报, Acta Ecologica Sinica], V28, P470; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Yavitt JB, 2011, AUSTRAL ECOL, V36, P433, DOI 10.1111/j.1442-9993.2010.02157.x; Yuan ZY, 2012, P ROY SOC B-BIOL SCI, V279, P3796, DOI 10.1098/rspb.2012.0955; Zhang T, 2011, BIOGEOSCIENCES, V8, P2805, DOI 10.5194/bg-8-2805-2011	56	35	50	8	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82661	10.1371/journal.pone.0082661	http://dx.doi.org/10.1371/journal.pone.0082661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376562	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100049
J	Cao, Y; Lupo, PJ; Swartz, MD; Nousome, D; Scheurer, ME				Cao, Ying; Lupo, Philip J.; Swartz, Michael D.; Nousome, Darryl; Scheurer, Michael E.			Using a Bayesian Hierarchical Model for Identifying Single Nucleotide Polymorphisms Associated with Childhood Acute Lymphoblastic Leukemia Risk in Case-Parent Triads	PLOS ONE			English	Article							VARIABLE SELECTION; STOCHASTIC SEARCH; GENE; HOMOCYSTEINE; METAANALYSIS; PATHWAY; DISEASE	Childhood acute lymphoblastic leukemia (ALL) is a condition that arises from complex etiologies. The absence of consistent environmental risk factors and the presence of modest familial associations suggest ALL is a complex trait with an underlying genetic component. The identification of genetic factors associated with disease is complicated by complex genetic covariance structures and multiple testing issues. Both issues can be resolved with appropriate Bayesian variable selection methods. The present study was undertaken to extend our hierarchical Bayesian model for case-parent triads to incorporate single nucleotide polymorphisms (SNPs) and incorporate the biological grouping of SNPs within genes. Based on previous evidence that genetic variation in the folate metabolic pathway influences ALL risk, we evaluated 128 tagging SNPs in 16 folate metabolic genes among 118 ALL case-parent triads recruited from the Texas Children's Cancer Center (Houston, TX) between 2003 and 2010. We used stochastic search gene suggestion (SSGS) in hierarchical Bayesian models to evaluate the association between folate metabolic SNPs and ALL. Using Bayes factors among these variants in childhood ALL case-parent triads, two SNPs were identified with a Bayes factor greater than 1. There was evidence that the minor alleles of NOS3 rs3918186 (OR = 2.16; 95% CI: 1.51-3.15) and SLC19A1 rs1051266 (OR = 2.07; 95% CI: 1.25-3.46) were positively associated with childhood ALL. Our findings are suggestive of the role of inherited genetic variation in the folate metabolic pathway on childhood ALL risk, and they also suggest the utility of Bayesian variable selection methods in the context of case-parent triads for evaluating the role of SNPs on disease risk.	[Cao, Ying; Swartz, Michael D.] Univ Texas Houston, Sch Publ Hlth, Div Biostat, Houston, TX USA; [Lupo, Philip J.; Scheurer, Michael E.] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [Nousome, Darryl] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Scheurer, ME (corresponding author), Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA.	scheurer@bcm.edu	Swartz, Michael/AEX-2820-2022; Lupo, Philip/R-8314-2019	Lupo, Philip/0000-0003-0978-5863; Swartz, Michael/0000-0003-3953-8775; Scheurer, Michael/0000-0002-8379-6088; Nousome, Darryl/0000-0002-5259-8599	Dan L. Duncan Cancer Center at Baylor College of Medicine [P30CA125123]; NCI [K07CA131505]; Kurt Groten Family Research Scholars Award; NATIONAL CANCER INSTITUTE [P30CA125123, K07CA131505] Funding Source: NIH RePORTER	Dan L. Duncan Cancer Center at Baylor College of Medicine; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kurt Groten Family Research Scholars Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The genotyping for this work was supported by an Inter-Institutional Pilot Project (to M. E. S. and P.J.L.) from the Dan L. Duncan Cancer Center at Baylor College of Medicine, P30CA125123 (PI: Osborne). M. E. S. was also supported in part by an NCI Career Development Award, K07CA131505 and in part by Kurt Groten Family Research Scholars Award (P.J.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bialecka M, 2012, PHARMACOGENET GENOM, V22, P716, DOI 10.1097/FPC.0b013e32835693f7; Brown KS, 2003, ARTERIOSCL THROM VAS, V23, P1014, DOI 10.1161/01.ATV.0000071348.70527.F4; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chipman H., 2001, PRACTICAL IMPLEMENTA; Collin SM, 2009, CANCER EPIDEM BIOMAR, V18, P2528, DOI 10.1158/1055-9965.EPI-09-0223; Dervieux T, 2004, ARTHRITIS RHEUM-US, V50, P2766, DOI 10.1002/art.20460; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gauderman WJ, 2006, COMPUTER PROGRAM POW; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Genome Variation Server, 2010, GVS GEN VAR SERV VER; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Infante-Rivard C, 2007, AM J EPIDEMIOL, V165, P1248, DOI 10.1093/aje/kwm022; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Koppen IJN, 2010, BRIT J HAEMATOL, V148, P3, DOI 10.1111/j.1365-2141.2009.07898.x; Levine AJ, 2011, CANCER CAUSE CONTROL, V22, P541, DOI 10.1007/s10552-011-9726-7; Lightfoot TJ, 2010, BLOOD, V115, P3923, DOI 10.1182/blood-2009-10-249722; Lupo PJ, 2012, PEDIATR HEMAT ONCOL, V29, P679, DOI 10.3109/08880018.2012.722747; Lupo PJ, 2012, CANCER CAUSE CONTROL, V23, P1797, DOI 10.1007/s10552-012-0058-z; Margolin JF, 2011, PRINCIPLES PRACTICE, P518; Metayer C, 2011, CANCER CAUSE CONTROL, V22, P1243, DOI 10.1007/s10552-011-9795-7; National Heart L, 2010, GVS GEN VAR SERV VER; Nousome D, 2013, LEUKEMIA RES, V37, P531, DOI 10.1016/j.leukres.2013.01.020; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Sherborne AL, 2011, HAEMATOL-HEMATOL J, V96, P1049, DOI 10.3324/haematol.2011.040121; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Smith BJ, 2008, BAYESIAN OUTPUT ANAL; Sobel E, 1996, AM J HUM GENET, V58, P1323; Spector LG, 2013, PEDIATR BLOOD CANCER, V60, P1059, DOI 10.1002/pbc.24434; Swartz MD, 2006, BIOMETRICS, V62, P495, DOI 10.1111/j.1541-0420.2005.00451.x; Swartz Michael D, 2007, BMC Proc, V1 Suppl 1, pS113; Swartz MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053475; Swartz MD, 2008, STAT MED, V27, P6158, DOI 10.1002/sim.3434; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337	37	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84658	10.1371/journal.pone.0084658	http://dx.doi.org/10.1371/journal.pone.0084658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367687	Green Submitted, gold, Green Published			2022-12-27	WOS:000328741900062
J	Maketa, V; Vuna, M; Baloji, S; Lubanza, S; Hendrickx, D; Inocencio da Luz, RA; Boelaert, M; Lutumba, P				Maketa, Vivi; Vuna, Mimy; Baloji, Sylvain; Lubanza, Symphorien; Hendrickx, David; Inocencio da Luz, Raquel Andrea; Boelaert, Marleen; Lutumba, Pascal			Perceptions of Health, Health Care and Community-Oriented Health Interventions in Poor Urban Communities of Kinshasa, Democratic Republic of Congo	PLOS ONE			English	Article							PUBLIC-HEALTH; INITIATIVES; PROGRAM; IMPACT	In Democratic Republic of Congo access to health care is limited because of many geographical and financial barriers, while quality of care is often low. Global health donors assist the country with a number of community-oriented interventions such as free distribution of bednets, antihelminthic drugs, vitamin A supplementation and vaccination campaigns, but uptake of these interventions is not always optimal. The aim of this study was to explore the perceptions of poor urban communities of the capital Kinshasa with regard to health issues in general as well as their experiences and expectations concerning facility-based health services and community-oriented health interventions. Applying an approach rooted in the grounded theory framework, focus group discussions were conducted in eight neighborhoods of poor urban areas in the city of Kinshasa in July 2011. Study participants were easily able to evoke the city's major health problems, with the notable exceptions of malnutrition and HIV/AIDS. They perceive the high out-of-pocket cost of health services as the major obstacle when seeking access to quality care. Knowledge of ongoing community-oriented health interventions seems good. Still, while the study participants agree that those interventions are beneficial; their acceptability seems to be problematic. This is chiefly put down to a lack of information and government communication about the programs and their interventions. Furthermore, the study participants referred to rumors and the deterring effect of stories about alleged harmful consequences of those interventions. Along with improving the provision and quality of general health care, the government and international actors must improve their efforts in informing the communities about disease control programs, their rationale and benefit/risk ratio. Directly engaging community members in a dialogue might be beneficial in terms of improving acceptability and overall access to health services and interventions. Novel ways of reducing the high out-of-pocket expenditure should also be explored.	[Maketa, Vivi; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Vuna, Mimy; Lutumba, Pascal] Inst Natl Rech Biomed, Epidemiol Unit, Kinshasa, DEM REP CONGO; [Baloji, Sylvain] Inst Super Tech Med, Epidemiol Unit, Kinshasa, DEM REP CONGO; [Lubanza, Symphorien] Univ Kinshasa, Dept Social Sci, Kinshasa, DEM REP CONGO; [Hendrickx, David; Boelaert, Marleen; Lutumba, Pascal] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Hendrickx, David] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, Australia; [Inocencio da Luz, Raquel Andrea] Univ Antwerp, Fac Med, Int Hlth Unit, B-2020 Antwerp, Belgium	Universite de Kinshasa; Institute Nacional de Recherche Biomedical; Universite de Kinshasa; Institute of Tropical Medicine (ITM); Telethon Kids Institute; University of Western Australia; University of Antwerp	Maketa, V (corresponding author), Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO.	vmaketa@yahoo.fr	Inocencio da Luz, Raquel/ABE-8206-2021; da Luz, Raquel A Inocencio/L-9676-2016; Boelaert, Marleen/E-2698-2012	Inocencio da Luz, Raquel/0000-0002-2870-0311; da Luz, Raquel A Inocencio/0000-0002-2870-0311; Boelaert, Marleen/0000-0001-8051-6776	World Health Organization/TDR [A90072]	World Health Organization/TDR(World Health Organization)	This study has been done with the financial support of World Health Organization/TDR through the grant A90072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MC, 2007, INT J HEALTH PLAN M, V22, P337, DOI 10.1002/hpm.900; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; BRACHT N, 1994, HEALTH EDUC RES, V9, P243, DOI 10.1093/her/9.2.243; Faltermaier T, 1997, EUR J PUBLIC HEALTH, V7, P357, DOI 10.1093/eurpub/7.4.357; Fatungase KO, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-11; Gilson Lucy, 2006, J Health Organ Manag, V20, P359, DOI 10.1108/14777260610701768; Glaser B., 1992, BASICS GROUNDED THEO; Husserl Edmund, 1989, IDEAS PERTAINING PUR; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; Olsen OE, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-14; Remme JHF, 2010, B WORLD HEALTH ORGAN, V88, P509, DOI 10.2471/BLT.09.069203; Remme JHF, 2002, TRENDS PARASITOL, V18, P421, DOI 10.1016/S1471-4922(02)02387-5; Republique Democratique du Congo Ministere de la Sante Publique, 2010, STRATEGIE RENFORCEME; Republique Democratique du Congo Ministere du Plan, 2010, DOCUMNET STRATEGIQUE; Republique Democratique du Congo Ministere du Plan en collaboration avec le Ministere de la Sante Publique, 2008, ENQUETE DEMOGRAPHIQU; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Schulz AJ, 2011, HEALTH PROMOT PRACT, V12, P900, DOI 10.1177/1524839909359156; Wagstaff A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P181	20	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84314	10.1371/journal.pone.0084314	http://dx.doi.org/10.1371/journal.pone.0084314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HY	24367653	Green Submitted, gold, Green Published			2022-12-27	WOS:000328741900044
J	Liu, JS; Jung, F; Yang, SH; Chou, SSP; Huang, JL; Lu, CL; Huang, GL; Yang, PC; Lin, JC; Jow, GM				Liu, Jung-Sen; Jung, Fang; Yang, Shih-Hsing; Chou, Shang-Shing P.; Huang, Jhih-Liang; Lu, Chang-Lin; Huang, Guan-Lin; Yang, Pan-Chyr; Lin, Jau-Chen; Jow, Guey-Mei			FJU-C4, a New 2-Pyridone Compound, Attenuates Lipopolysaccharide-Induced Systemic Inflammation via p38MAPK and NF-kappa B in Mice	PLOS ONE			English	Article							THIO-SUBSTITUTED 1,3-DIENES; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; DIELS-ALDER REACTIONS; COX-2 INHIBITORS; GENE-EXPRESSION; UNITED-STATES; SEPTIC SHOCK; TNF-ALPHA; PYRIDONE	Despite advances in antibiotic therapy and intensive care, the mortality caused by systemic inflammatory response syndrome and severe sepsis remains high. The use of anti-inflammatory agents to attenuate inflammatory response during acute systemic inflammatory reactions may improve survival rates. Here we show that a newly synthesized 2-pyridone compound (FJU-C4) can suppress the expression of late inflammatory mediators such as iNOS and COX-2 in murine macrophages. The pro-inflammatory cytokines, including TNF alpha, IL-1 beta, and IL-6, were dose-dependently suppressed by FJU-C4 both in mRNA and protein levels. In addition, the expression of TNF alpha was inhibited from as early as 2 hours after exposure to LPS stimulation. The production of mature pro-inflammatory cytokines was also suppressed by pretreatment with FJU-C4 in either cell culture medium or mice serum when stimulated by LPS. FJU-C4 prolongs mouse survival and prevents mouse death from LPS-induced systemic inflammation when the dose of FJU-C4 is over 5 mg/kg. The activities of ERK, JNK, and p38MAPK were induced by LPS stimulation on murine macrophage cell line, but only p38MAPK signaling was dramatically suppressed by pretreatment with the FJU-C4 compound in a dose-dependent manner. NF-kappa B activation also was suppressed by FJU-C4 compound. These findings suggest that the FJU-C4 compound may act as a promising therapeutic agent against inflammatory diseases by inhibiting the p38MAPK and NF-kappa B signaling pathway.	[Liu, Jung-Sen; Jung, Fang; Yang, Shih-Hsing; Lin, Jau-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, New Taipei, Taiwan; [Chou, Shang-Shing P.; Huang, Jhih-Liang; Lu, Chang-Lin; Huang, Guan-Lin] Fu Jen Catholic Univ, Dept Chem, New Taipei, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ, Sch Med, Taipei 10764, Taiwan; [Jow, Guey-Mei] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan	Fu Jen Catholic University; Fu Jen Catholic University; National Taiwan University; Fu Jen Catholic University	Lin, JC (corresponding author), Fu Jen Catholic Univ, Dept Resp Therapy, New Taipei, Taiwan.	080659@mail.fju.edu.tw; 039666@mail.fju.edu.tw		YANG, PAN-CHYR/0000-0001-6330-6048	National Science Council of Taiwan [NSC101-2320-B-030-008-MY3]; Cathay General Hospital [100CGH-FJU-04]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Cathay General Hospital	This research was supported by grant NSC101-2320-B-030-008-MY3 from the National Science Council of Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp=7) and grant 100CGH-FJU-04 from the Cathay General Hospital (http://www.cgh.org.tw/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amr AGE, 2006, BIOORGAN MED CHEM, V14, P4341, DOI 10.1016/j.bmc.2006.02.045; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bode JG, 2012, CELL SIGNAL, V24, P1185, DOI 10.1016/j.cellsig.2012.01.018; Cain WC, 1998, INT J IMMUNOPHARMACO, V20, P685, DOI 10.1016/S0192-0561(98)00042-3; Cheng YW, 2008, J ETHNOPHARMACOL, V120, P264, DOI 10.1016/j.jep.2008.09.002; Chou SSP, 2007, TETRAHEDRON, V63, P8267, DOI 10.1016/j.tet.2007.05.104; Chou SSP, 2011, J ORG CHEM, V76, P692, DOI 10.1021/jo102092b; Chou SSP, 2005, TETRAHEDRON LETT, V46, P8551, DOI 10.1016/j.tetlet.2005.09.191; Chou SSP, 2001, SYNTHESIS-STUTTGART, P2450; Chou SSP, 2000, TETRAHEDRON LETT, V41, P8323, DOI 10.1016/S0040-4039(00)01447-7; Chou YY, 2011, FEBS J, V278, P85, DOI 10.1111/j.1742-4658.2010.07929.x; Clancy RM, 1998, ARTHRITIS RHEUM-US, V41, P1141, DOI 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; De Smet BD, 2006, J GEN INTERN MED, V21, P694, DOI 10.1111/j.1525-1497.2006.00463.x; DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433; Funk CD, 2007, J CARDIOVASC PHARM, V50, P470, DOI 10.1097/FJC.0b013e318157f72d; Gottlieb S, 2001, BRIT MED J, V323, P471, DOI 10.1136/bmj.323.7311.471a; Grattendick Ken J., 2009, Research Communications in Molecular Pathology and Pharmacology, V122-23, P27; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kent LM, 2009, J PHARMACOL EXP THER, V328, P458, DOI 10.1124/jpet.108.142950; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lee Sang Kook, 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P141; Lin JC, 2009, J MED CHEM, V52, P1903, DOI 10.1021/jm801344j; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Mestre JR, 2001, J BIOL CHEM, V276, P3977, DOI 10.1074/jbc.M005077200; Michael JP, 2008, NAT PROD REP, V25, P139, DOI 10.1039/b612166g; MONCADA S, 1991, PHARMACOL REV, V43, P109; Nakagawa R, 2011, J IMMUNOL, V187, P4611, DOI 10.4049/jimmunol.1100649; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Shen KP, 2007, J PHARM PHARMACOL, V59, P879, DOI 10.1211/jpp.59.6.0015; Su YW, 2011, INT IMMUNOPHARMACOL, V11, P1166, DOI 10.1016/j.intimp.2011.03.014; Tang BMP, 2009, CRIT CARE MED, V37, P1594, DOI 10.1097/CCM.0b013e31819fb507; Tang YT, 2010, INT IMMUNOPHARMACOL, V10, P580, DOI 10.1016/j.intimp.2010.02.005; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Uto T, 2005, BIOCHEM PHARMACOL, V70, P1772, DOI 10.1016/j.bcp.2005.09.023; Vallieres L, 1999, ENDOCRINOLOGY, V140, P3890, DOI 10.1210/en.140.9.3890	37	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82877	10.1371/journal.pone.0082877	http://dx.doi.org/10.1371/journal.pone.0082877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376600	Green Submitted, gold, Green Published			2022-12-27	WOS:000328882000036
J	Morimoto, K; Mizoi, J; Qin, F; Kim, JS; Sato, H; Osakabe, Y; Shinozaki, K; Yamaguchi-Shinozaki, K				Morimoto, Kyoko; Mizoi, Junya; Qin, Feng; Kim, June-Sik; Sato, Hikaru; Osakabe, Yuriko; Shinozaki, Kazuo; Yamaguchi-Shinozaki, Kazuko			Stabilization of Arabidopsis DREB2A Is Required but Not Sufficient for the Induction of Target Genes under Conditions of Stress	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORY NETWORKS; SIGNAL-TRANSDUCTION; LOW-TEMPERATURE; DROUGHT; EXPRESSION; RESPONSES; DNA; DEHYDRATION; TOLERANCE; ELEMENT	The Arabidopsis thaliana transcription factor DEHYDRATION-RESPONSIVE ELEMENT-BINDING PROTEIN2A (DREB2A) controls the expression of many genes involved in the plant's response to dehydration and heat stress. Despite the significance of post-translational regulation in DREB2A activation, the mechanism underlying this activation remains unclear. Here, with the aid of a newly produced antibody against DREB2A, we characterized the regulation of DREB2A stability in plants exposed to stress stimuli. Endogenous DREB2A accumulated in wild-type Arabidopsis plants subjected to dehydration and heat stress. A degradation assay using Arabidopsis T87 suspension-cultured cells revealed that DREB2A protein degradation was inhibited at high temperatures. The proteasome-dependent degradation of DREB2A required the import of this protein into the nucleus. The E3 ligases DRIP1 and DRIP2 were involved in this process under both normal and stressful conditions; however, other E3 ligases may have also been involved, at least during the late stages of the heat stress response. Although the constitutive expression of DREB2A resulted in an overproduction of DREB2A and enhanced target gene induction during stress in transgenic plants, the accumulation of DREB2A caused by proteasome inhibitors did not induce target gene expression. Thus, the stabilization of DREB2A is important but not sufficient to induce target gene expression; further activation processes are required.	[Morimoto, Kyoko; Mizoi, Junya; Sato, Hikaru; Osakabe, Yuriko; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Bunkyo Ku, Tokyo, Japan; [Morimoto, Kyoko; Qin, Feng; Yamaguchi-Shinozaki, Kazuko] Japan Int Res Ctr Agr Sci, Biol Resources & Postharvest Div, Tsukuba, Ibaraki, Japan; [Kim, June-Sik] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Shinozaki, Kazuo] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan	University of Tokyo; Japan International Research Center for Agricultural Sciences; Seoul National University (SNU); RIKEN	Yamaguchi-Shinozaki, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Bunkyo Ku, Tokyo, Japan.	akys@mail.ecc.u-tokyo.ac.jp	Sato, Hikaru/C-9685-2017; Osakabe, Yuriko/GRI-9818-2022; Yamaguchi-Shinozaki, Kazuko/K-9004-2015; Osakabe, Yuriko/Y-2507-2019; Kim, June-Sik/R-6474-2017; Mizoi, Junya/Y-6261-2019	Sato, Hikaru/0000-0001-7628-0414; Osakabe, Yuriko/0000-0001-5503-1427; Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Osakabe, Yuriko/0000-0001-5503-1427; Kim, June-Sik/0000-0002-4703-609X; Mizoi, Junya/0000-0002-3383-8059; Qin, Feng/0000-0001-9134-4711	Ministry of Education, Culture, Sports, Science and Technology of Japan [22119004]; Science and Technology Research Partnership for Sustainable Development (SATREPS) of the Japan Science and Technology Agency/Japan International Cooperation Agency; Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Research Partnership for Sustainable Development (SATREPS) of the Japan Science and Technology Agency/Japan International Cooperation Agency; Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (number 22119004 to KYS), the Science and Technology Research Partnership for Sustainable Development (SATREPS) of the Japan Science and Technology Agency/Japan International Cooperation Agency and the Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan to KYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2007, MOL GENET GENOMICS, V277, P189, DOI 10.1007/s00438-006-0183-z; Antoni R, 2011, CURR OPIN PLANT BIOL, V14, P547, DOI 10.1016/j.pbi.2011.06.004; AXELOS M, 1992, PLANT PHYSIOL BIOCH, V30, P123; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; Blomberg J, 2012, NUCLEIC ACIDS RES, V40, P5938, DOI 10.1093/nar/gks265; Covarrubias AA, 2010, PLANT CELL ENVIRON, V33, P481, DOI 10.1111/j.1365-3040.2009.02048.x; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Howell SH, 2013, ANNU REV PLANT BIOL, V64, P477, DOI 10.1146/annurev-arplant-050312-120053; Kidokoro S, 2009, PLANT PHYSIOL, V151, P2046, DOI 10.1104/pp.109.147033; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lyzenga WJ, 2012, J EXP BOT, V63, P599, DOI 10.1093/jxb/err310; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Miura K, 2010, TRENDS CELL BIOL, V20, P223, DOI 10.1016/j.tcb.2010.01.007; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Osakabe Y, 2005, PLANT CELL, V17, P1105, DOI 10.1105/tpc.104.027474; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Tanaka H, 2012, PLANT J, V70, P599, DOI 10.1111/j.1365-313X.2012.04901.x; Vainonen JP, 2012, BIOCHEM J, V442, P573, DOI 10.1042/BJ20111739; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida T, 2011, MOL GENET GENOMICS, V286, P321, DOI 10.1007/s00438-011-0647-7; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	36	43	47	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e80457	10.1371/journal.pone.0080457	http://dx.doi.org/10.1371/journal.pone.0080457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376497	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000002
J	Zhou, J; Mo, YF; Li, H; Ran, XW; Yang, WY; Li, Q; Peng, YD; Li, YB; Gao, X; Luan, XJ; Wang, WQ; Xie, Y; Jia, WP				Zhou, Jian; Mo, Yifei; Li, Hong; Ran, Xingwu; Yang, Wenying; Li, Qiang; Peng, Yongde; Li, Yanbing; Gao, Xin; Luan, Xiaojun; Wang, Weiqing; Xie, Yun; Jia, Weiping			Relationship between HbA1c and Continuous Glucose Monitoring in Chinese Population: A Multicenter Study	PLOS ONE			English	Article							GLYCATED HEMOGLOBIN; PRIMARY PREVENTION; DIABETES-MELLITUS; A1C; COMPLICATIONS; ATORVASTATIN; METAANALYSIS; ASSOCIATION; PREVALENCE; DISEASE	Objective: Since there is a paucity of reference data in the literature to indicate the relationship between HbA1c, and 24 h mean blood glucose (MBG) from continuous glucose monitoring (CGM) in Chinese populations, we described the above relationship in adult Chinese subjects with different glucose tolerance status. Methods: Seven-hundred-and-forty-two individuals without history of diabetes were included to the study at 11 hospitals in urban areas across China from 2007-2009 and data of 673 subjects were included into the final analysis. Oral glucose tolerance test (OGTT) classified the participants as nondiabetic subjects, including those with normal glucose regulation (NGR; n = 121) and impaired glucose regulation (IGR; n = 209), or newly diagnosed type 2 diabetes (n = 343). All participants completed testing for HbA1c levels and wore a CGM system for three consecutive days. The 24 h MBG levels were calculated. Spearman correlations and linear regression analyses were applied to quantify the relationship between glucose markers. Results: The levels of HbA1c and 24 h MBG significantly increased with presence of glucose intolerance (NGR, IGR, type 2 diabetes; both, P<0.001). Analysis of the total population indicated that HbA1c was strongly correlated with 24 h MBG (r = 0.735). The correlation was also found to be significant for the subgroup of participants with newly diagnosed type 2 diabetes (r = 0.694, P<0.001). Linear regression analysis of the total study population yielded the following equation: 24 h MBG (mmol/L) = 1.198xHbA1c-0.582 (24 h MBG (mg/dL) = 21.564xHbA1c-10.476) (R-2 = 0.670, P<0.001). The model fit was not improved by application of exponential or quadratic modeling. When HbA1c was 6.5%, the calculated 24 h MBG was 7.2 (6.4-8.1) mmol/L (130 (115-146) mg/dL); and when HbA1c was 7.0%, the 24 h MBG was 7.8 (6.9-8.7) mmol/L (140 (124-157) mg/dL). Conclusions: Our study provided the reference data of the relationship between HbA1c and CGM in Chinese subjects.	[Zhou, Jian; Mo, Yifei; Jia, Weiping] Shanghai Jiao Tong Univ, Shanghai Key Clin Ctr Metab Dis,Shanghai Diabet I, Affiliated Peoples 6 Hosp,Shanghai Key Lab Diabet, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China; [Li, Hong] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Endocrinol & Metab, Hangzhou 310003, Zhejiang, Peoples R China; [Ran, Xingwu] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Peoples R China; [Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China; [Li, Qiang] Harbin Med Univ, Dept Endocrinol & Metab, Affiliated Hosp 2, Harbin, Peoples R China; [Peng, Yongde] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Li, Yanbing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Xin] Fudan Univ, Affiliated Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Luan, Xiaojun] First Peoples Hosp Foshan, Dept Endocrinol & Metab, Foshan, Peoples R China; [Wang, Weiqing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrinol & Metab, Shanghai 200030, Peoples R China; [Xie, Yun] Tianjin Med Univ, Metab Dis Hosp, Dept Diabet Neurol, Tianjin, Peoples R China	Shanghai Jiao Tong University; Zhejiang University; Sichuan University; China-Japan Friendship Hospital; Harbin Medical University; Shanghai Jiao Tong University; Sun Yat Sen University; Fudan University; Shanghai Jiao Tong University; Tianjin Medical University	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Clin Ctr Metab Dis,Shanghai Diabet I, Affiliated Peoples 6 Hosp,Shanghai Key Lab Diabet, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	li, yan/GTI-4638-2022; Jia, Weiping/B-7483-2012		National Natural Science Foundation of China [81100590]; Shanghai Rising-Star Program [12QA1402500]; Shanghai Medical Program for Outstanding Young Talent [XYQ2011013]; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Shanghai Medical Program for Outstanding Young Talent; Shanghai United Developing Technology Project of Municipal Hospitals	This work was funded by the National Natural Science Foundation of China (81100590), http://www.nsfc.gov.cn; the Shanghai Rising-Star Program (12QA1402500), http://www.stcsm.gov.cn; the Shanghai Medical Program for Outstanding Young Talent (XYQ2011013), http://wsj.sh.gov.cn/; and the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010115), http://www.shdc.org.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294; Chetty VT, 2008, DIABETES RES CLIN PR, V81, P79, DOI 10.1016/j.diabres.2008.02.014; Chinese Diabetes Society, 2011, Zhonghua Yi Xue Za Zhi, V91, P656; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Gao X, 2012, CHINESE MED J-PEKING, V125, P4167, DOI 10.3760/cma.j.issn.0366-6999.2012.23.002; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Kilpatrick ES, 1998, DIABETES CARE, V21, P261, DOI 10.2337/diacare.21.2.261; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Makris K, 2008, DIABETIC MED, V25, P174, DOI 10.1111/j.1464-5491.2007.02379.x; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Poolsup N, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-39; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; Selvin E, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-5-201103010-00004; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Snieder H, 2001, DIABETES, V50, P2858, DOI 10.2337/diabetes.50.12.2858; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Szypowska A, 2012, EUR J ENDOCRINOL, V166, P567, DOI 10.1530/EJE-11-0642; Virtue MA, 2004, DIABETES CARE, V27, P931, DOI 10.2337/diacare.27.4.931; Wilson DM, 2008, DIABETES CARE, V31, P381, DOI 10.2337/dc07-1835; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; YUDKIN JS, 1990, DIABETOLOGIA, V33, P208, DOI 10.1007/BF00404798; Zhou J, 2009, DIABETES CARE, V32, P1188, DOI 10.2337/dc09-0076	26	15	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83827	10.1371/journal.pone.0083827	http://dx.doi.org/10.1371/journal.pone.0083827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376762	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000122
J	Augustin, JO; Groenewald, JZ; Nascimento, RJ; Mizubuti, ESG; Barreto, RW; Elliot, SL; Evans, HC				Augustin, Juliana O.; Groenewald, Johannes Z.; Nascimento, Robson J.; Mizubuti, Eduardo S. G.; Barreto, Robert W.; Elliot, Simon L.; Evans, Harry C.			Yet More "Weeds" in the Garden: Fungal Novelties from Nests of Leaf-Cutting Ants	PLOS ONE			English	Article							ATTINE ANT; WASTE MANAGEMENT; HYMENOPTERA; BACTERIA; ESCOVOPSIS; FORMICIDAE; PARASITE; SPECIFICITY; PUBLICATION; TRICHODERMA	Background: Symbiotic relationships modulate the evolution of living organisms in all levels of biological organization. A notable example of symbiosis is that of attine ants (Attini; Formicidae: Hymenoptera) and their fungal cultivars (Lepiotaceae and Pterulaceae; Agaricales: Basidiomycota). In recent years, this mutualism has emerged as a model system for studying coevolution, speciation, and multitrophic interactions. Ubiquitous in this ant-fungal symbiosis is the "weedy" fungus Escovopsis (Hypocreales: Ascomycota), known only as a mycoparasite of attine fungal gardens. Despite interest in its biology, ecology and molecular phylogeny-noting, especially, the high genetic diversity encountered which has led to a steady flow of publications over the past decade, only two species of Escovopsis have formally been described. Methods and Results: We sampled from fungal gardens and garden waste (middens) of nests of the leaf-cutting ant genus Acromyrmex in a remnant of subtropical Atlantic rainforest in Minas Gerais, Brazil. In culture, distinct morphotypes of Escovopsis sensu lato were recognized. Using both morphological and molecular analyses, three new species of Escovopsis were identified. These are described and illustrated herein E. lentecrescens, E. microspora, and E. moelleri-together with a re-description of the genus and the type species, E. weberi. The new genus Escovopsioides is erected for a fourth morphotype. We identify, for the first time, a mechanism for horizontal transmission via middens. Conclusions:The present study makes a start at assigning names and formal descriptions to these specific fungal parasites of attine nests. Based on the results of this exploratory and geographically-restricted survey, we expect there to be many more species of the genus Escovopsis and its relatives associated with nests of both the lower and higher Attini throughout their neotropical range, as suggested in previous studies.	[Augustin, Juliana O.; Elliot, Simon L.; Evans, Harry C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Groenewald, Johannes Z.] Ctr Bur Schimmelcultures Fungal Biodivers Ctr, Utrecht, Netherlands; [Nascimento, Robson J.; Mizubuti, Eduardo S. G.; Barreto, Robert W.; Evans, Harry C.] Univ Fed Vicosa, Dept Fitopatol, BR-36570 Vicosa, MG, Brazil; [Evans, Harry C.] Ctr Agr & Biosci Int, Egham, Surrey, England	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Augustin, JO (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	julianaaugustin@gmail.com	Groenewald, Johannes Z/F-4667-2011; Elliot, Simon Luke/A-5557-2013; Mizubuti, Eduardo/C-3578-2013	Groenewald, Johannes Z/0000-0002-9474-6246; Elliot, Simon Luke/0000-0002-7469-2949; Mizubuti, Eduardo/0000-0001-9612-5155	FAPEMIG [CRA-APQ-01593-10]; CAPES; CNPq [401610/2009-8, 311787/2011-8]	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was funded by FAPEMIG (CRA-APQ-01593-10), CAPES and CNPq (grant no. 401610/2009-8 and 311787/2011-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin JO, 2011, INSECT SOC, V58, P197, DOI 10.1007/s00040-010-0137-7; Augustin JO, 2007, BIOL, V69, P385; Augustin JD, 2008, SOCIOBIOLOGY, V51, P265; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Boomsma JJ, 2009, P NATL ACAD SCI USA, V106, P17611, DOI 10.1073/pnas.0910004106; Bot ANM, 2001, ETHOL ECOL EVOL, V13, P225, DOI 10.1080/08927014.2001.9522772; Brockhurst MA, 2011, SCIENCE, V333, P166, DOI 10.1126/science.1209420; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Chaverri P, 2011, MYCOLOGIA, V103, P139, DOI 10.3852/10-078; Currie CR, 2006, SCIENCE, V311, P81, DOI 10.1126/science.1119744; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, OECOLOGIA, V128, P99, DOI 10.1007/s004420100630; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Evans Harry C, 2011, Commun Integr Biol, V4, P598, DOI 10.4161/cib.4.5.16721; Evans HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017024; Farji-Brener AG, 2000, STUD NEOTROP FAUNA E, V35, P131, DOI 10.1076/0165-0521(200008)35:2;1-9;FT131; Fernandez-Marin H, 2007, INSECT SOC, V54, P64, DOI 10.1007/s00040-007-0907-z; Fernandez-Marin H, 2003, INSECT SOC, V50, P304, DOI 10.1007/s00040-003-0687-z; Fernandez-Marin H, 2009, P ROY SOC B-BIOL SCI, V276, P2263, DOI 10.1098/rspb.2009.0184; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gerardo NM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-88; Gerardo NM, 2007, ISME J, V1, P373, DOI 10.1038/ismej.2007.57; Gerardo NM, 2006, PLOS BIOL, V4, P1358, DOI 10.1371/journal.pbio.0040235; Gerardo NM, 2004, P ROY SOC B-BIOL SCI, V271, P1791, DOI 10.1098/rspb.2004.2792; Haeder S, 2009, P NATL ACAD SCI USA, V106, P4742, DOI 10.1073/pnas.0812082106; Hart Adam G., 2002, Entomologist's Monthly Magazine, V138, P41; Hawksworth DL, 2011, IMA FUNGUS, V2, P155, DOI 10.5598/imafungus.2011.02.02.06; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Holldobler B., 1990, pi; JOHNSTON A, 1983, PLANT PATHOLOGISTS P; Kendrick B, 2011, GENERA HYPHOMYCETES; Kirk PM., 2008, DICT FUNGI, V10th ed; Knapp Sandra, 2011, Plant Diversity and Resources, V33, P509, DOI 10.3724/SP.J.1143.2011.11134; Kobmoo N, 2012, MOL ECOL, V21, P3022, DOI 10.1111/j.1365-294X.2012.05574.x; Kost C, 2007, NATURWISSENSCHAFTEN, V94, P821, DOI 10.1007/s00114-007-0262-y; KREISEL H, 1972, Z ALLG MIKROBIOL, V12, P643, DOI 10.1002/jobm.3630120805; Little AEF, 2008, ECOLOGY, V89, P1216, DOI 10.1890/07-0815.1; May RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001130; Mikheyev AS, 2006, P NATL ACAD SCI USA, V103, P10702, DOI 10.1073/pnas.0601441103; Mikheyev AS, 2010, AM NAT, V175, pE126, DOI 10.1086/652472; Moeller A, 1893, BOT MITTHEILUNGEN TR; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; MUCHOVEJ JJ, 1990, MYCOTAXON, V37, P191; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Nylander JAA., 2004, BIOINFORMATICS; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; Pagnocca FC, 2008, ANTON LEEUW INT J G, V94, P517, DOI 10.1007/s10482-008-9268-5; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Reynolds HT, 2004, MYCOLOGIA, V96, P955, DOI 10.2307/3762079; Rodrigues A, 2008, MICROB ECOL, V56, P604, DOI 10.1007/s00248-008-9380-0; Rodrigues A, 2005, SOCIOBIOLOGY, V46, P329; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Samuels GJ, 2006, PHYTOPATHOLOGY, V96, P195, DOI 10.1094/PHYTO-96-0195; Samuels Richard Ian, 2013, Communicative & Integrative Biology, V6, pe23095, DOI 10.4161/cib.23095; SEIFERT KA, 1995, MYCOLOGIA, V87, P407, DOI 10.2307/3760838; Sen R, 2009, P NATL ACAD SCI USA, V106, P17805, DOI 10.1073/pnas.0904827106; Spatafora JW, 2007, MOL ECOL, V16, P1701, DOI 10.1111/j.1365-294X.2007.03225.x; STAHEL GEROLD, 1941, REV ENT [RIO DE JANEIRO], V12, P243; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Taerum SJ, 2010, ENVIRON ENTOMOL, V39, P105, DOI 10.1603/EN09137; Taerum SJ, 2007, P ROY SOC B-BIOL SCI, V274, P1971, DOI 10.1098/rspb.2007.0431; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waddington SJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1219, DOI 10.1007/s00265-010-0936-x; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; WEBER NA, 1957, ANAT REC, V128, P638; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	72	32	33	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82265	10.1371/journal.pone.0082265	http://dx.doi.org/10.1371/journal.pone.0082265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376525	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100023
J	Beggel, B; Neumann-Fraune, M; Kaiser, R; Verheyen, J; Lengauer, T				Beggel, Bastian; Neumann-Fraune, Maria; Kaiser, Rolf; Verheyen, Jens; Lengauer, Thomas			Inferring Short-Range Linkage Information from Sequencing Chromatograms	PLOS ONE			English	Article							DNA-POLYMERASE; HEPATITIS-B; VARIANTS; THERAPY; PHASE	Direct Sanger sequencing of viral genome populations yields multiple ambiguous sequence positions. It is not straightforward to derive linkage information from sequencing chromatograms, which in turn hampers the correct interpretation of the sequence data. We present a method for determining the variants existing in a viral quasispecies in the case of two nearby ambiguous sequence positions by exploiting the effect of sequence context-dependent incorporation of dideoxynucleotides. The computational model was trained on data from sequencing chromatograms of clonal variants and was evaluated on two test sets of in vitro mixtures. The approach achieved high accuracies in identifying the mixture components of 97.4% on a test set in which the positions to be analyzed are only one base apart from each other, and of 84.5% on a test set in which the ambiguous positions are separated by three bases. In silk experiments suggest two major limitations of our approach in terms of accuracy. First, due to a basic limitation of Sanger sequencing, it is not possible to reliably detect minor variants with a relative frequency of no more than 10%. Second, the model cannot distinguish between mixtures of two or four clonal variants, if one of two sets of linear constraints is fulfilled. Furthermore, the approach requires repetitive sequencing of all variants that might be present in the mixture to be analyzed. Nevertheless, the effectiveness of our method on the two in vitro test sets shows that short-range linkage information of two ambiguous sequence positions can be inferred from Sanger sequencing chromatograms without any further assumptions on the mixture composition. Additionally, our model provides new insights into the established and widely used Sanger sequencing technology. The source code of our method is made available at http://bioinf.mpi-inf.mpg.de/publications/beggel/linkageinformation.zip.	[Beggel, Bastian; Lengauer, Thomas] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithms, D-66123 Saarbrucken, Germany; [Neumann-Fraune, Maria; Kaiser, Rolf] Univ Cologne, Inst Virol, D-50931 Cologne, Germany; [Verheyen, Jens] Univ Duisburg Essen, Inst Virol, Essen, Germany	Max Planck Society; University of Cologne; University of Duisburg Essen	Beggel, B (corresponding author), Max Planck Inst Informat, Dept Computat Biol & Appl Algorithms, D-66123 Saarbrucken, Germany.	beggel@mpi-inf.mpg.de			German Centre for Infection Research [8000 802-3]; German Bundesministerium fur Bildung und Forschung [BMBF01ES0822]	German Centre for Infection Research; German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The work of BB was supported by the German Centre for Infection Research (grant no. 8000 802-3). The work of MNF was supported by the German Bundesministerium fur Bildung und Forschung (grant no. BMBF01ES0822). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; Flot JF, 2007, MOL ECOL NOTES, V7, P974, DOI 10.1111/j.1471-8286.2007.01857.x; Flot JF, 2006, MOL ECOL NOTES, V6, P627, DOI 10.1111/j.1471-8286.2006.01355.x; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; KWOK PY, 1994, GENOMICS, V23, P138, DOI 10.1006/geno.1994.1469; LEE LG, 1992, NUCLEIC ACIDS RES, V20, P2471, DOI 10.1093/nar/20.10.2471; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Lengauer T, 2006, NAT REV MICROBIOL, V4, P790, DOI 10.1038/nrmicro1477; Li Y, 1999, P NATL ACAD SCI USA, V96, P9491, DOI 10.1073/pnas.96.17.9491; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Parker LT, 1996, BIOTECHNIQUES, V21, P694; Schildgen O, 2004, AIDS, V18, P2325, DOI 10.1097/00002030-200411190-00014; Seroussi Y, 2007, BIOTECHNIQUES, V43, P452, DOI 10.2144/000112552; Sousa Santos C, 2005, DNA SEQUENCE, V16, P462; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; Zhang QR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-92; Zoulim F, 2009, LIVER INT, V29, P108, DOI 10.1111/j.1478-3231.2008.01939.x	20	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e81687	10.1371/journal.pone.0081687	http://dx.doi.org/10.1371/journal.pone.0081687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376502	Green Published, gold			2022-12-27	WOS:000328745100006
J	Brim, H; Yooseph, S; Zoetendal, EG; Lee, E; Torralbo, M; Laiyemo, AO; Shokrani, B; Nelson, K; Ashktorab, H				Brim, Hassan; Yooseph, Shibu; Zoetendal, Erwin G.; Lee, Edward; Torralbo, Manolito; Laiyemo, Adeyinka O.; Shokrani, Babak; Nelson, Karen; Ashktorab, Hassan			Microbiome Analysis of Stool Samples from African Americans with Colon Polyps	PLOS ONE			English	Article							BACTEROIDES-FRAGILIS ENTEROTOXIN; COLORECTAL-CANCER; RIBOSOMAL-RNA; GUT FLORA; PREVALENCE; BACTERIA; EXPRESSION; DIVERSITY; FEATURES; TRENDS	Background: Colonic polyps are common tumors occurring in similar to 50% of Western populations with similar to 10% risk of malignant progression. Dietary agents have been considered the primary environmental exposure to promote colorectal cancer (CRC) development. However, the colonic mucosa is permanently in contact with the microbiota and its metabolic products including toxins that also have the potential to trigger oncogenic transformation. Aim: To analyze fecal DNA for microbiota composition and functional potential in African Americans with pre-neoplastic lesions. Materials & Methods: We analyzed the bacterial composition of stool samples from 6 healthy individuals and 6 patients with colon polyps using 16S ribosomal RNA-based phylogenetic microarray; the Human intestinal Tract Chip (HITChip) and 16S rRNA gene barcoded 454 pyrosequencing. The functional potential was determined by sequence-based metagenomics using 454 pyrosequencing. Results: Fecal microbiota profiling of samples from the healthy and polyp patients using both a phylogenetic microarraying (HITChip) and barcoded 454 pyrosequencing generated similar results. A distinction between both sets of samples was only obtained when the analysis was performed at the sub-genus level. Most of the species leading to the dissociation were from the Bacteroides group. The metagenomic analysis did not reveal major differences in bacterial gene prevalence/abundances between the two groups even when the analysis and comparisons were restricted to available Bacteroides genomes. Conclusion: This study reveals that at the pre-neoplastic stages, there is a trend showing microbiota changes between healthy and colon polyp patients at the sub-genus level. These differences were not reflected at the genome/functions levels. Bacteria and associated functions within the Bacteroides group need to be further analyzed and dissected to pinpoint potential actors in the early colon oncogenic transformation in a large sample size.	[Brim, Hassan; Lee, Edward; Laiyemo, Adeyinka O.; Shokrani, Babak; Ashktorab, Hassan] Howard Univ, Coll Med, Dept Pathol, Dept Med, Washington, DC 20059 USA; [Brim, Hassan; Lee, Edward; Laiyemo, Adeyinka O.; Shokrani, Babak; Ashktorab, Hassan] Howard Univ, Coll Med, Ctr Canc, Washington, DC USA; [Yooseph, Shibu] JCVI, San Diego, CA USA; [Torralbo, Manolito; Nelson, Karen] JCVI, Rockville, MD USA; [Zoetendal, Erwin G.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands	Howard University; Howard University; J. Craig Venter Institute; J. Craig Venter Institute; Wageningen University & Research	Brim, H (corresponding author), Howard Univ, Coll Med, Dept Pathol, Dept Med, Washington, DC 20059 USA.	hbrim@howard.edu	Ashktorab, hassan/AAJ-2908-2020	Yooseph, Shibu/0000-0001-5581-5002	Howard-Hopkins U54 from the National Institutes of Health; Howard University College of Medicine Bridge fund; National Institute on Minority Health and Health Disparities of the National Institutes of Health [G12MD007597]; Federal funds [UL1TR000101]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA) [UL1RR031975]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031975] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER	Howard-Hopkins U54 from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard University College of Medicine Bridge fund; National Institute on Minority Health and Health Disparities of the National Institutes of Health; Federal funds; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported (in part) by a Howard-Hopkins U54 from the National Institutes of Health, by Howard University College of Medicine Bridge fund, by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under Award Number G12MD007597. This project was also funded in part with Federal funds (Grant #UL1TR000101 previously UL1RR031975) from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA), a trademark of DHHS, part of the Roadmap Initiative, "Re-Engineering the Clinical Research Enterprise. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2005, AM J GASTROENTEROL, V100, P515, DOI 10.1111/j.1572-0241.2005.41829.x; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ashktorab H, 2012, DIGEST DIS SCI, V57, P905, DOI 10.1007/s10620-011-2026-y; Ashktorab H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025314; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Ashktorab H, 2009, DIGEST DIS SCI, V54, P2109, DOI 10.1007/s10620-008-0601-7; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Balter M, 2012, SCIENCE, V336, P1246, DOI 10.1126/science.336.6086.1246; Berer K, 2012, ACTA NEUROPATHOL, V123, P639, DOI 10.1007/s00401-012-0949-9; Blumenstein I, 2013, EUR J GASTROEN HEPAT, V25, P556, DOI 10.1097/MEG.0b013e32835d1ef4; Bodaker I, 2010, ISME J, V4, P399, DOI 10.1038/ismej.2009.141; Boleij A, 2012, MOL CELL PROTEOMICS, V11, P851, DOI 10.1074/mcp.M112.019315; BOND PL, 1995, APPL ENVIRON MICROB, V61, P1910, DOI 10.1128/AEM.61.5.1910-1916.1995; Brim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040392; Brim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020216; Brim H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-68; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chandran P, 2003, SURG-J R COLL SURG E, V1, P63, DOI 10.1016/S1479-666X(03)80118-X; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Friedenberg FK, 2012, DIGEST DIS SCI, V57, P489, DOI 10.1007/s10620-011-1952-z; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Graham Alice, 2012, J Glob Health, V2, P020404, DOI 10.7189/jogh.02.020204; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; KUMAR K, 2009, CLIN CANC R IN PRESS, P68; Lax AJ, 2002, TRENDS MICROBIOL, V10, P293, DOI 10.1016/S0966-842X(02)02360-0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lopez-Boado YS, 2000, J CELL BIOL, V148, P1305, DOI 10.1083/jcb.148.6.1305; Lyra A, 2012, WORLD J GASTROENTERO, V18, P4404, DOI 10.3748/wjg.v18.i32.4404; Marteau P, 2011, DIGEST DIS, V29, P166, DOI 10.1159/000323879; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Nelson RL, 1999, J SURG ONCOL, V71, P123, DOI 10.1002/(SICI)1096-9098(199906)71:2<123::AID-JSO13>3.0.CO;2-C; Nouraie M, 2010, DIGEST DIS SCI, V55, P1442, DOI 10.1007/s10620-010-1133-5; Pick Marcelle, 2012, Adv NPs PAs, V3, P35; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Ray Katrina, 2011, Nat Rev Gastroenterol Hepatol, V8, P662, DOI 10.1038/nrgastro.2011.208; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schutze T, 2011, ANAL BIOCHEM, V410, P155, DOI 10.1016/j.ab.2010.11.029; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Sharon I, 2011, J COMPUT BIOL, V18, P495, DOI 10.1089/cmb.2010.0260; Sinicrope PS, 2012, CANCER EPIDEM BIOMAR, V21, P347, DOI 10.1158/1055-9965.EPI-11-0818; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoshino Y, 2012, INFECTION, V40, P63, DOI 10.1007/s15010-011-0159-8; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	60	34	36	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e81352	10.1371/journal.pone.0081352	http://dx.doi.org/10.1371/journal.pone.0081352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376500	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100004
J	Kirby, ER; Broom, AF; Sibbritt, DW; Refshauge, KM; Adams, J				Kirby, Emma R.; Broom, Alex F.; Sibbritt, David W.; Refshauge, Kathryn M.; Adams, Jon			Health Care Utilisation and Out-of-Pocket Expenditure Associated with Back Pain: A Nationally Representative Survey of Australian Women	PLOS ONE			English	Article							ALTERNATIVE MEDICINE USE; UNITED-STATES; COMPLEMENTARY; PRACTITIONERS; PATTERNS; ILLNESS; SWEDEN; ADULTS; COST	Background: Back pain impacts on a significant proportion of the Australian population over the life course and has high prevalence rates among women, particularly in older age. Back pain care is characterised by multiple practitioner and self-prescribed treatment options, and the out-of-pocket costs associated with consultations and self-prescribed treatments have not been examined to date. Objective: To analyse the extent of health care practitioner consultations and self-prescribed treatment for back pain care among Australian women, and to assess the self-reported costs associated with such usage. Methods: Survey of 1,310 women (response rate 80.9%) who reported seeking help for back pain from the '1946-51 cohort' of the Australian Longitudinal Study on Women's Health. Women were asked about their use of health care practitioners and self-prescribed treatments for back pain and the costs associated with such usage. Results: In the past year 76.4% consulted a complementary and alternative practitioner, 56% an allied health practitioner and 59.2% a GP/medical specialist. Overall, women consulted with, on average, 3.0 (SD = 2.0) different health care practitioners, and had, on average, 12.2 (SD = 9.7) discrete health care practitioner consultations for back pain. Average self-reported out-of-pocket expenditure on practitioners and self-prescribed treatments for back pain care per annum was AU$873.10. Conclusions: Multiple provider usage for various but distinct purposes (i.e. pain/mobility versus anxiety/stress) points to the need for further research into patient motivations and experiences of back pain care in order to improve and enhance access to and continuity of care. Our results suggest that the cost of back pain care represents a significant burden, and may ultimately limit women's access to multiple providers. We extrapolate that for Australian working-age women, total out-of-pocket expenditure on back pain care per annum is in excess of AU$1.4billion, thus indicating the prominence of back pain as a major economic, social and health burden.	[Kirby, Emma R.; Broom, Alex F.; Adams, Jon] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia; [Sibbritt, David W.; Adams, Jon] Univ Technol Sydney, Fac Hlth, Sydney, NSW 2007, Australia; [Refshauge, Kathryn M.] Univ Sydney, Fac Hlth, Sydney, NSW 2006, Australia	University of Queensland; University of Technology Sydney; University of Sydney	Kirby, ER (corresponding author), Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia.	e.kirby@uq.edu.au	Sibbritt, David W/F-8070-2017	Sibbritt, David W/0000-0003-3561-9447; Adams, Jon/0000-0002-9901-5717; Broom, Alexander/0000-0003-1258-1140; refshauge, kathryn/0000-0002-8127-6847; Kirby, Emma/0000-0001-9754-0342	Australian Research Council [DP110104636, FT100100294]	Australian Research Council(Australian Research Council)	The research on which this paper is based was funded by the Australian Research Council(DP110104636 & FT100100294; www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Access Economics, 2001, PREV COST DIS BURD A; Australian Bureau of Statistics, 2011, AUSTR DEM STAT POP A; Australian Institute of Health and Welfare, 2010, AUSTR HLTH SER; Banks Emily, 2009, Aust New Zealand Health Policy, V6, P17, DOI 10.1186/1743-8462-6-17; Brice S, 2006, P PHCC C AD AUSTR; BRIDGESWEBB C, 1993, MED J AUSTRALIA, V158, P652; Broom AF, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-98; Broom AF, 2012, COMPLEMENT THER MED, V20, P275, DOI 10.1016/j.ctim.2012.05.003; Brown WJ, 1999, J WOMEN HEALTH GEN-B, V8, P681, DOI 10.1089/jwh.1.1999.8.681; Buchbinder R, 2011, MED J AUSTRALIA, V175, P456; Cohen MM, 2005, J ALTERN COMPLEM MED, V11, P995, DOI 10.1089/acm.2005.11.995; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Depont F, 2010, FUND CLIN PHARMACOL, V24, P101, DOI 10.1111/j.1472-8206.2009.00730.x; Ekman M, 2005, SPINE, V30, P1777, DOI 10.1097/01.brs.0000171911.99348.90; Ekman M, 2005, ACTA ORTHOP, V76, P275, DOI 10.1080/00016470510030698; Gaul C, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-89; Holdsworth LK, 2008, PHYSIOTHERAPY, V94, P236, DOI 10.1016/j.physio.2008.01.006; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Kent Peter M, 2005, Chiropr Osteopat, V13, P13, DOI 10.1186/1746-1340-13-13; Kirby ER, 2013, EUR J INTEGR MED, V5, P36, DOI 10.1016/j.eujim.2012.08.005; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; Mapel DW, 2004, J RHEUMATOL, V31, P573; Masters Scott, 2004, Aust Fam Physician, V33, P389; Robinson A, 2004, COMPLEMENT THER MED, V12, P90, DOI 10.1016/j.ctim.2004.09.006; Sibbritt DW, 2010, CLIN RHEUMATOL, V29, P25, DOI 10.1007/s10067-009-1299-4; Spinks J, 2012, J ALTERN COMPLEM MED, V18, P371, DOI 10.1089/acm.2010.0817; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P327, DOI 10.1016/j.jmpt.2004.04.006; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; Wardle J, 2012, J ALTERN COMPLEM MED, V18, P363, DOI 10.1089/acm.2011.0480; Wieser S, 2011, EUR J HEALTH ECON, V12, P455, DOI 10.1007/s10198-010-0258-y; Wolsko PM, 2003, SPINE, V28, P292, DOI 10.1097/00007632-200302010-00018; Xue CCL, 2007, J ALTERN COMPLEM MED, V13, P643, DOI 10.1089/acm.2006.6355	32	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83559	10.1371/journal.pone.0083559	http://dx.doi.org/10.1371/journal.pone.0083559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376716	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100126
J	Lambert, JA; John, S; Sobel, JD; Akins, RA				Lambert, Janet A.; John, Susan; Sobel, Jack D.; Akins, Robert A.			Longitudinal Analysis of Vaginal Microbiome Dynamics in Women with Recurrent Bacterial Vaginosis: Recognition of the Conversion Process	PLOS ONE			English	Article							REAL-TIME PCR; GARDNERELLA-VAGINALIS; ATOPOBIUM-VAGINAE; HIGH-RISK; QUANTITATIVE BACTERIOLOGY; METRONIDAZOLE THERAPY; ENTEROCOCCUS-FAECIUM; MYCOPLASMA-HOMINIS; NATURAL-HISTORY; HIV ACQUISITION	Bacterial vaginosis (BV) affects similar to 30% of women of reproductive age has a high rate of recurrence, and is associated with miscarriage, preterm birth, and increased risk of acquiring other sexually transmitted infections, including HIV-1. Little is known of the daily changes in the vaginal bacterial composition as it progresses from treatment to recurrence, or whether any of these might be useful prediction or an understanding of its causes. We used phylogenetic branch-inclusive quantitative PCR (PB-qPCR) and Lactobacillus blocked/unblocked qPCR (Lb-qPCR) to characterize longitudinal changes in the vaginal microbiota in sequential vaginal self-swabs from five women with recurrent BV, from diagnosis through remission to recurrence. Both patients with acute BV samples dominated by G. vaginalis recurred during the study with similar profiles, whereas the three patients with acute BV samples dominated by other anaerobes did not recur or recurred to an intermediate Nugent score. L. iners dominated remission phases, with intermittent days of abnormal microbial profiles typically associated with menses. The exception was a newly discovered phenomenon, a sustained period of abnormal profiles, termed conversion, which preceded symptomatic acute By. Species known to have antagonistic activity towards Lactobacillus were detected in pre-conversion samples, possibly contributing to the decline in Lactobacillus. Lb-qPCR scores define two categories of response in the initial post-treatment visit males; scores <5 may correspond with poor response to treatment or rapid recurrence, whereas scores >8 may predict delayed or no recurrence. Amsel criteria or Nugent scores did not have this potential predictive capability. Larger studies are warranted to evaluate the prognostic potential of detecting conversion and poor Lb-qPCR scores at the post-treatment visit of recurrent BV patients.	[Lambert, Janet A.; John, Susan; Akins, Robert A.] Wayne State Univ, Sch Med, Dept Biochem, Detroit, MI 48201 USA; [Lambert, Janet A.; Sobel, Jack D.] Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI 48202 USA	Wayne State University; Wayne State University	Sobel, JD (corresponding author), Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI 48202 USA.	jsobel@med.wayne.edu; rakins@med.wayne.edu			Wayne State University	Wayne State University	Funding for this work was provided by Wayne State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Austin MN, 2005, J CLIN MICROBIOL, V43, P4492, DOI 10.1128/JCM.43.9.4492-4497.2005; AVONTS D, 1990, SEX TRANSM DIS, V17, P23; Baczynska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-35; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; Balkus JE, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-188; Beigi RH, 2004, AM J OBSTET GYNECOL, V191, P1124, DOI 10.1016/j.ajog.2004.05.033; Biagi E, 2009, EUR J CLIN MICROBIOL, V28, P281, DOI 10.1007/s10096-008-0617-0; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; Bradshaw CS, 2013, CLIN INFECT DIS, V56, P777, DOI 10.1093/cid/cis1030; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Brotman RM, 2010, SEX TRANSM INFECT, V86, P297, DOI 10.1136/sti.2009.040592; Burton JP, 2004, J CLIN MICROBIOL, V42, P1829, DOI 10.1128/JCM.42.4.1829-1831.2004; Burton JP, 2003, INT J GYNECOL OBSTET, V81, P61, DOI 10.1016/S0020-7292(02)00408-3; Calzolari E, 2000, INT J GYNECOL OBSTET, V70, P341, DOI 10.1016/S0020-7292(00)00217-4; Cintas LM, 1998, J BACTERIOL, V180, P1988, DOI 10.1128/JB.180.8.1988-1994.1998; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Coburn PS, 2003, CELL MICROBIOL, V5, P661, DOI 10.1046/j.1462-5822.2003.00310.x; Cohen CR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001251; COOK RL, 1992, J CLIN MICROBIOL, V30, P870, DOI 10.1128/JCM.30.4.870-877.1992; Dezwaan Diane C., 2007, Microbial Ecology in Health and Disease, V19, P241, DOI 10.1080/08910600701538240; Eschenbach DA, 2007, CLIN INFECT DIS, V44, P220, DOI 10.1086/509584; Ferris MJ, 2004, J CLIN MICROBIOL, V42, P5892, DOI [10.1128/JCM.42.12.5892-5894.2004, 10.1128/jcm.42.12.5892-5894.2004]; Ferris MJ, 2007, J CLIN MICROBIOL; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gallo MF, 2012, ANN EPIDEMIOL, V22, P213, DOI 10.1016/j.annepidem.2011.11.005; Guedou FA, 2012, SEX TRANSM INFECT, V88, P545, DOI 10.1136/sextrans-2011-050319; Haggerty CL, 2009, SEX TRANSM INFECT, V85, P242, DOI 10.1136/sti.2008.032821; Hay PE, 1997, INT J STD AIDS, V8, P603, DOI 10.1258/0956462971918850; HAY PE, 1994, BRIT J OBSTET GYNAEC, V101, P1048, DOI 10.1111/j.1471-0528.1994.tb13580.x; Hilber AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009119; Huang Mei, 2005, Journal of Microbiology Immunology and Infection, V38, P137; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Imbert M, 1998, CURR MICROBIOL, V37, P64, DOI 10.1007/s002849900339; Jamieson DJ, 2001, OBSTET GYNECOL, V98, P656, DOI 10.1016/S0029-7844(01)01525-3; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Keane FE, 1997, INT J STD AIDS, V8, pS10; Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631; Kelly Maureen C, 2003, Infect Dis Obstet Gynecol, V11, P147, DOI 10.1080/10647440300025513; Klebanoff MA, 2004, OBSTET GYNECOL, V104, P267, DOI 10.1097/01.AOG.0000134783.98382.b0; Klomp JM, 2008, DIAGN CYTOPATHOL, V36, P277, DOI 10.1002/dc.20793; Lambert JA, 2013, APPL ENVIRON MICROB, V79, P4181, DOI 10.1128/AEM.01160-13; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Lamont RF, 2011, AM J OBSTET GYNECOL, V205, P177, DOI 10.1016/j.ajog.2011.03.047; LEVISON ME, 1979, AM J OBSTET GYNECOL, V133, P139, DOI 10.1016/0002-9378(79)90464-2; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Lopes dos Santos Santiago G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045281; Lopes dos Santos Santiago G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028180; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Marrazzo JM, 2008, ANN INTERN MED, V149, P20, DOI 10.7326/0003-4819-149-1-200807010-00006; Marrazzo JM, 2011, ANAEROBE, V17, P186, DOI 10.1016/j.anaerobe.2011.03.016; MASFARI AN, 1986, GENITOURIN MED, V62, P256; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Mitchell CM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-89; Nansel TR, 2006, AM J OBSTET GYNECOL, V194, P381, DOI 10.1016/j.ajog.2005.07.047; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pirotta M, 2009, AUST FAM PHYSICIAN, V38, P394; PLATZCHRISTENSEN JJ, 1993, ACTA OBSTET GYN SCAN, V72, P99, DOI 10.3109/00016349309023420; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; Rathod SD, 2011, SEX TRANSM DIS, V38, P882, DOI 10.1097/OLQ.0b013e31821f91a1; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reichman O, 2009, SEX TRANSM DIS, V36, P732, DOI 10.1097/OLQ.0b013e3181b08456; Reid G, 2010, GUT MICROBES, V1, P200, DOI 10.4161/gmic.1.3.12013; Schellenberg JJ, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/131243; Schwebke JR, 2007, SEX TRANSM DIS, V34, P876, DOI 10.1097/OLQ.0b013e318073bd82; Schwebke JR, 2007, AM J OBSTET GYNECOL, V196, P517, DOI 10.1016/j.ajog.2007.02.048; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; Semedo T, 2003, J CLIN MICROBIOL, V41, P2569, DOI 10.1128/JCM.41.6.2569-2576.2003; Sha BE, 2005, J CLIN MICROBIOL, V43, P4607, DOI 10.1128/JCM.43.9.4607-4612.2005; Shoubnikova M, 1997, CONTRACEPTION, V55, P355, DOI 10.1016/S0010-7824(97)00044-9; Simmon KE, 2008, J CLIN MICROBIOL, V46, P3087, DOI 10.1128/JCM.00920-08; Sobel JD, 2013, CURR INFECT DIS REP, V15, P104, DOI 10.1007/s11908-013-0325-5; SOBEL JD, 1989, ANN INTERN MED, V111, P551, DOI 10.7326/0003-4819-111-7-551; Sobel JD, 2000, ANNU REV MED, V51, P349, DOI 10.1146/annurev.med.51.1.349; SOBEL JD, 1990, BRIT J CLIN PRACT, V44, P65; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Thoma ME, 2011, SEX TRANSM DIS, V38, P1040, DOI 10.1097/OLQ.0b013e3182275499; Trama JP, 2008, MOL CELL PROBE, V22, P96, DOI 10.1016/j.mcp.2007.08.002; Vallor AC, 2001, J INFECT DIS, V184, P1431, DOI 10.1086/324445; van de Wijgert DHHM, 2008, JAIDS-J ACQ IMM DEF, V48, P203, DOI 10.1097/QAI.0b013e3181743936; van de Wijgert JHHM, 2009, SEX TRANSM DIS, V36, P357, DOI 10.1097/OLQ.0b013e3181a4f695; Verstraelen H, 2004, AM J OBSTET GYNECOL, V191, P1130, DOI 10.1016/j.ajog.2004.04.013; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Verstraelen H, 2009, J REPROD IMMUNOL, V79, P163, DOI 10.1016/j.jri.2008.10.006; Waters TP, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.061; Watts DH, 2006, JAIDS-J ACQ IMM DEF, V43, P161, DOI 10.1097/01.qai.0000242448.90026.13; Weinberg ED, 1997, PERSPECT BIOL MED, V40, P578; WILKS M, 1984, J MED MICROBIOL, V18, P217, DOI 10.1099/00222615-18-2-217; Zariffard MR, 2002, FEMS IMMUNOL MED MIC, V34, P277, DOI 10.1111/j.1574-695X.2002.tb00634.x; Zhou X, 2009, INFECT IMMUN, V77, P4130, DOI 10.1128/IAI.00436-09; Zozaya-Hinchliffe M, 2008, APPL ENVIRON MICROB, V74, P1656, DOI 10.1128/AEM.02127-07	98	71	75	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82599	10.1371/journal.pone.0082599	http://dx.doi.org/10.1371/journal.pone.0082599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376552	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100042
J	Li, SN; Paterno, GD; Gillespie, LL				Li, Shengnan; Paterno, Gary D.; Gillespie, Laura L.			Nuclear Localization of the Transcriptional Regulator MIER1 alpha Requires Interaction with HDAC1/2 in Breast Cancer Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE FAMILY; FIBROBLAST-GROWTH-FACTOR; ESTROGEN-RECEPTOR; SUBCELLULAR-LOCALIZATION; BETA-CATENIN; GENE; IMPORT; PROTEIN; CLONING; MI-ER1	MIER1 alpha is a transcriptional regulator that functions in gene repression through its ability to interact with various chromatin modifiers and transcription factors. We have also shown that MIER1 alpha interacts with ER alpha and inhibits estrogen-stimulated growth. While MIER1 alpha is localized in the nucleus of MCF7 cells, previous studies have shown that it does not contain a nuclear localization signal. In this report, we investigate the mechanism involved in transporting MIER1 alpha into the nucleus. We explored the possibility that MIER1 alpha is transported into the nucleus through a 'piggyback' mechanism. One obvious choice is via interaction with ER alpha, however we demonstrate that nuclear targeting of MIER1 alpha does not require ER alpha. Knockdown of ER alpha reduced protein expression to 22% of control, but did not alter the percentage of cells with nuclear MIER1 alpha (98% nuclear with scrambled shRNA vs. 95% with ER alpha shRNA). Further evidence was obtained using two stable transfectants derived from the ER-negative MDA231 cell line: MC2 (ER alpha+) and VC5 (ER alpha-). Confocal analysis showed no difference in MIER1 alpha localization (86% nuclear in MC2 vs. 89% in VC5). These data demonstrate that ER alpha is not involved in nuclear localization of MIER1 alpha. To identify the critical MIER1 alpha sequence, we performed a deletion analysis and determined that the ELM2 domain was necessary and sufficient for nuclear localization. This domain binds HDAC1 & 2, therefore we investigated their role. Confocal analysis of an MIER1 alpha containing an ELM2 point mutation previously shown to abolish HDAC binding revealed that this mutation results in almost complete loss of nuclear targeting: 10% nuclear vs. 97% with WT-MIER1 alpha. Moreover, double knockdown of HDAC1 and 2 caused a reduction in percent nuclear from 86% to 44%. The results of this study demonstrate that nuclear targeting of MIER1 alpha requires an intact ELM2 domain and is dependent on interaction with HDAC1/2.	[Li, Shengnan; Paterno, Gary D.; Gillespie, Laura L.] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, Terry Fox Canc Res Labs, St John, NF, Canada	Memorial University Newfoundland	Gillespie, LL (corresponding author), Mem Univ Newfoundland, Fac Med, Div Biomed Sci, Terry Fox Canc Res Labs, St John, NF, Canada.	lgillesp@mun.ca			Canadian Institutes of Health Research FRN [MOP97938]; Canadian Breast Cancer Foundation	Canadian Institutes of Health Research FRN(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	Canadian Institutes of Health Research FRN# MOP97938 (http://www.cihr-irsc.gc.ca); Canadian Breast Cancer Foundation (no grant number assigned) (http://www.cbcf.org/atlantic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Asally M, 2005, EXP CELL RES, V308, P357, DOI 10.1016/j.yexcr.2005.05.011; Banach-Orlowska M, 2009, BIOCHEM J, V423, P389, DOI 10.1042/BJ20090086; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Blackmore Tina M, 2008, BMC Res Notes, V1, P68, DOI 10.1186/1756-0500-1-68; Boonyaratanakornkit V, 2007, SEMIN REPROD MED, V25, P139, DOI 10.1055/s-2007-973427; Clements JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032499; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Ding ZH, 2004, J BIOL CHEM, V279, P28009, DOI 10.1074/jbc.M403793200; Ding ZH, 2003, MOL CELL BIOL, V23, P250, DOI 10.1128/MCB.23.1.250-258.2003; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Joshi P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.26; Liu H, 2001, CANCER RES, V61, P3632; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; McCarthy PL, 2008, BRIT J CANCER, V99, P639, DOI 10.1038/sj.bjc.6604518; Moriarty K, 2006, ENDOCRINOLOGY, V147, P5557, DOI 10.1210/en.2006-0729; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Ordonez-Moran P, 2009, CELL CYCLE, V8, P1675, DOI 10.4161/cc.8.11.8579; Paterno GD, 1997, J BIOL CHEM, V272, P25591, DOI 10.1074/jbc.272.41.25591; Paterno GD, 1998, GENE, V222, P77, DOI 10.1016/S0378-1119(98)00473-9; Paterno GD, 2002, GENE, V295, P79, DOI 10.1016/S0378-1119(02)00823-5; Pearce ST, 2003, J BIOL CHEM, V278, P7630, DOI 10.1074/jbc.M211129200; Post JN, 2001, FEBS LETT, V502, P41, DOI 10.1016/S0014-5793(01)02653-9; Ryan PJ, 1998, BIOCHEM BIOPH RES CO, V244, P763, DOI 10.1006/bbrc.1998.8326; Thompson ME, 2010, FEBS J, V277, P3072, DOI 10.1111/j.1742-4658.2010.07733.x; Thorne LB, 2005, DNA SEQUENCE, V16, P237, DOI 10.1080/10425170500069783; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang L, 2008, EMBO REP, V9, P555, DOI 10.1038/embor.2008.67; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7	33	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84046	10.1371/journal.pone.0084046	http://dx.doi.org/10.1371/journal.pone.0084046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376786	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000328745100155
J	Ni, N; Hu, YH; Ren, HX; Luo, CM; Li, P; Wan, JB; Su, HX				Ni, Na; Hu, Yaohua; Ren, Huixia; Luo, Chuanming; Li, Peng; Wan, Jian-Bo; Su, Huanxing			Self-Assembling Peptide Nanofiber Scaffolds Enhance Dopaminergic Differentiation of Mouse Pluripotent Stem Cells in 3-Dimensional Culture	PLOS ONE			English	Article							COMPLEMENTARY OLIGOPEPTIDE; HIGHLY EFFICIENT; HUMAN ES; NEURONS; MIDBRAIN; EXPRESSION; GENERATION; LMX1A	Dopaminergic differentiation of embryonic stem cells (ESCs) gains more and more attention worldwide owing to its potential use for neurorestorative therapy for the treatment of Parkinson's disease. The conventional 2D cell culture on petri dishes with various animal derived substrata such as collagen gels, laminin, and Matrigel is widely used to induce dopaminergic differentiation and it may limit the efficiency in the generation of dopaminergic neurons from ESCs and prevent their application for human therapies. Here, we reported that a self-assembling peptide made from natural amino acids has a property to generate a true 3D environment for dopaminergic differentiation. Mouse ESCs (R1) and mouse iPSCs (TTF-1) embedded in RADA16-I peptide-derived nanofiber scaffolds led to a marked increase in dopaminergic differentiation compared to the laminin-coated 2D culture or Matrigel-encapsulated 3D culture, These differentiated neurons expressed specific dopaminergic markers and produced appropriate patterns of action potential firing. Consistent with the increase in the number of dopaminergic neurons differentiated from R1 or TTF-1 in the self-assembling peptide nanofiber scaffold (SAPNS), both the expression levels of genes that involve in dopaminergic differentiation and maturation and the dopamine release in SAPNS culture were significantly elevated. The results of the study suggest that SAPNS provides a promising 3D culture system for dopaminergic differentiation.	[Ni, Na; Hu, Yaohua; Ren, Huixia; Luo, Chuanming; Li, Peng; Wan, Jian-Bo; Su, Huanxing] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China	University of Macau	Su, HX (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China.	HuanxingSu@umac.mo	Su, Huanxing/X-3954-2019; Su, Huanxing/X-3980-2019; Wan, Jian-Bo/D-8368-2014	Su, Huanxing/0000-0003-3254-825X; Su, Huanxing/0000-0002-0513-4943; Wan, Jian-Bo/0000-0002-6750-2617	university of Macau [MYRG122 (Y1-L3)-ICMS12-SHX, MYRG110 (Y1-L2)-ICMS13-SHX]; Macao Science and Technology Development Fund [003/2012/A, 018/2013/A1]	university of Macau; Macao Science and Technology Development Fund	This study was supported by multi-year research grant, university of Macau, MYRG122 (Y1-L3)-ICMS12-SHX and MYRG110 (Y1-L2)-ICMS13-SHX, and Macao Science and Technology Development Fund (003/2012/A and 018/2013/A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Burbach JPH, 2006, TRENDS NEUROSCI, V29, P601, DOI 10.1016/j.tins.2006.09.003; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003; Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001; Hamada K, 2008, J BIOMED MATER RES A, V84A, P128, DOI 10.1002/jbm.a.31439; Hayashi H, 2008, EUR J NEUROSCI, V27, P261, DOI 10.1111/j.1460-9568.2008.06027.x; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Iacovitti L, 2007, BRAIN RES, V1127, P19, DOI 10.1016/j.brainres.2006.10.022; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Ko JY, 2009, MOL THER, V17, P1761, DOI 10.1038/mt.2009.148; Koutsopoulos S, 2013, ACTA BIOMATER, V9, P5162, DOI 10.1016/j.actbio.2012.09.010; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lin W, 2009, DEV BIOL, V333, P386, DOI 10.1016/j.ydbio.2009.07.006; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Salti A, 2013, STEM CELLS DEV, V22, P397, DOI 10.1089/scd.2012.0238; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114; Shimada H, 2009, J BIOSCI BIOENG, V107, P447, DOI 10.1016/j.jbiosc.2008.12.013; Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380; Spancake KM, 1999, CANCER RES, V59, P6042; Su HX, 2013, STEM CELL RES, V10, P338, DOI 10.1016/j.scr.2013.01.003; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhan XD, 2013, NANOMED-NANOTECHNOL, V9, P305, DOI 10.1016/j.nano.2012.08.009; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhau HE, 1997, IN VITRO CELL DEV-AN, V33, P375	38	22	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84504	10.1371/journal.pone.0084504	http://dx.doi.org/10.1371/journal.pone.0084504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376815	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100169
J	Pascucci, T; Giacovazzo, G; Andolina, D; Accoto, A; Fiori, E; Ventura, R; Orsini, C; Conversi, D; Carducci, C; Leuzzi, V; Puglisi-Allegra, S				Pascucci, Tiziana; Giacovazzo, Giacomo; Andolina, Diego; Accoto, Alessandra; Fiori, Elena; Ventura, Rossella; Orsini, Cristina; Conversi, David; Carducci, Claudia; Leuzzi, Vincenzo; Puglisi-Allegra, Stefano			Behavioral and Neurochemical Characterization of New Mouse Model of Hyperphenylalaninemia	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; PREFRONTAL CORTEX; TREATED PHENYLKETONURIA; SUSTAINED ATTENTION; COGNITIVE DEFICITS; PHENYLALANINE; PKU; DYSFUNCTION; TYROSINE; 5-HYDROXYTRYPTOPHAN	Hyperphenylalaninemia (HPA) refers to all clinical conditions characterized by increased amounts of phenylalanine (PHE) in blood and other tissues. According to their blood PHE concentrations under a free diet, hyperphenylalaninemic patients are commonly classified into phenotypic subtypes: classical phenylketonuria (PKU) (PHE > 1200 mu M/L), mild PKU (PHE 600-1200 mu M/L) and persistent HPA (PHE 120-600 mu M/L) (normal blood PHE < 120 mu M/L). The current treatment for hyperphenylalaninemic patients is aimed to keep blood PHE levels within the safe range of 120-360 mu M/L through a PHE-restricted diet, difficult to achieve. If untreated, classical PKU presents variable neurological and mental impairment. However, even mildly elevated blood PHE levels, due to a bad compliance to dietary treatment, produce cognitive deficits involving the prefrontal cortical areas, extremely sensible to PHE-induced disturbances. The development of animal models of different degrees of HPA is a useful tool for identifying the metabolic mechanisms underlying cognitive deficits induced by PHE. In this paper we analyzed the behavioral and biochemical phenotypes of different forms of HPA (control, mild-HPA, mild-PKU and classic-PKU), developed on the base of plasma PHE concentrations. Our results demonstrated that mice with different forms of HPA present different phenotypes, characterized by increasing severity of behavioral symptoms and brain aminergic deficits moving from mild HPA to classical PKU forms. In addition, our data identify preFrontal cortex and amygdala as the most affected brain areas and confirm the highest susceptibility of brain serotonin metabolism to mildly elevated blood PHE.	[Pascucci, Tiziana; Giacovazzo, Giacomo; Accoto, Alessandra; Fiori, Elena; Ventura, Rossella; Orsini, Cristina; Conversi, David; Puglisi-Allegra, Stefano] Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; [Pascucci, Tiziana; Giacovazzo, Giacomo; Accoto, Alessandra; Fiori, Elena; Ventura, Rossella; Orsini, Cristina; Conversi, David; Puglisi-Allegra, Stefano] Univ Roma La Sapienza, Ctr Daniel Bovet, I-00185 Rome, Italy; [Pascucci, Tiziana; Giacovazzo, Giacomo; Andolina, Diego; Accoto, Alessandra; Fiori, Elena; Ventura, Rossella; Orsini, Cristina; Conversi, David; Puglisi-Allegra, Stefano] IRCCS, Fdn Santa Lucia, Rome, Italy; [Andolina, Diego] Univ Aquila, Dipartimento Sci Clin Appl & Biotecnol, I-67100 Laquila, Italy; [Carducci, Claudia] Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, I-00185 Rome, Italy; [Leuzzi, Vincenzo] Univ Rome, Dipartimento Sci Neurol Psichiatr & Riabilitat Et, Rome, Italy	Sapienza University Rome; Sapienza University Rome; IRCCS Santa Lucia; University of L'Aquila; Sapienza University Rome; Sapienza University Rome	Pascucci, T (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy.	tiziana.pascucci@uniroma1.it	Ventura, Rossella/AAA-8816-2019; Conversi, David/AAH-2834-2021; Pascucci, Tiziana/AAB-9706-2019; carducci, claudia/K-5412-2018; Puglisi-Allegra, Stefano/ABI-7468-2020	Ventura, Rossella/0000-0002-7601-8683; Puglisi-Allegra, Stefano/0000-0002-9433-2000; Fiori, Elena/0000-0003-2990-9624; Giacovazzo, Giacomo/0000-0001-7430-2835; Pascucci, Tiziana/0000-0003-1520-7373; ORSINI, Cristina/0000-0003-1280-3233; Leuzzi, Vincenzo/0000-0002-2314-6139; CARDUCCI, Claudia/0000-0003-0515-9208	Comitato Telethon Fondazione ONLU [GGP09254]; Sapienza University of Roma	Comitato Telethon Fondazione ONLU(Fondazione Telethon); Sapienza University of Roma	This work was supported by the Comitato Telethon Fondazione ONLUS (GGP09254) and Sapienza University of Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolina D, 2011, INT J NEUROPSYCHOPH, V14, P479, DOI 10.1017/S1461145710001288; Brumm VL, 2010, MOL GENET METAB, V99, pS59, DOI 10.1016/j.ymgme.2009.10.182; Brumm VL, 2004, J INHERIT METAB DIS, V27, P549, DOI 10.1023/B:BOLI.0000042985.02049.ff; Burlina AB, 2000, J INHERIT METAB DIS, V23, P313, DOI 10.1023/A:1005694122277; BUTLER IJ, 1981, J PEDIATR-US, V98, P729, DOI 10.1016/S0022-3476(81)80832-3; Cabib S, 2003, BEHAV GENET, V33, P301, DOI 10.1023/A:1023498508987; CHACE DH, 1993, CLIN CHEM, V39, P66; Channon S, 2004, NEUROPSYCHOLOGY, V18, P613, DOI 10.1037/0894-4105.18.4.613; de Groot MJ, 2010, MOL GENET METAB, V99, pS86, DOI 10.1016/j.ymgme.2009.10.016; DeRoche K, 2008, DEV NEUROPSYCHOL, V33, P474, DOI 10.1080/87565640802101482; Diamond A, 1997, MONOGR SOC RES CHILD, V62, P1; dos Santos LL, 2006, GENET MOL RES, V5, P33; Huijbregts SCJ, 2002, NEUROPSYCHOLOGIA, V40, P7, DOI 10.1016/S0028-3932(01)00078-1; Joseph B, 2003, J NEUROCHEM, V86, P615, DOI 10.1046/j.1471-4159.2003.01887.x; Leuzzi V, 2004, J INHERIT METAB DIS, V27, P115, DOI 10.1023/B:BOLI.0000028781.94251.1f; LOU H, 1985, LANCET, V2, P150; Martynyuk AE, 2010, MOL GENET METAB, V99, pS100, DOI 10.1016/j.ymgme.2009.10.181; MCDONALD JD, 1990, P NATL ACAD SCI USA, V87, P1965, DOI 10.1073/pnas.87.5.1965; McKean CM, 1972, THE EFFECTS OF HIGH, V47, P469, DOI [10.1016/0006-8993(72)90653-1, DOI 10.1016/0006-8993(72)90653-1]; Mizoguchi K, 2000, J NEUROSCI, V20, P1568; MORAN PM, 1993, PHARMACOL BIOCHEM BE, V45, P533, DOI 10.1016/0091-3057(93)90502-K; Pascucci T, 2002, NEUROREPORT, V13, P2561, DOI 10.1097/00001756-200212200-00036; Pascucci T, 2008, BRAIN RES, V1217, P232, DOI 10.1016/j.brainres.2008.04.006; Pascucci T, 2012, J INHERIT METAB DIS, V35, P1001, DOI 10.1007/s10545-012-9473-2; Pascucci T, 2009, INT J NEUROPSYCHOPH, V12, P1067, DOI 10.1017/S1461145709990381; Puglisi-Allegra S, 2000, NEUROREPORT, V11, P1361, DOI 10.1097/00001756-200004270-00042; SCHMIDT E, 1994, J CLIN EXP NEUROPSYC, V16, P681, DOI 10.1080/01688639408402681; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; Smith CB, 2000, P NATL ACAD SCI USA, V97, P11014, DOI 10.1073/pnas.97.20.11014; Smith ML, 1998, ARCH DIS CHILD, V78, P116, DOI 10.1136/adc.78.2.116; Stemerdink BA, 2000, J INHERIT METAB DIS, V23, P548, DOI 10.1023/A:1005669610722; VANHAAREN F, 1985, BEHAV BRAIN RES, V18, P41, DOI 10.1016/0166-4328(85)90167-6; White DA, 2002, J INT NEUROPSYCH SOC, V8, P1, DOI 10.1017/S135561770102001X; Zagreda L, 1999, J NEUROSCI, V19, P6175, DOI 10.1523/JNEUROSCI.19-14-06175.1999; Zahrt J, 1997, J NEUROSCI, V17, P8528	35	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84697	10.1371/journal.pone.0084697	http://dx.doi.org/10.1371/journal.pone.0084697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376837	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100183
J	Philipp, O; Hamann, A; Servos, J; Werner, A; Koch, I; Osiewacz, HD				Philipp, Oliver; Hamann, Andrea; Servos, Joerg; Werner, Alexandra; Koch, Ina; Osiewacz, Heinz D.			A Genome-Wide Longitudinal Transcriptome Analysis of the Aging Model Podospora anserine	PLOS ONE			English	Article							MITOCHONDRIAL-DNA REARRANGEMENTS; CHRONOLOGICAL LIFE-SPAN; FILAMENTOUS FUNGUS; QUALITY-CONTROL; COPPER HOMEOSTASIS; GENE-EXPRESSION; MOBILE INTRON; SENESCENCE; AUTOPHAGY; PATHWAY	Aging of biological systems controlled by various processes which have a potential impact on gene expression. Here we report a genome-wide an scriptome analysis of the fungal aging model Podospora anserina. Total RNA of three individuals defined age were pooled and analyzed by SuperSAGE (serial analysis of gene expression). A bioinformatics analysts identified different molecular pathways to be affected during aging. While the abundance of transcripts linked to ribosomes and to the proteasome quality control system were found to decrease during aging, those associated with autophagy increase, suggesting that autophagy may act as a compensatory quality control pathway. Transcript profiles associated with the energy metabolism including mitochondrial functions were identified to fluctuate during aging. Comparison of wild type transcripts, which are continuously down-regulated during aging, with those down-regulated in the long-lived, copper-uptake mutant grisea, validated the relevance of age-related changes in cellular copper metabolism. Overall, we (i) present a unique age-related data set of a longitudinal study of the experimental aging model P. anserina which represents a reference resource for future investigations in a variety of organisms, (ii) suggest autophagy to be a key quality control hat becomes active once other pathways fail, and (iii) present testable predictions for subsequent experimental investigations.	[Philipp, Oliver; Hamann, Andrea; Servos, Joerg; Werner, Alexandra; Osiewacz, Heinz D.] Goethe Univ Frankfurt, Fac Biosci, Inst Mol Biosci, D-60054 Frankfurt, Germany; [Philipp, Oliver; Hamann, Andrea; Servos, Joerg; Werner, Alexandra; Koch, Ina; Osiewacz, Heinz D.] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60054 Frankfurt, Germany; [Philipp, Oliver; Koch, Ina] Goethe Univ Frankfurt, Inst Comp Sci, Fac Comp Sci & Math, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Osiewacz, HD (corresponding author), Goethe Univ Frankfurt, Fac Biosci, Inst Mol Biosci, D-60054 Frankfurt, Germany.	Osiewacz@bio.uni-frankfurt.de	Koch, Ina/D-8899-2011	Osiewacz, Heinz D./0000-0002-0360-6994; Hamann, Andrea/0000-0001-9821-7491; Koch, Ina/0000-0002-3621-003X	Bundesministerium fur Bildung und Forschung (BMBF) [GerontoMitoSys 0315584A]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant by the Bundesministerium fur Bildung und Forschung (BMBF; GerontoMitoSys 0315584A) to HDO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Averbeck NB, 2001, MOL GEN GENET, V264, P604, DOI 10.1007/s004380000346; Averbeck NB, 2000, CURR GENET, V37, P200, DOI 10.1007/s002940050520; Borghouts C, 2000, CURR GENET, V37, P268, DOI 10.1007/s002940050528; Borghouts C, 2002, INT J BIOCHEM CELL B, V34, P1355, DOI 10.1016/S1357-2725(02)00078-X; Borghouts C, 2002, BIOGERONTOLOGY, V3, P143, DOI 10.1023/A:1015696404723; Borghouts C, 1998, MOL GEN GENET, V260, P492, DOI 10.1007/s004380050922; Borghouts C, 2001, MOL CELL BIOL, V21, P390, DOI 10.1128/MCB.21.2.390-399.2001; Brust D, 2010, AGING CELL, V9, P761, DOI 10.1111/j.1474-9726.2010.00609.x; Brust D, 2010, CURR GENET, V56, P225, DOI 10.1007/s00294-010-0295-1; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P163, DOI 10.1089/ars.2006.8.163; Eriksen JL, 2005, ARCH NEUROL-CHICAGO, V62, P353, DOI 10.1001/archneur.62.3.353; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; ESSER K, 1981, CURR GENET, V4, P83, DOI 10.1007/BF00376791; ESSER K, 1980, MOL GEN GENET, V178, P213, DOI 10.1007/BF00267231; Esser K., 1974, BACTERIA BACTERIOPHA, P531; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Groebe K, 2007, EXP GERONTOL, V42, P887, DOI 10.1016/j.exger.2007.07.001; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kil IS, 2006, FREE RADICAL BIO MED, V40, P110, DOI 10.1016/j.freeradbiomed.2005.08.021; Knab B, 2010, CELL CYCLE, V9, P3387, DOI 10.4161/cc.9.17.13016; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; KUCK U, 1985, CURR GENET, V9, P373, DOI 10.1007/BF00421608; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Kunstmann B, 2008, AGING CELL, V7, P651, DOI 10.1111/j.1474-9726.2008.00412.x; Kunstmann B, 2009, AGING-US, V1, P328, DOI 10.18632/aging.100029; Lilienbaum Alain, 2013, Int J Biochem Mol Biol, V4, P1; Lin WD, 2011, PLANT PHYSIOL, V155, P1383, DOI 10.1104/pp.110.166520; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553; Nappi AJ, 1998, BBA-GEN SUBJECTS, V1425, P159, DOI 10.1016/S0304-4165(98)00062-2; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Nitsche BM, 2013, APPL MICROBIOL BIOT, V97, P8205, DOI 10.1007/s00253-013-4971-1; OSIEWACZ HD, 1994, CURR GENET, V26, P87, DOI 10.1007/BF00326309; OSIEWACZ HD, 1984, CURR GENET, V8, P299, DOI 10.1007/BF00419728; Osiewacz HD, 1999, EXP GERONTOL, V34, P901, DOI 10.1016/S0531-5565(99)00063-7; OSIEWACZ HD, 1992, AGING-CLIN EXP RES, V4, P273, DOI 10.1007/BF03324108; OSIEWACZ HD, 1991, APPL MICROBIOL BIOT, V35, P38; Osiewacz HD, 1997, J MOL MED, V75, P715, DOI 10.1007/s001090050158; Osiewacz HD, 2002, MECH AGEING DEV, V123, P755, DOI 10.1016/S0047-6374(01)00421-3; Osiewacz HD, 2002, GENE, V286, P65, DOI 10.1016/S0378-1119(01)00804-6; OSIEWACZ HD, 1990, CURR GENET, V18, P481, DOI 10.1007/BF00309921; Osiewacz HD, 2001, ARCH GERONTOL GERIAT, V32, P185, DOI 10.1016/S0167-4943(01)00096-6; Osiewacz HD, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1275; Osiewacz HD, 1996, MOL GEN GENET, V252, P115, DOI 10.1007/BF02173211; OSIEWACZ HD, 1989, MUTAT RES, V219, P9, DOI 10.1016/0921-8734(89)90036-2; Osiewacz Heinz D, 2013, Methods Mol Biol, V965, P439, DOI 10.1007/978-1-62703-239-1_29; Osiewacz HD, 2011, BIOCHEM SOC T, V39, P1488, DOI 10.1042/BST0391488; Pal NR, 1996, NEURAL NETWORKS, V9, P787, DOI 10.1016/0893-6080(95)00094-1; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pinan-Lucarre B, 2006, CURR GENET, V50, P23, DOI 10.1007/s00294-006-0064-3; Pollack JK, 2009, FUNGAL GENET BIOL, V46, P1, DOI 10.1016/j.fgb.2008.10.010; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; R Core Team, 2021, R LANGUAGE ENV STAT; Reiter A, 2011, MOL CELL BIOL, V31, P803, DOI 10.1128/MCB.01227-10; Rexroth S, 2012, BBA-BIOENERGETICS, V1817, P381, DOI 10.1016/j.bbabio.2011.11.006; RIZET G, 1953, CR HEBD ACAD SCI, V237, P838; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Scheckhuber CQ, 2008, MOL GENET GENOMICS, V280, P365, DOI 10.1007/s00438-008-0378-6; Scheckhuber CQ, 2010, AGING-US, V2, P969, DOI 10.18632/aging.100251; Scheckhuber CQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004919; SELLEM CH, 1993, NATURE, V366, P176, DOI 10.1038/366176a0; Servos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049292; STAHL U, 1978, MOL GEN GENET, V162, P341, DOI 10.1007/BF00268860; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Voigt O, 2013, APPL MICROBIOL BIOTE; Voigt O, 2013, MICROBIOL RES; Wallace D C, 2001, Novartis Found Symp, V235, P247; Wang S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-138; Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018; Yiu G, 2008, J GERONTOL A-BIOL, V63, P21, DOI 10.1093/gerona/63.1.21; ZHU BT, 1994, J BIOL CHEM, V269, P292	89	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83109	10.1371/journal.pone.0083109	http://dx.doi.org/10.1371/journal.pone.0083109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376646	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100091
J	Scholz, EP; Carrillo-Bustamante, P; Fischer, F; Wilhelms, M; Zitron, E; Dossel, O; Katus, HA; Seemann, G				Scholz, Eberhard P.; Carrillo-Bustamante, Paola; Fischer, Fathima; Wilhelms, Mathias; Zitron, Edgar; Doessel, Olaf; Katus, Hugo A.; Seemann, Gunnar			Rotor Termination Is Critically Dependent on Kinetic Properties of I-Kur Inhibitors in an In Silico Model of Chronic Atrial Fibrillation	PLOS ONE			English	Article							COMPUTER-MODEL; DIPHENYLPHOSPHINE OXIDE; MECHANISMS; BLOCKER; INSIGHTS; CELLS; RAT	Inhibition of the atrial ultra-rapid delayed rectifier potassium current represents a promising therapeutic strategy in the therapy of atrial fibrillation. However, experimental and clinical data on the antiarrhythmic efficacy remain controversial. tested the hypothesis that antiarrhythmic effects of I-Kur inhibitors are dependent on kinetic properties of channel blockade A mathematical description of I-Kur blockade was introduced into Courtemanche-Ramirez-Nattel models of normal and remodeled atrial electrophysiology. Effects of five model compounds with different kinetic properties were analyzed. hough a reduction of dominant frequencies could be observed in two dimensional tissue simulations for all compounds, reduction of spiral wave activity could be only be detected in two cases. We found that an increase of the percent area of refractory tissue due to a prolongation of the wavelength seems to be particularly important. By automatic tracking of spiral movement we find that increased refractoriness resulted in rotor extinction caused by an increased spiral-tip meandering. We show that antiarrhythmic effects of inhibitors are dependent on kinetic properties of blockade. We find hat an increase of the percent area of refractory tissue is the underlying mechanism for an increased spiral-tip meandering suiting in the extinction of re-entrant circuits	[Scholz, Eberhard P.; Fischer, Fathima; Zitron, Edgar; Katus, Hugo A.] Univ Heidelberg Hosp, Dept Internal Med 3, Heidelberg, Germany; [Wilhelms, Mathias; Doessel, Olaf; Seemann, Gunnar] Karlsruhe Inst Technol KIT, Inst Biomed Engn, Karlsruhe, Germany; [Carrillo-Bustamante, Paola] Univ Utrecht, Utrecht, Netherlands; [Zitron, Edgar; Katus, Hugo A.] German Ctr Cardiovasc Res DZHK Partner Site Heide, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Utrecht University; German Centre for Cardiovascular Research	Scholz, EP (corresponding author), Univ Heidelberg Hosp, Dept Internal Med 3, Heidelberg, Germany.	eberhard.scholz@med.uni-heidelberg.de	Seemann, Gunnar/D-3091-2011; Doessel, Olaf/D-3203-2011	Seemann, Gunnar/0000-0001-7111-7992; Doessel, Olaf/0000-0003-4551-7970; Carrillo-Bustamante, Paola/0000-0001-8322-8286; Scholz, Eberhard/0000-0003-2893-4086	German Research Foundation [Scho1350/2-1, Se1758/3-1]; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS); DZHK (German Centre for Cardiovascular Research)	German Research Foundation(German Research Foundation (DFG)); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS); DZHK (German Centre for Cardiovascular Research)	This work was supported by grants from the German Research Foundation (Scho1350/2-1 to ES, Se1758/3-1 to GS]. FF was supported by the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS). HAK was supported by the DZHK (German Centre for Cardiovascular Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Blaauw Y, 2004, CIRCULATION, V110, P1717, DOI 10.1161/01.CIR.0000143050.22291.2E; Blass BE, 2009, J MED CHEM, V52, P6531, DOI 10.1021/jm901042m; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Burashnikov A, 2003, CIRCULATION, V107, P2355, DOI 10.1161/01.CIR.0000065578.00869.7C; Burashnikov A, 2008, HEART RHYTHM, V5, P1304, DOI 10.1016/j.hrthm.2008.05.020; Cherry EM, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125016; Courtemanche M, 1999, CARDIOVASC RES, V42, P477, DOI 10.1016/S0008-6363(99)00034-6; Dobrev D, 2010, LANCET, V375, P1212, DOI 10.1016/S0140-6736(10)60096-7; Eckstein J, 2011, CARDIOVASC RES, V89, P816, DOI 10.1093/cvr/cvq336; Ehrlich JR, 2008, J AM COLL CARDIOL, V51, P787, DOI 10.1016/j.jacc.2007.08.067; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Hocini M, 2002, CIRCULATION, V105, P2442, DOI 10.1161/01.CIR.0000016062.80020.11; Jacquemet V, 2005, EUROPACE, V7, pS83, DOI 10.1016/j.eupc.2005.03.017; Kneller J, 2005, CIRC RES, V96, pE35, DOI 10.1161/01.RES.0000160709.49633.2b; Kneller J, 2002, CIRC RES, V90, pE73, DOI 10.1161/01.RES.0000019783.88094.BA; Lagrutta A, 2006, J PHARMACOL EXP THER, V317, P1054, DOI 10.1124/jpet.106.101162; Nattel S, 1999, CELL PHYSIOL BIOCHEM, V9, P217, DOI 10.1159/000016318; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Nattel S, 2006, NAT REV DRUG DISCOV, V5, P1034, DOI 10.1038/nrd2112; Ng J, 2006, HEART RHYTHM, V3, P1295, DOI 10.1016/j.hrthm.2006.07.027; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Pandit SV, 2005, BIOPHYS J, V88, P3806, DOI 10.1529/biophysj.105.060459; Raitt MH, 2004, AM J CARDIOL, V93, P107, DOI 10.1016/j.amjcard.2003.08.079; Regan CP, 2007, J CARDIOVASC PHARM, V49, P236, DOI 10.1097/FJC.0b013e3180325b2a; Regan CP, 2006, J PHARMACOL EXP THER, V316, P727, DOI 10.1124/jpet.105.094839; Seemann G, 2010, MATH INDUST, V15, P363, DOI 10.1007/978-3-642-12110-4_55; Seemann G, 2010, COMPUT CARDIOL CONF, V37, P417; Stump GL, 2005, J PHARMACOL EXP THER, V315, P1362, DOI 10.1124/jpet.105.092197; Tobon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050883; Tsujimae K, 2008, AM J PHYSIOL-HEART C, V294, pH793, DOI 10.1152/ajpheart.01229.2007; van der Velden HMW, 2000, CARDIOVASC RES, V46, P476, DOI 10.1016/S0008-6363(00)00026-2; Wettwer E, 2004, CIRCULATION, V110, P2299, DOI 10.1161/01.CIR.0000145155.60288.71; Wilhelms M, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00487; Yamazaki M, 2012, CARDIOVASC RES, V94, P48, DOI 10.1093/cvr/cvr357	36	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83179	10.1371/journal.pone.0083179	http://dx.doi.org/10.1371/journal.pone.0083179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376659	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100097
J	Tritt, SM; Inzlicht, M; Peterson, JB				Tritt, Shona M.; Inzlicht, Michael; Peterson, Jordan B.			Preliminary Support for a Generalized Arousal Model of Political Conservatism	PLOS ONE			English	Article							POSITIVE AFFECT; DISGUST; EMOTION; ANXIETY; UNCERTAINTY; ORIENTATION; ATTENTION; SYSTEM; LIKING; NEEDS	It is widely held that negative emotions such as threat, anxiety, and disgust represent the core psychological factors that enhance conservative political beliefs. We put forward an alternative hypothesis: that conservatism is fundamentally motivated by arousal, and that, in this context, the effect of negative emotion is due to engaging intensely arousing states. Here we show that study participants agreed more with right but not left-wing political speeches after being exposed to positive as well as negative emotion-inducing film-clips. No such effect emerged for neutral-content videos. A follow-up study replicated and extended this effect. These results are consistent with the idea that emotional arousal, in general, and not negative valence, specifically, may underlie political conservatism.	[Tritt, Shona M.; Peterson, Jordan B.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Inzlicht, Michael] Univ Toronto Scarborough, Dept Psychol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Scarborough	Tritt, SM (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	shona.tritt@utoronto.ca		Tritt, Shona/0000-0003-0096-6019	Social Sciences and Humanities Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	Funds from the Social Sciences and Humanities Research Council of Canada were used to run this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Atunji BO, 2008, J RES PERS, V42, P1364, DOI 10.1016/j.jrp.2008.04.001; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bolte A, 2003, PSYCHOL SCI, V14, P416, DOI 10.1111/1467-9280.01456; Bonanno GA, 2006, BASIC APPL SOC PSYCH, V28, P311, DOI 10.1207/s15324834basp2804_4; Bouchard TJ, 2003, PERS INDIV DIFFER, V34, P959, DOI 10.1016/S0191-8869(02)00080-6; Cacioppo JT, 1999, J PERS SOC PSYCHOL, V76, P839, DOI 10.1037/0022-3514.76.5.839; Carraro L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026456; Carroll J, 2007, MOST AM VERY SATISFI; Carver CS, 2009, COGNITIVE THER RES, V33, P552, DOI 10.1007/s10608-008-9213-y; COHEN D, 1980, BIOL PSYCHIAT, V15, P699; CONOVER PJ, 1981, AM J POLIT SCI, V25, P617, DOI 10.2307/2110756; Dodd MD, 2012, PHILOS T R SOC B, V367, P640, DOI 10.1098/rstb.2011.0268; Dolcos F, 2002, COGN AFFECT BEHAV NE, V2, P252, DOI 10.3758/CABN.2.3.252; Dombrink J, 2006, CONTEMP SOCIOL, V35, P346; Dreisbach G, 2004, J EXP PSYCHOL LEARN, V30, P343, DOI 10.1037/0278-7393.30.2.343; Eidelman S, 2012, PERS SOC PSYCHOL B, V38, P808, DOI 10.1177/0146167212439213; Eysenck H. J., 1981, POLITICAL PSYCHOL, V3, P234, DOI [10.2307/3791293, DOI 10.2307/3791293]; GEEN RG, 1984, J PERS SOC PSYCHOL, V46, P1303, DOI 10.1037/0022-3514.46.6.1303; Giuliani NR, 2008, EMOTION, V8, P714, DOI 10.1037/a0013236; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Greenberg J, 2003, PSYCHOL BULL, V129, P376, DOI 10.1037/0033-2909.129.3.376; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gross JJ, 1997, J ABNORM PSYCHOL, V106, P95, DOI 10.1037/0021-843X.106.1.95; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Hibbing JR, 2013, BRAIN BEHAV IN PRESS; Hirsh JB, 2010, EMOTION, V10, P717, DOI 10.1037/a0019466; Hodson G, 2007, PSYCHOL SCI, V18, P691, DOI 10.1111/j.1467-9280.2007.01962.x; Horberg EJ, 2009, J PERS SOC PSYCHOL, V97, P963, DOI 10.1037/a0017423; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Inbar Y, 2009, EMOTION, V9, P435, DOI 10.1037/a0015960; Inzlicht M, 2012, PERSPECT PSYCHOL SCI, V7, P450, DOI 10.1177/1745691612454134; ISEN AM, 1983, SOC COGNITION, V2, P18, DOI 10.1521/soco.1983.2.1.18; Ito T, 1998, PERS SOC PSYCHOL B, V24, P855, DOI 10.1177/0146167298248006; Johnson SD, 2001, J SOC PSYCHOL, V141, P233, DOI 10.1080/00224540109600549; Jost JT, 2007, PERS SOC PSYCHOL B, V33, P989, DOI 10.1177/0146167207301028; Jost JT, 2009, ANNU REV PSYCHOL, V60, P307, DOI 10.1146/annurev.psych.60.110707.163600; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kerlinger F.N., 1984, LIBERALISM CONSERVAT; Krantz J. H., 2000, PSYCHOL EXPT INTERNE, P35, DOI DOI 10.1016/B978-012099980-4/50003-4; LARUE A, 1985, EXP AGING RES, V11, P215, DOI 10.1080/03610738508259190; Leone L, 2008, J RES PERS, V42, P755, DOI 10.1016/j.jrp.2007.08.001; Lodge M., 2013, RATIONALIZING VOTER; McGregor I, 2005, J PERS SOC PSYCHOL, V89, P978, DOI 10.1037/0022-3514.89.6.978; McGregor I, 2001, J PERS SOC PSYCHOL, V80, P472, DOI 10.1037//0022-3514.80.3.472; McLean SP, 2013, POLIT PSYCH IN PRESS; MCPHAIL C, 1983, ANNU REV SOCIOL, V9, P579, DOI 10.1146/annurev.so.09.080183.003051; Nail PR, 2009, J EXP SOC PSYCHOL, V45, P901, DOI 10.1016/j.jesp.2009.04.013; Napier JL, 2008, PSYCHOL SCI, V19, P565, DOI 10.1111/j.1467-9280.2008.02124.x; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Peterson BE, 1997, J PERS SOC PSYCHOL, V72, P1202, DOI 10.1037/0022-3514.72.5.1202; RANKIN EJ, 1994, PSYCHOL REP, V75, P1176, DOI 10.2466/pr0.1994.75.3.1176; Rottenberg J., 2007, HDB EMOTION ELICITAT; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; Schlenker BR, 2013, J RES PERS IN PRESS; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Smith NK, 2003, NEUROPSYCHOLOGIA, V41, P171, DOI 10.1016/S0028-3932(02)00147-1; Taylor P., 2006, ARE WE HAPPY YET; Thorisdottir H, 2007, PUBLIC OPIN QUART, V71, P175, DOI 10.1093/poq/nfm008; Tritt SM, 2013, BRAIN BEHAV IN PRESS; Tritt SM, 2013, WHAT REALLY IN PRESS; Tritt SM, 2013, J EXP PSYCH IN PRESS; Vettehen PH, 2008, COMMUN RES, V35, P319, DOI 10.1177/0093650208315960; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242; WEST RL, 1984, EXP AGING RES, V10, P197, DOI 10.1080/03610738408258464; Yoon K, 1998, J MARK COMMUN, V4, P101, DOI 10.1080/13527269800000003	67	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83333	10.1371/journal.pone.0083333	http://dx.doi.org/10.1371/journal.pone.0083333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376687	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100112
J	Kabeya, Y; Goto, A; Kato, M; Takahashi, Y; Matsushita, Y; Inoue, M; Mizoue, T; Tsugane, S; Kadowaki, T; Noda, M				Kabeya, Yusuke; Goto, Atsushi; Kato, Masayuki; Takahashi, Yoshihiko; Matsushita, Yumi; Inoue, Manami; Mizoue, Tetsuya; Tsugane, Shoichiro; Kadowaki, Takashi; Noda, Mitsuhiko			History of Having a Macrosomic Infant and the Risk of Diabetes: The Japan Public Health Center-Based Prospective Diabetes Study	PLOS ONE			English	Article							PREGNANCY OUTCOMES; WOMEN; HYPERGLYCEMIA; ALCOHOL; IMPACT	Objective: The aim of the present study was to test a hypothesis that a history of having a macrosomic infant (>= 4000g) is associated with the risk of diabetes. Methods: Data on the Japan Public Health Center-based Prospective diabetes cohort were analyzed, which is a population-based cohort study on diabetes. The survey of diabetes was performed at baseline and at the 5-year follow-up. A history of having a macrosomic infant was assessed using a self-administered questionnaire. A cross-sectional analysis was performed among 12,153 women who participated in the 5-year survey of the cohort. Logistic regression was used to examine the relationship between a history of having a macrosomic infant and the presence of diabetes. A longitudinal analysis was also conducted among 7,300 women without diabetes who participated in the baseline survey. Logistic regression was used to investigate the relationship between a history of having a macrosomic infant and the incidence of diabetes between the baseline survey and the 5-year survey. Results: In the cross-sectional analysis, parous women with a positive history were more likely to have diabetes in relation to parous women without (OR = 1.44, 95% CI = 1.13-1.83). The longitudinal analysis showed a modest but non-significant increased risk of developing diabetes among women with a positive history (OR = 1.24, 95% CI = 0.80-1.94). Conclusions: An increased risk of diabetes was implied among women with a history of having a macrosomic infant although the longitudinal analysis showed a non-significant increased risk.	[Kabeya, Yusuke; Goto, Atsushi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan; [Kabeya, Yusuke] Saiseikai Cent Hosp, Dept Internal Med, Tokyo, Japan; [Kato, Masayuki; Matsushita, Yumi] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Clin Res Coordinat, Tokyo, Japan; [Takahashi, Yoshihiko] Iwate Med Univ, Sch Med, Div Diabet & Metab, Morioka, Iwate 020, Japan; [Inoue, Manami; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, AXA Dept Hlth & Human Secur, Tokyo, Japan; [Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Kadowaki, Takashi] Univ Tokyo, Dept Diabet & Metab Dis, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Tokyo Saiseikai Central Hospital; National Center for Global Health & Medicine - Japan; Iwate Medical University; National Cancer Center - Japan; University of Tokyo; National Center for Global Health & Medicine - Japan; University of Tokyo	Noda, M (corresponding author), Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan.	mnoda@hosp.ncgm.go.jp	Noda, Mitsuhiko/W-3905-2019; Tsugane, Shoichiro/A-2424-2015	Noda, Mitsuhiko/0000-0003-0413-4631; Tsugane, Shoichiro/0000-0003-4105-2774; Goto, Atsushi/0000-0003-0669-654X	Health Sciences Research Grants [H10-074]; Medical Frontier Strategy Research [H13-008]; Clinical Research for Evidence-based Medicine [H14-008, H15-006]; Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus [H16-019, H17-019, H18-028, H19-016, H25-016]; Ministry of Health, Labour and Welfare of Japan	Health Sciences Research Grants; Medical Frontier Strategy Research; Clinical Research for Evidence-based Medicine; Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Health Sciences Research Grants (Research on Health Services H10-074, Medical Frontier Strategy Research H13-008, Clinical Research for Evidence-based Medicine H14-008 and H15-006, and Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus H16-019, H17-019, H18-028, H19-016, and H25-016) and a grant-in-aid for Cancer Research and a grant-in-aid for the Third Term Comprehensive Ten-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; HERMAN WH, 1995, DIABETES CARE, V18, P382, DOI 10.2337/diacare.18.3.382; Jensen DM, 2001, AM J OBSTET GYNECOL, V185, P413, DOI 10.1067/mob.2001.115864; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Makino S, 1985, Nihon Eiseigaku Zasshi, V40, P756; Mariscal M, 2006, ANN EPIDEMIOL, V16, P432, DOI 10.1016/j.annepidem.2005.07.058; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Ministry of Internal Affairs and Communications, 2006, KOR SHAK HAK; Tsugane S, 2001, J Epidemiol, V11, pS24; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; Vambergue A, 2000, DIABETIC MED, V17, P203, DOI 10.1046/j.1464-5491.2000.00237.x; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Yang XL, 2002, DIABETES CARE, V25, P1619, DOI 10.2337/diacare.25.9.1619	13	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84542	10.1371/journal.pone.0084542	http://dx.doi.org/10.1371/journal.pone.0084542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367673	gold, Green Submitted, Green Published			2022-12-27	WOS:000328741900053
J	Li, G; Qiu, YZ; Su, ZW; Ren, SL; Liu, C; Tian, YQ; Liu, Y				Li, Guo; Qiu, Yuanzheng; Su, Zhongwu; Ren, Shuling; Liu, Chao; Tian, Yongquan; Liu, Yong			Genome-Wide Analyses of Radioresistance-Associated miRNA Expression Profile in Nasopharyngeal Carcinoma Using Next Generation Deep Sequencing	PLOS ONE			English	Article							BREAST-CANCER CELLS; RADIATION-THERAPY; MICRORNA GENES; LUNG-CANCER; INVASION; MIGRATION; IDENTIFICATION; APOPTOSIS; MIR-375; PREDICTION	Background: Rapidly growing evidence suggests that microRNAs (miRNAs) are involved in a wide range of cancer malignant behaviours including radioresistance. Therefore, the present study was designed to investigate miRNA expression patterns associated with radioresistance in NPC. Methods: The differential expression profiles of miRNAs and mRNAs associated with NPC radioresistance were constructed. The predicted target mRNAs of miRNAs and their enriched signaling pathways were analyzed via biological informatical algorithms. Finally, partial miRNAs and pathways-correlated target mRNAs were validated in two NPC radioreisitant cell models. Results: 50 known and 9 novel miRNAs with significant difference were identified, and their target mRNAs were narrowed down to 53 nasopharyngeal-/NPC-specific mRNAs. Subsequent KEGG analyses demonstrated that the 53 mRNAs were enriched in 37 signaling pathways. Further qRT-PCR assays confirmed 3 down-regulated miRNAs (miR-324-3p, miR-93-3p and miR-4501), 3 up-regulated miRNAs (miR-371a-5p, miR-34c-5p and miR-1323) and 2 novel miRNAs. Additionally, corresponding alterations of pathways-correlated target mRNAs were observed including 5 up-regulated mRNAs (ICAM1, WNT2B, MYC, HLA-F and TGF-beta 1) and 3 down-regulated mRNAs (CDH1, PTENP1 and HSP90AA1). Conclusions: Our study provides an overview of miRNA expression profile and the interactions between miRNA and their target mRNAs, which will deepen our understanding of the important roles of miRNAs in NPC radioresistance.	[Li, Guo; Qiu, Yuanzheng; Su, Zhongwu; Ren, Shuling; Liu, Chao; Tian, Yongquan; Liu, Yong] Cent S Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China; [Li, Guo; Qiu, Yuanzheng; Su, Zhongwu; Ren, Shuling; Liu, Chao; Tian, Yongquan; Liu, Yong] Otolaryngol Major Dis Res Key Lab Hunan Prov, Changsha, Hunan, Peoples R China	Central South University	Liu, Y (corresponding author), Cent S Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China.	braver19840112@hotmail.com		Liu, Chao/0000-0003-2184-9102	National Natural Science Foundation of China [81202128, 81272974]; Research Fund for the Doctoral Program of Higher Education of China [20120162120049]; Freedom Explore Program of Central South University [2012QNZT099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Freedom Explore Program of Central South University	Grants were provided by the National Natural Science Foundation of China (No. 81202128 and No. 81272974), the Research Fund for the Doctoral Program of Higher Education of China (No. 20120162120049), and the Freedom Explore Program of Central South University (No. 2012QNZT099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Cai KM, 2010, INT J MOL MED, V25, P565, DOI 10.3892/ijmm_00000378; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Catuogno S, 2013, ONCOGENE, V32, P341, DOI 10.1038/onc.2012.51; CHATANI M, 1986, CANCER, V57, P2267, DOI 10.1002/1097-0142(19860615)57:12<2267::AID-CNCR2820571205>3.0.CO;2-C; Cheng Jin-Jian, 2006, Ai Zheng, V25, P45; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FAHRAEUS R, 1988, INT J CANCER, V42, P329, DOI 10.1002/ijc.2910420305; Feng XP, 2010, CANCER RES, V70, P3450, DOI 10.1158/0008-5472.CAN-09-4099; Frankel LB, 2012, CARCINOGENESIS, V33, P2018, DOI 10.1093/carcin/bgs266; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo Y, 2012, INT J ONCOL, V40, P85, DOI 10.3892/ijo.2011.1172; Hashiguchi Y, 2012, INT J ONCOL, V40, P1477, DOI 10.3892/ijo.2012.1363; Henness S, 2002, INT J RADIAT ONCOL, V54, P895, DOI 10.1016/S0360-3016(02)03037-7; Ho CM, 2011, HEPATOLOGY, V54, P1105, DOI 10.1002/hep.24521; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kesanakurti D, 2013, ONCOGENE, V32, P5144, DOI 10.1038/onc.2012.546; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee HC, 2004, INT J MOL MED, V13, P883; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li Guo, 2013, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V48, P662; Li G, 2013, EUR J CANCER, V49, P2596, DOI 10.1016/j.ejca.2013.03.001; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li T, 2011, ONCOL REP, V25, P1353, DOI 10.3892/or.2011.1204; Li Y, 2010, INT J CLIN EXP PATHO, V3, P254; Liang ZX, 2013, PHARM RES-DORDR, V30, P1008, DOI 10.1007/s11095-012-0936-9; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Luo Zhaohui, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P604, DOI 10.3969/j.issn.1672-7347.2011.07.004; Lynam-Lennon N, 2012, J MOL MED, V90, P1449, DOI 10.1007/s00109-012-0924-x; Ma XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024647; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; Ng EKO, 2009, J ONCOL, V2009, DOI 10.1155/2009/305420; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Qu CJ, 2012, CELL CYCLE, V11, P785, DOI 10.4161/cc.11.4.19228; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roses RE, 2008, ONCOGENE, V27, P200, DOI 10.1038/sj.onc.1210909; Schmitz KJ, 2011, J CLIN PATHOL, V64, P529, DOI 10.1136/jcp.2010.085621; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh D, 2000, P NATL ACAD SCI USA, V97, P388, DOI 10.1073/pnas.97.1.388; Virsik-Kopp P, 2005, RADIAT RES, V164, P148, DOI 10.1667/RR3396.1; von Rahden BHA, 2006, MOL CARCINOGEN, V45, P786, DOI 10.1002/mc.20259; Wang FF, 2011, AM J PATHOL, V179, P2580, DOI 10.1016/j.ajpath.2011.07.037; Wang F, 2013, J PATHOL, V229, P12, DOI 10.1002/path.4078; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zhang H, 2012, ONCOGENE, DOI [10.1038/onc.2012.574, DOI 10.1038/0NC.2012.574.PUBMED:23222716]; Zhang M, 2011, CANCER RES, V71, P7155, DOI 10.1158/0008-5472.CAN-11-1212	57	59	60	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84486	10.1371/journal.pone.0084486	http://dx.doi.org/10.1371/journal.pone.0084486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367666	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900050
J	Choi, SH; Yin, HY; Ravandi, A; Armando, A; Dumlao, D; Kim, J; Almazan, F; Taylor, AM; McNamara, CA; Tsimikas, S; Dennis, EA; Witztum, JL; Miller, YI				Choi, Soo-Ho; Yin, Huiyong; Ravandi, Amir; Armando, Aaron; Dumlao, Darren; Kim, Jungsu; Almazan, Felicidad; Taylor, Angela M.; McNamara, Coleen A.; Tsimikas, Sotirios; Dennis, Edward A.; Witztum, Joseph L.; Miller, Yury I.			Polyoxygenated Cholesterol Ester Hydroperoxide Activates TLR4 and SYK Dependent Signaling in Macrophages	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; TOLL-LIKE RECEPTOR-4; OXIDATION-SPECIFIC EPITOPES; ASP299GLY POLYMORPHISM; LIPID-PEROXIDATION; ATHEROSCLEROSIS; CORONARY; EXPRESSION; DEFICIENT; 12/15-LIPOXYGENASE	Oxidation of low-density lipoprotein (LDL) is one of the major causative mechanisms in the development of atherosclerosis. In previous studies, we showed that minimally oxidized LDL (mmLDL) induced inflammatory responses in macrophages, macropinocytosis and intracellular lipid accumulation and that oxidized cholesterol esters (OxCEs) were biologically active components of mmLDL. Here we identified a specific OxCE molecule responsible for the biological activity of mmLDL and characterized signaling pathways in macrophages in response to this OxCE. Using liquid chromatography - tandem mass spectrometry and biological assays, we identified an oxidized cholesteryl arachidonate with bicyclic endoperoxide and hydroperoxide groups (BEP-CE) as a specific OxCE that activates macrophages in a TLR4/MD-2-dependent manner. BEP-CE induced TLR4/MD-2 binding and TLR4 dimerization, phosphorylation of SYK, ERK1/2, JNK and c-Jun, cell spreading and uptake of dextran and native LDL by macrophages. The enhanced macropinocytosis resulted in intracellular lipid accumulation and macrophage foam cell formation. Bone marrow-derived macrophages isolated from TLR4 and SYK knockout mice did not respond to BEP-CE. The presence of BEP-CE was demonstrated in human plasma and in the human plaque material captured in distal protection devices during percutaneous intervention. Our results suggest that BEP-CE is an endogenous ligand that activates the TLR4/SYK signaling pathway. Because BEP-CE is present in human plasma and human atherosclerotic lesions, BEP-CE-induced and TLR4/SYK-mediated macrophage responses may contribute to chronic inflammation in human atherosclerosis.	[Choi, Soo-Ho; Kim, Jungsu; Almazan, Felicidad; Tsimikas, Sotirios; Witztum, Joseph L.; Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Yin, Huiyong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, Shanghai, Peoples R China; [Yin, Huiyong] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China; [Yin, Huiyong] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Ravandi, Amir] Univ Manitoba, Inst Cardiovasc Sci, Winnipeg, MB, Canada; [Armando, Aaron; Dumlao, Darren; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Armando, Aaron; Dumlao, Darren; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Angela M.; McNamara, Coleen A.] Univ Virginia, Dept Med, Cardiovasc Res Ctr, Charlottesville, VA USA	University of California System; University of California San Diego; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University; University of Manitoba; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Virginia	Miller, YI (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	yumiller@ucsd.edu	Ravandi, Amir/O-7552-2019; Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140; yin, hui yong/0000-0001-7049-1560; Taylor, Angela/0000-0003-4927-4320	National Institutes of Health [GM069338, HL055798, HL088093, P30 CA23100]; American Heart Association [SDG14710028]; Ministry of Science and Technology of China [2012BAK01B00]; National Natural Science Foundation of China [31170809]; National Key Basic Research Program of China (973 Program) [2012CB524900]; CAS [2012OHTP07]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL055798, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); CAS(Chinese Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants GM069338 (E. A. D., J. L. W., Y. I. M.), HL055798 (Y. I. M., J. L. W., S. T., C. A. M., A. M. T.) and HL088093 (J. L. W., Y. I. M., S. T.) from the National Institutes of Health, and SDG14710028 (S.-H. C.) from the American Heart Association. The UCSD Microscopy Core is supported by the grant P30 CA23100 from the National Institutes of Health. H. Y. acknowledges the financial support by grants from Ministry of Science and Technology of China (2012BAK01B00), National Natural Science Foundation of China (31170809), National Key Basic Research Program of China (973 Program, #2012CB524900) and Hundred Talents Program from CAS (2012OHTP07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameziane N, 2003, ARTERIOSCL THROM VAS, V23, pE61, DOI 10.1161/01.ATV.0000101191.92392.1D; Assimes TL, 2008, ATHEROSCLEROSIS, V198, P136, DOI 10.1016/j.atherosclerosis.2007.09.003; Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Boekholdt SM, 2003, CIRCULATION, V107, P2416, DOI 10.1161/01.CIR.0000068311.40161.28; Boullier A, 2006, ARTERIOSCL THROM VAS, V26, P1169, DOI 10.1161/01.ATV.0000210279.97308.9a; Choi SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032378; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Coenen KR, 2009, DIABETOLOGIA, V52, P318, DOI 10.1007/s00125-008-1221-7; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Cyrus T, 2001, CIRCULATION, V103, P2277; EZAKI M, 1995, J LIPID RES, V36, P1996; Fairfax BP, 2009, HUM MOL GENET, P530; Fang LH, 2010, J BIOL CHEM, V285, P32343, DOI 10.1074/jbc.M110.137257; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOLCIK VA, 1995, J CLIN INVEST, V96, P504, DOI 10.1172/JCI118062; Geng HL, 2006, CLIN EXP IMMUNOL, V143, P269, DOI 10.1111/j.1365-2249.2005.02982.x; George J, 2001, CIRCULATION, V104, P1646, DOI 10.1161/hc3901.095772; Gertow K, 2011, ATHEROSCLEROSIS, V215, P411, DOI 10.1016/j.atherosclerosis.2011.01.015; Harkewicz R, 2008, J BIOL CHEM, V283, P10241, DOI 10.1074/jbc.M709006200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Havrilla CM, 2000, J AM CHEM SOC, V122, P8042, DOI 10.1021/ja001180f; Hazen SL, 2008, J BIOL CHEM, V283, P15527, DOI 10.1074/jbc.R700054200; Hersberger M, 2009, ATHEROSCLEROSIS, V205, P192, DOI 10.1016/j.atherosclerosis.2008.11.017; Higashimori M, 2011, ARTERIOSCL THROM VAS, V31, P50, DOI 10.1161/ATVBAHA.110.210971; Hoppe G, 1997, J LIPID RES, V38, P1347; Huber J, 2002, ARTERIOSCL THROM VAS, V22, P581, DOI 10.1161/01.ATV.0000012782.59850.41; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; Hutchins PM, 2012, J LIPID RES, V53, P1588, DOI 10.1194/jlr.M026799; Hutchins PM, 2011, J LIPID RES, V52, P2070, DOI 10.1194/jlr.M019174; Katsargyris A, 2011, CEREBROVASC DIS, V31, P29, DOI 10.1159/000320259; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; KUHN H, 1994, J EXP MED, V179, P1903, DOI 10.1084/jem.179.6.1903; Lee S, 2012, CIRC RES, V111, P778, DOI 10.1161/CIRCRESAHA.111.256859; Leibundgut G, 2013, CURR OPIN PHARMACOL, V13, P168, DOI 10.1016/j.coph.2013.02.005; Leitinger Norbert, 2003, Molecular Aspects of Medicine, V24, P239, DOI 10.1016/S0098-2997(03)00019-0; Leitinger N, 2013, ARTERIOSCL THROM VAS, V33, P1120, DOI 10.1161/ATVBAHA.112.300173; Lemaitre Rozenn N, 2009, Atherosclerosis, V204, pe58, DOI 10.1016/j.atherosclerosis.2008.10.011; McGeachie M, 2009, CIRCULATION, V120, P2448, DOI 10.1161/CIRCULATIONAHA.109.865501; Merched AJ, 2011, J NUTRIGENET NUTRIGE, V4, P12, DOI 10.1159/000326890; Methe H, 2005, CIRCULATION, V111, P2654, DOI 10.1161/CIRCULATIONAHA.104.498865; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Miller YI, 2012, BRIT J PHARMACOL, V167, P990, DOI 10.1111/j.1476-5381.2012.02097.x; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Miller YI, 2010, SUBCELL BIOCHEM, V51, P229, DOI 10.1007/978-90-481-8622-8_8; Musashi M, 1997, J PHARMACOL EXP THER, V280, P225; Netea MG, 2004, EUR J CLIN INVEST, V34, P94, DOI 10.1111/j.1365-2362.2004.01303.x; Owens AP, 2011, ARTERIOSCL THROM VAS, V31, P2813, DOI 10.1161/ATVBAHA.111.238642; Poeckel D, 2009, J BIOL CHEM, V284, P21077, DOI 10.1074/jbc.M109.000901; Reilly KB, 2004, J BIOL CHEM, V279, P9440, DOI 10.1074/jbc.M303857200; Reismann P, 2004, J NEUROL, V251, P853, DOI 10.1007/s00415-004-0447-7; Richards MR, 2013, INNATE IMMUN-LONDON, V19, P20, DOI 10.1177/1753425912447130; Rong SX, 2012, J LIPID RES, V53, P686, DOI 10.1194/jlr.M022723; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Salomon RG, 2005, ANN NY ACAD SCI, V1043, P327, DOI 10.1196/annals.1333.040; Sawka-Verhelle D, 2004, J BIOL CHEM, V279, P17772, DOI 10.1074/jbc.M311991200; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Tsimikas S, 2011, CURR PHARM DESIGN, V17, P27, DOI 10.2174/138161211795049831; Turner WW, 2012, J MED CHEM, V55, P8178, DOI 10.1021/jm300685s; Upston JM, 2002, AM J PATHOL, V160, P701, DOI 10.1016/S0002-9440(10)64890-0; van Dijk RA, 2012, J LIPID RES, V53, P2773, DOI 10.1194/jlr.P030890; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Xie P, 2010, CLIN MED INSIGHTS-CA, V4, P89, DOI 10.4137/CMC.S5659; Yang IA, 2003, ATHEROSCLEROSIS, V170, P187, DOI 10.1016/S0021-9150(03)00286-7; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Yin HY, 2004, J BIOL CHEM, V279, P3766, DOI 10.1074/jbc.M307137200; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959	71	37	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83145	10.1371/journal.pone.0083145	http://dx.doi.org/10.1371/journal.pone.0083145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376657	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000065
J	Hoarau, JJ; Gay, F; Pelle, O; Samri, A; Jaffar-Bandjee, MC; Gasque, P; Autran, B				Hoarau, Jean-Jacques; Gay, Frederick; Pelle, Olivier; Samri, Assia; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe; Autran, Brigitte			Identical Strength of the T Cell Responses against E2, nsP1 and Capsid CHIKV Proteins in Recovered and Chronic Patients after the Epidemics of 2005-2006 in La Reunion Island	PLOS ONE			English	Article							ROSS-RIVER-VIRUS; CHIKUNGUNYA VIRUS; VIRAL REPLICATION; SEVERE DISEASE; SINDBIS VIRUS; RISK-FACTORS; INFECTION; ALPHAVIRUSES; MANIFESTATIONS; ANTIBODIES	To characterize the immunity developed by patients infected by chikungunya virus (CHIKV), we studied the intensity and specificity of CHIKV-specific T cells mediated responses in chronic and recovered patients at 12 to 24 months post-infection. T cells were challenged in vitro against CHIKV synthetic peptides covering the length of three viral proteins, capsid, E2 and nsP1 proteins as well as all inactivated virus particles. Cytokine production was assessed by ELISPOT and intracellular labeling. T cells producing IFN-gamma were detected against CHIKV in 85% patient's cells either by direct ELISPOT assay (69% of patients) or after expansion of memory T cells allowing the detection of both CD4 and CD8 specific-T cells in 16% additional cases. The IFN-gamma response was mainly engaged in response to nsP1 or E2 (52% and 46% cases, respectively) but in only 27% cases against the capsid. The anti-E2 response represented half the magnitude of the total CHIKV IFN-gamma production and was mainly directed against the C-terminal half part of the protein. Almost all patients had conserved a T cell specific response against CHIKV with a clear hierarchy of T cell responses (CD8 > CD4) engaged against E2 > nsP1 > capsid. More importantly, the intensity of responses was not significantly different between recovered and chronic patients. These findings constitute key elements to a better understanding of patient T cell immunoreactivity against CHIKV and argue against a possible defect of T cell immunoresponse in the chronicity post-CHIKV infection.	[Hoarau, Jean-Jacques; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe] Univ La Reunion, GRI IRG EA4517, Immunopathol & Infect Dis Res Grp, St Denis, Reunion, France; [Hoarau, Jean-Jacques; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe] CHU North Felix Guyon, Ctr Hosp Univ, St Denis, Reunion, France; [Gay, Frederick] Univ Paris 06, Pitie Salpetriere Hosp, Dept Med Biol, Paris, France; [Pelle, Olivier; Samri, Assia; Autran, Brigitte] INSERM, Lab Immun & Infect, U945, Paris, France; [Jaffar-Bandjee, Marie-Christine] CHU North Felix Guyon, Ctr Hosp Univ, Biol Unit, St Denis, Reunion, France; [Jaffar-Bandjee, Marie-Christine] CHU North Felix Guyon, Ctr Hosp Univ, Microbiol Unit, St Denis, Reunion, France; [Jaffar-Bandjee, Marie-Christine] CHU North Felix Guyon, Ctr Hosp Univ, Virol Unit, St Denis, Reunion, France; [Jaffar-Bandjee, Marie-Christine] CHU North Felix Guyon, Ctr Hosp Univ, Biochem Unit, St Denis, Reunion, France; [Autran, Brigitte] Univ Paris 06, Lab Immun & Infect, Unite Mixte Rech S945, Paris, France; [Autran, Brigitte] INSERM, IFR 113, Paris, France	University of La Reunion; CHU Reunion; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hoarau, JJ (corresponding author), Univ La Reunion, GRI IRG EA4517, Immunopathol & Infect Dis Res Grp, St Denis, Reunion, France.	jean-jacques.hoarau@univ-reunion-reunion.fr		HOARAU, Jean-Jacques/0000-0002-7612-2018	PHRC; ANR; ICRES/FP7 program (Integrated Chikungunya Research)	PHRC; ANR(French National Research Agency (ANR)); ICRES/FP7 program (Integrated Chikungunya Research)	This work was supported by a PHRC grant to Dr. Jaffar-Bandjee and an ANR grant to Pr. B. Autran. Laboratory funding was also granted through the ICRES/FP7 program (Integrated Chikungunya Research). PG is an INSERM fellow of U945 unit (Pr. B Autran). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Chopra A, 2008, ARTHRITIS RHEUM, V58, P2921, DOI 10.1002/art.23753; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167; Gardner CL, 2009, VIROLOGY, V390, P338, DOI 10.1016/j.virol.2009.05.030; GRIFFIN DE, 1995, SEMIN VIROL, V6, P249, DOI 10.1006/smvy.1995.0030; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Hunt AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000739; Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213; Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033; KERR PJ, 1992, VIROLOGY, V187, P338, DOI 10.1016/0042-6822(92)90324-I; Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432; Lee CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002390; Messaoudi I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002343; Paquet C., 2006, EUROSURVEILLANCE, V11; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Ravi V, 2006, Indian J Med Microbiol, V24, P83; Ribera A, 2012, Med Trop (Mars), V72 Spec No, P83; Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Rulli NE, 2007, ANN NY ACAD SCI, V1102, P96, DOI 10.1196/annals.1408.007; Ryman KD, 2000, J VIROL, V74, P3366, DOI 10.1128/JVI.74.7.3366-3378.2000; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5; Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; STRAUSS EG, 1991, J VIROL, V65, P4654, DOI 10.1128/JVI.65.9.4654-4664.1991; Suhrbier A, 2004, CURR OPIN RHEUMATOL, V16, P374, DOI 10.1097/01.bor.0000130537.76808.26; Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64; Tandale BV, 2009, J CLIN VIROL, V46, P145, DOI 10.1016/j.jcv.2009.06.027; Toivanen A, 2008, CURR OPIN RHEUMATOL, V20, P486, DOI 10.1097/BOR.0b013e328303220b; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006	35	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84695	10.1371/journal.pone.0084695	http://dx.doi.org/10.1371/journal.pone.0084695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376836	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000160
J	Jung, K; Kralik, JD				Jung, Kanghoon; Kralik, Jerald D.			Get It While It's Hot: A Peak-First Bias in Self-Generated Choice Order in Rhesus Macaques	PLOS ONE			English	Article							DECISION-MAKING; RISK; SIGNALS; HAND; REPRESENTATION; VALUATION; EVOLUTION; GAMBLERS; SYSTEMS; VISION	Animals typically must make a number of successive choices to achieve a goal: e.g., eating multiple food items before becoming satiated. However, it is unclear whether choosing the best first or saving the best for last represents the best choice strategy to maximize overall reward. Specifically, since outcomes can be evaluated prospectively (with future rewards discounted and more immediate rewards preferred) or retrospectively (with prior rewards discounted and more recent rewards preferred), the conditions under which each are used remains unclear. On the one hand, humans and non-human animals clearly discount future reward, preferring immediate rewards to delayed ones, suggesting prospective evaluation; on the other hand, it has also been shown that a sequence that ends well, i.e., with the best event or item last, is often preferred, suggesting retrospective evaluation. Here we hypothesized that when individuals are allowed to build the sequence themselves they are more likely to evaluate each item individually and therefore build a sequence using prospective evaluation. We examined the relationship between self-generated choice order and preference in rhesus monkeys in two experiments in which the distinctiveness of options were relatively high and low, respectively. We observed a positive linear relationship between choice order and preference among highly distinct options, indicating that the rhesus monkeys chose their preferred food first: i.e., a peak-first order preference. Overall, choice order depended on the degree of relative preference among alternatives and a peak-first bias, providing evidence for prospective evaluation when choice order is self-generated.	[Jung, Kanghoon; Kralik, Jerald D.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Kralik, JD (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	Jerald.D.Kralik@Dartmouth.edu			Dartmouth College	Dartmouth College	Dartmouth College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie G., 1992, PICOECONOMICS; AINSLIE GW, 1974, J EXP ANAL BEHAV, V21, P485, DOI 10.1901/jeab.1974.21-485; [Anonymous], 1982, JUDGMENT UNCERTAINTY; Baumgartner H, 1997, J MARKETING RES, V34, P219, DOI 10.2307/3151860; Berkman ET, 2011, PSYCHOL SCI, V22, P498, DOI 10.1177/0956797611400918; BJORK RA, 1974, COGNITIVE PSYCHOL, V6, P173, DOI 10.1016/0010-0285(74)90009-7; Cohen JR, 2010, COMMON NEURAL BASIS, P141; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Delgado MR, 2008, NAT NEUROSCI, V11, P880, DOI 10.1038/nn.2141; Dezfouli A, 2012, EUR J NEUROSCI, V35, P1036, DOI 10.1111/j.1460-9568.2012.08050.x; Diener E, 2001, PSYCHOL SCI, V12, P124, DOI 10.1111/1467-9280.00321; Do AM, 2008, PSYCHON B REV, V15, P96, DOI 10.3758/PBR.15.1.96; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Evans TA, 2007, J GEN PSYCHOL, V134, P199, DOI 10.3200/GENP.134.2.199-216; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gottlieb J, 2012, NEURON, V76, P281, DOI 10.1016/j.neuron.2012.09.034; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Green L, 1996, AM ZOOL, V36, P496; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hassin R. R., 2010, SELF CONTROL SOC MIN; Hayden BY, 2008, JUDGM DECIS MAK, V3, P389; Hayden BY, 2009, ANIM COGN, V12, P201, DOI 10.1007/s10071-008-0186-8; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Heilbronner SR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00007; Iyengar S., 2010, ART CHOOSING; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; KAHNEMAN D, 1993, PSYCHOL SCI, V4, P401, DOI 10.1111/j.1467-9280.1993.tb00589.x; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D., 2002, REPRESENTATIVENESS R; Kahneman D, 2003, OBJECTIVE HAPPINESS, P3; Kahnt T, 2013, J NEUROSCI, V33, P863, DOI 10.1523/JNEUROSCI.3531-12.2013; Khan SA, 2011, PSYCHOL SCI, V22, P1001, DOI 10.1177/0956797611415543; KIRBY KN, 1995, PSYCHOL SCI, V6, P83, DOI 10.1111/j.1467-9280.1995.tb00311.x; Klos A, 2005, MANAGE SCI, V51, P1777, DOI 10.1287/mnsc.1050.0429; Kober H, 2010, P NATL ACAD SCI USA, V107, P14811, DOI 10.1073/pnas.1007779107; Kralik JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046240; Kralik JD, 2012, BEHAV PROCESS, V89, P197, DOI 10.1016/j.beproc.2011.09.010; Li Y, 2009, J BEHAV DECIS MAKING, V22, P378, DOI 10.1002/bdm.638; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Louie K, 2012, ANN NY ACAD SCI, V1251, P13, DOI [10.1111/j.1749-6632.2012.06496.x, 10.1111/j.1749-6632.2012.06496]; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; MONTGOMERY H, 1982, ORGAN BEHAV HUM PERF, V29, P39, DOI 10.1016/0030-5073(82)90241-0; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Paulsen DJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00072; Rabin M, 2010, REV ECON STUD, V77, P730, DOI 10.1111/j.1467-937X.2009.00582.x; RACHLIN H, 1972, J EXP ANAL BEHAV, V17, P15, DOI 10.1901/jeab.1972.17-15; Redelmeier DA, 2003, PAIN, V104, P187, DOI 10.1016/S0304-3959(03)00003-4; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; SAMUELSON PA, 1963, SCIENTIA, V98, P108; Scheibehenne B, 2010, J CONSUM RES, V37, P409, DOI 10.1086/651235; Schreiber CA, 2000, J EXP PSYCHOL GEN, V129, P27, DOI 10.1037//0096-3445.129.1.27; Schwartz B., 2009, PARADOX CHOICE WHY M; Stephens DW, 2002, PHILOS T R SOC B, V357, P1527, DOI 10.1098/rstb.2002.1062; Stevens JR, 2005, CURR BIOL, V15, P1855, DOI 10.1016/j.cub.2005.09.016; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Sundali J, 2006, JUDGM DECIS MAK, V1, P1; Thierry B., 2004, MACAQUE SOC MODEL ST; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Xu ER, 2011, Q J EXP PSYCHOL, V64, P2301, DOI 10.1080/17470218.2011.591936; Xueqing Sun, 2011, Journal of Control Theory and Applications, V9, P440, DOI 10.1007/s11768-011-1047-6	66	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83814	10.1371/journal.pone.0083814	http://dx.doi.org/10.1371/journal.pone.0083814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376758	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000118
J	Peters, H; O'Leary, BC; Hawkins, JP; Carpenter, KE; Roberts, CM				Peters, Howard; O'Leary, Bethan C.; Hawkins, Julie P.; Carpenter, Kent E.; Roberts, Callum M.			Conus: First Comprehensive Conservation Red List Assessment of a Marine Gastropod Mollusc Genus	PLOS ONE			English	Article							EXTINCTION RISK; VENOM PEPTIDES; HABITAT LOSS; CORAL-REEFS; EVOLUTION; SPECIALIZATION; ABUNDANCE; FISHERIES; BENTHOS; MODE	Marine molluscs represent an estimated 23% of all extant marine taxa, but research into their conservation status has so far failed to reflect this importance, with minimal inclusion on the authoritative Red List of the International Union for the Conservation of Nature (IUCN). We assessed the status of all 632 valid species of the tropical marine gastropod mollusc, Conus (cone snails), using Red List standards and procedures to lay the groundwork for future decadal monitoring, one of the first fully comprehensive global assessments of a marine taxon. Three-quarters (75.6%) of species were not currently considered at risk of extinction owing to their wide distribution and perceived abundance. However, 6.5% were considered threatened with extinction with a further 4.1% near threatened. Data deficiency prevented 13.8% of species from being categorised although they also possess characteristics that signal concern. Where hotspots of endemism occur, most notably in the Eastern Atlantic, 42.9% of the 98 species from that biogeographical region were classified as threatened or near threatened with extinction. All 14 species included in the highest categories of Critically Endangered and Endangered are endemic to either Cape Verde or Senegal, with each of the three Critically Endangered species restricted to single islands in Cape Verde. Threats to all these species are driven by habitat loss and anthropogenic disturbance, in particular from urban pollution, tourism and coastal development. Our findings show that levels of extinction risk to which cone snails are exposed are of a similar magnitude to those seen in many fully assessed terrestrial taxa. The widely held view that marine species are less at risk is not upheld.	[Peters, Howard; O'Leary, Bethan C.; Hawkins, Julie P.; Roberts, Callum M.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Carpenter, Kent E.] Old Dominion Univ, Int Union Conservat Nat, Norfolk, VA USA	University of York - UK; Old Dominion University	Peters, H (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.	hp510@york.ac.uk		O'Leary, Bethan C/0000-0001-6595-6634	Natural Environment Research Council (NERC); Economic and Social Research Council (ESRC); Biodiversity Synthesis Center of the Encyclopedia of Life (EOL) at the Field Museum of Natural History, Chicago	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biodiversity Synthesis Center of the Encyclopedia of Life (EOL) at the Field Museum of Natural History, Chicago	The Natural Environment Research Council (NERC) and Economic and Social Research Council (ESRC) generously supported the Red List research under a studentship grant to Howard Peters http://www.nerc.ac.uk/funding/. The authors gratefully acknowledge funding from the Biodiversity Synthesis Center of the Encyclopedia of Life (EOL) at the Field Museum of Natural History, Chicago for the Conus Synthesis Workshop http://synthesis.eol.org/center/funding; also Tom Haas and the New Hampshire Charitable Foundation and the Thomas W. Haas Foundation for their support of the Global Marine Species Assessment under the IUCN Global Species Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; [Anonymous], 1995, MANUAL LIVING CONIDA; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Australian Government, 2012, REC BREAK NIN EV AN; BOUCHET P, 1990, MALACOLOGIA, V32, P69; CARLTON JT, 1993, AM ZOOL, V33, P499; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chadwick Ashley, 2009, Cone Collector, V12, P16; Chivian E, 2004, SCIENCE, V303, P956; Chivian E, 2003, SCIENCE, V302, P391; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Craig AG, 1999, EUR J BIOCHEM, V264, P271, DOI 10.1046/j.1432-1327.1999.00624.x; Cunha RL, 2005, SYST BIOL, V54, P634, DOI 10.1080/106351591007471; Darwall Will, 2012, P26; DEVANTIER LM, 1992, MAR ECOL PROG SER, V86, P301, DOI 10.3354/meps086301; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Duda TF, 1999, P NATL ACAD SCI USA, V96, P10272, DOI 10.1073/pnas.96.18.10272; Duda TF, 2004, SCIENCE, V303, P955, DOI 10.1126/science.303.5660.955; Duda TF, 2001, BIOL J LINN SOC, V73, P391, DOI 10.1006/bijl.2001.0544; Duda TF, 2005, MOL PHYLOGENET EVOL, V34, P257, DOI 10.1016/j.ympev.2004.09.012; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Franklin JB, 2007, MOLLUSCAN RES, V27, P111; Garber K, 2005, NAT BIOTECHNOL, V23, P399, DOI 10.1038/nbt0405-399; Gerlach Justin, 2012, P46; Gray JS, 2006, MAR POLLUT BULL, V52, P840, DOI 10.1016/j.marpolbul.2006.07.003; Harnik PG, 2012, P ROY SOC B-BIOL SCI, V279, P4969, DOI 10.1098/rspb.2012.1902; HOPKINS C, 1995, J BIOL CHEM, V270, P22361, DOI 10.1074/jbc.270.38.22361; Irwin A, 2011, CAPE VERDE; IUCN, 2013, IUCN RED LIST THREAT; IUCN Standards and Petitions Subcommittee, 2010, GUID US IUCN RED LIS; JAMIESON GS, 1993, AM ZOOL, V33, P551; Kemp Rachael, 2012, P34; Kohn A.J., 1994, LIFE HIST BIOGEOGRAP; KOHN AJ, 1959, ECOL MONOGR, V29, P47, DOI 10.2307/1948541; KOHN AJ, 1983, B MAR SCI, V33, P528; KOHN AJ, 1990, MALACOLOGIA, V32, P55; KOHN AJ, 1968, ECOLOGY, V49, P1046, DOI 10.2307/1934489; Livett BG, 2004, CURR MED CHEM, V11, P1715, DOI 10.2174/0929867043364928; Livett BG, 2006, TOXICON, V48, P810, DOI 10.1016/j.toxicon.2006.07.023; Lopes Evandro P., 2010, Zoologia Caboverdiana, V1, P59; Gonzalez-Mancebo JM, 2012, BIODIVERS CONSERV, V21, P3613, DOI 10.1007/s10531-012-0385-0; McKinney Michael L., 1998, Diversity and Distributions, V4, P3; McManus JW, 1997, CORAL REEFS, V16, pS121, DOI 10.1007/s003380050248; Monteiro A., 2004, CONCHOLOGICAL ICONOG; Monteiro A, 2012, ENDANGERED CONE SPEC, P36; Moore A, 2008, P 11 INT COR REEF S, P840; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; National Marine Fisheries Service, 2008, WHIT AB REC PLAN; NEWTON LC, 1993, BIOL CONSERV, V63, P241, DOI 10.1016/0006-3207(93)90719-H; Olivera BM, 1999, ANN NY ACAD SCI, V870, P223, DOI 10.1111/j.1749-6632.1999.tb08883.x; Olivera BM, 1997, MOL BIOL CELL, V8, P2101, DOI 10.1091/mbc.8.11.2101; Queensland Government Dept of Primary Industries and Fisheries, 2007, ANN STAT REP 2007 QU; Remigio EA, 2008, MOL ECOL, V17, P1156, DOI 10.1111/j.1365-294X.2007.03627.x; Riascos JM, 2008, HELGOLAND MAR RES, V62, pS63, DOI 10.1007/s10152-007-0083-6; Rice T., 2007, CATALOG DEALERS PRIC; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Roberts CM, 2012, OCEAN LIFE; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Skilleter GA, 2000, J EXP MAR BIOL ECOL, V244, P107, DOI 10.1016/S0022-0981(99)00133-1; Taylor J. D., 1993, ZOOLOGY, V59, P125; Tenorio MJ, 2012, CONCHOLOGICAL ICONOG, P200; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Thurstan RH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1013; TONGE S, 1991, International Zoo Yearbook, V30, P51; Urbarova I, 2012, MAR DRUGS, V10, P2265, DOI 10.3390/md10102265; Watling L, 1998, CONSERV BIOL, V12, P1178, DOI 10.1046/j.1523-1739.1998.0120061178.x; Wells S., 1997, GIANT CLAMS STATUS T; Zou SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026619; Zuschin M, 2001, CORAL REEFS, V20, P107, DOI 10.1007/s003380100140	72	33	35	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83353	10.1371/journal.pone.0083353	http://dx.doi.org/10.1371/journal.pone.0083353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376693	Green Published, Green Accepted, gold			2022-12-27	WOS:000328882000082
J	Prins, M; Eriksson, C; Wierinckx, A; Bol, JGJM; Binnekade, R; Tilders, FJH; Van Dam, AM				Prins, Marloes; Eriksson, Charlotta; Wierinckx, Anne; Bol, John G. J. M.; Binnekade, Rob; Tilders, Fred J. H.; Van Dam, Anne-Marie			Interleukin-1 beta and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MESSENGER-RNA EXPRESSION; RAT-BRAIN; CORTICAL DEMYELINATION; IN-VIVO; COGNITIVE IMPAIRMENT; MEMORY IMPAIRMENT; IL-1 EXPRESSION	Background: Multiple sclerosis (MS) has been mainly attributed to white matter (WM) pathology. However, recent evidence indicated the presence of grey matter (GM) lesions. One of the principal mediators of inflammatory processes is interleukin-1 beta (IL-1 beta), which is known to play a role in MS pathogenesis. It is unknown whether IL-1 beta is solely present in WM or also in GM lesions. Using an experimental MS model, we questioned whether IL-1 beta and the IL-1 receptor antagonist (IL-1ra) are present in GM in addition to affected WM regions. Methods: The expression of IL-1 beta and IL-1ra in chronic-relapsing EAE (cr-EAE) rats was examined using in situ hybridization, immunohistochemistry and real-time PCR. Rats were sacrificed at the peak of the first disease phase, the trough of the remission phase, and at the peak of the relapse. Histopathological characteristics of CNS lesions were studied using immunohistochemistry for PLP, CD68 and CD3 and Oil-Red O histochemistry. Results: IL-1 beta and IL-ra expression appears to a similar extent in affected GM and WM regions in the brain and spinal cord of cr-EAE rats, particularly in perivascular and periventricular locations. IL-1 beta and IL-1ra expression was dedicated to macrophages and/or activated microglial cells, at sites of starting demyelination. The time-dependent expression of IL-1 beta and IL-1ra revealed that within the spinal cord IL-1 beta and IL-1ra mRNA remained present throughout the disease, whereas in the brain their expression disappeared during the relapse. Conclusions: The appearance of IL-1 beta expressing cells in GM within the CNS during cr-EAE may explain the occurrence of several clinical deficits present in EAE and MS which cannot be attributed solely to the presence of IL-1 beta in WM. Endogenously produced IL-1ra seems not capable to counteract IL-1 beta-induced effects. We put forward that IL-1 beta may behold promise as a target to address GM, in addition to WM, related pathology in MS.	[Prins, Marloes; Eriksson, Charlotta; Wierinckx, Anne; Bol, John G. J. M.; Binnekade, Rob; Tilders, Fred J. H.; Van Dam, Anne-Marie] Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands; [Wierinckx, Anne] Ctr Rech Cancerol Lyon, UNIV UMR1052, Lyon, France	Vrije Universiteit Amsterdam; UNICANCER; Centre Leon Berard	Van Dam, AM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	amw.vandam@vumc.nl	Wierinckx, Anne/AAF-5233-2021	Wierinckx, Anne/0000-0002-0186-6645	EU [ERBBMH1CT93-1450]	EU(European Commission)	This work was supported by the EU Concerted Action 'Neuril' (grant number ERBBMH1CT93-1450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmann M, 1995, J NEUROIMMUNOL, V63, P17, DOI 10.1016/0165-5728(95)00124-7; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622; Badovinac V, 1998, J NEUROIMMUNOL, V85, P87, DOI 10.1016/S0165-5728(98)00020-4; Bagnato F, 2006, AM J NEURORADIOL, V27, P2161; Balcer LJ, 2006, NEW ENGL J MED, V354, P1273, DOI 10.1056/NEJMcp053247; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Batoulis H, 2012, GLIA, V60, P794, DOI 10.1002/glia.22309; BAUER J, 1993, J NEUROIMMUNOL, V48, P13, DOI 10.1016/0165-5728(93)90053-2; Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO;2-2; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Bo L, 2009, ACTA NEUROL SCAND, V120, P51, DOI 10.1111/j.1600-0404.2009.01216.x; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; BROSNAN CF, 1995, NEUROLOGY, V45, pS16, DOI 10.1212/WNL.45.6_Suppl_6.S16; Brough D, 2011, TRENDS PHARMACOL SCI, V32, P617, DOI 10.1016/j.tips.2011.06.002; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Cai ZW, 2004, PEDIATR RES, V56, P377, DOI 10.1203/01.PDR.0000134249.92944.14; Calabrese M, 2009, NEUROLOGY, V72, P1330, DOI 10.1212/WNL.0b013e3181a0fee5; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Coelho A, 2007, EAR HEARING, V28, P593, DOI 10.1097/AUD.0b013e31812f716e; Comabella M, 2008, J NEUROL, V255, P1136, DOI 10.1007/s00415-008-0855-1; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Cruccu G, 2009, PAIN, V143, P186, DOI 10.1016/j.pain.2008.12.026; D'Intino G, 2005, P NATL ACAD SCI USA, V102, P3070, DOI 10.1073/pnas.0500073102; de Groot V, 2009, ARCH PHYS MED REHAB, V90, P1478, DOI 10.1016/j.apmr.2009.03.018; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dragunow M, 2013, BRAIN RES, V1501, P32, DOI 10.1016/j.brainres.2013.01.013; Dujmovic I, 2009, J NEUROIMMUNOL, V207, P101, DOI 10.1016/j.jneuroim.2008.11.004; Dutt M, 2010, INVEST OPHTH VIS SCI, V51, P1439, DOI 10.1167/iovs.09-4009; Eriksson C, 1999, NEUROSCIENCE, V93, P915, DOI 10.1016/S0306-4522(99)00178-5; Eriksson C, 2000, CYTOKINE, V12, P423, DOI 10.1006/cyto.1999.0582; Fan LW, 2010, NEUROSCIENCE, V168, P240, DOI 10.1016/j.neuroscience.2010.03.024; Fan LW, 2009, EXP NEUROL, V220, P143, DOI 10.1016/j.expneurol.2009.08.003; FEDER LS, 1994, J LEUKOCYTE BIOL, V55, P507, DOI 10.1002/jlb.55.4.507; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Filippi M, 2012, MULT SCLER J, P1; Furlan R, 2007, GENE THER, V14, P93, DOI 10.1038/sj.gt.3302805; GARCIA JH, 1995, AM J PATHOL, V147, P1477; Gay FW, 1997, BRAIN, V120, P1461, DOI 10.1093/brain/120.8.1461; Geurts JJ, 2007, J NEUROPATHOLOGY EXP; Gilmore CP, 2009, J NEUROL NEUROSUR PS, V80, P182, DOI 10.1136/jnnp.2008.148767; Giovannini MG, 2002, NEUROBIOL DIS, V11, P257, DOI 10.1006/nbdi.2002.0538; GIULIAN D, 1988, Brain Behavior and Immunity, V2, P352, DOI 10.1016/0889-1591(88)90040-2; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; GRANOWITZ EV, 1992, BLOOD, V79, P2356; Haase CG, 2003, BEHAV NEUROL, V14, P39, DOI 10.1155/2003/843760; Hobom M, 2004, BRAIN PATHOL, V14, P148, DOI 10.1111/j.1750-3639.2004.tb00047.x; HONG LL, 1993, J NEUROIMMUNOL, V44, P163, DOI 10.1016/0165-5728(93)90038-Z; Issazadeh S, 1996, J NEUROIMMUNOL, V69, P103; Jana M, 2005, FREE RADICAL BIO MED, V39, P823, DOI 10.1016/j.freeradbiomed.2005.05.014; Kalkers NF, 2007, CLIN NEUROPHYSIOL, V118, P1332, DOI 10.1016/j.clinph.2007.02.018; Kleine TO, 2003, BRAIN RES BULL, V61, P327, DOI 10.1016/S0361-9230(03)00096-0; Kooi EJ, 2012, NEUROLOGY, V79, P1369, DOI 10.1212/WNL.0b013e31826c1b1c; Kooi EJ, 2011, ACTA NEUROPATHOL, V122, P313, DOI 10.1007/s00401-011-0849-4; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Laman JD, 1998, J NEUROIMMUNOL, V86, P30, DOI 10.1016/S0165-5728(98)00024-1; Lassmann H, 2011, NEUROPATH APPL NEURO, V37, P698, DOI 10.1111/j.1365-2990.2011.01189.x; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; LAUTERBORN JC, 1993, MOL BRAIN RES, V17, P59, DOI 10.1016/0169-328X(93)90073-X; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Li H, 1996, NEUROPATH APPL NEURO, V22, P207; Li QM, 2011, BRAIN BEHAV IMMUN, V25, P160, DOI 10.1016/j.bbi.2010.09.009; Li YK, 2003, J NEUROSCI, V23, P1605; Liu JSH, 1998, J IMMUNOL, V161, P1989; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; MARTIN D, 1995, J NEUROIMMUNOL, V61, P241, DOI 10.1016/0165-5728(95)00108-E; MATTHAEI I, 1989, J NEUROIMMUNOL, V23, P25, DOI 10.1016/0165-5728(89)90068-4; MCDONALD WI, 1992, J NEUROL NEUROSUR PS, V55, P747, DOI 10.1136/jnnp.55.9.747; McGuinness MC, 1997, J NEUROIMMUNOL, V75, P174, DOI 10.1016/S0165-5728(97)00020-9; Moreno B, 2011, ANN NEUROL, V70, P932, DOI 10.1002/ana.22550; Mulcahy NJ, 2009, BRIT J PHARMACOL, V140, P471; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Murugesan N, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-15; Musgrave T, 2011, BRAIN BEHAV IMMUN, V25, P1677, DOI 10.1016/j.bbi.2011.06.011; Nicoletti F, 1996, CYTOKINE, V8, P395, DOI 10.1006/cyto.1996.0054; Nistico R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054666; Olechowski CJ, 2009, PAIN, V141, P156, DOI 10.1016/j.pain.2008.11.002; Palin K, 2004, J NEUROIMMUNOL, V149, P22, DOI 10.1016/j.jneuroim.2003.12.005; Palin K, 2001, NEUROSCIENCE, V103, P161, DOI 10.1016/S0306-4522(00)00544-3; PAPADOPOULOS A, 1994, NEURORADIOLOGY, V36, P130, DOI 10.1007/BF00588078; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; PERRETTI M, 1992, AGENTS ACTIONS, V35, P71, DOI 10.1007/BF01990954; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Pollak Y, 2002, BRAIN BEHAV IMMUN, V16, P533, DOI 10.1016/S0889-1591(02)00010-7; Prosperini L, 2011, J NEUROL SCI, V304, P55, DOI 10.1016/j.jns.2011.02.014; Quan N, 1998, NEUROSCIENCE, V83, P281, DOI 10.1016/S0306-4522(97)00350-3; Quinn Thomas A, 2011, Front Neurol, V2, P50, DOI 10.3389/fneur.2011.00050; RADA P, 1991, BRAIN RES, V550, P287, DOI 10.1016/0006-8993(91)91330-4; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RIMVALL K, 1985, DEV BRAIN RES, V19, P267, DOI 10.1016/0165-3806(85)90198-1; Rossi S, 2012, ANN NEUROL, V71, P76, DOI 10.1002/ana.22512; SCHOTANUS K, 1995, ENDOCRINOLOGY, V136, P332, DOI 10.1210/en.136.1.332; Schulz D, 2006, J NEUROL, V253, P1002, DOI 10.1007/s00415-006-0145-8; Sethi V, 2012, J NEUROL NEUROSUR PS, V83, P877, DOI 10.1136/jnnp-2012-303023; Shindler KS, 2007, INVEST OPHTH VIS SCI, V48, P3602, DOI 10.1167/iovs.07-0131; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sloane E, 2009, BRAIN BEHAV IMMUN, V23, P92, DOI 10.1016/j.bbi.2008.09.004; Storch MK, 2006, J NEUROPATH EXP NEUR, V65, P1137, DOI 10.1097/01.jnen.0000248547.13176.9d; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Taepavarapruk P, 2010, J NEUROCHEM, V112, P1054, DOI 10.1111/j.1471-4159.2009.06524.x; TAGO H, 1989, BRAIN RES, V495, P271, DOI 10.1016/0006-8993(89)90221-7; Takahashi JL, 2003, ANN NEUROL, V53, P588, DOI 10.1002/ana.10519; Tallantyre EC, 2010, MULT SCLER J, V16, P406, DOI 10.1177/1352458510364992; Thibault K, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.07.010; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Van Dam AM, 1995, ANN NY ACAD SCI, V840, P128; VANDAM AM, 1992, BRAIN RES, V588, P291, DOI 10.1016/0006-8993(92)91588-6; VanDam AM, 1996, FASEB J, V10, P351, DOI 10.1096/fasebj.10.2.8641570; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Vogt C, 2008, J NEUROSCI RES, V86, P3314, DOI 10.1002/jnr.21792; WHITE SR, 1975, BRAIN RES, V84, P123, DOI 10.1016/0006-8993(75)90805-7; Wierinckx A, 2005, J NEUROIMMUNOL, V166, P132, DOI 10.1016/j.jneuroim.2005.05.013; WINOCUR G, 1985, BEHAV BRAIN RES, V16, P135, DOI 10.1016/0166-4328(85)90088-9; Young W, 1990, HDB CHEM NEUROANATOM, P481; Zackowski KM, 2009, BRAIN, V132, P1200, DOI 10.1093/brain/awp032; Zhao BY, 1998, J NEUROSCI RES, V52, P7, DOI 10.1002/(SICI)1097-4547(19980401)52:1<7::AID-JNR2>3.0.CO;2-I; Ziehn MO, 2010, LAB INVEST, V0, P1	123	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83835	10.1371/journal.pone.0083835	http://dx.doi.org/10.1371/journal.pone.0083835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376764	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000124
J	Wang, PH; Wan, DH; Chen, YG; Weng, SP; Yu, XQ; He, JG				Wang, Pei-Hui; Wan, Ding-Hui; Chen, Yong-Gui; Weng, Shao-Ping; Yu, Xiao-Qiang; He, Jian-Guo			Characterization of Four Novel Caspases from Litopenaeus vannamei (Lvcaspase2-5) and Their Role in WSSV Infection through dsRNA-Mediated Gene Silencing	PLOS ONE			English	Article							SPOT-SYNDROME-VIRUS; PENAEUS-MONODON; WHITE SHRIMP; APOPTOSIS; ACTIVATION; RECEPTOR; PROTEIN; REQUIREMENT; EXPRESSION; JAPONICUS	Apoptosis plays an important role in white spot syndrome virus (WSSV) pathogenesis, and caspases are central players in apoptosis. Here, we cloned four novel caspases (Lvcaspase2-5) from the Pacific white shrimp Litopenaeus vannamei, and investigated their potential roles in WSSV replication using dsRNA-mediated gene silencing. Lvcaspase2-5 have the typical domain structure of caspase family proteins, with the conserved consensus motifs p20 and p10. Lvcaspase2 and Lvcaspase5 were highly expressed in muscle, while Lvcaspase3 was highly expressed in hemocytes and Lvcaspase4 was mainly expressed in intestine. Lvcaspase2-5 could also be upregulated by WSSV infection, and they showed different patterns in various tissues. When overexpressed in Drosophila S2 cells, Lvcaspase2-5 showed different cellular localizations. Using dsRNA-medicated gene silencing, the expression of Lvcaspase2, Lvcaspase3, and Lvcaspase5 were effectively knocked down. In Lvcaspase2-, Lvcaspase3- or Lvcaspase5-silenced L. vannamei, expression of WSSV VP28 gene was significantly enhanced, suggesting protective roles for Lvcaspase2, Lvcaspase3 and Lvcaspase5 in the host defense against WSSV infection.	[Wang, Pei-Hui; Wan, Ding-Hui; Weng, Shao-Ping; He, Jian-Guo] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, MOE Key Lab Aquat Prod Safety, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yong-Gui; He, Jian-Guo] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Xiao-Qiang] Univ Missouri Kansas City, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO USA	Sun Yat Sen University; Sun Yat Sen University; University of Missouri System; University of Missouri Kansas City	Wang, PH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, MOE Key Lab Aquat Prod Safety, Guangzhou 510275, Guangdong, Peoples R China.	wph326@gmail.com; lsshjg@mail.sysu.edu.cn	YU, XIAO-QIANG/AAL-1797-2021; YU, XiaoQiang/GRJ-1077-2022; Wang, Pei-Hui/F-7682-2014	YU, XIAO-QIANG/0000-0003-1419-9009; Wang, Pei-Hui/0000-0001-6853-2423	National Natural Science Foundation of China [U1131002]; National High Technology Research and Development Program of China (973 Program) [2012CB114401]; China Agriculture Research System, the Special Fund for Agro-scientific Research in the Public Interest [201103034]; Foundation of Administration of Ocean and Fisheries of Guangdong Province [A201101B02]; Open Project of the State Key Laboratory of Biocontrol [SKLBC09K04]; Foundation of Science and Technology Bureau of Guangdong Province [2011A 020102002, 2009A 020102002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (973 Program)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); China Agriculture Research System, the Special Fund for Agro-scientific Research in the Public Interest; Foundation of Administration of Ocean and Fisheries of Guangdong Province; Open Project of the State Key Laboratory of Biocontrol; Foundation of Science and Technology Bureau of Guangdong Province	This research was supported by the National Natural Science Foundation of China under Grant No. U1131002, the National High Technology Research and Development Program of China (973 Program) 2012CB114401, the China Agriculture Research System, the Special Fund for Agro-scientific Research in the Public Interest 201103034, the Foundation of Administration of Ocean and Fisheries of Guangdong Province A201101B02, the Open Project of the State Key Laboratory of Biocontrol (SKLBC09K04) and the Foundation of Science and Technology Bureau of Guangdong Province (2011A 020102002 and 2009A 020102002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Hameed A.S. Sahul, 2006, Aquaculture, V256, P111, DOI 10.1016/j.aquaculture.2006.02.054; Hardwick JM, 2001, CELL DEATH DIFFER, V8, P109, DOI 10.1038/sj.cdd.4400820; He F, 2006, J VIROL, V80, P3884, DOI 10.1128/JVI.80.8.3884-3892.2006; Hobbs JA, 2003, HUM IMMUNOL, V64, P82, DOI 10.1016/S0198-8859(02)00702-4; Kauppila S, 2003, ONCOGENE, V22, P4860, DOI 10.1038/sj.onc.1206715; Leu J.H., 2012, FISH SHELLFISH IMMUN; Leu JH, 2008, DEV COMP IMMUNOL, V32, P476, DOI 10.1016/j.dci.2007.08.006; Leu JH, 2010, DEV COMP IMMUNOL, V34, P1068, DOI 10.1016/j.dci.2010.05.010; Nupan B, 2011, DEV COMP IMMUNOL, V35, P469, DOI 10.1016/j.dci.2010.11.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phongdara A, 2006, AQUACULTURE, V252, P114, DOI 10.1016/j.aquaculture.2005.07.024; Rijiravanich A, 2008, FISH SHELLFISH IMMUN, V24, P308, DOI 10.1016/j.fsi.2007.11.017; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Sahtout AH, 2001, DIS AQUAT ORGAN, V44, P155, DOI 10.3354/dao044155; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Tonganunt M, 2008, FISH SHELLFISH IMMUN, V25, P633, DOI 10.1016/j.fsi.2008.08.006; Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X; Wang KCHC, 2010, FISH SHELLFISH IMMUN, V29, P94, DOI 10.1016/j.fsi.2010.02.020; Wang L, 2008, DEV COMP IMMUNOL, V32, P706, DOI 10.1016/j.dci.2007.10.010; Wang PH, 2013, CELL MOL IMMUNOL, V10, P423, DOI 10.1038/cmi.2013.30; Wang PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072592; Wang PH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052088, 10.1371/journal.pone.0057020]; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2012, DEV COMP IMMUNOL, V36, P39, DOI 10.1016/j.dci.2011.06.002; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang PH, 2009, MOL IMMUNOL, V46, P1897, DOI 10.1016/j.molimm.2009.01.005; Wang W, 2008, FISH SHELLFISH IMMUN, V25, P522, DOI 10.1016/j.fsi.2008.07.016; Wang ZM, 2004, BIOCHEM BIOPH RES CO, V325, P899, DOI 10.1016/j.bbrc.2004.09.224; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wongprasert K, 2007, J BIOTECHNOL, V131, P9, DOI 10.1016/j.jbiotec.2007.05.032; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhi B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024955; Zhi B, 2011, MAR BIOTECHNOL, V13, P575, DOI 10.1007/s10126-010-9328-5	43	33	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e80418	10.1371/journal.pone.0080418	http://dx.doi.org/10.1371/journal.pone.0080418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376496	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000001
J	Zhao, J; Tian, T; Zhang, Q; Wang, YG; Li, YP				Zhao, Jing; Tian, Tian; Zhang, Qiong; Wang, Yonggang; Li, Yanping			Use of Granulocyte Colony-Stimulating Factor for the Treatment of Thin Endometrium in Experimental Rats	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; STEM-CELLS; CHEMOKINES; THICKNESS; CYTOKINES; EMBRYO; CYCLE	Granulocyte colony-stimulating factor (G-CSF) induces stem cells to mobilize to the injury site, which have beneficial effect on tissue repair. The aim of this study was to investigate the effect of G-CSF on the thin endometrium in rat models. In the present study, rats with thin endometrium were divided into 4 groups (experimental group I: administrated with G-CSF (40 mg/kg/d) 4-6 hours post-modeling; control group I: administrated with saline 4-6 hours post-modeling; experimental group II: administrated with G-CSF (40 mg/kg/d) 12 days post-modeling; control group II: administrated with saline 12 days post-modeling. The agentia was given once daily and last for 5 days. Endometrial morphology was analyzed by Hematoxylin-Eosin staining, and the regeneration of endometrial cells was evaluated by immunohistochemistry and western-blot with cytokeratin and vimentin. We found that endometrial thickness and morphology presented a significant difference between experimental groups and control groups. No matter when we start with G-CSF, there was a significantly thicker endometrium and stronger expression of cytokeratin/vimintin in the experimental groups compared with the control groups (P < 0.01). There were significant thicker endometrial lining and stronger expression of cytokeratin/vimintin in experimental group I than that of experimental group II (P < 0.05), but there was no difference in the endometrial lining and the expression of cytokeratin/vimintin between the two control groups (P > 0.05). In conclusion, G-CSF can promote the regeneration of endometrial cells in animal research, especially when the G-CSF was administrated earlier.	[Zhao, Jing; Tian, Tian; Zhang, Qiong; Wang, Yonggang; Li, Yanping] Cent S Univ, Xiangya Hosp, Reprod Med Ctr, Changsha, Hunan, Peoples R China	Central South University	Li, YP (corresponding author), Cent S Univ, Xiangya Hosp, Reprod Med Ctr, Changsha, Hunan, Peoples R China.	zhaojing19840427@sina.com	zhao, jing/B-3868-2019					Al-Ghamdi A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-37; Basir GS, 2002, ULTRASOUND OBST GYN, V19, P484, DOI 10.1046/j.1469-0705.2002.00685.x; Bratincsak A, 2007, STEM CELLS, V25, P2820, DOI 10.1634/stemcells.2007-0301; Carter D, 2009, US patent application, Patent No. [0226397 A1, 0226397]; Clark DA, 2003, J ASSIST REPROD GEN, V20, P63, DOI 10.1023/A:1021788024214; Dieckgraefe BK, 2002, LANCET, V360, P1478, DOI 10.1016/S0140-6736(02)11437-1; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Gleicher N, 2013, HUM REPROD, V28, P172, DOI 10.1093/humrep/des370; Gleicher N, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2011.01.143; Granot I, 2012, REPRODUCTION, V144, P661, DOI 10.1530/REP-12-0217; Harvey BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022135; Ikoma T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.026; Jensen JR, 2010, FERTIL STERIL, V93, P251, DOI 10.1016/j.fertnstert.2008.09.050; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Ledee N, 2008, HUM REPROD, V23, P2001, DOI 10.1093/humrep/den192; McWilliams GDE, 2007, FERTIL STERIL, V88, P74, DOI 10.1016/j.fertnstert.2006.11.089; MEREU G, 1984, BRAIN RES, V292, P63, DOI 10.1016/0006-8993(84)90890-4; Narahara H, 2003, AM J OBSTET GYNECOL, V188, P157, DOI 10.1067/mob.2003.106; Robertson SA, 1999, BIOL REPROD, V60, P251, DOI 10.1095/biolreprod60.2.251; Salmassi A, 2005, HUM REPROD, V20, P2434, DOI 10.1093/humrep/dei071; Salmassi A, 2004, FERTIL STERIL, V81, P786, DOI 10.1016/j.fertnstert.2003.09.039; Scarpellini F, 2009, HUM REPROD, V24, P2703, DOI 10.1093/humrep/dep240; Schneider A, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-36; Spandorfer SD, 1998, AM J REPROD IMMUNOL, V40, P377; Takasaki A, 2008, FERTIL STERIL, V90, P2287, DOI 10.1016/j.fertnstert.2007.10.043; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; W?rfel W., 2000, J ASSIST REPROD GEN, V17, P473; Wang HB, 2005, HUM REPROD, V20, P2749, DOI 10.1093/humrep/dei123; Yanagi K, 2002, HUM REPROD, V17, P3046, DOI 10.1093/humrep/17.12.3046; Yu D, 2008, FERTIL STERIL, V89, P759, DOI 10.1016/j.fertnstert.2008.02.096; Zhang ZF, 2008, FERTIL STERIL, V90, P749, DOI 10.1016/j.fertnstert.2007.06.098; Zhao J, 2012, J FERT IN VITRO, V2, P109, DOI [10.4172/2165-7491.1000109, DOI 10.4172/2165-7491.1000109]	33	18	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82375	10.1371/journal.pone.0082375	http://dx.doi.org/10.1371/journal.pone.0082375			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376532	Green Published, gold			2022-12-27	WOS:000328882000010
J	Dong, YL; Kabir, SM; Lee, ES; Son, DS				Dong, Yuan-Lin; Kabir, Syeda M.; Lee, Eun-Sook; Son, Deok-Soo			CXCR2-Driven Ovarian Cancer Progression Involves Upregulation of Proinflammatory Chemokines by Potentiating NF-kappa B Activation via EGFR-Transactivated Akt Signaling	PLOS ONE			English	Article							PROMOTES INVASION; INDUCED APOPTOSIS; PROSTATE-CANCER; CARCINOMA-CELLS; RECEPTOR CXCR2; TUMOR-GROWTH; TNF-ALPHA; EXPRESSION; GADD45A; PROLIFERATION	Ovarian cancer is an inflammation-associated malignancy with a high mortality rate, CXCR2 expressing ovarian cancers are aggressive with poorer outcomes. We therefore investigated molecular mechanisms involved in CXCR2-driven cancer progression by comparing CXCR2 positive and negative ovarian cancer cell lines. Stably CXCR2 transfected SKOV-3 cells had a faster growth rate as compared to control cells transfected with empty vector. Particularly, tumor necrosis factor (TNF), abundantly expressed in ovarian cancer, enhanced cell proliferation by decreasing the GO-G1 phase in CXCR2 transfected cells. TNF increased nuclear factor-kappa B (NF-kappa B) activity to a greater degree in CXCR2 transfected cells than control cells as well as provided a greater activation of I kappa B. CXCR2 transfected cells expressed higher levels of its proinflarnmatory ligands, CXCL1/2 and enhanced more proliferation, migration, invasion and colony formation. CXCR2 positive cells also activated more EGFR, which led to higher Akt activation. Enhanced NF-kappa B activity in CXCR2 positive cells was reduced by a PI3K/Akt nhibitor rather than an Ek inhibitor. CXCL1 added to CXCR2 positive cells led to an increased activation of I kappa B. CXCL1 also led to a significantly greater number of invasive cells in CXCR2 transfected cells, which was blocked by the NF-kappa B inhibitor Bay 11-7082. In addition, enhanced cell proliferation in CXCR2 positive cells was more sensitive to CXCL1 antibody or an NF kappa B inhibitor. Finally, CXCR2 transfection of parental cells increased CXCL1 promoter activity via an NF-kappa B site. Thus aumentation of proinflammatonj chemokines CXCL1/2 by potentiating NF-kappa B activation through EGFR-transactivated Akt, contributes to CXCR2-driven ovarian cancer progression.	[Dong, Yuan-Lin; Kabir, Syeda M.; Son, Deok-Soo] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Lee, Eun-Sook] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College	Son, DS (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA.	dson@mmc.edu			National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [SC1 089630]; National Institute of Allergy and Infectious Diseases (NIAID) [SC1A1089073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI089073] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) SC1 089630 (EL) and National Institute of Allergy and Infectious Diseases (NIAID) SC1A1089073 (DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Agarwal A, 2010, CANCER RES, V70, P5880, DOI 10.1158/0008-5472.CAN-09-4341; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Benelli R, 2013, PROSTATE, V73, P941, DOI 10.1002/pros.22640; Bolitho C, 2010, ENDOCR-RELAT CANCER, V17, P929, DOI 10.1677/ERC-10-0107; Bondurant KL, 2013, INT J CANCER, V132, P905, DOI 10.1002/ijc.27660; Cheng WL, 2011, ANN ONCOL, V22, P2267, DOI 10.1093/annonc/mdq739; Chobanian N, 2008, SURG CLIN N AM, V88, P285, DOI 10.1016/j.suc.2007.12.002; Dobrzycka B, 2009, EUR CYTOKINE NETW, V20, P131, DOI 10.1684/ecn.2009.0161; Ewington L, 2012, CYTOKINE, V59, P417, DOI 10.1016/j.cyto.2012.04.036; Fayolle C, 2008, J INVEST DERMATOL, V128, P196, DOI 10.1038/sj.jid.5700963; Han L, 2012, MED ONCOL, V29, P2466, DOI 10.1007/s12032-011-0152-1; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Jiang T, 2007, J CELL PHYSIOL, V212, P771, DOI 10.1002/jcp.21073; Keane MP, 2004, J IMMUNOL, V172, P2853, DOI 10.4049/jimmunol.172.5.2853; Kim DS, 2007, MOL IMMUNOL, V44, P1409, DOI 10.1016/j.molimm.2006.05.001; Kuo PL, 2012, CARCINOGENESIS, V33, P2477, DOI 10.1093/carcin/bgs299; Lee YS, 2012, BRIT J CANCER, V106, P1833, DOI 10.1038/bjc.2012.177; Liebermann Dan A., 2011, Critical Reviews in Oncogenesis, V16, P129; Lin CR, 2011, J NEUROSCI RES, V89, P689, DOI 10.1002/jnr.22589; Liu Z, 2011, J SURG RES, V166, P241, DOI 10.1016/j.jss.2009.07.014; Maccio A, 2012, CYTOKINE, V58, P133, DOI 10.1016/j.cyto.2012.01.015; Mestas J, 2005, J IMMUNOL, V175, P5351, DOI 10.4049/jimmunol.175.8.5351; Ning Y, 2012, MOL CANCER THER, V11, P1353, DOI 10.1158/1535-7163.MCT-11-0915; Ogatai H, 2010, ONCOL REP, V24, P1479, DOI 10.3892/or_00001008; Oladipo O, 2011, BRIT J CANCER, V104, P480, DOI 10.1038/sj.bjc.6606055; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Saintigny P, 2013, CANCER RES, V73, P571, DOI 10.1158/0008-5472.CAN-12-0263; Seppanen M, 2008, ACTA OBSTET GYN SCAN, V87, P902, DOI 10.1080/00016340802283921; Shan ZH, 2012, CANCER BIOL THER, V13, P1112, DOI 10.4161/cbt.21186; Shen H, 2006, PROSTATE, V66, P1721, DOI 10.1002/pros.20476; Singh Rajesh, 2011, Front Biosci (Schol Ed), V3, P1569; Son DS, 2007, CANCER BIOL THER, V6, P1302; Son DS, 2006, MOL ENDOCRINOL, V20, P2999, DOI 10.1210/me.2006-0001; Son DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051116; Szlosarek PW, 2006, MOL CANCER THER, V5, P382, DOI 10.1158/1535-7163.MCT-05-0303; Takamori H, 2000, PANCREAS, V21, P52, DOI 10.1097/00006676-200007000-00051; Tront JS, 2010, CANCER RES, V70, P9671, DOI 10.1158/0008-5472.CAN-10-2177; von Vietinghoff S, 2010, J IMMUNOL, V185, P670, DOI 10.4049/jimmunol.1000339; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; Yang F, 2013, J BIOL CHEM, V288, P6552, DOI 10.1074/jbc.M112.418335; Yang G, 2010, CLIN CANCER RES, V16, P3875, DOI 10.1158/1078-0432.CCR-10-0483; Yang RH, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-26	43	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83789	10.1371/journal.pone.0083789	http://dx.doi.org/10.1371/journal.pone.0083789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376747	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100140
J	Gianelli, C; Lugli, L; Baroni, G; Nicoletti, R; Borghi, AM				Gianelli, Claudia; Lugli, Luisa; Baroni, Giulia; Nicoletti, Roberto; Borghi, Anna M.			The Impact of Social Context and Language Comprehension on Behaviour: A Kinematic Investigation	PLOS ONE			English	Article							ACQUISITION; PERCEPTION; FRAMEWORK; SYSTEM	We investigated whether and how comprehending sentences that describe a social context influences our motor behaviour. Our stimuli were sentences that referred to objects having different connotations (e.g., attractive/ugly vs smooth/prickly) and that could be directed towards the self or towards "another person" target (e The object is ugly/smooth. Bring it to you/Give it to another person"). Participants judged whether each sentence was sensible or non-sensible by moving the mouse towards or away from their body. Mouse movements were analysed according to behavioral and kinematics parameters. In order to enhance the social meaning of the linguistic stimuli, participants performed the task either individually (Individual condition) or in a social setting, in co-presence with the experimenter. The experimenter could either act as a mere observer (Social condition) or as a confederate, interacting with participants in an off-line modality at the end of task execution (Joint condition), Results indicated that the different roles taken by the experimenter affected motor behaviour and are discussed within an embodied approach to language processing and joint actions.	[Gianelli, Claudia] Univ Potsdam, Div Cognit Sci, Potsdam, Germany; [Lugli, Luisa; Baroni, Giulia; Nicoletti, Roberto] Univ Bologna, Dept Philosophy & Commun, Bologna, Italy; [Borghi, Anna M.] Univ Bologna, Dept Psychol, Bologna, Italy; [Borghi, Anna M.] CNR, Inst Cognit Sci & Technol, Rome, Italy	University of Potsdam; University of Bologna; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Gianelli, C (corresponding author), Univ Potsdam, Div Cognit Sci, Potsdam, Germany.	claudia.gianelli@uni-potsdam.de; annamaria.borghi@unibo.it	Gianelli, Claudia/AAC-1518-2019; Lugli, Luisa/AAG-1408-2021	Borghi, Anna M./0000-0001-9455-8408; Gianelli, Claudia/0000-0002-3970-9055	MIUR (Ministero Italiano dell' Istruzione, dell'Universita e della Ricerca); European Community; Emergence of Communication in Robots through Sensorimotor and Social Interaction [216125]	MIUR (Ministero Italiano dell' Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission); Emergence of Communication in Robots through Sensorimotor and Social Interaction	This work was supported by the MIUR (Ministero Italiano dell' Istruzione, dell'Universita e della Ricerca) and by the European Community, FP7 project ROSSI (vvww.rossiproject.eu), Emergence of Communication in Robots through Sensorimotor and Social Interaction (Grant agreement n. 216125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2009, PHILOS T R SOC B, V364, P1281, DOI 10.1098/rstb.2008.0319; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2008, COGNITION, V106, P894, DOI 10.1016/j.cognition.2007.05.004; Borghi A.M., 2009, P ANN C COGENTIVE SC, P2304; Borghi AM, 2013, CONT TOP COGN NEUROS, P125; Borghi Anna M, 2010, Front Neurorobot, V4, P3, DOI 10.3389/fnbot.2010.00003; Borghi AM, 2010, NEUROPSYCHOLOGIA, V48, P763, DOI 10.1016/j.neuropsychologia.2009.10.029; Chambers CG, 2002, J MEM LANG, V47, P30, DOI 10.1006/jmla.2001.2832; Clark H.H., 1996, USING LANGUAGE; Dalla Volta R, 2009, EXP BRAIN RES, V196, P403, DOI 10.1007/s00221-009-1864-8; Ferri F, 2010, EXP BRAIN RES, V203, P637, DOI 10.1007/s00221-010-2271-x; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Gallese V, 2008, SOC NEUROSCI-UK, V3, P317, DOI 10.1080/17470910701563608; Gallese V, 2009, PSYCHOL RES-PSYCH FO, V73, P486, DOI 10.1007/s00426-009-0232-4; Garrod S, 2009, TOP COGN SCI, V1, P292, DOI 10.1111/j.1756-8765.2009.01020.x; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Glenberg AM, 2000, J MEM LANG, V43, P379, DOI 10.1006/jmla.2000.2714; Glenberg AM, 2012, CORTEX, V48, P905, DOI 10.1016/j.cortex.2011.04.010; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Jeannerod M, 2007, J PHYSIOL-PARIS, V101, P161, DOI 10.1016/j.jphysparis.2007.11.005; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lugli L, 2012, MEM COGNITION, V40, P1373, DOI 10.3758/s13421-012-0218-0; Molnar-Szakacs I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000626; Neumann R, 2000, J PERS SOC PSYCHOL, V79, P39, DOI 10.1037//0022-3514.79.1.39; Neumann R, 2003, PSYCHOLOGY OF EVALUATION, P371; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rueschemeyer SA, 2009, EUR J SOC PSYCHOL, V39, P1180, DOI 10.1002/ejsp.662; Sartori L, 2011, EXP BRAIN RES, V211, P557, DOI 10.1007/s00221-011-2650-y; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Semin GR, 2008, EMBODIED GROUNDING: SOCIAL, COGNITIVE, AFFECTIVE, AND NEUROSCIENTIFIC APPROACHES, P1; Singer T, 2012, NEUROIMAGE, V61, P437, DOI 10.1016/j.neuroimage.2012.01.109; Spivey MJ, 2001, PSYCHOL SCI, V12, P282, DOI 10.1111/1467-9280.00352; Tanenhaus MK, 2008, PHILOS T R SOC B, V363, P1105, DOI 10.1098/rstb.2007.2162; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Toni I, 2008, J PHYSIOL-PARIS, V102, P71, DOI 10.1016/j.jphysparis.2008.03.005; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35	45	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85151	10.1371/journal.pone.0085151	http://dx.doi.org/10.1371/journal.pone.0085151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376869	Green Published, gold			2022-12-27	WOS:000328745100198
J	Jansma, JM; van Raalten, TR; Boessen, R; Neggers, SFW; Jacobs, RHAH; Kahn, RS; Ramsey, NF				Jansma, Johan Martijn; van Raalten, Tamar R.; Boessen, Ruud; Neggers, Sebastiaan F. W.; Jacobs, Richard H. A. H.; Kahn, Rene S.; Ramsey, Nick F.			fMRI Guided rTMS Evidence for Reduced Left Prefrontal Involvement after Task Practice	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; VERBAL WORKING-MEMORY; FUNCTIONAL-ANATOMY; AUTOMATICITY; ACTIVATION; SEARCH; CORTEX; NETWORK	Introduction: Cognitive tasks that do not change the required response for a stimulus over time ('consistent mapping') show dramatically improved performance after relative short periods of practice. This improvement is associated with reduced brain activity in a large network of brain regions, including left prefrontal and parietal cortex. The present study used fMRI-guided repetitive transcranial magnetic stimulation (rTMS), which has been shown to reduce processing efficacy, to examine if the reduced activity in these regions also reflects reduced involvement, or possibly increased efficiency. Methods: First, subjects performed runs of a Sternberg task in the scanner with novel or practiced target-sets. This data was used to identify individual sites for left prefrontal and parietal peak brain activity, as well as to examine the change in activity related to practice. Outside of the scanner, real and sham rTMS was applied at left prefrontal and parietal cortex to examine their involvement novel and practiced conditions. Results: Prefrontal as well as parietal rTMS significantly reduced target accuracy for novel targets. Prefrontal, but not parietal, rTMS interference was significantly lower for practiced than novel target-sets. rTMS did not affect nontarget accuracy, or reaction time in any condition. Discussion: These results show that task practice in a consistent environment reduces involvement of the prefrontal cortex. Our findings suggest that prefrontal cortex is predominantly involved in target maintenance and comparison, as rTMS interference was only detectable for targets. Findings support process switching hypotheses that propose that practice creates the possibility to select a response without the need to compare with target items. Our results also support the notion that practice allows for redistribution of limited maintenance resources.	[Jansma, Johan Martijn; van Raalten, Tamar R.; Boessen, Ruud; Jacobs, Richard H. A. H.; Ramsey, Nick F.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Utrecht, Netherlands; [van Raalten, Tamar R.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Child & Adolescent Psychiat, Utrecht, Netherlands; [Neggers, Sebastiaan F. W.; Kahn, Rene S.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Jansma, JM (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Utrecht, Netherlands.	jjansma2@umcutrecht.nl		ramsey, nick/0000-0002-7136-259X	Netherlands Organization for Scientific Research (NWO); Utrecht University [016.036.401]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Utrecht University	This work was supported by Netherlands Organization for Scientific Research (NWO) and Utrecht University, Grant 016.036.401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby FG, 2007, PSYCHOL REV, V114, P632, DOI 10.1037/0033-295X.114.3.632; Ashby FG, 2005, TRENDS COGN SCI, V9, P83, DOI 10.1016/j.tics.2004.12.003; BURROWS D, 1969, J EXP PSYCHOL, V82, P7; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Cousineau D, 2004, PSYCHOL RES-PSYCH FO, V69, P77, DOI 10.1007/s00426-003-0170-5; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Hamidi M, 2009, NEUROPSYCHOLOGIA, V47, P295, DOI 10.1016/j.neuropsychologia.2008.08.026; Jansma JM, 2001, NEUROIMAGE, V13, pS421; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Kirschen MP, 2005, NEUROIMAGE, V24, P462, DOI 10.1016/j.neuroimage.2004.08.036; Koch K, 2006, BRAIN RES, V1107, P140, DOI 10.1016/j.brainres.2006.06.003; Lee J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00026; LOGAN GD, 1985, CAN J PSYCHOL, V39, P367, DOI 10.1037/h0080066; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; LOGAN GD, 1991, J EXP PSYCHOL LEARN, V17, P478; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mottaghy FM, 2000, NUKLEARMED-NUCL MED, V39, P196; Mottaghy FM, 2002, EUR J NEUROSCI, V16, P1627, DOI 10.1046/j.1460-9568.2002.02209.x; Mull BR, 2001, CLIN NEUROPHYSIOL, V112, P1672, DOI 10.1016/S1388-2457(01)00606-X; Neggers SFW, 2004, NEUROIMAGE, V21, P1805, DOI 10.1016/j.neuroimage.2003.12.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PASCUALLEONE A, 1994, NEUROREPORT, V5, P2517, DOI 10.1097/00001756-199412000-00028; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Ramsey NF, 2004, BRAIN, V127, P517, DOI 10.1093/brain/awh060; RYAN C, 1983, PSYCHOL REV, V90, P171, DOI 10.1037/0033-295X.90.2.171; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Schutter DJLG, 2006, J ECT, V22, P176, DOI 10.1097/01.yct.0000235924.60364.27; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SHIFFRIN RM, 1984, PSYCHOL REV, V91, P269, DOI 10.1037/0033-295X.91.2.269; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Raalten TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003270; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	38	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e80256	10.1371/journal.pone.0080256	http://dx.doi.org/10.1371/journal.pone.0080256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376494	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100001
J	Jones, BE; Krupa, M; Tate, KW				Jones, Bobette E.; Krupa, Monika; Tate, Kenneth W.			Aquatic Ecosystem Response to Timber Harvesting for the Purpose of Restoring Aspen	PLOS ONE			English	Article							SIERRA-NEVADA; SNOW ACCUMULATION; STREAM TEMPERATURE; SOIL-MOISTURE; WATER-QUALITY; EXPERIMENTAL MANIPULATION; RIPARIAN BUFFERS; FOREST STREAMS; CLEAR-CUT; SEDIMENT	The removal of conifers through commercial timber harvesting has been successful in restoring aspen, however many aspen stands are located near streams, and there are concerns about potential aquatic ecosystem impairment. We examined the effects of management-scale conifer removal from aspen stands located adjacent to streams on water quality, solar radiation, canopy cover, temperature, aquatic macroinvertebrates, and soil moisture. This 8-year study (2003-2010) involved two projects located in Lassen National Forest. The Pine-Bogard Project consisted of three treatments adjacent to Pine and Bogard Creeks: (i) Phase 1 in January 2004, (ii) Phase 2 in August 2005, and (iii) Phase 3 in January 2008. The Bailey Project consisted of one treatment adjacent to Bailey Creek in September 2006. Treatments involved whole tree removal using track-laying harvesters and rubber tire skidders. More than 80% of all samples analyzed for NO3-N, NH4-N, and PO4-P at Pine, Bogard, and Bailey Creeks were below the detection limit, with the exception of naturally elevated PO4-P in Bogard Creek. All nutrient concentrations (NO3-N, NH4-N, PO4P, K, and SO4-S) showed little variation within streams and across years. Turbidity and TSS exhibited annual variation, but there was no significant increase in the difference between upstream and downstream turbidity and TSS levels. There was a significant decrease in stream canopy cover and increase in the potential fraction of solar radiation reaching the streams in response to the Pine-Bogard Phase 3 and Bailey treatments; however, there was no corresponding increase in stream temperatures. Macroinvertebrate metrics indicated healthy aquatic ecosystem conditions throughout the course of the study. Lastly, the removal of vegetation significantly increased soil moisture in treated stands relative to untreated stands. These results indicate that, with careful planning and implementation of site-specific best management practices, conifer removal to restore aspen stands can be conducted without degrading aquatic ecosystems.	[Jones, Bobette E.] US Forest Serv, Lassen Natl Forest, USDA, Susanville, CA USA; [Krupa, Monika; Tate, Kenneth W.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Davis	Krupa, M (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	kmonia@gmail.com			USDA Forest Service, Pacific Southwest Region	USDA Forest Service, Pacific Southwest Region(United States Department of Agriculture (USDA)United States Forest Service)	This research was funded by the USDA Forest Service, Pacific Southwest Region. The funders did assist in study design, provided field data collection assistance, and input on the methods section during preparation of the manuscript. The funders had no role in data analysis or in the decision to publish.	ADAMS PW, 1991, FOREST ECOL MANAG, V41, P249, DOI 10.1016/0378-1127(91)90107-7; Barbour M. T., 1999, 841B99002 USEPA; BARTON D R, 1985, North American Journal of Fisheries Management, V5, P364, DOI 10.1577/1548-8659(1985)5<364:DORBSR>2.0.CO;2; Bartos D. L., 1998, Rangelands, V20, P17; Beche LA, 2006, FRESHWATER BIOL, V51, P56, DOI 10.1111/j.1365-2427.2005.01473.x; Beche LA, 2007, FRESHWATER BIOL, V52, P2317, DOI 10.1111/j.1365-2427.2007.01859.x; Beschta R.L., 1987, University of Washington Institute of Forest Resources Contribution, P191; Binkley D, 2004, J AM WATER RESOUR AS, V40, P1277, DOI 10.1111/j.1752-1688.2004.tb01586.x; Bolda KS, 1997, J SOIL WATER CONSERV, V52, P49; Bourque CPA, 2001, HYDROL EARTH SYST SC, V5, P599, DOI 10.5194/hess-5-599-2001; Calder WJ, 2011, TREE PHYSIOL, V31, P582, DOI 10.1093/treephys/tpr041; CAMPBELL IC, 1989, AUST J MAR FRESH RES, V40, P519; Carmona-Catot G, 2010, N AM J FISH MANAGE, V30, P1315, DOI 10.1577/M10-077.1; Carter J. L., 2000, 00212 USGS; Chizinski CJ, 2010, FOREST ECOL MANAG, V259, P1946, DOI 10.1016/j.foreco.2010.02.006; COOPER AB, 1988, NEW ZEAL J MAR FRESH, V22, P279, DOI 10.1080/00288330.1988.9516300; Croke JC, 2006, ENVIRON REV, V14, P59, DOI 10.1139/A05-016; CUFFNEY T. F., 1993, 93406 US GEOL SURV; DeByle N.V., 1985, U S Forest Service General Technical Report RM, P135; DOUCET R, 1989, FOREST CHRON, V65, P23, DOI 10.5558/tfc65023-1; Dubrovsky N.M., 2010, QUALITY OUR NATIONS; Dunford E. G., 1944, JOUR FOREST, V42, P673; Eaton A.D., 2005, STANDARD METHODS EXA, V21st; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fechner G.H., 1976, EISENHOWER CONSORTIU, V4; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Flosi G., 1998, CALIFORNIA SALMONID; FOWLER WB, 1989, SOIL SCI SOC AM J, V53, P302, DOI 10.2136/sssaj1989.03615995005300010057x; Fraser EC, 2002, CAN J FOREST RES, V32, P1685, DOI 10.1139/X02-080; Gomi T, 2005, J AM WATER RESOUR AS, V41, P877, DOI 10.1111/j.1752-1688.2005.tb03775.x; Gravelle JA, 2007, FOREST SCI, V53, P189; Gravelle JA, 2009, FOREST ECOL MANAG, V257, P1663, DOI 10.1016/j.foreco.2009.01.017; Gravelle JA, 2009, FOREST SCI, V55, P352; Gray AN, 2002, CAN J FOREST RES, V32, P332, DOI [10.1139/x01-200, 10.1139/X01-200]; Griffis-Kyle KL, 2003, BIOL CONSERV, V110, P375, DOI 10.1016/S0006-3207(02)00237-9; Hassan MA, 2005, J AM WATER RESOUR AS, V41, P853, DOI 10.1111/j.1752-1688.2005.tb03774.x; HAWKINS CP, 1982, ECOLOGY, V63, P1840, DOI 10.2307/1940125; Hemstad NA, 2008, CAN J FOREST RES, V38, P247, DOI 10.1139/X07-157; Herlihy AT, 2005, FRESHWATER BIOL, V50, P905, DOI 10.1111/j.1365-2427.2005.01363.x; HOKANSON KEF, 1977, J FISH RES BOARD CAN, V34, P639, DOI 10.1139/f77-100; Honkala BH, 1991, HDB USDA, V654, P555; Hotta N, 2007, HYDROL PROCESS, V21, P3565, DOI 10.1002/hyp.6583; Hubbart JA, 2007, FOREST SCI, V53, P169; Hutchens Jr JJ, 2003, WATER AIR SOIL POLL, V00, P1; Jewett K, 1995, CAN J SOIL SCI, V75, P475, DOI 10.4141/cjss95-069; JOHNS BW, 1993, WILSON BULL, V105, P256; Johnson DW, 1997, GLOBAL BIOGEOCHEM CY, V11, P673, DOI 10.1029/97GB01750; Jones BE, 2005, RESTOR ECOL, V13, P373, DOI 10.1111/j.1526-100X.2005.00046.x; Jones BE, 2011, RANGELAND ECOL MANAG, V64, P625, DOI 10.2111/REM-D-10-00089.1; Jones BE, 2009, RANGELAND ECOL MANAG, V62, P557, DOI 10.2111/.1/REM-D-09-00082.1; Jones J.R., 1985, U S Forest Service General Technical Report RM, P107; Jost G, 2007, J HYDROL, V347, P101, DOI 10.1016/j.jhydrol.2007.09.006; Karwan DL, 2007, FOREST SCI, V53, P181; KAUFMANN MR, 1985, FOREST ECOL MANAG, V13, P235, DOI 10.1016/0378-1127(85)90037-4; Kiffney PM, 2004, J N AM BENTHOL SOC, V23, P542, DOI 10.1899/0887-3593(2004)023&lt;0542:ELAACM&gt;2.0.CO;2; Kiffney PM, 2003, J APPL ECOL, V40, P1060, DOI 10.1111/j.1365-2664.2003.00855.x; Kilpatrick S, 2002, US FOR SERV RMRS-P, P93; Klein RD, 2012, GEOMORPHOLOGY, V139, P136, DOI 10.1016/j.geomorph.2011.10.011; Kreutzweiser D, 2009, FOREST ECOL MANAG, V258, P1578, DOI 10.1016/j.foreco.2009.07.005; Kreutzweiser DR, 2005, J N AM BENTHOL SOC, V24, P208, DOI 10.1899/0887-3593(2005)024&lt;0208:MCRTSL&gt;2.0.CO;2; Kuhn TJ, 2011, PLANT ECOL, V212, P1451, DOI 10.1007/s11258-011-9920-4; LaMalfa EM, 2008, ECOSYSTEMS, V11, P569, DOI 10.1007/s10021-008-9143-2; Litschert SE, 2009, FOREST ECOL MANAG, V259, P143, DOI 10.1016/j.foreco.2009.09.038; Macdonald JS, 2003, CAN J FOREST RES, V33, P1397, DOI [10.1139/x03-110, 10.1139/X03-110]; Martin CW, 2000, CAN J FISH AQUAT SCI, V57, P19, DOI 10.1139/cjfas-57-S2-19; Moore RD, 2005, J AM WATER RESOUR AS, V41, P813, DOI 10.1111/j.1752-1688.2005.tb04465.x; Mosley MP, 1993, HDB HYDROLOGY, P81; MURPHY ML, 1981, T AM FISH SOC, V110, P469, DOI 10.1577/1548-8659(1981)110<469:EOCMAA>2.0.CO;2; Mykra H, 2008, BIOL CONSERV, V141, P1218, DOI 10.1016/j.biocon.2008.02.017; Nijboer RC, 2004, ECOL MODEL, V177, P17, DOI 10.1016/j.ecolmodel.2003.12.050; Olden JD, 2006, CAN J FISH AQUAT SCI, V63, P1812, DOI 10.1139/F06-082; Pierce AD, 2010, J VEG SCI, V21, P507, DOI 10.1111/j.1654-1103.2009.01158.x; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Platts W. S., 1987, INT221 USDA FOR SERV; Pomeroy JW, 2002, HYDROL PROCESS, V16, P3543, DOI 10.1002/hyp.1228; Pomeroy JW, 1998, HYDROL PROCESS, V12, P2317, DOI 10.1002/(SICI)1099-1085(199812)12:15&lt;2317::AID-HYP799&gt;3.0.CO;2-X; Poole GC, 2001, ENVIRON MANAGE, V27, P787, DOI 10.1007/s002670010188; Powlson DS, 2008, J ENVIRON QUAL, V37, P291, DOI 10.2134/jeq2007.0177; PRISM Climate Group, 2010, PRISM DAT EXPL; Quinn JM, 2004, FOREST ECOL MANAG, V191, P129, DOI 10.1016/j.foreco.2003.11.013; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rehfeldt GE, 2009, FOREST ECOL MANAG, V258, P2353, DOI 10.1016/j.foreco.2009.06.005; Reid DJ, 2010, FOREST ECOL MANAG, V260, P1804, DOI 10.1016/j.foreco.2010.08.025; REMPEL RS, 1986, CAN J ZOOL, V64, P2457, DOI 10.1139/z86-366; Richardson T. Will, 2004, Transactions of the Western Section of the Wildlife Society, V40, P68; Roche LM, 2012, RANGELAND ECOL MANAG, V65, P56, DOI 10.2111/REM-D-11-00092.1; Roche LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068127; Rogers P, 2002, FOREST ECOL MANAG, V155, P223, DOI 10.1016/S0378-1127(01)00560-6; Shepperd W.D., 2006, RMRSGTR178 US DEP AG, P132, DOI [10.2737/RMRS-GTR-178, DOI 10.2737/RMRS-GTR-178]; Shepperd WD, 2001, T W SECTION WILDLIFE, V40, P52; Sickman JO, 2003, LIMNOL OCEANOGR, V48, P1885, DOI 10.4319/lo.2003.48.5.1885; Sickman JO, 2002, BIOGEOCHEMISTRY, V57, P341, DOI 10.1023/A:1016564816701; Smith AE, 2005, FOREST ECOL MANAG, V213, P338, DOI 10.1016/j.foreco.2005.03.018; Smith EA, 2011, FOREST ECOL MANAG, V262, P325, DOI 10.1016/j.foreco.2011.03.038; StataCorp, 2009, STAT SE 11 1 WIND; Storck P, 1999, NORTHWEST SCI, V73, P87; Swank WT, 2001, FOREST ECOL MANAG, V143, P163, DOI 10.1016/S0378-1127(00)00515-6; Tremblay Y, 2009, HYDROL PROCESS, V23, P764, DOI 10.1002/hyp.7175; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Wang X, 2006, FOREST ECOL MANAG, V223, P103, DOI 10.1016/j.foreco.2005.10.060; Western Regional Climate Center, 2012, MANZ LAK PER REC GEN; White CA, 1998, WILDLIFE SOC B, V26, P449; WIENS JA, 1981, AM NAT, V117, P90, DOI 10.1086/283689; Wilkerson E, 2006, FOREST SCI, V52, P221; Winkler RD, 2005, HYDROL PROCESS, V19, P51, DOI 10.1002/hyp.5757; Wood PJ, 1997, ENVIRON MANAGE, V21, P203, DOI 10.1007/s002679900019	107	3	3	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84561	10.1371/journal.pone.0084561	http://dx.doi.org/10.1371/journal.pone.0084561			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376826	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100177
J	Leicht, G; Troschutz, S; Andreou, C; Karamatskos, E; Ertl, M; Naber, D; Mulert, C				Leicht, Gregor; Troschuetz, Stefan; Andreou, Christina; Karamatskos, Evangelos; Ertl, Matthias; Naber, Dieter; Mulert, Christoph			Relationship between Oscillatory Neuronal Activity during Reward Processing and Trait Impulsivity and Sensation Seeking	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; FEEDBACK-RELATED NEGATIVITY; GAMBLING TASK; HUMAN BRAIN; DELTA OSCILLATIONS; THETA OSCILLATIONS; BAND OSCILLATIONS; MONETARY LOSS; RESPONSES; EEG	Background: The processing of reward and punishment stimuli in humans appears to involve brain oscillatory activity of several frequencies, probably each with a distinct function. The exact nature of associations of these electrophysiological measures with impulsive or risk-seeking personality traits is not completely clear. Thus, the aim of the present study was to investigate event-related oscillatory activity during reward processing across a wide spectrum of frequencies, and its associations with impulsivity and sensation seeking in healthy subjects. Methods: During recording of a 32-channel EEG 22 healthy volunteers were characterized with the Barratt Impulsiveness and the Sensation Seeking Scale and performed a computerized two-choice gambling task comprising different feedback options with positive vs. negative valence (gain or loss) and high or low magnitude (5 vs. 25 points). Results: We observed greater increases of amplitudes of the feedback-related negativity and of activity in the theta, alpha and low-beta frequency range following loss feedback and, in contrast, greater increase of activity in the high-beta frequency range following gain feedback. Significant magnitude effects were observed for theta and delta oscillations, indicating greater amplitudes upon feedback concerning large stakes. The theta amplitude changes during loss were negatively correlated with motor impulsivity scores, whereas alpha and low-beta increase upon loss and high-beta increase upon gain were positively correlated with various dimensions of sensation seeking. Conclusions: The findings suggest that the processing of feedback information involves several distinct processes, which are subserved by oscillations of different frequencies and are associated with different personality traits.	[Leicht, Gregor; Troschuetz, Stefan; Andreou, Christina; Karamatskos, Evangelos; Ertl, Matthias; Naber, Dieter; Mulert, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, PNB, Hamburg, Germany; [Ertl, Matthias] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Ertl, Matthias] Univ Munich, Grad Sch Syst Neurosci, Munich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Munich	Leicht, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, PNB, Hamburg, Germany.	g.leicht@uke.de	Mulert, Christoph/F-2576-2012; Ertl, Matthias/E-2861-2013; Leicht, Gregor/AAF-7364-2020; Leicht, Gregor/ABE-2404-2020; Mulert, Christoph/AAB-3210-2020; Andreou, Christina/C-8746-2014	Ertl, Matthias/0000-0002-6823-1935; Leicht, Gregor/0000-0002-5104-9336; Leicht, Gregor/0000-0002-5104-9336; Andreou, Christina/0000-0002-6656-9043				Bernat EM, 2007, INT J PSYCHOPHYSIOL, V64, P62, DOI 10.1016/j.ijpsycho.2006.07.015; Bornovalova MA, 2009, PHARMACOL BIOCHEM BE, V93, P258, DOI 10.1016/j.pbb.2008.10.023; COHEN M, 2009, J COGNITIVE NEUROSCI, V43, P21; Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114; Cohen MX, 2007, NEUROIMAGE, V35, P968, DOI 10.1016/j.neuroimage.2006.11.056; Comings DE, 2000, PROG BRAIN RES, V126, P325; De Pascalis V, 2012, INT J PSYCHOPHYSIOL, V85, P68, DOI 10.1016/j.ijpsycho.2011.06.005; De Pascalis V, 2010, CLIN NEUROPHYSIOL, V121, P60, DOI 10.1016/j.clinph.2009.10.004; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Ergen M, 2008, NEUROSCI LETT, V440, P304, DOI 10.1016/j.neulet.2008.05.054; Fernandes R, 2007, J SAFETY RES, V38, P59, DOI 10.1016/j.jsr.2006.09.003; Gehring W.J., 2004, ERRORS CONFLICTS BRA, V14, P20; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; Grosskopf NA, 2011, AM J MENS HEALTH, V5, P378, DOI 10.1177/1557988310372801; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P151, DOI 10.1111/j.1469-8986.2005.00270.x; HajiHosseini A, 2012, NEUROIMAGE, V60, P1678, DOI 10.1016/j.neuroimage.2012.01.125; Herrmann CS, 1999, CLIN NEUROPHYSIOL, V110, P636, DOI 10.1016/S1388-2457(99)00002-4; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Ishii R, 2009, CLIN NEUROPHYSIOL, V120, P497, DOI 10.1016/j.clinph.2008.11.023; Kamarajan C, 2008, BRAIN RES, V1235, P45, DOI 10.1016/j.brainres.2008.06.051; Kamarajan C, 2012, HUM BRAIN MAPP, V33, P1019, DOI 10.1002/hbm.21267; Kamarajan C, 2010, J PSYCHIATR RES, V44, P576, DOI 10.1016/j.jpsychires.2009.11.019; Kamarajan C, 2009, BEHAV BRAIN RES, V197, P62, DOI 10.1016/j.bbr.2008.08.011; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029766; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Knyazev GG, 2012, NEUROSCI BIOBEHAV R, V36, P677, DOI 10.1016/j.neubiorev.2011.10.002; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lega BC, 2011, NEUROREPORT, V22, P795, DOI 10.1097/WNR.0b013e32834b2975; Leicht G, 2011, J PSYCHIATR RES, V45, P699, DOI 10.1016/j.jpsychires.2010.10.002; Leicht G, 2010, BIOL PSYCHIAT, V67, P224, DOI 10.1016/j.biopsych.2009.07.033; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Magid V, 2007, ADDICT BEHAV, V32, P2046, DOI 10.1016/j.addbeh.2007.01.015; Marco-Pallares J, 2008, NEUROPSYCHOLOGIA, V46, P241, DOI 10.1016/j.neuropsychologia.2007.07.016; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pizzagalli DA, 2005, PSYCHOL SCI, V16, P805, DOI 10.1111/j.1467-9280.2005.01618.x; Schurmann M, 2001, INT J PSYCHOPHYSIOL, V39, P229, DOI 10.1016/S0167-8760(00)00144-6; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Sutton SK, 2000, NEUROPSYCHOLOGIA, V38, P1723, DOI 10.1016/S0028-3932(00)00076-2; van Wingerden M, 2010, J NEUROSCI, V30, P7078, DOI 10.1523/JNEUROSCI.3860-09.2010; Vollm B, 2007, PSYCHIAT RES-NEUROIM, V156, P151, DOI 10.1016/j.pscychresns.2007.04.008; Weinstein ND, 1999, BRIT J HEALTH PSYCH, V4, P289, DOI 10.1348/135910799168641; Wyart V, 2012, NEURON, V76, P847, DOI 10.1016/j.neuron.2012.09.015; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139	57	32	33	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83414	10.1371/journal.pone.0083414	http://dx.doi.org/10.1371/journal.pone.0083414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376698	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100117
J	Lam, PY; Harvie, EA; Huttenlocher, A				Lam, Pui-ying; Harvie, Elizabeth A.; Huttenlocher, Anna			Heat Shock Modulates Neutrophil Motility in Zebrafish	PLOS ONE			English	Article							TRANSLATIONAL PROFILING APPROACH; FEVER-LIKE TEMPERATURES; GENE-EXPRESSION; ACTIN POLYMERIZATION; LEUKOCYTE MIGRATION; STREPTOCOCCUS-INIAE; IMMUNE-RESPONSE; ER STRESS; HSP27; PROTEINS	Heat shock is a routine method used for inducible gene expression in animal models including zebrafish. Environmental temperature plays an important role in the immune system and infection progression of ectotherms. In this study, we analyzed the impact of short-term heat shock on neutrophil function using zebrafish (Danio rerio) as an animal model. Short-term heat shock decreased neutrophil recruitment to localized Streptococcus iniae infection and tail fin wounding. Heat shock also increased random neutrophil motility transiently and increased the number of circulating neutrophils. With the use of the translating ribosome affinity purification (TRAP) method for RNA isolation from specific cell types such as neutrophils, macrophages and epithelial cells, we found that heat shock induced the immediate expression of heat shock protein 70 (hsp70) and a prolonged expression of heat shock protein 27 (hsp27). Heat shock also induced cell stress as detected by the splicing of X-box binding protein 1 (xbp1) mRNA, a marker for endoplasmic reticulum (ER) stress. Exogenous expression of Hsp70, Hsp27 and spliced Xbp1 in neutrophils or epithelial cells did not reproduce the heat shock induced effects on neutrophil recruitment. The effect of heat shock on neutrophils is likely due to a combination of complex changes, including, but not limited to changes in gene expression. Our results indicate that routine heat shock can alter neutrophil function in zebrafish. The findings suggest that caution should be taken when employing a heat shock-dependent inducible system to study the innate immune response.	[Lam, Pui-ying] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI USA; [Lam, Pui-ying; Harvie, Elizabeth A.; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Harvie, Elizabeth A.] Univ Wisconsin, Microbiol Doctoral Training Program, Madison, WI USA; [Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	huttenlocher@wisc.edu		Lam, Pui-Ying/0000-0002-6319-5752	National Institutes of Health [GM074827]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health [grant numbers GM074827 to A. H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]; Bacaj T, 2007, GENETICS, V176, P2651, DOI 10.1534/genetics.107.074369; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Boltana S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1381; Borges TJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00095; Chen CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020654; Colaco CA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/461230; Costa CZF, 2011, SCAND J IMMUNOL, V73, P436, DOI 10.1111/j.1365-3083.2010.02504.x; COVERT JB, 1977, NATURE, V267, P43, DOI 10.1038/267043a0; Davis MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000028; Deng Q, 2013, J LEUKOCYTE BIOL, V93, P761, DOI 10.1189/jlb.1012534; Deng Q, 2012, J CELL SCI, V125, P3949, DOI 10.1242/jcs.093633; Deng Q, 2011, DEV CELL, V21, P735, DOI 10.1016/j.devcel.2011.07.013; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Doshi BM, 2009, CELL STRESS CHAPERON, V14, P445, DOI 10.1007/s12192-008-0098-1; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Faucherre A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016587; Grans A, 2012, J FISH BIOL, V81, P1111, DOI 10.1111/j.1095-8649.2012.03333.x; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hu MC, 2007, BIOCHEM BIOPH RES CO, V359, P778, DOI 10.1016/j.bbrc.2007.05.183; Jog NR, 2007, J IMMUNOL, V178, P2421, DOI 10.4049/jimmunol.178.4.2421; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kettritz R, 2006, J AM SOC NEPHROL, V17, P1345, DOI 10.1681/ASN.2005090948; Kitaguchi T, 2009, MECH DEVELOP, V126, P314, DOI 10.1016/j.mod.2009.02.007; Kudo K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq024; Lam PY, 2013, CURR OPIN CELL BIOL, V25, P650, DOI 10.1016/j.ceb.2013.05.007; Lam PY, 2012, J CELL SCI, V125, P4973, DOI 10.1242/jcs.106625; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Lee CL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037897, 10.1371/journal.pone.0030077]; Mao L, 2005, EXP CELL RES, V306, P230, DOI 10.1016/j.yexcr.2005.02.007; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mathias JR, 2009, DEV COMP IMMUNOL, V33, P1212, DOI 10.1016/j.dci.2009.07.003; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; NAHAS GG, 1971, P SOC EXP BIOL MED, V138, P350; Ndong D, 2007, FISH SHELLFISH IMMUN, V22, P686, DOI 10.1016/j.fsi.2006.08.015; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; REYNOLDS WW, 1976, NATURE, V259, P41, DOI 10.1038/259041a0; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Salanova B, 2005, FASEB J, V19, P816, DOI 10.1096/fj.04-2983fje; Schneider GB, 1998, J CELL PHYSIOL, V177, P575, DOI 10.1002/(SICI)1097-4652(199812)177:4<575::AID-JCP8>3.0.CO;2-1; Senf SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062687; Shoji W, 2008, DEV GROWTH DIFFER, V50, P401, DOI [10.1111/j.1440-169x.2008.01038.x, 10.1111/j.1440-169X.2008.01038.x]; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Stocki P, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/617213; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Todryk SM, 2003, IMMUNOLOGY, V110, P1, DOI 10.1046/j.1365-2567.2003.01725.x; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tucker NR, 2009, EXP CELL RES, V315, P3176, DOI 10.1016/j.yexcr.2009.06.030; Tucker NR, 2009, CELL STRESS CHAPERON, V14, P521, DOI 10.1007/s12192-009-0105-1; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Vidyasagar A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-7; Vinokurov M, 2012, CELL STRESS CHAPERON, V17, P89, DOI 10.1007/s12192-011-0288-0; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Willett CE, 1999, DEV DYNAM, V214, P323, DOI 10.1002/(SICI)1097-0177(199904)214:4<323::AID-AJA5>3.3.CO;2-V; Wu TC, 2006, CELL STRESS CHAPERON, V11, P1, DOI 10.1379/CSC-155R.1; Wu YL, 2008, GENE, V408, P85, DOI 10.1016/j.gene.2007.10.027; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Yoo SK, 2011, J LEUKOCYTE BIOL, V89, P661, DOI 10.1189/jlb.1010567; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	67	20	21	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84436	10.1371/journal.pone.0084436	http://dx.doi.org/10.1371/journal.pone.0084436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367659	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900046
J	Tian, Y; Ding, WC; Wang, YY; Ji, T; Sun, SJ; Mo, QQ; Chen, PB; Fang, Y; Liu, J; Wang, BB; Zhou, JF; Ma, D; Wu, P				Tian, Yuan; Ding, Wencheng; Wang, Yingying; Ji, Teng; Sun, Shujuan; Mo, Qingqing; Chen, Pingbo; Fang, Yong; Liu, Jia; Wang, Beibei; Zhou, Jianfeng; Ma, Ding; Wu, Peng			Ubiquitin B in Cervical Cancer: Critical for the Maintenance of Cancer Stem-Like Cell Characters	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; MOLECULAR-MECHANISMS; POLYUBIQUITIN; IRRADIATION; TUMORS; GENES	Cervical cancer cells exhibit an increased requirement for ubiquitin-dependent protein degradation associated with an elevated metabolic turnover rate. Ubiquitin, which is a small, highly conserved protein expressed in all eukaryotic cells, can be covalently linked to certain target proteins to mark them for degradation by the ubiquitin-proteasome system. Previous studies highlight the essential role of Ubiquitin B (UbB) and UbB-dependent proteasomal protein degradation in histone deacetylase inhibitor (HDACi) -induced tumor selectivity. We hypothesized that UbB plays a critical role in the function of cervical cancer stem cells. We measured endogenous UbB levels in mammospheres in vitro by real-time PCR and Western blotting. The function of UbB in cancer stem-like cells was assessed after knockdown of UbB expression in prolonged Trichostatin A-selected HeLa cells (HeLa/TSA) by measuring in vitro cell proliferation, cell apoptosis, invasion, and chemotherapy resistance as well as by measuring in vivo growth in an orthotopic model of cervical cancer. We also assessed the cancer stem cell frequency, tumorsphere formation, and in vivo growth of human cervical cancer xenografts after UbB silencing. We found that HeLa/TSA were resistant to chemotherapy, highly expressed the UbB gene and the stem cell markers Sox2, Oct4 and Nanog. These cells also displayed induced differentiation abilities, including enhanced migration/invasion/malignancy capabilities in vitro and in vivo. Furthermore, an elevated expression of UbB was shown in the tumor samples of chemotherapy patients. Silencing of UbB inhibited tumorsphere formation, lowered the expression of stem cell markers and decreased cervical xenograft growth. Our results demonstrate that UbB was significantly increased in prolonged Trichostatin A-selected HeLa cells and it played a key role in the maintenance of cervical cancer stem-like cells.	[Tian, Yuan; Ding, Wencheng; Ji, Teng; Sun, Shujuan; Mo, Qingqing; Chen, Pingbo; Fang, Yong; Liu, Jia; Wang, Beibei; Zhou, Jianfeng; Ma, Ding; Wu, Peng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China; [Wang, Yingying] Zhengzhou Univ, Affiliated Hosp 3, Dept Gynecol, Zhengzhou 450052, Henan, Peoples R China	Huazhong University of Science & Technology; Zhengzhou University	Wu, P (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China.	pengwu8626@126.com	wu, peng/M-1812-2019; wang, yingying/GRS-3058-2022	wu, peng/0000-0002-4016-6641; 	National Science Foundation of China [81372806, 81101962, 81101965, 81202060]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science Foundation of China (No. 81372806; 81101962; 81101965; 81202060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bosch FX, 2012, VACCINE, V30, pF1, DOI 10.1016/j.vaccine.2012.05.090; Cadron I, 2007, GYNECOL ONCOL, V107, pS113, DOI 10.1016/j.ygyno.2007.07.004; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; DELIC J, 1993, MOL CELL BIOL, V13, P4875, DOI 10.1128/MCB.13.8.4875; FINCH JS, 1992, CELL GROWTH DIFFER, V3, P269; Hemmings C, 2010, PATHOLOGY, V42, P105, DOI 10.3109/00313020903488773; KENWARD N, 1994, J NEUROCHEM, V62, P1870; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim HJ, 2011, AM J TRANSL RES, V3, P166; NENOI M, 1992, INT J RADIAT BIOL, V61, P205, DOI 10.1080/09553009214550831; Peralta-Zaragoza O, 2012, ONCOTARGETS THER, V5, P315, DOI 10.2147/OTT.S25123; Rizzo S, 2011, MOL CANCER THER, V10, P325, DOI 10.1158/1535-7163.MCT-10-0788; Todaro M, 2010, CELL CYCLE, V9, P1238; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wu P, 2010, CELL DEATH DIFFER, V17, P109, DOI 10.1038/cdd.2009.142; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	18	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84457	10.1371/journal.pone.0084457	http://dx.doi.org/10.1371/journal.pone.0084457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367661	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300141
J	Bidokhti, MRM; Ullman, K; Jensen, TH; Chriel, M; Mottahedin, A; Munir, M; Andersson, AM; Detournay, O; Hammer, AS; Baule, C				Bidokhti, Mehdi R. M.; Ullman, Karin; Jensen, Trine H.; Chriel, Mariann; Mottahedin, Amin; Munir, Muhammad; Andersson, Anna Maria; Detournay, Olivier; Hammer, Anne Sofie; Baule, Claudia			Establishment of Stably Transfected Cells Constitutively Expressing the Full-Length and Truncated Antigenic Proteins of Two Genetically Distinct Mink Astroviruses	PLOS ONE			English	Article							STRUCTURAL PROTEIN; COAT PROTEIN; CODON OPTIMIZATION; CLASSICAL PATHWAY; RNA SEQUENCE; PARTICLES; DIARRHEA; SEROTYPE-8; POLYPROTEIN; COMPLEMENT	Astroviruses are becoming a growing concern in veterinary and public health. To date there are no registered vaccines against astrovirus-induced disease, mostly due to the difficulty to cultivate astroviruses to high titer for vaccine development using conventional techniques. As means to circumvent this drawback, we have developed stably transfected mink fetal cells and BHK21 cells constitutively expressing the full-length and truncated capsid proteins of two distinct genotypes of mink astrovirus. Protein expression in these stably transfected cells was demonstrated by strong signals as evaluated by in-situ PLA and IFA, and confirmed by Western blotting. The recombinant full-length and truncated proteins induced a high level of antibodies in mink, evaluated by ELISA, demonstrating their immunogenicity. In a challenge experiment in mink, a reduction in presentation clinical signs and virus shedding was observed in mink kits born from immunized females. The gene integration and protein expression were sustained through cell passage, showing that the used approach is robust and reliable for expression of functional capsid proteins for vaccine and diagnostic applications.	[Bidokhti, Mehdi R. M.; Ullman, Karin; Mottahedin, Amin; Detournay, Olivier; Baule, Claudia] Natl Vet Inst SVA, Dept Virol Immunobiol & Parasitol, Joint R&D Div Virol, Uppsala, Sweden; [Jensen, Trine H.; Chriel, Mariann; Hammer, Anne Sofie] Tech Univ Denmark, Natl Vet Inst, Div Vet Diagnost & Res, Copenhagen, Denmark; [Munir, Muhammad] Swedish Univ Agr Sci, Div Virol, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Andersson, Anna Maria] Natl Vet Inst, Dept Anim Hlth & Antimicrobial Resistance, S-75007 Uppsala, Sweden	National Veterinary Institute SVA; Technical University of Denmark; Swedish University of Agricultural Sciences; National Veterinary Institute SVA	Baule, C (corresponding author), Natl Vet Inst SVA, Dept Virol Immunobiol & Parasitol, Joint R&D Div Virol, Uppsala, Sweden.	claudia.baule@sva.se	Munir, Muhammad/T-4965-2019; Ullman, Karin/HGB-8576-2022; Andersson, Anna-Maria/F-5842-2013	Munir, Muhammad/0000-0002-7889-1398; Andersson, Anna-Maria/0000-0002-7300-1659; Andersson, Anna-Maria/0000-0002-1978-9916; Munir, Muhammad/0000-0003-4038-0370; Mottahedin, Amin/0000-0002-3677-2198	Danish Fur Breeder's Association; Department of Virology, Immunobiology and Parasitology of the National Veterinary Institute (SVA); Division of Veterinary Diagnostics and Research of the Danish Technical University (DTU-VET)	Danish Fur Breeder's Association; Department of Virology, Immunobiology and Parasitology of the National Veterinary Institute (SVA); Division of Veterinary Diagnostics and Research of the Danish Technical University (DTU-VET)	This study was funded by a Grant of the Danish Fur Breeder's Association and by internal funds from the Department of Virology, Immunobiology and Parasitology of the National Veterinary Institute (SVA) and from the Division of Veterinary Diagnostics and Research of the Danish Technical University (DTU-VET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass DM, 2000, J VIROL, V74, P1810, DOI 10.1128/JVI.74.4.1810-1814.2000; Belliot G, 1997, VIRUS RES, V49, P49, DOI 10.1016/S0168-1702(97)01457-3; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Bonaparte RS, 2008, J VIROL, V82, P817, DOI 10.1128/JVI.01847-07; Caballero S, 2004, J VIROL, V78, P13285, DOI 10.1128/JVI.78.23.13285-13292.2004; Ulloa JC, 2010, CAN J MICROBIOL, V56, P569, DOI [10.1139/W10-042, 10.1139/w10-042]; CHAPMAN MS, 1993, VIROLOGY, V195, P745, DOI 10.1006/viro.1993.1425; Dalton RM, 2003, J VIROL, V77, P9094, DOI 10.1128/JVI.77.16.9094-9098.2003; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; Englund L, 2002, VET MICROBIOL, V85, P1, DOI 10.1016/S0378-1135(01)00472-2; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Finkbeiner SR, 2009, EMERG INFECT DIS, V15, P441, DOI 10.3201/eid1503.081213; Geigenmuller U, 2002, J VIROL, V76, P2003, DOI 10.1128/JVI.76.4.2003-2008.2002; GOUGH RE, 1984, VET REC, V114, P279, DOI 10.1136/vr.114.11.279-a; Gronemus JQ, 2010, MOL IMMUNOL, V48, P305, DOI 10.1016/j.molimm.2010.07.012; Guix S, 2004, VIROLOGY, V319, P249, DOI 10.1016/j.virol.2003.10.036; Hair PS, 2010, MOL IMMUNOL, V47, P792, DOI 10.1016/j.molimm.2009.10.006; HENRIKSEN P, 1987, Dansk Veterinaertidsskrift, V70, P580; Imada T, 2000, J VIROL, V74, P8487, DOI 10.1128/JVI.74.18.8487-8493.2000; JIANG BM, 1993, P NATL ACAD SCI USA, V90, P10539, DOI 10.1073/pnas.90.22.10539; Jonassen CM, 2001, J GEN VIROL, V82, P1061, DOI 10.1099/0022-1317-82-5-1061; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; Kaufman RJ, 2000, MOL BIOTECHNOL, V16, P151, DOI 10.1385/MB:16:2:151; Kim HJ, 2013, BIOTECHNOL LETT, V35, P413, DOI 10.1007/s10529-012-1097-y; Koci MD, 2000, J VIROL METHODS, V90, P79, DOI 10.1016/S0166-0934(00)00228-7; Koci MD, 2003, J VIROL, V77, P11798, DOI 10.1128/JVI.77.21.11798-11808.2003; Krishna NK, 2008, ADV EXP MED BIOL, V632, P237, DOI 10.1007/978-0-387-78952-1_17; LEWIS TL, 1994, J VIROL, V68, P77, DOI 10.1128/JVI.68.1.77-83.1994; Lukashov VV, 2002, J GEN VIROL, V83, P1397, DOI 10.1099/0022-1317-83-6-1397; Luo ZY, 2011, VET MICROBIOL, V149, P316, DOI 10.1016/j.vetmic.2010.11.026; Mendez E, 2004, J VIROL, V78, P8601, DOI 10.1128/JVI.78.16.8601-8608.2004; Mendez E, 2003, J VIROL, V77, P11378, DOI 10.1128/JVI.77.21.11378-11384.2003; Mendez E, 2002, J VIROL, V76, P7996, DOI 10.1128/JVI.76.16.7996-8002.2002; Mendez E, 2007, J VIROL, V81, P10649, DOI 10.1128/JVI.00785-07; Mendez-Toss M, 2000, J GEN VIROL, V81, P2891, DOI 10.1099/0022-1317-81-12-2891; Mittelholzer C, 2003, J GEN VIROL, V84, P3087, DOI 10.1099/vir.0.19267-0; MONROE SS, 1993, J VIROL, V67, P3611, DOI 10.1128/JVI.67.6.3611-3614.1993; MONROE SS, 1991, J VIROL, V65, P641, DOI 10.1128/JVI.65.2.641-648.1991; Moser LA, 2005, VIRAL IMMUNOL, V18, P4, DOI 10.1089/vim.2005.18.4; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; REYNOLDS DL, 1986, AVIAN DIS, V30, P728, DOI 10.2307/1590577; SANCHEZFAUQUIER A, 1994, VIROLOGY, V201, P312, DOI 10.1006/viro.1994.1296; SCHNEIDER RR, 1993, CAN VET J, V34, P159; Sellers H, 2010, VACCINE, V28, P1253, DOI 10.1016/j.vaccine.2009.11.016; SHIMIZU M, 1990, J CLIN MICROBIOL, V28, P201, DOI 10.1128/JCM.28.2.201-206.1990; SNODGRASS DR, 1977, ARCH VIROL, V55, P287, DOI 10.1007/BF01315050; Tse H, 2011, J GEN VIROL, V92, P1888, DOI 10.1099/vir.0.030817-0; Walter JE, 2000, CURR OPIN PEDIATR, V12, P275, DOI 10.1097/00008480-200006000-00018; Wang QH, 2001, J MED VIROL, V64, P245, DOI 10.1002/jmv.1043; Wang Q, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/732017; WILLCOCKS MM, 1994, J GEN VIROL, V75, P1785, DOI 10.1099/0022-1317-75-7-1785; Zhi N, 2010, J VIROL, V84, P13059, DOI 10.1128/JVI.00912-10	54	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82978	10.1371/journal.pone.0082978	http://dx.doi.org/10.1371/journal.pone.0082978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376619	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000049
J	Chiaruttini, N; Letellier, L; Viasnoff, V				Chiaruttini, Nicolas; Letellier, Lucienne; Viasnoff, Virgile			A Novel Method to Couple Electrophysiological Measurements and Fluorescence Imaging of Suspended Lipid Membranes: The Example of T5 Bacteriophage DNA Ejection	PLOS ONE			English	Article							GIANT UNILAMELLAR VESICLES; COLI OUTER-MEMBRANE; BACTERIOPHAGE-LAMBDA; PHAGE-LAMBDA; FHUA; RECONSTITUTION; PROTEIN; TRANSPORTER; BINDING; LIPOSOMES	We present an innovative method to couple electrophysiological measurements with fluorescence imaging of functionalized suspended bilayers. Our method combines several advantages: it is well suited to study transmembrane proteins that are difficult to incorporate in suspended bilayers, it allows single molecule resolution both in terms of electrophysiological measurements and fluorescence imaging, and it enables mechanical stimulations of the membrane. The approach comprises of two steps: first the reconstitution of membrane proteins in giant unilamellar vesicles; then the formation of a suspended bilayer spanning a 5 to 15 micron-wide aperture that can be visualized by high NA microscope objectives. We exemplified how the technique can be used to detect in real time the translocation of T5 DNA across the bilayer during its ejection from the bacteriophage capsid.	[Chiaruttini, Nicolas; Viasnoff, Virgile] ESPCI Paristech, CNRS, Paris, France; [Chiaruttini, Nicolas; Viasnoff, Virgile] Univ Geneva, Dept Biochem, Aurelien Roux Lab, CH-1211 Geneva, Switzerland; [Chiaruttini, Nicolas; Viasnoff, Virgile] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, CNRS, Orsay, France; [Viasnoff, Virgile] MechanoBiol Inst Singapore, Singapore, Singapore	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); University of Geneva; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Chiaruttini, N (corresponding author), ESPCI Paristech, CNRS, Paris, France.	nicolas.chiaruttini@gmail.com	viasnoff, virgile/H-8832-2012	viasnoff, virgile/0000-0003-3949-2244	ANR [ANR-06-PCVI-0002]; French ministry of research	ANR(French National Research Agency (ANR)); French ministry of research(Ministry of Research, FranceEuropean Commission)	This project was funded by the ANR grant Virnanomotor (ANR-06-PCVI-0002) and by the French ministry of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025529; Andres D, 2012, MOL MICROBIOL, V83, P1244, DOI 10.1111/j.1365-2958.2012.08006.x; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Bernard AL, 2002, BBA-BIOMEMBRANES, V1567, P1, DOI 10.1016/S0005-2736(02)00617-X; Berrier C, 2000, FEBS LETT, V476, P129, DOI 10.1016/S0014-5793(00)01705-1; Bertin A, 2011, CURR OPIN MICROBIOL, V14, P492, DOI 10.1016/j.mib.2011.07.010; Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9; Bonhivers M, 1996, EMBO J, V15, P1850, DOI 10.1002/j.1460-2075.1996.tb00535.x; Borisenko V, 2003, BIOPHYS J, V84, P612, DOI 10.1016/S0006-3495(03)74881-4; Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673; Chiaruttini N, 2010, BIOPHYS J, V99, P447, DOI 10.1016/j.bpj.2010.04.048; Dezi M, 2013, P NATL ACAD SCI USA, V110, P7276, DOI 10.1073/pnas.1303857110; Eriksson M, 2007, J PHYS CHEM B, V111, P1139, DOI 10.1021/jp064322m; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Evans E, 2003, BIOPHYS J, V85, P2342, DOI 10.1016/S0006-3495(03)74658-X; Flayhan A, 2012, BIOCHIMIE, V94, P1982, DOI 10.1016/j.biochi.2012.05.021; Girard P, 2004, BIOPHYS J, V87, P419, DOI 10.1529/biophysj.104.040360; Gornall JL, 2011, NANO LETT, V11, P3334, DOI 10.1021/nl201707d; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; Gurnev PA, 2006, J MOL BIOL, V359, P1447, DOI 10.1016/j.jmb.2006.04.034; Hamai C, 2007, BIOPHYS J, V92, P1988, DOI 10.1529/biophysj.106.093831; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Heron AJ, 2007, J AM CHEM SOC, V129, P16042, DOI 10.1021/ja075715h; Honigmann A, 2010, BIOPHYS J, V98, P2886, DOI 10.1016/j.bpj.2010.03.033; Ide T, 2002, SINGLE MOL, V3, P33, DOI 10.1002/1438-5171(200204)3:1<33::AID-SIMO33>3.0.CO;2-U; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kodandaramaiah SB, 2012, NAT METHODS, V9, P585, DOI [10.1038/NMETH.1993, 10.1038/nmeth.1993]; Lambert O, 1998, MOL MICROBIOL, V30, P761, DOI 10.1046/j.1365-2958.1998.01107.x; Letellier L, 1999, RES MICROBIOL, V150, P499, DOI 10.1016/S0923-2508(99)00107-2; Mangenot S, 2005, CURR BIOL, V15, P430, DOI 10.1016/j.cub.2004.12.080; Mohammad MM, 2012, J AM CHEM SOC, V134, P9521, DOI 10.1021/ja3043646; Mohammad MM, 2011, J BIOL CHEM, V286, P8000, DOI 10.1074/jbc.M110.197723; Montes LR, 2007, BIOPHYS J, V93, P3548, DOI 10.1529/biophysj.107.116228; NOVICK SL, 1988, BIOCHEMISTRY-US, V27, P7919, DOI 10.1021/bi00420a050; Plancon L, 2002, J MOL BIOL, V318, P557, DOI 10.1016/S0022-2836(02)00089-X; Plancon L, 1997, J BIOL CHEM, V272, P16868, DOI 10.1074/jbc.272.27.16868; Pott T, 2008, CHEM PHYS LIPIDS, V154, P115, DOI 10.1016/j.chemphyslip.2008.03.008; Ramadurai S, 2009, J AM CHEM SOC, V131, P12650, DOI 10.1021/ja902853g; Richmond DL, 2011, P NATL ACAD SCI USA, V108, P9431, DOI 10.1073/pnas.1016410108; Robertson JWF, 2007, P NATL ACAD SCI USA, V104, P8207, DOI 10.1073/pnas.0611085104; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sonnleitner A, 2002, P NATL ACAD SCI USA, V99, P12759, DOI 10.1073/pnas.192261499; Udho E, 2012, BIOCHEMISTRY-US, V51, P6753, DOI 10.1021/bi300493u; Udho E, 2009, P NATL ACAD SCI USA, V106, P21990, DOI 10.1073/pnas.0910023106; Ursell T, 2011, BIOPHYS J, V101, P1913, DOI 10.1016/j.bpj.2011.08.057; Van Valen D, 2012, CURR BIOL, V22, P1339, DOI 10.1016/j.cub.2012.05.023; Varnier A, 2010, J MEMBRANE BIOL, V233, P85, DOI 10.1007/s00232-010-9227-8; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; Wu D, 2010, BIOPHYS J, V99, P1101, DOI 10.1016/j.bpj.2010.06.024	49	5	5	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84376	10.1371/journal.pone.0084376	http://dx.doi.org/10.1371/journal.pone.0084376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376806	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000146
J	Horowitz, G; Amit, M; Ben-Ari, O; Gil, Z; Abergel, A; Margalit, N; Cavel, O; Wasserzug, O; Fliss, DM				Horowitz, Gilad; Amit, Moran; Ben-Ari, Oded; Gil, Ziv; Abergel, Abraham; Margalit, Nevo; Cavel, Oren; Wasserzug, Oshri; Fliss, Dan M.			Cranialization of the Frontal Sinus for Secondary Mucocele Prevention following Open Surgery for Benign Frontal Lesions	PLOS ONE			English	Article							SKULL BASE; OSTEOPLASTIC FLAP; PERICRANIAL FLAP; OBLITERATION; FRACTURES; MANAGEMENT; RECONSTRUCTION; COMPLICATIONS; DIAGNOSIS; ALGORITHM	Objective: To compare frontal sinus cranialization to obliteration for future prevention of secondary mucocele formation following open surgery for benign lesions of the frontal sinus. Study Design: Retrospective case series. Setting: Tertiary academic medical center. Patients: Sixty-nine patients operated for benign frontal sinus pathology between 1994 and 2011. Interventions: Open excision of benign frontal sinus pathology followed by either frontal obliteration (n = 41, 59%) or frontal cranialization (n = 28, 41%). Main Outcome Measures: The prevalence of post-surgical complications and secondary mucocele formation were compiled. Results: Pathologies included osteoma (n = 34, 49%), mucocele (n = 27, 39%), fibrous dysplasia (n = 6, 9%), and encephalocele (n = 2, 3%). Complications included skin infections (n = 6), postoperative cutaneous fistula (n = 1), telecanthus (n = 4), diplopia (n = 3), nasal deformity (n = 2) and epiphora (n = 1). None of the patients suffered from postoperative CSF leak, meningitis or pneumocephalus. Six patients, all of whom had previously undergone frontal sinus obliteration, required revision surgery due to secondary mucocele formation. Statistical analysis using non-inferiority test reveal that cranialization of the frontal sinus is non-inferior to obliteration for preventing secondary mucocele formation (P<0.0001). Conclusion: Cranialization of the frontal sinus appears to be a good option for prevention of secondary mucocele development after open excision of benign frontal sinus lesions.	[Horowitz, Gilad; Ben-Ari, Oded; Abergel, Abraham; Cavel, Oren; Wasserzug, Oshri; Fliss, Dan M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Otolaryngol Head & Neck & Maxillofacial Surg, IL-69978 Tel Aviv, Israel; [Amit, Moran; Gil, Ziv] Rambam Med Ctr, Dept Otolaryngol & Head & Neck Surg, Haifa, Israel; [Margalit, Nevo] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurosurg, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Fliss, DM (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Otolaryngol Head & Neck & Maxillofacial Surg, IL-69978 Tel Aviv, Israel.	danf@tasmc.health.gov.il	Ben-Ari, Oded/AAX-9712-2020	Cavel, Oren/0000-0002-3535-8913				Bell RB, 2007, J ORAL MAXIL SURG, V65, P825, DOI 10.1016/j.joms.2006.05.058; CATALANO PJ, 1991, OTOLARYNG HEAD NECK, V104, P225, DOI 10.1177/019459989110400211; Constantinidis J, 2000, HNO, V48, P361, DOI 10.1007/s001060050581; DONALD PJ, 1982, ARCH OTOLARYNGOL, V108, P142; DONALD PJ, 1978, LARYNGOSCOPE, V88, P225, DOI 10.1288/00005537-197802000-00002; Donath A, 2006, LARYNGOSCOPE, V116, P1585, DOI 10.1097/01.mlg.0000232514.31101.39; El Khatib K, 2004, J CRANIO MAXILL SURG, V32, P314, DOI 10.1016/j.jcms.2004.04.007; Fliss DM, 2007, ARCH OTOLARYNGOL, V133, P888, DOI 10.1001/archotol.133.9.888; Fliss Dan M, 2002, Neurosurg Focus, V12, pe10; Fliss DM, 1999, LARYNGOSCOPE, V109, P153, DOI 10.1097/00005537-199901000-00029; Georgalas C, 2011, OTOLARYNG CLIN N AM, V44, P875, DOI 10.1016/j.otc.2011.06.008; Gil Z, 2003, OTOLARYNG HEAD NECK, V128, P43, DOI 10.1067/mhn.2003.14; Gil Z, 2007, SKULL BASE-INTERD AP, V17, P25, DOI 10.1055/s-2006-959333; Gossman DG, 2006, LARYNGOSCOPE, V116, P1357, DOI 10.1097/01.mlg.0000226009.00145.85; HARDY JM, 1976, ANN OTO RHINOL LARYN, V85, P523, DOI 10.1177/000348947608500414; LOEVNER LA, 1995, AM J NEURORADIOL, V16, P1721; Lothrop HA, 1914, ANN SURG, V59, P937, DOI 10.1097/00000658-191406000-00014; Moshaver A, 2006, OTOLARYNG HEAD NECK, V135, P413, DOI 10.1016/j.otohns.2006.03.041; Murphy J, 2004, J LARYNGOL OTOL, V118, P637, DOI 10.1258/0022215041917943; Parhiscar A, 2001, OTOLARYNG HEAD NECK, V124, P304, DOI 10.1067/mhn.2001.113662; Peltola MJ, 2003, J BIOMED MATER RES B, V66B, P364, DOI 10.1002/jbm.b.10023; Petruzzelli GJ, 2002, LARYNGOSCOPE, V112, P32, DOI 10.1097/00005537-200201000-00006; Rodriguez ED, 2008, PLAST RECONSTR SURG, V122, P1850, DOI 10.1097/PRS.0b013e31818d58ba; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; SCHENCK NL, 1976, ARCH OTOLARYNGOL, V102, P524; SHUMRICK KA, 1994, ARCH OTOLARYNGOL, V120, P1003; Sivori LA, 2010, J ORAL MAXIL SURG, V68, P2041, DOI 10.1016/j.joms.2010.05.041; van Dijk JMC, 2012, J NEUROSURG, V116, P531, DOI 10.3171/2011.11.JNS101849; WALLIS A, 1988, LARYNGOSCOPE, V98, P593; Weber R., 1999, Rhinology (Utrecht), V37, P1; Weber R, 2000, LARYNGOSCOPE, V110, P1037, DOI 10.1097/00005537-200006000-00028; Weber R, 2001, LARYNGOSCOPE, V111, P137, DOI 10.1097/00005537-200101000-00024; WOLFE SA, 1988, PLAST RECONSTR SURG, V82, P781, DOI 10.1097/00006534-198811000-00009; Wormald PJ, 2003, LARYNGOSCOPE, V113, P1988, DOI 10.1097/00005537-200311000-00025; Wormald PJ, 2003, LARYNGOSCOPE, V113, P276, DOI 10.1097/00005537-200302000-00015; Xie C, 2000, J Craniomaxillofac Trauma, V6, P7; Xie C, 2000, J CRANIOMAXILLOFAC T, V6, P16	37	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83820	10.1371/journal.pone.0083820	http://dx.doi.org/10.1371/journal.pone.0083820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376760	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000120
J	Iwashiro, N; Yahata, N; Kawamuro, Y; Kasai, K; Yamasue, H				Iwashiro, Norichika; Yahata, Noriaki; Kawamuro, Yu; Kasai, Kiyoto; Yamasue, Hidenori			Aberrant Interference of Auditory Negative Words on Attention in Patients with Schizophrenia	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; GRAY-MATTER VOLUME; EMOTIONAL PROSODY; ANGRY PROSODY; PERCEPTION; BRAIN; METAANALYSIS; RESPONSES; INDIVIDUALS; PREFERENCE	Previous research suggests that deficits in attention-emotion interaction are implicated in schizophrenia symptoms. Although disruption in auditory processing is crucial in the pathophysiology of schizophrenia, deficits in interaction between emotional processing of auditorily presented language stimuli and auditory attention have not yet been clarified. To address this issue, the current study used a dichotic listening task to examine 22 patients with schizophrenia and 24 age-, sex-, parental socioeconomic background-, handedness-, dexterous ear-, and intelligence quotient-matched healthy controls. The participants completed a word recognition task on the attended side in which a word with emotionally valenced content (negative/positive/neutral) was presented to one ear and a different neutral word was presented to the other ear. Participants selectively attended to either ear. In the control subjects, presentation of negative but not positive word stimuli provoked a significantly prolonged reaction time compared with presentation of neutral word stimuli. This interference effect for negative words existed whether or not subjects directed attention to the negative words. This interference effect was significantly smaller in the patients with schizophrenia than in the healthy controls. Furthermore, the smaller interference effect was significantly correlated with severe positive symptoms and delusional behavior in the patients with schizophrenia. The present findings suggest that aberrant interaction between semantic processing of negative emotional content and auditory attention plays a role in production of positive symptoms in schizophrenia. (224 words)	[Iwashiro, Norichika; Yahata, Noriaki; Kasai, Kiyoto; Yamasue, Hidenori] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo, Japan; [Yahata, Noriaki] Univ Tokyo, Global Ctr Excellence COE Program, Bunkyo Ku, Tokyo, Japan; [Kawamuro, Yu] Takada Nishishiro Hosp, Joetsu, Niigata, Japan; [Kasai, Kiyoto] NBDC, JST, Chiyoda Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Iwashiro, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo, Japan.	iwashiro-tky@umin.ac.jp; yamasue-tky@umin.ac.jp		Kasai, Kiyoto/0000-0002-4443-4535	KAKENHI [22689034]; Global Center of Excellence (COE) Program "Comprehensive Center of Education and Research for Chemical Biology of the Diseases''; National Bioscience Database Center (NBDC) of Japan Science and Technology Agency (JST)	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global Center of Excellence (COE) Program "Comprehensive Center of Education and Research for Chemical Biology of the Diseases''; National Bioscience Database Center (NBDC) of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	Part of this study was supported by KAKENHI (22689034 to H. Y.), the Global Center of Excellence (COE) Program "Comprehensive Center of Education and Research for Chemical Biology of the Diseases'' (N. Y.) and National Bioscience Database Center (NBDC) of Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba-Ferrara L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00059; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Angrilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004507; [Anonymous], 1999, C1 CTR RES PSYCH, DOI DOI 10.1002/PER.2410010304; Aue T, 2011, PSYCHOPHYSIOLOGY, V48, P385, DOI 10.1111/j.1469-8986.2010.01064.x; Bach DR, 2009, PSYCHOL MED, V39, P927, DOI 10.1017/S0033291708004704; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Besnier N, 2011, PSYCHOPATHOLOGY, V44, P1, DOI 10.1159/000322097; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; BRYSBAERT M, 1994, CORTEX, V30, P413, DOI 10.1016/S0010-9452(13)80338-3; Buchanan TW, 2007, PSYCHOL BULL, V133, P761, DOI 10.1037/0033-2909.133.5.761; Carraro L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026456; COREN S, 1993, B PSYCHONOMIC SOC, V31, P1, DOI 10.3758/bf03334122; DeLisi LE, 2001, SCHIZOPHRENIA BULL, V27, P481, DOI 10.1093/oxfordjournals.schbul.a006889; Demily C, 2010, EUR PSYCHIAT, V25, P75, DOI 10.1016/j.eurpsy.2009.02.003; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Dollfus S, 2008, SCHIZOPHR RES, V99, P304, DOI 10.1016/j.schres.2007.11.016; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fear C, 1996, BRIT J PSYCHIAT, V168, P61, DOI 10.1192/bjp.168.1.61; First M. B., 1997, STRUCTURED CLIN INTE; Fisher M, 2009, AM J PSYCHIAT, V166, P805, DOI 10.1176/appi.ajp.2009.08050757; Francis AN, 2012, SCHIZOPHR RES, V141, P65, DOI 10.1016/j.schres.2012.07.015; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Gaillard R, 2006, P NATL ACAD SCI USA, V103, P7524, DOI 10.1073/pnas.0600584103; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Green MJ, 2004, NEUROSCI BIOBEHAV R, V28, P333, DOI 10.1016/j.neubiorev.2004.03.006; Hahn B, 2010, BIOL PSYCHIAT, V68, P603, DOI 10.1016/j.biopsych.2010.04.014; Hollingshead AB., 1957, 2 FACTOR INDEX SOCIA; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P11, DOI 10.1111/j.1467-9450.2008.00676.x; Ikegami A, 1998, DAIJISEN; Ikehara S., 1999, GOI TAIKEI JAPANESE; Irani F, 2012, SCHIZOPHR RES, V137, P203, DOI 10.1016/j.schres.2012.01.023; Iwashiro N, 2012, SCHIZOPHR RES, V137, P124, DOI 10.1016/j.schres.2012.02.024; Jung WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051975; Kasai K, 2003, AM J PSYCHIAT, V160, P156, DOI 10.1176/appi.ajp.160.1.156; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KINDERMAN P, 1994, BRIT J MED PSYCHOL, V67, P53, DOI 10.1111/j.2044-8341.1994.tb01770.x; Koeda M, 2006, BIOL PSYCHIAT, V59, P948, DOI 10.1016/j.biopsych.2006.01.013; Leitman DI, 2007, AM J PSYCHIAT, V164, P474, DOI 10.1176/appi.ajp.164.3.474; Li XB, 2009, CURR OPIN PSYCHIATR, V22, P131, DOI 10.1097/YCO.0b013e328324bc43; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Matsuoka K., 2006, JAPANESE ADULT READI; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; Mitchell RLC, 2005, BRAIN, V128, P963, DOI 10.1093/brain/awh466; Miyanishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061152; Moncrieff J, 2010, PSYCHOL MED, V40, P1409, DOI 10.1017/S0033291709992297; Ngan ETC, 2003, NEUROIMAGE, V20, P889, DOI 10.1016/S1053-8119(03)00385-9; Nishitani N, 2005, PHYSIOLOGY, V20, P60, DOI 10.1152/physiol.00043.2004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park SH, 2011, PSYCHIAT RES, V187, P18, DOI 10.1016/j.psychres.2010.11.007; Polemikos N, 2000, PERCEPT MOTOR SKILL, V91, P1083, DOI 10.2466/PMS.91.7.1083-1090; Rajji TK, 2008, SCHIZOPHR RES, V102, P122, DOI 10.1016/j.schres.2008.03.015; Rao NP, 2010, PSYCHIAT RES, V180, P99, DOI 10.1016/j.psychres.2009.10.017; Roux P, 2010, NEUROPSYCHOLOGIA, V48, P3642, DOI 10.1016/j.neuropsychologia.2010.08.021; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Sass K, 2012, HUM BRAIN MAPP; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; Schneider F, 2006, PSYCHIAT RES, V144, P123, DOI 10.1016/j.psychres.2004.12.013; Smith DM, 2013, CLIN NEUROPHYSIOL, V124, P1329, DOI 10.1016/j.clinph.2013.02.004; Strauss GP, 2011, SCHIZOPHR RES, V131, P219, DOI 10.1016/j.schres.2011.06.001; Suga M, 2010, EUR ARCH PSY CLIN N, V260, P465, DOI 10.1007/s00406-009-0094-1; Sumich A, 2005, BIOL PSYCHIAT, V57, P947, DOI 10.1016/j.biopsych.2004.12.041; Takahashi T, 2009, ARCH GEN PSYCHIAT, V66, P366, DOI 10.1001/archgenpsychiatry.2009.12; Tandon R, 2009, SCHIZOPHR RES, V110, P1, DOI 10.1016/j.schres.2009.03.005; Taylor SF, 2012, BIOL PSYCHIAT, V71, P136, DOI 10.1016/j.biopsych.2011.09.007; Uetsuki M., 2006, SEISHIN IGAKU, V48, P15; ULLMANN L. P., 1969, PSYCHOL APPROACH ABN; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025435; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Yamasaki S, 2007, EUR ARCH PSY CLIN N, V257, P318, DOI 10.1007/s00406-007-0723-5	74	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83201	10.1371/journal.pone.0083201	http://dx.doi.org/10.1371/journal.pone.0083201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	278IG	24376662	Green Submitted, gold, Green Published			2022-12-27	WOS:000328882000068
J	Takahashi, N; Watanabe, S; Wakasugi, K				Takahashi, Nozomu; Watanabe, Seiji; Wakasugi, Keisuke			Crucial Roles of Glu60 in Human Neuroglobin as a Guanine Nucleotide Dissociation Inhibitor and Neuroprotective Agent	PLOS ONE			English	Article							VERTEBRATE GLOBIN FAMILY; OXIDATIVE STRESS; ZEBRAFISH NEUROGLOBIN; MASS-SPECTROMETRY; LIGAND-BINDING; MESSENGER-RNA; PROTEIN; CELLS; CYTOGLOBIN; BRAIN	Mammalian neuroglobin (Ngb) protects neuronal cells under conditions of oxidative stress. We previously showed that human Ngb acts as a guanine nucleotide dissociation inhibitor (GDI) for the alpha-subunits of heterotrimeric G(i/o) proteins and inhibits reductions in cAMP concentration, leading to protection against cell death. In the present study, we created human E60Q Ngb mutant and clarified that Glu60 of human Ngb is a crucial residue for its GDI and neuroprotective activities. Moreover, we investigated structural and functional properties of several human Ngb mutants and demonstrated that the neuroprotective effect of human Ngb is due to its GDI activity and not due to its scavenging activity against reactive oxygen species.	[Takahashi, Nozomu; Watanabe, Seiji; Wakasugi, Keisuke] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan	University of Tokyo	Wakasugi, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan.	wakasugi@bio.c.u-tokyo.ac.jp	Wakasugi, Keisuke/AAQ-1642-2020	Watanabe, Seiji/0000-0001-8038-7919; Wakasugi, Keisuke/0000-0002-8408-5616	PRESTO program of Japan Science and Technology (JST); Fuji Foundation for Protein Research; Ministry of Education, Culture, Sports, Science and Technology of Japan [23117704]; JSPS; Grants-in-Aid for Scientific Research [25860252] Funding Source: KAKEN	PRESTO program of Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)); Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the PRESTO program of Japan Science and Technology (JST) (to K. W.), the Fuji Foundation for Protein Research (to K. W.), and a Grant-in-Aid for Scientific Research on Innovative Areas (No. 23117704) (to K. W.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. S. W. was supported by the JSPS Research Fellowships for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Anselmi M, 2007, BIOPHYS J, V93, P434, DOI 10.1529/biophysj.106.099648; Austin RJ, 2008, J MOL BIOL, V377, P1406, DOI 10.1016/j.jmb.2008.01.032; Awenius C, 2001, BIOCHEM BIOPH RES CO, V287, P418, DOI 10.1006/bbrc.2001.5614; Brunori M, 2006, FASEB J, V20, P2192, DOI 10.1096/fj.06-6643rev; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Fuchs C, 2004, J BIOL CHEM, V279, P24116, DOI 10.1074/jbc.M402011200; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Greenberg D. A., 2007, CURR OPIN PHARMACOL, V8, P1; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Ja WW, 2005, J BIOL CHEM, V280, P32057, DOI 10.1074/jbc.C500319200; Ja WW, 2004, BIOCHEMISTRY-US, V43, P9265, DOI 10.1021/bi0498398; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Kamioka Y, 2013, BBA-PROTEINS PROTEOM, V1834, P1779, DOI 10.1016/j.bbapap.2013.02.021; Kitatsuji C, 2007, J MOL BIOL, V368, P150, DOI 10.1016/j.jmb.2007.02.002; Lardinois OM, 2008, BIOCHEMISTRY-US, V47, P10440, DOI 10.1021/bi800771k; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Li WG, 2011, PROTEINS, V79, P115, DOI 10.1002/prot.22863; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nienhaus K, 2007, IUBMB LIFE, V59, P490, DOI 10.1080/15216540601188538; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Reuss S, 2002, NEUROSCIENCE, V115, P645, DOI 10.1016/S0306-4522(02)00536-5; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Wakasugi K, 2005, ANN NY ACAD SCI, V1053, P220, DOI 10.1196/annals.1344.020; Wakasugi K, 2005, BIOCHEM BIOPH RES CO, V330, P591, DOI 10.1016/j.bbrc.2005.03.021; Wakasugi K, 2005, BIOCHEMISTRY-US, V44, P2943, DOI 10.1021/bi0477539; Wakasugi K, 2004, BIOCHEM BIOPH RES CO, V318, P453, DOI 10.1016/j.bbrc.2004.04.045; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Wakasugi K., 2011, AM J NEUROPROTEC NEU, V3, P42; Wakasugi K, 2011, MAR GENOM, V4, P137, DOI 10.1016/j.margen.2011.03.001; Watanabe S, 2008, BIOCHEMISTRY-US, V47, P5266, DOI 10.1021/bi800286m; Watanabe S, 2008, BIOCHEM BIOPH RES CO, V369, P695, DOI 10.1016/j.bbrc.2008.02.089; Watanabe S, 2012, J BIOL CHEM, V287, P30128, DOI 10.1074/jbc.M112.373381; Willard FS, 2006, BIOCHEM BIOPH RES CO, V339, P1107, DOI 10.1016/j.bbrc.2005.11.132	41	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83698	10.1371/journal.pone.0083698	http://dx.doi.org/10.1371/journal.pone.0083698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376733	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000108
J	Yu, SY; Sun, L; Liu, Z; Huang, XY; Zuo, LJ; Cao, CJ; Zhang, W; Wang, XM				Yu, Shu-yang; Sun, Li; Liu, Zhuo; Huang, Xi-yan; Zuo, Li-jun; Cao, Chen-jie; Zhang, Wei; Wang, Xiao-min			Sleep Disorders in Parkinson's Disease: Clinical Features, Iron Metabolism and Related Mechanism	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; RHEUMATOID-ARTHRITIS; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; DISTURBANCES; QUALITY; PATHOLOGY; ALPHA	Objective: To investigate clinical features, iron metabolism and neuroinflammation in Parkinson's disease (PD) patients with sleep disorders (SD). Methods: 211 PD patients were evaluated by Pittsburgh Sleep Quality Index (PSQI) and a body of scales for motor symptoms and non-motor symptoms. 94 blood and 38 cerebral spinal fluid (CSF) samples were collected and iron and its metabolism-relating proteins, neuroinflammatory factors were detected and analyzed. Results: 136 cases (64.5%) of PD patients were accompanied by SD. Factor with the highest score in PSQI was daytime dysfunction. Depression, restless leg syndrome, autonomic symptoms and fatigue contributed 68.6% of the variance of PSQI score. Transferrin level in serum and tumor necrosis factor-alpha level in CSF decreased, and the levels of iron, transferrin, lactoferrin and prostaglandin E-2 in CSF increased in PD patients with SD compared with those without SD. In CSF, prostaglandin E-2 level was positively correlated with the levels of transferrin and lactoferrin, and tumor necrosis factor-alpha level was negatively correlated with the levels of iron, transferrin and lactoferrin in CSF. Conclusions: Depression, restless leg syndrome, autonomic disorders and fatigue are the important contributors for the poor sleep in PD patients. Abnormal iron metabolism may cause excessive iron deposition in brain and be related to SD in PD patients through dual potential mechanisms, including neuroinflammation by activating microglia and neurotoxicity by targeting neurons. Hence, inhibition of iron deposition-related neuroinflammation and neurotoxicity may cast a new light for drug development for SD in PD patients.	[Yu, Shu-yang; Sun, Li; Liu, Zhuo; Huang, Xi-yan; Zuo, Li-jun; Cao, Chen-jie; Zhang, Wei] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Xiao-min] Capital Med Univ, Dept Physiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhang, W (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	ttyyzw@163.com			National Basic Research Program of China [2011CB504100]; National Natural Science Foundation of China [81071015, 81030062]; High Level Technical Personnel Training Project of Beijing Health System [2009-3-26]; Capital Clinical Characteristic Application Research [Z121107001012161]; Capital Medical University [10JL49]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Level Technical Personnel Training Project of Beijing Health System; Capital Clinical Characteristic Application Research; Capital Medical University	This work was supported by the National Basic Research Program of China (2011CB504100, http://www.973.gov.cn/AreaAppl.aspx), the National Natural Science Foundation of China (81071015, http://www.nsfc.gov.cn/Portal0/default152.htm), High Level Technical Personnel Training Project of Beijing Health System (2009-3-26, http://www.bjwsrc.org/hhrnew/), Capital Clinical Characteristic Application Research (Z121107001012161, http://www.bjkw.gov.cn/n8785584/index.html), the National Natural Science Foundation of China (81030062, http://www.nsfc.gov.cn/Portal0/default152.htm), and Basic-Clinical Research Cooperation Funding of Capital Medical University (10JL49, http://www.ccmu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Arreguin S, 2009, J INORG BIOCHEM, V103, P87, DOI 10.1016/j.jinorgbio.2008.09.007; Boddy F, 2007, INT J GERIATR PSYCH, V22, P529, DOI 10.1002/gps.1709; Borie C, 2002, J NEUROL, V249, P801, DOI 10.1007/s00415-002-0704-6; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Diederich NJ, 2012, J NEUROL SCI, V314, P12, DOI 10.1016/j.jns.2011.10.025; Febbraro F, 2013, EXP NEUROL; Fragiadaki K, 2012, J RHEUMATOL, V39, P60, DOI 10.3899/jrheum.110617; Haack M, 2009, PAIN, V145, P136, DOI 10.1016/j.pain.2009.05.029; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kaynak D, 2005, EUR J NEUROL, V12, P199, DOI 10.1111/j.1468-1331.2004.00971.x; Menza M, 2010, MOVEMENT DISORD, V25, pS117, DOI 10.1002/mds.22788; Murillo-Rodriguez Eric, 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P38; OESTREICHER E, 1994, BRAIN RES, V660, P8, DOI 10.1016/0006-8993(94)90833-8; Ondo WG, 2002, ARCH NEUROL-CHICAGO, V59, P421, DOI 10.1001/archneur.59.3.421; Pal PK, 2004, PARKINSONISM RELAT D, V10, P157, DOI 10.1016/j.parkreldis.2003.11.002; Pedroso JL, 2012, J NEUROL SCI, V319, P59, DOI 10.1016/j.jns.2012.05.015; Powers KM, 2009, PARKINSONISM RELAT D, V15, P47, DOI 10.1016/j.parkreldis.2008.03.002; Riedel O, 2010, J NEUROL, V257, P1073, DOI 10.1007/s00415-010-5465-z; Rye DB, 2004, NEUROLOGY, V63, pS2, DOI 10.1212/WNL.63.8_suppl_3.S2; Rye DB, 2000, J SLEEP RES, V9, P63, DOI 10.1046/j.1365-2869.2000.00201.x; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Scaccabarozzi A, 2000, BRIT J HAEMATOL, V110, P978, DOI 10.1046/j.1365-2141.2000.02280.x; Scaravilli T, 2003, NEUROL SCI, V24, P209, DOI 10.1007/s10072-003-0134-y; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; SIMEONOVA PP, 1995, AM J RESP CELL MOL, V12, P676, DOI 10.1165/ajrcmb.12.6.7539275; Suzuki Keisuke, 2012, Brain and Nerve (Tokyo), V64, P342; Tandberg E, 1998, MOVEMENT DISORD, V13, P895, DOI 10.1002/mds.870130606; Wells G, 2010, ANN RHEUM DIS, V69, P1768, DOI 10.1136/ard.2009.119727; Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066	31	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82924	10.1371/journal.pone.0082924	http://dx.doi.org/10.1371/journal.pone.0082924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376607	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000039
J	Dean, KE; Fields, A; Geer, MJ; King, EC; Lynch, BT; Manohar, RR; McCall, JR; Palozola, KC; Zhang, Y; Liebl, EC				Dean, Kathryn E.; Fields, April; Geer, Marcus J.; King, Eric C.; Lynch, Brian T.; Manohar, Rohan R.; McCall, Julianne R.; Palozola, Katherine C.; Zhang, Yan; Liebl, Eric C.			An Allele of Sequoia Dominantly Enhances a Trio Mutant Phenotype to Influence Drosophila Larval Behavior	PLOS ONE			English	Article							ABL TYROSINE KINASE; GENETIC INTERACTIONS; MELANOGASTER; PROTEIN; GENERATION; COVERAGE; SUBUNIT; GROWTH; AXONS	The transition of Drosophila third instar larvae from feeding, photo-phobic foragers to non-feeding photo-neutral wanderers is a classic behavioral switch that precedes pupariation. The neuronal network responsible for this behavior has recently begun to be defined. Previous genetic analyses have identified signaling components for food and light sensory inputs and neuropeptide hormonal outputs as being critical for the forager to wanderer transition. Trio is a Rho-Guanine Nucleotide Exchange Factor integrated into a variety of signaling networks including those governing axon pathfinding in early development. Sequoia is a pan-neuronally expressed zinc-finger transcription factor that governs dendrite and axon outgrowth. Using pre-pupal lethality as an endpoint, we have screened for dominant second-site enhancers of a weakly lethal trio mutant background. In these screens, an allele of sequoia has been identified. While these mutants have no obvious disruption of embryonic central nervous system architecture and survive to third in star larvae similar to controls, they retain forager behavior and thus fail to pupariate at high frequency.	[Dean, Kathryn E.; Fields, April; Geer, Marcus J.; King, Eric C.; Lynch, Brian T.; Manohar, Rohan R.; McCall, Julianne R.; Palozola, Katherine C.; Zhang, Yan; Liebl, Eric C.] Denison Univ, Dept Biol, Granville, OH 43023 USA	Denison University	Liebl, EC (corresponding author), Denison Univ, Dept Biol, Talbot Hall Biol Sci, Granville, OH 43023 USA.	liebl@denison.edu			NSF [IBN-0344053, IBN-0990239]; NIH [1R15HD059924-01]; Denison University Research Foundation; Denison's Anderson Endowment Program; Bowman Summer Scholarship Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD059924] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Denison University Research Foundation; Denison's Anderson Endowment Program; Bowman Summer Scholarship Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NSF grants IBN-0344053 and IBN-0990239 to E.C.L., NIH grant 1R15HD059924-01 to E.C.L., funds from the Denison University Research Foundation, and Denison's Anderson Endowment Program and Bowman Summer Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsley JA, 2008, DEV BIOL, V322, P46, DOI 10.1016/j.ydbio.2008.07.003; Alpatov WW, 1929, J EXP ZOOL, V52, P407, DOI 10.1002/jez.1400520303; Ashburner M, 1989, DROSOPHILA LAB HDB, P139; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bateman J, 2001, J CELL SCI, V114, P1973; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; Costanzo M, 2011, CURR OPIN BIOTECH, V22, P66, DOI 10.1016/j.copbio.2010.11.001; Ferveur JF, 2010, CURR OPIN NEUROBIOL, V20, P764, DOI 10.1016/j.conb.2010.09.007; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; Goossens T, 2011, DEVELOPMENT, V138, P1595, DOI 10.1242/dev.052787; Grueber WB, 2002, DEVELOPMENT, V129, P2867; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Gunsalus Kristin C, 2008, J Biol, V7, P8, DOI 10.1186/jbiol70; HILL KK, 1995, GENETICS, V141, P595; Iyengar B, 1999, GENETICS, V153, P1809; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; Kurusu M, 2002, DEVELOPMENT, V129, P409; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; LASKO PF, 1988, GENETICS, V120, P495; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Liebl EC, 2003, DEVELOPMENT, V130, P3217, DOI 10.1242/dev.00545; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Nichols CD, 2012, JOVE-J VIS EXP, DOI 10.3791/3795; Oishi I, 1997, J BIOL CHEM, V272, P11916, DOI 10.1074/jbc.272.18.11916; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Rayburn LYM, 2003, GENETICS, V163, P227; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Scantlebury N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010652; SOKOLOWSKI MB, 1984, ANIM BEHAV, V32, P645, DOI 10.1016/S0003-3472(84)80139-6; Strasburger EH, 1932, DROSOPHILA MELANOGAS; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Wegener C, 2011, J NEUROCHEM, V118, P581, DOI 10.1111/j.1471-4159.2010.07130.x; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yamamoto D, 2007, ADV GENET, V59, P39, DOI 10.1016/S0065-2660(07)59002-4	40	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84149	10.1371/journal.pone.0084149	http://dx.doi.org/10.1371/journal.pone.0084149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376789	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100158
J	Huang, QD; Zhang, YR; Liu, ST; Wang, W; Luo, YP				Huang, Qingda; Zhang, Yurong; Liu, Shuting; Wang, Wen; Luo, Yiping			Intraspecific Scaling of the Resting and Maximum Metabolic Rates of the Crucian Carp (Carassius auratus)	PLOS ONE			English	Article							BODY-MASS; PAGRUS-MAJOR; AEROBIC CAPACITY; RELATIVE GROWTH; MARINE TELEOST; ACTIVITY LEVEL; CELL-SIZE; HEART; LIFE; RESPIRATION	The question of how the scaling of metabolic rate with body mass (M) is achieved in animals is unresolved. Here, we tested the cell metabolism hypothesis and the organ size hypothesis by assessing the mass scaling of the resting metabolic rate (RMR), maximum metabolic rate (MMR), erythrocyte size, and the masses of metabolically active organs in the crucian carp (Carassius auratus). The M of the crucian carp ranged from 4.5 to 323.9 g, representing an approximately 72-fold difference. The RMR and MMR increased with M according to the allometric equations RMR = 0.212M(0.776) and MMR=0.753M(0.785). The scaling exponents for RMR (b(r)) and MMR (b(m)) obtained in crucian carp were close to each other. Thus, the factorial aerobic scope remained almost constant with increasing M. Although erythrocyte size was negatively correlated with both mass-specific RMR and absolute RMR adjusted to M, it and all other hematological parameters showed no significant relationship with M. These data demonstrate that the cell metabolism hypothesis does not describe metabolic scaling in the crucian carp, suggesting that erythrocyte size may not represent the general size of other cell types in this fish and the metabolic activity of cells may decrease as fish grows. The mass scaling exponents of active organs was lower than 1 while that of inactive organs was greater than 1, which suggests that the mass scaling of the RMR can be partly due to variance in the proportion of active/inactive organs in crucian carp. Furthermore, our results provide additional evidence supporting the correlation between locomotor capacity and metabolic scaling.	[Huang, Qingda; Zhang, Yurong; Liu, Shuting; Wang, Wen; Luo, Yiping] Southwest Univ, Sch Life Sci, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing, Peoples R China	Southwest University - China	Luo, YP (corresponding author), Southwest Univ, Sch Life Sci, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing, Peoples R China.	luoguo@swu.edu.cn	Luo, Yiping/L-5382-2013	Luo, Yiping/0000-0003-3312-6403	National Natural Science Foundation of China [31000958]; Chongqing Key Laboratory (CSTC)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Key Laboratory (CSTC)	This study was supported by the National Natural Science Foundation of China (31000958) and the Special Fund of Chongqing Key Laboratory (CSTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agutter PS, 2011, J EXP BIOL, V214, P1055, DOI 10.1242/jeb.054502; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Bishop CM, 1999, P ROY SOC B-BIOL SCI, V266, P2275, DOI 10.1098/rspb.1999.0919; Blaikie HB, 1996, CAN J FISH AQUAT SCI, V53, P2093, DOI 10.1139/cjfas-53-9-2093; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burpee JL, 2010, J COMP PHYSIOL B, V180, P967, DOI 10.1007/s00360-010-0474-x; Chown SL, 2007, FUNCT ECOL, V21, P282, DOI 10.1111/j.1365-2435.2007.01245.x; Clark TD, 2011, J EXP BIOL, V214, P887, DOI 10.1242/jeb.051607; Cutts CJ, 2002, FUNCT ECOL, V16, P73, DOI 10.1046/j.0269-8463.2001.00603.x; Dacie JV., 1984, PRACTICAL HEMATOLOGY, V6; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; DAVISON J, 1956, BIOL BULL, V110, P264, DOI 10.2307/1538832; DAVISON J, 1955, BIOL BULL, V109, P407, DOI 10.2307/1539173; Fu SJ, 2009, J EXP BIOL, V212, P2296, DOI 10.1242/jeb.027102; Fu SJ, 2009, J COMP PHYSIOL B, V179, P509, DOI 10.1007/s00360-008-0337-x; Glazier DS, 2008, P ROY SOC B-BIOL SCI, V275, P1405, DOI 10.1098/rspb.2008.0118; Glazier DS, 2010, BIOL REV, V85, P111, DOI 10.1111/j.1469-185X.2009.00095.x; Glazier DS, 2009, J COMP PHYSIOL B, V179, P821, DOI 10.1007/s00360-009-0363-3; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Grim JM, 2012, FISH PHYSIOL BIOCHEM, V38, P1409, DOI 10.1007/s10695-012-9628-y; HOPPELER H, 1984, RESP PHYSIOL, V55, P131, DOI 10.1016/0034-5687(84)90018-5; Hoppeler H, 2000, ACTA PHYSIOL SCAND, V168, P445, DOI 10.1046/j.1365-201x.2000.00696.x; ITAZAWA Y, 1983, EXPERIENTIA, V39, P160, DOI 10.1007/BF01958874; Kamler E., 1992, EARLY LIFE HIST FISH; Kearney MR, 2012, AM NAT, V180, P546, DOI 10.1086/667860; Killen SS, 2007, P ROY SOC B-BIOL SCI, V274, P431, DOI 10.1098/rspb.2006.3741; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; KOOIJMAN SALM, 1986, J THEOR BIOL, V121, P269, DOI 10.1016/S0022-5193(86)80107-2; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; Kozlowski J, 2010, BIOL LETTERS, V6, P792, DOI 10.1098/rsbl.2010.0288; Luo YP, 2008, COMP BIOCHEM PHYS A, V149, P150, DOI 10.1016/j.cbpa.2007.11.003; Luo YP, 2013, FISH PHYSIOL BIOCHEM, V39, P513, DOI 10.1007/s10695-012-9716-z; Luo YP, 2013, MAR FRESHW BEHAV PHY, V45, P333, DOI 10.1080/10236244.2012.750059; Maciak Sebastian, 2011, Zoologica Poloniae, V56, P35; Maciak S, 2011, FUNCT ECOL, V25, P1072, DOI 10.1111/j.1365-2435.2011.01870.x; Maino JL, 2014, J ANIM ECOL, V83, P20, DOI 10.1111/1365-2656.12085; Moran D, 2007, COMP BIOCHEM PHYS A, V148, P611, DOI 10.1016/j.cbpa.2007.08.006; NITECKI C, 1972, B ACAD POL SCI BIOL, V20, P241; Norin T, 2012, PHYSIOL BIOCHEM ZOOL, V85, P645, DOI 10.1086/665982; OIKAWA S, 1991, J FISH BIOL, V38, P483, DOI 10.1111/j.1095-8649.1991.tb03136.x; OIKAWA S, 1992, JPN J ICHTHYOL, V39, P243, DOI 10.1007/BF02905482; OIKAWA S, 1993, COMP BIOCHEM PHYS A, V105, P741; OIKAWA S, 1984, COPEIA, P800; Pis T, 2008, COMP BIOCHEM PHYS A, V151, P211, DOI 10.1016/j.cbpa.2008.06.026; Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR226, DOI 10.1152/ajpregu.1995.269.1.R226; Post JR, 1996, CAN J FISH AQUAT SCI, V53, P910, DOI 10.1139/cjfas-53-4-910; POUGH FH, 1984, COMP BIOCHEM PHYS A, V79, P415, DOI 10.1016/0300-9629(84)90537-1; Riisgard HU, 1998, ECOL LETT, V1, P71; Rombough P, 2011, RESP PHYSIOL NEUROBI, V178, P22, DOI 10.1016/j.resp.2011.04.026; Savage VM, 2007, P NATL ACAD SCI USA, V104, P4718, DOI 10.1073/pnas.0611235104; Snelling EP, 2011, J EXP BIOL, V214, P3218, DOI 10.1242/jeb.058420; Starostova Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064715; Starostova Z, 2009, AM NAT, V174, pE100, DOI 10.1086/603610; van der Meer J, 2006, TRENDS ECOL EVOL, V21, P136, DOI 10.1016/j.tree.2005.11.004; Weibel ER, 2004, RESP PHYSIOL NEUROBI, V140, P115, DOI 10.1016/j.resp.2004.01.006; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; White CR, 2013, J COMP PHYSIOL B, V183, P1, DOI 10.1007/s00360-012-0676-5; Yagi M, 2010, P ROY SOC B-BIOL SCI, V277, P2793, DOI 10.1098/rspb.2010.0583; Yan GJ, 2012, J THERM BIOL, V37, P424, DOI 10.1016/j.jtherbio.2012.04.006; Zhu DM, 2012, IN VITRO CELL DEV-AN, V48, P507, DOI 10.1007/s11626-012-9543-7	66	24	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82837	10.1371/journal.pone.0082837	http://dx.doi.org/10.1371/journal.pone.0082837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376588	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100061
J	Jaun-Frutiger, K; Cazzoli, D; Muri, RM; Bassetti, CL; Nyffeler, T				Jaun-Frutiger, Katrin; Cazzoli, Dario; Mueri, Rene M.; Bassetti, Claudio L.; Nyffeler, Thomas			The Frontal Eye Field Is Involved in Visual Vector Inversion in Humans - A Theta Burst Stimulation Study	PLOS ONE			English	Article							MEMORY ANTISACCADES; ATTENTION; SELECTION; SACCADES	In the antisaccade task, subjects are requested to suppress a reflexive saccade towards a visual target and to perform a saccade towards the opposite side. In addition, in order to reproduce an accurate saccadic amplitude, the visual saccade vector (i.e., the distance between a central fixation point and the peripheral target) must be exactly inverted from one visual hemifield to the other. Results from recent studies using a correlational approach (i.e., fMRI, MEG) suggest that not only the posterior parietal cortex (PPC) but also the frontal eye field (FEF) might play an important role in such a visual vector inversion process. In order to assess whether the FEF contributes to visual vector inversion, we applied an interference approach with continuous theta burst stimulation (cTBS) during a memory-guided antisaccade task. In 10 healthy subjects, one train of cTBS was applied over the right FEF prior to a memory-guided antisaccade task. In comparison to the performance without stimulation or with sham stimulation, cTBS over the right FEF induced a hypometric gain for rightward but not leftward antisaccades. These results obtained with an interference approach confirm that the FEF is also involved in the process of visual vector inversion.	[Jaun-Frutiger, Katrin; Cazzoli, Dario; Mueri, Rene M.; Bassetti, Claudio L.; Nyffeler, Thomas] Univ Hosp Bern, Inselspital, Dept Neurol, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland; [Jaun-Frutiger, Katrin; Cazzoli, Dario; Mueri, Rene M.; Bassetti, Claudio L.; Nyffeler, Thomas] Univ Hosp Bern, Inselspital, Dept Clin Res, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland; [Jaun-Frutiger, Katrin; Cazzoli, Dario; Mueri, Rene M.; Bassetti, Claudio L.; Nyffeler, Thomas] Univ Bern, Bern, Switzerland; [Cazzoli, Dario] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Nyffeler, Thomas] Luzerner Kantonsspital, Ctr Neurol & Neurorehabil, Luzern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Oxford; Lucerne Cantonal Hospital	Nyffeler, T (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurol, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland.	thomas.nyffeler@luks.ch	Müri, René M/E-9320-2012	Müri, René M/0000-0001-6990-4188; Bassetti, Claudio/0000-0002-4535-0245; Cazzoli, Dario/0000-0001-7217-7153; Nyffeler, Thomas/0000-0003-2504-8935	Swiss National Science Foundation [320030_140696/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by the Swiss National Science Foundation (320030_140696/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Bichot NP, 2001, J NEUROSCI, V21, P713, DOI 10.1523/JNEUROSCI.21-02-00713.2001; Brown MRG, 2006, NEUROIMAGE, V33, P644, DOI 10.1016/j.neuroimage.2006.07.002; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Cazzoli D, 2009, NEUROSCIENCE, V164, P1609, DOI 10.1016/j.neuroscience.2009.09.044; Cazzoli D, 2012, BRAIN, V135, P3426, DOI 10.1093/brain/aws182; Cazzoli D, 2009, EUR J NEUROSCI, V29, P1271, DOI 10.1111/j.1460-9568.2009.06665.x; Ettinger U, 2008, CEREB CORTEX, V18, P1148, DOI 10.1093/cercor/bhm147; Everling S, 1998, EXP BRAIN RES, V118, P27, DOI 10.1007/s002210050252; Gaymard B, 1999, EXP BRAIN RES, V129, P288, DOI 10.1007/s002210050899; Medendorp WP, 2005, J NEUROPHYSIOL, V94, P734, DOI 10.1152/jn.01331.2004; Moon SY, 2007, NEUROIMAGE, V36, P1313, DOI 10.1016/j.neuroimage.2007.04.040; MURI RM, 1991, EXP BRAIN RES, V86, P219; Nyffeler T, 2008, EUR J NEUROSCI, V27, P1809, DOI 10.1111/j.1460-9568.2008.06154.x; Nyffeler T, 2007, NEUROREPORT, V18, P917, DOI 10.1097/WNR.0b013e32811d6cf5; Nyffeler T, 2006, EUR J NEUROSCI, V24, P2961, DOI 10.1111/j.1460-9568.2006.05154.x; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; Nyffeler T, 2008, PROG BRAIN RES, V171, P429, DOI 10.1016/S0079-6123(08)00663-8; Nyffeler T, 2009, STROKE, V40, P2791, DOI 10.1161/STROKEAHA.109.552323; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; Ro T, 1999, NEUROPSYCHOLOGIA, V37, P225; Sato T, 2001, NEURON, V30, P583, DOI 10.1016/S0896-6273(01)00304-X; Sato TR, 2003, NEURON, V38, P637, DOI 10.1016/S0896-6273(03)00237-X; Schall JD, 2004, VISION RES, V44, P1453, DOI 10.1016/j.visres.2003.10.025; Sommer MA, 1997, EXP BRAIN RES, V116, P229, DOI 10.1007/PL00005752; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Tian JR, 1996, J NEUROPHYSIOL, V76, P2754, DOI 10.1152/jn.1996.76.4.2754; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Weiss MM, 2009, NEUROIMAGE, V44, P1063, DOI 10.1016/j.neuroimage.2008.09.042; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013; Zhang MS, 2000, NATURE, V408, P971, DOI 10.1038/35050097; Zhang MS, 2004, J NEUROPHYSIOL, V91, P1424, DOI 10.1152/jn.00504.2003	32	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83297	10.1371/journal.pone.0083297	http://dx.doi.org/10.1371/journal.pone.0083297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376682	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100109
J	Lutz, JA; Larson, AJ; Freund, JA; Swanson, ME; Bible, KJ				Lutz, James A.; Larson, Andrew J.; Freund, James A.; Swanson, Mark E.; Bible, Kenneth J.			The Importance of Large-Diameter Trees to Forest Structural Heterogeneity	PLOS ONE			English	Article							ANCIENT MONTANE FOREST; PSEUDOTSUGA-MENZIESII; SPATIAL-PATTERNS; GROWTH; FIR; MORTALITY; DISTURBANCES; COMMUNITIES; COMPETITION; COMPLEXITY	Large-diameter trees dominate the structure, dynamics and function of many temperate and tropical forests. However, their attendant contributions to forest heterogeneity are rarely addressed. We established the Wind River Forest Dynamics Plot, a 25.6 ha permanent plot within which we tagged and mapped all 30,973 woody stems >= 1 cm dbh, all 1,966 snags >= 10 cm dbh, and all shrub patches >= 2 m(2). Basal area of the 26 woody species was 62.18 m(2)/ha, of which 61.60 m(2)/ha was trees and 0.58 m(2)/ha was tall shrubs. Large-diameter trees (>= 100 cm dbh) comprised 1.5% of stems, 31.8% of basal area, and 17.6% of the heterogeneity of basal area, with basal area dominated by Tsuga heterophylla and Pseudotsuga menziesii. Small-diameter subpopulations of Pseudotsuga menziesii, Tsuga heterophylla and Thuja plicata, as well as all tree species combined, exhibited significant aggregation relative to the null model of complete spatial randomness (CSR) up to 9 m (P <= 0.001). Patterns of large-diameter trees were either not different from CSR (Tsuga heterophylla), or exhibited slight aggregation (Pseudotsuga menziesii and Thuja plicata). Significant spatial repulsion between large-diameter and small-diameter Tsuga heterophylla suggests that large-diameter Tsuga heterophylla function as organizers of tree demography over decadal timescales through competitive interactions. Comparison among two forest dynamics plots suggests that forest structural diversity responds to intermediate-scale environmental heterogeneity and disturbances, similar to hypotheses about patterns of species richness, and richness-ecosystem function. Large mapped plots with detailed within-plot environmental spatial covariates will be required to test these hypotheses.	[Lutz, James A.] Utah State Univ, Wildland Resources Dept, Logan, UT 84322 USA; [Larson, Andrew J.] Univ Montana, Dept Forest Management, Missoula, MT 59812 USA; [Freund, James A.; Bible, Kenneth J.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Swanson, Mark E.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA	Utah System of Higher Education; Utah State University; University of Montana System; University of Montana; University of Washington; University of Washington Seattle; Washington State University	Lutz, JA (corresponding author), Utah State Univ, Wildland Resources Dept, Logan, UT 84322 USA.	james.lutz@usu.edu	Lutz, James/AAA-9574-2019	Lutz, James/0000-0002-2560-0710	Smithsonian Institution Center for Tropical Forest Science; University of Washington College of the Environment; Division Of Environmental Biology [1354741] Funding Source: National Science Foundation	Smithsonian Institution Center for Tropical Forest Science; University of Washington College of the Environment; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was received from the Smithsonian Institution Center for Tropical Forest Science (http://www.ctfs.si.edu) and the University of Washington College of the Environment (http://coenv.washington.edu). In-kind support was received from the University of Washington, and the US Forest Service Pacific Northwest Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos JA, 2005, J ECOL, V93, P536, DOI 10.1111/j.1365-2745.2005.00968.x; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Braun DM, 2002, NORTHWEST SCI, V76, P315; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Chen JQ, 2004, FOREST SCI, V50, P364; Chisholm RA, 2013, J ECOL, V101, DOI 10.1111/1365-2745.12132; Churchill D, REMOTE SENS IN PRESS; Clark DB, 1996, FOREST ECOL MANAG, V80, P235, DOI 10.1016/0378-1127(95)03607-5; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Das A, 2011, FOREST ECOL MANAG, V261, P1203, DOI 10.1016/j.foreco.2010.12.035; Das AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069917; Diggle P., 2003, STAT ANAL SPATIAL PO; Edmonds RL, 2000, FOREST HLTH PROTECTI; Flora of North America Editorial Committee, 1993, FLORA N AM N MEXICO; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Franklin J.F., 1988, US DEP AGR FOR SERV, P8; Franklin JF, 2012, J FOREST, V110, P429, DOI 10.5849/jof.10-006; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Franklin JF, 2004, J FOREST, V102, P22; FRANKLIN JF, 1988, CAN J FOREST RES, V18, P633, DOI 10.1139/x88-093; FURNISS RL, 1977, USDA FOREST SERVICE, V1339; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; GRIER CC, 1977, ECOL MONOGR, V47, P373, DOI 10.2307/1942174; Halpern CB, 2013, ECOL MONOGR, V83, P19; Halversen NM, 1986, R6ECOL230A1986 USDA; Hawksworth FG, 1996, USDA AGR HDB, V709; Kane VR, 2011, CAN J FOREST RES, V41, P2276, DOI [10.1139/X11-128, 10.1139/x11-128]; Kane VR, 2010, CAN J FOREST RES, V40, P774, DOI 10.1139/X10-064; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Kolden CA, 2012, FOREST ECOL MANAG, V286, P38, DOI 10.1016/j.foreco.2012.08.020; Larson AJ, 2012, FOREST ECOL MANAG, V267, P74, DOI 10.1016/j.foreco.2011.11.038; Larson AJ, 2010, CAN J FOREST RES, V40, P2091, DOI 10.1139/X10-149; Larson AJ, 2008, CAN J FOREST RES, V38, P2814, DOI 10.1139/X08-123; Larson JA, 2006, J VEG SCI, V17, P489, DOI 10.1111/j.1654-1103.2006.tb02470.x; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Lindenmayer DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041864; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Lutz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036131; Lutz JA, 2010, J BIOGEOGR, V37, P936, DOI 10.1111/j.1365-2699.2009.02268.x; North M, 2004, FOREST SCI, V50, P299; Parish R, 2004, OECOLOGIA, V141, P562, DOI 10.1007/s00442-004-1690-4; PRISM, 2004, 800 M CLIM NORM 1971; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ruchty A, 2001, BRYOLOGIST, V104, P274, DOI 10.1639/0007-2745(2001)104[0274:CIECAT]2.0.CO;2; Shaw DC, 2004, ECOSYSTEMS, V7, P427, DOI 10.1007/s10021-004-0135-6; Sillett SC, 2007, ECOL MONOGR, V77, P335, DOI 10.1890/06-0994.1; Slik JWF, 2013, GLOBAL ECOL BIOGEOGR, V22, P1261, DOI 10.1111/geb.12092; Swanson ME, 2006, NORTHWEST SCI, V80, P207; Van Pelt R, 2004, FOREST SCI, V50, P326; Van Pelt R, 1999, ECOL APPL, V9, P504, DOI 10.2307/2641140; Van Pelt R, 2008, ECOL MONOGR, V78, P283, DOI 10.1890/07-0158.1; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Winter LE, 2002, CAN J FOREST RES, V32, P1057, DOI 10.1139/X02-030	58	89	92	7	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82784	10.1371/journal.pone.0082784	http://dx.doi.org/10.1371/journal.pone.0082784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376579	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100055
J	Pfortmueller, CA; Stotz, M; Lindner, G; Muller, T; Rodondi, N; Exadaktylos, AK				Pfortmueller, Carmen A.; Stotz, Manuela; Lindner, Gregor; Mueller, Thomas; Rodondi, Nicolas; Exadaktylos, Aristomenis K.			Multimorbidity in Adult Asylum Seekers: A First Overview	PLOS ONE			English	Article							HEPATITIS-B; SRI-LANKA; REFUGEES; HEALTH; PREVALENCE; CARE; IMMIGRANTS; MARKERS	Principals: Over the last two decades, the total annual number of applications for asylum in the countries of the European Union has increased from 15,000 to more than 300,000 people. The aim of this study was to give a first overview on multimorbidity of adult asylum seekers. Methods: Our retrospective Swiss single center data analysis examined multimorbidity of adult asylums seekers admitted to our ED between 1 January 2000 and 31 December 2012. Results: A total of 3170 patients were eligible for the study; they were predominantly male (2392 male, 75.5% versus 778 female, 24.5). The median age of the patients was 28 years (range 28-82). The most common region of origin was Africa (1544, 48.7%), followed by the Middle East (736, 23.6%). 2144 (67.6%) of all patients were not multimorbid. A total of 1183 (37.7%) of our patients were multimorbid. The mean Charlson comorbidity index was 0.25 (SD 1.1, range 0-12). 634 (20%) of all patients sufferem from psychiatric diseases, followed by chronic medical conditions (12.6%, 399) and infectious diseases (4.7%, 150). Overall, 11% (349) of our patients presented as a direct consequence of prior violence. Patients from Sri Lanka/India most often suffered from addictions problems (50/240, 20.8%, p<0.0001). Infectious diseases were most frequent in patients from Africa (6.6%), followed by the Balkans and Eastern Europe/Russia (each 3.8%). Conclusion: The health care problems of asylum seekers are manifold. More than 60% of the study population assessed in our study did not suffer from more than one disease. Nevertheless a significant percentage of asylum seekers is multimorbid and exhibits underlying psychiatric, infectious or chronic medical conditions despite their young age.	[Pfortmueller, Carmen A.; Lindner, Gregor; Rodondi, Nicolas] Univ Hosp Bern, Univ Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.; Lindner, Gregor; Mueller, Thomas; Rodondi, Nicolas; Exadaktylos, Aristomenis K.] Univ Bern, Bern, Switzerland; [Stotz, Manuela] Baden Cantonal Hosp, Div Gen Internal Med, Baden, Switzerland; [Mueller, Thomas] Univ Hosp Psychiat, Bern, Switzerland; [Exadaktylos, Aristomenis K.] Univ Hosp Bern, Univ Dept Emergency Med, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Pfortmueller, CA (corresponding author), Univ Hosp Bern, Univ Dept Gen Internal Med, CH-3010 Bern, Switzerland.	cpfortmueller@gmail.com	Müller, Thomas/D-1212-2010; Lindner, Gregor/AAR-6761-2020	Müller, Thomas/0000-0001-9315-8138; Lindner, Gregor/0000-0001-5551-8227; Pfortmueller, Carmen/0000-0003-0326-2770; Rodondi, Nicolas/0000-0001-9083-6896				Aarts S, 2012, J PSYCHOSOM RES, V73, P211, DOI 10.1016/j.jpsychores.2012.05.014; Alexander Abigail, 2007, Torture, V17, P1; Bentley JA, 2011, J TRAUMA STRESS, V24, P479, DOI 10.1002/jts.20651; Bischoff A, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13252; Brune M, 2003, EUR ADDICT RES, V9, P144, DOI 10.1159/000070985; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; De Jesus-Rentas G, 2010, J AM ACAD PSYCHIATRY, V38, P490; Eckstein B, 2011, AM FAM PHYSICIAN, V83, P429; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Harris MF, 2001, MED J AUSTRALIA, V175, P589, DOI 10.5694/j.1326-5377.2001.tb143739.x; Hatton TJ, 2004, ECON POLICY, P5; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Hollander AC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-180; Husain F, 2011, JAMA-J AM MED ASSOC, V306, P522, DOI 10.1001/jama.2011.1052; Laban CJ, 2008, SOC PSYCH PSYCH EPID, V43, P507, DOI 10.1007/s00127-008-0333-1; Maier T, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13110; Migration Bf, 2011, AS 2011; Nickerson A, 2011, PSYCHIAT RES, V187, P267, DOI 10.1016/j.psychres.2010.12.015; PERRON NJ, 2006, BMC FAM PRACT, V7, P10, DOI DOI 10.1186/1471-2296-7-10; Pfortmueller CA, 2012, WIEN KLIN WOCHENSCHR, V124, P647, DOI 10.1007/s00508-012-0227-9; Piette John D, 2008, J Diabetes Sci Technol, V2, P15; Rajapakse T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-331; Roussos A, 2003, WORLD J GASTROENTERO, V9, P993; Savin D, 2005, PUBLIC HEALTH REP, V120, P224, DOI 10.1177/003335490512000303; Stauffer WM, 2002, PRIMARY CARE, V29, P879, DOI 10.1016/S0095-4543(02)00035-0; Tafuri S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-213; van den Bussche H, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-54	27	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82671	10.1371/journal.pone.0082671	http://dx.doi.org/10.1371/journal.pone.0082671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376565	Green Published, gold			2022-12-27	WOS:000328745100051
J	Rocher, C; Singla, DK				Rocher, Crystal; Singla, Dinender K.			SMAD-PI3K-Akt-mTOR Pathway Mediates BMP-7 Polarization of Monocytes into M2 Macrophages	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; CELLS INHIBIT APOPTOSIS; H9C2 CELLS; ATHEROSCLEROSIS; IMMUNE; DIFFERENTIATION; THERAPY; GROWTH	Previously we demonstrated that bone morphogenetic protein-7 (BMP-7) treatment polarizes monocytes into M2 macrophages and increases the expression of anti-inflammatory cytokines. Despite these findings, the mechanisms for the observed BMP-7 induced monocyte polarization into M2 macrophages are completely unknown. In this study, we demonstrate the mechanisms involved in the polarization of monocytes into M2 macrophages. Apoptotic conditioned media (ACM) was generated to mimic the stressed conditions, inducing monocyte polarization. Monocytes were treated with ACM along with BMP-7 and/or its inhibitor, follistatin, for 48 hours. Furthermore, an inhibitor of the PI3K pathway, LY-294002, was also studied. Our data show that BMP-7 induces polarization of monocytes into M2 macrophages while significantly increasing the expression of anti-inflammatory markers, arginase-1 and IL-10, and significantly (p<0.05) decreasing the expression of pro-inflammatory markers iNOS, IL-6, TNF-alpha and MCP-1; (p<0.05). Moreover, addition of the PI3K inhibitor, LY-294002, significantly (p<0.05) decreases upregulation of IL-10 and arginase-1, suggesting involvement of the PI3K pathway in M2 macrophage polarization. Next, following BMP-7 treatment, a significant (p<0.05) increase in p-SMAD1/5/8 and p-PI3K expression resulting in downstream activation of p-Akt and p-mTOR was observed. Furthermore, expression of p-PTEN, an inhibitor of the PI3K pathway, was significantly (p<0.05) increased in the ACM group. However, BMP-7 treatment inhibited its expression, suggesting involvement of the PI3K-Akt-mTOR pathway. In conclusion, we demonstrate that BMP-7 polarizes monocytes into M2 macrophages and enhances anti-inflammatory cytokine expression which is mediated by the activated SMAD-PI3K-Akt-mTOR pathway.	[Rocher, Crystal; Singla, Dinender K.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Singla, DK (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA.	Dinender.Singla@ucf.edu			 [R01HL090646-01];  [5R01HL094467-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094467, R01HL090646] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge support in part is provided by R01HL090646-01 and 5R01HL094467-02 to Dr. Singla. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthor H, 2002, DEV BIOL, V243, P115, DOI 10.1006/dbio.2001.0555; Araki K, 2011, CURR OPIN CELL BIOL, V23, P707, DOI 10.1016/j.ceb.2011.08.006; Boon MR, 2011, CYTOKINE GROWTH F R, V22, P221, DOI 10.1016/j.cytogfr.2011.08.001; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lovren F, 2010, AM J PHYSIOL-HEART C, V299, pH656, DOI 10.1152/ajpheart.00115.2010; Manson SR, 2011, J UROLOGY, V185, P2523, DOI 10.1016/j.juro.2011.01.034; Maric I, 2012, AM J PHYSIOL-GASTR L, V302, pG1151, DOI 10.1152/ajpgi.00244.2011; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Perron JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008198; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Rocher C, 2012, CAN J PHYSIOL PHARM, V90, P947, DOI [10.1139/Y2012-102, 10.1139/y2012-102]; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Shimizu T, 2012, BIOCHEM BIOPH RES CO, V417, P869, DOI 10.1016/j.bbrc.2011.12.064; Singla DK, 2008, AM J PHYSIOL-HEART C, V295, pH907, DOI 10.1152/ajpheart.00279.2008; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1590, DOI 10.1152/ajpheart.00431.2007; Sinha P, 2005, CANCER RES, V65, P11743, DOI 10.1158/0008-5472.CAN-05-0045; Tardif G, 2009, OSTEOARTHR CARTILAGE, V17, P263, DOI 10.1016/j.joca.2008.06.022; Wang S, 2003, KIDNEY INT, V63, P2037, DOI 10.1046/j.1523-1755.2003.00035.x; Weichhart T, 2008, ANN RHEUM DIS, V67, P70, DOI 10.1136/ard.2008.098459; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wolfs IMJ, 2011, THROMB HAEMOSTASIS, V106, P763, DOI 10.1160/TH11-05-0320; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144	26	95	99	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84009	10.1371/journal.pone.0084009	http://dx.doi.org/10.1371/journal.pone.0084009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376781	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100152
J	Romon, M; Soustre-Gacougnolle, I; Schmitt, C; Perrin, M; Burdloff, Y; Chevalier, E; Mutterer, J; Himber, C; Zervudacki, J; Montavon, T; Zimmermann, A; Elmayan, T; Vaucheret, H; Dunoyer, P; Masson, JE				Romon, Marjorie; Soustre-Gacougnolle, Isabelle; Schmitt, Carine; Perrin, Mireille; Burdloff, Yannick; Chevalier, Elodie; Mutterer, Jerome; Himber, Christophe; Zervudacki, Jerome; Montavon, Thomas; Zimmermann, Aude; Elmayan, Taline; Vaucheret, Herve; Dunoyer, Patrice; Masson, Jean E.			RNA Silencing Is Resistant to Low-Temperature in Grapevine	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; TRANSGENE; GENE; COSUPPRESSION; ARABIDOPSIS; PARENTAGE	RNA silencing is a natural defence mechanism against viruses in plants and transgenes expressing viral RNA-derived sequences were previously shown to confer silencing-based enhanced resistance against the cognate virus in several species., RNA silencing was shown to dysfunction at low temperatures in several species, questioning the relevance of this strategy in perennial plants such as grapevines, which are often exposed to low temperatures during the winter season. Here show that inverted-repeat (IR) constructs trigger highly efficient silencing reaction in all somatic tissues in grapevines. Similarly to other plant species, IR-derived siRNAs trigger production of secondary transitive siRNAs. However, and in sharp contrast to other species tested to date where RNA silencing is hindered at low temperature, this process remained active in grapevine cultivated at 4 degrees C. Consistently, siRNA levels remained steady in grapevines cultivated between 26 degrees C and 4 degrees C, whereas they are severely decreased in Arabidopsis grown at 15 degrees C and almost undetectable at 4 degrees C. Altogether, these results demonstrate that RNA silencing operates in grapevine in a conserved manner but is resistant to far lower temperatures than ever described in other species.	[Romon, Marjorie; Schmitt, Carine; Perrin, Mireille; Burdloff, Yannick; Chevalier, Elodie; Masson, Jean E.] INRA Univ Strasbourg, Sante Vigne & Qualite Vin UMR1131, Colmar, France; [Soustre-Gacougnolle, Isabelle] Univ Haute Alsace, Lab Vigne Biotechnol & Environm, Colmar, France; [Mutterer, Jerome; Himber, Christophe; Zervudacki, Jerome; Montavon, Thomas; Zimmermann, Aude; Dunoyer, Patrice] CNRS, Inst Biol Mol Plantes, UPR2357, F-67084 Strasbourg, France; [Elmayan, Taline; Vaucheret, Herve] INRA AgroParisTech, Inst JeanPierre Bourgin, UMR1318, Versailles, France	INRAE; Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Masson, JE (corresponding author), INRA Univ Strasbourg, Sante Vigne & Qualite Vin UMR1131, Colmar, France.	Jean.masson@colmar.inra.fr		Montavon, Thomas/0000-0001-7394-7199; VAUCHERET, HERVE/0000-0002-9986-0988	INRA-GAP-BV (Institut National de la Recherche Agronomique); CIVA (Comite Interprofessionnel des Vins d'Alsace); Conseil Regional Alsace; CIVA-Conseil Regional Alsace; Agence National pour la Recherche [ANR-10-LABX-36]; Bettencourt-Schueller foundation	INRA-GAP-BV (Institut National de la Recherche Agronomique); CIVA (Comite Interprofessionnel des Vins d'Alsace); Conseil Regional Alsace; CIVA-Conseil Regional Alsace; Agence National pour la Recherche(French National Research Agency (ANR)); Bettencourt-Schueller foundation	This work was supported by a specific grant of INRA-GAP-BV (Institut National de la Recherche Agronomique) to HV and JEM, joint grants from the CIVA (Comite Interprofessionnel des Vins d'Alsace) and the Conseil Regional Alsace. MR had a stipend from CIVA-Conseil Regional Alsace. PD was supported by the Agence National pour la Recherche (ANR-10-LABX-36) and the Bettencourt-Schueller foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beachy RN, 1997, CURR OPIN BIOTECH, V8, P215, DOI 10.1016/S0958-1669(97)80105-X; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; Bouquet Alain, 2006, V344, P273; Boursiquot JM, 2009, AUST J GRAPE WINE R, V15, P144, DOI 10.1111/j.1755-0238.2008.00041.x; Bowers J, 1999, SCIENCE, V285, P1562, DOI 10.1126/science.285.5433.1562; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dunoyer P, 2006, NAT GENET, V38, P258, DOI 10.1038/ng1722; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; Griesbach RJ, 2007, J AM SOC HORTIC SCI, V132, P680, DOI 10.21273/JASHS.132.5.680; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hu Q, 2011, VIROL J, V8, P2; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kalantidis K, 2002, MOL PLANT MICROBE IN, V15, P826, DOI 10.1094/MPMI.2002.15.8.826; Kameda T, 2004, BIOCHEM BIOPH RES CO, V315, P599, DOI 10.1016/j.bbrc.2004.01.097; Kasai A, 2009, PLANT CELL PHYSIOL, V50, P1090, DOI 10.1093/pcp/pcp061; Martelli G.P., 2012, P 17 C INT COUNC STU, P13; MASSON J, 1992, PLANT J, V2, P829, DOI 10.1111/j.1365-313X.1992.tb00153.x; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Perrin M, 2004, PLANT SCI, V167, P1343, DOI 10.1016/j.plantsci.2004.07.009; Perrin M, 2001, PLANT SCI, V161, P107, DOI 10.1016/S0168-9452(01)00385-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prins M, 2008, MOL PLANT PATHOL, V9, P73, DOI [10.1111/J.1364-3703.2007.00447.X, 10.1111/j.1364-3703.2007.00447.x]; Que QD, 1997, PLANT CELL, V9, P1357, DOI 10.1105/tpc.9.8.1357; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Vaucheret H, 1997, PLANT CELL, V9, P1495, DOI 10.1105/tpc.9.8.1495; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; WEISCHER B, 1976, NEMATOLOGICA, V22, P319, DOI 10.1163/187529276X00607; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x	30	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82652	10.1371/journal.pone.0082652	http://dx.doi.org/10.1371/journal.pone.0082652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376561	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100048
J	Santoro, S; Green, AJ; Figuerola, J				Santoro, Simone; Green, Andy John; Figuerola, Jordi			Environmental Instability as a Motor for Dispersal: A Case Study from a Growing Population of Glossy Ibis	PLOS ONE			English	Article							DENSITY-DEPENDENT DISPERSAL; BREEDING DISPERSAL; PLEGADIS-FALCINELLUS; NATAL DISPERSAL; HABITAT QUALITY; LESSER KESTREL; DYNAMICS; SURVIVAL; DONANA; IMPACT	Dispersal is a life-history trait directly affecting population dynamics and species range shifts and thus playing a prominent role in the response to climate change. Nonetheless, the relationship between extreme climatic events and dispersal has received little attention in birds. Here we focused on climatic, demographic and individual factors affecting the dispersal propensity of a major glossy ibis population. We performed a capture-resighting analysis on individuals born and observed at Donana (South-West Spain) over fourteen years. We applied a multiple analytical approach to show that single-site capture-resighting estimates were a reliable index of dispersal propensity from the area. We focused on the emigration of Donana-born individuals sporadically (transients) and regularly (residents) frequenting their natal area. Droughts during two out of 14 study years caused higher apparent dispersal rates, explaining most of the annual variation in these rates. The age structure of Donana-born individuals resighted simultaneously locally and in Morocco in one week over the 2010 autumn confirmed that the 2005 drought boosted permanent emigration. As numbers increased steadily during non-drought years since the formation of the colony in 1996 to several thousand pairs, philopatry increased gradually, while transients probability appeared to be related to average breeding success. Age, sex, density, quality of foraging habitat and breeding success in the previous season were not found to directly affect apparent dispersal. Nonetheless, autumn sex ratio gradually switched from male (approximate to 0.68) to female-skewed (approximate to 0.44) by the end of the study period, suggesting that males and females respond differently to high densities reached in recent years. This study demonstrates the importance of extreme climatic events as a powerful motor for spread of species in expansion. Also, it suggests different factors drive emigration of individuals according to their amount of experience in the area (e.g. transients vs residents).	[Santoro, Simone; Green, Andy John; Figuerola, Jordi] CSIC, Dept Wetland Ecol, Estn Biol Donana, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Santoro, S (corresponding author), CSIC, Dept Wetland Ecol, Estn Biol Donana, E-41080 Seville, Spain.	santoro@ebd.csic.es	SANTORO, SIMONE/B-2162-2015; Green, Andy J/A-5189-2008; Figuerola, Jordi/B-7917-2008	SANTORO, SIMONE/0000-0003-0986-3278; Green, Andy J/0000-0002-1268-4951; Figuerola, Jordi/0000-0002-4664-9011	Ministry of Environment's National Parks research program [028/2002]; Regional Government of Andalusia (Junta de Andalucia); JAE PhD grant from CSIC; FEDER	Ministry of Environment's National Parks research program; Regional Government of Andalusia (Junta de Andalucia)(Junta de Andalucia); JAE PhD grant from CSIC; FEDER(European Commission)	This study has been funded by the projects Ministry of Environment's National Parks research program (Project 028/2002) and by the Regional Government of Andalusia (Junta de Andalucia). SS has been supported by a JAE PhD grant from CSIC (co-funded by the FEDER Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz P, 2012, J ANIM ECOL, V81, P1113, DOI 10.1111/j.1365-2656.2012.01972.x; Amezian Mohamed, 2012, Alauda, V80, P33; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; Baguette M, 2011, ECOGRAPHY, V34, P170, DOI 10.1111/j.1600-0587.2010.06212.x; Balkiz O, 2010, J ANIM ECOL, V79, P1045, DOI 10.1111/j.1365-2656.2010.01721.x; Barbraud C, 2003, J ANIM ECOL, V72, P246, DOI 10.1046/j.1365-2656.2003.00695.x; Bonte D, 2008, BASIC APPL ECOL, V9, P308, DOI 10.1016/j.baae.2007.03.004; Boucheker A, 2009, WATERBIRDS, V32, P345, DOI 10.1675/063.032.0215; Boulinier T, 1996, J AVIAN BIOL, V27, P252, DOI 10.2307/3677230; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Choquet R, 2011, 5175 UMR CEFE; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Coulson JC, 2001, IBIS, V143, P500, DOI 10.1111/j.1474-919X.2001.tb04953.x; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Delany S, 2006, WATERBIRD POPULATION, P202; Duckworth RA, 2008, AM NAT, V172, pS4, DOI 10.1086/588289; Duckworth RA, 2007, P NATL ACAD SCI USA, V104, P15017, DOI 10.1073/pnas.0706174104; Dugger KM, 2010, P NATL ACAD SCI USA, V107, P12375, DOI 10.1073/pnas.1000623107; Figuerola J., 2004, LIBRO ROJO AVES ESPA, P74; Figuerola J, 2006, ARDEOLA, V53, P229; Figuerola J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000539; Genovart M, 2012, J ANIM ECOL, V81, P970, DOI 10.1111/j.1365-2656.2012.01991.x; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Grosbois V, 2003, ECOLOGY, V84, P1225, DOI 10.1890/0012-9658(2003)084[1225:MDWCDD]2.0.CO;2; Hancock J., 1992, STORKS IBISES SPOONB; HANSKI I, 1991, OIKOS, V62, P48, DOI 10.2307/3545445; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, P1; Kayser Yves, 2006, Ornithos, V13, P322; Kendall WL, 2002, ECOLOGY, V83, P3276; Kim SY, 2007, J ANIM ECOL, V76, P471, DOI 10.1111/j.1365-2656.2007.01236.x; Kim SY, 2009, ECOLOGY, V90, P230, DOI 10.1890/08-0133.1; Kloskowski J, 2009, AQUAT CONSERV, V19, P815, DOI 10.1002/aqc.1027; Le Galliard Jean Francois, 2012, P317; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Macias M, 2004, WATERBIRDS, V27, P234, DOI 10.1675/1524-4695(2004)027[0234:TDOTGI]2.0.CO;2; Manez M, 2009, MORITO COMUN ESPATUL; Marion Loic, 2011, Alauda, V79, P215; Mathieu J, 2010, SOIL BIOL BIOCHEM, V42, P203, DOI 10.1016/j.soilbio.2009.10.018; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Matthysen E, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P3; Moreno J, 2011, CURR ZOOL, V57, P375, DOI 10.1093/czoolo/57.3.375; Nefla A., 2012, J LIFE SCI, V6, P776; Negro JJ, 1997, J ANIM ECOL, V66, P640, DOI 10.2307/5917; Newton I., 2003, SPECIATION BIOGEOGRA; Nichols James D., 1993, P265; Noivo C., 2007, ANUARIO ORNITOLOGICO, V5, P133; Pakanen VM, 2011, OIKOS, V120, P615, DOI 10.1111/j.1600-0706.2010.18953.x; Patten M.A., 2000, N AM BIRDS, V54, P241; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Pradel R, 2009, ENVIRON ECOL STAT SE, V3, P781, DOI 10.1007/978-0-387-78151-8_36; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Roche EA, 2012, AUK, V129, P296, DOI 10.1525/auk.2012.11196; Santoro S, 2010, BIRD STUDY, V57, P515, DOI 10.1080/00063657.2010.501371; Sanz-Aguilar A, 2012, J ANIM ECOL, V81, P1171, DOI 10.1111/j.1365-2656.2012.01997.x; Schaub M, 2006, OIKOS, V115, P389, DOI 10.1111/j.2006.0030-1299.15374.x; Serrano D, 2003, ECOLOGY, V84, P3044, DOI 10.1890/02-0231; Serrano D, 2001, J ANIM ECOL, V70, P568, DOI 10.1046/j.1365-2656.2001.00512.x; Skalski J.R., 1993, P9; SMITH AT, 1990, CONSERV BIOL, V4, P320, DOI 10.1111/j.1523-1739.1990.tb00294.x; SWITZER PV, 1993, EVOL ECOL, V7, P533, DOI 10.1007/BF01237820; Tavecchia G, 2007, OIKOS, V116, P1481, DOI 10.1111/j.2007.0030-1299.15791.x; Toral GM, 2012, BIOL CONSERV, V148, P19, DOI 10.1016/j.biocon.2012.02.001	67	19	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82983	10.1371/journal.pone.0082983	http://dx.doi.org/10.1371/journal.pone.0082983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376620	Green Published, gold			2022-12-27	WOS:000328745100075
J	Vuga, LJ; Milosevic, J; Pandit, K; Ben-Yehudah, A; Chu, YX; Richards, T; Sciurba, J; Myerburg, M; Zhang, YZ; Parwani, AV; Gibson, KF; Kaminski, N				Vuga, Louis J.; Milosevic, Jadranka; Pandit, Kusum; Ben-Yehudah, Ahmi; Chu, Yanxia; Richards, Thomas; Sciurba, Joshua; Myerburg, Michael; Zhang, Yingze; Parwani, Anil V.; Gibson, Kevin F.; Kaminski, Naftali			Cartilage Oligomeric Matrix Protein in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; GENE-EXPRESSION PROFILES; SYSTEMIC-SCLEROSIS; GROWTH-FACTOR; COLLAGEN FIBRILLOGENESIS; INTERSTITIAL PNEUMONIAS; KNEE OSTEOARTHRITIS; LUNG-DISEASE; COMP; SERUM	Idiopathic pulmonary fibrosis (IPF) progressive and life threatening disease with median survival of 2.5-3 years characterized by abnormal lung remodeling, epithelial cell hyperplasia, myofibroblast foci formation extracellular matrix deposition. Analysis of gene expression. microarray data revealed that cartilage oligomeric matric protein (COMP), a non-collagenous extracellular matrix protein is among the most significantly up-regulated genes (Fold hange 13, p-value <0.05) in IPF lungs. This finding was confirmed at the mRNA level by nCounter (R) expression analysis in additional 115 IPF lungs and 154 control lungs as well as at the protein level by western blot analysis. Immunohistochemical analysis revealed that COMP was expressed in dense fibrotic regions of IPF lungs and co-localized with vimentin and around pSMAD3 expressing cells. Stimulation of normal human lung fibroblasts with TGF-beta 1 induced an increase in COMP mRNA and protein expression. Silencing COMP in normal human lung fibroblasts significantly inhibited cell proliferation and negatively impacted the effects of TGF-beta 1 on COL1A1 and PAl1. COMP protein concentration measured by ELISA assay was significantly increased in serum of IPF patients compared to controls. Analysis of serum COMP concentrations in 23 patient who had prospective blood draws revealed that COMP levels increased in a time dependent fashion and correlated with declines in force vital capacity (FVC). Taken together, our results should encourage more research into the potential use of COMP as a biomarker for disease activity and TGF-beta 1 activity in patients with IPF. Hence, studies that explore modalities affect COMP expression, alleviate extracellular matrix rigidity and lung restriction in IPF and interfere with the amplification TGF-beta 1 signaling should be persuaded	[Vuga, Louis J.; Milosevic, Jadranka; Pandit, Kusum; Chu, Yanxia; Richards, Thomas; Sciurba, Joshua; Myerburg, Michael; Zhang, Yingze; Gibson, Kevin F.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA; [Parwani, Anil V.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Ben-Yehudah, Ahmi] Univ Pittsburgh, Sch Med, Pittsburgh Dev Ctr, Magee Womens Res Inst & Fdn, Pittsburgh, PA USA; [Kaminski, Naftali] Yale Univ, Sch Med, New Haven, CT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Yale University	Vuga, LJ (corresponding author), Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA.	vugalj@upmc.edu	parwani, anil/AAH-5464-2020; Pandit, Kusum/E-7265-2018	Kaminski, Naftali/0000-0001-5917-4601; Pandit, Kusum/0000-0001-7458-4705; Milosevic, Jadranka/0000-0003-0002-8727	National Institutes of Health (NIH) through the National Heart, Lung, and Blood Institute (NHLBI) [HL108869, HL073745, R01HL095397, RC2HL101715, U01HL108642, P50HL0894932]; Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073745, RC2HL101715, K01HL108869, U01HL108642, R01HL095397, R01HL112863] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the National Heart, Lung, and Blood Institute (NHLBI); Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this research was provided by the Grants funded by National Institutes of Health (NIH) through the National Heart, Lung, and Blood Institute (NHLBI): HL108869, HL073745, R01HL095397, RC2HL101715, U01HL108642, and P50HL0894932 as well as funded by the Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research, a generous donation from the Dorothy P. and Richard P. Simmons Family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2013, MATRIX BIOL, V32, P325, DOI 10.1016/j.matbio.2013.02.010; Bridges RS, 2009, AM J PATHOL, V175, P2351, DOI 10.2353/ajpath.2009.080954; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Canfield AE, 2002, J PATHOL, V196, P228, DOI 10.1002/path.1020; Chaganti RK, 2008, OSTEOARTHR CARTILAGE, V16, P566, DOI 10.1016/j.joca.2007.09.008; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Chen HC, 2008, ARTHRITIS RHEUM-US, V58, P3854, DOI 10.1002/art.24319; Cosgrove GP, 2004, AM J RESP CRIT CARE, V170, P242, DOI 10.1164/rccm.200308-1151OC; Deere M, 1998, AM J MED GENET, V80, P510, DOI 10.1002/(SICI)1096-8628(19981228)80:5<510::AID-AJMG14>3.0.CO;2-F; Demedts M, 2002, EUR RESPIR J, V19, P794, DOI 10.1183/09031936.02.00492002; DICESARE PE, 1995, J ORTHOPAED RES, V13, P422, DOI 10.1002/jor.1100130316; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Farina G, 2009, ANN RHEUM DIS, V68, P435, DOI 10.1136/ard.2007.086850; Farina G, 2006, MATRIX BIOL, V25, P213, DOI 10.1016/j.matbio.2006.01.007; Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P1722, DOI 10.1164/ajrccm.164.9.2103074; Gilani SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008959; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Hansen U, 2011, ARTHRITIS RHEUM-US, V63, P159, DOI 10.1002/art.30073; Haudenschild DR, 2011, J BIOL CHEM, V286, P43250, DOI 10.1074/jbc.M111.234716; Hesselstrand R, 2008, ANN RHEUM DIS, V67, P1242, DOI 10.1136/ard.2007.082099; Hesselstrand R, 2012, RHEUMATOLOGY, V51, P915, DOI 10.1093/rheumatology/ker442; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Ikegawa S, 1998, HUM GENET, V103, P633, DOI 10.1007/s004390050883; Inui S, 2011, AM J PATHOL, V179, P1951; Kadota J, 2005, RESP MED, V99, P111, DOI 10.1016/j.rmed.2004.04.018; Khalil N, 2005, J BIOL CHEM, V280, P43000, DOI 10.1074/jbc.M510441200; Kim W, 2006, J AM SOC NEPHROL, V17, P2474, DOI 10.1681/ASN.2006020109; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Korthagen NM, 2011, RESP MED, V105, P106, DOI 10.1016/j.rmed.2010.09.012; Liao Q, 2003, SCAND J GASTROENTERO, V38, P207, DOI 10.1080/00365520310000717; Lynch JP, 2006, SEMIN RESP CRIT CARE, V27, P634, DOI 10.1055/s-2006-957335; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Milosevic J, 2012, AM J RESP CELL MOL, V47, P879, DOI 10.1165/rcmb.2011-0377OC; Neidhart M, 2005, ANN RHEUM DIS, V64, P419, DOI 10.1136/ard.2004.023135; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; Okamoto M, 2011, EUR RESPIR J, V37, P1119, DOI 10.1183/09031936.00059810; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pardo A, 2008, INT J BIOCHEM CELL B, V40, P1141, DOI 10.1016/j.biocel.2007.11.020; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; STANESCU R, 1993, AM J MED GENET, V45, P501, DOI 10.1002/ajmg.1320450420; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Tufan AC, 2007, EUR J HUM GENET, V15, P1023, DOI 10.1038/sj.ejhg.5201882; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wislowska M, 2005, RHEUMATOL INT, V25, P373, DOI 10.1007/s00296-004-0581-7; Xiao Y, 2004, J GASTROEN HEPATOL, V19, P296, DOI 10.1111/j.1440-1746.2003.03268.x; Yamamoto M, 2007, RHEUMATOLOGY, V46, P1858, DOI 10.1093/rheumatology/kem254; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	56	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83120	10.1371/journal.pone.0083120	http://dx.doi.org/10.1371/journal.pone.0083120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376648	gold, Green Published, Green Accepted			2022-12-27	WOS:000328745100093
J	Xia, AP; Song, YH; Wang, R; Gao, SS; Clifton, W; Raphael, P; Chao, SI; Pereira, FA; Groves, AK; Oghalai, JS				Xia, Anping; Song, Yohan; Wang, Rosalie; Gao, Simon S.; Clifton, Will; Raphael, Patrick; Chao, Sung-il; Pereira, Fred A.; Groves, Andrew K.; Oghalai, John S.			Prestin Regulation and Function in Residual Outer Hair Cells after Noise-Induced Hearing Loss	PLOS ONE			English	Article							MAMMALIAN COCHLEAR AMPLIFICATION; GUINEA-PIG COCHLEA; MOTOR PROTEIN; OLIVOCOCHLEAR BUNDLE; MEMBRANE CAPACITANCE; GENE-EXPRESSION; VOLTAGE SENSOR; MOUSE COCHLEA; UP-REGULATION; ACH RECEPTOR	The outer hair cell (OHC) motor protein prestin is necessary for electromotility, which drives cochlear amplification and produces exquisitely sharp frequency tuning. Tecta(C1509G) transgenic mice have hearing loss, and surprisingly have increased OHC prestin levels. We hypothesized, therefore, that prestin up-regulation may represent a generalized response to compensate for a state of hearing loss. In the present study, we sought to determine the effects of noise-induced hearing loss on prestin expression. After noise exposure, we performed cytocochleograms and observed OHC loss only in the basal region of the cochlea. Next, we patch clamped OHCs from the apical turn (9-12 kHz region), where no OHCs were lost, in noise-exposed and age-matched control mice. The non-linear capacitance was significantly higher in noise-exposed mice, consistent with higher functional prestin levels. We then measured prestin protein and mRNA levels in whole-cochlea specimens. Both Western blot and qPCR studies demonstrated increased prestin expression after noise exposure. Finally, we examined the effect of the prestin increase in vivo following noise damage. Immediately after noise exposure, ABR and DPOAE thresholds were elevated by 30-40 dB. While most of the temporary threshold shifts recovered within 3 days, there were additional improvements over the next month. However, DPOAE magnitudes, basilar membrane vibration, and CAP tuning curve measurements from the 9-12 kHz cochlear region demonstrated no differences between noise-exposed mice and control mice. Taken together, these data indicate that prestin is up-regulated by 32-58% in residual OHCs after noise exposure and that the prestin is functional. These findings are consistent with the notion that prestin increases in an attempt to partially compensate for reduced force production because of missing OHCs. However, in regions where there is no OHC loss, the cochlea is able to compensate for the excess prestin in order to maintain stable auditory thresholds and frequency discrimination.	[Xia, Anping; Song, Yohan; Wang, Rosalie; Gao, Simon S.; Raphael, Patrick; Chao, Sung-il; Oghalai, John S.] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Clifton, Will; Pereira, Fred A.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Chao, Sung-il] Chosun Univ, Dept Otolaryngol Head & Neck Surg, Kwangju, South Korea; [Gao, Simon S.] Rice Univ, Dept Bioengn, Houston, TX USA; [Groves, Andrew K.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Groves, Andrew K.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Groves, Andrew K.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Stanford University; Baylor College of Medicine; Chosun University; Rice University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Oghalai, JS (corresponding author), Stanford Univ, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	joghalai@stanford.edu		Groves, Andrew/0000-0002-0784-7998; Gao, Simon/0000-0002-7020-037X	Department of Defense [W81XWH-11-2-0004]; NIH [P30DC010363, DC006185]; Howard Hughes Medical Institute; Stanford Society of Physicians Scholars collaborative research grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000354, P30DC010363, R01DC006185] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stanford Society of Physicians Scholars collaborative research grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was funded by Department of Defense W81XWH-11-2-0004, NIH P30DC010363 (J.S.O), NIH DC006185 (A.K.G), and the Howard Hughes Medical Institute research training fellowship grant for medical students and the Stanford Society of Physicians Scholars collaborative research grant (Y.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2007, J MEMBR BIOL; Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Moreno-Pelayo MA, 2008, JARO-J ASSOC RES OTO, V9, P202, DOI 10.1007/s10162-008-0116-0; ASHMORE JF, 1986, NATURE, V322, P368, DOI 10.1038/322368a0; Belyantseva IA, 2000, J NEUROSCI, V20, P8996; BROWN MC, 1983, SCIENCE, V222, P69, DOI 10.1126/science.6623058; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Cheatham MA, 2005, J PHYSIOL-LONDON, V569, P229, DOI 10.1113/jphysiol.2005.093518; Cheatham MA, 2009, J NEUROSCI, V29, P12000, DOI 10.1523/JNEUROSCI.1651-09.2009; Chen GD, 2006, HEARING RES, V222, P54, DOI 10.1016/j.heares.2006.08.011; DALLOS P, 1976, J ACOUST SOC AM, V59, P591, DOI 10.1121/1.380903; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Duncan LJ, 2006, J COMP NEUROL, V499, P691, DOI 10.1002/cne.21114; EYBALIN M, 1993, PHYSIOL REV, V73, P309, DOI 10.1152/physrev.1993.73.2.309; FORGE A, 1991, CELL TISSUE RES, V265, P473, DOI 10.1007/BF00340870; Frolenkov GI, 2006, J PHYSIOL-LONDON, V576, P43, DOI 10.1113/jphysiol.2006.114975; Gale JE, 1997, PFLUG ARCH EUR J PHY, V434, P267, DOI 10.1007/s004240050395; Gao SS, 2013, BIOMED OPT EXPRESS, V4, P230, DOI 10.1364/BOE.4.00230; Gross J, 2011, CELL MOL NEUROBIOL, V31, P1089, DOI 10.1007/s10571-011-9708-z; Gross J, 2011, DEV NEUROBIOL, V71, P650, DOI 10.1002/dneu.20881; Gueta R, 2011, BIOPHYS J, V100, P2530, DOI 10.1016/j.bpj.2011.04.024; He DZZ, 2004, DEV BRAIN RES, V148, P19, DOI 10.1016/j.devbrainres.2003.10.003; HOUSLEY GD, 1991, P ROY SOC B-BIOL SCI, V244, P161, DOI 10.1098/rspb.1991.0065; HUANG GJ, 1993, BIOPHYS J, V65, P2228, DOI 10.1016/S0006-3495(93)81248-7; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu CS, 2011, J APPL STAT, V38, P2575, DOI 10.1080/02664763.2011.559213; Liu CC, 2011, JARO-J ASSOC RES OTO, V12, P577, DOI 10.1007/s10162-011-0269-0; Luebke AE, 2002, J NEUROSCI, V22, P4241, DOI 10.1523/JNEUROSCI.22-10-04241.2002; Maison SF, 2002, J NEUROSCI, V22, P10838; Maison SF, 2007, J NEUROPHYSIOL, V97, P3269, DOI 10.1152/jn.00067.2007; Mazurek B, 2007, HEARING RES, V231, P73, DOI 10.1016/j.heares.2007.05.008; Oghalai John S, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P431, DOI 10.1097/01.moo.0000134449.05454.82; Ohlemiller KK, 2010, JARO-J ASSOC RES OTO, V11, P605, DOI 10.1007/s10162-010-0228-1; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rajagopalan L, 2010, JARO-J ASSOC RES OTO, V11, P39, DOI 10.1007/s10162-009-0196-5; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; Santos-Sacchi J, 2004, BIOPHYS J, V87, P714, DOI 10.1529/biophysj.103.033993; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2002, PFLUG ARCH EUR J PHY, V444, P99, DOI 10.1007/s00424-002-0804-2; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sfondouris J, 2008, J BIOL CHEM, V283, P22473, DOI 10.1074/jbc.M803722200; SIEGEL JH, 1982, HEARING RES, V6, P171, DOI 10.1016/0378-5955(82)90052-1; Song L, 2008, J NEUROPHYSIOL, V99, P344, DOI 10.1152/jn.00983.2007; Turcan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009058; Vetter DE, 1999, NEURON, V23, P93, DOI 10.1016/S0896-6273(00)80756-4; Viberg A, 2004, HEARING RES, V197, P1, DOI 10.1016/j.heares.2004.04.016; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Weber T, 2002, P NATL ACAD SCI USA, V99, P2901, DOI 10.1073/pnas.052609899; Weddell TD, 2011, CURR BIOL, V21, pR682, DOI 10.1016/j.cub.2011.08.001; WIEDERHOLD ML, 1970, J ACOUST SOC AM, V48, P950, DOI 10.1121/1.1912234; Wu M, 1998, J MEMBRANE BIOL, V166, P111, DOI 10.1007/s002329900453; Wu XD, 2007, DEV NEUROBIOL, V67, P483, DOI 10.1002/dneu.20357; Xia AP, 2007, JARO-J ASSOC RES OTO, V8, P447, DOI 10.1007/s10162-007-0092-9; Xia AP, 2010, DIS MODEL MECH, V3, P209, DOI 10.1242/dmm.004135; Yamashita T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045453; Yu N, 2008, CELL MOL LIFE SCI, V65, P2407, DOI 10.1007/s00018-008-8195-y; Yu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007923; Yuan T, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3290799; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	66	53	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82602	10.1371/journal.pone.0082602	http://dx.doi.org/10.1371/journal.pone.0082602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376553	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100043
J	Yoshino, F; Yoshida, A; Nakajima, A; Wada-Takahashi, S; Takahashi, S; Lee, MCI				Yoshino, Fumihiko; Yoshida, Ayaka; Nakajima, Atsushi; Wada-Takahashi, Satoko; Takahashi, Shunsuke; Lee, Masaichi Chang-il			Alteration of the Redox State with Reactive Oxygen Species for 5-Fluorouracil-Induced Oral Mucositis in Hamsters	PLOS ONE			English	Article							ELECTRON-SPIN-RESONANCE; IN-VIVO ESR; OXIDATIVE STRESS; LIPID PEROXIDES; ECONOMIC OUTCOMES; FREE-RADICALS; SPECTROSCOPY; BRAIN; RATS; THERAPY	Oral mucositis is often induced in patients receiving cancer chemotherapy treatment. It has been reported that oral mucositis can reduce quality of life, as well as increasing the incidence of mortality. The participation of reactive oxygen species (ROS) in the pathogenesis of oral mucositis is well known, but no report has actually demonstrated the presence of ROS. Thus, the purpose of this study was thus to demonstrate the involvement of ROS and the alteration of the redox state in oral mucositis using an in vivo L-band electron spin resonance (ESR) technique. An oral mucositis animal model induced by treatment of 5-fluorouracil with 10% acetic acid in hamster cheek pouch was used. Lipid peroxidation was measured as the level of malondialdehyde determined by the thiobarbituric acid reaction. The rate constants of the signal decay of nitroxyl compounds using in vivo L-band ESR were calculated from the signal decay curves. Firstly, we established the oral mucositis animal model induced by treatment of 5-fluorouracil with acetic acid in hamster cheek pouch. An increased level of lipid peroxidation in oral mucositis was found by measuring malondialdehyde using isolated hamster cheek pouch ulcer. In addition, as a result of in vivo L-band ESR measurements using our model animals, the decay rate constants of carbamoyl-PROXYL, which is a reagent for detecting the redox balance in tissue, were decreased. These results suggest that a redox imbalance might occur by excessive generation of ROS at an early stage of oral mucositis and the consumption of large quantities of antioxidants including glutathione in the locality of oral mucositis. These findings support the presence of ROS involved in the pathogenesis of oral mucositis with anti-cancer therapy, and is useful for the development of novel therapies drugs for oral mucositis.	[Yoshino, Fumihiko; Yoshida, Ayaka] Kanagawa Dent Univ, Grad Sch, Dept Oral Sci, Photomed Dent Div, Yokosuka, Kanagawa, Japan; [Nakajima, Atsushi] Kanagawa Dent Univ, Dept Clin Care Med, Div Pharmacol, Yokosuka, Kanagawa, Japan; [Wada-Takahashi, Satoko; Takahashi, Shunsuke] Kanagawa Dent Univ, Grad Sch, Dept Oral Sci, Dent Circulat Control Div, Yokosuka, Kanagawa, Japan; [Lee, Masaichi Chang-il] Kanagawa Dent Univ, Grad Sch, Yokosuka Shonan Disaster Hlth Emergency Res Ctr, Yokosuka, Kanagawa, Japan; [Lee, Masaichi Chang-il] Kanagawa Dent Univ, Grad Sch, ESR Labs, Yokosuka, Kanagawa, Japan	Kanagawa Dental College; Kanagawa Dental College; Kanagawa Dental College; Kanagawa Dental College; Kanagawa Dental College	Yoshino, F (corresponding author), Kanagawa Dent Univ, Grad Sch, Dept Oral Sci, Photomed Dent Div, Yokosuka, Kanagawa, Japan.	poppo3737@gmail.com	Yoshino, Fumihiko/E-5067-2012; Yoshida, Ayaka/D-9382-2014	Yoshino, Fumihiko/0000-0001-6068-6268; Yoshida, Ayaka/0000-0001-8855-9228	Ministry of Education, Culture, Sports, Science and Technology of Japan [24593013]; Grants-in-Aid for Scientific Research [24792045] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24593013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; ASMUS KD, 1976, INT J RADIAT BIOL, V29, P211, DOI 10.1080/09553007614550241; BARTOLD PM, 1984, J PERIODONTAL RES, V19, P390, DOI 10.1111/j.1600-0765.1984.tb01012.x; BERLIN V, 1981, J BIOL CHEM, V256, P4747; BERLINER LJ, 1989, MAGNET RESON MED, V9, P430, DOI 10.1002/mrm.1910090317; Chapple ILC, 1996, J CLIN PATHOL-CL MOL, V49, pM247; CHATEAUNEUF J, 1988, J ORG CHEM, V53, P1629, DOI 10.1021/jo00243a007; CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526; Dorr W, 2001, INT J RADIAT BIOL, V77, P341, DOI 10.1080/09553000010018873; DUSRE L, 1989, CHEM-BIOL INTERACT, V71, P63, DOI 10.1016/0009-2797(89)90090-2; Elting LS, 2003, CANCER, V98, P1531, DOI 10.1002/cncr.11671; Epstein JB, 2001, CANCER, V92, P875, DOI 10.1002/1097-0142(20010815)92:4<875::AID-CNCR1396>3.0.CO;2-1; Fuchs J, 1997, FREE RADICAL BIO MED, V22, P967, DOI 10.1016/S0891-5849(96)00433-9; GOMI F, 1993, LIFE SCI, V52, P2027, DOI 10.1016/0024-3205(93)90687-X; Guo HL, 2003, RADIAT RES, V159, P361, DOI 10.1667/0033-7587(2003)159[0361:PORIOC]2.0.CO;2; Hirayama A, 2008, HYPERTENS RES, V31, P1643, DOI 10.1291/hypres.31.1643; Inaba K, 1997, FREE RADICAL RES, V27, P37, DOI 10.3109/10715769709097836; Ishiyama Hironobu, 2002, Inflammopharmacology, V10, P391, DOI 10.1163/156856002321544864; Kobayashi K, 2008, ANESTHESIOLOGY, V109, P426, DOI 10.1097/ALN.0b013e318182a903; Lee C, 2000, J BIOL CHEM, V275, P38965, DOI 10.1074/jbc.M006341200; Lee MC, 2004, HYPERTENS RES, V27, P485, DOI 10.1291/hypres.27.485; Matsunaga T, 2010, CANCER CHEMOTH PHARM, V66, P517, DOI 10.1007/s00280-009-1192-5; Miura Y, 2000, FREE RADICAL BIO MED, V28, P854, DOI 10.1016/S0891-5849(00)00162-3; Murphy CK, 2008, CLIN CANCER RES, V14, P4292, DOI 10.1158/1078-0432.CCR-07-4669; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Panahi Y, 2010, EUR J CANCER CARE, V19, P308, DOI 10.1111/j.1365-2354.2008.01042.x; PATTON S, 1951, J DAIRY SCI, V34, P669, DOI 10.3168/jds.S0022-0302(51)91763-8; Rose-Ped AM, 2002, CANCER NURS, V25, P461, DOI 10.1097/00002820-200212000-00010; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Siomek A, 2006, INT J CANCER, V119, P2228, DOI 10.1002/ijc.22088; Slomiany BL, 1999, BIOCHEM BIOPH RES CO, V257, P373, DOI 10.1006/bbrc.1999.0483; Sonis S, 1991, Oncology (Williston Park), V5, P11; Sonis S, 1991, ONCOLOGY WILLISTON P, V5, P18; Sonis ST, 2002, CELL PROLIFERAT, V35, P93, DOI 10.1046/j.1365-2184.35.s1.10.x; Sonis ST, 2001, J CLIN ONCOL, V19, P2201, DOI 10.1200/JCO.2001.19.8.2201; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Sonis ST, 2000, ORAL ONCOL, V36, P373, DOI 10.1016/S1368-8375(00)00012-9; Sonis Stephen T, 2004, J Support Oncol, V2, P3; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Sugiyama S, 2012, J CLIN BIOCHEM NUTR, V51, P108, DOI 10.3164/jcbn.11-103; TAKAHASHI M, 1989, J AM CHEM SOC, V111, P6350, DOI 10.1021/ja00198a054; Takeshita K, 2002, BBA-GEN SUBJECTS, V1573, P156, DOI 10.1016/S0304-4165(02)00420-8; TSAVARIS N, 1988, EUR J SURG ONCOL, V14, P405; TSUKIMI Y, 1994, J GASTROEN HEPATOL, V9, pS60, DOI 10.1111/j.1440-1746.1994.tb01304.x; Ueda Y, 1998, MAGNET RESON MED, V40, P491, DOI 10.1002/mrm.1910400321; Yagi K, 1998, Methods Mol Biol, V108, P101; Yamashita N, 1999, J EXP MED, V189, P1699, DOI 10.1084/jem.189.11.1699; Yoshida A, 2011, J CLIN BIOCHEM NUTR, V49, P79, DOI 10.3164/jcbn.10-103; Yoshino F, 2012, J PHOTOCH PHOTOBIO B, V114, P73, DOI 10.1016/j.jphotobiol.2012.05.012; Yoshino F, 2012, ARCH ORAL BIOL, V57, P654, DOI 10.1016/j.archoralbio.2011.12.009; Yoshino F, 2011, J CLIN BIOCHEM NUTR, V49, P182, DOI 10.3164/jcbn.11-01	51	36	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82834	10.1371/journal.pone.0082834	http://dx.doi.org/10.1371/journal.pone.0082834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376587	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100060
J	Fierro, A; Liccardo, A				Fierro, Annalisa; Liccardo, Antonella			Lattice Model for Influenza Spreading with Spontaneous Behavioral Changes	PLOS ONE			English	Article							PANDEMIC INFLUENZA; SOCIAL CONTACTS; SELF-INTEREST; VACCINATION; STRATEGIES; TRANSMISSION	Individual behavioral response to the spreading of an epidemic plays a crucial role in the progression of the epidemic itself. The risk perception induces individuals to adopt a protective behavior, as for instance reducing their social contacts, adopting more restrictive hygienic measures or undergoing prophylaxis procedures. In this paper, starting with a previously developed lattice-gas SIR model, we construct a coupled behavior-disease model for influenza spreading with spontaneous behavioral changes. The focus is on self-initiated behavioral changes that alter the susceptibility to the disease, without altering the contact patterns among individuals. Three different mechanisms of awareness spreading are analyzed: the local spreading due to the presence in the neighborhood of infective individuals; the global spreading due to the news published by the mass media and to educational campaigns implemented at institutional level; the local spreading occurring through the "thought contagion" among aware and unaware individuals. The peculiarity of the present approach is that the awareness spreading model is calibrated on available data on awareness and concern of the population about the risk of contagion. In particular, the model is validated against the A(H1N1) epidemic outbreak in Italy during the 2009/2010 season, by making use of the awareness data gathered by the behavioral risk factor surveillance system (PASSI). We find that, increasing the accordance between the simulated awareness spreading and the PASSI data on risk perception, the agreement between simulated and experimental epidemiological data improves as well. Furthermore, we show that, within our model, the primary mechanism to reproduce a realistic evolution of the awareness during an epidemic, is the one due to globally available information. This result highlights how crucial is the role of mass media and educational campaigns in influencing the epidemic spreading of infectious diseases.	[Fierro, Annalisa] CNR, Inst Superconductors Oxides & Other Innovat Mat &, I-80125 Naples, Italy; [Fierro, Annalisa; Liccardo, Antonella] Univ Naples Federico II, Dept Phys, Naples, Italy; [Liccardo, Antonella] Ist Nazl Fis Nucl, Sez Napoli, I-80125 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN)	Liccardo, A (corresponding author), Univ Naples Federico II, Dept Phys, Naples, Italy.	liccardo@na.infn.it	Fierro, Annalisa/G-8479-2013	Fierro, Annalisa/0000-0001-8431-942X				Bagnoli F, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061904; Baldissera S, 2011, PREV CHRONIC DIS, V8; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Blendon R, 2002, MED GEN MED, V2; Bomlitz LJ, 2008, J PUBLIC HEALTH-UK, V30, P202, DOI 10.1093/pubmed/fdn009; Ciofidegli Atti ML, 2008, PLOS ONE, V3, pe1790; Costanzo S, 2012, INT J PUBLIC HEALTH, V57, P569, DOI 10.1007/s00038-012-0346-0; d'Onofrio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045653; Epstein JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003955; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferrante G, 2011, EUR J EPIDEMIOL, V26, P211, DOI 10.1007/s10654-011-9576-3; Fierro A, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11011-2; Funk S, 2009, P NATL ACAD SCI; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; GOFFMAN W, 1964, NATURE, V204, P225, DOI 10.1038/204225a0; Halloran ME, 2002, VACCINE, V20, P3254; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; INFLUNET, 2010, RIS SORV EP STAG 200; Kasperson RE, 1996, ANN AM ACAD POLIT SS, V545, P95, DOI 10.1177/0002716296545001010; Liccardo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063935; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mbah MLN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002469; MERLER S, 2009, P ROYAL SOC B; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Olowokure B, 2012, J CLIN VIROL, V55, P75, DOI 10.1016/j.jcv.2012.05.013; Perra N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023084; Poletti P, 2011, PLOS ONE, V7, P1; Poletti P, 2012, MATH BIOSCIENCES; Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03; Sahneh FD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00632; Salathe M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	39	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83641	10.1371/journal.pone.0083641	http://dx.doi.org/10.1371/journal.pone.0083641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376727	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000104
J	Han, WX; Tang, LY; Chen, YH; Fang, JY				Han, Wenxuan; Tang, Luying; Chen, Yahan; Fang, Jingyun			Relationship between the Relative Limitation and Resorption Efficiency of Nitrogen vs Phosphorus in Woody Plants	PLOS ONE			English	Article							N-P STOICHIOMETRY; NUTRIENT RESORPTION; TERRESTRIAL PLANTS; MINERAL-NUTRITION; WILD PLANTS; PATTERNS; RATIOS; LEAVES; PROFICIENCY; LATITUDE	Most previous studies have ascribed variations in the resorption of a certain plant nutrient to its corresponding environmental availability or level in tissues, regardless of the other nutrients' status. However, given that plant growth relies on both sufficient and balanced nutrient supply, the nutrient resorption process should not only be related to the absolute nutrient status, but also be regulated by the relative limitation of the nutrient. Here, based on a global woody-plants dataset from literature, we test the hypothesis that plants resorb proportionately more nitrogen (or phosphorus) when they are nitrogen (or phosphorus) limited, or similar proportions of nitrogen (N) and phosphorus (P) when co-limited by both nutrients (the relative resorption hypothesis). Using the N: P ratio in green foliage as an indicator of nutrient limitation, we found an inverse relationship between the difference in the proportionate resorption of N vs P and this foliar N: P ratio, consistent across species, growth-forms, and vegetation-types globally. Moreover, according to the relative resorption hypothesis, communities with higher/lower foliar N: P (more likely P/N limited) tend to produce litter with disproportionately higher/lower N: P, causing a worsening status of P/N availability; this positive feedback may somehow be counteracted by several negative-feedback mechanisms. Compared to N, P generally shows higher variability in resorption efficiency (proportion resorbed), and higher resorption sensitivity to nutrient availability, implying that the resorption of P seems more important for plant nutrient conservation and N: P stoichiometry. Our findings elucidate the nutrient limitation effects on resorption efficiency in woody plants at the global scale, and thus can improve the understanding of nutrient resorption process in plants. This study also suggests the importance of the foliar N: P ratio as a key parameter for biogeochemical modeling, and the relative resorption hypothesis used to deduce the critical (optimal) N: P ratio for a specific plant community.	[Han, Wenxuan] China Agr Univ, Coll Resources & Environm Sci, Minist Educ, Key Lab Plant Soil Interact, Beijing 100094, Peoples R China; [Tang, Luying; Fang, Jingyun] Peking Univ, Dept Ecol, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Chen, Yahan] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	China Agricultural University; Peking University; Chinese Academy of Sciences; Institute of Botany, CAS	Han, WX (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Minist Educ, Key Lab Plant Soil Interact, Beijing 100094, Peoples R China.	hanwenxuan@cau.edu.cn; jyfang@urban.pku.edu.cn	Han, Wenxuan/B-8791-2016	Han, Wenxuan/0000-0001-8678-7147	National Natural Science Foundation of China [41173083, 31021001]; National Basic Research Program of China on Global Change [2010CB950600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China on Global Change(National Basic Research Program of China)	The research was funded by National Natural Science Foundation of China (41173083, 31021001), and National Basic Research Program of China on Global Change (2010CB950600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Craine JM, 2011, RESOURCE STRATEGIES; Gusewell S, 2005, FUNCT ECOL, V19, P344, DOI 10.1111/j.0269-8463.2005.00967.x; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Killingbeck KT, 1996, ECOLOGY, V77, P1716, DOI 10.2307/2265777; Kobe RK, 2005, ECOLOGY, V86, P2780, DOI 10.1890/04-1830; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Lovelock CE, 2007, ECOL LETT, V10, P1154, DOI 10.1111/j.1461-0248.2007.01112.x; Manzoni S, 2008, SCIENCE, V321, P684, DOI 10.1126/science.1159792; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Menge DNL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042045; Oleksyn J, 2003, OECOLOGIA, V136, P220, DOI 10.1007/s00442-003-1265-9; Ostertag R, 2010, PLANT SOIL, V334, P85, DOI 10.1007/s11104-010-0281-x; R Development Core Team, 2012, R LANG ENV STAT COMP; Reed SC, 2012, NEW PHYTOL, V196, P173, DOI 10.1111/j.1469-8137.2012.04249.x; Reich PB, 1998, INHERENT VARIATION IN PLANT GROWTH, P467; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Richardson SJ, 2005, ECOLOGY, V86, P20, DOI 10.1890/04-0524; Sadras VO, 2006, FIELD CROP RES, V95, P13, DOI 10.1016/j.fcr.2005.01.020; Sokal R.R., 2012, BIOMETRY; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Tessier JT, 2003, J APPL ECOL, V40, P523, DOI 10.1046/j.1365-2664.2003.00820.x; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Tilman D., 1982, Monographs in Population Biology, pi; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; van Heerwaarden LM, 2003, J ECOL, V91, P1060, DOI 10.1046/j.1365-2745.2003.00828.x; van Heerwaarden LM, 2003, OIKOS, V101, P664, DOI 10.1034/j.1600-0706.2003.12351.x; Vergutz L, 2012, ECOL MONOGR, V82, P205, DOI 10.1890/11-0416.1; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wright IJ, 2003, FUNCT ECOL, V17, P10, DOI 10.1046/j.1365-2435.2003.00694.x; Yuan ZY, 2009, GLOBAL ECOL BIOGEOGR, V18, P11, DOI 10.1111/j.1466-8238.2008.00425.x	38	81	109	23	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83366	10.1371/journal.pone.0083366	http://dx.doi.org/10.1371/journal.pone.0083366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376694	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000083
J	Kant, R; Hu, ZY; Malhotra, JK; Krogh-Madsen, T; Christini, DJ; Heerdt, PM; Abbott, GW				Kant, Ritu; Hu, Zhaoyang; Malhotra, Jaideep K.; Krogh-Madsen, Trine; Christini, David J.; Heerdt, Paul M.; Abbott, Geoffrey W.			NHE Isoform Switching and KChIP2 Upregulation in Aging Porcine Atria	PLOS ONE			English	Article							HYDROGEN EXCHANGE INHIBITION; MYOCARDIAL-INFARCTION; NA+/H+ EXCHANGE; CARIPORIDE; RISK; REPERFUSION; PROTECTION; ISCHEMIA; TRIAL	Aging increases the risk of cardiac pathologies including atrial fibrillation and can alter myocardial responsiveness to therapeutic agents. Here, seeking molecular correlates of myocardial aging processes, we performed global "whole transcript" analysis of 25,388 genes using 572,667 probes to compare the left atrial (LA) transcriptomes of young adult (9 months old) versus elderly (10 years old) female swine. NHE2 (>9-fold) and KChIP2 (3.8-fold) exhibited the highest aging-related expression increases. Real-time qPCR recapitulated these findings and indicated a 50% decrease in LA NHE1, a twofold increase in right atrial KChIP2, but no significant changes for these transcripts in either ventricle. Notably, even in young adult pigs, NHE2 transcript was detectable and enriched in the atria over the ventricles. NHE1, the recognized cardiac isoform of the sodium hydrogen exchanger, has proven a compelling but clinically disappointing therapeutic target with respect to reperfusion arrhythmias. Our data challenge the dogma that NHE1 is alone in the myocardium and suggest that NHE2 could negatively impact the pharmacological responsiveness of atrial tissue to NHE1-specific inhibitors. KChIP2 is a cytosolic beta subunit essential for generation of I-to. The increased KChIP2 expression we observed with aging substantially shortened in silico atrial myocyte action potential duration, a predisposing factor in atrial fibrillation. Consistent with this, 4/5 elderly swine sustained pacing-induced AF >= 15 s after cessation of stimulation, compared to 0/3 young swine. Our findings uncover potential molecular bases for increased arrhythmogenicity and reduced pharmacologic efficacy in the aging atrium, in a large animal model of human cardiac physiology.	[Kant, Ritu; Hu, Zhaoyang; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, Bioelect Lab, Irvine, CA 92717 USA; [Kant, Ritu; Hu, Zhaoyang; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Malhotra, Jaideep K.; Heerdt, Paul M.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA; [Krogh-Madsen, Trine; Christini, David J.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Heerdt, Paul M.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Cornell University; Cornell University; Cornell University	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, Bioelect Lab, Irvine, CA 92717 USA.	abbottg@uci.edu		Christini, David/0000-0003-0852-2922	US National Institutes of Health, National Heart, Lung and Blood Institute [HL079275, HL101190]; University of California, Irvine; Memorial Sloan-Kettering Steps for Breath Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275, R01HL101190] Funding Source: NIH RePORTER	US National Institutes of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of California, Irvine(University of California System); Memorial Sloan-Kettering Steps for Breath Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the US National Institutes of Health, National Heart, Lung and Blood Institute HL079275 and HL101190 (G. W. A. and D.J.C.) and University of California, Irvine setup funds (G. W. A.). In addition, support was provided by the Memorial Sloan-Kettering Steps for Breath Fund (PMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avkiran M, 2008, CURR OPIN PHARMACOL, V8, P133, DOI 10.1016/j.coph.2007.12.007; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyce SW, 2003, J THORAC CARDIOV SUR, V126, P420, DOI 10.1016/S0022-5223(03)00209-5; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; Fotiadis P, 2013, J BIOL RHYTHM, V28, P69, DOI 10.1177/0748730412469499; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Joliffe I. T., 1986, PRINCIPAL COMPONENT; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Mentzer RM, 2008, ANN THORAC SURG, V85, P1261, DOI 10.1016/j.athoracsur.2007.10.054; Minino AM, 2011, NCHS DATA BRIEF, V115, P1; Murphy E, 2009, J MOL CELL CARDIOL, V46, P137, DOI 10.1016/j.yjmcc.2008.09.715; Rupprecht HJ, 2000, CIRCULATION, V101, P2902, DOI 10.1161/01.CIR.101.25.2902; SCHOLZ W, 1995, CARDIOVASC RES, V29, P260, DOI 10.1016/S0008-6363(96)88579-8; Simm A, 2008, EXP GERONTOL, V43, P691, DOI 10.1016/j.exger.2008.04.017; Tamhane AC, 2006, STAT DATA ANAL ELEME; Theroux P, 2000, CIRCULATION, V102, P3032; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Zeymer U, 2001, J AM COLL CARDIOL, V38, P1644	20	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82951	10.1371/journal.pone.0082951	http://dx.doi.org/10.1371/journal.pone.0082951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376615	Green Published, gold			2022-12-27	WOS:000328882000045
J	Maacha, S; Planque, N; Laurent, C; Pegoraro, C; Anezo, O; Maczkowiak, F; Monsoro-Burq, AH; Saule, S				Maacha, Selma; Planque, Nathalie; Laurent, Cecile; Pegoraro, Caterina; Anezo, Oceane; Maczkowiak, Frederique; Monsoro-Burq, Anne H.; Saule, Simon			Protein Tyrosine Phosphatase 4A3 (PTP4A3) Is Required for Xenopus laevis Cranial Neural Crest Migration In Vivo	PLOS ONE			English	Article							PRL-3; EXPRESSION; GENE; METASTASIS; INDUCTION; PROMOTES; CELLS; PROLIFERATION; DROSOPHILA; REGULATOR	Uveal melanoma is the most common intraocular malignancy in adults, representing between about 4% and 5% of all melanomas. High expression levels of Protein Tyrosine Phosphatase 4A3, a dual phosphatase, is highly predictive of metastasis development and PTP4A3 overexpression in uveal melanoma cells increases their in vitro migration and in vivo invasiveness. Melanocytes, including uveal melanocytes, are derived from the neural crest during embryonic development. We therefore suggested that PTP4A3 function in uveal melanoma metastasis may be related to an embryonic role during neural crest cell migration. We show that PTP4A3 plays a role in cephalic neural crest development in Xenopus laevis. PTP4A3 loss of function resulted in a reduction of neural crest territory, whilst gain of function experiments increased neural crest territory. Isochronic graft experiments demonstrated that PTP4A3-depleted neural crest explants are unable to migrate in host embryos. Pharmacological inhibition of PTP4A3 on dissected neural crest cells significantly reduced their migration velocity in vitro. Our results demonstrate that PTP4A3 is required for cephalic neural crest migration in vivo during embryonic development.	[Maacha, Selma; Planque, Nathalie; Laurent, Cecile; Pegoraro, Caterina; Anezo, Oceane; Maczkowiak, Frederique; Monsoro-Burq, Anne H.; Saule, Simon] Inst Curie, Div Res, F-91405 Orsay, France; [Maacha, Selma; Planque, Nathalie; Laurent, Cecile; Pegoraro, Caterina; Anezo, Oceane; Maczkowiak, Frederique; Monsoro-Burq, Anne H.; Saule, Simon] CNRS, UMR3347, F-91405 Orsay, France; [Maacha, Selma; Planque, Nathalie; Laurent, Cecile; Pegoraro, Caterina; Anezo, Oceane; Maczkowiak, Frederique; Monsoro-Burq, Anne H.; Saule, Simon] Univ Paris 11, INSERM, U1021, F-91405 Orsay, France; [Maacha, Selma; Planque, Nathalie; Laurent, Cecile; Pegoraro, Caterina; Anezo, Oceane; Maczkowiak, Frederique; Monsoro-Burq, Anne H.; Saule, Simon] Univ Paris 11, Orsay, France; [Planque, Nathalie] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Monsoro-Burq, AH (corresponding author), Inst Curie, Div Res, F-91405 Orsay, France.	anne-helene.monsoro-burq@curie.fr; simon.saule@curie.fr		Laurent, Cecile/0000-0002-3022-2283; Monsoro-Burq, Anne H./0000-0003-2427-982X	Retina France; Fondation de France [12062]; Labex CelTisPhyBio; PIC Uveal Melanoma from the Curie Institute	Retina France; Fondation de France(Fondation de France); Labex CelTisPhyBio; PIC Uveal Melanoma from the Curie Institute	This work was supported by grants from Retina France, Fondation de France (No. 12062), Labex CelTisPhyBio, and The PIC Uveal Melanoma from the Curie Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Couly G, 2002, DEVELOPMENT, V129, P1061; DIENERWEST M, 1992, ARCH OPHTHALMOL-CHIC, V110, P245, DOI 10.1001/archopht.1992.01080140101036; EGAN KM, 1988, SURV OPHTHALMOL, V32, P239, DOI 10.1016/0039-6257(88)90173-7; Grammer TC, 2000, DEV BIOL, V228, P197, DOI 10.1006/dbio.2000.9945; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; Laurent C, 2011, CANCER RES, V71, P666, DOI 10.1158/0008-5472.CAN-10-0605; Lian YX, 2012, GENE, V511, P169, DOI 10.1016/j.gene.2012.09.079; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Lin MD, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-18; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; MONSOROBURQ AH, 2007, COLD SPRING HARBOR P, DOI DOI 10.1101/PDB.PR0T4809.PUBMED:21357147; Nakamura T, 2009, P NATL ACAD SCI USA, V106, P11270, DOI 10.1073/pnas.0902230106; NIEUWKOOP PD, 1994, TABLE XENOPUS LAEVIS; Onken MD, 2010, J MOL DIAGN, V12, P461, DOI 10.2353/jmoldx.2010.090220; Park H, 2008, BIOORG MED CHEM LETT, V18, P2250, DOI 10.1016/j.bmcl.2008.03.013; Peng LR, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-110; SATER AK, 1993, DEV DYNAM, V197, P268, DOI 10.1002/aja.1001970405; Sauka-Spengler T, 2008, GENESIS, V46, P673, DOI 10.1002/dvg.20436; Sive H.L., 2000, EARLY DEV XENOPUS LA, P249; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zheng P, 2011, CANCER BIOL THER, V12, P742, DOI 10.4161/cbt.12.8.15981; Zimmerman MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058300	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84717	10.1371/journal.pone.0084717	http://dx.doi.org/10.1371/journal.pone.0084717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376839	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000162
J	Nagaraja, TN; Aryal, MP; Brown, SL; Bagher-Ebadian, H; Mikkelsen, T; Yang, JJ; Panda, S; Keenan, KA; Cabral, G; Ewing, JR				Nagaraja, Tavarekere N.; Aryal, Madhava P.; Brown, Stephen L.; Bagher-Ebadian, Hassan; Mikkelsen, Tom; Yang, James J.; Panda, Swayamprava; Keenan, Kelly A.; Cabral, Glauber; Ewing, James R.			Cilengitide-Induced Temporal Variations in Transvascular Transfer Parameters of Tumor Vasculature in a Rat Glioma Model: Identifying Potential MRI Biomarkers of Acute Effects	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GLIOBLASTOMA; INTEGRIN; CANCER; NORMALIZATION; RADIATION; PERMEABILITY; SELECTION; ALPHA(V)BETA(3); ANGIOGENESIS	Increased efficacy of radiotherapy (RT) 4-8 h after Cilengitide treatment has been reported. We hypothesized that the effects of Cilengitide on tumor transvascular transfer parameters might underlie, and thus predict, this potentiation. Athymic rats with orthotopic U251 glioma were studied at similar to 21 days after implantation using dynamic contrast-enhanced (DCE)-MRI. Vascular parameters, viz: plasma volume fraction (v(p)), forward volume transfer constant (K-trans) and interstitial volume fraction (v(e)) of a contrast agent, were determined in tumor vasculature once before, and again in cohorts 2, 4, 8, 12 and 24 h after Cilengitide administration (4 mg/kg; N = 31; 6-7 per cohort). Perfusion-fixed brain sections were stained for von Willebrand factor to visualize vascular segments. A comparison of pre- and post-treatment parameters showed that the differences between MR indices before and after Cilengitide treatment pivoted around the 8 h time point, with 2 and 4 h groups showing increases, 12 and 24 h groups showing decreases, and values at the 8 h time point close to the baseline. The vascular parameter differences between group of 2 and 4 h and group of 12 and 24 h were significant for K-trans (p = 0.0001 and v(e) (p = 0,0271). Vascular staining showed little variation with time after Cilengitide. The vascular normalization occurring 8 h after Cilengitide treatment coincided with similar previous reports of increased treatment efficacy when RT followed Cilengitide by 8 h. Pharmacological normalization of vasculature has the potential to increase sensitivity to RT. Evaluating acute temporal responses of tumor vasculature to putative anti-angiogenic drugs may help in optimizing their combination with other treatment modalities.	[Nagaraja, Tavarekere N.; Keenan, Kelly A.] Henry Ford Hosp, Dept Anesthesiol, Detroit, MI 48202 USA; [Aryal, Madhava P.; Panda, Swayamprava; Cabral, Glauber; Ewing, James R.] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Brown, Stephen L.] Henry Ford Hosp, Dept Radiat Oncol, Detroit, MI 48202 USA; [Bagher-Ebadian, Hassan] Henry Ford Hosp, Dept Diagnost Radiol, Detroit, MI 48202 USA; [Mikkelsen, Tom] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Yang, James J.] Henry Ford Hosp, Detroit, MI 48202 USA; [Aryal, Madhava P.; Bagher-Ebadian, Hassan; Ewing, James R.] Oakland Univ, Dept Phys, Rochester, MI USA; [Ewing, James R.] Wayne State Univ, Dept Neurol, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University; Wayne State University	Nagaraja, TN (corresponding author), Henry Ford Hosp, Dept Anesthesiol, Detroit, MI 48202 USA.	tnagara1@hfhs.org			National Cancer Institute of the National Institutes of Health [R01CA135329]; NATIONAL CANCER INSTITUTE [R01CA135329] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by National Cancer Institute of the National Institutes of Health under award number R01CA135329. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, CLIN CANCER RES, V11, P6270, DOI 10.1158/1078-0432.CCR-04-1223; Aryal MP, 2013, MAGN RESON MED; Bagher-Ebadian H, 2012, MAGN RESON MED, V68, P241, DOI 10.1002/mrm.23211; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Beal K, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-2; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Brown JM, 2013, INT J RADIAT ONCOL, V85, P1159, DOI 10.1016/j.ijrobp.2012.11.003; Carter A, 2010, J NATL CANCER I, V102, P675, DOI 10.1093/jnci/djq186; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; Escorcia FE, 2010, CANCER RES, V70, P9277, DOI 10.1158/0008-5472.CAN-10-2029; Ewing JR, 2008, J MAGN RESON IMAGING, V27, P1430, DOI 10.1002/jmri.21356; Ewing JR, 2013, NMR BIOMED, V26, P1028, DOI 10.1002/nbm.2996; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Gladson CL, 1996, J NEUROPATH EXP NEUR, V55, P1143, DOI 10.1097/00005072-199611000-00005; Goel S, 2012, P NATL ACAD SCI USA, V109, pE1214, DOI 10.1073/pnas.1203794109; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Huang YH, 2013, CANCER RES, V73, P2943, DOI 10.1158/0008-5472.CAN-12-4354; Huber PE, 2005, CANCER RES, V65, P3643, DOI 10.1158/0008-5472.CAN-04-1668; Izumi Y, 2002, NATURE, V416, P279, DOI 10.1038/416279b; Jacobs VL, 2011, ASN NEURO, V3, DOI 10.1042/AN20110014; Kawataki T, 2007, EXP CELL RES, V313, P3819, DOI 10.1016/j.yexcr.2007.07.038; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; MacDonald TJ, 2001, NEUROSURGERY, V48, P151, DOI 10.1097/00006123-200101000-00026; Maurer GD, 2009, NEURO-ONCOLOGY, V11, P747, DOI 10.1215/15228517-2009-012; Mawrin C, 2013, J CLIN ONCOL, V31; Maxwell RJ, 2002, NMR BIOMED, V15, P89, DOI 10.1002/nbm.754; Mikkelsen T, 2009, INT J CANCER, V124, P2719, DOI 10.1002/ijc.24240; Nagaraja TN, 2011, METHODS MOL BIOL, V686, P193, DOI 10.1007/978-1-60761-938-3_8; NAKAGAWA H, 1987, J CEREBR BLOOD F MET, V7, P687, DOI 10.1038/jcbfm.1987.123; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ostergaard L, 1999, J NEUROSURG, V90, P300, DOI 10.3171/jns.1999.90.2.0300; Papadopoulos MC, 2001, BRIT J NEUROSURG, V15, P101; Reardon DA, 2008, EXPERT OPIN INV DRUG, V17, P1225, DOI 10.1517/13543784.17.8.1225 ; REED RK, 1992, CIRC RES, V71, P978, DOI 10.1161/01.RES.71.4.978; Stupp R, 2013, J CLIN ONCOL, V31; Svendsen OS, 2009, ARTERIOSCL THROM VAS, V29, P1864, DOI 10.1161/ATVBAHA.109.194308; Truman JP, 2010, PLOS ONE, V5, DOI [10.1371/annotation/6e222ad5-b175-4a00-9d04-4d120568a897, 10.1371/journal.pone.0012310]; Weller M., 2011, SWISS MED WEEKLY, V24, P141; Yamada S, 2006, NEUROSURGERY, V59, P1304, DOI 10.1227/01.NEU.0000245622.70344.BE	43	11	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84493	10.1371/journal.pone.0084493	http://dx.doi.org/10.1371/journal.pone.0084493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376814	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000152
J	Su, WH; Shugart, YY; Chang, KP; Tsang, NM; Tse, KP; Chang, YS				Su, Wen-Hui; Shugart, Yin Yao; Chang, Kai-Ping; Tsang, Ngan-Ming; Tse, Ka-Po; Chang, Yu-Sun			How Genome-Wide SNP-SNP Interactions Relate to Nasopharyngeal Carcinoma Susceptibility	PLOS ONE			English	Article							GENE-GENE INTERACTIONS; MISSING HERITABILITY; CLASS-I; ASSOCIATION; PROSTATE; STRATEGIES; EPISTASIS; LOCI; VISUALIZATION; HAPLOTYPES	This study is the first to use genome-wide association study (GWAS) data to evaluate the multidimensional genetic architecture underlying nasopharyngeal cancer. Since analysis of data from GWAS confirms a close and consistent association between elevated risk for nasopharyngeal carcinoma (NPC) and major histocompatibility complex class 1 genes, our goal here was to explore lesser effects of gene-gene interactions. We conducted an exhaustive genome-wide analysis of GWAS data of NPC, revealing two-locus interactions occurring between single nucleotide polymorphisms (SNPs), and identified a number of suggestive interaction loci which were missed by traditional GWAS analyses. Although none of the interaction pairs we identified passed the genome-wide Bonferroni-adjusted threshold for significance, using independent GWAS data from the same population (Stage 2), we selected 66 SNP pairs in 39 clusters with P < 0.01. We identified that in several chromosome regions, multiple suggestive interactions group to form a block-like signal, effectively reducing the rate of false discovery. The strongest cluster of interactions involved the CREB5 gene and a SNP rs1607979 on chromosome 17q22 (P = 9.86 x 10(-11)) which also show trans-expression quantitative loci (eQTL) association in Chinese population. We then detected a complicated cis-interaction pattern around the NPC-associated HLA-B locus, which is immediately adjacent to copy-number variations implicated in male susceptibility for NPC. While it remains to be seen exactly how and to what degree SNP-SNP interactions such as these affect susceptibility for nasopharyngeal cancer, future research on these questions holds great promise for increasing our understanding of this disease's genetic etiology, and possibly also that of other gene-related cancers.	[Su, Wen-Hui] Chang Gung Univ, Dept Biomed Sci, Tao Yuan, Taiwan; [Su, Wen-Hui] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Su, Wen-Hui; Tse, Ka-Po; Chang, Yu-Sun] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Tao Yuan, Taiwan; [Shugart, Yin Yao] NIMH, Genom Res Branch, Div Neurosci & Behav Sci, NIH, Bethesda, MD 20892 USA; [Shugart, Yin Yao] Johns Hopkins Med Sch, Dept Gastroenterol, Baltimore, MD USA; [Chang, Kai-Ping] Chang Gung Mem Hosp Lin Kou, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Tsang, Ngan-Ming] Chang Gung Mem Hosp Lin Kou, Dept Radiat Oncol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; Johns Hopkins Medicine; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Su, WH (corresponding author), Chang Gung Univ, Dept Biomed Sci, Tao Yuan, Taiwan.	whsu@mail.cgu.edu.tw; kay1yao@mail.nih.gov		YAO, YIN/0000-0003-3053-8429; Su, Wen-Hui/0000-0003-1037-4615	Ministry of Education (Chang Gung University); National Science Council [NSC 101-2314-B-182-051-MY3]; Chang Gung Memorial Hospital, Taiwan [CMRPD1A0381, CMRPD1A0382, CMRPD1A0383]; NIMH	Ministry of Education (Chang Gung University); National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Ministry of Education (Chang Gung University), the National Science Council (NSC 101-2314-B-182-051-MY3), and Chang Gung Memorial Hospital (CMRPD1A0381, CMRPD1A0382 and CMRPD1A0383), Taiwan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Yin Yao Shugart was supported by the Intramural Research Program at NIMH.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Aleshin AE, 2012, J BIOL CHEM, V287, P19642, DOI 10.1074/jbc.M112.361121; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Bell JT, 2011, ANN HUM GENET, V75, P10, DOI 10.1111/j.1469-1809.2010.00629.x; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Ciampa J, 2011, HUM HERED, V72, P182, DOI 10.1159/000331222; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hassen E, 2010, MOL BIOL REP, V37, P119, DOI 10.1007/s11033-009-9548-9; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; Hildesheim A, 2012, SEMIN CANCER BIOL, V22, P107, DOI 10.1016/j.semcancer.2012.01.007; Kooperberg C, 2008, GENET EPIDEMIOL, V32, P255, DOI 10.1002/gepi.20300; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Ma L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002714; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Moskvina V, 2011, BIOL PSYCHIAT, V70, P198, DOI 10.1016/j.biopsych.2011.01.034; Nakayama Y, 2012, J BIOL CHEM, V287, P32222, DOI 10.1074/jbc.M112.370932; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Tang MZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003103; Tao S, 2012, HUM GENET, V131, P1225, DOI 10.1007/s00439-012-1148-4; Team RC, 2012, R LANG ENV STAT COMP; Tse KP, 2011, HUM MOL GENET, V20, P2889, DOI 10.1093/hmg/ddr191; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Vokes EE, 1997, LANCET, V350, P1087, DOI 10.1016/S0140-6736(97)07269-3; Wang S, 2003, AM J EPIDEMIOL, V158, P899, DOI 10.1093/aje/kwg233; Wei WH, 2012, EUR J HUM GENET, V20, P857, DOI 10.1038/ejhg.2012.17; Wei WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023836; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	43	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83034	10.1371/journal.pone.0083034	http://dx.doi.org/10.1371/journal.pone.0083034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376627	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000052
J	Vikram, S; Pandey, J; Kumar, S; Raghava, GPS				Vikram, Surendra; Pandey, Janmejay; Kumar, Shailesh; Raghava, Gajendra Pal Singh			Genes Involved in Degradation of para-Nitrophenol Are Differentially Arranged in Form of Non-Contiguous Gene Clusters in Burkholderia sp strain SJ98	PLOS ONE			English	Article							P-NITROPHENOL; METHYL PARATHION; 4-NITROPHENOL HYDROXYLASE; BIODEGRADATION; IDENTIFICATION; REDUCTASE; PATHWAY; 4-NITROCATECHOL; PURIFICATION; EVOLUTION	Biodegradation of para-Nitrophenol (PNP) proceeds via two distinct pathways, having 1,2,3-benzenetriol (BT) and hydroquinone (HQ) as their respective terminal aromatic intermediates. Genes involved in these pathways have already been studied in different PNP degrading bacteria. Burkholderia sp. strain SJ98 degrades PNP via both the pathways. Earlier, we have sequenced and analyzed a similar to 41 kb fragment from the genomic library of strain SJ98. This DNA fragment was found to harbor all the lower pathway genes; however, genes responsible for the initial transformation of PNP could not be identified within this fragment. Now, we have sequenced and annotated the whole genome of strain SJ98 and found two ORFs (viz., pnpA and pnpB) showing maximum identity at amino acid level with p-nitrophenol 4-monooxygenase (PnpM) and p-benzoquinone reductase (BqR). Unlike the other PNP gene clusters reported earlier in different bacteria, these two ORFs in SJ98 genome are physically separated from the other genes of PNP degradation pathway. In order to ascertain the identity of ORFs pnpA and pnpB, we have performed in-vitro assays using recombinant proteins heterologously expressed and purified to homogeneity. Purified PnpA was found to be a functional PnpM and transformed PNP into benzoquinone (BQ), while PnpB was found to be a functional BqR which catalyzed the transformation of BQ into hydroquinone (HQ). Noticeably, PnpM from strain SJ98 could also transform a number of PNP analogues. Based on the above observations, we propose that the genes for PNP degradation in strain SJ98 are arranged differentially in form of non-contiguous gene clusters. This is the first report for such arrangement for gene clusters involved in PNP degradation. Therefore, we propose that PNP degradation in strain SJ98 could be an important model system for further studies on differential evolution of PNP degradation functions.	[Vikram, Surendra; Kumar, Shailesh; Raghava, Gajendra Pal Singh] CSIR Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India; [Pandey, Janmejay] CSIR Inst Microbial Technol, Microbial Type Culture Collect Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raghava, GPS (corresponding author), CSIR Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.	raghava@imtech.res.in	Raghava, Gajendra P.S./AAA-2413-2022; Kumar, Shailesh/C-3459-2016; Raghava, Gajendra/B-1717-2009	Raghava, Gajendra P.S./0000-0002-8902-2876; Kumar, Shailesh/0000-0002-1872-9903; Vikram, Surendra/0000-0002-4721-2890	Council for Scientific and Industrial Research (CSIR), India; Department of Biotechnology (DBT), India	Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This study was partly supported by Council for Scientific and Industrial Research (CSIR), India and Department of Biotechnology (DBT), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bhushan B, 2000, BIOCHEM BIOPH RES CO, V274, P626, DOI 10.1006/bbrc.2000.3193; Binter A, 2009, FEBS J, V276, P5263, DOI 10.1111/j.1742-4658.2009.07222.x; BRAUDE EA, 1945, J CHEM SOC, P490, DOI 10.1039/jr9450000490; BROCK BJ, 1995, APPL ENVIRON MICROB, V61, P3076, DOI 10.1128/AEM.61.8.3076-3081.1995; Chauhan A, 2000, BIOCHEM BIOPH RES CO, V270, P733, DOI 10.1006/bbrc.2000.2500; Chauhan A, 2010, ENVIRON SCI TECHNOL, V44, P3435, DOI 10.1021/es9024172; Esteban E, 1996, J EXPO ANAL ENV EPID, V6, P375; Ghosh A, 2010, ENVIRON SCI TECHNOL, V44, P1069, DOI 10.1021/es9034123; Guizzetti M, 2005, TOXICOLOGY, V215, P182, DOI 10.1016/j.tox.2005.07.004; HAIGLER BE, 1994, J BACTERIOL, V176, P3433, DOI 10.1128/jb.176.11.3433-3437.1994; Imtiaz R, 2002, ENVIRON HEALTH PERSP, V110, P1071, DOI 10.1289/ehp.02110s61071; JAIN RK, 1994, APPL ENVIRON MICROB, V60, P3030, DOI 10.1128/AEM.60.8.3030-3032.1994; Kadiyala V, 1998, APPL ENVIRON MICROB, V64, P2479; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070624; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SS, 2007, J MICROBIOL, V45, P333; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; MUNNECKE DM, 1976, APPL ENVIRON MICROB, V31, P63, DOI 10.1128/AEM.31.1.63-69.1976; Nielsen MB, 2013, BIODEGRADATION, V24, P79, DOI 10.1007/s10532-012-9559-4; Nielsen MB, 2011, ANTON LEEUW INT J G, V99, P489, DOI 10.1007/s10482-010-9513-6; Omelchenko MV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r55; Pandey J, 2011, APPL MICROBIOL BIOT, V92, P597, DOI 10.1007/s00253-011-3254-y; Parales RE, 2004, CURR OPIN BIOTECH, V15, P374, DOI 10.1016/j.copbio.2004.06.003; Perry LL, 2007, J BACTERIOL, V189, P7563, DOI 10.1128/JB.01849-06; Riveros-Rosas H, 2003, EUR J BIOCHEM, V270, P3309, DOI 10.1046/j.1432-1033.2003.03704.x; Rubin C, 2002, ENVIRON HEALTH PERSP, V110, P1037, DOI 10.1289/ehp.02110s61037; Sahoo NK, 2011, APPL BIOCHEM BIOTECH, V165, P1587, DOI 10.1007/s12010-011-9379-8; Shen WJ, 2010, BIORESOURCE TECHNOL, V101, P7516, DOI 10.1016/j.biortech.2010.04.052; SMITH LW, 1988, DRUG CHEM TOXICOL, V11, P319, DOI 10.3109/01480548809017886; SPAIN JC, 1979, BIOCHEM BIOPH RES CO, V88, P634, DOI 10.1016/0006-291X(79)92095-3; SPAIN JC, 1991, APPL ENVIRON MICROB, V57, P812, DOI 10.1128/AEM.57.3.812-819.1991; Takeo M, 2003, J BIOSCI BIOENG, V95, P139, DOI 10.1016/S1389-1723(03)80119-6; Takeo M, 2008, J BACTERIOL, V190, P7367, DOI 10.1128/JB.00742-08; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vikram S, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-30; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei Q, 2010, BIODEGRADATION, V21, P575, DOI 10.1007/s10532-009-9325-4; Wissiack R, 2002, J CHROMATOGR A, V963, P149, DOI 10.1016/S0021-9673(02)00546-0; Yamamoto K, 2011, J BIOSCI BIOENG, V111, P687, DOI 10.1016/j.jbiosc.2011.01.016; Yi S, 2006, ENVIRON SCI TECHNOL, V40, P2396, DOI 10.1021/es0517771; Zaslaver A, 2006, PHYS BIOL, V3, P183, DOI 10.1088/1478-3975/3/3/003; Zhang JS, 2009, J HAZARD MATER, V163, P723, DOI 10.1016/j.jhazmat.2008.07.018; Zhang JJ, 2009, J BACTERIOL, V191, P2703, DOI 10.1128/JB.01566-08; Zhang SY, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-27	46	19	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84766	10.1371/journal.pone.0084766	http://dx.doi.org/10.1371/journal.pone.0084766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376843	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000164
J	Albrecht, A; Thiere, M; Bergado-Acosta, JR; Poranzke, J; Muller, B; Stork, O				Albrecht, Anne; Thiere, Marlen; Bergado-Acosta, Jorge Ricardo; Poranzke, Janine; Mueller, Bettina; Stork, Oliver			Circadian Modulation of Anxiety: A Role for Somatostatin in the Amygdala	PLOS ONE			English	Article							CONTEXTUAL FEAR MEMORY; NEUROPEPTIDE-Y; LATERAL AMYGDALA; DIURNAL RHYTHMS; RAT AMYGDALA; MOUSE MODELS; MICE; BEHAVIOR; CORTICOSTERONE; RECEPTORS	Pharmacological evidence suggests that the neuropeptide somatostatin (SST) exerts anxiol amygdala, but findings concerning the putative role of endogenous SST in the regulation of emotional responses are contradictory. We hypothesized that an endogenous regulation of SST expression over the course of the day may determine its function and tested both SST gene expression and the behavior of SST knock out (SST) mice in different aversive tests in relation to circadian rhythm. In an open field and a light/dark avoidance test, SST 4- mice showed significant hyperactivity and anxiety-like behavior during the second, but not during the first half of the active phase, failing to show the circadian modulation of behavior that was evident in their wild type littermates. Behavioral differences occurred independently of changes of intrinsically motivated activity in the home cage. A circadian regulation of SST mRNA and protein expression that was evident in the basolateral complex of the amygdala of wild type mice may provide a neuronal substrate for the observed behavior. However, fear memory towards auditory cue or the conditioning context displayed neither a time- nor genotype-dependent modulation. Together this indicates that SST, in a circadian manner and putatively via it. regulation of expression n the amygdala, modulates behavior esponding to mildly aversive conditions in mice.	[Albrecht, Anne; Thiere, Marlen; Bergado-Acosta, Jorge Ricardo; Poranzke, Janine; Mueller, Bettina; Stork, Oliver] Univ Magdeburg, Inst Biol, Dept Genet & Mol Neurobiol, D-39106 Magdeburg, Germany; [Mueller, Bettina; Stork, Oliver] Ctr Behav Brain Sci, Magdeburg, Germany	Otto von Guericke University	Albrecht, A (corresponding author), Univ Magdeburg, Inst Biol, Dept Genet & Mol Neurobiol, D-39106 Magdeburg, Germany.	anne.albrecht@ovgu.de	Albrecht, Anne/GNP-7475-2022	Albrecht, Anne/0000-0001-8613-2968; Stork, Oliver/0000-0003-4285-7507	German Research Foundation; federal state of Sachsonia-Anhalt (Center for Behavioral Brain Sciences)	German Research Foundation(German Research Foundation (DFG)); federal state of Sachsonia-Anhalt (Center for Behavioral Brain Sciences)	The work was supported by the German Research Foundation (SFB779 TPB5 and German Israeli Project Cooperation to OS) and by the federal state of Sachsonia-Anhalt (Center for Behavioral Brain Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2013, NEUROPSYCHOPHARMACOL, V38, P386, DOI 10.1038/npp.2012.192; Albrecht A, 2010, INT J NEUROPSYCHOPH, V13, P661, DOI 10.1017/S1461145709991106; Alldredge B, 2010, NEUROPEPTIDES, V44, P215, DOI 10.1016/j.npep.2009.12.014; Amir S, 2009, BIOL PSYCHIAT, V65, P829, DOI 10.1016/j.biopsych.2008.12.019; Ardayfio P, 2006, BEHAV NEUROSCI, V120, P249, DOI 10.1037/0735-7044.120.2.249; Beeler JA, 2006, PHYSIOL BEHAV, V87, P870, DOI 10.1016/j.physbeh.2006.01.037; Bertoglio LJ, 2002, BEHAV BRAIN RES, V132, P135, DOI 10.1016/S0166-4328(01)00396-5; Butler RK, 2012, EXP NEUROL, V238, P52, DOI 10.1016/j.expneurol.2012.08.002; CAMERON OG, 1986, J AFFECT DISORDERS, V11, P213, DOI 10.1016/0165-0327(86)90072-8; Cammalleri M, 2006, EUR J NEUROSCI, V23, P2404, DOI 10.1111/j.1460-9568.2006.04770.x; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Dalm S, 2005, NEUROENDOCRINOLOGY, V81, P372, DOI 10.1159/000089555; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; GERACI MF, 1992, BRIT J PSYCHIAT, V161, P512, DOI 10.1192/bjp.161.4.512; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Hannon JP, 2002, J MOL NEUROSCI, V18, P15, DOI 10.1385/JMN:18:1-2:15; Jones N, 2001, PHYSIOL BEHAV, V72, P99, DOI 10.1016/S0031-9384(00)00388-7; Kaouane N, 2012, SCIENCE, V335, P1510, DOI 10.1126/science.1207615; Kluge C, 2008, LEARN MEMORY, V15, P252, DOI 10.1101/lm.793008; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCDONALD AJ, 1989, BRAIN RES, V500, P37, DOI 10.1016/0006-8993(89)90297-7; Meis S, 2005, EUR J NEUROSCI, V21, P755, DOI 10.1111/j.1460-9568.2005.03922.x; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Molosh AI, 2013, NEUROPSYCHOPHARMACOL, V38, P1352, DOI 10.1038/npp.2013.33; O'Brien J, 2007, HIPPOCAMPUS, V17, P1149, DOI 10.1002/hipo.20346; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Post AM, 2011, BEHAV BRAIN RES, V218, P99, DOI 10.1016/j.bbr.2010.11.031; Rotzinger S, 2010, PEPTIDES, V31, P736, DOI 10.1016/j.peptides.2009.12.015; Sajdyk TJ, 2002, NEUROPHARMACOLOGY, V43, P1165, DOI 10.1016/S0028-3908(02)00234-4; Sosulina L, 2010, J NEUROPHYSIOL, V104, P617, DOI 10.1152/jn.00207.2010; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; Videau C, 2003, N-S ARCH PHARMACOL, V367, P562, DOI 10.1007/s00210-003-0758-8; Wang LM, 2009, NEW EUR, V1; Yeung M, 2012, PHARMACOL BIOCHEM BE, V101, P88, DOI 10.1016/j.pbb.2011.12.012; Yeung M, 2011, PSYCHOPHARMACOLOGY, V216, P557, DOI 10.1007/s00213-011-2248-x; Zeyda T, 2008, MOL CELL ENDOCRINOL, V286, P18, DOI 10.1016/j.mce.2007.11.029; Zeyda T, 2001, BRAIN RES, V906, P107, DOI 10.1016/S0006-8993(01)02563-X	39	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84668	10.1371/journal.pone.0084668	http://dx.doi.org/10.1371/journal.pone.0084668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376834	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100182
J	Chaves, LF				Chaves, Luis Fernando			The Dynamics of Latifundia Formation	PLOS ONE			English	Article							DEFORESTATION; POPULATION	Land tenure inequity is a major social problem in developing nations worldwide. In societies, where land is a commodity, inequities in land tenure are associated with gaps in income distribution, poverty and biodiversity loss. A common pattern of land tenure inequities through the history of civilization has been the formation of latifundia [Zhuangyuan in chinese], i.e., a pattern where land ownership is concentrated by a small fraction of the whole population. Here, we use simple Markov chain models to study the dynamics of latifundia formation in a heterogeneous landscape where land can transition between forest, agriculture and recovering land. We systematically study the likelihood of latifundia formation under the assumption of pre-capitalist trade, where trade is based on the average utility of land parcels belonging to each individual landowner during a discrete time step. By restricting land trade to that under recovery, we found the likelihood of latifundia formation to increase with the size of the system, i.e., the amount of land and individuals in the society. We found that an increase of the transition rate for land use changes, i.e., how quickly land use changes, promotes more equitable patterns of land ownership. Disease introduction in the system, which reduced land profitability for infected individual landowners, promoted the formation of latifundia, with an increased likelihood for latifundia formation when there were heterogeneities in the susceptibility to infection. Finally, our model suggests that land ownership reforms need to guarantee an equitative distribution of land among individuals in a society to avoid the formation of latifundia.	[Chaves, Luis Fernando] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Chaves, Luis Fernando] Univ Nacl, Escuela Med Vet, PIET, Heredia, Costa Rica; [Chaves, Luis Fernando] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 852, Japan	Hokkaido University; Universidad Nacional Costa Rica; Nagasaki University	Chaves, LF (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	lchaves@nagasaki-u.ac.jp	Chaves, Luis Fernando/F-3448-2010	Chaves, Luis Fernando/0000-0002-5301-2764	Japan Society for the Promotion of Science(JSPS)	Japan Society for the Promotion of Science(JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by Japan Society for the Promotion of Science(JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adshead SAM, 2004, T'ANG CHINA: THE RISE OF THE EAST IN WORLD HISTORY, P1, DOI 10.1057/9780230005518; Beauchamp C, 1988, ANN ESC, V43, P248; Bonilla-Carrion R, 2004, COSTA RICA LUZ CENSO, P575; Celli A, 1933, HIST MALARIA ROMAN C; Chaves LF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000176; FEARNSIDE PM, 1993, AMBIO, V22, P537; Honjo K, 2013, PARASITOLOGY, V140, P580, DOI 10.1017/S0031182012002077; LEVINS R, 1994, AM SCI, V82, P52; Levins R, 1999, INT J HEALTH SERV, V29, P261, DOI 10.2190/WLVK-D0RR-KVBV-A1DH; LEVINS R, 1995, TRENDS ECOL EVOL, V10, P304, DOI 10.1016/0169-5347(95)90043-8; LEWONTIN Richard, 2007, BIOL INFLUENCE DIALE; Mangel M, 2006, THEORETICAL BIOLOGIST'S TOOLBOX: QUANTITATIVE METHODS FOR ECOLOGY AND EVOLUTIONARY BIOLOGY, P1, DOI 10.2277/ 0521537487; Marx K, 1949, CAPITAL CRITICA EC P; Mathanga DP, 2006, TROP MED INT HEALTH, V11, P1367, DOI 10.1111/j.1365-3156.2006.01684.x; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; PHOMBEAH G, 2005, BBC FOCUS AFRICA, V16, P30; Pulleyblank Edwin G., 1955, BACKGROUND REBELLION; Rodrigues A, 2009, J THEOR BIOL, V258, P127, DOI 10.1016/j.jtbi.2009.01.005; Rosero-Bixby L, 2002, REV BIOL TROP, V50, P585; Rosero-Bixby L, 1998, POPUL ENVIRON, V20, P149, DOI 10.1023/A:1023319327838; Saldana A, 2013, AM J TROP MED HYG, V88, P572, DOI 10.4269/ajtmh.12-0579; Satake A, 2006, ECOL RES, V21, P370, DOI 10.1007/s11284-006-0167-9; Satake A, 2007, ECOL APPL, V17, P2024, DOI 10.1890/07-0283.1; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Sutter PS, 2007, ISIS, V98, P724, DOI 10.1086/529265; Turchin P, 2003, HYSTORICAL DYNAMICS; Turchin P., 2009, SECULAR CYCLES; Wright AL., 2003, INHERIT EARTH LANDLE; Xiong VC, 1999, TOUNG PAO, V85, P328, DOI 10.1163/1568532992642468; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450	30	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82863	10.1371/journal.pone.0082863	http://dx.doi.org/10.1371/journal.pone.0082863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376597	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100067
J	Hossain, MS; Ifuku, M; Take, S; Kawamura, J; Miake, K; Katafuchi, T				Hossain, Md. Shamim; Ifuku, Masataka; Take, Sachiko; Kawamura, Jun; Miake, Kiyotaka; Katafuchi, Toshihiko			Plasmalogens Rescue Neuronal Cell Death through an Activation of AKT and ERK Survival Signaling	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; RETINOIC ACID; PHOSPHOLIPID-COMPOSITION; CASPASE-9 ACTIVATION; LIPID RAFTS; DEFICIENCY; APOPTOSIS; MEMBRANE; BINDING; PHOSPHORYLATION	Neuronal cells are susceptible to many stresses, which will cause the apoptosis and neurodegenerative diseases. The precise molecular mechanism behind the neuronal protection against these apoptotic stimuli is necessary for drug discovery. In the present study, we have found that plasmalogens (Pls), which are glycerophospholipids containing vinyl ether linkage at sn-1 position, can protect the neuronal cell death upon serum deprivation. Interestingly, caspse-9, but not caspase-8 and caspase-12, was cleaved upon the serum starvation in Neuro-2A cells. Pls treatments effectively reduced the activation of caspase-9. Furthermore, cellular signaling experiments showed that Pls enhanced phosphorylation of the phosphoinositide 3-kinase (PI3K)-dependent serine/threonine-specific protein kinase AKT and extracellular-signal-regulated kinases ERK1/2. PI3K/AKT inhibitor LY294002 and MAPK/ERK kinase (MEK) inhibitor U0126 treatments study clearly indicated that Pls-mediated cell survival was dependent on the activation of these kinases. In addition, Pls also inhibited primary mouse hippocampal neuronal cell death induced by nutrient deprivation, which was associated with the inhibition of caspase-9 and caspase-3 cleavages. It was reported that Pls content decreased in the brain of the Alzheimer's patients, which indicated that the reduction of Pls content could endanger neurons. The present findings, taken together, suggest that Pls have an anti-apoptotic action in the brain. Further studies on precise mechanisms of Pls-mediated protection against cell death may lead us to establish a novel therapeutic approach to cure neurodegenerative disorders.	[Hossain, Md. Shamim; Ifuku, Masataka; Take, Sachiko; Katafuchi, Toshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Integrat Physiol, Fukuoka 812, Japan; [Kawamura, Jun; Miake, Kiyotaka] Marudai Food Co Ltd, Cent Res Inst, Osaka, Japan	Kyushu University	Katafuchi, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Integrat Physiol, Fukuoka 812, Japan.	kataf@physiol.med.kyushu-u.ac.jp			Japan Society for the Promotion 1 of Science (JSPS), Md. Shamim Hossain [FY2013]; JSPS KAKENHI Grant [25.03094]	Japan Society for the Promotion 1 of Science (JSPS), Md. Shamim Hossain(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion 1 of Science (JSPS) postdoctoral fellowship for foreign researcher (FY2013, Md. Shamim Hossain) and JSPS KAKENHI Grant Number 25.03094 to T.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albi E, 2004, BIOL CELL, V96, P657, DOI 10.1016/j.biolcel.2004.05.004; Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Farooqui AA, 2001, NEUROSCIENTIST, V7, P232, DOI 10.1177/107385840100700308; Farooqui AA, 2010, MOL NEUROBIOL, V41, P267, DOI 10.1007/s12035-009-8091-y; Fujita E, 1999, CELL DEATH DIFFER, V6, P1109, DOI 10.1038/sj.cdd.4400585; Gasperi V, 2013, CURR MED CHEM, V20, P64; Ginsberg L, 1998, J NEUROCHEM, V70, P2533; GINSBERG L, 1995, BRAIN RES, V698, P223, DOI 10.1016/0006-8993(95)00931-F; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guan ZZ, 1999, J NEUROPATH EXP NEUR, V58, P740, DOI 10.1097/00005072-199907000-00008; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Hartmann T, 2007, J NEUROCHEM, V103, P159, DOI 10.1111/j.1471-4159.2007.04715.x; Hermann C, 2000, ARTERIOSCL THROM VAS, V20, P402, DOI 10.1161/01.ATV.20.2.402; Hossain MS, 2013, ADV NEUROIMMUNE BIOL, V4, P35, DOI 10.3233/NIB-130055; Ifuku M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-197; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Katafuchi T, 2012, ANN NY ACAD SCI, V1262, P85, DOI 10.1111/j.1749-6632.2012.06641.x; Khan M, 2008, J NEUROCHEM, V106, P1766, DOI 10.1111/j.1471-4159.2008.05513.x; Kitazumi I, 2011, FEBS J, V278, P427, DOI 10.1111/j.1742-4658.2010.07975.x; Krajewska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024341; Masetti R, 2012, EXPERT REV ANTICANC, V12, P1191, DOI [10.1586/ERA.12.101, 10.1586/era.12.101]; Mawatari S, 2009, BIOSCI BIOTECH BIOCH, V73, P2621, DOI 10.1271/bbb.90455; Meister B, 1998, ANTICANCER RES, V18, P1777; Moser AB, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-101; Murphy EJ, 2000, BRAIN RES, V867, P9, DOI 10.1016/S0006-8993(00)02205-8; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Oma S, 2012, DEMENT GER COGN D EX, V2, P298, DOI 10.1159/000341603; Oubrahim H, 2005, P NATL ACAD SCI USA, V102, P2322, DOI 10.1073/pnas.0409874102; Rothhaar TL, 2012, THESCIENTIFICWORLDJO, V2012, DOI DOI 10.1100/2012/141240; Shibata M, 2003, NEUROSCIENCE, V118, P491, DOI 10.1016/S0306-4522(02)00910-7; Siddikuzzaman, 2011, IMMUNOPHARM IMMUNOT, V33, P241, DOI 10.3109/08923973.2010.521507; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Valverde AM, 2004, MOL BIOL CELL, V15, P5101, DOI 10.1091/mbc.E03-11-0853; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Wanders RJA, 2005, CLIN GENET, V67, P107, DOI 10.1111/j.1399-0004.2004.00329.x; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Wood PL, 2010, J PSYCHIATR NEUROSCI, V35, P59, DOI 10.1503/jpn.090059; Zubiaur M, 2002, J BIOL CHEM, V277, P13, DOI 10.1074/jbc.M107474200	45	69	73	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83508	10.1371/journal.pone.0083508	http://dx.doi.org/10.1371/journal.pone.0083508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376709	Green Published, gold			2022-12-27	WOS:000328745100123
J	Laurens, J; Heiney, SA; Kim, G; Blazquez, PM				Laurens, Jean; Heiney, Shane A.; Kim, Gyutae; Blazquez, Pablo M.			Cerebellar Cortex Granular Layer Interneurons in the Macaque Monkey AAe Functionally Driven by Mossy Fiber Pathways through Net Excitation or Inhibition	PLOS ONE			English	Article							GOLGI CELLS; RESPONSES; FLOCCULUS; CIRCUIT; OPERATE; INPUTS	The granular layer is the input layer of the cerebellar cortex. It receives information through mossy fibers, which contact local granular layer interneurons (GLIs) and granular layer output neurons (granule cells). GLIs provide one of the first signal processing stages in the cerebellar cortex by exciting or inhibiting granule cells. Despite the importance of this early processing stage for later cerebellar computations, the responses of GLIs and the functional connections of mossy fibers with GLIs in awake animals are poorly understood. Here, we recorded Gus and mossy fibers in the macaque ventral-paraflocculus (VPFL) during oculomotor tasks, providing the first full inventory of GLI responses in the VPFL of awake primates. We found that while mossy fiber responses are characterized by a linear monotonic relationship between firing rate and eye position, GLIs show complex response profiles characterized by "eye position fields" and single or double directional tunings. For the majority of GLIs, prominent features of their responses can be explained by assuming that a single GLI receives inputs from mossy fibers with similar or opposite directional preferences, and that these mossy fiber inputs influence GLI discharge through net excitatory or inhibitory pathways. Importantly, GLIs receiving mossy fiber inputs through these putative excitatory and inhibitory pathways show different firing properties, suggesting that they indeed correspond to two distinct classes of interneurons. We propose a new interpretation of the information flow through the cerebellar cortex granular layer, in which mossy fiber input patterns drive the responses of GLIs not only through excitatory but also through net inhibitory pathways, and that excited and inhibited GLIs can be identified based on their responses and their intrinsic properties.	[Laurens, Jean; Kim, Gyutae; Blazquez, Pablo M.] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA; [Heiney, Shane A.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	Washington University (WUSTL); University of Pennsylvania	Blazquez, PM (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA.	pablo@pcg.wustl.edu	Heiney, Shane/P-5646-2019	Heiney, Shane/0000-0001-9706-2133	NIH [R01-N5065099]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065099] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant R01-N5065099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; Dugue GP, 2009, NEURON, V61, P126, DOI 10.1016/j.neuron.2008.11.028; Eccles JC, 1967, CEREBELLUM NEURONAL; Heine SA, 2010, J NEUROSCI, V30, P17004, DOI 10.1523/JNEUROSCI.3513-10.2010; Heiney SA, 2011, EXP BRAIN RES, V212, P409, DOI 10.1007/s00221-011-2746-4; Holtzman T, 2006, J PHYSIOL-LONDON, V577, P69, DOI 10.1113/jphysiol.2006.117218; Holtzman T, 2011, J PHYSIOL-LONDON, V589, P3837, DOI 10.1113/jphysiol.2011.207167; Hull C, 2012, NEURON, V73, P149, DOI 10.1016/j.neuron.2011.10.030; Kanichay RT, 2008, J NEUROSCI, V28, P8955, DOI 10.1523/JNEUROSCI.5469-07.2008; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; Paxinos G., 2000, RHESUS MONKEY BRAIN; Prsa M, 2009, J NEUROSCI, V29, P250, DOI 10.1523/JNEUROSCI.4791-08.2009; Rambold H, 2002, J NEUROPHYSIOL, V87, P912, DOI 10.1152/jn.00768.2000; Rousseau CV, 2012, J NEUROSCI, V32, P4632, DOI 10.1523/JNEUROSCI.5122-11.2012; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Schonewille M, 2006, NAT NEUROSCI, V9, P459, DOI 10.1038/nn0406-459; Simat M, 2007, J COMP NEUROL, V500, P71, DOI 10.1002/cne.21142; Tahon K, 2005, NEUROSCI LETT, V390, P156, DOI 10.1016/j.neulet.2005.08.018; Van Dijck G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057669; Vos BP, 1999, J NEUROSCI, V19; Watanabe D, 2003, NEURON, V39, P821, DOI 10.1016/S0896-6273(03)00530-0	23	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82239	10.1371/journal.pone.0082239	http://dx.doi.org/10.1371/journal.pone.0082239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376524	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100022
J	Madeira, A; Camps, M; Zorzano, A; Moura, TF; Soveral, G				Madeira, Ana; Camps, Marta; Zorzano, Antonio; Moura, Teresa F.; Soveral, Grace			Biophysical Assessment of Human Aquaporin-7 as a Water and Glycerol Channel in 3T3-L1 Adipocytes	PLOS ONE			English	Article							ADIPOSE-TISSUE; FAT-CELLS; EXPRESSION; OBESITY; PERMEABILITY; TRANSPORT	The plasma membrane aquaporin-7 (AQP7) has been shown to be expressed in adipose tissue and its role in glycerol release/uptake in adipocytes has been postulated and correlated with obesity onset. However, some studies have contradicted this view. Based on this situation, we have re-assessed the precise localization of AQP7 in adipose tissue and analyzed its function as a water and/or glycerol channel in adipose cells. Fractionation of mice adipose tissue revealed that AQP7 is located in both adipose and stromal vascular fractions. Moreover, AQP7 was the only aquaglyceroporin expressed in adipose tissue and in 3T3-L1 adipocytes. By overexpressing the human AQP7 in 3T3-L1 adipocytes it was possible to ascertain its role as a water and glycerol channel in a gain-of-function scenario. AQP7 expression had no effect in equilibrium cell volume but AQP7 loss of function correlated with higher triglyceride content. Furthermore it is also reported for the first time a negative correlation between water permeability and the cell non-osmotic volume supporting the observation that AQP7 depleted cells are more prone to lipid accumulation. Additionally, the strong positive correlation between the rates of water and glycerol transport highlights the role of AQP7 as both a water and a glycerol channel and reflects its expression levels in cells. In all, our results clearly document a direct involvement of AQP7 in water and glycerol transport, as well as in triglyceride content in adipocytes.	[Madeira, Ana; Moura, Teresa F.; Soveral, Grace] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal; [Madeira, Ana; Soveral, Grace] Univ Lisbon, Fac Farm, Dept Bioquim & Biol Humana, P-1699 Lisbon, Portugal; [Camps, Marta; Zorzano, Antonio] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Camps, Marta; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Zorzano, Antonio] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain; [Moura, Teresa F.; Soveral, Grace] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, REQUIMTE, Caparica, Portugal	Universidade de Lisboa; Universidade de Lisboa; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidade Nova de Lisboa	Soveral, G (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal.	gsoveral@ff.ul.pt	Zorzano, Antonio/R-5479-2018; iMed.ULisboa, MetGen/B-5293-2014; Madeira, Ana/K-4714-2014; Soveral, Graça/L-1550-2013; Moura, Teresa F/E-2485-2014; Camps, Marta/F-6557-2016	Madeira, Ana/0000-0003-3186-359X; Soveral, Graça/0000-0001-8487-110X; Camps, Marta/0000-0001-5392-1792; Fonseca de Moura, Teresa Maria/0000-0003-3069-0770	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/45930/2008]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	Madeira received a Ph.D. fellowship from Fundacao para a Ciencia e Tecnologia, Portugal, http://www.fct.pt (SFRH/BD/45930/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ceperuelo-Mallafre V, 2007, J CLIN ENDOCR METAB, V92, P3640, DOI 10.1210/jc.2007-0531; Fain JN, 2008, METABOLISM, V57, P1005, DOI 10.1016/j.metabol.2008.02.019; FROST SC, 1985, J BIOL CHEM, V260, P2646; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P15493, DOI 10.1074/jbc.C500028200; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; Kishida K, 2000, J BIOL CHEM, V275, P20896, DOI 10.1074/jbc.M001119200; Kuriyama H, 2002, DIABETES, V51, P2915, DOI 10.2337/diabetes.51.10.2915; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; Marrades MP, 2006, BIOCHEM BIOPH RES CO, V339, P785, DOI 10.1016/j.bbrc.2005.11.080; Miranda M, 2010, J CLIN ENDOCR METAB, V95, P3470, DOI 10.1210/jc.2009-2655; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Ozu M, 2013, BIOPHYS J, V104, P85, DOI 10.1016/j.bpj.2012.11.3818; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Skowronski MT, 2007, AM J PHYSIOL-RENAL, V292, pP956, DOI 10.1152/ajprenal.00314.2006; Soveral G, 1997, J MEMBRANE BIOL, V158, P219; Soveral G, 2008, BIOCH BIOPHYS ACTA	22	38	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83442	10.1371/journal.pone.0083442	http://dx.doi.org/10.1371/journal.pone.0083442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376702	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100119
J	Nakamura, A; Niimura, H; Kuwabara, K; Takezaki, T; Morita, E; Wakai, K; Hamajima, N; Nishida, Y; Turin, TC; Suzuki, S; Ohnaka, K; Uemura, H; Ozaki, E; Hosono, S; Mikami, H; Kubo, M; Tanaka, H				Nakamura, Akihiko; Niimura, Hideshi; Kuwabara, Kazuyo; Takezaki, Toshiro; Morita, Emi; Wakai, Kenji; Hamajima, Nobuyuki; Nishida, Yuichiro; Turin, Tanvir Chowdhury; Suzuki, Sadao; Ohnaka, Keizo; Uemura, Hirokazu; Ozaki, Etsuko; Hosono, Satoyo; Mikami, Haruo; Kubo, Michiaki; Tanaka, Hideo			Gene-Gene Combination Effect and Interactions among ABCA1, APOA1, SR-B1, and CETP Polymorphisms for Serum High-Density Lipoprotein-Cholesterol in the Japanese Population	PLOS ONE			English	Article							ESTER TRANSFER PROTEIN; MULTIINSTITUTIONAL COLLABORATIVE COHORT; CORONARY-ARTERY-DISEASE; HDL-CHOLESTEROL; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; HEART-DISEASE; LOWER RISK; EXERCISE; MEN	Background/Objective: Gene-gene interactions in the reverse cholesterol transport system for high-density lipoprotein-cholesterol (HDL-C) are poorly understood. The present study observed gene-gene combination effect and interactions between single nucleotide polymorphisms (SNPs) in ABCA1, APOA1, SR-81, and CETP in serum HDL-C from a cross-sectional study in the Japanese population. Methods:The study population comprised 1,535 men and 1,515 women aged 35-69 years who were enrolled in the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study. We selected 13 SNPs in the ABCA1, APOA1, CETP, and SR-81 genes in the reverse cholesterol transport system. The effects of genetic and environmental factors were assessed using general linear and logistic regression models after adjusting for age, sex, and region. Principal Findings: Alcohol consumption and daily activity were positively associated with HDL-C levels, whereas smoking had a negative relationship. The T allele of CETP, rs3764261, was correlated with higher HDL-C levels and had the highest coefficient (2.93 mg/dL/allele) among the 13 SNPs, which was statistically significant after applying the Bonferroni correction (p<0.001). Gene-gene combination analysis revealed that CETP rs3764261 was associated with high HDL-C levels with any combination of SNPs from ABCA1, APOA1, and SR-B1, although no gene-gene interaction was apparent. An increasing trend for serum HDL-C was also observed with an increasing number of alleles (p<0.001). Conclusions:The present study identified a multiplier effect from a polymorphism in CETP with ABCA1, APOA1, and SR-B1, as well as a dose-dependence according to the number of alleles present.	[Nakamura, Akihiko; Niimura, Hideshi; Takezaki, Toshiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Int Isl & Community Med, Kagoshima 890, Japan; [Kuwabara, Kazuyo] Kagoshima Univ, Grad Sch Med & Dent Sci, Educ Ctr Doctors Remote Isl & Rural Areas, Kagoshima 890, Japan; [Morita, Emi; Wakai, Kenji] Nagoya Univ, Grad Sch Med, Dept Prevent Med, Nagoya, Aichi 4648601, Japan; [Hamajima, Nobuyuki] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Nishida, Yuichiro] Saga Univ, Fac Med, Dept Prevent Med, Saga 840, Japan; [Turin, Tanvir Chowdhury] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga 52021, Japan; [Turin, Tanvir Chowdhury] Univ Calgary, Dept Med, Calgary, AB, Canada; [Suzuki, Sadao] Nagoya City Univ, Grad Sch Med Sci, Dept Publ Hlth, Nagoya, Aichi, Japan; [Ohnaka, Keizo] Kyushu Univ, Grad Sch Med Sci, Dept Geriatr Med, Fukuoka 812, Japan; [Uemura, Hirokazu] Univ Tokushima, Dept Prevent Med, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Ozaki, Etsuko] Kyoto Prefectural Univ Med, Dept Epidemiol Community Hlth & Med, Kyoto, Japan; [Hosono, Satoyo; Tanaka, Hideo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Mikami, Haruo] Chiba Canc Ctr, Div Canc Registry Prevent & Epidemiol, Chiba 2608717, Japan; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan	Kagoshima University; Kagoshima University; Nagoya University; Nagoya University; Saga University; Shiga University of Medical Science; University of Calgary; Nagoya City University; Kyushu University; Tokushima University; Kyoto Prefectural University of Medicine; Aichi Cancer Center; Chiba Cancer Center; RIKEN	Takezaki, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Int Isl & Community Med, Kagoshima 890, Japan.	takezaki@m.kufm.kagoshima-u.ac.jp	Hamajima, Nobuyuki/I-7237-2014; Kubo, Michiaki/N-7947-2015; Nishida, Yuichiro/H-8791-2019; Tanaka, Hideo/A-8145-2016; Turin, Tanvir C/L-7617-2016; Wakai, Kenji/I-7248-2014	Nishida, Yuichiro/0000-0003-2320-7234; Turin, Tanvir C/0000-0002-7499-5050; Wakai, Kenji/0000-0001-7388-7157	Japanese Ministry of Education, Culture, Sports, Science and Technology [17015018, 22150001]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas of Cancer (No. 17015018) and Innovative Areas (No. 22150001) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boes E, 2009, EXP GERONTOL, V44, P136, DOI 10.1016/j.exger.2008.11.003; Brown CM, 2006, J MOL MED, V84, P561, DOI 10.1007/s00109-005-0037-x; Buyske S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035651; CAULEY JA, 1987, ATHEROSCLEROSIS, V66, P247, DOI 10.1016/0021-9150(87)90068-2; CRIQUI MH, 1980, CIRCULATION, V62, P70; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; Eslick GD, 2009, INT J CARDIOL, V136, P4, DOI 10.1016/j.ijcard.2008.03.092; Fonong T, 1996, ATHEROSCLEROSIS, V127, P177, DOI 10.1016/S0021-9150(96)05950-3; Greenland S, 2008, INT J EPIDEMIOL, V37, P430, DOI 10.1093/ije/dyn064; Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317; HANNUKSELA M, 1992, J LIPID RES, V33, P737; Hiura Y, 2009, CIRC J, V73, P1119, DOI 10.1253/circj.CJ-08-1101; Hoang A, 2008, ATHEROSCLEROSIS, V197, P197, DOI 10.1016/j.atherosclerosis.2007.03.017; Jensen Majken K, 2007, Atherosclerosis, V195, pe172, DOI 10.1016/j.atherosclerosis.2007.01.025; Junyent M, 2009, J LIPID RES, V50, P565, DOI 10.1194/jlr.P800041-JLR200; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Mackay J, 2004, ATLAS HEART DIS STRO; Marques-Vidal P, 2010, ATHEROSCLEROSIS, V211, P551, DOI 10.1016/j.atherosclerosis.2010.04.001; Mero N, 1998, J LIPID RES, V39, P1493; Naito Mariko, 2008, Nagoya J Med Sci, V70, P107; NAKAMURA T, 1995, ANN NUTR METAB, V39, P261, DOI 10.1159/000177871; Nishiyama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035000; Rejeb J, 2008, ARCH CARDIOVASC DIS, V101, P629, DOI 10.1016/j.acvd.2008.09.013; Rhthman KJ, 1990, EPIDEMIOLOGY, V1, P43; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Roberts CGP, 2007, HUM HERED, V64, P107, DOI 10.1159/000101962; Smith KM, 2009, PUBLIC HEALTH NUTR, V12, P1261, DOI 10.1017/S1368980008003844; Takeuchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046385; Tokudome Shinkan, 2004, Asian Pac J Cancer Prev, V5, P40; Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135; Tsompanidi EM, 2010, ATHEROSCLEROSIS, V208, P3, DOI 10.1016/j.atherosclerosis.2009.05.034; Turner SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019586; van Acker BAC, 2008, ATHEROSCLEROSIS, V200, P161, DOI 10.1016/j.atherosclerosis.2007.11.019; van Tol A, 1999, ATHEROSCLEROSIS, V147, P87, DOI 10.1016/S0021-9150(99)00167-7; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wakai K, 2011, J EPIDEMIOL, V21, P223, DOI 10.2188/jea.JE20100139; Weggemans RM, 2001, AM J CLIN NUTR, V73, P885; WILLIAMS PT, 1994, METABOLISM, V43, P917, DOI 10.1016/0026-0495(94)90277-1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Zhou YJ, 2008, ALCOHOL, V42, P583, DOI 10.1016/j.alcohol.2008.08.004; Zmuda JM, 1998, ATHEROSCLEROSIS, V137, P215, DOI 10.1016/S0021-9150(97)00257-8	42	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82046	10.1371/journal.pone.0082046	http://dx.doi.org/10.1371/journal.pone.0082046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376512	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100014
J	Patel, KK; Webley, WC				Patel, Katir K.; Webley, Wilmore C.			Evidence of Infectious Asthma Phenotype: Chlamydia-Induced Allergy and Pathogen-Specific IgE in a Neonatal Mouse Model	PLOS ONE			English	Article							UNITED-STATES; EXPOSURE; TRACHOMATIS; DISEASE	Asthma is a chronic respiratory disease whose etiology is poorly understood. Recent studies suggest that early-life respiratory infections with atypical bacteria may play an important role in the induction or exacerbation of chronic respiratory disease. The current study utilized a neonatal mouse ovalbumin (OVA) sensitization model of asthma to determine the course of early-life respiratory tract infection by Chlamydia. Neonatal (day 1) and adult (6 wks) BALB/c mice were infected intranasally with Chlamydia (MoPn) and 7 weeks later were sensitized and challenged with ovalbumin. Allergic airway disease was characterized by examination of serum and bronchoalveolar lavage fluid (BAL) cellularity, cytokine production and antibody response. The presence of Chlamydia was determined by PCR and culture. Ova-specific IgE was quantified by ELISA and Chlamydia-specific IgE was determined via Western blot analysis. Chlamydial infection in neonatal mice induced increased production of Th-2 cytokines (IL-4, 5, 10, and 13) in both BAL and serum, while infected adult mice produced increased Th-1 cytokines (IL-2, IFN-gamma). The BAL from infected neonates contained significantly elevated levels of eosinophils compared to infected adult mice. Although adult mice cleared the infection similar to 30 days post infection (pi), neonates were still infected 66 days after initial infection. Chlamydia-specific IgE was detected in both the BAL and serum of neonatal mice beginning 28 days post infection, however, infected adult mice did not produce Chlamydia-specific IgE antibodies over the course of the study. When allergic airway was induced using Ova, infected neonatal mice increased their production of IL-4, IL-5 and IL-13 by >2 fold compared to uninfected controls and infected adult groups. Our findings demonstrate that early-life Chlamydia infection induces a Th-2-dominant cytokine response in the airways of neonatal mice, leading to chronic infection. More significantly, early life respiratory colonization with Chlamydia elicits pathogen-specific IgE production, which further supports an infectious asthma phenotype.	[Patel, Katir K.; Webley, Wilmore C.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Webley, WC (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	wilmore@microbio.umass.edu	Webley, Wilmore/I-7145-2012	Webley, Wilmore/0000-0003-4490-395X	Healey Endowment/Faculty Research Grant [P1FRG0000000030]	Healey Endowment/Faculty Research Grant	This study was supported by a Healey Endowment/Faculty Research Grant (Grant #P1FRG0000000030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Centers for Disease Control and Prevention, 2012, ASTHM IMP NAT; Colice GL, 2012, ANN ALLERG ASTHMA IM, V108, P157, DOI 10.1016/j.anai.2011.12.017; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; Fishbein AB, 2012, CURR OPIN PEDIATR, V24, P98, DOI 10.1097/MOP.0b013e32834ee57c; Hahn DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035945; Hansbro PM, 2004, PHARMACOL THERAPEUT, V101, P193, DOI 10.1016/j.pharmthera.2003.10.007; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Jurstrand M, 2001, J CLIN MICROBIOL, V39, P3915, DOI 10.1128/JCM.39.11.3915-3919.2001; Lau Susanne, 2002, Paediatr Respir Rev, V3, P265, DOI 10.1016/S1526-0542(02)00189-6; McGrath KW, 2012, AM J RESP CRIT CARE; O'Byrne PM, 2012, CLIN EXP ALLERGY, V42, P706, DOI 10.1111/j.1365-2222.2012.03965.x; Patel KK, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-32; Patel KK, 2010, PEDIATR INFECT DIS J, V29, P1093, DOI 10.1097/INF.0b013e3181eaebdc; Pearce N, 2000, THORAX, V55, P424, DOI 10.1136/thorax.55.5.424; Pearce N, 1999, THORAX, V54, P268, DOI 10.1136/thx.54.3.268; Pearce N, 2012, INDIAN J PEDIAT; Siegle JS, 2011, CLIN EXP IMMUNOL, V165, P19, DOI 10.1111/j.1365-2249.2011.04392.x; Siegle JS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-14; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Starkey MR, 2013, CLIN OBSTET GYNECOL; Webley WC, 2009, EUR RESPIR J, V33, P360, DOI 10.1183/09031936.00019508; Webley WC, 2005, AM J RESP CRIT CARE, V171, P1083, DOI 10.1164/rccm.200407-917OC; You DH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-107	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83453	10.1371/journal.pone.0083453	http://dx.doi.org/10.1371/journal.pone.0083453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376704	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100120
J	Siebelmann, S; Gehlsen, U; Huttmann, G; Koop, N; Bolke, T; Gebert, A; Stern, ME; Niederkorn, JY; Steven, P				Siebelmann, Sebastian; Gehlsen, Uta; Huettmann, Gereon; Koop, Norbert; Boelke, Torsten; Gebert, Andreas; Stern, Michael E.; Niederkorn, Jerry Y.; Steven, Philipp			Development, Alteration and Real Time Dynamics of Conjunctiva-Associated Lymphoid Tissue	PLOS ONE			English	Article							M-CELLS; T-CELLS; ANTIGEN; ACTIVATION; FOLLICLE; MUCOSA; INDUCTION; RABBIT; ROUTE; BIND	Purpose: Conjunctiva-associated lymphoid tissue (CALT) is thought to play a key role in initiating ocular surface related immune responses. This study was planned to get first profound insights into the function of CALT related to development, cellular dynamics and morphological alteration using a novel mouse model. Methods: Expression and morphology of CALT were investigated using BALB/c mice kept under different housing conditions, after topical antigen-stimulation and following lymphadenectomy and splenectomy. Particles and bacteria were applied topically to study antigen-transport. Intravital visualization was performed using two-photon microscopy. Results: Postnatal development and ultrastructure of CALT in the mouse is similar to humans. Topical antigen-challenge significantly alters CALT expression. Bacterial translocation is demonstrated via lymphoepithelium whereas cellular velocities within follicles were approximately 8 mu m/min. Conclusions: CALT in the mouse is an immunological interface of the ocular surface, featuring dynamic processes such as morphological plasticity, particle/bacteria transport and cellular migration.	[Siebelmann, Sebastian; Gehlsen, Uta; Steven, Philipp] Univ Cologne, Dept Ophthalmol, D-50931 Cologne, Germany; [Huettmann, Gereon; Koop, Norbert] Med Univ Lubeck, Inst Biomed, D-23538 Lubeck, Germany; [Boelke, Torsten; Gebert, Andreas] Univ Hosp Jena, Inst Anat 2, Jena, Germany; [Stern, Michael E.] Allergan Pharmaceut Inc, Biol Sci, Irvine, CA 92715 USA; [Niederkorn, Jerry Y.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA	University of Cologne; University of Lubeck; Friedrich Schiller University of Jena; AbbVie; Allergan; University of Texas System; University of Texas Southwestern Medical Center Dallas	Steven, P (corresponding author), Univ Cologne, Dept Ophthalmol, D-50931 Cologne, Germany.	philipp.steven@uk-koeln.de	Hüttmann, Gereon/A-9072-2012	Hüttmann, Gereon/0000-0002-5051-3037; Gehlsen, Uta/0000-0001-9057-9199; Steven, Philipp/0000-0001-6892-3619	University of Luebeck; GlaxoSmithKline; BVA Sicca Research Grant; Helmut und Ruth Lingen-Stiftung; Koeln Fortune Program/Faculty of Medicine, University of Cologne; Deutsche Forschungsgemeinschaft (DFG) [STE1928/2-1]	University of Luebeck; GlaxoSmithKline(GlaxoSmithKline); BVA Sicca Research Grant; Helmut und Ruth Lingen-Stiftung; Koeln Fortune Program/Faculty of Medicine, University of Cologne; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	University of Luebeck, Medical faculty grants to PS and GH, GlaxoSmithKline to PS, BVA Sicca Research Grant to SS, UG and PS, Helmut und Ruth Lingen-Stiftung to PS, Koeln Fortune Program/Faculty of Medicine, University of Cologne and Deutsche Forschungsgemeinschaft (DFG) STE1928/2-1 to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandtzaeg P, 2010, IMMUNOL INVEST, V39, P303, DOI 10.3109/08820131003680369; Buonfiglio D, 2000, EUR J IMMUNOL, V30, P3463, DOI 10.1002/1521-4141(2000012)30:12<3463::AID-IMMU3463>3.0.CO;2-5; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; Chodosh J, 1998, DEV COMP IMMUNOL, V22, P621, DOI 10.1016/S0145-305X(98)00022-6; Chodosh J, 2002, DNA CELL BIOL, V21, P421, DOI 10.1089/10445490260099719; CRABBE PA, 1970, LAB INVEST, V22, P448; Cyster JG, 2003, IMMUNOL REV, V195, P5, DOI 10.1034/j.1600-065X.2003.00075.x; Darrell R.W., 1985, VIRAL DIS EYE, P296; Egan RM, 2000, J IMMUNOL, V164, P4543, DOI 10.4049/jimmunol.164.9.4543; FIX AS, 1991, AVIAN DIS, V35, P100, DOI 10.2307/1591301; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gebert A, 1997, HISTOCHEM CELL BIOL, V108, P455, DOI 10.1007/s004180050186; Gehlsen U, 2010, DEV OPHTHALMOL, V45, P40, DOI 10.1159/000315018; Giddings OK, 2006, INFECT IMMUN, V74, P5549, DOI 10.1128/IAI.00319-06; Isaacson P G, 1992, Verh Dtsch Ges Pathol, V76, P14; Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710; Kessing SV, 1968, ACTA OPHTHALMOL S95, P91; Knop E, 2005, J ANAT, V206, P271, DOI 10.1111/j.1469-7580.2005.00394.x; Knop E, 2002, ADV EXP MED BIOL, V506, P835; Knop N, 2000, INVEST OPHTH VIS SCI, V41, P1270; Liang H, 2010, INVEST OPHTH VIS SCI, V51, P1008, DOI 10.1167/iovs.09-3509; Liu HS, 2005, INVEST OPHTH VIS SCI, V46, P4217, DOI 10.1167/iovs.05-0280; McDonald KG, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-1; Meagher CK, 2005, EXP EYE RES, V80, P545, DOI 10.1016/j.exer.2004.11.005; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Nagatake T, 2009, J EXP MED, V206, P2351, DOI 10.1084/jem.20091436; Osterlind G., 1944, ACTA OPHTHALMOL    S, V23, P1; Pabst R, 2010, AM J RESP CELL MOL, V43, P137, DOI 10.1165/rcmb.2010-0152RT; Petris CK, 2007, INVEST OPHTH VIS SCI, V48, P2172, DOI 10.1167/iovs.06-1202; SCHWARTZALBIEZ R, 1991, INT IMMUNOL, V3, P623, DOI 10.1093/intimm/3.7.623; Seo KY, 2010, J IMMUNOL, V185, P3610, DOI 10.4049/jimmunol.1000680; SMINIA T, 1983, ANAT REC, V207, P309, DOI 10.1002/ar.1092070209; Steven P, 2008, INVEST OPHTH VIS SCI, V49, P1512, DOI 10.1167/iovs.07-0809; Steven P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026253; Steven P, 2009, OPHTHAL RES, V42, P2, DOI 10.1159/000219678; Taylor RT, 2005, IMMUNOL RES, V33, P167, DOI 10.1385/IR:33:2:167; Tsuji NM, 2003, INT IMMUNOL, V15, P525, DOI 10.1093/intimm/dxg051; WOTHERSPOON AC, 1994, J PATHOL, V174, P33, DOI 10.1002/path.1711740106	40	29	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82355	10.1371/journal.pone.0082355	http://dx.doi.org/10.1371/journal.pone.0082355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376530	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100028
J	Zhu, LB; Yuan, H; Jiang, T; Wang, RX; Ma, HX; Zhang, SY				Zhu, Longbiao; Yuan, Hua; Jiang, Tao; Wang, Ruixia; Ma, Hongxia; Zhang, Shuangyue			Association of TLR2 and TLR4 Polymorphisms with Risk of Cancer: A Meta-Analysis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SINGLE-NUCLEOTIDE POLYMORPHISMS; LYMPHOID-TISSUE LYMPHOMA; NORTH INDIAN POPULATION; NON-HODGKIN-LYMPHOMA; PROSTATE-CANCER; GENE POLYMORPHISMS; GASTRIC-CANCER; HELICOBACTER-PYLORI; CHINESE POPULATION	Backgrounds: The activation of Toll-like receptors (TLRs) may be an important event in the immune evasion of tumor cell. Recently, numerous studies have investigated the associations between TLR2 -196 to -174 del and two SNPs of TLR4 (rs4986790 and rs4986791) and the susceptibility to different types of cancer; however, the results remain conflicting. The aim of this study was to assess the association between TLR2 and TLR4 polymorphisms and cancer risk in a meta-analysis with eligible published studies. Methodology/Principle Findings: A dataset composed of 14627 cases and 17438 controls from 34 publications were included in a meta-analysis to evaluate the association between overall cancer risk or cancer-specific risk and three SNPs of TLRs (TLR2 -196 to -174 del, TLR4 rs4986790 and rs4986791). The results showed that all of these three polymorphisms were significantly associated with the increased cancer risk (dominant model: OR=1.64, 95% CI: 1.04-2.60 for TLR2 -196 to -174 del; OR=1.19, 95% CI: 1.01-1.41 for TLR4 rs4986790; and OR=1.47, 95% CI: 1.120-1.80 for TLR4 rs4986791; respectively). In stratified analysis, we found the effect of TLR2 -196 to -174 del on cancer risk remained significant in the subgroup of Caucasians and South Asians, but not in East Asians. However, the association between rs4986791 and cancer risk was significant in both South Asians and East Asians, but not in Caucasians. Furthermore, the association between rs4986790 and cancer risk was statistically significant in digestive cancers (dominant model: OR=1.76, 95% CI: 1.13-2.73) and female-specific cancers (dominant model: OR=1.50, 95% Cl: 1.16-1.94). However, no significant association with risk of digestive system cancers was observed for TLR2 -196 to -174 del and TLR4 rs4986791. Conclusions/Significance: This meta-analysis presented additional evidence for the association between TLR2 and TLR4 polymorphisms and cancer risk. Further well-designed investigations with large sample sizes are required to confirm this conclusion.	[Zhu, Longbiao; Yuan, Hua; Wang, Ruixia] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China; [Zhu, Longbiao; Yuan, Hua; Ma, Hongxia] Nanjing Med Univ, Clin Epidemiol Sect, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Jiang, Tao; Ma, Hongxia] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, MOE Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Zhang, Shuangyue] Nanjing Med Univ, Huaian Peoples Hosp 1, Cent Lab, Huaian, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Ma, HX (corresponding author), Nanjing Med Univ, Clin Epidemiol Sect, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China.	mahongxia927@gmail.com; zsy2005edu@sina.com			National Natural Science Foundation of China [81270044, 81302361]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Natural Science Foundation [BK2011764]; Jiangsu Province Clinical Science and Technology Projects [BL2012008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Province Clinical Science and Technology Projects	This work was supported in part by National Natural Science Foundation of China (81270044 and 81302361), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Jiangsu Natural Science Foundation (BK2011764) and Jiangsu Province Clinical Science and Technology Projects (BL2012008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Agundez JA, 2012, ONCOLOGY-BASEL, V82, P35, DOI 10.1159/000335606; Ahmed A., 2012, ANN SURG ONCOL; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Ashton KA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-382; Balistreri CR, 2010, CURR PHARM DESIGN, V16, P718, DOI 10.2174/138161210790883877; Basith S, 2012, ARCH PHARM RES, V35, P1297, DOI 10.1007/s12272-012-0802-7; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Castano-Rodriguez N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060327; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Cheng I, 2007, CANCER EPIDEM BIOMAR, V16, P352, DOI 10.1158/1055-9965.EPI-06-0429; de Oliveira JG, 2012, WORLD J GASTROENTERO, V18, P1235, DOI 10.3748/wjg.v18.i11.1235; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Etokebe GE, 2009, GENET TEST MOL BIOMA, V13, P729, DOI 10.1089/gtmb.2009.0045; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Forrest MS, 2006, BRIT J HAEMATOL, V134, P180, DOI 10.1111/j.1365-2141.2006.06141.x; Garza-Gonzalez E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-70; Gast A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024370; Harberts E, 2013, J INVEST DERMATOL, V133, P296, DOI 10.1038/jid.2012.288; He WG, 2007, MOL IMMUNOL, V44, P2850, DOI 10.1016/j.molimm.2007.01.022; Hellmig S, 2005, LEUKEMIA LYMPHOMA, V46, P869, DOI 10.1080/1042819050086451; Hishida A, 2010, GASTRIC CANCER, V13, P251, DOI 10.1007/s10120-010-0567-y; Hold GL, 2007, GASTROENTEROLOGY, V132, P905, DOI 10.1053/j.gastro.2006.12.026; Huang B, 2007, CANCER RES, V67, P4346, DOI 10.1158/0008-5472.CAN-06-4067; Jelavic TB, 2006, CLIN GENET, V70, P156, DOI 10.1111/j.1399-0004.2006.00651.x; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Landi S, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-15; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lindstrom S, 2010, CANCER EPIDEM BIOMAR, V19, P873, DOI 10.1158/1055-9965.EPI-09-0618; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Mandal RK, 2012, MOL BIOL REP, V39, P7263, DOI 10.1007/s11033-012-1556-5; MANTEL N, 1959, J NATL CANCER I, V22, P719; Menendez D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001360; Miedema KGE, 2012, LEUKEMIA, V26, P1203, DOI 10.1038/leu.2011.341; Nieters A, 2006, GENES IMMUN, V7, P615, DOI 10.1038/sj.gene.6364337; Nischalke HD, 2012, INT J CANCER, V130, P1470, DOI 10.1002/ijc.26143; Pandey S, 2009, GYNECOL ONCOL, V114, P501, DOI 10.1016/j.ygyno.2009.05.032; Purdue MP, 2009, CARCINOGENESIS, V30, P275, DOI 10.1093/carcin/bgn262; Rigoli L, 2010, ANTICANCER RES, V30, P513; Sabroe I, 2005, CLIN INFECT DIS, V41, pS421, DOI 10.1086/431992; Santini D, 2008, CLIN EXP IMMUNOL, V154, P360, DOI 10.1111/j.1365-2249.2008.03776.x; Shen YZ, 2013, PATHOL ONCOL RES, V19, P275, DOI 10.1007/s12253-012-9579-8; Singh V, 2013, ARCH MED RES, V44, P54, DOI 10.1016/j.arcmed.2012.10.008; Srivastava K, 2010, LIVER INT, V30, P1067, DOI 10.1111/j.1478-3231.2010.02268.x; Su B, 2003, INFECT IMMUN, V71, P3496, DOI 10.1128/IAI.71.6.3496-3502.2003; Tahara T, 2007, CANCER SCI, V98, P1790, DOI 10.1111/j.1349-7006.2007.00590.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Theodoropoulos GE, 2012, BREAST, V21, P534, DOI 10.1016/j.breast.2012.04.001; Trejo-de la O A, 2008, CLIN IMMUNOL, V129, P333, DOI 10.1016/j.clim.2008.07.009; Ture-Ozdemir F, 2008, ANTICANCER RES, V28, P3697; Wang JH, 2003, J IMMUNOL, V170, P795, DOI 10.4049/jimmunol.170.2.795; Wang MH, 2009, PROSTATE, V69, P874, DOI 10.1002/pros.20933; Wang RF, 2008, ONCOGENE, V27, P181, DOI 10.1038/sj.onc.1210906; Wroblewski LE, 2013, GASTROENTEROL CLIN N, V42, P285, DOI 10.1016/j.gtc.2013.01.006; Yang ZH, 2012, CANCER SCI, V103, P653, DOI 10.1111/j.1349-7006.2012.02210.x; Zeng HM, 2011, CANCER EPIDEM BIOMAR, V20, P2594, DOI 10.1158/1055-9965.EPI-11-0702; Zhang K, 2013, EUR J CANCER, V49, P946, DOI 10.1016/j.ejca.2012.09.022; Zheng SL, 2004, CANCER RES, V64, P2918, DOI 10.1158/0008-5472.CAN-03-3280; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	64	29	33	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82858	10.1371/journal.pone.0082858	http://dx.doi.org/10.1371/journal.pone.0082858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376595	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100066
J	Wei, HF; Zhao, LK; Li, W; Fan, KX; Qian, WZ; Hou, S; Wang, H; Dai, M; Hellstrom, I; Hellstrom, KE; Guo, YJ				Wei, Huafeng; Zhao, Likun; Li, Wei; Fan, Kexing; Qian, Weizhu; Hou, Sheng; Wang, Hao; Dai, Min; Hellstrom, Ingegerd; Hellstrom, Karl Erik; Guo, Yajun			Combinatorial PD-1 Blockade and CD137 Activation Has Therapeutic Efficacy in Murine Cancer Models and Synergizes with Cisplatin	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; PERIPHERAL-BLOOD LYMPHOCYTES; EPITHELIAL OVARIAN-CANCER; ANTITUMOR IMMUNITY; T-CELLS; MONOCLONAL-ANTIBODY; ANTI-PD-1 ANTIBODY; DENDRITIC CELLS; IMMUNOTHERAPY; INFLAMMATION	There is an urgent need for improved therapy for advanced ovarian carcinoma, which may be met by administering immune-modulatory monoclonal antibodies (mAbs) to generate a tumor-destructive immune response. Using the ID8 mouse ovarian cancer model, we investigated the therapeutic efficacy of various mAb combinations in mice with intraperitoneal (i.p.) tumor established by transplanting 3 x 10(6) ID8 cells 10 days previously. While most of the tested mAbs were ineffective when given individually or together, the data confirm our previous finding that 2 i.p. injections of a combination of anti-CD137 with anti-PD-1 mAbs doubles overall survival. Mice treated with this mAb combination have a significantly increased frequency and total number of CD8(+) T cells both in the peritoneal lavage and spleens, and these cells are functional as demonstrated by antigen-specific cytolytic activity and IFN-gamma production. While administration of anti-CD137 mAb as a single agent similarly increases CD8(+) T cells, these have no functional activity, which may be attributed to up-regulation of co-inhibitory PD-1 and TIM-3 molecules induced by CD137. Addition of the anti-cancer drug cisplatin to the 2 mAb combination increased overall survival >90 days (and was probably curative) by a mechanism which included a systemic CD8(+) T cell response with tumor specificity and immunological memory. Strikingly, combined treatment of cisplatin and CD137/PD-1 mAb also gave rise to the long-term survival of mice with established TC1 lung tumors. A similar combination of the 2 mAbs and cisplatin should be considered for clinical 'translation'.	[Wei, Huafeng; Li, Wei; Fan, Kexing; Qian, Weizhu; Hou, Sheng; Wang, Hao; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China; [Zhao, Likun; Guo, Yajun] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Wei, Huafeng; Li, Wei; Fan, Kexing; Qian, Weizhu; Hou, Sheng; Wang, Hao; Guo, Yajun] Liaocheng Univ, Sch Pharm, Liaocheng, Peoples R China; [Dai, Min; Hellstrom, Ingegerd; Hellstrom, Karl Erik] Univ Washington, Harborview Med Ctr, Dept Pathol, Seattle, WA 98104 USA	Naval Medical University; South China University of Technology; Liaocheng University; Harborview Medical Center; University of Washington; University of Washington Seattle	Guo, YJ (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China.	yguo_smmu@163.com	DAI, M/GPS-8291-2022		National Natural Science Foundation of China [81372528]; Ministry of Science & Technology of China "973" [2012CB917104]; Ministry of Education of China; Shanghai Commission of Education for excellent research team in Oncology; U.S. National Institutes of Health [RO1CA134487]; NATIONAL CANCER INSTITUTE [R01CA134487] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science & Technology of China "973"; Ministry of Education of China(Ministry of Education, China); Shanghai Commission of Education for excellent research team in Oncology; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (No. 81372528), Ministry of Science & Technology of China "973" (No. 2012CB917104), special grants from Ministry of Education of China and Shanghai Commission of Education for excellent research team in Oncology and Shanghai Key Project in Oncology as well as by RO1CA134487 from U.S. National Institutes of Health. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AY, 2012, ANN NY ACAD SCI, V1271, P58, DOI 10.1111/j.1749-6632.2012.06734.x; Ascierto PA, 2010, SEMIN ONCOL, V37, P508, DOI 10.1053/j.seminoncol.2010.09.008; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cubillos-Ruiz JR, 2009, J CLIN INVEST, V119, P2231, DOI 10.1172/JCI37716; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Dai M, 2013, J IMMUNOTHER, V36, P248, DOI 10.1097/CJI.0b013e3182943549; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Feng QH, 2012, GYNECOL ONCOL, V127, P412, DOI 10.1016/j.ygyno.2012.07.098; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Graziani G, 2012, PHARMACOL RES, V65, P9, DOI 10.1016/j.phrs.2011.09.002; Hall M, 2013, BRIT J CANCER, V108, P250, DOI 10.1038/bjc.2012.541; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Kandalaft LE, 2011, J CLIN ONCOL, V29, P925, DOI 10.1200/JCO.2009.27.2369; Kim YH, 2008, CANCER RES, V68, P7264, DOI 10.1158/0008-5472.CAN-08-1365; Krempski J, 2011, J IMMUNOL, V186, P6905, DOI 10.4049/jimmunol.1100274; Leary A, 2012, B CANCER, V99, P1161, DOI 10.1684/bdc.2012.1667; Li QS, 2004, CANCER RES, V64, P1130, DOI 10.1158/0008-5472.CAN-03-1715; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; Mantia-Smaldone GM, 2012, HUM VACC IMMUNOTHER, V8, P1179, DOI 10.4161/hv.20738; McNamara JO, 2008, J CLIN INVEST, V118, P376, DOI 10.1172/JCI33365; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Pardoll D, 2012, J EXP MED, V209, P201, DOI 10.1084/jem.20112275; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Ramakrishna V, 2003, INT IMMUNOL, V15, P751, DOI 10.1093/intimm/dxg074; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Santin AD, 2001, GYNECOL OBSTET INVES, V51, P254, DOI 10.1159/000058060; Schondorf T, 1998, J SOC GYNECOL INVEST, V5, P102, DOI 10.1016/S1071-5576(97)00112-3; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Verbrugge I, 2012, CANCER RES, V72, P3163, DOI 10.1158/0008-5472.CAN-12-0210; Vermeij R, 2012, CURR PHARM DESIGN, V18, P3804, DOI 10.2174/138161212802002805; Wei HF, 2008, CANCER RES, V68, P3854, DOI 10.1158/0008-5472.CAN-07-6051; Wei HF, 2012, GYNECOL ONCOL, V125, P727, DOI 10.1016/j.ygyno.2012.03.018; Wei HF, 2012, J IMMUNOTHER, V35, P267, DOI 10.1097/CJI.0b013e31824d72ee; Wilcox RA, 2002, J CLIN INVEST, V109, P651, DOI 10.1172/JCI200214184; Xiao H, 2007, CLIN CANCER RES, V13, P1823, DOI 10.1158/1078-0432.CCR-06-2154; Yang Y, 2007, CANCER RES, V67, P2339, DOI 10.1158/0008-5472.CAN-06-3593; Yao S, 2013, NAT REV DRUG DISCOV, V12, P130, DOI 10.1038/nrd3877; Zhang HT, 2006, MOL CANCER THER, V5, P149, DOI 10.1158/1535-7163.MCT-05-0206; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	44	66	91	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84927	10.1371/journal.pone.0084927	http://dx.doi.org/10.1371/journal.pone.0084927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367702	Green Published, gold			2022-12-27	WOS:000328741900071
J	Ahn, SY; Ryu, J; Baek, SH; Kim, S; Na, KY; Kim, KW; Chae, DW; Chin, HJ				Ahn, Shin Young; Ryu, Jiwon; Baek, Seon Ha; Kim, Sejoong; Na, Ki Young; Kim, Ki Woong; Chae, Dong-Wan; Chin, Ho Jun			Incident Chronic Kidney Disease and Newly Developed Complications Related to Renal Dysfunction in an Elderly Population during 5 Years: A Community-Based Elderly Population Cohort Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RISK-FACTORS; FAILURE; ADULTS; ONSET	Background: Few studies have evaluated the association between incident chronic kidney disease (CKD) and related complications, especially in elderly population. We attempted to verify the association between GFR and concurrent CKD complications and elucidate the temporal relationship between incident CKD and new CKD complications in a community-based prospective elderly cohort. Method: We analyzed the available data from 984 participants in the Korean Longitudinal Study on Health and Aging. Participants were categorized into 6 groups according to eGFR at baseline examination (>= 90, 75-89, 60-74, 45-59, 30-44, and <30 ml/min/1.73 m(2)). Result: The mean age of study population was 76 +/- 9.1 years and mean eGFR was 72.3 +/- 17.0 ml/min/1.73 m(2). Compared to eGFR group 1, the odds ratio (OR) for hypertension was 2.363 (95% CI, 1.299-4.298) in group 4, 5.191 (2.074-12.995) in group 5, and 13.675 (1.611-115.806) in group 6; for anemia, 7.842 (2.265-27.153) in group 5 and 13.019 (2.920-58.047) in group 6; for acidosis, 69.580 (6.770-715.147) in group 6; and for hyperkalemia, 19.177 (1.798-204.474) in group 6. Over a 5-year observational period, CKD developed in 34 (9.6%) among 354 participants with GFR >= 60 ml/min/1.73 m(2) at basal examination. The estimated mean number of new complications according to analysis of co-variance was 0.52 (95% CI, 0.35-0.68) in subjects with incident CKD and 0.24 (0.19-0.29) in subjects without CKD (p = 0.002). Subjects with incident CKD had a 2.792-fold higher risk of developing new CKD complications. A GFR level of 52.4 ml/min/1.73 m(2) (p = 0.032) predicted the development of a new CKD complication with a 90% sensitivity. Conclusion: In an elderly prospective cohort, CKD diagnosed by current criteria is related to an increase in the number of concurrent CKD complications and the development of new CKD complications.	[Ahn, Shin Young; Ryu, Jiwon; Baek, Seon Ha; Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ Bundang Hopsital, Dept Internal Med, Seong Nam, South Korea; [Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ Coll Med, Dept Internal Mecidine, Seoul, South Korea; [Kim, Ki Woong] Seoul Natl Univ Bundang Hopsital, Dept Neuropsychiat, Seong Nam, South Korea; [Chin, Ho Jun] Seoul Natl Univ Coll Med, Clin Res Ctr, Renal Inst, Seoul, South Korea	Seoul National University (SNU); Samsung; Seoul National University (SNU)	Chin, HJ (corresponding author), Seoul Natl Univ Bundang Hopsital, Dept Internal Med, Seong Nam, South Korea.	mednep@snubh.org	Kim, Ki Woong/D-5801-2012; Kim, Sejoong/J-5356-2015	Kim, Ki Woong/0000-0002-1103-3858; Kim, Sejoong/0000-0002-7238-9962	Pfizer Global Pharmaceuticals [06-05-039]; Seongnam City Government in Korea [800-20050211]	Pfizer Global Pharmaceuticals(Pfizer); Seongnam City Government in Korea	This work was supported by an independent Research Grant (IRG) from Pfizer Global Pharmaceuticals (grant number. 06-05-039) and a Grant for developing Seongnam Health Promotion Program for the Elderly from Seongnam City Government in Korea (grant number. 800-20050211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleyer AJ, 2000, KIDNEY INT, V57, P2072, DOI 10.1046/j.1523-1755.2000.00056.x; Bowling CB, 2012, J GERONTOL A-BIOL, V67, P1379, DOI 10.1093/gerona/gls173; Bowling CB, 2011, CLIN J AM SOC NEPHRO, V6, P2822, DOI 10.2215/CJN.06770711; Chin HJ, 2008, NEPHROL DIAL TRANSPL, V23, P2810, DOI 10.1093/ndt/gfn132; Cirillo M, 2006, KIDNEY INT, V70, P800, DOI 10.1038/sj.ki.5001641; Drawz PE, 2012, J AM GERIATR SOC, V60, P310, DOI 10.1111/j.1532-5415.2011.03818.x; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Glassock Richard J, 2009, Trans Am Clin Climatol Assoc, V120, P419; Hollowell Joseph G, 2005, Vital Health Stat 11, P1; Kim YC, 2012, TOHOKU J EXP MED, V227, P149, DOI 10.1620/tjem.227.149; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Mercadal L, 2012, CLIN J AM SOC NEPHRO, V7, P35, DOI 10.2215/CJN.04690511; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Oh SW, 2012, NEPHROL DIAL TRANSPL, V27, P267, DOI 10.1093/ndt/gfr296; PERRY HM, 1995, HYPERTENSION, V25, P587, DOI 10.1161/01.HYP.25.4.587; RADTKE HW, 1979, BLOOD, V54, P877; Shastri S, 2011, CLIN J AM SOC NEPHRO, V6, P1410, DOI 10.2215/CJN.08801010; Vaziri ND, 2004, KIDNEY INT, V66, P262, DOI 10.1111/j.1523-1755.2004.00724.x; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Wang XW, 2012, CARDIORENAL MED, V2, P57, DOI 10.1159/000335509; 1968, WHO TECH REP SER, P5	23	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84467	10.1371/journal.pone.0084467	http://dx.doi.org/10.1371/journal.pone.0084467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367663	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300142
J	Dilek, N; Poirier, N; Hulin, P; Coulon, F; Mary, C; Ville, S; Vie, H; Clemenceau, B; Blancho, G; Vanhove, B				Dilek, Nahzli; Poirier, Nicolas; Hulin, Philippe; Coulon, Flora; Mary, Caroline; Ville, Simon; Vie, Henri; Clemenceau, Beatrice; Blancho, Gilles; Vanhove, Bernard			Targeting CD28, CTLA-4 and PD-L1 Costimulation Differentially Controls Immune Synapses and Function of Human Regulatory and Conventional T-Cells	PLOS ONE			English	Article							IN-VITRO; ANTI-CD28 ANTIBODY; EXTRINSIC CONTROL; DENDRITIC CELLS; UP-REGULATION; CUTTING EDGE; ACTIVATION; TOLERANCE; LYMPHOCYTES; HOMEOSTASIS	CD28, CTLA-4 and PD-L1, the three identified ligands for CD80/86, are pivotal positive and negative costimulatory molecules that, among other functions, control T cell motility and formation of immune synapse between T cells and antigen-presenting cells (APCs). What remains incompletely understood is how CD28 leads to the activation of effector T cells (Teff) but inhibition of suppression by regulatory T cells (Tregs), while CTLA-4 and PD-L1 inhibit Teff function but are crucial for the suppressive function of Tregs. Using alloreactive human T cells and blocking antibodies, we show here by live cell dynamic microscopy that CD28, CTLA-4, and PD-L1 differentially control velocity, motility and immune synapse formation in activated Teff versus Tregs. Selectively antagonizing CD28 costimulation increased Treg dwell time with APCs and induced calcium mobilization which translated in increased Treg suppressive activity, in contrast with the dampening effect on Teff responses. The increase in Treg suppressive activity after CD28 blockade was also confirmed with polyclonal Tregs. Whereas CTLA-4 played a critical role in Teff by reversing TCR-induced STOP signals, it failed to affect motility in Tregs but was essential for formation of the Treg immune synapse. Furthermore, we identified a novel role for PD-L1-CD80 interactions in suppressing motility specifically in Tregs. Thus, our findings reveal that the three identified ligands of CD80/86, CD28, CTLA-4 and PD-L1, differentially control immune synapse formation and function of the human Teff and Treg cells analyzed here. Individually targeting CD28, CTLA-4 and PD-L1 might therefore represent a valuable therapeutic strategy to treat immune disorders where effector and regulatory T cell functions need to be differentially targeted.	[Dilek, Nahzli; Poirier, Nicolas; Coulon, Flora; Mary, Caroline; Ville, Simon; Blancho, Gilles; Vanhove, Bernard] INSERM, Unite Mixte Rech 1064, Nantes, France; [Hulin, Philippe; Vie, Henri; Clemenceau, Beatrice] INSERM, Unite Mixte Rech 892, Nantes, France; [Hulin, Philippe] Cellular & Tissular Imaging Core Facil MicroPICel, Nantes, France; [Mary, Caroline; Vanhove, Bernard] Effimune SAS, Nantes, France; [Blancho, Gilles] Ctr Hosp Univ Nantes, Inst Transplantat Urol Nephrol, Nantes, France; [Blancho, Gilles; Vanhove, Bernard] Univ Nantes, Fac Med, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite	Vanhove, B (corresponding author), INSERM, Unite Mixte Rech 1064, Nantes, France.	Bernard.vanhove@univ-nantes.fr	Vie, Henri/L-2651-2015; CLEMENCEAU, Béatrice BC/L-2605-2015; Vanhove, Bernard/AAE-8658-2019	Vanhove, Bernard/0000-0002-2872-8648; Poirier, Nicolas/0000-0003-2335-9385	European Commission [EC-GA 281493]; Progreffe foundation; Effimune; French ANRS	European Commission(European CommissionEuropean Commission Joint Research Centre); Progreffe foundation; Effimune; French ANRS(ANRSFrench National Research Agency (ANR))	This work was funded by the "Tolerance Restoration In Autoimmune Disease" FP7 Health 2011 Program # EC-GA no281493 of the European Commission and supported in part by the Progreffe foundation and by a joint grant from Effimune and the French ANRS, in the framework of a CIFRE convention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Alvarez-Quiroga C, 2011, J CLIN IMMUNOL, V31, P588, DOI 10.1007/s10875-011-9527-5; Barnes MJ, 2012, MUCOSAL IMMUNOL; Blair PJ, 1998, J IMMUNOL, V160, P12; Boonen GJJC, 1999, EUR J IMMUNOL, V29, P789; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Chavez H, 2007, TRANSPL IMMUNOL, V17, P243, DOI 10.1016/j.trim.2007.01.005; Chen Y, 2012, J IMMUNOL, V188, P1698, DOI 10.4049/jimmunol.1102448; Dillon TJ, 2005, MOL CELL BIOL, V25, P4117, DOI 10.1128/MCB.25.10.4117-4128.2005; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Gallot G, 2006, CLIN EXP IMMUNOL, V144, P158, DOI 10.1111/j.1365-2249.2006.03035.x; Gogishvili T, 2013, EUR J IMMUNOL, V43, P188, DOI 10.1002/eji.201242824; Graf B, 2007, J IMMUNOL, V179, P1616, DOI 10.4049/jimmunol.179.3.1616; Haspot F, 2005, AM J TRANSPLANT, V5, P2339, DOI 10.1111/j.1600-6143.2005.01018.x; Holling TM, 2004, HUM IMMUNOL, V65, P282, DOI 10.1016/j.humimm.2004.01.005; Ibisch C, 2000, J IMMUNOL, V164, P4924, DOI 10.4049/jimmunol.164.9.4924; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kirchhoff S, 2000, EUR J IMMUNOL, V30, P2765, DOI 10.1002/1521-4141(200010)30:10<2765::AID-IMMU2765>3.0.CO;2-W; Lu YN, 2012, BLOOD, V120, P4560, DOI 10.1182/blood-2012-04-421420; MARY C, 2012, MABS, V5; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Ohkura N, 2010, IMMUNITY, V33, P835, DOI 10.1016/j.immuni.2010.12.004; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Page EK, 2012, TRANSPL INT, V25, P707, DOI 10.1111/j.1432-2277.2012.01456.x; Pentcheva-Hoang T, 2009, IMMUNOL REV, V229, P67, DOI 10.1111/j.1600-065X.2009.00763.x; Perrin PJ, 1999, J IMMUNOL, V163, P1704; Poirier N, 2012, AM J TRANSPLANT, V12, P2630, DOI 10.1111/j.1600-6143.2012.04164.x; Poirier N, 2012, AM J TRANSPLANT, V12, P1682, DOI 10.1111/j.1600-6143.2012.04032.x; POIRIER N, 2012, AM J TRANSPLANT; Poirier N, 2010, IMMUNOTHERAPY-UK, V2, P625, DOI 10.2217/IMT.10.57; Poirier N, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000116; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Raychaudhuri SP, 2008, J INVEST DERMATOL, V128, P1969, DOI 10.1038/jid.2008.38; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Scheipers P, 1998, P NATL ACAD SCI USA, V95, P10083, DOI 10.1073/pnas.95.17.10083; Schneider H, 2005, P NATL ACAD SCI USA, V102, P12861, DOI 10.1073/pnas.0505802102; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Silver PB, 2000, J IMMUNOL, V165, P5041, DOI 10.4049/jimmunol.165.9.5041; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tomiyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073874; Vondran FWR, 2012, TRANSPL INT, V25, P455, DOI 10.1111/j.1432-2277.2012.01441.x; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wei B, 2007, J IMMUNOL, V179, P400, DOI 10.4049/jimmunol.179.1.400; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yao S, 2011, IMMUNITY, V34, P729, DOI 10.1016/j.immuni.2011.03.014; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zhang T, 2011, AM J TRANSPLANT, V11, P1599, DOI 10.1111/j.1600-6143.2011.03624.x; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778	58	50	55	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83139	10.1371/journal.pone.0083139	http://dx.doi.org/10.1371/journal.pone.0083139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376655	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000063
J	Charrier, M; Marie, A; Guillaume, D; Bedouet, L; Le Lannic, J; Roiland, C; Berland, S; Pierre, JS; Le Floch, M; Frenot, Y; Lebouvier, M				Charrier, Maryvonne; Marie, Arul; Guillaume, Damien; Bedouet, Laurent; Le Lannic, Joseph; Roiland, Claire; Berland, Sophie; Pierre, Jean-Sebastien; Le Floch, Marie; Frenot, Yves; Lebouvier, Marc			Soil Calcium Availability Influences Shell Ecophenotype Formation in the Sub-Antarctic Land Snail, Notodiscus hookeri	PLOS ONE			English	Article							SIZE; PROTEINS; GASTROPODA; RESOLUTION; COMPONENT; NMR	Ecophenotypes reflect local matches between organisms and their environment, and show plasticity across generations in response to current living conditions. Plastic responses in shell morphology and shell growth have been widely studied in gastropods and are often related to environmental calcium availability, which influences shell biomineralisation. To date, all of these studies have overlooked micro-scale structure of the shell, in addition to how it is related to species responses in the context of environmental pressure. This study is the first to demonstrate that environmental factors induce a bi-modal variation in the shell micro-scale structure of a land gastropod. Notodiscus hookeri is the only native land snail present in the Crozet Archipelago (sub-Antarctic region). The adults have evolved into two ecophenotypes, which are referred to here as MS (mineral shell) and OS (organic shell). The MS- ecophenotype is characterised by a thick mineralised shell. It is primarily distributed along the coastline, and could be associated to the presence of exchangeable calcium in the clay minerals of the soils. The Os-ecophenotype is characterised by a thin organic shell. It is primarily distributed at high altitudes in the mesic and xeric fell-fields in soils with large particles that lack clay and exchangeable calcium. Snails of the Os-ecophenotype are characterised by thinner and larger shell sizes compared to snails of the MS- ecophenotype, indicating a trade-off between mineral thickness and shell size. This pattern increased along a temporal scale; whereby, older adult snails were more clearly separated into two clusters compared to the younger adult snails. The prevalence of glycine-rich proteins in the organic shell layer of N. hookeri, along with the absence of chitin, differs to the organic scaffolds of molluscan biominerals. The present study provides new insights for testing the adaptive value of phenotypic plasticity in response to spatial and temporal environmental variations.	[Charrier, Maryvonne; Pierre, Jean-Sebastien] Univ Europeenne Bretagne, Univ Rennes 1, UMR CNRS 6553, Rennes, France; [Marie, Arul] Museum Natl Hist Nat, UMR CNRS 7245, Dept Regulat Dev & Divers Mol, F-75231 Paris, France; [Guillaume, Damien] Univ Toulouse, Observ Midi Pyrenees, Geosci Environm Toulouse, UMR CNRS UPS IRD CNES 5563, Toulouse, France; [Bedouet, Laurent; Berland, Sophie] Museum Natl Hist Nat, UMR CNRS 7208, IRD 207, F-75231 Paris, France; [Le Lannic, Joseph] Univ Europeenne Bretagne, Univ Rennes 1, Serv Commun Microscopie Elect Balayage & Microana, Rennes, France; [Le Floch, Marie] Univ Europeenne Bretagne, Univ Rennes 1, Sci Chim Rennes, UMR CNRS 6226, Rennes, France; [Frenot, Yves] Inst Polaire Francais Paul Emile Victor, Plouzane, France; [Lebouvier, Marc] Univ Europeenne Bretagne, Univ Rennes 1, UMR CNRS 6553, Stn Biol, Paimpont, France	Centre National de la Recherche Scientifique (CNRS); Universite de Bretagne Occidentale; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universite de Bretagne Occidentale; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Bretagne Occidentale; Universite de Rennes; Universite de Bretagne Occidentale; Universite de Rennes	Charrier, M (corresponding author), Univ Europeenne Bretagne, Univ Rennes 1, UMR CNRS 6553, Campus Beaulieu, Rennes, France.	maryvonne.charrier@univ-rennes1.fr	Roiland, Claire/E-9551-2019; roiland, claire/AAG-7816-2019; Guillaume, Damien/D-9803-2012	Roiland, Claire/0000-0001-9587-1340; roiland, claire/0000-0001-9587-1340; Guillaume, Damien/0000-0001-5232-8380; MARIE, Arul/0000-0003-4104-140X; Frenot, Yves/0000-0003-2666-1272	French Polar Institute (Institut Polaire Francais Paul-Emile Victor)	French Polar Institute (Institut Polaire Francais Paul-Emile Victor)	The work was funded by a grant from the French Polar Institute (Institut Polaire Francais Paul-Emile Victor) within the context of the program 136 "Ecobio". No additional external funding was received for this study. Civil Volunteers helped with data collection: S.P. Babski, S. Guthjar, J. Thevenot and A. Atamaniuk in 2006, 2008 and 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansart A, 2004, COMP BIOCHEM PHYS A, V139, P205, DOI 10.1016/j.cbpb.2004.09.003; Berland S, 2011, CHEMBIOCHEM, V12, P950, DOI 10.1002/cbic.201000667; Bertin A, 2012, NATURWISSENSCHAFTEN, V99, P225, DOI 10.1007/s00114-012-0890-8; BHATTACHARYA CG, 1967, BIOMETRICS, V23, P115, DOI 10.2307/2528285; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; Chevalier L, 2003, MALACOLOGIA, V45, P125; Chevallier L., 1983, Antarctic Earth Science. Fourth International Symposium, P652; Chiba S, 2005, EVOLUTION, V59, P1712, DOI 10.1111/j.0014-3820.2005.tb01820.x; Chown SL, 2008, P ROY SOC B-BIOL SCI, V275, P1469, DOI 10.1098/rspb.2008.0137; Cimino G, 1999, CHEMOECOLOGY, V9, P187, DOI 10.1007/s000490050052; Convey P, 1997, J THERM BIOL, V22, P429, DOI 10.1016/S0306-4565(97)00062-4; Dell R. K., 1964, Transactions of the Royal Society of New Zealand Zoology, V4, P167; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; FOURNIE J, 1984, AM ZOOL, V24, P857; Frenot Y, 2005, BIOL REV, V80, P45, DOI 10.1017/S1464793104006542; Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011; GOODFRIEND GA, 1986, SYST ZOOL, V35, P204, DOI 10.2307/2413431; Guillaume D, 2004, CLAY MINER, V39, P17, DOI 10.1180/0009855043910117; Hausdorf B, 2003, GLOBAL ECOL BIOGEOGR, V12, P389, DOI 10.1046/j.1466-822X.2003.00050.x; Hollander J, 2006, J EVOLUTION BIOL, V19, P1861, DOI 10.1111/j.1420-9101.2006.01171.x; Koster H. M., 1995, Z GEOL WISSENSCHAFT, V23, P287; LEVINS RICHARD, 1968; Lin SH, 2001, EUR J MASS SPECTROM, V7, P131, DOI 10.1255/ejms.398; Madec L, 2007, POLAR BIOL, V30, P1571, DOI 10.1007/s00300-007-0318-7; Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984; MEENAKSHI VR, 1970, COMP BIOCHEM PHYSIOL, V34, P953, DOI 10.1016/0010-406X(70)91018-2; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; PALMER AR, 1981, NATURE, V292, P150, DOI 10.1038/292150a0; Piersma T, 2011, FLEXIBLE PHENOTYPE B, P147; PINES A, 1972, J CHEM PHYS, V56, P1776, DOI 10.1063/1.1677439; POULICEK M, 1991, MALACOLOGIA, V32, P223; Pugh PJA, 2011, ANTARCT SCI, V23, P442, DOI 10.1017/S0954102011000289; Ringli C, 2001, CELL MOL LIFE SCI, V58, P1430, DOI 10.1007/PL00000786; Rundle SD, 2004, P ROY SOC B-BIOL SCI, V271, pS67, DOI 10.1098/rsbl.2003.0106; SMITH VR, 1992, S AFR J BOT, V58, P105, DOI 10.1016/S0254-6299(16)30880-8; SOLEM A, 1968, Proceedings of the Malacological Society of London, V38, P251; SOUTH A, 1992, TERRESTRIAL SLUGS BI; TOMPA AS, 1977, NATURE, V270, P53, DOI 10.1038/270053a0; Urdy S, 2010, J EXP ZOOL PART B, V314B, P303, DOI 10.1002/jez.b.21338; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Watson SA, 2012, GLOBAL CHANGE BIOL, V18, P3026, DOI 10.1111/j.1365-2486.2012.02755.x; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhong YS, 2006, INSECT BIOCHEM MOLEC, V36, P99, DOI 10.1016/j.ibmb.2005.07.005	46	16	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84527	10.1371/journal.pone.0084527	http://dx.doi.org/10.1371/journal.pone.0084527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376821	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100173
J	Favreau, FR; Pays, O; Goldizen, AW; Fritz, H				Favreau, Francois-Rene; Pays, Olivier; Goldizen, Anne W.; Fritz, Herve			Short-Term Behavioural Responses of Impalas in Simulated Antipredator and Social Contexts	PLOS ONE			English	Article							PREDATION RISK; VIGILANCE BEHAVIOR; GROUP-SIZE; LIONS; PERCEPTION; HERBIVORES; DECISIONS; CHEETAHS; COSTS; RATES	Prey animals often have to trade off foraging against vigilance. However, vigilance is costly and individuals are expected to adjust their vigilance and its cost in relation to social cues and their predation risk, To test this, we conducted playback experiments in the field to study how lions' (Panthera leo) roars and male impalas (Aepyceros lampus) territorial vocalizations affected the vigilance and foraging behaviours as well as movements of female impalas. Our results show that impalas adjusted their activities in different ways depending on the vocalizations broadcast. After lions' roars were played, female impalas increased their vigilance activity (in particular increasing heir high-cost vigilance vigilance without chewing), decreased their bite rates and increased their movements, hereas male impalas' vocalizations caused females to decrease their vigilance (decreasing their low-cost vigilance vigilance while chewing) and increase their movements without affecting their bite rates. Therefore, it appears that predators' vocalizations stimulate anti-predator behaviours such as vigilance and movement at the expense of oraging, whereas males' vocalizations increase individuals' displacements at the expense of vigilance. Overall, this udy shows that both predator and social cues have direct effects on the behaviour of gregarious prey and need to be considered in future studies.	[Favreau, Francois-Rene; Goldizen, Anne W.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Favreau, Francois-Rene; Fritz, Herve] Univ Lyon 1, UMR CNRS 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Favreau, Francois-Rene; Pays, Olivier] Univ Angers, Grp Ecol & Conservat, Angers, France; [Pays, Olivier; Fritz, Herve] Hwange Natl Pk, CNRS HERD Project, Hwange, Zimbabwe	University of Queensland; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Universite d'Angers	Pays, O (corresponding author), Univ Angers, Grp Ecol & Conservat, Angers, France.	olivier.pays@univ-angers.fr	Fritz, Herve/D-1729-2014; Goldizen, Anne/G-7366-2012	Fritz, Herve/0000-0002-7106-3661; Goldizen, Anne/0000-0003-0101-4108	French "Ministere des Affaires Etrangeres"; Ambassade de France au Zimbabwe; CIRAD; CNRS; Agence National de la Recherche [ANR-08-BLAN-0022]	French "Ministere des Affaires Etrangeres"; Ambassade de France au Zimbabwe; CIRAD; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche(French National Research Agency (ANR))	This study has been part of the HERD project (Hwange Environmental Research Development(http:/www.za-hwange.org/)), funded by the French "Ministere des Affaires Etrangeres" (www.diplomatie.gouv.fr/), the "Ambassade de France au Zimbabwe" (http://www.ambafrance-zw.org/), the CIRAD (www.cirad.fr/), the CNRS (www.cnrs.fr/) and the Agence National de la Recherche (www.agence-nationale-recherche.fr/): FEAR project (ANR-08-BLAN-0022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekoff M, 1995, BEHAV PROCESS, V35, P225, DOI 10.1016/0376-6357(95)00050-X; Blanchard P, 2007, OIKOS, V116, P1603, DOI 10.1111/j.2007.0030-1299.15799.x; Blumstein DT, 2008, BEHAV ECOL SOCIOBIOL, V62, P457, DOI 10.1007/s00265-007-0473-4; Bousquet CAH, 2011, P ROY SOC B-BIOL SCI, V278, P1482, DOI 10.1098/rspb.2010.1739; Bro-Jorgensen J, 2010, AM NAT, V176, pE33, DOI 10.1086/653078; Brown JS, 1999, EVOL ECOL RES, V1, P49; Caro TM, 2004, ANIM BEHAV, V67, P205, DOI 10.1016/j.anbehav.2002.12.007; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; Dasmann R. F., 1962, Journal of Mammalogy, V43, P375, DOI 10.2307/1376947; Di Blanco Y, 2006, BEHAV ECOL SOCIOBIOL, V61, P173, DOI 10.1007/s00265-006-0248-3; Durant SM, 2000, BEHAV ECOL, V11, P624, DOI 10.1093/beheco/11.6.624; Favreau FR, 2010, P ROY SOC B-BIOL SCI, V277, P2089, DOI 10.1098/rspb.2009.2337; Fernandez-Juricic E, 2004, TRENDS ECOL EVOL, V19, P25, DOI 10.1016/j.tree.2003.10.003; FITZGIBBON CD, 1990, ANIM BEHAV, V40, P837, DOI 10.1016/S0003-3472(05)80984-4; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Gil-da-Costa R, 2003, P ROY SOC B-BIOL SCI, V270, P605, DOI 10.1098/rspb.2002.2281; GRINNELL J, 1995, ANIM BEHAV, V49, P95, DOI 10.1016/0003-3472(95)80157-X; Grinnell J, 1996, BEHAV ECOL, V7, P55, DOI 10.1093/beheco/7.1.55; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; ILLIUS AW, 1994, ANIM BEHAV, V47, P481, DOI 10.1006/anbe.1994.1067; JARMAN M V, 1973, East African Wildlife Journal, V11, P75; Jarman MV, 1979, FORTSCHR VERHALTENSF, V21, P1; JARMAN P J, 1973, East African Wildlife Journal, V11, P329; Kitchen DM, 2010, ANIM COGN, V13, P861, DOI 10.1007/s10071-010-0334-9; Lea AJ, 2008, BEHAV ECOL, V19, P1041, DOI 10.1093/beheco/arn064; LEUTHOLD W, 1970, Zeitschrift fuer Tierpsychologie, V27, P693; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lingle S, 2001, ETHOLOGY, V107, P295, DOI 10.1046/j.1439-0310.2001.00664.x; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; Mooring MS, 2004, J WILDLIFE MANAGE, V68, P519, DOI 10.2193/0022-541X(2004)068[0519:VPRATA]2.0.CO;2; MURRAY MG, 1982, Z TIERPSYCHOL, V59, P319; Okello MM, 2002, S AFR J WILDL RES, V32, P93; Oliver CM, 2005, THESIS U PRETORIA PR; Pays O, 2012, OECOLOGIA, V169, P419, DOI 10.1007/s00442-011-2218-3; Pays O, 2009, BEHAV ECOL, V20, P469, DOI 10.1093/beheco/arp019; Periquet S, 2010, ANIM BEHAV, V79, P665, DOI 10.1016/j.anbehav.2009.12.016; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; SCHENKEL RUDOLF, 1966, EAST AFB WILDLIFE J, V4, P99; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Smith AS, 2009, AM J PRIMATOL, V71, P324, DOI 10.1002/ajp.20656; SPALINGER DE, 1992, AM NAT, V140, P325, DOI 10.1086/285415; STANDER P E, 1988, Madoqua, V15, P315; Tchabovsky AV, 2001, ANIM BEHAV, V62, P965, DOI 10.1006/anbe.2001.1833; Townsend SW, 2012, BIOL LETTERS, V8, P179, DOI 10.1098/rsbl.2011.0844; UNDERWOOD R, 1982, BEHAVIOUR, V79, P81, DOI 10.1163/156853982X00193; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Wilmshurst JE, 1999, ECOLOGY, V80, P2338, DOI 10.1890/0012-9658(1999)080[2338:WCDIIT]2.0.CO;2	52	17	17	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84970	10.1371/journal.pone.0084970	http://dx.doi.org/10.1371/journal.pone.0084970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376859	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100194
J	Gous, N; Scott, L; Potgieter, J; Ntabeni, L; Enslin, S; Newman, R; Stevens, W				Gous, Natasha; Scott, Lesley; Potgieter, Joachim; Ntabeni, Lumka; Enslin, Sharon; Newman, Ronel; Stevens, Wendy			Feasibility of Performing Multiple Point of Care Testing for HIV Anti-Retroviral Treatment Initiation and Monitoring from Multiple or Single Fingersticks	PLOS ONE			English	Article							SOUTH-AFRICA; CD4 ANALYZER; CLINICS; DIAGNOSIS; THERAPY; PROGRAM; LINKAGE; SITES; BLOOD	Background: Point of Care testing (POCT) provides on-site, rapid, accessible results. With current South African anti-retroviral treatment guidelines, up to 4 fingersticks /patient/clinic visit could be required if utilizing POC. We determined the feasibility and accuracy of a nurse performing multiple POCT on multiple fingersticks followed by simplification of the process by performance of multiple POC on a single fingerstick. Method and Findings: Random HIV positive adult patients presenting at a HIV treatment clinic in South Africa, for ART initiation/ monitoring, were approached to participate in the study between April-June 2012. Phase I: n=150 patients approached for multiple POCT on multiple fingersticks. Phase II: n=150 patients approached for multiple POCT on a single fingerstick. The following POC tests were performed by a dedicated nurse: PIMA (CD4), HemoCue (hemoglobin), Reflotron (alanine aminotransferase, creatinine). A venepuncture specimen was taken for predicate laboratory methodology. Normal laboratory ranges and Royal College of Pathologists Australasia (RCPA) allowable differences were used as guidelines for comparison. In 67% of participants, tests were requested per visit. All POCT were accurate but ranged in variability. Phase I: Hemoglobin was accurate (3.2%CV) while CD4, alanine aminotransferase and creatinine showed increased variability (16.3%CV; 9.3c/oCV; 12.9%CV respectively). PIMA generated a misclassification of 12.4%. Phase II: Hemoglobin, alanine aminotransferase and creatinine showed good accuracy (3.2%CV, 8.7%CV, 6.4%CV respectively) with increased variability on CD4 (12.4%CV) but low clinical misclassification (4.1%). No trends were observed for the sequence in which POC was performed on a single fingerstick. Overall, PIMA CD4 generated the highest error rate (16-19%). Conclusions: Multiple POCT for ART initiation and/or monitoring can be performed practically by a dedicated nurse on multiple fingersticks. The process is as accurate as predicate methodology and can be simplified using a single fingerstick.	[Gous, Natasha; Scott, Lesley; Stevens, Wendy] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Mol Med & Haematol, Johannesburg, South Africa; [Potgieter, Joachim; Ntabeni, Lumka; Enslin, Sharon; Newman, Ronel] Tshwane Acad Div, Dept Haematol, Pretoria, South Africa; [Potgieter, Joachim; Ntabeni, Lumka; Enslin, Sharon; Newman, Ronel] Univ Pretoria, ZA-0002 Pretoria, South Africa; [Potgieter, Joachim; Ntabeni, Lumka; Enslin, Sharon; Newman, Ronel; Stevens, Wendy] Natl Hlth Lab Serv, Johannesburg, South Africa	University of Witwatersrand; Tshwane University of Technology; University of Pretoria; National Health Laboratory Service	Gous, N (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Mol Med & Haematol, Johannesburg, South Africa.	natasha.gous@gmail.com	Potgieter, Joachim JC/AAA-2963-2022	Potgieter, Joachim JC/0000-0001-5366-6744; Scott, Lesley/0000-0001-6573-9525	Grand Challenges Canada [0007-02-01-01]; American people through the United States Agency for International Development [PEPFAR] [674-A-00-08-0005-00]; National Health Laboratory Services, South Africa	Grand Challenges Canada(CGIAR); American people through the United States Agency for International Development [PEPFAR](United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Health Laboratory Services, South Africa	This work was supported by Grand Challenges Canada [Grant number 0007-02-01-01]. Additional staff and logistical support was provided by the American people through the United States Agency for International Development [PEPFAR grant number 674-A-00-08-0005-00] and the National Health Laboratory Services, South Africa. The contents are the responsibility of the authors and do not necessarily reflect the views of United States Agency for International Development or the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alere Inc, 2010, TRAIN PIMA MAN FING; [Anonymous], 2008, MAP DECL STRENGTH LA; Begg K, ANAL POCT VCT PERFOR; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Cvitkovic M, 2011, CRIT CARE NURS Q, V34, P116, DOI 10.1097/CNQ.0b013e31820f6f0a; Denny TN, 2008, CYTOM PART B-CLIN CY, V74B, pS52, DOI 10.1002/cyto.b.20417; Department of Health, NAT STRAT PLAN HIV S; Diaw PA, 2011, ACQUIR IMMUNE DEFIC, V58, pe103, DOI [10.1097/QAI.0b013e318235b378, DOI 10.1097/QAI.0B013E318235B378]; Gehring H, 2002, ACTA ANAESTH SCAND, V46, P980, DOI 10.1034/j.1399-6576.2002.460809.x; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Gounden V, 2012, CLIN LAB, V58, P27; Hollis VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043702; Jacobs E, 2001, CLIN CHIM ACTA, V307, P49, DOI 10.1016/S0009-8981(01)00432-6; Jaeger M, 1996, CAN J ANAESTH, V43, P795, DOI 10.1007/BF03013031; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kilgore ML, 1998, CLIN CHEM, V44, P1597; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Lippi G, 2006, CLIN CHEM LAB MED, V44, P311, DOI 10.1515/CCLM.2006.054; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Massimo Corporation, 2009, MASS CORP TECHN B; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Nkengasong JN, 2010, AM J CLIN PATHOL, V134, P359, DOI 10.1309/AJCPY5ASUEJYQ5RK; Patton JC, 2007, CLIN VACCINE IMMUNOL, V14, P201, DOI 10.1128/CVI.00223-06; Pronyk PM, 2002, AIDS CARE, V14, P859, DOI 10.1080/0954012021000031921; Roche Diagnostics, ROCH ACC CHEK LANC D; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Shephard Mark Ds, 2011, Clin Biochem Rev, V32, P109; South African National Department of Health, 2011, PROV GUID IMPL 3 STR; South African National Department of Health, 2010, S AFR ANT TREATM GUI; SUKAPIROM K, 2011, ACQUIR IMMUNE DEFIC, V58, P141, DOI DOI 10.1097/QAI.0B013E31822866A2; Summit Health, HLTH SCREEN FING VEN; The Centre for the Study of AIDS, 2013, S AFR FIGHT HIV STAC; UNAIDS, 2013, UNAIDS REP MOR 7 MIL; World Health Organization, 2012, WHO PREQ DIAGN PROGR	37	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85265	10.1371/journal.pone.0085265	http://dx.doi.org/10.1371/journal.pone.0085265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376873	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100199
J	Gruhn, JR; Rubio, C; Broman, KW; Hunt, PA; Hassold, T				Gruhn, Jennifer R.; Rubio, Carmen; Broman, Karl W.; Hunt, Patricia A.; Hassold, Terry			Cytological Studies of Human Meiosis: Sex-Specific Differences in Recombination Originate at, or Prior to, Establishment of Double-Strand Breaks	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX LENGTH; DNA METHYLATION; CROSSING-OVER; MEIOTIC RECOMBINATION; GENETIC-MAP; MLH1; INITIATION; LANDSCAPE; CROSSOVER; RNF212	Meiotic recombination is sexually dimorphic in most mammalian species, including humans, but the basis for the male:female differences remains unclear. In the present study, we used cytological methodology to directly compare recombination levels between human males and females, and to examine possible sex-specific differences in upstream events of double-strand break (DSB) formation and synaptic initiation. Specifically, we utilized the DNA mismatch repair protein MLH1 as a marker of recombination events, the RecA homologue RAD51 as a surrogate for DSBs, and the synaptonemal complex proteins SYCP3 and/or SYCP1 to examine synapsis between homologs. Consistent with linkage studies, genome-wide recombination levels were higher in females than in males, and the placement of exchanges varied between the sexes. Subsequent analyses of DSBs and synaptic initiation sites indicated similar male:female differences, providing strong evidence that sex-specific differences in recombination rates are established at or before the formation of meiotic DSBs. We then asked whether these differences might be linked to variation in the organization of the meiotic axis and/or axis-associated DNA and, indeed, we observed 'king male:female differences in synaptonemal complex (SC) length and DNA loop size. Taken together, our observations suggest that sex specific differences in recombination in humans may derive from chromatin differences established prior to the onset of the recombination pathway.	[Gruhn, Jennifer R.; Hunt, Patricia A.; Hassold, Terry] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Gruhn, Jennifer R.; Hunt, Patricia A.; Hassold, Terry] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Rubio, Carmen] Iviomics, Preimplantat Genet Diag Unit, Valencia, Spain; [Broman, Karl W.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	Washington State University; Washington State University; University of Wisconsin System; University of Wisconsin Madison	Hassold, T (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	terryhassold@vetmed.wsu.edu	Gruhn, Jennifer/AAE-9439-2020; Rubio, Carmen/D-7753-2018	Gruhn, Jennifer/0000-0002-4093-142X; Broman, Karl/0000-0002-4914-6671	NIH [HD21341, E5013527]; NIH training grant awarded to the School of Molecular Biosciences at Washington State University [GM083864]; Institut de Salud Carlos III (Spain) [PS09/01725]; European Union through the European Regional Development Fund "A way to make Europe"; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD021341] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083864] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant awarded to the School of Molecular Biosciences at Washington State University; Institut de Salud Carlos III (Spain)(Instituto de Salud Carlos III); European Union through the European Regional Development Fund "A way to make Europe"; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants HD21341 (to TH), E5013527 (to PH), and an NIH training grant awarded to the School of Molecular Biosciences at Washington State University (GM083864 to JG). Additional support for human male collections was financed by the Institut de Salud Carlos III (Spain; PS09/01725) and the European Union through the European Regional Development Fund "A way to make Europe" (to CR). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Anderson LK, 1999, GENETICS, V151, P1569; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Barlow AL, 1997, EMBO J, V16, P5207, DOI 10.1093/emboj/16.17.5207; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brown PW, 2005, AM J HUM GENET, V77, P556, DOI 10.1086/468188; Cheng EY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000661; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Codina-Pascual M, 2006, MOL HUM REPROD, V12, P123, DOI 10.1093/molehr/gal007; Colome-Tatche M, 2012, P NATL ACAD SCI USA, V109, P16240, DOI 10.1073/pnas.1212955109; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; de los Santos T, 2003, GENETICS, V164, P81; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Gonsalves J, 2004, HUM MOL GENET, V13, P2875, DOI 10.1093/hmg/ddh302; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hall HE, 2007, AM J MED GENET A, V143A, P2242, DOI 10.1002/ajmg.a.31913; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2004, CYTOGENET GENOME RES, V107, P249, DOI 10.1159/000080602; HASSOLD T, 1995, AM J HUM GENET, V57, P867; Hassold T, 1996, ENVIRON MOL MUTAGEN, V28, P167; Hassold T, 2000, CLIN GENET, V57, P95, DOI 10.1034/j.1399-0004.2000.570201.x; Hassold T, 2009, CYTOGENET GENOME RES, V124, P132, DOI 10.1159/000207519; HASSOLD TJ, 1986, TRENDS GENET, V2, P105, DOI 10.1016/0168-9525(86)90194-0; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Hunt PA, 2012, P NATL ACAD SCI USA, V109, P17525, DOI 10.1073/pnas.1207854109; Jorgenson E, 2005, AM J HUM GENET, V76, P276, DOI 10.1086/427926; Ju YS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-554; Kelly TLJ, 2004, CLIN GENET, V65, P247, DOI 10.1111/j.0009-9163.2004.00236.x; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Lynn A, 2004, ANNU REV GENOM HUM G, V5, P317, DOI 10.1146/annurev.genom.4.070802.110217; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Maloisel L, 1998, GENE DEV, V12, P1381, DOI 10.1101/gad.12.9.1381; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; Melamed-Bessudo C, 2012, P NATL ACAD SCI USA, V109, pE981, DOI 10.1073/pnas.1120742109; Mirouze M, 2012, P NATL ACAD SCI USA, V109, P5880, DOI 10.1073/pnas.1120841109; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Novak I, 2008, J CELL BIOL, V180, P83, DOI 10.1083/jcb.200706136; Oliver-Bonet M, 2005, MOL HUM REPROD, V11, P517, DOI 10.1093/molehr/gah193; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Reeves A., 2000, MICROMEASURE WINDOWS; Reynolds A, 2013, NAT GENET, V45, P269, DOI 10.1038/ng.2541; Ross LO, 1996, P NATL ACAD SCI USA, V93, P4979, DOI 10.1073/pnas.93.10.4979; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Sun F, 2008, HUM REPROD, V23, P1691, DOI 10.1093/humrep/den027; Sun F, 2006, HUM MOL GENET, V15, P2376, DOI 10.1093/hmg/ddl162; Tanneti NS, 2011, CURR BIOL, V21, P1852, DOI 10.1016/j.cub.2011.10.005; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; Topping D, 2006, HUM REPROD, V21, P3171, DOI 10.1093/humrep/del281; VONWETTSTEIN D, 1984, ANNU REV GENET, V18, P331, DOI 10.1146/annurev.ge.18.120184.001555; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yelina NE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002844; ZICKLER D, 1992, GENETICS, V132, P135	62	73	73	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85075	10.1371/journal.pone.0085075	http://dx.doi.org/10.1371/journal.pone.0085075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376867	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100196
J	Okamoto, KW; Robert, MA; Lloyd, AL; Gould, F				Okamoto, Kenichi W.; Robert, Michael A.; Lloyd, Alun L.; Gould, Fred			A Reduce and Replace Strategy for Suppressing Vector-Borne Diseases: Insights from a Stochastic, Spatial Model	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; LIFE TABLE MODEL; CULICIDAE PRODUCTION; GENETIC-CONTROL; DENGUE VECTOR; POPULATION; DISPERSAL; WOLBACHIA; IQUITOS; SYSTEMS	Two basic strategies have been proposed for using transgenic Aedes aegypti mosquitoes to decrease dengue virus transmission: population reduction and population replacement. Here we model releases of a strain of Ae. aegypti carrying both a gene causing conditional adult female mortality and a gene blocking virus transmission into a wild population to assess whether such releases could reduce the number of competent vectors. We find this "reduce and replace" strategy can decrease the frequency of competent vectors below 50% two years after releases end. Therefore, this combined approach appears preferable to releasing a strain carrying only a female-killing gene, which is likely to merely result in temporary population suppression. However, the fixation of anti-pathogen genes in the population is unlikely. Genetic drift at small population sizes and the spatially heterogeneous nature of the population recovery after releases end prevent complete replacement of the competent vector population. Furthermore, releasing more individuals can be counterproductive in the face of immigration by wild-type mosquitoes, as greater population reduction amplifies the impact wildtype migrants have on the long-term frequency of the anti-pathogen gene. We expect the results presented here to give pause to expectations for driving an anti-pathogen construct to fixation by relying on releasing individuals carrying this two-gene construct. Nevertheless, in some dengue-endemic environments, a spatially heterogeneous decrease in competent vectors may still facilitate decreasing disease incidence.	[Okamoto, Kenichi W.; Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Robert, Michael A.; Lloyd, Alun L.] N Carolina State Univ, Dept Math, Raleigh, NC 27695 USA; [Robert, Michael A.; Lloyd, Alun L.] N Carolina State Univ, Biomath Grad Program, Raleigh, NC 27695 USA; [Lloyd, Alun L.; Gould, Fred] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Okamoto, KW (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	kenichi_okamoto@ncsu.edu	Okamoto, Kenichi/AAA-3763-2021; Lloyd, Alun/AAN-6639-2020; Lloyd, Alun L/H-4944-2012	Okamoto, Kenichi/0000-0002-1889-4538; Lloyd, Alun/0000-0002-6389-6321; Robert, Michael/0000-0003-3705-0952	National Institutes of Health (NIH) [R01AI091980-01A1]; Foundation for the NIH through the Bill and Melinda Gates Foundation Grand Challenges in Global Health initiative; University of Pretoria North Carolina State University Strategic Collaboration Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091980] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH through the Bill and Melinda Gates Foundation Grand Challenges in Global Health initiative; University of Pretoria North Carolina State University Strategic Collaboration Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded in part by National Institutes of Health (NIH) grant R01AI091980-01A1, a grant to the Regents of the University of California from the Foundation for the NIH through the Bill and Melinda Gates Foundation Grand Challenges in Global Health initiative, and in part by a University of Pretoria North Carolina State University Strategic Collaboration Seed Grant (to A. L. Lloyd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Eappen G., 2007, Entomological Research, V37, P213, DOI 10.1111/j.1748-5967.2007.00117.x; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Bargielowski I, 2012, VECTOR-BORNE ZOONOT, V12, P1053, DOI 10.1089/vbz.2012.0994; Berens C, 2003, EUR J BIOCHEM, V270, P3109, DOI 10.1046/j.1432-1033.2003.03694.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chopard B., 1998, CELLULAR AUTOMATA MO; DIETZ K, 1976, THEOR POPUL BIOL, V9, P58, DOI 10.1016/0040-5809(76)90035-6; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Fujita Y., 2005, JBICI REV, V11, P59; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; GILPIN ME, 1979, FORTS ZOOL, V25, P355; Gould F, 2006, AM SCI, V94, P238, DOI 10.1511/2006.3.238; Hancock PA, 2012, J R SOC INTERFACE, V9, P3045, DOI 10.1098/rsif.2012.0253; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Huang YX, 2011, EVOL APPL, V4, P415, DOI 10.1111/j.1752-4571.2010.00153.x; Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771; Legros M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052235; Legros M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022701; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; Morrison AC, 2006, ANN TROP MED PARASIT, V100, pS73, DOI 10.1179/136485906X105534; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; PROUT T, 1978, THEOR POPUL BIOL, V13, P40, DOI 10.1016/0040-5809(78)90035-7; Rasgon JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005833; Robert MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073233; Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Valerio L, 2012, AM J TROP MED HYG, V86, P665, DOI 10.4269/ajtmh.2012.11-0513; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; WEIDHAAS DE, 1971, MOSQ NEWS, V31, P177; Xu CG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000830; Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x; Yakob L, 2009, J ECON ENTOMOL, V102, P50, DOI 10.1603/029.102.0108	39	20	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e81860	10.1371/journal.pone.0081860	http://dx.doi.org/10.1371/journal.pone.0081860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376506	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100010
J	Schneider, DI; Riegler, M; Arthofer, W; Mercot, H; Stauffer, C; Miller, WJ				Schneider, Daniela I.; Riegler, Markus; Arthofer, Wolfgang; Mercot, Herve; Stauffer, Christian; Miller, Wolfgang J.			Uncovering Wolbachia Diversity upon Artificial Host Transfer	PLOS ONE			English	Article							INDUCED CYTOPLASMIC INCOMPATIBILITY; RHAGOLETIS-CERASI DIPTERA; LIFE-SHORTENING WOLBACHIA; CHERRY FRUIT-FLY; BIDIRECTIONAL INCOMPATIBILITY; EVOLUTIONARY DYNAMICS; INSERTION SEQUENCES; GENOME SEQUENCE; TSETSE-FLIES; DROSOPHILA	The common endosymbiotic Wolbachia bacteria influence arthropod hosts in multiple ways. They are mostly recognized for their manipulations of host reproduction, yet, more recent studies demonstrate that Wolbachia also impact host behavior, metabolic pathways and immunity. Besides their biological and evolutionary roles Wolbachia are new potential biological control agents for pest and vector management. Importantly, Wolbachia-based control strategies require controlled symbiont transfer between host species and predictable outcomes of novel Wolbachia-host associations. Theoretically, this artificial horizontal transfer could inflict genetic changes within transferred Wolbachia populations. This could be facilitated through de novo mutations in the novel recipient host or changes of haplotype frequencies of polymorphic Wolbachia populations when transferred from donor to recipient hosts. Here we show that Wolbachia resident in the European cherry fruit fly, Rhagoletis cerasi, exhibit ancestral and cryptic sequence polymorphism in three symbiont genes, which are exposed upon microinjection into the new hosts Drosophila simulans and Ceratitis capitata. Our analyses of Wolbachia in microinjected D. simulans over 150 generations after microinjection uncovered infections with multiple Wolbachia strains in trans-infected lines that had previously been typed as single infections. This confirms the persistence of low-titer Wolbachia strains in microinjection experiments that had previously escaped standard detection techniques. Our study demonstrates that infections by multiple Wolbachia strains can shift in prevalence after artificial host transfer driven by either stochastic or selective processes. Trans-infection of Wolbachia can claim fitness costs in new hosts and we speculate that these costs may have driven the shifts of Wolbachia strains that we saw in our model system.	[Schneider, Daniela I.; Miller, Wolfgang J.] Med Univ Vienna, Dept Cell & Dev Biol, Labs Genome Dynam, Vienna, Austria; [Riegler, Markus] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia; [Arthofer, Wolfgang] Univ Innsbruck, Inst Ecol, Mol Ecol Grp, A-6020 Innsbruck, Austria; [Mercot, Herve] Univ Paris 06, CNRS, UMR 7138, Paris, France; [Stauffer, Christian] Univ Nat Resources & Life Sci, Dept Forest & Soil Sci, Inst Forest Entomol Forest Pathol & Forest Protec, Vienna, Austria	Medical University of Vienna; Western Sydney University; University of Innsbruck; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Natural Resources & Life Sciences, Vienna	Miller, WJ (corresponding author), Med Univ Vienna, Dept Cell & Dev Biol, Labs Genome Dynam, Vienna, Austria.	wolfgang.miller@meduniwien.ac.at	Miller, Wolfgang J/E-5716-2015	Miller, Wolfgang J/0000-0002-5044-6276; Schneider, Daniela/0000-0002-7740-8827; Riegler, Markus/0000-0001-7363-431X	Austrian Science Fund [FWF P19206-B17, P22634-B17]; EU-COST Action [FA0701]; Austrian Science Fund (FWF) [P 22634] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); EU-COST Action(European Cooperation in Science and Technology (COST)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	WJM and DS were partly supported by the research grant FWF P19206-B17 and P22634-B17 from the Austrian Science Fund and the EU-COST Action FA0701 "Arthropod Symbiosis: From Fundamental Studies to Pest and Disease Management". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthofer W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022198; Arthofer W, 2009, ENVIRON MICROBIOL, V11, P1923, DOI 10.1111/j.1462-2920.2009.01914.x; Arthofer W, 2009, MOL ECOL, V18, P3816, DOI 10.1111/j.1365-294X.2009.04321.x; Augustinos AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028695; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Ben Ami E, 2010, ISME J, V4, P28, DOI 10.1038/ismej.2009.82; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bordenstein SR, 2007, HEREDITY, V99, P278, DOI 10.1038/sj.hdy.6800994; Bourtzis K, 2008, ADV EXP MED BIOL, V627, P104, DOI 10.1007/978-0-387-78225-6_9; Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38; Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368; Casper-Lindley C, 2011, APPL ENVIRON MICROB, V77, P4788, DOI 10.1128/AEM.00215-11; Cerveau N, 2011, GENOME BIOL EVOL, V3, P1175, DOI 10.1093/gbe/evr096; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Cordaux R, 2008, MOL BIOL EVOL, V25, P1889, DOI 10.1093/molbev/msn134; Dobson SL, 2001, J MED ENTOMOL, V38, P382, DOI 10.1603/0022-2585-38.3.382; Doudoumis V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S3; Duplouy A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-20; Ellegaard KM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003381; GAREN A, 1968, SCIENCE, V160, P149, DOI 10.1126/science.160.3824.149; GILMORE RA, 1971, J MOL BIOL, V61, P157, DOI 10.1016/0022-2836(71)90213-0; GOODMAN HM, 1968, NATURE, V217, P1019, DOI 10.1038/2171019a0; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Helinski MEH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S6; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; HOFFMANN AA, 1990, GENETICS, V126, P933; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; Jaenike J, 2007, EVOLUTION, V61, P2244, DOI 10.1111/j.1558-5646.2007.00180.x; Jamnongluk W, 2002, CURR MICROBIOL, V45, P255, DOI 10.1007/s00284-002-3746-1; Junakovic N, 2004, METH MOL B, V260, P41, DOI 10.1385/1-59259-755-6:041; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; King R. C., 1970, OVARIAN DEV DROSOPHI; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Koukou K, 2006, EVOLUTION, V60, P87, DOI 10.1111/j.0014-3820.2006.tb01084.x; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Masui S, 1999, PLASMID, V42, P13, DOI 10.1006/plas.1999.1407; Mavingui P, 2012, J BACTERIOL, V194, P1840, DOI 10.1128/JB.00036-12; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; MERCOT H, 1995, GENETICS, V141, P1015; Miller WJ, 2006, APPL ENVIRON MICROB, V72, P826, DOI 10.1128/AEM.72.1.826-835.2006; Miller WJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001214; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mouton L, 2003, MOL ECOL, V12, P3459, DOI 10.1046/j.1365-294X.2003.02015.x; ONEILL SL, 1990, NATURE, V348, P178, DOI 10.1038/348178a0; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; OSAWA S, 1989, J MOL EVOL, V28, P271, DOI 10.1007/BF02103422; Pecoraro V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016392; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Poinsot D, 1998, GENETICS, V150, P227; Richardson MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003129; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Riegler M, 2004, APPL ENVIRON MICROB, V70, P273, DOI 10.1128/AEM.70.1.273-279.2004; Riegler M, 2002, MOL ECOL, V11, P2425, DOI 10.1046/j.1365-294X.2002.01614.x; Rousset F, 1999, HEREDITY, V82, P620, DOI 10.1046/j.1365-2540.1999.00501.x; Schneider DI, 2013, J INVERTEBR PATHOL, V112, pS104, DOI 10.1016/j.jip.2012.03.024; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Starr DJ, 2002, NATURE, V418, P76, DOI 10.1038/nature00843; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Suh E, 2009, APPL ENVIRON MICROB, V75, P7783, DOI 10.1128/AEM.01331-09; Symula RE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-31; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tobiason DM, 2006, PLOS BIOL, V4, P1069, DOI 10.1371/journal.pbio.0040185; Van Borm S, 2003, MOL PHYLOGENET EVOL, V26, P102, DOI 10.1016/S1055-7903(02)00298-1; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488	86	51	51	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82402	10.1371/journal.pone.0082402	http://dx.doi.org/10.1371/journal.pone.0082402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376534	Green Published, gold			2022-12-27	WOS:000328745100031
J	Zou, Y; Sang, WG; Bai, F; Axmacher, JC				Zou, Yi; Sang, Weiguo; Bai, Fan; Axmacher, Jan Christoph			Relationships between Plant Diversity and the Abundance and alpha-Diversity of Predatory Ground Beetles (Coleoptera: Carabidae) in a Mature Asian Temperate Forest Ecosystem	PLOS ONE			English	Article							SPECIES-DIVERSITY; LEAF-LITTER; MULTITROPHIC INTERACTIONS; AGRICULTURAL LANDSCAPE; VEGETATIONAL DIVERSITY; INVERTEBRATE HERBIVORY; ENEMIES HYPOTHESIS; GEOMETRID MOTHS; NORTHERN CHINA; PITFALL TRAPS	A positive relationship between plant diversity and both abundance and diversity of predatory arthropods is postulated by the Enemies Hypothesis, a central ecological top-down control hypothesis. It has been supported by experimental studies and investigations of agricultural and grassland ecosystems, while evidence from more complex mature forest ecosystems is limited. Our study was conducted on Changbai Mountain in one of the last remaining large pristine temperate forest environments in China. We used predatory ground beetles (Coleoptera: Carabidae) as target taxon to establish the relationship between phytodiversity and their activity abundance and diversity. Results showed that elevation was the only variable included in both models predicting carabid activity abundance and alpha-diversity. Shrub diversity was negatively and herb diversity positively correlated with beetle abundance, while shrub diversity was positively correlated with beetle alpha-diversity. Within the different forest types, a negative relationship between plant diversity and carabid activity abundance was observed, which stands in direct contrast to the Enemies Hypothesis. Furthermore, plant species density did not predict carabid alpha-diversity. In addition, the density of herbs, which is commonly believed to influence carabid movement, had little impact on the beetle activity abundance recorded on Changbai Mountain. Our study indicates that in a relatively large and heterogeneous mature forest area, relationships between plant and carabid diversity are driven by variations in environmental factors linked with altitudinal change. In addition, traditional top-down control theories that are suitable in explaining diversity patterns in ecosystems of low diversity appear to play a much less pronounced role in highly complex forest ecosystems.	[Zou, Yi; Axmacher, Jan Christoph] UCL, UCL Dept Geog, London, England; [Sang, Weiguo; Bai, Fan] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Sang, Weiguo] Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China	University of London; University College London; Chinese Academy of Sciences; Institute of Botany, CAS; Minzu University of China	Sang, WG (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	swg@ibcas.ac.cn; jan.axmacher@web.de	Zou, Yi/AAH-1226-2021; Axmacher, Jan/C-4412-2008	Zou, Yi/0000-0002-7082-9258; Axmacher, Jan/0000-0003-1406-928X	National Natural Science Foundation of China [31270478]; '111 Program' of the Bureau of China Foreign Experts; Ministry of Education [2008-B08044]; Chinese Academy of Science [2011T2S18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); '111 Program' of the Bureau of China Foreign Experts; Ministry of Education; Chinese Academy of Science(Chinese Academy of Sciences)	This research was financially supported by the National Natural Science Foundation of China (31270478), the '111 Program' of the Bureau of China Foreign Experts and the Ministry of Education (2008-B08044) and the Chinese Academy of Science and their Fellowship for International Scientists programme (2011T2S18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbarashan Padmavathy, 2011, International Journal of Agricultural Research, V6, P805, DOI 10.3923/ijar.2011.805.818; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; Axmacher JC, 2011, BIOL CONSERV, V144, P2362, DOI 10.1016/j.biocon.2011.06.016; Axmacher JC, 2009, J BIOGEOGR, V36, P337, DOI 10.1111/j.1365-2699.2008.01997.x; Axmacher JC, 2004, J BIOGEOGR, V31, P895, DOI 10.1111/j.1365-2699.2004.00995.x; Bai F, 2011, FOREST ECOL MANAG, V262, P2052, DOI 10.1016/j.foreco.2011.08.046; Borer ET, 2012, ECOL LETT, V15, P1457, DOI 10.1111/ele.12006; Brehm G, 2003, ECOGRAPHY, V26, P456, DOI 10.1034/j.1600-0587.2003.03498.x; Condon MA, 2008, SCIENCE, V320, P928, DOI 10.1126/science.1155832; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Cuevas-Reyes P, 2003, BIODIVERS CONSERV, V12, P411, DOI 10.1023/A:1022415907109; Davies KF, 1998, J ANIM ECOL, V67, P460, DOI 10.1046/j.1365-2656.1998.00210.x; De Deyn GB, 2007, OIKOS, V116, P923, DOI [10.1111/j.2007.0030-1299.15761.x, 10.1111/j.0030-1299.2007.15761.x]; DESENDER K, 1994, SERIES ENTOM, V51, P247; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Dyer LA, 2010, ECOLOGY, V91, P3707, DOI 10.1890/08-1634.1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GREENSLADE PJM, 1964, J ANIM ECOL, V33, P301, DOI 10.2307/2632; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jactel H, 2005, ECOL STUD-ANAL SYNTH, V176, P235; JANSEN MJW, 1979, ACTA BIOTHEOR, V28, P98, DOI 10.1007/BF00046807; Jonsson M, 2009, ECOGRAPHY, V32, P963, DOI 10.1111/j.1600-0587.2009.05784.x; Koivula M, 1999, ECOGRAPHY, V22, P424, DOI 10.1111/j.1600-0587.1999.tb00579.x; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Kotze DJ, 2011, ZOOKEYS, P55, DOI 10.3897/zookeys.100.1523; Kromp B, 1999, AGR ECOSYST ENVIRON, V74, P187, DOI 10.1016/S0167-8809(99)00037-7; LAMONT BB, 1977, NATURE, V265, P438, DOI 10.1038/265438a0; Lang A, 1999, AGR ECOSYST ENVIRON, V72, P189, DOI 10.1016/S0167-8809(98)00186-8; Li X., 1980, RES FOREST ECOSYSTEM, V1, P193; Liu YH, 2006, AGR ECOSYST ENVIRON, V113, P45, DOI 10.1016/j.agee.2005.08.035; Liu YH, 2012, RESTOR ECOL, V20, P234, DOI 10.1111/j.1526-100X.2010.00755.x; Liu YH, 2010, INSECT CONSERV DIVER, V3, P34, DOI 10.1111/j.1752-4598.2009.00069.x; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; LUFF ML, 1975, OECOLOGIA, V19, P345, DOI 10.1007/BF00348110; Magura T, 2005, BIODIVERS CONSERV, V14, P475, DOI 10.1007/s10531-004-7307-8; MATSON PA, 1992, ECOLOGY, V73, P723, DOI 10.2307/1940151; Melbourne BA, 1999, AUST J ECOL, V24, P228, DOI 10.1046/j.1442-9993.1999.00967.x; MITCHELL B, 1963, J ANIM ECOL, V32, P377, DOI 10.2307/2599; Moreira X, 2012, P ROY SOC B-BIOL SCI, V279, P4464, DOI 10.1098/rspb.2012.0893; Mulder CPH, 1999, ECOL LETT, V2, P237; NIEMALA J, 1992, CAN ENTOMOL, V124, P521, DOI 10.4039/Ent124521-3; Niemela J, 2000, J INSECT CONSERV, V4, P3, DOI 10.1023/A:1009655127440; Novotny V, 2012, AM NAT, V179, P351, DOI 10.1086/664082; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Oliver I, 1996, ECOL APPL, V6, P594, DOI 10.2307/2269394; OLSON DM, 1994, J TROP ECOL, V10, P129, DOI 10.1017/S0266467400007793; Pearce JL, 2003, CAN ENTOMOL, V135, P337; Pearson CV, 2006, J INSECT SCI, V6; Perner J, 2003, ECOGRAPHY, V26, P788, DOI 10.1111/j.0906-7590.2003.03549.x; Pretzsch H., 2005, FOREST DIVERSITY FUN; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Rapoport E. H., 1982, AREOGRAPHY GEOGRAPHI, P269; Riihimaki J, 2005, OECOLOGIA, V142, P90, DOI 10.1007/s00442-004-1696-y; RISCH SJ, 1983, ENVIRON ENTOMOL, V12, P625, DOI 10.1093/ee/12.3.625; Rodriguez-Castaneda G, 2010, ECOL LETT, V13, P1348, DOI 10.1111/j.1461-0248.2010.01525.x; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; RUSSELL EP, 1989, ENVIRON ENTOMOL, V18, P590, DOI 10.1093/ee/18.4.590; Rzanny M, 2012, J ANIM ECOL, V81, P614, DOI 10.1111/j.1365-2656.2012.01951.x; Sang W, 2009, PLANT ECOL, V201, P115; Scherber C, 2006, OECOLOGIA, V147, P489, DOI 10.1007/s00442-005-0281-3; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schuldt A, 2008, BIODIVERS CONSERV, V17, P1267, DOI 10.1007/s10531-008-9330-7; Schuldt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022905; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Siemann E, 1999, ECOGRAPHY, V22, P406, DOI 10.1111/j.1600-0587.1999.tb00577.x; Sobek S, 2009, ECOL ENTOMOL, V34, P772, DOI 10.1111/j.1365-2311.2009.01132.x; SPENCE JR, 1994, CAN ENTOMOL, V126, P881, DOI 10.4039/Ent126881-3; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; SWANK WT, 1981, OECOLOGIA, V51, P297, DOI 10.1007/BF00540897; Thomas CFG, 2006, AGR ECOSYST ENVIRON, V113, P51, DOI 10.1016/j.agee.2005.08.033; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Unsicker SB, 2006, OECOLOGIA, V150, P233, DOI 10.1007/s00442-006-0511-3; Varchola JM, 1999, AGR ECOSYST ENVIRON, V73, P41, DOI 10.1016/S0167-8809(99)00009-2; Vehvilainen H, 2008, OIKOS, V117, P935, DOI 10.1111/j.2008.0030-1299.15972.x; Walker M, 2001, OIKOS, V93, P177, DOI 10.1034/j.1600-0706.2001.930201.x; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; Weisser W.W., 2004, INSECTS ECOSYSTEM FU; Wenninger EJ, 2008, J ARID ENVIRON, V72, P24, DOI 10.1016/j.jaridenv.2007.04.005; Zhang J, 2010, SPAA SPECIS ASS ANAL; Zhang YJ, 2011, J ECOL, V99, P370, DOI 10.1111/j.1365-2745.2010.01770.x; Zou Y, 2013, INSECT CONS IN PRESS	87	26	29	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82792	10.1371/journal.pone.0082792	http://dx.doi.org/10.1371/journal.pone.0082792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376582	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100057
J	Blume-Kohout, ME; Clack, JW				Blume-Kohout, Margaret E.; Clack, John W.			Are Graduate Students Rational? Evidence from the Market for Biomedical Scientists	PLOS ONE			English	Article							SCIENCE; VARIABLES; CAREERS; COLLEGE; SCHOOL; FIELD	The U.S. National Institutes of Health (NIH) budget expansion from 1998 through 2003 increased demand for biomedical research, raising relative wages and total employment in the market for biomedical scientists. However, because research doctorates in biomedical sciences can often take six years or more to complete, the full labor supply response to such changes in market conditions is not immediate, but rather is observed over a period of several years. Economic rational expectations models assume that prospective students anticipate these future changes, and also that students take into account the opportunity costs of their pursuing graduate training. Prior empirical research on student enrollment and degree completions in science and engineering (S&E) fields indicates that "cobweb" expectations prevail: that is, at least in theory, prospective graduate students respond to contemporaneous changes in market wages and employment, but do not forecast further changes that will arise by the time they complete their degrees and enter the labor market. In this article, we analyze time-series data on wages and employment of biomedical scientists versus alternative careers, on completions of S&E bachelor's degrees and biomedical sciences PhDs, and on research expenditures funded both by NIH and by biopharmaceutical firms, to examine the responsiveness of the biomedical sciences labor supply to changes in market conditions. Consistent with previous studies, we find that enrollments and completions in biomedical sciences PhD programs are responsive to market conditions at the time of students' enrollment. More striking, however, is the close correspondence between graduate student enrollments and completions, and changes in availability of NIH-funded traineeships, fellowships, and research assistantships.	[Blume-Kohout, Margaret E.] Univ New Mexico, Robert Wood Johnson Fdn Ctr Hlth Policy, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Econ, Albuquerque, NM 87131 USA	Robert Wood Johnson Foundation (RWJF); University of New Mexico; University of New Mexico	Blume-Kohout, ME (corresponding author), Univ New Mexico, Robert Wood Johnson Fdn Ctr Hlth Policy, Albuquerque, NM 87131 USA.	meg@newmexicoconsortium.org	Blume-Kohout, Margaret/H-7566-2019	Blume-Kohout, Margaret/0000-0002-3236-0030	National Institute of General Medical Sciences of the National Institutes of Health [U01GM099002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM099002] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health, under award number U01GM099002. No individual employed or contracted by NIH/NIGMS, other than the named authors, had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist JD, 2001, J ECON PERSPECT, V15, P69, DOI 10.1257/jep.15.4.69; Bedard K, 2008, ECON EDUC REV, V27, P197, DOI 10.1016/j.econedurev.2006.09.007; Blume-Kohout ME, 2012, SO EC ASS 82 ANN M N; Brotman JS, 2008, J RES SCI TEACH, V45, P971, DOI 10.1002/tea.20241; Bureau of Labor Statistics U.S. Department of Labor, 2007, TECHN NOT 1999 OES E; DURBIN J, 1970, ECONOMETRICA, V38, P410, DOI 10.2307/1909547; Eagan MK, 2010, INVESTING HUMAN CAPI; EHRENBERG RG, 1993, REV ECON STAT, V75, P671, DOI 10.2307/2110021; Fox MF, 2001, SOC STUD SCI, V31, P109, DOI 10.1177/030631201031001006; FREEMAN RB, 1976, IND LABOR RELAT REV, V29, P236, DOI 10.2307/2522143; Garrison HH, 2005, FASEB J, V19, P1938, DOI 10.1096/fj.05-1203ufm; Greene J, 2010, J CHEM EDUC, V87, P381, DOI 10.1021/ed800042z; Husbands Fealing K, 2012, PATHWAYS V PIPELINES, DOI DOI 10.2139/SSRN.2020504.ACCESSED; Levitt DG, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-80; Lorden JF, 2011, RES DOCTORATE PROGRA; Loscalzo J, 2006, NEW ENGL J MED, V354, P1665, DOI 10.1056/NEJMp068050; Mullen AL, 2003, SOCIOL EDUC, V76, P143, DOI 10.2307/3090274; Roach M, 2010, RES POLICY, V39, P422, DOI 10.1016/j.respol.2010.01.004; Ryoo JW, 2004, J POLIT ECON, V112, pS110, DOI 10.1086/379946; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; St John EP, 2005, J HIGH EDUC-UK, V76, P545, DOI 10.1353/jhe.2005.0035; Stephan P., 2012, EC SHAPES SCI; Stephan P, 2012, NATURE, V484, P29, DOI 10.1038/484029a; Taylor JB, 1985, FRONTIERS EC; Teitelbaum MS, 2008, SCIENCE, V321, P644, DOI 10.1126/science.1160272; Tilghman S., 2012, BIOMEDICAL RES WORKF; U.S. Bureau of Economic Analysis, 2010, TABL C CONTR ANN GRO; Whittington KB, 2008, GENDER SOC, V22, P194, DOI 10.1177/0891243207313928	28	8	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82759	10.1371/journal.pone.0082759	http://dx.doi.org/10.1371/journal.pone.0082759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	278IG	24376573	Green Published, gold			2022-12-27	WOS:000328882000027
J	Napolitano, F; Izzo, MT; Di Giuseppe, G; Angelillo, IF				Napolitano, Francesco; Izzo, Maria Teresa; Di Giuseppe, Gabriella; Angelillo, Italo F.			Public Knowledge, Attitudes, and Experience Regarding the Use of Antibiotics in Italy	PLOS ONE			English	Article							SELF-MEDICATION PRACTICES; ANTIMICROBIAL RESISTANCE; POPULATION; COMMUNITY; CROSS; DETERMINANTS; BEHAVIOR; CHILDREN; EUROPE; IMPACT	Background: The objectives of the study were to investigate the level of knowledge, attitudes, and behaviors regarding antibiotics of the general population in Italy, and to assess the correlates of these outcomes of interest. Methods: A cross-sectional survey was conducted on a random sample of 630 parents of students attending nine randomly selected public primary and secondary schools. A self-administered questionnaire included questions on demographic characteristics, knowledge about antibiotic use and resistance, attitudes and behaviors towards antibiotic use, and sources of information. Results: A total of 419 parents participated. Only 9.8% knew the definition of antibiotic resistance and 21.2% knew when it was appropriate to use antibiotics. Respondents with higher education, employed, with a family member working in the health care sector, and with no need for additional information on antibiotics were more likely to know the definition of antibiotic resistance. One third (32.7%) self-classified them as users of self-medication with antibiotics and those with a lower self-rated health status, who did not use the physician as source of information on antibiotics, and who have attended a physician in the last year were more likely to use self-medication. One-fourth (22.7%) of those who had never been self-medicated would be willing to take an antibiotic without a prescription of a physician. Respondents were more likely to be willing to take antibiotics without a prescription if they were under 40 years of age, if they had a lower self-rated health status, if they did not know that antibiotics are not indicated for treating flu and sore throat, and if they knew that antibiotics are not indicated for treating colds. Conclusions: The survey has generated information about knowledge, attitudes, and behaviors regarding antibiotics in the general population and effective public education initiative should provide practical and appropriate means to change their behavior.	[Napolitano, Francesco; Izzo, Maria Teresa; Di Giuseppe, Gabriella; Angelillo, Italo F.] Univ Naples 2, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli	Angelillo, IF (corresponding author), Univ Naples 2, Dept Expt Med, Naples, Italy.	italof.angelillo@unina2.it	Angelillo, Italo Francesco/AAK-1301-2021	Angelillo, Italo Francesco/0000-0003-1213-6602; DI GIUSEPPE, Gabriella/0000-0003-4466-6683; Napolitano, Francesco/0000-0003-4694-2418				Abasaeed A, 2009, J INFECT DEV COUNTR, V3, P491, DOI 10.3855/jidc.466; Alumran A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-39; Andre M, 2010, J ANTIMICROB CHEMOTH, V65, P1292, DOI 10.1093/jac/dkq104; Askarian M, 2012, INT J PREVENTIVE MED, V3, P839, DOI 10.4103/2008-7802.104854; Awad A, 2005, J PHARM PHARM SCI, V8, P326; Azevedo MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-359; Berzanskyte Ausra, 2006, International Journal of Occupational Medicine and Environmental Health, V19, P246, DOI [10.2478/v10001-006-0030-9, 10.2478/v10001-006-0030.9]; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Buke C, 2005, J INFECTION, V51, P135, DOI 10.1016/j.jinf.2004.12.001; Carrasco-Garrido P, 2009, PHARMACOEPIDEM DR S, V18, P743, DOI 10.1002/pds.1776; Chan G. C., 2006, SMJ Singapore Medical Journal, V47, P266; Chan YH, 2012, AM J INFECT CONTROL, V40, P113, DOI 10.1016/j.ajic.2011.03.017; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Dancer SJ, 2004, LANCET INFECT DIS, V4, P611, DOI 10.1016/S1473-3099(04)01145-4; Davey P, 2002, CLIN MICROBIOL INFEC, V8, P43, DOI 10.1046/j.1469-0691.8.s.2.6.x; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Eng JV, 2003, EMERG INFECT DIS, V9, P1128; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gould IM, 2008, INT J ANTIMICROB AG, V32, pS2, DOI 10.1016/j.ijantimicag.2008.06.016; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Grigoryan L, 2008, J ANTIMICROB CHEMOTH, V61, P1172, DOI 10.1093/jac/dkn054; Harbarth S, 2005, EMERG INFECT DIS, V11, P794, DOI 10.3201/eid1106.050167; Hassali MA, 2011, INT J CLIN PHARM-NET, V33, P794, DOI 10.1007/s11096-011-9539-5; Hulscher MEJL, 2010, INT J MED MICROBIOL, V300, P351, DOI 10.1016/j.ijmm.2010.04.003; Ilhan MN, 2009, PHARMACOEPIDEM DR S, V18, P1150, DOI 10.1002/pds.1829; Maragakis LL, 2008, EXPERT REV ANTI-INFE, V6, P751, DOI 10.1586/14787210.6.5.751; McGowan JE, 2001, EMERG INFECT DIS, V7, P286, DOI 10.3201/eid0702.010228; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; Oh AL, 2011, J INFECT DEV COUNTR, V5, P338; Pan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041314; Panagakou SG, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-52; Raz R, 2005, ISRAEL MED ASSOC J, V7, P722; Rouusounides A, 2011, INT J ENV RES PUB HE, V8, P3246, DOI 10.3390/ijerph8083246; Sawair FA, 2009, MED PRIN PRACT, V18, P21, DOI 10.1159/000163041; Skliros E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-58; Stata Corporation, 2007, STAT REF MAN REL 10; Thriemer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055495; Togoobaatar G, 2010, B WORLD HEALTH ORGAN, V88, P930, DOI 10.2471/BLT.10.079004; Vaandnen MH, 2006, HEALTH POLICY, V77, P166, DOI 10.1016/j.healthpol.2005.07.001; Wun YT, 2012, INT J CLIN PRACT, V66, P1197, DOI 10.1111/j.1742-1241.2012.03013.x; You JHS, 2008, INFECTION, V36, P153, DOI 10.1007/s15010-007-7214-5	43	151	151	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84177	10.1371/journal.pone.0084177	http://dx.doi.org/10.1371/journal.pone.0084177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376793	Green Submitted, gold, Green Published			2022-12-27	WOS:000328882000141
J	Rampanelli, E; Dessing, MC; Claessen, N; Teske, GJD; Joosten, SPJ; Pals, ST; Leemans, JC; Florquin, S				Rampanelli, Elena; Dessing, Mark C.; Claessen, Nike; Teske, Gwendoline J. D.; Joosten, Sander P. J.; Pals, Steven T.; Leemans, Jaklien C.; Florquin, Sandrine			CD44-Deficiency Attenuates the Immunologic Responses to LPS and Delays the Onset of Endotoxic Shock-Induced Renal Inflammation and Dysfunction	PLOS ONE			English	Article							NF-KAPPA-B; MACROPHAGE RECRUITMENT; NITRIC-OXIDE; CD44; LIPOPOLYSACCHARIDE; ACTIVATION; INJURY; RECEPTOR; HYALURONAN; EXPRESSION	Acute kidney injury (AKI) is a common complication during systemic inflammatory response syndrome (SIRS), a potentially deadly clinical condition characterized by whole-body inflammatory state and organ dysfunction. CD44 is a ubiquitously expressed cell-surface transmembrane receptor with multiple functions in inflammatory processes, including sterile renal inflammation. The present study aimed to assess the role of CD44 in endotoxic shock-induced kidney inflammation and dysfunction by using CD44 KO and WT mice exposed intraperitoneally to LPS for 2, 4, and 24 hours. Upon LPS administration, CD44 expression in WT kidneys was augmented at all time-points. At 2 and 4 hours, CD44 KO animals showed a preserved renal function in comparison to WT mice. In absence of CD44, the pro-inflammatory cytokine levels in plasma and kidneys were lower, while renal expression of the anti-inflammatory cytokine IL-10 was higher. The cytokine levels were associated with decreased leukocyte influx and endothelial activation in CD44 KO kidneys. Furthermore, in vitro assays demonstrated a role of CD44 in enhancing macrophage cytokine responses to LPS and leukocyte migration. In conclusion, our study demonstrates that lack of CD44 impairs the early pro-inflammatory cytokine response to LPS, diminishes leukocyte migration/chemotaxis and endothelial activation, hence, delays endotoxic shock-induced AKI.	[Rampanelli, Elena; Dessing, Mark C.; Claessen, Nike; Teske, Gwendoline J. D.; Joosten, Sander P. J.; Pals, Steven T.; Leemans, Jaklien C.; Florquin, Sandrine] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Florquin, Sandrine] Radboud Univ Nijmegen Ctr, Dept Pathol, Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen	Rampanelli, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	E.Rampanelli@amc.uva.nl	Rampanelli, Elena/AAJ-9119-2020; Leemans, Jaklien/AAM-4958-2020	Rampanelli, Elena/0000-0002-7742-0092; Pals, Steven/0000-0002-1419-0939; Joosten, Sander/0000-0002-6699-3717; Florquin, Sandrine/0000-0002-9676-1722	Dutch Kidney Foundation [C08-2261]	Dutch Kidney Foundation	This work was supported by the Dutch Kidney Foundation, grant C08-2261. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen BC, 2001, BRIT J PHARMACOL, V134, P1055, DOI 10.1038/sj.bjp.0704334; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; de Geus HRH, 2012, CLIN KIDNEY J, V5, P102, DOI 10.1093/ckj/sfs008; Florquin S, 2002, AM J KIDNEY DIS, V39, P407, DOI 10.1053/ajkd.2002.30563; Hamada Jun-Ichi, 1998, Frontiers in Bioscience, V3, pD657; Hasan Z, 2011, SHOCK, V35, P567, DOI 10.1097/SHK.0b013e3182144935; Herishanu Y, 2011, LEUKEMIA LYMPHOMA, V52, P1758, DOI 10.3109/10428194.2011.569962; Hollingsworth JW, 2007, AM J RESP CELL MOL, V37, P248, DOI 10.1165/rcmb.2006-0363OC; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kamimoto M, 2009, INT J MOL MED, V24, P161, DOI 10.3892/ijmm_00000219; Kamimoto M, 2009, BIOCHEM BIOPH RES CO, V380, P333, DOI 10.1016/j.bbrc.2009.01.080; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawana H, 2008, J IMMUNOL, V180, P4235, DOI 10.4049/jimmunol.180.6.4235; Kers J, 2010, TRANSPLANTATION, V90, P502, DOI 10.1097/TP.0b013e3181e86b42; Khan S, 2013, J ETHNOPHARMACOL, V145, P626, DOI 10.1016/j.jep.2012.12.001; Kim HG, 2007, J ETHNOPHARMACOL, V114, P307, DOI 10.1016/j.jep.2007.08.011; Knotek M, 2001, KIDNEY INT, V59, P2243, DOI 10.1046/j.1523-1755.2001.00740.x; Leemans JC, 2003, J CLIN INVEST, V111, P681, DOI 10.1172/JCI200316936; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Murphy S. L., 2012, NATL VITAL STAT REP, V60, P4; Muto J, 2009, MOL IMMUNOL, V47, P449, DOI 10.1016/j.molimm.2009.08.026; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Rampanelli E, 2013, AM J PHYYSIOLOGY; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rouschop KMA, 2006, KIDNEY INT, V70, P1127, DOI 10.1038/sj.ki.5001711; Rouschop KMA, 2006, J IMMUNOL, V177, P7225, DOI 10.4049/jimmunol.177.10.7225; Rouschop KMA, 2005, J AM SOC NEPHROL, V16, P2034, DOI 10.1681/ASN.2005010054; Rouschop KMA, 2004, J AM SOC NEPHROL, V15, P674, DOI 10.1097/01.ASN.0000115703.30835.96; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Simmons EM, 2004, KIDNEY INT, V65, P1357, DOI 10.1111/j.1523-1755.2004.00512.x; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Tiwari MM, 2005, AM J PHYSIOL-RENAL, V289, pF1324, DOI 10.1152/ajprenal.00124.2005; Vachon E, 2007, BLOOD, V110, P4492, DOI 10.1182/blood-2007-02-076539; van der Windt GJW, 2010, INFECT IMMUN, V78, P115, DOI 10.1128/IAI.00949-09; Wang Q, 2002, AM J PATHOL, V161, P2219, DOI 10.1016/S0002-9440(10)64498-7; Weischenfeldt J, 2008, CSH PROTOCOLS; Wu LP, 2007, AM J PHYSIOL-RENAL, V292, pF261, DOI 10.1152/ajprenal.00263.2006; Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	46	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84479	10.1371/journal.pone.0084479	http://dx.doi.org/10.1371/journal.pone.0084479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376813	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000151
J	Shen, FH; Yuan, JX; Sun, ZQ; Hua, ZB; Qin, TB; Yao, SQ; Fan, XY; Chen, WH; Liu, HB; Chen, J				Shen, Fuhai; Yuan, Juxiang; Sun, Zhiqian; Hua, Zhengbing; Qin, Tianbang; Yao, Sanqiao; Fan, Xueyun; Chen, Weihong; Liu, Hongbo; Chen, Jie			Risk Identification and Prediction of Coal Workers' Pneumoconiosis in Kailuan Colliery Group in China: A Historical Cohort Study	PLOS ONE			English	Article							MINERS PNEUMOCONIOSIS; PREVALENCE; DUST; SURVEILLANCE; SILICOSIS; MORTALITY; EXPOSURE	Background: Prior to 1970, coal mining technology and prevention measures in China were poor. Mechanized coal mining equipment and advanced protection measures were continuously installed in the mines after 1970. All these improvements may have resulted in a change in the incidence of coal workers' pneumoconiosis (CWP). Therefore, it is important to identify the characteristics of CWP today and trends for the incidence of CWP in the future. Methodology/Principal Findings: A total of 17,023 coal workers from the Kailuan Colliery Group were studied. A life-table method was used to calculate the cumulative incidence rate of CWP and predict the number of new CWP patients in the future. The probability of developing CWP was estimated by a multilayer perceptron artificial neural network for each coal worker without CWP. The results showed that the cumulative incidence rates of CWP for tunneling, mining, combining, and helping workers were 31.8%, 27.5%, 24.2%, and 2.6%, respectively, during the same observation period of 40 years. It was estimated that there would be 844 new CWP cases among 16,185 coal workers without CWP within their life expectancy. There would be 273.1, 273.1, 227.6, and 69.9 new CWP patients in the next < 10, 10-, 20-, and 30-years respectively in the study cohort within their life expectancy. It was identified that coal workers whose risk probabilities were over 0.2 were at high risk for CWP, and whose risk probabilities were under 0.1 were at low risk. Conclusion/Significance: The present and future incidence trends of CWP remain high among coal workers. We suggest that coal workers at high risk of CWP undergo a physical examination for pneumoconiosis every year, and the coal workers at low risk of CWP be examined every 5 years.	[Shen, Fuhai; Liu, Hongbo; Chen, Jie] China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China; [Shen, Fuhai; Yuan, Juxiang; Sun, Zhiqian; Hua, Zhengbing; Yao, Sanqiao; Fan, Xueyun] Hebei United Univ, Sch Publ Hlth, Tangshan, Hebei, Peoples R China; [Qin, Tianbang] Occupat Dis Prevent & Treatment Hosp, Kailuan Colliery Grp, Tangshan, Hebei, Peoples R China; [Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Hubei, Peoples R China	China Medical University; North China University of Science & Technology; Huazhong University of Science & Technology	Chen, J (corresponding author), China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China.	chenjie@mail.cmu.edu.cn			National Natural Science Foundation of China [71073176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (number 71073176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbod MF, 2007, J UROLOGY, V178, P1150, DOI 10.1016/j.juro.2007.05.122; Ahmed FE, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-29; Amar RK, 2012, RESPIRATION, V84, P200, DOI 10.1159/000338116; American Lung Association, 2013, PNEUM BLACK LUNG DIS; ATTFIELD MD, 1992, AM J PUBLIC HEALTH, V82, P978, DOI 10.2105/AJPH.82.7.978; ATTFIELD MD, 1992, AM J PUBLIC HEALTH, V82, P971, DOI 10.2105/AJPH.82.7.971; ATTFIELD MD, 1995, AM J IND MED, V27, P137, DOI 10.1002/ajim.4700270113; Black J, 2004, ANN OCCUP HYG, V48, P595, DOI 10.1093/glycob/meh064; Castranova V, 2000, ENVIRON HEALTH PERSP, V108, P675, DOI 10.2307/3454404; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P336; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P401; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P1321; Centers for Disease Control and Prevention (CDC) Department of Health and Human Services (HHS), 2012, FED REGISTER, V77, P56717; Chen WH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001206; Dayhoff JE, 2001, CANCER, V91, P1616; Delen D, 2006, ACCIDENT ANAL PREV, V38, P434, DOI 10.1016/j.aap.2005.06.024; Finkelstein MM, 2013, AM J IND MED, V56, P550, DOI 10.1002/ajim.22159; Hsieh KC, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-21; Hughes VF, 2001, LIVER TRANSPLANT, V7, P496, DOI 10.1053/jlts.2001.24642; Kailuan Colliery Group, 2013, INSTR KAIL GROUP; Kenny L.C., 2002, ANN OCCUP HYG, P257, DOI [10.1093/annhyg/46.suppl_1.257, DOI 10.1093/ANNHYG/46.SUPPL_1.257]; Laney A. Scott, 2012, Morbidity and Mortality Weekly Report, V61, P431; Lee WJ, 2013, TUBERC RESPIR DIS, V74, P56, DOI 10.4046/trd.2013.74.2.56; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Liu FD, 2007, HEALTH PHYS, V93, P127, DOI 10.1097/01.HP.0000261600.29366.b4; Liu HB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-366; Liu HB, 2009, IND HEALTH, V47, P369, DOI 10.2486/indhealth.47.369; LOU JZ, 1989, AM J PUBLIC HEALTH, V79, P1613, DOI 10.2105/AJPH.79.12.1613; Mamuya SHD, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-17; Mo J, 2013, INT J HYG ENV HLTH, V26; Mukherjee AK, 2005, IND HEALTH, V43, P277, DOI 10.2486/indhealth.43.277; Naidoo RN, 2005, AM J IND MED, V48, P217, DOI 10.1002/ajim.20207; National Health and Family Planning Commission of the People's Republic of China, 2007, GBZ1882007 NAT HLTH; National Health and Family Planning Commission of the People's Republic of China, 2009, 702009 GBZ NAT HLTH; National Health and Family Planning Commission of the People's Republic of China, 2007, 19222007 GBZT NAT HL; National Health and Family Planning Commission of the People's Republic of China, 2007, 19212007 GBZT NAT HL; National Health and Family Planning Commission of the People's Republic of China, 2007, 19242007 GBZT NAT HL; National institute of occupational health and poison control, 2013, 2012 NAT REP OCC DIS; Oyunbileg S, 2011, AM J IND MED, V54, P285, DOI 10.1002/ajim.20930; Petsonk EL, 2013, AM J RESP CRIT CARE; Pingle S, 2012, IND HEALTH, V50, P167, DOI 10.2486/indhealth.MS1366; Ren XW, 2012, J OCCUP ENVIRON HYG, V9, pD77, DOI 10.1080/15459624.2012.667288; Scarisbrick DA, 2005, OCCUP MED-OXFORD, V55, P72, DOI 10.1093/occmed/kqi005; Scott DF, 2004, J OCCUP ENVIRON MED, V46, P1272, DOI 10.1097/01.jom.0000147209.92261.5b; Shen B, 2004, 2004 ANN C CHIN ASS; Smith DR, 2006, J OCCUP HEALTH, V48, P309, DOI 10.1539/joh.48.309; Suarthana E, 2007, OCCUP ENVIRON MED, V64, P595, DOI 10.1136/oem.2006.027904; Tse LA, 2012, PUBLIC HEALTH, V126, P1013, DOI 10.1016/j.puhe.2012.09.012; Weeks JL, 2003, AM J PUBLIC HEALTH, V93, P1236, DOI 10.2105/AJPH.93.8.1236	49	18	26	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82181	10.1371/journal.pone.0082181	http://dx.doi.org/10.1371/journal.pone.0082181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	278IG	24376519	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000008
J	Adhikary, G; Grun, D; Kerr, C; Balasubramanian, S; Rorke, EA; Vemuri, M; Boucher, S; Bickenbach, JR; Hornyak, T; Xu, W; Fisher, ML; Eckert, RL				Adhikary, Gautam; Grun, Dan; Kerr, Candace; Balasubramanian, Sivaprakasam; Rorke, Ellen A.; Vemuri, Mohan; Boucher, Shayne; Bickenbach, Jackie R.; Hornyak, Thomas; Xu, Wen; Fisher, Matthew L.; Eckert, Richard L.			Identification of a Population of Epidermal Squamous Cell Carcinoma Cells with Enhanced Potential for Tumor Formation	PLOS ONE			English	Article							KERATINOCYTE STEM-CELLS; ALDEHYDE DEHYDROGENASE 1; EZH2 HISTONE METHYLTRANSFERASE; PROTEASOME-DEPENDENT MECHANISM; POLYCOMB GROUP; SKIN-CANCER; INITIATING CELLS; PROTEIN-LEVEL; SELF-RENEWAL; EXPRESSION	Epidermal squamous cell carcinoma is among the most common cancers in humans. These tumors are comprised of phenotypically diverse populations of cells that display varying potential for proliferation and differentiation. An important goal is identifying cells from this population that drive tumor formation. To enrich for tumor-forming cells, cancer cells were grown as spheroids in non-attached conditions. We show that spheroid-selected cells form faster growing and larger tumors in immune-compromised mice as compared to non-selected cells. Moreover, spheroid-selected cells gave rise to tumors following injection of as few as one hundred cells, suggesting these cells have enhanced tumor-forming potential. Cells isolated from spheroid-selected tumors retain an enhanced ability to grow as spheroids when grown in non-attached culture conditions. Thus, these tumor-forming cells retain their phenotype following in vivo passage as tumors. Detailed analysis reveals that spheroid-selected cultures are highly enriched for expression of epidermal stem cell and embryonic stem cell markers, including aldehyde dehydrogenase 1, keratin 15, CD200, keratin 19, Oct4, Bmi-1, Ezh2 and trimethylated histone H3. These studies indicate that a subpopulation of cells that possess stem cell-like properties and express stem cell markers can be derived from human epidermal cancer cells and that these cells display enhanced ability to drive tumor formation.	[Adhikary, Gautam; Grun, Dan; Kerr, Candace; Balasubramanian, Sivaprakasam; Hornyak, Thomas; Xu, Wen; Fisher, Matthew L.; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Hornyak, Thomas; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Reprod Biol, Baltimore, MD 21201 USA; [Rorke, Ellen A.; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Vemuri, Mohan; Boucher, Shayne] Life Technol Inc, Stem Cell Technol, Frederick, MD USA; [Bickenbach, Jackie R.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Thermo Fisher Scientific; University of Iowa	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	reckert@umaryland.edu		Grun, Daniel/0000-0003-4261-7765	NIH [R01CA131074]; University of Maryland Greenebaum Cancer Center [P30CA134274]; NATIONAL CANCER INSTITUTE [R01CA131074, P30CA134274] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an NIH grant to R. Eckert (R01CA131074) and a pilot and University of Maryland Greenebaum Cancer Center (P30CA134274) Pilot and Feasibility Award to C. Kerr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Balasubramanian S, 2008, NUTR REV, V66, pS65, DOI 10.1111/j.1753-4887.2008.00071.x; Balasubramanian S, 2012, J BIOL CHEM, V287, P36179, DOI 10.1074/jbc.M112.359281; Balasubramanian S, 2011, MOL PHARMACOL, V80, P870, DOI 10.1124/mol.111.072363; Balasubramanian S, 2010, CARCINOGENESIS, V31, P496, DOI 10.1093/carcin/bgp314; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Bortolomai I, 2010, CELL CYCLE, V9, P1194, DOI 10.4161/cc.9.6.11108; Calenic B, 2010, ROM J MORPHOL EMBRYO, V51, P641; Changchien YC, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-216; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016466; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Choudhury SR, 2011, CARCINOGENESIS, V32, P1525, DOI 10.1093/carcin/bgr171; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Crea F, 2012, CANCER METAST REV, V31, P753, DOI 10.1007/s10555-012-9387-3; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Eckert RL, 2013, BBA-GEN SUBJECTS, V1830, P2427, DOI 10.1016/j.bbagen.2012.07.002; Eckert RL, 2011, J INVEST DERMATOL, V131, P295, DOI 10.1038/jid.2010.318; Geng SM, 2013, ARCH DERMATOL RES, V305, P35, DOI 10.1007/s00403-012-1260-2; Geng SM, 2011, ARCH DERMATOL RES, V303, P181, DOI 10.1007/s00403-010-1100-1; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Gupta S, 2002, CANCER METAST REV, V21, P363, DOI 10.1023/A:1021275330385; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Inoue K, 2009, LAB INVEST, V89, P844, DOI 10.1038/labinvest.2009.48; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Johnson KE, 2012, J SKIN CANCER, V2012, DOI 10.1155/2012/483439; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kong DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033729; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Liu AF, 2013, CHIN J CANCER, V32, P483, DOI 10.5732/cjc.012.10282; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Lopez J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-48; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Mancini R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021320; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ott M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047663; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Patel GK, 2012, J INVEST DERMATOL, V132, P401, DOI 10.1038/jid.2011.317; Patel GK, 2012, J INVEST DERMATOL, V132, P284, DOI 10.1038/jid.2011.284; Pincelli C, 2010, J CELL PHYSIOL, V225, P310, DOI 10.1002/jcp.22275; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Singh A, 2012, PHOTOCHEM PHOTOBIOL, V88, P1099, DOI 10.1111/j.1751-1097.2012.01079.x; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Streit M, 1999, AM J PATHOL, V155, P441, DOI 10.1016/S0002-9440(10)65140-1; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Zhang G, 2012, MOL MED REP, V6, P519, DOI 10.3892/mmr.2012.939	64	43	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84324	10.1371/journal.pone.0084324	http://dx.doi.org/10.1371/journal.pone.0084324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376802	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100163
J	Gong, K; Tang, M; Hui, PM; Zhang, HF; Do, Y; Lai, YC				Gong, Kai; Tang, Ming; Hui, Pak Ming; Zhang, Hai Feng; Do, Younghae; Lai, Ying-Cheng			An Efficient Immunization Strategy for Community Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; EPIDEMIC	An efficient algorithm that can properly identify the targets to immunize or quarantine for preventing an epidemic in a population without knowing the global structural information is of obvious importance. Typically, a population is characterized by its community structure and the heterogeneity in the weak ties among nodes bridging over communities. We propose and study an effective algorithm that searches for bridge hubs, which are bridge nodes with a larger number of weak ties, as immunizing targets based on the idea of referencing to an expanding friendship circle as a self-avoiding walk proceeds. Applying the algorithm to simulated networks and empirical networks constructed from social network data of five US universities, we show that the algorithm is more effective than other existing local algorithms for a given immunization coverage, with a reduced final epidemic ratio, lower peak prevalence and fewer nodes that need to be visited before identifying the target nodes. The effectiveness stems from the breaking up of community networks by successful searches on target nodes with more weak ties. The effectiveness remains robust even when errors exist in the structure of the networks.	[Gong, Kai; Tang, Ming] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China; [Gong, Kai; Tang, Ming; Hui, Pak Ming] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China; [Tang, Ming; Do, Younghae; Lai, Ying-Cheng] Kyungpook Natl Univ, Dept Math, Taegu, South Korea; [Zhang, Hai Feng] Anhui Univ, Sch Math Sci, Hefei 230039, Peoples R China; [Lai, Ying-Cheng] Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ USA	University of Electronic Science & Technology of China; Chinese University of Hong Kong; Kyungpook National University; Anhui University; Arizona State University; Arizona State University-Tempe	Tang, M (corresponding author), Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China.	tangminghuang521@hotmail.com; pmhui@phy.cuhk.edu.hk	Hui, Pak Ming/S-2586-2017; Zhang, Haifeng/B-2499-2012; Do, Younghae/G-3522-2011; Zhang, Hai-Feng/AAG-6272-2020	Hui, Pak Ming/0000-0002-5201-8689; Zhang, Haifeng/0000-0002-7094-669X; 	National Natural Science Foundation of China [11105025, 11005001]; Fundamental Research Funds for the Central Universities [ZYGX2012J075]; Direct Grant for Research from the Faculty of Science at the Chinese University of Hong Kong; Ministry of Education, Science and Technology [NRF-2013R1A1A2010067]; Program of Outstanding PhD Candidate in Academic Research by UESTC [YBXSZC20131027]; AFOSR [FA9550-10-1-0083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Direct Grant for Research from the Faculty of Science at the Chinese University of Hong Kong; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Program of Outstanding PhD Candidate in Academic Research by UESTC; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was partially supported by the National Natural Science Foundation of China (Grants Nos. 11105025, 11005001) and the Fundamental Research Funds for the Central Universities (Grant No. ZYGX2012J075). P. M. Hui acknowledges the support of a Direct Grant for Research from the Faculty of Science at the Chinese University of Hong Kong in 2013-14. Y. Do acknowledges Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2010067). K. Gong acknowledges the support from the Program of Outstanding PhD Candidate in Academic Research by UESTC (Grant No. YBXSZC20131027). Y.-C. Lai was supported by AFOSR under Grant No. FA9550-10-1-0083. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelemy M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178701; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Chen YP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.058701; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Chu XW, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07043; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferrar E, 2012, ARXIV12030535V1; Ferrara Emilio, 2012, International Journal of Social Network Mining, V1, P67, DOI 10.1504/IJSNM.2012.045106; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Gong K, 2011, CHAOS, V21, DOI 10.1063/1.3664403; Grenfell B, 2005, NATURE, V433, P366, DOI 10.1038/433366a; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hebert-Dufresne L, 2012, ARXIV12085768; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Huang L, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.035103; Huang W, 2007, J STAT MECH-THEORY E, V01; Jones JH, 2003, NATURE, V423, P605, DOI 10.1038/423605a; Keeling, 2008, MODELING INFECT DIS; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Liu ZH, 2005, EUROPHYS LETT, V72, P315, DOI 10.1209/epl/i2004-10550-5; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Madar N, 2004, EUR PHYS J B, V38, P269, DOI 10.1140/epjb/e2004-00119-8; Masuda N, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123018; Mihalik A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002187; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Newman MEJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108701; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Red V, 2011, SIAM REV, V53, P526, DOI 10.1137/080734315; Ruan ZY, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036117; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Shu PP, 2012, CHAOS, V22, DOI 10.1063/1.4767955; Wang LF, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.125436; Wu XY, 2008, PHYSICA A, V387, P623, DOI 10.1016/j.physa.2007.09.039; Yamada Yuu, 2012, Active Media Technology. 8th International Conference, AMT 2012. Proceedings, P328, DOI 10.1007/978-3-642-35236-2_33; Yang H, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/12/123017; Zhang HF, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/6/068901; Zhao JC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016105; Zhou J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036107; Zhou J, 2009, PHYSICA A, V388, P1228, DOI 10.1016/j.physa.2008.12.014	56	46	49	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83489	10.1371/journal.pone.0083489	http://dx.doi.org/10.1371/journal.pone.0083489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376708	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100122
J	Zhang, SC; Liu, L; Wang, RJ; Tuo, HZ; Guo, YJ; Yi, L; Wang, DX; Wang, JW				Zhang, Shanchao; Liu, Lei; Wang, Ruijin; Tuo, Houzhen; Guo, Yanjun; Yi, Li; Wang, Dexin; Wang, Jiawei			MicroRNA-217 Promotes Angiogenesis of Human Cytomegalovirus-Infected Endothelial Cells through Downregulation of SIRT1 and FOXO3A	PLOS ONE			English	Article							EXPRESSION; REPLICATION; DISEASE; ATHEROSCLEROSIS; INHIBITION; MECHANISMS; TARGET; ROLES; DICER; ENOS	Human cytomegalovirus(HCMV) infection has been shown to contribute to vascular disease through the induction of angiogenesis. However, the role of microRNA in angiogenesis induced by HCMV infection remains unclear. The present study was thus designed to explore the potential effect of miR-1217 on angiogenesis and to disclose the underlying mechanism in endothelial cells. We found that HCMV infection of endothelial cells(ECs) enhanced expression of miR-217 and reduced SIRT1 and FOXO3A protein level in 24 hours post infection(hpi). Transfection of miR-217 inhibitor not only depressed cellular migration and tube formation induced by HCMV infection, but also enhanced SIRT1 and FOXO3A protein expression. Additionally, luciferase assay confirmed that miR-217 directly targeted FOXO3A mRNA 3' UTR. Furthermore, pretreatment with resveratrol depressed motility and tube formation of HCMV-infected ECs, which could be reversed by SIRT1 siRNA. Similarly, delivery of FOXO3A overexpression lentivirus suppressed proliferative rate, migration and tube formation of HCMV-infected ECs, which reversed by transfection of FOXO3A siRNA. In summary, HCMV infection of endothelial cells induces angiogenesis by both of miR-217/SIRT1 and miR-217/FOXO3A axis.	[Zhang, Shanchao; Liu, Lei; Wang, Ruijin; Tuo, Houzhen; Guo, Yanjun; Yi, Li; Wang, Dexin; Wang, Jiawei] Capital Med Univ, Beijing Friendship Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Wang, JW (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Neurol, Beijing, Peoples R China.	wangjwcq@163.com		zhang, Shanchao/0000-0002-5543-4530; wang, jia wei/0000-0002-4716-928X	Beijing Natural Science Foundation [7102040, 7132060]; National Natural Science Foundation of China [81041020, 81271311, 81241039]; Traditional Chinese Medicine, Beijing Technology Development Fund [SF-2007-III-22]; Beijing Excellent Talent Foundation [20071-D0300100062]; high-level technical training project funding of Beijing health system [2011-3-004]; Beijing city staff to go abroad preferential funding scheme	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Traditional Chinese Medicine, Beijing Technology Development Fund; Beijing Excellent Talent Foundation; high-level technical training project funding of Beijing health system; Beijing city staff to go abroad preferential funding scheme	The work was supported by Beijing Natural Science Foundation (NOs. 7102040,7132060), National Natural Science Foundation of China (NOs. 81041020, 81271311 and 81241039), Traditional Chinese Medicine, Beijing Technology Development Fund (NO. SF-2007-III-22), Beijing Excellent Talent Foundation (NO. 20071-D0300100062), high-level technical training project funding of Beijing health system (2011-3-004) and Beijing city staff to go abroad preferential funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bentz GL, 2008, P NATL ACAD SCI USA, V105, P5531, DOI 10.1073/pnas.0800037105; Botto S, 2011, BLOOD, V117, P352, DOI 10.1182/blood-2010-06-291245; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Caposio P, 2007, ANTIVIR RES, V73, P175, DOI 10.1016/j.antiviral.2006.10.001; Caposio P, 2011, VIRUS RES, V157, P204, DOI 10.1016/j.virusres.2010.09.011; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cheeran MCJ, 2001, J NEUROVIROL, V7, P135; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; Dumortier J, 2008, J VIROL, V82, P6524, DOI 10.1128/JVI.00502-08; Fiorentini S, 2011, J GEN VIROL, V92, P650, DOI 10.1099/vir.0.025395-0; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Huang YJ, 2013, J BIOSCIENCES, V38, P479, DOI 10.1007/s12038-013-9353-4; Jia YY, 2013, SCI CHINA LIFE SCI, V56, P19, DOI 10.1007/s11427-012-4407-7; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Lee SH, 2012, P NATL ACAD SCI USA, V109, P9575, DOI 10.1073/pnas.1207496109; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Ota H, 2010, J ATHEROSCLER THROMB, V17, P431, DOI 10.5551/jat.3525; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Potente M, 2008, CELL CYCLE, V7, P2117, DOI 10.4161/cc.7.14.6267; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Qi ML, 2013, FEBS LETT, V587, P2266, DOI 10.1016/j.febslet.2013.05.057; Revello MG, 2010, REV MED VIROL, V20, P136, DOI 10.1002/rmv.645; Shen YH, 2006, CARDIOVASC RES, V69, P502, DOI 10.1016/j.cardiores.2005.10.007; Stein S, 2011, CELL CYCLE, V10, P640, DOI 10.4161/cc.10.4.14863; Streblow DN, 2008, CURR TOP MICROBIOL, V325, P397; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Zhang SC, 2013, ARCH VIROL, V158, P2443, DOI 10.1007/s00705-013-1744-1	32	19	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83620	10.1371/journal.pone.0083620	http://dx.doi.org/10.1371/journal.pone.0083620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376725	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100128
J	Zhang, X; Zhang, H; Pu, JJ; Qi, YX; Yu, QF; Xie, YX; Peng, J				Zhang, Xin; Zhang, He; Pu, Jinji; Qi, Yanxiang; Yu, Qunfang; Xie, Yixian; Peng, Jun			Development of a Real-Time Fluorescence Loop-Mediated Isothermal Amplification Assay for Rapid and Quantitative Detection of Fusarium oxysporum f. sp cubense Tropical Race 4 In Soil	PLOS ONE			English	Article							SENSITIVE DETECTION; POTATO-TUBERS; PCR; WILT; TAIWAN; DNA; SOLANI; BANANA; LAMP; QUANTIFICATION	Fusarium oxysporum f. sp. cubense (Foc), the causal agent of Fusarium wilt (Panama disease), is one of the most devastating diseases of banana (Musa spp.). The Foc tropical race 4 (TR4) is currently known as a major concern in global banana production. No effective resistance is known in Musa to Foc, and no effective measures for controlling Foc once banana plants have been infected in place. Early and accurate detection of Foc TR4 is essential to protect banana industry and guide banana planting. A real-time fluorescence loop-mediated isothermal amplification assay (RealAmp) was developed for the rapid and quantitative detection of Foc TR4 in soil. The detection limit of the RealAmp assay was approximately 0.4 pg/mu l plasmid DNA when mixed with extracted soil DNA or 10(3) spores/g of artificial infested soil, and no cross-reaction with other relative pathogens were observed. The RealAmp assay for quantifying genomic DNA of TR4 was confirmed by testing both artificially and naturally infested samples. Quantification of the soil-borne pathogen DNA of Foc TR4 in naturally infested samples was no significant difference compared to classic real-time PCR (P>0.05). Additionally, RealAmp assay was visual with an improved closed-tube visual detection system by adding SYBR Green I fluorescent dye to the inside of the lid prior to amplification, which avoided the inhibitory effects of the stain on DNA amplification and makes the assay more convenient in the field and could thus become a simple, rapid and effective technique that has potential as an alternative tool for the detection and monitoring of Foc TR4 in field, which would be a routine DNA-based testing service for the soilborne pathogen in South China.	[Zhang, Xin; Zhang, He; Pu, Jinji; Qi, Yanxiang; Yu, Qunfang; Xie, Yixian; Peng, Jun] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Minist Agr, Key Lab Integrated Pest Management Trop Crops, Haikou, Peoples R China; [Peng, Jun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Peng, Jun] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing 100094, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Peng, J (corresponding author), Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Minist Agr, Key Lab Integrated Pest Management Trop Crops, Haikou, Peoples R China.	swaupj2@126.com	Zhang, He/AAF-5700-2020		Central Nonprofit Scientific Research Institutes for Basic Scientific Research Special Fund [1630042013021]	Central Nonprofit Scientific Research Institutes for Basic Scientific Research Special Fund	Central Nonprofit Scientific Research Institutes for Basic Scientific Research Special Fund (1630042013021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekele B, 2011, PLANT PATHOL, V60, P345, DOI 10.1111/j.1365-3059.2010.02384.x; Bentley S, 1998, PHYTOPATHOLOGY, V88, P1283, DOI 10.1094/PHYTO.1998.88.12.1283; Bilodeau G, 2010, PHYTOPATHOLOGY S, V100, pS14; Brierley JL, 2009, APPL SOIL ECOL, V41, P234, DOI 10.1016/j.apsoil.2008.11.004; Buddenhagen I. W., 2009, ISHS ACTA HORTICULTU, V828, P193; Cullen DW, 2002, PLANT PATHOL, V51, P281, DOI 10.1046/j.1365-3059.2002.00690.x; Cullen DW, 2001, EUR J PLANT PATHOL, V107, P387, DOI 10.1023/A:1011247826231; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; Eischeid Anne C, 2011, BMC Res Notes, V4, P263, DOI 10.1186/1756-0500-4-263; Fourie G, 2011, INFECT GENET EVOL, V11, P533, DOI 10.1016/j.meegid.2011.01.012; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Hwang SC, 2004, PLANT DIS, V88, P580, DOI 10.1094/PDIS.2004.88.6.580; Inami K, 2010, J GEN PLANT PATHOL, V76, P116, DOI 10.1007/s10327-010-0224-7; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Lees AK, 2012, PLANT PATHOL, V61, P867, DOI 10.1111/j.1365-3059.2011.02574.x; Lees AK, 2002, PLANT PATHOL, V51, P293, DOI 10.1046/j.1365-3059.2002.00712.x; Li BJ, 2013, EUR J PLANT PATHOL, V135, P903, DOI 10.1007/s10658-012-0136-9; Li MH, 2011, CAN J PLANT PATHOL, V33, P168, DOI 10.1080/07060661.2011.559176; Li S, 2003, PLANT PATHOL, V52, P74, DOI 10.1046/j.1365-3059.2003.00797.x; Lin YH, 2013, EUR J PLANT PATHOL, V135, P395, DOI 10.1007/s10658-012-0096-0; Lin YH, 2010, NEW BIOTECHNOL, V27, P409, DOI 10.1016/j.nbt.2010.05.005; Lin YH, 2009, EUR J PLANT PATHOL, V123, P353, DOI 10.1007/s10658-008-9372-4; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Molina AB, 2009, ACTA HORTIC, V828, P109; Moore N. Y., 1995, FUSARIUM WILT BANANA, V5; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Nagamine K, 2001, CLIN CHEM, V47, P1742; Njiru ZK, 2012, J CLIN MICROBIOL, V50, P1737, DOI 10.1128/JCM.06460-11; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ophel-Keller K, 2008, AUSTRALAS PLANT PATH, V37, P243, DOI 10.1071/AP08029; Paul JY, 2011, PLANT BIOTECHNOL J, V9, P1141, DOI 10.1111/j.1467-7652.2011.00639.x; Pegg K., 1994, IMPROVEMENT TESTING, P70; PEGG KG, 1993, RECENT DEV BANANA CU, P255; PLOETZ RC, 1990, FUSARIUM WILT OF BANANA, P9; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Ploetz RC, 2009, ISHS P MUS BAN S GUN, P1; QI P, 2001, BANANA FUSARIUM WILT, P119; Ratti C, 2004, J VIROL METHODS, V122, P95, DOI 10.1016/j.jviromet.2004.08.013; Schroeder KL, 2006, PHYTOPATHOLOGY, V96, P637, DOI 10.1094/PHYTO-96-0637; Snyder WC, 1940, AM J BOT, V27, P64, DOI 10.2307/2436688; SU HJ, 1986, PLANT DIS, V70, P814, DOI 10.1094/PD-70-814; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Tomlinson JA, 2010, LETT APPL MICROBIOL, V51, P650, DOI 10.1111/j.1472-765X.2010.02949.x; WAITE B. H., 1960, Canadian Journal of Botany, V38, P985, DOI 10.1139/b60-087; Wallenhammar AC, 2012, PLANT PATHOL, V61, P16, DOI 10.1111/j.1365-3059.2011.02477.x; Yip MK, 2011, PLANT BIOTECHNOL REP, V5, P245, DOI 10.1007/s11816-011-0179-y; Zoheir KMA, 2011, THERIOGENOLOGY, V76, P83, DOI 10.1016/j.theriogenology.2011.01.020	48	24	29	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82841	10.1371/journal.pone.0082841	http://dx.doi.org/10.1371/journal.pone.0082841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376590	gold, Green Published			2022-12-27	WOS:000328745100063
J	Koehler, S; Ovadia-Caro, S; van der Meer, E; Villringer, A; Heinz, A; Romanczuk-Seiferth, N; Margulies, DS				Koehler, Saskia; Ovadia-Caro, Smadar; van der Meer, Elke; Villringer, Arno; Heinz, Andreas; Romanczuk-Seiferth, Nina; Margulies, Daniel S.			Increased Functional Connectivity between Prefrontal Cortex and Reward System in Pathological Gambling	PLOS ONE			English	Article							TOURETTE-SYNDROME; PROBLEM GAMBLERS; DECISION-MAKING; BRAIN ACTIVITY; ACTIVATION; DYSFUNCTION; TASK; HYPERSENSITIVITY; ABNORMALITIES; METAANALYSIS	Pathological gambling (PG) shares clinical characteristics with substance-use disorders and is thus discussed as a behavioral addiction. Recent neuroimaging studies on PG report functional changes in prefrontal structures and the mesolimbic reward system. While an imbalance between these structures has been related to addictive behavior, whether their dysfunction in PG is reflected in the interaction between them remains unclear. We addressed this question using functional connectivity resting-state fMRI in male subjects with PG and controls. Seed-based functional connectivity was computed using two regions-of-interest, based on the results of a previous voxel-based morphometry study, located in the prefrontal cortex and the mesolimbic reward system (right middle frontal gyrus and right ventral striatum). PG patients demonstrated increased connectivity from the right middle frontal gyrus to the right striatum as compared to controls, which was also positively correlated with nonplanning aspect of impulsiveness, smoking and craving scores in the PG group. Moreover, PG patients demonstrated decreased connectivity from the right middle frontal gyrus to other prefrontal areas as compared to controls. The right ventral striatum demonstrated increased connectivity to the right superior and middle frontal gyrus and left cerebellum in PG patients as compared to controls. The increased connectivity to the cerebellum was positively correlated with smoking in the PG group. Our results provide further evidence for alterations in functional connectivity in PG with increased connectivity between prefrontal regions and the reward system, similar to connectivity changes reported in substance use disorder.	[Koehler, Saskia; Ovadia-Caro, Smadar; van der Meer, Elke; Villringer, Arno; Heinz, Andreas; Margulies, Daniel S.] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany; [Koehler, Saskia; Ovadia-Caro, Smadar; van der Meer, Elke; Villringer, Arno; Heinz, Andreas; Margulies, Daniel S.] Humboldt Univ, Mind Brain Inst, D-10099 Berlin, Germany; [Koehler, Saskia; Heinz, Andreas; Romanczuk-Seiferth, Nina] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Koehler, Saskia; Ovadia-Caro, Smadar; van der Meer, Elke] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Koehler, Saskia; Ovadia-Caro, Smadar; Villringer, Arno; Margulies, Daniel S.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany	Humboldt University of Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Max Planck Society	Koehler, S (corresponding author), Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany.	saskia.koehler@psychologie.hu-berlin.de	Heinz, Andreas/ABB-7736-2020; Romanczuk-Seiferth, Nina/AFN-7029-2022; Romanczuk-Seiferth, Nina/AFN-0829-2022; Margulies, Daniel/L-4719-2016	Heinz, Andreas/0000-0001-5405-9065; Romanczuk-Seiferth, Nina/0000-0002-6931-269X; Villringer, Arno/0000-0003-2604-2404; Margulies, Daniel/0000-0002-8880-9204	Senatsverwaltung fur Gesundheit, Umwelt und Verbraucherschutz, Berlin; Deutsche Forschungsgemeinschaft (DFG); graduate school 86 "Berlin School of Mind and Brain"; Minerva Stiftung; German Research Foundation (Deutsche Forschungsgemeinschaft) [HE 2597/4-3, 7-3, 13-1, 14-1, 15-1, 1430/2-1]; German Federal Ministry of Education and Research [01GQ0411, 01QG87164, NGFN Plus 01 GS 08152, 01 GS 08 159]	Senatsverwaltung fur Gesundheit, Umwelt und Verbraucherschutz, Berlin; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); graduate school 86 "Berlin School of Mind and Brain"; Minerva Stiftung; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was funded by "Senatsverwaltung fur Gesundheit, Umwelt und Verbraucherschutz, Berlin", Deutsche Forschungsgemeinschaft (DFG), graduate school 86 "Berlin School of Mind and Brain" (Koehler and Ovadia-Caro), and Minerva Stiftung (Ovadia-Caro). Andreas Heinz has received research funding from the German Research Foundation (Deutsche Forschungsgemeinschaft; HE 2597/4-3; 7-3; 13-1; 14-1; 15-1; Excellence Cluster Exc 257 & STE 1430/2-1) and the German Federal Ministry of Education and Research (01GQ0411; 01QG87164; NGFN Plus 01 GS 08152 and 01 GS 08 159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Balodis IM, 2012, BIOL PSYCHIAT, V71, P749, DOI 10.1016/j.biopsych.2012.01.006; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Buchsbaum BR, 2005, HUM BRAIN MAPP, V25, P35, DOI 10.1002/hbm.20128; Camara E, 2009, FRONT NEUROSCI-SWITZ, V3, P350, DOI 10.3389/neuro.01.034.2009; Camara E, 2009, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.019.2008; Cauda F, 2011, J COGNITIVE NEUROSCI, V23, P2864, DOI 10.1162/jocn.2011.21624; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; CHANRAUD S, 2011, CEREB CORTEX, V21, P1; Choi JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045938; Cohen J.R., 2010, SELF CONTROL SOC MIN, P141, DOI [10.1093/acprof:oso/9780195391381.003.0008, DOI 10.1093/ACPROF:OSO/9780195391381.003.0008]; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; de Ruiter MB, 2009, NEUROPSYCHOPHARMACOL, V34, P1027, DOI 10.1038/npp.2008.175; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Diekhof EK, 2010, J NEUROSCI, V30, P1488, DOI 10.1523/JNEUROSCI.4690-09.2010; Diekhof EK, 2012, HUM BRAIN MAPP, V33, P2768, DOI 10.1002/hbm.21398; First M.B., 2014, STRUCTURED CLIN INTE; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Goudriaan AE, 2005, COGNITIVE BRAIN RES, V23, P137, DOI 10.1016/j.cogbrainres.2005.01.017; Grant JE, 2010, AM J DRUG ALCOHOL AB, V36, P233, DOI 10.3109/00952990.2010.491884; Gu H, 2010, NEUROIMAGE, V53, P593, DOI 10.1016/j.neuroimage.2010.06.066; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; Hewig J, 2010, BIOL PSYCHIAT, V67, P781, DOI 10.1016/j.biopsych.2009.11.009; Jia ZR, 2011, BIOL PSYCHIAT, V70, P553, DOI 10.1016/j.biopsych.2011.05.008; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Kim SW, 2009, PSYCHIAT RES, V166, P76, DOI 10.1016/j.psychres.2007.11.008; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Knoch D, 2007, ANN NY ACAD SCI, V1104, P123, DOI 10.1196/annals.1390.004; KOEHLER S, 2013, BRAIN STRUCT FUNCT; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Lutz R, 2005, MMW Fortschr Med, V147, P41; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Marazziti Donatella, 2008, Clin Pract Epidemiol Ment Health, V4, P7, DOI 10.1186/1745-0179-4-7; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Oberg SAK, 2011, NEUROPSYCHOLOGIA, V49, P3768, DOI 10.1016/j.neuropsychologia.2011.09.037; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Peters J, 2011, AM J PSYCHIAT, V168, P540, DOI 10.1176/appi.ajp.2010.10071024; PETRY J, 1996, KFG KURZFRAGEBOGEN Z, P300; Potenza MN, 2003, AM J PSYCHIAT, V160, P1990, DOI 10.1176/appi.ajp.160.11.1990; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Roca M, 2010, BRAIN, V133, P234, DOI 10.1093/brain/awp269; Rogers BP, 2012, ALCOHOL CLIN EXP RES, V36, P294, DOI 10.1111/j.1530-0277.2011.01614.x; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Tomasi Dardo, 2010, PLoS One, V5, pe10815, DOI 10.1371/journal.pone.0010815; Tschernegg M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00625; Upadhyay J, 2010, BRAIN, V133, P2098, DOI 10.1093/brain/awq138; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; van Hell HH, 2010, EUR NEUROPSYCHOPHARM, V20, P153, DOI 10.1016/j.euroneuro.2009.11.010; van Holst RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030909; van Holst RJ, 2012, BIOL PSYCHIAT, V71, P741, DOI 10.1016/j.biopsych.2011.12.030; von Aster M., 2006, WECHSLER INTELLIGENZ, V2; Wang YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058098; Wilcox CE, 2011, DRUG ALCOHOL DEPEN, V115, P137, DOI 10.1016/j.drugalcdep.2011.01.009; Wrase J, 2007, NEUROIMAGE, V35, P787, DOI 10.1016/j.neuroimage.2006.11.043; Yuan K, 2010, NEUROSCI LETT, V482, P101, DOI 10.1016/j.neulet.2010.07.005	70	38	38	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84565	10.1371/journal.pone.0084565	http://dx.doi.org/10.1371/journal.pone.0084565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367675	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900055
J	Xu, WJ; Shi, LL; Chan, O; Li, J; Casper, P; Zou, XM				Xu, Wenjing; Shi, Lingling; Chan, Onchim; Li, Jiao; Casper, Peter; Zou, Xiaoming			Assessing the Effect of Litter Species on the Dynamic of Bacterial and Fungal Communities during Leaf Decomposition in Microcosm by Molecular Techniques	PLOS ONE			English	Article							NUTRIENT DYNAMICS; HEADWATER STREAM; DECAYING LEAVES; FOREST STREAM; DIVERSITY; QUALITY; ECOSYSTEMS; COLONIZATION; TANNINS; BEECH	Although bacteria and fungi are well-known to be decomposers of leaf litter, few studies have examined their compositions and diversities during the decomposition process in tropical stream water. Xishuangbanna is a tropical region preserving one of the highest floristic diversity areas in China. In this study, leaf litter of four dominant plant species in Xishuangbanna was incubated in stream water for 42 days during which samples were taken regularly. Following DNA extraction, PCR-DGGE (denaturing gradient gel electrophoresis) and clone-sequencing analyses were performed using bacterial and fungal specific primers. Leaf species have slightly influences on bacterial community rather than fungal community. The richness and diversity of bacteria was higher than that of fungi, which increased towards the end of the 42-day-incubation. The bacterial community was initially more specific upon the type of leaves and gradually became similar at the later stage of decomposition with alpha-proteobacteria as major component. Sequences affiliated to methanotrophs were obtained that indicates potentially occurrence of methane oxidation and methanogenesis. For the fungal community, sequences affiliated to Aspergillus were predominant at the beginning and then shifted to Pleosporales. Our results suggest that the microorganisms colonizing leaf biofilm in tropical stream water were mostly generalists that could exploit the resources of leaves of various species equally well.	[Xu, Wenjing; Shi, Lingling; Chan, Onchim; Li, Jiao] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China; [Xu, Wenjing; Shi, Lingling] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Wenjing] Anhui Acad Agr Sci, Inst Agr Engn, Hefei, Anhui, Peoples R China; [Li, Jiao] Yunnan Univ, Fac Life Sci, Dept Biol, Kunming, Yunnan, Peoples R China; [Casper, Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Expt Limnol, Stechlin, Germany; [Zou, Xiaoming] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China; [Zou, Xiaoming] Univ Puerto Rico, Inst Trop Ecosyst Studies, San Juan, PR 00936 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Anhui Academy of Agricultural Sciences; Yunnan University; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Nanjing Forestry University; University of Puerto Rico; University of Puerto Rico Rio Piedras	Shi, LL (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China.	shill@xtbg.ac.cn	Casper, Peter/B-7384-2011; Zou, Xiaoming/GWV-5608-2022	Casper, Peter/0000-0002-5956-4674; Zou, Xiaoming/0000-0001-9023-3067	National Science Foundation of China [30670308]; Chinese Academy of Sciences	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors thank National Science Foundation of China (Grant no. 30670308) and Program of Studying Abroad, Chinese Academy of Sciences, for the financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja MK, 2006, MICROB ECOL, V52, P127, DOI 10.1007/s00248-006-9006-3; Buesing N, 2006, APPL ENVIRON MICROB, V72, P596, DOI 10.1128/AEM.72.1.596-605.2006; CHAMIER AC, 1984, OECOLOGIA, V64, P92, DOI 10.1007/BF00377550; Chan OC, 2008, FEMS MICROBIOL ECOL, V64, P449, DOI 10.1111/j.1574-6941.2008.00488.x; Cortez J, 1996, SOIL BIOL BIOCHEM, V28, P443, DOI 10.1016/0038-0717(96)00005-3; COVICH AP, 1988, J N AM BENTHOL SOC, V7, P361, DOI 10.2307/1467297; Cox P., 1997, Mycologist, V11, P55, DOI 10.1016/S0269-915X(97)80034-1; Das M, 2008, MYCOL PROG, V7, P267, DOI 10.1007/s11557-008-0569-x; Duarte S, 2009, APPL ENVIRON MICROB, V75, P6211, DOI 10.1128/AEM.00971-09; EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353; Enya J, 2007, J PHYTOPATHOL, V155, P446, DOI 10.1111/j.1439-0434.2007.01256.x; GALLARDO A, 1993, ECOLOGY, V74, P152, DOI 10.2307/1939510; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gulis V, 2003, AQUAT MICROB ECOL, V30, P149, DOI 10.3354/ame030149; Gulis V, 2003, FRESHWATER BIOL, V48, P123, DOI 10.1046/j.1365-2427.2003.00985.x; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Leys NMEJ, 2004, APPL ENVIRON MICROB, V70, P1944, DOI 10.1128/AEM.70.4.1944-1955.2004; Mathuriau C, 2002, J N AM BENTHOL SOC, V21, P384, DOI 10.2307/1468477; May LA, 2001, CAN J MICROBIOL, V47, P829, DOI 10.1139/cjm-47-9-829; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Mfilinge PL, 2002, TREES-STRUCT FUNCT, V16, P172, DOI 10.1007/s00468-001-0156-0; Mille-Lindblom C, 2006, FRESHWATER BIOL, V51, P730, DOI 10.1111/j.1365-2427.2006.01532.x; Moller J, 1999, SOIL BIOL BIOCHEM, V31, P367, DOI 10.1016/S0038-0717(98)00138-2; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Nikolcheva LG, 2005, ENVIRON MICROBIOL, V7, P270, DOI 10.1111/j.1462-2920.2004.00709.x; Nikolcheva LG, 2003, APPL ENVIRON MICROB, V69, P2548, DOI 10.1128/AEM.69.5.2548-2554.2003; Nikolcheva Liliya G., 2005, P169, DOI 10.1007/1-4020-3466-0_22; Pearson RG, 2000, FRESHWATER BIOL, V43, P31, DOI 10.1046/j.1365-2427.2000.00504.x; Sridhar KR, 2000, APPL ENVIRON MICROB, V66, P1114, DOI 10.1128/AEM.66.3.1114-1119.2000; SRINIVASAN MC, 1991, WORLD J MICROB BIOT, V7, P171, DOI 10.1007/BF00328987; STOUT RJ, 1989, CAN J FISH AQUAT SCI, V46, P1097, DOI 10.1139/f89-142; TEUBEN A, 1990, BIOL FERT SOILS, V9, P145, DOI 10.1007/BF00335798; Tuchman NC, 2003, HYDROBIOLOGIA, V495, P203, DOI 10.1023/A:1025493018012; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Wardle DA, 2006, SOIL BIOL BIOCHEM, V38, P1052, DOI 10.1016/j.soilbio.2005.09.003; Webster JR, 1997, J N AM BENTHOL SOC, V16, P3, DOI 10.2307/1468223; Weidner S, 2000, MICROBIAL ECOL, V39, P22, DOI 10.1007/s002489900194; White, 1990, PCR PROTOCOLS GUIDE, P315; Wohl DL, 1998, FEMS MICROBIOL ECOL, V26, P135, DOI 10.1111/j.1574-6941.1998.tb00499.x; Wright MS, 2005, MICROB ECOL, V49, P536, DOI 10.1007/s00248-004-0052-4	40	14	14	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84613	10.1371/journal.pone.0084613	http://dx.doi.org/10.1371/journal.pone.0084613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367682	Green Submitted, Green Published, gold			2022-12-27	WOS:000328741900058
J	Lee, Y				Lee, Youngseok			Contribution of Drosophila TRPA1-Expressing Neurons to Circadian Locomotor Activity Patterns	PLOS ONE			English	Article							TEMPERATURE SYNCHRONIZATION; FRUIT-FLY; CLOCK; LIGHT; BEHAVIOR; CHANNEL; GENE; RHYTHM; CRYPTOCHROME; NEUROPEPTIDE	In both vertebrates and invertebrates, Transient Receptor Potential (TRP) channels are expressed in sensory neurons and mediate environmental stimuli such as light, sound, temperature, and taste. Some of these channels, however, are expressed only in the brain and their functions remain incompletely understood. Using the GAL4/UAS binary system with a line in which the GAL4 had been knocked into the trpA1 locus in Drosophila, we recently reported new insights into TRPA1 localization and function, including its expression in approximately 15% of all circadian neurons. TRPA1 is expressed in lateral posterior neurons (LPNs), which are known to be highly sensitive to entrainment by temperature cycles. Here, I used the bacterial sodium channel, NaChBac, to examine the effects of altering the electrical properties of trpA1 neurons on circadian rhythms. My results indicate that circadian activity of the flies in the morning, daytime, and evening was affected in a temperature-dependent manner following TRPA1 neuronal activation. Remarkably, TRPA1 neuron activation in flies kept at 18 degrees C impacted the morning peak of circadian activity even though TRPA1 is not expressed in morning cells. Taken together, these results suggest that the activation of TRPA1-expressing neurons may differentially coordinate light/dark circadian entrainment, depending on the temperature.	Kookmin Univ, Dept Bio & Fermentat Convergence Technol, Seoul, South Korea	Kookmin University	Lee, Y (corresponding author), Kookmin Univ, Dept Bio & Fermentat Convergence Technol, Seoul, South Korea.	ylee@kookmin.ac.kr		Lee, Youngseok/0000-0003-0459-1138	National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning [2012M3A9B2052525]; Basic Science Research Program of the NRF of Korea; Ministry of Education [2012R1A1A2003727]; Kookmin University in Korea [J2013-0027]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Basic Science Research Program of the NRF of Korea(National Research Foundation of Korea); Ministry of Education; Kookmin University in Korea	This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012M3A9B2052525), the Basic Science Research Program of the NRF of Korea funded by the Ministry of Education (2012R1A1A2003727) and the new faculty research program (J2013-0027) of Kookmin University in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Gentile C, 2013, CURR BIOL, V23, P185, DOI 10.1016/j.cub.2012.12.023; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Kaneko H, 2012, CURR BIOL, V22, P1851, DOI 10.1016/j.cub.2012.08.006; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Lee Y, 2013, J NEUROSCI, V33, P6716, DOI 10.1523/JNEUROSCI.4237-12.2013; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2009, J BIOL RHYTHM, V24, P271, DOI 10.1177/0748730409338508; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wolfgang W, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0959; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yoshii T, 2005, EUR J NEUROSCI, V22, P1176, DOI 10.1111/j.1460-9568.2005.04295.x; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	36	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e85189	10.1371/journal.pone.0085189	http://dx.doi.org/10.1371/journal.pone.0085189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367706	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300160
J	Nakielski, J; Lipowczan, M				Nakielski, Jerzy; Lipowczan, Marcin			Spatial and Directional Variation of Growth Rates in Arabidopsis Root Apex: A Modelling Study	PLOS ONE			English	Article							TENSOR-BASED MODEL; CELL DIVISIONS; THALIANA; ANISOTROPY; MERISTEM; MOTION; APICES	Growth and cellular organization of the Arabidopsis root apex are investigated in various aspects, but still little is known about spatial and directional variation of growth rates in very apical part of the apex, especially in 3D. The present paper aims to fill this gap with the aid of a computer modelling based on the growth tensor method. The root apex with a typical shape and cellular pattern is considered. Previously, on the basis of two types of empirical data: the published velocity profile along the root axis and dimensions of cell packets formed in the lateral part of the root cap, the displacement velocity field for the root apex was determined. Here this field is adopted to calculate the linear growth rate in different points and directions. The results are interpreted taking principal growth directions into account. The root apex manifests a significant anisotropy of the linear growth rate. The directional preferences depend on a position within the root apex. In the root proper the rate in the periclinal direction predominates everywhere, while in the root cap the predominating direction varies with distance from the quiescent centre. The rhizodermis is distinguished from the neighbouring tissues (cortex, root cap) by relatively high contribution of the growth rate in the anticlinal direction. The degree of growth anisotropy calculated for planes defined by principal growth directions and exemplary cell walls may be as high as 25. The changes in the growth rate variation are modelled.	[Nakielski, Jerzy; Lipowczan, Marcin] Univ Silesia, Dept Biophys & Morphogenesis Plants, Katowice, Poland	University of Silesia in Katowice	Nakielski, J (corresponding author), Univ Silesia, Dept Biophys & Morphogenesis Plants, Katowice, Poland.	jerzy.nakielski@us.edu.pl	Lipowczan, Marcin/ABF-6842-2020	Lipowczan, Marcin/0000-0002-2508-3354				Barlow Peter W., 1997, P29, DOI 10.1016/B978-012563455-7/50003-9; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Baskin TI, 1999, PLANT PHYSIOL, V119, P681, DOI 10.1104/pp.119.2.681; Campilho A, 2006, PLANT J, V48, P619, DOI 10.1111/j.1365-313X.2006.02892.x; CLOWES FAL, 1956, J EXP BOT, V7, P307, DOI 10.1093/jxb/7.3.307; DOLAN L, 1993, DEVELOPMENT, V119, P71; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; ERICKSON RO, 1986, PLANT PHYSIOL, V82, P1153, DOI 10.1104/pp.82.4.1153; ERICKSON RO, 1966, J EXP BOT, V17, P390, DOI 10.1093/jxb/17.2.390; GANDAR PW, 1983, BOT GAZ, V144, P1, DOI 10.1086/337337; HEJNOWICZ Z, 1984, ACTA SOC BOT POL, V53, P29; HEJNOWICZ Z, 1988, ACTA SOC BOT POL, V57, P31, DOI 10.5586/asbp.1988.004; HEJNOWICZ Z, 1989, ENVIRON EXP BOT, V29, P85, DOI 10.1016/0098-8472(89)90041-5; HEJNOWICZ Z, 1984, J THEOR BIOL, V110, P93, DOI 10.1016/S0022-5193(84)80017-X; HEJNOWICZ Z, 1986, J THEOR BIOL, V121, P59, DOI 10.1016/S0022-5193(86)80028-5; HEJNOWICZ Z, 1993, AM J BOT, V80, P309, DOI 10.2307/2445354; Jiang K, 2005, ANNU REV CELL DEV BI, V21, P485, DOI 10.1146/annurev.cellbio.21.122303.114753; Kennaway R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002071; Kidner C, 2000, PLANTA, V211, P191, DOI 10.1007/s004250000284; Kwiatkowska D, 2004, AM J BOT, V91, P1277, DOI 10.3732/ajb.91.9.1277; NAKIELSKI J, 1987, ACTA SOC BOT POL, V56, P625, DOI 10.5586/asbp.1987.055; Nakielski J, 2003, NATO SCI SER II-MATH, V121, P119; Nakielski J, 2008, PLANTA, V228, P179, DOI 10.1007/s00425-008-0728-y; Nakielski Jerzy, 1991, Acta Societatis Botanicorum Poloniae, V60, P77, DOI 10.5586/asbp.1991.005; Nakielski J, 2012, PLANTA, V236, P1547, DOI 10.1007/s00425-012-1707-x; Priestley J., 1930, NEW PHYTOL, V29, P96, DOI [10.1111/j.1469-8137.1930.tb06983.x, DOI 10.1111/J.1469-8137.1930.TB06983.X]; Richards OW, 1943, AM NAT, V77, P385, DOI 10.1086/281140; Romberger JA, 2004, PLANT STRUCTURE FUNC, V1st; Sachs J., 1887, LECT PLANT PHYSL, P431; SILK WK, 1979, J THEOR BIOL, V76, P481, DOI 10.1016/0022-5193(79)90014-6; Silk WK, 2006, J PLANT RES, V119, P23, DOI 10.1007/s10265-005-0248-9; SILK WK, 1984, ANNU REV PLANT PHYS, V35, P479, DOI 10.1146/annurev.pp.35.060184.002403; Spiegel M.R., 1959, THEORY PROBLEMS VECT; Szymanowska-Pulka J, 2010, PLANTA, V232, P1207, DOI 10.1007/s00425-010-1239-1; van den Berg C, 1998, PLANTA, V205, P483, DOI 10.1007/s004250050347; van der Weele CM, 2003, PLANT PHYSIOL, V132, P1138, DOI 10.1104/pp.103.021345; Waishel, 1996, PLANT ROOTS HIDDEN H, P51; Wasteneys GO, 2006, J PLANT RES, V119, P5, DOI 10.1007/s10265-005-0233-3; Wiese A, 2007, NEW PHYTOL, V174, P752, DOI 10.1111/j.1469-8137.2007.02053.x; Wuyts N, 2011, PLANTA, V234, P769, DOI 10.1007/s00425-011-1435-7	40	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84337	10.1371/journal.pone.0084337	http://dx.doi.org/10.1371/journal.pone.0084337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367654	Green Submitted, Green Published, gold			2022-12-27	WOS:000328740300137
J	Pereira, NZ; Cardoso, EC; Oliveira, LMD; de Lima, JF; Branco, ACCC; Ruocco, RMDA; Zugaib, M; de Oliveira, JB; Duarte, AJD; Sato, MN				Pereira, Natalli Zanete; Cardoso, Elaine Cristina; da Silva Oliveira, Luanda Mara; de Lima, Josenilson Feitosa; Calvielli Castelo Branco, Anna Claudia; de Souza Aveiro Ruocco, Rosa Maria; Zugaib, Marcelo; de Oliveira Filho, Joao Bosco; da Silva Duarte, Alberto Jose; Sato, Maria Notomi			Upregulation of Innate Antiviral Restricting Factor Expression in the Cord Blood and Decidual Tissue of HIV-Infected Mothers	PLOS ONE			English	Article							IMMUNE-RESPONSE; DISEASE PROGRESSION; UNINFECTED INFANTS; INFLUENZA-VIRUS; EDITING ENZYME; BREAST-MILK; APOBEC3G; CELLS; TRANSMISSION; PROTEIN	Programs for the prevention of mother-to-child transmission of HIV have reduced the transmission rate of perinatal HIV infection and have thereby increased the number of HIV-exposed uninfected (HEU) infants. Natural immunity to HIV-1 infection in both mothers and newborns needs to be further explored. In this study, we compared the expression of antiviral restricting factors in HIV-infected pregnant mothers treated with antiretroviral therapy (ART) in pregnancy (n=23) and in cord blood (CB) (n=16), placental tissues (n=10-13) and colostrum (n=5-6) samples and compared them to expression in samples from uninfected (UN) pregnant mothers (n=21). Mononuclear cells (MNCs) were prepared from maternal and CB samples following deliveries by cesarean section. Maternal (decidua) and fetal (chorionic villus) placental tissues were obtained, and colostrum was collected 24 h after delivery. The mRNA and protein expression levels of antiviral factors were then evaluated. We observed a significant increase in the mRNA expression levels of antiviral factors in MNCs from HIV-infected mothers and CB, including the apolipoprotein B mRNA-editing enzyme 3G (A3G), A3F, tripartite motif family-5 alpha (TRIM-5 alpha), TRIM-22, myxovirus resistance protein A (MxA), stimulator of interferon (IFN) genes (STING) and IFN-beta, compared with the levels detected in uninfected (UN) mother-CB pairs. Moreover, A3G transcript and protein levels and alpha-defensin transcript levels were decreased in the decidua of HIV-infected mothers. Decreased TRIM-5 alpha protein levels in the villi and increased STING mRNA expression in both placental tissues were also observed in HIV-infected mothers compared with uninfected (UN) mothers. Additionally, colostrum cells from infected mothers showed increased tetherin and IFN-beta mRNA levels and CXCL9 protein levels. The data presented here indicate that antiviral restricting factor expression can be induced in utero in HIV-infected mothers. Future studies are warranted to determine whether this upregulation of antiviral factors during the perinatal period has a protective effect against HIV-1 infection.	[Pereira, Natalli Zanete; Cardoso, Elaine Cristina; da Silva Oliveira, Luanda Mara; de Lima, Josenilson Feitosa; Calvielli Castelo Branco, Anna Claudia; da Silva Duarte, Alberto Jose; Sato, Maria Notomi] Univ Sao Paulo, Sch Med, Lab Dermatol & Immunodeficiencies, LIM 56,Dept Dermatol,Trop Med Inst Sao Paulo, Sao Paulo, Brazil; [de Souza Aveiro Ruocco, Rosa Maria; Zugaib, Marcelo] Univ Sao Paulo, Sch Med, Dept Obstet & Gynecol, Hosp Clin, Sao Paulo, Brazil; [de Oliveira Filho, Joao Bosco] Med Inst Prof Fernando Figueira IMIP, Dept Pediat, Recife, PE, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto de Medicina Integral Professor Fernando Figueira (IMIP)	Sato, MN (corresponding author), Univ Sao Paulo, Sch Med, Lab Dermatol & Immunodeficiencies, LIM 56,Dept Dermatol,Trop Med Inst Sao Paulo, Sao Paulo, Brazil.	marisato@usp.br	Sato, Maria N/C-2853-2012; Zugaib, Marcelo/A-5724-2013; de Oliveira, João/GWV-0126-2022; Duarte, Alberto J S/D-4382-2012; Oliveira, Joao Bosco/AAC-9947-2021; Pereira, Nátalli Zanete/U-7291-2019; da Silva Oliveira, Luanda Mara/E-7273-2013; Sato, Maria N/C-1196-2012	Zugaib, Marcelo/0000-0003-1155-2671; Oliveira, Joao Bosco/0000-0001-9388-8173; Pereira, Nátalli Zanete/0000-0002-8875-9470; da Silva Oliveira, Luanda Mara/0000-0003-0903-8219; Sato, Maria N/0000-0002-7911-1824	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/55962-3, 2012/18837-1]; Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2008/55962-3, 2012/18837-1) and the Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2006, HUM REPROD, V21, P2432, DOI 10.1093/humrep/del178; Abramczuk BM, 2011, CLIN VACCINE IMMUNOL, V18, P1406, DOI 10.1128/CVI.05065-11; Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Amoedo ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024118; Arhel NJ, 2008, BLOOD, V112, P3772, DOI 10.1182/blood-2008-04-151761; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Biasin M, 2007, J INFECT DIS, V195, P960, DOI 10.1086/511988; Bosire R, 2007, BREASTFEED MED, V2, P129, DOI 10.1089/bfm.2007.0009; Bunupuradah T, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-34; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Cardoso EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067036; Farquhar C, 2008, CLIN EXP IMMUNOL, V153, P37, DOI 10.1111/j.1365-2249.2008.03664.x; Farquhar C, 2005, CURR HIV RES, V3, P361, DOI 10.2174/157016205774370393; Feiterna-Sperling C, 2007, JAIDS-J ACQ IMM DEF, V45, P43, DOI 10.1097/QAI.0b013e318042d5e3; Futata EA, 2012, EXPERT REV ANTI-INFE, V10, P289, DOI [10.1586/eri.12.9, 10.1586/ERI.12.9]; Giaquinto C, 2005, BJOG-INT J OBSTET GY, V112, P881, DOI 10.1111/j.1471-0528.2005.00569.x; Hattlmann Clayton J, 2012, Mol Biol Int, V2012, P153415, DOI 10.1155/2012/153415; Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohman-Payne B, 2010, CLIN PERINATOL, V37, P787, DOI 10.1016/j.clp.2010.08.005; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mazzola TN, 2011, AIDS, V25, P2079, DOI 10.1097/QAD.0b013e32834bba0a; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Mous K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033934; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Sanchez-Rodriguez EN, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-8; Sewram S, 2009, J INFECT DIS, V199, P1657, DOI 10.1086/598861; Singh KK, 2013, JAIDS-J ACQ IMM DEF, V62, P197, DOI 10.1097/QAI.0b013e31827ab612; Speelmon EC, 2006, J VIROL, V80, P2463, DOI 10.1128/JVI.80.5.2463-2471.2006; Takahata Y, 2003, ACTA PAEDIATR, V92, P659, DOI 10.1080/08035250310002614; Tomescu C, 2011, CLIN EXP IMMUNOL, V164, P158, DOI 10.1111/j.1365-2249.2011.04379.x; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Uchide N, 2002, BIOL PHARM BULL, V25, P109, DOI 10.1248/bpb.25.109; Vazquez-Perez JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-23; Vince GS, 2000, BIOCHEM SOC T, V28, P191, DOI 10.1042/bst0280191; VONWUSSOW P, 1990, AIDS, V4, P119, DOI 10.1097/00002030-199002000-00004; Ziske J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055633	43	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84917	10.1371/journal.pone.0084917	http://dx.doi.org/10.1371/journal.pone.0084917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367701	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300159
J	Vazquez-de-Aldana, BR; Garcia-Ciudad, A; Garcia-Criado, B; Vicente-Tavera, S; Zabalgogeazcoa, I				Vazquez-de-Aldana, Beatriz R.; Garcia-Ciudad, Antonia; Garcia-Criado, Balbino; Vicente-Tavera, Santiago; Zabalgogeazcoa, Inigo			Fungal Endophyte (Epichloe festucae) Alters the Nutrient Content of Festuca rubra Regardless of Water Availability	PLOS ONE			English	Article							INFECTED TALL FESCUE; LOLIUM-PERENNE; ACREMONIUM-COENOPHIALUM; DEFENSIVE MUTUALISM; STRESS TOLERANCE; ALKALOID CONTENT; GROWTH; DROUGHT; GRASSES; RESISTANCE	Festuca rubra plants maintain associations with the vertically transmitted fungal endophyte Epichloe festucae. A high prevalence of infected host plants in semiarid grasslands suggests that this association could be mutualistic. We investigated if the Epichloe-endophyte affects the growth and nutrient content of F. rubra plants subjected to drought. Endophyte-infected (E+) and non-infected (E-) plants of two half-sib lines (PEN and RAB) were subjected to three water availability treatments. Shoot and root biomass, nutrient content, proline, phenolic compounds and fungal alkaloids were measured after the treatments. The effect of the endophyte on shoot and root biomass and dead leaves depended on the plant line. In the PEN line, E+ plants had a greater S: R ratio than E-, but the opposite occurred in RAB. In both plant lines and all water treatments, endophyte-infected plants had greater concentrations of N, P and Zn in shoots and Ca, Mg and Zn in roots than E- plants. On average, E+ plants contained in their shoots more P (62%), Zn (58%) and N (19%) than E- plants. While the proline in shoots increased in response to water stress, the endophyte did not affect this response. A multivariate analysis showed that endophyte status and plant line impose stronger differences in the performance of the plants than the water stress treatments. Furthermore, differences between PEN and RAB lines seemed to be greater in E- than in E+ plants, suggesting that E+ plants of both lines are more similar than those of their non-infected version. This is probably due to the endophyte producing a similar effect in both plant lines, such as the increase in N, P and Zn in shoots. The remarkable effect of the endophyte in the nutrient balance of the plants could help to explain the high prevalence of infected plants in natural grasslands.	[Vazquez-de-Aldana, Beatriz R.; Garcia-Ciudad, Antonia; Garcia-Criado, Balbino; Zabalgogeazcoa, Inigo] CSIC, Inst Recursos Nat & Agrobiol Salamanca IRNASA, Dept Abiot Stress, Salamanca, Spain; [Vicente-Tavera, Santiago] Univ Salamanca, Dept Stat, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Salamanca (IRNASA); University of Salamanca	Vazquez-de-Aldana, BR (corresponding author), CSIC, Inst Recursos Nat & Agrobiol Salamanca IRNASA, Dept Abiot Stress, Salamanca, Spain.	beatriz.dealdana@irnasa.csic.es	Vazquez de Aldana, Beatriz R/A-7760-2008; Vicente-Tavera, Santiago/L-5605-2014; Zabalgogeazcoa, Iñigo/F-9523-2016; Vázquez-de-Aldana, Beatriz R./AGN-2436-2022	Vazquez de Aldana, Beatriz R/0000-0001-6549-3545; Vicente-Tavera, Santiago/0000-0001-5929-6844; Zabalgogeazcoa, Iñigo/0000-0002-9524-7799; Vázquez-de-Aldana, Beatriz R./0000-0001-6549-3545	Spanish Ministry of Economy and Competitiveness [AGL2008-01159, AGL2011-22783]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was funded by projects AGL2008-01159 and AGL2011-22783 from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlholm JU, 2002, OIKOS, V99, P173, DOI 10.1034/j.1600-0706.2002.990118.x; [Anonymous], 2004, WILD SOWN GRASSES PR; AOAC, 2002, OFFICIAL METHODS ANA, V15th, DOI DOI 10.1007/978-3-642-31241-0; ARACHEVALETA M, 1989, AGRON J, V81, P83, DOI 10.2134/agronj1989.00021962008100010015x; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Assuero SG, 2000, NEW ZEAL J AGR RES, V43, P49, DOI 10.1080/00288233.2000.9513408; Bacon C.W., 1994, BIOTECHNOLOGY ENDOPH, P47; BACON CW, 1995, J ANIM SCI, V73, P861; Barker DJ., 1993, P 2 INT S ACR GRASS, P67; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bayat F, 2009, RUSS J PLANT PHYSL+, V56, P510, DOI 10.1134/S1021443709040104; Bazely DR, 1997, J APPL ECOL, V34, P847, DOI 10.2307/2405276; BELESKY DP, 1989, ANN BOT-LONDON, V64, P343, DOI 10.1093/oxfordjournals.aob.a087850; Bush LP, 1997, PLANT PHYSIOL, V114, P1, DOI 10.1104/pp.114.1.1; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Cheplick GP, 2004, AM J BOT, V91, P1960, DOI 10.3732/ajb.91.12.1960; Cheplick GP, 2000, FUNCT ECOL, V14, P657, DOI 10.1046/j.1365-2435.2000.00466.x; Christensen MJ, 1997, MYCOL RES, V101, P493, DOI 10.1017/S0953756296002833; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Duque Macias F, 1970, AN EDAFOL AGROBIOL, V30, P207; Elbersen HW, 1996, GRASS FORAGE SCI, V51, P333, DOI 10.1111/j.1365-2494.1996.tb02068.x; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Galindo P., 1986, PUBLICACIONES BIOEST, V17, P45; Galindo Villardon M.P., 1986, QUESTIIO, V10, P13; Gange AC, 1999, NEW PHYTOL, V142, P123, DOI 10.1046/j.1469-8137.1999.00371.x; Garcia RA, 2002, MOL ECOL, V11, P355, DOI 10.1046/j.0962-1083.2001.01456.x; Garcia-Talegon J, 1999, CHEM GEOL, V153, P37, DOI 10.1016/S0009-2541(98)00151-X; GARNER GB, 1993, AGR ECOSYST ENVIRON, V44, P65, DOI 10.1016/0167-8809(93)90039-R; Gibert A, 2012, NEW PHYTOL, V194, P561, DOI 10.1111/j.1469-8137.2012.04073.x; Granath G, 2007, ECOGRAPHY, V30, P422, DOI [10.1111/j.2007.0906-7590.05027.x, 10.1111/j.0906-7590.2007.05027.x]; Gundel PE, 2011, CROP PASTURE SCI, V62, P1010, DOI 10.1071/CP11300; Hahn H, 2008, ENVIRON EXP BOT, V63, P183, DOI 10.1016/j.envexpbot.2007.10.021; Hamilton CE, 2012, FUNGAL DIVERS, V54, P1, DOI 10.1007/s13225-012-0158-9; Hesse U, 2005, EUR J AGRON, V22, P45, DOI 10.1016/j.eja.2003.12.002; HILL NS, 1993, CROP SCI, V33, P331, DOI 10.2135/cropsci1993.0011183X003300020024x; Hyde KD, 2008, FUNGAL DIVERS, V33, P163; Kane KH, 2011, ENVIRON EXP BOT, V71, P337, DOI 10.1016/j.envexpbot.2011.01.002; LEUCHTMANN A, 1994, MYCOLOGIA, V86, P802, DOI 10.2307/3760595; LEWIS GC, 1992, GRASS FORAGE SCI, V47, P302, DOI 10.1111/j.1365-2494.1992.tb02274.x; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048010; LYONS PC, 1990, PLANT PHYSIOL, V92, P726, DOI 10.1104/pp.92.3.726; Malinowski DP, 1998, PLANT SOIL, V205, P1, DOI 10.1023/A:1004331932018; Malinowski DP, 2000, PLANT SOIL, V227, P115, DOI 10.1023/A:1026518828237; Malinowski DP, 1998, PLANT SOIL, V198, P53, DOI 10.1023/A:1004279401196; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; Monnet F, 2005, FUNCT PLANT BIOL, V32, P131, DOI 10.1071/FP04129; Ponce MA, 2009, BIOCHEM SYST ECOL, V37, P245, DOI 10.1016/j.bse.2009.03.010; READ JC, 1986, AGRON J, V78, P848, DOI 10.2134/agronj1986.00021962007800050021x; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Ren AZ, 2011, PLANT SOIL, V346, P363, DOI 10.1007/s11104-011-0824-9; Richardson MD, 1999, J PLANT NUTR, V22, P67, DOI 10.1080/01904169909365607; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez R, 2008, J EXP BOT, V59, P1109, DOI 10.1093/jxb/erm342; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saint Yves A, 1930, CANDOLLEA, V4, P146; Marquez SS, 2012, FUNGAL ECOL, V5, P289, DOI 10.1016/j.funeco.2010.12.001; Schardl CL, 2007, PHYTOCHEMISTRY, V68, P980, DOI 10.1016/j.phytochem.2007.01.010; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Torres MS, 2012, FUNGAL ECOL, V5, P322, DOI 10.1016/j.funeco.2011.05.006; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; de Aldana BRV, 2014, GRASS FORAGE SCI, V69, P462, DOI 10.1111/gfs.12049; Vazquez-de-Aldana BR, 2008, AUST J AGR RES, V59, P769, DOI 10.1071/AR07359; Vazquez-de-Aldana BR, 2011, ANN APPL BIOL, V159, P281, DOI 10.1111/j.1744-7348.2011.00495.x; Vazquez-de-Aldana BR, 2013, PLANT SOIL, V362, P201, DOI 10.1007/s11104-012-1283-7; Vicente-Tavera S, 1992, THESIS U SALAMANCA S; Vicente-Villardon J.L., 2012, MULTBIPLOT MULTIVARI; Volaire F, 1998, NEW PHYTOL, V140, P439, DOI [10.1046/j.1469-8137.1998.00288.x, 10.1111/j.1469-8137.1998.00288.x]; Wali PR, 2007, MICROB ECOL, V53, P20, DOI 10.1007/s00248-006-9076-2; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; WEST CP, 1993, AGRON J, V85, P264, DOI 10.2134/agronj1993.00021962008500020019x; White JF, 2010, PHYSIOL PLANTARUM, V138, P440, DOI 10.1111/j.1399-3054.2009.01332.x; White Philip J., 2008, V7, P51; Yue Q, 2000, J CHEM ECOL, V26, P279, DOI 10.1023/A:1005410115940; Zabalgogeazcoa I, 2008, PLANT PATHOL, V57, P467, DOI 10.1111/j.1365-3059.2007.01784.x; Zabalgogeazcoa I, 2006, EUR J AGRON, V24, P374, DOI 10.1016/j.eja.2006.01.003; Zabalgogeazcoa I, 2006, GRASS FORAGE SCI, V61, P71, DOI 10.1111/j.1365-2494.2006.00509.x; Zabalgogeazcoa I, 1999, GRASS FORAGE SCI, V54, P91, DOI 10.1046/j.1365-2494.1999.00155.x	81	49	50	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84539	10.1371/journal.pone.0084539	http://dx.doi.org/10.1371/journal.pone.0084539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367672	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300147
J	Cardemil, C; Elgali, I; Xia, W; Emanuelsson, L; Norlindh, B; Omar, O; Thomsen, P				Cardemil, Carina; Elgali, Ibrahim; Xia, Wei; Emanuelsson, Lena; Norlindh, Birgitta; Omar, Omar; Thomsen, Peter			Strontium-Doped Calcium Phosphate and Hydroxyapatite Granules Promote Different Inflammatory and Bone Remodelling Responses in Normal and Ovariectomised Rats	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; RANELATE; INTERLEUKIN-6; RESORPTION; MODEL; OSTEOPOROSIS; METABOLISM; ACTIVATION; PARTICLES	The healing of bone defects may be hindered by systemic conditions such as osteoporosis. Calcium phosphates, with or without ion substitutions, may provide advantages for bone augmentation. However, the mechanism of bone formation with these materials is unclear. The aim of this study was to evaluate the healing process in bone defects implanted with hydroxyapatite (HA) or strontium-doped calcium phosphate (SCP) granules, in non-ovariectomised (non-OVX) and ovariectomised (OVX) rats. After 0 (baseline), six and 28d, bone samples were harvested for gene expression analysis, histology and histomorphometry. Tumour necrosis factor-alpha (TNF-alpha), at six days, was higher in the HA, in non-OVX and OVX, whereas interleukin-6 (IL-6), at six and 28d, was higher in SCP, but only in non-OVX. Both materials produced a similar expression of the receptor activator of nuclear factor kappa-B ligand (RANKL). Higher expression of osteoclastic markers, calcitonin receptor (CR) and cathepsin K (CatK), were detected in the HA group, irrespective of non-OVX or OVX. The overall bone formation was comparable between HA and SCP, but with topological differences. The bone area was higher in the defect centre of the HA group, mainly in the OVX, and in the defect periphery of the SCP group, in both non-OVX and OVX. It is concluded that HA and SCP granules result in comparable bone formation in trabecular bone defects. As judged by gene expression and histological analyses, the two materials induced different inflammatory and bone remodelling responses. The modulatory effects are associated with differences in the spatial distribution of the newly formed bone.	[Cardemil, Carina; Elgali, Ibrahim; Emanuelsson, Lena; Norlindh, Birgitta; Omar, Omar; Thomsen, Peter] Univ Gothenburg, Dept Biomat, Inst Clin Sci, Sahlgrenska Acad, Gothenburg, Sweden; [Cardemil, Carina] Orebro Univ Hosp, Dept Oral & Maxillofacial Surg, Orebro, Sweden; [Xia, Wei] Uppsala Univ, Dept Engn Sci, Uppsala, Sweden; [Cardemil, Carina; Elgali, Ibrahim; Xia, Wei; Emanuelsson, Lena; Norlindh, Birgitta; Omar, Omar; Thomsen, Peter] BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden	University of Gothenburg; Orebro University; Uppsala University	Cardemil, C (corresponding author), Univ Gothenburg, Dept Biomat, Inst Clin Sci, Sahlgrenska Acad, Gothenburg, Sweden.	carina.cardemil@biomaterials.gu.se	Omar, Omar/I-2126-2017; Omar, Omar/C-9264-2019	Omar, Omar/0000-0002-2610-1294; Omar, Omar/0000-0002-2610-1294; Thomsen, Peter/0000-0003-3910-6665	Swedish Research Council [K2012-52X-09495-25-3]; BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; Vastra Gotaland Region; Stiftelsen Handlanden Hjalmar Svensson	Swedish Research Council(Swedish Research CouncilEuropean Commission); BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; Vastra Gotaland Region; Stiftelsen Handlanden Hjalmar Svensson	This study was supported by the Swedish Research Council (K2012-52X-09495-25-3), the BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy, the Vastra Gotaland Region and the Stiftelsen Handlanden Hjalmar Svensson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Atkins GJ, 2009, OSTEOPOROSIS INT, V20, P653, DOI 10.1007/s00198-008-0728-6; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Baron R, 2002, EUR J PHARMACOL, V450, P11, DOI 10.1016/S0014-2999(02)02040-X; Boanini E, 2011, J MATER SCI-MATER M, V22, P2079, DOI 10.1007/s10856-011-4379-3; Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Cardemil C, 2013, BIOMATERIALS, V34, P1546, DOI 10.1016/j.biomaterials.2012.11.003; Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002; Choi S, 2012, ACTA BIOMATER, V8, P2340, DOI 10.1016/j.actbio.2012.02.019; Ding WG, 2011, CONNECT TISSUE RES, V52, P25, DOI 10.3109/03008201003783011; Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd; Gallacher SJ, 2010, CALCIFIED TISSUE INT, V87, P469, DOI 10.1007/s00223-010-9420-x; Hao YJ, 2007, BONE, V41, P631, DOI 10.1016/j.bone.2007.06.006; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Ishihara K, 2002, BBA-MOL CELL RES, V1592, P281, DOI 10.1016/S0167-4889(02)00321-X; Itoh S, 2006, BONE, V39, P505, DOI 10.1016/j.bone.2006.02.074; Julien M, 2007, BIOMATERIALS, V28, P956, DOI 10.1016/j.biomaterials.2006.10.018; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D; Lerner UH, 2006, J DENT RES, V85, P584, DOI 10.1177/154405910608500703; Li YF, 2010, OSTEOPOROSIS INT, V21, P1889, DOI 10.1007/s00198-009-1140-6; MARIE PJ, 1993, J BONE MINER RES, V8, P607; Marie PJ, 2003, OSTEOPOROSIS INT, V14, pS9, DOI 10.1007/s00198-002-1344-5; Masi L, 2001, Q J NUCL MED, V45, P2; Mohan BG, 2013, J BIOMED MATER RES A, V101, P261, DOI 10.1002/jbm.a.34324; MOROHASHI T, 1995, JPN J PHARMACOL, V68, P153, DOI 10.1254/jjp.68.153; Nishimura R, 1998, J BONE MINER RES, V13, P777, DOI 10.1359/jbmr.1998.13.5.777; Obadia L, 2011, J MATER SCI-MATER M, V22, P593, DOI 10.1007/s10856-010-4219-x; Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9; Ozawa S, 2002, BONE, V30, P137, DOI 10.1016/S8756-3282(01)00646-9; Park JW, 2013, J BIOMED MATER RES A, V101, P298, DOI 10.1002/jbm.a.34433; Peng SL, 2011, BONE, V49, P1290, DOI 10.1016/j.bone.2011.08.031; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rozen S, 2000, Methods Mol Biol, V132, P365; Schrooten I, 2003, KIDNEY INT, V63, P927, DOI 10.1046/j.1523-1755.2003.00809.x; Schumacher M, 2013, ACTA BIOMATER, V9, P9547, DOI 10.1016/j.actbio.2013.07.027; Turner R T, 2001, Rev Endocr Metab Disord, V2, P117, DOI 10.1023/A:1010067326811; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035; Verberckmoes SC, 2003, KIDNEY INT, V64, P534, DOI 10.1046/j.1523-1755.2003.00123.x; Vestermark MT, 2011, DAN MED BULL, V58; Canettieri ACV, 2009, INT J EXP PATHOL, V90, P520, DOI 10.1111/j.1365-2613.2009.00674.x; Vogel M, 2004, J BIOMED MATER RES A, V70A, P370, DOI 10.1002/jbm.a.30048; Xia W, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/30/305610; Yang L, 2010, BIOMATERIALS, V31, P2976, DOI 10.1016/j.biomaterials.2010.01.002; Yoshitake F, 2008, J BIOL CHEM, V283, P11535, DOI 10.1074/jbc.M607999200	50	50	50	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84932	10.1371/journal.pone.0084932	http://dx.doi.org/10.1371/journal.pone.0084932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376855	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000169
J	Daniel, C; Vogelbacher, R; Stief, A; Grigo, C; Hugo, C				Daniel, Christoph; Vogelbacher, Regina; Stief, Andrea; Grigo, Christina; Hugo, Christian			Long-Term Gene Therapy with Thrombospondin 2 Inhibits TGF-beta Activation, Inflammation and Angiogenesis in Chronic Allograft Nephropathy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ENDOTHELIAL-CELL PROLIFERATION; FIBROTIC RENAL-DISEASE; EXPERIMENTAL GLOMERULONEPHRITIS; TUBULOINTERSTITIAL FIBROSIS; ENDOGENOUS REGULATOR; EXPRESSION; VEGF; TRANSPLANTATION; MECHANISMS	We recently identified Thrombospondin-2 (TSP-2) as a regulator of matrix remodelling and inflammation in experimental kidney disease by using TSP-2 null mice and successfully proved TSP-2 overexpression as a therapeutic concept in a short term glomerulonephritis model in the rat. In this current study, we investigated if long-term TSP-2 overexpression is also capable to ameliorate the progression of chronic kidney disease in the setting of the chronic allograft nephropathy F344-Lewis model in the rat. Two weeks after renal transplantation, two rat thigh muscles were transfected once only with either a TSP-2 overexpressing plasmid (n = 8) or a luciferase-expressing plasmid as control (n = 8). Rats were monitored for renal function, histological changes and gene expression in the graft for up to 30 weeks after transplantation. Unexpectedly, only in the TSP-2 treated group 2 rats died before the end of the experiment and renal function tended to be worsened in the TSP-2 group compared to the luciferase-treated controls. In addition, glomerular sclerosis and tubular interstitial injury as well as cortical fibronectin deposition was significantly increased in the TSP-2 treated kidneys despite reduced TGF-beta activation and marked anti-inflammatory (macrophages, T-cells and B-cells) effects in this group. Long-term TSP-2 therapy impaired repair of renal endothelium, as demonstrated by significant higher glomerular and peritubular endothelial rarefaction and reduced endothelial cell proliferation in the transplanted kidneys from TSP-2 treated rats compared to controls. This TSP-2 effect was associated with decreased levels of renal VEGF but not VEGF1 receptor. In conclusion, despite its anti-inflammatory and TGF-beta activation blocking effects, TSP-2 gene therapy did not ameliorate but rather worsened experimental chronic allograft nephropathy most likely via its anti-angiogenic properties on the renal microvasculature.	[Vogelbacher, Regina] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany; [Daniel, Christoph; Stief, Andrea; Grigo, Christina] Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany; [Hugo, Christian] Univ Dresden, Div Nephrol, Med Clin 3, Dresden, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Technische Universitat Dresden	Daniel, C (corresponding author), Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany.	Christoph.Daniel@uk-erlangen.de	Daniel, Christoph/AAK-2136-2021	Daniel, Christoph/0000-0002-6803-4755	Deutsche Forschungsgemeinschaft [SFB 423, TP B6]; Interdisciplinary Center for Clinical Research [A12]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research	This study was supported in part by a grant from the Deutsche Forschungsgemeinschaft (SFB 423, TP B6) and the Interdisciplinary Center for Clinical Research project A12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrass CK, 2000, ADV RENAL REPLACE TH, V7, P4, DOI 10.1016/S1073-4449(00)70001-X; Altun B, 1999, BLOOD COAGUL FIBRIN, V10, P233; Armstrong LC, 2002, MOL BIOL CELL, V13, P1893, DOI 10.1091/mbc.E01-09-0066; Belotti D, 2003, CANCER RES, V63, P5224; Campanholle G, 2013, AM J PHYSIOL-CELL PH, V304, pC591, DOI 10.1152/ajpcell.00414.2012; Campistol JM, 2001, NEPHROL DIAL TRANSPL, V16, P114, DOI 10.1093/ndt/16.suppl_1.114; Daniel C, 2004, KIDNEY INT, V65, P459, DOI 10.1111/j.1523-1755.2004.00395.x; Daniel C, 2003, AM J PATHOL, V163, P1185, DOI 10.1016/S0002-9440(10)63478-5; Daniel C, 2007, DIABETES, V56, P2982, DOI 10.2337/db07-0551; Daniel C, 2007, J AM SOC NEPHROL, V18, P788, DOI 10.1681/ASN.2006080873; Daniel C, 2009, AM J PHYSIOL-RENAL, V297, pF1299, DOI 10.1152/ajprenal.00254.2009; Dimmler A, 2003, DIAGN MOL PATHOL, V12, P108, DOI 10.1097/00019606-200306000-00007; Djamali A, 2009, TRANSPLANTATION, V88, P1149, DOI 10.1097/TP.0b013e3181bcccea; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Harris S, 2007, J NEPHROL, V20, P177; Hotchkiss H, 2006, TRANSPLANTATION, V81, P342, DOI 10.1097/01.tp.0000195773.24217.95; Hugo C, 1998, KIDNEY INT, V53, P302, DOI 10.1046/j.1523-1755.1998.00774.x; Hugo C, 2002, NEPHRON, V90, P460, DOI 10.1159/000054735; HUGO C, 1995, KIDNEY INT, V48, P1846, DOI 10.1038/ki.1995.483; Hugo C, 2009, NEPHRON EXP NEPHROL, V111, pE61, DOI 10.1159/000198235; IRUELAARISPE L, 1995, AM J PATHOL, V147, P1715; Jevnikar AM, 2008, CLIN J AM SOC NEPHRO, V3, pS56, DOI 10.2215/CJN.03040707; JOHNSON RJ, 1991, AM J PATHOL, V138, P313; Kajihara I, 2012, AM J PATHOL, V180, P703, DOI 10.1016/j.ajpath.2011.10.030; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Keller K, 2006, NEPHROL DIAL TRANSPL, V21, P2724, DOI 10.1093/ndt/gfl340; Kroening S, 2010, AM J PHYSIOL-RENAL, V298, pF796, DOI 10.1152/ajprenal.00528.2009; Kyriakides TR, 1999, J INVEST DERMATOL, V113, P782, DOI 10.1046/j.1523-1747.1999.00755.x; Kyriakides TR, 2001, AM J PATHOL, V159, P1255, DOI 10.1016/S0002-9440(10)62512-6; Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lamy L, 2007, J IMMUNOL, V178, P5930, DOI 10.4049/jimmunol.178.9.5930; LAULAJAINEN T, 1993, LAB INVEST, V69, P183; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Liu Y, 2011, J IMMUNOL, V187, P2814, DOI 10.4049/jimmunol.1003260; MCGREGOR B, 1994, AM J PATHOL, V144, P1281; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Mirochnik Y, 2008, CURR DRUG TARGETS, V9, P851, DOI 10.2174/138945008785909347; Oganesian A, 2008, MOL BIOL CELL, V19, P563, DOI 10.1091/mbc.E07-07-0649; Papageorgiou AP, 2012, CARDIOVASC RES, V94, P115, DOI 10.1093/cvr/cvs077; Park YW, 2004, AM J PATHOL, V165, P2087, DOI 10.1016/S0002-9440(10)63259-2; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Reinecke H, 2013, CARDIOVASC PATHOL, V22, P91, DOI 10.1016/j.carpath.2012.03.005; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Rodder S, 2009, AM J TRANSPLANT, V9, P517, DOI 10.1111/j.1600-6143.2008.02512.x; Sarkozi R, 2012, BIOCHEM BIOPH RES CO, V424, P801, DOI 10.1016/j.bbrc.2012.07.042; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; Steegh FMEG, 2011, J AM SOC NEPHROL, V22, P1024, DOI 10.1681/ASN.2010050531; Swinnen M, 2009, CIRCULATION, V120, P1585, DOI 10.1161/CIRCULATIONAHA.109.863266; Tomii Y, 2002, INT J ONCOL, V20, P339; Vogelbacher R, 2010, NEPHROL DIAL TRANSPL, V25, P3764, DOI 10.1093/ndt/gfq230; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Wittmann S, 2008, NEPHRON EXP NEPHROL, V108, P45, DOI 10.1159/000116112; Yin ZK, 2011, CHINESE MED J-PEKING, V124, P655, DOI 10.3760/cma.j.issn.0366-6999.2011.05.004; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200	58	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83846	10.1371/journal.pone.0083846	http://dx.doi.org/10.1371/journal.pone.0083846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376766	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000126
J	Kang, G; Hwang, WC; Do, IG; Wang, K; Kang, SY; Lee, J; Park, SH; Park, JO; Kang, WK; Jang, J; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, S; Kim, MJ; Kim, S; Park, CK; Kim, KM				Kang, Guhyun; Hwang, Woo Cheol; Do, In-Gu; Wang, Kai; Kang, So Young; Lee, Jeeyun; Park, Se Hoon; Park, Joon Oh; Kang, Won Ki; Jang, Jiryeon; Choi, Min-Gew; Lee, Jun Ho; Sohn, Tae Sung; Bae, Jae Moon; Kim, Sung; Kim, Min Ji; Kim, Seonwoo; Park, Cheol Keun; Kim, Kyoung-Mee			Exome Sequencing Identifies Early Gastric Carcinoma as an Early Stage of Advanced Gastric Cancer	PLOS ONE			English	Article							SOMATIC MUTATIONS; ADENOCARCINOMA; GENE; METHYLATION; SIGNATURES; DIFFUSE	Gastric carcinoma is one of the major causes of cancer-related mortality worldwide. Early detection and treatment leads to an excellent prognosis in patients with early gastric cancer (EGC), whereas the prognosis of patients with advanced gastric cancer (AGC) remains poor. It is unclear whether EGCs and AGCs are distinct entities or whether EGCs are the beginning stages of AGCs. We performed whole exome sequencing of four samples from patients with EGC and compared the results with those from AGCs. In both EGCs and AGCs, a total of 268 genes were commonly mutated and independent mutations were additionally found in EGCs (516 genes) and AGCs (3104 genes). A higher frequency of C>G transitions was observed in intestinal-type compared to diffuse-type carcinomas (P = 0.010). The DYRK3, GPR116, MCM10, PCDH17, PCDHB1, RDH5 and UNC5C genes are recurrently mutated in EGCs and may be involved in early carcinogenesis.	[Kang, Guhyun; Hwang, Woo Cheol; Do, In-Gu; Kang, So Young; Park, Cheol Keun; Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Wang, Kai] Pfizer Inc, Oncol Res Unit, San Diego, CA USA; [Lee, Jeeyun; Park, Se Hoon; Park, Joon Oh; Kang, Won Ki; Jang, Jiryeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Choi, Min-Gew; Lee, Jun Ho; Sohn, Tae Sung; Bae, Jae Moon; Kim, Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Hwang, Woo Cheol] Sungkyunkwan Univ, Sch Med, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea; [Kim, Min Ji; Kim, Seonwoo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biostat Unit,Samsung Biomed Res Inst, Seoul, South Korea; [Kang, Guhyun] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Pathol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Pfizer; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Inje University	Kim, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea.	kkmkys@skku.edu	Park, Se Hoon/GMX-1199-2022; Kim, Sung/G-4114-2014; Lee, Jeeyun/I-7171-2015; Lee, Jee Yun/C-9646-2011	Park, Se Hoon/0000-0001-5084-9326; Wang, Kai/0000-0003-0567-3004	National Research Foundation of Korea [2012-P4KR 003]; Samsung Biomedical Research Institute [SBRI-SP1B20111]	National Research Foundation of Korea(National Research Foundation of Korea); Samsung Biomedical Research Institute(Samsung)	This study was supported by a grant from the National Research Foundation of Korea (2012-P4KR 003) and a Samsung Biomedical Research Institute grant (#SBRI-SP1B20111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ascano JJ, 2001, MODERN PATHOL, V14, P942, DOI 10.1038/modpathol.3880416; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Corso G, 2011, EUR J CANCER, V47, P443, DOI 10.1016/j.ejca.2010.09.008; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Dong SM, 2005, MODERN PATHOL, V18, P170, DOI 10.1038/modpathol.3800261; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; FUCHS CS, 1995, NEW ENGL J MED, V333, P32, DOI 10.1056/NEJM199507063330107; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Graham D., 2010, WHO CLASSIFICATION T, V4th; Hibi K, 2009, ANTICANCER RES, V29, P4397; Holbrook JD, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-119; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huntsman DG, 2001, NEW ENGL J MED, V344, P1904, DOI 10.1056/NEJM200106213442504; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagarajan N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r115; Osato T, 1996, SEMIN CANCER BIOL, V7, P175, DOI 10.1006/scbi.1996.0024; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Shimizu Takahiro, 2012, Gastroenterology, V143, P1385, DOI 10.1053/j.gastro.2012.09.027; Song HJ, 2010, GASTROENTEROLOGY, V139, P84, DOI 10.1053/j.gastro.2010.04.002; Vecchi M, 2007, ONCOGENE, V26, P4284, DOI 10.1038/sj.onc.1210208; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	27	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82770	10.1371/journal.pone.0082770	http://dx.doi.org/10.1371/journal.pone.0082770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376576	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000029
J	Li, CH; Ren, N; Wen, XM; Zhou, PC; Huang, X; Gong, RE; Lv, YX; Feng, L; Wu, HM; Liu, ZR; Fu, CC; Huang, X; Li, J; Chen, YH; Zeng, C; Zuo, SY; Xiong, XR; Xu, XH; Wu, AH				Li, Chunhui; Ren, Nan; Wen, Ximao; Zhou, Pengcheng; Huang, Xun; Gong, Ruie; Lv, Yixin; Feng, Li; Wu, Hongman; Liu, Zhenru; Fu, Chenchao; Huang, Xin; Li, Jie; Chen, Yuhua; Zeng, Cui; Zuo, Shuangyan; Xiong, Xinrui; Xu, Xiuhua; Wu, Anhua			Changes in Antimicrobial Use Prevalence in China: Results from Five Point Prevalence Studies	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; ADIPOSE-TISSUE MACROPHAGES; BLOOD-CELL COUNT; DIABETES-MELLITUS; RANDOMIZED-TRIAL; IKK-BETA; INFLAMMATION; OBESITY; MONOCYTES; SALSALATE	Objective: The abuse of antimicrobials is a serious concern in China. Several measures have been taken to improve the rational use of antimicrobials, including the establishment of a national surveillance network for antimicrobial use. This study describes the dynamic changes in antimicrobial use in China between 2001 and 2010, with the scope of identifying targets to improve the prescription of antimicrobials. Methods: Five point prevalence surveys were performed in hospitals across mainland China in 2001, 2003, 2005, 2008, and 2010. All inpatients who were admitted for at least 24 hours were included in the study. Details regarding antimicrobial use by these patients and the collection of samples for bacterial culture from inpatients administered therapeutic antimicrobials were recorded. Results: The surveys encompassed tertiary hospitals from all 31 provinces of mainland China. Antimicrobial use prevalence decreased from 54.79% in 2001 to 46.63% in 2010. While this decline was observed in most hospital departments, antimicrobial use remained stable or increased in others. Antimicrobial use prevalence was relatively high in the Pediatrics departments and general intensive care units, whereas it was lower in the Obstetrics (Neonatal group) departments in each survey. The proportion of patients administered a single antimicrobial increased from 60.78% in 2001 to 70.16% in 2010, while the proportion of administration of two or more antimicrobials declined. The bacterial culture rate increased from 25.22% in 2003 to 34.71% in 2010. Antimicrobial use prevalence (47.96% vs 46.16%), bacterial culture rate (36.40% vs 34.19%), and the proportion of administration of a single antimicrobial (71.41% vs 67.33%) were higher in teaching hospitals than in nonteaching hospitals in 2010. Conclusion: Although measures for enhancing the rational use of antimicrobials have been effective, further improvements are required. The findings from this study can promote such improvements.	[Li, Chunhui; Ren, Nan; Wen, Ximao; Zhou, Pengcheng; Huang, Xun; Gong, Ruie; Lv, Yixin; Feng, Li; Wu, Hongman; Liu, Zhenru; Fu, Chenchao; Huang, Xin; Li, Jie; Chen, Yuhua; Zeng, Cui; Zuo, Shuangyan; Xiong, Xinrui; Xu, Xiuhua; Wu, Anhua] Cent S Univ, Xiangya Hosp, Infect Control Ctr, Changsha, Hunan, Peoples R China	Central South University	Wu, AH (corresponding author), Cent S Univ, Xiangya Hosp, Infect Control Ctr, Changsha, Hunan, Peoples R China.	xywuanhua@csu.edu.cn	Li, Chunhui/Y-4731-2019		Chinese Ministry of Health [201002021]	Chinese Ministry of Health	The work was supported by the specialty fund of Chinese Ministry of Health (No. 201002021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, AM J PHYSIOL-RENAL, V290, pF600, DOI 10.1152/ajprenal.00289.2005; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bays Harold, 2007, Diab Vasc Dis Res, V4, P181; Berria R, 2007, CLIN PHARMACOL THER, V82, P275, DOI 10.1038/sj.clpt.6100146; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P1275, DOI 10.1056/NEJM197406062902302; Gillum RF, 2005, ANN EPIDEMIOL, V15, P266, DOI 10.1016/j.annepidem.2004.08.009; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Kiermayer C, 2007, GENESIS, V45, P11, DOI 10.1002/dvg.20244; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kullo IJ, 2002, AM J CARDIOL, V89, P1441, DOI 10.1016/S0002-9149(02)02366-4; Lee BC, 2013, BIOCH BIOPH IN PRESS; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	30	16	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82785	10.1371/journal.pone.0082785	http://dx.doi.org/10.1371/journal.pone.0082785			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376580	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000032
J	Mao, WS; Cong, PS; Wang, ZH; Lu, LJ; Zhu, ZL; Li, TH				Mao, Wusong; Cong, Peisheng; Wang, Zhiheng; Lu, Longjian; Zhu, Zhongliang; Li, Tonghua			NMRDSP: An Accurate Prediction of Protein Shape Strings from NMR Chemical Shifts and Sequence Data	PLOS ONE			English	Article							SECONDARY STRUCTURE; STRUCTURE GENERATION; ANGLES	Shape string is structural sequence and is an extremely important structure representation of protein backbone conformations. Nuclear magnetic resonance chemical shifts give a strong correlation with the local protein structure, and are exploited to predict protein structures in conjunction with computational approaches. Here we demonstrate a novel approach, NMRDSP, which can accurately predict the protein shape string based on nuclear magnetic resonance chemical shifts and structural profiles obtained from sequence data. The NMRDSP uses six chemical shifts (HA, H, N, CA, CB and C) and eight elements of structure profiles as features, a non-redundant set (1,003 entries) as the training set, and a conditional random field as a classification algorithm. For an independent testing set (203 entries), we achieved an accuracy of 75.8% for S8 (the eight states accuracy) and 87.8% for S3 (the three states accuracy). This is higher than only using chemical shifts or sequence data, and confirms that the chemical shift and the structure profile are significant features for shape string prediction and their combination prominently improves the accuracy of the predictor. We have constructed the NMRDSP web server and believe it could be employed to provide a solid platform to predict other protein structures and functions. The NMRDSP web server is freely available at http://cal.tongji.edu.cn/NMRDSP/index.jsp.	[Mao, Wusong; Cong, Peisheng; Wang, Zhiheng; Lu, Longjian; Zhu, Zhongliang; Li, Tonghua] Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China	Tongji University	Cong, PS (corresponding author), Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.	pshcong@tongji.edu.cn; lith@tongji.edu.cn			National Natural Science Foundation of China [21275108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are thankful for the financial support of the National Natural Science Foundation of China (21275108) (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Deschavanne P, 2009, PROTEINS, V76, P129, DOI 10.1002/prot.22324; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Ikeda K, 2013, J BIOMOL NMR, V55, P189, DOI 10.1007/s10858-012-9701-y; Ison RE, 2005, IEEE ENG MED BIOL, V24, P41, DOI 10.1109/MEMB.2005.1436459; Kountouris P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-437; Le Q, 2009, J MOL BIOL, V387, P431, DOI 10.1016/j.jmb.2008.12.044; Li DP, 2012, BIOINFORMATICS, V28, P32, DOI 10.1093/bioinformatics/btr611; Markley JL, 2008, J BIOMOL NMR, V40, P153, DOI 10.1007/s10858-008-9221-y; Mielke SP, 2009, PROG NUCL MAG RES SP, V54, P141, DOI 10.1016/j.pnmrs.2008.06.002; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Song Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048389; Sun JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016808; Sun JM, 2012, NUCLEIC ACIDS RES, V40, pW298, DOI 10.1093/nar/gks361; Tang ZH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-283; Tyagi M, 2008, PROTEINS, V71, P920, DOI 10.1002/prot.21776; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Wang CC, 2007, J BIOMOL NMR, V38, P57, DOI 10.1007/s10858-007-9146-x; Wang DD, 2013, BIOCHIMIE, V95, P354, DOI 10.1016/j.biochi.2012.10.006; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305; Wishart DS, 1997, J BIOMOL NMR, V10, P329, DOI 10.1023/A:1018373822088; Zemla A, 1999, PROTEINS, V34, P220, DOI 10.1002/(SICI)1097-0134(19990201)34:2<220::AID-PROT7>3.0.CO;2-K; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060559; Zhou TP, 2010, BIOINFORMATICS, V26, P470, DOI 10.1093/bioinformatics/btp679; Zhu YJ, 2012, AMINO ACIDS, V42, P1749, DOI 10.1007/s00726-011-0889-z	31	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83532	10.1371/journal.pone.0083532	http://dx.doi.org/10.1371/journal.pone.0083532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376713	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000094
J	Moorman, CE; Plush, CJ; Orr, DB; Reberg-Horton, C				Moorman, Christopher E.; Plush, Charles J.; Orr, David B.; Reberg-Horton, Chris			Beneficial Insect Borders Provide Northern Bobwhite Brood Habitat	PLOS ONE			English	Article							NATURAL ENEMIES; SET-ASIDE; MANAGEMENT; CHICKS; PLANTS; GRASS	Strips of fallow vegetation along cropland borders are an effective strategy for providing brood habitat for declining populations of upland game birds (Order: Galliformes), including northern bobwhite (Colinus virginianus), but fallow borders lack nectar-producing vegetation needed to sustain many beneficial insect populations (e.g., crop pest predators, parasitoids, and pollinator species). Planted borders that contain mixes of prairie flowers and grasses are designed to harbor more diverse arthropod communities, but the relative value of these borders as brood habitat is unknown. We used groups of six human-imprinted northern bobwhite chicks as a bioassay for comparing four different border treatments (planted native grass and prairie flowers, planted prairie flowers only, fallow vegetation, or mowed vegetation) as northern bobwhite brood habitat from June-August 2009 and 2010. All field border treatments were established around nine organic crop fields. Groups of chicks were led through borders for 30-min foraging trials and immediately euthanized, and eaten arthropods in crops and gizzards were measured to calculate a foraging rate for each border treatment. We estimated arthropod prey availability within each border treatment using a modified blower-vac to sample arthropods at the vegetation strata where chicks foraged. Foraging rate did not differ among border treatments in 2009 or 2010. Total arthropod prey densities calculated from blower-vac samples did not differ among border treatments in 2009 or 2010. Our results showed plant communities established to attract beneficial insects should maximize the biodiversity potential of field border establishment by providing habitat for beneficial insects and young upland game birds.	[Moorman, Christopher E.; Plush, Charles J.] N Carolina State Univ, Fisheries Wildlife & Conservat Biol Program, Raleigh, NC 27695 USA; [Orr, David B.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Reberg-Horton, Chris] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Moorman, CE (corresponding author), N Carolina State Univ, Fisheries Wildlife & Conservat Biol Program, Raleigh, NC 27695 USA.	chris_moorman@ncsu.edu		Reberg-Horton, S. Chris/0000-0001-5002-106X	United States Department of Agriculture, Organic Research and Extension Initiative	United States Department of Agriculture, Organic Research and Extension Initiative	Funding for the project was provided by United States Department of Agriculture, Organic Research and Extension Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer NJ, 2010, IBIS, V152, P530, DOI 10.1111/j.1474-919X.2010.01037.x; Burkhart JK, 2004, THESIS U GEORGIA; Champlin TB, 2009, ECOLOGY, V90, P1586, DOI 10.1890/08-1190.1; Daniels RB, 1996, SOIL SCI SOC AM J, V60, P246, DOI 10.2136/sssaj1996.03615995006000010037x; Doxon ED, 2010, J WILDLIFE MANAGE, V74, P249, DOI 10.2193/2008-522; Evans AR, 2005, AUST J ZOOL, V53, P9, DOI 10.1071/ZO04018; Fiedler AK, 2007, ENVIRON ENTOMOL, V36, P751, DOI 10.1603/0046-225X(2007)36[751:AOMNPT]2.0.CO;2; Forehand LM, 2006, ENVIRON ENTOMOL, V35, P1541, DOI 10.1603/0046-225X(2006)35[1541:ICAWBI]2.0.CO;2; Forrester ND, 1998, J WILDLIFE MANAGE, V62, P1506, DOI 10.2307/3802017; GEORGE R R, 1979, Wildlife Society Bulletin, V7, P4; Giuliano WM, 2002, BIOL CONSERV, V106, P1, DOI 10.1016/S0006-3207(01)00126-4; Guthery FS, 1997, J WILDLIFE MANAGE, V61, P291, DOI 10.2307/3802584; Harper CA, 1998, WILDLIFE SOC B, V26, P302; Heimpel George E., 2005, P267, DOI 10.1017/CBO9780511542220.010; Jackson John R., 1987, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V41, P303; Kimmel R.O., 1987, PERD 4 GRAY PARTR WO, P39; Landis DA, 2005, WEED SCI, V53, P902, DOI 10.1614/WS-04-050R1.1; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Moorman CE, 2013, WILDLIFE SOC B, V37, P209, DOI 10.1002/wsb.226; Olson DM, 2007, J APPL ECOL, V44, P13, DOI 10.1111/j.1365-2664.2006.01241.x; Palmer WE, 2001, J WILDLIFE MANAGE, V65, P861, DOI 10.2307/3803035; Palmer WE, 1995, THESIS N CAROLINA ST; Plush CJ, 2013, J WILDLIFE MANAGE, V77, P200, DOI 10.1002/jwmg.436; Potts GR, 1997, FARMING BIRDS EUROPE, P150; Potts GR, 1986, PARTRIDGE PESTICIDES; Rands MRW, 1992, P PERD 6 1 INT S PAR, V9, P493; Riddle JD, 2008, J WILDLIFE MANAGE, V72, P1376, DOI 10.2193/2007-469; SAUER JR, 2011, N AM BREEDING BIRD S; Smith MD, 2005, WILDLIFE SOC B, V33, P596, DOI 10.2193/0091-7648(2005)33[596:UOINBC]2.0.CO;2; Sotherton NW, 1998, BIOL CONSERV, V83, P259, DOI 10.1016/S0006-3207(97)00082-7; Taylor JS, 1999, J WILDLIFE MANAGE, V63, P686, DOI 10.2307/3802658; Wackers Felix L., 2005, P1, DOI 10.1017/CBO9780511542220.002	32	10	10	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83815	10.1371/journal.pone.0083815	http://dx.doi.org/10.1371/journal.pone.0083815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376759	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000119
J	Nicolato, RD; de Abreu, RT; Roatt, BM; Aguiar-Soares, RDD; Reis, LES; Carvalho, MD; Carneiro, CM; Giunchetti, RC; Bouillet, LEM; Lemos, DS; Coura-Vital, W; Reis, AB				Nicolato, Roney de Carvalho; de Abreu, Raquel Tropia; Roatt, Bruno Mendes; de Oliveira Aguiar-Soares, Rodrigo Dian; Soares Reis, Levi Eduardo; Carvalho, Maria das Gracas; Carneiro, Claudia Martins; Giunchetti, Rodolfo Cordeiro; Maduro Bouillet, Leoneide Erica; Lemos, Denise Silveira; Coura-Vital, Wendel; Reis, Alexandre Barbosa			Clinical Forms of Canine Visceral Leishmaniasis in Naturally Leishmania infantum-Infected Dogs and Related Myelogram and Hemogram Changes	PLOS ONE			English	Article							TISSUE PARASITE DENSITY; BONE-MARROW; CIRCULATING LEUKOCYTES; IMMUNE-RESPONSE; EMPERIPOLESIS; PARAMETERS; PCR	Hematological analysis has limited applications for disease diagnosis in Leishmania infantum-infected dogs, but it can be very important in evaluating the clinical forms of the disease and in understanding the evolution of canine visceral leishmaniasis (CVL) pathogenesis. Recently, we demonstrated that alterations in leucopoiesis and erythropoiesis are related to clinical status and bone marrow parasite density in dogs naturally infected by L. infantum. To further characterize these alterations, we evaluated the association between the hematological parameters in bone marrow and peripheral blood alterations in groups of L. infantum-infected dogs: asymptomatic I (AD-I: serum negative/PCR+), asymptomatic II (AD-II: serum positive), oligosymptomatic (OD), and symptomatic (SD). Results were compared with those from noninfected dogs (NID). The SD group was found to present a decrease in erythropoietic lineage with concomitant reductions in erythrocytes, hemoglobin, and hematocrit parameters, resulting in anemia. The SD group also had increased neutrophils and precursors and decreased band eosinophils and eosinophils, leading to peripheral blood leucopenia. In the AD-II group, lymphocytosis occurred in both the peripheral blood and the bone marrow compartments. The SD group exhibited lymphocytosis in the bone marrow, with lymphopenia in the peripheral blood. In contrast, the AD-I group, showed no significant changes suggestive of CVL, presenting normal counts in bone marrow and peripheral blood. Our results showed for the first time that important changes in hematopoiesis and hematological parameters occur during ongoing CVL in naturally infected dogs, mainly in symptomatic disease. Taken together, our results based on myelogram and hemogram parameters enable better understanding of the pathogenesis of the anemia, lymphocytosis, and lymphopenia, as well as the leucopenia (eosinopenia and monocytopenia), that contribute to CVL prognosis.	[Nicolato, Roney de Carvalho; de Abreu, Raquel Tropia; Roatt, Bruno Mendes; de Oliveira Aguiar-Soares, Rodrigo Dian; Soares Reis, Levi Eduardo; Carneiro, Claudia Martins; Giunchetti, Rodolfo Cordeiro; Maduro Bouillet, Leoneide Erica; Coura-Vital, Wendel; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol NUPEB, Lab Imunopatol, Ouro Preto, MG, Brazil; [Nicolato, Roney de Carvalho; Roatt, Bruno Mendes; de Oliveira Aguiar-Soares, Rodrigo Dian; Soares Reis, Levi Eduardo; Carneiro, Claudia Martins; Maduro Bouillet, Leoneide Erica; Coura-Vital, Wendel; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Escola Farm, Dept Anal Clin, Lab Pesquisas Clin, Ouro Preto, MG, Brazil; [Carvalho, Maria das Gracas] Univ Fed Minas Gerais, Fac Farm, Lab Hematol Clin, Belo Horizonte, MG, Brazil; [Giunchetti, Rodolfo Cordeiro] Univ Fed Minas Gerais, Dept Morfol, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil; [Lemos, Denise Silveira] Univ Fed Minas Gerais, Dept Parasitol, Lab Imunol & Genom Parasitos, Belo Horizonte, MG, Brazil; [Coura-Vital, Wendel] Univ Fed Minas Gerais, Lab Epidemiol Doencas Infecto Parasitarias, Belo Horizonte, MG, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Reis, AB (corresponding author), Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol NUPEB, Lab Imunopatol, Ouro Preto, MG, Brazil.	alexreis@nupeb.ufop.br	de Oliveira Aguiar-Soares, Rodrigo Dian/ABB-7973-2020; Giunchetti, Rodolfo/O-9878-2014; carneiro, claudia m/B-6205-2013; Coura-Vital, Wendel/AAP-9624-2021; Roatt, Bruno M/R-5502-2016; Reis, Alexandre Barbosa/I-9945-2014; carneiro, Claudia Martins/AAP-4455-2020; Carvalho, Maria das Graças/AAY-1619-2021; Bouillet, Leoneide/GRO-4340-2022	de Oliveira Aguiar-Soares, Rodrigo Dian/0000-0001-8705-7357; Roatt, Bruno M/0000-0001-5281-3263; Reis, Alexandre Barbosa/0000-0001-8123-4164; carneiro, Claudia Martins/0000-0002-6002-857X; Cordeiro Giunchetti, Rodolfo/0000-0003-4181-7546; /0000-0002-1434-7676; Silveira Lemos, Denise/0000-0003-0955-458X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil [CBB-APQ-02473-10, CBB-APQ-00356-10-PPSUS, CBB-APQ-01052-11, APQ-01698-12]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico- CNPq, Brazil; CAPES; Federal University of Ouro Preto; CNPq; PNPD/CAPES	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico- CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Federal University of Ouro Preto; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PNPD/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil (grant: CBB-APQ-02473-10; CBB-APQ-00356-10-PPSUS; CBB-APQ-01052-11; APQ-01698-12), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico- CNPq, Brazil, CAPES and Federal University of Ouro Preto. MGC, CMC, RCG, and ABR are grateful to CNPq for fellowships. WCV, LEMB, and DSL are grateful to PNPD/CAPES for fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, PARASITE IMMUNOL, V13, P537, DOI 10.1111/j.1365-3024.1991.tb00550.x; Amusategui I, 2003, EUR J EPIDEMIOL, V18, P147, DOI 10.1023/A:1023090929302; ANOSA VO, 1983, ZBL VET MED B, V30, P600; Barrouin-Melo SM, 2006, VET J, V171, P331, DOI 10.1016/j.tvjl.2004.11.010; Bourdoiseau G, 1997, VET IMMUNOL IMMUNOP, V56, P345, DOI 10.1016/S0165-2427(96)05768-6; CASHELL AW, 1992, ANN HEMATOL, V64, P273, DOI 10.1007/BF01695470; Ciaramella P, 1997, VET REC, V141, P539, DOI 10.1136/vr.141.21.539; Coura-Vital W, 2011, Vet J, V190, pe43, DOI 10.1016/j.tvjl.2011.04.005; Coura-Vital W, 2013, VET PARASIT IN PRESS; Coura-Vital W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071833; Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291; da Costa-Val AP, 2007, VET J, V174, P636, DOI 10.1016/j.tvjl.2006.11.006; de Abreu RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018873; De Luna R, 2000, J COMP PATHOL, V122, P213, DOI 10.1053/jcpa.1999.0357; DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032; Diebold J, 2000, HISTOPATHOLOGY, V37, P199, DOI 10.1046/j.1365-2559.2000.00965.x; Elmore SA, 2006, TOXICOL PATHOL, V34, P666, DOI 10.1080/01926230600939971; Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005; Guerra LL, 2009, PARASITOL RES, V104, P611, DOI 10.1007/s00436-008-1237-4; Jain NC, 1986, SCHALMS VET HEMATOLO, P8; KEENAN CM, 1984, VET PATHOL, V21, P74, DOI 10.1177/030098588402100113; Koutinas AF, 1999, J AM ANIM HOSP ASSOC, V35, P376, DOI 10.5326/15473317-35-5-376; LEE KP, 1989, VET PATHOL, V26, P473, DOI 10.1177/030098588902600603; Manzillo VF, 2006, VET REC, V158, P690, DOI 10.1136/vr.158.20.690; Manzillo VF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002225; Nunes CM, 2010, VET PARASITOL, V170, P131, DOI 10.1016/j.vetpar.2010.01.044; PENNY RHC, 1974, J SMALL ANIM PRACT, V15, P553, DOI 10.1111/j.1748-5827.1974.tb06535.x; PINELLI E, 1994, INFECT IMMUN, V62, P229, DOI 10.1128/IAI.62.1.229-235.1994; PIPPARD MJ, 1986, ANN TROP MED PARASIT, V80, P317, DOI 10.1080/00034983.1986.11812022; Reis AB, 2006, CLIN EXP IMMUNOL, V146, P303, DOI 10.1111/j.1365-2249.2006.03206.x; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Reis AB, 2006, RES VET SCI, V81, P68, DOI 10.1016/j.rvsc.2005.09.011; Reis AB, 2009, VET IMMUNOL IMMUNOP, V128, P87, DOI 10.1016/j.vetimm.2008.10.307; Saeed AM, 1998, BRIT J HAEMATOL, V100, P720, DOI 10.1046/j.1365-2141.1998.00624.x; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; TRYPHONAS L, 1977, CAN J COMP MED, V41, P1; Vercosa BLA, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-45; Volpini AC, 2004, ACTA TROP, V90, P31, DOI 10.1016/j.actatropica.2003.10.008; Weiss DJ, 2006, J VET INTERN MED, V20, P955, DOI 10.1892/0891-6640(2006)20[955:ARSOTI]2.0.CO;2	39	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82947	10.1371/journal.pone.0082947	http://dx.doi.org/10.1371/journal.pone.0082947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376612	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000043
J	Nonoguchi, H; Izumi, Y; Nakayama, Y; Matsuzaki, T; Yasuoka, Y; Inoue, T; Inoue, H; Mouri, T; Kawahara, K; Saito, H; Tomita, K				Nonoguchi, Hiroshi; Izumi, Yuichiro; Nakayama, Yushi; Matsuzaki, Takanobu; Yasuoka, Yukiko; Inoue, Takeaki; Inoue, Hideki; Mouri, Tomohiko; Kawahara, Katsumasa; Saito, Hideyuki; Tomita, Kimio			Effects of Atrial Natriuretic Peptide on Bicarbonate Transport in Long- and Short-Looped Medullary Thick Ascending Limbs of Rats	PLOS ONE			English	Article							CYCLIC ADENOSINE-MONOPHOSPHATE; CORTICAL COLLECTING DUCT; V2 VASOPRESSIN RECEPTOR; HCO3-ABSORPTION; DOWN-REGULATION; CHLORIDE REABSORPTION; ANTIDIURETIC-HORMONE; KIDNEY; INHIBITION; LOCALIZATION	Atrial natriuretic peptide (ANP) is known to influence NaCl transport in the medullary thick ascending limbs (MAL), where the largest NaCl reabsorption occurs among distal nephron segments in response to arginine vasopressin (AVP). In the present study, we investigated the effect of ANP on bicarbonate (HCO3-) transport in the MAL using an isolated tubule perfusion technique. The HCO3- concentration was measured using free-flow ultramicro-fluorometer. We first observed basal HCO3- reabsorption in both long-and short-looped MALs (lMALs, and sMALs, respectively). AVP inhibited HCO3- reabsorption in both lMALs and sMALs, whereas ANP did not change HCO3- transport. However, in the presence of AVP, ANP restored the HCO3- reabsorption inhibited by AVP both in lMAL and sMAL. The effects of ANP on HCO3- transport was mimicked by cyclic GMP. The mRNA expression level of the vasopressin V2 receptor in lMALs was significantly higher than in sMALs, whereas expression of the V1a receptor was unchanged. In summary, AVP inhibits HCO3- transport, and ANP counteracts the action of AVP on HCO3- transport both in lMALs and sMALs.	[Nonoguchi, Hiroshi] Kitasato Univ, Med Ctr, Dept Internal Med, Kitamoto, Saitama, Japan; [Nonoguchi, Hiroshi] Kitasato Univ, Med Ctr, Educ & Res Ctr, Kitamoto, Saitama, Japan; [Izumi, Yuichiro] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Nakayama, Yushi; Inoue, Takeaki; Inoue, Hideki; Mouri, Tomohiko; Tomita, Kimio] Kumamoto Univ, Grad Sch Med Sci, Dept Nephrol, Kumamoto, Japan; [Matsuzaki, Takanobu; Saito, Hideyuki] Kumamoto Univ Hosp, Dept Pharm, Kumamoto, Japan; [Yasuoka, Yukiko; Kawahara, Katsumasa] Kitasato Univ, Sch Med, Dept Physiol, Sagamihara, Kanagawa 228, Japan	Kitasato University; Kitasato University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Kumamoto University; Kumamoto University; Kitasato University	Nonoguchi, H (corresponding author), Kitasato Univ, Med Ctr, Dept Internal Med, Kitamoto, Saitama, Japan.	nono@insti.kitasato-u.ac.jp		Nonoguchi, Hiroshi/0000-0001-7831-7380; Matsuzaki, Takanobu/0000-0003-1439-2431; YASUOKA, YUKIKO/0000-0002-9380-1653	Ministry of Education, Culture, Sports, Science and Technology of Japan [21591034, 21591064, 24591244]; Science Research Promotion Fund from the promotion and Mutual Aid Corporation for Private Schools of Japan; Grants-in-Aid for Scientific Research [23591224] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science Research Promotion Fund from the promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21591034, 21591064, 24591244) and by the Science Research Promotion Fund from the promotion and Mutual Aid Corporation for Private Schools of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann D, 2010, AM J PHYSIOL-RENAL, V299, pF1473, DOI 10.1152/ajprenal.00437.2010; Bailly C, 2000, J AM SOC NEPHROL, V11, P1791, DOI 10.1681/ASN.V11101791; BESSEGHIR K, 1986, AM J PHYSIOL, V251, pF271, DOI 10.1152/ajprenal.1986.251.2.F271; BICHARA M, 1987, J CLIN INVEST, V80, P621, DOI 10.1172/JCI113114; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; CAPASSO G, 1991, J CLIN INVEST, V88, P430, DOI 10.1172/JCI115322; Carmosino M, 2007, AM J PHYSIOL-RENAL, V292, pF351, DOI 10.1152/ajprenal.00049.2006; Good DW, 2006, AM J PHYSIOL-CELL PH, V290, pC757, DOI 10.1152/ajpcell.00391.2005; Good DW, 2004, AM J PHYSIOL-RENAL, V287, pF1244, DOI 10.1152/ajprenal.00176.2004; GOOD DW, 1984, AM J PHYSIOL, V247, pF35, DOI 10.1152/ajprenal.1984.247.1.F35; Good DW, 1996, AM J PHYSIOL-RENAL, V270, pF978, DOI 10.1152/ajprenal.1996.270.6.F978; GOOD DW, 1990, J CLIN INVEST, V85, P1006, DOI 10.1172/JCI114530; Good DW, 1995, P NATL ACAD SCI USA, V92, P12525, DOI 10.1073/pnas.92.26.12525; HEBERT SC, 1984, AM J PHYSIOL, V246, pF745, DOI 10.1152/ajprenal.1984.246.6.F745; Hori K, 2012, AM J PHYSIOL-RENAL, V303, pF1080, DOI 10.1152/ajprenal.00052.2012; Inoue T, 2001, CARDIOVASC RES, V51, P470, DOI 10.1016/S0008-6363(01)00248-6; Izumi Y, 2007, AM J PHYSIOL-RENAL, V292, pF1418, DOI 10.1152/ajprenal.00358.2006; Izumi Y, 2011, J AM SOC NEPHROL, V22, P673, DOI 10.1681/ASN.2010050468; JAMISON RL, 1987, KIDNEY INT, V31, P597, DOI 10.1038/ki.1987.40; KNEPPER MA, 1991, CAN J PHYSIOL PHARM, V69, P1537, DOI 10.1139/y91-229; Knepper MA, 1999, J AM SOC NEPHROL, V10, P628; Koeppen BM, 2009, ADV PHYSIOL EDUC, V33, P275, DOI 10.1152/advan.00054.2009; KRIZ W, 1981, AM J PHYSIOL, V241, pR3, DOI 10.1152/ajpregu.1981.241.1.R3; LIGHT DB, 1989, SCIENCE, V243, P383, DOI 10.1126/science.2463673; Machida K, 2007, AM J PHYSIOL-RENAL, V292, pF1274, DOI 10.1152/ajprenal.00154.2006; Matsuzaki T, 2007, KIDNEY INT, V71, P539, DOI 10.1038/sj.ki.5002104; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; NONOGUCHI H, 1989, AM J PHYSIOL, V256, pF179, DOI 10.1152/ajprenal.1989.256.1.F179; NONOGUCHI H, 1995, J CLIN INVEST, V96, P1768, DOI 10.1172/JCI118222; NONOGUCHI H, 1988, J CLIN INVEST, V82, P1383, DOI 10.1172/JCI113742; NONOGUCHI H, 1987, J CLIN INVEST, V79, P500, DOI 10.1172/JCI112840; NONOGUCHI H, 1992, J CLIN INVEST, V90, P349, DOI 10.1172/JCI115869; Sands JM, 2009, SEMIN NEPHROL, V29, P178, DOI 10.1016/j.semnephrol.2009.03.008; STAR RA, 1990, AM J PHYSIOL, V258, pF429, DOI 10.1152/ajprenal.1990.258.2.F429; Tashima Y, 2001, PFLUG ARCH EUR J PHY, V442, P652, DOI 10.1007/s004240100590; TODDTURLA KM, 1993, AM J PHYSIOL, V264, pF781, DOI 10.1152/ajprenal.1993.264.5.F781; TOMITA K, 1986, J CLIN INVEST, V77, P136, DOI 10.1172/JCI112268; Wang WD, 2006, AM J PHYSIOL-RENAL, V290, pF530, DOI 10.1152/ajprenal.00070.2005; WITTNER M, 1990, PFLUG ARCH EUR J PHY, V415, P707, DOI 10.1007/BF02584009; WORK J, 1985, AM J PHYSIOL, V249, pF698, DOI 10.1152/ajprenal.1985.249.5.F698; Yasuoka Y, 2013, CLIN EXP NE IN PRESS; ZEIDEL ML, 1986, AM J PHYSIOL, V251, pF379, DOI 10.1152/ajprenal.1986.251.2.F379	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83146	10.1371/journal.pone.0083146	http://dx.doi.org/10.1371/journal.pone.0083146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376658	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000066
J	Wang, B; Guan, L; Zhong, T; Li, KB; Yin, J; Cao, YZ				Wang, Bing; Guan, Li; Zhong, Tao; Li, Kebin; Yin, Jiao; Cao, Yazhong			Potential Cooperations between Odorant-Binding Proteins of the Scarab Beetle Holotrichia oblita Faldermann (Coleoptera: Scarabaeidae)	PLOS ONE			English	Article							PHEROMONE-BINDING; IMMUNOCYTOCHEMICAL LOCALIZATION; CHEMOSENSORY PROTEINS; OLFACTORY SENSILLA; CRYSTAL-STRUCTURE; LIGAND-BINDING; SEX-PHEROMONE; SILKWORM MOTH; NMR STRUCTURE; BIOCHEMICAL-CHARACTERIZATION	It was previously thought that the odorant binding proteins (OBPs) in the sensillum lymph might serve as carriers, which could carry lipophilic odorant molecules to olfactory receptors. In this study, two novel OBP genes of the scarab beetle Holotrichia oblita were screened using an antennal cDNA library. The full cDNA of HoblOBP3 and HoblOBP4 was cloned using reverse transcription PCR and rapid amplification of the cDNA ends. Homology modeling of both OBPs was performed using SWISS-MODEL on-line tools. Next, the two OBPs were expressed in Escherichia coli and purified using Ni ion affinity chromatography. The ligand-binding properties of HoblOBP3 and HoblOBP4 in 42 ligands respectively were measured using the fluorescence probe N-phenyl-naphthylamine (1-NPN). The results obtained from competitive binding assays demonstrated that HoblOBP4 showed a broader range of binding affinities to the test compounds, while HoblOBP3 displays more specific binding affinity. Furthermore, other OBPs and CSPs were expressed in Escherichia coli and purified using Ni ion affinity chromatography. Binding curves were measured for binary mixtures of OBPs and CSPs using 1-NPN, and the Scatchard plots exhibited "J"-like nonlinear correlation trends in some samples. In addition, competitive binding assays of the HoblOBP1 and HoblOBP2 mixtures and of the HoblOBP2 and HoblOBP4 mixtures with representative compounds unexpectedly demonstrated good affinity, which revealed extreme differences that were only obtained using the individual proteins. In the immunocytochemical analysis, colocalization of HoblOBP1 and HoblOBP2, and of HoblOBP2 and HoblOBP4, was detected in the sensilla basiconica and sensilla placodea, respectively. All of these results suggested that HoblOBP1 and HoblOBP2, as well as HoblOBP2 and HoblOBP4, may serve as heterodimers in the sensillum lymph.	[Wang, Bing; Guan, Li; Zhong, Tao; Li, Kebin; Yin, Jiao; Cao, Yazhong] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yin, J (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	jyin@ippcaas.cn; yzcao@ippcaas.cn	Zhong, Tao/AAG-4454-2021		Special Fund for Agro-Scientific Research in the Public Interest [201003025]; Natural Science Foundation of China [31000853]	Special Fund for Agro-Scientific Research in the Public Interest; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the Special Fund for Agro-Scientific Research in the Public Interest (No. 201003025); and the Natural Science Foundation of China (No. 31000853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Ban LP, 2002, BIOCHEM BIOPH RES CO, V293, P50, DOI 10.1016/S0006-291X(02)00185-7; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BIENZ K, 1986, J HISTOCHEM CYTOCHEM, V34, P1337, DOI 10.1177/34.10.3745912; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briand L, 2001, EUR J BIOCHEM, V268, P752, DOI 10.1046/j.1432-1327.2001.01927.x; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; Campanacci V, 1999, EUR J BIOCHEM, V264, P707, DOI 10.1046/j.1432-1327.1999.00666.x; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Dani FR, 2010, J PROTEOME RES, V9, P1822, DOI 10.1021/pr900969k; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P81, DOI 10.1007/BF00592572; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; [邓思思 Deng Sisi], 2011, [植物保护, Plant Protection], V37, P62; Deng SS, 2012, CHEM SENSES, V37, P141, DOI 10.1093/chemse/bjr084; Field LM, 2000, INSECT MOL BIOL, V9, P545, DOI 10.1046/j.1365-2583.2000.00221.x; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; HekmatScafe DS, 1997, J NEUROSCI, V17, P1616; Hu JH, 2011, ARTHROPOD STRUCT DEV, V40, P420, DOI 10.1016/j.asd.2011.03.003; Jiang QY, 2009, INSECT BIOCHEM MOLEC, V39, P440, DOI 10.1016/j.ibmb.2009.04.004; Jin X, 2005, CELL MOL LIFE SCI, V62, P1156, DOI 10.1007/s00018-005-5014-6; Ju Q, 2012, GENOME, V55, P537, DOI [10.1139/g2012-042, 10.1139/G2012-042]; Kaissling KE, 1998, ANN NY ACAD SCI, V855, P320, DOI 10.1111/j.1749-6632.1998.tb10590.x; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Kaissling KE, 2004, ANIR, V6, P73, DOI DOI 10.1371/journal.pone.0152147; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Klusak V, 2003, CHEM BIOL, V10, P331, DOI 10.1016/S1074-5521(03)00074-7; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; LAUE M, 1994, NATURWISSENSCHAFTEN, V81, P178, DOI 10.1007/BF01134537; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 1998, ANNU REV ENTOMOL, V43, P39, DOI 10.1146/annurev.ento.43.1.39; LEAL WS, 1993, J CHEM ECOL, V19, P1381, DOI 10.1007/BF00984883; LEAL WS, 1992, NATURWISSENSCHAFTEN, V79, P184, DOI 10.1007/BF01134440; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Lee D, 2002, FEBS LETT, V531, P314, DOI 10.1016/S0014-5793(02)03548-2; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; MUELLER D, 1990, J KANSAS ENTOMOL SOC, V63, P548; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Pophof B, 2002, NATURWISSENSCHAFTEN, V89, P515, DOI 10.1007/s00114-002-0364-5; PRESTWICH GD, 1993, PROTEIN SCI, V2, P420; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shanbhag SR, 2005, ARTHROPOD STRUCT DEV, V34, P153, DOI 10.1016/j.asd.2005.01.003; STEINBRECHT RA, 1992, CELL TISSUE RES, V270, P287, DOI 10.1007/BF00328015; STEINBRECHT RA, 1995, CELL TISSUE RES, V282, P203, DOI 10.1007/BF00319112; Sun YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032759; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; [王惠 Wang Hui], 2002, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V30, P91; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Xu W, 2011, BIOCHEM BIOPH RES CO, V404, P335, DOI 10.1016/j.bbrc.2010.11.119; Xu XZ, 2010, BIOCHEMISTRY-US, V49, P1469, DOI 10.1021/bi9020132; Yin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033589; Zhang SG, 2001, CHEM SENSES, V26, P885, DOI 10.1093/chemse/26.7.885; Zhong T, 2012, J INSECT PHYSIOL, V58, P771, DOI 10.1016/j.jinsphys.2012.01.011; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x; Ziemba BP, 2013, PROTEIN SCI, V22, P11, DOI 10.1002/pro.2179; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	80	27	31	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84795	10.1371/journal.pone.0084795	http://dx.doi.org/10.1371/journal.pone.0084795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376847	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000166
J	Bi, CL; Li, B; Du, LL; Wang, LS; Zhang, YQ; Cheng, ZF; Zhai, AX				Bi, Changlong; Li, Bo; Du, Lili; Wang, Lishan; Zhang, Yingqi; Cheng, Zhifeng; Zhai, Aixia			Vitamin D Receptor, an Important Transcription Factor Associated with Aldosterone-Producing Adenoma	PLOS ONE			English	Article							GENE-EXPRESSION; KCNJ5 MUTATIONS; ADRENAL-CORTEX; RENIN; ACTIVATION; DIAGNOSIS; SYSTEM; CELLS; TRRD	Objective: To explore the endocrine mechanisms of aldosterone-producing adenoma (APA) by using the microarray expression profiles of normal and APA samples. Methods: The gene expression profile GSE8514 was downloaded from Gene Expression Omnibus database, including samples from normal adrenals (n = 5) and APAs (n = 10). The differentially expressed genes (DEGs) were identified by samr package and endocrine DEGs were obtained according to Clinical Genome Database. Then, functional enrichment analysis of screened DEGs was performed by DAVID (Database for Annotation, Visualization and Integrated Discovery). Finally, a regulatory network was constructed to screen endocrine genes related with adrenal dysfunction and pathway enrichment analysis for the constructed network was performed. Results: A total of 2149 DEGs were identified including 379 up- and 1770 down-regulated genes. And 26 endocrine genes were filtered from the DEGs. Furthermore, the down-regulated DEGs are mainly related to protein kinase cascade, response to molecule of bacterial origin, response to lipopolysaccharide, cellular macromolecule catabolic process and macromolecule catabolic process, while the up-regulated DEGs are related with regulation of ion transport. The target genes of VDR (vitamin D receptor), one of the three endocrine genes differentially expressed in the regulatory network, were endocrine genes including CYP24A1 (25-hydroxyvitamin D-24-hydroxylase) and PTH (parathyroid hormone). Three pathways may be associated with APA pathogenesis including cytokine-cytokine receptor interaction, pathways in cancer and autoimmune thyroid disease. Conclusion: The VDR is the most significant transcription factor and related endocrine genes might play important roles in the endocrine mechanisms of APA.	[Bi, Changlong; Li, Bo; Du, Lili; Zhang, Yingqi; Cheng, Zhifeng] Harbin Med Univ, Affiliated Hosp 4, Dept Endocrinol, Harbin, Peoples R China; [Wang, Lishan] FengHe ShangHai Informat Technol Co Ltd, Shanghai, Peoples R China; [Wang, Lishan] Shanghai Jiao Tong Univ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Zhai, Aixia] Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China; [Zhai, Aixia] Harbin Med Univ, Heilongjiang Prov Sci & Technol Innovat Team, Higher Educ Inst Infect & Immun, Harbin, Peoples R China; [Zhai, Aixia] Harbin Med Univ, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China	Harbin Medical University; Shanghai Jiao Tong University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhai, AX (corresponding author), Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China.	aixiazhai@hotmail.com			Foundation of Heilongjiang Provincial Education Department of China [12531319, 11551238]; Foundation of Heilongjiang Provincial Health Department of China [2009-181, 2009-207, 2012-715]; Foundation of Heilongjiang Provincial Postdoctor of China [LBH-Z11086]	Foundation of Heilongjiang Provincial Education Department of China; Foundation of Heilongjiang Provincial Health Department of China; Foundation of Heilongjiang Provincial Postdoctor of China	This work was funded by grants from the Foundation of Heilongjiang Provincial Education Department of China (12531319, 11551238), Foundation of Heilongjiang Provincial Health Department of China (2009-181, 2009-207, 2012-715), and Foundation of Heilongjiang Provincial Postdoctor of China (LBH-Z11086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar L, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-9; Asmah BJ, 1997, HORM METAB RES, V29, P580, DOI 10.1055/s-2007-979105; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Boulkroun S, 2013, MOL CELL ENDOCRINOL, V371, P221, DOI 10.1016/j.mce.2013.01.018; Boulkroun S, 2011, ENDOCRINOLOGY, V152, P4753, DOI 10.1210/en.2011-1205; Chan NN, 1999, LANCET, V353, P1013, DOI 10.1016/S0140-6736(05)70723-6; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Correa P, 2002, EUR J ENDOCRINOL, V147, P671, DOI 10.1530/eje.0.1470671; de Borst MH, 2011, J AM SOC NEPHROL, V22, P1603, DOI 10.1681/ASN.2010121251; Delarue C, 2004, J MOL ENDOCRINOL, V32, P1, DOI 10.1677/jme.0.0320001; Dunbar LA, 2001, J BIOL CHEM, V276, P29617, DOI 10.1074/jbc.R100023200; Fang F, 2009, AM J PATHOL, V174, P297, DOI 10.2353/ajpath.2009.080753; Fujita Andre, 2009, Journal of Bioinformatics and Computational Biology, V7, P663, DOI 10.1142/S0219720009004230; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsegge I, 2009, BMC P S4, V3, pS10, DOI [10.1186/1753-6561-3-s1-s10, DOI 10.1186/1753-6561-3-S1-S10.PUBMED:19615110]; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kolchanov NA, 2002, NUCLEIC ACIDS RES, V30, P312, DOI 10.1093/nar/30.1.312; Kong J, 2008, KIDNEY INT, V74, P1577, DOI 10.1038/ki.2008.452; Krone N, 2009, BEST PRACT RES CL EN, V23, P181, DOI 10.1016/j.beem.2008.10.014; Lenzini L, 2007, HYPERTENSION, V50, P1106, DOI 10.1161/HYPERTENSIONAHA.107.100438; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Monticone S, 2012, J CLIN ENDOCR METAB, V97, pE1567, DOI 10.1210/jc.2011-3132; Mosso L, 2003, HYPERTENSION, V42, P161, DOI 10.1161/01.HYP.0000079505.25750.11; Mulatero P, 1998, J CLIN ENDOCR METAB, V83, P2573, DOI 10.1210/jc.83.7.2573; Nishimoto K, 2013, MOL CELL ENDOCRINOL, V371, P107, DOI 10.1016/j.mce.2012.12.023; Nishimoto K, 2012, ENDOCRINOLOGY, V153, P1755, DOI 10.1210/en.2011-1915; Pilon C, 1999, J CLIN ENDOCR METAB, V84, P4228, DOI 10.1210/jc.84.11.4228; Roff A, 2008, J STEROID BIOCHEM, V112, P47, DOI 10.1016/j.jsbmb.2008.08.009; Romero DG, 2010, PHYSIOL GENOMICS, V42A, P259, DOI 10.1152/physiolgenomics.00098.2010; Sackmann S, 2011, HORM METAB RES, V43, P106, DOI 10.1055/s-0030-1269899; Sakuma I, 2013, ENDOCR J, V60, P329; Santoro M, 2004, ENDOCRINOLOGY, V145, P5448, DOI 10.1210/en.2004-0922; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Solomon BD, 2013, P NATL ACAD SCI USA; Szabo PM, 2010, ONCOGENE, V29, P3163, DOI 10.1038/onc.2010.80; Tanahashi H, 2005, J CLIN ENDOCR METAB, V90, P6226, DOI 10.1210/jc.2005-0299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang T, 2011, EUR J ENDOCRINOL, V164, P613, DOI 10.1530/EJE-10-1085; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Ye P, 2007, J ENDOCRINOL, V195, P39, DOI 10.1677/JOE-07-0037; Young WF, 2004, SURGERY, V136, P1227, DOI 10.1016/j.surg.2004.06.051; Young WF, 2007, REV ENDOCR METAB DIS, V8, P309, DOI 10.1007/s11154-007-9055-z	45	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82309	10.1371/journal.pone.0082309	http://dx.doi.org/10.1371/journal.pone.0082309			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376526	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100024
J	Burgess, RC; Sebesta, M; Sisakova, A; Marini, VP; Lisby, M; Damborsky, J; Klein, H; Rothstein, R; Krejci, L				Burgess, Rebecca C.; Sebesta, Marek; Sisakova, Alexandra; Marini, Victoria P.; Lisby, Michael; Damborsky, Jiri; Klein, Hannah; Rothstein, Rodney; Krejci, Lumir			The PCNA Interaction Protein Box Sequence in Rad54 Is an Integral Part of Its ATPase Domain and Is Required for Efficient DNA Repair and Recombination	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; NUCLEOPROTEIN FILAMENT; REMODELING ENZYME; YEAST RAD51; SRS2; REPLICATION; CHROMATIN; ROLES	Rad54 is an ATP-driven translocase involved in the genome maintenance pathway of homologous recombination (HR) Although its activity has been implicated in several steps of HR, its exact role(s) at each step are still not fully understood. We have identified a new interaction between Rad54 and the replicative DNA clamp, proliferating cell nuclear antigen (PCNA). This interaction was only mildly weakened by the mutation of two key hydrophobic residues in the highly-conserved PCNA interaction PIP-box) of Rad54 (Rad54-AA). Intriguingly, the rad54-AA mutant cells displayed sensitivity to DNA damage and showed HR defects similar to the null mutant, despite retaining its ability to interact with HR proteins and to be recruited to HR foci in vivo. We therefore surmised that the PCNA interaction might be impaired in vivo and was Linable to promote repair synthesis during Indeed, the Rad54-AA mutant was defective in primer extension at the MAT locus as well as in vitro, but additional biochemical chemical analysis revealed that this mutant also had diminished ATPase activity and an inability to promote D-loop formation. Further mutational analysis of the putative PIP-box uncovered that other phenotypically relevant mutants in this domain also resulted in a loss of ATPase activity. Therefore, we have found that although Rad54 interacts with, the PIP-box motif likely plays only a minor role in stabilizing the PCNA interaction, and rather, this conserved domain is probably an extension of the ATPase domain III.	[Burgess, Rebecca C.; Rothstein, Rodney] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY USA; [Sebesta, Marek; Krejci, Lumir] Masaryk Univ, Natl Ctr Biomol Res, Brno, Czech Republic; [Sebesta, Marek; Sisakova, Alexandra; Marini, Victoria P.; Krejci, Lumir] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Sebesta, Marek; Sisakova, Alexandra; Krejci, Lumir] St Annes Univ Hosp, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno, Czech Republic; [Lisby, Michael] Univ Copenhagen, Dept Mol Biol, Copenhagen N, Denmark; [Damborsky, Jiri] Masaryk Univ, Fac Sci, Dept Expt Biol, CS-61137 Brno, Czech Republic; [Klein, Hannah] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA	Columbia University; Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); University of Copenhagen; Masaryk University Brno; New York University	Krejci, L (corresponding author), Masaryk Univ, Natl Ctr Biomol Res, Brno, Czech Republic.	lkrejci@chemi.muni.cz	Lisby, Michael/K-9814-2014; Damborsky, Jiri/H-3799-2012; Palomeque, María Victoria Marini/L-7480-2017; Krejci, Lumir/B-7842-2009; Šebesta, Marek/G-6332-2019	Lisby, Michael/0000-0002-4830-5247; Damborsky, Jiri/0000-0002-7848-8216; Krejci, Lumir/0000-0002-4732-1405; Sebesta, Marek/0000-0001-9546-4921; Rothstein, Rodney/0000-0002-4107-9654; Klein, Hannah/0000-0003-4228-8535	Czech Science Foundation [GACR 13-26629S, 207/12/2323]; European Regional Development Fund (Project FNUSA-ICRC) [CZ.1.05/1.1.00/02.0123]; NIH [GM50237, GM67055, GM05378, GM070711]; Danish Agency for Science, Technology and Innovation (DFF); Villum Kann Rasmussen Foundation; European Research Council (ERC); European Social Fund; state budget of the Czech Republic;  [CZ.1.07/2.3.00/20.0011]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050237, R01GM067055, R37GM050237, R01GM053738] Funding Source: NIH RePORTER	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund (Project FNUSA-ICRC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Agency for Science, Technology and Innovation (DFF); Villum Kann Rasmussen Foundation(Villum Fonden); European Research Council (ERC)(European Research Council (ERC)European Commission); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Czech Science Foundation [GACR 13-26629S and 207/12/2323] and European Regional Development Fund (Project FNUSA-ICRC) [No. CZ.1.05/1.1.00/02.0123] to LK; NIH grants GM50237 and GM67055 to RR; NIH grants GM05378 and GM070711 to HK; and by The Danish Agency for Science, Technology and Innovation (DFF), the Villum Kann Rasmussen Foundation, and the European Research Council (ERC) to ML. We are grateful to Wolf-Dietrich Heyer for communicating unpublished results and openly discussing data. Funding for open access charge: Grant number [CZ.1.07/2.3.00/20.0011] co-financed from European Social Fund and the state budget of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, J CELL BIOL, V192, P735, DOI 10.1083/jcb.201011025; AGUILERA A, 1988, GENETICS, V119, P779; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Arbel A, 1999, EMBO J, V18, P2648, DOI 10.1093/emboj/18.9.2648; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Balajee AS, 2001, NUCLEIC ACIDS RES, V29, P1341, DOI 10.1093/nar/29.6.1341; Bernstein KA, 2009, EMBO J, V28, P915, DOI 10.1038/emboj.2009.28; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Ceballos SJ, 2011, BBA-GENE REGUL MECH, V1809, P509, DOI 10.1016/j.bbagrm.2011.06.006; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Freudenthal BD, 2010, NAT STRUCT MOL BIOL, V17, P479, DOI 10.1038/nsmb.1776; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Klein H, 2001, GENETICS, V157, P557; Kolesar P, 2012, NUCLEIC ACIDS RES, V40, P7831, DOI 10.1093/nar/gks484; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Li X, 2009, NUCLEIC ACIDS RES, V37, P638, DOI 10.1093/nar/gkn980; Maloisel L, 2004, GENETICS, V167, P1133, DOI 10.1534/genetics.104.026260; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; Matulova P, 2009, J BIOL CHEM, V284, P7733, DOI 10.1074/jbc.M806192200; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Mazina OM, 2008, P NATL ACAD SCI USA, V105, P18249, DOI 10.1073/pnas.0807016105; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; PALLADINO F, 1992, GENETICS, V132, P23; Burkovics P, 2013, EMBO J, V32, P742, DOI 10.1038/emboj.2013.9; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova G, 1999, J BIOL CHEM, V274, P33839, DOI 10.1074/jbc.274.48.33839; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Sebesta M, 2011, DNA REPAIR, V10, P567, DOI 10.1016/j.dnarep.2011.03.003; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shinohara M, 1997, GENETICS, V147, P1545; Smirnova M, 2004, J BIOL CHEM, V279, P24081, DOI 10.1074/jbc.M402719200; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Solinger JA, 2001, P NATL ACAD SCI USA, V98, P8447, DOI 10.1073/pnas.121009898; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugawara N, 2006, METHOD ENZYMOL, V408, P416, DOI 10.1016/S0076-6879(06)08026-8; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Ulrich HD, 2007, BIOCHEM SOC T, V35, P1385, DOI 10.1042/BST0351385; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Wolner B, 2005, J BIOL CHEM, V280, P10855, DOI 10.1074/jbc.M414388200; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	65	7	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82630	10.1371/journal.pone.0082630	http://dx.doi.org/10.1371/journal.pone.0082630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376557	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100046
J	Ilic, O; Kovic, V; Styles, SJ				Ilic, Olivera; Kovic, Vanja; Styles, Suzy J.			In the Absence of Animacy: Superordinate Category Structure Affects Subordinate Label Verification	PLOS ONE			English	Article							LIVING THINGS; SEMANTIC CATEGORIES; CONCEPTUAL KNOWLEDGE; DISTRIBUTED ACCOUNT; ALZHEIMERS-DISEASE; DEFICITS; IDENTIFICATION; ORGANIZATION; VARIABILITY; PICTURES	Theoretical accounts as well as behavioral studies reporting animacy effects offer inconsistent and sometimes contradictory results. A possible explanation for these inconsistencies may be inadvertent biases in the stimuli selected for test - with category-specific effects driven by characteristics of test stimuli other than animacy per se. In this study, we pit animacy against feature structure (intra-item variability), in a picture-word matching task. For unimpaired adults, regardless of whether objects were from animate (mammals; insects) or inanimate (clothes; musical instruments) superordinate categories, participants were faster to match basic level labels with objects from categories with low intra-item variability (mammals; clothes) than from categories with high intra-item variability (insects; instruments). Thus, pitting animacy against variability allowed us to clarify that observable differences in processing speed between animals and instruments are systematically driven by the intra-item variability of the superordinate categories, and not by animacy itself.	[Ilic, Olivera; Kovic, Vanja] Univ Belgrade, Dept Psychol, Belgrade, Serbia; [Styles, Suzy J.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Styles, Suzy J.] Nanyang Technol Univ, Div Psychol, Singapore 639798, Singapore	University of Belgrade; University of Oxford; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ilic, O (corresponding author), Univ Belgrade, Dept Psychol, Belgrade, Serbia.	olivera.ilic@f.bg.ac.rs	Kovic, Vanja/K-4937-2019; Styles, Suzy/K-8256-2018; Savic, Olivera/AAQ-3022-2021; Kovic, Vanja/O-9504-2016	Styles, Suzy/0000-0003-3517-9680; Savic, Olivera/0000-0002-7014-9017; Kovic, Vanja/0000-0002-3954-1125	Ministry of Science and Technological Development of Serbia [179006, 179033]	Ministry of Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This research was supported by the Ministry of Science and Technological Development of Serbia (http://www.mpn.gov.rs/), grant numbers 179006 and 179033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen RH, 2010, INT J PSYCHOL RES, V3, P12; Bates D., 2005, R R NEWS, V5, P27, DOI DOI 10.18637/JSS.V067.I01; Bielak AAM, 2010, NEUROPSYCHOLOGY, V24, P731, DOI 10.1037/a0019802; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Cree GS, 2003, J EXP PSYCHOL GEN, V132, P163, DOI 10.1037/0096-3445.132.2.163; Devlin JT, 2002, NEUROPSYCHOLOGIA, V40, P54, DOI 10.1016/S0028-3932(01)00066-5; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Marques JF, 2011, VIS COGN, V19, P705, DOI 10.1080/13506285.2011.575414; GAFFAN D, 1993, J COGNITIVE NEUROSCI, V5, P118, DOI 10.1162/jocn.1993.5.1.118; Gonnerman LM, 1997, BRAIN LANG, V57, P254, DOI 10.1006/brln.1997.1752; HUMPHREYS GW, 1988, COGNITIVE NEUROPSYCH, V5, P67, DOI 10.1080/02643298808252927; KOSTIC DJ, 1999, FREQUENCY DICT CONT; Lag T, 2005, CORTEX, V41, P833, DOI 10.1016/S0010-9452(08)70302-2; Laws KR, 2007, J INT NEUROPSYCH SOC, V13, P401, DOI 10.1017/S1355617707070610; Laws KR, 2000, BRAIN LANG, V75, P123, DOI 10.1006/brln.2000.2348; Laws KR, 2002, CORTEX, V38, P7, DOI 10.1016/S0010-9452(08)70635-X; Laws KR, 1999, NEUROPSYCHOLOGIA, V37, P1263, DOI 10.1016/S0028-3932(99)00018-4; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; McClelland JL, 2003, NAT REV NEUROSCI, V4, P310, DOI 10.1038/nrn1076; Moss HE, 1997, COGNITIVE NEUROPSYCH, V14, P901, DOI 10.1080/026432997381394; Oberauer K, 2006, J MEM LANG, V55, P601, DOI 10.1016/j.jml.2006.08.009; PERANI D, 1995, NEUROREPORT, V6, P1637, DOI 10.1097/00001756-199508000-00012; Pilgrim LK, 2002, NEUROIMAGE, V16, P713, DOI 10.1006/nimg.2002.1105; Proverbio Alice M, 2007, BMC Neurosci, V8, P24, DOI 10.1186/1471-2202-8-24; Rabbitt P, 2001, Q J EXP PSYCHOL-A, V54, P981, DOI 10.1080/02724980042000534; ROSCH E, 1975, J EXP PSYCHOL GEN, V104, P192, DOI 10.1037/0096-3445.104.3.192; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Tyler LK, 2001, TRENDS COGN SCI, V5, P244, DOI 10.1016/S1364-6613(00)01651-X; Tyler LK, 2003, COGN NEUROPSYCHOL, V20, P541, DOI 10.1080/02643290244000211; Tyler LK, 2000, BRAIN LANG, V75, P195, DOI 10.1006/brln.2000.2353; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273	35	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83282	10.1371/journal.pone.0083282	http://dx.doi.org/10.1371/journal.pone.0083282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376678	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100105
J	Jozefiak, D; Kieronczyk, B; Juskiewicz, J; Zdunczyk, Z; Rawski, M; Dlugosz, J; Sip, A; Hojberg, O				Jozefiak, Damian; Kieronczyk, Bartosz; Juskiewicz, Jerzy; Zdunczyk, Zenon; Rawski, Mateusz; Dlugosz, Jakub; Sip, Anna; Hojberg, Ole			Dietary Nisin Modulates the Gastrointestinal Microbial Ecology and Enhances Growth Performance of the Broiler Chickens	PLOS ONE			English	Article							DIVERGENS AS7 BACTERIOCIN; CLOSTRIDIUM-PERFRINGENS; NUTRIENT RETENTION; LACTOCOCCUS-LACTIS; TRANSIT-TIME; ALBUSIN B; IN-VITRO; FERMENTATION; ABSORPTION; WHEAT	Due to antimicrobial properties, nisin is one of the most commonly used and investigated bacteriocins for food preservation. Surprisingly, nisin has had limited use in animal feed as well as there are only few reports on its influence on microbial ecology of the gastrointestinal tract (GIT). The present study therefore aimed at investigating effects of dietary nisin on broiler chicken GIT microbial ecology and performance in comparison to salinomycin, the widely used ionophore coccidiostat. In total, 720 one-day-old male Ross 308 chicks were randomly distributed to six experimental groups. The positive control (PC) diet was supplemented with salinomycin (60 mg/kg). The nisin (NI) diets were supplemented with increasing levels (100, 300, 900 and 2700 IU nisin/g, respectively) of the bacteriocin. The negative control (NC) diet contained no additives. At slaughter (35 days of age), activity of specific bacterial enzymes (alpha-and beta-glucosidases, alpha-galactosidases and beta-glucuronidase) in crop, ileum and caeca were significantly higher (P<0.05) in the NC group, and nisin supplementation decreased the enzyme activities to levels observed for the PC group. A similar inhibitory influence on bacterial activity was reflected in the levels of short-chain fatty acids (SCFA) and putrefactive SCFA (PSCFA) in digesta from crop and ileum; no effect was observed in caeca. Counts of Bacteroides and Enterobacteriacae in ileum digesta were significantly (P<0.001) decreased by nisin and salinomycin, but no effects were observed on the counts of Clostridium perfringens, Lactobacillus/Enterococcus and total bacteria. Like salinomycin, nisin supplementation improved broiler growth performance in a dose-dependent manner; compared to the NC group, the body weight gain of the NI900 and NI2700 groups was improved by 4.7 and 8.7%, respectively. Our findings suggest that dietary nisin exerts a mode of action similar to salinomycin and could be considered as a dietary supplement for broiler chickens.	[Jozefiak, Damian; Kieronczyk, Bartosz; Rawski, Mateusz; Dlugosz, Jakub] Poznan Univ Life Sci, Dept Anim Nutr & Feed Management, Poznan, Poland; [Juskiewicz, Jerzy; Zdunczyk, Zenon] Polish Acad Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland; [Sip, Anna] Poznan Univ Life Sci, Dept Biotechnol & Food Microbiol, Poznan, Poland; [Hojberg, Ole] Aarhus Univ, Dept Anim Sci, Tjele, Denmark	Poznan University of Life Sciences; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; Poznan University of Life Sciences; Aarhus University	Jozefiak, D (corresponding author), Poznan Univ Life Sci, Dept Anim Nutr & Feed Management, Poznan, Poland.	damjo@up.poznan.pl	Juśkiewicz, Jerzy/H-7193-2017; Zduńczyk, Zenon/H-7272-2017; Kierończyk, Bartosz/I-8760-2019	Juśkiewicz, Jerzy/0000-0003-0068-5970; Zduńczyk, Zenon/0000-0002-0640-7552; Kierończyk, Bartosz/0000-0001-6006-117X; Sip, Anna/0000-0002-0120-2734; Rawski, Mateusz/0000-0001-8734-724X; Jozefiak, Damian/0000-0002-6606-7975	Innovative Economy Programme [UDA-POIG 01.03.01-30-179/09]	Innovative Economy Programme	The current study was supported by the following grant: "Bacteriocins-innovative supplements for poultry diets" UDA-POIG 01.03.01-30-179/09, Innovative Economy Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoloni A, 2004, J CHEMOTHERAPY, V16, P119, DOI 10.1179/joc.2004.16.2.119; Bernbom N, 2006, APPL ENVIRON MICROB, V72, P239, DOI 10.1128/AEM.72.1.239-244.2006; Bjerrum L, 2005, AVIAN DIS, V49, P9, DOI 10.1637/7223-061504R; Callaway TR, 1997, CURR MICROBIOL, V35, P90, DOI 10.1007/s002849900218; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; Dalloul RA, 2005, COMP IMMUNOL MICROB, V28, P351, DOI 10.1016/j.cimid.2005.09.001; DELVESBROUGHTON J, 1990, J SOC DAIRY TECHNOL, V43, P73, DOI 10.1111/j.1471-0307.1990.tb02449.x; Drew MD, 2004, POULTRY SCI, V83, P414, DOI 10.1093/ps/83.3.414; DUBOIS A, 1995, EMERG INFECT DIS, V1, P79, DOI 10.3201/eid0103.950302; Engberg RM, 2000, POULTRY SCI, V79, P1311, DOI 10.1093/ps/79.9.1311; Fowler G. G., 1991, FOOD PRESERVATIVES, P135; Grilli E, 2009, POULTRY SCI, V88, P2152, DOI 10.3382/ps.2009-00160; Guban J, 2006, POULTRY SCI, V85, P2186, DOI 10.1093/ps/85.12.2186; Harmsen HJM, 1999, MICROB ECOL HEALTH D, V11, P3, DOI DOI 10.1080/089106099435862; Hughes RJ, 2008, BRIT POULTRY SCI, V49, P716, DOI 10.1080/00071660802449145; Jalc D, 2002, BERL MUNCH TIERARZTL, V115, P6; Jozefiak D, 2006, BRIT POULTRY SCI, V47, P57, DOI 10.1080/00071660500475145; Jozefiak D, 2012, POULTRY SCI, V91, P1899, DOI 10.3382/ps.2012-02151; Jozefiak D, 2011, J ANIM FEED SCI, V20, P401, DOI 10.22358/jafs/66195/2011; Jozefiak D, 2011, BRIT POULTRY SCI, V52, P492, DOI 10.1080/00071668.2011.602963; Jozefiak D, 2010, BRIT POULTRY SCI, V51, P546, DOI 10.1080/00071668.2010.507243; Jozefiak D, 2010, J ANIM FEED SCI, V19, P460; Jozefiak D, 2013, ANN ANIM SCI, V13, P449, DOI 10.2478/aoas-2013-0031; Juskiewicz J, 2003, J ANIM FEED SCI, V12, P133; Kaldhusdal M, 1999, FEMS IMMUNOL MED MIC, V24, P337, DOI 10.1111/j.1574-695X.1999.tb01303.x; Knarreborg A, 2004, J NUTR, V134, P1487, DOI 10.1093/jn/134.6.1487; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P6425, DOI 10.1128/AEM.68.12.6425-6428.2002; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P5918, DOI 10.1128/AEM.68.12.5918-5924.2002; MANZ W, 1993, APPL ENVIRON MICROB, V59, P2293, DOI 10.1128/AEM.59.7.2293-2298.1993; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Matsusaki E, 1995, J FAC AGR KYUSHU U, V40, P73; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Mills S, 2011, ANNU REV FOOD SCI T, V2, P299, DOI 10.1146/annurev-food-022510-133721; MOORE RJ, 1986, CAN J ANIM SCI, V66, P257, DOI 10.4141/cjas86-026; Organization WH, 1970, WHO EXP COMM BIOL ST; Owusu-Asiedu A, 2006, J ANIM SCI, V84, P843, DOI 10.2527/2006.844843x; Platel K, 2001, NUTR RES, V21, P1309, DOI 10.1016/S0271-5317(01)00331-1; Ross RP, 2002, INT J FOOD MICROBIOL, V79, P3, DOI 10.1016/S0168-1605(02)00174-5; Santoso B, 2006, ANIM FEED SCI TECH, V129, P187, DOI 10.1016/j.anifeedsci.2006.01.001; Sar C, 2004, ANIM FEED SCI TECH, V115, P129, DOI 10.1016/j.anifeedsci.2004.01.006; SAS Institute, 1990, SAS US GUID STAT VER; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; SPEARS JW, 1990, J NUTR, V120, P632, DOI 10.1093/jn/120.6.632; Stern NJ, 2005, J FOOD PROTECT, V68, P1450, DOI 10.4315/0362-028X-68.7.1450; Svetoch EA, 2010, POULTRY SCI, V89, P1763, DOI 10.3382/ps.2010-00659; Travers Marie-Agnes, 2011, J Parasitol Res, V2011, P610769, DOI 10.1155/2011/610769; Udompijitkul P, 2012, J FOOD SCI, V77, pM51, DOI 10.1111/j.1750-3841.2011.02475.x; Valenta C, 1996, J PHARM PHARMACOL, V48, P988, DOI 10.1111/j.2042-7158.1996.tb06019.x; Wang HT, 2013, J SCI FOOD AGR, V93, P284, DOI 10.1002/jsfa.5754; Wang HT, 2011, J SCI FOOD AGR, V91, P2338, DOI 10.1002/jsfa.4463	50	44	49	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85347	10.1371/journal.pone.0085347	http://dx.doi.org/10.1371/journal.pone.0085347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376878	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100202
J	Lions, C; Bui-Quoc, E; Wiener-Vacher, S; Seassau, ML; Bucci, MP				Lions, Cynthia; Bui-Quoc, Emmanuel; Wiener-Vacher, Sylvette; Seassau, Maga Li; Bucci, Maria Pia			Smooth Pursuit Eye Movements in Children with Strabismus and in Children with Vergence Deficits	PLOS ONE			English	Article							BINOCULAR COORDINATION; SACCADES; ASYMMETRIES; TRACKING; ONSET	Purpose: The objective of our study was to examine horizontal smooth pursuit performance in strabismic children and in children with vergence deficits, and to compare these data with those recorded in a group of control age-matched children. Methods: Binocular eye movements were recorded by video-oculography in ten strabismic children (mean age: 9.8+/-0.8) and seven children with vergence deficits (mean age: 10.8+/-0.6). Data were compared to that of age-matched control children (mean age: 9.8+/-0.8 years). Results: Catch-up saccades amplitude in strabismic children and in children with vergence deficits were significantly higher than in control age-matched children. Moreover, in strabismic children the amplitude of catch-up saccades was significantly higher in rightward than in leftward direction. The number of catch-up saccades was also significantly higher in rightward than in leftward direction. The gain value of pursuits in rightward direction was significantly higher in the right eye than in the left one; for the right eye, the gain value was significantly higher in rightward than in leftward direction. Binocular coordination of pursuit was better in control age-matched children than in children with vergence deficits and than in strabismic children. Conclusions: Binocular coordination of pursuit is abnormal in children with vergence deficits and worse in strabismic children. Binocular vision plays an important role in improving binocular coordination of pursuit.	[Lions, Cynthia; Bucci, Maria Pia] Univ Paris Diderot, Hop Robert Debre, INSERM, Unite Mixte Rech 676, Paris, France; [Bui-Quoc, Emmanuel] Hop Robert Debre, Serv Ophtalmol, F-75019 Paris, France; [Wiener-Vacher, Sylvette] Robert Debre Hosp, ORL Dept, Vestibular & Oculomotor Evaluat Unit, Paris, France; [Seassau, Maga Li] E Ye BRAIN, Ivry, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Lions, C (corresponding author), Univ Paris Diderot, Hop Robert Debre, INSERM, Unite Mixte Rech 676, Paris, France.	cynthia.lions.giraud@gmail.com						ACCARDO AP, 1995, VISION RES, V35, P539, DOI 10.1016/0042-6989(94)00145-C; Anoh-Tanon MJ, 2000, PEDIATR NEUROL, V23, P49, DOI 10.1016/S0887-8994(00)00140-5; Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099; BEDELL HE, 1990, INVEST OPHTH VIS SCI, V31, P968; Bucci MP, 2009, VISION RES, V49, P460, DOI 10.1016/j.visres.2008.12.006; CIUFFREDA KJ, 1979, INVEST OPHTH VIS SCI, V18, P506; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1772, DOI 10.1152/jn.00621.2001; Espinasse-Berrod M-A, STRABOLOGIE APPROCHE; Gaertner C, 2013, VISION RES, V87, P22, DOI 10.1016/j.visres.2013.05.006; Hofsten C., 1997, VISION RES, V37, P1799; Ingster-Moati I, 2009, EUR J PAEDIATR NEURO, V13, P362, DOI 10.1016/j.ejpn.2008.07.003; Jacobsen LK, 1996, BIOL PSYCHIAT, V40, P1144, DOI 10.1016/S0006-3223(95)00630-3; Jeanrot N, 2003, MANUEL STRABOLOGIE A; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lions C, 2013, INVEST OPHTH VIS SCI, V54, P620, DOI 10.1167/iovs.12-10526; Nawrot M, 2008, VISION RES, V48, P799, DOI 10.1016/j.visres.2007.12.010; ROBINSON DA, 1965, J PHYSIOL-LONDON, V180, P569, DOI 10.1113/jphysiol.1965.sp007718; Salman MS, 2006, EXP BRAIN RES, V169, P139, DOI 10.1007/s00221-005-0292-7; SCHOR C, 1975, INVEST OPHTH VISUAL, V14, P692; Takeichi N, 2003, EXP BRAIN RES, V149, P380, DOI 10.1007/s00221-002-1367-3; TYCHSEN L, 1985, ARCH OPHTHALMOL-CHIC, V103, P536; TYCHSEN L, 1986, J NEUROSCI, V6, P2495; Von Noorden GK, 2001, AM ORTHOPT J, V51, P161	23	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83972	10.1371/journal.pone.0083972	http://dx.doi.org/10.1371/journal.pone.0083972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376777	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100149
J	Lv, YR; Song, SS; Zhang, K; Gao, HD; Ma, R				Lv, Yanrong; Song, Shanshan; Zhang, Kai; Gao, Haidong; Ma, Rong			CHIP Regulates AKT/FoxO/Bim Signaling in MCF7 and MCF10A Cells	PLOS ONE			English	Article							UBIQUITIN LIGASE CHIP; FOXO TRANSCRIPTION FACTORS; PROTEASOMAL DEGRADATION; CANCER CELLS; BCL-2 FAMILY; E3 LIGASE; APOPTOSIS; PROTEIN; PTEN; BIM	A number of studies have shown that apoptosis resistance can be observed in multiple human tumors; however the detailed mechanism remains unclear. In the present study, we demonstrated that the abnormal overexpression of the C terminus of Hsc70-interacting protein (CHIP) induced apoptosis resistance by regulating the AKT/FoxO/Bim signaling pathway in the breast cancer cell MCF7 and the human non-tumorigenic cell MCF10A. We found that CHIP overexpression in MCF7 and MCF10A cells activated AKT and inhibited the Forkhead box O (FoxO) transcription factors FoxO1, FoxO3, and FoxO4, thereby inhibiting transcription of the target genes bim and pten. Inhibition of PI3K by a chemical reagent revealed that these events may be critical for CHIP-induced apoptosis resistance. We also determined that inhibition of FoxO3 by CHIP led to the decrease in PTEN and further activated the AKT survival pathway. We corroborated our findings in breast cancer tissues. In general, the CHIP-modulated AKT/FoxO/Bim signaling pathway was shown to induce apoptosis resistance by decreasing the protein level of the tumor suppressor PTEN in both transcriptional and post-translational regulations.	[Lv, Yanrong; Zhang, Kai; Gao, Haidong; Ma, Rong] Shandong Univ, QiLu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Song, Shanshan] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA USA	Shandong University; University of Southern California	Gao, HD (corresponding author), Shandong Univ, QiLu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	haidongao@163.com; marongw2000@163.com	ma, rong/GVU-3096-2022		Nature Science of Shandong Province [Q2008C08]	Nature Science of Shandong Province	The source of funding that has supported this work is the Nature Science of Shandong Province, Q2008C08 (http://www.sdnsf.gov.cn/portal/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dudgeon C, 2010, MOL CANCER THER, V9, P2893, DOI 10.1158/1535-7163.MCT-10-0635; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Lee JH, 2010, J BIOL CHEM, V285, P42033, DOI 10.1074/jbc.M110.149831; Li Y, 2008, J BIOL CHEM, V283, P27707, DOI 10.1074/jbc.M802759200; Luo H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.3; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Narayan V, 2011, J BIOL CHEM, V286, P607, DOI 10.1074/jbc.M110.153122; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Oh KH, 2011, CELL DEATH DIFFER, V18, P1326, DOI 10.1038/cdd.2011.3; Sharma G, 2012, J CELL PHYSIOL, V227, P1923, DOI 10.1002/jcp.22920; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Strasser A, 2000, ANN NY ACAD SCI, V917, P541; Subbareddy M., 2011, NAT CELL BIOL, V13, P728; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; van der Vos Kristan E, 2012, Adv Biol Regul, V52, P122; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Zhang YQ, 2011, CANCER BIOL THER, V12, P253, DOI 10.4161/cbt.12.4.15954	27	27	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83312	10.1371/journal.pone.0083312	http://dx.doi.org/10.1371/journal.pone.0083312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376685	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100110
J	Nickolls, SA; Humphreys, S; Clark, M; McMurray, G				Nickolls, Sarah A.; Humphreys, Sian; Clark, Mellissa; McMurray, Gordon			Co-Expression of GRK2 Reveals a Novel Conformational State of the mu-Opioid Receptor	PLOS ONE			English	Article							BETA-ARRESTIN; AGONIST AFFINITY; ACTIVATION; PHOSPHORYLATION; MORPHINE; KINASE; BETA-ARRESTIN-2; PROTEINS; DESENSITIZATION; MEMBRANE	Agonists at the mu-opioid receptor are known to produce potent analgesic responses in the clinical setting, therefore, an increased understanding of the molecular interactions of ligands at this receptor could lead to improved analgesics. As historically morphine has been shown to be a poor recruiter of beta-arrestin in recombinant cell systems and this can be overcome by the co-expression of GRK2, we investigated the effects of GRK2 co-expression, in a recombinant m-opioid receptor cell line, on ligand affinity and intrinsic activity in both b-arrestin recruitment and [S-35]GTP gamma S binding assays. We also investigated the effect of receptor depletion in the beta-arrestin assay. GRK2 co-expression increased both agonist Emax and potency in the beta-arrestin assay. The increase in agonist potency could not be reversed using receptor depletion, supporting that the effects were due to a novel receptor conformation not system amplification. We also observed a small but significant effect on agonist K-L values. Potency values in the [S-35]GTP gamma S assay were unchanged; however, inverse agonist activity became evident with GRK2 co-expression. We conclude that this is direct evidence that the m-opioid receptor is an allosteric protein and the co-expression of signalling molecules elicits changes in its conformation and thus ligand affinity. This has implications when describing how ligands interact with the receptor and how efficacy is determined.	[Nickolls, Sarah A.; Humphreys, Sian; Clark, Mellissa; McMurray, Gordon] Neusentis, Cambridge, England		Nickolls, SA (corresponding author), Neusentis, Granta Pk, Cambridge, England.	sarah.nickolls@pfizer.com			Neusentis	Neusentis	This study was funded by Neusentis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEN JR, 1995, J NEUROCHEM, V65, P1636; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Berg KA, 1998, MOL PHARM, V36, P601; Birdsong WT, 2013, J NEUROSCI, V33, P4118, DOI 10.1523/JNEUROSCI.4187-12.2013; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Burford NT, 1998, EUR J PHARMACOL, V342, P123, DOI 10.1016/S0014-2999(97)01556-2; Chen CG, 1996, J BIOL CHEM, V271, P21422, DOI 10.1074/jbc.271.35.21422; Chen YJ, 2013, J NEUROCHEM, V124, P189, DOI 10.1111/jnc.12071; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Doll C, 2012, BRIT J PHARMACOL, V167, P1259, DOI 10.1111/j.1476-5381.2012.02080.x; Evron T, 2012, TRENDS PHARMACOL SCI, V33, P154, DOI 10.1016/j.tips.2011.12.003; JACOBSON AR, 1989, J MED CHEM, V32, P1708, DOI 10.1021/jm00128a007; Jorgensen R, 2011, PHARMACOLOGY, V88, P174, DOI 10.1159/000330742; Kenakin T, 2011, PHARMACOL REV, V62, P265; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Li JL, 2003, J BIOL CHEM, V278, P30219, DOI 10.1074/jbc.M302385200; Liu JG, 2001, MOL PHARMACOL, V60, P53, DOI 10.1124/mol.60.1.53; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; Magnan R, 2013, J AM CHEM SOC, V135, P2560, DOI 10.1021/ja308784w; Mary S, 2012, P NATL ACAD SCI USA, V109, P8304, DOI 10.1073/pnas.1119881109; Nickolls SA, 2004, NEUROPHARMACOLOGY, V47, P860, DOI 10.1016/j.neuropharm.2004.06.010; Nickolls SA, 2011, J BIOMOL SCREEN, V16, P706, DOI 10.1177/1087057111406548; Nobles KN, 2012, SCI SIGNAL, V4, P1; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; Rivero G, 2012, MOL PHARMACOL, V82, P178, DOI 10.1124/mol.112.078659; Wang DX, 2004, J PHARMACOL EXP THER, V308, P512, DOI 10.1124/jpet.103.054049; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954, DOI 10.1124/mol.58.5.954; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Yan F, 2008, BIOCHEMISTRY-US, V47, P1567, DOI 10.1021/bi701476b; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	37	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83691	10.1371/journal.pone.0083691	http://dx.doi.org/10.1371/journal.pone.0083691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376730	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100129
J	Palladino, C; Briz, V; Bellon, JM; Bartolo, I; Carvalho, P; Camacho, R; Munoz-Fernandez, MA; Bastoss, R; Manuels, R; Casanovas, J; Taveira, N				Palladino, Claudia; Briz, Veronica; Maria Bellon, Jose; Bartolo, Ines; Carvalho, Patricia; Camacho, Ricardo; Angeles Munoz-Fernandez, M.; Bastoss, Rui; Manuels, Rolanda; Casanovas, Jose; Taveira, Nuno			Predictors of Attrition and Immunological Failure in HIV-1 Patients on Highly Active Antiretroviral Therapy from Different Healthcare Settings in Mozambique	PLOS ONE			English	Article							TREATMENT PROGRAMS; INFECTION; REDISTRIBUTION; INITIATION; RETENTION; RECOVERY; OUTCOMES	In Mozambique, the evaluation of retention in HIV care and ART programmes is limited. To assess rate and predictors of attrition (no retention in care) and HAART effectiveness in HIV-1 infected patients who pay for medication and laboratory testing in Mozambique, we conducted a multicenter survey of HIV-1-infected patients who started HAART during 2002-2006. Cox proportional hazard models were used to assess risk of attrition and of therapy failure. Overall, 142 patients from 16 healthcare centers located in the capital city Maputo were followed-up for 22.2 months (12.1-46.7). The retention rate was 75%, 48% and 37% after one, two and three years, respectively. Risk of attrition was lower in patients with higher baseline CD4 count (P = 0.022) and attending healthcare center 1 (HCC1) (P = 0.013). The proportion of individuals with CD4 count <= 200 cells/mu L was 55% (78/142) at baseline and decreased to 6% (3/52) at 36 months. Among the patients with available VL, 86% (64/74) achieved undetectable VL levels. The rate of immunologic failure was 17.2% (95% CI: 12.6-22.9) per 100 person-years. Risk of failure was associated to higher baseline CD4 count (P = 0.002), likely reflecting low adherence levels, and decreased with baseline VL >= 10,000 copies/mL (P = 0.033). These results suggest that HAART can be effective in HIV-1 infected patients from Mozambique that pay for their medication and laboratory testing. Further studies are required to identify the causes for low retention rates in patients with low CD4 counts and to better understand the association between healthcare setting and attrition rate.	[Palladino, Claudia; Bartolo, Ines; Taveira, Nuno] Univ Lisbon, Fac Farm, Ctr Patogenese Mol, Unidade Retrovirus & Infeccoes Associadas, P-1699 Lisbon, Portugal; [Palladino, Claudia; Briz, Veronica; Angeles Munoz-Fernandez, M.] Hosp Gen Univ Gregorio Maranon, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Lab Inmunobiol Mol, Madrid, Spain; [Maria Bellon, Jose] Hosp Gen Univ Gregorio Maranon, Fdn Invest Biomed, Unidad Invest, Madrid, Spain; [Carvalho, Patricia; Camacho, Ricardo] Ctr Hosp Lisboa Ocidental, Mol Biol Lab, Lisbon, Portugal; [Bastoss, Rui; Manuels, Rolanda] Hosp Cent Maputo, Hosp Dia, Serv Dermatol & Venereol, Maputo, Mozambique; [Casanovas, Jose] Univ Eduardo Mondlane, Fac Med, Dept Acad Microbiol, Unidade Imunodiagnost Viral, Maputo, Mozambique; [Bartolo, Ines; Taveira, Nuno] Inst Super Ciencias Saude Egas Moniz, CiiEM, Caparica, Portugal	Universidade de Lisboa; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Eduardo Mondlane University; Instituto Superior de Ciencias da Saude Egas Moniz	Palladino, C (corresponding author), Univ Lisbon, Fac Farm, Ctr Patogenese Mol, Unidade Retrovirus & Infeccoes Associadas, P-1699 Lisbon, Portugal.	claudiapalladino@ff.ul.pt; veronica.briz@gmail.com	Bellon-Cano, José María/G-6120-2016; Bártolo, Inês/A-7477-2014; Carvalho, Patrícia Sousa Vindeirinho Albuquerque/HCI-2410-2022; iMed.ULisboa, EEPHIV/B-4222-2014; Briz, Veronica VB/T-4183-2017; Cano, Jose Maria Bellon/G-3061-2012; Taveira, Nuno C/A-6252-2014; Palladino, Claudia/E-2523-2014; Camacho, Ricardo J/I-7629-2012	Bellon-Cano, José María/0000-0002-8492-1565; Bártolo, Inês/0000-0002-2022-8921; Briz, Veronica VB/0000-0003-2297-5098; Cano, Jose Maria Bellon/0000-0002-8492-1565; Taveira, Nuno C/0000-0003-0176-5585; Palladino, Claudia/0000-0002-8148-0928; Camacho, Ricardo J/0000-0002-9129-3237; Munoz-Fernandez/0000-0002-0813-4500	Portuguese Fundacao para a Ciencia e Tecnologia (FCT) [PSIDA/ESP/49699, PTDC/SAUFAR/115290/2009, SFRH/BPD/77448/2011, SFRH/BPD/76225/2011]; Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN), from the European Unio; Spanish MICINN [JCI-200905650]; Spanish Fondo de Investigacion Sanitaria [CD09/00433]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-FAR/115290/2009] Funding Source: FCT	Portuguese Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN), from the European Unio; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundação para a Ciência e a Tecnologia	The Maputo HIV-1 Cohort (MHIVC) was supported by the Portuguese Fundacao para a Ciencia e Tecnologia (FCT) (PSIDA/ESP/49699 and PTDC/SAUFAR/115290/2009) and the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN), from the European Union. Claudia Palladino is currently supported by the Portuguese Fundacao para a Ciencia e Tecnologia (FCT) (SFRH/BPD/77448/2011) and was supported by The Spanish MICINN (Juan de la Cierva JCI-200905650) until March 2012. Veronica Briz is supported by the Spanish Fondo de Investigacion Sanitaria (Sara Borrell CD09/00433). Ines Bartolo is supported by the Portuguese Fundacao para a Ciencia e Tecnologia (FCT) (SFRH/BPD/76225/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Uria G, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21682; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dragsted UB, 2004, J INFECT DIS, V190, P148, DOI 10.1086/420786; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Grant P, 2011, 18 C RETR ACTG STUD; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Joint United Nations Programme on HIV/AIDS, 2010, UN GEN ASS SPEC SESS; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Lambdin BH, 2011, JAIDS-J ACQ IMM DEF, V57, pE33, DOI 10.1097/QAI.0b013e3182167e90; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Macharia DK, 2003, AIDS, V17, P938, DOI 10.1097/00002030-200304110-00028; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Palombi L, 2010, AM J TROP MED HYG, V83, P1128, DOI 10.4269/ajtmh.2010.09-0705; Richard N, 2004, AIDS RES HUM RETROV, V20, P355, DOI 10.1089/088922204323048104; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; WHO, 2010, ANT THER HIV INF AD	24	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82718	10.1371/journal.pone.0082718	http://dx.doi.org/10.1371/journal.pone.0082718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376569	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100053
J	van Remoortel, H; Camillo, CA; Langer, D; Hornikx, M; Demeyer, H; Burtin, C; Decramer, M; Gosselink, R; Janssens, W; Troosters, T				van Remoortel, Hans; Camillo, Carlos Augusto; Langer, Daniel; Hornikx, Miek; Demeyer, Heleen; Burtin, Chris; Decramer, Marc; Gosselink, Rik; Janssens, Wim; Troosters, Thierry			Moderate Intense Physical Activity Depends on Selected Metabolic Equivalent of Task (MET) Cut-Off and Type of Data Analysis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DAILY ENERGY-EXPENDITURE; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; ACTIVITY MONITORS; AMERICAN-COLLEGE; SPORTS-MEDICINE; PUBLIC-HEALTH; POPULATION; ADULTS	Background: Accelerometry data are frequently analyzed without considering whether moderate-to-vigorous physical activities (MVPA) were performed in bouts of >10 minutes as defined in most physical activity guidelines. We aimed i) to quantify MVPA by using different commonly-applied physical activity guidelines, ii) to investigate the effect of bouts versus non-bouts analysis, and iii) to propose and validate a MVPA non-bouts cut-point to classify (in-) active subjects. Methods: Healthy subjects (n=110;62 +/- 6yrs) and patients with Chronic Obstructive Pulmonary Disease (COPD) (n=113;62 +/- 5yrs) wore an activity monitor for 7 days. Three Metabolic Equivalent of Task (MET) cut-offs and one individual target (50% VO2 reserve) were used to define MVPA. First, all minutes of MVPA were summed up (NON-BOUTS). Secondly, only minutes performed in bouts of >10 minutes continuous activity were counted (BOUTS). Receiver operating characteristic (ROC) curve analyses were used to propose and (cross-) validate new MVPA non-bout cut-points based on the criterion of 30 minutes MVPA per day (BOUTS). Likelihood ratios (sensitivity/[1-specificity]) were used to express the association between the proposed MVPA non-bout target and the MVPA bout target of 30 min*day(-1). Results: MVPA was variable across physical activity guidelines with lowest values for age-specific cut-offs. Selecting a METs cut-point corresponding to 50% VO2 reserve revealed no differences in MVPA between groups. MVPA's analyzed in BOUTS in healthy subjects were 2 to 4 fold lower than NON-BOUTS analyses and this was even 3 to 12 fold lower in COPD. The MVPA non-bouts cut-point of 80 min*day(-1) using a 3 METs MVPA threshold delivered positive likelihood ratios of 5.1[1.5-19.6] (healthy subjects) and 2.3[1.6-3.3] (COPD). Conclusion: MVPA varies upon the selected physical activity guideline/targets and bouts versus non-bouts analysis. Accelerometry measured MVPA non-bouts target of 80 min*day(-1), using a 3 METs MVPA threshold, is associated to the commonly-used MVPA bout target of 30 min*day(-1).	[van Remoortel, Hans; Camillo, Carlos Augusto; Langer, Daniel; Hornikx, Miek; Demeyer, Heleen; Burtin, Chris; Gosselink, Rik; Troosters, Thierry] Katholieke Univ Leuven, Dept Rehabil Sci, Fac Kinesiol & Rehabil Sci, Louvain, Belgium; [van Remoortel, Hans; Camillo, Carlos Augusto; Langer, Daniel; Hornikx, Miek; Demeyer, Heleen; Burtin, Chris; Decramer, Marc; Gosselink, Rik; Janssens, Wim; Troosters, Thierry] Univ Hosp Gasthuisberg, Div Resp, Louvain, Belgium; [van Remoortel, Hans; Camillo, Carlos Augusto; Langer, Daniel; Hornikx, Miek; Demeyer, Heleen; Burtin, Chris; Decramer, Marc; Gosselink, Rik; Janssens, Wim; Troosters, Thierry] Univ Hosp Gasthuisberg, Louvain, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Troosters, T (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Fac Kinesiol & Rehabil Sci, Louvain, Belgium.	thierry.troosters@med.kuleuven.be	Camillo, Carlos Augusto/G-6325-2012; Gosselink, Rik/AAK-4655-2020; Van Remoortel, Hans/AAH-2425-2019; burtin, chris/B-3343-2015; Hornikx, Miek/ABI-5441-2020; Langer, Daniel/B-7307-2014	Camillo, Carlos Augusto/0000-0001-7648-8573; Langer, Daniel/0000-0001-8738-9482; Gosselink, Rik/0000-0003-0444-8606; Demeyer, Heleen/0000-0001-8925-0564; Janssens, Wim/0000-0003-1830-2982	FWO Vlaanderen [G.0598.09N]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil [204525/2011-8]	FWO Vlaanderen(FWO); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by FWO Vlaanderen (G.0598.09N). CAC is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil (204525/2011-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Avesani CM, 2012, NEPHROL DIAL TRANSPL, V27, P2430, DOI 10.1093/ndt/gfr692; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Bhasin SK, 2011, WORLD J CARDIOL, V3, P201, DOI 10.4330/wjc.v3.i6.201; Cadilhac DA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-99; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Donaire-Gonzalez D, 2013, EUR RESPIR J, V42, P993, DOI 10.1183/09031936.00101512; *FAO, 1985, EN PROT REQ; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HELMRICH SP, 1994, MED SCI SPORT EXER, V26, P824; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; Kozey S, 2010, J PHYS ACT HEALTH, V7, P508, DOI 10.1123/jpah.7.4.508; LEON AS, 1987, JAMA-J AM MED ASSOC, V258, P2388, DOI 10.1001/jama.258.17.2388; Ma G, 2008, OBES REV, V9, P113, DOI 10.1111/j.1467-789X.2007.00451.x; Mackey DC, 2011, J GERONTOL A-BIOL, V66, P1108, DOI 10.1093/gerona/glr101; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; MCARDLE WD, 2005, ENERGY EXPENDITURE R, P722; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; MILLER GD, 2012, OBESITY, V20, P1122; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rabinovich RA, 2013, EUR RESPIR J, V42, P1205, DOI 10.1183/09031936.00134312; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Scheers T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-136; Scheers T, 2012, EUR J APPL PHYSIOL, V112, P1653, DOI 10.1007/s00421-011-2131-9; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Staudenmayer J, 2012, MED SCI SPORT EXER, V44, pS61, DOI 10.1249/MSS.0b013e3182399e0f; Thompson D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004337; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Troosters T, 2010, RESP MED, V104, P1005, DOI 10.1016/j.rmed.2010.01.012; Van Remoortel H, 2013, THORAX, V68, P962, DOI 10.1136/thoraxjnl-2013-203534; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; Vatten LJ, 2006, J HYPERTENS, V24, P1939, DOI 10.1097/01.hjh.0000244941.49793.f9; Vorrink SNW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-33; Waschki B, 2011, CHEST, V140, P331, DOI 10.1378/chest.10-2521; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608; Watz H, 2008, AM J RESP CRIT CARE, V177, P743, DOI 10.1164/rccm.200707-1011OC; Welk GJ, 2012, MED SCI SPORT EXER, V44, pS39, DOI 10.1249/MSS.0b013e3182399d8f; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104	49	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84365	10.1371/journal.pone.0084365	http://dx.doi.org/10.1371/journal.pone.0084365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376804	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100165
J	Zhang, NN; Zhuang, MQ; Ma, AX; Wang, GC; Cheng, P; Yang, YJ; Wang, XF; Zhang, J; Chen, XD; Lu, M				Zhang, Nana; Zhuang, Maoqiang; Ma, Aixia; Wang, Guochang; Cheng, Ping; Yang, Yajun; Wang, Xiaofeng; Zhang, Juan; Chen, Xingdong; Lu, Ming			Association of Levels of Mannose-Binding Lectin and the MBL2 Gene with Type 2 Diabetes and Diabetic Nephropathy	PLOS ONE			English	Article							ELEVATED LEVELS; COMPLICATIONS; POLYMORPHISMS; VARIANTS	Objective: To investigate the association of Mannose-binding lectin (MBL) and the MBL2 gene with type 2 diabetes and diabetic nephropathy and the influence of MBL2 polymorphisms on serum MBL levels. Methods: The study population included 675 type 2 diabetic patients with or without nephropathy and 855 normoglycemic controls. The single nucleotide polymorphisms (SNPs) of rs1800450, rs1800451, and rs11003125 of the MBL2 gene were determined by the Multiplex Snapshot method. Serum MBL levels were measured by enzyme-linked immune sorbent assay. Results: Rs1800450 and rs11003125 SNPs demonstrated strong linkage disequilibrium in the study population (r(2) = 0.97). The haplotypes constructed from the G allele of rs1800450 and the C allele of rs11003125 increased the risk for type 2 diabetes (OR = 1.2, 95% CI = 1.1-1.4, P = 0.01). For rs1800450, GG and GA genotypes were associated with type 2 diabetes (P = 0.02, 0.01, respectively). For rs11003125, the GC genotype frequency was significantly different between patients and controls (18.1% vs. 24.9%, P = 0.001). Analyses of genotypes and allele frequency distributions among patients with normal UAE, microalbuminuria, and macroalbuminuria showed that there was no obvious evidence of association between the MBL2 gene and diabetic nephropathy. Subjects with the GG genotype of rs1800450 and the CC genotype of rs11003125 had much higher serum MBL levels. Conclusions: The rs1800450 and rs11003125 SNPs of the MBL2 gene have strong linkage disequilibrium and are associated with type 2 diabetes in the North Chinese Han population. No association was observed between the MBL2 gene and diabetic nephropathy. Subjects with the GG genotype of rs1800450 and the CC genotype of rs11003125 had much higher serum MBL levels. An association between elevated serum MBL and diabetic nephropathy was also observed.	[Zhang, Nana; Zhuang, Maoqiang; Ma, Aixia; Wang, Guochang; Cheng, Ping; Lu, Ming] Shandong Univ, Clin Epidemiol Unit, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Yang, Yajun; Wang, Xiaofeng; Chen, Xingdong; Lu, Ming] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Yang, Yajun; Wang, Xiaofeng; Chen, Xingdong; Lu, Ming] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Yang, Yajun; Wang, Xiaofeng; Zhang, Juan; Chen, Xingdong; Lu, Ming] CMC Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China	Shandong University; Fudan University; Fudan University	Lu, M (corresponding author), Shandong Univ, Clin Epidemiol Unit, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	lvming@sdu.edu.cn	zhuang, maoqiang/M-6562-2019	zhuang, maoqiang/0000-0001-9093-2626	NSFC [30973595]; SDSTC [BS2009SW038]	NSFC(National Natural Science Foundation of China (NSFC)); SDSTC	This work was supported by a grant from NSFC (30973595) and a grant from SDSTC (BS2009SW038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2001, DIABETES CARE S1, V24, pS69; Araujo J, 2007, HUM IMMUNOL, V68, P739, DOI 10.1016/j.humimm.2007.05.007; Bouwman LH, 2005, DIABETES, V54, P3002, DOI 10.2337/diabetes.54.10.3002; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Elawa G, 2011, SAUDI MED J, V32, P784; Fernandez-Real JM, 2006, DIABETOLOGIA, V49, P2402, DOI 10.1007/s00125-006-0381-6; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; [谷翔 Gu Xiang], 2005, [临床心血管病杂志, Journal of Clinical Cardiology], V21, P423; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P1082, DOI 10.1210/jc.2002-021478; Hansen TK, 2004, DIABETES, V53, P1570, DOI 10.2337/diabetes.53.6.1570; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P4857, DOI 10.1210/jc.2003-030742; Hansen TK, 2006, ARCH INTERN MED, V166, P2007, DOI 10.1001/archinte.166.18.2007; Kaunisto MA, 2009, DIABETES, V58, P1710, DOI 10.2337/db08-1495; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P401, DOI 10.1016/S0304-4165(02)00321-5; Mellbin LG, 2010, DIABETES CARE, V33, P2451, DOI 10.2337/dc10-0903; Muller YL, 2010, DIABETES, V59, P2080, DOI 10.2337/db09-1593; NUYTINCK L, 2004, PERS MED, V1, P35; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Saraheimo M, 2005, DIABETOLOGIA, V48, P198, DOI 10.1007/s00125-004-1594-1; Saraheimo M, 2003, DIABETOLOGIA, V46, P1402, DOI 10.1007/s00125-003-1194-5; Shi H, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P202; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; SOELL M, 1995, J IMMUNOL, V154, P851; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; Tsutsumi A, 2003, HUM IMMUNOL, V64, P621, DOI 10.1016/S0198-8859(03)00054-5; Turner M W, 2000, Rev Immunogenet, V2, P305; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	30	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83059	10.1371/journal.pone.0083059	http://dx.doi.org/10.1371/journal.pone.0083059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376633	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100083
J	Beury-Cirou, A; Tannieres, M; Minard, C; Soulere, L; Rasamiravaka, T; Dodd, RH; Queneau, Y; Dessaux, Y; Guillou, C; Vandeputte, OM; Faure, D				Beury-Cirou, Amelie; Tannieres, Melanie; Minard, Corinne; Soulere, Laurent; Rasamiravaka, Tsiry; Dodd, Robert H.; Queneau, Yves; Dessaux, Yves; Guillou, Catherine; Vandeputte, Olivier M.; Faure, Denis			At a Supra-Physiological Concentration, Human Sexual Hormones Act as Quorum-Sensing Inhibitors	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; COMMUNICATION; BACTERIA; ANALOGS; BINDING; STRAIN	N-Acylhomoserine lactone (AHL)-mediated quorum-sensing (QS) regulates virulence functions in plant and animal pathogens such as Agrobacterium tumefaciens and Pseudomonas aeruginosa. A chemolibrary of more than 3500 compounds was screened using two bacterial AHL-biosensors to identify QS-inhibitors (QSIs). The purity and structure of 15 QSIs selected through this screening were verified using HPLC MS/MS tools and their activity tested on the A. tumefaciens and P. aeruginosa bacterial models. The IC50 value of the identified QSIs ranged from 2.5 to 90 mu g/ml, values that are in the same range as those reported for the previously identified QSI 4-nitropyridine-N-oxide (IC50 24 mu g/ml). Under the tested culture conditions, most of the identified QSIs did not exhibit bacteriostatic or bactericidal activities. One third of the tested QSIs, including the plant compound hordenine and the human sexual hormone estrone, decreased the frequency of the QS-regulated horizontal transfer of the tumor-inducing (Ti) plasmid in A. tumefaciens. Hordenine, estrone as well as its structural relatives estriol and estradiol, also decreased AHL accumulation and the expression of six QS-regulated genes (lasI, lasR, lasB, rhlI, rhlR, and rhlA) in cultures of the opportunist pathogen P. aeruginosa. Moreover, the ectopic expression of the AHL-receptors RhlR and LasR of P. aeruginosa in E. coli showed that their gene-regulatory activity was affected by the QSIs. Finally, modeling of the structural interactions between the human hormones and AHL-receptors LasR of P. aeruginosa and TraR of A. tumefaciens confirmed the competitive binding capability of the human sexual hormones. This work indicates potential interferences between bacterial and eukaryotic hormonal communications.	[Beury-Cirou, Amelie; Tannieres, Melanie; Dessaux, Yves; Faure, Denis] CNRS, ISV, UPR 2355, Gif Sur Yvette, France; [Beury-Cirou, Amelie] CNPPT, SIPRE, Achicourt, France; [Minard, Corinne; Dodd, Robert H.; Guillou, Catherine] CNRS, Inst Chim Subst Nat, UPR2301, Gif Sur Yvette, France; [Soulere, Laurent; Queneau, Yves] Univ Lyon 1, INSA, ICBMS, UMR 5246, F-69622 Villeurbanne, France; [Rasamiravaka, Tsiry; Vandeputte, Olivier M.] Univ Libre Bruxelles, Lab Biotechnol Vegetale, Gosselies, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Libre de Bruxelles	Vandeputte, OM (corresponding author), Univ Libre Bruxelles, Lab Biotechnol Vegetale, Gosselies, Belgium.	ovdeputt@ulb.ac.be; faure@isv.cnrs-gif.fr		Queneau, Yves/0000-0003-4052-061X; guillou, catherine/0000-0003-0693-0703; TANNIERES, Melanie/0000-0003-2335-3776	FRS-FNRS (Belgium; CNRS (France); ANR [SVSE7 2011 ECORUM]	FRS-FNRS (Belgium(Fonds de la Recherche Scientifique - FNRS); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR))	OMV was supported by FRS-FNRS (Belgium). TR is indebted to the AUF (Agence Universitaire de la Francophonie, Madagascar - Belgium) and the CUD (Cooperation Universitaire pour le Developpement, Belgium). The authors thank CNRS (France) and ANR (project SVSE7 2011 ECORUM) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara N, 2011, CHEM REV, V111, P195, DOI 10.1021/cr100101c; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; BARSI MC, 1985, J CHEM SOC CHEM COMM, P88, DOI 10.1039/c39850000088; Bayo M., 2002, International Microbiology, V5, P87, DOI 10.1007/s10123-002-0064-1; Bedu E, 1999, TETRAHEDRON LETT, V40, P835, DOI 10.1016/S0040-4039(98)02485-X; Boivin J, 2006, SYNTHESIS-STUTTGART, P1664, DOI 10.1055/s-2006-926464; Bottomley MJ, 2007, J BIOL CHEM, V282, P13592, DOI 10.1074/jbc.M700556200; Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11; Carlier A, 2004, MOL PLANT MICROBE IN, V17, P951, DOI 10.1094/MPMI.2004.17.9.951; Casetta A, 2003, J HOSP INFECT, V54, P158, DOI 10.1016/S0195-6701(03)00121-X; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Dumas C, 2000, EUR J ORG CHEM, V2000, P3601; Dupont C, 1999, BIOORGAN MED CHEM, V7, P2961, DOI 10.1016/S0968-0896(99)00241-2; FRANK M, 1990, EQUINE VET J, V22, P437, DOI 10.1111/j.2042-3306.1990.tb04312.x; Galloway WRJD, 2011, CHEM REV, V111, P28, DOI 10.1021/cr100109t; HAPKE HJ, 1995, DEUT TIERARZTL WOCH, V102, P228; Hosoda K, 2011, FEMS MICROBIOL LETT, V318, P68, DOI 10.1111/j.1574-6968.2011.02239.x; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Isabelle M, 2011, CAN J MICROBIOL, V57, P559, DOI [10.1139/W11-051, 10.1139/w11-051]; Ishida T, 2007, APPL ENVIRON MICROB, V73, P3183, DOI 10.1128/AEM.02233-06; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Janssens JCA, 2008, CURR MED CHEM, V15, P2144, DOI 10.2174/092986708785747580; Kalia VC, 2013, BIOTECHNOL ADV, V31, P224, DOI 10.1016/j.biotechadv.2012.10.004; Kretzschmar U, 2008, ARCH MICROBIOL, V190, P151, DOI 10.1007/s00203-008-0381-7; Liang RB, 2012, J BACTERIOL, V194, P4781, DOI 10.1128/JB.01060-12; Lindsay A, 2005, J BACTERIOL, V187, P5054, DOI 10.1128/JB.187.14.5054-5058.2005; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Nelson BC, 2007, J AGR FOOD CHEM, V55, P9769, DOI 10.1021/jf072030s; Nisenblat V, 2010, EUR J PAIN, V14, P840, DOI 10.1016/j.ejpain.2010.01.002; NWAUKWA SO, 1982, TETRAHEDRON LETT, V23, P35, DOI 10.1016/S0040-4039(00)97525-7; Pandey G, 2011, ORG LETT, V13, P4672, DOI 10.1021/ol201892j; Park J, 2008, J INFECT DIS, V198, P1198, DOI 10.1086/591916; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Peters L, 2003, APPL ENVIRON MICROB, V69, P3469, DOI 10.1128/AEM.69.6.3469-3475.2003; Phillips C, 2011, J AM CHEM SOC, V133, P9696, DOI 10.1021/ja202946k; Podust LM, 2004, STRUCTURE, V12, P1937, DOI 10.1016/j.str.2004.08.009; Rasmussen TB, 2005, J BACTERIOL, V187, P1799, DOI 10.1128/JB.187.5.1799-1814.2005; ROWLAND SS, 1992, J STEROID BIOCHEM, V42, P721, DOI 10.1016/0960-0760(92)90113-W; Rumbaugh KP, 2007, ANAL BIOANAL CHEM, V387, P425, DOI 10.1007/s00216-006-0694-9; Schwardt O, 2010, BIOORGAN MED CHEM, V18, P7239, DOI 10.1016/j.bmc.2010.08.027; Shabana M, 2006, NAT PROD RES, V20, P710, DOI 10.1080/14786410500137718; Soulere L, 2010, BIOORG MED CHEM LETT, V20, P4355, DOI 10.1016/j.bmcl.2010.06.081; Stevens AM, 2011, CHEM REV, V111, P4, DOI 10.1021/cr100064s; Su SC, 2008, J BACTERIOL, V190, P4398, DOI 10.1128/JB.01684-07; Thompson MA, 2004, ARGUSLAB 4 0 1 PLANE; Van Delden C, 1998, INFECT IMMUN, V66, P4499; Vandeputte OM, 2011, MICROBIOL-SGM, V157, P2120, DOI 10.1099/mic.0.049338-0; Vandeputte OM, 2010, APPL ENVIRON MICROB, V76, P243, DOI 10.1128/AEM.01059-09; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833	53	29	30	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83564	10.1371/journal.pone.0083564	http://dx.doi.org/10.1371/journal.pone.0083564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376718	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000096
J	Iqbal, MP; Yakub, M				Iqbal, Mohammad Perwaiz; Yakub, Mohsin			Smokeless Tobacco Use: A Risk Factor for Hyperhomocysteinemia in a Pakistani Population	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SOUTH-ASIA; KARACHI; HOMOCYSTEINE; PREVENTION; PREVALENCE; FOLATE; HEALTH; BETEL	Background: Smokeless tobacco (ST) use is highly prevalent in the South Asian populations. While there have been a number of reports on association of ST consumption with cancer, very few studies have been conducted to investigate its relationship with cardiovascular disease. Hyperhomocysteinemia is a well-recognized risk factor for cardiovascular disease; however, its association with ST use has never been investigated. The objective of this study was to evaluate the relationship of ST use with hyperhomocysteinemia in an urban Pakistani population. Methodology/Principal Findings: In a cross-sectional study for assessment of risks of hyperhomocysteinemia, 872 healthy adults (355 males and 517 females of age range 18-60 years) were recruited from a low-income population in Karachi, Pakistan. A detailed questionnaire was administered which included information about smoking, non-smoking, use of ST alone (chewing as well as sniffing) and use of ST with betel nuts. Fasting serum/plasma levels of homocysteine, folate, vitamin B12 and pyridoxal phosphate (PLP; a coenzymic form of vitamin B6) were analyzed. In this population, 43.4% males and 15.5% females were found to be regular users of ST products. Laborers and vendors were the major ST consumers. Smoking was not found to be associated with plasma/serum concentrations of homocysteine, folate, vitamin B12 and PLP. However, homocysteine concentrations in the group which consumed ST alone and the group which consumed ST along with betel nut were significantly higher compared to the non-user group (17.7 +/- 7.5 mu mol/L, 25.48 mu mol/L vs. 11.95 mu mol/L, respectively; p<0.01). Odds ratio for the association of hyperhomocysteinemia (>15 mu mol/L) was 11-fold higher in the ST-consumer group compared to the non-user group, [OR (95%CI) = 11.34 (7.58-16.96); p<0.001], when the model was adjusted for age, gender, folate and vitamin B12 status. Conclusion: This study shows a positive association between ST consumption and hyperhomocysteinemia in a low-income urban Pakistani population.	[Iqbal, Mohammad Perwaiz; Yakub, Mohsin] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan	Aga Khan University	Iqbal, MP (corresponding author), Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan.	perwaiz.iqbal@aku.edu	Iqbal, Mohammed/GYA-1556-2022; Iqbal, Mohammad Perwaiz/I-6763-2015		Pakistan Science Foundation [PSF/Res/S-AKU/Med (210)]; University Research Council, Aga Khan University [1UJ]; Bill and Melinda Gates Foundation [OPPGH5241]	Pakistan Science Foundation; University Research Council, Aga Khan University; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was supported by two grants, one from the Pakistan Science Foundation [No. PSF/Res/S-AKU/Med (210)], and another one from the University Research Council, Aga Khan University [No. 1UJ].Analysis and interpretation by MY were supported through a nutrition biomarker fellowship under OPPGH5241 from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali NS, 2011, NUTS AND SEEDS IN HEALTH AND DISEASE PREVENTION, P197, DOI 10.1016/B978-0-12-375688-6.10023-4; [Anonymous], 2013, SMOK TOB FACTS; [Anonymous], 2011, CHEWING TOBACCO NOT; BARTSCH H, 1989, FREE RADICAL BIO MED, V7, P637, DOI 10.1016/0891-5849(89)90144-5; BOLINDER G, 1994, AM J PUBLIC HEALTH, V84, P399, DOI 10.2105/AJPH.84.3.399; CAMP VM, 1983, CLIN CHEM, V29, P642; CHANARIN I, 1989, LAB HAEMATOLOGY, P131; Dietz NA, 2011, TOB INDUC DIS, V9, DOI 10.1186/1617-9625-9-6; Gabriel HE, 2006, AM J CLIN NUTR, V83, P835, DOI 10.1093/ajcn/83.4.835; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Ilyas F, 2010, PCSIR STUDY FINDS TO; Imam SZ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-231; Iqbal MP, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-94; Iqbal MP, 2012, PAK J MED SCI, V28, P564; Jacobsen DW, 1998, CLIN CHEM, V44, P1833; Khawaja Muhammad RizwanulHaq, 2006, Asian Pac J Cancer Prev, V7, P95; Kyaing NN, 2012, INDIAN J CANCER, V49, P347, DOI 10.4103/0019-509X.107727; Mazahir S, 2006, SUBST ABUSE TREAT PR, V1, DOI 10.1186/1747-597X-1-10; Mouhamed DH, 2011, CLIN CHEM LAB MED, V49, P479, DOI 10.1515/CCLM.2011.062; Nisar MI, 2011, J PAK MED ASSOC, V61, P711; Pandey Ambarish, 2009, Tob Induc Dis, V5, P15, DOI 10.1186/1617-9625-5-15; Piano MR, 2010, CIRCULATION, V122, P1520, DOI 10.1161/CIR.0b013e3181f432c3; Quadros EV, 2000, CHEM ANAL SERIES, P311; Ramakrishnan S, 2011, AM J CARDIOVASC DRUG, V11, P109, DOI 10.2165/11586750-000000000-00000; Rozi S., 2007, Eastern Mediterranean Health Journal, V13, P916; Shah F, 2010, EXPRESS TRIBUNE; Sinha DN, 2012, INDIAN J CANCER, V49, P342, DOI 10.4103/0019-509X.107726; Somatunga LC, 2012, INDIAN J CANCER, V49, P357, DOI 10.4103/0019-509X.107729; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thakur J S, 2011, Indian J Public Health, V55, P155, DOI 10.4103/0019-557X.89943; UELAND PM, 1989, J LAB CLIN MED, V114, P473; US-NCI, 2010, SMOK TOB CANC; Uthus EO, 1996, J NUTR, V126, pS2452; Whincup PH, 1999, HEART, V82, P448, DOI 10.1136/hrt.82.4.448; Yakub M, 2010, PAK J MED SCI, V26, P923; Yakub M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011706; Yakub M, 2010, J NUTR, V140, P1261, DOI 10.3945/jn.109.120477; Yusuf S, 2001, J AM COLL CARDIOL, V38, P688, DOI 10.1016/S0735-1097(01)01417-6	38	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83826	10.1371/journal.pone.0083826	http://dx.doi.org/10.1371/journal.pone.0083826			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376761	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000121
J	Prankerd, RJ; Nguyen, TH; Ibrahim, JP; Bischof, RJ; Nassta, GC; Olerile, LD; Russell, AS; Meiser, F; Parkington, HC; Coleman, HA; Morton, DAV; McIntosh, MP				Prankerd, Richard J.; Tri-Hung Nguyen; Ibrahim, Jibriil P.; Bischof, Robert J.; Nassta, Gemma C.; Olerile, Livesey D.; Russell, Adrian S.; Meiser, Felix; Parkington, Helena C.; Coleman, Harold A.; Morton, David A. V.; McIntosh, Michelle P.			Pulmonary Delivery of an Ultra-Fine Oxytocin Dry Powder Formulation: Potential for Treatment of Postpartum Haemorrhage in Developing Countries	PLOS ONE			English	Article							3RD STAGE; NONA-PEPTIDE; MISOPROSTOL; MANAGEMENT; LABOR; MYOMETRIUM; PREVENTION; EXPRESSION; RECEPTOR; PASSAGE	Oxytocin is recommended by the World Health Organisation as the most effective uterotonic for the prevention and treatment of postpartum haemorrhage. The requirement for parenteral administration by trained healthcare providers and the need for the drug solution to be maintained under cold-chain storage limit the use of oxytocin in the developing world. In this study, a spray-dried ultrafine formulation of oxytocin was developed with an optimal particle size diameter (1-5 mu m) to facilitate aerosolised delivery via the lungs. A powder formulation of oxytocin, using mannitol, glycine and leucine as carriers, was prepared with a volume-based median particle diameter of 1.9 mu m. Oxytocin content in the formulation was assayed using high-performance liquid chromatography-mass spectroscopy and was found to be unchanged after spray-drying. Ex vivo contractility studies utilising human and ovine uterine tissue indicated no difference in the bioactivity of oxytocin before and after spray-drying. Uterine electromyographic (EMG) activity in postpartum ewes following pulmonary (in vivo) administration of oxytocin closely mimicked that observed immediately postpartum (0-12 h following normal vaginal delivery of the lamb). In comparison to the intramuscular injection, pulmonary administration of an oxytocin dry powder formulation to postpartum ewes resulted in generally similar EMG responses, however a more rapid onset of uterine EMG activity was observed following pulmonary administration (129 +/- 18 s) than intramuscular injection (275 +/- 22 s). This is the first study to demonstrate the potential for oxytocin to elicit uterine activity after systemic absorption as an aerosolised powder from the lungs. Aerosolised oxytocin has the potential to provide a stable and easy to administer delivery system for effective prevention and treatment of postpartum haemorrhage in resource-poor settings in the developing world.	[Prankerd, Richard J.; Tri-Hung Nguyen; Ibrahim, Jibriil P.; Nassta, Gemma C.; Olerile, Livesey D.; Russell, Adrian S.; Morton, David A. V.; McIntosh, Michelle P.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Ibrahim, Jibriil P.; Bischof, Robert J.] Monash Univ, Dept Physiol, Biotechnol Res Labs, Clayton, Vic 3168, Australia; [Meiser, Felix] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia; [Parkington, Helena C.; Coleman, Harold A.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	Monash University; Monash University; University of Western Australia; Monash University	McIntosh, MP (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	Michelle.McIntosh@monash.edu	Olerile, Dr. Livesey David/GPC-5176-2022	Olerile, Dr. Livesey David/0000-0002-3680-7530; McIntosh, Michelle Paula/0000-0002-1605-7226; Morton, David/0000-0002-1491-6517	Saving Lives at Birth Partners (United States Agency for International Development (USAID); Saving Lives at Birth Partners (Government of Norway); Saving Lives at Birth Partners (Bill and Melinda Gates Foundation); Saving Lives at Birth Partners (Grand Challenges of Canada); Saving Lives at Birth Partners (World Bank); Bill and Melinda Gates Foundation through a Grand Challenges Exploration grant	Saving Lives at Birth Partners (United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Saving Lives at Birth Partners (Government of Norway)(United States Agency for International Development (USAID)Bill & Melinda Gates Foundation); Saving Lives at Birth Partners (Bill and Melinda Gates Foundation)(United States Agency for International Development (USAID)Bill & Melinda Gates Foundation); Saving Lives at Birth Partners (Grand Challenges of Canada)(United States Agency for International Development (USAID)Bill & Melinda Gates Foundation); Saving Lives at Birth Partners (World Bank)(United States Agency for International Development (USAID)Bill & Melinda Gates Foundation); Bill and Melinda Gates Foundation through a Grand Challenges Exploration grant	This work was supported by a grant from the Saving Lives at Birth Partners (United States Agency for International Development (USAID), the Government of Norway, the Bill and Melinda Gates Foundation, Grand Challenges of Canada, and the World Bank). This work was also supported by the Bill and Melinda Gates Foundation through a Grand Challenges Exploration grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfirevic Z, 2007, INT J GYNECOL OBSTET, V99, pS198, DOI 10.1016/j.ijgo.2007.09.012; Althabe F, 2011, INT J GYNECOL OBSTET, V114, P184, DOI 10.1016/j.ijgo.2011.05.003; Aronsson A, 2004, HUM REPROD, V19, P81, DOI 10.1093/humrep/deh005; Davis, 1999, Pharm Sci Technol Today, V2, P450, DOI 10.1016/S1461-5347(99)00199-6; DAVIS TV, 2004, LANCET, V363, P75, DOI DOI 10.1016/S0140-6736(03)15180-X; Deepak NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062801; FOLKESSON HG, 1992, EXP LUNG RES, V18, P595, DOI 10.3109/01902149209031697; FOLKESSON HG, 1993, ACTA PHYSIOL SCAND, V147, P173, DOI 10.1111/j.1748-1716.1993.tb09486.x; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; HASTINGS RH, 1992, J APPL PHYSIOL, V73, P1310, DOI 10.1152/jappl.1992.73.4.1310; Hawe A, 2009, PHARM RES-DORDR, V26, P1679, DOI 10.1007/s11095-009-9878-2; HOGERZEIL HV, 1994, BRIT MED J, V308, P59; Hogerzeil HV, 1996, EUR J OBSTET GYN R B, V69, P25, DOI 10.1016/0301-2115(95)02530-8; Irngartinger M, 2004, EUR J PHARM BIOPHARM, V58, P7, DOI 10.1016/j.ejpb.2004.03.016; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kimura T, 1996, ENDOCRINOLOGY, V137, P780, DOI 10.1210/en.137.2.780; Labiris NR, 2003, BRIT J CLIN PHARMACO, V56, P588, DOI 10.1046/j.1365-2125.2003.01892.x; Lalonde A, 2012, INT J GYNECOL OBSTET, V117, P108, DOI 10.1016/j.ijgo.2012.03.001; Meeusen EN, 2009, DRUG DISCOV TODAY DI, V6, P101, DOI [DOI 10.1016/J.DDM0D.2009.12.002, 10.1016/j.ddmod.2009.12.002]; MIHALKO PJ, 1988, LIPOSOMES DRUG CARRI, P679; Oladapo OT, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009336.pub2; PARKINGTON HC, 1985, J PHYSIOL-LONDON, V359, P1, DOI 10.1113/jphysiol.1985.sp015571; PARKINGTON HC, 1988, J REPROD FERTIL, V82, P697, DOI 10.1530/jrf.0.0820697; Parkington HC, 1998, J PHYSIOL-LONDON, V507P, p68P; Patton JS, 1996, ADV DRUG DELIVER REV, V19, P3, DOI 10.1016/0169-409X(95)00113-L; PRENDIVILLE WJ, 1988, BMJ-BRIT MED J, V297, P1295, DOI 10.1136/bmj.297.6659.1295; Rogers J, 1998, LANCET, V351, P693, DOI 10.1016/S0140-6736(97)09409-9; RUIS H, 1981, BRIT MED J, V283, P340, DOI 10.1136/bmj.283.6287.340; Sou T, 2013, EUR J PHARM BIOPHARM, V83, P234, DOI 10.1016/j.ejpb.2012.10.015; Tsu VD, 2003, INT J GYNECOL OBSTET, V83, P103, DOI 10.1016/S0020-7292(03)00186-3; Tsu VD, 2009, MIDWIFERY, V25, P461, DOI 10.1016/j.midw.2007.10.010; Tuncalp O, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000494.pub4; Villar J, 2002, OBSTET GYNECOL, V100, P1301, DOI 10.1016/S0029-7844(02)02371-2; Weers JG, 2007, EXPERT OPIN DRUG DEL, V4, P297, DOI 10.1517/17425247.4.3.297; *WHO, 2011, WHO TRS; Winikoff B, 2010, LANCET, V375, P210, DOI 10.1016/S0140-6736(09)61924-3; World Health Organization WHO, 2012, RECOMMENDATIONS PREV; Wu WX, 1996, ENDOCRINOLOGY, V137, P722, DOI 10.1210/en.137.2.722; YAMAHARA H, 1994, PHARMACEUT RES, V11, P1617, DOI 10.1023/A:1018918022865	39	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82965	10.1371/journal.pone.0082965	http://dx.doi.org/10.1371/journal.pone.0082965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376618	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000048
J	Rahman, M; Nakamura, K; Seino, K; Kizuki, M				Rahman, Mosiur; Nakamura, Keiko; Seino, Kaoruko; Kizuki, Masashi			Does Gender Inequity Increase the Risk of Intimate Partner Violence among Women? Evidence from a National Bangladeshi Sample	PLOS ONE			English	Article							DOMESTIC VIOLENCE; SPOUSAL VIOLENCE; EARLY MARRIAGE; HEALTH; MULTICOUNTRY; EMPOWERMENT; PREVALENCE; EXPERIENCE; ATTITUDES; AUTONOMY	Background: Evidence from developing countries regarding the association between gender inequity and intimate partner violence (IPV) victimization in women has been suggestive but inconclusive. Using nationally representative population-based data from Bangladesh, we examined the association between multidimensional aspects of gender inequity and the risk of IPV. Methods: We used data from the 2007 Bangladesh Demographic Health Survey. The analyses were based on the responses of 4,467 married women. The main explanatory variable was gender inequity, which reflects the multidimensional aspects of women's autonomy and the relationship inequality between women and their partner. The experience of physical and/or sexual IPV was the main outcome variable of interest. Results: Over 53% of married Bangladeshi women experienced physical and/or sexual violence from their husbands. In the adjusted models, women who had a higher level of autonomy (adjusted odds ratio [AOR] 0.48; 99% confidence interval [CI] 0.37-0.61), a particularly high level of economic-decision-making autonomy (AOR 0.12; 99% CI 0.08-0.17), and a higher level of non-supportive attitudes towards wife beating or raping (AOR 0.61; 99% CI 0.47-0.83) were less likely to report having experienced IPV. Education level, age at marriage, and occupational discrepancy between spouses were also found to be significant predictors of IPV. Conclusions: In conclusion, dimensions of gender inequities were significant predictors of IPV among married women in Bangladesh. An investigation of the causal link between multidimensional aspects of gender inequity and IPV will be critical to developing interventions to reduce the risk of IPV and should be considered a public health research priority.	[Rahman, Mosiur; Nakamura, Keiko; Seino, Kaoruko] Tokyo Med & Dent Univ, Grad Sch, Div Publ Hlth, Int Hlth Sect, Tokyo, Japan; [Kizuki, Masashi] Tokyo Med & Dent Univ, Grad Sch, Div Publ Hlth, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Rahman, M (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Div Publ Hlth, Int Hlth Sect, Tokyo, Japan.	rahman.ith@tmd.ac.jp		Nakamura, Keiko/0000-0002-9119-4730; Seino, Kaoruko/0000-0003-3145-6396				Ackerson LK, 2008, AM J PUBLIC HEALTH, V98, P507, DOI 10.2105/AJPH.2007.113738; Ali TS, 2011, INT J WOMENS HEALTH, V3, P105, DOI 10.2147/IJWH.S17016; Anand S, 2010, THESIS WILLIAMS COLL; Antai D, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-12; Basu A.M., 1992, CULTURE STATUS WOMEN; Bates LM, 2004, INT FAM PLAN PERSPEC, V30, P190, DOI 10.1363/3019004; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Burazeri G, 2005, BRIT MED J, V331, P197, DOI 10.1136/bmj.331.7510.197; Campbell J C, 1995, Womens Health Issues, V5, P214, DOI 10.1016/1049-3867(95)00058-5; Chan Y. H., 2004, SMJ Singapore Medical Journal, V45, P149; Chen YY, 2005, SOC SCI MED, V60, P49, DOI 10.1016/j.socscimed.2004.04.030; Coker AL, 2000, ARCH FAM MED, V9, P451, DOI 10.1001/archfami.9.5.451; Daga AS, 1998, DOMESTIC VIOLENCE WO; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Erulkar A, 2013, INT PERSPECT SEX R H, V39, P6, DOI 10.1363/3900613; Flake DF, 2005, VIOLENCE AGAINST WOM, V11, P353, DOI 10.1177/1077801204272129; Fotso Jean-Christophe, 2009, Reprod Health, V6, P9, DOI 10.1186/1742-4755-6-9; Furuta M, 2006, INT FAM PLAN PERSPEC, V32, P17, DOI 10.1363/3201706; Gage AJ, 2005, SOC SCI MED, V61, P343, DOI 10.1016/j.socscimed.2004.11.078; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gil-Gonzalez D, 2006, EUR J PUBLIC HEALTH, V16, P278, DOI 10.1093/eurpub/ckl016; Hadi A, 2001, ASIA PACIFIC POPULAT, V16, P1; Heise L., 2002, WORLD REPORT VIOLENC; Hindin M.J., 2008, INTIMATE PARTNER VIO; Hindin MJ, 2003, B WORLD HEALTH ORGAN, V81, P501; Hindin MJ, 2002, SOC SCI MED, V55, P1385, DOI 10.1016/S0277-9536(01)00273-8; HORNUNG CA, 1981, J MARRIAGE FAM, V43, P675, DOI 10.2307/351768; Ilika Amobi Linus, 2005, Afr J Reprod Health, V9, P77; Jejeebhoy SJ, 1998, ECON POLIT WEEKLY, V33, P855; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Johnson K, 2003, THESIS U MARYLAND CO; Kabeer Naila., 2005, GENDER DEV, V13, P13, DOI [10.1080/13552070512331332273, DOI 10.1080/13552070512331332273]; Khan M, 2002, 130 ANN M APHA; Kim JC, 2007, AM J PUBLIC HEALTH, V97, P1794, DOI 10.2105/AJPH.2006.095521; KISHOR S., 2008, DHS COMP REPORTS, V20; Koenig MA, 2003, DEMOGRAPHY, V40, P269, DOI 10.2307/3180801; Lamichhane P, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-19; Macmillan R, 1999, J MARRIAGE FAM, V61, P947, DOI 10.2307/354015; Martin SL, 1999, AM J EPIDEMIOL, V150, P417, DOI 10.1093/oxfordjournals.aje.a010021; McCluskey L, 2001, HERE OUR CULTURE IS; Moraes CL, 2002, INT J GYNECOL OBSTET, V79, P269, DOI 10.1016/S0020-7292(02)00250-3; Murali V., 2004, ADV PSYCHIAT TREAT, V10, P216, DOI DOI 10.1192/APT.10.3.216; National Institute of Population Research and Training (NIPORT) Mitra and Associates Macro International, 2009, BANGL DEM HLTH SURV; Okenwa LE, 2009, J FAM VIOLENCE, V24, P517, DOI 10.1007/s10896-009-9250-7; Pallitto CC, 2005, SOC SCI MED, V60, P2205, DOI 10.1016/j.socscimed.2004.10.017; d'Oliveira AFPL, 2009, REV SAUDE PUBL, V43, P299, DOI 10.1590/S0034-89102009005000013; Rahman M, 2013, EUR J CLIN NUTR, V67, P301, DOI 10.1038/ejcn.2012.202; Rahman M, 2011, J FAM VIOLENCE, V26, P411, DOI 10.1007/s10896-011-9375-3; Rahman M, 2014, INT J BEHAV MED, V21, P348, DOI 10.1007/s12529-013-9302-5; Rahman M, 2013, EUR J CONTRACEP REPR, V18, P49, DOI 10.3109/13625187.2012.745932; Rahman M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-913; Salam MA, 2006, MATERN CHILD HLTH J, V10, P83, DOI 10.1007/s10995-005-0030-6; Sambisa W, 2011, J INTERPERS VIOLENCE, V26, P2592, DOI 10.1177/0886260510388282; Santhya KG, 2010, INT PERSPECT SEX R H, V36, P132, DOI 10.1363/ipsrh.36.132.10; SCHULER SR, 1994, STUD FAMILY PLANN, V25, P65, DOI 10.2307/2138085; SEN A, 1992, BRIT MED J, V304, P587, DOI 10.1136/bmj.304.6827.587; Smith LC, 1995, THESIS U MICHIGAN AN; Standing H., 1991, DEPENDENCE AUTONOMY; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Tabachnick BG, 1996, USING MULTIVARIATE S, P100; Tinker Irene, 1990, PERSISTENT INEQUALIT; *UN DEV PROGR, 2005, HUM DEV REP 2005; Woldemicael G, 2010, HEALTH CARE WOMEN IN, V31, P599, DOI 10.1080/07399331003599555; World Health Origination, 1997, WORLD REP VIOL	64	36	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82423	10.1371/journal.pone.0082423	http://dx.doi.org/10.1371/journal.pone.0082423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	278IG	24376536	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000012
J	Rey, GU; Miao, CR; Caidi, H; Trivedi, SU; Harcourt, JL; Tripp, RA; Anderson, LJ; Haynes, LM				Rey, Gertrud U.; Miao, Congrong; Caidi, Hayat; Trivedi, Suvang U.; Harcourt, Jennifer L.; Tripp, Ralph A.; Anderson, Larry J.; Haynes, Lia M.			Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice	PLOS ONE			English	Article							PULMONARY INFLAMMATORY RESPONSE; MESSENGER-RNA EXPRESSION; ATTACHMENT G PROTEIN; SUBSTANCE-P; YOUNG-CHILDREN; T-CELLS; VACCINE; INFECTION; EOSINOPHILIA; IMMUNOGENICITY	Respiratory syncytial virus (RSV) is a high priority target for vaccine development. One concern in RSV vaccine development is that a non-live virus vaccine would predispose for enhanced disease similar to that seen with the formalin inactivated RSV (FI-RSV) vaccine. Since a mAb specific to RSV G protein can reduce pulmonary inflammation and eosinophilia seen after RSV infection of FI-RSV vaccinated mice, we hypothesized that RSV G peptides that induce antibodies with similar reactivity may limit enhanced disease after subunit or other non-live RSV vaccines. In support of this hypothesis, we show that FI-RSV vaccinated mice administered RSV G peptide vaccines had a significant reduction in enhanced disease after RSV challenge. These data support the importance of RSV G during infection to RSV disease pathogenesis and suggest that use of appropriately designed G peptide vaccines to reduce the risk of enhanced disease with non-live RSV vaccines merits further study.	[Rey, Gertrud U.; Miao, Congrong; Caidi, Hayat; Trivedi, Suvang U.; Harcourt, Jennifer L.; Haynes, Lia M.] Ctr Dis Control & Prevent CDC, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA 30333 USA; [Tripp, Ralph A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Anderson, Larry J.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Anderson, Larry J.] Childrens Healthcare Atlanta, Emory Childrens Ctr, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia; Emory University; Children's Healthcare of Atlanta (CHOA)	Haynes, LM (corresponding author), Ctr Dis Control & Prevent CDC, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA 30333 USA.	loh5@cdc.gov		Tripp, Ralph/0000-0002-2924-9956	appointment to the Research Participation Program at the Centers for Disease Control and Prevention (CDC); National Institutes of Health [5RO1AI06275-03]; Georgia Research Alliance	appointment to the Research Participation Program at the Centers for Disease Control and Prevention (CDC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance	This research was supported in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention (CDC) administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy and CDC. G. R. and SUT were ORISE Fellows at the time this study was performed. This research was also supported in part by the National Institutes of Health (5RO1AI06275-03) and through the Georgia Research Alliance to R. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LJ, 1988, J VIROL, V62, P4232, DOI 10.1128/JVI.62.11.4232-4238.1988; Belshe RB, 2004, J INFECT DIS, V190, P2096, DOI 10.1086/425981; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Collins Peter L, 2005, Proc Am Thorac Soc, V2, P166, DOI 10.1513/pats.200501-011AW; CONNORS M, 1992, J VIROL, V66, P7444, DOI 10.1128/JVI.66.12.7444-7451.1992; Elliott MB, 2004, J VIROL, V78, P8446, DOI 10.1128/JVI.78.16.8446-8454.2004; Falsey AR, 2008, J INFECT DIS, V198, P1317, DOI 10.1086/592168; Falsey AR, 1997, VACCINE, V15, P1130, DOI 10.1016/S0264-410X(97)00002-9; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hancock GE, 1996, J VIROL, V70, P7783, DOI 10.1128/JVI.70.11.7783-7791.1996; Haynes LM, 2009, J INFECT DIS, V200, P439, DOI 10.1086/600108; Haynes LM, 2003, J VIROL, V77, P9831, DOI 10.1128/JVI.77.18.9831-9844.2003; Johnson TR, 2004, J VIROL, V78, P6024, DOI 10.1128/JVI.78.11.6024-6032.2004; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Luongo C, 2009, VACCINE, V27, P5667, DOI 10.1016/j.vaccine.2009.07.022; McGinnes LW, 2011, J VIROL, V85, P366, DOI 10.1128/JVI.01861-10; Miao C, 2009, J GEN VIROL, V90, P1119, DOI DOI 10.1099/VIR.0.009308-0.PUBMED:19264600; Moghaddam A, 2006, NAT MED, V12, P905, DOI 10.1038/nm1456; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; PARADISO PR, 1994, PEDIATR INFECT DIS J, V13, P792, DOI 10.1097/00006454-199409000-00008; Pollack Paul, 2002, Journal of Infection and Chemotherapy, V8, P201, DOI 10.1007/s10156-002-0178-6; Power UF, 2008, J CLIN VIROL, V41, P38, DOI 10.1016/j.jcv.2007.10.024; PRINCE GA, 1986, J VIROL, V57, P721, DOI 10.1128/JVI.57.3.721-728.1986; Radu GU, 2010, J VIROL, V84, P9632, DOI 10.1128/JVI.00451-10; Ripple MJ, 2010, J IMMUNOL, V185, P4804, DOI 10.4049/jimmunol.1000484; Siegrist CA, 1999, J INFECT DIS, V179, P1326, DOI 10.1086/314778; Sparer TE, 1998, J EXP MED, V187, P1921, DOI 10.1084/jem.187.11.1921; Stegmann T, 2010, VACCINE, V28, P5543, DOI 10.1016/j.vaccine.2010.06.041; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; Tripp RA, 1999, J VIROL, V73, P7099, DOI 10.1128/JVI.73.9.7099-7107.1999; Tripp RA, 2000, J VIROL, V74, P1614, DOI 10.1128/JVI.74.4.1614-1622.2000; Tripp RA, 2000, J VIROL, V74, P6227, DOI 10.1128/JVI.74.13.6227-6229.2000; TRUDEL M, 1991, ARCH VIROL, V117, P59, DOI 10.1007/BF01310492; Waris ME, 1997, J VIROL, V71, P6935, DOI 10.1128/JVI.71.9.6935-6939.1997; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; Zhang WL, 2010, J VIROL, V84, P1148, DOI 10.1128/JVI.01755-09	43	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83075	10.1371/journal.pone.0083075	http://dx.doi.org/10.1371/journal.pone.0083075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376637	Green Published, gold			2022-12-27	WOS:000328882000056
J	Shao, HB; Ni, YC; Zhang, J; Chen, F; Dai, X; Fan, GG; Sun, ZP; Xu, K				Shao, Haibo; Ni, Yicheng; Zhang, Jian; Chen, Feng; Dai, Xu; Fan, Guoguang; Sun, Ziping; Xu, Ke			Dynamic Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Noninvasive Evaluation of Vascular Disrupting Treatment on Rabbit Liver Tumors	PLOS ONE			English	Article							COMBRETASTATIN A-4 PHOSPHATE; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; PHASE IB TRIAL; CANCER-THERAPY; A4 PHOSPHATE; AGENT OXI4503; SOLID TUMORS; MRI; CA4P; COMBINATION	Evaluation of vascular disrupting treatment (VDT) is generally based on tumor size and enhancement on conventional magnetic resonance imaging (MRI) which, unfortunately, may be limited in providing satisfactory information. The purpose of the study is to evaluate consecutive changes of 20 rabbit VX2 liver tumors after VDT by dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted imaging (DWI) at a 3.0 T MR unit. Twenty four hours after intravenous injection of Combretastatin A-4-phosphate (CA4P) at 20 mg/kg, DCE-MRI derived Maximum Slope of Increase (MSI) and Positive Enhancement Integral (PEI) decreased sharply due to sudden shutting down of tumor feeding vessels. DWI derived Apparent Diffusion Coefficient (ADC) in tumor periphery decreased because of ischemic cell edema. On day 4, an increase of MSI was probably caused by the recovery of blood supply. A remarkable increase of ADC represented a large scale of necrosis among tumors. On day 8, the blood perfusion further decreased and the extent of necrosis further increased, reflected by lower MSI and PEI values and higher ADC value. On day 12, a second decrease of ADC was noticed because the re-growth of periphery tumor. The experimental data indicate that the therapeutic effects of VDT may be noninvasively monitored with DCE-MRI (reflecting tumor blood perfusion) and DWI (reflecting the changes of histology), which provide powerful measures for assessment of anticancer treatments.	[Shao, Haibo; Dai, Xu; Fan, Guoguang; Xu, Ke] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Peoples R China; [Ni, Yicheng; Chen, Feng] Univ Louvain, Dept Med Diagnost Sci, Sect Radiol, Louvain, Belgium; [Zhang, Jian] Jiangsu Prov Acad Tradit Chinese Med, Nanjing, Peoples R China; [Sun, Ziping] Shandong Acad Med Sci, Radiat Med Inst, Jinan, Peoples R China	China Medical University; Nanjing University of Chinese Medicine; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Xu, K (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Peoples R China.	kexu@vip.sina.com	Fan, Guoguang/AAF-1892-2019; Ni, Yicheng/O-5887-2017	Ni, Yicheng/0000-0002-8553-7565	National Natural Science Foundation of China [81201169]; National High Technology Research and Development Program of China [2012AA022701]; LIAONING ST Project [2012225016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); LIAONING ST Project	The study was partially supported by National Natural Science Foundation of China (81201169), National High Technology Research and Development Program of China (2012AA022701) and LIAONING S&T Project (2012225016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley BC, 2010, FUTURE ONCOL, V6, P1537, DOI [10.2217/fon.10.122, 10.2217/FON.10.122]; Bihan DL, 1988, RADIOLOGY, V168, P497; Chen F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041140; Cummings J, 2012, BRIT J CANCER, V106, P1766, DOI 10.1038/bjc.2012.165; Dyke JP, 2003, RADIOLOGY, V228, P271, DOI 10.1148/radiol.2281011651; Eichten A, 2013, ANGIOGENESIS, V16, P429, DOI 10.1007/s10456-012-9328-3; Gadsby DC, 2009, PHILOS T R SOC B, V364, P229, DOI 10.1098/rstb.2008.0243; Gaya AM, 2005, CLIN ONCOL-UK, V17, P277, DOI 10.1016/j.clon.2004.11.011; Guo Y, 2012, INVEST RADIOL, V47, P116, DOI 10.1097/RLI.0b013e31822e57cc; Husband JE, 2004, BRIT J CANCER, V90, P2256, DOI 10.1038/sj.bjc.6601843; Kanthou C, 2009, INT J EXP PATHOL, V90, P284, DOI 10.1111/j.1365-2613.2009.00651.x; Ko YH, 2001, CANCER LETT, V173, P83, DOI 10.1016/S0304-3835(01)00667-X; Li J, 2013, THERANOSTICS, P27, DOI [10.7150/thno.5790, DOI 10.7150/THN0.5790]; Li JJ, 2013, TRANSL ONCOL, V6, P42, DOI 10.1593/tlo.12367; Li JJ, 2013, J CANCER, V4, P133, DOI 10.7150/jca.5635; Li JJ, 2011, RADIOLOGY, V260, P799, DOI 10.1148/radiol.11102120; Li SP, 2012, J MAGN RESON IMAGING, V35, P745, DOI 10.1002/jmri.22838; Linnik Inna V., 2012, International Journal of Medical Engineering and Informatics, V4, P362; Millward M, 2012, INVEST NEW DRUG, V30, P1065, DOI 10.1007/s10637-011-9642-4; Nathan P, 2013, THER ADV MED ONCOL, V5, P119, DOI 10.1177/1758834012463624; Nathan P, 2012, CLIN CANCER RES, V18, P3428, DOI 10.1158/1078-0432.CCR-11-3376; Ng QS, 2012, ANN ONCOL, V23, P231, DOI 10.1093/annonc/mdr332; Nielsen T, 2012, CLIN CANCER RES, V18, P6469, DOI 10.1158/1078-0432.CCR-12-2014; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Padhani AR, 2010, RADIOLOGY, V256, P348, DOI 10.1148/radiol.10091760; Padhani AR, 2001, CLIN RADIOL, V56, P607, DOI 10.1053/crad.2001.0762; Palma MD, 2012, CANCER DISCOV, V2, P395, DOI [10.1158/2159-8290.CD-12-0137, DOI 10.1158/2159-8290.CD-12-0137]; Prise VE, 2002, INT J ONCOL, V21, P717; Rajak H, 2013, CURR PHARM DESIGN, V19, P1923, DOI 10.2174/1381612811319100013; Rustin GJ, 2010, BRIT J CANCER, V102, P1355, DOI 10.1038/sj.bjc.6605650; Salmon HW, 2006, CLIN CANCER RES, V12, P4090, DOI 10.1158/1078-0432.CCR-06-0163; Sersa G, 2008, BRIT J CANCER, V98, P388, DOI 10.1038/sj.bjc.6604168; Shojaei F, 2012, CANC LETT, V8, P1249, DOI [10.1016/j.canlet.2012.03.008, DOI 10.1016/J.CAN-LET.2012.03.008]; Siemann DW, 2008, ANTICANCER RES, V28, P2027; Sosa JA, 2012, SURGERY, V152, P1078, DOI 10.1016/j.surg.2012.08.036; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thoeny HC, 2005, NEOPLASIA, V7, P779, DOI 10.1593/neo.04748; Tozer GM, 2003, BRIT J RADIOL, V76, pS23, DOI 10.1259/bjr/30165281; Tozer GM, 2002, INT J EXP PATHOL, V83, P21, DOI 10.1046/j.1365-2613.2002.00211.x; Wang ES, 2012, J CLIN ONCOL, V30, P760, DOI 10.1200/JCO.2011.39.3934; Wang HJ, 2009, INVEST RADIOL, V44, P44, DOI 10.1097/RLI.0b013e31818e5ace; Wang YQ, 2013, MAR DRUGS, V11, P903, DOI 10.3390/md11030903; Wijlemans JW, 2013, INVEST RADIOL, V48, P381, DOI 10.1097/RLI.0b013e3182820257; Yoon CJ, 2003, RADIOLOGY, V229, P126, DOI 10.1148/radiol.2291021029	44	12	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82649	10.1371/journal.pone.0082649	http://dx.doi.org/10.1371/journal.pone.0082649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376560	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000020
J	Zhang, TY; Pabst, B; Klapper, I; Stewart, PS				Zhang, Tianyu; Pabst, Breana; Klapper, Isaac; Stewart, Philip S.			General Theory for Integrated Analysis of Growth, Gene, and Protein Expression in Biofilms	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; MATHEMATICAL-MODEL; ANTIBIOTIC TOLERANCE; PROTEOMIC ANALYSIS; LIFE-STYLE; DIFFUSION; ADAPTATION; CORROSION; RESPONSES; CELLS	A theory for analysis and prediction of spatial and temporal patterns of gene and protein expression within microbial biofilms is derived. The theory integrates phenomena of solute reaction and diffusion, microbial growth, mRNA or protein synthesis, biomass advection, and gene transcript or protein turnover. Case studies illustrate the capacity of the theory to simulate heterogeneous spatial patterns and predict microbial activities in biofilms that are qualitatively different from those of planktonic cells. Specific scenarios analyzed include an inducible GFP or fluorescent protein reporter, a denitrification gene repressed by oxygen, an acid stress response gene, and a quorum sensing circuit. It is shown that the patterns of activity revealed by inducible stable fluorescent proteins or reporter unstable proteins overestimate the region of activity. This is due to advective spreading and finite protein turnover rates. In the cases of a gene induced by either limitation for a metabolic substrate or accumulation of a metabolic product, maximal expression is predicted in an internal stratum of the biofilm. A quorum sensing system that includes an oxygen-responsive negative regulator exhibits behavior that is distinct from any stage of a batch planktonic culture. Though here the analyses have been limited to simultaneous interactions of up to two substrates and two genes, the framework applies to arbitrarily large networks of genes and metabolites. Extension of reaction-diffusion modeling in biofilms to the analysis of individual genes and gene networks is an important advance that dovetails with the growing toolkit of molecular and genetic experimental techniques.	[Zhang, Tianyu] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA; [Pabst, Breana; Stewart, Philip S.] Montana State Univ, Dept Chem & Biol Engn, Bozeman, MT 59717 USA; [Klapper, Isaac] Temple Univ, Dept Math, Philadelphia, PA 19122 USA; [Stewart, Philip S.] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Montana State University System; Montana State University Bozeman	Stewart, PS (corresponding author), Montana State Univ, Dept Chem & Biol Engn, Bozeman, MT 59717 USA.	phils@biofilm.montana.edu		Stewart, Philip/0000-0001-7773-8570	National Science Foundation (NSF) [DMS-0934696]; National Institutes of Health (NIH) [R01GM109452]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109452] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T. Zhang and I. Klapper are supported by the National Science Foundation (NSF) through Grant DMS-0934696. P. Stewart and I. Klapper are supported by the National Institutes of Health (NIH) through award R01GM109452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Anguige K, 2006, MATH BIOSCI, V203, P240, DOI 10.1016/j.mbs.2006.05.009; ATKINSON B, 1974, T I CHEM ENG-LOND, V52, P248; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Biggs MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078011; Bonhomme J, 2011, MOL MICROBIOL, V80, P995, DOI 10.1111/j.1365-2958.2011.07626.x; Bore E, 2007, MICROBIOL-SGM, V153, P2289, DOI 10.1099/mic.0.2007/005942-0; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Cabral MP, 2011, J PROTEOME RES, V10, P3399, DOI 10.1021/pr101299j; De Kievit TR, 2001, APPL ENVIRON MICROB, V67, P1865, DOI 10.1128/AEM.67.4.1865-1873.2001; DIBDIN GH, 1992, COMPUT APPL BIOSCI, V8, P489; Dockery J, 2002, SIAM J APPL MATH, V62, P853, DOI 10.1137/S0036139900371709; Dockery JD, 2001, B MATH BIOL, V63, P95, DOI 10.1006/bulm.2000.0205; Folsom JP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-294; Hentzer M., 2005, BIOFILMS, V2, P37, DOI DOI 10.1017/S1479050505001699; KISSEL JC, 1984, J ENVIRON ENG-ASCE, V110, P393, DOI 10.1061/(ASCE)0733-9372(1984)110:2(393); Kofoed MVW, 2012, SYST APPL MICROBIOL, V35, P513, DOI 10.1016/j.syapm.2011.12.001; LAMOTTA EJ, 1976, ENVIRON SCI TECHNOL, V10, P765, DOI 10.1021/es60119a003; Lee KM, 2011, INFECT IMMUN, V79, P2792, DOI 10.1128/IAI.01361-10; Oosthuizen MC, 2002, APPL ENVIRON MICROB, V68, P2770, DOI 10.1128/AEM.68.6.2770-2780.2002; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; PENG CG, 1994, WATER ENVIRON RES, V66, P707, DOI 10.2175/WER.66.5.7; Pham TK, 2010, PROTEOMICS, V10, P3130, DOI 10.1002/pmic.200900448; Phillips NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038303; Picioreanu C, 2002, J ELECTROCHEM SOC, V149, pB211, DOI 10.1149/1.1470657; Picioreanu C, 1998, BIOTECHNOL BIOENG, V58, P101, DOI 10.1002/(SICI)1097-0290(19980405)58:1<101::AID-BIT11>3.0.CO;2-M; Rampioni G, 2006, J BACTERIOL; Rampioni G, 2007, MOL MICROBIOL, V66, P1557, DOI 10.1111/j.1365-2958.2007.06029.x; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; RITTMANN BE, 1980, BIOTECHNOL BIOENG, V22, P2343, DOI 10.1002/bit.260221110; Roberts ME, 2004, ANTIMICROB AGENTS CH, V48, P48, DOI 10.1128/AAC.48.1.48-52.2004; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; SIVAKANESAN R, 1980, J GEN MICROBIOL, V118, P143; STEWART PS, 1995, CHEM ENG SCI, V50, P3099, DOI 10.1016/0009-2509(95)00143-S; STEWART PS, 1993, BIOTECHNOL BIOENG, V41, P111, DOI 10.1002/bit.260410115; Teal TK, 2006, APPL ENVIRON MICROB, V72, P7324, DOI 10.1128/AEM.01163-06; Uppuluri P, 2006, MICROBIOL-SGM, V152, P2031, DOI 10.1099/mic.0.28745-0; Waite RD, 2005, J BACTERIOL, V187, P6571, DOI 10.1128/JB.187.18.6571-6576.2005; WANNER O, 1986, BIOTECHNOL BIOENG, V28, P314, DOI 10.1002/bit.260280304; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Werner E, 2004, APPL ENVIRON MICROB, V70, P6188, DOI 10.1128/AEM.70.10.6188-6196.2004; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; WILLIAMSON K, 1976, J WATER POLLUT CON F, V48, P9; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004; Zhang T, 2010, WATER SCI TECHNOL, V61, P2957, DOI 10.2166/wst.2010.064; Zheng P, 2007, J BIOTECHNOL, V132, P342, DOI 10.1016/j.jbiotec.2007.08.013	49	13	13	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83626	10.1371/journal.pone.0083626	http://dx.doi.org/10.1371/journal.pone.0083626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376726	gold, Green Published			2022-12-27	WOS:000328882000103
J	Bojmar, L; Karlsson, E; Ellegard, S; Olsson, H; Bjornsson, B; Hallbook, O; Larsson, M; Stal, O; Sandstrom, P				Bojmar, Linda; Karlsson, Elin; Ellegard, Sander; Olsson, Hans; Bjornsson, Bergthor; Hallbook, Olof; Larsson, Marie; Stal, Olle; Sandstrom, Per			The Role of MicroRNA-200 in Progression of Human Colorectal and Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200 FAMILY; REPRESSORS ZEB1; TARGETING ZEB1; METASTASIS; AMPLIFICATION; PHENOTYPE; MIGRATION; SURVIVAL; INVASION	The role of the epithelial-mesenchymal transition (EMT) in cancer has been studied extensively in vitro, but involvement of the EMT in tumorigenesis in vivo is largely unknown. We investigated the potential of microRNAs as clinical markers and analyzed participation of the EMT-associated microRNA-200 ZEB E-cadherin pathway in cancer progression. Expression of the microRNA-200 family was quantified by real-time RT-PCR analysis of fresh-frozen and microdissected formalin-fixed paraffin-embedded primary colorectal tumors, normal colon mucosa, and matched liver metastases. MicroRNA expression was validated by in situ hybridization and after in vitro culture of the malignant cells. To assess EMT as a predictive marker, factors considered relevant in colorectal cancer were investigated in 98 primary breast tumors from a treatment-randomized study. Associations between the studied EMTmarkers were found in primary breast tumors and in colorectal liver metastases. MicroRNA-200 expression in epithelial cells was lower in malignant mucosa than in normal mucosa, and was also decreased in metastatic compared to non-metastatic colorectal cancer. Low microRNA-200 expression in colorectal liver metastases was associated with bad prognosis. In breast cancer, low levels of microRNA-200 were related to reduced survival and high expression of microRNA-200 was predictive of benefit from radiotheraphy. MicroRNA-200 was associated with ER positive status, and inversely correlated to HER2 and overactivation of the PI3K/AKT pathway, that was associated with high ZEB1 mRNA expression. Our findings suggest that the stability of microRNAs makes them suitable as clinical markers and that the EMT-related microRNA-200 - ZEB - E-cadherin signaling pathway is connected to established clinical characteristics and can give useful prognostic and treatment-predictive information in progressive breast and colorectal cancers.	[Bojmar, Linda; Bjornsson, Bergthor; Hallbook, Olof; Sandstrom, Per] Linkoping Univ, Fac Hlth Sci, Cty Council Ostergotland, Dept Clin & Expt Med,Dept Surg Ostergotland, Linkoping, Sweden; [Karlsson, Elin; Ellegard, Sander; Stal, Olle] Linkoping Univ, Fac Hlth Sci, Cty Council Ostergotland, Dept Clin & Expt Med,Dept Oncol, Linkoping, Sweden; [Olsson, Hans] Linkoping Univ, Fac Hlth Sci, Cty Council Ostergotland, Dept Clin & Expt Med,Dept Pathol Ostergotland, Linkoping, Sweden; [Larsson, Marie] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden	City Council Ostergotland; Linkoping University; City Council Ostergotland; Linkoping University; City Council Ostergotland; Linkoping University; Linkoping University	Bojmar, L (corresponding author), Linkoping Univ, Fac Hlth Sci, Cty Council Ostergotland, Dept Clin & Expt Med,Dept Surg Ostergotland, Linkoping, Sweden.	linda.bojmar@liu.se	Björnsson, Bergthor/A-7716-2016; SandstrÃm, Per/AAF-1841-2019	Björnsson, Bergthor/0000-0001-9704-1260; Ellegard, Sander/0000-0002-0343-0140; Larsson, Marie/0000-0002-4524-0177	Swedish Cancer Foundation; Swedish Research Council; Research Council of Southeast Sweden; ALF; Juhlins Foundation; Gosta Miltons Foundation	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Research Council of Southeast Sweden; ALF; Juhlins Foundation; Gosta Miltons Foundation	This study was supported by grants from the Swedish Cancer Foundation, the Swedish Research Council, the Research Council of Southeast Sweden, an ALF grant, Juhlins Foundation and Gosta Miltons Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Anderson WF, 2003, CANCER METAST REV, V22, P67, DOI 10.1023/A:1022264002228; Aoyagi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018196; Askmalm MS, 2004, ACTA ONCOL, V43, P235, DOI 10.1080/02841860410029474; BAE SN, 1993, BREAST CANCER RES TR, V24, P241, DOI 10.1007/BF01833264; Brabletz T, 2013, NAT MED, V19, P1104, DOI 10.1038/nm.3327; Chen J, 2011, GYNECOL ONCOL, V121, P200, DOI 10.1016/j.ygyno.2010.12.339; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; de Jong MC, 2009, ANN SURG, V250, P440, DOI 10.1097/SLA.0b013e3181b4539b; Elson-Schwab I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013176; Esteban MA, 2012, CURR OPIN GENET DEV, V22, P423, DOI 10.1016/j.gde.2012.09.004; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gunnarsson C, 2003, ONCOGENE, V22, P34, DOI 10.1038/sj.onc.1206078; Han G, 2005, J CLIN INVEST, V115, P1714, DOI 10.1172/JCI24399; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Jeong H, 2012, HISTOPATHOLOGY, V60, pE87, DOI 10.1111/j.1365-2559.2012.04195.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karlsson E, 2011, GENE CHROMOSOME CANC, V50, P775, DOI 10.1002/gcc.20900; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Plaks V, 2013, SCIENCE, V341, P1186, DOI 10.1126/science.1235226; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Rutqvist LE, 2006, ACTA ONCOL, V45, P517, DOI 10.1080/02841860600702068; Schubert J, 2011, CELL RES, V21, P705, DOI 10.1038/cr.2011.62; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; STAL O, 1994, CYTOMETRY, V16, P160, DOI 10.1002/cyto.990160210; Stal O, 2003, BREAST CANCER RES, V5, pR37, DOI 10.1186/bcr569; Stoyianni A, 2012, ANTICANCER RES, V32, P1273; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Xue CS, 2003, CANCER RES, V63, P3386	38	42	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84815	10.1371/journal.pone.0084815	http://dx.doi.org/10.1371/journal.pone.0084815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376848	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100188
J	Calderon-Larranaga, A; Gimeno-Feliu, LA; Gonzalez-Rubio, F; Poblador-Plou, B; Lairla-San Jose, M; Abad-Diez, JM; Poncel-Falco, A; Prados-Torres, A				Calderon-Larranaga, Amaia; Gimeno-Feliu, Luis A.; Gonzalez-Rubio, Francisca; Poblador-Plou, Beatriz; Lairla-San Jose, Maria; Abad-Diez, Jose M.; Poncel-Falco, Antonio; Prados-Torres, Alexandra			Polypharmacy Patterns: Unravelling Systematic Associations between Prescribed Medications	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; RISK-FACTORS; THERAPY; DISEASE; COMORBIDITY; DEPRESSION; GUIDELINES; INHIBITORS; SYMPTOMS; IDENTIFY	Objectives: The aim of this study was to demonstrate the existence of systematic associations in drug prescription that lead to the establishment of patterns of polypharmacy, and the clinical interpretation of the associations found in each pattern. Methods: A cross-sectional study was conducted based on information obtained from electronic medical records and the primary care pharmacy database in 2008. An exploratory factor analysis of drug dispensing information regarding 79,089 adult patients was performed to identify the patterns of polypharmacy. The analysis was stratified by age and sex. Results: Seven patterns of polypharmacy were identified, which may be classified depending on the type of disease they are intended to treat: cardiovascular, depression-anxiety, acute respiratory infection (ARI), chronic obstructive pulmonary disease (COPD), rhinitis-asthma, pain, and menopause. Some of these patterns revealed a clear clinical consistency and included drugs that are prescribed together for the same clinical indication (i.e., AR! and COPD patterns). Other patterns were more complex but also clinically consistent: in the cardiovascular pattern, drugs for the treatment of known risk factors such as hypertension or dyslipidemia were combined with other medications for the treatment of diabetes or established cardiovascular pathology (e.g., antiplatelet agents). Almost all of the patterns included drugs for preventing or treating potential side effects of other drugs in the same pattern. Conclusions: The present study demonstrated the existence of non-random associations in drug prescription, resulting in patterns of polypharmacy that are sound from the pharmacological and clinical viewpoints and that exist in a significant proportion of the population. This finding necessitates future longitudinal studies to confirm some of the proposed causal associations. The information discovered would further the development and/or adaptation of clinical patient guidelines to patients with multimorbidity who are taking multiple drugs.	[Calderon-Larranaga, Amaia; Gimeno-Feliu, Luis A.; Gonzalez-Rubio, Francisca; Poblador-Plou, Beatriz; Lairla-San Jose, Maria; Abad-Diez, Jose M.; Poncel-Falco, Antonio; Prados-Torres, Alexandra] Miguel Servet Univ Hosp, IIS Aragon, Aragon Hlth Sci Inst IACS, EpiChron Res Grp Chron Dis, Zaragoza, Spain; [Calderon-Larranaga, Amaia; Abad-Diez, Jose M.; Prados-Torres, Alexandra] Univ Zaragoza, Dept Microbiol Prevent Med & Publ Hlth, Zaragoza, Spain; [Calderon-Larranaga, Amaia; Prados-Torres, Alexandra] Carlos III Hlth Inst, Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain; [Calderon-Larranaga, Amaia; Poblador-Plou, Beatriz; Prados-Torres, Alexandra] IIS Aragon, Aragon Hlth Sci Inst IACS, Teaching Unit Prevent Med & Publ Hlth, Zaragoza, Spain; [Gimeno-Feliu, Luis A.] San Pablo Hlth Ctr, Zaragoza, Spain; [Gonzalez-Rubio, Francisca] Delicias Sur Hlth Ctr, Zaragoza, Spain; [Gimeno-Feliu, Luis A.; Gonzalez-Rubio, Francisca] Univ Zaragoza, Dept Med Psychiat & Dermatol, Zaragoza, Spain; [Abad-Diez, Jose M.] Govt Aragon, Dept Hlth Wellbeing & Family, Zaragoza, Spain; [Poncel-Falco, Antonio] Aragon Hlth Serv, Primary Care Directorate, Zaragoza, Spain	Miguel Servet University Hospital; University of Zaragoza; University of Zaragoza	Calderon-Larranaga, A (corresponding author), Miguel Servet Univ Hosp, IIS Aragon, Aragon Hlth Sci Inst IACS, EpiChron Res Grp Chron Dis, Zaragoza, Spain.	acalderon.iacs@aragon.es	Rubio, Francisca Gonzalez/ABD-1444-2020; Gonzalez Rubio, Francisca/GPT-3556-2022; Calderón-Larrañaga, Amaia/ABC-6828-2021; Prados-Torres, Alexandra/P-5818-2017; Poblador-Plou, Beatriz/ABC-7915-2020; Gimeno-Feliu, Luis Andrés/E-5390-2016	Rubio, Francisca Gonzalez/0000-0001-5939-4436; Gonzalez Rubio, Francisca/0000-0001-5939-4436; Calderón-Larrañaga, Amaia/0000-0001-9064-9222; Prados-Torres, Alexandra/0000-0002-5704-6056; Poblador-Plou, Beatriz/0000-0002-5119-5093; Gimeno-Feliu, Luis Andrés/0000-0003-2928-6623; ABAD, JOSE MARIA/0000-0002-1510-7287	Carlos III Health Institute of the Spanish Ministry of Economy and Competitiveness [PI11/01126]	Carlos III Health Institute of the Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was funded by grant PI11/01126 from the Carlos III Health Institute of the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, EFPC RESP EU REFL CH; Benninger M, 2010, ANN ALLERG ASTHMA IM, V104, P13, DOI 10.1016/j.anai.2009.11.020; Bentsen SB, 2013, NURS HEALTH SCI, V15, P292, DOI 10.1111/nhs.12031; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Bhatt DL, 2008, AM J GASTROENTEROL, V103, P2890, DOI 10.1111/j.1572-0241.2008.02216.x; Bushardt RL, 2008, CLIN INTERV AGING, V3, P383, DOI 10.2147/CIA.S2468; Calderon-Larranaga A, 2010, BMC HEALTH SERV RES, V21, P10, DOI DOI 10.1186/1472-6963-10-S2-A22; Cano Parra J, 2005, Arch Soc Esp Oftalmol, V80, P137; Carville SF, 2008, ANN RHEUM DIS, V67, P536, DOI 10.1136/ard.2007.071522; Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, DOI 10.1316/S0782-051X03024046-9]; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; Echave-Susteeta JM, 2002, INF TER SIST NAC SAL, V26, P34; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Franssen FME, 2011, INT J CHRONIC OBSTR, V6, P493, DOI 10.2147/COPD.S24443; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Goldenberg DL, 2010, AM J MED, V123, P675, DOI 10.1016/j.amjmed.2010.01.014; Guglielmo R, 2012, CLIN NEUROPHARMACOL, V35, P45, DOI 10.1097/WNF.0b013e31823e669b; Gutierrez J, 2012, ARCH INTERN MED, V172, P909, DOI 10.1001/archinternmed.2012.2145; Heran BS, 2012, COCHRANE DB SYST REV, V4; Hoffmann F, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-190; Holdiness A, 2011, AM J MED, V124, P15, DOI 10.1016/j.amjmed.2010.07.021; Hull PR, 2005, DERMATOL CLIN, V23, P665, DOI 10.1016/j.det.2005.05.008; Kennel KA, 2009, MAYO CLIN PROC, V84, P632, DOI 10.1016/S0025-6196(11)60752-0; Lamkin S, 2009, J EMERG NURS, V35, P72, DOI 10.1016/j.jen.2008.10.014; Martin-Merino E, 2010, ALIMENT PHARM THER, V31, P1132, DOI 10.1111/j.1365-2036.2010.04280.x; Miglior S, 2007, AM J OPHTHALMOL, V144, P266, DOI 10.1016/j.ajo.2007.04.040; Muñoz Miguel A., 2006, Clínica y Salud, V17, P91; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Pasquale LR, 2006, OPHTHALMOLOGY, V113, P1081, DOI 10.1016/j.ophtha.2006.01.066; Gil SP, 2010, REV CALID ASSIST, V25, P321, DOI 10.1016/j.cali.2010.03.008; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Rotaeche del Campo R, 2008, GUIA PRACTICA CLIN D; Ruiz De Velasco Artaza E, 2002, Aten Primaria, V29, P414; Sauriyal DS, 2011, NEUROPEPTIDES, V45, P175, DOI 10.1016/j.npep.2010.12.004; Skerman HM, 2009, RES NURS HEALTH, V32, P345, DOI 10.1002/nur.20323; Tibaldi C, 2009, CLIN MICROBIOL INFEC, V15, P670, DOI 10.1111/j.1469-0691.2009.02842.x; Tinetti ME, 2011, NEW ENGL J MED, V364, P2478, DOI 10.1056/NEJMp1100535; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Vaccarino V, 2011, CARDIOVASC RES, V90, P9, DOI 10.1093/cvr/cvq394; Vacheron-Trystram MN, 2004, ENCEPHALE, V30, P417; WHO Collaborating Centre for Drug Statistics Methodology Anatomical Chemical, 2008, CLASS IND DEF DAIL; Xu L, 2007, AM J OPHTHALMOL, V144, P461, DOI 10.1016/j.ajo.2007.05.013	46	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84967	10.1371/journal.pone.0084967	http://dx.doi.org/10.1371/journal.pone.0084967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376858	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100193
J	de Silva, S; Webber, CE; Weerathunga, US; Pushpakumara, TV; Weerakoon, DK; Wittemyer, G				de Silva, Shermin; Webber, C. Elizabeth; Weerathunga, U. S.; Pushpakumara, T. V.; Weerakoon, Devaka K.; Wittemyer, George			Demographic Variables for Wild Asian Elephants Using Longitudinal Observations	PLOS ONE			English	Article							POPULATION VIABILITY; GENETIC DIVERSITY; NATIONAL-PARK; MAXIMUS; MANAGEMENT; HABITAT; BIOLOGY; GROWTH	Detailed demographic data on wild Asian elephants have been difficult to collect due to habitat characteristics of much of the species' remaining range. Such data, however, are critical for understanding and modeling population processes in this endangered species. We present data from six years of an ongoing study of Asian elephants (Elephas maximus) in Uda Walawe National Park, Sri Lanka. This relatively undisturbed population numbering over one thousand elephants is individually monitored, providing cohort-based information on mortality and reproduction. Reproduction was seasonal, such that most births occurred during the long inter-monsoon dry season and peaked in May. During the study, the average age at first reproduction was 13.4 years and the 50th percentile inter-birth interval was approximately 6 years. Birth sex ratios did not deviate significantly from parity. Fecundity was relatively stable throughout the observed reproductive life of an individual (ages 11-60), averaging between 0.13-0.17 female offspring per individual per year. Mortalities and injuries based on carcasses and disappearances showed that males were significantly more likely than females to be killed or injured through anthropogenic activity. Overall, however, most observed injuries did not appear to be fatal. This population exhibits higher fecundity and density relative to published estimates on other Asian elephant populations, possibly enhanced by present range constriction. Understanding the factors responsible for these demographic dynamics can shed insight on the future needs of this elephant population, with probable parallels to other populations in similar settings.	[de Silva, Shermin; Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [de Silva, Shermin; Weerathunga, U. S.; Pushpakumara, T. V.] Elephant Forest & Environm Conservat Trust, Colombo, Sri Lanka; [Webber, C. Elizabeth] Univ Stirling, Stirling FK9 4LA, Scotland; [Weerakoon, Devaka K.] Univ Colombo, Colombo, Sri Lanka; [de Silva, Shermin] Trunks & Leaves Inc, Somerville, MA USA	Colorado State University; University of Stirling; University of Colombo	de Silva, S (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.	Shermin@elephantresearch.net	Weerakoon, Devaka Kirthi/ABI-6507-2020; Wittemyer, George/AFQ-1840-2022	Weerakoon, Devaka/0000-0002-3473-4972	U.S. Fish and Wildlife Asian Elephant Conservation Fund [F11AP00258, 92210-7-G167]; National Science Foundation [1103468]; Colorado State University	U.S. Fish and Wildlife Asian Elephant Conservation Fund; National Science Foundation(National Science Foundation (NSF)); Colorado State University	This research was funded in part by the U.S. Fish and Wildlife Asian Elephant Conservation Fund (Grant nos. F11AP00258 and 92210-7-G167) to SdS and DW, as well as a Postdoctoral Research Fellowship in Biology from the National Science Foundation (Award No. 1103468, SdS). Publication was supported by Colorado State University's Open Access Research and Scholarship Fund (GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arivazhagan Chelliya, 2008, Gajah, V29, P11; Armbruster P, 1999, ANIM CONSERV, V2, P69, DOI 10.1111/j.1469-1795.1999.tb00050.x; Bergl RA, 2008, AM J PRIMATOL, V70, P848, DOI 10.1002/ajp.20559; Campos-Arceiz A, 2011, ACTA OECOL, V37, P542, DOI 10.1016/j.actao.2011.01.014; Campos-Arceiz A, 2009, BIOTROPICA, V41, P406, DOI 10.1111/j.1744-7429.2009.00525.x; Chiyo PI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031382; Choudhury A, 2008, IUCN RED LIST THREAT; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; EISENBERG JF, 1971, BEHAVIOUR, V38, P193, DOI 10.1163/156853971X00087; Fernando Prithiviraj, 2011, Gajah, V35, P93; Fernando Prithiviraj, 2011, Gajah, V35, P15; Foley CAH, 2010, ORYX, V44, P205, DOI 10.1017/S0030605309990706; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; Haynes G, 2012, GEOMORPHOLOGY, V157, P99, DOI 10.1016/j.geomorph.2011.04.045; Hedges S, 2005, BIOL CONSERV, V124, P35, DOI 10.1016/j.biocon.2005.01.004; HESS DL, 1983, BIOL REPROD, V28, P767, DOI 10.1095/biolreprod28.4.767; Hildebrandt T. B., 2006, International Zoo Yearbook, V40, P20, DOI 10.1111/j.1748-1090.2006.00020.x; ISHWARAN N, 1993, J TROP ECOL, V9, P169, DOI 10.1017/S0266467400007148; ISHWARAN N, 1981, BIOL CONSERV, V21, P303, DOI 10.1016/0006-3207(81)90084-7; Katugaha HIE, 1999, BIOL CONSERV, V89, P51, DOI 10.1016/S0006-3207(98)00122-0; Kumara HN, 2012, TROP CONSERV SCI, V5, P163, DOI 10.1177/194008291200500206; Kurt F., 1974, IUCN Publs (New Series), VNo. 24, P618; Lee P. C., 2013, BIOL LETT, V9; LEE PC, 1991, J ZOOL, V225, P99, DOI 10.1111/j.1469-7998.1991.tb03804.x; Leimgruber P, 2008, ANIM CONSERV, V11, P198, DOI 10.1111/j.1469-1795.2008.00172.x; Mar KU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032335; McKay G.M., 1973, Smithsonian Contributions to Zoology, VNo. 125, P1; Moss CJ., 2011, AMBOSELI ELEPHANTS; Mumby HS, 2013, ECOL EVOL, V3, P3794, DOI 10.1002/ece3.746; R Development Core Team, 2012, R LANG ENV STAT COMP; Robinson MR, 2012, ECOL LETT, V15, P260, DOI 10.1111/j.1461-0248.2011.01735.x; ROTH VL, 1988, J ZOOL, V214, P567, DOI 10.1111/j.1469-7998.1988.tb03760.x; Saragusty J, 2009, ANIM REPROD SCI, V115, P247, DOI 10.1016/j.anireprosci.2008.10.019; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Sukumar R, 1997, ZOO BIOL, V16, P263, DOI 10.1002/(SICI)1098-2361(1997)16:3<263::AID-ZOO6>3.3.CO;2-A; Sukumar R., 2006, International Zoo Yearbook, V40, P1, DOI 10.1111/j.1748-1090.2006.00001.x; SUKUMAR R, 1991, BIOL CONSERV, V55, P93, DOI 10.1016/0006-3207(91)90007-V; Sukumar R, 2003, BIOL CONSERV; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Sukumar R, 1985, ECOLOGY ASIAN ELEPHA; Trimble MJ, 2009, J ZOOL, V279, P18, DOI 10.1111/j.1469-7998.2009.00560.x; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; van Aarde RJ, 2007, BIOL CONSERV, V134, P289, DOI 10.1016/j.biocon.2006.08.027; Wiese RJ, 2000, ZOO BIOL, V19, P299, DOI 10.1002/1098-2361(2000)19:5<299::AID-ZOO2>3.0.CO;2-Z; Wittemyer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053726	45	36	36	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82788	10.1371/journal.pone.0082788	http://dx.doi.org/10.1371/journal.pone.0082788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376581	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100056
J	Duran, AP; Casalegno, S; Marquet, PA; Gaston, KJ				Duran, America P.; Casalegno, Stefano; Marquet, Pablo A.; Gaston, Kevin J.			Representation of Ecosystem Services by Terrestrial Protected Areas: Chile as a Case Study	PLOS ONE			English	Article							CLIMATE-CHANGE; CONSERVATION; BIODIVERSITY; FRAMEWORK; SYSTEM; NDVI	Protected areas are increasingly considered to play a key role in the global maintenance of ecosystem processes and the ecosystem services they provide. It is thus vital to assess the extent to which existing protected area systems represent those services. Here, for the first time, we document the effectiveness of the current Chilean protected area system and its planned extensions in representing both ecosystem services (plant productivity, carbon storage and agricultural production) and biodiversity. Additionally, we evaluate the effectiveness of protected areas based on their respective management objectives. Our results show that existing protected areas in Chile do not contain an unusually high proportion of carbon storage (14.9%), agricultural production (0.2%) or biodiversity (11.8%), and also represent a low level of plant productivity (Normalized Difference Vegetation Index of 0.38). Proposed additional priority sites enhance the representation of ecosystem services and biodiversity, but not sufficiently to attain levels of representation higher than would be expected for their area of coverage. Moreover, when the species groups were assessed separately, amphibians was the only one well represented. Suggested priority sites for biodiversity conservation, without formal protection yet, was the only protected area category that over-represents carbon storage, agricultural production and biodiversity. The low representation of ecosystem services and species' distribution ranges by the current protected area system is because these protected areas are heavily biased toward southern Chile, and contain large extents of ice and bare rock. The designation and management of proposed priority sites needs to be addressed in order to increase the representation of ecosystem services within the Chilean protected area system.	[Duran, America P.; Casalegno, Stefano; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Marquet, Pablo A.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Marquet, Pablo A.] IEB, Santiago, Chile; [Marquet, Pablo A.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Marquet, Pablo A.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Lab Int Cambio Global LINCGlobal, Santiago, Chile	University of Exeter; Pontificia Universidad Catolica de Chile; The Santa Fe Institute; Pontificia Universidad Catolica de Chile	Duran, AP (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England.	paz.duran.moya@gmail.com	Durán, A. Paz/E-6039-2013; Marquet, Pablo A/B-7732-2009	Durán, A. Paz/0000-0001-9719-7388; Marquet, Pablo A/0000-0001-6369-9339; Gaston, Kevin J./0000-0002-7235-7928	Chilean studentship under the Becas Chile program of the Comision Nacional de Investigacion Cientifica y Teconologica, Gobierno de Chile (CONICYT);  [ICM P05-002];  [PFB-23]	Chilean studentship under the Becas Chile program of the Comision Nacional de Investigacion Cientifica y Teconologica, Gobierno de Chile (CONICYT); ; 	This work has been funded by APD's studentship, which is a Chilean studentship under the Becas Chile program of the Comision Nacional de Investigacion Cientifica y Teconologica, Gobierno de Chile (CONICYT). PAM acknowledges support from grants ICM P05-002 and PFB-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalde H, 2006, IPCC GUIDELINES NATL, DOI DOI 10.1016/J.PHRS.2011.03.002; Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 2005, EC HUM WELL BEING SY; Armesto JJ, 1998, SCIENCE, V282, P1271, DOI 10.1126/science.282.5392.1271; Armesto JJ, 2010, LAND USE POLICY, V27, P148, DOI 10.1016/j.landusepol.2009.07.006; Arroyo M. K., 1997, NOTICIERO BIOL, V5, P48; Asmussen MV, 2007, ENVIRON CONSERV, V34, P183, DOI 10.1017/S0376892907004183; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Cantu-Salazar L, 2010, BIOSCIENCE, V60, P808, DOI 10.1525/bio.2010.60.10.7; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; CONAMA-PNUD, 2006, CREAC SIST NAC INT A; Daily G. C., 1997, Nature's services: societal dependence on natural ecosystems., P113; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; DFG-CONAMA, 2006, EST VAR CLIM CHIL SI; Di Bellat CM, 2004, INT J REMOTE SENS, V25, P5415, DOI 10.1080/01431160412331269724; Eigenbrod F, 2010, CONSERV LETT, V3, P184, DOI 10.1111/j.1755-263X.2010.00102.x; Eigenbrod F, 2010, J APPL ECOL, V47, P377, DOI 10.1111/j.1365-2664.2010.01777.x; Eigenbrod F, 2009, P ROY SOC B-BIOL SCI, V276, P2903, DOI 10.1098/rspb.2009.0528; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; European Commission JRC, 2003, GLOB LAND COV 2000 D; FAO, 2000, GLOB EC ZON GLOB FOR; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; Garbulsky MF, 2004, J VEG SCI, V15, P711, DOI 10.1111/j.1654-1103.2004.tb02313.x; IUCN, 1994, GUID PROT AR MAN CAT; IUCN, 2012, IUCN RED LIST THREAT; Klorvuttimontara S, 2011, BIOL CONSERV, V144, P2534, DOI 10.1016/j.biocon.2011.07.012; Luebert F, 1998, REPRESENTATIVIDAD VE; Marquet PA AM, 2011, ESTUDIO VULNERABILID; Mascia MB, 2011, CONSERV LETT, V4, P9, DOI 10.1111/j.1755-263X.2010.00147.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Paruelo JM, 1997, ECOLOGY, V78, P953, DOI 10.1890/0012-9658(1997)078[0953:AEFNFT]2.0.CO;2; Pauchard A, 2002, NAT AREA J, V22, P318; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Pettorelli N, 2012, ECOL INDIC, V20, P269, DOI 10.1016/j.ecolind.2012.02.014; Pimm SL, 2001, SCIENCE, V294, P788; Pliscoff P, 2011, ENVIRON CONSERV, V38, P303, DOI 10.1017/S0376892911000208; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; RAMANKUTTY N, 2008, GLOBAL BIOGEOCHEM CY, V0022; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Roldán Mateo, 2010, Ecol. austral, V20, P185; Running SW, 2000, METHODS IN ECOSYSTEM SCIENCE, P44; Samaniego H, 2009, REV CHIL HIST NAT, V82, P135, DOI 10.4067/S0716-078X2009000100009; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Squeo FA, 2012, PLANT ECOL DIVERS, V5, P233, DOI 10.1080/17550874.2012.679012; Tallis H, 2008, P NATL ACAD SCI USA, V105, P9457, DOI 10.1073/pnas.0705797105; Tognelli MF, 2008, DIVERS DISTRIB, V14, P148, DOI 10.1111/j.1472-4642.2007.00437.x; Tognelli MF, 2009, BIOL CONSERV, V142, P3147, DOI 10.1016/j.biocon.2009.08.016; Turner RK, 2008, ENVIRON RESOUR ECON, V39, P25, DOI 10.1007/s10640-007-9176-6; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3	53	31	35	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82643	10.1371/journal.pone.0082643	http://dx.doi.org/10.1371/journal.pone.0082643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376559	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100047
J	Gao, YN; Chen, L; Hou, M; Chen, YY; Ji, MJ; Wu, HW; Wu, GL				Gao, Yanan; Chen, Lin; Hou, Min; Chen, Yingying; Ji, Minjun; Wu, Haiwei; Wu, Guanling			TLR2 Directing PD-L2 Expression Inhibit T Cells Response in Schistosoma japonicum Infection	PLOS ONE			English	Article							DENDRITIC CELLS; CYTOKINE PRODUCTION; UP-REGULATION; ACTIVATION; IMMUNITY; LIGANDS; MACROPHAGES; PROLIFERATION; POLARIZATION; RECOGNITION	Toll-like receptor 2 (TLR2) was shown to be an important immune receptor involved in the recognition of schistosome antigens, especially soluble egg antigen (SEA). In mice models with Shistosoma japonicum acute infection, we observed enhanced T cell-mediated immune responses n TLR2 knock out (TLR2(-/-)) mice compared with B6 mice. In schistosoma japonicum chronic infection models, programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2) expression as well as TLR2 expression gradually increased in B6 mice, while only PD-L2 expression significantly decreased in TLR2(-/-) mice. Meanwhile, Programmed Death 1(PD-1) expression on CD4(+)T cells was down-regulated in TLR2(-/-) mice after a large number of egg appeared. We also found that stimulation with schistosome antigens, especially SEA, could up-regulate PD-L2 expression on BMDCs in a TLR2-dependent manner in vitro. Schistosome antigens primed-BMDCs with impaired expression of TLR2 or PD-L2 could induce CD4(+)T cells to produce low level of IL-10 or high level of IFN-gamma. Our results indicated that TLR2 signaling can direct PD-L2 expression on DCs which binds to PD-1 mainly on CD4(+)T cells to help inhibit T cells response in Schistosoma japonicum infection.	[Gao, Yanan; Chen, Lin; Hou, Min; Chen, Yingying; Ji, Minjun; Wu, Guanling] Nanjing Med Univ, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China; [Chen, Lin; Hou, Min; Ji, Minjun; Wu, Guanling] Jiangsu Prov Key Lab Modern Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Wu, Haiwei] Rhode Isl Hosp, Ctr Int Hlth Res, Providence, RI USA; [Gao, Yanan] Nanjing Univ Chinese Med, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Lifespan Health Rhode Island; Rhode Island Hospital; Nanjing University of Chinese Medicine	Ji, MJ (corresponding author), Nanjing Med Univ, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China.	jiminjun@njmu.edu.cn			National Basic Research Program of China (973 Program) [2007CB513102]; National Natural Science Foundation of China (NSFC) [81171593]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program No. 2007CB513102) and the National Natural Science Foundation of China (NSFC) (Project No. 81171593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Chen MY, 2012, J NEUROIMMUNOL, V242, P39, DOI 10.1016/j.jneuroim.2011.10.014; Colley DG, 2005, PARASITE IMMUNOL, V27, P45, DOI 10.1111/j.1365-3024.2005.00742.x; Collins M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-223; Correale J, 2009, J IMMUNOL, V183, P5999, DOI 10.4049/jimmunol.0900897; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Gaddis DE, 2013, J LEUKOCYTE BIOL, V93, P21, DOI 10.1189/jlb.0512220; Gao Y, 2012, CELL IMMUNOL, V272, P242, DOI 10.1016/j.cellimm.2011.10.007; Goh F, 2009, IMMUNOLOGY, V127, P326, DOI 10.1111/j.1365-2567.2008.02979.x; Grunig G, 2005, PHARMACOL THERAPEUT, V106, P75, DOI 10.1016/j.pharmthera.2004.11.004; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kiura K, 2006, FEMS IMMUNOL MED MIC, V48, P44, DOI 10.1111/j.1574-695X.2006.00119.x; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Layland LE, 2007, EUR J IMMUNOL, V37, P2174, DOI 10.1002/eji.200737063; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Mendoza-Coronel E, 2011, TUBERCULOSIS, V91, P36, DOI 10.1016/j.tube.2010.11.008; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Onguru D, 2011, AM J TROP MED HYG, V84, P321, DOI 10.4269/ajtmh.2011.10-0397; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Pentcheva-Hoang T, 2009, IMMUNOL REV, V229, P67, DOI 10.1111/j.1600-065X.2009.00763.x; Rozali EN, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/656340; Saunders PA, 2005, EUR J IMMUNOL, V35, P3561, DOI 10.1002/eji.200526347; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Smith P, 2004, J IMMUNOL, V173, P1240, DOI 10.4049/jimmunol.173.2.1240; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Terrazas LI, 2005, INT J PARASITOL, V35, P1349, DOI 10.1016/j.ijpara.2005.06.003; Thomas PG, 2003, J IMMUNOL, V171, P5837, DOI 10.4049/jimmunol.171.11.5837; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; van Riet E, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-9; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Zhang M, 2011, PARASITE IMMUNOL, V33, P199, DOI 10.1111/j.1365-3024.2010.01265.x; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103	40	20	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82480	10.1371/journal.pone.0082480	http://dx.doi.org/10.1371/journal.pone.0082480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376539	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100033
J	Gehlbach, S; Hooven, FH; Wyman, A; Diez-Perez, A; Adachi, JD; Luo, XM; Bushmakin, AG; Anderson, FA				Gehlbach, Stephen; Hooven, Frederick H.; Wyman, Allison; Diez-Perez, Adolfo; Adachi, Jonathan D.; Luo, Xuemei; Bushmakin, Andrew G.; Anderson, Frederick A.		GLOW Investigators	Patterns of Anti-Osteoporosis Medication Use among Women at High Risk of Fracture: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)	PLOS ONE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURES; FRAGILITY FRACTURES; DRUG-THERAPY; OLDER WOMEN; SELF-REPORT; ADHERENCE; PERSISTENCE; BELIEFS	Objective: To assess patterns of anti-osteoporosis medication (AOM) use over 3 years among women at high risk of major fracture. Methods: The GLOW registry follows a cohort of more than 40,000 women aged >= 55 from 615 primary care practices in 10 countries. Self-administered surveys (baseline, 12, 24, and 36 months) collected data on patient characteristics, perception of fracture risk, and AOM use. FRAX scores were calculated from the baseline surveys and women classified as high risk if their FRAX 10-year probability of major fracture was >= 20%. Results: A total of 5774 women were classified as at high risk and had complete data over 3 years. At baseline, 2271 (39%) reported receiving AOM, 739 (13%) reported prior but not current use, and 2764 (48%) said they had never used AOM. Over 3 years, 85% of baseline non-users continued as non-users and 15% initiated AOM; among baseline users, 49% continued the same medication class, 29% stopped AOM, and 12% switched. Women who stopped AOM were less likely to self-report osteoporosis (HR 0.56, 95% CI 0.42-0.75) than women who continued AOM. Compared with non-users who did not begin treatment, women initiating AOM were more likely to report a diagnosis of osteoporosis (HR 11.3, 95% CI 8.2-15.5) or osteopenia (HR 4.1, 95% CI 2.9-5.7) and be very concerned about osteoporosis (HR 1.9, 95% CI 1.3-2.8). Conclusions: Less than 40% of women at high risk of fracture reported taking AOM. Women who stopped AOM were less likely to believe they have osteoporosis. Women who initiated treatment appeared motivated primarily by a diagnosis of osteoporosis or osteopenia and concern about the condition.	[Gehlbach, Stephen; Hooven, Frederick H.; Wyman, Allison; Anderson, Frederick A.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Diez-Perez, Adolfo] Autonomous Univ Barcelona, Hosp del Mar, E-08193 Barcelona, Spain; [Adachi, Jonathan D.] McMaster Univ, St Josephs Hosp, Hamilton, ON, Canada; [Luo, Xuemei; Bushmakin, Andrew G.] Pfizer Inc, Groton, CT 06340 USA	University of Massachusetts System; University of Massachusetts Worcester; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; McGill University; McMaster University; Pfizer	Gehlbach, S (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.	gehlbach@schoolph.umass.edu		Diez-Perez, Adolfo/0000-0001-8162-0209	Warner Chilcott Company, LLC; sanofi-aventis; Pfizer Inc.; Pfizer	Warner Chilcott Company, LLC; sanofi-aventis(Sanofi-Aventis); Pfizer Inc.(Pfizer); Pfizer(Pfizer)	Financial support for the GLOW study is provided to the Center for Outcomes Research, University of Massachusetts Medical School by Warner Chilcott Company, LLC, and sanofi-aventis. This analysis was sponsored by Pfizer Inc. Stephen Gehlbach, Frederick Hooven, Allison Wyman, and Frederick Anderson are employees of University of Massachusetts Medical School, which received financial support from Pfizer in connection with the development of this manuscript. The funders (Warner Chilcott Company, LLC, and sanofi-aventis) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer had a role in the study as employer of authors Xuemei Luo and Andrew Bushmakin, who reviewed the data and wrote/contributed to the final manuscript. The authors had full access to all the data and the corresponding author had final responsibility for the decision to submit for publication. Editorial services provided by Sophie Rushton-Smith, PhD (COR, UMass Medical School, Worcester, USA) were funded by Pfizer.	Asche C, 2010, OSTEOPOROSIS INT, V21, P1427, DOI 10.1007/s00198-009-1079-7; Bessette L, 2009, OSTEOPOROSIS INT, V20, P1911, DOI 10.1007/s00198-009-0898-x; Bilezikian JP, 2009, AM J MED, V122, P14, DOI 10.1016/j.amjmed.2008.12.003; Brazier JE, 1996, QUAL LIFE RES, V5, P195, DOI 10.1007/BF00434741; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; Cline RR, 2005, MATURITAS, V50, P196, DOI 10.1016/j.maturitas.2004.05.004; Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Curtis JR, 2006, PHARMACOEPIDEM DR S, V15, P710, DOI 10.1002/pds.1226; Elliot-Gibson V, 2004, OSTEOPOROSIS INT, V15, P767, DOI 10.1007/s00198-004-1675-5; Garber MC, 2004, MED CARE, V42, P649, DOI 10.1097/01.mlr.0000129496.05898.02; Gehlbach SH, 2007, OSTEOPOROSIS INT, V18, P805, DOI 10.1007/s00198-006-0310-z; Greenspan SL, 2012, J AM GERIATR SOC, V60, P455, DOI 10.1111/j.1532-5415.2011.03854.x; Hamel ME, 2005, OSTEOPOROSIS INT, V16, P208, DOI 10.1007/s00198-004-1776-1; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hooven FH, 2009, OSTEOPOROSIS INT, V20, P1107, DOI 10.1007/s00198-009-0958-2; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jennings LA, 2010, J AM GERIATR SOC, V58, P650, DOI 10.1111/j.1532-5415.2010.02769.x; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2003, BONE, V33, P293, DOI 10.1016/S8756-3282(03)00200-X; Kanis JA, 2007, ASSESSMENT OSTEOPORO; Kothawala P, 2007, MAYO CLIN PROC, V82, P1493, DOI 10.4065/82.12.1493; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Marcus R, 2003, J BONE MINER RES, V18, P18, DOI 10.1359/jbmr.2003.18.1.18; McCloskey EV, 2009, OSTEOPOROSIS INT, V20, P811, DOI 10.1007/s00198-008-0786-9; McHorney CA, 2007, CURR MED RES OPIN, V23, P3137, DOI 10.1185/030079907X242890; Murad MH, 2012, J CLIN ENDOCR METAB, V97, P1871, DOI 10.1210/jc.2011-3060; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Rossini M, 2006, OSTEOPOROSIS INT, V17, P914, DOI 10.1007/s00198-006-0073-6; Ryder KM, 2006, J GEN INTERN MED, V21, P636, DOI 10.1111/j.1525-1497.2006.00468.x; Silverman SL, 2011, OSTEOPOROSIS INT, V22, P21, DOI 10.1007/s00198-010-1274-6; Tosteson ANA, 2003, AM J MED, V115, P209, DOI 10.1016/S0002-9343(03)00362-0; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; Weycker D, 2006, OSTEOPOROSIS INT, V17, P1645, DOI 10.1007/s00198-006-0179-x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yood RA, 2008, J GEN INTERN MED, V23, P1815, DOI 10.1007/s11606-008-0772-0	38	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82840	10.1371/journal.pone.0082840	http://dx.doi.org/10.1371/journal.pone.0082840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376589	gold, Green Published			2022-12-27	WOS:000328745100062
J	Hissa, B; Pontes, B; Roma, PMS; Alves, AP; Rocha, CD; Valverde, TM; Aguiar, PHN; Almeida, FP; Guimaraes, AJ; Guatimosim, C; Silva, AM; Fernandes, MC; Andrews, NW; Viana, NB; Mesquita, ON; Agero, U; Andrade, LO				Hissa, Barbara; Pontes, Bruno; Roma, Paula Magda S.; Alves, Ana Paula; Rocha, Carolina D.; Valverde, Thalita M.; Aguiar, Pedro Henrique N.; Almeida, Fernando P.; Guimaraes, Allan J.; Guatimosim, Cristina; Silva, Aristobolo M.; Fernandes, Maria C.; Andrews, Norma W.; Viana, Nathan B.; Mesquita, Oscar N.; Agero, Ubirajara; Andrade, Luciana O.			Membrane Cholesterol Removal Changes Mechanical Properties of Cells and Induces Secretion of a Specific Pool of Lysosomes	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INVASION; PLASMA-MEMBRANE; LIPID RAFTS; PROTEOMIC ANALYSIS; INSULIN-SECRETION; SYNAPTIC VESICLES; EPITHELIAL-CELLS; CHROMAFFIN CELLS; EXOCYTOSIS; ACTIN	In a previous study we had shown that membrane cholesterol removal induced unregulated lysosomal exocytosis events leading to the depletion of lysosomes located at cell periphery. However, the mechanism by which cholesterol triggered these exocytic events had not been uncovered. In this study we investigated the importance of cholesterol in controlling mechanical properties of cells and its connection with lysosomal exocytosis. Tether extraction with optical tweezers and defocusing microscopy were used to assess cell dynamics in mouse fibroblasts. These assays showed that bending modulus and surface tension increased when cholesterol was extracted from fibroblasts plasma membrane upon incubation with M beta CD, and that the membrane-cytoskeleton relaxation time increased at the beginning of MbCD treatment and decreased at the end. We also showed for the first time that the amplitude of membrane-cytoskeleton fluctuation decreased during cholesterol sequestration, showing that these cells become stiffer. These changes in membrane dynamics involved not only rearrangement of the actin cytoskeleton, but also de novo actin polymerization and stress fiber formation through Rho activation. We found that these mechanical changes observed after cholesterol sequestration were involved in triggering lysosomal exocytosis. Exocytosis occurred even in the absence of the lysosomal calcium sensor synaptotagmin VII, and was associated with actin polymerization induced by MbCD. Notably, exocytosis triggered by cholesterol removal led to the secretion of a unique population of lysosomes, different from the pool mobilized by actin depolymerizing drugs such as Latrunculin-A. These data support the existence of at least two different pools of lysosomes with different exocytosis dynamics, one of which is directly mobilized for plasma membrane fusion after cholesterol removal.	[Hissa, Barbara; Rocha, Carolina D.; Valverde, Thalita M.; Guatimosim, Cristina; Silva, Aristobolo M.; Andrade, Luciana O.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil; [Pontes, Bruno; Viana, Nathan B.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, LPO COPEA, Rio De Janeiro, RJ, Brazil; [Roma, Paula Magda S.; Alves, Ana Paula; Mesquita, Oscar N.; Agero, Ubirajara] Univ Fed Minas Gerais, Dept Fis, Inst Ciencias Exatas, BR-30161 Belo Horizonte, MG, Brazil; [Aguiar, Pedro Henrique N.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Almeida, Fernando P.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil; [Guimaraes, Allan J.] Univ Fed Fluminense, Inst Biomed, Dept Microbiol & Parasitol, Rio De Janeiro, RJ, Brazil; [Fernandes, Maria C.; Andrews, Norma W.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Viana, Nathan B.] Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, RJ, Brazil	Universidade Federal de Minas Gerais; Universidade Federal do Rio de Janeiro; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; University System of Maryland; University of Maryland College Park; Universidade Federal do Rio de Janeiro	Andrade, LO (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil.	landrade@icb.ufmg.br	Pontes, Bruno/L-5121-2015; Silva, Aristóbolo/AAA-2239-2021; Viana, Nathan/AAH-5868-2021; Agero, Ubirajara/B-2254-2010; Silva, Aristobolo/CAF-4874-2022; Guimaraes, Allan/AAQ-2343-2020; Silva, Aristobolo AMS/F-7326-2016; Guimaraes, Allan J/E-2160-2014; Andrade, Luciana Oliveira/F-8912-2012	Silva, Aristóbolo/0000-0001-7473-7433; Viana, Nathan/0000-0002-2528-0876; Agero, Ubirajara/0000-0002-4987-9031; Guimaraes, Allan/0000-0002-2856-9667; Guimaraes, Allan J/0000-0002-2856-9667; Andrade, Luciana Oliveira/0000-0002-0536-8790; Alves, Ana Paula/0000-0003-0594-8215; Andrews, Norma/0000-0002-0611-2412; Hissa, Barbara/0000-0001-7618-2689; Roma, Paula Magda da Silva Roma/0000-0002-3625-9837; Aguiar, Pedro/0000-0002-4942-5021	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Fluidos Complexos (INCTIFCx); PRONEX-FACEPE; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064625] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Fluidos Complexos (INCTIFCx); PRONEX-FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been funded by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia de Fluidos Complexos (INCTIFCx) and PRONEX-FACEPE. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agero U, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051904; Agero U, 2004, MICROSC RES TECHNIQ, V65, P159, DOI 10.1002/jemt.20117; Albertti LAG, 2010, MICROBES INFECT, V12, P784, DOI 10.1016/j.micinf.2010.05.015; AUNIS D, 1988, J EXP BIOL, V139, P253; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Boerke A, 2008, THERIOGENOLOGY, V70, P1188, DOI 10.1016/j.theriogenology.2008.06.021; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byfield FJ, 2004, BIOPHYS J, V87, P3336, DOI 10.1529/biophysj.104.040634; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Coelho Neto J, 2006, BIOPHYS J, V91, P1108, DOI 10.1529/biophysj.105.073783; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fuentes DE, 2012, CELL MOL BIOENG, V5, P143, DOI 10.1007/s12195-012-0225-z; Gasman S, 2003, CELL SIGNAL, V15, P893, DOI 10.1016/S0898-6568(03)00052-4; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108; Gauthier NC, 2009, MOL BIOL CELL, V20, P3261, DOI 10.1091/mbc.E09-01-0071; Gil C, 2005, BIOCHEM BIOPH RES CO, V329, P117, DOI 10.1016/j.bbrc.2005.01.111; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; He B, 2013, BIOMATERIALS, V34, P4309, DOI 10.1016/j.biomaterials.2013.01.100; Hissa B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001583; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jaiswal JK, 2004, PLOS BIOL, V2, P1224, DOI 10.1371/journal.pbio.0020233; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Khatibzadeh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057147; Khatibzadeh N, 2012, SOFT MATTER, V8, P8350, DOI 10.1039/c2sm25263e; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Levitan I, 2007, ANTIOXID REDOX SIGN, V9, P1519, DOI 10.1089/ars.2007.1686; Linetti A, 2010, J CELL SCI, V123, P595, DOI 10.1242/jcs.060681; Low SH, 2006, MOL BIOL CELL, V17, P977, DOI 10.1091/mbc.E05-05-0462; MacLellan DL, 2005, PROTEOMICS, V5, P4733, DOI 10.1002/pmic.200500044; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Masters TA, 2013, P NATL ACAD SCI US; Miklavc P, 2009, ANN NY ACAD SCI, V1152, P43, DOI 10.1111/j.1749-6632.2008.03989.x; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Morris CE, 2001, CELL MOL BIOL LETT, V6, P703; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; NAKATA T, 1992, J NEUROSCI, V12, P2186; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; NEEDHAM D, 1988, BIOCHEMISTRY-US, V27, P8261, DOI 10.1021/bi00421a041; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Norman LL, 2010, CELL MOL BIOENG, V3, P151, DOI 10.1007/s12195-010-0119-x; Pendleton A, 2001, CELL MOTIL CYTOSKEL, V48, P37; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Pontes B, 2011, BIOPHYS J, V101, P43, DOI 10.1016/j.bpj.2011.05.044; Pontes B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067708; Qi MS, 2009, J CELL BIOCHEM, V106, P1031, DOI 10.1002/jcb.22081; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rose SD, 2002, ANN NY ACAD SCI, V971, P222, DOI 10.1111/j.1749-6632.2002.tb04466.x; Salaun C, 2005, J BIOL CHEM, V280, P19449, DOI 10.1074/jbc.M501923200; Shen HY, 2012, CELL, V150, P1300, DOI 10.1016/j.cell.2012.08.017; Sun M, 2007, J CELL SCI, V120, P2223, DOI 10.1242/jcs.001370; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Tsai PS, 2007, MOL MEMBR BIOL, V24, P313, DOI 10.1080/09687860701228692; Vikman J, 2009, FASEB J, V23, P58, DOI 10.1096/fj.08-105734; Villanueva J, 2012, J MOL NEUROSCI, V48, P328, DOI 10.1007/s12031-012-9800-y; Villanueva J, 2010, HFSP J, V4, P85, DOI 10.2976/1.3338707; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029162; Wasser CR, 2007, J PHYSIOL-LONDON, V579, P413, DOI 10.1113/jphysiol.2006.123133; Xia FZ, 2008, ENDOCRINOLOGY, V149, P5136, DOI 10.1210/en.2008-0161; Xu J, 2012, J CELL SCI, V125, P5937, DOI 10.1242/jcs.109421; Yanagida M, 2007, PROTEOMICS, V7, P2398, DOI 10.1002/pmic.200700056; Yang N, 2010, BIOCHEM BIOPH RES CO, V391, P414, DOI 10.1016/j.bbrc.2009.11.072; Zamir O, 2006, J PHYSIOL-LONDON, V571, P83, DOI 10.1113/jphysiol.2005.098319; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	73	37	37	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82988	10.1371/journal.pone.0082988	http://dx.doi.org/10.1371/journal.pone.0082988			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376622	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100077
J	Lampropoulos, A; Sutikovic, Z; Wenzl, C; Maegele, I; Lohmann, JU; Forner, J				Lampropoulos, Athanasios; Sutikovic, Zoran; Wenzl, Christian; Maegele, Ira; Lohmann, Jan U.; Forner, Joachim			GreenGate - A Novel, Versatile, and Efficient Cloning System for Plant Transgenesis	PLOS ONE			English	Article							DNA CLONING; GENE; EXPRESSION; PROTEIN; TRANSFORMANTS; CONSTRUCTION; SELECTION; VECTORS	Building expression constructs for transgenesis is one of the fundamental day-to-day tasks in modern biology. Traditionally it is based on a multitude of type II restriction endonucleases and T4 DNA ligase. Especially in case of long inserts and applications requiring high-throughput, this approach is limited by the number of available unique restriction sites and the need for designing individual cloning strategies for each project. Several alternative cloning systems have been developed in recent years to overcome these issues, including the type IIS enzyme based Golden Gate technique. Here we introduce our GreenGate system for rapidly assembling plant transformation constructs, which is based on the Golden Gate method. GreenGate cloning is simple and efficient since it uses only one type IIS restriction endonuclease, depends on only six types of insert modules (plant promoter, N-terminal tag, coding sequence, C-terminal tag, plant terminator and plant resistance cassette), but at the same time allows assembling several expression cassettes in one binary destination vector from a collection of pre-cloned building blocks. The system is cheap and reliable and when combined with a library of modules considerably speeds up cloning and transgene stacking for plant transformation.	[Lampropoulos, Athanasios; Sutikovic, Zoran; Wenzl, Christian; Maegele, Ira; Lohmann, Jan U.; Forner, Joachim] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Baden Wurttembe, Germany	Ruprecht Karls University Heidelberg	Lohmann, JU (corresponding author), Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Baden Wurttembe, Germany.	jlohmann@meristemania.org	Lohmann, Jan/T-3776-2019	Lohmann, Jan/0000-0003-3667-187X; Forner, Joachim/0000-0002-6406-7066	Collaborative Research Centre of the DFG [SFB873]; ERC [282139]	Collaborative Research Centre of the DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	The work was funded by the Collaborative Research Centre SFB873 of the DFG (www.dfg.de) and the ERC (erc.europa.eu) grant 282139 "StemCellAdapt''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; CORUZZI G, 1984, EMBO J, V3, P1671, DOI 10.1002/j.1460-2075.1984.tb02031.x; De Buck S, 2009, PLANT J, V60, P134, DOI 10.1111/j.1365-313X.2009.03942.x; De Rybel B, 2011, PLANT PHYSIOL, V156, P1292, DOI 10.1104/pp.111.177337; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Erikson O, 2004, NAT BIOTECHNOL, V22, P455, DOI 10.1038/nbt946; GALLIE DR, 1992, NUCLEIC ACIDS RES, V20, P4631, DOI 10.1093/nar/20.17.4631; GUERINEAU F, 1990, PLANT MOL BIOL, V15, P127, DOI 10.1007/BF00017730; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989; Laux T, 1996, DEVELOPMENT, V122, P87; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; MORROW JF, 1974, P NATL ACAD SCI USA, V71, P1743, DOI 10.1073/pnas.71.5.1743; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sakvarelidze L, 2007, PLANT BIOTECHNOL J, V5, P465, DOI 10.1111/j.1467-7652.2007.00254.x; Sarrion-Perdigones A, 2013, PLANT PHYSIOL, V162, P1618, DOI 10.1104/pp.113.217661; Sasaki Y, 2004, J BIOTECHNOL, V107, P233, DOI 10.1016/j.jbiotec.2003.10.001; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Schubert D, 2004, PLANT CELL, V16, P2561, DOI 10.1105/tpc.104.024547; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stahl FW, 2005, GENETICS, V170, P487; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	33	176	181	7	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83043	10.1371/journal.pone.0083043	http://dx.doi.org/10.1371/journal.pone.0083043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376629	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100081
J	Larsen, AK; Nymo, IH; Briquemont, B; Sorensen, KK; Godfroid, J				Larsen, Anett K.; Nymo, Ingebjorg H.; Briquemont, Benjamin; Sorensen, Karen K.; Godfroid, Jacques			Entrance and Survival of Brucella pinnipedialis Hooded Seal Strain in Human Macrophages and Epithelial Cells	PLOS ONE			English	Article							MARINE MAMMALS; INTRACELLULAR TRAFFICKING; LYSOSOME FUSION; THP-1 CELLS; INFECTION; ABORTUS; SPP.; DIFFERENTIATION; HETEROGENEITY; LUNGWORMS	Marine mammal Brucella spp. have been isolated from pinnipeds (B. pinnipedialis) and cetaceans (B. ceti) from around the world. Although the zoonotic potential of marine mammal brucellae is largely unknown, reports of human disease exist. There are few studies of the mechanisms of bacterial intracellular invasion and multiplication involving the marine mammal Bruce//a spp. We examined the infective capacity of two genetically different B. pinnipedialis strains (reference strain; NTCT 12890 and a hooded seal isolate; B17) by measuring the ability of the bacteria to enter and replicate in cultured phagocytes and epithelial cells. Human macrophage-like cells (THP-1), two murine macrophage cell lines (RAVV264.7 and J774A.1), and a human malignant epithelial cell line (He La S3) were challenged with bacteria in a gentamicin protection assay. Our results show that B. pinnipedialis is internalized, but is then gradually eliminated during the next 72 96 hours. Confocal microscopy revealed that intracellular B. pinnipedialis hooded seal strain colocalized with lysosomal compartments at 1.5 and 24 hours after infection. Intracellular presence of B. pinnipedialis hooded seal strain was verified by transmission electron microscopy. By using a cholesterol-scavenging lipid inhibitor, entrance of B. pinnipedialis hooded seal strain in human macrophages was significantly reduced by 65.8 % ( 17.3), suggesting involvement of lipid-rafts in intracellular entry. Murine macrophages invaded by B. pinnipedialis do not release nitric oxide (NO) and intracellular bacterial presence does not induce cell death. In summary, B. pinnipedialis hooded seal strain can enter human and murine macrophages, as well as human epithelial cells. Intracellular entry of B. pinnipedialis hooded seal strain involves, but seems not to be limited to, lipid-rafts in human macrophages. Brucella pinnipedialis does not multiply or survive for prolonged periods intracellulary.	[Larsen, Anett K.; Nymo, Ingebjorg H.; Godfroid, Jacques] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Sect Arctic Vet Med, Tromso, Norway; [Larsen, Anett K.; Nymo, Ingebjorg H.; Godfroid, Jacques] High North Res Ctr Climate & Environm, Fram Ctr, Tromso, Norway; [Briquemont, Benjamin] Catholic Univ Louvain, Fac Sci, B-3000 Louvain, Belgium; [Sorensen, Karen K.] Univ Tromso, Dept Med Biol, Vasc Biol Res Grp, Tromso, Norway	Norwegian University of Life Sciences; Universite Catholique Louvain; UiT The Arctic University of Tromso	Larsen, AK (corresponding author), Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Sect Arctic Vet Med, Tromso, Norway.	anett.larsen@nvh.no	Godfroid, Jacques/HCI-7835-2022; Larsen, Anett Kristin/K-6020-2019; godfroid, jacques/U-3524-2017	Larsen, Anett Kristin/0000-0002-2121-2286; godfroid, jacques/0000-0002-0782-7858; Nymo, Ingebjorg Helena/0000-0002-4844-8344	Fram Centre - High North Research Centre for Climate and the Environment; Astri and Birger Thorstedts foundation	Fram Centre - High North Research Centre for Climate and the Environment; Astri and Birger Thorstedts foundation	This work was funded by The Fram Centre - High North Research Centre for Climate and the Environment and Astri and Birger Thorstedts foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton G G, 1975, Monogr Ser World Health Organ, P1; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Baucheron S, 2002, RES MICROBIOL, V153, P277, DOI 10.1016/S0923-2508(02)01317-7; Bingham J, 2008, NEW ZEAL VET J, V56, P10, DOI 10.1080/00480169.2008.36798; Bohlin J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-249; Brew SD, 1999, VET REC, V144, P483; Brubaker M, 2010, CCH B, V5; CHAN J, 1989, SCAND J INFECT DIS, V21, P337, DOI 10.3109/00365548909035706; Cloeckaert A, 1998, CLIN DIAGN LAB IMMUN, V5, P862, DOI 10.1128/CDLI.5.6.862-870.1998; Cloeckaert A, 2000, CLIN DIAGN LAB IMMUN, V7, P835, DOI 10.1128/CDLI.7.5.835-839.2000; Corbel MJ, 1984, J BACTERIOL, V1, P377; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; de Bagues MPJ, 2004, INFECT IMMUN, V72, P2429, DOI 10.1128/IAI.72.4.2429-2433.2004; El-Tras WF, 2010, VET MICROBIOL, V141, P321, DOI 10.1016/j.vetmic.2009.09.017; EWALT DR, 1994, J VET DIAGN INVEST, V6, P448, DOI 10.1177/104063879400600408; Fang FC, 2002, AM J PHYSIOL-LUNG C, V282, pL941, DOI 10.1152/ajplung.00017.2002; Fernandez-Prada CM, 2003, INFECT IMMUN, V71, P2110, DOI 10.1128/IAI.71.4.2110-2119.2003; Foster G, 2002, VET MICROBIOL, V90, P563, DOI 10.1016/S0378-1135(02)00236-5; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Garner MM, 1997, J VET DIAGN INVEST, V9, P298, DOI 10.1177/104063879700900311; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Jahans KL, 1997, VET MICROBIOL, V57, P373, DOI 10.1016/S0378-1135(97)00118-1; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; Kohler S, 2003, TRENDS MICROBIOL, V11, P215, DOI 10.1016/S0966-842X(03)00078-7; Lambourn D, 2013, J WILDLIFE DIS, V49, P802, DOI 10.7589/2012-05-137; Larsen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070186; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Liautard Jean-Pierre, 1996, Microbiologia (Madrid), V12, P197; Lund S, 2006, ICES ADV 2006 BOOKS, P1; Maquart M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-145; Maquart M, 2009, MICROBES INFECT, V11, P361, DOI 10.1016/j.micinf.2008.12.012; Martin-Martin AI, 2010, MICROBES INFECT, V12, P246, DOI 10.1016/j.micinf.2009.12.008; McDonald WL, 2006, J CLIN MICROBIOL, V44, P4363, DOI 10.1128/JCM.00680-06; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Nymo IH, 2013, DIS AQUAT ORGAN, V106, P187, DOI 10.3354/dao02659; Nymo IH, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-93; OIE World Organization for Animal Health, 2013, BOV BRUC; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pei JW, 2008, MICROBES INFECT, V10, P582, DOI 10.1016/j.micinf.2008.01.005; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Perrett LL, 2004, VET REC, V154, P800; Perrett LL, 2004, SMALL RUMINANT RES, V51, P221, DOI 10.1016/S0921-4488(03)00233-5; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Pizarro-Cerda J, 2000, MICROBES INFECT, V2, P829, DOI 10.1016/S1286-4579(00)90368-X; Porte F, 2003, INFECT IMMUN, V71, P1481, DOI 10.1128/IAI.71.3.1481-1490.2003; Rhyan JC, 2001, J VET DIAGN INVEST, V13, P379, DOI 10.1177/104063870101300502; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; ROSS HM, 1994, VET REC, V134, P359, DOI 10.1136/vr.134.14.359-b; Scholz HC, 2008, INT J SYST EVOL MICR, V58, P375, DOI 10.1099/ijs.0.65356-0; Scholz HC, 2010, INT J SYST EVOL MICR, V60, P801, DOI 10.1099/ijs.0.011148-0; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Sohn AH, 2003, EMERG INFECT DIS, V9, P485, DOI 10.3201/eid0904.020576; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; Tryland M, 1999, VET REC, V144, P588, DOI 10.1136/vr.144.21.588; Tryland M, 2005, VET MICROBIOL, V105, P103, DOI 10.1016/j.vetmic.2004.11.001; TSUCHIYA S, 1982, CANCER RES, V42, P1530; von Bargen K, 2012, FEMS MICROBIOL REV, V36, P533, DOI 10.1111/j.1574-6976.2012.00334.x; Watarai M, 2002, CELL MICROBIOL, V4, P341, DOI 10.1046/j.1462-5822.2002.00195.x; Whatmore AM, 2008, EMERG INFECT DIS, V14, P517, DOI 10.3201/eid1403.070829; YOUNG EJ, 1983, REV INFECT DIS, V5, P821; Zaccheus MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053941	64	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84861	10.1371/journal.pone.0084861	http://dx.doi.org/10.1371/journal.pone.0084861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376851	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100190
J	Liu, QL; Xu, KD; Zhong, M; Pan, YZ; Jiang, BB; Liu, GL; Jia, Y				Liu, Qing-Lin; Xu, Ke-Dong; Zhong, Ming; Pan, Yuan-Zhi; Jiang, Bei-Bei; Liu, Guang-Li; Jia, Yin			Cloning and Characterization of a Novel Vacuolar Na+/H+ Antiporter Gene (Dgnhx1) from Chrysanthemum	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GENE; SALT TOLERANCE; OVEREXPRESSION; EXPRESSION; ATNHX1	Plant vacuolar Na+/H+ antiporter genes play significant roles in salt tolerance. However, the roles of the chrysanthemum vacuolar Na+/H+ antiporter genes in salt stress response remain obscure. In this study, we isolated and characterized a novel vacuolar Na+/H+ antiporter gene DgNHX1 from chrysanthemum. The DgNHX1 sequence contained 1920 bp with a complete open reading frame of 1533 bp encoding a putative protein of 510 amino acids with a predicted protein molecular weight of 56.3 kDa. DgNHX1 was predicted containing nine transmembrane domains. Its expression in the chrysanthemum was upregulated by salt stress, but not by abscisic acid (ABA). To assess roles of DgNHX1 in plant salt stress responses, we performed gain-of-function experiment. The DgNHX1-overexpression tobacco plants showed significant salt tolerance than the wild type (WT). The transgenic lines exhibited more accumulation of Na+ and K+ under salt stress. These findings suggest that DgNHX1 plays a positive regulatory role in salt stress response.	[Liu, Qing-Lin; Zhong, Ming; Pan, Yuan-Zhi; Jiang, Bei-Bei; Liu, Guang-Li; Jia, Yin] Sichuan Agr Univ, Dept Ornamental Hort, Chengdu, Peoples R China; [Xu, Ke-Dong] Zhoukou Normal Univ, Dept Life Sci, Key Lab Plant Genet & Mol Breeding, Zhoukou, Peoples R China	Sichuan Agricultural University; Zhoukou Normal University	Liu, QL (corresponding author), Sichuan Agr Univ, Dept Ornamental Hort, Chengdu, Peoples R China.	qinglinliu@126.com	Pan, YZ/GVS-2269-2022; Liu, Qing/GWC-9222-2022; liu, qingqing/HHD-0360-2022		National Natural Science Foundation of China [31201649]; Key Scientific Research Project of Education Department of Sichuan Province [10ZA051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific Research Project of Education Department of Sichuan Province	This research was supported by National Natural Science Foundation of China (31201649) and the Key Scientific Research Project of Education Department of Sichuan Province (10ZA051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; AN G, 1986, PLANT PHYSIOL, V81, P301, DOI 10.1104/pp.81.1.301; Asif MA, 2011, MOL BIOTECHNOL, V49, P250, DOI 10.1007/s12033-011-9399-1; Baltierra F, 2013, BIOCHEM BIOPH RES CO, V430, P535, DOI 10.1016/j.bbrc.2012.11.118; Chen LH, 2008, TRANSGENIC RES, V17, P121, DOI 10.1007/s11248-007-9085-z; Fukuda A, 2004, PLANT CELL PHYSIOL, V45, P146, DOI 10.1093/pcp/pch014; Guan B, 2011, MOL BIOL REP, V38, P1889, DOI 10.1007/s11033-010-0307-8; Li C, 2013, PLANT PHYSIOL BIOCH, V70, P164, DOI 10.1016/j.plaphy.2013.05.005; Liu QL, 2014, PLANT MOL BIOL REP, V32, P282, DOI 10.1007/s11105-013-0639-3; Liu QL, 2013, PLANT PHYSIOL BIOCH, V69, P27, DOI 10.1016/j.plaphy.2013.04.016; Liu QL, 2011, BIOTECHNOL LETT, V33, P2073, DOI 10.1007/s10529-011-0659-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Rodriguez-Rosales MP, 2008, NEW PHYTOL, V179, P366, DOI 10.1111/j.1469-8137.2008.02461.x; Wu CA, 2004, PLANT CELL PHYSIOL, V45, P600, DOI 10.1093/pcp/pch071; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xu K, 2010, J BIOL CHEM, V285, P22997, DOI 10.1074/jbc.M109.073783; Zhou SF, 2011, BIOTECHNOL LETT, V33, P375, DOI 10.1007/s10529-010-0418-2; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8	18	2	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83702	10.1371/journal.pone.0083702	http://dx.doi.org/10.1371/journal.pone.0083702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376735	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100132
J	Zhou, L; Chen, TW; Zhang, XM; Li, CJ; Yang, ZF; Zeng, NL; Wang, LY; Li, T; Wang, D; Li, J; Li, CP; Li, L; Xie, XY				Zhou, Li; Chen, Tian-wu; Zhang, Xiao-ming; Li, Cheng-jun; Yang, Zhen-feng; Zeng, Nan-lin; Wang, Li-ying; Li, Ting; Wang, Dan; Li, Jie; Li, Chun-ping; Li, Li; Xie, Xian-yong			Spleen Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a New Method for Staging Liver Fibrosis in a Piglet Model	PLOS ONE			English	Article							SPLENIC BLOOD-FLOW; PORTAL-HYPERTENSION; CIRRHOSIS	Objective: To explore spleen hemodynamic alteration in liver fibrosis with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), and to determine how to stage liver fibrosis with spleen DCE-MRI parameters. Materials and Methods: Sixteen piglets were prospectively used to model liver fibrosis staged by liver biopsy, and underwent spleen DCE-MRI on 0, 5th, 9th, 16th and 21st weekend after modeling this disease. DCE-MRI parameters including time to peak (TTP), positive enhancement integral (PEI), maximum slope of increase (MSI) and maximum slope of decrease (MSD) of spleen were measured, and statistically analyzed to stage this disease. Results: Spearman's rank correlation tests showed that TTP tended to increase with increasing stages of liver fibrosis (r = 0.647, P<0.001), and that PEI tended to decrease from stage 0 to 4 (r = -0.709, P<0.001). MSD increased slightly from stage 0 to 2 (P>0.05), and decreased from stage 2 to 4 (P<0.05). MSI increased from stage 0 to 1, and decreased from stage 1 to 4 (all P>0.05). Mann-Whitney tests demonstrated that TTP and PEI could classify fibrosis between stage 0 and 1-4, between 0-1 and 2-4, between 0-2 and 3-4, or between 0-3 and 4 (all P<0.01). MSD could discriminate between 0-2 and 3-4 (P = 0.006), or between 0-3 and 4 (P = 0.012). MSI could not differentiate between any two stages. Receiver operating characteristic analysis illustrated that area under receiver operating characteristic curve (AUC) of TTP was larger than of PEI for classifying stage >= 1 and >= 2 (AUC = 0.851 and 0.783, respectively). PEI could best classify stage >= 3 and 4 (AUC = 0.903 and 0.96, respectively). Conclusion: Spleen DCE-MRI has potential to monitor spleen hemodynamic alteration and classify liver fibrosis stages.	[Zhou, Li; Chen, Tian-wu; Zhang, Xiao-ming; Zeng, Nan-lin; Wang, Li-ying; Li, Ting; Wang, Dan; Li, Jie; Li, Chun-ping] North Sichuan Med Coll, Affiliated Hosp, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China; [Zhou, Li; Chen, Tian-wu; Zhang, Xiao-ming; Zeng, Nan-lin; Wang, Li-ying; Li, Ting; Wang, Dan; Li, Jie; Li, Chun-ping] North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Nanchong, Sichuan, Peoples R China; [Li, Cheng-jun] North Sichuan Med Coll, Dept Anat, Nanchong, Sichuan, Peoples R China; [Li, Cheng-jun] North Sichuan Med Coll, Morphometr Res Lab, Nanchong, Sichuan, Peoples R China; [Yang, Zhen-feng] Xinxiang Med Coll, Affiliated Hosp 3, Dept Radiol, Xinxiang, Henan, Peoples R China; [Li, Li; Xie, Xian-yong] North Sichuan Med Coll, Affiliated Hosp, Dept Pathol, Nanchong, Sichuan, Peoples R China	North Sichuan Medical University; North Sichuan Medical University; North Sichuan Medical University; North Sichuan Medical University; Xinxiang Medical University; North Sichuan Medical University	Chen, TW (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China.	tianwuchen_nsmc@163.com; cli2@nsmc.edu.cn	Zhang, Xiao Ming/H-7104-2019	Zhang, Xiao Ming/0000-0001-5327-8506	National Natural Science Foundation of China [81050033]; Key Projects in the Sichuan Province Science and Technology Pillar Program [2011SZ0237]; Science Foundation for Distinguished Young Scholars of Sichuan Province in China [2010JQ0039]; Key Science and Technology Project of Chinese Ministry of Public Health [2014114]; Natural Science Key Project of North Sichuan Medical College [CBY12-A-ZD03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the Sichuan Province Science and Technology Pillar Program; Science Foundation for Distinguished Young Scholars of Sichuan Province in China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Science and Technology Project of Chinese Ministry of Public Health; Natural Science Key Project of North Sichuan Medical College	This study was supported by the National Natural Science Foundation of China (Grant No. 81050033), the Key Projects in the Sichuan Province Science and Technology Pillar Program (Grant No. 2011SZ0237), the Science Foundation for Distinguished Young Scholars of Sichuan Province in China (Grant No. 2010JQ0039), the Key Science and Technology Project of Chinese Ministry of Public Health (Grant No. 2014114), and the Natural Science Key Project of North Sichuan Medical College (Grant No. CBY12-A-ZD03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Blomley MJK, 1997, ACAD RADIOL, V4, P13, DOI 10.1016/S1076-6332(97)80155-9; Bolognesi M, 2002, HEPATOLOGY, V35, P601, DOI 10.1053/jhep.2002.31352; Bolognesi M, 2002, DIGEST LIVER DIS, V34, P144, DOI 10.1016/S1590-8658(02)80246-8; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; De Schepper AM, 2005, ABDOM IMAGING, V30, P96, DOI 10.1007/s00261-004-0181-8; Do RKG, 2009, MAGN RESON IMAGING C, V17, P339, DOI 10.1016/j.mric.2009.01.009; Faria SC, 2009, RADIOGRAPHICS, V29, P1615, DOI 10.1148/rg.296095512; Goshima S, 2012, J MAGN RESON IMAGING, V36, P1148, DOI 10.1002/jmri.23758; Guan S, 2007, WORLD J GASTROENTERO, V13, P1182, DOI 10.3748/wjg.v13.i8.1182; Heintges T, 1998, DIGEST DIS SCI, V43, P1562, DOI 10.1023/A:1018827201670; HENNEBRUNS D, 1989, LANGENBECK ARCH CHIR, V374, P150, DOI 10.1007/BF01261725; Kisseleva T, 2011, BEST PRACT RES CL GA, V25, P305, DOI 10.1016/j.bpg.2011.02.011; Kumar M, 2007, INDIAN J PEDIATR, V74, P393, DOI 10.1007/s12098-007-0067-1; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Lucey BC, 2002, AM J ROENTGENOL, V179, P1591, DOI 10.2214/ajr.179.6.1791591; Motosugi U, 2012, EUR J RADIOL, V81, P2533, DOI 10.1016/j.ejrad.2011.11.054; Nedredal GI, 2011, J MAGN RESON IMAGING, V34, P79, DOI 10.1002/jmri.22610; Perisic Mirjana D, 2005, Rom J Intern Med, V43, P141; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Shu J, 2009, CONTRAST MEDIA MOL I, V4, P127, DOI 10.1002/cmmi.273; Taniguchi H, 2001, NUCL MED COMMUN, V22, P755, DOI 10.1097/00006231-200107000-00005; Tarantino G, 2011, WORLD J GASTROENTERO, V17, P1606, DOI 10.3748/wjg.v17.i12.1606; Tsushima Y, 1998, AM J ROENTGENOL, V170, P153, DOI 10.2214/ajr.170.1.9423623; Zhang JJ, 2009, EUR SURG RES, V42, P35, DOI 10.1159/000167855; ZWIEBEL WJ, 1995, RADIOLOGY, V194, P807, DOI 10.1148/radiology.194.3.7862983	27	4	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83697	10.1371/journal.pone.0083697	http://dx.doi.org/10.1371/journal.pone.0083697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376732	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100130
J	Bryson, DM; Ofria, C				Bryson, David M.; Ofria, Charles			Understanding Evolutionary Potential in Virtual CPU Instruction Set Architectures	PLOS ONE			English	Article								We investigate fundamental decisions in the design of instruction set architectures for linear genetic programs that are used as both model systems in evolutionary biology and underlying solution representations in evolutionary computation. We subjected digital organisms with each tested architecture to seven different computational environments designed to present a range of evolutionary challenges. Our goal was to engineer a general purpose architecture that would be effective under a broad range of evolutionary conditions. We evaluated six different types of architectural features for the virtual CPUs: (1) genetic flexibility: we allowed digital organisms to more precisely modify the function of genetic instructions, (2) memory: we provided an increased number of registers in the virtual CPUs, (3) decoupled sensors and actuators: we separated input and output operations to enable greater control over data flow. We also tested a variety of methods to regulate expression: (4) explicit labels that allow programs to dynamically refer to specific genome positions, (5) position-relative search instructions, and (6) multiple new flow control instructions, including conditionals and jumps. Each of these features also adds complication to the instruction set and risks slowing evolution due to epistatic interactions. Two features (multiple argument specification and separated I/O) demonstrated substantial improvements in the majority of test environments, along with versions of each of the remaining architecture modifications that show significant improvements in multiple environments. However, some tested modifications were detrimental, though most exhibit no systematic effects on evolutionary potential, highlighting the robustness of digital evolution. Combined, these observations enhance our understanding of how instruction architecture impacts evolutionary potential, enabling the creation of architectures that support more rapid evolution of complex solutions to a broad range of challenges.	[Bryson, David M.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Bryson, DM (corresponding author), Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA.	brysonda@egr.msu.edu		Ofria, Charles/0000-0003-2924-1732	National Science Foundation [DBI-0939454, CCF-0643952]	National Science Foundation(National Science Foundation (NSF))	This material is based in part upon work supported by the National Science Foundation under Cooperative Agreement No. DBI-0939454 and Grant CCF-0643952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann B, 2007, P 1 IEEE INT C SELF; Bryson DM, 2013, FIGSHARE, DOI [10.6084/m9.fig-share.826206, DOI 10.6084/M9.FIG-SHARE.826206]; Bryson DM, 2012, ARTIF LIFE, P19; Chow SS, 2004, SCIENCE, V305, P84, DOI 10.1126/science.1096307; Clune J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000187; Forrest Stephanie, 2009, P 11 ANN C GEN EV CO, P947, DOI 10.1145/1569901.1570031; Goldsby HJ, 2007, P ICSE WORKSH SOFTW; Gomez FJ, 2003, LECT NOTES COMPUT SC, V2724, P2084; Grabowski L.M., 2010, ARTIFICIAL LIFE 12 P, P224; Grabowski LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060466; Grabowski LM, 2008, GECCO 08; Grabowski LM, 2011, PROCEEDINGS OF THE E; Holland J.H., 1975, ADAPTATION NATURAL A; Knoester DB, 2007, P 9 EUR C ART LIF; Koza John R., 1990, TECHNICAL REPORT; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; McKinley PK, 2008, IEEE COMPUTER, V41; Misevic D, 2006, P ROY SOC B-BIOL SCI, V273, P457, DOI 10.1098/rspb.2005.3338; Ofria C, 2005, ARTIFICIAL LIFE MODELS IN SOFTWARE, P3, DOI 10.1007/1-84628-214-4_1; Ofria C, 2002, IEEE T EVOLUT COMPUT, V6, P420, DOI 10.1109/TEVC.2002.802442; Rechenberg I, 1971, THESIS BERLIN TU; Simon D., 2013, EVOLUTIONARY OPTIMIZ; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569	24	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83242	10.1371/journal.pone.0083242	http://dx.doi.org/10.1371/journal.pone.0083242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376669	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000073
J	Fiorcari, S; Brown, WS; McIntyre, BW; Estrov, Z; Maffei, R; O'Brien, S; Sivina, M; Hoellenriegel, J; Wierda, WG; Keating, MJ; Ding, W; Kay, NE; Lannutti, BJ; Marasca, R; Burger, JA				Fiorcari, Stefania; Brown, Wells S.; McIntyre, Bradley W.; Estrov, Zeev; Maffei, Rossana; O'Brien, Susan; Sivina, Mariela; Hoellenriegel, Julia; Wierda, William G.; Keating, Michael J.; Ding, Wei; Kay, Neil E.; Lannutti, Brian J.; Marasca, Roberto; Burger, Jan A.			The PI3-Kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-Mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; B-CELLS; SURVIVAL; APOPTOSIS; RECEPTOR; CAL-101; EXPRESSION; MIGRATION; MICROENVIRONMENT; MOLECULE-1	CLL cell trafficking between blood and tissue compartments is an integral part of the disease process. Idelalisib, a phosphoinositide 3-kinase delta (PI3K delta) inhibitor causes rapid lymph node shrinkage, along with an increase in lymphocytosis, prior to inducing objective responses in CLL patients. This characteristic activity presumably is due to CLL cell redistribution from tissues into the blood, but the underlying mechanisms are not fully understood. We therefore analyzed idelalisib effects on CLL cell adhesion to endothelial and bone marrow stromal cells (EC, BMSC). We found that idelalisib inhibited CLL cell adhesion to EC and BMSC under static and shear flow conditions. TNF alpha-induced VCAM-1 (CD106) expression in supporting layers increased CLL cell adhesion and accentuated the inhibitory effect of idelalisib. Co-culture with EC and BMSC also protected CLL from undergoing apoptosis, and this EC- and BMSC-mediated protection was antagonized by idelalisib. Furthermore, we demonstrate that CLL cell adhesion to EC and VLA-4 (CD49d) resulted in the phosphorylation of Akt, which was sensitive to inhibition by idelalisib. These findings demonstrate that idelalisib interferes with integrin-mediated CLL cell adhesion to EC and BMSC, providing a novel mechanism to explain idelalisib-induced redistribution of CLL cells from tissues into the blood.	[Fiorcari, Stefania; Estrov, Zeev; O'Brien, Susan; Sivina, Mariela; Hoellenriegel, Julia; Wierda, William G.; Keating, Michael J.; Burger, Jan A.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Brown, Wells S.; McIntyre, Bradley W.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Ding, Wei; Kay, Neil E.] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN USA; [Lannutti, Brian J.] Gilead Sci Inc, Washington, DC USA; [Fiorcari, Stefania; Maffei, Rossana; Marasca, Roberto] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Hematol Unit, Modena, Italy	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; Gilead Sciences; Universita di Modena e Reggio Emilia	Burger, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	jaburger@mdanderson.org	Sivina, Mariela/ABC-7620-2021; Marasca, Roberto/I-8072-2013; Fiorcari, Stefania/I-7240-2018; Maffei, Rossana/O-4836-2016	Marasca, Roberto/0000-0002-6431-6878; Fiorcari, Stefania/0000-0002-8582-4951; Maffei, Rossana/0000-0002-3518-2006	CLL Global Research Foundation; Cancer Prevention and Research Institute of Texas (CPRIT); Associazione Italiana per la Ricerca sul Cancro (Milan, Italy) [AIRC IG10621-2010]; NATIONAL CANCER INSTITUTE [P01CA081534, K23CA160345] Funding Source: NIH RePORTER	CLL Global Research Foundation; Cancer Prevention and Research Institute of Texas (CPRIT); Associazione Italiana per la Ricerca sul Cancro (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This manuscript was supported by CLL Global Research Foundation grants (to J.B. and W. G. W.), a Cancer Prevention and Research Institute of Texas (CPRIT) grant (to J.A.B.), and a Associazione Italiana per la Ricerca sul Cancro (AIRC IG10621-2010, Milan, Italy) grant (to S. F. and R. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDNARCZYK JL, 1994, J BIOL CHEM, V269, P8348; Brachtl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023758; Buggins AGS, 2010, CANCER RES, V70, P7523, DOI 10.1158/0008-5472.CAN-10-1634; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Burger JA, 2001, J CLIN INVEST, V107, P305, DOI 10.1172/JCI11092; Burger JA, 2011, HEMATOL-AM SOC HEMAT, P96, DOI 10.1182/asheducation-2011.1.96; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chiorazzi N, 2005, ANN NY ACAD SCI, V1062, P1, DOI 10.1196/annals.1358.002; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Freeman SN, 2011, J IMMUNOL, V187, P5887, DOI 10.4049/jimmunol.1102233; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Furman RR, 2010, BLOOD, V116, p31a; Gattei V, 2008, BLOOD, V111, P865, DOI 10.1182/blood-2007-05-092486; Herman S. E., 2011, BLOOD; Herman SEM, 2010, BLOOD, V116, P2078, DOI 10.1182/blood-2010-02-271171; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; Ikeda H, 2010, BLOOD, V116, P1460, DOI 10.1182/blood-2009-06-222943; Kawano Y, 2003, BLOOD, V101, P532, DOI 10.1182/blood-2002-04-1268; Kay NE, 2007, LEUKEMIA RES, V31, P899, DOI 10.1016/j.leukres.2006.11.024; Lagneaux L, 1998, BLOOD, V91, P2387, DOI 10.1182/blood.V91.7.2387.2387_2387_2396; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Maffei R, 2010, LEUKEMIA RES, V34, P312, DOI 10.1016/j.leukres.2009.06.023; Meadows SA, 2012, BLOOD, V119, P1897, DOI 10.1182/blood-2011-10-386763; Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI200523409; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; O'Brien S, 2011, BLOOD, V118, P983; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Panayiotidis P, 1996, BRIT J HAEMATOL, V92, P97, DOI 10.1046/j.1365-2141.1996.00305.x; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Quiroga MP, 2009, BLOOD, V114, P1029, DOI 10.1182/blood-2009-03-212837; Rose DM, 2002, IMMUNOL REV, V186, P118, DOI 10.1034/j.1600-065X.2002.18611.x; Shanafelt TD, 2008, BRIT J HAEMATOL, V140, P537, DOI 10.1111/j.1365-2141.2007.06965.x; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STEIN H, 1980, J HISTOCHEM CYTOCHEM, V28, P746, DOI 10.1177/28.8.7003001; SWERLICK RA, 1992, J IMMUNOL, V149, P698	40	68	68	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83830	10.1371/journal.pone.0083830	http://dx.doi.org/10.1371/journal.pone.0083830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376763	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000123
J	Madec, Y; Leroy, S; Rey-Cuille, MA; Huber, F; Calmy, A				Madec, Yoann; Leroy, Sandrine; Rey-Cuille, Marie-Anne; Huber, Florence; Calmy, Alexandra			Persistent Difficulties in Switching to Second-Line ART in Sub-Saharan Africa - A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							1ST-LINE ANTIRETROVIRAL TREATMENT; RESOURCE-LIMITED SETTINGS; HIV-1 DRUG-RESISTANCE; TREATMENT FAILURE; IMMUNOLOGICAL CRITERIA; VIROLOGICAL FAILURE; THERAPEUTIC OPTIONS; RURAL DISTRICT; PREDICTORS; OUTCOMES	Objectives: Switching to second-line antiretroviral therapy (ART) largely depends on careful clinical assessment and access to biological measurements. We performed a systematic review and meta-analysis to estimate the incidence of switching to second-line ART in sub-Saharan Africa and its main programmatic determinants. Methods: We searched 2 databases for studies reporting the incidence rate of switching to second-line ART in adults living in sub-Saharan Africa. Data on the incidence rate of switching were pooled, and random-effect models were used to evaluate the effect of factors measured at the programme level on this incidence rate. Results: Nine studies (157,340 patients) in 21 countries were included in the meta-analysis. All studies considered patients under first-line ART and conditions to initiate ART were similar across studies. Overall, 3,736 (2.4%) patients switched to second-line ART. Incidence rate of switch was in mean 2.65 per 100 person-years (PY) (95% confidence interval: 2.01-3.30); it ranged from 0.42 to 4.88 per 100 PY and from 0 to 4.80 per 100 PY in programmes with and without viral load monitoring, respectively. No factors measured at the programme level were associated with the incidence rate of switching to second-line ART. Conclusion: The low incidence rate of switching to second-line ART suggests that the monitoring of patients under ART is challenging and that access to second-line ART is ineffective; efforts should be made to increase access to second-line ART to those in need by providing monitoring tools, education and training, as well as a more convenient regimen.	[Madec, Yoann; Leroy, Sandrine; Rey-Cuille, Marie-Anne] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [Huber, Florence] SOLTHIS, Paris, France; [Calmy, Alexandra] Univ Hosp Geneva, Dept Internal Med, HIV Unit, Geneva, Switzerland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Geneva	Madec, Y (corresponding author), Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France.	yoann.madec@pasteur.fr	Leroy, Sandrine/I-9136-2014	Leroy, Sandrine/0000-0002-2964-2002; Madec, Yoann/0000-0002-6201-1261; Huber, Florence/0000-0002-4340-0106				Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; [Anonymous], 2012, WHO HIV DRUG RES REP; [Anonymous], 2009, SYST REV CRDS GUID U; [Anonymous], 2013, CONSOLIDATED GUIDELI; [Anonymous], 2012, UNDETECTABLE VIRAL L; [Anonymous], 2013, GUID US ANT AG HIV 1; [Anonymous], 2010, ANTIRETROVIRAL THERA; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Barth RE, 2012, ANTIVIR THER, V17, P377, DOI 10.3851/IMP2010; Dagnra AY, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-30; De Luca A, 2012, JAIDS-J ACQ IMM DEF, V59, P236, DOI 10.1097/QAI.0b013e31824276e9; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Keiser O, 2010, TROP MED INT HEALTH, V15, P251, DOI 10.1111/j.1365-3156.2009.02445.x; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Landier J, 2011, AIDS CARE, V23, P75, DOI 10.1080/09540121.2010.498867; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Levison JH, 2011, ANTIVIR THER, V16, P853, DOI 10.3851/IMP1819; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Orrell C, 2007, ANTIVIR THER, V12, P83; Palombi L, 2009, CLIN INFECT DIS, V48, P115, DOI 10.1086/593312; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9; Pujades-Rodriguez M, 2010, JAMA-J AM MED ASSOC, V304, P303, DOI 10.1001/jama.2010.980; Ramadhani HO, 2007, CLIN INFECT DIS, V45, P1492, DOI 10.1086/522991; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; Schoffelen AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058526; Sigaloff KCE, 2012, J INFECT DIS, V205, P1739, DOI 10.1093/infdis/jis261; Sigaloff KCE, 2012, AIDS RES HUM RETROV, V28, P171, DOI 10.1089/aid.2011.0136; Srasuebkul Preeyaporn, 2007, AIDS Res Ther, V4, P18, DOI 10.1186/1742-6405-4-18; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; van Zyl GU, 2011, J MED VIROL, V83, P1764, DOI 10.1002/jmv.22189; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	42	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82724	10.1371/journal.pone.0082724	http://dx.doi.org/10.1371/journal.pone.0082724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376570	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000024
J	Peng, QL; Lao, XJ; Chen, ZP; Lai, H; Deng, Y; Wang, J; Mo, CJ; Sui, JZ; Wu, JR; Zhai, LM; Yang, S; Qin, X; Li, S				Peng, Qiliu; Lao, Xianjun; Chen, Zhiping; Lai, Hao; Deng, Yan; Wang, Jian; Mo, Cuiju; Sui, Jingzhe; Wu, Junrong; Zhai, Limin; Yang, Shi; Qin, Xue; Li, Shan			TP53 and MDM2 Gene Polymorphisms, Gene-Gene Interaction, and Hepatocellular Carcinoma Risk: Evidence from an Updated Meta-Analysis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; CODON 72 POLYMORPHISM; HEPATITIS-C VIRUS; FUNCTIONAL POLYMORPHISM; PROMOTER SNP309; PRO VARIANT; P53; SUSCEPTIBILITY; ASSOCIATION; CANCER	Background: The association between TP53 R72P and/or MDM2 SNP309 polymorphisms and hepatocellular carcinoma (HCC) risk has been widely reported, but results were inconsistent. To clarify the effects of these polymorphisms on HCC risk, an updated meta-analysis of all available studies was conducted. Methods: Eligible articles were identified by search of databases including PubMed, Cochrane Library, EMBASE and Chinese Biomedical Literature database (CBM) for the period up to July 2013. Data were extracted by two independent authors and pooled odds ratio (OR) with 95% confidence interval (CI) was calculated. Metaregression and subgroup analyses were performed to identify the source of heterogeneity. Results: Finally, a total of 10 studies including 2,243 cases and 3,615 controls were available for MDM2 SNP309 polymorphism and 14 studies containing 4,855 cases and 6,630 controls were included for TP53 R72P polymorphism. With respect to MDM2 SNP309 polymorphism, significantly increased HCC risk was found in the overall population. In subgroup analysis by ethnicity and hepatitis virus infection status, significantly increased HCC risk was found in Asians, Caucasians, Africans, and HCV positive patients. With respect to TP53 R72P polymorphism, no significant association with HCC risk was observed in the overall and subgroup analyses. In the MDM2 SNP309-TP53 R72P interaction analysis, we found that subjects with MDM2 309TT and TP53 Pro/Pro genotype, MDM2 309 TG and TP53 Arg/Pro genotype, and MDM2 309 GG and TP53 Pro/Pro genotype were associated with significantly increased risk of developing HCC as compared with the reference MDM2 309TT and TP53 Arg/Arg genotype. Conclusions: We concluded that MDM2 SNP309 polymorphism may play an important role in the carcinogenesis of HCC. In addition, our findings further suggest that the combination of MDM2 SNP 309 and TP53 Arg72Pro genotypes confers higher risk to develop HCC. Further large and well-designed studies are needed to confirm this association.	[Peng, Qiliu; Lao, Xianjun; Deng, Yan; Wang, Jian; Mo, Cuiju; Sui, Jingzhe; Wu, Junrong; Zhai, Limin; Yang, Shi; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Chen, Zhiping] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China; [Lai, Hao] Guangxi Med Univ, Tumor Hosp, Dept Gastrointestinal Surg, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Qin, X (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	qinxue919@126.com; lis8858@126.com			National Natural Science Foundation of China [81260302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (number 81260302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2010, CANCER EPIDEMIOL, V34, P448, DOI 10.1016/j.canep.2010.04.008; Anzola M, 2003, CANCER LETT, V193, P199, DOI 10.1016/S0304-3835(03)00046-6; Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Bond GL, 2005, CANCER RES, V65, P5481, DOI 10.1158/0008-5472.CAN-05-0825; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Castello G, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-109; Chan HLY, 2006, SEMIN LIVER DIS, V26, P153, DOI 10.1055/s-2006-939753; Chen JD, 1996, MOL CELL BIOL, V16, P2445; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dharel N, 2006, CLIN CANCER RES, V12, P4867, DOI 10.1158/1078-0432.CCR-06-0111; Di Vuolo V, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-13; Ding C, 2012, J INT MED RES, V40, P446, DOI 10.1177/147323001204000206; Dragani TA, 2010, J HEPATOL, V52, P252, DOI 10.1016/j.jhep.2009.11.015; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Ezzikouri S, 2007, HEPATOL RES, V37, P748, DOI 10.1111/j.1872-034X.2007.00126.x; Ezzikouri S, 2011, INT J BIOL MARKER, V26, P229, DOI 10.5301/JBM.2011.8881; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hong Y, 2005, CANCER RES, V65, P9582, DOI 10.1158/0008-5472.CAN-05-1460; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Leu JD, 2009, WORLD J GASTROENTERO, V15, P5592, DOI 10.3748/wjg.15.5592; Leveri M, 2004, CANCER LETT, V208, P75, DOI 10.1016/j.canlet.2004.02.016; Li Qian, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P554; Lind H, 2006, INT J CANCER, V119, P718, DOI 10.1002/ijc.21872; Lv L, 2013, TUMOR BIOL, V34, P1451, DOI 10.1007/s13277-013-0649-7; Ma HB, 2012, ASIAN PAC J CANCER P, V13, P2841, DOI 10.7314/APJCP.2012.13.6.2841; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marte B, 2002, NATURE, V420, P279, DOI 10.1038/420279a; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Orsted DD, 2007, J EXP MED, V204, P1295, DOI 10.1084/jem.20062476; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Son MS, 2013, GENE, V524, P156, DOI 10.1016/j.gene.2013.04.042; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sumbul AT, 2012, MOL BIOL REP, V39, P1639, DOI 10.1007/s11033-011-0903-2; Talseth BA, 2007, INT J CANCER, V120, P563, DOI 10.1002/ijc.22339; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Tomoda T, 2012, J GASTROEN HEPATOL, V27, P797, DOI 10.1111/j.1440-1746.2011.06948.x; Tong WM, 2001, MOL CELL BIOL, V21, P4046, DOI 10.1128/MCB.21.12.4046-4054.2001; Wang X, 2012, LIVER INT, V32, P1172, DOI 10.1111/j.1478-3231.2012.02787.x; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Yang Y, 2013, PROTEIN CELL, V4, P71, DOI 10.1007/s13238-012-2067-9; Yoon YJ, 2008, CARCINOGENESIS, V29, P1192, DOI 10.1093/carcin/bgn090; Yu MW, 1999, HEPATOLOGY, V29, P697, DOI 10.1002/hep.510290330; Zhang XM, 2006, HUM MUTAT, V27, P110, DOI 10.1002/humu.20277; Zhu Zhong-zheng, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P632; Zhu ZZ, 2005, CANCER LETT, V229, P77, DOI 10.1016/j.canlet.2005.04.014	53	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82773	10.1371/journal.pone.0082773	http://dx.doi.org/10.1371/journal.pone.0082773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376578	Green Submitted, gold, Green Published			2022-12-27	WOS:000328882000031
J	Risseeuw, E; Venglat, P; Xiang, DQ; Komendant, K; Daskalchuk, T; Babic, V; Crosby, W; Datla, R				Risseeuw, Eddy; Venglat, Prakash; Xiang, Daoquan; Komendant, Kristina; Daskalchuk, Tim; Babic, Vivijan; Crosby, William; Datla, Raju			An Activated Form of UFO Alters Leaf Development and Produces Ectopic Floral and Inflorescence Meristems	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENE-EXPRESSION; FLOWER DEVELOPMENT; BOX PROTEINS; TENDRIL-LESS; IDENTITY; INITIATION; LEAVES; ORGANS; DOMAIN	Plants are unique in their ability to continuously produce new meristems and organ primordia. In Arabidopsis, the transcription factor LEAFY (LFY) functions as a master regulator of a gene network that is important for floral meristem and organ specification. UNUSUAL FLORAL ORGANS (UFO) is a co-activator of LEAFY and is required for proper activation of APETALA3 in the floral meristem during the specification of stamens and petals. The ufo mutants display defects in other parts of the flower and the inflorescence, suggestive of additional roles. Here we show that the normal determinacy of the developing Arabidopsis leaves is affected by the expression of a gain-of-function UFO fusion protein with the VP16 transcriptional activator domain. In these lines, the rosette and cauline leaf primordia exhibit reiterated serration, and upon flowering produce ectopic meristems that develop into flowers, bract leaves and inflorescences. These striking phenotypes reveal that developing leaves maintain the competency to initiate flower and inflorescence programs. Furthermore, the gain-of-function phenotypes are dependent on LFY and the SEPALLATA (SEP) MADS-box transcription factors, indicative of their functional interactions with UFO. The findings of this study also suggest that UFO promotes the establishment of the lateral meristems and primordia in the peripheral zone of the apical and floral meristems by enhancing the activity of LFY. These novel phenotypes along with the mutant phenotypes of UFO orthologs in other plant species suggest a broader function for UFO in plants.	[Risseeuw, Eddy; Venglat, Prakash; Xiang, Daoquan; Komendant, Kristina; Daskalchuk, Tim; Babic, Vivijan; Datla, Raju] CNR, Inst Plant Biotechnol, Saskatoon, SK, Canada; [Crosby, William] Univ Windsor, Dept Biol Sci, Windsor, ON N9B 3P4, Canada	University of Windsor	Risseeuw, E (corresponding author), CNR, Inst Plant Biotechnol, Saskatoon, SK, Canada.	erisseeuw@gmail.com; raju.datla@nrc-cnrc.gc.ca	Datla, Raju/AGR-7376-2022; Datla, Raju/H-3820-2011	Datla, Raju/0000-0003-0790-5569	Genome Canada; National Research Council [50141]	Genome Canada(Genome Canada); National Research Council	This work was supported by Genome Canada, National Research Council publication number 50141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Castillejo C, 2005, PLANT J, V43, P586, DOI 10.1111/j.1365-313X.2005.02476.x; Chae E, 2008, DEVELOPMENT, V135, P1235, DOI 10.1242/dev.015842; Chahtane H, 2013, PLANT J, V74, P678, DOI 10.1111/tpj.12156; Chandler JW, 2012, CELL MOL LIFE SCI, V69, P3807, DOI 10.1007/s00018-012-0999-0; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Efroni I, 2010, PLANT CELL, V22, P1019, DOI 10.1105/tpc.109.073601; Gourlay CW, 2000, PLANT CELL, V12, P1279, DOI 10.1105/tpc.12.8.1279; Hepworth SR, 2006, PLANTA, V223, P769, DOI 10.1007/s00425-005-0138-3; Hofer J, 2009, PLANT CELL, V21, P420, DOI 10.1105/tpc.108.064071; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; Kaufmann K, 2010, NAT REV GENET, V11, P830, DOI 10.1038/nrg2885; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; KELLY AJ, 1995, PLANT CELL, V7, P225, DOI 10.1105/tpc.7.2.225; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Lee I, 1997, CURR BIOL, V7, P95, DOI 10.1016/S0960-9822(06)00053-4; LEVIN JZ, 1995, PLANT CELL, V7, P529, DOI 10.1105/tpc.7.5.529; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Long JA, 1998, DEVELOPMENT, V125, P3027; Maizel A, 2005, SCIENCE, V308, P260, DOI 10.1126/science.1108229; Mckim S, 2010, CURR OPIN GENET DEV, V20, P448, DOI 10.1016/j.gde.2010.04.007; Molinero-Rosales N, 1999, PLANT J, V20, P685, DOI 10.1046/j.1365-313X.1999.00641.x; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Moyroud E, 2010, TRENDS PLANT SCI, V15, P346, DOI 10.1016/j.tplants.2010.03.007; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; Reddy GV, 2008, CURR OPIN PLANT BIOL, V11, P88, DOI 10.1016/j.pbi.2007.10.012; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Samach A, 1999, PLANT J, V20, P433, DOI 10.1046/j.1365-313x.1999.00617.x; Siriwardana NS, 2012, INT J DEV BIOL, V56, P207, DOI 10.1387/ijdb.113450ns; Smaczniak C, 2012, P NATL ACAD SCI US; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Song JB, 2012, PLANT CELL PHYSIOL, V53, P1283, DOI 10.1093/pcp/pcs080; Souer E, 1998, DEVELOPMENT, V125, P733; Souer E, 2008, PLANT CELL, V20, P2033, DOI 10.1105/tpc.108.060871; Taylor S, 2001, PLANT CELL, V13, P31, DOI 10.1105/tpc.13.1.31; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang XP, 2003, PLANT CELL, V15, P1071, DOI 10.1105/tpc.009936; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; WILKINSON MD, 1995, PLANT CELL, V7, P1485, DOI 10.1105/tpc.7.9.1485; Wu Shang, 2012, [Frontiers in Biology, 生物学前沿], V7, P144; Xiang DQ, 2011, PLANT CELL, V23, P4348, DOI 10.1105/tpc.111.091777; Yamaguchi N, 2013, DEV CELL, V24, P271, DOI 10.1016/j.devcel.2012.12.017; Zhao DZ, 2001, DEVELOPMENT, V128, P2735	53	17	19	7	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83807	10.1371/journal.pone.0083807	http://dx.doi.org/10.1371/journal.pone.0083807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376756	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000116
J	Roos, AM; Agren, EO				Roos, Anna M.; Agren, Erik O.			High Prevalence of Proposed Mullerian Duct Remnant Cysts on the Spermatic Duct in Wild Eurasian Otters (Lutra lutra) from Sweden	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; BEARS URSUS-MARITIMUS; JUVENILE ALLIGATORS; FLORIDA PANTHER; CRYPTORCHIDISM; TESTOSTERONE; REDUCTION; HORMONE; SIZE	The spermatic ducts (vasa deferentia) of 235 otters (Lutra lutra) found dead between 1999 and 2012 in Sweden were examined for presence of paraductular cysts. Single or multiple elongated uni- or bilateral cysts parallel to the spermatic duct were noted in 72% of the examined males. The cysts were adjacent to, but did not communicate with the lumen of the spermatic duct, and were usually located within a few centimeters of the testis and epididymis. The cysts are proposed to be congenital Mullerian duct remnants. Other morphologic abnormalities in the reproductive organs were not noted within this study. Possible causes of the incomplete regression of the embryonic female gonadal duct are exposure to environmental contaminants such as elevated concentrations of estrogen-like compounds (endocrine disrupting chemicals), inbreeding, or a naturally occurring anatomic defect. No obvious geographical pattern was observed for otters with or without cysts. This is the first study and description of cysts on the spermatic duct in otters.	[Roos, Anna M.] Swedish Museum Nat Hist, Dept Environm Res, S-10405 Stockholm, Sweden; [Roos, Anna M.] Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden; [Agren, Erik O.] Natl Vet Inst, Dept Pathol & Wildlife Dis, S-75007 Uppsala, Sweden	Swedish Museum of Natural History; Uppsala University; National Veterinary Institute SVA	Roos, AM (corresponding author), Swedish Museum Nat Hist, Dept Environm Res, S-10405 Stockholm, Sweden.	anna.roos@nrm.se						Bergman A., 2013, STATE SCI ENDOCRINE, DOI DOI 10.1016/J; Dunbar MR, 1996, J WILDLIFE DIS, V32, P661, DOI 10.7589/0090-3558-32.4.661; Edwards TM, 2006, INT J ANDROL, V29, P109, DOI 10.1111/j.1365-2605.2005.00631.x; FACEMIRE CF, 1995, ENVIRON HEALTH PERSP, V103, P79, DOI 10.2307/3432416; FRY DM, 1981, SCIENCE, V213, P922, DOI 10.1126/science.7256288; Guillette LJ, 1996, GEN COMP ENDOCR, V101, P32, DOI 10.1006/gcen.1996.0005; GUILLETTE LJ, 1994, ENVIRON HEALTH PERSP, V102, P680, DOI 10.2307/3432198; Jensen AA, 2008, INT J ANDROL, V31, P161, DOI 10.1111/j.1365-2605.2008.00870.x; Karlsson S, 2006, EXP TOXICOL PATHOL, V58, P1, DOI 10.1016/j.etp.2006.03.011; MASON CF, 1992, CHEMOSPHERE, V25, P865, DOI 10.1016/0045-6535(92)90077-5; MEYERSWALLEN VN, 1991, BIOL REPROD, V45, P626, DOI 10.1095/biolreprod45.4.626; MEYERSWALLEN VN, 1993, BIOL REPROD, V48, P1410, DOI 10.1095/biolreprod48.6.1410; NEWBOLD RR, 1987, TERATOGEN CARCIN MUT, V7, P377, DOI 10.1002/tcm.1770070405; Oskam IC, 2003, J TOXICOL ENV HEAL A, V66, P2119, DOI 10.1080/15287390390211342; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Roos A, 2013, ENVIRON SCI TECHNOL, V47, P11757, DOI 10.1021/es401485t; Sasaki K, 2009, AM J CLIN PATHOL, V132, P893, DOI 10.1309/AJCPQZX4WS8UPKGG; Sonne C, 2006, ENVIRON SCI TECHNOL, V40, P5668, DOI 10.1021/es060836n; van Bree PJH, 1966, DAN REV GAME BIOL, V4, P1; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Virtanen H E, 2005, Toxicol Appl Pharmacol, V207, P501, DOI 10.1016/j.taap.2005.01.058; Virtanen HE, 2012, MOL CELL ENDOCRINOL, V355, P208, DOI 10.1016/j.mce.2011.11.015	22	4	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84660	10.1371/journal.pone.0084660	http://dx.doi.org/10.1371/journal.pone.0084660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376831	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000157
J	Etxebeste, O; Villarino, M; Markina-Inarrairaegui, A; Araujo-Bazan, L; Espeso, EA				Etxebeste, Oier; Villarino, Maria; Markina-Inarrairaegui, Ane; Araujo-Bazan, Lidia; Espeso, Eduardo A.			Cytoplasmic Dynamics of the General Nuclear Import Machinery in Apically Growing Syncytial Cells	PLOS ONE			English	Article							ACTIN-RELATED PROTEIN; ASPERGILLUS-NIDULANS; NUCLEOCYTOPLASMIC TRANSPORT; TRANSCRIPTION FACTORS; DYNACTIN COMPLEX; DYNEIN; LOCALIZATION; DISTANCE; POLARITY; IDENTIFICATION	Karyophenns are transporters involved in the bidirectional, selective and active transport of macromolecules through nuclear pores. Importin-beta 1 is the paradigm of karyopherins and together with its cargo-adapter importin-a mediates the general nuclear import pathway. Here we show the existence of different cellular pools of both imporkin-alpha and -beta 1. homologues, KapA and KapB, n the coenocytic ascomycete Aspergillus rildulans. Fluorescence analysis of hap bid and diploid strains expressing KapB::GFP and/or KapA::mRFP showed patches of both karyopherins concurrently translocating long distances in apically-growing cells. Anterograde and retrograde movements allowed those patches to reach cell tips and distal regions with an average speed in the range of mu m/s. This bidirectional traffic required rnicrotubules as well as kiriesin and dynein motors, since it is blocked by benomyl and also by the inactivation of the dynein/dynactin complex through nudA1 or nudK317 mutations. Deletion of Kinesin-3 motor UncA, required for the transport through detyrosinated microtubules, strongly inhibited KapA and KaplE3 movement along hyphae. Overall, this is the first report describing the bidirectional dynamics of the main nuclear import system in coenocytic fungi. A functional link is proposed between two key cellular machines of the filamentous fungal cell: nuclear transport and the tip-growth apparatus	[Etxebeste, Oier; Villarino, Maria; Markina-Inarrairaegui, Ane; Araujo-Bazan, Lidia; Espeso, Eduardo A.] CSIC, Ctr Invest Biol, Dept Cellular & Mol Biol, Madrid, Spain; [Etxebeste, Oier; Markina-Inarrairaegui, Ane] Univ Basque Country, Fac Chem, Dept Appl Chem, San Sebastian, Spain; [Araujo-Bazan, Lidia] CSIC, Ctr Invest Biol, Dept Mol Microbiol & Infect Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Espeso, EA (corresponding author), CSIC, Ctr Invest Biol, Dept Cellular & Mol Biol, Madrid, Spain.	eespeso@cib.csic.es	Espeso, Eduardo A/AAC-7238-2022; Villarino, Maria/ABE-9137-2021; Espeso, Eduardo A/C-5259-2011; Etxebeste, Oier/H-8064-2019	Espeso, Eduardo A/0000-0002-5873-6059; Espeso, Eduardo A/0000-0002-5873-6059; Villarino Perez, Maria/0000-0002-5635-8146; Etxebeste, Oier/0000-0002-9786-6091; ARAUJO-BAZAN, LIDIA/0000-0002-8750-7706	Spanish Ministerio de Ciencia y Tecnologia and Ciencia e Innovacion [BFU2006-04185, BFU2009-08701]; Ministerio de Economia y Competitividad [BFU2006-04185, BFU2012-33142]; Ministerio de Educacion y Ciencia [BFU2010-17528, BFU-2009-08701]; Basque Government [IT599-13]	Spanish Ministerio de Ciencia y Tecnologia and Ciencia e Innovacion; Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Educacion y Ciencia(Spanish Government); Basque Government(Basque Government)	This work has been supported by former Spanish Ministerio de Ciencia y Tecnologia and Ciencia e Innovacion, through grants BFU2006-04185 and BFU2009-08701, and current Ministerio de Economia y Competitividad through grant BFU2012-33142 to E.A.E. O.E. held a research contract associated to grant BFU2006-04185 at the CIB, a research contract at The University of The Basque Country (UPV/EHU) with funds from Ministerio de Educacion y Ciencia (BFU2010-17528) and is now a Lecturer at the UPV/EHU with funds from the Basque Government (IT599-13). Maria Villarino held a research contract associated to grant BFU-2009-08701. AM.-I. held a predoctoral F.P.I. fellowship from the Ministerio de Educacion y Ciencia and is now a contract researcher of The University of The Basque Country associated to a grant for Specialization of Researchers of the UPV/EHU(2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2012, MOL BIOL CELL, V23, P1889, DOI 10.1091/mbc.E11-11-0925; Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Araujo-Bazan L, 2008, FUNGAL GENET BIOL, V45, P278, DOI 10.1016/j.fgb.2007.08.003; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Berepiki A, 2011, NAT REV MICROBIOL, V9, P876, DOI 10.1038/nrmicro2666; Chen YN, 2008, CURR OPIN PLANT BIOL, V11, P695, DOI 10.1016/j.pbi.2008.10.005; Cheng PL, 2012, ANNU REV NEUROSCI, V35, P181, DOI 10.1146/annurev-neuro-061010-113618; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; Dudek J, 2005, NAT STRUCT MOL BIOL, V12, P1008, DOI 10.1038/nsmb1007; Egan MJ, 2012, CURR OPIN MICROBIOL, V15, P637, DOI 10.1016/j.mib.2012.10.003; Espeso Eduardo A., 2008, V26, P261; Etxebeste O, 2008, EUKARYOT CELL, V7, P38, DOI 10.1128/EC.00207-07; Etxebeste O, 2009, MICROBIOL-SGM, V155, P3934, DOI 10.1099/mic.0.032615-0; Etxebeste O, 2009, MOL MICROBIOL, V73, P775, DOI 10.1111/j.1365-2958.2009.06804.x; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fainzilber M, 2011, J NEUROSCI, V31, P16045, DOI 10.1523/JNEUROSCI.4006-11.2011; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Fiserova J, 2010, BIOCHEM SOC T, V38, P273, DOI 10.1042/BST0380273; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Garzia A, 2009, MOL MICROBIOL, V71, P172, DOI 10.1111/j.1365-2958.2008.06520.x; GIRBARDT M, 1957, PLANTA, V50, P47, DOI 10.1007/BF01912343; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Hatanaka Y, 2012, DEV GROWTH DIFFER, V54, P398, DOI 10.1111/j.1440-169X.2012.01344.x; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Hood JK, 1998, J BIOL CHEM, V273, P35142, DOI 10.1074/jbc.273.52.35142; Huenniger K, 2010, CELL MOL LIFE SCI, V67, P3187, DOI 10.1007/s00018-010-0378-7; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; KAFER E, 1965, GENETICS, V52, P217; Karpova A, 2012, ADV EXP MED BIOL, V970, P355, DOI 10.1007/978-3-7091-0932-8_16; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Markina-Inarrairaegui A, 2011, MOL BIOL CELL, V22, P3874, DOI 10.1091/mbc.E11-03-0262; Michaelevski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000952; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; OAKLEY BR, 1980, CELL, V19, P255, DOI 10.1016/0092-8674(80)90407-9; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; Pantazopoulou A, 2011, TRAFFIC, V12, P386, DOI 10.1111/j.1600-0854.2011.01164.x; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; Penalva Miguel A, 2012, Cell Logist, V2, P2; Perry RBT, 2009, SEMIN CELL DEV BIOL, V20, P600, DOI 10.1016/j.semcdb.2009.04.014; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Riquelme M, 2013, EUKARYOT CELL; Rodriguez-Galan O, 2009, J BIOL CHEM, V284, P4404, DOI 10.1074/jbc.M808645200; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; Sarpal R, 2002, J BIOSCIENCES, V27, P479, DOI 10.1007/BF02705044; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schuchardt I, 2005, MOL BIOL CELL, V16, P5191, DOI 10.1091/mbc.E05-04-0272; Schuster M, 2012, EMBO J, V31, P214, DOI 10.1038/emboj.2011.361; Schuster M, 2011, MOL BIOL CELL, V22, P3645, DOI [10.1091/E11-03-0217, 10.1091/mbc.E11-03-0217]; Shen Z, 2009, MOL BIOL CELL, V20, P2265, DOI 10.1091/mbc.E08-11-1151; Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384; Smith EF, 2000, CELL MOTIL CYTOSKEL, V46, P157, DOI 10.1002/1097-0169(200007)46:3<157::AID-CM1>3.0.CO;2-D; Smith HMS, 1998, PLANT CELL, V10, P1791, DOI 10.1105/tpc.10.11.1791; Steinberg G, 2007, TRENDS MICROBIOL, V15, P14, DOI 10.1016/j.tim.2006.11.007; Strom AC, 2001, GENOME BIOL, V2; Taheri-Talesh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031218; Tang FS, 2006, TRAFFIC, V7, P1368, DOI 10.1111/j.1600-0854.2006.00458.x; ten Hoopen R, 2012, CURR BIOL, V22, P1075, DOI 10.1016/j.cub.2012.04.059; Thompson BJ, 2013, DEVELOPMENT, V140, P13, DOI 10.1242/dev.083634; Thompson BJ, 2012, EMBO REP, V13, P670, DOI 10.1038/embor.2012.98; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Watson FL, 1999, J NEUROSCI, V19, P7889; Wu CB, 2009, J PROTEOMICS, V72, P46, DOI 10.1016/j.jprot.2008.10.007; Xiang X, 2000, CURR BIOL, V10, P603, DOI 10.1016/S0960-9822(00)00488-7; Xiang X, 1999, CURR GENET, V35, P626, DOI 10.1007/s002940050461; Xiang X, 2004, FUNGAL GENET BIOL, V41, P411, DOI 10.1016/j.fgb.2003.11.010; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; Xiang X, 2012, CURR BIOL, V22, pR496, DOI 10.1016/j.cub.2012.04.044; Xiong Y, 2009, J CELL SCI, V122, P4218, DOI 10.1242/jcs.059196; Yan C, 1997, EMBO J, V16, P3572, DOI 10.1093/emboj/16.12.3572; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Zekert N, 2009, MOL BIOL CELL, V20, P673, DOI 10.1091/mbc.E08-07-0685; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028575; Zupicich J, 2001, GENOME BIOL, V2	85	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85076	10.1371/journal.pone.0085076	http://dx.doi.org/10.1371/journal.pone.0085076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376868	Green Published, gold			2022-12-27	WOS:000328745100197
J	Mercker, M; Hartmann, D; Marciniak-Czochra, A				Mercker, Moritz; Hartmann, Dirk; Marciniak-Czochra, Anna			A Mechanochemical Model for Embryonic Pattern Formation: Coupling Tissue Mechanics and Morphogen Expression	PLOS ONE			English	Article							SURFACE GEOMETRY; DEFORMATION; DYNAMICS; INTERPLAY	Motivated by recent experimental findings, we propose a novel mechanism of embryonic pattern formation based on coupling of tissue curvature with diffusive signaling by a chemical factor. We derive a new mathematical model using energy minimization approach and show that the model generates a variety of morphogen and curvature patterns agreeing with experimentally observed structures The mechanism proposed transcends the classical Turing concept which requires interactions between two morphogens with a significantly different diffusivity. Our studies show how biomechanical forces may replace the elusive long-range inhibitor and lead to formation of stable spatially heterogeneous structures without existence of chemical prepatterns. We propose new experimental approaches to decisively test our central hypothesis that tissue curvature and morphogen expression are coupled in a positive feedback loop.	[Mercker, Moritz; Marciniak-Czochra, Anna] Heidelberg Univ, Inst Appl Math, BioQuant & Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany; [Hartmann, Dirk] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany; [Hartmann, Dirk] Siemens AG, Corp Technol, Munich, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Siemens AG; Siemens Germany	Mercker, M (corresponding author), Heidelberg Univ, Inst Appl Math, BioQuant & Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany.	mmercker_bioscience@gmx.de	Hartmann, Dirk/B-4081-2016	Hartmann, Dirk/0000-0002-6020-1061	ViroQuant Project (German FORSYS initiative); WIN Project of the Heidelberg Academy of Sciences and Humanities; ERC; Emmy Noether Programme of the German Research Council (DFG)	ViroQuant Project (German FORSYS initiative); WIN Project of the Heidelberg Academy of Sciences and Humanities; ERC(European Research Council (ERC)European Commission); Emmy Noether Programme of the German Research Council (DFG)(German Research Foundation (DFG))	The authors acknowledge the financial support of the ViroQuant Project (German FORSYS initiative) and WIN Project "Principles in the generation of the biological form" of the Heidelberg Academy of Sciences and Humanities. MM and AM-C have been supported by the ERC Starting Grant 'Biostruct' and the Emmy Noether Programme of the German Research Council (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beloussov L. V., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P53, DOI 10.1080/1025584021000047641; Beloussov LV, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015009; Beloussov LV, 2006, INT J DEV BIOL, V50, P81, DOI 10.1387/ijdb.052056lb; Braybrook SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057813; Brouzes E, 2004, CURR OPIN GENET DEV, V14, P367, DOI 10.1016/j.gde.2004.06.005; CUMMINGS FW, 1989, J THEOR BIOL, V137, P215, DOI 10.1016/S0022-5193(89)80207-3; Cummings FW, 2001, J THEOR BIOL, V212, P303, DOI 10.1006/jtbi.2001.2377; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Farge E, 2011, CURR TOP DEV BIOL, V95, P243, DOI 10.1016/B978-0-12-385065-2.00008-6; Fernandez-Sanchez ME, 2010, METHOD CELL BIOL, V98, P295, DOI 10.1016/S0091-679X(10)98012-6; FOLTIN G, 1994, PHYS REV E, V49, P5243, DOI 10.1103/PhysRevE.49.5243; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; HAROLD FM, 1995, MICROBIOL-UK, V141, P2765, DOI 10.1099/13500872-141-11-2765; Hartmann D, 2007, THESIS HEIDELBERG U; Hartmann D, 2010, BIOMECH MODEL MECHAN, V9, P1, DOI 10.1007/s10237-009-0154-5; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Holman HA, 2006, MOL BIOL CELL, V17; Keller R, 2012, SCIENCE, V338, P201, DOI 10.1126/science.1230718; Mercker M, 2013, SIAM J APPL MATH, V73, P1768, DOI 10.1137/120885553; Mercker M, 2012, J THEOR BIOL, V301, P67, DOI 10.1016/j.jtbi.2012.01.039; Murray J. D., 2001, MATH BIOL, V18; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Nelson CM, 2011, COMMUNICATION; Soriano J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258102; Soriano J, 2009, BIOPHYS J, V96, P1649, DOI 10.1016/j.bpj.2008.09.062; The I, 2000, NAT CELL BIOL, V2, pE79, DOI 10.1038/35010511; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012	29	27	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82617	10.1371/journal.pone.0082617	http://dx.doi.org/10.1371/journal.pone.0082617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376555	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100045
J	Niarchos, A; Zouridakis, M; Douris, V; Georgostathi, A; Kalamida, D; Sotiriadis, A; Poulas, K; Iatrou, K; Tzartos, SJ				Niarchos, Athanasios; Zouridakis, Marios; Douris, Vassilis; Georgostathi, Assimina; Kalamida, Dimitra; Sotiriadis, Alexandros; Poulas, Konstantinos; Iatrou, Kostas; Tzartos, Socrates J.			Expression of a Highly Antigenic and Native-Like Folded Extracellular Domain of the Human alpha 1 Subunit of Muscle Nicotinic Acetylcholine Receptor, Suitable for Use in Antigen Specific Therapies for Myasthenia Gravis	PLOS ONE			English	Article							MAIN IMMUNOGENIC REGION; PATHOGENIC AUTOANTIBODIES; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; INSECT CELLS; APHERESIS; BINDING; GLYCOSYLATION; BUNGAROTOXIN; PROTEINS	We describe the expression of he extracellular domain of the human alpha 1 nicotinic acetylcholine receptor (nAChFR) in epidopteran insect cells (i-alpha 1-ECD) and its suitability for use in antigen-specific therapies for Myasthenia Gravis MG). Compared to the previously expressed protein in P. pastoris (y-alpha 1-ECD), i-alpha 1-ECD had a 2-fold increased expression yield, bound anti-nAChR monoclonal antibodies and autoantibodies from MG patients two to several-fold more efficiently and resulted in a secondary structure closer to that of the crystal structure of mouse alpha 1-ECD. Our results indicate that i-alpha 1-ECD is an improved protein for use in antigen-specific MG therapeutic strategies.	[Niarchos, Athanasios; Georgostathi, Assimina; Kalamida, Dimitra; Poulas, Konstantinos; Tzartos, Socrates J.] Univ Patras, Dept Pharm, Patras, Greece; [Zouridakis, Marios; Sotiriadis, Alexandros; Tzartos, Socrates J.] Hellenic Pasteur Inst, Dept Biochem, Athens, Greece; [Douris, Vassilis; Iatrou, Kostas] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece	University of Patras; National Centre of Scientific Research "Demokritos"	Poulas, K (corresponding author), Univ Patras, Dept Pharm, Patras, Greece.	kpoulas@upatras.gr; stzartos@gmail.com	Douris, Vassilis/AAG-9423-2020; Poulas, Konstantinos/L-4874-2018	Douris, Vassilis/0000-0003-4608-7482; Zouridakis, Marios/0000-0001-9760-1838; Poulas, Konstantinos/0000-0002-5397-1543	European Commission [242210, 264083]; Greek NSRF "Thalis" Autoimmunity grant	European Commission(European CommissionEuropean Commission Joint Research Centre); Greek NSRF "Thalis" Autoimmunity grant	This work was supported by grants from the European Commission (FP7 FightMG no. 242210, and FP7 REGPOT 2010-1 NeuroSign no. 264083) and the Greek NSRF "Thalis" Autoimmunity grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Douris V, 2006, ADV VIRUS RES, V68, P113, DOI 10.1016/S0065-3527(06)68004-4; ENGEL AG, 2008, CLIN NEUROL, V91, P103; Farrell PJ, 1998, BIOTECHNOL BIOENG, V60, P656, DOI 10.1002/(SICI)1097-0290(19981220)60:6<656::AID-BIT2>3.0.CO;2-9; Juel VC, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-44; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; Keith MBA, 2000, BIOTECHNIQUES, V28, P148, DOI 10.2144/00281rr03; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KUKURUZINSKA MA, 1987, ANNU REV BIOCHEM, V56, P915, DOI 10.1146/annurev.biochem.56.1.915; Lagoumintzis G, 2010, AUTOIMMUNITY, V43, P436, DOI 10.3109/08916930903518099; Lavdas AA, 2010, J NEUROCHEM, V115, P1137, DOI 10.1111/j.1471-4159.2010.07003.x; Parekh R B, 1991, Curr Opin Biotechnol, V2, P730, DOI 10.1016/0958-1669(91)90043-5; Psaridi-Linardaki L, 2002, J BIOL CHEM, V277, P26980, DOI 10.1074/jbc.M110731200; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TZARTOS S, 1986, J NEUROIMMUNOL, V10, P235, DOI 10.1016/0165-5728(86)90105-0; TZARTOS S, 1983, FEBS LETT, V158, P116, DOI 10.1016/0014-5793(83)80688-7; TZARTOS SJ, 1991, AUTOIMMUNITY, V8, P259, DOI 10.3109/08916939109007633; Tzartos SJ, 2008, ANN NY ACAD SCI, V1132, P291, DOI 10.1196/annals.1405.017; Zisimopoulou P, 2008, J NEUROIMMUNOL, V201, P95, DOI 10.1016/j.jneuroim.2008.06.020; Zisimopoulou P, 2008, J NEUROIMMUNOL, V200, P133, DOI 10.1016/j.jneuroim.2008.06.002; ZOURIDAKIS M, 2007, INT J BIOL MACROMOL, V41, P323, DOI DOI 10.1016/J.IJBI0MAC.2007.05.012.PUBMED:17659334	24	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84791	10.1371/journal.pone.0084791	http://dx.doi.org/10.1371/journal.pone.0084791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376846	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100187
J	Taghavian, O; Spiegel, H; Hauck, R; Hafez, HM; Fischer, R; Schillberg, S				Taghavian, Omid; Spiegel, Holger; Hauck, Ruediger; Hafez, Hafez M.; Fischer, Rainer; Schillberg, Stefan			Protective Oral Vaccination against Infectious bursal disease virus Using the Major Viral Antigenic Protein VP2 Produced in Pichia pastoris	PLOS ONE			English	Article							IMMUNE-RESPONSES; CAPSID PROTEIN; IBDV; INTERMEDIATE; IMMUNOGENICITY; IMMUNIZATION; PREVENTION; PARTICLES; CHICKENS; EFFICACY	Infectious bursal disease virus (IBDV) causes economically important immunosuppressive disease in young chickens. The self-assembling capsid protein (VP2) from IBDV strain IR01 was expressed in Pichia pastoris resulting in the formation of homomeric, 23-nm infectious bursal disease subviral particles (IBD-SVPs) with a yield of 76 mg/I before and 38 mg/I after purification. Anti-IBDV antibodies were detected in chickens injected with purified IBD-SVPs or fed with either purified IBD-SVPs or inactivated P. pastoris cells containing IBD-VP2 (cell-encapsulated). Challenge studies using the heterologous classical IBDV strain (M83) showed that intramuscular vaccination with 20 mu g purified IBD-SVPs conferred full protection, achieved complete virus clearance and prevented bursal damage and atrophy, compared with only 40% protection, 0-10% virus clearance accompanied by severe atrophy and substantial bursal damage in mock-vaccinated and challenge controls. The commercial IBDV vaccine also conferred full protection and achieved complete virus clearance, albeit with partial bursal atrophy. Oral administration of 500 mu g purified IBD-SVPs with and without adjuvant conferred 100% protection but achieved only 60% virus clearance with adjuvant and none without it. Moderate bursal damage was observed in both cases but the inclusion of adjuvant resulted in bursal atrophy similar to that observed with live-attenuated vaccine and parenteral administration of 20 pg purified IBD-SVPs. The oral administration of 250 mg P. pastoris cells containing IBD-VP2 resulted in 100% protection with adjuvant and 60% without, accompanied by moderate bursal damage and atrophy in both groups, whereas 25 mg P. pastoris cells containing IBD-VP2 resulted in 90-100% protection with moderate bursal lesions and severe atrophy. Finally, the oral delivery of 50 pg purified IBD-SVPs achieved 40-60% protection with severe bursal lesions and atrophy. Both oral and parenteral administration of yeast-derived IBD-VP2 can therefore induce a specific and protective immune response against IBDV without affecting the growth rate of chickens.	[Taghavian, Omid; Spiegel, Holger; Fischer, Rainer; Schillberg, Stefan] Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany; [Hauck, Ruediger; Hafez, Hafez M.] Free Univ Berlin, Fac Vet Med, Inst Poultry Dis, Berlin, Germany; [Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biotechnol, Aachen, Germany; [Schillberg, Stefan] Univ Giessen, Dept Phytopathol, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany	Fraunhofer Gesellschaft; Free University of Berlin; RWTH Aachen University; Justus Liebig University Giessen	Schillberg, S (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany.	stefan.schillberg@ime.fraunhofer.de	Schillberg, Stefan/I-5449-2013; Schillberg, Stefan/K-4211-2019	Schillberg, Stefan/0000-0002-1896-4575; Hauck, Rudiger/0000-0002-2468-2507	German Academic Exchange Service (DAAD)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The authors acknowledge funding from the German Academic Exchange Service (DAAD) to Omid Taghavian (first author). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042870; AZAD AA, 1991, VACCINE, V9, P715, DOI 10.1016/0264-410X(91)90286-F; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Block H, 2007, AVIAN PATHOL, V36, P401, DOI 10.1080/03079450701589175; Brandt M, 2001, J VIROL, V75, P11974, DOI 10.1128/JVI.75.24.11974-11982.2001; Caston JR, 2001, J VIROL, V75, P10815, DOI 10.1128/JVI.75.22.10815-10828.2001; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Delgui L, 2009, VIROLOGY, V386, P360, DOI 10.1016/j.virol.2008.12.036; FAHEY KJ, 1989, J GEN VIROL, V70, P1473, DOI 10.1099/0022-1317-70-6-1473; ISMAIL NM, 1991, AVIAN DIS, V35, P460, DOI 10.2307/1591208; JACKWOOD DH, 1987, AVIAN DIS, V31, P766, DOI 10.2307/1591028; Jackwood DJ, 2001, AVIAN DIS, V45, P330, DOI 10.2307/1592972; Kumar K, 2000, TROP ANIM HEALTH PRO, V32, P357, DOI 10.1023/A:1005225501513; Lai SY, 2004, PROCESS BIOCHEM, V39, P571, DOI 10.1016/S0032-9592(03)00124-9; Lee MS, 2006, BIOTECHNOL PROGR, V22, P763, DOI 10.1021/bp050426n; Lejal N, 2000, J GEN VIROL, V81, P983, DOI 10.1099/0022-1317-81-4-983; Li JR, 2004, VIROLOGY, V329, P89, DOI 10.1016/j.virol.2004.07.033; Lombardo E, 2000, VIROLOGY, V277, P345, DOI 10.1006/viro.2000.0595; Lukert PD, 1997, DIS POULTRY, P721; MACREADIE IG, 1990, VACCINE, V8, P549, DOI 10.1016/0264-410X(90)90006-8; Mahgoub HA, 2012, ARCH VIROL, V157, P2047, DOI 10.1007/s00705-012-1377-9; Carballeda JM, 2011, IMMUNOBIOLOGY, V216, P1028, DOI 10.1016/j.imbio.2011.03.003; Martinez-Torrecuadrada JL, 2003, VACCINE, V21, P3342, DOI 10.1016/S0264-410X(02)00804-6; Meeusen ENT, 2007, CLIN MICROBIOL REV, V20, P489, DOI 10.1128/CMR.00005-07; Muller H, 2012, AVIAN PATHOL, V41, P133, DOI 10.1080/03079457.2012.661403; Muller H, 2003, VET MICROBIOL, V97, P153, DOI 10.1016/j.vetmic.2003.08.005; Pitcovski J, 2003, VACCINE, V21, P4736, DOI 10.1016/S0264-410X(03)00525-5; Rautenschlein S, 2005, AVIAN DIS, V49, P231, DOI 10.1637/7310-112204R; Rong J, 2005, VACCINE, V23, P4844, DOI 10.1016/j.vaccine.2005.05.015; Shamsara M, 2006, ACTA VIROL, V50, P229; Sharma JM, 2000, DEV COMP IMMUNOL, V24, P223, DOI 10.1016/S0145-305X(99)00074-9; Shaw I, 2000, VACCINE, V18, P3230, DOI 10.1016/S0264-410X(00)00133-X; SNYDER DB, 1990, AVIAN PATHOL, V19, P419, DOI 10.1080/03079459008418695; Taghavian O, 2012, RSC ADV, V2, P1970, DOI [10.1039/C2RA00857B, 10.1039/c2ra00857b]; van den Berg TP, 2000, AVIAN PATHOL, V29, P175, DOI 10.1080/03079450050045431; VASCONCELOS AC, 1994, J GEN VIROL, V75, P1803, DOI 10.1099/0022-1317-75-7-1803; Wu H, 2004, AVIAN DIS, V48, P663, DOI 10.1637/7074; Wu JX, 2007, PLANT BIOTECHNOL J, V5, P570, DOI 10.1111/j.1467-7652.2007.00270.x; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; WYETH P J, 1976, Avian Pathology, V5, P253, DOI 10.1080/03079457608418194; Zhang XF, 2007, VACCINE, V25, P3254, DOI 10.1016/j.vaccine.2007.01.052	41	27	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83210	10.1371/journal.pone.0083210	http://dx.doi.org/10.1371/journal.pone.0083210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376665	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100100
J	Wang, ZH; Peng, H; Kilian, N				Wang, Ze-Huan; Peng, Hua; Kilian, Norbert			Molecular Phylogeny of the Lactuca Alliance (Cichorieae Subtribe Lactucinae, Asteraceae) with Focus on Their Chinese Centre of Diversity Detects Potential Events of Reticulation and Chloroplast Capture	PLOS ONE			English	Article							GROUP-II INTRON; SYNCALATHIUM ASTERACEAE; SEQUENCE ALIGNMENT; NONCODING REGIONS; TIBETAN PLATEAU; GENUS; DNA; EVOLUTION; IDENTIFICATION; AMPLIFICATION	The first comprehensive molecular phylogenetic reconstruction of the Cichorieae subtribe Lactucinae is provided. Sequences for two datasets, one of the nuclear rDNA ITS region, the other of five concatenated non-coding chloroplast DNA markers including the petD region and the psbA-trnH, 5'trnL((UAA))-trnF, rpl32-trnL((UAG)) and trnQ((UUG))-5'rps16 spacers, were, with few exceptions, newly generated for 130 samples of 78 species. The sampling spans the entire subtribe Lactucinae while focusing on its Chinese centre of diversity; more than 3/4 of the Chinese Lactucinae species are represented. The nuclear and plastid phylogenies inferred from the two independent datasets show various hard topological incongruences. They concern the internal topology of major lineages, in one case the placement of taxa in major lineages, the relationships between major lineages and even the circumscription of the subtribe, indicating potential events of ancient as well as of more recent reticulation and chloroplast capture in the evolution of the subtribe. The core of the subtribe is clearly monophyletic, consisting of the six lineages, Cicerbita, Cicerbita II, Lactuca, Melanoseris, Notoseris and Paraprenanthes. The Faberia lineage and the monospecific Prenanthes purpurea lineage are part of a monophyletic subtribe Lactucinae only in the nuclear or plastid phylogeny, respectively. Morphological and karyological support for their placement is considered. In the light of the molecular phylogenetic reconstruction and of additional morphological data, the conflicting taxonomies of the Chinese Lactuca alliance are discussed and it is concluded that the major lineages revealed are best treated at generic rank. An improved species level taxonomy of the Chinese Lactucinae is outlined; new synonymies and some new combinations are provided.	[Wang, Ze-Huan; Peng, Hua] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Wang, Ze-Huan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Kilian, Norbert] Free Univ Berlin, Bot Garden & Bot Museum Berlin Dahlem, Berlin, Germany	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Free University of Berlin	Peng, H (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China.	hpeng@mail.kib.ac.cn; n.kilian@bgbm.org			German Academic Exchange Service (DAAD); Verein der Freunde des BGBM	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Verein der Freunde des BGBM	The authors thank the German Academic Exchange Service (DAAD, four months' research stay of the first author at the Botanic Garden and Botanical Museum Berlin-Dahlem (BGBM)) and the Verein der Freunde des BGBM (lab facilities for the second author). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JF, 2003, MOL PHYLOGENET EVOL, V28, P430, DOI 10.1016/S1055-7903(02)00301-9; [Anonymous], 1988, J SYST EVOL; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Beauverd G., 1910, B SOC BOT GENEVA, V2, P99; BENTHAM G., 1873, GENERA PLANTARUM, V2, P163, DOI DOI 10.5962/BHL.TITLE.747; Blattner FR, 1999, BIOTECHNIQUES, V27, P1180, DOI 10.2144/99276st04; Boissier E, 1879, FLORA ORIENTALIS SIV; Borsch T, 2003, J EVOLUTION BIOL, V16, P558, DOI 10.1046/j.1420-9101.2003.00577.x; Borsch Thomas, 2009, Willdenowia, V39, P7, DOI 10.3372/wi.39.39101; Bremer K., 1994, ASTERACEAE CLADISTIC; Clarke C.B., 1876, COMPOSITAE INDICAE D; Cody ML, 1996, J ECOL, V84, P53, DOI 10.2307/2261699; Comes HP, 2001, EVOLUTION, V55, P1943, DOI 10.1111/j.0014-3820.2001.tb01312.x; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Deng T, 2011, J SYST EVOL, V49, P339, DOI 10.1111/j.1759-6831.2011.00114.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Droege G, 2013, NUCL ACIDS RES; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgeworth M.P., 1846, T LINNEAN SOC LONDON, V20, P23, DOI [10.1111/j.1096-3642.1846.tb00410.x, DOI 10.1111/J.1096-3642.1846.TB00410.X]; Enke N, 2012, ORG DIVERS EVOL, V12, P1, DOI 10.1007/s13127-011-0064-0; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fehrer J, 2007, MOL PHYLOGENET EVOL, V42, P347, DOI 10.1016/j.ympev.2006.07.004; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Ferakova V., 1977, GENUS LACTUCA L EURO; Goertzen LR, 2003, MOL PHYLOGENET EVOL, V29, P216, DOI 10.1016/S1055-7903(03)00094-0; Hand R., 2009, INT CICHORIEAE NETWO; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Harris N, 2006, PALAEOGEOGR PALAEOCL, V241, P4, DOI 10.1016/j.palaeo.2006.07.009; Hoffmann O, 1890, NATURLICHEN PFLANZEN, V4, P87, DOI DOI 10.5962/BHL.TITLE.4635; HOOKER JD, 1882, FLORA BRIT INDIA; JEFFREY C., 1966, KEW BULL, V18, P427, DOI 10.2307/4115797; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; KESSELI R, 1991, GENOME, V34, P430, DOI 10.1139/g91-065; Kilian N., 2009, SYSTEMATICS, P343; Kilian Norbert, 2007, Willdenowia, V37, P283, DOI 10.3372/wi.37.37117; Koopman WJM, 2001, AM J BOT, V88, P1881, DOI 10.2307/3558364; Koopman WJM, 1998, AM J BOT, V85, P1517, DOI 10.2307/2446479; Lack H.W., 2006, FAMILIES GENERA FLOW, V8, P180; Lessing C.F., 1832, SYNOPSIS GENERUM COM, DOI [10.5962/bhl.title.51470, DOI 10.5962/BHL.TITLE.51470]; LIU SW, 2001, ACTA PHYTOTAXONOMICA, V39, P553; Liu Y., 2013, NORD J BOT; Liu Y, 2012, NORD J BOT, V30, P365, DOI 10.1111/j.1756-1051.2011.01305.x; Lohne C, 2005, MOL BIOL EVOL, V22, P317, DOI 10.1093/molbev/msi019; Long DC, 2001, FLORA BHUTAN INCLUDI; Mamgain SK, 1995, FLORA INDIA, P226; Muller K, 2004, MOL PHYLOGENET EVOL, V31, P780, DOI 10.1016/j.ympev.2003.12.006; Muller K, 2010, PHYDER PHYLOGENETIC; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Muller KF, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-58; NAZAROVA E A, 1990, Biologicheskii Zhurnal Armenii, V43, P179; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nylander J. A. A., 2004, MRMODELTEST V2; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; RIESEBERG LH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P171; RIESEBERG LH, 1993, CRIT REV PLANT SCI, V12, P213, DOI 10.1080/713608045; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sennikov A. N., 1997, Botanicheskii Zhurnal (St. Petersburg), V82, P110; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shih C., 1987, ACTA PHYTOTAXON SIN, V25, P189; Shih C, 1997, COMPOSITAE 10 CICHOR; Shih C, 2011, FLORA CHIN 20 21 AST, V20-21, p[195, 211, 325]; Shih C., 1988, ACTA PHYTOTAXON SIN, V26, P382; SHIN, 1991, ACTA PHYTOTAXONOMICA, V29, P394; Simmons MP, 2007, MOL PHYLOGENET EVOL, V44, P724, DOI 10.1016/j.ympev.2007.04.001; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Sojak J, 1961, NOVITATES BOT HORTI, V1961, P33; STEBBINS G. L., 1937, BULL JARD BOT ETAT BRUXELLES, V14, P333, DOI 10.2307/3666566; Stebbins G.L., 1940, MEM TORREY BOT CLUB, V19, P1; Stebbins G.L., 1937, J BOT, V75, P12; STEBBINS G. LEDYARD, 1953, MADRONO, V12, P65; STEBBINS G. LEDYARD, 1939, INDIAN FOREST REC BOT, V1, P237; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thiers B, 2019, INDEX HERBARIORUM GL; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Tremetsberger K, 2013, ORG DIVERS EVOL, V13, P1, DOI 10.1007/s13127-012-0094-2; Tsitrone A, 2003, EVOLUTION, V57, P1776, DOI 10.1111/j.0014-3820.2003.tb00585.x; TUISL G, 1968, Annalen des Naturhistorischen Museums in Wien, V72, P587; Watanabe K, 2012, INDEX CHROMOSOME NUM; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; WHITTON J, 1995, CAN J BOT, V73, P1058, DOI 10.1139/b95-115; WOLFE AD, 1995, SYST BOT, V20, P395, DOI 10.2307/2419800; [袁庆军 Yuan Qingjun], 2002, [西南农业大学学报, Journal of Southwest Agricultural University], V24, P30; Zhang JW, 2011, TAXON, V60, P1678, DOI 10.1002/tax.606012; Zhang JW, 2011, TAXON, V60, P15, DOI 10.1002/tax.601003; Zhang JW, 2009, J SYST EVOL, V47, P226, DOI 10.1111/j.1759-6831.2009.00024.x	91	38	44	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82692	10.1371/journal.pone.0082692	http://dx.doi.org/10.1371/journal.pone.0082692			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376566	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100052
J	Shen, B; He, PJ; Shao, CL				Shen, Bo; He, Pei-Jie; Shao, Chun-Lin			Norcantharidin Induced DU145 Cell Apoptosis through ROS-Mediated Mitochondrial Dysfunction and Energy Depletion	PLOS ONE			English	Article							ORAL-CANCER CELLS; CASPASE; GROWTH; PROLIFERATION; INHIBITION; ACTIVATION; AMPK	Norcantharidin (NCTD), a demethylated analog of cantharidin derived from blister beetles, has attracted considerable attentions in recent years due to their definitely toxic properties and the noteworthy advantages in stimulating bone marrow and increasing the peripheral leukocytes. Hence, it is worth studying the anti-tumor effect of NCTD on human prostate cancer cells DU145. It was found that after the treatment of NCTD with different concentrations (25-100 mu M), the cell proliferation was significantly inhibited, which led to the appearance of micronucleus (MN). Moreover, the cells could be killed in a dose-/ time-dependent manner along with the reduction of PCNA (proliferating cell nuclear antigen) expression, destruction of mitochondrial membrane potential (MMP), down-regulation of MnSOD, induction of ROS, depletion of ATP, and activation of AMPK (Adenosine 5'-monophosphate -activated protein kinase). In addition, a remarkable release of cytochrome c was found in the cells exposed to 100 mu M NCTD and exogenous SOD-PEG could eliminate the generation of NCTD-induced MN. In conclusion, our studies indicated that NCTD could induce the collapse of MMP and mitochondria dysfunction. Accumulation of intercellular ROS could eventually switch on the apoptotic pathway by causing DNA damage and depleting ATP.	[Shen, Bo; Shao, Chun-Lin] Fudan Univ, Inst Radiat Med, Shanghai 200433, Peoples R China; [He, Pei-Jie] Fudan Univ, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Shen, B (corresponding author), Fudan Univ, Inst Radiat Med, Shanghai 200433, Peoples R China.	shenbo@fudan.edu.cn; clshao@shmu.edu.cn		Shao, Chunlin/0000-0001-9336-9912	National Natural Science Foundation of China [11105031]; Youth Foundation of Fudan University of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of Fudan University of China	This study was supported the by the National Natural Science Foundation of China (No. 11105031) (http://www.nsfc.gov.cn/Portal0/default152.html) and the Youth Foundation of Fudan University of China (http://dst.fudan.edu.cn/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An W, 2004, J KOREAN MED SCI, V19, P560, DOI 10.3346/jkms.2004.19.4.560; An WW, 2004, ACTA PHARMACOL SIN, V25, P1502; Bononi Angela, 2011, Enzyme Res, V2011, P329098, DOI 10.4061/2011/329098; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; Chang C, 2011, MOL BIOL REP, V38, P163, DOI 10.1007/s11033-010-0090-6; Chang C, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-145; Chen MB, 2013, CELL SIGNAL, V25, P1993, DOI 10.1016/j.cellsig.2013.05.026; Chen YC, 2009, LIFE SCI, V84, P218, DOI 10.1016/j.lfs.2008.11.020; Chen YJ, 2009, CHEM-BIOL INTERACT, V181, P440, DOI 10.1016/j.cbi.2009.07.004; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Donaghy L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046594; Fan YZ, 2010, HEPATOB PANCREAT DIS, V9, P414; Fan Yue-Zu, 2004, Hepatobiliary Pancreat Dis Int, V3, P603; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gast RE, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-28; He M, 2011, ONCOGENE, V30, P1947, DOI 10.1038/onc.2010.567; Hong CY, 2000, BIOCHEM BIOPH RES CO, V276, P278, DOI 10.1006/bbrc.2000.3341; Huang WW, 2011, INT J ONCOL, V38, P1067, DOI 10.3892/ijo.2011.922; Huang Y, 2009, CYTOTECHNOLOGY, V59, P201, DOI [10.1007/s10616-009-9210-3, 10.1007/s10616-009-9221-0]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Kok SH, 2005, CANCER LETT, V217, P43, DOI 10.1016/j.canlet.2004.07.045; Kok SH, 2003, ORAL ONCOL, V39, P19, DOI 10.1016/S1368-8375(01)00129-4; Kuo JH, 2010, INT J ONCOL, V37, P1243, DOI 10.3892/ijo_00000775; Liao HF, 2007, FOOD CHEM TOXICOL, V45, P1678, DOI 10.1016/j.fct.2007.03.003; Liao HF, 2011, TOXICOL IN VITRO, V25, P206, DOI 10.1016/j.tiv.2010.11.001; LIU XH, 1995, EUR J CANCER, V31A, P953, DOI 10.1016/0959-8049(95)00050-X; Luan JL, 2010, CYTOTECHNOLOGY, V62, P349, DOI 10.1007/s10616-009-9250-8; Meador JA, 2008, ONCOGENE, V27, P5662, DOI 10.1038/onc.2008.187; Miyaguchi Chosei, 2004, Physiological Chemistry and Physics and Medical NMR, V36, P21; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Takeuchi I, 2012, PROSTATE, V72, P1124, DOI 10.1002/pros.22460; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; VERMA A, 1982, PHOTOCHEM PHOTOBIOL, V36, P627, DOI 10.1111/j.1751-1097.1982.tb09482.x; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Wong YT, 2006, FREE RADICAL RES, V40, P393, DOI 10.1080/10715760600556074; Yang PQ, 2010, CHINESE J MED, V45, P11; Yang Yan, 2011, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V19, P594; YI SN, 1991, LEUKEMIA RES, V15, P883, DOI 10.1016/0145-2126(91)90163-N; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027441; Zou J, 2012, GLIA, V60, P661, DOI 10.1002/glia.22302	44	47	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84610	10.1371/journal.pone.0084610	http://dx.doi.org/10.1371/journal.pone.0084610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367681	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900057
J	Li, XX; Shen, YD; Huang, QQ; Fan, ZW; Huang, DD				Li, Xiaoxia; Shen, Yide; Huang, Qiaoqiao; Fan, Zhiwei; Huang, Dongdong			Regeneration Capacity of Small Clonal Fragments of the Invasive Mikania micrantha HBK: Effects of Burial Depth and Stolon Internode Length	PLOS ONE			English	Article							RHIZOME FRAGMENTS; SAND BURIAL; VEGETATIVE REGENERATION; REPENS L; GROWTH; SOIL; SURVIVAL; INTEGRATION; ALLOCATION; RESOURCES	The perennial stoloniferous herbaceous vine Mikania micrantha H. B. K. is among the most noxious exotic invaders in China and the world. Disturbance can fragment stolons of M. micrantha and disperse these fragments over long distances or bury them in soils at different depths. To test their regeneration capacity, single-node stolon fragments with stolon internode lengths of 0, 3, 6 and 12 cm were buried in soil at 0, 2, 5 and 8 cm depths, respectively. The fragments were growing for nine weeks, and their emergence status, growth and morphological traits were measured. The results indicated that increasing burial depth significantly decreased survival rate and increased the emergence time of the M. micrantha plants. At an 8-cm burial depth, very few fragments (2.19%) emerged and survived. Burial did not affect the total biomass and root to shoot ratio of the surviving M. micrantha plants that emerged from the 0- and 2-cm burial depths. Increasing internode length significantly increased survival rate and growth measures, but there was no interaction effect with burial depth for any traits measured. These results suggest that M. micrantha can regenerate from buried stolon fragments, and thus, disturbance may contribute to the spread of this exotic invader. Any human activities producing stolon fragments or facilitating dispersal should be avoided.	[Li, Xiaoxia; Shen, Yide; Huang, Qiaoqiao; Fan, Zhiwei; Huang, Dongdong] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Peoples R China	Chinese Academy of Tropical Agricultural Sciences	Huang, QQ (corresponding author), Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Peoples R China.	Cosplete@126.com; Fanweed@163.com			Provincial Natural Science Found of Hainan [313084]; International Cooperative Project of the Ministry of Science and Technology [2011DFB30040]; Fundamental Research Funds for Environment and Plant Protection Institute, CATAS [2012hzs1J007-1]; Project of Research on and Demonstrations of the Techniques in Monitoring and Managing Herbicide-Resistant Weeds [201303031]; Key Science and Technology Project of Hainan Province [080149]	Provincial Natural Science Found of Hainan; International Cooperative Project of the Ministry of Science and Technology; Fundamental Research Funds for Environment and Plant Protection Institute, CATAS; Project of Research on and Demonstrations of the Techniques in Monitoring and Managing Herbicide-Resistant Weeds; Key Science and Technology Project of Hainan Province	This research is supported by the Provincial Natural Science Found of Hainan (313084), the International Cooperative Project of the Ministry of Science and Technology (2011DFB30040), the Fundamental Research Funds for Environment and Plant Protection Institute, CATAS (2012hzs1J007-1), the Project of Research on and Demonstrations of the Techniques in Monitoring and Managing Herbicide-Resistant Weeds (201303031), and the Key Science and Technology Project of Hainan Province (080149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine H, 2007, WEED BIOL MANAG, V7, P188, DOI 10.1111/j.1445-6664.2007.00255.x; BALDWIN KA, 1983, CAN J BOT, V61, P241, DOI 10.1139/b83-028; Balestri E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072598; BAURHOCH B, 1990, J EXP BOT, V41, P573, DOI 10.1093/jxb/41.5.573; Bimova K, 2003, PLANT ECOL, V166, P1, DOI 10.1023/A:1023299101998; Brown JF, 1997, J ECOL, V85, P151, DOI 10.2307/2960647; Chen BM, 2009, BIOL INVASIONS, V11, P1291, DOI 10.1007/s10530-008-9336-9; Chen JS, 2010, ACTA OECOL, V36, P23, DOI 10.1016/j.actao.2009.09.006; Cordazzo CV, 1999, J COASTAL RES, V15, P520; D'Hertefeldt T, 1998, OIKOS, V81, P229, DOI 10.2307/3547044; D'Ulisse A., 1996, J COAST CONSERV, V2, P3, DOI [10.1007/BF02743032, DOI 10.1007/BF02743032]; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dietz H, 2002, PLANT ECOL, V158, P171, DOI 10.1023/A:1015567316004; Dong BC, 2010, EVOL ECOL, V24, P1447, DOI 10.1007/s10682-010-9390-5; Dong BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013631; Dong B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021012; [范志伟 Fan Zhiwei], 2010, [热带作物学报, Chinese Journal of Tropical Crops], V31, P1596; Feng Hui-ling, 2002, Journal of Tropical and Subtropical Botany, V10, P263; Frosini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047561; Gilbert ME, 2010, AUSTRAL ECOL, V35, P53, DOI 10.1111/j.1442-9993.2009.02011.x; HARRIS D, 1986, J ECOL, V74, P1057, DOI 10.2307/2260233; Henry GM, 2007, WEED SCI, V55, P486, DOI 10.1614/WS-07-030.1; Hou YP, 2011, BIOL INVASIONS, V13, P381, DOI 10.1007/s10530-010-9830-8; Huang QQ, 2009, BIODIVERS CONSERV, V18, P305, DOI 10.1007/s10531-008-9485-2; KLIMES L, 1993, VEGETATIO, V109, P153, DOI 10.1007/BF00044747; Klingeman WE, 2004, HORTSCIENCE, V39, P746; LEAKEY RRB, 1978, ANN BOT-LONDON, V42, P205, DOI 10.1093/oxfordjournals.aob.a085441; Li SL, 2010, TREES-STRUCT FUNCT, V24, P515, DOI 10.1007/s00468-010-0422-0; Li WH, 2006, PLANT SOIL, V281, P309, DOI 10.1007/s11104-005-9641-3; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; Moles AT, 2008, J ECOL, V96, P13, DOI 10.1111/j.1365-2745.2007.01332.x; Moles AT, 2012, J ECOL, V100, P116, DOI 10.1111/j.1365-2745.2011.01915.x; Pan XY, 2007, ACTA PHYTOTAXON SIN, V45, P884, DOI 10.1360/aps06134; Pan Y, 2009, J AQUAT PLANT MANAGE, V47, P96; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ren MX, 2005, WEED RES, V45, P236, DOI 10.1111/j.1365-3180.2005.00445.x; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Shi L, 2004, ANN BOT-LONDON, V94, P553, DOI 10.1093/aob/mch174; Song YB, 2013, BIOL INVASIONS, V15, P1367, DOI 10.1007/s10530-012-0374-y; Suzuki Jun-ichirou, 1999, Plant Species Biology, V14, P11, DOI 10.1046/j.1442-1984.1999.00002.x; SYKES MT, 1990, ACTA BOT NEERL, V39, P171, DOI 10.1111/j.1438-8677.1990.tb01485.x; Wang T, 2008, J HERED, V99, P22, DOI 10.1093/jhered/esm080; Weber E, 2011, BIOL INVASIONS, V13, P2947, DOI 10.1007/s10530-011-9977-y; Yu FH, 2004, NEW PHYTOL, V162, P697, DOI 10.1111/j.1469-8137.2004.01073.x; Yu H, 2009, BIOL INVASIONS, V11, P835, DOI 10.1007/s10530-008-9297-z; YUAN T, 1993, FUNCT ECOL, V7, P676, DOI 10.2307/2390188; ZHANG JH, 1990, CAN J BOT, V68, P304, DOI 10.1139/b90-041; Zhang LY, 2004, WEED RES, V44, P42, DOI 10.1111/j.1365-3180.2003.00371.x	48	23	26	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84657	10.1371/journal.pone.0084657	http://dx.doi.org/10.1371/journal.pone.0084657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367686	Green Submitted, gold, Green Published			2022-12-27	WOS:000328740300153
J	Pandey, RN; Wang, TS; Tadjuidje, E; McDonald, MG; Rettie, AE; Hegde, RS				Pandey, Ram Naresh; Wang, Tim Sen; Tadjuidje, Emmanuel; McDonald, Matthew G.; Rettie, Allan E.; Hegde, Rashmi S.			Structure-Activity Relationships of Benzbromarone Metabolites and Derivatives as EYA Inhibitory Anti-Angiogenic Agents	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; EYES ABSENT; DRUG-INTERACTIONS; CANCER; DEPHOSPHORYLATION; PROLIFERATION; SURVIVAL; MARKET; MODEL; 1B	The tyrosine phosphatase activity of the phosphatase-transactivator protein Eyes Absent (EYA) is angiogenic through its roles in endothelial cell migration and tube formation. Benzbromarone, a known anti-gout agent, was previously identified as an inhibitor of EYA with anti-angiogenic properties. Here we show that the major metabolite of BBR, 6-hydroxy benzbromarone, is a significantly more potent inhibitor of cell migration, tubulogenesis and angiogenic sprouting. In contrast, other postulated metabolites of BBR such as 5-hydroxy benzbromaorne and 1'-hydroxy benzbromarone are less potent inhibitors of EYA tyrosine phosphatase activity as well as being less effective in cellular assays for endothelial cell migration and angiogenesis. Longer substituents at the 2 position of the benzofuran ring promoted EYA3 binding and inhibition, but were less effective in cellular assays, likely reflecting nonspecific protein binding and a resulting reduction in free, bio-available inhibitor. The observed potency of 6-hydroxy benzbromarone is relevant in the context of the potential re-purposing of benzbromarone and its derivatives as anti-angiogenic agents. 6-hydroxy benzbromarone represents a metabolite with a longer half-life and greater pharmacological potency than the parent compound, suggesting that biotransformation of benzbromarone could contribute to its therapeutic activity.	[Pandey, Ram Naresh; Wang, Tim Sen; Tadjuidje, Emmanuel; Hegde, Rashmi S.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [McDonald, Matthew G.; Rettie, Allan E.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	Cincinnati Children's Hospital Medical Center; University of Washington; University of Washington Seattle	Hegde, RS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	rashmi.hegde@cchmc.org		Wang, Tim/0000-0001-5518-508X	National Institutes of Health, National Eye Institute [R01 EY014648]; NATIONAL EYE INSTITUTE [R01EY022917, R01EY014648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032165] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Eye Institute [Grant R01 EY014648]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; DEVRIES JX, 1993, CLIN INVESTIGATOR, V71, P947; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Farabaugh SM, 2012, ONCOGENE, V31, P552, DOI 10.1038/onc.2011.259; Jansen TLTA, 2004, CLIN EXP RHEUMATOL, V22, P651; Krishnan N, 2009, J BIOL CHEM, V284, P16066, DOI 10.1074/jbc.C900032200; Lee MHH, 2008, DRUG SAFETY, V31, P643, DOI 10.2165/00002018-200831080-00002; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Locuson CW, 2003, DRUG METAB DISPOS, V31, P967, DOI 10.1124/dmd.31.7.967; Malamas MS, 2000, J MED CHEM, V43, P1293, DOI 10.1021/jm990560c; McDonald MG, 2012, CLIN PHARMACOL THER, V91, P709, DOI 10.1038/clpt.2011.283; McDonald MG, 2007, CHEM RES TOXICOL, V20, P1833, DOI 10.1021/tx7001228; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Rayapureddi JP, 2005, BIOCHEMISTRY-US, V44, P751, DOI 10.1021/bi0481794; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Reed MJ, 2007, MICROVASC RES, V73, P248, DOI 10.1016/j.mvr.2007.02.002; Robin TP, 2012, MOL CANCER RES, V10, P1098, DOI 10.1158/1541-7786.MCR-12-0086; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tadjuidje E, 2013, CELL MOL LIFE SCI, V70, P1897, DOI 10.1007/s00018-012-1144-9; Tadjuidje E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034806; Takahashi H, 1999, CLIN PHARMACOL THER, V66, P569, DOI 10.1016/S0009-9236(99)90064-4; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Trujillo TC, 2000, DRUG SAFETY, V23, P509, DOI 10.2165/00002018-200023060-00003; Uchida S, 2010, DRUG METAB PHARMACOK, V25, P605, DOI 10.2133/dmpk.DMPK-10-NT-040; WALTERSACK I, 1990, EUR J CLIN PHARMACOL, V39, P577, DOI 10.1007/BF00316099; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wrobel J, 1999, J MED CHEM, V42, P3199, DOI 10.1021/jm990260v; Wu KM, 2013, CANCER RES, V73, P4488, DOI 10.1158/0008-5472.CAN-12-4078; Zhang L, 2005, CANCER RES, V65, P925	34	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84582	10.1371/journal.pone.0084582	http://dx.doi.org/10.1371/journal.pone.0084582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367676	Green Published, gold, Green Submitted			2022-12-27	WOS:000328740300148
J	Chen, LC; Lee, WS				Chen, Li-Ching; Lee, Wen-Sen			Estradiol Reduces Ferrous Citrate Complex-Induced NOS2 Up-Regulation in Cerebral Endothelial Cells by Interfering the Nuclear Factor Kappa B Transactivation through an Estrogen Receptor beta-Mediated Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; ACUTE BRAIN-INJURY; OXIDATIVE STRESS; VASOSPASM; IRON; ACTIVATION; TRANSCRIPTION; MECHANISMS; EXPRESSION	Hemorrhagic stroke caused leakage of red blood cells which converts to hemoglobin, heme, and iron accumulated at the lesions. High concentration of ferrous iron from subarachnoid hemorrhage (SAH) induced cerebral vasospasm. Using the two-hemorrhage SAH model in rats, we previously demonstrated that estradiol (E2) significantly attenuated the SAH-induced vasospasm by inhibiting the NOS2 expression. Adding ferrous citrate (FC) complexes to the primary cultured mouse cerebral endothelial cells (CEC) to mimic the SAH conditions, we also showed that FC up-regulates NOS2 through nuclear translocation of NFkB induced by free radicals generation. Here, we further studied the molecular mechanism underlying E2-mediated reduction of the FC-induced up-regulation of NOS2. Treatment with E2 (100 nM) reduced the FC (100 mu M)-induced increases of free radical generation and the levels of NOS2 mRNA and protein in the CEC. Moreover, E2 also prevented the FC-induced increases of I kappa B alpha phosphorylation, NF kappa B nuclear translocation, NF kappa B binding onto the NOS2 promoter, and the NOS2 promoter luciferase activity. However, knock-down the estrogen receptor beta (ER beta), but not ER alpha, abolished the E2-mediated prevention on the FC-induced increases of NOS2 mRNA and protein. The data from the present study suggest that E2 inhibited NOS2 gene expression by interfering with NF kappa B nuclear translocation and NF kappa B binding onto the NOS2 through an ER beta-mediated pathway. Our results provide the molecular basis for designing the applicable therapeutic or preventive strategies in the treatment SAH patients.	[Chen, Li-Ching; Lee, Wen-Sen] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ, Dept Physiol, Coll Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University	Lee, WS (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan.	wslee@tmu.edu.tw			National Science Council [NSC 101-2320-B-038-005, NSC 101-2629-B-037-001]	National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council grant NSC 101-2320-B-038-005 and NSC 101-2629-B-037-001 to Dr. Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladag MA, 2009, NEUROCHEM RES; Asano T, 1999, CRIT REV NEUROSURG, V9, P303, DOI 10.1007/s003290050147; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Barros MH, 2003, FREE RADICAL BIO MED, V35, P179, DOI 10.1016/S0891-5849(03)00307-1; Berra L V, 2007, J Neurosurg Sci, V51, P1; Bertuglia S, 2005, ADV EXP MED BIOL, V566, P23; Bidmon HJ, 2001, EXP NEUROL, V168, P1, DOI 10.1006/exnr.2000.7456; Bishop GM, 2001, BRAIN RES, V907, P175, DOI 10.1016/S0006-8993(01)02303-4; Chen C. S., 2010, BREAST CANC RES TREA; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Chen LC, 2009, J AGR FOOD CHEM, V57, P7331, DOI 10.1021/jf901477g; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Clark JF, 2006, J CEREBR BLOOD F MET, V26, P1223, DOI 10.1038/sj.jcbfm.9600280; de Rooij NK, 2007, J NEUROL NEUROSURG P; Deshpande R, 1997, AM J REPROD IMMUNOL, V38, P46; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; EDWARDS DH, 1992, J NEUROSURG, V76, P830, DOI 10.3171/jns.1992.76.5.0830; Evans MJ, 2001, CIRC RES, V89, P823, DOI 10.1161/hh2101.098543; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Grasso G, 2004, BRAIN RES REV, V44, P49, DOI 10.1016/j.brainresrev.2003.10.003; Hanggi D, 2006, ACTA NEUROCHIR, V148, P605, DOI 10.1007/s00701-005-0721-1; Harnish DC, 2000, ENDOCRINOLOGY, V141, P3403, DOI 10.1210/en.141.9.3403; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Ho PY, 2006, MOL CANCER THER, V5, P3130, DOI 10.1158/1535-7163.MCT-06-0457; Horky LL, 1998, J NEUROSURG, V88, P298, DOI 10.3171/jns.1998.88.2.0298; Ishimaru H, 1996, BRAIN RES, V726, P23, DOI 10.1016/0006-8993(96)00294-6; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Keshari RS, 2013, J CELL BIOCHEM, V114, P532, DOI 10.1002/jcb.24391; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; Kuo PC, 2000, GASTROENTEROLOGY, V118, P608, DOI 10.1016/S0016-5085(00)70268-X; Kwan AL, 1997, ACTA NEUROCHIR, V139, P240, DOI 10.1007/BF01844759; Li XD, 2004, AM J PHYSIOL-HEART C, V287, pH588, DOI 10.1152/ajpheart.01176.2003; Love B B, 1994, Hawaii Med J, V53, P258; LUO ZY, 1995, NEUROSURGERY, V37, P1154, DOI 10.1227/00006123-199512000-00015; Mocco J, 2006, Neurosurg Focus, V21, pE9; Mukhopadhyay S, 2005, BBA-MOL CELL RES, V1745, P145, DOI 10.1016/j.bbamcr.2005.03.010; Ong WY, 2005, REPROD NUTR DEV, V45, P647, DOI 10.1051/rnd:2005051; Ono S, 1998, HUM GENE THER, V9, P1003, DOI 10.1089/hum.1998.9.7-1003; ONOUE H, 1995, J NEUROSURG, V83, P510, DOI 10.3171/jns.1995.83.3.0510; Osuka K, 2009, J NEUROTRAUMA; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Ql WN, 2004, MICROSURG, V24, P316, DOI 10.1002/micr.20030; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothoerl RD, 2007, NEUROL RES, V29, P636, DOI 10.1179/016164107X240224; Sehba FA, 2006, NEUROL RES, V28, P381, DOI 10.1179/016164106X114991; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Shih HC, 2006, STROKE, V37, P3025, DOI 10.1161/01.STR.0000249008.18669.5a; Shih YL, 2010, J AGR FOOD CHEM, V58, P235, DOI 10.1021/jf9031684; Stice JP, 2012, SHOCK, V38, P128, DOI 10.1097/SHK.0b013e31825da754; Stirone C, 2005, MOL PHARMACOL, V68, P959, DOI 10.1124/mol.105.014662; Suhardja A, 2004, NAT CLIN PRACT CARD, V1, P110, DOI 10.1038/ncpcardio0046; Suzuki H, 2003, STROKE, V34, P2796, DOI 10.1161/01.STR.0000103743.62248.12; Utkan T, 1996, PHARMACOLOGY, V52, P353, DOI 10.1159/000139402; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Vijay A, 2006, NEUROL RES, V28, P759, DOI 10.1179/016164106X152034; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Xu J, 2000, STROKE, V31, P1744, DOI 10.1161/01.STR.31.7.1744; Young HM, 1997, HISTOCHEM CELL BIOL, V107, P19, DOI 10.1007/s004180050085; Zhou ML, 2007, J CEREBR BLOOD F MET, V27, P1583, DOI 10.1038/sj.jcbfm.9600456	62	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e84320	10.1371/journal.pone.0084320	http://dx.doi.org/10.1371/journal.pone.0084320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376801	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000145
J	Lam, MMY; Martin-Creuzburg, D; Rothhaupt, KO; Safi, K; Yohannes, E; Salvarina, I				Lam, Monika My-Y; Martin-Creuzburg, Dominik; Rothhaupt, Karl-Otto; Safi, Kamran; Yohannes, Elizabeth; Salvarina, Ioanna			Tracking Diet Preferences of Bats Using Stable Isotope and Fatty Acid Signatures of Faeces	PLOS ONE			English	Article							MYOTIS-DAUBENTONII; FOOD; INSECTS; SPECIALIZATION; MARINE; LAKE	Stable isotope and fatty acid signatures of biomaterials can provide important information about the dietary niche of animals. Stable isotope and fatty acid signatures differ between aquatic and terrestrial food webs, and therefore can be used to assess the aquatic and terrestrial contributions to the diets of species. We studied faecal samples of three co-occurring bat species with known differences in feeding preferences. The aim was to assess whether stable isotope and fatty acid signatures of faeces can be used to determine feeding preferences. We used bat faeces because they can be easily and non-invasively collected. We hypothesised that faeces stable isotope and fatty acid signatures will reveal the terrestrial, aquatic and mixed feeding niches of Myotis myotis, M. daubentonii, and M. mystacinus, respectively. As predicted, the faeces of M. myotis were characterized by higher delta C-13 values and higher concentrations of linoleic acid and total omega 6 polyunsaturated fatty acids (PUFAs), which are typically higher in terrestrial food webs. The faeces of M. daubentonii had higher delta N-15 values and higher concentrations of docosahexaenoic acid and total omega 3 PUFAs, characteristic features of aquatic systems. Myotis mystacinus faeces had intermediate delta N-15 values and concentrations of both types of fatty acids. Our results show that analysing stable isotope and/or fatty acid signatures of faeces provides a promising, non-invasive tool to study the feeding ecology of bats and to assess aquatic-terrestrial interactions.	[Lam, Monika My-Y; Martin-Creuzburg, Dominik; Rothhaupt, Karl-Otto; Yohannes, Elizabeth; Salvarina, Ioanna] Univ Konstanz, Limnol Inst, Constance, Germany; [Safi, Kamran] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Safi, Kamran] Univ Konstanz, Dept Biol, Constance, Germany	University of Konstanz; Max Planck Society; University of Konstanz	Salvarina, I (corresponding author), Univ Konstanz, Limnol Inst, Constance, Germany.	Ioanna.Salvarina@uni-konstanz.de	Safi, Kamran/B-2079-2008; Martin-Creuzburg, Dominik/C-6361-2011; Yohannes, Elizabeth/AAM-4457-2020	Safi, Kamran/0000-0002-8418-6759; Martin-Creuzburg, Dominik/0000-0002-4248-0730; Salvarina, Ioanna/0000-0002-9354-4095	Limnological Institute, University of Konstanz, Germany; International Max Planck Research School for Organismal Biology (IMPRS)	Limnological Institute, University of Konstanz, Germany; International Max Planck Research School for Organismal Biology (IMPRS)	The study was funded by the Limnological Institute, University of Konstanz, Germany. IS was partially funded by the International Max Planck Research School for Organismal Biology (IMPRS http://www.orn.mpg.de/2453/Short_portrait). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdennadher A, 2011, ENVIRON MONIT ASSESS, V175, P677, DOI 10.1007/s10661-010-1560-y; Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; BARCLAY RMR, 1991, CAN J ZOOL, V69, P1853, DOI 10.1139/z91-256; Bat Conservation Trust, 2007, BAT SURV GOOD PRACT; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Brack V, 2001, ACTA CHIROPTEROL, V3, P203; Brenna JT, 2011, MATERN CHILD NUTR, V7, P59, DOI 10.1111/j.1740-8709.2011.00301.x; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; CHANMUGAM P, 1983, J FOOD SCI, V48, P1440, DOI 10.1111/j.1365-2621.1983.tb03511.x; Cryan PM, 2012, J MAMMAL, V93, P381, DOI 10.1644/11-MAMM-S-162.1; DESMARAIS DJ, 1980, GEOCHIM COSMOCHIM AC, V44, P2075, DOI 10.1016/0016-7037(80)90205-7; Encarnacao JA, 2010, CAN J ZOOL, V88, P1192, DOI 10.1139/Z10-085; Encarnacao JA, 2006, EUR J WILDLIFE RES, V52, P221, DOI 10.1007/s10344-006-0046-2; Fontaneto D, 2011, ECOL FOOD NUTR, V50, P351, DOI 10.1080/03670244.2011.586316; FRANCE RL, 1994, MAR ECOL PROG SER, V115, P205, DOI 10.3354/meps115205; Fry B, 2011, LIMNOL OCEANOGR, V56, P1563, DOI 10.4319/lo.2011.56.5.1563; Grey J, 2004, FRESHWATER BIOL, V49, P681, DOI 10.1111/j.1365-2427.2004.01217.x; IUCN, 2013, IUCN RED LIST THREAT; Keith M. L., 1964, Geochimica et Cosmochimica Acta, V28, P1757, DOI 10.1016/0016-7037(64)90021-3; Koussoroplis AM, 2008, LIPIDS, V43, P461, DOI 10.1007/s11745-008-3166-5; Kruger F, 2012, ACTA CHIROPTEROL, V14, P347, DOI 10.3161/150811012X661666; Martin-Creuzburg D, 2009, P R SOC B, V276, P1805, DOI 10.1098/rspb.2008.1540; McGuire LP, 2013, J EXP BIOL, V216, P800, DOI 10.1242/jeb.072868; Melo BES, 2012, BRAZ J BIOL, V72, P181, DOI 10.1590/S1519-69842012000100022; Morales M., 2010, SCIPLOT SCI GRAPHING; Napolitano GE, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P21; Nehlich O, 2010, J ARCHAEOL SCI, V37, P1131, DOI 10.1016/j.jas.2009.12.013; Olsen Y, 1999, LIPIDS FRESHWATER EC, p[4, 161], DOI [10.1007/978-1-4612-0547-0_9, DOI 10.1007/978-1-4612-0547-0_]; Paetzold A, 2005, ECOSYSTEMS, V8, P748, DOI 10.1007/s10021-005-0004-y; Painter ML, 2009, CAN J ZOOL, V87, P865, DOI 10.1139/Z09-075; Parrish CC, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P4; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Popa-Lisseanu AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030388; Privat KL, 2007, J ARCHAEOL SCI, V34, P1197, DOI 10.1016/j.jas.2006.10.008; R Development Core Team, 2012, R LANG ENV STAT COMP; Raikow DF, 2011, ECOL APPL, V21, P983, DOI 10.1890/09-1504.1; Ramos R, 2012, FRONT ECOL ENVIRON, V10, P258, DOI 10.1890/110140; Richards MP, 2003, INT J OSTEOARCHAEOL, V13, P37, DOI 10.1002/oa.654; Safi K, 2004, CONSERV BIOL, V18, P1293, DOI 10.1111/j.1523-1739.2004.00155.x; Salvarina I, 2013, RAPID COMMUN MASS SP, V27, P1945, DOI 10.1002/rcm.6649; Siemers BM, 2001, ACTA CHIROPTEROL, V3, P71; SMUKALLA R, 1988, HYDROBIOLOGIA, V169, P149, DOI 10.1007/BF00007307; Sullivan JC, 2006, ECOSCIENCE, V13, P11, DOI 10.2980/1195-6860(2006)13[11:MDFCAN]2.0.CO;2; Torres-Ruiz M, 2007, J N AM BENTHOL SOC, V26, P509, DOI 10.1899/06-070.1; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Venables WN., 2002, MODERN APPL STAT S 4; Voigt CC, 2003, J EXP BIOL, V206, P1419, DOI 10.1242/jeb.00274; Voigt CC, 2009, BIOTROPICA, V41, P271, DOI 10.1111/j.1744-7429.2009.00509.x; Walters DM, 2008, ECOL APPL, V18, P1835, DOI 10.1890/08-0354.1; Wickramasinghe LP, 2004, CONSERV BIOL, V18, P1283, DOI 10.1111/j.1523-1739.2004.00152.x; Zortéa M., 2003, Braz. J. Biol., V63, P159, DOI 10.1590/S1519-69842003000100020	52	29	29	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83452	10.1371/journal.pone.0083452	http://dx.doi.org/10.1371/journal.pone.0083452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376703	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000088
J	Lin, L; Hutzen, B; Lee, HF; Peng, ZG; Wang, WL; Zhao, CQ; Lin, HJ; Sun, D; Li, PK; Li, CL; Korkaya, H; Wicha, MS; Lin, J				Lin, Li; Hutzen, Brian; Lee, Hsiu-Fang; Peng, Zhengang; Wang, Wenlong; Zhao, Chongqiang; Lin, Huey-Jen; Sun, Duxin; Li, Pui-Kai; Li, Chenglong; Korkaya, Hasan; Wicha, Max S.; Lin, Jiayuh			Evaluation of STAT3 Signaling in ALDH plus and ALDH+/CD44+/CD24-Subpopulations of Breast Cancer Cells	PLOS ONE			English	Article							SMALL-MOLECULE; STEM-CELLS; ACTIVATION; TRANSCRIPTION-3; EXPRESSION; RESISTANCE; TARGETS	Background: STAT3 activation is frequently detected in breast cancer and this pathway has emerged as an attractive molecular target for cancer treatment. Recent experimental evidence suggests ALDH-positive (ALDH(+)), or cell surface molecule CD44-positive (CD44(+)) but CD24-negative (CD24(-)) breast cancer cells have cancer stem cell properties. However, the role of STAT3 signaling in ALDH(+) and ALDH(+)/CD44(+)/CD24(-) subpopulations of breast cancer cells is unknown. Methods and Results: We examined STAT3 activation in ALDH(+) and ALDH(+)/CD44(+)/CD24(-) subpopulations of breast cancer cells by sorting with flow cytometer. We observed ALDH-positive (ALDH(+)) cells expressed higher levels of phosphorylated STAT3 compared to ALDH-negative (ALDH(-)) cells. There was a significant correlation between the nuclear staining of phosphorylated STAT3 and the expression of ALDH1 in breast cancer tissues. These results suggest that STAT3 is activated in ALDH(+) subpopulations of breast cancer cells. STAT3 inhibitors Stattic and LLL12 inhibited STAT3 phosphorylation, reduced the ALDH(+) subpopulation, inhibited breast cancer stem-like cell viability, and retarded tumorisphere-forming capacity in vitro. Similar inhibition of STAT3 phosphorylation, and breast cancer stem cell viability were observed using STAT3 ShRNA. In addition, LLL12 inhibited STAT3 downstream target gene expression and induced apoptosis in ALDH(+) subpopulations of breast cancer cells. Furthermore, LLL12 inhibited STAT3 phosphorylation and tumor cell proliferation, induced apoptosis, and suppressed tumor growth in xenograft and mammary fat pad mouse models from ALDH(+) breast cancer cells. Similar in vitro and tumor growth in vivo results were obtained when ALDH(+) cells were further selected for the stem cell markers CD44(+) and CD24(-). Conclusion: These studies demonstrate an important role for STAT3 signaling in ALDH(+) and ALDH(+)/CD44(+) /CD24(-) subpopulations of breast cancer cells which may have cancer stem cell properties and suggest that pharmacologic inhibition of STAT3 represents an effective strategy to selectively target the cancer stem cell-like subpopulation.	[Lin, Li; Wang, Wenlong; Zhao, Chongqiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Cardiol,Dept Internal Med, Wuhan 430074, Hubei, Peoples R China; [Lin, Li; Hutzen, Brian; Lin, Jiayuh] Nationwide Childrens Hosp, Dept Pediat, Res Inst, Ctr Childhood Canc, Columbus, OH USA; [Hutzen, Brian; Lin, Jiayuh] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Lee, Hsiu-Fang; Sun, Duxin] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Peng, Zhengang; Lin, Huey-Jen] Sch Allied Med Profess, Med Technol Div, Columbus, OH USA; [Lin, Huey-Jen] Univ Delaware, Coll Hlth Sci, Dept Med Lab Sci, Newark, DE USA; [Li, Pui-Kai; Li, Chenglong] Ohio State Univ, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Korkaya, Hasan; Wicha, Max S.] Univ Michigan, Ctr Comprehens Canc, Dept Internal Med, Ann Arbor, MI 48109 USA	Huazhong University of Science & Technology; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; University of Delaware; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan	Lin, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Cardiol,Dept Internal Med, Wuhan 430074, Hubei, Peoples R China.	linlee271227@163.com; lin.674@osu.edu	Korkaya, Hasan/GRY-1016-2022; Korkaya, Hasan/ABD-6282-2020; Sun, Duxin/AAA-1774-2022; Wicha, Max/AAE-7268-2019	Korkaya, Hasan/0000-0002-0719-5862; Li, Pui Kai/0000-0002-4831-7213	Department of Defense [BC073892]; Susan G. Komen Breast Cancer Foundation [KG081123]; National Natural Science Foundation of China [81001005]; NATIONAL CANCER INSTITUTE [R01CA129765] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partly supported by Start-up fund to Jiayuh Lin and funds from the Department of Defense (BC073892), the Susan G. Komen Breast Cancer Foundation (KG081123) to Huey-Jen L. Lin, and supported by National Natural Science Foundation of China (81001005) to Li Lin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bhasin D, 2008, BIOORG MED CHEM LETT, V18, P391, DOI 10.1016/j.bmcl.2007.10.031; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buettner R, 2002, CLIN CANCER RES, V8, P945; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Dave B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030207; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Douville J, 2009, STEM CELLS DEV, V18, P17, DOI 10.1089/scd.2008.0055; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Germain D, 2007, CLIN CANCER RES, V13, P5665, DOI 10.1158/1078-0432.CCR-06-2491; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Landen CN, 2007, CANCER RES, V67, P10389, DOI 10.1158/0008-5472.CAN-07-0858; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Marotta LL, 2011, J CLIN INVEST, V121, P44745, DOI DOI 10.41172/JC144745; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Villalva C, 2011, INT J CANCER, V128, P826, DOI 10.1002/ijc.25416; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674	36	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82821	10.1371/journal.pone.0082821	http://dx.doi.org/10.1371/journal.pone.0082821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V44GX	24376586	gold, Green Published, Green Submitted			2022-12-27	WOS:000209738600001
J	Nespoulet, H; Rupp, T; Bachasson, D; Tamisier, R; Wuyam, B; Levy, P; Verges, S				Nespoulet, Hugo; Rupp, Thomas; Bachasson, Damien; Tamisier, Renaud; Wuyam, Bernard; Levy, Patrick; Verges, Samuel			Positive Expiratory Pressure Improves Oxygenation in Healthy Subjects Exposed to Hypoxia	PLOS ONE			English	Article							ACUTE MOUNTAIN-SICKNESS; NEAR-INFRARED SPECTROSCOPY; ALTITUDE PULMONARY-EDEMA; AIRWAY PRESSURE; BREATHING PATTERN; CARDIAC-OUTPUT; EXERCISE; ILLNESS; VENTILATION; DYSPNEA	Introduction: Positive end-expiratory pressure (PEEP) is commonly used in critical care medicine to improve gas exchange. Altitude sickness is associated with exaggerated reduction in arterial oxygenation. We assessed the effect of PEEP and pursed lips breathing (PLB) on arterial and tissue oxygenation under normobaric and hypobaric hypoxic conditions. Methods: Sixteen healthy volunteers were exposed to acute normobaric hypoxia (Laboratory study, FiO(2)=0.12). The protocol consisted in 3-min phases with PEEPs of 0, 5 or 10 cmH(2)O, PLB or similar ventilation than with PEEP-10, interspaced with 3-min phases of free breathing. Arterial (pulse oximetry) and quadriceps (near-infrared spectroscopy) oxygenation, ventilation, cardiac function, esophageal and gastric pressures and subjects' subjective perceptions were recorded continuously. In addition, the effect of PEEP on arterial oxygenation was tested at 4,350 m of altitude in 9 volunteers breathing for 20 min with PEEP-10 (Field study). Results: During the laboratory study, PEEP-10 increased arterial and quadriceps oxygenation (arterial oxygen saturation +5.6 +/- 5.0% and quadriceps oxyhemoglobin +58 +/- 73 mu mol. cm compared to free breathing; p<0.05). Conversely, PLB did not increase oxygenation. Oxygenation improvement with PEEP-10 was accompanied by an increase in expiratory esophageal and gastric pressures (esophageal pressure swing +5.4 +/- 3.2 cmH(2)O, p<0.05) but no change in minute ventilation, breathing pattern, end-tidal CO2 or cardiac function (all p>0.05) compared to PEEP-0. During the field study, PEEP-10 increased arterial oxygen saturation by +6.7 +/- 6.0% after the 3rd minute with PEEP-10 without further significant increase until the 20th minute with PEEP-10. Subjects did not report any significant discomfort with PEEP. Conclusions: These data indicate that 10-cmH(2)O PEEP significantly improves arterial and muscle oxygenation under both normobaric and hypobaric hypoxic conditions in healthy subjects. PEEP-10 could be an attractive non-pharmacological tool to limit blood oxygen desaturation and possibly symptoms at altitude.	[Nespoulet, Hugo; Rupp, Thomas; Bachasson, Damien; Tamisier, Renaud; Wuyam, Bernard; Levy, Patrick; Verges, Samuel] INSERM, U1042, Grenoble, France; [Nespoulet, Hugo; Rupp, Thomas; Bachasson, Damien; Tamisier, Renaud; Wuyam, Bernard; Levy, Patrick; Verges, Samuel] Univ Grenoble Alpes, Hypoxia Physiopathol Lab HP2, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Verges, S (corresponding author), INSERM, U1042, Grenoble, France.	sverges@chu-grenoble.fr	Bachasson, Damien/U-4233-2019; LEVY, Patrick/AAX-2802-2020; wuyam, bernard MF/M-7438-2014; Tamisier, Renaud/M-6858-2014; Verges, Samuel/M-7040-2014; Bachasson, Damien/ABC-1705-2020	LEVY, Patrick/0000-0003-3174-7935; Tamisier, Renaud/0000-0003-1128-6529; Verges, Samuel/0000-0002-0831-9222; Bachasson, Damien/0000-0001-6335-9916	scientific council of AGIRadom	scientific council of AGIRadom	The present study was funded by the scientific council of AGIRadom (http://www.agiradom.com/spip.php?article35). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni P, 2010, EUR HEART J, V31, P457, DOI 10.1093/eurheartj/ehp472; Aguilaniu B, 2008, EUR RESPIR J, V31, P1091, DOI 10.1183/09031936.00063207; Bouzat P, 2013, RESP PHYSIOL NEUROBI, V186, P16, DOI 10.1016/j.resp.2012.12.009; Burtscher M, 2004, HIGH ALT MED BIOL, V5, P335, DOI 10.1089/ham.2004.5.335; Charloux A, 2000, EUR J APPL PHYSIOL, V82, P313, DOI 10.1007/s004210000226; Da Costa NP, 2011, CRIT CARE MED, V39, P2283, DOI 10.1097/CCM.0b013e3182227fce; Di Marco F, 2010, CRIT CARE MED, V38, P127, DOI 10.1097/CCM.0b013e3181b4a7e7; Dongelmans DA, 2012, MINERVA ANESTESIOL, V78, P790; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Ferrari M, 2011, PHILOS T R SOC A, V369, P4577, DOI 10.1098/rsta.2011.0230; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; LARSON EB, 1985, LANCET, V1, P371; Launay JC, 2004, SCAND J WORK ENV HEA, V30, P322, DOI 10.5271/sjweh.801; Luecke T, 2005, CRIT CARE, V9, P607, DOI 10.1186/cc3877; Millet GP, 2012, J APPL PHYSIOL, V112, P1783, DOI 10.1152/japplphysiol.00067.2012; MUELLER RE, 1970, J APPL PHYSIOL, V28, P784, DOI 10.1152/jappl.1970.28.6.784; Nespoulet H, 2012, EUR RESPIR J, V40, P673, DOI 10.1183/09031936.00073111; Nield MA, 2007, J CARDIOPULM REHABIL, V27, P237; Reissmann HK, 2000, INTENS CARE MED, V26, P1764, DOI 10.1007/s001340000725; Richalet JP, 2012, AM J RESP CRIT CARE, V185, P192, DOI 10.1164/rccm.201108-1396OC; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Savourey G, 1998, EUR J APPL PHYSIOL O, V77, P32; Savourey G, 2001, AVIAT SPACE ENVIR MD, V72, P21; SCHOENE RB, 1985, CHEST, V87, P330, DOI 10.1378/chest.87.3.330; Spahija J, 2005, CHEST, V128, P640, DOI 10.1378/chest.128.2.640; Tannheimer M, 2009, SLEEP BREATH, V13, P195, DOI 10.1007/s11325-008-0237-z; Ugalde V, 2000, ARCH PHYS MED REHAB, V81, P472, DOI 10.1053/mr.2000.3790; Yasuma F, 2004, CHEST, V125, P683, DOI 10.1378/chest.125.2.683	28	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85219	10.1371/journal.pone.0085219	http://dx.doi.org/10.1371/journal.pone.0085219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376872	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000180
J	Watanabe, H; Kohaya, N; Kamoshita, M; Fujiwara, K; Matsumura, K; Hyon, SH; Ito, J; Kashiwazaki, N				Watanabe, Hitomi; Kohaya, Natsuki; Kamoshita, Maki; Fujiwara, Katsuyoshi; Matsumura, Kazuaki; Hyon, Suong-Hyu; Ito, Junya; Kashiwazaki, Naomi			Efficient Production of Live Offspring from Mouse Oocytes Vitrified with a Novel Cryoprotective Agent, Carboxylated epsilon-poly-L-lysine	PLOS ONE			English	Article							HIGH DEVELOPMENTAL RATES; IN-VITRO; ETHYLENE-GLYCOL; BOVINE OOCYTES; VITRIFICATION; CRYOPRESERVATION; EMBRYOS; CELLS; POLYAMPHOLYTES	In cryopreservation of mammalian germ cells, unfertilized oocytes are one of the most available stages because these cryopreserved oocytes can be used for assisted reproductive technologies, including in vitro fertilization (IVF) and intracytoplasmic sperm injection. However, it has been generally reported that the fertility and developmental ability of the oocytes are reduced by cryopreservation. Therefore further improvement will be required. Very recently, a new cryoprotective agent (CPA), called as carboxylated epsilon-poly-L-lysine (COOH-PLL), has been developed to reduce physical and physiological damage by cryopreservation in mammalian stem cells. However, it is unclear the effect of COOH-PLL on fertility and developmental ability of vitrified oocytes. In this study, we used COOH-PLL as a CPA with ethylene glycol (EG) for vitrification of mouse oocytes. Cumulus-oocyte complexes (COCs) were collected from ICR mice and then vitrified with Cryotop using different concentration of COOH-PLL and EG. A combined treatment with COOH-PLL and EG showed high survival rate (more than 90%) of vitrified-warmed COCs after in vitro fertilization. In addition, the fertility and developmental ability of COCs vitrified with E20P10 [EG 20% (v/v) and COOH-PLL 10% (w/v)] or E15P15 group (EG 15% and COOH-PLL 15%) were significantly higher than those with E10P20 (EG10% and COOH-PLL 20%) or P30 group (PLL30%). The vitrified COCs in E20P10 group developed to term at a high success rate (46.2%) and it was significantly higher than that in control (E30) group (34.8%). Our present study demonstrated for the first time that COOH-PLL is effective for vitrification of mouse oocytes.	[Watanabe, Hitomi; Kohaya, Natsuki; Kamoshita, Maki; Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Sch Vet Med, Lab Anim Reprod, Sagamihara, Kanagawa, Japan; [Fujiwara, Katsuyoshi; Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Grad Sch Vet Sci, Sagamihara, Kanagawa, Japan; [Matsumura, Kazuaki] Japan Adv Inst Sci & Technol, Nomi, Ishikawa, Japan; [Hyon, Suong-Hyu] Kyoto Inst Technol, Ctr Fiber & Text Sci, Matsugasaki, Kyoto, Japan	Azabu University; Azabu University; Japan Advanced Institute of Science & Technology (JAIST); Kyoto Institute of Technology	Ito, J (corresponding author), Azabu Univ, Sch Vet Med, Lab Anim Reprod, Sagamihara, Kanagawa, Japan.	itoj@azabu-u.ac.jp	Matsumura, Kazuaki/I-1627-2014	Matsumura, Kazuaki/0000-0001-9484-3073	JSPS (KAKENHI) [25242050, 22658085, 24780272]; Azabu University Research Services Division; JSPS [2410249]; Grants-in-Aid for Scientific Research [12J10249] Funding Source: KAKEN	JSPS (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Azabu University Research Services Division; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from JSPS (KAKENHI, 25242050 to SHH and KM, 22658085 to NK and 24780272 to JI). This research was partially supported by a research project grant awarded by the Azabu University Research Services Division to JI and NK. This study is also partially supported by JSPS research fellowship (2410249) to KF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dinnyes A, 2000, BIOL REPROD, V63, P513, DOI 10.1095/biolreprod63.2.513; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Ito J, 2010, J REPROD ENG, V13, P21; Ito J, 2010, ANIM SCI J, V81, P34, DOI 10.1111/j.1740-0929.2009.00699.x; Kohaya N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058063; Kohaya N, 2011, J REPROD DEVELOP, V57, P675, DOI 10.1262/jrd.11-066H; Kuwayama M, 2008, FERTIL STERIL, V90, P281; Leibo SP, 2008, THERIOGENOLOGY, V69, P37, DOI 10.1016/j.theriogenology.2007.10.006; Maehara M, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-58; Martino A, 1996, MOL REPROD DEV, V45, P503, DOI 10.1002/(SICI)1098-2795(199612)45:4&lt;503::AID-MRD13&gt;3.0.CO;2-X; Matsumura K, 2011, CRYOBIOLOGY, V63, P76, DOI 10.1016/j.cryobiol.2011.05.003; Matsumura K, 2010, CELL TRANSPLANT, V19, P691, DOI 10.3727/096368910X508780; Matsumura K, 2009, BIOMATERIALS, V30, P4842, DOI 10.1016/j.biomaterials.2009.05.025; MOCHIDA K, 1987, B ENVIRON CONTAM TOX, V38, P151, DOI 10.1007/BF01606573; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Shaw JM, 1997, CRYOBIOLOGY, V35, P219, DOI 10.1006/cryo.1997.2043; Sheehan CB, 2006, HUM REPROD, V21, P2978, DOI 10.1093/humrep/del253; SONGSASEN N, 1995, CRYOBIOLOGY, V32, P78, DOI 10.1006/cryo.1995.1007; TAKESHIMA T, 1991, EXP ANIM TOKYO, V40, P493, DOI 10.1538/expanim1978.40.4_493; Whittingham D G, 1971, J Reprod Fertil Suppl, V14, P7; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	22	23	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83613	10.1371/journal.pone.0083613	http://dx.doi.org/10.1371/journal.pone.0083613			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376724	Green Submitted, gold, Green Published			2022-12-27	WOS:000328882000102
J	Brockmann, MD; Kukovic, M; Schonfeld, M; Sedlacik, J; Hanganu-Opatz, IL				Brockmann, Marco D.; Kukovic, Maja; Schoenfeld, Michael; Sedlacik, Jan; Hanganu-Opatz, Ileana L.			Hypoxia-Ischemia Disrupts Directed Interactions within Neonatal Prefrontal-Hippocampal Networks	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; PERIVENTRICULAR LEUKOMALACIA; BRAIN-DAMAGE; NEURODEVELOPMENTAL OUTCOMES; MATERNAL-BEHAVIOR; SUBPLATE NEURONS; SPINDLE BURSTS; CORTEX; INJURY; TERM	Due to improved survival rates and outcome of human infants experiencing a hypoxic-ischemic episode, cognitive dysfunctions have become prominent. They might result from abnormal communication within prefrontal-hippocampal networks, as synchrony and directed interactions between the prefrontal cortex and hippocampus account for mnemonic and executive performance. Here, we elucidate the structural and functional impact of hypoxic-ischemic events on developing prefrontal-hippocampal networks in an immature rat model of injury. The magnitude of infarction, cell loss and astrogliosis revealed that an early hypoxic-ischemic episode had either a severe or a mild/moderate outcome. Without affecting the gross morphology, hypoxia-ischemia with mild/moderate outcome diminished prefrontal neuronal firing and gamma network entrainment. This dysfunction resulted from decreased coupling synchrony within prefrontal-hippocampal networks and disruption of hippocampal theta drive. Thus, early hypoxia-ischemia may alter the functional maturation of neuronal networks involved in cognitive processing by disturbing the communication between the neonatal prefrontal cortex and hippocampus.	[Brockmann, Marco D.; Kukovic, Maja; Hanganu-Opatz, Ileana L.] Univ Med Ctr Hamburg Eppendorf, Dev Neurophysiol, Hamburg, Germany; [Schoenfeld, Michael; Sedlacik, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Neuroradiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hanganu-Opatz, IL (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dev Neurophysiol, Hamburg, Germany.	hangop@zmnh.uni-hamburg.de			Emmy Noether-Program of German Research Foundation [Ha4466/3-1]; German Ministry of Education and Research [01GQ0809]	Emmy Noether-Program of German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Emmy Noether-Program of German Research Foundation (Ha4466/3-1 to ILH-O) and the German Ministry of Education and Research (01GQ0809 to ILH-O). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALLEVA E, 1989, J COMP PSYCHOL, V103, P83, DOI 10.1037/0735-7036.103.1.83; Allin M, 2004, DEV MED CHILD NEUROL, V46, P46, DOI 10.1017/S0012162204000088; Anderson KL, 2010, CEREB CORTEX, V20, P1604, DOI 10.1093/cercor/bhp223; Aylward EH, 2003, NEUROLOGY, V61, P212, DOI 10.1212/01.WNL.0000068363.05974.64; Aylward GP, 2005, J DEV BEHAV PEDIATR, V26, P427, DOI 10.1097/00004703-200512000-00008; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Brockmann MD, 2011, NEURON, V71, P332, DOI 10.1016/j.neuron.2011.05.041; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; BROWN MA, 1995, CLIN EXP PHARMACOL P, V22, P781, DOI 10.1111/j.1440-1681.1995.tb01937.x; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Catalano SM, 1998, SCIENCE, V281, P559, DOI 10.1126/science.281.5376.559; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Colgin LL, 2011, CURR OPIN NEUROBIOL, V21, P467, DOI 10.1016/j.conb.2011.04.006; Cui J, 2008, NEURAL NETWORKS, V21, P1094, DOI 10.1016/j.neunet.2008.05.007; Davies DLBDW, 2013, IEEE PATTERN ANAL MA, V1, P224; de Vries LS, 2010, ARCH DIS CHILD-FETAL, V95, pF220, DOI 10.1136/adc.2008.148205; Delcour M, 2012, BRAIN PATHOL, V22, P1, DOI 10.1111/j.1750-3639.2011.00504.x; Deng WB, 2010, NAT REV NEUROL, V6, P328, DOI 10.1038/nrneurol.2010.53; Ding L, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3670; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Fan LW, 2005, BEHAV BRAIN RES, V165, P80, DOI 10.1016/j.bbr.2005.06.033; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Frye RE, 2009, DEV NEUROPSYCHOL, V34, P254, DOI 10.1080/87565640902805727; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Hanganu IL, 2002, J NEUROSCI, V22, P7165; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; Haynes RL, 2008, PEDIATR RES, V63, P656, DOI 10.1203/PDR.0b013e31816c825c; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Inder T, 1999, J PEDIATR-US, V134, P631, DOI 10.1016/S0022-3476(99)70251-9; Janiesch PC, 2011, J NEUROSCI, V31, P17955, DOI 10.1523/JNEUROSCI.2644-11.2011; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kinney HC, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/295389; KOSTOVIC I, 1980, J NEUROCYTOL, V9, P219, DOI 10.1007/BF01205159; Kruger HS, 2012, NEUROBIOL LEARN MEM, V97, P470, DOI 10.1016/j.nlm.2012.04.001; Lindstrom K, 2006, PEDIATR NEUROL, V35, P268, DOI 10.1016/j.pediatrneurol.2006.05.003; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Maneru C, 2001, BRAIN INJURY, V15, P1029, DOI 10.1080/02699050110074178; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Mayoral SR, 2009, PEDIATR RES, V66, P248, DOI 10.1203/PDR.0b013e3181b1bc34; McQuillen PS, 2003, J NEUROSCI, V23, P3308; Meng SZ, 1997, BRAIN DEV-JPN, V19, P480, DOI 10.1016/S0387-7604(97)00068-5; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Northington FJ, 2006, ILAR J, V47, P32, DOI 10.1093/ilar.47.1.32; Oakden E, 2002, PEDIATR RES, V52, P692, DOI 10.1203/01.PDR.0000032070.60058.BB; Parent MA, 2010, CEREB CORTEX, V20, P393, DOI 10.1093/cercor/bhp108; Raz S, 2012, J INT NEUROPSYCH SOC, V18, P200, DOI 10.1017/S1355617711001767; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; ROBERTSON CMT, 1993, CLIN PERINATOL, V20, P483, DOI 10.1016/S0095-5108(18)30405-6; RUTHERFORD MA, 1995, NEUROPEDIATRICS, V26, P183, DOI 10.1055/s-2007-979751; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Sasaoka N, 2009, ACTA ANAESTH SCAND, V53, P46, DOI 10.1111/j.1399-6576.2008.01822.x; Schwindel CD, 2011, PROG BRAIN RES, V193, P163, DOI 10.1016/B978-0-444-53839-0.00011-9; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; SHARPE RM, 1975, ANIM BEHAV, V23, P551, DOI 10.1016/0003-3472(75)90132-3; Shigematsu Y, 1999, JMRI-J MAGN RESON IM, V10, P939; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sizonenko SV, 2008, INT J DEV NEUROSCI, V26, P37, DOI 10.1016/j.ijdevneu.2007.08.014; Sizonenko SV, 2005, PEDIATR RES, V57, P865, DOI 10.1203/01.PDR.0000157673.36848.67; Sizonenko SV, 2003, PEDIATR RES, V54, P263, DOI 10.1203/01.PDR.0000072517.01207.87; Spath H, 2013, CLUSTER ANAL ALGORIT; Stone BS, 2008, ANN NEUROL, V64, P535, DOI 10.1002/ana.21517; SWANSON LW, 1981, BRAIN RES, V217, P150, DOI 10.1016/0006-8993(81)90192-X; TAKASHIMA S, 1978, ARCH NEUROL-CHICAGO, V35, P11, DOI 10.1001/archneur.1978.00500250015003; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Towfighi J, 1997, DEV BRAIN RES, V100, P149, DOI 10.1016/S0165-3806(97)00036-9; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; VANEDEN CG, 1985, J COMP NEUROL, V241, P253, DOI 10.1002/cne.902410302; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P81, DOI 10.1159/000085978; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Woodward LJ, 2005, BRAIN, V128, P2578, DOI 10.1093/brain/awh618	84	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83074	10.1371/journal.pone.0083074	http://dx.doi.org/10.1371/journal.pone.0083074			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376636	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100085
J	Daya, M; van der Merwe, L; Galal, U; Moller, M; Salie, M; Chimusa, ER; Galanter, JM; van Helden, PD; Henn, BM; Gignoux, CR; Hoal, E				Daya, Michelle; van der Merwe, Lize; Galal, Ushma; Moeller, Mario; Salie, Muneeb; Chimusa, Emile R.; Galanter, Joshua M.; van Helden, Paul D.; Henn, Brenna M.; Gignoux, Chris R.; Hoal, Eileen			A Panel of Ancestry Informative Markers for the Complex Five-Way Admixed South African Coloured Population	PLOS ONE			English	Article							DETERMINING CONTINENTAL ORIGIN; HUMAN GENETIC SUSCEPTIBILITY; ASSOCIATION; STRATIFICATION; TUBERCULOSIS; DIVERSITY; ADMIXTURE; CANCER; POLYMORPHISMS; INFERENCE	Admixture is a well known confounder in genetic association studies. If genome-wide data is not available, as would be the case for candidate gene studies, ancestry informative markers (AIMs) are required in order to adjust for admixture. The predominant population group in the Western Cape, South Africa, is the admixed group known as the South African Coloured (SAC). A small set of AIMs that is optimized to distinguish between the five source populations of this population (African San, African non-San, European, South Asian, and East Asian) will enable researchers to cost-effectively reduce false-positive findings resulting from ignoring admixture in genetic association studies of the population. Using genome-wide data to find SNPs with large allele frequency differences between the source populations of the SAC, as quantified by Rosenberg et. al's -statistic, we developed a panel of AIMs by experimenting with various selection strategies. Subsets of different sizes were evaluated by measuring the correlation between ancestry proportions estimated by each AIM subset with ancestry proportions estimated using genome-wide data. We show that a panel of 96 AIMs can be used to assess ancestry proportions and to adjust for the confounding effect of the complex five-way admixture that occurred in the South African Coloured population.	[Daya, Michelle; van der Merwe, Lize; Moeller, Mario; Salie, Muneeb; van Helden, Paul D.; Hoal, Eileen] Univ Stellenbosch, Fac Med & Hlth Sci, MRC Ctr Mol & Cellular Biol, ZA-7505 Tygerberg, South Africa; [Daya, Michelle; van der Merwe, Lize; Moeller, Mario; Salie, Muneeb; van Helden, Paul D.; Hoal, Eileen] Univ Stellenbosch, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, ZA-7505 Tygerberg, South Africa; [van der Merwe, Lize; Galal, Ushma] MRC, Biostat Unit, Tygerberg, South Africa; [van der Merwe, Lize] Univ Western Cape, Dept Stat, Cape Town, South Africa; [Chimusa, Emile R.] Univ Cape Town, Sch Med, Computat Biol Grp, Dept Clin Lab Sci,Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Galanter, Joshua M.; Gignoux, Chris R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Henn, Brenna M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; University of the Western Cape; University of Cape Town; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hoal, E (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, MRC Ctr Mol & Cellular Biol, ZA-7505 Tygerberg, South Africa.	egvh@sun.ac.za	Moller, Marlo/AAC-6973-2020; van der Merwe, Lize/C-9445-2013; Emile Rugamika, Chimusa/T-3048-2017	Moller, Marlo/0000-0002-0805-6741; Salie, Muneeb/0000-0002-7980-0048; van der Merwe, Lize/0000-0001-9705-8126; Emile Rugamika, Chimusa/0000-0001-8846-2047; Hoal, Eileen/0000-0002-6444-5688	National Research Foundation (NRF) National Bioinformatics Functional Programme; NRF DAAD Scholarships; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL111636] Funding Source: NIH RePORTER	National Research Foundation (NRF) National Bioinformatics Functional Programme; NRF DAAD Scholarships; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work was provided by the National Research Foundation (NRF) National Bioinformatics Functional Programme (http://hicd.nrfac.za/?q=node/11) and NRF DAAD Scholarships (http://www.nrEac.za/funding_overview.php?fid=190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2011, EUR J HUM GENET, V19, P676, DOI 10.1038/ejhg.2011.1; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2013, PEOPLES SO AFRICA TH; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Barreiro LB, 2007, HUM IMMUNOL, V68, P106, DOI 10.1016/j.humimm.2006.10.020; Bensmail C, 2012, EFFICIENT ALGORITHMS; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Chimusa ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073971; Chimusa ER, 2013, HUMAN MOL GENETICS; Collins-Schramm HE, 2004, HUM GENET, V114, P263, DOI 10.1007/s00439-003-1058-6; Dandara C, 2005, CANCER LETT, V225, P275, DOI 10.1016/j.canlet.2004.11.004; de Wit E, 2010, MAMM GENOME, P1; de Wit E, 2010, HUM GENET, V128, P145, DOI 10.1007/s00439-010-0836-1; Fernandez P, 2008, CARCINOGENESIS, V29, P2347, DOI 10.1093/carcin/bgn245; Galanter JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002554; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; JORDE LB, 1995, AM J HUM GENET, V57, P523; Keegan Tim., 1996, COLONIAL S AFRICA OR; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lao O, 2006, AM J HUM GENET, V78, P680, DOI 10.1086/501531; Lehohla P., 2012, 030141 STAT S AFR; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Moller M, 2010, AM J RESP CRIT CARE, V181, P388, DOI 10.1164/rccm.200905-0678OC; Moller M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-154; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Moller M, 2009, TUBERCULOSIS, V89, P189, DOI 10.1016/j.tube.2008.10.001; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; Mountain A., 2003, 1 PEOPLE CAPE; Mountain A, 2004, UNSUNG HERITAGE; Nassir R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-39; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Patterson N, 2010, HUM MOL GENET, V19, P411, DOI 10.1093/hmg/ddp505; Phillips C, 2007, FORENSIC SCI INT-GEN, V1, P273, DOI 10.1016/j.fsigen.2007.06.008; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014; Rayner BL, 2003, J HYPERTENS, V21, P921, DOI 10.1097/00004872-200305000-00016; Rosenberg NA, 2005, J COMPUT BIOL, V12, P1183, DOI 10.1089/cmb.2005.12.1183; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Shell R, 1994, CHILDREN BONDAGE; Shriver Mark D, 2004, Hum Genomics, V1, P274; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Viljoen DL, 2001, ALCOHOL CLIN EXP RES, V25, P1719; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wu CQ, 2011, ANN HUM GENET, V75, P418, DOI 10.1111/j.1469-1809.2010.00639.x	53	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82224	10.1371/journal.pone.0082224	http://dx.doi.org/10.1371/journal.pone.0082224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376522	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100020
J	Joshua, CJ; Perez, LD; Keasling, JD				Joshua, Chijioke J.; Perez, Luis D.; Keasling, Jay D.			Functional Characterization of the Origin of Replication of pRN1 from Sulfolobus islandicus REN1H1	PLOS ONE			English	Article							ROLLING-CIRCLE REPLICATION; PLASMID PRN1; HYPERTHERMOPHILIC ARCHAEON; MODEL ORGANISMS; DNA; ACIDOCALDARIUS; SOLFATARICUS; SEQUENCE; GENE; GENOME	Plasmid pRN1 from Sulfolc)bus islandicus REN1H1 is believed to replicate by a rolling circle mechanism but its origin and mechanism of replication are not well understood. We sought to create minimal expression vectors based on pRN1 that would be useful for heterologous gene expression in S. acidocaidarius, and n the process improve our understanding of the mechanism of replication. We constructed and transformed shuttle vectors that harbored different contiguous stretches of DNA from pFZNI1 into S. aciclocaidarius E4-39, a uracil ataxotropli. A 232-bp region of orf904 was found to be critical for pRN1 replication and is therefore proposed to be the putative origin of replication. This 232-bp region contains a 100-bp stem-loop structure believed to be the double-strand origin of replication. The loop of the 100-bp structure contains a GTG tri-nucleotide motif, a feature that was previously reported to be important for the primase activity of 0rf904. This putative origin and the associated orf56 and orf904 ere identified as the minimal replicon of pRN1 because transforrnants of plasmids lacking any of these three eatures were not recovered. Plasmids lacking orf904 and or156 but harboring the putative origin were transformable hen orf904 and orf56 were provided in-trans; a 75-bp region 5' of the 011904 start codon was found to be essential or this complementation. Detailed knowledge of he pRN1 origin of replication will broaden the application of the plasmid as a genetic tool for Suffo/obtis species.	[Joshua, Chijioke J.; Keasling, Jay D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Perez, Luis D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Joshua, Chijioke J.; Perez, Luis D.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Joshua, Chijioke J.; Perez, Luis D.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	Keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088	United States Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-ACO2-05CH11231]	United States Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was part of the Department of Energy Joint BioEnergy Institute (http://vvww.jbei.org) supported by the United States Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-ACO2-05CH11231 between Lawrence Berkeley National Laboratory and the United States Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGAARD C, 1994, J BACTERIOL, V176, P7744, DOI 10.1128/JB.176.24.7744-7747.1994; Beck K, 2007, NUCLEIC ACIDS RES, V35, P5635, DOI 10.1093/nar/gkm625; Beck K, 2010, NUCLEIC ACIDS RES, V38, P6707, DOI 10.1093/nar/gkq447; Berkner S, 2008, ARCH MICROBIOL, V190, P217, DOI 10.1007/s00203-008-0392-4; Berkner S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm449; Berkner S, 2007, J BACTERIOL, V189, P1711, DOI 10.1128/JB.01586-06; Berkner S, 2010, EXTREMOPHILES, V14, P249, DOI 10.1007/s00792-010-0304-9; CAMMARANO P, 1985, EMBO J, V4, P811, DOI 10.1002/j.1460-2075.1985.tb03702.x; Cannio R, 1998, J BACTERIOL, V180, P3237, DOI 10.1128/JB.180.12.3237-3240.1998; Chen LM, 2005, J BACTERIOL, V187, P4992, DOI 10.1128/JB.187.14.4992-4999.2005; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; GENNARO ML, 1989, J MOL BIOL, V205, P355, DOI 10.1016/0022-2836(89)90346-X; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grogan DW, 2003, J BACTERIOL, V185, P4657, DOI 10.1128/JB.185.15.4657-4661.2003; GROGAN DW, 1989, J BACTERIOL, V171, P6710, DOI 10.1128/jb.171.12.6710-6719.1989; GRUSS AD, 1987, P NATL ACAD SCI USA, V84, P2165, DOI 10.1073/pnas.84.8.2165; Hatzinikolaou DG, 2001, WORLD J MICROB BIOT, V17, P229, DOI 10.1023/A:1016675924997; Jonuscheit M, 2003, MOL MICROBIOL, V48, P1241, DOI 10.1046/j.1365-2958.2003.03509.x; Joshua CJ, 2011, J BACTERIOL, V193, P1293, DOI 10.1128/JB.01219-10; Keeling PJ, 1996, PLASMID, V35, P141, DOI 10.1006/plas.1996.0016; Khan SA, 2005, PLASMID, V53, P126, DOI 10.1016/j.plasmid.2004.12.008; Khan SA, 1997, MICROBIOL MOL BIOL R, V61, P442, DOI 10.1128/.61.4.442-455.1997; Kletzin A, 1999, GENETICS, V152, P1307; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Kurosawa N, 2005, FEMS MICROBIOL LETT, V253, P141, DOI 10.1016/j.femsle.2005.09.031; Leigh JA, 2011, FEMS MICROBIOL REV, V35, P577, DOI 10.1111/j.1574-6976.2011.00265.x; Lipps G, 2001, NUCLEIC ACIDS RES, V29, P904, DOI 10.1093/nar/29.4.904; Lipps G, 2009, BIOCHEM SOC T, V37, P42, DOI 10.1042/BST0370042; MAGASANIK B, 1961, COLD SPRING HARB SYM, V26, P249, DOI 10.1101/SQB.1961.026.01.031; Mamie ZL, 2007, SLIC SUBCLONING USIN; Peng X, 2000, J MOL BIOL, V303, P449, DOI 10.1006/jmbi.2000.4160; Reilly MS, 2001, J BACTERIOL, V183, P2943, DOI 10.1128/JB.183.9.2943-2946.2001; Sanchez M, 2009, NUCLEIC ACIDS RES, V37, P6831, DOI 10.1093/nar/gkp742; Schelert J, 2004, J BACTERIOL, V186, P427, DOI 10.1128/JB.186.2.427-437.2004; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Solar G, 1993, MOL GEN GENETICS MGG, V241, P97; Wagner M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00214; Wagner M, 2009, BIOCHEM SOC T, V37, P97, DOI 10.1042/BST0370097; Zhao AC, 1997, MOL MICROBIOL, V24, P535, DOI 10.1046/j.1365-2958.1997.3641730.x; Zhao AC, 1996, J BACTERIOL, V178, P5222, DOI 10.1128/jb.178.17.5222-5228.1996; ZILLIG W, 1994, SYST APPL MICROBIOL, V16, P609; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e84664	10.1371/journal.pone.0084664	http://dx.doi.org/10.1371/journal.pone.0084664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376833	gold, Green Published, Green Submitted			2022-12-27	WOS:000328745100181
J	Licata, SC; Shinday, NM; Huizenga, MN; Darnell, SB; Sangrey, GR; Rudolph, U; Rowlett, JK; Sadri-Vakili, G				Licata, Stephanie C.; Shinday, Nina M.; Huizenga, Megan N.; Darnell, Shayna B.; Sangrey, Gavin R.; Rudolph, Uwe; Rowlett, James K.; Sadri-Vakili, Ghazaleh			Alterations in Brain-Derived Neurotrophic Factor in the Mouse Hippocampus Following Acute but Not Repeated Benzodiazepine Treatment	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; LONG-TERM POTENTIATION; C-FOS EXPRESSION; BDNF GENE; GABA(A) RECEPTORS; RAT HIPPOCAMPUS; MESSENGER-RNA; IMMUNOCYTOCHEMICAL DISTRIBUTION; HISTONE ACETYLATION; DIAZEPAM	Benzodiazepines (BZs) are safe drugs for treating anxiety, sleep, and seizure disorders, but their use also results in unwanted effects including memory impairment, abuse, and dependence. The present study aimed to reveal the molecular mechanisms that may contribute to the effects of BZs in the hippocampus (HIP), an area involved in drug-related plasticity, by investigating the regulation of immediate early genes following BZ administration. Previous studies have demonstrated that both brain derived neurotrophic factor (BDNF) and c-Fos contribute to memory-and abuse-related processes that occur within the HIP, and their expression is altered in response to BZ exposure. In the current study, mice received acute or repeated administration of BZs and HIP tissue was analyzed for alterations in BDNF and c-Fos expression. Although no significant changes in BDNF or c-Fos were observed in response to twice-daily intraperitoneal (i.p.) injections of diazepam (10 mg/kg + 5 mg/kg) or zolpidem (ZP; 2.5 mg/kg + 2.5 mg/kg), acute i.p. administration of both triazolam (0.03 mg/kg) and ZP (1.0 mg/kg) decreased BDNF protein levels within the HIP relative to vehicle, without any effect on c-Fos. ZP specifically reduced exon IV-containing BDNF transcripts with a concomitant increase in the association of methyl-CpG binding protein 2 (MeCP2) with BDNF promoter IV, suggesting that MeCP2 activity at this promoter may represent a ZP-specific mechanism for reducing BDNF expression. ZP also increased the association of phosphorylated cAMP response element binding protein (pCREB) with BDNF promoter I. Future work should examine the interaction between ZP and DNA as the cause for altered gene expression in the HIP, given that BZs can enter the nucleus and intercalate into DNA directly.	[Licata, Stephanie C.; Rudolph, Uwe] McLean Hosp, Belmont, MA 02178 USA; [Shinday, Nina M.; Rowlett, James K.] New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Huizenga, Megan N.; Darnell, Shayna B.; Sangrey, Gavin R.; Sadri-Vakili, Ghazaleh] Massachusetts Gen Hosp, Charlestown, MA 02114 USA; [Licata, Stephanie C.; Shinday, Nina M.; Huizenga, Megan N.; Darnell, Shayna B.; Sangrey, Gavin R.; Rudolph, Uwe; Rowlett, James K.; Sadri-Vakili, Ghazaleh] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; McLean Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sadri-Vakili, G (corresponding author), Massachusetts Gen Hosp, Charlestown, MA 02114 USA.	gsadrivakili@partners.org			National Institutes of Health [DA011792, AG035361, RR000168/OD011103, DA015036, DA033795]; NATIONAL INSTITUTE ON AGING [R01AG035361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033795, T32DA015036, R01DA011792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded collectively by the National Institutes of Health (http://www.nih.gov/) grants DA011792, AG035361, RR000168/OD011103, DA015036, and DA033795. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Alme Maria Nordheim, 2007, Neural Plast, V2007, P26496, DOI 10.1155/2007/26496; BABA A, 1983, J NEUROCHEM, V40, P280, DOI 10.1111/j.1471-4159.1983.tb12683.x; BALKIN TJ, 1992, PSYCHOPHARMACOLOGY, V107, P83, DOI 10.1007/BF02244970; Balu DT, 2008, BRAIN RES, V1211, P37, DOI 10.1016/j.brainres.2008.03.023; BENAVIDES J, 1988, J PHARMACOL EXP THER, V245, P1033; BERNINGER B, 1995, DEVELOPMENT, V121, P2327; BOSMANN HB, 1980, P NATL ACAD SCI-BIOL, V77, P1195, DOI 10.1073/pnas.77.2.1195; Bozas E, 1997, CELL MOL NEUROBIOL, V17, P157, DOI 10.1023/A:1026309727518; Braveman Melissa W., 2004, V277, P261; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; CHANG SL, 1988, BIOCHEM BIOPH RES CO, V157, P698, DOI 10.1016/S0006-291X(88)80306-1; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; DALEZIOS Y, 1993, NEUROCHEM RES, V18, P305, DOI 10.1007/BF00969087; DELCERRO S, 1992, NEUROSCIENCE, V49, P1, DOI 10.1016/0306-4522(92)90071-9; Eisch AJ, 2006, HIPPOCAMPUS, V16, P271, DOI 10.1002/hipo.20161; Elliot EE, 2000, PHARMACOL BIOCHEM BE, V66, P361, DOI 10.1016/S0091-3057(00)00176-3; EVANS SM, 1990, J PHARMACOL EXP THER, V255, P1246; Fedele E, 2000, J NEUROCHEM, V75, P782, DOI 10.1046/j.1471-4159.2000.0750782.x; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fuchikami M, 2010, PSYCHIAT INVEST, V7, P251, DOI 10.4306/pi.2010.7.4.251; Fuchikami M, 2009, INT J NEUROPSYCHOPH, V12, P73, DOI 10.1017/S1461145708008997; Fukuda K, 2002, ANESTH ANALG, V95, P373, DOI 10.1097/00000539-200208000-00024; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; HADINGHAM KL, 1993, MOL PHARMACOL, V43, P970; Higashima M, 1998, NEUROSCI LETT, V245, P77, DOI 10.1016/S0304-3940(98)00178-5; Huang TL, 2009, PROG NEURO-PSYCHOPH, V33, P158, DOI 10.1016/j.pnpbp.2008.10.016; Huopaniemi L, 2004, J NEUROCHEM, V88, P1059, DOI 10.1046/j.1471-4159.2003.02216.x; Ichisaka S, 2003, NEUROSCIENCE, V117, P361, DOI 10.1016/S0306-4522(02)00771-6; Jiang XY, 2008, J NEUROSCI, V28, P1118, DOI 10.1523/JNEUROSCI.2262-07.2008; Kellogg CK, 2000, DEV BRAIN RES, V121, P157, DOI 10.1016/S0165-3806(00)00039-0; Khan GM, 2000, EUR J PHARMACOL, V407, P139, DOI 10.1016/S0014-2999(00)00720-2; Kim DH, 2009, BRIT J PHARMACOL, V158, P1131, DOI 10.1111/j.1476-5381.2009.00378.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Licata SC, 2008, PHARMACOL BIOCHEM BE, V90, P74, DOI 10.1016/j.pbb.2008.01.001; Licata SC, 2013, NEUROIMAGE, V70, P211, DOI 10.1016/j.neuroimage.2012.12.055; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lu B, 1999, J NEUROSCI RES, V58, P76, DOI 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.0.CO;2-0; Malkani S, 2000, BRAIN RES, V860, P53, DOI 10.1016/S0006-8993(00)01976-4; Marie-Claire C, 2003, NEUROSCI LETT, V345, P77, DOI 10.1016/S0304-3940(03)00307-0; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Maubach KA, 2004, NEUROREPORT, V15, P1145, DOI 10.1097/00001756-200405190-00013; McGinty JF, 2010, BRAIN RES, V1314, P183, DOI 10.1016/j.brainres.2009.08.078; Mikkelsen JD, 2005, EUR J PHARMACOL, V519, P223, DOI 10.1016/j.ejphar.2005.06.049; Mikkelsen JD, 2008, ANN NY ACAD SCI, V1148, P384, DOI 10.1196/annals.1410.044; Mintzer MZ, 1999, PSYCHOPHARMACOLOGY, V144, P8, DOI 10.1007/s002130050971; Moore AN, 1996, J BIOL CHEM, V271, P14214, DOI 10.1074/jbc.271.24.14214; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Mori K, 2001, PHARMACOL BIOCHEM BE, V69, P367, DOI 10.1016/S0091-3057(01)00546-9; Niles LP, 1997, NEUROSCI LETT, V236, P5, DOI 10.1016/S0304-3940(97)00755-6; Oliveira DR, 2009, BRAIN RES, V1269, P68, DOI 10.1016/j.brainres.2008.11.105; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; PRITCHETT DB, 1991, P NATL ACAD SCI USA, V88, P1421, DOI 10.1073/pnas.88.4.1421; Raivio N, 2012, EUR J PHARMACOL, V687, P9, DOI 10.1016/j.ejphar.2012.04.021; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Russo SJ, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.059; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Sadri-Vakili G, 2010, J NEUROSCI, V30, P11735, DOI 10.1523/JNEUROSCI.2328-10.2010; Saha B, 2009, J BIOMOL STRUCT DYN, V26, P421, DOI 10.1080/07391102.2009.10507257; Salminen O, 1996, PHARMACOL BIOCHEM BE, V54, P241, DOI 10.1016/0091-3057(95)02132-9; SANGER DJ, 1986, PSYCHOPHARMACOLOGY, V90, P207; Sanna E, 2002, EUR J PHARMACOL, V451, P103, DOI 10.1016/S0014-2999(02)02191-X; Saraf MK, 2008, NEUROSCIENCE, V155, P476, DOI 10.1016/j.neuroscience.2008.05.043; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Schmidt HD, 2012, J NEUROCHEM, V120, P202, DOI 10.1111/j.1471-4159.2011.07571.x; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Stewart SA, 2005, J CLIN PSYCHIAT, V66, P9; Sun YH, 2013, NEUROPHARMACOLOGY, V72, P20, DOI 10.1016/j.neuropharm.2013.04.021; TALLMAN JF, 1978, NATURE, V274, P383, DOI 10.1038/274383a0; Thompson BL, 2006, NEUROPHARMACOLOGY, V50, P57, DOI 10.1016/j.neuropharm.2005.07.024; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; van Rijnsoever C, 2004, J NEUROSCI, V24, P6785, DOI 10.1523/JNEUROSCI.1067-04.2004; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; Wu XF, 2009, BIOL PSYCHIAT, V66, P5, DOI 10.1016/j.biopsych.2009.01.023; Xu HY, 2006, HIPPOCAMPUS, V16, P551, DOI 10.1002/hipo.20184; Xu JY, 2005, BRAIN RES, V1062, P134, DOI 10.1016/j.brainres.2005.09.008; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	82	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84806	10.1371/journal.pone.0084806	http://dx.doi.org/10.1371/journal.pone.0084806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367698	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900069
J	Romero, A; Ramirez-Rozzi, FV; De Juan, J; Perez-Perez, A				Romero, Alejandro; Ramirez-Rozzi, Fernando V.; De Juan, Joaquin; Perez-Perez, Alejandro			Diet-Related Buccal Dental Microwear Patterns in Central African Pygmy Foragers and Bantu-Speaking Farmer and Pastoralist Populations	PLOS ONE			English	Article							UNDERGROUND-STORAGE ORGANS; MECHANICAL-PROPERTIES; HUNTER-GATHERERS; ENAMEL; VARIABILITY; INFERENCES; ORIGINS; TRACES; MIDDLE	Pygmy hunter-gatherers from Central Africa have shared a network of socioeconomic interactions with non-Pygmy Bantu speakers since agropastoral lifestyle spread across sub-Saharan Africa. Ethnographic studies have reported that their diets differ in consumption of both animal proteins and starch grains. Hunted meat and gathered plant foods, especially underground storage organs (USOs), are dietary staples for pygmies. However, scarce information exists about forager-farmer interaction and the agricultural products used by pygmies. Since the effects of dietary preferences on teeth in modern and past pygmies remain unknown, we explored dietary history through quantitative analysis of buccal microwear on cheek teeth in well-documented Baka pygmies. We then determined if microwear patterns differ among other Pygmy groups (Aka, Mbuti, and Babongo) and between Bantu-speaking farmer and pastoralist populations from past centuries. The buccal dental microwear patterns of Pygmy hunter-gatherers and non-Pygmy Bantu pastoralists show lower scratch densities, indicative of diets more intensively based on nonabrasive foodstuffs, compared with Bantu farmers, who consume larger amounts of grit from stoneground foods. The Baka pygmies showed microwear patterns similar to those of ancient Aka and Mbuti, suggesting that the mechanical properties of their preferred diets have not significantly changed through time. In contrast, Babongo pygmies showed scratch densities and lengths similar to those of the farmers, consistent with sociocultural contacts and genetic factors. Our findings support that buccal microwear patterns predict dietary habits independent of ecological conditions and reflect the abrasive properties of preferred or fallback foods such as USOs, which may have contributed to the dietary specializations of ancient human populations.	[Romero, Alejandro; De Juan, Joaquin] Univ Alicante, Dept Biotecnol, E-03080 Alicante, Spain; [Ramirez-Rozzi, Fernando V.] CNRS, Unite Propre Rech Dynam Evolut Humaine, Paris, France; [Perez-Perez, Alejandro] Univ Barcelona, Dept Biol Anim, Barcelona, Spain	Universitat d'Alacant; Centre National de la Recherche Scientifique (CNRS); University of Barcelona	Perez-Perez, A (corresponding author), Univ Barcelona, Dept Biol Anim, Barcelona, Spain.	martinez.perez-perez@ub.edu	Romero, Alejandro/J-9405-2014; Pérez-Pérez, Alejandro/K-6715-2014; De Juan, Joaquin/AAB-7011-2020	Romero, Alejandro/0000-0002-5743-0613; Pérez-Pérez, Alejandro/0000-0002-1442-1397; De Juan, Joaquin/0000-0002-9670-6344	Spanish Conselleria d'Educacio de la Generalitat Valenciana [BEST/2009/258]; Ministerio de Educacion y Ciencia [CGL2010-15340, CGL2011-22999]; Universidad de Alicante [UAUSTI10-02]; National Geographic Society [8863-10]; French National Research Agency; ANR Blanc Program [ANR-11-BSV7-0011]; Wenner-Gren Foundation [7819]	Spanish Conselleria d'Educacio de la Generalitat Valenciana; Ministerio de Educacion y Ciencia(Spanish Government); Universidad de Alicante; National Geographic Society(National Geographic Society); French National Research Agency(French National Research Agency (ANR)); ANR Blanc Program(French National Research Agency (ANR)); Wenner-Gren Foundation	This work was funded by Spanish Conselleria d'Educacio de la Generalitat Valenciana (BEST/2009/258), Ministerio de Educacion y Ciencia (CGL2010-15340 and CGL2011-22999), Universidad de Alicante (UAUSTI10-02), grants from National Geographic Society (8863-10), The French National Research Agency, ANR Blanc Program (ANR-11-BSV7-0011), and the Wenner-Gren Foundation (7819). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON E, 1983, BONGO RIMBA, P1012; Bahuchet S., 1992, Mobility and territoriality: social and spatial boundaries among foragers, fishers, pastoralists and peripatetics., P205; BAHUCHET S, 1991, HUM ECOL, V19, P213, DOI 10.1007/BF00888746; Bahuchet S, 1999, CAMBRIDGE ENCY HUNTE, P190; Bahuchet S, 1985, TECHNIQUES CONSERVAT, V3, P15; BAHUCHET S, 1988, COPING UNCERTAINTY F, P119; Bahuchet S., 1982, POLITICS HIST BAND S, P189; Batini C, 2011, MOL BIOL EVOL, V28, P1099, DOI 10.1093/molbev/msq294; Becker NSA, 2011, AM J PHYS ANTHROPOL, V145, P390, DOI 10.1002/ajpa.21512; Berbesque JC, 2012, HUM NATURE-INT BIOS, V23, P270, DOI 10.1007/s12110-012-9145-9; Buikstra J. E., 1994, STANDARDS DATA COLLE; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Carmody RN, 2011, P NATL ACAD SCI USA, V108, P19199, DOI 10.1073/pnas.1112128108; Carroll R., 1992, CONSERVATION ATLAS T, DOI [10.1007/978-1-349-12961-4_29, 10.1007/978-1-349-12961-4_14, DOI 10.1007/978-1-349-12961-4_14]; Cavalli-Sforza LL, 1986, AFRICAN PYGMIES, P361; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Constantino PJ, 2012, AM J PHYS ANTHROPOL, V148, P171, DOI 10.1002/ajpa.21576; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; Dounias E., 2001, AFR ST MON SUPP ISS, V26, P135, DOI DOI 10.14989/68403; Estebaranz F, 2012, J ANTHROPOL SCI, V90, P163, DOI [10.4436/JASS.90006, 10.4436/jass.90006]; FOX CL, 1994, J ARCHAEOL SCI, V21, P29, DOI 10.1006/jasc.1994.1005; Froment Alain, 1995, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V7, P79, DOI 10.3406/bmsap.1995.2412; Galbany J, 2006, MICROSC RES TECHNIQ, V69, P246, DOI 10.1002/jemt.20296; Galbany J, 2005, SCANNING, V27, P23; Gugel IL, 2001, AM J PHYS ANTHROPOL, V114, P124, DOI 10.1002/1096-8644(200102)114:2&lt;124::AID-AJPA1012&gt;3.0.CO;2-S; HART TB, 1986, HUM ECOL, V14, P29, DOI 10.1007/BF00889209; Hattori S., 2006, AFR STUDY MONOGR, V33, P29; Hewlett B. S., 1996, CULTURAL DIVERSITY 2, P215; HEYMER A, 1986, J COMP HUM BIOL, V37, P160; Ichikawa M., 1999, CAMBRIDGE ENCY HUNTE, P210; Ichikawa M, 1983, AFR STUDY MONOGR, V4, P55, DOI [10.14989/68001, DOI 10.14989/68001]; Kitanishi K., 1995, AFR STUDY MONOGR, V16, P73, DOI [DOI 10.14989/68133, 10.14989/68133]; Klieman Kairn, 2003, PYGMIES WERE OUR COM; Knight J, 2003, AFR STUDY MONOGR S, V28, P81; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; Lalueza C, 1996, AM J PHYS ANTHROPOL, V100, P367, DOI 10.1002/(SICI)1096-8644(199607)100:3<367::AID-AJPA5>3.0.CO;2-R; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Lucas PW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0923; Marean CW, 1997, J ANTHROPOL ARCHAEOL, V16, P189, DOI 10.1006/jaar.1997.0309; Marquer, 1972, MEMOIRES MUSEE NAT A, V72, P122; MARSHALL F, 1990, AM ANTHROPOL, V92, P873, DOI 10.1525/aa.1990.92.4.02a00020; Matsuura N, 2006, AFR STUDY MONOGR S, V33, P71; Organ C, 2011, P NATL ACAD SCI USA, V108, P14555, DOI 10.1073/pnas.1107806108; Perez-Perez A, 2003, J HUM EVOL, V44, P497, DOI 10.1016/S0047-2484(03)00030-7; PEREZPEREZ A, 1994, AM J PHYS ANTHROPOL, V94, P175, DOI 10.1002/ajpa.1330940203; PHILLIPSON DW, 2005, AFRICAN ARCHAEOLOGY; Piperno D.R., 2006, PHYTOLITH COMPREHENS; POLOCERDA M, 2007, J COMP HUM BIOL, V58, P297; Putnam P., 1948, READER GEN ANTHR, P322; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Regnault M, 1911, ANTHROPOLOGIE, V22, P261; Romero A, 2013, ADV MICROS MICROANAL, P236; Romero A, 2012, AM J PHYS ANTHROPOL, V148, P467, DOI 10.1002/ajpa.22054; Romero A, 2007, ANTHROPOL-INT J HUM, V45, P61; Rozzi FVR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013620; Sato H, 2012, ANTHROPOL SCI, V120, P129, DOI 10.1537/ase.110913; SCHNELL R, 1976, FLORE VEGETATION AFR, V1, P468; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Terashima, 2003, AFR STUDY MONOGR, V24, P1, DOI DOI 10.14989/68220; Timah EA, 2008, ECOL ECON, V64, P475, DOI 10.1016/j.ecolecon.2007.08.024; TURNBULL CM, 1965, ANTHR PAPERS AM MUSE, V50, P1012; Ungar Peter S., 2009, P121, DOI 10.1007/978-1-4020-9980-9_11; Verdu P, 2010, BIOL LETTERS, V6, P858, DOI 10.1098/rsbl.2010.0192; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; WALKER PL, 1990, AM ANTHROPOL, V92, P383, DOI 10.1525/aa.1990.92.2.02a00080	66	23	23	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84804	10.1371/journal.pone.0084804	http://dx.doi.org/10.1371/journal.pone.0084804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HY	24367696	Green Published, gold			2022-12-27	WOS:000328741900067
J	Donadieu, E; Lowenski, S; Servely, JL; Laloy, E; Lilin, T; Nowotny, N; Richardson, J; Zientara, S; Lecollinet, S; Coulpier, M				Donadieu, Emilie; Lowenski, Steeve; Servely, Jean-Luc; Laloy, Eve; Lilin, Thomas; Nowotny, Norbert; Richardson, Jennifer; Zientara, Stephan; Lecollinet, Sylvie; Coulpier, Muriel			Comparison of the Neuropathology Induced by Two West Nile Virus Strains	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; MEDITERRANEAN BASIN; KUNJIN STRAIN; T-CELLS; PROTEIN; ENCEPHALITIS; INFECTION; MOUSE; EPIDEMIOLOGY; PATHOGENESIS	Some strains of West Nile virus (WNV) are neuroinvasive and may induce fatal encephalitis/meningitis in a variety of animal species including humans. Whether, however, there is a strain-specific signature in the brain is as yet unknown. Here we investigated the neuropathogenesis induced by two phylogenetically distant WNV strains of lineage 1, WNVIS98 and WNVKUN35 911. While four-week old C57Bl/6J mice were susceptible to both strains and succumbed rapidly after intraperitoneal inoculation, differences were observed in virulence and clinical disease. WNVKUN35 911, the less virulent strain as judged by determination of LD50, induced typical signs of encephalitis. Such signs were not observed in WNVIS98-infected mice, although they died more rapidly. Histological examination of brain sections also revealed differences, as the level of apoptosis and inflammation was higher in WNVKUN35 911- than WNVIS98-infected mice. Moreover, staining for cleaved caspase 3 showed that the two WNV strains induced apoptotic death through different molecular mechanisms in one particular brain area. Finally, the two strains showed similar tropism in cortex, striatum, brainstem, and cerebellum but a different one in hippocampus. In summary, our data show that, upon peripheral administration, WNVIS98 and WNVKUN35 911 strains induce partially distinct lesions and tissue tropism in the brain. They suggest that the virulence of a WNV strain is not necessarily correlated with the severity of apoptotic and inflammatory lesions in the brain.	[Donadieu, Emilie; Lowenski, Steeve; Richardson, Jennifer; Zientara, Stephan; Lecollinet, Sylvie; Coulpier, Muriel] French Natl Inst Agr Res INRA, Virol UMR1161, Maisons Alfort, France; [Donadieu, Emilie; Lowenski, Steeve; Richardson, Jennifer; Zientara, Stephan; Lecollinet, Sylvie; Coulpier, Muriel] French Agcy Food Environm & Occupat Hlth & Safety, Virol UMR1161, Maisons Alfort, France; [Donadieu, Emilie; Lowenski, Steeve; Richardson, Jennifer; Zientara, Stephan; Lecollinet, Sylvie; Coulpier, Muriel] Paris Est Univ, Natl Vet Sch Alfort, Virol UMR1161, Maisons Alfort, France; [Servely, Jean-Luc] French Natl Inst Agr Res INRA, Nouzilly, France; [Servely, Jean-Luc; Laloy, Eve] Paris Est Univ, Natl Vet Sch Alfort, Maisons Alfort, France; [Lilin, Thomas] Paris Est Univ, Biomed Res Ctr, Natl Vet Sch Alfort, Maisons Alfort, France; [Nowotny, Norbert] Univ Vet Med, Inst Virol, Vienna, Austria; [Nowotny, Norbert] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Muscat, Oman	INRAE; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Ecole Nationale Veterinaire d'Alfort (ENVA); Ecole Nationale Veterinaire d'Alfort (ENVA); University of Veterinary Medicine Vienna; Sultan Qaboos University	Coulpier, M (corresponding author), French Natl Inst Agr Res INRA, Virol UMR1161, Maisons Alfort, France.	mcoulpier@vet-alfort.fr	Zientara, Stephan/A-5336-2016; Lecollinet, Sylvie/M-1728-2019; Nowotny, Norbert/A-5474-2019; Zientara, Stephan/AAA-7661-2021; Lecollinet, Sylvie/AAV-5276-2021	Zientara, Stephan/0000-0003-0089-8175; Nowotny, Norbert/0000-0002-3548-571X; Zientara, Stephan/0000-0002-6733-8503; Coulpier, Muriel/0000-0001-5400-8727; Lecollinet, Sylvie/0000-0001-8535-2133; Richardson, Jennifer/0000-0002-4137-3984	European Commission [EUROWESTNILE - HEALTH-F3-2011-261391]; ANSES (French Agency for food, environmental and occupational Health Safety); INRA (French National Institute for Agricultural Research)	European Commission(European CommissionEuropean Commission Joint Research Centre); ANSES (French Agency for food, environmental and occupational Health Safety); INRA (French National Institute for Agricultural Research)	This work was financially supported by the European Commission (EUROWESTNILE - HEALTH-F3-2011-261391). ED received financial support from ANSES (French Agency for food, environmental and occupational Health Safety) and INRA (French National Institute for Agricultural Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audsley M, 2011, VIROLOGY, V414, P63, DOI 10.1016/j.virol.2011.03.008; Bahuon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047666; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; BERNKOPF H, 1953, J INFECT DIS, V93, P207, DOI 10.1093/infdis/93.3.207; Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293; Botha EM, 2008, EMERG INFECT DIS, V14, P222, DOI 10.3201/eid1402.070457; Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097; Burt FJ, 2002, EMERG INFECT DIS, V8, P820, DOI 10.3201/eid0808.020027; Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939; Chiesa R, 2005, P NATL ACAD SCI USA, V102, P238, DOI 10.1073/pnas.0406173102; Daffis S, 2011, J VIROL, V85, P5664, DOI 10.1128/JVI.00232-11; Dietzschold B, 2005, CURR TOP MICROBIOL, V292, P45; ELDADAH AH, 1967, AM J EPIDEMIOL, V86, P776, DOI 10.1093/oxfordjournals.aje.a120786; Frost MJ, 2012, EMERG INFECT DIS, V18, P792, DOI 10.3201/eid1805.111720; Girard S, 1999, J VIROL, V73, P6066, DOI 10.1128/JVI.73.7.6066-6072.1999; Gray RR, 2010, MOL PHYLOGENET EVOL, V56, P195, DOI 10.1016/j.ympev.2010.01.019; Gray TJ, 2011, AM J TROP MED HYG, V85, P952, DOI 10.4269/ajtmh.2011.11-0165; Hail N, 2006, APOPTOSIS, V11, P889, DOI 10.1007/s10495-006-6712-8; Hall RA, 2002, CURR TOP MICROBIOL, V267, P253; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12; Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kuang Y, 2009, VIRUS RES, V144, P18, DOI 10.1016/j.virusres.2009.03.014; Kutasi O, 2011, J VET INTERN MED, V25, P586, DOI 10.1111/j.1939-1676.2011.0715.x; Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Lim SM, 2011, VIRUSES-BASEL, V3, P811, DOI 10.3390/v3060811; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Linke S, 2007, J VIROL METHODS, V146, P355, DOI 10.1016/j.jviromet.2007.05.021; Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006; Lucas M, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-9; Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217; McGavern DB, 2002, J INFECT DIS, V186, pS145, DOI 10.1086/344264; Morrey JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038672; Murgue B, 2001, ANN NY ACAD SCI, V951, P117; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Platonov A. E., 2011, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P29; Pradier S, 2012, REV SCI TECH OIE, V31, P829; Roy A, 2007, J VIROL, V81, P7993, DOI 10.1128/JVI.00710-07; Samuel MA, 2007, J VIROL, V81, P2614, DOI 10.1128/JVI.02311-06; Savarin C, 2010, J VIROL, V84, P4878, DOI 10.1128/JVI.00051-10; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Scherret JH, 2001, EMERG INFECT DIS, V7, P697, DOI 10.3201/eid0704.010418; Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; van Marle G, 2007, J VIROL, V81, P10933, DOI 10.1128/JVI.02422-06; Vanlandingham DL, 2004, AM J TROP MED HYG, V71, P120, DOI 10.4269/ajtmh.2004.71.120; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Watson JT, 2004, ANN INTERN MED, V141, P360, DOI 10.7326/0003-4819-141-5-200409070-00010; Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007; Wodak E, 2011, VET MICROBIOL, V149, P358, DOI 10.1016/j.vetmic.2010.12.012; Xiao SY, 2001, EMERG INFECT DIS, V7, P714; Yu L, 2008, VACCINE, V26, P5981, DOI 10.1016/j.vaccine.2008.08.064; Zeller HG, 2004, EUR J CLIN MICROBIOL, V23, P147, DOI 10.1007/s10096-003-1085-1	63	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84473	10.1371/journal.pone.0084473	http://dx.doi.org/10.1371/journal.pone.0084473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367664	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300143
J	Zunhammer, M; Eberle, H; Eichhammer, P; Busch, V				Zunhammer, Matthias; Eberle, Hanna; Eichhammer, Peter; Busch, Volker			Somatic Symptoms Evoked by Exam Stress in University Students: The Role of Alexithymia, Neuroticism, Anxiety and Depression	PLOS ONE			English	Article							MEDICALLY UNEXPLAINED SYMPTOMS; SALIVARY CORTISOL; SOMATIZATION; SCALE; PERSONALITY; RESPONSES; VALIDATION; QUESTIONNAIRE; HYPOTHESIS; INVENTORY	Objective: The etiology of somatization is incompletely understood, but could be elucidated by models of psychosocial stress. Academic exam stress has effectively been applied as a naturalistic stress model, however its effect on somatization symptoms according to ICD-10 and DSM-IV criteria has not been reported so far. Baseline associations between somatization and personality traits, such as alexithymia, have been studied exhaustively. Nevertheless, it is largely unknown if personality traits have an explanatory value for stress induced somatization. Methods: This longitudinal, quasi-experimental study assessed the effects of university exams on somatization and the reversal of effects after an exam-free period. Repeated-observations were obtained within 150 students, measuring symptom intensity before, during and after an exam period, according to the Screening for Somatoform Symptoms 7-day (SOMS-7d). Additionally, self-reports on health status were used to differentiate between medically explained and medically unexplained symptoms. Alexithymia, neuroticism, trait-anxiety and baseline depression were surveyed using the Toronto-Alexithymia Scale (TAS-20), the Big-Five Personality Interview (NEO-FFI), the State Trait Anxiety Inventory (STAI) and Beck's Depression Inventory (BDI-II). These traits were competitively tested for their ability to explain somatization increases under exam stress. Results: Somatization significantly increased across a wide range of symptoms under exam stress, while health reports pointed towards a reduction in acute infections and injuries. Neuroticism, alexithymia, trait anxiety and depression explained variance in somatization at baseline, but only neuroticism was associated with symptom increases under exam stress. Conclusion: Exam stress is an effective psychosocial stress model inducing somatization. A comprehensive quantitative description of bodily symptoms under exam stress is supplied. The results do not support the stress-alexithymia hypothesis, but favor neuroticism as a personality trait of importance for somatization.	[Zunhammer, Matthias; Eberle, Hanna] Univ Regensburg, Dept Expt Psychol, D-93053 Regensburg, Germany; [Zunhammer, Matthias; Eichhammer, Peter; Busch, Volker] Univ Regensburg, Dept Psychiat, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Zunhammer, M (corresponding author), Univ Regensburg, Dept Expt Psychol, D-93053 Regensburg, Germany.	matthias.zunhammer@klinik.uni-regensburg.de			German National Merit Foundation	German National Merit Foundation	Author MZ is supported by a scholarship of the "German National Merit Foundation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research received no other specific grant from any funding agency in the public, commercial, or not-for-profit sectors.	Arndt S, 1999, J PSYCHIAT RES, V33, P97, DOI 10.1016/S0022-3956(98)90046-2; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bailey PE, 2007, PSYCHIAT RES, V150, P13, DOI 10.1016/j.psychres.2006.05.024; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BOLGER N, 1995, J PERS SOC PSYCHOL, V69, P890, DOI 10.1037/0022-3514.69.5.890; Borella P, 1999, PSYCHONEUROENDOCRINO, V24, P613, DOI 10.1016/S0306-4530(99)00016-5; Connelly M, 2007, J PSYCHOSOM RES, V62, P649, DOI 10.1016/j.jpsychores.2006.12.008; COSTA P T JR, 1980, Journal of Behavioral Medicine, V3, P245, DOI 10.1007/BF00845050; De Gucht V, 2003, J PSYCHOSOM RES, V54, P425, DOI 10.1016/S0022-3999(02)00467-1; De Gucht V, 2004, J PSYCHOSOM RES, V57, P25, DOI 10.1016/S0022-3999(03)00577-4; De Gucht V, 2004, J PSYCHOSOM RES, V56, P279, DOI 10.1016/S0022-3999(03)00127-2; de Timary P, 2008, PSYCHONEUROENDOCRINO, V33, P1160, DOI 10.1016/j.psyneuen.2008.06.005; Dewhurst SA, 2003, APPL COGNITIVE PSYCH, V17, P695, DOI 10.1002/acp.903; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dimsdale J, 2009, J PSYCHOSOM RES, V66, P473, DOI 10.1016/j.jpsychores.2009.03.005; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Franz M, 2008, SOC PSYCH PSYCH EPID, V43, P54, DOI 10.1007/s00127-007-0265-1; Fukunishi I, 1997, COMPR PSYCHIAT, V38, P166, DOI 10.1016/S0010-440X(97)90070-5; Gil FP, 2008, NORD J PSYCHIAT, V62, P366, DOI 10.1080/08039480801983554; Gunthert KC, 1999, J PERS SOC PSYCHOL, V77, P1087, DOI 10.1037/0022-3514.77.5.1087; Hiller W, 2006, SOC PSYCH PSYCH EPID, V41, P704, DOI 10.1007/s00127-006-0082-y; Johannsen A, 2010, INT J DENT HYG, V8, P22, DOI 10.1111/j.1601-5037.2009.00397.x; KELLNER R, 1990, J NERV MENT DIS, V178, P150, DOI 10.1097/00005053-199003000-00002; Klaus K, 2013, INT J BEHAV MED, V20, P161, DOI 10.1007/s12529-012-9245-2; Koh KB, 2006, PSYCHIAT RES, V143, P223, DOI 10.1016/j.psychres.2005.04.008; Kooiman CG, 2004, PSYCHOSOM MED, V66, P224, DOI 10.1097/01.psy.0000116714.38868.06; Kooiman CG, 2002, J PSYCHOSOM RES, V53, P1083, DOI 10.1016/S0022-3999(02)00348-3; Korner A., 2008, Z FUER MEDIZINISCHE, V17, P133; Lane RD, 2011, PSYCHOSOM MED, V73, P185, DOI 10.1097/PSY.0b013e318203b86a; Laux L, 1981, MANUAL STATE TRAIT A; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; Loft P, 2007, PSYCHONEUROENDOCRINO, V32, P367, DOI 10.1016/j.psyneuen.2007.02.004; Lumley MA, 1996, J PSYCHOSOM RES, V41, P505, DOI 10.1016/S0022-3999(96)00222-X; MARTIN JB, 1985, PSYCHOTHER PSYCHOSOM, V43, P169, DOI 10.1159/000287876; Mattila AK, 2008, PSYCHOSOM MED, V70, P716, DOI 10.1097/PSY.0b013e31816ffc39; Noyes R, 2001, PSYCHOSOMATICS, V42, P320, DOI 10.1176/appi.psy.42.4.320; PITTS FN, 1961, AM J PSYCHIAT, V118, P333, DOI 10.1176/ajp.118.4.333; Ree MJ, 2008, BEHAV COGN PSYCHOTH, V36, P313, DOI 10.1017/S1352465808004232; Rief W, 1996, J CLIN PSYCHOL, V52, P423, DOI 10.1002/(SICI)1097-4679(199607)52:4<423::AID-JCLP6>3.3.CO;2-C; Rief W, 2003, PSYCHOSOMATICS, V44, P492, DOI 10.1176/appi.psy.44.6.492; Rief W., 2008, SOMS SCREENING SOMAT; Rief W, 2007, CLIN PSYCHOL REV, V27, P821, DOI 10.1016/j.cpr.2007.07.005; Sherman DK, 2009, HEALTH PSYCHOL, V28, P554, DOI 10.1037/a0014663; Simic N., 2012, Human Physiology, V38, P67, DOI 10.1134/S0362119712010161; Spangler G, 1997, PSYCHONEUROENDOCRINO, V22, P423, DOI 10.1016/S0306-4530(97)00040-1; SPIELBERGER CD, 2003, INT J CLIN HLTH PSYC, V3, P209; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Suslow T, 2000, SCAND J PSYCHOL, V41, P329, DOI 10.1111/1467-9450.00205; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Weik U, 2010, HORM BEHAV, V58, P405, DOI 10.1016/j.yhbeh.2010.06.001; WISE TN, 1994, J PSYCHOSOM RES, V38, P515, DOI 10.1016/0022-3999(94)90048-5	54	46	51	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84911	10.1371/journal.pone.0084911	http://dx.doi.org/10.1371/journal.pone.0084911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367700	Green Published, Green Submitted, gold			2022-12-27	WOS:000328740300158
J	Chung, Y; Fu, E				Chung, Yi; Fu, Earl			Crosstalk between Shh and TGF-beta Signaling in Cyclosporine-Enhanced Cell Proliferation in Human Gingival Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SONIC HEDGEHOG; TRANSFORMING GROWTH-FACTOR-BETA-1; PROSTATE-CANCER; UP-REGULATION; IN-VITRO; EXPRESSION; ACTIVATION; INDUCTION; PATHWAY	Background: Immunosuppressant cyclosporine-A induces gingival hyperplasia, which is characterized by increased fibroblast proliferation and overproduction of extracellular matrix components and regulated by transforming growth factor-beta (TGF-beta). The TGF-beta and Sonic hedgehog (Shh) pathways both mediate cell proliferation. Crosstalk between these pathways in cancer has recently been proposed, but the hierarchical pattern of this crosstalk remains unclear. In normal fibroblasts, a TGF-beta-stimulating Shh pattern was observed in induced fibrosis. However, Shh pathway involvement in cyclosporine-enhanced gingival proliferation and the existence of crosstalk with the TGF-beta pathway remain unclear. Methodology/Principal Findings: Cyclosporine enhanced mRNA and protein levels of TGF-beta and Shh in human gingival fibroblasts (RT-PCR and western blotting). A TGF-beta pathway inhibitor mitigated cyclosporine-enhanced cell proliferation and an Shh pathway inhibitor attenuated cyclosporine-enhanced proliferation in fibroblasts (MTS assay and/or RT-PCR of PCNA). Exogenous TGF-beta increased Shh expression; however, exogenous Shh did not alter TGF-beta expression. The TGF-beta pathway inhibitor mitigated cyclosporine-upregulated Shh expression, but the Shh pathway inhibitor did not alter cyclosporineupregulated TGF-beta expression. Conclusions/Significance: The TGF-beta and Shh pathways mediate cyclosporine-enhanced gingival fibroblast proliferation. Exogenous TGF-beta increased Shh expression, and inhibition of TGF-beta signaling abrogated the cyclosporine-induced upregulation of Shh expression; however, TGF-beta expression appeared unchanged by enhanced or inhibited Shh signaling. This is the first study demonstrating the role of Shh in cyclosporine-enhanced gingival cell proliferation; moreover, it defines a hierarchical crosstalk pattern in which TGF-beta regulates Shh in gingival fibroblasts. Understanding the regulation of cyclosporine-related Shh and TGF-beta signaling and crosstalk in gingival overgrowth will clarify the mechanism of cyclosporine-induced gingival enlargement and help develop targeted therapeutics for blocking these pathways, which can be applied in pre-clinical and clinical settings.	[Chung, Yi; Fu, Earl] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chung, Yi; Fu, Earl] Natl Def Med Ctr, Dept Periodontol, Sch Dent, Taipei, Taiwan; [Chung, Yi; Fu, Earl] Tri Serv Gen Hosp, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Fu, E (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	dentalab@tpts5.seed.net.tw	Wooten, Ronald Mark/AAO-4263-2020	Fu, Earl/0000-0003-0637-0208; Chung, Yi/0000-0001-7733-6459	Tri-Service General Hospital [TSGH-C98-29]; National Science Council [NSC-100-2314-B-016-022-MY3]; C.Y. Foundation for Advancement of Education, Sciences, and Medicine, Republic of China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073452] Funding Source: NIH RePORTER	Tri-Service General Hospital; National Science Council(Ministry of Science and Technology, Taiwan); C.Y. Foundation for Advancement of Education, Sciences, and Medicine, Republic of China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partially supported by research grants from Tri-Service General Hospital (TSGH-C98-29), National Science Council (NSC-100-2314-B-016-022-MY3), and C.Y. Foundation for Advancement of Education, Sciences, and Medicine, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJ, 1998, J CLIN PERIODONTOL, V25, P48, DOI 10.1111/j.1600-051X.1998.tb02363.x; BARTOLD PM, 1989, J PERIODONTAL RES, V24, P314, DOI 10.1111/j.1600-0765.1989.tb00876.x; Buduneli N, 2001, J PERIODONTOL, V72, P526, DOI 10.1902/jop.2001.72.4.526; Chae HJ, 2006, J DENT RES, V85, P515, DOI 10.1177/154405910608500607; Chen M, 2009, CELL CYCLE, V8, P149, DOI 10.4161/cc.8.1.7532; Chen YT, 2005, J PERIODONTOL, V76, P2267, DOI 10.1902/jop.2005.76.12.2267; Chiang CY, 2007, J PERIODONTAL RES, V42, P443, DOI 10.1111/j.1600-0765.2006.00967.x; Chiang CY, 2011, J PERIODONTAL RES, V46, P158, DOI 10.1111/j.1600-0765.2010.01312.x; Chiu HC, 2009, J PERIODONTAL RES, V44, P338, DOI 10.1111/j.1600-0765.2008.01126.x; Cotrim P, 2003, J PERIODONTOL, V74, P1625, DOI 10.1902/jop.2003.74.11.1625; Cotrim P, 2002, J PERIODONTOL, V73, P1313, DOI 10.1902/jop.2002.73.11.1313; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Furler RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040874; Horn A, 2012, ARTHRITIS RHEUM-US, V64, P2724, DOI 10.1002/art.34444; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jung Y, 2008, GASTROENTEROLOGY, V134, P1532, DOI 10.1053/j.gastro.2008.02.022; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; KHANNA A, 1994, BIOCHEM BIOPH RES CO, V204, P1061, DOI 10.1006/bbrc.1994.2570; KHANNA A, 1994, TRANSPLANTATION, V57, P577; Kiefer JC, 2010, DEV DYNAM, V239, P1255, DOI 10.1002/dvdy.22278; King PJ, 2008, J ENDOCRINOL, V198, P439, DOI 10.1677/JOE-08-0161; Kuo PJ, 2012, J PERIODONTAL RES, V47, P431, DOI 10.1111/j.1600-0765.2011.01450.x; Lal BK, 2003, J VASC SURG, V37, P1285, DOI 10.1016/S0741-5214(02)75295-6; Lin YT, 2010, J PERIODONTOL, V81, P1250, DOI 10.1902/jop.2010.090743; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Mas C, 2010, BIOCHEM PHARMACOL, V80, P712, DOI 10.1016/j.bcp.2010.04.016; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Perrot CY, 2013, PHARMACOL THERAPEUT, V137, P183, DOI 10.1016/j.pharmthera.2012.10.002; Pierrat MJ, 2012, J BIOL CHEM, V287, P17996, DOI 10.1074/jbc.M112.358341; Qualtrough D, 2004, INT J CANCER, V110, P831, DOI 10.1002/ijc.20227; Sanchez P, 2005, CANCER RES, V65, P2990, DOI 10.1158/0008-5472.CAN-05-0439; SCHINCAGLIA GP, 1992, J ORAL PATHOL MED, V21, P181, DOI 10.1111/j.1600-0714.1992.tb00098.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; TIPTON DA, 1990, J CELL BIOCHEM, V44, P253, DOI 10.1002/jcb.240440407; TIPTON DA, 1991, J CELL BIOCHEM, V46, P152, DOI 10.1002/jcb.240460209; Tu HP, 2006, J PERIODONTOL, V77, P832, DOI 10.1902/jop.2006.050316; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Yoshida T, 2005, J PERIODONTAL RES, V40, P11, DOI 10.1111/j.1600-0765.2004.00762.x; ZEBROWSKI EJ, 1994, J PERIODONTOL, V65, P565, DOI 10.1902/jop.1994.65.6.565	45	49	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70128	10.1371/journal.pone.0070128	http://dx.doi.org/10.1371/journal.pone.0070128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922933	gold, Green Published, Green Submitted			2022-12-27	WOS:000322838900150
J	Lim, L; Marquand, A; Cubillo, AA; Smith, AB; Chantiluke, K; Simmons, A; Mehta, M; Rubia, K				Lim, Lena; Marquand, Andre; Cubillo, Ana A.; Smith, Anna B.; Chantiluke, Kaylita; Simmons, Andrew; Mehta, Mitul; Rubia, Katya			Disorder-Specific Predictive Classification of Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) Relative to Autism Using Structural Magnetic Resonance Imaging	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; SPECTRUM DISORDER; ALZHEIMERS-DISEASE; BRAIN STRUCTURE; METAANALYSIS; MRI; CHILDREN; ABNORMALITIES; NEUROANATOMY; PREVALENCE	Objective: Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder, but diagnosed by subjective clinical and rating measures. The study's aim was to apply Gaussian process classification (GPC) to grey matter (GM) volumetric data, to assess whether individual ADHD adolescents can be accurately differentiated from healthy controls based on objective, brain structure measures and whether this is disorder-specific relative to autism spectrum disorder (ASD). Method: Twenty-nine adolescent ADHD boys and 29 age-matched healthy and 19 boys with ASD were scanned. GPC was applied to make disorder-specific predictions of ADHD diagnostic status based on individual brain structure patterns. In addition, voxel-based morphometry (VBM) analysis tested for traditional univariate group level differences in GM. Results: The pattern of GM correctly classified 75.9% of patients and 82.8% of controls, achieving an overall classification accuracy of 79.3%. Furthermore, classification was disorder-specific relative to ASD. The discriminating GM patterns showed higher classification weights for ADHD in earlier developing ventrolateral/premotor fronto-temporo-limbic and stronger classification weights for healthy controls in later developing dorsolateral fronto-striato-parieto-cerebellar networks. Several regions were also decreased in GM in ADHD relative to healthy controls in the univariate VBM analysis, suggesting they are GM deficit areas. Conclusions: The study provides evidence that pattern recognition analysis can provide significant individual diagnostic classification of ADHD patients and healthy controls based on distributed GM patterns with 79.3% accuracy and that this is disorder-specific relative to ASD. Findings are a promising first step towards finding an objective differential diagnostic tool based on brain imaging measures to aid with the subjective clinical diagnosis of ADHD.	[Lim, Lena; Cubillo, Ana A.; Smith, Anna B.; Chantiluke, Kaylita; Rubia, Katya] Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London WC2R 2LS, England; [Lim, Lena] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore 117595, Singapore; [Marquand, Andre; Simmons, Andrew; Mehta, Mitul] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England; [Simmons, Andrew] South London & Maudsley Fdn NHS Trust, NIHR Biomed Res Ctr, London, England; [Simmons, Andrew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of London; King's College London; National University of Singapore; University of London; King's College London; University of London; King's College London	Rubia, K (corresponding author), Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London WC2R 2LS, England.	katya.rubia@kcl.ac.uk	Simmons, Andrew/B-8848-2008; Mehta, Mitul/F-3960-2010; Hassan, Randa/AAW-3624-2021; Marquand, Andre F/B-6050-2012; Cubillo, Ana I/J-6822-2019; Cubillo, Ana I/AAC-5908-2022; Rubia, Katya/H-7497-2012	Simmons, Andrew/0000-0003-2306-5811; Marquand, Andre F/0000-0001-5903-203X; Cubillo, Ana I/0000-0001-5657-7341; Smith, Anna Belinda/0000-0001-5493-9089; Lim, Lena/0000-0002-3301-923X; Wah, Win/0000-0002-4242-5651; Hsu, Li Yang/0000-0002-0396-066X; Rubia, Katya/0000-0002-1410-7701	NIHR Biomedical Research Centre (BRC) for Mental Health at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Lilly Pharmaceuticals; National Medical Research Council (Singapore); NIHR BRC; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust; EPSRC [WT088641/Z/09/Z]; Medical Research Council [G0300155] Funding Source: researchfish; MRC [G0300155] Funding Source: UKRI	NIHR Biomedical Research Centre (BRC) for Mental Health at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Lilly Pharmaceuticals; National Medical Research Council (Singapore)(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR BRC; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Data collection was supported by grants by the NIHR Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London and Lilly Pharmaceuticals. LL was supported by the National Medical Research Council (Singapore). A, Smith, AC, A. Simmonds and KC were supported by the NIHR BRC. AM was supported by the King's College London Centre of Excellence in Medical Engineering, funded by the Wellcome Trust and EPSRC under grant no. WT088641/Z/09/Z. Lilly Pharmaceuticals had no input into the design, analysis, data interpretation or write-up. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; [Anonymous], 1994, ICD 10 CLASS MENT BE; APA, 2000, DIAGN STAT MAN MENT; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bledsoe J, 2009, BIOL PSYCHIAT, V65, P620, DOI 10.1016/j.biopsych.2008.11.030; Brieber S, 2007, J CHILD PSYCHOL PSYC, V48, P1251, DOI 10.1111/j.1469-7610.2007.01799.x; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Cauda F, 2011, J NEUROL NEUROSUR PS, V82, P1304, DOI 10.1136/jnnp.2010.239111; Cheng W, 2012, FRONT SYST NEUROSCI, P6; Christakou A, 2013, MOL PSYCHIATR, V18, P236, DOI 10.1038/mp.2011.185; Colby JB, 2012, FRONT SYST NEUROSCI, P6; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Cubillo A, 2012, CORTEX, V48, P194, DOI 10.1016/j.cortex.2011.04.007; Dai D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00063; Durston S, 2004, J AM ACAD CHILD PSY, V43, P332, DOI 10.1097/00004583-200403000-00016; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Ellison-Wright I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-51; Eloyan A, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00061; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Goldberg D. P, 2002, MAUDSLEY HDB PRACTIC; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hahn T, 2013, HUM BRAIN MAPP, V34, P1102, DOI 10.1002/hbm.21497; Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277; Hart H, 2012, NEUROSCI BIOBEHAV R, V36, P2248, DOI 10.1016/j.neubiorev.2012.08.003; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Ivanov I, 2010, AM J PSYCHIAT, V167, P397, DOI 10.1176/appi.ajp.2009.09030398; Kuntsi J, 2004, AM J MED GENET B, V124B, P41, DOI 10.1002/ajmg.b.20076; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mackie S, 2007, AM J PSYCHIAT, V164, P647, DOI 10.1176/appi.ajp.164.4.647; Marquand A, 2010, INT C PATT REC IST T; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; Noreika V, 2013, NEUROPSYCHOLOGIA, V51, P235, DOI 10.1016/j.neuropsychologia.2012.09.036; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pliszka SR, 2006, NEUROLOGY, V67, P1023, DOI 10.1212/01.wnl.0000237385.84037.3c; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rubia K, 2007, P NATL ACAD SCI USA, V104, P19663, DOI 10.1073/pnas.0710329105; Rubia K, 2013, EUR CHILD ADOLES PSY, V22, P719, DOI 10.1007/s00787-012-0291-8; Rubia K, 2011, BIOL PSYCHIAT, V69, pE69, DOI 10.1016/j.biopsych.2010.09.023; Rutter M., 2003, SOCIAL COMMUNICATION; Schrouff J, 2013, NEUROINFORMATICS, V11, P319, DOI 10.1007/s12021-013-9178-1; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2012, BIOL PSYCHIAT, V72, P191, DOI 10.1016/j.biopsych.2012.01.031; Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385; Shaw P, 2009, AM J PSYCHIAT, V166, P58, DOI 10.1176/appi.ajp.2008.08050781; Simmons A, 2011, INT J GERIATR PSYCH, V26, P75, DOI 10.1002/gps.2491; Simmons A, 2009, ANN NY ACAD SCI, V1180, P47, DOI 10.1111/j.1749-6632.2009.05063.x; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Sobel LJ, 2010, AM J PSYCHIAT, V167, P977, DOI 10.1176/appi.ajp.2010.09091259; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Yu KK, 2011, J PSYCHIATR NEUROSCI, V36, P412, DOI 10.1503/jpn.100138; Zhu CZ, 2005, LECT NOTES COMPUT SC, V3750, P468, DOI 10.1007/11566489_58	65	63	65	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63660	10.1371/journal.pone.0063660	http://dx.doi.org/10.1371/journal.pone.0063660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696841	Green Published, gold			2022-12-27	WOS:000319081900048
J	Huang, JH; Zhang, AB; Mao, SL; Huang, Y				Huang, Jianhua; Zhang, Aibing; Mao, Shaoli; Huang, Yuan			DNA Barcoding and Species Boundary Delimitation of Selected Species of Chinese Acridoidea (Orthoptera: Caelifera)	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC ANALYSIS; MITOCHONDRIAL CYTOCHROME-B; NEIGHBOR-JOINING METHOD; OXIDASE SUBUNIT-I; GRASSHOPPERS ORTHOPTERA; COLOR PATTERN; TAXONOMY; IDENTIFICATION; SEQUENCES; EVOLUTION	We tested the performance of DNA barcoding in Acridoidea and attempted to solve species boundary delimitation problems in selected groups using COI barcodes. Three analysis methods were applied to reconstruct the phylogeny. K2P distances were used to assess the overlap range between intraspecific variation and interspecific divergence. "Best match (BM)", "best close match (BCM)", all species barcodes (ASB)" and "back-propagation neural networks (BP-based method)" were utilized to test he success rate of species identification. Phylogenetic species concept and network analysis were employed to delimitate the species boundary in eight selected species groups. The results demonstrated that the COI barcode region performed better in phylogenetic reconstruction at genus and species levels than at hi her-levels, but showed a little improvement in resolving the higher-level relationships when the third base data or both first and third base data were excluded. Most overlaps and incorrect identifications may be due to imperfect taxonomy, indicating the critical role of taxonomic revision in DNA barcoding study. Species boundary delimitation confirmed the presence of oversplitting in six species groups and suggested that each group should be treated as a single species	[Huang, Jianhua; Mao, Shaoli; Huang, Yuan] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Huang, Jianhua] Guangxi Normal Univ, Coll Life Sci, Guilin, Peoples R China; [Zhang, Aibing] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China	Shaanxi Normal University; Guangxi Normal University; Capital Normal University	Huang, Y (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China.	yuanh@snnu.edu.cn		zhang, ai bing/0000-0002-6580-5462; ZHANG, Ai-bing/0000-0003-3450-5421	National Natural Science Foundation of China [30970346, 31172076, 31260523]; Fundamental Research Funds for the Central Universities [GK201001004]; China Postdoctoral Science Foundation [20070421105]; Guangxi Natural Science Foundation [2010GXNSFA013070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This study is supported by National Natural Science Foundation of China (No. 30970346, 31172076, 31260523), the Fundamental Research Funds for the Central Universities (GK201001004), China Postdoctoral Science Foundation (20070421105) and Guangxi Natural Science Foundation (2010GXNSFA013070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedegnato C, 2003, MOL PHYLOGENET EVOL, V29, P115, DOI 10.1016/S1055-7903(03)00074-5; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Baker AJ, 2005, P NATL ACAD SCI USA, V102, P8257, DOI 10.1073/pnas.0409435102; Bugrov A, 2006, SYST ENTOMOL, V31, P362, DOI 10.1111/j.1365-3113.2005.00317.x; Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Campbell DC, 2008, MOL ECOL RESOUR, V8, P711, DOI 10.1111/j.1755-0998.2008.02108.x; Chapco W, 1997, ANN ENTOMOL SOC AM, V90, P555, DOI 10.1093/aesa/90.5.555; Chapco W, 2001, MOL PHYLOGENET EVOL, V18, P460, DOI 10.1006/mpev.2000.0902; Chapco William, 2011, Journal of Orthoptera Research, V20, P173, DOI 10.1665/034.020.0205; Chintauan-Marquier IC, 2011, MOL PHYLOGENET EVOL, V58, P22, DOI 10.1016/j.ympev.2010.07.003; Chu KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S8; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Contreras Daniel, 2006, Journal of Orthoptera Research, V15, P91, DOI 10.1665/1082-6467(2006)15[91:MPEFMD]2.0.CO;2; Cui Ai-Ming, 2012, Yichuan, V34, P597, DOI 10.3724/SP.J.1005.2012.00597; Dai QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032544; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; DEARN JM, 1981, HEREDITY, V47, P111, DOI 10.1038/hdy.1981.64; DEARN JM, 1978, J AUST ENTOMOL SOC, V17, P135; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; deWaard JR, 2009, BIODIVERS CONSERV, V18, P3825, DOI 10.1007/s10531-009-9682-7; Ding Fang-Mei, 2008, Acta Entomologica Sinica, V51, P55; Eades DC, 2013, ORTHOPTERA SPECIES F; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Feng J, 2010, J THEOR BIOL, V266, P703, DOI 10.1016/j.jtbi.2010.07.040; Flook PK, 1999, SYST BIOL, V48, P233, DOI 10.1080/106351599260274; Flook PK, 1998, INSECT MOL BIOL, V7, P163, DOI 10.1046/j.1365-2583.1998.72060.x; Flook PK, 1997, MOL PHYLOGENET EVOL, V8, P89, DOI 10.1006/mpev.1997.0412; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2009, MOL ECOL RESOUR, V9, P188, DOI 10.1111/j.1755-0998.2009.02644.x; Fries Megan, 2007, Journal of Orthoptera Research, V16, P115, DOI 10.1665/1082-6467(2007)16[115:AMPAOT]2.0.CO;2; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gaines SB, 1991, T NEBRASKA ACAD SCI, V18, P67; Grunshaw J. P., 1988, Journal of the East Africa Natural History Society and National Museum, V78, P1; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Huang Jianhua, 2007, Zootaxa, V1436, P55; Huang JH, 2009, ZOOTAXA, P39, DOI 10.11646/zootaxa.1976.1.3; Huo Guangming, 2007, Journal of Genetics and Genomics, V34, P294, DOI 10.1016/S1673-8527(07)60031-9; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuksa P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S9; Kumar S, 2000, J MOL EVOL, V51, P544, DOI 10.1007/s002390010118; La Rosa M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S4; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Lan Ma, 2006, Acta Entomologica Sinica, V49, P982; Lawrence HA, 2009, MOL ECOL RESOUR, V9, P458, DOI 10.1111/j.1755-0998.2008.02370.x; Li HC, 2006, FAUNA SINICA INSECTA, V43; Lis JA, 2011, ZOOTAXA, P47, DOI 10.11646/zootaxa.2932.1.5; Litzenberger G, 2003, ANN ENTOMOL SOC AM, V96, P491, DOI 10.1603/0013-8746(2003)096[0491:TNAMOA]2.0.CO;2; Litzenberger G, 2001, ANN ENTOMOL SOC AM, V94, P505, DOI 10.1603/0013-8746(2001)094[0505:MPOSEP]2.0.CO;2; Liu Dian-Feng, 2005, Acta Entomologica Sinica, V48, P759; Liu Dian-Feng, 2005, Acta Entomologica Sinica, V48, P232; Lopez H, 2007, CONSERV GENET, V8, P587, DOI 10.1007/s10592-006-9199-5; Lu HM, 2001, J NW U NAT SCI ED, V31, P7; Lu Hong-Juan, 2012, Zoological Research, V33, P319, DOI 10.3724/SP.J.1141.2012.03319; LU Hui-Meng, 2006, Insect Science, V13, P103, DOI 10.1111/j.1744-7917.2006.00072.x; Lu Rong-Sheng, 2010, Acta Zootaxonomica Sinica, V35, P782; Luo AR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-84; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Monaghan MT, 2006, P ROY SOC B-BIOL SCI, V273, P887, DOI 10.1098/rspb.2005.3391; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Nei M, 2000, MOL EVOLUTION PHYLOG; Pan Cheng-ying, 2006, Entomotaxonomia, V28, P103; Pan Zhao, 2011, Acta Zootaxonomica Sinica, V36, P179; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rivera J, 2009, MOL ECOL RESOUR, V9, P224, DOI 10.1111/j.1755-0998.2009.02648.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowell C. H. F., 2004, Journal of Orthoptera Research, V13, P35, DOI 10.1665/1082-6467(2004)013[0035:ADMPOT]2.0.CO;2; Rowell C.H.F., 1998, Journal of Orthoptera Research, V7, P147; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Staden R, 2000, Methods Mol Biol, V132, P115; Storozhenko Sergey, 1994, Articulata, V8, P1; Storozhenko SY, 1983, SYSTEMATICS ECOLOGIC, P48; Sun Zheng-Li, 2006, Acta Zoologica Sinica, V52, P302; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1992, GENETICS, V132, P619; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Ying-fang, 1999, Journal of Shaanxi Normal University Natural Science Edition, V27, P82; Tinkham E. R., 1936, Lingnan Science Journal, V15, P47; Trewick SA, 2008, CLADISTICS, V24, P240, DOI 10.1111/j.1096-0031.2007.00174.x; UVAROV B. P., 1931, LINGNAN SCI JOUR, V10, P217; Virgilio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031581; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Wang Nai-Xin, 2008, Acta Entomologica Sinica, V51, P1187; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Wei Tao, 2012, Far Eastern Entomologist, V255, P11; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Yassin A, 2009, MOL PHYLOGENET EVOL, V53, P404, DOI 10.1016/j.ympev.2009.06.012; Yin Hong, 2004, Acta Entomologica Sinica, V47, P809; Yin Hong, 2003, Acta Genetica Sinica, V30, P766; Yin XC, 2003, FAUNA SINICA INSECTA, V32; Zhang AB, 2008, SYST BIOL, V57, P202, DOI 10.1080/10635150802032982; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014; Zhang AB, 2009, MOL ECOL RESOUR, V9, P104, DOI 10.1111/j.1755-0998.2008.02372.x; Zhang AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030986; Zhang DC, 2011, INSECT SCI, V18, P234, DOI 10.1111/j.1744-7917.2010.01359.x; Zhang Dao-Chuan, 2005, Zootaxa, V1103, P41; Zheng ZM, 1998, FAUNA SINICA INSECTA, V10; Zhou ZJ, 2010, J GENET GENOMICS, V37, P315, DOI 10.1016/S1673-8527(09)60049-7	116	49	51	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e82400	10.1371/journal.pone.0082400	http://dx.doi.org/10.1371/journal.pone.0082400			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	23874723	Green Submitted, gold, Green Published			2022-12-27	WOS:000328745100030
J	Chung, YT; Zhang, N; Wooten, RM				Chung, Yutein; Zhang, Nan; Wooten, R. Mark			Borrelia burgdorferi Elicited-IL-10 Suppresses the Production of Inflammatory Mediators, Phagocytosis, and Expression of Co-Stimulatory Receptors by Murine Macrophages and/or Dendritic Cells	PLOS ONE			English	Article							OUTER SURFACE LIPOPROTEINS; HOST-PATHOGEN INTERACTIONS; LYME-DISEASE SPIROCHETE; TOLL-LIKE RECEPTOR-2; FACTOR-KAPPA-B; GENE-EXPRESSION; INTERLEUKIN-10 PRODUCTION; ARTHRITIS DEVELOPMENT; INNATE; MICE	Borrelia burgdorferi (Bb) is a tick-borne spirochete that is the causative agent for Lyme disease. Our previous studies indicate that virulent Bb can potently enhance IL-10 production by macrophages (MOs) and that blocking IL-10 production significantly enhances bacterial clearance. We hypothesize that skin-associated APC types, such as MOs and dendritic cells (DCs) are potent producers of IL-10 in response to Bb, which may act in autocrine fashion to suppress APC responses critical for efficient Bb clearance. Our goal is to delineate which APC immune functions are dysregulated by Bb-elicited IL-10 using a murine model of Lyme disease. Our in vitro studies indicated that both APCs rapidly produce IL-10 upon exposure to Bb, that these levels inversely correlate with the production of many Lyme-relevant proinflammatory cytokines and chemokines, and that APCs derived from IL-10(-/-) mice produced greater amounts of these proinflammatory mediators than wild-type APCs. Phagocytosis assays determined that Bb-elicited IL-10 levels can diminish Bb uptake and trafficking by MOs, suppresses ROS production, but does not affect NO production; Bb-elicited IL-10 had little effect on phagocytosis, ROS, and NO production by DCs. In general, Bb exposure caused little-to-no upregulation of several critical surface co-stimulatory markers by MOs and DCs, however eliminating Bb-elicited IL-10 allowed a significant upregulation in many of these co-stimulatory receptors. These data indicate that IL-10 elicited from Bb-stimulated MOs and DCs results in decreased production of proinflammatory mediators and co-stimulatory molecules, and suppress phagocytosis-associated events that are important for mediating both innate and adaptive immune responses by APCs.	[Chung, Yutein; Zhang, Nan; Wooten, R. Mark] Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Wooten, RM (corresponding author), Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	r.mark.wooten@utoledo.edu	Wooten, Ronald Mark/AAO-4263-2020	Fu, Earl/0000-0003-0637-0208; Chung, Yi/0000-0001-7733-6459	NIH [R01 AI073452]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding for this study was NIH grant R01 AI073452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barthold S. W., 1996, Journal of Spirochetal and Tick-borne Diseases, V3, P22; Barthold SW, 1996, LAB INVEST, V74, P57; BARTHOLD SW, 1993, INFECT IMMUN, V61, P4696, DOI 10.1128/IAI.61.11.4696-4702.1993; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; Behera AK, 2006, INFECT IMMUN, V74, P1462, DOI 10.1128/IAI.74.3.1462-1470.2006; BENACH JL, 1984, YALE J BIOL MED, V57, P599; Berende A, 2010, EUR CYTOKINE NETW, V21, P7, DOI 10.1684/ecn.2009.0179; Bolz DD, 2004, J IMMUNOL, V173, P2003, DOI 10.4049/jimmunol.173.3.2003; Bouis DA, 2001, INFECT IMMUN, V69, P518, DOI 10.1128/IAI.69.1.518-528.2001; Bourret TJ, 2011, MOL MICROBIOL, V81, P259, DOI 10.1111/j.1365-2958.2011.07691.x; Boylan JA, 2008, MOL MICROBIOL, V68, P786, DOI 10.1111/j.1365-2958.2008.06204.x; Boylan Julie A., 2008, V431, P213; Brown CR, 1999, J INFECT DIS, V179, P1573, DOI 10.1086/314774; Brown JP, 1999, INFECT IMMUN, V67, P5142, DOI 10.1128/IAI.67.10.5142-5150.1999; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; CINCO M, 1994, FEMS MICROBIOL LETT, V122, P187, DOI 10.1111/j.1574-6968.1994.tb07163.x; Cortez-Retamozo V, 2012, J INNATE IMMUN, V4, P411, DOI 10.1159/000335733; Crandall H, 2005, AM J PATHOL, V167, P775, DOI 10.1016/S0002-9440(10)62050-0; Crandall H, 2006, J IMMUNOL, V177, P7930, DOI 10.4049/jimmunol.177.11.7930; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; DING AH, 1988, J IMMUNOL, V141, P2407; Ebnet K, 1997, J IMMUNOL, V158, P3285; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gautam A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043860; Gautam A, 2011, INFECT IMMUN, V79, P4876, DOI 10.1128/IAI.05451-11; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Giambartolomei GH, 1998, INFECT IMMUN, V66, P2691, DOI 10.1128/IAI.66.6.2691-2697.1998; Giambartolomei GH, 1999, INFECT IMMUN, V67, P140, DOI 10.1128/IAI.67.1.140-147.1999; Giambartolomei GH, 2002, INFECT IMMUN, V70, P1881, DOI 10.1128/IAI.70.4.1881-1888.2002; HASTEY CJ, 2012, INFECT J IMMUNOL; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Iliopoulou BP, 2010, CURR OPIN RHEUMATOL, V22, P451, DOI 10.1097/BOR.0b013e328338f73f; Kenedy MR, 2012, FEMS IMMUNOL MED MIC, V66, P1, DOI 10.1111/j.1574-695X.2012.00980.x; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Lazarus JJ, 2008, INFECT IMMUN, V76, P1153, DOI 10.1128/IAI.01404-07; Lazarus JJ, 2006, J IMMUNOL, V177, P7076, DOI 10.4049/jimmunol.177.10.7076; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; MA Y, 1993, INFECT IMMUN, V61, P3843, DOI 10.1128/IAI.61.9.3843-3853.1993; MA Y, 1994, INFECT IMMUN, V62, P3663, DOI 10.1128/IAI.62.9.3663-3671.1994; Marangoni A, 2006, WORLD J GASTROENTERO, V12, P3077, DOI 10.3748/wjg.v12.i19.3077; Marietta EV, 1997, J IMMUNOL, V159, P2840; Matsushima H, 2009, BLOOD, V114, P64, DOI 10.1182/blood-2009-02-204297; Miller JC, 2006, MICROB PATHOGENESIS, V41, P43, DOI 10.1016/j.micpath.2006.04.004; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Montgomery RR, 2004, INFECT IMMUN, V72, P2989, DOI 10.1128/IAI.72.5.2989-2994.2004; MONTGOMERY RR, 1994, J INFECT DIS, V170, P890, DOI 10.1093/infdis/170.4.890; Montgomery RR, 1996, INFECT IMMUN, V64, P2867, DOI 10.1128/IAI.64.7.2867-2872.1996; Montgomery RR, 2002, J INFECT DIS, V185, P1773, DOI 10.1086/340826; Moreira AP, 2010, CELL IMMUNOL, V263, P196, DOI 10.1016/j.cellimm.2010.03.016; Morrison TB, 1997, J IMMUNOL, V158, P4838; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Salazar JC, 2005, CLIN DIAGN LAB IMMUN, V12, P949, DOI 10.1128/CDLI.12.8.949-958.2005; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Schulze RJ, 2006, MOL MICROBIOL, V59, P1473, DOI 10.1111/j.1365-2958.2006.05039.x; Sellati TJ, 1998, J IMMUNOL, V160, P5455; SELLER KP, 1995, INFECT IMMUN, V63, P3886, DOI 10.1128/IAI.63.10.3886-3895.1995; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Shanafelt MC, 1998, INFECT IMMUN, V66, P266, DOI 10.1128/IAI.66.1.266-271.1998; Shin OS, 2008, INFECT IMMUN, V76, P2341, DOI 10.1128/IAI.01600-07; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Singh SK, 2006, CLIN MICROBIOL INFEC, V12, P705, DOI 10.1111/j.1469-0691.2006.01440.x; Sonderegger FL, 2012, J IMMUNOL, V188, P1381, DOI 10.4049/jimmunol.1102359; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Suhonen J, 2003, SCAND J IMMUNOL, V58, P67, DOI 10.1046/j.1365-3083.2003.01284.x; Thoma-Uszynski S, 2000, J IMMUNOL, V165, P3804, DOI 10.4049/jimmunol.165.7.3804; Weis J.J., 2010, BORRELIA MOL BIOL HO, P413; Weis JJ, 2002, CURR OPIN RHEUMATOL, V14, P399, DOI 10.1097/00002281-200207000-00011; Wooten RM, 1996, J IMMUNOL, V157, P4584; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wooten RM, 2001, CURR OPIN MICROBIOL, V4, P274, DOI 10.1016/S1369-5274(00)00202-2; Wooten RM, 1998, J IMMUNOL, V160, P5485; Xu QL, 2007, J IMMUNOL, V178, P5109, DOI 10.4049/jimmunol.178.8.5109; Yoder A, 2003, INFECT IMMUN, V71, P3894, DOI 10.1128/IAI.71.7.3894-3900.2003	88	49	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84980	10.1371/journal.pone.0084980	http://dx.doi.org/10.1371/journal.pone.0084980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	23922933	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900074
J	Huang, JH; Zhong, Y; Fang, XW; Xie, QD; Kang, XJ; Wu, RR; Li, FZ; Xu, XQ; Lu, H; Xu, L; Huang, TH				Huang, JiHua; Zhong, Ying; Fang, XiaoWu; Xie, QingDong; Kang, XiangJin; Wu, RiRan; Li, FangZheng; Xu, XiaoQin; Lu, Hui; Xu, Lan; Huang, TianHua			Hepatitis B Virus S Protein Enhances Sperm Apoptosis and Reduces Sperm Fertilizing Capacity In Vitro	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; INDUCED ACROSOME REACTION; HYPERACTIVATED MOTILITY; HUMAN SPERMATOZOA; CELL-DEATH; PORE; TRANSMISSION; ACTIVATION; CASPASES; TARGET	Objective: Studying the impact of Hepatitis B virus S protein (HBs) on early apoptotic events in human spermatozoa and sperm fertilizing capacity. Methodology/Principal Findings: Spermatozoa were exposed to HBs (0, 25, 50, 100 mu g/ml) for 3 h, and then fluo-4 AM calcium assay, Calcein/Co2+ assay, protein extraction and ELISA, ADP/ATP ratio assay, sperm motility and hyperactivation and sperm-zona pellucida (ZP) binding and ZP-induced acrosome reaction (ZPIAR) tests were performed. The results showed that in the spermatozoa, with increasing concentration of HBs, (1) average cytosolic free Ca2+ concentration ([Ca2+](i)) rose; (2) fluorescence intensity of Cal-AM declined; (3) average levels of cytochrome c decreased in mitochondrial fraction and increased in cytosolic fraction; (4) ADP/ATP ratios rose; (5) average rates of total motility and mean hyperactivation declined; (6) average rate of ZPIAR declined. In the above groups the effects of HBs exhibited dose dependency. However, there was no significant difference in the number of sperms bound to ZP between the control and all test groups. Conclusion: HBs could induce early events in the apoptotic cascade in human spermatozoa, such as elevation of [Ca2+](i), opening of mitochondrial permeability transition pore (MPTP), release of cytochrome c (cyt c) and increase of ADP/ATP ratio, but exerted a negative impact on sperm fertilizing capacity.	[Huang, JiHua; Xie, QingDong; Kang, XiangJin; Li, FangZheng; Xu, XiaoQin; Lu, Hui; Xu, Lan; Huang, TianHua] Shantou Univ, Coll Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Res Ctr Reprod Med, Shantou, Guangdong, Peoples R China; [Zhong, Ying] Chengdu Jingjiang Hosp Maternal & Child Hlth Care, Ctr Reprod Med, Chengdu, Sichuan, Peoples R China; [Fang, XiaoWu; Wu, RiRan] Boai Hosp Zhongshan, Ctr Reprod Med, Zhongshan, Guangdong, Peoples R China	Shantou University	Huang, TH (corresponding author), Shantou Univ, Coll Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Res Ctr Reprod Med, Shantou, Guangdong, Peoples R China.	thhuang@stu.edu.cn		zhang, ai bing/0000-0002-6580-5462; ZHANG, Ai-bing/0000-0003-3450-5421	National Natural Science Foundation of China [30972526]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 30972526) and the Li Ka Shing Shantou University Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejarano I, 2012, MALE INFERTILITY, V20, P51; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; CROSS NL, 1991, HUM REPROD, V6, P1279, DOI 10.1093/oxfordjournals.humrep.a137526; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Ganem D., 1996, FIELDS VIROLOGY, P2703; HADCHOUEL M, 1985, J MED VIROL, V16, P61, DOI 10.1002/jmv.1890160109; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Ho HC, 2001, BIOL REPROD, V65, P1606, DOI 10.1095/biolreprod65.5.1606; Huang JM, 2002, ASIAN J ANDROL, V4, P209; Javadov S, 2009, J PHARMACOL EXP THER, V330, P670, DOI 10.1124/jpet.109.153213; Kang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033471; Lang Z W, 1993, Zhonghua Yi Xue Za Zhi, V73, P329; Liu DY, 2007, HUM REPROD, V22, P2632, DOI 10.1093/humrep/dem245; Liu DY, 2004, HUM REPROD, V19, P228, DOI 10.1093/humrep/deh067; Liu DY, 1996, HUM REPROD, V11, P551, DOI 10.1093/HUMREP/11.3.551; Misro M.M., 2012, MALE INFERTILITY CON, P209; Moretti E, 2008, ANDROLOGIA, V40, P286, DOI 10.1111/j.1439-0272.2008.00855.x; Oger P, 2011, REPROD BIOMED ONLINE, V23, P207, DOI 10.1016/j.rbmo.2011.04.008; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paasch U, 2004, ANN NY ACAD SCI, V1030, P403, DOI 10.1196/annals.1329.050; Patrat C, 2000, BIOL CELL, V92, P255, DOI 10.1016/S0248-4900(00)01072-8; Richburg JH, 2000, TOXICOL LETT, V112, P79, DOI 10.1016/S0378-4274(99)00253-2; Said TM, 2004, HUM REPROD UPDATE, V10, P39, DOI 10.1093/humupd/dmh003; Salisbury J.J., 2004, AM SOC CELL BIOL 44; Schinder AF, 1996, J NEUROSCI, V16, P6125; SCOTT RM, 1980, J INFECT DIS, V142, P67, DOI 10.1093/infdis/142.1.67; Shen HM, 2002, HUM REPROD, V17, P1266, DOI 10.1093/humrep/17.5.1266; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VANDEVOORT CA, 1995, J ANDROL, V16, P327; Vasudevan SR, 2010, J BIOL CHEM, V285, P18262, DOI 10.1074/jbc.M109.087858; White RJ, 1996, J NEUROSCI, V16, P5688; World Health Organization, 2008, HEP B; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Yanagimachi R., 1994, P189; Zhou XL, 2009, HUM REPROD, V24, P1575, DOI 10.1093/humrep/dep050; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	38	49	51	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68688	10.1371/journal.pone.0068688	http://dx.doi.org/10.1371/journal.pone.0068688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874723	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300064
J	Lemola, S; Ledermann, T; Friedman, EM				Lemola, Sakari; Ledermann, Thomas; Friedman, Elliot M.			Variability of Sleep Duration Is Related to Subjective Sleep Quality and Subjective Well-Being: An Actigraphy Study	PLOS ONE			English	Article							POSITIVE AFFECT; OLDER-ADULTS; LIFE; POPULATION; INSOMNIA; HEALTH; PARAMETERS; COHORT; MEN	While there is a large body of evidence that poor subjective sleep quality is related to lower subjective well-being, studies on the relation of objective sleep measures and subjective well-being are fewer in number and less consistent in their findings. Using data of the Survey of Mid-Life in the United States (MIDUS), we investigated whether duration and quality of sleep, assessed by actigraphy, were related to subjective well-being and whether this relationship was mediated by subjective sleep quality. Three hundred and thirteen mainly white American individuals from the general population and 128 urban-dwelling African American individuals between 35 and 85 years of age were studied cross-sectionally. Sleep duration, variability of sleep duration, sleep onset latency, and time awake after sleep onset were assessed by actigraphy over a period of 7 days. Subjective sleep quality was assessed with the Pittsburgh Sleep Quality Index, positive psychological well-being and symptoms of psychological distress were assessed with the Satisfaction with Life Scale and the Mood and Anxiety Symptom Questionnaire. In both white and African Americans high day-to-day variability in sleep duration was related to lower levels of subjective well-being controlling age, gender, educational and marital status, and BMI. By contrast, sleep duration, sleep onset latency, and time awake after sleep onset were not related to subjective well-being controlling covariates and other sleep variables. Moreover, the relationship between variability in sleep duration and well-being was partially mediated by subjective sleep quality. The findings show that great day-to-day variability in sleep duration - more than average sleep duration - is related to poor subjective sleep quality and poor subjective well-being.	[Lemola, Sakari; Ledermann, Thomas] Univ Basel, Dept Psychol, Basel, Switzerland; [Friedman, Elliot M.] Purdue Univ, W Lafayette, IN 47907 USA	University of Basel; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Lemola, S (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	sakari.lemola@unibas.ch	Lemola, Sakari/A-2659-2008; Friedman, Elliot M/AAT-2585-2020	Lemola, Sakari/0000-0002-1314-6194; 	National Institute on Aging [P01-AG020166]; John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development; General Clinical Research Centers Program [M01-RR023942, M01-RR00865]; Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health [1UL1RR025011]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865, M01RR023942, UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020166] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development; General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The longitudinal follow-up of the MIDUS investigation was supported by grant P01-AG020166 from the National Institute on Aging (www.nia.nih.gov). The original MIDUS study was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development (http://midmac.med.harvard.edu). Further support comes from the following grants: M01-RR023942 (Georgetown), M01-RR00865 (UCLA) from the General Clinical Research Centers Program, and 1UL1RR025011 (UW) from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Arbuckle JL, 2003, AMOS 18; Baker FC, 1999, J PSYCHOSOM RES, V47, P335, DOI 10.1016/S0022-3999(99)00017-3; BILLIARD M, 1987, SLEEP, V10, P297, DOI 10.1093/sleep/10.4.297; Buysse DJ, 2010, SLEEP MED, V11, P56, DOI 10.1016/j.sleep.2009.02.010; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carvalho-Bos SS, 2007, AM J GERIAT PSYCHIAT, V15, P92, DOI 10.1097/01.JGP.0000236584.03432.dc; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Ertel KA, 2011, SLEEP, V34, P509, DOI 10.1093/sleep/34.4.509; Faubel R, 2009, SLEEP, V32, P1059; Fortier-Brochu E, 2010, J PSYCHOSOM RES, V69, P475, DOI 10.1016/j.jpsychores.2010.05.005; Frey W. H., 2010, NEW RACIAL SEGREGATI; Fuligni AJ, 2006, J RES ADOLESCENCE, V16, P353, DOI 10.1111/j.1532-7795.2006.00498.x; Hale L, 2007, SLEEP, V30, P1096, DOI 10.1093/sleep/30.9.1096; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jean-Louis G, 2000, SLEEP, V23, P1115; KLINK ME, 1992, ARCH INTERN MED, V152, P1634, DOI 10.1001/archinte.152.8.1634; Knutson KL, 2007, SLEEP, V30, P793, DOI 10.1093/sleep/30.6.793; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Lemola S, 2013, INT J BEHAV MED, V20, P567, DOI 10.1007/s12529-012-9272-z; Lemola S, 2013, J GERONTOL B-PSYCHOL, V68, P721, DOI 10.1093/geronb/gbs113; Lemola S, 2012, J ADOLESCENCE, V35, P97, DOI 10.1016/j.adolescence.2011.06.001; Love GD, 2010, J AGING HEALTH, V22, P1059, DOI 10.1177/0898264310374355; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Magee CA, 2011, SLEEP MED, V12, P346, DOI 10.1016/j.sleep.2010.09.013; Manber R, 1996, SLEEP, V19, P432, DOI 10.1093/sleep/19.5.432; Mezick EJ, 2009, PSYCHONEUROENDOCRINO, V34, P1346, DOI 10.1016/j.psyneuen.2009.04.005; Monk TH, 2003, CHRONOBIOL INT, V20, P97, DOI 10.1081/CBI-120017812; MORIN CM, 2005, PRINCIPLES PRACTICE, P726; MYERS DG, 1995, PSYCHOL SCI, V6, P10, DOI 10.1111/j.1467-9280.1995.tb00298.x; Oakley NR., 1997, VALIDATION POLYSOMN; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ong AD, 2013, ANN BEHAV MED, V46, P52, DOI 10.1007/s12160-013-9484-8; Paunio T, 2009, AM J EPIDEMIOL, V169, P206, DOI 10.1093/aje/kwn305; Perlis ML, 2005, SLEEP MED REV, V9, P381, DOI 10.1016/j.smrv.2005.05.001; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Rowe M, 2008, BEHAV SLEEP MED, V6, P127, DOI 10.1080/15402000801952872; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Ryff CD, 2004, PHILOS T R SOC B, V359, P1383, DOI 10.1098/rstb.2004.1521; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Steptoe A, 2008, J PSYCHOSOM RES, V64, P409, DOI 10.1016/j.jpsychores.2007.11.008; Tworoger SS, 2005, J PSYCHOSOM RES, V59, P11, DOI 10.1016/j.jpsychores.2005.03.008; Vallieres A, 2005, J SLEEP RES, V14, P447, DOI 10.1111/j.1365-2869.2005.00480.x; Van Someren EJW, 2007, J SLEEP RES, V16, P269, DOI 10.1111/j.1365-2869.2007.00592.x; Vitiello MV, 2004, J PSYCHOSOM RES, V56, P503, DOI 10.1016/S0022-3999(04)00023-6; Wohlgemuth WK, 1999, PSYCHOPHYSIOLOGY, V36, P233, DOI 10.1111/1469-8986.3620233	54	192	192	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71292	10.1371/journal.pone.0071292	http://dx.doi.org/10.1371/journal.pone.0071292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	202MQ	23967186	gold, Green Submitted, Green Published			2022-12-27	WOS:000323221500072
J	Zhang, XY; Nie, ZH; Wang, WJ; Leung, DWM; Xu, DG; Chen, BL; Chen, Z; Zeng, LX; Liu, EE				Zhang, Xian Yong; Nie, Zhuan Hua; Wang, Wen Juan; Leung, David W. M.; Xu, Da Gao; Chen, Bai Ling; Chen, Zhe; Zeng, Lie Xian; Liu, E. E.			Relationship between Disease Resistance and Rice Oxalate Oxidases in Transgenic Rice	PLOS ONE			English	Article							GERMIN-LIKE PROTEINS; SCLEROTINIA-SCLEROTIORUM; BRASSICA-NAPUS; GENE; WHEAT; ASSOCIATION; DEFENSE; BARLEY; FAMILY; SENSITIVITY	Differential expression of rice oxalate oxidase genes (OsOxO1-4) in rice leaves (Oryza sativa L.) in response to biotic stress was assayed using RT-PCR. OsOxO4 was induced transiently at 12 h in plants inoculated with the pathogens of bacterial blight and that of the wounding control. Inoculation with the rice blast pathogen induced OsOxO2 expression compared to the mock spray control. Overexpressing OsOxO1 or OsOxO4 in rice resulted in elevated transcript levels of the respective transgene as well as OsOxO3 in leaves compared to that in untransformed wild type (WT). In a line of RNA-i transgenic rice plants (i-12), expression of all four OsOxO genes except that of OsOxO2 was severely inhibited. Oxalate oxidase (OxO, EC 1.2.3.4) activity in plants overexpressing OsOxO1 or OsOxO4 was substantially higher than that in WT and the RNA-i lines. It was found that transgenic rice plants with substantially higher OxO activity were not more resistant to rice blast and bacterial blight than WT. In contrast, some RNA-i lines with less OxO activity seemed to be more resistant to rice blast while some overexpressing lines were more susceptible to rice blast than WT. Therefore, OxO might not be a disease resistance factor in rice.	[Zhang, Xian Yong; Nie, Zhuan Hua; Chen, Bai Ling; Chen, Zhe; Liu, E. E.] South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Wen Juan; Zeng, Lie Xian] Guangdong Acad Agr Sci, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China; [Leung, David W. M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Xu, Da Gao] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Guangdong Academy of Agricultural Sciences; University of Canterbury; South China Agricultural University	Liu, EE (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	eeliu70@163.com			National Natural Science Foundation of China [31071345]; Guangdong Province Science and technology plan project [2010B020301007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and technology plan project	This work was supported by the National Natural Science Foundation of China (31071345) and Guangdong Province Science and technology plan project (2010B020301007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee J, 2010, BIOCHEM BIOPH RES CO, V402, P637, DOI 10.1016/j.bbrc.2010.10.073; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V394, P178, DOI 10.1016/j.bbrc.2010.02.142; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Carrillo MGC, 2009, RICE, V2, P67, DOI 10.1007/s12284-009-9024-0; Chipps TJ, 2005, PHYTOPATHOLOGY, V95, P292, DOI 10.1094/PHYTO-95-0292; Davidson RM, 2010, RICE, V3, P43, DOI 10.1007/s12284-010-9038-7; Donaldson PA, 2001, PHYSIOL MOL PLANT P, V59, P297, DOI 10.1006/pmpp.2001.0369; Dong XB, 2008, PLANTA, V228, P331, DOI 10.1007/s00425-008-0740-2; Faris JD, 1999, THEOR APPL GENET, V98, P219, DOI 10.1007/s001220051061; Feng Jie, 2004, Journal of Agricultural Biotechnology, V12, P312; Godfrey D, 2007, MOL PLANT MICROBE IN, V20, P1112, DOI 10.1094/MPMI-20-9-1112; GRZELCZAK ZF, 1984, CAN J BIOCHEM CELL B, V62, P1351, DOI 10.1139/o84-172; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hu X, 2003, PLANT PHYSIOL, V133, P170, DOI 10.1104/pp.103.024026; Hurkman WJ, 1996, PLANT PHYSIOL, V111, P735, DOI 10.1104/pp.111.3.735; Kim ST, 2009, PROTEOMICS, V9, P1302, DOI 10.1002/pmic.200800589; LANE BG, 1993, J BIOL CHEM, V268, P12239; Lane BG, 2002, IUBMB LIFE, V53, P67, DOI 10.1080/15216540211474; Liang HY, 2001, PLANT MOL BIOL, V45, P619, DOI 10.1023/A:1010631318831; Lou YG, 2006, PLANT PHYSIOL, V140, P1126, DOI 10.1104/PP.105.073700; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; Ramalingam J, 2003, MOL PLANT MICROBE IN, V16, P14, DOI 10.1094/MPMI.2003.16.1.14; Rietz S, 2012, J EXP BOT, V63, P5507, DOI 10.1093/jxb/ers203; THOMPSON EW, 1980, J BIOL CHEM, V255, P5965; Walz A, 2008, PLANT PATHOL, V57, P453, DOI 10.1111/j.1365-3059.2007.01815.x; Wu JL, 2004, THEOR APPL GENET, V108, P1024, DOI 10.1007/s00122-003-1528-1; Xin GL, 1987, CHINESE J RICE SCI, V1, P118; Yadav S, 2012, WORLD J MICROB BIOT, V28, P3197, DOI 10.1007/s11274-012-1130-2; Yang JY, 2008, RICE SCI, V15, P311, DOI 10.1016/S1672-6308(09)60009-3; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhang ZG, 1996, PLANT MOL BIOL REP, V14, P266, DOI 10.1007/BF02671662; Zhou FS, 1998, PLANT PHYSIOL, V117, P33, DOI 10.1104/pp.117.1.33; Zimmermann G, 2006, PLANT PHYSIOL, V142, P181, DOI 10.1104/pp.106.083824	33	53	54	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78348	10.1371/journal.pone.0078348	http://dx.doi.org/10.1371/journal.pone.0078348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205207	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300052
J	Wu, JB; Hong, JT; Wang, XD; Sun, J; Lu, XY; Fan, JH; Cai, YJ				Wu, Jianbo; Hong, Jiangtao; Wang, Xiaodan; Sun, Jian; Lu, Xuyang; Fan, Jihui; Cai, Yanjiang			Biomass Partitioning and Its Relationship with the Environmental Factors at the Alpine Steppe in Northern Tibet	PLOS ONE			English	Article							BELOW-GROUND BIOMASS; CARBON ALLOCATION; ABOVEGROUND BIOMASS; NUTRIENT AVAILABILITY; SPECIES COMPOSITION; SOIL PROPERTIES; PLANT BIOMASS; GROWTH; ROOT; GRASSLANDS	Alpine steppe is considered to be the largest grassland type on the Tibetan Plateau. This grassland contributes to the global carbon cycle and is sensitive to climate changes. The allocation of biomass in an ecosystem affects plant growth and the overall functioning of the ecosystem. However, the mechanism by which plant biomass is allocated on the alpine steppe remains unclear. In this study, biomass allocation and its relationship to environmental factors on the alpine grassland were studied by a meta-analysis of 32 field sites across the alpine steppe of the northern Tibetan Plateau. We found that there is less above-ground biomass (M-A) and below-ground biomass (M-B) in the alpine steppe than there is in alpine meadows and temperate grasslands. By contrast, the root-to-shoot ratio (R:S) in the alpine steppe is higher than it is in alpine meadows and temperate grasslands. Although temperature maintained the biomass in the alpine steppe, precipitation was found to considerably influence M-A, M-B, and R:S, as shown by ordination space partitioning. After standardized major axis (SMA) analysis, we found that allocation of biomass on the alpine steppe is supported by the allometric biomass partitioning hypothesis rather than the isometric allocation hypothesis. Based on these results, we believe that M-A and M-B will decrease as a result of the increased aridity expected to occur in the future, which will reduce the landscape's capacity for carbon storage.	[Wu, Jianbo; Hong, Jiangtao; Wang, Xiaodan; Sun, Jian; Lu, Xuyang; Fan, Jihui; Cai, Yanjiang] Chinese Acad Sci, Inst Mt Hazard & Environm, Key Lab Mt Environm Evolut & Its Regulat, Chengdu, Peoples R China; [Hong, Jiangtao; Sun, Jian] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XD (corresponding author), Chinese Acad Sci, Inst Mt Hazard & Environm, Key Lab Mt Environm Evolut & Its Regulat, Chengdu, Peoples R China.	wxd@imde.ac.cn	Sun, Jian/I-9740-2016; Cai, Yanjiang/N-6694-2013; Cai, Yanjiang/AAD-1470-2020	Sun, Jian/0000-0001-8765-5015; Cai, Yanjiang/0000-0002-5376-7884; Lu, Xuyang/0000-0001-6653-6009	CAS [XDB03030505, SDS-135-1203-01]; National science and technology support project [2011BAC09B03]; Program of the IMDE; Science Foundation for Young Scientists of IMDE, CAS	CAS(Chinese Academy of Sciences); National science and technology support project; Program of the IMDE; Science Foundation for Young Scientists of IMDE, CAS	This study was financially supported by the Strategic leading science and technology projects, CAS (XDB03030505), the National science and technology support project (2011BAC09B03), Program of the IMDE, CAS (SDS-135-1203-01), and the Science Foundation for Young Scientists of IMDE, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzaz Fakhri A., 1997, P1, DOI 10.1016/B978-012083490-7/50002-5; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Bradford JB, 2005, ECOLOGY, V86, P1863, DOI 10.1890/04-0493; Burke IC, 1997, ECOLOGY, V78, P1330, DOI 10.1890/0012-9658(1997)078[1330:RATVIN]2.0.CO;2; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Cheng DL, 2007, ANN BOT-LONDON, V99, P95, DOI 10.1093/aob/mcl206; Cronin G, 2003, OECOLOGIA, V137, P32, DOI 10.1007/s00442-003-1315-3; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Fan JW, 2009, J ARID ENVIRON, V73, P521, DOI 10.1016/j.jaridenv.2008.12.004; Gao YZ, 2008, PLANT SOIL, V307, P41, DOI 10.1007/s11104-008-9579-3; Gao YZ, 2011, OECOLOGIA, V165, P855, DOI 10.1007/s00442-010-1890-z; Genard M, 2008, TREES-STRUCT FUNCT, V22, P269, DOI 10.1007/s00468-007-0176-5; Giese M, 2009, APPL SOIL ECOL, V41, P8, DOI 10.1016/j.apsoil.2008.08.002; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Gill RA, 2002, GLOBAL ECOL BIOGEOGR, V11, P79, DOI 10.1046/j.1466-822X.2001.00267.x; Glynn C, 2003, OIKOS, V101, P385, DOI 10.1034/j.1600-0706.2003.12089.x; Grechi I, 2007, ENVIRON EXP BOT, V59, P139, DOI 10.1016/j.envexpbot.2005.11.002; Gugerli F, 2001, BOT HELV, V111, P169; [韩文轩 Han Wenxuan], 2003, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V39, P583; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; KORNER C, 1987, OECOLOGIA, V74, P411, DOI 10.1007/BF00378938; Korner C., 2003, ALPINE PLANT LIFE, V2, P101; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Lacointe A, 2000, ANN FOREST SCI, V57, P521; Li W, 2011, J SOIL SCI PLANT NUT, V11, P27, DOI 10.4067/S0718-95162011000400003; Li XJ, 2011, ENVIRON EARTH SCI, V64, P1911, DOI 10.1007/s12665-011-1004-1; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Ma WH, 2008, SCI CHINA SER C, V51, P263, DOI 10.1007/s11427-008-0029-5; Marcelis LFM, 2007, WAG UR FRON, V22, P103; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Mony C, 2007, AQUAT BOT, V86, P236, DOI 10.1016/j.aquabot.2006.11.007; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; Niklas KJ, 2005, ANN BOT-LONDON, V95, P315, DOI 10.1093/aob/mci028; O'Connor TG, 2001, J ECOL, V89, P850, DOI 10.1046/j.0022-0477.2001.00605.x; Reynolds JF, 2002, GLOBAL DESERTIFICATI, P1; Schenk HJ, 2005, GEODERMA, V126, P129, DOI 10.1016/j.geoderma.2004.11.018; Shi FS, 2010, POL J ECOL, V58, P125; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Solow AR, 2005, ECOL LETT, V8, P361, DOI 10.1111/j.1461-0248.2005.00738.x; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Sun J, 2013, BIOGEOSCIENCES, V10, P1707, DOI 10.5194/bg-10-1707-2013; Vanninen P, 2005, TREE PHYSIOL, V25, P17, DOI 10.1093/treephys/25.1.17; Wang CT, 2008, SCI CHINA SER C, V51, P86, DOI 10.1007/s11427-008-0011-2; [王根绪 WANG Genxu], 2007, [冰川冻土, Journal of Glaciology and Geocryology], V29, P671; [王景升 WANG Jing-sheng], 2008, [资源科学, Resources Science], V30, P1852; Wang LA, 2010, SCI CHINA LIFE SCI, V53, P851, DOI 10.1007/s11427-010-4027-z; Warembourg FR, 2001, SOIL BIOL BIOCHEM, V33, P1291, DOI 10.1016/S0038-0717(01)00033-5; WOODWARD FI, 1987, VEGETATIO, V69, P189, DOI 10.1007/BF00038700; Wright I.J., 2003, S MATR STANDARDIZED; Wu JianShuang, 2012, Journal of Resources and Ecology, V3, P236; [鄢燕 YAN Yan], 2005, [生态学报, Acta Ecologica Sinica], V25, P2818; Yang YH, 2009, J ARID ENVIRON, V73, P91, DOI 10.1016/j.jaridenv.2008.09.027; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zhang BC, 2013, CLIMATIC CHANGE, V118, P197, DOI 10.1007/s10584-012-0622-2; Zhou X. M, 2001, CHINESE KOBRESIA MEA; Zhou XM, 2001, KOBRESIA MEADOW CHIN, P136	61	205	228	7	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81986	10.1371/journal.pone.0081986	http://dx.doi.org/10.1371/journal.pone.0081986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349170	Green Submitted, gold, Green Published			2022-12-27	WOS:000328731800031
J	Wu, JF; Bi, HS; Wang, SM; Hu, YY; Wu, H; Sun, W; Lu, TL; Wang, XR; Jonas, JB				Wu, Jian Feng; Bi, Hong Sheng; Wang, Shu Mei; Hu, Yuan Yuan; Wu, Hui; Sun, Wei; Lu, Tai Liang; Wang, Xing Rong; Jonas, Jost B.			Refractive Error, Visual Acuity and Causes of Vision Loss in Children in Shandong, China. The Shandong Children Eye Study	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; CHINESE CHILDREN; BEIJING EYE; PARENTAL MYOPIA; SOUTHERN CHINA; PREVALENCE; IMPAIRMENT; SCHOOLCHILDREN; POPULATION; PROGRESSION	Purpose: To examine the prevalence of refractive errors and prevalence and causes of vision loss among preschool and school children in East China. Methods: Using a random cluster sampling in a cross-sectional school-based study design, children with an age of 4-18 years were selected from kindergartens, primary schools, and junior and senior high schools in the rural Guanxian County and the city of Weihai. All children underwent a complete ocular examination including measurement of uncorrected (UCVA) and best corrected visual acuity (BCVA) and auto-refractometry under cycloplegia. Myopia was defined as refractive error of <=-0.5 diopters (D), high myopia as <=-6.0D, and amblyopia as BCVA <= 20/32 without any obvious reason for vision reduction and with strabismus or refractive errors as potential reasons. Results: Out of 6364 eligible children, 6026 (94.7%) children participated. Prevalence of myopia (overall: 36.9 +/- 0.6%; 95% confidence interval (CI): 36.0,38.0) increased (P<0.001) from 1.7 +/- 1.2% (95% CI: 0.0,4.0) in the 4-years olds to 84.6 +/- 3.2% (95% CI: 78.0,91.0) in 17-years olds. Myopia was associated with older age (OR: 1.56; 95% CI: 1.52,1.60; P<0.001), female gender (OR: 1.22; 95% CI: 1.08,1.39; P = 0.002) and urban region (OR: 2.88; 95% CI: 2.53,3.29; P<0.001). Prevalence of high myopia (2.0 +/- 0.2%) increased from 0.7 +/- 0.3% (95% CI: 0.1,1.3) in 10-years olds to 13.9 +/- 3.0 (95% CI: 7.8,19.9) in 17-years olds. It was associated with older age (OR: 1.50; 95% CI: 1.41,1.60; P<0.001) and urban region (OR: 3.11; 95% CI: 2.08,4.66); P<0.001). Astigmatism (>= 0.75D) (36.3 +/- 0.6%; 95% CI: 35.0,38.0) was associated with older age (P<0.001; OR: 1.06; 95% CI: 1.04,1.09), more myopic refractive error (P<0.001; OR: 0.94; 95% CI: 0.91,0.97) and urban region (P<0.001; OR: 1.47; 95% CI: 1.31,1.64). BCVA was <= 20/40 in the better eye in 19 (0.32%) children. UCVA <= 20/40 in at least one eye was found in 2046 (34.05%) children, with undercorrected refractive error as cause in 1975 (32.9%) children. Amblyopia (BCVA <= 20/32) was detected in 44 (0.7%) children (11 children with bilateral amblyopia). Conclusions: In coastal East China, about 14% of the 17-years olds were highly myopic, and 80% were myopic. Prevalence of myopia increased with older age, female gender and urban region. About 0.7% of pre-school children and school children were amblyopic.	[Wu, Jian Feng] Shandong Univ Tradit Chinese Med, Dept Ophthalmol, Jinan, Shandong, Peoples R China; [Bi, Hong Sheng; Wu, Hui; Wang, Xing Rong] Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China; [Wang, Shu Mei] Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Hu, Yuan Yuan; Sun, Wei; Lu, Tai Liang] Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Jinan, Shandong, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Shandong University; Shandong University of Traditional Chinese Medicine; Ruprecht Karls University Heidelberg	Bi, HS (corresponding author), Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China.	hongshengbi@126.com; jost.jonas@medma.ma.uni-heidelberg.de	Sun, Jian/I-9740-2016; Cai, Yanjiang/N-6694-2013; Cai, Yanjiang/AAD-1470-2020	Sun, Jian/0000-0001-8765-5015; Cai, Yanjiang/0000-0002-5376-7884; Lu, Xuyang/0000-0001-6653-6009	Shandong Science & Technology Department [2011GGB14097, 2011GGH21835, 2012YD18081]; Shandong Health Department [2011HD014]; Jinan Science & Technology Bureau [201102061]	Shandong Science & Technology Department; Shandong Health Department; Jinan Science & Technology Bureau	This study was supported by Shandong Science & Technology Department (2011GGB14097, 2011GGH21835, 2012YD18081), Shandong Health Department (2011HD014), Jinan Science & Technology Bureau (201102061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anera RG, 2009, CLIN EXP OPHTHALMOL, V37, P191, DOI 10.1111/j.1442-9071.2009.02001.x; Casson RJ, 2012, OPHTHALMOLOGY, V119, P2021, DOI 10.1016/j.ophtha.2012.03.049; Chia A, 2013, OPHTHAL EPIDEMIOL, V20, P138, DOI 10.3109/09286586.2013.767354; Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; Czepita D, 2007, OPHTHAL PHYSL OPT, V27, P60, DOI 10.1111/j.1475-1313.2006.00419.x; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; Fledelius HC, 2000, ACTA OPHTHALMOL SCAN, V78, P501, DOI 10.1034/j.1600-0420.2000.078005501.x; Fotouhi A, 2007, BRIT J OPHTHALMOL, V91, P287, DOI 10.1136/bjo.2006.099937; French AN, 2013, OPHTHALMOLOGY, V120, P1482, DOI 10.1016/j.ophtha.2012.12.018; Goh PP, 2005, OPHTHALMOLOGY, V112, P678, DOI 10.1016/j.ophtha.2004.10.048; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; He MG, 2009, INVEST OPHTH VIS SCI, V50, P5130, DOI 10.1167/iovs.09-3455; Ip JM, 2008, EYE, V22, P649, DOI 10.1038/sj.eye.6702701; Jamali P, 2009, OPTOMETRY VISION SCI, V86, P364, DOI 10.1097/OPX.0b013e3181993f42; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Lee Sang Joon, 2011, J Prev Med Public Health, V44, P56, DOI 10.3961/jpmph.2011.44.1.56; Li Z, 2013, CLIN EXPT OPHTHALMOL, DOI [10.1111/ceo.12198, DOI 10.1111/CE0.12198.[]; Liang YB, 2013, BRIT J OPHTHALMOL, V97, P765, DOI 10.1136/bjophthalmol-2012-302468; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; McKean-Cowdin R, 2013, OPHTHALMOLOGY, V120, P2117, DOI 10.1016/j.ophtha.2013.03.001; Midelfart A, 2002, ACTA OPHTHALMOL SCAN, V80, P501, DOI 10.1034/j.1600-0420.2002.800508.x; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Morgan IG, 2010, ACTA OPHTHALMOL, V88, P877, DOI 10.1111/j.1755-3768.2009.01800.x; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murthy GVS, 2002, INVEST OPHTH VIS SCI, V43, P623; Naidoo KS, 2003, INVEST OPHTH VIS SCI, V44, P3764, DOI 10.1167/iovs.03-0283; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; O'Donoghue L, 2013, INVEST OPHTH VIS SCI, V54, P602, DOI 10.1167/iovs.12-11066; Ostadimoghaddam H, 2011, CLIN EXP OPHTHALMOL, V39, P743, DOI 10.1111/j.1442-9071.2011.02584.x; Pi LH, 2012, J EPIDEMIOL, V22, P37, DOI 10.2188/jea.JE20110063; Salomao SR, 2008, INVEST OPHTH VIS SCI, V49, P4308, DOI 10.1167/iovs.08-2073; Saw SM, 2006, BRIT J OPHTHALMOL, V90, P1230, DOI 10.1136/bjo.2006.093450; Sun J, 2012, INVEST OPHTH VIS SCI, V53, P7504, DOI 10.1167/iovs.11-8343; Tarczy-Hornoch K, 2013, OPHTHALMOLOGY, V120, P1220, DOI 10.1016/j.ophtha.2012.12.029; Tong L, 2004, AM J OPHTHALMOL, V137, P474, DOI 10.1016/j.ajo.2003.10.028; Villarreal GM, 2003, OPTOMETRY VISION SCI, V80, P369, DOI 10.1097/00006324-200305000-00011; Villarreal MG, 2000, ACTA OPHTHALMOL SCAN, V78, P177, DOI 10.1034/j.1600-0420.2000.078002177.x; Xiang F, 2013, EYE LOND, DOI [10.1038/eye.2013.194, DOI 10.1038/EYE.2013.194.[]; Xiang F, 2012, OPTOMETRY VISION SCI, V89, P1487, DOI 10.1097/OPX.0b013e31826912e0; Xiang F, 2012, OPTOMETRY VISION SCI, V89, P884, DOI 10.1097/OPX.0b013e318255dc33; Xu L, 2005, OPHTHALMOLOGY, V112, P1676, DOI 10.1016/j.ophtha.2005.05.015; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Yekta A, 2010, CLIN EXP OPHTHALMOL, V38, P242, DOI 10.1111/j.1442-9071.2010.02247.x; You QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052668; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	47	205	228	7	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82763	10.1371/journal.pone.0082763	http://dx.doi.org/10.1371/journal.pone.0082763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24349170	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000028
